PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kitano, A; Yamauchi, H; Hosaka, T; Yagata, H; Hosokawa, K; Ohde, S; Nakamura, S; Takimoto, M; Tsunoda, H				Kitano, Atsuko; Yamauchi, Hideko; Hosaka, Takashi; Yagata, Hiroshi; Hosokawa, Keiko; Ohde, Sachiko; Nakamura, Seigo; Takimoto, Masafumi; Tsunoda, Hiroko			Psychological impact of breast cancer screening in Japan	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Psychological distress; Breast screening; Breast cancer; Psychological impact	SERVICES TASK-FORCE; ABNORMAL MAMMOGRAMS; FAMILY-HISTORY; WOMEN; DISTRESS; ANXIETY; CONSEQUENCES; DEPRESSION; BENEFITS; HEALTH	The purpose of this study was to evaluate the psychological impact of breast cancer screening by use of mammography and/or ultrasound, and to reveal factors related to psychological distress. Three hundred and twenty women were recalled to our hospital because of suspicious malignant findings from breast cancer screening between March and November 2012. They were asked to complete three questionnaires: the Hospital Anxiety and Depression Scale (HADS) for anxiety and depression, the Brief Coping Orientations to Problems Experienced scale (Brief COPE) for coping styles, and an original questionnaire for personal information. Complete data were available for 312 of 320 women (97.5 %). The median age was 45 years (range 23-73). The HADS revealed borderline or clinically significant anxiety for 70 % of the women. Family history of breast cancer, area of residence, number of times screened, number of recalls, and the period before the first visit were significantly related to psychological distress (p < 0.05). Brief COPE scores showed that self-blame, behavioral disengagement, self-distraction, use of emotional support, venting, denial, and less acceptance were related to increased anxiety. Seventy percent of women who were recalled after breast cancer screening experienced psychological distress. Thus, negative psychological impact should be regarded as an adverse effect of breast cancer screening.	[Kitano, Atsuko] St Lukes Int Hosp, Dept Med Oncol, Tokyo 1048560, Japan; [Yamauchi, Hideko; Yagata, Hiroshi] St Lukes Int Hosp, Dept Breast Surg Oncol, Tokyo 1048560, Japan; [Hosaka, Takashi] St Lukes Int Hosp, Dept Psychooncol, Tokyo 1048560, Japan; [Hosokawa, Keiko] St Lukes Int Hosp, Dept Nursing, Tokyo 1048560, Japan; [Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Kitano, Atsuko; Nakamura, Seigo] Showa Univ, Sch Med, Dept Breast Surg Oncol, Tokyo 142, Japan; [Kitano, Atsuko; Takimoto, Masafumi] Showa Univ, Sch Med, Dept Pathol & Lab Med, Tokyo 142, Japan; [Tsunoda, Hiroko] St Lukes Int Hosp, Dept Radiol, Chuo Ku, Tokyo 1048560, Japan	Tsunoda, H (reprint author), St Lukes Int Hosp, Dept Radiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	atkitano@ncc.go.jp; hirokots@luke.ac.jp					Brett J, 1998, J PUBLIC HEALTH MED, V20, P396; Woolf SH, 2010, JAMA-J AM MED ASSOC, V303, P162, DOI 10.1001/jama.2009.1989; Barton MB, 2004, J NATL CANCER I, V96, P529, DOI 10.1093/jnci/djh083; Lowe JB, 1999, CANCER, V85, P1114, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1114::AID-CNCR15>3.0.CO;2-Y; Gilbert FJ, 1998, EUR J CANCER, V34, P2010, DOI 10.1016/S0959-8049(98)00294-9; Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Montgomery M, 2010, J ADV NURS, V66, P2372, DOI 10.1111/j.1365-2648.2010.05439.x; Otsuka Y, 2009, IND HEALTH, V47, P22; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635; Watson EK, 2005, PSYCHO-ONCOL, V14, P939, DOI 10.1002/pon.903; Brett J, 2005, PSYCHO-ONCOL, V14, P917, DOI 10.1002/pon.904; GRAM IT, 1992, AM J PUBLIC HEALTH, V82, P249, DOI 10.2105/AJPH.82.2.249; Otsuka Y, 2008, PSYCHOL REP, V103, P395, DOI 10.2466/PR0.103.2.395-405; Kasahara Y, 2013, BREAST CANCER-TOKYO, V20, P310, DOI 10.1007/s12282-012-0333-6; LERMAN C, 1991, ANN INTERN MED, V114, P657; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Brett J, 2001, J PUBLIC HEALTH MED, V23, P292, DOI 10.1093/pubmed/23.4.292; Ong G, 1997, J PUBLIC HEALTH MED, V19, P29; Pieterse K, 2007, PSYCHO-ONCOL, V16, P851, DOI 10.1002/pon.1135; Williams-Piehota P, 2005, HEALTH PSYCHOL, V24, P58, DOI 10.1037/0278-6133.24.1.58; Lindfors KK, 2001, RADIOLOGY, V218, P247; Lampic C, 2001, EUR J CANCER, V37, P463, DOI 10.1016/S0959-8049(00)00426-3; Austoker J, 1994, J Med Screen, V1, P238; Barron Cecilia R, 2005, Health Care Women Int, V26, P247, DOI 10.1080/07399330590917807; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Elmore Joann G., 1998, New England Journal of Medicine, V338, P1089, DOI 10.1056/NEJM199804163381601; Gotzsche PC, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD001877.PUB5; Independent UK, 2012, LANCET, V380, P1778, DOI DOI 10.1016/S0140-6736(12)61611-0; Ohnuki Koji, 2005, Breast Cancer, V12, P258, DOI 10.2325/jbcs.12.258; Calonge N, 2009, ANN INTERN MED, V151, P716; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1110	1116		10.1007/s10147-015-0845-0		7	Oncology	Oncology	CX5FS	WOS:000365728100009		
J	Asai, K; Nakamura, K; Shioyama, Y; Sasaki, T; Matsuo, Y; Ohga, S; Yoshitake, T; Terashima, K; Shinoto, M; Matsumoto, K; Hirata, H; Honda, H				Asai, Kaori; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Sasaki, Tomonari; Matsuo, Yoshio; Ohga, Saiji; Yoshitake, Tadamasa; Terashima, Kotaro; Shinoto, Makoto; Matsumoto, Keiji; Hirata, Hidenari; Honda, Hiroshi			Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Pneumothorax; Stereotactic body radiotherapy; Lung cancer	RADIATION-THERAPY; CANCER; RISK	We retrospectively investigated the clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy (SBRT) for lung tumors. Between April 2003 and July 2012, 473 patients with lung tumors were treated with SBRT. We identified 12 patients (2.5 %) with pneumothorax caused by SBRT, and evaluated the clinical features of pneumothorax. All of the tumors were primary lung cancers. The severity of radiation pneumonitis was grade 1 in 10 patients and grade 2 in two patients. Nine patients had emphysema. The planning target volume and pleura overlapped in 11 patients, and the tumors were attached to the pleura in 7 patients. Rib fractures were observed in three patients before or at the same time as the diagnosis of pneumothorax. The median time to onset of pneumothorax after SBRT was 18.5 months (4-84 months). The severity of pneumothorax was grade 1 in 11 patients and grade 3 in one patient. Although pneumothorax was a relatively rare late adverse effect after SBRT, some patients demonstrated pneumothorax after SBRT for peripheral lung tumors. Although most pneumothorax was generally tolerable and self-limiting, careful follow-up is needed.	[Asai, Kaori; Nakamura, Katsumasa; Sasaki, Tomonari; Matsuo, Yoshio; Ohga, Saiji; Terashima, Kotaro; Matsumoto, Keiji; Hirata, Hidenari; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan; [Shioyama, Yoshiyuki; Shinoto, Makoto] SAGA HIMAT Fdn, Ion Beam Therapy Ctr, Saga, Japan; [Yoshitake, Tadamasa] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan	Nakamura, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Japan.	nakam@radiol.med.kyushu-u.ac.jp			 [26670563];  [25461917];  [26461894];  [24591842]	This work is supported in part by Grant-in-Aid for Scientific Research, Japan (no. 26670563, 25461917, 26461894, and 24591842).	ROWINSKY EK, 1985, CHEST, V88, P703, DOI 10.1378/chest.88.5.703; Siva S, 2010, J THORAC ONCOL, V5, P1091, DOI 10.1097/JTO.0b013e3181de7143; BAYDUR A, 1976, WESTERN J MED, V124, P144; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Asai K, 2012, INT J RADIAT ONCOL, V84, P768, DOI 10.1016/j.ijrobp.2012.01.027; Yoshitake T, 2009, PHYS MED BIOL, V54, P7171, DOI 10.1088/0031-9155/54/23/009; LIBSHITZ HI, 1974, RADIOLOGY, V112, P199; PEZNER RD, 1990, INT J RADIAT ONCOL, V18, P193; Ohnishi K, 2009, JPN J RADIOL, V27, P269, DOI 10.1007/s11604-009-0333-4; Maniwa T, 2011, INTERACT CARDIOV TH, V13, P257, DOI 10.1510/icvts.2011.273201; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; LAI RS, 1992, JPN J CLIN ONCOL, V22, P194; Fiorelli Alfonso, 2011, J Thorac Dis, V3, P138, DOI 10.3978/j.issn.2072-1439.2010.12.01; MELTON LJ, 1979, AM REV RESPIR DIS, V120, P1379; Shioyama Yoshiyuki, 2005, Radiat Med, V23, P407; Yoshitake T, 2014, INT J CLIN IN PRESS	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1117	1121		10.1007/s10147-015-0833-4		5	Oncology	Oncology	CX5FS	WOS:000365728100010		
J	Yokoyama, Y; Sonobe, M; Yamada, T; Sato, M; Menju, T; Aoyama, A; Sato, T; Chen, FS; Omasa, M; Date, H				Yokoyama, Yuhei; Sonobe, Makoto; Yamada, Tetsu; Sato, Masaaki; Menju, Toshi; Aoyama, Akihiro; Sato, Toshihiko; Chen, Fengshi; Omasa, Mitsugu; Date, Hiroshi			Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Lung cancer; Epidermal growth factor receptor; Postoperative recurrence; Gefitinib	EGFR MUTATIONS; OPEN-LABEL; PHASE-III; CARBOPLATIN-PACLITAXEL; 1ST-LINE TREATMENT; JAPANESE PATIENTS; SURVIVAL; ADENOCARCINOMA; CHEMOTHERAPY; ERLOTINIB	The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib is an effective treatment for recurrent or advanced lung cancer harboring EGFR gene mutations, and has improved progression-free survival in several clinical trials. However, the effect of gefitinib treatment for recurrent lung cancers with EGFR gene mutations after complete resection and the influence of the timing of such treatment have not been fully elucidated in a practical setting. We investigated 64 patients (median age: 68 years; men: 22; women: 42; adenocarcinoma: 61; adenosquamous cell carcinoma: 2; combined large cell neuroendocrine carcinoma: 1) with recurrent lung cancer after complete resection who received gefitinib for the recurrent lesions and in whom the tumors had EGFR gene mutations. Progression-free survival, response rate, and safety were analyzed. Complete response and partial response were achieved in 2 patients and in 42 patients, respectively (objective response rate: 69 %). Stable disease was obtained in 16 patients, the disease control rate was 94 %, and median progression-free survival was 16 months. The timing of gefitinib treatment (first line, second line, or later) and the type of EGFR gene mutation present did not influence progression-free survival. However, a smaller number of recurrent sites at the start of gefitinib treatment was linked to better progression-free survival. Hematologic and nonhematologic toxicities were generally mild, but 1 patient experienced interstitial lung disease. Our results suggest that gefitinib treatment for recurrent lung cancer with gene EGFR mutations is a useful option in a practical setting, irrespective of the timing of such treatment and the type of EGFR gene mutation present.	[Yokoyama, Yuhei; Sonobe, Makoto; Yamada, Tetsu; Sato, Masaaki; Menju, Toshi; Aoyama, Akihiro; Sato, Toshihiko; Chen, Fengshi; Omasa, Mitsugu; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan	Sonobe, M (reprint author), Kyoto Univ Hosp, Dept Thorac Surg, Sakyo Ku, Shogoin Kawahara Cho 54, Kyoto 6068507, Japan.	mysonobe@kuhp.kyoto-u.ac.jp					Niibe Y, 2010, JPN J CLIN ONCOL, V40, P107, DOI 10.1093/jjco/hyp167; Furukawa K, 2012, EXP THER MED, V3, P53, DOI 10.3892/etm.2011.360; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Sonobe M, 2005, BRIT J CANCER, V93, P355, DOI 10.1038/sj.bjc.6602707; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Satoh H, 2011, J THORAC ONCOL, V6, P1413, DOI 10.1097/JTO.0b013e31821d43a8; Okami J, 2007, ONCOLOGY-BASEL, V72, P234, DOI 10.1159/000112947; Katayama T, 2010, SURG ONCOL, V19, pE144, DOI 10.1016/j.suronc.2010.07.002; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; HELLMAN S, 1995, J CLIN ONCOL, V13, P8; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Yamada K, 2013, JPN J CLIN ONCOL, V43, P629, DOI 10.1093/jjco/hyt056; Sonobe M, 2014, ANN SURG ONCOL, V21, P2546, DOI 10.1245/s10434-014-3630-9; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Sonobe M, 2012, ANN SURG ONCOL, V19, pS347, DOI 10.1245/s10434-011-1799-8; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Locatelli-Sanchez M, 2013, LUNG, V191, P491, DOI 10.1007/s00408-013-9482-4; Masuda M., 2012, GEN THORAC CARDIOVAS, V62, P734; Nakagawa Masatsugu, 2009, BMC Res Notes, V2, P157, DOI 10.1186/1756-0500-2-157; Non-Small Cell Lung Cancer Collaborative Group, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007309.pub2, DOI 10.1002/14651858.CD007309.PUB2, DOI 10.1002/14651858]; Travis WD, 2004, WHO CLASSIFICATION T	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1122	1129		10.1007/s10147-015-0838-z		8	Oncology	Oncology	CX5FS	WOS:000365728100011		
J	Suzuki, T; Sadahiro, S; Tanaka, A; Okada, K; Saito, G; Kamijo, A; Akiba, T; Kawada, S				Suzuki, Toshiyuki; Sadahiro, Sotaro; Tanaka, Akira; Okada, Kazutake; Saito, Gota; Kamijo, Akemi; Akiba, Takeshi; Kawada, Shuichi			Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Rectal cancer; Chemoradiotherapy; Prognostic factor	MEDIAN FOLLOW-UP; PREOPERATIVE RADIOTHERAPY; THYMIDYLATE SYNTHASE; NEOADJUVANT THERAPY; RADIATION-THERAPY; TUMOR-REGRESSION; G(1) ARREST; EXPRESSION; P53; RADIOCHEMOTHERAPY	Preoperative chemoradiotherapy (CRT) significantly decreases local recurrence in patients with rectal cancer. Although various biomarkers in biopsy specimens obtained before starting CRT have been examined, reliable prognostic factors have yet to be established. We tested the hypothesis that biopsy specimens obtained soon after the start of CRT can be used as prognostic factors. Preoperative CRT was given to 70 consecutive patients with rectal cancer. Biopsies were taken before and about 7 days after starting CRT. The specimens were stained with hematoxylin and eosin (HE), and the expressions of Ki67, p53, and p21 and apoptosis were evaluated immunohistochemically. The expressions of Ki67, p53, and p21 and apoptosis before treatment were not significantly related to histologic response or tumor shrinkage. In specimens obtained about 7 days after CRT began, marked histologic regression was significantly higher in p21-positive, apoptosis-positive cases, and in cases with moderate changes on HE specimens (p = 0.017, p = 0.010, and p = 0.004, respectively). The tumor shrinkage was significantly higher in apoptosis-positive cases and cases with moderate changes on HE specimens (p = 0.002 and p < 0.001, respectively). Disease-free survival (DFS) was significantly higher in patients who had marked regression than in those who did not (p = 0.019). DFS was also significantly higher in patients with moderate changes on HE specimens than in those with mild changes (p = 0.016). Changes on HE-stained biopsy specimens obtained about 1 week after starting CRT are a reliable prognostic factor, similar to histologic marked regression in resected specimens; a major advantage is that the former results are available at an early phase.	[Suzuki, Toshiyuki; Sadahiro, Sotaro; Tanaka, Akira; Okada, Kazutake; Saito, Gota; Kamijo, Akemi] Tokai Univ, Dept Surg, Isehara, Kanagawa 2591193, Japan; [Akiba, Takeshi; Kawada, Shuichi] Tokai Univ, Dept Radiol, Isehara, Kanagawa 2591193, Japan	Suzuki, T (reprint author), Tokai Univ, Dept Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tsuzuki@is.icc.u-tokai.ac.jp					MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Sadahiro S, 2001, DIS COLON RECTUM, V44, P1689, DOI 10.1007/BF02234391; Chang HJ, 2005, HUM PATHOL, V36, P364, DOI 10.1016/j.humpath.2005.01.018; Rau B, 2003, J CLIN ONCOL, V21, P3391, DOI 10.1200/JCO.2003.07.077; Garrity MM, 2004, J CLIN ONCOL, V22, P1572, DOI 10.1200/JCO.2004.10.042; Negri FV, 2008, BRIT J CANCER, V98, P143, DOI 10.1038/sj.bjc.6604131; Charara M, 2004, ANTICANCER RES, V24, P3161; Kikuchi M, 2009, BRIT J CANCER, V101, P116, DOI 10.1038/sj.bjc.6605105; Reerink O, 2004, ANTICANCER RES, V24, P1217; Lin LC, 2006, SURG ONCOL, V15, P211, DOI 10.1016/j.suronc.2007.01.001; WILLETT CG, 1995, J CLIN ONCOL, V13, P1417; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; FAN SJ, 1994, CANCER RES, V54, P5824; Jakob C, 2008, WORLD J GASTROENTERO, V14, P1060, DOI 10.3748/wjg.14.1060; Bertolini F, 2007, INT J RADIAT ONCOL, V68, P1455, DOI 10.1016/j.ijrobp.2007.02.018; Kim NK, 2001, ANN SURG ONCOL, V8, P418, DOI 10.1245/aso.2001.8.5.418; Sogawa N, 2002, INT J ONCOL, V21, P787; Cascinu S, 2002, BRIT J CANCER, V86, P744, DOI 10.1038/sj/bjc/6600155; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; NAMBA H, 1995, CANCER RES, V55, P2075; Rodel C, 2002, INT J RADIAT ONCOL, V52, P294, DOI 10.1016/S0360-3016(01)02643-8; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Berger C, 1997, INT J RADIAT ONCOL, V37, P619, DOI 10.1016/S0360-3016(96)00577-9; Suzuki T, 2004, JPN J CLIN ONCOL, V34, P740, DOI 10.1093/jjco/hyh140; Kuremsky JG, 2009, INT J RADIAT ONCOL, V74, P673, DOI 10.1016/j.ijrobp.2009.03.003; de Campos-Lobato LF, 2010, ANN SURG ONCOL, V17, P1758, DOI 10.1245/s10434-010-0924-4; Edden Y, 2012, COLORECTAL DIS, V14, P555, DOI 10.1111/j.1463-1318.2011.02697.x; NAKANO T, 1991, CANCER, V68, P517, DOI 10.1002/1097-0142(19910801)68:3<517::AID-CNCR2820680312>3.0.CO;2-9; Park IJ, 2012, J CLIN ONCOL, V30, P1770, DOI 10.1200/JCO.2011.39.7901; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; ELDEIRY WS, 1994, CANCER RES, V54, P1169; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Huerta S, 2010, DIGEST LIVER DIS, V42, P679, DOI 10.1016/j.dld.2010.02.003; JSCCR, 1997, JAP CLASS COL CARC; Sadahiro S, 2004, EJSO, V30, P750, DOI 10.1016/j.ejso.2004.04.012; Sadahiro Sotaro, 1999, International Journal of Clinical Oncology, V4, P210, DOI 10.1007/s101470050055; Spolverato Gaya, 2011, Cancers (Basel), V3, P2176, DOI 10.3390/cancers3022176	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1130	1139		10.1007/s10147-015-0822-7		10	Oncology	Oncology	CX5FS	WOS:000365728100012		
J	Miyamoto, Y; Hayashi, N; Sakamoto, Y; Ohuchi, M; Tokunagam, R; Kurashige, J; Hiyoshi, Y; Baba, Y; Iwagami, S; Yoshida, N; Yoshida, M; Baba, H				Miyamoto, Yuji; Hayashi, Naoko; Sakamoto, Yasuo; Ohuchi, Mayuko; Tokunagam, Ryuma; Kurashige, Junji; Hiyoshi, Yukiharu; Baba, Yoshifumi; Iwagami, Shiro; Yoshida, Naoya; Yoshida, Megumi; Baba, Hideo			Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Colorectal cancer; Stage IV; Multi-organ metastasis; Prognostic factor	LIVER METASTASES; COLON-CANCER; PULMONARY METASTASES; TUMOR LOCATION; RESECTION; IMPACT; CARCINOMA; SURGERY; DISEASE; SCORE	The prognosis for most patients with stage IV colorectal cancer (CRC) and multi-organ metastases is poor. However, little information is currently available on prognostic factors in these patients. The aim of this study was to identify predictors of a good prognosis in this patient group. This was a single-center retrospective study in which we examined the relationship between patient characteristics and prognosis in 161 stage IV CRC patients with indications for first-line systemic chemotherapy. Cox proportional-hazards models were used to compute hazard ratios (HR) for death, adjusted for clinical and pathological characteristics. Of the 161 patients recruited to the study, 83 had single-organ and 78 had multi-organ metastases. Median survival time was significantly shorter in patients with multi-organ metastases than in those with single-organ metastases (19.2 vs. 42.0 months, respectively; log-rank, P < 0.001). There was no significant difference in survival between patients with metastases in two versus three or more organs (log-rank; P = 0.368). According to univariate analysis, primary tumor sites in the left side of the colon and in the rectum, a pretreatment carcinoembryonic antigen concentration of > 50 ng/mL, a well-/moderately differentiated tumor, and R0 resection of metastatic lesions were associated with better overall survival. According to multivariate analysis, left-sided location of the primary tumor [HR 0.414, 95 % confidence interval (CI) 0.216-0.815; P = 0.011] and R0 resection of metastatic lesions (HR 0.247, 95 % CI 0.04 0-0.834; P = 0.021) were independently associated with good prognosis. Our results indicate that the site of the primary tumor in the left side of the colon and in the rectum and R0 resection of metastatic lesions are predictors of a good prognosis in patients with stage IV CRC and multi-organ metastases.	[Miyamoto, Yuji; Sakamoto, Yasuo; Ohuchi, Mayuko; Tokunagam, Ryuma; Kurashige, Junji; Hiyoshi, Yukiharu; Baba, Yoshifumi; Iwagami, Shiro; Yoshida, Naoya; Yoshida, Megumi; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Hayashi, Naoko] Kumamoto Hosp, Natl Hosp Org, Dept Surg, Uki 8690593, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, I-1-1 Honjo, Kumamoto 8608556, Japan.	miyamotoyuji@gmail.com; hdobaba@kumamoto-u.ac.jp					Yun HR, 2007, INT J COLORECTAL DIS, V22, P1301, DOI 10.1007/s00384-007-0315-x; Ng K, 2011, J CLIN ONCOL, V29, P1599, DOI 10.1200/JCO.2010.31.7255; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Murata S, 1998, CANCER-AM CANCER SOC, V83, P1086, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1086::AID-CNCR6>3.0.CO;2-6; Bae JM, 2013, BRIT J CANCER, V109, P1004, DOI 10.1038/bjc.2013.430; Kishiki T, 2013, AM J SURG, V206, P234, DOI 10.1016/j.amjsurg.2012.07.051; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Lee WS, 2013, ANN SURG ONCOL, V20, P697, DOI 10.1245/s10434-012-2752-1; Brown RE, 2010, SURG CLIN N AM, V90, P839, DOI 10.1016/j.suc.2010.04.012; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Ruo L, 2003, J AM COLL SURGEONS, V196, P722, DOI 10.1016/S1072-7515(03)00136-4; Ishizuka M, 2013, AM J SURG, V205, P22, DOI 10.1016/j.amjsurg.2012.04.012; de Cuba EMV, 2013, CANCER TREAT REV, V39, P321, DOI 10.1016/j.ctrv.2012.11.003; Kuo LJ, 2003, DIS COLON RECTUM, V46, P1646, DOI 10.1097/01.DCR.0000093624.29029.3A; Chua TC, 2012, EUR J CANCER, V48, P1757, DOI 10.1016/j.ejca.2011.10.034; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Shah SA, 2006, J AM COLL SURGEONS, V202, P468, DOI 10.1016/j.jamcollsurg.2005.11.008; Ishihara S, 2014, INT J SURG, V12, P925, DOI 10.1016/j.ijsu.2014.07.270; Price TJ, 2015, CANCER-AM CANCER SOC, V121, P830, DOI 10.1002/cncr.29129; Watanabe T, 2010, INT J CLIN ONCOL, V17, P1, DOI DOI 10.1007/S10147-011-0315-2	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1140	1146		10.1007/s10147-015-0835-2		7	Oncology	Oncology	CX5FS	WOS:000365728100013		
J	Inoue, M; Takahashi, S; Soeda, H; Shimodaira, H; Watanabe, M; Miura, K; Sasaki, I; Kato, S; Ishioka, C				Inoue, Masahiro; Takahashi, Shin; Soeda, Hiroshi; Shimodaira, Hideki; Watanabe, Mika; Miura, Koh; Sasaki, Iwao; Kato, Shunsuke; Ishioka, Chikashi			Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Colorectal cancer; Comprehensive gene-expression analysis; Subtype classification; Anti-EGFR therapy	GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-III; K-RAS; CETUXIMAB EFFICACY; 1ST-LINE TREATMENT; CONTROLLED-TRIAL; COLON-CANCER; OXALIPLATIN; IRINOTECAN; KRAS	Comprehensive gene-expression analysis is very useful for classifying specific cancers into subgroups on the basis of their biological characteristics; it is used both prognostically and predictively. The purpose of this study was to classify unresectable advanced or recurrent colorectal cancer (CRC) by gene-expression profiling of formalin-fixed paraffin-embedded tissues and to correlate CRC subgroups with clinicopathological and molecular features and clinical outcomes. One hundred patients with advanced or recurrent CRC were enrolled. RNA extracted from FFPE tissues was subjected to gene-expression microarray analysis. The patients were stratified into four subgroups (subtypes A1, A2, B1, and B2) by unsupervised hierarchical clustering. By use of principle-components analysis (PCA), the patients were divided into subtypes A and B on the basis of component 1 and into subtypes 1 and 2 on the basis of component 2. Subtype A was significantly enriched among patients without the KRAS mutation and with an earlier clinical stage at diagnosis. With regard to anti-EGFR therapy, progression-free survival (PFS) was better for patients in subtype A without the KRAS mutation than for those with the KRAS mutation (P = 0.047). PFS for patients without the KRAS mutation in subtype B was comparable with that for patients with the KRAS mutation (P = 0.55). Similar results were observed in a validation set. We found that gene-expression profiles enabled stratification of CRC patients into four subgroups. The efficacy of anti-EGFR therapy was correlated with component 1 from PCA. This comprehensive study may explain the heterogeneity of unresectable advanced or recurrent CRC and could be useful for identifying novel biomarkers for CRC treatment.	[Inoue, Masahiro; Takahashi, Shin; Soeda, Hiroshi; Shimodaira, Hideki; Kato, Shunsuke; Ishioka, Chikashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Inoue, Masahiro; Takahashi, Shin; Soeda, Hiroshi; Shimodaira, Hideki; Kato, Shunsuke; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Watanabe, Mika] Tohoku Univ Hosp, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Miura, Koh; Sasaki, Iwao] Tohoku Univ Hosp, Dept Surg Gastroenterol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Ishioka, C (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	chikashi@idac.tohoku.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)	We thank Satoko Aoki for her technical assistance. This work was partially supported by a grant from Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT).	Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Calistri D, 2005, J CELL PHYSIOL, V204, P484, DOI 10.1002/jcp.20310; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Yoshioka T, 2009, BRIT J CANCER, V101, P1972, DOI 10.1038/sj.bjc.6605432; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-06-1554; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Takahashi S, 2008, CANCER SCI, V99, P324, DOI 10.1111/j.1349-7006.2007.00691.x; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Soeda H, 2013, INT J CLIN ONCOL, V18, P670, DOI 10.1007/s10147-012-0422-8; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Dienstmann R, 2014, ASCO M, V32, P3511; International Agency for Research on Cancer (IARC), IARC TP53 MUT DAT DA; Zerbini G, 2008, NEW ENGL J MED, V358, P2039	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1147	1155		10.1007/s10147-015-0841-4		9	Oncology	Oncology	CX5FS	WOS:000365728100014		
J	Tanaka, Y; Ueda, Y; Kishida, H; Hosogai, N; Morimoto, A; Egawa-Takata, T; Matsuzaki, S; Kobayashi, E; Yoshino, K; Kimura, T				Tanaka, Yusuke; Ueda, Yutaka; Kishida, Hisayo; Hosogai, Noriko; Morimoto, Akiko; Egawa-Takata, Tomomi; Matsuzaki, Shinya; Kobayashi, Eiji; Yoshino, Kiyoshi; Kimura, Tadashi			Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Cervical cancer screening; Free coupon; Participation rates; Registry data; Young females	MORTALITY; YOUNG	The objective of our study was to evaluate trends in the cervical cancer screening rate in a city in Japan between the years of 2004 and 2013. The cervical cancer screening rates for all female residents 20-49 years of age living in Toyonaka City for each year between 2004 and 2013 were analyzed and the effects of reminder letters and a free coupon program for cervical cancer screening on the subjects' behavior were evaluated. The screening rate increased on a single-year basis from 8.9 % (2004) to 12.7 % (2009) as a result of the free coupon program. From 2009 onward, the screening rate on a single-year basis remained stable. Although the free coupon program increased the rate of screening participation, it did not achieve a continuous increase in the number of subjects undergoing screening. Furthermore, despite recommendations for biennial screening, some subjects participated in consecutive screening within the last 2 years after receiving visits for a regularly scheduled residential screening program 1 year before/after the current screening program with a free coupon. There was a peak in the rate of screening participation at the end of the fiscal year among females eligible for the free coupon program. Excessive cervical cancer screening performed unnecessarily in the young is an unexpected limitation of free coupon programs. Further efforts to improve the screening rates are required, and the various factors leading young Japanese females to have a negative attitude toward cervical cancer screening should be identified.	[Tanaka, Yusuke; Ueda, Yutaka; Morimoto, Akiko; Egawa-Takata, Tomomi; Matsuzaki, Shinya; Kobayashi, Eiji; Yoshino, Kiyoshi; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Kishida, Hisayo; Hosogai, Noriko] Toyonaka City Publ Hlth Ctr, Community Hlth Div, Toyonaka, Osaka, Japan	Ueda, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	zvf03563@nifty.ne.jp					Mosavel M, 2007, J HEALTH COMMUN, V12, P707, DOI 10.1080/10810730701671985; Franceschi S, 2009, INT J CANCER, V125, P2246, DOI 10.1002/ijc.24634; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Waller J, 2012, BJOG-INT J OBSTET GY, V119, P26, DOI 10.1111/j.1471-0528.2011.03030.x; Henderson JT, 2014, PREV MED, V62, P49, DOI 10.1016/j.ypmed.2014.02.004; Lee JY, 2014, J GYNECOL ONCOL, V25, P174, DOI 10.3802/jgo.2014.25.3.174; Black Agnes T, 2011, Can J Nurs Res, V43, P8; Center for Cancer Control and Information Services National Cancer Center, 2015, CANC SCREEN RAT; Committee on Practice Bulletins-Gynecology, 2012, OBSTET GYNECOL, V120, P1222; Lu MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-413; Morimoto A, 2014, INT J CLIN ONCOL; Ueda Y, 2015, J EPIDEMIOL, V25, P50, DOI 10.2188/jea.JE20140080; Virtanen A, 2015, INT J CANCER, V136, pE677, DOI 10.1002/ijc.29176	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1156	1160		10.1007/s10147-015-0842-3		5	Oncology	Oncology	CX5FS	WOS:000365728100015		
J	Ito, N; Kojima, S; Teramukai, S; Mikami, Y; Ogawa, O; Kamba, T				Ito, Noriyuki; Kojima, Shinsuke; Teramukai, Satoshi; Mikami, Yoshiki; Ogawa, Osamu; Kamba, Tomomi			Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Central pathology; Cytokine; Histological subtypes; Prognostic factors; Renal cell carcinoma	HISTOLOGIC SUBTYPES; MULTICENTER EXPERIENCE; RADICAL NEPHRECTOMY; SURVIVAL; IMPACT; CLASSIFICATION; FEATURES; CANCER; GENDER	The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathological review based on the current World Health Organization classification and the staging system of the American Joint Committee on Cancer/Union for International Cancer Control. We collected glass slides and clinical data sets for 914 cases of RCC treated with curative nephrectomy from 1995 to 2000. Overall (OS), cancer-specific (CSS), and relapse-free (RFS) survival were compared for HS and nuclear grades determined by a central pathology review board comprising 5 board-certified pathologists, pathological staging, and a variety of clinical factors. The 5 and 7-year CSS in this study were 96 and 93 %, respectively, values superior to those reported in Western countries. Concordance between the original and reviewed HS and nuclear grades were 90.9 and 21.1 %, respectively. HS correlated with OS (P = 0.043) but was not an independent prognostic factor in the multivariate analysis (P = 0.820). Tumor size, Fuhrman grade, and infiltration type were common independent prognostic factors for OS, CSS, and RFS. This study revealed RCC outcomes in the era of cytokine treatment for metastasis. Central pathological review is an essential component of a multicenter study with long-term follow-up. Tumor size, Fuhrman grade, and infiltration type had much greater effects than HS on survival after curative nephrectomy.	[Ito, Noriyuki] Nishi Kobe Med Ctr, Dept Urol, Kobe, Hyogo 6512273, Japan; [Kojima, Shinsuke] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Grad Sch Med Sci, Kyoto, Japan; [Mikami, Yoshiki] Kumamoto Univ Hosp, Dept Diagnost Pathol, Kumamoto, Japan; [Ogawa, Osamu; Kamba, Tomomi] Kyoto Univ, Dept Urol, Grad Sch Med, Kyoto, Japan	Ito, N (reprint author), Nishi Kobe Med Ctr, Dept Urol, Kobe, Hyogo 6512273, Japan.	nito@kuhp.kyoto-u.ac.jp			Kyoto University; Pfizer, Inc.	We thank Drs F. Kono, Y. Kotani, T Manabe, and Y. Nagashima for participation in the central pathology review and Dr M. Fukushima for study design. We also thank Drs T. Hayashi, Y. Nishio, K. Nishimura, Y. Taki, M. Nonomura, T. Hashimura, T. Matsuda, K. Ogura, H. Kanamaru, Y. Kakehi, A. Terai, M. Kawakita, M. Nishimura, H. Okuno, S. Fukuzawa, K. Okumura, Y. Shichiri, T. Ueda, H. Onishi, and H. Kinoshita for data collection. Support for this study was provided by Kyoto University, and partial support was provided by Pfizer, Inc. as Investigator-Initiated Research.	Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Russo P, 2008, CANCER, V113, P84, DOI 10.1002/cncr.23520; Amin MB, 2002, AM J SURG PATHOL, V26, P281, DOI 10.1097/00000478-200203000-00001; Hemal AK, 2007, WORLD J UROL, V25, P619, DOI 10.1007/s00345-007-0210-7; Fujii Y, 2008, J UROLOGY, V180, P1290, DOI 10.1016/j.juro.2008.06.014; Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q; Jeon SH, 2011, BJU INT, V107, P817, DOI 10.1111/j.1464-410X.2010.09688.x; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Skolarikos A, 2007, EUR UROL, V51, P1490, DOI 10.1016/j.eururo.2006.12.031; Ficarra V, 2006, EUR UROL, V50, P786, DOI 10.1016/j.eururo.2006.04.009; Keegan KA, 2012, J UROLOGY, V188, P391, DOI 10.1016/j.juro.2012.04.006; Delahunt B, 2007, AM J SURG PATHOL, V31, P957, DOI 10.1097/01.pas.0000249446.28713.53; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Lam JS, 2007, EUR UROL, V52, P155, DOI 10.1016/j.eururo.2007.01.106; Crispen PL, 2010, UROLOGY, V76, P580, DOI 10.1016/j.urology.2009.12.037; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Marumo K, 2007, INT J UROL, V14, P479, DOI 10.1111/j.1442-2042.2007.01739.x; Cindolo L, 2005, CANCER, V104, P1362, DOI 10.1002/cncr.21331; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Crepel M, 2009, UROLOGY, V74, P842, DOI 10.1016/j.urology.2009.02.013; Capitanio U, 2008, BJU INT, V103, P1496; Eble JN, 2004, PATHOLOGY GENETICS T; Lee S, 2012, BJU INT, V110, pE28, DOI 10.1111/j.1464-410X.2011.10667.x; Sobin LH, 2010, TNM CLASSIFICATION M; The Japanese Urological Association. The Japanese Society of Pathology Japan Radiological Society, 2011, GEN RUL CLIN PATH ST	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1161	1170		10.1007/s10147-015-0840-5		10	Oncology	Oncology	CX5FS	WOS:000365728100016		
J	Urakami, S; Yuasa, T; Yamamoto, S; Sakura, M; Tanaka, H; Hayashi, T; Uehara, S; Inoue, Y; Fujii, Y; Masuda, H; Fukui, I; Yonese, J				Urakami, Shinji; Yuasa, Takeshi; Yamamoto, Shinya; Sakura, Mizuaki; Tanaka, Hajime; Hayashi, Tatsuro; Uehara, Sho; Inoue, Yasushi; Fujii, Yasuhisa; Masuda, Hitoshi; Fukui, Iwao; Yonese, Junji			Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Consolidative surgery; Induction chemotherapy; Lymph node metastasis; Multimodality treatment; Urothelial carcinoma	TRANSITIONAL-CELL CARCINOMA; POSITIVE BLADDER-CANCER; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; RADICAL CYSTECTOMY; CISPLATIN CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; DOXORUBICIN; METHOTREXATE; VINBLASTINE	To determine the indications for post-chemotherapy consolidative surgery in patients with clinical lymph node (LN) metastatic (cN+) urothelial carcinoma (UC). Sixty UC patients with measurable cN+ but without detectable systemic visceral/bone dissemination received induction platinum-based chemotherapy. Consolidative surgery was offered to all patients except for those with progressive disease. We retrospectively analyzed the clinicopathological response to induction chemotherapy and identified prognostic factors for overall survival (OS). The primary cancer site was the urinary bladder in 31 patients (52 %) and upper urinary tract in 29 (48 %). The median number of chemotherapy courses was 4. Forty-five patients (75 %) showed a clinically objective response to the induction chemotherapy. Fifty-one patients (85 %) underwent subsequent consolidative surgery. Histopathological analysis indicated pT0 status in 10 (20 %) and pN0 in 17 (33 %). When all 60 patients were considered, clinical tumor response was found to be significantly correlated with achievement of pathological complete response. At the median follow-up of 22 months, the median progression-free survival and OS periods were excellent: 18.6 and 31.6 months, respectively. In the multivariate analysis, clinical tumor response was found to be an independent pre-surgical prognostic factor for OS, and pathologically negative lymph node, negative resection margin, more LNs removed, and negative lymphovascular invasion were found to be independent post-surgical prognostic parameters for OS. The median OS in induction chemotherapy followed by consolidative surgery was very encouraging. Our results suggest that achieving a good clinical response to pre-surgical induction chemotherapy is a good indication for subsequent consolidative surgery in UC patients with cN+ to improve OS through a good pathological response.	[Urakami, Shinji; Yuasa, Takeshi; Yamamoto, Shinya; Sakura, Mizuaki; Tanaka, Hajime; Hayashi, Tatsuro; Uehara, Sho; Inoue, Yasushi; Fujii, Yasuhisa; Masuda, Hitoshi; Fukui, Iwao; Yonese, Junji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo 1058470, Japan; [Urakami, Shinji] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Urol, Minato Ku, Tokyo 1058470, Japan	Urakami, S (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo 1058470, Japan.	shinurakami@ybb.ne.jp			Smoking Research Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partly supported by the Smoking Research Foundation and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Griffiths G, 2011, J CLIN ONCOL, V29, P2171, DOI 10.1200/JCO.2010.32.3139; Meijer RP, 2014, UROLOGY, V83, P134, DOI 10.1016/j.urology.2013.08.082; Lim MC, 2010, ONKOLOGIE, V33, P324, DOI 10.1159/000313823; Dodd PM, 1999, J CLIN ONCOL, V17, P2546; Fossa SD, 1996, BRIT J CANCER, V74, P1655, DOI 10.1038/bjc.1996.605; Calabro F, 2009, EUR UROL, V55, P348, DOI 10.1016/j.eururo.2008.10.016; Sweeney P, 2003, J UROLOGY, V169, P2113, DOI 10.1097/01.ju.0000067601.29966.4a; Hautmann RE, 2012, EUR UROL, V61, P1039, DOI 10.1016/j.eururo.2012.02.028; Milowsky MI, 2009, J CLIN ONCOL, V27, P4062, DOI 10.1200/JCO.2008.21.2241; Nieuwenhuijzen JA, 2005, J UROLOGY, V174, P80, DOI 10.1097/01.ju.0000162018.40891.ba; Tsukamoto T, 2006, CANCER, V106, P2363, DOI 10.1002/cncr.21897; Siefker-Radtke AO, 2013, CANCER-AM CANCER SOC, V119, P540, DOI 10.1002/cncr.27751; Weight CJ, 2009, CANCER, V115, P792, DOI 10.1002/cncr.24106; DIMOPOULOS MA, 1994, J UROLOGY, V151, P598; Kassouf W, 2009, UROLOGY, V73, P147, DOI 10.1016/j.urology.2008.07.035; Siefker-Radtke AO, 2002, J CLIN ONCOL, V20, P1361, DOI 10.1200/JCO.20.5.1361; Ghadjar P, 2011, BJU INT, V107, P894, DOI 10.1111/j.1464-410X.2010.09574.x; Rosenblatt R, 2012, EUR UROL, V61, P1229, DOI 10.1016/j.eururo.2011.12.010; Kaag MG, 2011, BJU INT, V108, P272; Urakami S, 2014, UROL ONCOL, V32; Zehnder P, 2014, BJU INT, V113, P554, DOI 10.1111/bju.12520	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1171	1178		10.1007/s10147-015-0839-y		8	Oncology	Oncology	CX5FS	WOS:000365728100017		
J	Yoneyama, T; Imai, A; Hatakeyama, S; Hashimoto, Y; Koie, T; Ohyama, C				Yoneyama, Takahiro; Imai, Atsushi; Hatakeyama, Shingo; Hashimoto, Yasuhiro; Koie, Takuya; Ohyama, Chikara			Sequential chemotherapy using gemcitabine plus carboplatin followed by gemcitabine plus carboplatin plus docetaxel for advanced upper-tract urothelial cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Upper-urinary tract; Urothelial carcinoma; Carboplatin; Gemcitabine; Docetaxel	TRANSITIONAL-CELL CARCINOMA; CISPLATIN-BASED CHEMOTHERAPY; PHASE-II TRIAL; RADICAL NEPHROURETERECTOMY; 1ST-LINE TREATMENT; RENAL-FUNCTION; UNFIT; COMBINATION; GEMCITABINE/CARBOPLATIN; EXPERIENCE	Retrospective evaluation of the effectiveness and adverse events (AEs) of a sequential chemotherapy regimen using gemcitabine + carboplatin (GCarbo) followed by GCarbo + docetaxel (GCarboD) for advanced upper-tract urothelial carcinoma (UTUC). We treated 56 patients with advanced UTUC. Mean patient age was 68.9 years, creatinine clearance was 51.2 mL/min, and the observation period was 20 months. Patients received two courses of GCarbo comprising 800 mg/m(2) gemcitabine on days 1, 8, and 15, and carboplatin at an area under the curve of four on day 2. If this regimen was effective, we administered two more courses of GCarbo; if the regimen was ineffective, we switched to two courses of GCarboD (70 mg/m(2)). Complete (n = 3) and partial response (PR; n = 25) were achieved after GCarbo. Mean response duration was 9.7 months. Two of 17 cases achieved PR after GCarboD treatment (mean duration, 31.5 months). Median survival was 14.0 months with the GCarbo/GCarboD regimen. Responders to GCarbo therapy survived significantly longer. AEs with the GCarbo regimen included 31 instances of G3/4 blood toxicity and 8 instances of G3/4 urticaria; however, there were only 6 instances of G3/4 gastrointestinal complications. AEs with the GCarboD regimen included 16 instances of blood toxicity and 8 instances of gastrointestinal complications. Neither regimen resulted in G3/4 renal toxicity. GCarbo and GCarboD chemotherapy may be administered safely to patients with advanced UTUC, with or without renal dysfunction. Response to GCarbo was high (50.0 %) whereas GCarboD was of limited effectiveness for non-responders to GCarbo.	[Yoneyama, Takahiro; Imai, Atsushi; Hatakeyama, Shingo; Hashimoto, Yasuhiro; Koie, Takuya; Ohyama, Chikara] Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Hashimoto, Y (reprint author), Hirosaki Univ, Dept Urol, Grad Sch Med, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	bikkuri@opal.plala.or.jp					Bellmunt J, 1997, CANCER, V80, P1966, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO;2-W; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; McCaffrey JA, 1997, J CLIN ONCOL, V15, P1853; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Kaag MG, 2010, EUR UROL, V58, P581, DOI 10.1016/j.eururo.2010.06.029; Park JH, 2013, CANCER CHEMOTH PHARM, V71, P1033, DOI 10.1007/s00280-013-2098-9; Boukovinas I, 2006, ANN ONCOL, V17, P1687, DOI 10.1093/annonc/mdl286; Alva AS, 2012, NAT REV UROL, V9, P266, DOI 10.1038/nrurol.2012.57; Galsky MD, 2007, CANCER, V109, P549, DOI 10.1002/cncr.22454; Tsuruta H, 2011, INT J CLIN ONCOL, V16, P533, DOI 10.1007/s10147-011-0224-4; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Bamias A, 2006, CANCER, V106, P297, DOI 10.1002/cncr.21604; Tanaka N, 2013, BJU INT, V112, pE28, DOI 10.1111/bju.12133; Audenet F, 2013, UROL ONCOL-SEMIN ORI, V31, P407, DOI 10.1016/j.urolonc.2010.07.016; Galsky MD, 2011, J CLIN ONCOL, V29, P2432, DOI 10.1200/JCO.2011.34.8433; Koie T, 2013, INT J CLIN ONCOL, V18, P724, DOI 10.1007/s10147-012-0447-z; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; Dogliotti L, 2007, EUR UROL, V52, P134, DOI 10.1016/j.eururo.2006.12.029; Youssef RF, 2013, INT BRAZ J UROL, V39, P614, DOI 10.1590/S1677-5538.IBJU.2013.05.02; Hoschke B, 2004, INT J UROL, V11, P461, DOI 10.1111/j.0919-8172.2004.00846.x; Artz A, 2005, AM J CLIN ONCOL-CANC, V28, P109, DOI 10.1097/01.coc.0000142591.62299.8f; Hellenthal NJ, 2009, J UROLOGY, V182, P900, DOI 10.1016/j.juro.2009.05.011; Hoshi Senji, 2004, Int J Clin Oncol, V9, P125, DOI 10.1007/s10147-003-0379-8; Xu N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-98; Yoneyama T, 2014, INT J CLIN IN PRESS	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1179	1184		10.1007/s10147-015-0846-z		6	Oncology	Oncology	CX5FS	WOS:000365728100018		
J	Namekawa, T; Fukasawa, S; Komaru, A; Kobayashi, M; Imamura, Y; Ohzeki, T; Takagi, K; Sato, Y; Akakura, K; Ichikawa, T; Ueda, T				Namekawa, Takeshi; Fukasawa, Satoshi; Komaru, Atsushi; Kobayashi, Masayuki; Imamura, Yusuke; Ohzeki, Takayuki; Takagi, Kimiaki; Sato, Yosuke; Akakura, Koichiro; Ichikawa, Tomohiko; Ueda, Takeshi			Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Adverse events; Prostate cancer; Transperineal biopsy; Questionnaire	PROSPECTIVE RANDOMIZED-TRIAL; COMPLICATION RATES; SEXUAL FUNCTION; CANCER; MEN	Although transperineal (TP) prostate biopsy is growing in popularity, its safety has not been evaluated based on extensive studies. We prospectively assessed the adverse events associated with transrectal ultrasound (TRUS)-guided TP 16-core prostate biopsy at a single institution. We enrolled 2,086 males who underwent first-time TRUS-guided TP prostate biopsy under lumbar spinal anesthesia at Chiba Cancer Center between 2009 and 2013. Eight adverse events were assessed prospectively using a purpose-designed questionnaire. The prevalence and duration of all adverse events were evaluated. We performed subgroup analyses for hematuria and urinary retention in relation to clinical factors. Questionnaires were collected from 1,663 cases (79.7 %). The cancer detection rate was 53.5 % in all patients. The prevalence and duration of complications were as follows: hematuria, 73.4 % and 4.51 +/- A 2.88 days; perineal bleeding, 7.1 % and 2.20 +/- A 2.24 days; hematospermia 14.4 %; dysuria, 15.7 % and 3.12 +/- A 2.71 days; urinary tract pain, 49.5 % and 2.43 +/- A 2.08 days; perineal pain, 35.5 % and 3.53 +/- A 2.59 days; fever a parts per thousand yen37 A degrees C, 1.7 % and 1.79 +/- A 1.72 days; and headache, 22.1 % and 3.40 +/- A 2.10 days. Seventeen patients (1.1 %) required indwelling urethral catheterization for grade 2 urinary retention. Pre-biopsy International Prostate Symptom Score (p = 0.014) was an independent related factor for hematuria. Prostate volume (p = 0.001) was an independent related factor for grade 2 urinary retention. TRUS-guided TP prostate biopsy under lumbar spinal anesthesia can be performed safely with only minor adverse events.	[Namekawa, Takeshi; Fukasawa, Satoshi; Komaru, Atsushi; Kobayashi, Masayuki; Imamura, Yusuke; Ohzeki, Takayuki; Takagi, Kimiaki; Sato, Yosuke; Ueda, Takeshi] Chiba Canc Ctr, Prostate Ctr, Chuo Ku, Chiba, Chiba 2608717, Japan; [Namekawa, Takeshi; Fukasawa, Satoshi; Komaru, Atsushi; Kobayashi, Masayuki; Imamura, Yusuke; Ohzeki, Takayuki; Takagi, Kimiaki; Sato, Yosuke; Ueda, Takeshi] Chiba Canc Ctr, Div Urol, Chuo Ku, Chiba, Chiba 2608717, Japan; [Akakura, Koichiro] Japan Community Hlth Care Org, Div Urol, Tokyo Shinjuku Med Ctr, Tokyo, Japan; [Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chuo Ku, Chiba 2608670, Japan	Ueda, T (reprint author), Chiba Canc Ctr, Prostate Ctr, Chuo Ku, 666-2 Nitona Cho, Chiba, Chiba 2608717, Japan.	urolccc@yahoo.co.jp					Brullet E, 2000, ENDOSCOPY, V32, P792, DOI 10.1055/s-2000-7709; Jeon SS, 2003, UROLOGY, V62, P461, DOI 10.1016/S0090-4295(03)00470-9; Feliciano J, 2008, J UROLOGY, V179, P952, DOI 10.1016/j.juro.2007.10.071; Rodgers A, 2000, BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Grummet JP, 2014, BJU INT, V114, P384, DOI 10.1111/bju.12536; Giannarini G, 2007, UROLOGY, V70, P501, DOI 10.1016/j.urology.2007.04.016; Hara R, 2008, UROLOGY, V71, P191, DOI 10.1016/j.urology.2007.09.029; Masumori N, 1999, UROLOGY, V54, P335, DOI 10.1016/S0090-4295(99)00108-9; Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049; Klein T, 2010, J UROLOGY, V184, P1447, DOI 10.1016/j.juro.2010.06.021; Zaytoun OM, 2011, UROLOGY, V77, P910, DOI 10.1016/j.urology.2010.12.033; Tuncel A, 2008, UROLOGY, V71, P1128, DOI 10.1016/j.urology.2008.01.055; Aktoz T, 2010, ANDROLOGIA, V42, P35, DOI 10.1111/j.1439-0272.2009.00952.x; Cook TM, 2009, BRIT J ANAESTH, V102, P179, DOI 10.1093/bja/aen360; Raaijmakers R, 2002, UROLOGY, V60, P826, DOI 10.1016/S0090-4295(02)01958-1; Vyas L, 2014, BJU INT, V114, P32, DOI 10.1111/bju.12282; Shen PF, 2012, ASIAN J ANDROL, V14, P310, DOI 10.1038/aja.2011.130; Kakehi Y, 2008, INT J UROL, V15, P319, DOI 10.1111/j.1442-2042.2008.02048.x; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; Fujita K, 2009, J UROLOGY, V182, P2664, DOI 10.1016/j.juro.2009.08.044; Vallejo MC, 2000, ANESTH ANALG, V91, P916, DOI 10.1097/00000539-200010000-00027; Campbell MF, 2007, CAMPBELL WALSH UROLO, P2758; HODGE KK, 1989, J UROLOGY, V142, P71; Jabbari Ali, 2013, Caspian J Intern Med, V4, P595; Rolland J. S., 1987, FAMILY SYSTEMS MED, V5, P467, DOI 10.1093/jpepsy/jsl038; Rosario DJ, 2012, BMJ, V344; Takenaka A, 2007, PROSTATE CANCER P D, V11, P134; Wagenlehner FM, 2010, EUR UROL, V63, P521	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1185	1191		10.1007/s10147-015-0831-6		7	Oncology	Oncology	CX5FS	WOS:000365728100019		
J	Naya, Y; Nakamura, T; Oishi, M; Ueda, T; Nakanishi, H; Naitoh, Y; Hongo, F; Kamoi, K; Okihara, K; Tanaka, O; Yamagami, T; Yamada, K; Miki, T				Naya, Yoshio; Nakamura, Terukazu; Oishi, Masakatsu; Ueda, Takashi; Nakanishi, Hiroyuki; Naitoh, Yasuyuki; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Tanaka, Osamu; Yamagami, Takuji; Yamada, Kei; Miki, Tsuneharu			The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Radio-frequency ablation; Lung or liver metastases; Germ cell tumor	POSTCHEMOTHERAPY RESIDUAL MASSES; RESECTION; RETROPERITONEAL; EXPERIENCE; MARKERS	The aim of this study was to assess the efficacy of radio-frequency ablation (RFA) for metastatic lung or liver tumors of germ cell tumors (GCTs) after chemotherapy. RFA with computed tomography guidance and monitoring was performed in 24 patients with 48 metastatic lung or liver tumors of GCTs. Group A consisted of 9 patients with tumor marker normalization after salvage chemotherapy and group B consisted of 15 patients without tumor marker normalization in spite ofintensive treatment. Out of 48 tumors, 41 tumors in 21 patients were evaluated for the efficacy of the RFA treatment. Of the 41 tumors, successful ablation was achieved in 34 (82.9 %). The patients in group A had significantly better survival than the patients in group B (p = 0.0003). In group A, all 9 patients are still alive with no evidence of disease (NED). Patients with a solitary tumor had significantly better survival than those with multiple tumors (p = 0.0247). In group B, 2 patients are alive with NED, 1 patient is alive with disease, and the remaining 12 patients have died a tumor-related death. Three cases of pneumothorax requiring intubation were observed. RFA is less invasive than surgery and is an effective treatment option for curative and palliative therapy as an alternative to invasive salvage surgery for post-chemotherapeutic metastatic lung or liver lesions from GCT.	[Naya, Yoshio; Nakamura, Terukazu; Oishi, Masakatsu; Ueda, Takashi; Nakanishi, Hiroyuki; Naitoh, Yasuyuki; Hongo, Fumiya; Kamoi, Kazumi; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Dept Urol, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan; [Tanaka, Osamu; Yamagami, Takuji; Yamada, Kei] Kyoto Prefectural Univ Med, Dept Radiol, Grad Sch Med Sci, Kyoto 6028566, Japan	Naya, Y (reprint author), Kyoto Prefectural Univ Med, Dept Urol, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028566, Japan.	ynaya@koto.kpu-m.ac.jp					Alberts P, 2011, GUIDELINES TESTICULA; Brenner PC, 1996, J CLIN ONCOL, V14, P1765; Steinke K, 2004, ANTICANCER RES, V24, P339; Curley SA, 1999, ANN SURG, V230, P1, DOI 10.1097/00000658-199907000-00001; Gillams AR, 2008, EUR RADIOL, V18, P672, DOI 10.1007/s00330-007-0811-y; Beck SDW, 2005, J CLIN ONCOL, V23, P6149, DOI 10.1200/JCO.2005.11.684; Hartmann JT, 1997, EUR J CANCER, V33, P843, DOI 10.1016/S0959-8049(96)00517-5; Okuma T, 2010, CARDIOVASC INTER RAD, V33, P787, DOI 10.1007/s00270-009-9770-9; Albers P, 2000, J UROLOGY, V164, P381, DOI 10.1016/S0022-5347(05)67365-X; Hiraoka K, 2009, INT J UROL, V16, P869, DOI 10.1111/j.1442-2042.2009.02378.x; Petre EN, 2013, CLIN COLORECTAL CANC, V12, P37, DOI [10.1016/j.clcc.2012.07.003, 10.1016/clcc.2012.07.003]; Wood TF, 2000, ANN SURG ONCOL, V7, P593; Ukimura O, 2004, INT J UROL, V11, P1051, DOI 10.1111/j.1442-2042.2004.00966.x; Evrard S, 2004, EJSO, V30, P399, DOI 10.1016/j.ejso.2004.01.019; Motzer RJ, 2012, NCCN CLIN PRACTICE G; Stenning SP, 1998, CANCER-AM CANCER SOC, V83, P1409, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1409::AID-CNCR19>3.3.CO;2-1	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1192	1197		10.1007/s10147-015-0824-5		6	Oncology	Oncology	CX5FS	WOS:000365728100020		
J	Yuasa, T; Inoshita, N; Tanaka, H; Urakami, S; Yamamoto, S; Fujii, Y; Masuda, H; Fukui, I; Ishikawa, Y; Yonese, J				Yuasa, Takeshi; Inoshita, Naoko; Tanaka, Hajime; Urakami, Shinji; Yamamoto, Shinya; Fujii, Yasuhisa; Masuda, Hitoshi; Fukui, Iwao; Ishikawa, Yuichi; Yonese, Junji			Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Testicular cancer; Germ cell cancer; Stage I; Surveillance; Multi-detector computed tomography; Recurrence free survival	ADJUVANT CHEMOTHERAPY; LYMPH-NODES; TUMORS; TESTIS; MANAGEMENT; SURGERY; CS1	The outcome of surveillance for Japanese patients with clinical stage I testicular germ cell cancer (GCC) was investigated in the multi-detector computed tomography (MDCT) era. The medical records of 92 Japanese patients with stage I GCC, who received treatment in our institution between March 1999 and February 2013, were reviewed. As six patients requested and received prophylactic chemotherapy and two patients seriously deviated from surveillance schedule, these patients were excluded from the study. Data from a total 84 patients were analyzed, The median follow-up period following diagnosis was 5.1 years (inter-quartile range: IQR, 2.3-7.7 years). Of the 84 patients, eight (9.5 %) had a recurrence of their cancer in this observation period. Regarding histologic subtypes, the recurrence rates were five (9.3 %) of the 54 patients with seminoma and three (10 %) of the 30 patients with nonseminomatous germ cell tumor (NSGCT). All eight patients who experienced a recurrence did so within 2 years; they all underwent induction chemotherapy and remain alive at the time of writing, with no evidence of disease. Among 31 seminoma patients with a tumor more than 4 cm in size and rete testis invasion, cancer recurred in three (9.7 %) during the surveillance period. On the other hand, among the 13 patients with NSGCT and vascular invasion, three (23 %) experienced a recurrence, whereas the figure was zero for the 11 (0 %) patients without vascular invasion. Fewer than 10 % of Japanese patients with stage I testicular GCC suffered a recurrence in the 5-year observation period of this study. The risk of occult disease, which will result in relapse, might be decreased in the MDCT era. All patients must be fully informed of the anticipated recurrence rate and the potential risks of exposure to chemotherapy agents.	[Yuasa, Takeshi; Tanaka, Hajime; Urakami, Shinji; Yamamoto, Shinya; Fujii, Yasuhisa; Masuda, Hitoshi; Fukui, Iwao; Yonese, Junji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Ariake, Tokyo 1358550, Japan; [Inoshita, Naoko; Ishikawa, Yuichi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Ariake, Tokyo 1358550, Japan	Yuasa, T (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Ariake, Tokyo 1358550, Japan.	takeshi.yuasa@jfcr.or.jp			Smoking Research Foundation; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	The work was partly supported by the Smoking Research Foundation, the Takeda Science Foundation, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Tandstad T, 2010, ANN ONCOL, V21, P1858, DOI 10.1093/annonc/mdq026; Oliver RTD, 2011, J CLIN ONCOL, V29, P957, DOI 10.1200/JCO.2009.26.4655; Hao D, 1998, J UROLOGY, V160, P768, DOI 10.1016/S0022-5347(01)62782-4; KLEPP O, 1990, ANN ONCOL, V1, P281; STUDER UE, 1993, EUR UROL, V23, P444; Zuniga A, 2009, BJU INT, V104, P1351, DOI 10.1111/j.1464-410X.2009.08858.x; Kanamoto T, 2007, J COMPUT ASSIST TOMO, V31, P831; Nasu Y, 2010, SURG TODAY, V40, P1023, DOI 10.1007/s00595-009-4185-4; Shelley MD, 2002, CANCER TREAT REV, V28, P237, DOI 10.1016/S0305-7372(02)00059-2; Cullen MH, 1996, J CLIN ONCOL, V14, P1106; Kollmannsberger C, 2010, ANN ONCOL, V21, P1296, DOI 10.1093/annonc/mdp473; Shinohara T, 2005, EJSO, V31, P743, DOI 10.1016/j.ejso.2005.03.005; Maroto P, 2005, ANN ONCOL, V16, P1915, DOI 10.1093/annonc/mdi397; Sturgeon JF, 2011, EUR UROL, V59, P556, DOI 10.1016/j.eururo.2010.12.010; Albers P, 2011, EUR UROL, V60, P304, DOI 10.1016/j.eururo.2011.05.038; Kollmannsberger C, 2011, ANN ONCOL, V22, P808, DOI 10.1093/annonc/mdq466; Stephenson JA, 2012, CAMPBELL WALSH UROLO, P837	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1198	1202		10.1007/s10147-015-0828-1		5	Oncology	Oncology	CX5FS	WOS:000365728100021		
J	Hosoya, K; Mochinaga, S; Emoto, A; Yokoo, H; Tokushima, H; Egoshi, M; Sueoka-Aragane, N; Kimura, S				Hosoya, Kazuhisa; Mochinaga, Sakiko; Emoto, Akiko; Yokoo, Hiromi; Tokushima, Hideaki; Egoshi, Masayoshi; Sueoka-Aragane, Naoko; Kimura, Shinya			Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Chronic myeloid leukemia; Failure mode and effects analysis; Adherence; ABL tyrosine kinase inhibitor	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITORS; IMATINIB; NONADHERENCE; THERAPY; TRIAL	Poor adherence to ABL tyrosine kinase inhibitors (ABL TKIs) is associated with reduced treatment efficacy and increased healthcare costs. To examine the hazards associated with poor adherence, we implemented failure mode and effects analysis (FMEA). We surveyed 54 chronic myeloid leukemia (CML) patients treated at Saga University Hospital from October 2012 to May 2014. The survey consisted of items regarding the type of ABL TKI used, adherence to ABL TKIs, the appearance of adverse effects, utilisation of the high cost medical care benefit system, and factors affecting adherence. Four factors that likely affected adherence were identified, including the level of understanding of ABL TKIs treatment outcomes, adverse effects, the high cost of medications, and careless slips in the taking of medicine. Results of the survey were analysed by FMEA. The risk priority number was highest for careless slips in the taking of medicine at 7.0 +/- A 1.0 (mean +/- A SEM), followed in descending order by the inadequate understanding of treatment outcomes (4.9 +/- A 0.6), adverse effects (3.8 +/- A 0.8), and high medication cost (2.2 +/- A 0.5). Thus, the prevention of careless slips was the most important factor affecting adherence to ABL TKIs. Contrary to our preoccupation, FMEA revealed that high medication cost was the lowest risk factor for poor adherence. This finding may be attributed to the high utilisation (96.3 %) of the high cost medical care benefit system. These findings suggest that an inadequate medication-taking habit such as careless slips may represent a potential target to improve and maximize adherence in CML patients.	[Hosoya, Kazuhisa; Mochinaga, Sakiko; Emoto, Akiko; Yokoo, Hiromi; Tokushima, Hideaki; Egoshi, Masayoshi; Sueoka-Aragane, Naoko] Saga Univ Hosp, Dept Pharm, Saga, Japan; [Sueoka-Aragane, Naoko; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 8498501, Japan	Kimura, S (reprint author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, 5-1-1 Nabeshima, Saga 8498501, Japan.	shkimu@cc.saga-u.ac.jp			Bristol-Myers Squibb; Novartis	The authors declare that they except S.K. have no conflict of interest. S.K. has received research funding and honoraria from Bristol-Myers Squibb and Novartis.	Sumi M, 2005, CLIN LAB HAEMATOL, V27, P416, DOI 10.1111/j.1365-2257.2005.00723.x; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Noens L, 2009, BLOOD, V113, P5401, DOI 10.1182/blood-2008-12-196543; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Wu EQ, 2010, CURR MED RES OPIN, V26, P61, DOI 10.1185/03007990903396469; Zedler BK, 2011, CLIN THER, V33, P581, DOI 10.1016/j.clinthera.2011.04.020; Moon JH, 2012, MED ONCOL, V29, P1179, DOI 10.1007/s12032-011-9926-8; Drucker AM, 2013, EUR J HAEMATOL, V90, P142, DOI 10.1111/ejh.12052; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Vervloet M, 2014, DIABETIC MED, V31, P821, DOI 10.1111/dme.12439; Efficace F, 2014, LEUKEMIA RES, V38, P294, DOI 10.1016/j.leukres.2013.07.003; Neugut AI, 2011, J CLIN ONCOL, V29, P2534, DOI 10.1200/JCO.2010.33.3179; Reason J, 2000, BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Montes JM, 2012, PSYCHIAT RES, V200, P89, DOI 10.1016/j.psychres.2012.07.034; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Eliasson L, 2011, LEUKEMIA RES, V35, P626, DOI 10.1016/j.leukres.2010.10.017; Darkow T, 2007, PHARMACOECONOMICS, V25, P481, DOI 10.2165/00019053-200725060-00004; Clifford S, 2006, PHARM WORLD SCI, V28, P165, DOI 10.1007/s11096-006-9026-6; Hosoya K, 2012, J JPN SOC HOSP PHARM, V48, P1489; Kimura Shinya, 2010, Rinsho Ketsueki, V51, P597; Lago P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001249; Latino Robert J, 2004, J Healthc Risk Manag, V24, P21, DOI 10.1002/jhrm.5600240305; Mochinaga S, 2006, JPN J PHARM HLTH CAR, V32, P1050; Walsh Kathleen E, 2013, J Oncol Pract, V9, pe1, DOI 10.1200/JOP.2012.000601; Weingart Saul N, 2011, J Oncol Pract, V7, P2, DOI 10.1200/JOP.2010.000064; Yagasaki Fumiharu, 2009, Rinsho Ketsueki, V50, P481	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1203	1210		10.1007/s10147-015-0843-2		8	Oncology	Oncology	CX5FS	WOS:000365728100022		
J	Nishida, Y; Tsukushi, S; Urakawa, H; Hamada, S; Kozawa, E; Ikuta, K; Ando, Y; Ishiguro, N				Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Hamada, Shunsuke; Kozawa, Eiji; Ikuta, Kunihiro; Ando, Yuichi; Ishiguro, Naoki			Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Desmoid tumor; CTNNB1; Methotrexate; Vinblastine	ADVANCED AGGRESSIVE FIBROMATOSIS; FRENCH SARCOMA GROUP; PHASE-II TRIAL; PROGNOSTIC-FACTORS; RADIATION-THERAPY; SEE POLICY; CHILDREN; EFFICACY; IMATINIB; SURGERY	This study was conducted to determine the efficacy and safety of low-dose chemotherapy with methotrexate (MTX) and vinblastine (VBL) for patients with desmoid tumors refractory to meloxicam treatment, focusing in particular on the relationship between the efficacy of this chemotherapy and catenin beta-1 (CTNNB1) mutation status. Since March 2003, patients pathologically diagnosed with extraperitoneal desmoid tumors have been prospectively treated with meloxicam, a COX-2 inhibitor, at our institution. Patients with inoperable tumors who were resistant to meloxicam treatment underwent MTX and VBL therapy every other week. The responses of all patients were evaluated, and factors that were correlated with efficacy were analyzed, including CTNNB1 mutation status. Sixty-eight patients were prospectively treated with meloxicam. MTX + VBL therapy was administered in 15 patients. Six patients showed a partial response. Only one patient presented disease progression. A few patients showed grade 3-4 treatment-related toxicity with the administration of MTX and VBL every other week. Intriguingly, CTNNB1 status did not affect the efficacy of this treatment. MTX and VBL treatment every other week is well tolerated and achieved a favorable response in patients resistant to meloxicam treatment, regardless of CTNNB1 mutation status.	[Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Hamada, Shunsuke; Kozawa, Eiji; Ikuta, Kunihiro; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Hamada, Shunsuke; Kozawa, Eiji; Ikuta, Kunihiro; Ishiguro, Naoki] Nagoya Univ, Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Urakawa, Hiroshi; Ando, Yuichi] Nagoya Univ, Dept Clin Oncol & Chemotherapy, Grad Sch, Showa Ku, Nagoya, Aichi 4668550, Japan; [Urakawa, Hiroshi; Ando, Yuichi] Nagoya Univ, Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Nishida, Y (reprint author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	ynishida@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [262933341]; Health Labour Sciences Research Grant of Japan	We thank Ms. Eri Ishihara for her secretarial assistance with this study, and Dr. Yoshie Shimoyama for pathological diagnosis. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 262933341 for Scientific Research (B)], and the Health Labour Sciences Research Grant of Japan.	Meazza C, 2010, CANCER, V116, P233, DOI 10.1002/cncr.24679; Shido Y, 2009, ARCH ORTHOP TRAUM SU, V129, P929, DOI 10.1007/s00402-008-0750-3; Garbay D, 2012, ANN ONCOL, V23, P182, DOI 10.1093/annonc/mdr051; Gronchi A, 2014, ANN ONCOL, V25, P578, DOI 10.1093/annonc/mdt485; Heinrich MC, 2006, J CLIN ONCOL, V24, P1195, DOI 10.1200/JCO.2005.04.0717; van Broekhoven DLM, 2015, ANN SURG ONCOL, V22, P1464, DOI 10.1245/s10434-014-4156-x; Ballo MT, 1999, J CLIN ONCOL, V17, P158; de Camargo VP, 2010, CANCER-AM CANCER SOC, V116, P2258, DOI 10.1002/cncr.25089; POSNER MC, 1989, ARCH SURG-CHICAGO, V124, P191; Domont J, 2010, BRIT J CANCER, V102, P1032, DOI 10.1038/sj.bjc.6605557; Merchant NB, 1999, CANCER, V86, P2045, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2045::AID-CNCR23>3.0.CO;2-F; Azzarelli A, 2001, CANCER, V92, P1259, DOI 10.1002/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO;2-Y; Poon R, 2001, ONCOGENE, V20, P451, DOI 10.1038/sj.onc.1204107; Salas S, 2011, J CLIN ONCOL, V29, P3553, DOI 10.1200/JCO.2010.33.5489; Gronchi A, 2003, J CLIN ONCOL, V21, P1390, DOI 10.1200/JCO.2003.05.150; Jo JC, 2014, INVEST NEW DRUG, V32, P369, DOI 10.1007/s10637-013-0059-0; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1108, DOI 10.1002/pbc.24457; Lev D, 2007, J CLIN ONCOL, V25, P1785, DOI 10.1200/JCO.2006.10.5015; Hamada S, 2014, TUMOR BIOL, V35, P4561, DOI 10.1007/s13277-013-1600-7; Bonvalot S, 2008, EJSO-EUR J SURG ONC, V34, P462, DOI 10.1016/j.ejso.2007.06.006; Lazar AJF, 2008, AM J PATHOL, V173, P1518, DOI 10.2353/ajpath.2008.080475; Gounder MM, 2011, CLIN CANCER RES, V17, P4082, DOI 10.1158/1078-0432.CCR-10-3322; Gega M, 2006, J CLIN ONCOL, V24, P102, DOI 10.1200/JCO.2005.02.1923; Briand S, 2014, J BONE JOINT SURG AM, V96A, P631, DOI 10.2106/JBJS.M.00988; Penel N, 2011, ANN ONCOL, V22, P452, DOI 10.1093/annonc/mdq341; Nishida Y, 2010, J CLIN ONCOL, V28, pE107, DOI 10.1200/JCO.2009.25.5950; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Lackner H, 1997, CANCER, V80, P334, DOI 10.1002/(SICI)1097-0142(19970715)80:2<334::AID-CNCR22>3.0.CO;2-U; Huang K, 2009, J SURG ONCOL, V100, P563, DOI 10.1002/jso.21384; Chugh R, 2010, CLIN CANCER RES, V16, P4884, DOI 10.1158/1078-0432.CCR-10-1177; Skapek SX, 2007, J CLIN ONCOL, V25, P501, DOI 10.1200/JCO.2006.08.2966; Nuyttens JJ, 2000, CANCER, V88, P1517, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.0.CO;2-9; Colombo C, 2013, CANCER-AM CANCER SOC, V119, P3696, DOI 10.1002/cncr.28271; Hamada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096391	34	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1211	1217		10.1007/s10147-015-0829-0		7	Oncology	Oncology	CX5FS	WOS:000365728100023		
J	Nishida, Y; Tsukushi, S; Urakawa, H; Toriyama, K; Kamei, Y; Yokoi, K; Ishiguro, N				Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Toriyama, Kazuhiro; Kamei, Yuzuru; Yokoi, Kohei; Ishiguro, Naoki			Post-operative pulmonary and shoulder function after sternal reconstruction for patients with chest wall sarcomas	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Sternectomy; Sarcoma; Respiratory function; Shoulder function; Paradoxical breathing	LATISSIMUS-DORSI MUSCLE; MALIGNANT-TUMORS; RESECTION; FLAP; DEFECTS; SYSTEM	Sternal resection is occasionally required for patients with malignant tumors, particularly sarcomas, in the sternal region. Few reports have described post-operative respiratory and shoulder function after sternal resection for patients with bone and soft-tissue sarcomas. Eight consecutive patients with bone and soft tissue sarcomas requiring sternal resection were the focus of this study. Chest wall was reconstructed with a non-rigid or semi-rigid prosthesis combined, in most cases, with soft tissue flap reconstruction. Clinical outcomes investigated included complications, shoulder function, evaluated with Musculoskeletal Tumor Society-International Symposium of Limb Salvage system, and respiratory function, evaluated by use of spirometry. The anterior chest wall was reconstructed with non-rigid strings for 3 patients and with polypropylene mesh for 5. There were no severe post-operative complications, for example surgical site infection or pneumonia. All 3 patients with non-rigid reconstruction experienced paradoxical breathing, whereas none with polypropylene mesh did so. Post-operatively, FEV(1)% was unchanged but %VC was significantly reduced (p = 0.01), irrespective of the reconstruction method used (strings or polypropylene mesh). Shoulder function was not impaired. Among patients undergoing sternal resection, post-operative shoulder function was excellent. Pulmonary function was slightly restricted, but not sufficiently so to interfere with the activities of daily living (ADL). Paradoxical breathing is a slight concern for non-rigid reconstruction.	[Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch & Sch Med, Showa, Nagoya, Aichi 4668550, Japan; [Yokoi, Kohei] Nagoya Univ, Dept Thorac Surg, Grad Sch & Sch Med, Showa, Nagoya, Aichi 4668550, Japan; [Toriyama, Kazuhiro; Kamei, Yuzuru] Nagoya Univ, Dept Plast & Reconstruct Surg, Grad Sch & Sch Med, Showa, Nagoya, Aichi 4668550, Japan	Nishida, Y (reprint author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch & Sch Med, Showa, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	ynishida@med.nagoya-u.ac.jp			Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare [H26-084]	We thank Eri Ishihara, for secretarial assistance, and Dr Noriyasu Usami, for technical support during surgery. This study was supported in part by the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (H26-084).	Martini N, 1996, J THORAC CARDIOV SUR, V111, P96, DOI 10.1016/S0022-5223(96)70405-1; BRUMBACK RJ, 1992, J BONE JOINT SURG AM, V74A, P377; MORGAN RF, 1988, ANN SURG, V207, P707, DOI 10.1097/00000658-198806000-00010; Lequaglie C, 2002, ANN SURG ONCOL, V9, P472, DOI 10.1245/aso.2002.9.5.472; Incarbone M, 1997, J THORAC CARDIOV SUR, V114, P93, DOI 10.1016/S0022-5223(97)70121-1; CHAPELIER A, 1994, EUR J CARDIO-THORAC, V8, P351, DOI 10.1016/1010-7940(94)90028-0; Hanna WC, 2011, SURGERY, V150, P590, DOI 10.1016/j.surg.2011.07.055; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Weyant MJ, 2006, ANN THORAC SURG, V81, P279, DOI 10.1016/j.athoracsur.2005.07.001; Pfannschmidt J, 2005, THORAC CARDIOV SURG, V53, P234, DOI 10.1055/s.-2005-837649; TOBIN GR, 1983, J THORAC CARDIOV SUR, V85, P219; Matsumura N, 2013, J SHOULDER ELB SURG, V22, P333, DOI 10.1016/j.jse.2012.02.006; Moukarbel RV, 2010, LARYNGOSCOPE, V120, P1129, DOI 10.1002/lary.20900; Mansour KA, 2002, ANN THORAC SURG, V73, P1720, DOI 10.1016/S0003-4975(02)03527-0; Lardinois D, 2000, ANN THORAC SURG, V69, P919, DOI 10.1016/S0003-4975(99)01422-8; Fabre D, 2012, EUR J CARDIO-THORAC, V42, P965, DOI 10.1093/ejcts/ezs211; Granetzny Andreas, 2005, Interact Cardiovasc Thorac Surg, V4, P583, DOI 10.1510/icvts.2005.111807; LAITUNG JKG, 1985, BRIT J PLAST SURG, V38, P375, DOI 10.1016/0007-1226(85)90245-0; Mansour KA, 2002, ANN THORAC SURG, V73, P1725; Martini N, 1996, J THORAC CARDIOVASC, V111, P105; Netscher DT, 2003, ANN PLAST SURG, V51, P123; Netscher DT, 2009, PLAST RECONSTR SURG, V124, P240; Netscher DT, 2003, ANN PLAS SURG, V51, P115, DOI 10.1097/01.SAP.0000058497.92264.E2; Thomas Pascal A, 2010, Thorac Surg Clin, V20, P551, DOI 10.1016/j.thorsurg.2010.06.006; Tsukushi S, 2014, SURG TODAY, V45, P150	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	DEC	2015	20	6					1218	1225		10.1007/s10147-015-0844-1		8	Oncology	Oncology	CX5FS	WOS:000365728100024		
J	Miyakawa, Y; Katsutani, S; Yano, T; Nomura, S; Nishiwaki, K; Tomiyama, Y; Higashihara, M; Shirasugi, Y; Nishikawa, M; Ozaki, K; Abe, T; Kikuchi, K; Kanakura, Y; Fujimura, K; Ikeda, Y; Okamoto, S				Miyakawa, Yoshitaka; Katsutani, Shinya; Yano, Takahiro; Nomura, Shosaku; Nishiwaki, Kaichi; Tomiyama, Yoshiaki; Higashihara, Masaaki; Shirasugi, Yukari; Nishikawa, Masakatsu; Ozaki, Katsutoshi; Abe, Takayuki; Kikuchi, Kayoko; Kanakura, Yuzuru; Fujimura, Kingo; Ikeda, Yasuo; Okamoto, Shinichiro			Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Immune thrombocytopenia; Platelets; Rituximab	B-CELL DEPLETION; DEXAMETHASONE MONOTHERAPY; ADULT PATIENTS; PURPURA; MANAGEMENT; TRIAL; SPLENECTOMY; MULTICENTER	Primary immune thrombocytopenia (ITP) is an autoimmune disease mediated by the production of auto-antibody against platelets. Rituximab, an anti-CD20 antibody, is reported to be useful for treatment of ITP. In Japan, however, robust evidence on this treatment has not been accumulated. Hence, we conducted this open-label phase III clinical trial to confirm the efficacy and safety of rituximab, administered at 375 mg/m(2) once per week at weekly intervals for 4 consecutive weeks in Japanese patients with chronic ITP, who had relapsed and were refractory to conventional therapy. The primary endpoint was defined as the percentage of patients with a platelet count above 50 x 10(9)/L at week 24 after the first dose of rituximab, which was 30.8 % of 26 patients (95 % confidence interval 14.3-51.8 %). Although the lower confidence limit of primary endpoint failed to meet the pre-specified threshold of 20 %, the clinical efficacy of rituximab is substantial in consideration of the 2 % response rate in the placebo arm in other clinical studies in patients with chronic ITP. We conclude that rituximab is clinically useful and safe in the treatment of Japanese patients with chronic ITP, achieving the goal of maintaining platelet count and reducing risk of bleeding while minimizing treatment-related toxicity.	[Miyakawa, Yoshitaka] Saitama Med Univ, Dept Gen Internal Med, Moroyama, Saitama 3500495, Japan; [Katsutani, Shinya] Hiroshima Univ, Dept Hematol & Oncol, Hiroshima, Japan; [Yano, Takahiro] Natl Hosp Org Tokyo Med Ctr, Hematol, Internal Med, Tokyo, Japan; [Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Hirakata Hosp, Osaka, Japan; [Nishiwaki, Kaichi] Jikei Univ, Dept Hematol & Oncol, Sch Med, Kashiwa Hosp, Chiba, Japan; [Tomiyama, Yoshiaki] Osaka Univ Hosp, Dept Blood Transfus, Osaka, Japan; [Higashihara, Masaaki] Kitasato Univ Hosp, Dept Hematol, Sagamihara, Kanagawa, Japan; [Shirasugi, Yukari] Tokai Univ Hosp, Dept Hematol & Oncol, Sagamihara, Kanagawa, Japan; [Nishikawa, Masakatsu] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan; [Ozaki, Katsutoshi] Jichi Med Univ, Div Hematol, Shimotsuke, Tochigi, Japan; [Abe, Takayuki; Kikuchi, Kayoko] Keio Univ, Sch Med, Clin Res Ctr, Tokyo, Japan; [Kanakura, Yuzuru] Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, Osaka, Japan; [Fujimura, Kingo] Yasuda Womens Univ, Hiroshima, Japan; [Ikeda, Yasuo] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo, Japan	Miyakawa, Y (reprint author), Saitama Med Univ, Dept Gen Internal Med, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	miyakawa@saitama-med.ac.jp			Zenyaku Kogyo Co., Ltd.; Quintiles Transnational Japan Inc.; Center for Clinical Trials, Japan Medical Association (JMACCT)	This study is a research project of the Ministry of Health, Labour, and Welfare (MHLW) Scientific Research Project. The authors are gratefully indebted to Zenyaku Kogyo Co., Ltd. for the supply of the investigational product and support for preparation of the manuscript, and to Quintiles Transnational Japan Inc. for support in conducting the clinical trial and in preparation of the manuscript, and Center for Clinical Trials, Japan Medical Association (JMACCT) for financial support. We also appreciated CTD Inc. for providing professional advises to our study group.	Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Li ZY, 2011, INT J HEMATOL, V93, P91, DOI 10.1007/s12185-010-0753-z; Cooper N, 2004, BRIT J HAEMATOL, V125, P232, DOI 10.1111/j.1365-2141.2004.04889.x; Fujimura K, 2005, INT J HEMATOL, V81, P162, DOI 10.1532/IJH97.04146; Ghanima W, 2015, LANCET, V385, P1653, DOI 10.1016/S0140-6736(14)61495-1; Zaja F, 2006, EXP HEMATOL, V34, P571, DOI 10.1016/j.exphem.2006.02.009; Arnold DM, 2007, ANN INTERN MED, V146, P25; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Arnold DM, 2012, BLOOD, V119, P1356, DOI 10.1182/blood-2011-08-374777; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; Looney R John, 2005, J Rheumatol Suppl, V73, P25; Gudbrandsdottir S, 2013, BLOOD, V121, P1976, DOI 10.1182/blood-2012-09-455691; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Kurata Y, 2011, INT J HEMATOL, V93, P329, DOI 10.1007/s12185-011-0791-1; Zaja F, 2010, BLOOD, V115, P2755, DOI 10.1182/blood-2009-07-229815; Kashiwagi H, 2013, INT J HEMATOL, V98, P24, DOI 10.1007/s12185-013-1370-4; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Reddy V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3910; Siegal Deborah, 2013, Semin Hematol, V50 Suppl 1, pS18, DOI 10.1053/j.seminhematol.2013.03.005; Tran H, 2014, BRIT J HAEMATOL, V167, P243, DOI 10.1111/bjh.13029	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					654	661		10.1007/s12185-015-1887-9		8	Hematology	Hematology	CX7HC	WOS:000365871800002		
J	Okina, S; Yanagisawa, N; Yokoyama, M; Sakurai, Y; Numata, Y; Umezawa, A; Higashihara, M; Murakumo, Y				Okina, Sosei; Yanagisawa, Nobuyuki; Yokoyama, Maki; Sakurai, Yasutaka; Numata, Yoshiko; Umezawa, Atsuko; Higashihara, Masaaki; Murakumo, Yoshiki			High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Diffuse large B-cell lymphoma; Immunohistochemistry; Prognosis; REV7; Rituximab	NON-HODGKINS-LYMPHOMA; DNA-POLYMERASE-ZETA; CHOP CONSORTIUM PROGRAM; R-CHOP; ELDERLY-PATIENTS; CARCINOMA-CELLS; PROTEIN; GENE; SURVIVAL; MAD2L2	REV7 is a multifunctional protein involved in DNA damage tolerance, cell-cycle regulation, gene expression, and carcinogenesis. Although its expression is reportedly associated with poor prognosis in human solid tissue cancers, the significance of REV7 expression in hematopoietic malignancies is unclear. This study evaluated the prognostic significance of REV7 expression in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab-combined chemotherapy. Using immunohistochemistry, we analyzed 83 specimens of de novo DLBCL [38 germinal center B-cell-like (GCB) and 45 non-GCB DLBCLs] treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone for REV7 expression. Aberrant REV7 expression was detected in DLBCL cell nuclei. High REV7 expression was associated with significantly shorter overall survival (OS) and progression-free survival (PFS) using Kaplan-Meier analysis and log-rank tests (P < 0.01 and P < 0.01, respectively). Multivariate analysis revealed that REV7 expression is an independent prognostic factor for both OS and PFS. Additionally, when patients were divided into four groups using a combination of REV7 expression and international prognostic index (IPI) or Bcl-2 expression, REV7(High)/IPIPoor and REV7(High)/Bcl-2(High) patients showed the poorest outcome. These results indicate that REV7 may be a useful biomarker to predict the prognosis of patients with DLBCL treated with rituximab.	[Okina, Sosei; Yanagisawa, Nobuyuki; Yokoyama, Maki; Sakurai, Yasutaka; Numata, Yoshiko; Umezawa, Atsuko; Murakumo, Yoshiki] Kitasato Univ, Dept Pathol, Sch Med, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Okina, Sosei; Yokoyama, Maki; Higashihara, Masaaki] Kitasato Univ, Dept Hematol, Sch Med, Sagamihara, Kanagawa 2520374, Japan	Murakumo, Y (reprint author), Kitasato Univ, Dept Pathol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	murakumo@med.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24590479]	This work was supported by Grants-in-Aid for Scientific Research (C) commissioned by the Ministry of Education, Culture, Sports, Science and Technology of Japan (to YM, 24590479).	Hermine O, 1996, BLOOD, V87, P265; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Goto N, 2012, ANN HEMATOL, V91, P705, DOI 10.1007/s00277-011-1363-4; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Ren YR, 2015, CHINESE MED J-PEKING, V128, P378, DOI 10.4103/0366-6999.150111; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Nyman H, 2007, BLOOD, V109, P4930, DOI 10.1182/blood-2006-09-047068; Zhao J, 2011, J CLIN NEUROSCI, V18, P827, DOI 10.1016/j.jocn.2010.11.009; Watanabe N, 2013, J BIOL CHEM, V288, P10459, DOI 10.1074/jbc.M112.421966; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Jain P, 2013, AM J HEMATOL, V88, P798, DOI 10.1002/ajh.23467; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Niimi K, 2014, CANCER SCI, V105, P545, DOI 10.1111/cas.12390; Read JA, 2014, CL LYMPH MYELOM LEUK, V14, P460, DOI 10.1016/j.clml.2014.05.002; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Castillo JJ, 2012, LEUKEMIA RES, V36, P413, DOI 10.1016/j.leukres.2011.12.012; HARRIS NL, 1994, BLOOD, V84, P1361; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Leroy K, 2002, ANN ONCOL, V13, P1108, DOI 10.1093/annonc/mdf185; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; Makarova AV, 2015, DNA REPAIR, V29, P47, DOI 10.1016/j.dnarep.2015.02.012; Muris JJF, 2006, J PATHOL, V208, P714, DOI 10.1002/path.1924; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06; Mounier N, 2003, BLOOD, V101, P4279, DOI 10.1182/blood-2002-11-3442; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Lossos IS, 2001, BLOOD, V98, P945, DOI 10.1182/blood.V98.4.945; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493; CARBONE PP, 1971, CANCER RES, V31, P1860; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Cheung HW, 2006, CANCER RES, V66, P4357, DOI 10.1158/008-5472.CAN-05-3602; Chang CC, 2000, AM J CLIN PATHOL, V113, P512; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; Li L, 2007, MOL CELL BIOCHEM, V304, P297, DOI 10.1007/s11010-007-9512-8; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Yamaguchi M, 2002, BLOOD, V99, P815, DOI 10.1182/blood.V99.3.815; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Murakumo Y, 2002, MUTAT RES-FUND MOL M, V510, P37, DOI 10.1016/S0027-5107(02)00250-6; Sakai Akira, 2014, J Clin Exp Hematop, V54, P49; Sehn LH, 2015, BLOOD, V125, P22, DOI 10.1182/blood-2014-05-577189	50	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					662	669		10.1007/s12185-015-1880-3		8	Hematology	Hematology	CX7HC	WOS:000365871800003		
J	Kikuchi, T; Mori, T; Koda, Y; Kohashi, S; Kato, J; Toyama, T; Nakazato, T; Aisa, Y; Shimizu, T; Okamoto, S				Kikuchi, Taku; Mori, Takehiko; Koda, Yuya; Kohashi, Sumiko; Kato, Jun; Toyama, Takaaki; Nakazato, Tomonori; Aisa, Yoshinobu; Shimizu, Takayuki; Okamoto, Shinichiro			Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Allogeneic hematopoietic stem cell transplantation; Multiple myeloma; Reduced-intensity conditioning; Melphalan; Fludarabine	NEWLY-DIAGNOSED MYELOMA; VERSUS-HOST-DISEASE; TERM-FOLLOW-UP; AUTOLOGOUS TRANSPLANTATION; MARROW-TRANSPLANTATION; BONE-MARROW; BORTEZOMIB; THERAPY; TRIAL; GRAFT	We retrospectively evaluated single-institute outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with a reduced-intensity conditioning regimen consisting of fludarabine (125 mg/m(2)) and melphalan (140 mg/m(2)) for multiple myeloma. Twenty-three patients (median age: 46 years) were evaluated. Stem cell sources were bone marrow or peripheral blood stem cells from siblings (n = 4) and bone marrow from unrelated donors (n = 19). For graft-versus-host disease prophylaxis, cyclosporine A or tacrolimus with short-term methotrexate was given. Disease status at time of transplant was complete response in four patients, very good partial or partial response in 13, and stable or progressive disease in six. The median follow-up period of 7 survivors at analysis was 73.2 months (range 46.0-158.9 months). During the follow-up, disease recurrence or progression was observed in 21 patients, and was primary causes of death in 88 % of the patients. The 5-year overall survival and progression-free survival rates were 38.6 % (95 % CI 19.3-57.7 %) and 5.4 % (95 % CI 0.4-21.6 %), respectively. Although allo-HSCT with this conditioning could be safely performed, further refinement of this approach aiming at more effective eradication of myeloma cells is clearly warranted.	[Kikuchi, Taku; Mori, Takehiko; Koda, Yuya; Kohashi, Sumiko; Kato, Jun; Toyama, Takaaki; Shimizu, Takayuki; Okamoto, Shinichiro] Keio Univ, Div Hematol, Dept Med, Sch Med,Shinjuku Ku, Tokyo 1608582, Japan; [Nakazato, Tomonori; Aisa, Yoshinobu] Yokohama Municipal Citizens Hosp, Dept Hematol, Yokohama, Kanagawa, Japan	Mori, T (reprint author), Keio Univ, Div Hematol, Dept Med, Sch Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tmori@a3.keio.jp			GlaxoSmithKline; Sanofi K.K.	SO received research funding from GlaxoSmithKline and Sanofi K.K.	Bensinger WI, 1996, BLOOD, V88, P2787; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Crawley C, 2007, BLOOD, V109, P3588, DOI 10.1182/blood-2006-07-036848; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Gahrton G, 2013, BLOOD, V121, P5055, DOI 10.1182/blood-2012-11-469452; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; Kroger N, 2013, BONE MARROW TRANSPL, V48, P403, DOI 10.1038/bmt.2012.142; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Moreau P, 2008, BLOOD, V112, P3914, DOI 10.1182/blood-2008-07-168823; Rosinol L, 2008, BLOOD, V112, P3591, DOI 10.1182/blood-2008-02-141598; Crawley C, 2005, BLOOD, V105, P4532, DOI 10.1182/blood-2004-06-2387; BIRD JM, 1993, BONE MARROW TRANSPL, V12, P651; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Kumar S, 2008, BONE MARROW TRANSPL, V42, P413, DOI 10.1038/bmt.2008.180; Giaccone L, 2011, BLOOD, V117, P6721, DOI 10.1182/blood-2011-03-339945; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Baron F, 2006, BEST PRACT RES CL HA, V19, P637, DOI 10.1016/j.beha.2006.06.002; Lokhorst HM, 2012, BLOOD, V119, P6219, DOI 10.1182/blood-2011-11-393801; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Koreth J, 2012, J CLIN ONCOL, V30, P3202, DOI 10.1200/JCO.2012.42.0984; Watanabe R, 2013, INT J HEMATOL, V97, P333, DOI 10.1007/s12185-013-1294-z; Barlogie B, 2006, J CLIN ONCOL, V24, P929, DOI 10.1200/JCO.2005.04.5807; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Gahrton G, 2001, BRIT J HAEMATOL, V113, P209, DOI 10.1046/j.1365-2141.2001.02726.x; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sun K, 2004, P NATL ACAD SCI USA, V101, P8120, DOI 10.1073/pnas.0401563101; Shimazaki C, 2005, INT J HEMATOL, V81, P342, DOI 10.1532/IJH97.04174; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Cancer Therapy Evaluation Program [CTCAE], 2009, CANC THER EV PROGR C	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					670	677		10.1007/s12185-015-1873-2		8	Hematology	Hematology	CX7HC	WOS:000365871800004		
J	Takashima, S; Miyamoto, T; Kamimura, T; Yoshimoto, G; Yoshida, S; Henzan, H; Takase, K; Kato, K; Ito, Y; Ohno, Y; Nagafuji, K; Eto, T; Teshima, T; Akashi, K				Takashima, Shuichiro; Miyamoto, Toshihiro; Kamimura, Tomohiko; Yoshimoto, Goichi; Yoshida, Shuro; Henzan, Hideho; Takase, Ken; Kato, Koji; Ito, Yoshikiyo; Ohno, Yuju; Nagafuji, Koji; Eto, Tetsuya; Teshima, Takanori; Akashi, Koichi			Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Ph(+)ALL; Tyrosine kinase inhibitor; Pretransplant conditioning; Allo-SCT; Minimal residual disease	MINIMAL RESIDUAL DISEASE; LONG-TERM OUTCOMES; COMPLETE REMISSION; REDUCED-INTENSITY; ADULT PATIENTS; MARROW TRANSPLANTATION; MAINTENANCE THERAPY; INDUCTION THERAPY; EUROPEAN GROUP; IMATINIB	We retrospectively analyzed the outcomes of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph(+)ALL) who underwent first allogeneic stem cell transplantation (allo-SCT) at complete remission (CR) with myeloablative conditioning (MAC, n = 31) or reduced-intensity conditioning (RIC, n = 15) between 2001 and 2012. All the patients had received tyrosine kinase inhibitor (TKI)-based chemotherapy prior to allo-SCT. Overall survival (OS) rates (57 vs 63 %, p = 0.53), leukemia-free survival rates (50 vs 65 %, p = 0.29), and non-relapse mortality rates (39 vs 35 %, p = 0.62) at 2 years were similar between the MAC and RIC groups. The minimal residual disease (MRD) status evaluated by sensitive polymerase chain reaction prior to allo-SCT did not influence the OS rate (77 vs 54 %, p = 0.28) and leukemia-free survival rate (69 vs 51 %, p = 0.48), irrespective of the conditioning intensity. Our data suggest that the RIC regimen may represent a sufficient intensity of therapeutic pre-transplant conditioning for patients with Ph(+)ALL who have maintained a hematological CR with TKI-combined chemotherapy.	[Takashima, Shuichiro; Miyamoto, Toshihiro; Yoshimoto, Goichi; Kato, Koji; Akashi, Koichi] Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Takashima, Shuichiro; Kamimura, Tomohiko] Harasanshin Hosp, Dept Hematol, Hakata Ku, Fukuoka 8120033, Japan; [Yoshida, Shuro; Henzan, Hideho; Takase, Ken; Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Chuo Ku, Fukuoka 8108539, Japan; [Ito, Yoshikiyo] Kyushu Univ, Dept Internal Med, Beppu Hosp, Beppu, Oita 8740838, Japan; [Ohno, Yuju] Kitakyushu Municipal Med Ctr, Dept Internal Med, Kokurakita Ku, Kitakyushu, Fukuoka 8020077, Japan; [Nagafuji, Koji] Kurume Univ, Dept Med, Div Hematol & Oncol, Sch Med, Kurume, Fukuoka 8300011, Japan; [Teshima, Takanori] Hokkaido Univ, Grad Sch Med, Dept Hematol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Miyamoto, T (reprint author), Kyushu Univ, Dept Med & Biosyst Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	toshmiya@intmed1.med.kyushu-u.ac.jp			JSPS KAKENHI [23390254, 24659462]	We appreciate the medical and nursing staff working on Kyushu University Hospital and participating hospitals. This work was supported by JSPS KAKENHI (23390254, 24659462 to T.M.).	Tucunduva L, 2014, BRIT J HAEMATOL, V166, P749, DOI 10.1111/bjh.12970; Wahid SFA, 2013, INT J HEMATOL, V97, P581, DOI 10.1007/s12185-013-1313-0; Eom KS, 2013, AM J HEMATOL, V88, P634, DOI 10.1002/ajh.23465; Lee S, 2005, BLOOD, V105, P3449, DOI 10.1182/blood-2004-09-3785; Aoe M, 2014, INT J HEMATOL, V99, P609, DOI 10.1007/s12185-014-1565-3; Caocci G, 2012, BIOL BLOOD MARROW TR, V18, P652, DOI 10.1016/j.bbmt.2011.12.587; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177; Mizuta S, 2014, BLOOD, V123, P2325, DOI 10.1182/blood-2013-11-538728; Bassan R, 2010, J CLIN ONCOL, V28, P3644, DOI 10.1200/JCO.2010.28.1287; Mortuza FY, 2002, J CLIN ONCOL, V20, P1094, DOI 10.1200/JCO.20.4.1094; Preudhomme C, 1997, LEUKEMIA, V11, P294, DOI 10.1038/sj.leu.2400567; Thomas DA, 2004, BLOOD, V103, P4396, DOI 10.1182/blood-2003-08-2958; Watanabe A, 2013, PEDIATR INT, V55, pe56, DOI 10.1111/ped.12019; Pane F, 2005, LEUKEMIA, V19, P628, DOI 10.1038/sj.leu.2403683; Mohty M, 2010, BLOOD, V116, P4439, DOI 10.1182/blood-2010-02-266551; Ribera JM, 2010, HAEMATOL-HEMATOL J, V95, P87, DOI 10.3324/haematol.2009.011221; Pfeifer H, 2013, LEUKEMIA, V27, P1254, DOI 10.1038/leu.2012.352; Ueda T, 1998, INT J HEMATOL, V68, P279; LINKER CA, 1991, BLOOD, V78, P2814; Teng CLJ, 2013, ANN HEMATOL, V92, P1137, DOI 10.1007/s00277-012-1670-4; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Bachanova V, 2014, LEUKEMIA, V28, P658, DOI 10.1038/leu.2013.253; Fielding AK, 2014, BLOOD, V123, P843, DOI 10.1182/blood-2013-09-529008; Ravandi F, 2013, BLOOD, V122, P1214, DOI 10.1182/blood-2012-11-466482; LARSON RA, 1995, BLOOD, V85, P2025; Wassmann B, 2005, BLOOD, V106, P458, DOI 10.1182/blood-2004-05-1746; Takeuchi J, 2002, LEUKEMIA, V16, P1259, DOI 10.1038/sj.leu.2402526; Brissot E, 2015, HAEMATOLOGICA, V100, P392, DOI 10.3324/haematol.2014.116954; Wassmann B, 2006, BLOOD, V108, P1469, DOI 10.1182/blood-2005-11-4386; Raff T, 2007, BLOOD, V109, P910, DOI 10.1182/blood-2006-07-037093; Ito Yoshikiyo, 2015, Clin Lymphoma Myeloma Leuk, V15, pe47, DOI 10.1016/j.clml.2014.09.006	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					689	696		10.1007/s12185-015-1883-0		8	Hematology	Hematology	CX7HC	WOS:000365871800006		
J	Hatanaka, M; Miyamura, T; Koh, K; Taga, T; Tawa, A; Hasegawa, D; Kajihara, R; Adachi, S; Ishii, E; Tomizawa, D				Hatanaka, Michiki; Miyamura, Takako; Koh, Katsuyoshi; Taga, Takashi; Tawa, Akio; Hasegawa, Daisuke; Kajihara, Ryosuke; Adachi, Souichi; Ishii, Eiichi; Tomizawa, Daisuke			Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Respiratory syncytial virus; Acute leukemia; Infants	ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; AEROSOLIZED RIBAVIRIN; TRANSPLANT PATIENTS; CHILDREN; HEMATOLOGY; OUTBREAK; ONCOLOGY	Respiratory syncytial virus (RSV) can cause life-threatening complications of lower respiratory tract infection (LRTI) in young children with malignancies, but reports remain limited. We performed a retrospective nationwide survey to clarify the current status of RSV disease among infants with hematological malignancies. Clinical course, treatment, and outcome of patients with hematological malignancies who suffered from RSV infections at the age of < 24 months during anti-tumor therapy from April 2006 to March 2009 were investigated by sending a questionnaire to all member institutions of the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG). Twelve patients with acute leukemia were identified as having experienced RSV disease. The primary diseases were acute myeloid leukemia (n = 8) and acute lymphoblastic leukemia (n = 4). RSV infection occurred pre- or during induction therapy (n = 8) and during consolidation therapy (n = 4). Eight patients developed LRTI, four of whom had severe pneumonia or acute respiratory distress syndrome; these four patients died despite receiving intensive care. In our survey, the prognosis of RSV disease in pediatric hematological malignancies was poor, and progression of LRTI in particular was associated with high mortality. In the absence of RSV-specific therapy, effective prevention and treatment strategies for severe RSV disease must be investigated.	[Hatanaka, Michiki] Fukuoka Univ, Dept Pediat, Fukuoka 81401, Japan; [Miyamura, Takako] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Taga, Takashi] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan; [Tawa, Akio] Osaka Natl Hosp, Natl Hosp Org, Dept Pediat, Osaka, Japan; [Hasegawa, Daisuke] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Kajihara, Ryosuke] Yokohama City Univ, Dept Pediat, Yokohama, Kanagawa 232, Japan; [Adachi, Souichi] Kyoto Univ, Human Hlth Sci, Kyoto, Japan; [Ishii, Eiichi] Ehime Univ, Dept Pediat, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Div Leukemia & Lymphoma, Childrens Canc Ctr, Tokyo, Japan	Miyamura, T (reprint author), Osaka Univ, Dept Pediat, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	miyamu@ped.med.osaka-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan [H26-KakushintekiGan-Ippan-061, 068]; National Center for Child Health and Development [27-4]	The authors gratefully acknowledge all the patients and the JPLSG institutions who participated in this study. This work was supported in part by a Grant for Clinical Cancer Research from the Ministry of Health, Labour, and Welfare of Japan (H26-KakushintekiGan-Ippan-061 and 068) and by a Grant of the National Center for Child Health and Development (27-4).	Adams RH, 2001, BIOL BLOOD MARROW TR, V7, p16S, DOI 10.1053/bbmt.2001.v7.pm11777099; Shah DP, 2013, J ANTIMICROB CHEMOTH, V68, P1872, DOI 10.1093/jac/dkt111; Shah JN, 2011, BLOOD, V117, P2755, DOI 10.1182/blood-2010-08-263400; Tomizawa D, 2013, INT J HEMATOL, V98, P578, DOI 10.1007/s12185-013-1429-2; Anak S, 2010, PEDIATR PULM, V45, P307, DOI 10.1002/ppul.21184; Chavez-Bueno S, 2007, PEDIATR INFECT DIS J, V26, P1089, DOI 10.1097/INF.0b013e3181343b7e; Sandherr M, 2006, ANN ONCOL, V17, P1051, DOI 10.1093/annonc/mdj132; Mori M, 2014, J INFECT CHEMOTHER, V20, P455, DOI 10.1016/j.jiac.2014.05.001; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Kudo K, 2007, J CLIN ONCOL, V25, P5442, DOI 10.1200/JCO.2007.12.3687; Lehners N, 2013, BONE MARROW TRANSPL, V48, P1548, DOI 10.1038/bmt.2013.94; Koh K, 2015, LEUKEMIA, V29, P290, DOI 10.1038/leu.2014.172; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Shachor-Meyouhas Y, 2013, J PEDIAT HEMATOL ONC, V35, P124, DOI 10.1097/MPH.0b013e3182756edc; Sung L, 2008, PEDIATR BLOOD CANCER, V51, P784, DOI 10.1002/pbc.21710; Camplin RE, 2001, BIOL BLOOD MARROW S, V7, p8S; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; Lambert L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00466; Ljungman P, 2001, BIOL BLOOD MARROW TR, V7, p5S, DOI 10.1053/bbmt.2001.v7.pm11777102; Wendt C H, 1995, Semin Respir Infect, V10, P224	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					697	701		10.1007/s12185-015-1890-1		5	Hematology	Hematology	CX7HC	WOS:000365871800007		
J	Kakinoki, Y; Hashiguchi, J; Ishio, T; Chiba, K; Niino, D; Ohshima, K				Kakinoki, Yasutaka; Hashiguchi, Junichi; Ishio, Takashi; Chiba, Koji; Niino, Daisuke; Ohshima, Koichi			CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Review						Peripheral T-cell lymphoma; CD20; Primary gastric lymphoma; Rituximab	ANTI-CD20 MONOCLONAL-ANTIBODY; HEAVY-CHAIN; CD20; EXPRESSION; LEUKEMIA; IMMUNOGLOBULIN; REARRANGEMENT; LYMPHOCYTES; THERAPY; ANTIGEN	There have been rare reported cases of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) that co-expressed CD20. A 44-year-old Japanese male was initially misdiagnosed as CD20-positive diffuse large B-cell lymphoma with a background of reactive CD3-positive T-cells in the stomach. After four cycles of R-CHOP [rituximab plus cyclophosphamide (CY), doxorubicin, vincristine, and prednisolone (PSL)], total gastrectomy with regional lymph node dissection was performed due to the poor response to R-CHOP. A final diagnosis of CD20-positive primary gastric PTCL-NOS was made based on the immunohistochemical, flow cytometric, and molecular genetic findings. In the present case, CD20 immunostaining for T-cell lymphoma cells in tumor tissue varied; in a large part, these were strong to weak-positive, and in some parts, absent. We additionally reviewed the literature focusing on CD20-positive PTCL-NOS treated with rituximab. The administration of rituximab has been performed as an initial treatment in 11 cases, including the case reported here. The response was good in cases with high expression of CD20, while it was poor in cases with variable intensity in CD20 staining, which is consistent with our experience in the present case. The efficacy of rituximab may be associated with intensity of CD20 expression in T cells and its homogeneity in the tumor tissue.	[Kakinoki, Yasutaka; Ishio, Takashi; Chiba, Koji] Asahikawa City Hosp, Dept Hematol, Asahikawa, Hokkaido 0708610, Japan; [Hashiguchi, Junichi] Hokkaido Univ, Dept Hematol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Niino, Daisuke; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan	Kakinoki, Y (reprint author), Asahikawa City Hosp, Dept Hematol, 1-65,Kinseicho 1, Asahikawa, Hokkaido 0708610, Japan.	y_kakinoki@city.asahikawa.hokkaido.jp					Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Went P, 2006, J CLIN ONCOL, V24, P2472, DOI 10.1200/JCO.2005.03.6327; Magro CM, 2006, AM J CLIN PATHOL, V126, P14, DOI 10.1309/HPYGFLNXKFBHDQEV; Mohrmann RL, 2000, MODERN PATHOL, V13, P1244, DOI 10.1038/modpathol.3880229; Rahemtullah A, 2008, AM J SURG PATHOL, V32, P1593, DOI 10.1097/PAS.0b013e31817d7452; Szczepanski T, 1998, AM J HEMATOL, V59, P99, DOI 10.1002/(SICI)1096-8652(199809)59:1<99::AID-AJH21>3.0.CO;2-W; Park YH, 2006, LEUKEMIA RES, V30, P1253, DOI 10.1016/j.leukres.2006.01.018; Buckner CL, 2007, ANN CLIN LAB SCI, V37, P263; Yachida S, 2010, HEPATO-GASTROENTEROL, V57, P383; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Maloney DG, 1997, BLOOD, V90, P2188; HULTIN LE, 1993, CYTOMETRY, V14, P196, DOI 10.1002/cyto.990140212; Algino KM, 1996, AM J CLIN PATHOL, V106, P78; Yao X, 2001, MODERN PATHOL, V14, P105, DOI 10.1038/modpathol.3880265; Jilani I, 2003, BLOOD, V102, P3514, DOI 10.1182/blood-2003-01-0055; Coiffier B, 1998, BLOOD, V92, P1927; Sun T, 2004, J CLIN PATHOL, V57, P442, DOI 10.1136/jcp.2003.011734; Szczepanski T, 1999, BLOOD, V93, P4079; Kamata M, 2014, INT J DERMATOL, V53, pE24, DOI 10.1111/j.1365-4632.2012.05483.x; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Arai Honoka, 2012, Rinsho Ketsueki, V53, P705; Cumiskey J, 2010, DIAGN HISTOPATHOL, V16, P111; Hirata Yuji, 2009, Leuk Res, V33, pe13, DOI 10.1016/j.leukres.2008.09.034; Intlekofer AM, 2014, INT J HEMATOL, V99, P249, DOI 10.1007/s12185-014-1521-2; Kitamura A, 2005, J CLIN EXP HEMATOPAT, V45, P45, DOI 10.3960/jslrt.45.45; [李媛媛 Li Yuanyuan], 2012, [中国实验血液学杂志, Journal of Experimental Hematology], V20, P1374; Makita Masanori, 2009, Rinsho Ketsueki, V50, P413; Matnani RG, 2013, CASE REP HEMATOL, V2013, pe1; QUINTANILLAMARTINEZ L, 1994, AM J CLIN PATHOL, V102, P483; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tomita A, 2008, HEMATOL ONCOL, V56, P466; Warzynski JJ, 1994, CYTOMETRY, V18, P88	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					702	708		10.1007/s12185-015-1841-x		7	Hematology	Hematology	CX7HC	WOS:000365871800008		
J	Mashima, K; Suzuki, S; Mori, T; Shimizu, T; Yamada, S; Hirose, S; Okamoto, S; Suzuki, N				Mashima, Kyoko; Suzuki, Shigeaki; Mori, Takehiko; Shimizu, Toshihiko; Yamada, Satoshi; Hirose, Shigemichi; Okamoto, Shinichiro; Suzuki, Norihiro			Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after treatment for Hodgkin's lymphoma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						CNS lymphoma; CLIPPERS; MRI; Brain biopsy	B-CELL LYMPHOMA; CNS LYMPHOMA	Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a rare central nervous system (CNS) disorder with distinct radiological features. However, CLIPEERS may mimic CNS lymphoma, and several cases in which CLIPPERS occurred premonitory to CNS lymphoma have been reported. We report a 31-year-old man presenting with progressive gait ataxia and the characteristic MRI features of CLIPPERS. He was diagnosed with stage II Hodgkin's lymphoma at the age of 15, and we considered the possibility of newly emerged CNS lymphoma occurring in the immunosuppressive condition after the treatment of Hodgkin's lymphoma. Histological findings showed no evidence of CNS lymphoma and the neurological symptoms were resolved by steroids. Although CLIPPERS developed in the reverse order in this case, CLIPPERS should be considered in different diagnosis for CNS lymphoma.	[Mashima, Kyoko; Suzuki, Shigeaki; Shimizu, Toshihiko; Yamada, Satoshi; Suzuki, Norihiro] Keio Univ, Dept Neurol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Mori, Takehiko; Okamoto, Shinichiro] Keio Univ, Div Hematol, Dept Med, Sch Med, Tokyo 1608582, Japan; [Hirose, Shigemichi] Keio Univ, Div Diagnost Pathol, Sch Med, Tokyo 1608582, Japan	Suzuki, S (reprint author), Keio Univ, Dept Neurol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	k-mash.1992@live.jp; sgsuzuki@z3.keio.jp; tmori@a3.keio.jp; shimizu-toshi@umin.ac.jp; ymd.jan.88@image.ocn.ne.jp; shirose1231@gmail.com; okamoto@a7.keio.jp; nrsuzuki@a2.keio.jp	Suzuki, Norihiro/J-5125-2013				Taieb G, 2014, J NEUROL SCI, V344, P224, DOI 10.1016/j.jns.2014.06.015; De Graaff HJ, 2013, JAMA NEUROL, V70, P915, DOI 10.1001/jamaneurol.2013.2016; Ortega MR, 2012, NEUROLOGY, V79, P715, DOI 10.1212/WNL.0b013e3182648b77; Pittock SJ, 2010, BRAIN, V133, P2626, DOI 10.1093/brain/awq164; Limousin N, 2012, J NEURO-ONCOL, V107, P223, DOI 10.1007/s11060-011-0724-0; Dalia S, 2014, INT J HEMATOL, V99, P450, DOI 10.1007/s12185-014-1540-z; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Lin AW, 2014, CAN J NEUROL SCI, V41, P528, DOI 10.1017/S0317167100018631; Symmonds M, 2015, NEUROLOGY, V84, P1177, DOI 10.1212/WNL.0000000000001370	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					709	712		10.1007/s12185-015-1850-9		4	Hematology	Hematology	CX7HC	WOS:000365871800009		
J	Kikuma, T; Nakamachi, Y; Noguchi, Y; Okazaki, Y; Shimomura, D; Yakushijin, K; Yamamoto, K; Matsuoka, H; Minami, H; Itoh, T; Kawano, S				Kikuma, Tomoe; Nakamachi, Yuji; Noguchi, Yoriko; Okazaki, Yoko; Shimomura, Daisuke; Yakushijin, Kimikazu; Yamamoto, Katsuya; Matsuoka, Hiroshi; Minami, Hironobu; Itoh, Tomoo; Kawano, Seiji			A new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute promyelocytic leukemia; Myeloid sarcoma; t(5;17)(q35;q12-21); NPM1/RARA; All-trans retinoic acid	MYELOID SARCOMA; CYTOGENETIC CHARACTERIZATION; NPM-RAR; NUCLEOPHOSMIN; PLZF; PML	We report here the first case of NPM1/RARA-positive acute promyelocytic leukemia (APL) preceded by myeloid sarcoma (MS) in the vertebra. A 52-year-old man was diagnosed with MS, as the tumor cells were positive for myeloperoxidase and CD68 but negative for CD163. After treatment with steroids and radiation, the size of the tumor was markedly reduced and peripheral blood count was normal. Bone marrow examination showed 89.2 % consisted of unclassified promyelocytes characterized by round nuclei and abundant small azurophilic granules but no Auer rods. The results of chromosome analysis showed 46,XY,t(5;17)(q35;q12). Reverse-transcription polymerase chain reaction amplified the NPM1/RARA fusion transcripts derived from a combination of NPM1 exon 4 and RARA exon 5, or of NPM1 exon 1 and RARA exon 5; the latter of these has not been reported previously. Electron microscopic examination of the promyelocyte nuclei showed they were oval with mild nuclear chromatin condensation and small- to medium-sized nucleoli. Hematological and molecular complete remission was attained after induction therapy including all-trans retinoic acid. As MS was also diagnosed in two of the seven other reported cases of APL with NPM1/RARA, MS may occur more frequently in APL with NPM1/RARA than APL with PML/RARA.	[Kikuma, Tomoe; Nakamachi, Yuji; Noguchi, Yoriko; Okazaki, Yoko] Kobe Univ Hosp, Dept Clin Lab, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Shimomura, Daisuke] Tenri Hosp, Dept Clin Pathol, Tenri, Nara 632, Japan; [Yakushijin, Kimikazu; Yamamoto, Katsuya; Matsuoka, Hiroshi; Minami, Hironobu] Kobe Univ, Dept Med, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo, Japan; [Itoh, Tomoo] Kobe Univ, Grad Sch Med, Div Diagnost Pathol, Dept Pathol, Kobe, Hyogo 657, Japan; [Kawano, Seiji] Kobe Univ, Grad Sch Med, Div Lab Med, Kobe, Hyogo 657, Japan	Nakamachi, Y (reprint author), Kobe Univ Hosp, Dept Clin Lab, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nakamati@med.kobe-u.ac.jp					Wiernik PH, 1996, CANCER, V78, P2510, DOI 10.1002/(SICI)1097-0142(19961215)78:12<2510::AID-CNCR10>3.0.CO;2-Z; Cheng GX, 1999, P NATL ACAD SCI USA, V96, P6318, DOI 10.1073/pnas.96.11.6318; Hummel JL, 1999, ONCOGENE, V18, P633, DOI 10.1038/sj.onc.1202357; Nakahara F, 2014, INT J HEMATOL, V100, P18, DOI 10.1007/s12185-014-1518-x; Xu L, 2001, LEUKEMIA, V15, P1359, DOI 10.1038/sj.leu.2402205; Pollock SL, 2014, LEUKEMIA LYMPHOMA, V55, P1383, DOI 10.3109/10428194.2013.830303; Benekli M, 1996, LEUKEMIA LYMPHOMA, V22, P183, DOI 10.3109/10428199609051748; Grimwade D, 2000, BLOOD, V96, P1297; Sirulnik A, 2003, BEST PRACT RES CL HA, V16, P387, DOI 10.1053/ybeha.2003.273; Okazuka K, 2007, INT J HEMATOL, V86, P246, DOI 10.1532/IJH97.07036; Redner RL, 1996, BLOOD, V87, P882; Otsubo K, 2012, PEDIATR BLOOD CANCER, V59, P959, DOI 10.1002/pbc.24199; Nicci C, 2005, LEUKEMIA, V19, P470, DOI 10.1038/sj.leu.2403645; Pinan MA, 2014, ANN HEMATOL, V93, P339, DOI 10.1007/s00277-013-1795-0; Kyaw TZ, 2012, TURK J HEMATOL, V29, P278, DOI 10.5505/tjh.2012.94809; Tirado CA, 2010, CANCER GENET CYTOGEN, V200, P47, DOI 10.1016/j.cancergencyto.2010.03.016; Kanegane H, 2009, INT J HEMATOL, V89, P86, DOI 10.1007/s12185-008-0216-y; Naoe T, 2006, CANCER SCI, V97, P963, DOI 10.1111/j.1349-7006.2006.00270.x; Catalano A, 2007, BLOOD, V110, P4073, DOI 10.1182/blood-2007-06-095554; Pacilli L, 2010, ADV HEMATOL, V2010; Pileri SA, 2008, WHO CLASSIFICATION T, P140	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					713	718		10.1007/s12185-015-1857-2		6	Hematology	Hematology	CX7HC	WOS:000365871800010		
J	Hiramoto, R; Imamura, T; Muramatsu, H; Wang, XN; Kanayama, T; Zuiki, M; Yoshida, H; Moroto, M; Fujiki, A; Chiyonobu, T; Osone, S; Ishida, H; Kojima, S; Hosoi, H				Hiramoto, Rika; Imamura, Toshihiko; Muramatsu, Hideki; Wang, Xinan; Kanayama, Takuyo; Zuiki, Masashi; Yoshida, Hideki; Moroto, Masaharu; Fujiki, Atsushi; Chiyonobu, Tomohiro; Osone, Shinya; Ishida, Hiroyuki; Kojima, Seiji; Hosoi, Hajime			Serial investigation of PTPN11 mutation in nonhematopoietic tissues in a patient with juvenile myelomonocytic leukemia who was treated with unrelated cord blood transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						PTPN11; Juvenile myelomonocytic leukemia; Nonhematological tissue; Somatic mosaicism; Cord blood transplantation	MYELODYSPLASTIC SYNDROMES; MYELOID-LEUKEMIA; RECIPIENTS	After allogeneic stem-cell transplantation, nonhematopoietic tissues contain donor-derived cells; however, whether cells from malignant hematological disease can also be found in nonhematopoietic tissues is unclear. This report describes a juvenile myelomonocytic leukemia (JMML) case with a typical PTPN11 mutation (p.E76K) at different allele frequencies in the bone marrow mononuclear cells, buccal smear cells, and fingernails at diagnosis, which was suggestive of PTPN11 somatic mosaicism; however, the PTPN11 mutation in the buccal smear cells and fingernails was lost after unrelated cord blood transplantation. These results suggest that JMML-derived cells may migrate into and reside in nonhematopoietic tissues and furthermore that these cells can be eradicated by cord blood transplantation.	[Hiramoto, Rika; Imamura, Toshihiko; Kanayama, Takuyo; Zuiki, Masashi; Yoshida, Hideki; Moroto, Masaharu; Chiyonobu, Tomohiro; Osone, Shinya; Hosoi, Hajime] Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan; [Muramatsu, Hideki; Wang, Xinan; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Fujiki, Atsushi; Ishida, Hiroyuki] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan	Imamura, T (reprint author), Kyoto Prefectural Univ Med, Dept Pediat, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	imamura@koto.kpu-m.ac.jp					Imanishi D, 2007, BLOOD, V110, P2231, DOI 10.1182/blood-2007-02-071423; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; Doisaki S, 2012, BLOOD, V120, P1485, DOI 10.1182/blood-2012-02-406090; Yoshida R, 2004, AM J MED GENET A, V128A, P63, DOI 10.1002/ajmg.a.30029; Niemeyer CM, 2008, BRIT J HAEMATOL, V140, P610, DOI 10.1111/j.1365-2141.2007.06958.x; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Rovo A, 2005, EXP HEMATOL, V33, P909, DOI 10.1016/j.exphem.2005.04.010; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; EMANUEL PD, 1991, BLOOD, V77, P925	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					719	722		10.1007/s12185-015-1877-y		4	Hematology	Hematology	CX7HC	WOS:000365871800011		
J	Akiyama, M; Yamaoka, M; Mikami-Terao, Y; Ohyama, W; Yokoi, K; Arakawa, Y; Takita, J; Suzuki, H; Yamada, H				Akiyama, Masaharu; Yamaoka, Masayoshi; Mikami-Terao, Yoko; Ohyama, Wataru; Yokoi, Kentaro; Arakawa, Yasuhiro; Takita, Junko; Suzuki, Hideaki; Yamada, Hisashi			Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Maffucci syndrome; Acute myeloid leukemia; Hemangioma; Isocitrate dehydrogenase; Nucleophosmin	INTERNAL TANDEM DUPLICATION; OLLIER-DISEASE; PROGNOSIS; FLT3; NUCLEOPHOSMIN; NUCLEI; AML	Maffucci syndrome is a nonhereditary congenital disorder characterized by multiple enchondromas and with soft-tissue hemangiomas. Somatic mutations of the isocitrate dehydrogenase (IDH) gene have been detected in enchondroma and hemangioma tissue from patients with Maffucci syndrome. The rate of malignant transformation in Maffucci syndrome is high, with enchondromas transforming into chondrosarcomas and the development of secondary neoplasms, including pancreatic and hepatic adenocarcinoma, mesenchymal ovarian tumors, and brain tumors such as glioma. However, hematopoietic malignancies arising in Maffucci syndrome are rare. We report a 7-year-old girl with Maffucci syndrome in whom acute myeloid leukemia (AML) with cup-like nuclear invagination developed. Both leukemic cells and hemangioma had the same gene mutations: an insertion frameshift c.863_864insTCTG (p.W288 fs) in the nucleophosmin (NPM1) gene and a missense mutation c.392_395GTCG > CTCT (p.G131_R132 > AL) in the IDH1 gene. However, buccal mucosa cells and peripheral blood mononuclear cells harvested after two cycles of chemotherapy showed wild-type genotypes. These results suggest that the multiple somatic mutations of the IDH1 and NPM1 genes in hemangioblasts are related to the development of cup-like AML associated with Maffucci syndrome. However, further studies are needed to identify additional molecular events in AML but not in hemangioma.	[Akiyama, Masaharu; Yamaoka, Masayoshi; Mikami-Terao, Yoko; Ohyama, Wataru; Yokoi, Kentaro] Jikei Univ, Dept Pediat, Sch Med, Minato Ku, Tokyo 1058461, Japan; [Arakawa, Yasuhiro] Jikei Univ, Sch Med, Dept Adult Oncol & Hematol, Tokyo 1058461, Japan; [Suzuki, Hideaki] Jikei Univ, Sch Med, Dept Anat, Tokyo 1058461, Japan; [Akiyama, Masaharu; Yamada, Hisashi] Jikei Univ, Res Ctr Med Sci, Core Res Facil Basic Sci, Sch Med, Tokyo 1058461, Japan; [Takita, Junko] Univ Tokyo, Dept Pediat, Grad Sch Med, Tokyo, Japan	Akiyama, M (reprint author), Jikei Univ, Dept Pediat, Sch Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	makiyama@jikei.ac.jp			Jikei University Research Fund	The authors thank Dr. Hiroyuki Kataoka, Department of Pediatric Orthopaedic Surgery, Shiga Medical Center for Children, for providing the hemangioma sample. The study was supported by The Jikei University Research Fund (to M. Akiyama).	Chen WN, 2009, CANCER, V115, P5481, DOI 10.1002/cncr.24610; White MS, 2008, PEDIATR BLOOD CANCER, V50, P645, DOI 10.1002/pbc.21050; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Oki K, 2011, LEUKEMIA, V25, P382, DOI 10.1038/leu.2010.307; Moriya K, 2014, CANCER SCI, V105, P359, DOI 10.1111/cas.12337; LAWSON JP, 1990, SKELETAL RADIOL, V19, P158; Verdegaal SHM, 2011, ONCOLOGIST, V16, P1771, DOI 10.1634/theoncologist.2011-0200; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Au WY, 2004, LEUKEMIA LYMPHOMA, V45, P613, DOI 10.1080/10428190310001602381; RECTOR JT, 1993, AM J PEDIAT HEMATOL, V15, P427; Park BG, 2013, ANN HEMATOL, V92, P451, DOI 10.1007/s00277-012-1645-5; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2015	102	6					723	728		10.1007/s12185-015-1892-z		6	Hematology	Hematology	CX7HC	WOS:000365871800012		
J	Oliveira, JL; Ince, G; Nakamura, K; Nakadai, K; Okuno, HG; Gouyon, F; Reis, LP				Oliveira, Joao Lobato; Ince, Gokhan; Nakamura, Keisuke; Nakadai, Kazuhiro; Okuno, Hiroshi G.; Gouyon, Fabien; Reis, Luis Paulo			Beat Tracking for Interactive Dancing Robots	INTERNATIONAL JOURNAL OF HUMANOID ROBOTICS			English	Article						Robot audition; beat tracking; noise suppression; robot dancing; human-robot interaction	SYSTEM; ENSEMBLE; AUDITION; AUDIO; MUSIC	Dance movement is intrinsically connected to the rhythm of music and is a fundamental form of nonverbal communication present in daily human interactions. In order to enable robots to interact with humans in natural real-world environments through dance, these robots must be able to listen to music while robustly tracking the beat of continuous musical stimuli and simultaneously responding to human speech. In this paper, we propose the integration of a real-time beat tracking system with state recovery with different preprocessing solutions used in robot audition for its application to interactive dancing robots. The proposed system is assessed under different real-world acoustic conditions of increasing complexity, which consider multiple audio sources of different kinds, multiple noise sources of different natures, continuous musical and speech stimuli, and the effects of beat-synchronous ego-motion noise and of jittering in ego noise (EN). The overall results suggest improved beat tracking accuracy with lower reaction times to music transitions, while still enhancing automatic speech recognition (ASR) run in parallel in the most challenging conditions. These results corroborate the application of the proposed system for interactive dancing robots.	[Oliveira, Joao Lobato] FEUP, Artificial Intelligence & Comp Sci Lab LIACC, P-4200465 Oporto, Portugal; [Ince, Gokhan] Istanbul Tech Univ, Fac Comp & Informat, TR-34469 Istanbul, Turkey; [Nakamura, Keisuke; Nakadai, Kazuhiro] Honda Res Inst Japan Co Ltd, Wako, Saitama 3510188, Japan; [Okuno, Hiroshi G.] Waseda Univ, Grad Sch Creat Sci & Engn, Grad Program Embodiment Informat, Shinjuku City, Tokyo 1690072, Japan; [Gouyon, Fabien] INESC TEC, Inst Syst & Comp Engn Sci & Technol, P-4200465 Oporto, Portugal; [Reis, Luis Paulo] Univ Minho, Sch Engn DSI, Artificial Intelligence & Comp Sci Lab LIACC, P-4800058 Guimaraes, Portugal	Oliveira, JL (reprint author), FEUP, Artificial Intelligence & Comp Sci Lab LIACC, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	joao.lobato.oliveira@fe.up.pt; gokhan.ince@itu.edu.tr; keisuke@jp.honda-ri.com; nakadai@jp.honda-ri.com; okuno@nue.org; fgouyon@inescporto.pt; lpreis@dsi.uminho.pt			Istanbul Technical University Scientific Research Projects Foundation [BAP 37537];  [SFRH/BD/43704/2008]	This work was partially supported by SFRH/BD/43704/2008 PhD scholarship endorsed by the Portuguese Government through FCT and partially supported by Istanbul Technical University Scientific Research Projects Foundation under the contract BAP 37537.	Davies MEP, 2007, IEEE T AUDIO SPEECH, V15, P1009, DOI 10.1109/TASL.2006.885257; Santiago CB, 2012, INT J COMPUT INT SYS, V5, P700, DOI 10.1080/18756891.2012.718120; Grunberg DK, 2011, IEEE INT C INT ROBOT, P2916, DOI 10.1109/IROS.2011.6048663; Gouyon F, 2005, COMPUT MUSIC J, V29, P34, DOI 10.1162/comj.2005.29.1.34; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Oliveira JL, 2012, IEEE T AUDIO SPEECH, V20, P2696, DOI 10.1109/TASL.2012.2210878; Nakajima H, 2010, IEEE T AUDIO SPEECH, V18, P1476, DOI 10.1109/TASL.2009.2035219; Murata K, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P2459, DOI 10.1109/IROS.2008.4650596; Mizumoto T, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1538, DOI 10.1109/IROS.2008.4650821; Or J, 2007, INT J HUM ROBOT, V4, P21, DOI 10.1142/S0219843607000935; Gouyon F, 2007, INT CONF ACOUST SPEE, P1309; Murata K, 2008, IEEE-RAS INT C HUMAN, P79, DOI 10.1109/ICHR.2008.4755935; Otsuka T, 2010, LECT NOTES ARTIF INT, V6096, P102, DOI 10.1007/978-3-642-13022-9_11; Oliveira JL, 2012, IEEE INT C INT ROBOT, P992, DOI 10.1109/IROS.2012.6386100; Nakadai K, 2010, ADV ROBOTICS, V24, P739, DOI 10.1163/016918610X493561; Goto M, 2001, J NEW MUSIC RES, V30, P159, DOI 10.1076/jnmr.30.2.159.7114; Oliveira JL, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P403, DOI 10.1109/ICRA.2012.6224998; Klapuri AP, 2006, IEEE T AUDIO SPEECH, V14, P342, DOI 10.1109/TSA.2005.854090; Mizumoto T, 2010, IEEE INT C INT ROBOT, P1957; Collins N., 2006, THESIS, P1; Davies M. E. P., 2009, TRANSITION YOUTH YOU, P1; Ince G., 2011, ADV ROBOTICS, V25, P360; Ince G., 2011, ICRA, P3517; Ince G., 2012, IEEE RSJ INT C INT R, P3282; Itohara T, 2012, EURASIP J AUDIO SPEE, DOI 10.1186/1687-4722-2012-6; Lee A., 2009, AS PAC SIGN INF PROC, P131; Moelants D., 2003, TRIENN ESCOM C HAN G, P649; Murata K., 2008, INT SOC MUS INF RETR, P199; Oliveira J. L., 2012, IEEE INT S ROB HUM I, P1078; Otsuka T., 2008, IEEE RSJ INT C INT R, P2289; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Weinberg G., 2009, INT C NEW INT MUS EX, P70; Yoshii K., 2007, IROS, P1743	33	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-8436	1793-6942		INT J HUM ROBOT	Int. J. Humanoid Robot.	DEC	2015	12	4							1550023	10.1142/S0219843615500231		24	Robotics	Robotics	CX4WC	WOS:000365700100007		
J	Katagiri, H; Nakayama, K; Razia, S; Nakamura, K; Sato, E; Ishibashi, T; Ishikawa, M; Iida, K; Ishikawa, N; Otsuki, Y; Nakayama, S; Kyo, S				Katagiri, Hiroshi; Nakayama, Kentaro; Razia, Sultana; Nakamura, Kohei; Sato, Emi; Ishibashi, Tomoka; Ishikawa, Masako; Iida, Kouji; Ishikawa, Noriyoshi; Otsuki, Yoshiro; Nakayama, Satoru; Kyo, Satoru			Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						ovarian clear cell carcinoma; Beclin 1; autophagy	DISTINCT-HISTOLOGIC-TYPE; SURGICAL CYTOREDUCTION; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; CANCER; GENE; TUMORIGENESIS; EXPRESSION; DISEASE; PROGRESSION	The aim of the present study was to clarify the role of autophagy in cisplatin (CDDP) sensitivity in OCCCs and the role of Beclin 1 in OCCC progression. Autophagy was measured using: i) western blot analysis of LC3 and p62 and ii) microscopic observation of GFP-LC3 puncta. Autophagy was suppressed using chloroquine and Beclin 1 siRNA. Surgical specimens were examined for Beclin 1 protein expression by immunohistochemistry. The correlations between the loss of Beclin 1 expression and clinicopathological characteristics, prognosis and chemosensitivity were investigated. Inhibition of autophagy by chloroquine or Beclin 1 siRNA did not enhance the sensitivity of the ES2 and TOV-21G OCCC cell lines to CDDP. Loss of Beclin 1 expression was observed in 38.3% (23/60) of the analyzed tumors. There was no significant correlation between loss of Beclin 1 expression and FIGO stage, CA 125 levels, patient age, status of endometriosis, Ki-67 labeling index, chemotherapy regimen or status of residual tumor. However, negative expression of Beclin 1 was associated with a shorter progression-free survival in comparison to positive Beclin 1 expression in OCCC who received cytoreductive surgery, followed by a standard platinum-based chemotherapy regimen (P=0.027, log-rank test). Beclin 1-negative tumors were no more resistant to primary adjuvant chemotherapy than were Beclin 1-positive tumors (50.0 vs. 66.7%, P=0.937). Beclin 1 knockdown using siRNA increased cell growth but not cell migration and invasion in ES2 and TOV-21G OCCC cell lines. Autophagy defects caused by loss of Beclin 1 are not related to chemoresistance and metastasis, but may be associated with malignant phenotype and poor prognosis of OCCC.	[Katagiri, Hiroshi; Nakayama, Kentaro; Razia, Sultana; Nakamura, Kohei; Sato, Emi; Ishibashi, Tomoka; Ishikawa, Masako; Iida, Kouji; Kyo, Satoru] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan; [Nakayama, Satoru] Seirei Hamamatsu Gen Hosp, Dept Obstet & Gynecol, Hamamatsu, Shizuoka 4308558, Japan; [Otsuki, Yoshiro] Seirei Hamamatsu Gen Hosp, Dept Pathol, Hamamatsu, Shizuoka 4308558, Japan; [Ishikawa, Noriyoshi] Shimane Univ, Sch Med, Dept Organ Pathol, Izumo, Shimane 6938501, Japan	Nakayama, K (reprint author), Shimane Univ, Sch Med, Dept Obstet & Gynecol, Enyacho 89-1, Izumo, Shimane 6938501, Japan.	kn88@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	The present study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Gadducci A, 2000, ANTICANCER RES, V20, P1959; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Zang RY, 2004, CANCER, V100, P1152, DOI 10.1002/cncr.20106; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; Ho CM, 2010, INT J GYNECOL CANCER, V20, P1490, DOI 10.1111/IGC.0b013e3181e68a4d; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Liang XH, 1999, NATURE, V402, P672; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Rahman M, 2012, HUM PATHOL, V43, P2197, DOI 10.1016/j.humpath.2012.03.011; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Kobel M, 2009, MODERN PATHOL, V22, P469, DOI 10.1038/modpathol.2008.206; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Wang JR, 2008, AUTOPHAGY, V4, P947; Sun Y, 2012, INT J GYNECOL CANCER, V22, P1118, DOI 10.1097/IGC.0b013e31825e0caa; Nakayama K, 2001, ONCOL REP, V8, P1285; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Rahman MT, 2012, CANCER-AM CANCER SOC, V118, P2846, DOI 10.1002/cncr.26598; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harter P, 2005, CURR OPIN ONCOL, V17, P505, DOI 10.1097/01.cco.0000174166.06734.c7; Mandai M, 2011, CANCER LETT, V310, P129, DOI 10.1016/j.canlet.2011.06.039; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Gadducci A, 2000, GYNECOL ONCOL, V79, P344, DOI 10.1006/gyno.2000.5992; Schwartz DR, 2002, CANCER RES, V62, P4722; Katagiri A, 2012, MODERN PATHOL, V25, P282, DOI 10.1038/modpathol.2011.161; Furuya D, 2005, EXP CELL RES, V307, P26, DOI 10.1016/j.yexcr.2005.02.023; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Díaz-Montes Teresa P, 2005, Curr Oncol Rep, V7, P451, DOI 10.1007/s11912-005-0010-4; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Siegel Rebecca, 2012, CA Cancer J Clin, V62, P283, DOI 10.3322/caac.21153	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2037	2044		10.3892/ijo.2015.3191		8	Oncology	Oncology	CX1OM	WOS:000365465500005		
J	Kang, N; Cao, SJ; Zhou, Y; He, H; Tashiro, SI; Onodera, S; Qiu, F; Ikejima, T				Kang, Ning; Cao, Shi-Jie; Zhou, Yan; He, Hao; Tashiro, Shin-Ichi; Onodera, Satoshi; Qiu, Feng; Ikejima, Takashi			Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						oridonin; caspase-9; apoptosis; autophagy; reactive oxygen species	CYTOCHROME-C RELEASE; GROWTH-FACTOR-BETA; REACTIVE OXYGEN; HELA-CELLS; FETAL HEPATOCYTES; OXIDATIVE STRESS; JNK ACTIVATION; AUTOPHAGY; DEATH; CARCINOMA	Rabdosia rubescens, a commonly used traditional Chinese medicine, has increasingly gained attention for its use as an antitumor herb. Oridonin, a bioactive diterpenoid isolated from Rabdosia rubescens, has been reported to induce apoptosis in human laryngeal cancer HEp-2 cells by our group. Here, we made unexpected observations that the caspase-9 inhibitor (C9i) enhanced apoptosis in response to selected stimuli, and HEp-2 cells which were made deficient in caspase-9 using siRNA exhibited no resistance to apoptotic signals and actually demonstrated increased apoptotic sensitivity to oridonin. The results were reversed by the transfection of an exogenous caspase-9 expression vector. Caspase-9 reduced sensitivity to apoptotic stimuli through reactive oxygen species (ROS)-suppressing and autophagy-promoting methods. ROS triggered the progression of apoptosis through activation of both the caspase-9-independent mitochondrial pathway and death receptor pathways, and the autophagy had an anti-apoptotic function in oridonin-treated HEp-2 cells. These collective results suggest that oridonin targets caspase-9 to alter ROS production and autophagy situation to promote HEp-2 cell apoptosis. Therefore, oridonin has the potential to be developed as an anticancer agent, and the combination of oridonin with those agents leading to reduction of caspase-9 expression in tumor cells could represent a novel approach to human laryngeal cancer treatment.	[Kang, Ning] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 300193, Peoples R China; [Qiu, Feng] Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin 300193, Peoples R China; [Kang, Ning; He, Hao; Ikejima, Takashi] Shenyang Pharmaceut Univ, China Japan Res Inst Med & Pharmaceut Sci, Shenyang 110016, Peoples R China; [Cao, Shi-Jie; Zhou, Yan] Shenyang Pharmaceut Univ, Dept Nat Prod Chem, Shenyang 110016, Peoples R China; [Tashiro, Shin-Ichi] Inst Clin & Biomed Sci, Kyoto 6038072, Japan; [Onodera, Satoshi] Showa Pharmaceut Univ, Dept Clin & Biomed Sci, Tokyo 1948543, Japan	Ikejima, T (reprint author), Shenyang Pharmaceut Univ, China Japan Res Inst Med & Pharmaceut Sci, 103 Wenhua Rd, Shenyang 110016, Peoples R China.	fengqiu20070118@163.com; ikejimat@vip.sina.com			National Natural Science Foundation of China [81102855]; China Postdoctoral Science Foundation [2013M541192]; China Postdoctoral Science Special Foundation [2014T70224]	This study was supported by National Natural Science Foundation of China (no. 81102855), China Postdoctoral Science Foundation (no. 2013M541192) and China Postdoctoral Science Special Foundation (no. 2014T70224).	Zhang YH, 2008, BIOCHEM BIOPH RES CO, V377, P1205, DOI 10.1016/j.bbrc.2008.10.151; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Shah N, 2004, BLOOD, V104, P2873, DOI 10.1182/blood-2003-10-3720; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Mitsiades CS, 2006, CLIN CANCER RES, V12, P3705, DOI 10.1158/1078-0432.CCR-05-2493; Sakahira H, 1999, J BIOL CHEM, V274, P15740, DOI 10.1074/jbc.274.22.15740; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Jeong HS, 2011, BBA-MOL CELL RES, V1813, P80, DOI 10.1016/j.bbamcr.2010.09.016; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Yu CF, 2008, BIOCHEM BIOPH RES CO, V369, P622, DOI 10.1016/j.bbrc.2008.02.055; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Lee KH, 1999, J BIOMED SCI, V6, P236, DOI 10.1007/BF02253565; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Lu YB, 2006, J SEP SCI, V29, P314, DOI 10.1002/jssc.200500326; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074; Wang HJ, 2008, J PHARMACOL SCI, V107, P260, DOI 10.1254/jphs.08054FP; Wang ZY, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/873175; FUJITA T, 1988, Planta Medica, V54, P414, DOI 10.1055/s-2006-962485; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Marioni G, 2006, CANCER TREAT REV, V32, P504, DOI 10.1016/j.ctrv.2006.07.002; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Rafferty MA, 2001, CLIN OTOLARYNGOL, V26, P442, DOI 10.1046/j.1365-2273.2001.00507.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Wang ZH, 2007, GYNECOL ONCOL, V107, P107, DOI 10.1016/j.ygyno.2007.05.034; Liu JR, 2002, CANCER RES, V62, P924; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Yang YC, 2012, PHYTOCHEM ANALYSIS, V23, P627, DOI 10.1002/pca.2365; Herrera B, 2001, HEPATOLOGY, V34, P548, DOI 10.1053/jhep.2001.27447; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Wu JN, 2008, J PHARMACOL SCI, V108, P32, DOI 10.1254/jphs.FP0072079; Kang N, 2010, J NAT PROD, V73, P1058, DOI 10.1021/np9008199; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Kang N, 2010, CANCER LETT, V294, P147, DOI 10.1016/j.canlet.2010.01.032; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Trejo-Solis C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-156	50	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2045	2056		10.3892/ijo.2015.3186		12	Oncology	Oncology	CX1OM	WOS:000365465500006		
J	Takahashi, Y; Saga, Y; Koyanagi, T; Takei, Y; Machida, S; Taneichi, A; Mizukami, H; Sato, Y; Matsubara, S; Fujiwara, H				Takahashi, Yoshifumi; Saga, Yasushi; Koyanagi, Takahiro; Takei, Yuji; Machida, Sizuo; Taneichi, Akiyo; Mizukami, Hiroaki; Sato, Yasufumi; Matsubara, Shigeki; Fujiwara, Hiroyuki			The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						angiogenesis; ovarian cancer; peritoneal dissemination; SKOV-3; vasohibin-1	NEGATIVE FEEDBACK REGULATOR; MUSCLE-MEDIATED EXPRESSION; TUMOR-GROWTH; EPITHELIAL OVARIAN; ENDOMETRIAL CANCER; POTENT INHIBITOR; CARCINOMA; NEOVASCULARIZATION; ENDOTHELIUM; BEVACIZUMAB	Vasohibin-1 (VASH1) is expressed in vascular endothelial cells stimulated by several angiogenic growth factors and displays autocrine activity to regulate angiogenesis via a negative feedback mechanism. In this study, we investigated the effect of VASH1 on ovarian cancer progression using VASH1-expressing ovarian cancer cells in vitro and in vivo. The growth ability of ovarian cancer cells engineered to express the VASH1 gene remained unchanged in vitro. However, we showed that VASH1 secretion by tumor cells inhibited the growth of human umbilical vein endothelial cells. Further, animal experiments showed that VASH1 expression inhibited tumor angiogenesis and growth. In a murine model of peritoneal dissemination of ovarian cancer cells, VASH1 inhibited peritoneal dissemination and ascites, resulting in significantly prolonged survival in mice. This indicates that VASH1 exerts an antitumor effect on ovarian cancer by inhibiting angiogenesis in the tumor environment. These findings suggest that a novel therapy based on VASH1 could be a useful therapeutic strategy for ovarian cancer.	[Takahashi, Yoshifumi; Saga, Yasushi; Koyanagi, Takahiro; Takei, Yuji; Machida, Sizuo; Taneichi, Akiyo; Matsubara, Shigeki; Fujiwara, Hiroyuki] Jichi Med Univ, Sch Med, Ctr Mol Med, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Mizukami, Hiroaki] Jichi Med Univ, Sch Med, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi 3290498, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 980, Japan	Saga, Y (reprint author), Jichi Med Univ, Sch Med, Dept Obstet & Gynecol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	saga@jichi.ac.jp			Reserch Award to Jichi Medical University Graduate Student	This study was supported by The Reserch Award to Jichi Medical University Graduate Student (Y.T.).	HEINTZ APM, 1988, EUR J SURG ONCOL, V14, P91; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Takahashi K, 2013, CANCER SCI, V104, P1107, DOI 10.1111/cas.12184; Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073; FOGH J, 1977, J NATL CANCER I, V58, P209; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Sato H, 2009, DIABETOLOGIA, V52, P359, DOI 10.1007/s00125-008-1229-z; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takei Y, 2007, INT J CANCER, V120, P278, DOI 10.1002/ijc.22307; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Li DJ, 2010, CANCER SCI, V101, P448, DOI 10.1111/j.1349-7006.2009.01388.x; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Wakusawa R, 2008, AM J OPHTHALMOL, V146, P235, DOI 10.1016/j.ajo.2008.03.019; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Takei Y, 2003, ONCOL REP, V10, P951; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Wiener JR, 1999, CLIN CANCER RES, V5, P2164; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Wakusawa R, 2011, INVEST OPHTH VIS SCI, V52, P3272, DOI 10.1167/iovs.10-6295; Yoshinaga K, 2008, CANCER SCI, V99, P914, DOI 10.1111/j.1349-7006.2008.00777.x; Zhou SY, 2010, MOL VIS, V16, P1389; CLAPP C, 1993, ENDOCRINOLOGY, V133, P1292, DOI 10.1210/en.133.3.1292; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Tamaki K, 2010, CANCER SCI, V101, P1051, DOI 10.1111/j.1349-7006.2009.01483.x; Urabe M, 1997, GENE, V200, P157, DOI 10.1016/S0378-1119(97)00412-5; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; Miyashita H, 2011, PHARMACEUTICALS, V4, P782	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2057	2063		10.3892/ijo.2015.3193		7	Oncology	Oncology	CX1OM	WOS:000365465500007		
J	Mawatari, T; Ninomiya, I; Inokuchi, M; Harada, S; Hayashi, H; Oyama, K; Makino, I; Nakagawara, H; Miyashita, T; Tajima, H; Takamura, H; Fushida, S; Ohta, T				Mawatari, Toshiki; Ninomiya, Itasu; Inokuchi, Masafumi; Harada, Shinichi; Hayashi, Hironori; Oyama, Katsunobu; Makino, Isamu; Nakagawara, Hisatoshi; Miyashita, Tomoharu; Tajima, Hidehiro; Takamura, Hiroyuki; Fushida, Sachio; Ohta, Tetsuo			Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						valproic acid; HDAC inhibitor; Hsp70; Hsp90; breast cancer; HER2	HISTONE DEACETYLASE INHIBITORS; PROTEASOMAL DEGRADATION; TUBULIN ACETYLATION; CHAPERONE FUNCTION; DNA METHYLATION; IN-VIVO; HSP90; EXPRESSION; LINES; HDAC6	Breast cancer encompasses a heterogeneous group of diseases at the molecular level. It is known that chemosensitivity of breast cancer depends on its molecular subtype. We investigated the growth inhibitory effect of valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, and the mechanism of this inhibition on four breast cancer cell lines with different molecular subtypes. The growth inhibitory effect of VPA in the four different breast cancer cell lines was investigated. The alteration of levels of p21 WAF1, cleaved caspase-3, acetylated Heat shock protein (Hsp) 90, acetylated Hsp70, and acetylated a-tubulin by VPA was examined in VPA-sensitive, human epidermal receptor 2 (HER2)-overexpressing SKBR3 cells. The cell growth inhibition of breast cancer cell lines was dependent on the dose and exposure time of VPA. The cell growth of HER2-overexpressing SKBR3 cell line was inhibited by VPA to a much greater degree than other cell lines studied. In SKBR3 cell line, VPA upregulated expression of p21 WAF1 and cleaved caspase-3 in the early phase. VPA markedly increased Hsp70 acetylation in a time-dependent manner but did not increase Hsp90 acetylation. Our data demonstrated that VPA inhibited cell proliferation and induced cell cycle arrest and apoptosis of HER2-overexpressing breast cancer cells. This anti-proliferation effect might be the direct function of VPA as an HDAC inhibitor. We propose an alternative mechanism whereby acetylation of Hsp70 disrupts the function of Hsp90 and leads to downregulation of its client proteins, including HER2 that might be the indirect function of VPA, in the sense that non-histone proteins are acetylated.	[Mawatari, Toshiki; Ninomiya, Itasu; Hayashi, Hironori; Oyama, Katsunobu; Makino, Isamu; Nakagawara, Hisatoshi; Miyashita, Tomoharu; Tajima, Hidehiro; Takamura, Hiroyuki; Fushida, Sachio; Ohta, Tetsuo] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Gastroenterol Surg, Kanazawa, Ishikawa 9208641, Japan; [Inokuchi, Masafumi] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Breast Oncol, Kanazawa, Ishikawa 9208641, Japan; [Harada, Shinichi] Kanazawa Univ, Grad Sch Med Sci, Ctr Biomed Res & Educ, Kanazawa, Ishikawa 9208641, Japan	Inokuchi, M (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Breast Oncol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	inokuchi@staff.kanazawa-u.ac.jp					Li GF, 2012, GENET MOL RES, V11, P77, DOI 10.4238/2012.January.13.1; Fuino L, 2003, MOL CANCER THER, V2, P971; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Huang XP, 2009, CANCER RES, V69, P8403, DOI 10.1158/0008-5472.CAN-09-2146; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Sami S, 2008, J BIOCHEM, V144, P357, DOI 10.1093/jb/mvn074; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Powers MV, 2009, CELL CYCLE, V8, P518; Furumai R, 2002, CANCER RES, V62, P4916; Rocchi P, 2005, ONCOL REP, V13, P1139; Scott GK, 2002, MOL CANCER THER, V1, P385; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Wang Y, 2007, BIOCHEM BIOPH RES CO, V356, P998, DOI 10.1016/j.bbrc.2007.03.076; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Giacinti L, 2012, J CELL PHYSIOL, V227, P3426, DOI 10.1002/jcp.24043; Davie JR, 2000, CRIT REV EUKAR GENE, V10, P303; Olsen CM, 2004, MOL CELL ENDOCRINOL, V213, P173, DOI 10.1016/j.mce.2003.10.032; Yu XD, 2002, J NATL CANCER I, V94, P504; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Nimmanapalli R, 2003, CANCER RES, V63, P5126; Takai N, 2007, CURR MED CHEM, V14, P2548, DOI 10.2174/092986707782023299; Travaglini L, 2009, INT J BIOCHEM CELL B, V41, P225, DOI 10.1016/j.biocel.2008.08.019; Meng QW, 2011, MOL CELL BIOCHEM, V348, P165, DOI 10.1007/s11010-010-0651-y; Pratt WB, 2003, EXP BIOL MED, V228, P111; Bali P, 2005, CLIN CANCER RES, V11, P6382, DOI 10.1158/1078-0432.CCR-05-0344; Hodges-Gallagher L, 2007, BREAST CANCER RES TR, V105, P297, DOI 10.1007/s10549-006-9459-6; Fortunati N, 2008, CANCER LETT, V259, P156, DOI 10.1016/j.canlet.2007.10.006; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Catalano MG, 2007, ENDOCR-RELAT CANCER, V14, P839, DOI 10.1677/ERC-07-0096; Chavez-Blanco A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-2	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2073	2081		10.3892/ijo.2015.3213		9	Oncology	Oncology	CX1OM	WOS:000365465500009		
J	Muto, S; Owada, Y; Inoue, T; Watanabe, Y; Yamaura, T; Fukuhara, M; Okabe, N; Matsumura, Y; Hasegawa, T; Osugi, J; Hoshino, M; Higuchi, M; Suzuki, H; Gotoh, M				Muto, Satoshi; Owada, Yuki; Inoue, Takuya; Watanabe, Yuzuru; Yamaura, Takumi; Fukuhara, Mitsuro; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Osugi, Jun; Hoshino, Mika; Higuchi, Mitsunori; Suzuki, Hiroyuki; Gotoh, Mitsukazu			Clinical significance of expanded Foxp3(+) Helios(-) regulatory T cells in patients with non-small cell lung cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						regulatory T cells; Helios; non-small cell lung cancer; Ikaros gene family; Foxp3	1ST-LINE TREATMENT; INDUCED TREGS; IN-VIVO; EXPRESSION; CHEMOTHERAPY; VACCINES; TUMORS; SUPPRESSION; MULTICENTER; CRIZOTINIB	The functions of different regulatory T cell (T-reg) types in cancer progression are unclear. Recently, expression of the transcription factor Helios was proposed as a marker for natural (non-induced) T(reg)s. The present study investigated the clinical significance of Helios expression in patients with non-small cell lung cancer (NSCLC). We enrolled 64 patients with NSCLC, of whom 45 were treated surgically and 19 received chemotherapy because of advanced/recurrent disease. Their peripheral blood mononuclear cells were examined by flow cytometry. From the 45 surgery patients, we matched 9 patients with recurrent disease with 9 stage-matched patients without recurrence (n=18), compared their specimens immunohistochemically for tumor infiltrating lymphocytes (TILs) and analyzed these data against clinicopathological factors. Helios expression in Foxp3(+) T(reg)s was 47.5 +/- 13.3% in peripheral blood and 18.1 +/- 13.4% in tumor specimens. Percentage of Helios(-) T(reg)s among CD4(+) T cells were significantly higher in the cancer patients (2.4%), especially those with stage IA disease (2.6%) than in healthy donors (1.5%; P<0.001). Patients with low levels of Helios expression in T(reg)s among their TILs had significantly poorer survival (P=0.038). Helios(-) T(reg)s may affect immune suppression, even in early stage NSCLC; they could also be a useful prognostic biomarker in patients with NSCLC, and possibly a novel cancer immunotherapy target.	[Muto, Satoshi; Owada, Yuki; Inoue, Takuya; Watanabe, Yuzuru; Yamaura, Takumi; Fukuhara, Mitsuro; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Osugi, Jun; Hoshino, Mika; Higuchi, Mitsunori; Suzuki, Hiroyuki; Gotoh, Mitsukazu] Fukushima Med Univ, Sch Med, Dept Regenerat Surg, Fukushima 9601295, Japan	Suzuki, H (reprint author), Fukushima Med Univ, Sch Med, Dept Regenerat Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	hiro@fmu.ac.jp					Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Gallimore A, 2002, IMMUNOLOGY, V107, P5, DOI 10.1046/j.1365-2567.2002.01471.x; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Onizuka S, 1999, CANCER RES, V59, P3128; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rossignol M, 2003, J CELL BIOCHEM, V88, P744, DOI 10.1002/jcb.10384; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Elkord E, 2011, CLIN IMMUNOL, V140, P218, DOI 10.1016/j.clim.2011.04.014; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Hatam LJ, 2012, CLIN CANCER RES, V18, P1925, DOI 10.1158/1078-0432.CCR-11-2941; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Kim YC, 2012, BLOOD, V119, P2810, DOI 10.1182/blood-2011-09-377895; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Wainwright DA, 2011, NEURO-ONCOLOGY, V13, P1308, DOI 10.1093/neuonc/nor134; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Creelan BC, 2014, CANCER CONTROL, V21, P80; Garon E, 2013, IASLC 15 WORLD C LUN; Hasegawa T., 2014, MOL CLIN ONCOL, V2, P685, DOI DOI 10.3892/MC0.2014.299; Herbst RS, 2013, J CLIN ONCOL, V31; Horn L, 2012, IASLC 14 WORLD C LUN; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI 10.1056/NEJMoa1408440; Suzuki H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-97; Yadav M, 2012, J EXP MED, V209, pS1711; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2082	2090		10.3892/ijo.2015.3196		9	Oncology	Oncology	CX1OM	WOS:000365465500010		
J	Suzuki, O; Abe, M; Hashimoto, Y				Suzuki, Osamu; Abe, Masafumi; Hashimoto, Yuko			Sialylation and glycosylation modulate cell adhesion and invasion to extracellular matrix in human malignant lymphoma: Dependency on integrin and the Rho GTPase family	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						glycosylation inhibitors; N-linked glycosylation; O-linked glycosylation; sialic acid; cell adhesion; extracellular matrix; integrin; RGD peptide; Rac 1; Cdc42; Rho	N-GLYCOSYLATION; REGULATORY ROLES; O-GLYCOSYLATION; REACTIVE OLIGOSACCHARIDES; LINKED OLIGOSACCHARIDES; ADENOCARCINOMA CELLS; E-CADHERIN; GLYCANS; MIGRATION; FIBRONECTIN	To determine the biological roles of cell surface glycosylation, we modified the surface glycosylation of human malignant lymphoma cell lines using glycosylation inhibitors. The O-glycosylation inhibitor, benzyl-alpha-GalNAc (BZ) enhanced the fibronectin adhesion of HBL-8 cells, a human Burkitt's lymphoma cell line, and of H-ALCL cells, a human anaplastic large cell lymphoma cell line, both of which were established in our laboratory. The N-glycosylation inhibitor, tunicamycin (TM) inhibited the surface expression of Phaseolus vulgaris leukoagglutinating (L-PHA) lectin- and Canavalia ensiformis (ConA) lectin-reactive oligosaccharides in the HBL-8 cell line. Assay of the adhesion of HBL-8 cells to fibronectin showed that fibronectin adhesion is mediated by the integrin very late antigen (VLA)-4 and that not only BZ but also TM treatment enhanced HBL-8 cell adhesion to fibronectin. Furthermore, although BZ treatment also enhanced H-ALCL cell adhesion to fibronectin, this effect was not mediated by VLA-5 or the RGD sequence of fibronectin. We also showed that H-ALCL cell adhesion to galectin-3 was enhanced by pre-treatment with neuraminidase, which cleaves cell surface sialic acid. Additionally, H-ALCL cell adhesion to galectin-3 was inhibited by pre-treatment with the RGD peptide suggesting that cell adhesion to galectin-3 is mediated by integrin (VLA-5). Furthermore, H-ALCL cell invasion of galectin-1 and galectin-3 was inhibited by pre-treatment with the RGD peptide. Therefore, cell adhesion to and invasion of galectin-1 and galectin-3 are integrin-dependent. In addition to these findings, cell adhesion to galectin-3 was markedly inhibited by treatment with beta-lactose compared to treatment with sucrose. Therefore, interactions between integrins and galectin-3 may be mediated through beta-galactose that is linked to glycans of integrins. AZA1, an inhibitor of Ras homolog oncoprotein (Rho) GTPase family proteins, RAS-related C3 botulinus toxin substrate 1 (Rac 1) and Cell division control protein 42 homolog (Cdc42) markedly inhibited cell invasion of galectin-1 and galectin-3 suggesting that Rac 1 and Cdc42 may be involved in the regulation of H-ALCL cell invasion of galectins. In conclusion, artificial modification of cell surface glycosylation revealed the biological roles of glycosylation in the adhesion to and invasion of the extracellular matrix (ECM) by human malignant lymphoma cell lines. These findings will provide new insight into the glycobiology of human malignant lymphoma.	[Suzuki, Osamu; Abe, Masafumi; Hashimoto, Yuko] Fukushima Med Univ, Sch Med, Dept Diagnost Pathol, Fukushima 9601295, Japan	Suzuki, O (reprint author), Fukushima Med Univ, Sch Med, Dept Diagnost Pathol, 1 Hikarigaoka, Fukushima 9601295, Japan.	osuzuki@fmu.ac.jp					Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Sato T, 2005, EUR J PHARM SCI, V25, P221, DOI 10.1016/j.ejps.2005.02.011; Suzuki O, 1999, PATHOL INT, V49, P874, DOI 10.1046/j.1440-1827.1999.00960.x; KOJIMA N, 1994, EXP CELL RES, V214, P537, DOI 10.1006/excr.1994.1291; Matsuura N, 1996, AM J PATHOL, V148, P55; Suzuki O, 2005, INT J ONCOL, V26, P1063; KEMMNER W, 1992, BIOCHIMIE, V74, P117, DOI 10.1016/0300-9084(92)90191-G; Bironaite D, 2000, TUMOR BIOL, V21, P165, DOI 10.1159/000030123; de Freitas JCM, 2011, CANCER CHEMOTH PHARM, V68, P227, DOI 10.1007/s00280-010-1477-8; Zhang LP, 2011, BIOCHEM SOC T, V39, P378, DOI 10.1042/BST0390378; Suzuki O, 2014, INT J ONCOL, V44, P1433, DOI 10.3892/ijo.2014.2319; Suzuki O, 2003, ONCOL REP, V10, P1759; Schraen-Maschke S, 2003, BIOCHIMIE, V85, P219, DOI 10.1016/S0300-9084(03)00018-X; Suzuki O, 2015, INT J ONCOL, V46, P973, DOI 10.3892/ijo.2015.2818; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Suzuki O, 2006, INT J ONCOL, V28, P155; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Przybylo M, 2008, MOL VIS, V14, P625; Zhang Y, 2004, MOL CELL BIOCHEM, V260, P137, DOI 10.1023/B:MCBI.0000026065.84798.62; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Suzuki O, 2007, ONCOL REP, V17, P775; Porowska H, 2004, INT J MOL MED, V13, P459; Yu SJ, 2013, FEBS LETT, V587, P782, DOI 10.1016/j.febslet.2013.02.002; Bassaganas S, 2014, PANCREAS, V43, P109, DOI 10.1097/MPA.0b013e31829d9090; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Guo HB, 2002, CANCER RES, V62, P6837; Paszkiewicz-Gadek A, 2006, INT J MOL MED, V17, P669	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2091	2099		10.3892/ijo.2015.3211		9	Oncology	Oncology	CX1OM	WOS:000365465500011		
J	Tsumura, R; Sato, R; Furuya, F; Koga, Y; Yamamoto, Y; Fujiwara, Y; Yasunaga, M; Matsumura, Y				Tsumura, Ryo; Sato, Ryuta; Furuya, Fumiaki; Koga, Yoshikatsu; Yamamoto, Yoshiyuki; Fujiwara, Yuki; Yasunaga, Masahiro; Matsumura, Yasuhiro			Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						tissue factor; in vivo fluorescence imaging; antibody; Fab fragment; pancreatic cancer	FACTOR EXPRESSION; BREAST-CANCER; PANCREATIC-CANCER; SOLID TUMORS; GROWTH; ANGIOGENESIS; PROGRESSION; METASTASIS; INHIBITION; THROMBOSIS	Tissue factor (TF) is expressed strongly in various types of cancer, especially cancers that are often refractory to treatment, such as pancreatic cancer. In this study, we compared the differences in the biophysical and pharmacological properties of whole IgG and the Fab fragment of anti-human TF monoclonal antibody (1849 antibodies), in order to determine their suitability for application in the diagnosis and treatment of cancers. In the biophysical examination, we investigated the characteristics of 1849-whole IgG and 1849-Fab by SPR sensing and confocal fluorescence microscopy analysis using recombinant human TF antigen and TF-overexpressing human pancreatic cancer cell line, BxPC3, respectively. After conjugation with Alexa-Flour-647, in vivo imaging was conducted in mice bearing BxPC3 xenograft tumors. Furthermore, the distribution of the conjugates in tumors and major organs was evaluated by ex vivo study. The in vitro experiments showed that 1849 antibodies had high affinity against TF antigen. In addition, 1849-Fab showed a faster dissociation rate from the antigen than 1849-whole IgG. In mice, 1849-Fab-Alexa-Flour-647 showed rapid renal clearance and faster tumor accumulation, achieving a high contrast signal over nearby normal tissues in the early phase and enhanced tumor penetration after administration. On the other hand, 1849-whole IgG-Alexa-Flour-647 showed slow clearance from the blood and sustained high tumor accumulation. These results suggest that 1849-Fab may be a useful tool for pancreatic cancer diagnosis.	[Tsumura, Ryo; Sato, Ryuta; Furuya, Fumiaki; Koga, Yoshikatsu; Fujiwara, Yuki; Yasunaga, Masahiro; Matsumura, Yasuhiro] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Dev Therapeut, Kashiwa, Chiba 2778577, Japan; [Tsumura, Ryo; Sato, Ryuta; Fujiwara, Yuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Yamamoto, Yoshiyuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Clin Med, Dept Gastroenterol & Hepatol, Tsukuba, Ibaraki 3058576, Japan	Matsumura, Y (reprint author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Dev Therapeut, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	yhmatsum@east.ncc.go.jp			Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); National Cancer Center Research and Development Fund [23-A-45]	This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) initiated by the Council for Science and Technology Policy (CSTP) (to Y. Matsumura) and the National Cancer Center Research and Development Fund (23-A-45 to Y. Matsumura). We thank Mrs. M. Kanzaki for supporting the animal experiments and Ms. M. Nakayama for secretarial help.	Regina S, 2009, CLIN CHEM, V55, P1834, DOI 10.1373/clinchem.2009.123695; Breij ECW, 2014, CANCER RES, V74, P1214, DOI 10.1158/0008-5472.CAN-13-2440; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Shi SX, 2015, EUR J NUCL MED MOL I, V42, P1295, DOI 10.1007/s00259-015-3038-1; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Langer F, 2012, HAMOSTASEOLOGIE, V32, P95, DOI 10.5482/ha-1160; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; CALLANDER NS, 1992, CANCER, V70, P1194, DOI 10.1002/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO;2-E; Versteeg HH, 2006, SEMIN THROMB HEMOST, V32, P24, DOI 10.1055/s-2006-933337; Kaur S, 2012, CANCER LETT, V315, P97, DOI 10.1016/j.canlet.2011.10.017; Hong H, 2012, J NUCL MED, V53, P1748, DOI 10.2967/jnumed.112.105460; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Harter PN, 2013, NEUROPATHOLOGY, V33, P515, DOI 10.1111/neup.12018; Nitori N, 2005, CLIN CANCER RES, V11, P2531, DOI 10.1158/1078-0432.CCR-04-0866; Saito Y, 2011, EUR J CANCER, V47, P2230, DOI 10.1016/j.ejca.2011.04.028; Ueno T, 2000, BRIT J CANCER, V83, P164; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Khorana AA, 2007, CLIN CANCER RES, V13, P2870, DOI 10.1158/1078-0432.CCR-06-2351; Yamashita H, 2007, J SURG ONCOL, V95, P324, DOI 10.1002/jso.20680; Vrana JA, 1996, CANCER RES, V56, P5063; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Ricart AD, 2007, NAT CLIN PRACT ONCOL, V4, P245, DOI 10.1038/ncponc0774; RICKLES FR, 1992, CANCER METAST REV, V11, P237, DOI 10.1007/BF01307180; Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058; Gurbaxani B, 2013, MOL IMMUNOL, V56, P660, DOI 10.1016/j.molimm.2013.05.008; Schneider DW, 2009, J NUCL MED, V50, P435, DOI 10.2967/jnumed.108.055608; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Adams GP, 2001, CANCER RES, V61, P4750; Koga Y, 2015, INT J CANCER, V137, P1457, DOI 10.1002/ijc.29492; Kaido T, 2005, HEPATO-GASTROENTEROL, V52, P1383; Matsumura Y, 2012, ADV DRUG DELIVER REV, V64, P710, DOI 10.1016/j.addr.2011.12.010; Howlader N. A. M., 1975, SEER CANC STAT REV; Kampmeier F, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-13; Sato R, 2014, CANCER SCI, V105, P1631, DOI 10.1111/cas.12557	36	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2107	2114		10.3892/ijo.2015.3210		8	Oncology	Oncology	CX1OM	WOS:000365465500013		
J	Takeno, N; Inujima, A; Shinohara, K; Yamada, M; Shibahara, N; Sakurai, H; Saiki, I; Koizumi, K				Takeno, Nobuhiro; Inujima, Akiko; Shinohara, Kanna; Yamada, Miyuki; Shibahara, Naotoshi; Sakurai, Hiroaki; Saiki, Ikuo; Koizumi, Keiichi			Immune adjuvant effect of Juzentaihoto, a Japanese traditional herbal medicine, on tumor vaccine therapy in a mouse model	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						tumor vaccine; Juzentaihoto; Japanese traditional herbal medicine; immune adjuvant	JUZEN-TAIHO-TO; KAMPO MEDICINE; CELLS; INDUCTION; ANTIGEN; PHARMACOKINETICS; LYMPHOCYTES; EXPRESSION; PEPTIDES; LIVER	Japanese traditional herbal medicine (Kampo) have been used to improve the general physical condition after surgery and to mitigate the side effects of radiation and chemotherapy in tumor patients. Juzentaihoto (JTT) consists of ten medical herbs, and is also called Shi-Quan-Da-Bu-Tang in Chinese herbal medicine. Among Kampo medicines, JTT has especially gained attention as a biological response modifier. Currently, clinical trials of various tumor vaccine therapies are being performed world-wide. However, tumor antigens that are inoculated as vaccines do not have high immunogenicity; thus, it is difficult to obtain an effective therapeutic effect. Thus, it is necessary to develop a tumor vaccine adjuvant that is more potent and very safe. In the present study, we examined the efficacy of JTT as an oral adjuvant when given together with tumor vaccines. As a result, JTT enhanced the phagocytic ability of OVA antigen and the presentation ability of OVA antigen in dendritic cells in vitro. Furthermore, tumor growth was markedly decreased, and the survival period was significantly prolonged in mice inoculated with mouse lymphoma, which is expressed with tumor model antigen. In conclusion, these findings suggest that JTT can be used with tumor vaccines as an immune adjuvant.	[Takeno, Nobuhiro; Inujima, Akiko; Shinohara, Kanna; Yamada, Miyuki; Sakurai, Hiroaki; Saiki, Ikuo; Koizumi, Keiichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Inujima, Akiko; Shibahara, Naotoshi; Koizumi, Keiichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Inst Nat Med, Div Kampo Diagnost, Toyama 9300194, Japan; [Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan	Koizumi, K (reprint author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan.	kkoizumi@inm.u-toyama.ac.jp			Institute of Natural Medicine, University of Toyama	This study was supported by a Grant-in-Aid for Health Labour Sciences Research Grant and a Grant-in-Aid for the Cooperative Research Project from Institute of Natural Medicine, University of Toyama. We thank Dr Tsuyoshi Nakanishi (Laboratory of Hygienic Chemistry and Molecular Toxicology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Japan), Dr Takeshi Yamamoto, Dr Makoto Kadowaki (Division of Gastrointestinal Pathophysiology, Institute of Natural Medicine of Toyama, Japan) and Dr. Kazuo Ogawa (Tsumura Research Laboratories) for helpful advice and technical support.	Onishi Y, 1998, BIOL PHARM BULL, V21, P761; Nakanishi T, 2000, EUR J IMMUNOL, V30, P1740, DOI 10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U; Matsumoto T, 2000, IMMUNOPHARMACOLOGY, V46, P149, DOI 10.1016/S0162-3109(99)00166-6; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Kato S, 2010, BIOL PHARM BULL, V33, P1878, DOI 10.1248/bpb.33.1878; Chino A, 2005, INT IMMUNOPHARMACOL, V5, P871, DOI 10.1016/j.intimp.2005.01.004; Chen YR, 2009, EUR J DRUG METAB PH, V34, P51; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Xie Y, 2014, BIOMED CHROMATOGR, V28, P1294, DOI 10.1002/bmc.3165; Suzuki H, 2013, JPN J CLIN ONCOL, V43, P695, DOI 10.1093/jjco/hyt075; Saiki I, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/568074; Hayashi A, 2007, J CONTROL RELEASE, V117, P11, DOI 10.1016/j.jconrel.2006.10.011; KIYOHARA H, 1995, PLANTA MED, V61, P429, DOI 10.1055/s-2006-958130; Ohnishi Y, 1998, JPN J CANCER RES, V89, P206; BACIK I, 1994, J IMMUNOL, V152, P381; Mantani N, 2002, PHYTOMEDICINE, V9, P195, DOI 10.1078/0944-7113-00111; Yamakawa J, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/746486; Uezono Y, 2012, CURR PHARM DESIGN, V18, P4839, DOI 10.2174/138161212803216924; Kiyohara H, 2004, EVID-BASED COMPL ALT, V1, P83, DOI 10.1093/ecam/neh004; Babu JS, 1995, VACCINE, V13, P1669, DOI 10.1016/0264-410X(95)00120-P; Iijima K, 1999, AM J CHINESE MED, V27, P191; Munekage M, 2013, DRUG METAB DISPOS, V41, P1256, DOI 10.1124/dmd.112.050112; van der Bruggen P, 2007, J IMMUNOL, V178, P2617; TAKAHASHI H, 1990, NATURE, V344, P873, DOI 10.1038/344873a0; Harding CV, 1996, J CLIN IMMUNOL, V16, P90, DOI 10.1007/BF01540955; Zhao WJ, 2008, J CLIN PHARM THER, V33, P289, DOI 10.1111/j.1365-2710.2008.00899.x; Aranda F, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26621; Iwase S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-222; Okumi Hirokuni, 2014, Biopsychosoc Med, V8, P6, DOI 10.1186/1751-0759-8-6; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2115	2122		10.3892/ijo.2015.3208		8	Oncology	Oncology	CX1OM	WOS:000365465500014		
J	Ohnishi, Y; Yasui, H; Kakudo, K; Nozaki, M				Ohnishi, Yuichi; Yasui, Hiroki; Kakudo, Kenji; Nozaki, Masami			Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						epidermal growth factor receptor; cetuximab; aggregation culture; cell growth; cell migration	EPIDERMAL-GROWTH-FACTOR; INTESTINAL EPITHELIAL-CELLS; RECEPTOR TYROSINE KINASES; NECK-CANCER; C-SRC; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; COLORECTAL-CANCER; TUMOR PROGRESSION; PLUS CETUXIMAB	We have previously shown that growth of the oral squamous cell carcinoma cell line SAS, is resistant to cetuximab in monolayer culture conditions, even though epidermal growth factor receptor (EGFR) was phosphorylated, but the growth of SAS aggregates was sensitive to cetuximab. In the present study, we demonstrate differences in the EGFR signaling pathways utilized by SAS cells in monolayer and suspension cultures at the molecular level. Cetuximab treatment of SAS cells in monolayer cultures inhibits the phosphorylation of EGFR and ERK, and reduces the cell migratory potency, but not cell proliferation. AG1478 treatment reduces the phosphorylation of EGFR, ERK and AKT, and affects cell growth in monolayer cultures. The phosphorylation levels of EGFR and AKT are significantly higher in SAS cell aggregates compared to monolayer cultures. Treatment with cetuximab and AG1478 reduces the growth of SAS aggregates and eliminates the phosphorylation of EGFR and AKT. Furthermore, proliferation of SAS aggregates is also inhibited by LY294002 and MK2206, which are inhibitors of PI3K and AKT, respectively. In addition, treatment with the lipid raft disruptor filipin III reduced the phosphorylation levels of EGFR and Akt in SAS aggregates, but not in SAS monolayer culture. These results suggest the possibility that ligands in the serum stimulate the phosphorylation of EGFR localized in lipid rafts leading to PI3K-AKT activation, which results in the growth of SAS aggregates, therefore resulting in the sensitivity of SAS aggregates to cetuximab.	[Ohnishi, Yuichi; Yasui, Hiroki; Nozaki, Masami] Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, Suita, Osaka 5650871, Japan; [Ohnishi, Yuichi; Yasui, Hiroki; Kakudo, Kenji] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 2, Hirakata, Osaka 5731121, Japan	Nozaki, M (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	mnozaki@biken.osaka-u.ac.jp			Osaka University; Osaka Dental University	This manuscript has been edited for English language by Textcheck English consultants. Funding for this study was provided by Osaka University (M.N.) and Osaka Dental University (K.K.).	MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Laurent-Puig P, 2009, CLIN CANCER RES, V15, P1133, DOI 10.1158/1078-0432.CCR-08-0905; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; MONTESANO R, 1981, J CELL SCI, V51, P95; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; GRANDIS JR, 1993, CANCER RES, V53, P3579; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Ohnishi Y, 2014, ONCOL REP, V32, P780, DOI 10.3892/or.2014.3258; Boeckx C, 2013, ONCOLOGIST, V18, P850, DOI 10.1634/theoncologist.2013-0013; Santos NC, 1998, BIOPHYS J, V75, P1869; BLAY J, 1985, J CELL PHYSIOL, V124, P107, DOI 10.1002/jcp.1041240117; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Galizia G, 2007, ONCOGENE, V26, P3654, DOI 10.1038/sj.onc.1210381; MATTHAY MA, 1993, J CELL SCI, V106, P869; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; CHEN JD, 1993, EXP CELL RES, V209, P216, DOI 10.1006/excr.1993.1304; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; FUJII K, 1995, EXP CELL RES, V216, P261, DOI 10.1006/excr.1995.1032; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Quann K, 2013, CELL CYCLE, V12, P1510, DOI 10.4161/cc.24497; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Ang KK, 2002, CANCER RES, V62, P7350; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Lambert S, 2006, J INVEST DERMATOL, V126, P954, DOI 10.1038/sj.jid.5700168; Cohen EEW, 2004, J CLIN ONCOL, V22, P1743, DOI 10.1200/JCO.2004.06.147; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Bakin AV, 2002, J CELL SCI, V115, P3193; Morozevich GE, 2012, AGING-US, V4, P368; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Rebucci M, 2011, INT J ONCOL, V38, P189, DOI 10.3892/ijo_00000838; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; De Roock W, 2009, NEW ENGL J MED, V360, P834; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953; Nicholson RI, 2001, EUR J CANCER, V37, pS9; Pal HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077270; Rubin Grandis J, 1998, JNCI-J NATL CANCER I, V90, P824; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287	58	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2165	2172		10.3892/ijo.2015.3215		8	Oncology	Oncology	CX1OM	WOS:000365465500019		
J	Miura, R; Yokoyama, Y; Shigeto, T; Futagami, M; Mizunuma, H				Miura, Rie; Yokoyama, Yoshihito; Shigeto, Tatsuhiko; Futagami, Masayuki; Mizunuma, Hideki			Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						carbonyl reductase 1; ovarian cancer; tumor necrotic factor receptor 1; caspases; apoptosis; NF-kappa B	LYMPH-NODE METASTASIS; FACTOR-KAPPA-B; CELL-CARCINOMA; ALPHA; EXPRESSION; APOPTOSIS; DISEASE; ACID	We investigated the mechanisms of the inhibitory effect of carbonyl reductase 1 (CR1) on ovarian cancer growth mediated by the activation of the tumor necrotic factor receptor (TNFR) pathway. OVCAR-3 and TOV21G cells overexpressing CR1 were constructed by transfecting them with CR1 cDNA by lipofection. CR1-overexpressing and control OVCAR-3 and TOV21G cells were injected subcutaneously into nude mice and the tumor growth was compared between the two groups for 3-4 weeks. The expression of TNFR1 and TNFR2 in tumors was examined immunohistochemically at the end of the experiment. Expression levels of caspase-8 and -3 activated by TNFR1, c-Jun activated by TNFR2, and NF-kappa B activated by both TNFR1 and TNFR2 were determined using immunohistochemistry and western blot analysis. Tumor growth was significantly suppressed in mice injected with CR1-overexpressing cells. Tumor volume in the CR1 induction group decreased temporarily until 2 weeks. Tumor cell membranes in both CR1 induction and control groups were positive for TNFR1 expression; however, total protein levels did not differ between the two groups. TNFR-2 expression was comparatively weak in both groups. The expression of NF-kappa B and c-Jun was weaker in the CR1 induction group than in control. In contrast, caspase-8 and -3 expression was higher in the CR1 induction group. Furthermore, the number of apoptotic cells was significantly greater in tumors that appeared after injections of both types of CR1-overexpressing cells than in those of control cancer cells. These results suggest that CR1 induces apoptosis by activating the caspase pathway via binding to TNFR1.	[Miura, Rie; Yokoyama, Yoshihito; Shigeto, Tatsuhiko; Futagami, Masayuki; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 0368562, Japan	Yokoyama, Y (reprint author), Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yokoyama@hirosaki-u.ac.jp			Ministry of Education, Science and Culture of Japan [20591935]	This study was supported by a Grant-in Aid for Cancer Research from the Ministry of Education, Science and Culture of Japan (no. 20591935 to Y. Yokoyama).	Osawa Y, 2015, INT J ONCOL, V46, P1252, DOI 10.3892/ijo.2014.2810; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Yokoyama Y, 2007, MOL CANCER THER, V6, P1379, DOI 10.1158/1535-7163.MCT-06-0722; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Umemoto M, 2001, BRIT J CANCER, V85, P1032, DOI 10.1054/bjoc.2001.2034; Murakami A, 2012, CANCER LETT, V323, P69, DOI 10.1016/j.canlet.2012.03.035; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Takano M, 2010, INT J GYNECOL CANCER, V20, P1506, DOI 10.1111/IGC.0b013e3181fcd089; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Wakui M, 2010, J CANCER RES CLIN, V136, P1143, DOI 10.1007/s00432-010-0761-7; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; WERMUTH B, 1988, J BIOL CHEM, V263, P16185; Nishio H, 2014, BRIT J CANCER, V110, P2965, DOI 10.1038/bjc.2014.251; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Murakami A, 2011, CANCER LETT, V311, P77, DOI 10.1016/j.canlet.2011.06.036; Shigeto T, 2007, ONCOL REP, V18, P833; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066; Cebulla J, 2015, BRIT J CANCER, V112, P504, DOI 10.1038/bjc.2014.628; Gonzalez-Covarrubias V, 2007, DRUG METAB DISPOS, V35, P973, DOI 10.1124/dmd.107.014779; Hirakawa H, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-4; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Wang Hui, 2012, Clin Med Insights Oncol, V6, P107, DOI 10.4137/CMO.S9005; Zerbini LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024285	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2173	2180		10.3892/ijo.2015.3205		8	Oncology	Oncology	CX1OM	WOS:000365465500020		
J	Sophonnithiprasert, T; Nilwarangkoon, S; Nakamura, Y; Watanapokasini, R				Sophonnithiprasert, Thanet; Nilwarangkoon, Sirinun; Nakamura, Yukio; Watanapokasini, Ramida			Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						goniothalamin; TRAIL; DR5; cFLIP; apoptosis; colorectal cancer	DEATH RECEPTOR 5; C-FLIP; MEDIATED APOPTOSIS; PROSTATE-CANCER; CARCINOMA-CELLS; LEUKEMIA-CELLS; BREAST-CANCER; CYTOCHROME-C; CYCLE ARREST; GLIOMA-CELLS	The combination of TNF-related apoptosis-inducing ligand (TRAIL) and bioactive compound to enhance apoptosis in TRAIL-resistant cancer is one of cancer treatment strategies. TRAIL possesses the unique capacity to selectively induce apoptosis in cancer cells both in vitro and in vivo with little effect on normal tells. Recent studies have reported that there are many TRAIL-resistant cancers. Thus, bioactive compounds that enhance cytotoxicity of TRAIL would be potential candidates for cancer therapeutic application. This study evaluated the cytotoxic and apoptosis induction upon combined treatment of TRAIL and goniothalamin, the natural styryl-lactone compound extracted from plant Goniothalamus spp., in LoVo cells. The results showed that a combination of goniothalamin and TRAIL enhanced caspase-dependent apoptosis induction in LoVo cells via both death receptor- and mitochondrial-mediated apoptosis pathways. In addition, goniothalamin enhanced TRAIL-induced apoptosis through increased death receptor DR5 expression and decreased anti-apoptotic regulator cFLIP. Interestingly, goniothalamin increased translocation of DR5 to cell surface and consequently contributed to the enhancement of TRAIL-induced apoptosis. In conclusion, this is the first report showing the combined treatment of goniothalamin and TRAIL was able to effectively enhance TRAIL-mediated apoptosis induction in TRAIL-refractory colorectal cancer, LoVo cells. Therefore, this study may offer a strategic cancer treatment against TRAIL-resistant cancers.	[Sophonnithiprasert, Thanet; Nilwarangkoon, Sirinun; Watanapokasini, Ramida] Srinakharinwirot Univ, Fac Med, Dept Biochem, Bangkok 10110, Thailand; [Nakamura, Yukio] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 3908621, Japan	Watanapokasini, R (reprint author), Srinakharinwirot Univ, Fac Med, Dept Biochem, Bangkok 10110, Thailand.	ramidawa@yahoo.com			Royal Golden Jubilee (RGJ) Ph.D. Program from Thailand Research Fund (TRF) Thailand; Strategic Wisdom and Research Institute, Sri nakharinwirot University, Bangkok, Thailand	This study was supported by The Royal Golden Jubilee (RGJ) Ph.D. Program from Thailand Research Fund (TRF) Thailand and the Strategic Wisdom and Research Institute, Sri nakharinwirot University, Bangkok, Thailand.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Alabsi AM, 2012, ASIAN PAC J CANCER P, V13, P5131, DOI 10.7314/APJCP.2012.13.10.5131; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Kichev A, 2014, J BIOL CHEM, V289, P9430, DOI 10.1074/jbc.M113.512350; de Fatima A, 2005, BIOORGAN MED CHEM, V13, P2927, DOI 10.1016/j.bmc.2005.02.007; Sheikh MS, 1998, CANCER RES, V58, P1593; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Yamamoto K, 2012, J ANTIBIOT, V65, P295, DOI 10.1038/ja.2012.21; Tse AKW, 2014, J INVEST DERMATOL, V134, P1397, DOI 10.1038/jid.2013.471; Petsophonsakul P, 2013, ASIAN PAC J CANCER P, V14, P2885, DOI 10.7314/APJCP.2013.14.5.2885; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Garcia-Garcia C, 2010, BIOCHEM PHARMACOL, V79, P853, DOI 10.1016/j.bcp.2009.10.022; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Inayat-Hussain SH, 2003, TOXICOL IN VITRO, V17, P433, DOI 10.1016/S0887-2333(03)00051-1; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265; Nagane M, 2001, APOPTOSIS, V6, P191, DOI 10.1023/A:1011336726649; Murphy AC, 2014, APOPTOSIS, V19, P629, DOI 10.1007/s10495-013-0935-2; Ko H, 2015, ONCOTARGET, V6, P9970; Chen WY, 2005, EUR J PHARMACOL, V522, P20, DOI 10.1016/j.ejphar.2005.08.047; Yoon MJ, 2013, CARCINOGENESIS, V34, P1918, DOI 10.1093/carcin/bgt137; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Chen JJ, 2013, ONCOTARGET, V4, P206; Chan KM, 2006, CHEM-BIOL INTERACT, V159, P129, DOI 10.1016/j.cbi.2005.10.107; Day TW, 2008, BIOCHEM PHARMACOL, V76, P1694, DOI 10.1016/j.bcp.2008.09.007; Nagane M, 2000, CANCER RES, V60, P847; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Shi J, 2003, CURR MOL MED, V3, P727, DOI 10.2174/1566524033479401; Safa A. R., 2012, Experimental Oncology, V34, P176; Kikuchi H, 2007, J NAT PROD, V70, P1910, DOI 10.1021/np0703904; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.E04-03-0184; Wei MC, 2000, GENE DEV, V14, P2060; Grambihler A, 2003, J BIOL CHEM, V278, P26831, DOI 10.1074/jbc.M303229200; Lee SJ, 2011, INT J ONCOL, V38, P485, DOI 10.3892/ijo.2010.878; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; Walczak H, 1999, NAT MED, V5, P157; Fukuda M, 2003, ONCOL REP, V10, P1113; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Han HX, 2015, CELL BIOCHEM BIOPHYS, V72, P533, DOI 10.1007/s12013-014-0499-y; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Buchsbaum Donald J, 2007, Future Oncol, V3, P405, DOI 10.2217/14796694.3.4.405; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Henrich CJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.38; Krajarng A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0544-4; Kuo LJ, 2008, IN VIVO, V22, P305; Lee DH, 2014, TOXICOL APPL PHARM, V279, P253, DOI 10.1016/j.taap.2014.06.030; Pennati M, 2015, INT J CANCER, V136, P299, DOI 10.1002/ijc.28993; Safa AR, 2013, J CARCINOG MUTAGE S6; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Trang Kieu Thi Thu, 2014, Intest Res, V12, P34, DOI 10.5217/ir.2014.12.1.34; Trivedi R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.429; Wattanapiromsakul C, 2005, SONGKLANAKARIN J SCI, V27, P479; Yi Liu, 2014, Cancer Sci, V105, P520, DOI 10.1111/cas.12395; Zhou W, 2014, CELL BIOCH BIOPHYS, V72, P241	67	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2188	2196		10.3892/ijo.2015.3204		9	Oncology	Oncology	CX1OM	WOS:000365465500022		
J	Ishikawa, C; Senba, M; Mori, N				Ishikawa, Chie; Senba, Masachika; Mori, Naoki			Induction of I kappa B-zeta by Epstein-Barr virus latent membrane protein-1 and CD30	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						I kappa B-zeta; Burkitt's lymphoma; Hodgkin's lymphoma; latent membrane protein-1; CD30	LYMPHOCYTE GROWTH TRANSFORMATION; INDUCIBLE NUCLEAR-PROTEIN; REED-STERNBERG CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TAX PROTEIN; IKK-ALPHA; ACTIVATION; DOMAIN; RECEPTOR	Activation of nuclear factor-kappa B (NF-kappa B) in Burkitt's lymphoma (BL) and Hodgkin's lymphoma (HL) cells is important in the transformation and development process of these lymphomas. Epstein-Barr virus (EBV) latent membrane protein-1 (LMP-1) and ligand-independent signaling by overexpressed CD30 are known to cause permanent activation of NF-kappa B in lymphomas. However, hyperactivation of NF-kappa B triggers cellular senescence and apoptosis. Here, we show that I kappa B-zeta an inducible regulator of NF-kappa B, is constitutively expressed in BL and HL cell lines. In addition, immunohistochemical staining identified nuclear I kappa B-zeta-positive BL cells, and Hodgkin and Reed-Sternberg cells in lymph nodes. Expression of LMP-1 and CD30 increased I kappa B-zeta expression at the transcriptional level. I kappa B-zeta promoter was regulated by activation of the NF-kappa B-inducing kinase (NIK)/I kappa B kinase/NF-kappa B pathway via the carboxyl-terminal tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting regions of LMP-1 and CD30. Interestingly, I kappa B-zeta-inhibited NF-kappa B activation by LMP-1 and CD30. The results suggest that NF-kappa B-induced I kappa B-zeta negatively modulates NF-kappa B hyperactivation, resulting in a fine balance that ultimately endows a net evolutionary benefit to the survival of BL and HL cells.	[Ishikawa, Chie; Mori, Naoki] Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, Nishihara, Okinawa 9030215, Japan; [Ishikawa, Chie] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Nishihara, Okinawa 9030213, Japan; [Senba, Masachika] Nagasaki Univ, Inst Trop Med, Dept Pathol, Nagasaki 8528523, Japan	Mori, N (reprint author), Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	naokimori50@gmail.com			JSPS KAKENHI [90542358, 25461428]	We thank Dr Ryuichiro Kimura for excellent assistance and discussion. We express our gratitude to Dr Tatsushi Muta for providing the expression vectors for I kappa B-zeta and its mutants, and reporter plasmids for I kappa B-zeta. We also thank Drs Martin Rowe, Toshiki Watanabe, Lionel Larue, Dean W. Ballard, Romas Geleziunas, Kuan-Teh Jeang, Jun-Ichi Fujisawa, Ken-Ichi Yamamoto, Naofumi Mukaida, Timothy W. McKeithan for providing expression vectors for LMP-1 and its mutants; expression vectors for CD30 and its mutant, and TRAF2-dominant-negative mutant; expression vectors for RelA; for I kappa B alpha- and I kappa B beta-dominant-negative mutants; for NIK-, IKK alpha- and IKK beta-dominant-negative mutants; for IKK gamma-dominant negative mutant; reporter plasmids for NF-kappa B; for IL-6; for IL-8 and AP-1; and for Bcl-3. We acknowledge Dr Takeshi Sairenji for providing B95-8/Ramos. The present study was supported in part by JSPS KAKENHI grant nos. 90542358 and 25461428.	KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Sheehy AM, 1999, J BIOL CHEM, V274, P8708, DOI 10.1074/jbc.274.13.8708; HUEN DS, 1995, ONCOGENE, V10, P549; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Mori N, 1996, BLOOD, V87, P3410; Devergne O, 1998, J VIROL, V72, P7900; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561; Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Aizawa S, 1997, J BIOL CHEM, V272, P2042; Iha H, 2003, ONCOGENE, V22, P8912, DOI 10.1038/sj.onc.1207058; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Horie R, 2002, AM J PATHOL, V160, P1647, DOI 10.1016/S0002-9440(10)61112-1; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Horie R, 2003, DRUG NEWS PERSPECT, V16, P649, DOI 10.1358/dnp.2003.16.10.829295; Ge BS, 2003, J IMMUNOL, V171, P4210; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj/onc/1205337; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Floettmann JE, 1997, ONCOGENE, V15, P1851, DOI 10.1038/sj.onc.1201359; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Jing Hua, 2014, Mol Cells, V37, P189, DOI 10.14348/molcells.2014.2353; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Horie R, 1998, INT IMMUNOL, V10, P203, DOI 10.1093/intimm/10.2.203; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157; McKinsey TA, 1996, MOL CELL BIOL, V16, P2083; SUZUKI T, 1995, ONCOGENE, V10, P1199; Sylla BS, 1998, P NATL ACAD SCI USA, V95, P10106, DOI 10.1073/pnas.95.17.10106; Gasparini C, 2014, CELL MOL LIFE SCI, V71, P2083, DOI 10.1007/s00018-013-1545-4; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Canoz O, 2004, MODERN PATHOL, V17, P911, DOI 10.1038/modpathol.3800140; Carbone A, 2014, ADV EXP MED BIOL, V816, P315, DOI 10.1007/978-3-0348-0837-8_12; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Kimura Ryuichiro, 2013, Neoplasia, V15, P1110; Vockerodt M, 2015, J PATHOL, V235, P312, DOI 10.1002/path.4459	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2197	2207		10.3892/ijo.2015.3218		11	Oncology	Oncology	CX1OM	WOS:000365465500023		
J	Tang, B; Liang, XS; Tang, F; Zhang, J; Zeng, SE; Jin, SJ; Zhou, LH; Kudo, Y; Qi, GY				Tang, Bo; Liang, Xingsi; Tang, Fang; Zhang, Jing; Zeng, Sien; Jin, Shengjian; Zhou, Lihua; Kudo, Yasusei; Qi, Guangying			Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						USP22; survivin; cell cycle; hepatocellular carcinoma	STEM-CELL MARKER; AURORA-B; COLORECTAL-CANCER; METASTATIC CANCER; NUCLEAR SURVIVIN; APOPTOSIS; SIGNATURE; OVEREXPRESSION; PROLIFERATION; PROGRESSION	Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor type, ranking as the third leading cause of all cancer-related deaths in the world. The post-surgical 5-year survival rate is low, largely due to the high recurrence rate. Therefore, the identification of target molecules that control the biological characteristics of HCC is of great importance. Ubiquitin-specific protease 22 (USP22) is a newly discovered deubiquitinating enzyme and is a cancer stem cell marker that plays a role in tumorigenesis, therapy resistance and cell cycle progression. Survivin is a member of the inhibitor of apoptosis protein (TAP) family and is known to function either as an inhibitor for apoptosis or as a regulator of cell division. Levels of survivin are correlated with the aggressiveness of tumors and a poor prognosis in various cancers including HCC. In the present study, we examined the USP22 expression and its association with survivin expression and clinicopathological features in HCC. First, we examined the expression of USP22 and survivin in 151 HCC cases by immunohistochemistry. High expression of USP22 and survivin was frequently observed in HCC cases, in comparison with normal adjacent liver tissues. Expression of USP22 and survivin was well correlated with malignant behavior including tumor size, stage and differentiation in HCC cases. Importantly, HCC patients with high expression of USP22 and survivin showed poor prognosis. USP22 expression was well correlated with survivin expression in HCC cases. This correlation was confirmed in HCC cell lines and tissues by RT-PCR and western blot analysis. Next, to investigate the biological role of USP22 in HCC, we examined the effect of USP22 knockdown on the cell growth and the expression of cell cycle-related protein including survivin in HCC cells. USP22 siRNA suppressed cell growth. Moreover, USP22 siRNA decreased survivin expression together with upregulation of CDK inhibitor, p21 and downregulation of cyclin B. These findings suggest that USP22 may be involved in HCC progression in cooperation with survivin. We suggest that USP22 can be useful as a new prognostic marker and therapeutic target in HCC patients.	[Tang, Bo; Liang, Xingsi; Zhang, Jing] Guilin Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Guilin 541001, Guangxi, Peoples R China; [Tang, Bo; Liang, Xingsi; Zhang, Jing] Guilin Med Univ, Lab Liver Injury & Repair Mol Med, Guilin 541001, Guangxi, Peoples R China; [Tang, Fang] Guilin Med Univ, Affiliated Hosp, Dept Pathol, Guilin 541001, Guangxi, Peoples R China; [Zeng, Sien; Jin, Shengjian; Zhou, Lihua; Qi, Guangying] Guilin Med Univ, Dept Pathol & Physiopathol, Guilin 541004, Guangxi, Peoples R China; [Kudo, Yasusei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan	Kudo, Y (reprint author), Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 7708504, Japan.	yasusei@tokushima-u.ac.jp; 2608689827@qq.com			Important Research Grant from the Guilin Medical University and Affiliated Hospital; National Natural Science Foundation of China [81360367, 81160066, 81460411, 81160256, 30870719]	The present study was supported in part by the Important Research Grant from the Guilin Medical University and Affiliated Hospital. The research was supported in part by the National Natural Science Foundation of China (nos. 81360367, 81160066, 81460411, 81160256 and 30870719).	Peroukides S, 2010, HISTOL HISTOPATHOL, V25, P299; Tuncel H, 2012, ONCOL LETT, V3, P1109, DOI 10.3892/ol.2012.633; Zhang YX, 2011, J CANCER RES CLIN, V137, P1245, DOI 10.1007/s00432-011-0998-9; Bhattacharyya J, 2012, CANCER SCI, V103, P34, DOI 10.1111/j.1349-7006.2011.02121.x; Qi GY, 2010, ORAL ONCOL, V46, P263, DOI 10.1016/j.oraloncology.2010.01.004; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Glinsky GV, 2005, CELL CYCLE, V4, P1171; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Qi GY, 2009, ONCOL REP, V22, P557, DOI 10.3892/or_00000471; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101; Tang B, 2015, ONCOTARGET, V6, P12654; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Li ZJ, 2014, MOL CELL, V54, P805, DOI 10.1016/j.molcel.2014.03.046; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Acquati S, 2013, STEM CELLS, V31, P190, DOI 10.1002/stem.1274; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Liu YL, 2010, DIAGN MOL PATHOL, V19, P194, DOI 10.1097/PDM.0b013e3181e202f2; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Morinaga S, 2004, ONCOL REP, V12, P1189; Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Piao SL, 2013, ORAL ONCOL, V49, P796, DOI 10.1016/j.oraloncology.2013.03.454; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055710; Jin F, 1998, IARC SCI PUBL, V145, P37; Ning J, 2012, Eur J Histochem, V56, pe46, DOI 10.4081/ejh.2012.e46; Piao SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042540	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2208	2216		10.3892/ijo.2015.3214		9	Oncology	Oncology	CX1OM	WOS:000365465500024		
J	Hadisaputri, YE; Miyazaki, T; Suzuki, S; Kubo, N; Zuhrotun, A; Yokobori, T; Abdulah, R; Yazawa, S; Kuwano, H				Hadisaputri, Yuni Elsa; Miyazaki, Tatsuya; Suzuki, Shigemasa; Kubo, Norio; Zuhrotun, Ade; Yokobori, Takehiko; Abdulah, Rizky; Yazawa, Shin; Kuwano, Hiroyuki			Molecular characterization of antitumor effects of the rhizome extract from Curcuma zedoaria on human esophageal carcinoma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						Curcuma zedoaria; esophageal cancer; caspase; Akt/mTOR; apoptosis; angiogenesis; antitumor effects	ESSENTIAL OIL; ANTICANCER ACTIVITY; IN-VITRO; INHIBITS PROLIFERATION; ANTIMICROBIAL ACTIVITY; PANCREATIC-CANCER; ANGIOGENESIS; APOPTOSIS; AKT; ANTIOXIDANT	Curcuma zedoaria has been used as a traditional agent against malignant diseases. To elucidate detailed mechanisms producing such an activity, characterization and determination of molecular mechanisms of its antitumor effects was conducted. Inhibiting activities against cell proliferation, invasion and colony formation, and expression levels of corresponding molecules were investigated using human esophageal cancer TE-8 cells treated with the rhizome extract from C. zedoaria. Antitumor effect of the extract administered orally was also examined in tumor-bearing mice. The extract possessed strong anti-proliferation and invasion activities against TE-8 cells. Further, upregulated PTEN and downregulated phosphorylated Akt, mTOR and STAT3 expressions in the cells were induced shortly after treatment with the extract, followed by attenuation of FGFR1 and MMP-2, activation of caspase-9, caspase-3 and PARP, and suppression of Bcl-2 expressions, which led the cells to apoptotic cell death. Furthermore, tumor formation in mice was significantly suppressed through the oral administration of the extract. Taken together, these results suggest that the C. zedoaria extract could be a promising agent against esophageal cancer.	[Hadisaputri, Yuni Elsa; Miyazaki, Tatsuya; Suzuki, Shigemasa; Kubo, Norio; Yazawa, Shin; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718511, Japan; [Yokobori, Takehiko] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol, Maebashi, Gunma 3718511, Japan; [Zuhrotun, Ade; Abdulah, Rizky] Padjadjaran State Univ, Fac Pharm, Dept Pharmacol & Clin Pharm, Bandung 45363, Indonesia	Hadisaputri, YE (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	m12702030@gunma-uac.jp			Japan Society for the Promotion of Science (JSPS) [22591450, 23591857]	This study was supported in part by the following grants: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS nos. 22591450 and 23591857).	Syu WJ, 1998, J NAT PROD, V61, P1531, DOI 10.1021/np980269k; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Wilson B, 2005, J ETHNOPHARMACOL, V99, P147, DOI 10.1016/j.jep.2005.02.004; Liang G, 2012, TRENDS PHARMACOL SCI, V33, P531, DOI 10.1016/j.tips.2012.07.001; Kuo ML, 1996, BBA-MOL BASIS DIS, V1317, P95, DOI 10.1016/S0925-4439(96)00032-4; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Kanai M, 2013, CANCER CHEMOTH PHARM, V71, P1521, DOI 10.1007/s00280-013-2151-8; Chen H, 1999, ANTICANCER RES, V19, P3675; Mau JL, 2003, FOOD CHEM, V82, P583, DOI 10.1016/S0308-8146(03)00014-1; Chen WX, 2011, J ETHNOPHARMACOL, V133, P220, DOI 10.1016/j.jep.2010.09.031; Makabe H, 2006, NAT PROD RES, V20, P680, DOI 10.1080/14786410500462900; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Chen CC, 2013, J AGR FOOD CHEM, V61, P11418, DOI 10.1021/jf4026184; Carvalho FR, 2010, J VENOM ANIM TOXINS, V16, P324, DOI 10.1590/S1678-91992010000200013; Kim TH, 2011, INT J PHARMACEUT, V403, P285, DOI 10.1016/j.ijpharm.2010.10.041; Peng CH, 2010, DRUG CHEM TOXICOL, V33, P64, DOI 10.3109/01480540903170738; Peng JM, 2012, BRIT J PHARMACOL, V165, P479, DOI 10.1111/j.1476-5381.2011.01581.x; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Mehta K, 1997, ANTI-CANCER DRUG, V8, P470, DOI 10.1097/00001813-199706000-00010; LEE H, 1988, MUTAT RES, V204, P229, DOI 10.1016/0165-1218(88)90093-6; Zhou L, 2013, REPROD TOXICOL, V37, P62, DOI 10.1016/j.reprotox.2013.02.001; Faried A, 2014, J NEUROSURG, V120, P1298, DOI 10.3171/2014.1.JNS131534; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Bharti AC, 2003, J IMMUNOL, V171, P3863; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Johnson SM, 2009, ANTICANCER RES, V29, P3185; Mach CM, 2009, ANTICANCER RES, V29, P1895; Liu YB, 2013, PLANT FOOD HUM NUTR, V68, P72, DOI 10.1007/s11130-013-0333-5; STONER GD, 1991, CANCER RES, V51, P365; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Chen XP, 2011, PHYTOMEDICINE, V18, P1238, DOI 10.1016/j.phymed.2011.06.017; Seo WG, 2005, J ETHNOPHARMACOL, V101, P249, DOI 10.1016/j.jep.2005.04.037; PRETLOW TG, 1991, CANCER RES, V51, P3814; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Gorelik B, 2008, CANCER RES, V68, P9033, DOI 10.1158/0008-5472.CAN-08-1723; GUPTA SK, 1976, LLOYDIA, V39, P218; Faried A, 2007, CANCER SCI, V98, P1358, DOI 10.1111/j.1349-7006.2007.00563.x; Yu SW, 2008, MOL CANCER THER, V7, P2609, DOI 10.1158/1535-7163.MCT-07-2400; Kim KI, 2000, MOL CELLS, V10, P392; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Belcaro G, 2014, PHYTOTHER RES, V28, P444, DOI 10.1002/ptr.5014; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Hashimoto S, 2008, GLYCOCONJ J, V25, P531; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; Hu Y, 2014, ANTI-CANCER DRUG, V25, P183, DOI 10.1097/CAD.0000000000000034; KUROYANA.M, 1970, YAKUGA ZASSHI, V90, P1467; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; Lai EYC, 2004, AM J CHINESE MED, V32, P281, DOI 10.1142/S0192415X0400193X; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Napier Kyle J, 2014, World J Gastrointest Oncol, V6, P112, DOI 10.4251/wjgo.v6.i5.112; Shin Yujin, 2013, Toxicol Res, V29, P257, DOI 10.5487/TR.2013.29.4.257; Syed Abdul Rahman SN, 2013, EVID-BASED COMPL ALT, V2013	57	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	DEC	2015	47	6					2255	2263		10.3892/ijo.2015.3199		9	Oncology	Oncology	CX1OM	WOS:000365465500030		
J	Ohkado, A				Ohkado, Akihiro			How can we sensibly rule out previous episodes of pulmonary tuberculosis disease?	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Editorial Material									[Ohkado, Akihiro] JATA, RIT, Dept Epidemiol & Clin Res, Tokyo, Japan	Ohkado, A (reprint author), JATA, RIT, Dept Epidemiol & Clin Res, Tokyo, Japan.	ohkadoa@jata.or.jp					Allwood BW, 2015, INT J TUBERC LUNG D, V19, P1435, DOI 10.5588/ijtld.14.0992; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Chen-Yuan C, 2008, HDB DISTRICT HOSP RE	3	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	DEC	2015	19	12					1412	1412		10.5588/ijtld.15.0852		1	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CX6UL	WOS:000365837100002		
J	Ikeda, H; Ishii, A; Kikuchi, T; Ando, M; Chihara, H; Arai, D; Hattori, E; Miyamoto, S				Ikeda, Hiroyuki; Ishii, Akira; Kikuchi, Takayuki; Ando, Mitsushige; Chihara, Hideo; Arai, Daisuke; Hattori, Etsuko; Miyamoto, Susumu			Delayed aneurysm rupture due to residual blood flow at the inflow zone of the intracranial paraclinoid internal carotid aneurysm treated with the Pipeline embolization device: Histopathological investigation	INTERVENTIONAL NEURORADIOLOGY			English	Article						Cerebral aneurysm; flow diverter; Pipeline embolization device; aneurysm rupture	SACCULAR ANEURYSMS; EXPERIENCE; HEMODYNAMICS; DIVERSION; STENTS; ARTERY; RECONSTRUCTION; RESOLUTION; DIVERTORS	Cerebral aneurysm rupture is a serious complication that can occur after flow diverter (FD) placement, but the underlying mechanisms remain unclear. We encountered a case in which direct stress on the aneurysm wall caused by residual blood flow at the inflow zone near the neck during the process of thrombosis after FD placement appeared associated with aneurysm rupture. The patient was a 67-year-old woman with progressive optic nerve compression symptoms caused by a large intracranial paraclinoid internal carotid aneurysm. The patient had undergone treatment with a Pipeline embolization device (PED) with satisfactory adherence between the PED and vessel wall. Surgery was completed without complications, and optic nerve compression symptoms improved immediately after treatment. Postoperative clinical course was satisfactory, but the patient suddenly died 34 days postoperatively. Autopsy confirmed the presence of subarachnoid hemorrhage caused by rupture of the internal carotid aneurysm that had been treated with PED. Although the majority of the aneurysm lumen including the outflow zone was thrombosed, a non-thrombosed area was observed at the inflow zone. Perforation was evident in the aneurysm wall at the inflow zone near the neck, and this particular area of aneurysm wall was not covered in thrombus. Macrophage infiltration was not seen on immunohistochemical studies of the aneurysm wall near the perforation. A hemodynamically unstable period during the process of complete thrombosis of the aneurysm lumen after FD placement may be suggested, and blood pressure management and appropriate management with antiplatelet therapy may be important.	[Ikeda, Hiroyuki; Ishii, Akira; Kikuchi, Takayuki; Ando, Mitsushige; Chihara, Hideo; Arai, Daisuke; Hattori, Etsuko; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan	Ishii, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	ishii@kuhp.kyoto-u.ac.jp					Kallmes DF, 2009, AM J NEURORADIOL, V30, P1153, DOI 10.3174/ajnr.A1530; Hampton T, 2011, J NEUROINTERV SURG, V3, P167, DOI 10.1136/jnis.2010.002873; Pumar JM, 2005, AM J NEURORADIOL, V26, P2573; Kim M, 2008, ANN BIOMED ENG, V36, P726, DOI 10.1007/s10439-008-9449-4; Siddiqui AH, 2012, J NEUROSURG, V116, P1258, DOI [10.3171/2012.2.JNS111942, 10.3171/2012.2.JN5111942]; Szikora I, 2013, AM J NEURORADIOL, V34, P935, DOI 10.3174/ajnr.A3547; Meng H, 2006, AM J NEURORADIOL, V27, P1861; Siddiqui AH, 2012, NEUROSURGERY, V71, pE509, DOI 10.1227/NEU.0b013e318258e1f8; Kulcsar Z, 2010, STROKE, V41, P1690, DOI 10.1161/STROKEAHA.110.580308; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Larrabide I, 2012, MED IMAGE ANAL, V16, P721, DOI 10.1016/j.media.2010.04.009; Hassan T, 2011, ACTA NEUROCHIR, V153, P1633, DOI 10.1007/s00701-011-1055-9; Cebral JR, 2011, AM J NEURORADIOL, V32, P27, DOI 10.3174/ajnr.A2398; Turowski B, 2011, NEURORADIOLOGY, V53, P37, DOI 10.1007/s00234-010-0676-7; Szikora I, 2010, AM J NEURORADIOL, V31, P1139, DOI 10.3174/ajnr.A2023; Kulcsar Z, 2011, AM J NEURORADIOL, V32, P20, DOI 10.3174/ajnr.A2370; Nelson PK, 2011, AM J NEURORADIOL, V32, P34, DOI 10.3174/ajnr.A2421; Yu SCH, 2012, RADIOLOGY, V265, P893, DOI 10.1148/radiol.12120422; Fischer S, 2012, NEURORADIOLOGY, V54, P369, DOI 10.1007/s00234-011-0948-x; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; Chow M, 2012, AJNR Am J Neuroradiol, V33, pE46, DOI 10.3174/ajnr.A2532; Darsaut TE, 2013, INTERV NEURORADIOL, V19, P180; Fox B, 2014, J NEUROINTERV SURG, DOI [10.1136/neurintsurg-2014-011325.rep, DOI 10.1136/NEURINTSURG-2014-011325.REP]; Kallmes DF, 2015, AM J NEURORADIOL, V36, P108, DOI 10.3174/ajnr.A4111; Kan P, 2012, NEUROSURGERY, V71, P1080, DOI 10.1227/NEU.0b013e31827060d9; Lylyk P, 2009, NEUROSURGERY, V64, P632, DOI 10.1227/01.NEU.0000339109.98070.65; Moon K, 2014, J NEUROSURG, V121, P1085, DOI 10.3171/2014.7.JNS132677; Shobayashi Y, 2013, J NEUROINTERV SUR S3, V5, P38, DOI DOI 10.1136/NEURINTSURG-2012-010488; Tateshima S, 2014, J NEUROINTERV SURG, DOI [10.1136/neur-intsurg-2014-011214, DOI 10.1136/NEUR-INTSURG-2014-011214]	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	DEC	2015	21	6					674	683		10.1177/1591019915609121		10	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CX3UH	WOS:000365624400006		
J	Asai, K; Nakamura, H; Sakaguchi, M; Kawano, T; Ozaki, T; Ima, H; Kidani, T; Kadono, Y; Murakami, T; Yoshimine, T				Asai, Katsunori; Nakamura, Hajime; Sakaguchi, Manabu; Kawano, Tomohiro; Ozaki, Tomohiko; Ima, Hiroyuki; Kidani, Tomoki; Kadono, Yoshinori; Murakami, Tomoaki; Yoshimine, Toshiki			Direct aspiration first pass technique for a middle cerebral artery occlusion with a hidden aneurysm	INTERVENTIONAL NEURORADIOLOGY			English	Article						Direct aspiration first pass technique (ADAPT); thrombectomy; aneurysm	UNRUPTURED INTRACRANIAL ANEURYSMS; STROKE THROMBECTOMY; ISCHEMIC-STROKE; THROMBOLYSIS	Hidden aneurysms within occluded vessels present a challenge for interventionists because vessel perforation can lead to life-threatening complications. We present a case of middle cerebral artery ischemic stroke, refractory to thrombolysis. A direct aspiration first pass technique (ADAPT) was employed for revascularization. Following thrombectomy, an aneurysm of the occluded vessel was revealed. Despite this, the patient recovered without hemorrhagic complication. ADAPT permits the minimal insertion of endovascular devices and might be a safe procedure when hidden aneurysms are suspected.	[Asai, Katsunori; Nakamura, Hajime; Ozaki, Tomohiko; Ima, Hiroyuki; Kidani, Tomoki; Kadono, Yoshinori; Murakami, Tomoaki; Yoshimine, Toshiki] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Sakaguchi, Manabu; Kawano, Tomohiro] Osaka Univ, Grad Sch Med, Dept Neurol, Stroke Div, Suita, Osaka 5650871, Japan	Asai, K (reprint author), Osaka Univ, Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	asai-osk@umin.ac.jp					Edwards NJ, 2012, STROKE, V43, P412, DOI 10.1161/STROKEAHA.111.634147; Yilmaz U, 2015, CLIN NEURORADIOL, V25, P173, DOI 10.1007/s00062-014-0294-6; Ritter MA, 2003, J NEUROL, V250, P1255, DOI 10.1007/s00415-003-0177-2; Turk AS, 2014, J NEUROINTERV SURG, V6, P231, DOI 10.1136/neurintsurg-2013-010713; Turk AS, 2014, J NEUROINTERV SURG, V6, P260, DOI 10.1136/neurintsurg-2014-011125; Oh YS, 2008, CEREBROVASC DIS, V26, P650, DOI 10.1159/000166842; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Matsumaru Y, 1998, INTERV NEURORADIOL, V4, P165; Kühn Anna Luisa, 2014, J Vasc Interv Neurol, V7, P47	9	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	DEC	2015	21	6					700	702		10.1177/1591019915609169		3	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CX3UH	WOS:000365624400010		
J	Adachi, H; Mineharu, Y; Ishikawa, T; Imamura, H; Yamamoto, S; Todo, K; Yamagami, H; Sakai, N				Adachi, Hidemitsu; Mineharu, Yohei; Ishikawa, Tatsuya; Imamura, Hirotoshi; Yamamoto, Shiro; Todo, Kenichi; Yamagami, Hiroshi; Sakai, Nobuyuki			Stenting for acute cerebral venous sinus thrombosis in the superior sagittal sinus	INTERVENTIONAL NEURORADIOLOGY			English	Article						Superior sagittal sinus; venous thrombosis; sinus thrombosis; intracranial stent; endovascular treatment	BALLOON ANGIOPLASTY; THROMBOLYSIS; THROMBECTOMY; HEPARIN; HYPERTENSION	Endovascular treatment for superior sagittal sinus (SSS) thrombosis is not always successful because of difficult access and long thrombus lesions. We report the first two cases of patients with acute cerebral venous sinus thrombosis at the SSS that was not recanalized by anticoagulation, mechanical thrombectomy, or thrombolysis, but was successfully treated by stent placement. Case 1 was a 37-year-old woman with bilateral subdural hematomas. Digital subtraction angiography showed obstruction of the sinus from the SSS to the right transverse sinus. Recanalization was achieved by selective thrombolysis using urokinase followed by balloon angioplasty, but re-occlusion occurred on the next day of treatment. Repeated endovascular treatment including balloon angioplasty, thrombus aspiration and thrombolysis using recombinant tissue plasminogen activator failed to achieve recanalization. We thus placed intracranial stents in the SSS, which did achieve recanalization. Case 2 was a 69-year-old woman with a small infarction in the left parietal lobe. Digital subtraction angiography showed sinus obliteration from the SSS to the bilateral transverse sinuses. Recanalization was not achieved by balloon angioplasty, thrombus aspiration and selective thrombolysis. We thus placed intracranial stents in the SSS, which did achieve recanalization. Postoperative course was uneventful in both cases and venous sinus patency was confirmed by venography >1.5 years after treatment. When conventional endovascular strategies have been unsuccessful, placement of intracranial stents, which can easily gain access to the distal part of the SSS as compared with carotid stents, may be a useful treatment option for the acute sinus thrombosis in this region.	[Adachi, Hidemitsu; Mineharu, Yohei; Ishikawa, Tatsuya; Imamura, Hirotoshi; Yamamoto, Shiro; Todo, Kenichi; Sakai, Nobuyuki] Gen Hosp, Kobe City Med Ctr, Comprehens Stroke Ctr, Kobe, Hyogo 6500047, Japan; [Mineharu, Yohei; Sakai, Nobuyuki] Inst Biomed Res & Innovat, Div Neuroendovasc Therapy, Kobe, Hyogo, Japan; [Yamagami, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan	Adachi, H (reprint author), Gen Hosp, Kobe City Med Ctr, Comprehens Stroke Ctr, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	adachi64@pop21.odn.ne.jp					Formaglio M, 2010, J NEURORADIOLOGY, V37, P182, DOI 10.1016/j.neurad.2009.08.001; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Jankowitz BT, 2013, J NEUROINTERV SURG, V5, P534, DOI 10.1136/neurintsurg-2012-010476; Malek AM, 1999, NEUROSURGERY, V44, P896, DOI 10.1097/00006123-199904000-00133; Stam J, 2008, STROKE, V39, P1487, DOI 10.1161/STROKEAHA.107.502658; Chaloupka JC, 1999, NEUROSURGERY, V45, P650, DOI 10.1097/00006123-199909000-00045; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Curtin KR, 2004, AM J NEURORADIOL, V25, P1807; Wasay M, 2001, STROKE, V32, P2310, DOI 10.1161/hs1001.096192; Ohara N, 2012, INTERV NEURORADIOL, V18, P333; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Levrier O, 2006, J NEUROSURG, V104, P254, DOI 10.3171/jns.2006.104.2.254; Haghighi AB, 2014, CLIN APPL THROMB-HEM, V20, P507, DOI 10.1177/1076029612470968; Gala NB, 2013, J NEUROINTERV SURG, V5, P28, DOI 10.1136/neurintsurg-2011-010117; de Bruijn SFTM, 1999, STROKE, V30, P484; Arac A, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.9.FOCUS09165; Coutinho J, 2011, COCHRANE DB SYST REV, V8, P1	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	DEC	2015	21	6					719	723		10.1177/1591019915609120		5	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CX3UH	WOS:000365624400015		
J	Okawa, M; Higashi, T; Komiyama, M; Fukuda, K; Abe, H; Inoue, T				Okawa, Masakazu; Higashi, Toshio; Komiyama, Masaki; Fukuda, Kenji; Abe, Hiroshi; Inoue, Tooru			Left internal carotid artery agenesis with trans-sellar collateral and a right aortic arch: Case report	INTERVENTIONAL NEURORADIOLOGY			English	Article						Agenesis; internal carotid artery; avian artery; right aortic arch	OF-THE-LITERATURE; COMMUNICATING ARTERY; TRANSCAVERNOUS ANASTOMOSIS; INTERCAVERNOUS ANASTOMOSIS; INTERCAROTID ANASTOMOSIS; KOMMERELLS DIVERTICULUM; CONGENITAL ABSENCE; ANEURYSM; HYPOPLASIA; HYPOPITUITARISM	We present a case of unilateral internal carotid artery (ICA) agenesis with trans-sellar anastomosis associated with a right aortic arch, and discuss the embryonic development and clinical implications of this condition. A 26-year-old woman without significant medical history was referred to our hospital complaining of tinnitus. She denied any other symptoms, and examination did not reveal any other neurological deficits. Radiological examinations showed agenesis of the right ICA with trans-sellar anastomosis, and a right aortic arch. This vascular configuration reflects the anatomical homology with avian vascular structure. Recognition of this anomaly has important implications for clinical situations, such as the planning of carotid or transsphenoidal surgery, the management of thromboembolic disease, and the surveillance and detection of associated cerebral aneurysms.	[Okawa, Masakazu; Higashi, Toshio; Fukuda, Kenji; Abe, Hiroshi; Inoue, Tooru] Fukuoka Univ, Dept Neurosurg, Fac Med, Fukuoka 8140180, Japan; [Komiyama, Masaki] Osaka City Gen Hosp, Dept Neurointervent, Osaka, Japan	Okawa, M (reprint author), Fukuoka Univ, Dept Neurosurg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	okawam@fukuoka-u.ac.jp					SMITH KR, 1968, NEUROLOGY, V18, P1149; Bodhey NK, 2004, RIV NEURORADIOL, V17, P664; MIDKIFF RB, 1995, AM J NEURORADIOL, V16, P1356; Lee EJ, 2012, J CLIN NEUROSCI, V19, P597, DOI 10.1016/j.jocn.2011.07.034; BAUMEL JJ, 1968, AM J ANAT, V122, P1, DOI 10.1002/aja.1001220102; MCCONNELL EM, 1953, ANAT REC, V115, P175, DOI 10.1002/ar.1091150204; Cina CS, 2000, J VASC SURG, V32, P1208, DOI 10.1067/mva.2000.108012; QUINT DJ, 1989, AM J NEURORADIOL, V10, P435; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; FAIVRE J, 1979, J NEUROSURG, V51, P132; AFIFI AK, 1987, ARCH NEUROL-CHICAGO, V44, P232; JANICKI PC, 1979, AM J ROENTGENOL, V132, P130; ELEFANTE R, 1983, AM J NEURORADIOL, V4, P88; Moon WJ, 2002, NEURORADIOLOGY, V44, P138, DOI 10.1007/s002340100678; STAPLES GS, 1979, J NEUROSURG, V50, P393, DOI 10.3171/jns.1979.50.3.0393; KHANGURE MS, 1981, SURG NEUROL, V16, P300, DOI 10.1016/0090-3019(81)90067-7; LASJAUNIAS P, 1984, ANAT CLIN, V6, P133, DOI 10.1007/BF01773165; KISHORE PRS, 1979, RADIOLOGY, V132, P381; Ota T, 2006, J THORAC CARDIOV SUR, V131, P574, DOI 10.1016/j.jtcvs.2005.10.012; TRACY PT, 1987, J NEUROSURG, V67, P765, DOI 10.3171/jns.1987.67.5.0765; HUBER G, 1980, NEURORADIOLOGY, V20, P207; AUSTIN EH, 1985, J VASC SURG, V2, P571, DOI 10.1067/mva.1985.avs0020571; Claros P, 1999, INT J PEDIATR OTORHI, V49, P69, DOI 10.1016/S0165-5876(99)00012-9; Given CA, 2001, AM J NEURORADIOL, V22, P1953; Horie N, 2008, CLIN NEUROL NEUROSUR, V110, P622, DOI 10.1016/j.clineuro.2008.03.004; ALEXANDER MWT, 1984, J CAN ASSOC RADIOL, V35, P92; Mellado JM, 2001, NEURORADIOLOGY, V43, P237; SMITH RR, 1972, J NEUROSURG, V37, P460, DOI 10.3171/jns.1972.37.4.0460; Lie TA, 1968, CONGENITAL ANOMALIES; Padget D, 1948, CONTRIB EMBRYOL, V212, P207; Sinha R, 2011, TURK NEUROSURG, V22, P371	31	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	DEC	2015	21	6					759	764		10.1177/1591019915609130		6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CX3UH	WOS:000365624400022		
J	Kadooka, K; Tanaka, M				Kadooka, Keisuke; Tanaka, Michihiro			Ophthalmic systems completely supplied from dural arteries indicate the utility of endovascular treatment of cerebral aneurysms	INTERVENTIONAL NEURORADIOLOGY			English	Article						Ophthalmic artery; middle meningeal artery; cone beam computed tomography; endovascular treatment; recurrent meningeal artery		We report a 67-year-old man who harboured an unruptured left basilar-superior cerebellar artery aneurysm. Cerebral angiography and cone beam computed tomography with diluted contrast medium showed that the bilateral ophthalmic arteries were not supplied from internal carotid arteries but, rather, were supplied from the middle meningeal and accessory meningeal arteries. This meant that the ophthalmic system was predominantly supplied from the dural arteries and, therefore, pterional craniotomy might cause a compromise in blood supply to the retinal artery. To avoid this complication, coil embolization was selected instead of neck clipping, and this endovascular therapy succeeded without neurological deficit. This case report shows the importance of cerebral angiography (including cone beam computed tomography) and consideration of the patterns of ophthalmic artery perfusion when selecting operative procedures for management of aneurysms that require manipulation around the sphenoid ridge.	[Kadooka, Keisuke; Tanaka, Michihiro] Kameda Med Ctr, Dept Neurosurg, Chiba, Japan	Kadooka, K (reprint author), Kameda Med Ctr, Dept Neurosurg, 929 Higashi Cho, Chiba, Japan.	kadosan0313@ybb.ne.jp					Erturk M, 2005, CLIN ANAT, V18, P10, DOI 10.1002/ca.20020; Perrini P, 2007, J NEUROSURG, V106, P142, DOI 10.3171/jns.2007.106.1.142; Hayreh S S, 1962, Br J Ophthalmol, V46, P65, DOI 10.1136/bjo.46.2.65; Lasjannias P, 1986, SURG NEUROANGIOGRAPH, V1, P426; Liu QL, 2001, NEUROSURGERY, V49, P401, DOI 10.1097/00006123-200108000-00025; Shima K, 1995, JPN J NEUROSURG, V4, P163	6	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	DEC	2015	21	6					765	768		10.1177/1591019915609168		4	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CX3UH	WOS:000365624400023		
J	Okamoto, AS; Takeshita, T; Iwano, H; Danhara, T; Hirata, T; Nishido, H; Sakata, S				Okamoto, Ayumi S.; Takeshita, Toru; Iwano, Hideki; Danhara, Tohru; Hirata, Takafumi; Nishido, Hirotsugu; Sakata, Shuhei			Fission track and U-Pb zircon ages of psammitic rocks from the Harushinai unit, Kamuikotan metamorphic rocks, central Hokkaido, Japan: constraints on metamorphic histories	ISLAND ARC			English	Article						deformation microstructures; fission track ages; Kamuikotan metamorphic rocks; U-Pb ages; zircon	PLASMA-MASS SPECTROMETRY; SOUTH-WEST JAPAN; K-AR AGES; SUBGREENSCHIST CONDITIONS; GEOLOGICAL IMPLICATIONS; DYNAMIC-ANALYSIS; CENTRAL SHIKOKU; GRANITIC-ROCKS; SHRIMP ZIRCON; HIGH-PRESSURE	Accurate pressure-temperature-time (P-T-t) paths of rocks from sedimentation through maximum burial to exhumation are needed to determine the processes and mechanisms that form high-pressure and low-temperature type metamorphic rocks. Here, we present a new method combining laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) U-Pb with fission track (FT) dates for detrital zircons from two psammitic rock samples collected from the Harushinai unit of the Kamuikotan metamorphic rocks. The concordant zircon U-Pb ages for these samples vary markedly, from 1980 to 95 Ma, with the youngest age clusters in both samples yielding Albian-Cenomanian weighted mean ages of 100.8 +/- 1.1 and 99.3 +/- 1.0 Ma (2 sigma uncertainties). The zircon U-Pb ages were not reset by high-P/T type metamorphism, because there is no indication of overgrowth within the zircons with igneous oscillatory zoning. Therefore, these weighted mean ages are indicative of the maximum age of deposition of protolithic material. By comparison, the zircon FT data yield a pooled age of ca. 90 Ma, which is almost the same as the weighted mean age of the youngest U-Pb age cluster. This indicates that the zircon FT ages were reset at ca. 90 Ma while still at their source, but have not been reset since. This conclusion is supported by recorded temperature conditions of less than about 300 degrees C (the closure temperature of zircon FTs), as estimated from microstructures in the deformed detrital quartz grains in psammitic rocks, and no shortening of fission track lengths in the zircon. Combining these new data with previously reported white mica K-Ar ages indicates that the Harushinai unit was deposited after ca. 100 Ma, and underwent burial to its maximum depth before being subjected to a localized thermal overprint during exhumation at ca. 58 Ma.	[Okamoto, Ayumi S.; Takeshita, Toru] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Iwano, Hideki; Danhara, Tohru] Kyoto Fiss Track Co Ltd, Kita Ku, Kyoto 6038832, Japan; [Hirata, Takafumi; Sakata, Shuhei] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Nishido, Hirotsugu] Okayama Univ Sci, Kita Ku, Okayama 7000005, Japan	Okamoto, AS (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	ayuoka@mail.sci.hokudai.ac.jp	Takeshita, Toru/A-4547-2012		Sasakawa Scientific Research Grant from the Japan Science Society; Japan Society for the Promotion of Science [25.3294]	The authors thank H. Ueda and H. Yamamoto for detailed reviews of the manuscript. In particular, comments by H. Ueda, which made points of discussion clear, were very useful. The authors thank T. Nakayama and K. Umezawa for assistance during fieldwork and the separation of zircons from psammitic rocks. We also thank J. Maeda, M. Usuki, and Y. Hayasaka for their advice on zircon separation techniques, and H. Nomura and K. Nakamura for thin section preparation. H. Arai is also thanked for statistically analysing the youngest clusters of zircon UPb ages obtained in this study. This study was supported by grants to A. S. Okamoto provided by the Sasakawa Scientific Research Grant from the Japan Science Society and by the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS Fellows No. 25.3294).	Allegre C.J., 2008, ISOTOPE GEOLOGY; Takeshita T, 2001, ISL ARC, V10, P495, DOI 10.1046/j.1440-1738.2001.00348.x; Nishikawa O, 1999, TECTONOPHYSICS, V301, P21, DOI 10.1016/S0040-1951(98)00219-4; Takeshita T, 1998, J STRUCT GEOL, V20, P417, DOI 10.1016/S0191-8141(97)00108-9; Hidaka H, 2002, CHEM GEOL, V187, P279, DOI 10.1016/S0009-2541(02)00058-X; Zhao XL, 2013, ISL ARC, V22, P508, DOI 10.1111/iar.12045; ITAYA T, 1988, CONTRIB MINERAL PETR, V100, P281, DOI 10.1007/BF00379739; Imayama T, 2012, LITHOS, V134, P1, DOI 10.1016/j.lithos.2011.12.004; Yagi K, 2002, J METAMORPH GEOL, V20, P633, DOI 10.1046/j.1525-1314.2002.00392.x; SAKAKIBARA M, 1994, J GEOPHYS RES-SOL EA, V99, P22221, DOI 10.1029/94JB00958; Cho M, 2013, J ASIAN EARTH SCI, V63, P234, DOI 10.1016/j.jseaes.2012.08.020; Iwano H, 2013, ISL ARC, V22, P382, DOI 10.1111/iar.12038; Iwasaki I, 1995, GEOL J, V30, P281, DOI 10.1002/gj.3350300308; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Ring U, 1999, GEOL SOC SPEC PUBL, V154, P1, DOI 10.1144/GSL.SP.1999.154.01.01; Iizuka T, 2004, GEOCHEM J, V38, P229; Tsuchiya N, 2005, LITHOS, V79, P179, DOI 10.1016/j.lithos.2004.04.053; Sakashima T, 2003, J ASIAN EARTH SCI, V21, P1019, DOI 10.1016/S1367-9120(02)00108-6; HIRATA T, 1995, GEOCHIM COSMOCHIM AC, V59, P2491, DOI 10.1016/0016-7037(95)00144-1; Fujii M, 2008, ISL ARC, V17, P322, DOI 10.1111/j.1440-1738.2008.00623.x; Hasebe N, 2009, GEOL SOC SPEC PUBL, V324, P37, DOI 10.1144/SP324.3; Hirata T, 2005, J ANAL ATOM SPECTROM, V20, P696, DOI 10.1039/b504153h; Wallis S, 2004, J METAMORPH GEOL, V22, P17, DOI 10.1111/j.1525-1314.2003.00493.x; Danhara T, 2013, ISL ARC, V22, P264, DOI 10.1111/iar.12035; Stockhert B, 1999, J STRUCT GEOL, V21, P351, DOI 10.1016/S0191-8141(98)00114-X; Yokoyama TD, 2011, ANAL CHEM, V83, P8892, DOI 10.1021/ac2012448; Schmitz MD, 2001, GEOCHIM COSMOCHIM AC, V65, P2571, DOI 10.1016/S0016-7037(01)00616-0; TAKAYAMA M, 1986, J METAMORPH GEOL, V4, P445, DOI 10.1111/j.1525-1314.1986.tb00363.x; Tagami T, 1998, SOLID EARTH SCI LIBR, V10, P99; Nishikawa O, 2000, J STRUCT GEOL, V22, P259, DOI 10.1016/S0191-8141(99)00147-9; TAKASU A, 1990, TECTONOPHYSICS, V185, P111, DOI 10.1016/0040-1951(90)90408-Z; SMITH DL, 1984, J GEOPHYS RES, V89, P4125, DOI 10.1029/JB089iB06p04125; WILLIAMS IS, 1987, CONTRIB MINERAL PETR, V97, P205, DOI 10.1007/BF00371240; Harley SL, 2007, ELEMENTS, V3, P25, DOI 10.2113/gselements.3.1.25; TAKESHITA T, 1995, TECTONOPHYSICS, V245, P277, DOI 10.1016/0040-1951(94)00240-A; Aoki K., 2007, J GEOLOGICAL SOC JAP, V113, P171; Bikerman M., 1971, EARTH SCI, V25, P27; Cherniak D. J., 2000, CHEM GEOL, V172, P5, DOI [10.1016/S0009-2541(00)00233-3, DOI 10.1016/S0009-2541(00)00233-3]; Cohen KM, 2013, EPISODES, V36, P199; DODSON MH, 1973, CONTRIB MINERAL PETR, V40, P259, DOI 10.1007/BF00373790; Essene E. J., 1967, CONTRIB MINERAL PETR, V15, P1, DOI DOI 10.1007/BF01167213; Gouchi N., 1983, J JAPANESE ASS MINER, V78, P383; Hori R. S., 1994, J GEOLOGICAL SOC JAP, V100, P575; Imaizumi M., 1981, J MINERALOGY PETROLO, V76, P88; ISHIZUKA H, 1985, J PETROL, V26, P391; Ishizuka H., 1984, Journal of the Geological Society of Japan, V90, P59; Itaya T., 1994, ISL ARC, V3, P48, DOI DOI 10.1111/J.1440-1738.1994.TB00004.X; Kawamura M., 2004, NEOSCIENCE NATURAL H, P109; Kawamura M., 1986, MONOGR ASS GEOL COLL, V31, P17; Kawamura M., 2001, J GEOLOGICAL SOC JAP, V107, P237; Kawamura M., 2000, MEMOIRS GEOLOGICAL S, V57, P63; Kayama M., 2005, B RES I NATURAL SCI, V31, P43; Kiminami K., 1986, MONOGR ASS GEOL COLL, V31, P1; Kiminami K., 1983, ACCRETION TECTONICS, P107; Kimura J.-I., 2000, FISSION TRACK NEWS L, V13, P11; Komatsu M., 1985, MEM GEOL SOC JPN, V25, P137; Kondo H., 1991, Journal of the Geological Society of Japan, V97, P357; Minagawa K., 2012, ANN M JAP ASS MIN SC, P250; MITI (THE MINISTRY OF INTERNATIONAL TRADE AND INDUSTRY), 1989, REP SURV AB RAR MET; Nakagawa M., 1987, EARTH SCI, V41, P244; Nakano N., 1981, J GEOL SOC JPN, V87, P211; Niida K., 1986, MONOGR ASS GEOL COLL, V31, P379; Okada H., 1979, EARTH CHIKYU, V1, P869; Okamoto A., 2011, JAP GEOSC UN M 2011; Okawa H., 2013, MEM FUKUI PREFECT DI, V12, P35; Ota T., 1999, MEM GEOL SOC JPN, V52, P17; Ota T., 1997, J MINERALOGY PETROLO, V92, P103, DOI 10.2465/ganko.92.103; Ota T., 1993, J GEOL SOC JPN, V99, P335; Passchier C.W., 2005, MICROTECTONICS; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Sakakibara M., 2007, J GEOLOGICAL SOC J S, V113, P103; Sakata S, 2014, GEOSTAND GEOANAL RES, V38, P409, DOI 10.1111/j.1751-908X.2014.00320.x; Sanchez-Rodriguez L, 2000, TECTONOPHYSICS, V316, P19, DOI 10.1016/S0040-1951(99)00256-5; Shibakusa H., 1992, J GEOL SOC JPN, V98, P1061; SHIBAKUSA H, 1989, MINER PETROL, V40, P241, DOI 10.1007/BF01164601; Shibakusa H., 1974, J GEOL SOC JPN, V80, P341; Spear F., 1993, METAMORPHIC PHASE EQ; Takeshita T., 2013, J STRUCTURAL GEOLOGY, V46; Takigami Y., 1987, B VOLCANOL SOC JPN, V32, P365; Tsuchiya N., 1986, MONOGRAPH ASS GEOLOG, V31, P1; Ueda H., 2010, J GEOGR, V119, P362; Ueda H., 2010, GEOLOGY HOKKAIDO SER, P40; Watanabe T., 1994, IGCP PROJ 294 INT S, P145; Watanabe T., 1985, FORMATION ACTIVE OCE, P677; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x	85	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2015	24	4					379	403		10.1111/iar.12121		25	Geosciences, Multidisciplinary	Geology	CX5FL	WOS:000365727400001		
J	Mori, H; Wallis, S; Fujimoto, K; Shigematsu, N				Mori, Hiroshi; Wallis, Simon; Fujimoto, Koichiro; Shigematsu, Norio			Recognition of shear heating on a long-lived major fault using Raman carbonaceous material thermometry: implications for strength and displacement history of the MTL, SW Japan	ISLAND ARC			English	Article						carbonaceous material; coefficient of friction; core analysis; Median Tectonic Line; Raman spectral analysis; Sanbagawa belt; shear heating; thermal anomaly; thermal modeling	MEDIAN TECTONIC LINE; SAN-ANDREAS FAULT; SAMBAGAWA METAMORPHIC BELT; SOUTHWEST JAPAN; MATERIAL GEOTHERMOMETER; ALPINE FAULT; WEAK FAULTS; NEW-ZEALAND; FORE-ARC; ROCKS	The extent to which movement on major faults causes long term shear heating is a contentious issue and an important aspect in the debate about the strength of major faults in the crust. Comparing the results of experimental work on the kinetics of crystallization of carbonaceous material with results of thermal modeling show that the Raman carbonaceous material (CM) geothermometer is well suited to studying shear heating on geological time scales in suitable lithologies exposed around exhumed major fault zones. The Median Tectonic Line (MTL), SW Japan, is the largest on-land fault in Japan with a length of >800km. Application of Raman CM thermometry to pelitic schist adjacent to the fault reveals the presence of a rise in peak temperature of around 60 degrees C over a distance of around 150m perpendicular to the MTL fault plane. The spatial association of this thermal anomaly with the fault implies it is due to shear heating. Thermal modeling shows the recorded thermal anomaly and steep temperature gradient is compatible with very high rates of displacement over time scales of a few thousand years. However, the implied displacement rates lie outside those generally observed. An alternative explanation is that an originally broader thermal anomaly that developed during strike slip faulting was shortened due to the effects of normal faulting. Constraints on displacement rate, width of the original anomaly, duration of heating and peak temperature imply a coefficient of friction, , greater than 0.4.	[Mori, Hiroshi; Wallis, Simon] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Planetary Sci, Nagoya, Aichi 4648601, Japan; [Mori, Hiroshi; Shigematsu, Norio] Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; [Fujimoto, Koichiro] Tokyo Gakugei Univ, Fac Educ, Tokyo 1848501, Japan	Mori, H (reprint author), Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Planetary Sci, Nagoya, Aichi 4648601, Japan.	mori-hiroshi@aist.go.jp			Japan Society for the Promotion of Science [20340136, Mori: 23.3073]; Fukada Geological Institute	This research forms part of the first author's PhD thesis at Nagoya University, Japan. This work benefited from discussions with S. Shirono, Y. Kouketsu and members of the petrology group of Nagoya University. The authors are indebted to anonymous referees, A. Lin and S. Umino for their comments on an earlier version of this manuscript. We acknowledge N. Koizumi for providing the opportunity to study the borehole at the observatory of GSJ, AIST at Matsusaka-Iitaka. We are indebted to T. Takeshita, T. Nakajima, N. Kimura, N. Tanaka, and N. Furuya for their help with borehole core analysis, and to M. Mitsuishi, C. Shirakawa, and A. Nishii for their assistance in the field. This work was supported financially in part by Grants-in-Aid for Scientific Research (Fujimoto: 20340136) and Research Fellowship for JSPS Scientists (Mori: 23.3073) from the Japan Society for the Promotion of Science and by a grant from the Fukada Geological Institute.	Jefferies SP, 2006, J STRUCT GEOL, V28, P220, DOI 10.1016/j.jsg.2005.10.008; PASTERIS JD, 1991, CAN MINERAL, V29, P1; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; d'Alessio MA, 2003, GEOLOGY, V31, P541, DOI 10.1130/0091-7613(2003)031<0541:NFHATS>2.0.CO;2; SIBSON RH, 1992, TECTONOPHYSICS, V211, P283, DOI 10.1016/0040-1951(92)90065-E; JEHLICKA J, 1992, ORG GEOCHEM, V18, P211, DOI 10.1016/0146-6380(92)90132-H; SCHOLZ CH, 1980, J GEOPHYS RES, V85, P6174, DOI 10.1029/JB085iB11p06174; SCHOLZ CH, 1979, J GEOPHYS RES, V84, P6770, DOI 10.1029/JB084iB12p06770; Sakaguchi A, 2011, GEOLOGY, V39, P395, DOI 10.1130/G31642.1; Imber J, 2008, GEOL SOC SPEC PUBL, V299, P151, DOI 10.1144/SP299.10; Kubota Y, 2008, ISL ARC, V17, P129, DOI 10.1111/j.1440-1738.2007.00607.x; JARRARD RD, 1986, GEOLOGY, V14, P780, DOI 10.1130/0091-7613(1986)14<780:TMBSFO>2.0.CO;2; Yui TF, 1996, J METAMORPH GEOL, V14, P115, DOI 10.1046/j.1525-1314.1996.05792.x; Takeshita T, 2004, GEOL SOC SPEC PUBL, V227, P279, DOI 10.1144/GSL.SP.2004.227.01.14; TAGAMI T, 1988, J GEOPHYS RES-SOLID, V93, P13705, DOI 10.1029/JB093iB11p13705; JOHNSTON DC, 1983, TECTONOPHYSICS, V92, P241, DOI 10.1016/0040-1951(83)90092-6; Wallis SR, 2009, J METAMORPH GEOL, V27, P93, DOI 10.1111/j.1525-1314.2008.00806.x; Yamada R, 2007, TECTONOPHYSICS, V443, P153, DOI 10.1016/j.tecto.2007.01.014; Haines SH, 2012, J STRUCT GEOL, V43, P2, DOI 10.1016/j.jsg.2012.05.004; Lockner DA, 2011, NATURE, V472, P82, DOI 10.1038/nature09927; Beyssac O, 2003, EUR J MINERAL, V15, P937, DOI 10.1127/0935-1221/2003/0015-0937; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; Fukunari T, 2007, ISL ARC, V16, P243, DOI 10.1111/j.1440-1738.2007.00570.x; Wallis S, 1998, J METAMORPH GEOL, V16, P83, DOI 10.1111/j.1525-1314.1998.00072.x; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; Lahfid A, 2010, TERRA NOVA, V22, P354, DOI 10.1111/j.1365-3121.2010.00956.x; Tabei T, 2002, EARTH PLANETS SPACE, V54, P1065; Aoya M, 2010, J METAMORPH GEOL, V28, P895, DOI 10.1111/j.1525-1314.2010.00896.x; Wibberley CAJ, 2003, J STRUCT GEOL, V25, P59, DOI 10.1016/S0191-8141(02)00014-7; Hodges K, 1998, GEOLOGY, V26, P483, DOI 10.1130/0091-7613(1998)026<0483:EFRDOH>2.3.CO;2; BUCK WR, 1988, TECTONICS, V7, P959, DOI 10.1029/TC007i005p00959; ISOZAKI Y, 1990, J METAMORPH GEOL, V8, P401, DOI 10.1111/j.1525-1314.1990.tb00627.x; Fukunari T, 2011, ISL ARC, V20, P426, DOI 10.1111/j.1440-1738.2011.00778.x; INOUE A, 1991, AM MINERAL, V76, P628; MOLNAR P, 1990, J GEOPHYS RES-SOLID, V95, P4833, DOI 10.1029/JB095iB04p04833; ONEIL JR, 1980, J GEOPHYS RES, V85, P6286, DOI 10.1029/JB085iB11p06286; Holdsworth RE, 2004, SCIENCE, V303, P181, DOI 10.1126/science.1092491; Kouketsu Y, 2014, ISL ARC, V23, P33; Shigematsu N, 2012, TECTONOPHYSICS, V532, P103, DOI 10.1016/j.tecto.2012.01.024; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Tagami T, 2012, TECTONOPHYSICS, V538, P67, DOI 10.1016/j.tecto.2012.01.032; Carpenter BM, 2011, NAT GEOSCI, V4, P251, DOI [10.1038/ngeo1089, 10.1038/NGEO1089]; NAKAJIMA T, 1994, LITHOS, V33, P51, DOI 10.1016/0024-4937(94)90053-1; Mori N, 2015, ISL ARC, V24, P119, DOI 10.1111/iar.12093; Rahl JM, 2005, EARTH PLANET SC LETT, V240, P339, DOI 10.1016/j.epsl.2005.09.055; Wibberley CAJ, 2005, NATURE, V436, P689, DOI 10.1038/nature03901; WOPENKA B, 1993, AM MINERAL, V78, P533; Jefferies SP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004205; Tabei T, 2003, EARTH PLANETS SPACE, V55, P643; Nakamura Y, 2013, J MINER PETROL SCI, V108, P131, DOI 10.2465/jmps.120625; TAKASU A, 1990, TECTONOPHYSICS, V185, P111, DOI 10.1016/0040-1951(90)90408-Z; Suzuki K, 1998, J METAMORPH GEOL, V16, P23, DOI 10.1111/j.1525-1314.1998.00057.x; TAKASU A, 1994, LITHOS, V33, P119, DOI 10.1016/0024-4937(94)90057-4; LOCKNER DA, 1983, J GEOPHYS RES, V88, P4313, DOI 10.1029/JB088iB05p04313; O'Hara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018890; Behr WM, 2014, GEOPHYS RES LETT, V41, P8067, DOI 10.1002/2014GL061349; Carslaw H. S., 1959, CONDUCTION HEAT SOLI, P42; Faure M., 1983, J GEOL SOC JAPAN, V89, P319, DOI 10.5575/geosoc.89.319; Hara I., 1992, J SCI HIROSHIMA U C, V9, P495; Hori S., 1953, REPORTS GEOLOGICAL S, V154, P1; Huzita K., 1980, MEM GEOL SOC JAPAN, V18, P129; Ichikawa K., 1980, MEMOIRS GEOL SOC JAP, V18, P187; Isozaki Y., 1996, ISL ARC, V5, P289, DOI DOI 10.1111/J.1440-1738.1996.TB00033.X; Miyata T., 1980, MEM GEOL SOC JPN, V18, P51; Okada A., 1980, MEM GEOL SOC JPN, V18, P79; Shibata K., 1989, B GEOLOGICAL SURVEY, V40, P661; Shigematsu N., 2009, CHISHITSU NEWS, V662, P16; Shimada K., 1998, J GEOL SOC JPN, V104, P825; TAKAGI H, 1986, J STRUCT GEOL, V8, P3, DOI 10.1016/0191-8141(86)90013-1; Takagi H., 1991, J GEOLOGICAL SOC JAP, V97, P377; Takagi H., 1992, J GEOLOGICAL SOC JAP, V98, P1069; Takahashi M., 2006, J GEOLOGICAL SOC JAP, V112, P33; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Wallis S. R., 1990, J GEOLOGICAL SOC JAP, V96, P345; Wallis S. R., 1992, ISL ARC, V1, P176, DOI 10.1111/j.1440-1738.1992.tb00068.x; Yamaguchi K., 2009, CHISHITSU NEWS, V662, P23	76	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2015	24	4					425	446		10.1111/iar.12129		22	Geosciences, Multidisciplinary	Geology	CX5FL	WOS:000365727400003		
J	Chen-Jinnai, A; Yoshiki, W; Tanabe, T				Chen-Jinnai, Akitoshi; Yoshiki, Wataru; Tanabe, Takasumi			Broad-bandwidth pulse propagation through ultrahigh-quality-factor microcavity with chirped pulse	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PHOTONIC-CRYSTAL NANOCAVITY; TOROID MICROCAVITY; RING RESONATORS; GENERATION; LIGHT; CHIP	We propose and numerically investigate a method that enables the transmission of pulses with broader bandwidth than the spectrum width of the resonance of an ultrahigh-quality-factor (Q) microcavity. The method is based on prechirping of the input pulse and the use of the optical Kerr effect in a microcavity, with which we designed the instantaneous frequency of the input pulse to meet the resonant frequency of the dynamically modulated microcavity. We showed that a prechirped pulse can transmit about 11.8 times higher energy than a Fourier-limited pulse having the same spectrum width. We also found that adiabatic wavelength conversion is inherent in this system and the spectrum intensity of particular wavelength components is even higher than the peak of the transmitted spectrum of a linear cavity. (C) 2015 The Japan Society of Applied Physics	[Chen-Jinnai, Akitoshi; Yoshiki, Wataru; Tanabe, Takasumi] Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan	Chen-Jinnai, A (reprint author), Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.	takasumi@elec.keio.ac.jp			Strategic Information and Communications R&D Promotion Programme (SCOPE), from the Ministry of Internal Affairs and Communications, Japan	Part of this work was supported by Strategic Information and Communications R&D Promotion Programme (SCOPE), from the Ministry of Internal Affairs and Communications, Japan.	Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Lee H, 2012, NAT PHOTONICS, V6, P369, DOI 10.1038/NPHOTON.2012.109; Fushimi A, 2014, OPT EXPRESS, V22, P4466, DOI 10.1364/OE.22.004466; STRICKLAND D, 1985, OPT COMMUN, V55, P447, DOI 10.1016/0030-4018(85)90151-8; Xu QF, 2006, OPT LETT, V31, P341, DOI 10.1364/OL.31.000341; Baba T, 2008, NAT PHOTONICS, V2, P465, DOI 10.1038/nphoton.2008.146; Xu QF, 2007, OPT EXPRESS, V15, P924, DOI 10.1364/OE.15.000924; Tanabe T, 2007, NAT PHOTONICS, V1, P49, DOI 10.1038/nphoton.2006.51; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Tanabe T, 2004, IEEE J SEL TOP QUANT, V10, P221, DOI 10.1109/JSTQE.2004.824069; Manipatruni S, 2008, OPT LETT, V33, P1644, DOI 10.1364/OL.33.001644; Sekoguchi H, 2014, OPT EXPRESS, V22, P916, DOI 10.1364/OE.22.000916; Cundiff ST, 2010, NAT PHOTONICS, V4, P760, DOI [10.1038/nphoton.2010.196, 10.1038/NPHOTON.2010.196]; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Hill KO, 1997, J LIGHTWAVE TECHNOL, V15, P1263, DOI 10.1109/50.618320; Yoshiki W, 2014, OPT EXPRESS, V22, P24332, DOI 10.1364/OE.22.024332; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Manolatou C, 1999, IEEE J QUANTUM ELECT, V35, P1322, DOI 10.1109/3.784592; Carmon T, 2007, NAT PHYS, V3, P430, DOI 10.1038/nphys601; Xu QF, 2007, NAT PHYS, V3, P406, DOI 10.1038/nphys600; Nozaki K, 2010, NAT PHOTONICS, V4, P477, DOI [10.1038/NPHOTON.2010.89, 10.1038/nphoton.2010.89]; Tanabe T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.043907; Yoshiki W, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.122202; Tanaka Y, 2007, NAT MATER, V6, P862, DOI 10.1038/nmat1994; Ctistis G, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580615; Haus H. A., 1984, WAVES FIELDS OPTOELE, P197; Notomi M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.051803; Oden J, 2013, J EUR OPT SOC-RAPID, V8, DOI 10.2971/jeos.2013.13046; Pollinger M, 2010, OPT EXPRESS, V18, P17764, DOI 10.1364/OE.18.017764	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							122201	10.7567/JJAP.54.122201		5	Physics, Applied	Physics	CY1TU	WOS:000366191400006		
J	Endo, M; Nagaoka, R; Nagaoka, H; Nagai, T; Wani, F				Endo, Masamori; Nagaoka, Ryuji; Nagaoka, Hiroki; Nagai, Toru; Wani, Fumio			Output power characteristics of diode-pumped cesium vapor laser	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								We examine the output power as a function of the cesium vapor density in a diode-pumped cesium vapor laser. Since the pump light bandwidth of our apparatus is considerably wider than the absorption bandwidth, a fair amount of the pump power is unabsorbed. An optical-to-optical conversion efficiency of 70% is observed with respect to the absorbed pump power. Beyond a certain point, the output power starts to reduce despite linear increase in absorption power along with increase in the Cs number density. We perform a numerical simulation to study the observed phenomena, and it is found that spontaneous emission from the upper laser level is the main channel of the pump power loss. (C) 2015 The Japan Society of Applied Physics	[Endo, Masamori] Tokai Univ, Sch Sci, Dept Phys, Hiratsuka, Kanagawa 2591292, Japan; [Nagaoka, Ryuji; Nagaoka, Hiroki; Nagai, Toru; Wani, Fumio] Aerospace Co, Kawasaki Heavy Ind Ltd, Gifu 5048710, Japan	Endo, M (reprint author), Tokai Univ, Sch Sci, Dept Phys, Hiratsuka, Kanagawa 2591292, Japan.	endo@tokai.ac.jp					Bogachev AV, 2012, QUANTUM ELECTRON+, V42, P95, DOI 10.1070/QE2012v042n02ABEH014734; Zhdanov B, 2007, OPT LETT, V32, P2167, DOI 10.1364/OL.32.002167; Zhdanov BV, 2008, OPT EXPRESS, V16, P748, DOI 10.1364/OE.16.000748; Rafac RJ, 1999, PHYS REV A, V60, P3648, DOI 10.1103/PhysRevA.60.3648; Endo M, 2014, PROC SPIE, V8962, DOI 10.1117/12.2045391; Krupke WF, 2003, OPT LETT, V28, P2336, DOI 10.1364/OL.28.002336; Zhdanov BV, 2014, OPT EXPRESS, V22, P17266, DOI 10.1364/OE.22.017266; Zhdanov BV, 2008, ELECTRON LETT, V44, P582, DOI [10.1049/el:20080728, 10.1049/e1:20080728]; Zweiback J, 2009, OPT COMMUN, V282, P1871, DOI 10.1016/j.optcom.2009.01.043; Barmashenko B. D., 2012, P SOC PHOTO-OPT INS, V8547; Endo M, 2013, PROC SPIE, V8677, DOI 10.1117/12.2010341; Oliker BQ, 2014, PROC SPIE, V8962, DOI 10.1117/12.2045339; Zhdanov BV, 2013, PROC SPIE, V8898, DOI 10.1117/12.2033923	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							122701	10.7567/JJAP.54.122701		3	Physics, Applied	Physics	CY1TU	WOS:000366191400010		
J	Goto, T; Sugawa, S				Goto, Tetsuya; Sugawa, Shigetoshi			Observation of sputtering of yttrium from Y2O3 ceramics by low-energy Ar, Kr, and Xe ion bombardment in microwave-excited plasma	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DISTRIBUTIONS; THRESHOLDS; YIELDS	Y2O3 ceramics were immersed in microwave-excited Ar, Kr, and Xe plasmas, and the sputtering of yttrium atoms from Y2O3 ceramics as a result of low-energy (range of approximately 10 eV) Ar, Kr, and Xe ion bombardment was observed. The amount of sputtered yttrium atoms well correlated with the ion bombardment energy estimated by Langmuir probe measurement. The estimated sputtering yield was 10(-5) or less for such a low ion bombardment condition. (C) 2015 The Japan Society of Applied Physics	[Goto, Tetsuya; Sugawa, Shigetoshi] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan	Goto, T (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan.	tetsuya.goto.b2@tohoku.ac.jp					WEHNER GK, 1960, J APPL PHYS, V31, P177, DOI 10.1063/1.1735395; WEHNER GK, 1957, PHYS REV, V108, P35, DOI 10.1103/PhysRev.108.35; NANBU K, 1980, J PHYS SOC JPN, V49, P2042, DOI 10.1143/JPSJ.49.2042; STUART RV, 1960, PHYS REV LETT, V4, P409, DOI 10.1103/PhysRevLett.4.409; Kudriavtsev Y, 2008, APPL SURF SCI, V255, P877, DOI 10.1016/j.apsusc.2008.05.064; SIGMUND P, 1969, PHYS REV, V184, P383, DOI 10.1103/PhysRev.184.383; Hallil A, 2000, J VAC SCI TECHNOL A, V18, P882, DOI 10.1116/1.582271; BRADLEY RC, 1954, PHYS REV, V93, P719, DOI 10.1103/PhysRev.93.719; KELLY R, 1978, NUCL INSTRUM METHODS, V149, P553, DOI 10.1016/0029-554X(78)90925-4; KOMACHI K, 1993, J VAC SCI TECHNOL A, V11, P164, DOI 10.1116/1.578284; THOMPSON MW, 1968, PHILOS MAG, V18, P377, DOI 10.1080/14786436808227358; HUBER EJ, 1957, J PHYS CHEM-US, V61, P497, DOI 10.1021/j150550a027; MORGULIS ND, 1956, SOV PHYS JETP-USSR, V3, P52; HARRISON DE, 1961, PHYS REV, V122, P1421, DOI 10.1103/PhysRev.122.1421; Cunge G, 2005, PLASMA SOURCES SCI T, V14, P599, DOI 10.1088/0963-0252/14/3/025; ROSENBERG D, 1962, J APPL PHYS, V33, P1842, DOI 10.1063/1.1728843; Nakano T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.038002; Zabeida O, 1999, J APPL PHYS, V85, P6366, DOI 10.1063/1.370139; Chapman B., 1980, GLOW DISCHARGE PROCE, P70; Hofer W. O., J NUCL MAT, V76-77, P156; Lieberman M. A., 2005, PRINCIPLES PLASMA DI, P445; Miwa K., 2007, P INT S SEM MAN; Present R. D., 1958, KINETIC THEORY GASES, P55; Verhaverbeke S., 1991, International Electron Devices Meeting 1991. Technical Digest (Cat. No.91CH3075-9), DOI 10.1109/IEDM.1991.235421	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							128003	10.7567/JJAP.54.128003		3	Physics, Applied	Physics	CY1TU	WOS:000366191400026		
J	Hanasaki, I; Uehara, S; Arai, Y; Nagai, T; Kawano, S				Hanasaki, Itsuo; Uehara, Satoshi; Arai, Yoshiyuki; Nagai, Takeharu; Kawano, Satoyuki			Threshold-free evaluation of near-surface diffusion and adsorption-dominated motion from single-molecule tracking data of single-stranded DNA through total internal reflection fluorescence microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POLY(ETHYLENE GLYCOL)-MODIFIED LYSOZYME; LIQUID-SOLID INTERFACES; PROTEIN ADSORPTION; LIPID-BILAYERS; SOFT MATTER; DYNAMICS; SILICA; DISPLACEMENT; RATES; TIRF	Total internal reflection fluorescence (TIRF) microscopy enables the single-molecule observation in liquid near substrate surface. However, the evaluation of the diffusion from their individually-tracked positions entails the difficulty in the treatment of molecular adsorption on the substrate. We propose a novel technique to evaluate them, and two types of near-surface Brownian motion were determined for DNA. One is the diffusion near glass surface, and the other is the adsorption-dominated motion, which is also found to be diffusive rather than anchored to the substrate. Our technique does not require the threshold values for the distinction, and even the transition between them can be captured. Objective distinction of Brownian motion with and without adsorption does not require the adsorption-free sample preparation. It is also useful for the characterization of adsorption/desorption kinetics. Our method is not limited to TIRF but applicable to many other systems involving multiple states of Brownian motion. (C) 2015 The Japan Society of Applied Physics	[Hanasaki, Itsuo] Tokyo Univ Agr & Technol, Inst Engn, Koganei, Tokyo 1848588, Japan; [Uehara, Satoshi; Kawano, Satoyuki] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Arai, Yoshiyuki; Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Hanasaki, I (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Koganei, Tokyo 1848588, Japan.	kawano@me.es.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program);  [26709008]	This research was partly supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), and by a Grant-in-Aid for Young Scientists (A), No. 26709008.	Kastantin M, 2012, LANGMUIR, V28, P12443, DOI 10.1021/la3017134; Gon S, 2010, LANGMUIR, V26, P12147, DOI 10.1021/la1016752; Stellwagen E, 2003, BIOCHEMISTRY-US, V42, P11745, DOI 10.1021/bi035203p; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; Honciuc A, 2008, LANGMUIR, V24, P6562, DOI 10.1021/la8007365; Huang P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046307; Boroudjerdi H, 2005, PHYS REP, V416, P129, DOI 10.1016/j.physrep.2005.06.006; Xu XHN, 1998, SCIENCE, V281, P1650, DOI 10.1126/science.281.5383.1650; Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028; Chenouard N, 2014, NAT METHODS, V11, P281, DOI 10.1038/nmeth.2808; Mears M, 2011, MACROMOL RAPID COMM, V32, P1411, DOI 10.1002/marc.201100076; Choi CK, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2798811; Xu Z, 2000, BIOMATERIALS, V21, P1075, DOI 10.1016/S0142-9612(00)00004-1; Xu XH, 1997, SCIENCE, V275, P1106, DOI 10.1126/science.275.5303.1106; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Santore MM, 2007, LANGMUIR, V23, P4782, DOI 10.1021/la063546t; Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s; Daly SM, 2005, LANGMUIR, V21, P1328, DOI 10.1021/la048316y; Pinholt C, 2011, EXPERT OPIN DRUG DEL, V8, P949, DOI 10.1517/17425247.2011.577062; Hanasaki I, 2009, CMES-COMP MODEL ENG, V46, P191; Garland A, 2012, PROG SURF SCI, V87, P1, DOI 10.1016/j.progsurf.2012.02.001; Myers GA, 2012, J AM CHEM SOC, V134, P19652, DOI 10.1021/ja306074k; Yano YF, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/50/503101; Hanasaki I, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051134; Krieg AK, 2014, SENSOR ACTUAT B-CHEM, V203, P663, DOI 10.1016/j.snb.2014.07.036; Lundin M, 2010, COLLOID SURFACE B, V77, P1, DOI 10.1016/j.colsurfb.2009.12.019; Pinholt C, 2013, INT J PHARMACEUT, V440, P63, DOI 10.1016/j.ijpharm.2012.01.040; Kastantin M, 2011, ACS NANO, V5, P9861, DOI 10.1021/nn2035389; Monserud JH, 2014, ACS NANO, V8, P4488, DOI 10.1021/nn4064874; Hanasaki I, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4913748; He Y, 2005, J PHYS CHEM B, V109, P8820, DOI 10.1021/jp0447284; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Luthgens E, 2005, CHEMPHYSCHEM, V6, P444, DOI 10.1002/cphc.200400446; Uehara S, 2014, MICRO NANO LETT, V9, P257, DOI 10.1049/mnl.2013.0668; Hanasaki I, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.065201; Koo J, 2013, LANGMUIR, V29, P8025, DOI 10.1021/la401296f; Jennissen HP, 2004, BIOSENS BIOELECTRON, V19, P987, DOI 10.1016/j.bios.2003.09.008; Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g; Hanasaki I, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/46/465103; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Kang SH, 2001, ANAL CHEM, V73, P1091, DOI 10.1021/ac0013599; Conboy JC, 2002, J AM CHEM SOC, V124, P968, DOI 10.1021/ja011225s; Ross EE, 2003, LANGMUIR, V19, P1766, DOI 10.1021/la026198d; Monserud JH, 2012, BIOMACROMOLECULES, V13, P4002, DOI 10.1021/bm301289n; Mollmann SH, 2005, PHARM RES, V22, P1931, DOI 10.1007/s11095-005-7249-1; Hanasaki I, 2015, J COMPUT SCI-NETH, V10, P311, DOI 10.1016/j.jocs.2015.04.002; Chen JX, 2013, ACS APPL MATER INTER, V5, P9338, DOI 10.1021/am403984k; Hanasaki I, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/13/135402; Kastantin M, 2014, ADV COLLOID INTERFAC, V207, P240, DOI 10.1016/j.cis.2013.12.006; Pereira P, 2008, COLLOID SURFACE B, V64, P1, DOI 10.1016/j.colsurfb.2007.12.015; Woods DA, 2014, SOFT MATTER, V10, P1071, DOI 10.1039/c3sm52817k; Kastantin M, 2011, J AM CHEM SOC, V133, P4975, DOI 10.1021/ja110663u; Czeslik C, 2002, SPECTROSC-INT J, V16, P139; Czeslik C, 2003, BIOPHYS J, V84, P2533, DOI 10.1016/S0006-3495(03)75058-9; BRENNER H, 1961, CHEM ENG SCI, V16, P242, DOI 10.1016/0009-2509(61)80035-3; Holmqvist P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431175; Hanasaki I, 2014, PROCEDIA COMPUT SCI, V29, P281, DOI 10.1016/j.procs.2014.05.025; Jennissen HP, 1999, MATERIALWISS WERKST, V30, P850; Wu M, 2011, LANGMUIR, V27, P2731, DOI 10.1021/la1037926; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Daly SM, 2007, COLLOID SURFACE B, V57, P81, DOI 10.1016/j.colsurfb.2007.01.007; Cannon B, 2005, LANGMUIR, V21, P9666, DOI 10.1021/la0502645; Langdon BB, 2012, BIOPHYS J, V102, P2625, DOI 10.1016/j.bpj.2012.04.027; Jorgensen L, 2009, J LIPOSOME RES, V19, P99, DOI 10.1080/08982100902805475; Britt DW, 2000, PHYS CHEM CHEM PHYS, V2, P4594, DOI 10.1039/b003608k; Daly SM, 2003, LANGMUIR, V19, P3848, DOI 10.1021/la026690x; Carbajal-Tinoco MD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138303; Hanasaki I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/9/095301; Faxen H, 1922, ANN PHYS-BERLIN, V68, P89; Hanasaki I., 2014, APPL MECH MAT, V692, P420; Jin MY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6295; Tsutsui M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1141; Yamada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3033	74	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							125601	10.7567/JJAP.54.125601		6	Physics, Applied	Physics	CY1TU	WOS:000366191400018		
J	Hangyo, M				Hangyo, Masanori			Development and future prospects of terahertz technology	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Review							TIME-DOMAIN SPECTROSCOPY; QUANTUM-CASCADE LASERS; TEMPERATURE-GROWN GAAS; SUBMILLIMETER-WAVE EMISSION; PHOTOCONDUCTIVE ANTENNA; DIFFERENCE-FREQUENCY; REFLECTION SPECTROSCOPY; SEMICONDUCTOR SURFACES; RADIATION; GENERATION	Recently, the technology of terahertz (THz) waves, which have been called undeveloped electromagnetic waves, has been making remarkable progress. In addition to the technologies of generating THz waves using lasers, which are promoting this progress, advances are being made in THz generation methods using electronic devices and accelerators, and various THz optical components have been actively developed. The applications of THz technology are also becoming increasingly widespread. In this report, I will review these developments and discuss the future prospects of this field. (C) 2015 The Japan Society of Applied Physics	[Hangyo, Masanori] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Hangyo, M (reprint author), Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan.						Suzuki M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861495; DYAKONOV M, 1993, PHYS REV LETT, V71, P2465, DOI 10.1103/PhysRevLett.71.2465; NAKAZATO T, 1989, PHYS REV LETT, V63, P1245, DOI 10.1103/PhysRevLett.63.1245; Suizu K, 2008, OPT EXPRESS, V16, P7493, DOI 10.1364/OE.16.007493; Lin TT, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.012101; Kim KY, 2008, NAT PHOTONICS, V2, P605, DOI 10.1038/nphoton.2008.153; Nagashima T, 2001, APPL PHYS LETT, V79, P3917, DOI 10.1063/1.1426258; Williams BS, 2007, NAT PHOTONICS, V1, P517, DOI 10.1038/nphoton.2007.166; Scherger B, 2011, OPT EXPRESS, V19, P24884, DOI 10.1364/OE.19.024884; Yeh KL, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734374; Hokomoto Y, 1999, APPL PHYS LETT, V74, P3839, DOI 10.1063/1.124197; Tanabe T, 2003, APPL PHYS LETT, V83, P237, DOI 10.1063/1.1592889; Hangyo M, 2002, MEAS SCI TECHNOL, V13, P1727, DOI 10.1088/0957-0233/13/11/309; Katayama I, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463452; Kawase K, 1996, APPL PHYS LETT, V68, P2483, DOI 10.1063/1.115828; Hirota Y, 2006, OPT EXPRESS, V14, P4486, DOI 10.1364/OE.14.004486; Jahangiri F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3672814; Mizoguchi K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2033138; Tonouchi M, 1996, JPN J APPL PHYS 1, V35, P2624, DOI 10.1143/JJAP.35.2624; Komiyama S, 2000, NATURE, V403, P405, DOI 10.1038/35000166; Jeong YU, 2001, NUCL INSTRUM METH A, V475, P47, DOI 10.1016/S0168-9002(01)01533-9; Lin TT, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.022102; Kumar S, 2011, NAT PHYS, V7, P166, DOI [10.1038/nphys1846, 10.1038/NPHYS1846]; Beck M, 2010, OPT EXPRESS, V18, P9251, DOI 10.1364/OE.18.009251; Shiraishi M, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.064101; Qin Q, 2009, NAT PHOTONICS, V3, P732, DOI 10.1038/nphoton.2009.218; ZERNIKE F, 1965, PHYS REV LETT, V15, P999, DOI 10.1103/PhysRevLett.15.999; BROWN ER, 1995, APPL PHYS LETT, V66, P285, DOI 10.1063/1.113519; Otsuji T, 2011, J INFRARED MILLIM TE, V32, P629, DOI 10.1007/s10762-010-9714-0; Liu ZL, 2000, JPN J APPL PHYS 2, V39, pL366, DOI 10.1143/JJAP.39.L366; Mirzaei B, 2012, OPT LASER TECHNOL, V44, P378, DOI 10.1016/j.optlastec.2011.07.020; ZHANG XC, 1992, J APPL PHYS, V71, P326, DOI 10.1063/1.350710; Goto M, 2004, JPN J APPL PHYS 2, V43, pL317, DOI 10.1143/JJAP.43.L317; Kadow C, 1999, APPL PHYS LETT, V75, P3548, DOI 10.1063/1.125384; Sarukura N, 1998, J APPL PHYS, V84, P654, DOI 10.1063/1.368068; Nagashima T, 2009, OPT EXPRESS, V17, P8907, DOI 10.1364/OE.17.008907; Dekorsy T, 1996, PHYS REV B, V53, P4005, DOI 10.1103/PhysRevB.53.4005; Cook DJ, 2000, OPT LETT, V25, P1210, DOI 10.1364/OL.25.001210; Kawase K, 2002, J PHYS D APPL PHYS, V35, pR1, DOI 10.1088/0022-3727/35/3/201; Kawano Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3205125; Carr GL, 2002, NATURE, V420, P153, DOI 10.1038/nature01175; Scheller M, 2009, OPT EXPRESS, V17, P17723, DOI 10.1364/OE.17.017723; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; Tavallaee AA, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3648104; Tavallaee AA, 2010, IEEE J QUANTUM ELECT, V46, P1091, DOI 10.1109/JQE.2010.2043642; Imai K, 2001, APPL PHYS LETT, V78, P1026, DOI 10.1063/1.1350420; Yamada I, 2009, OPT LETT, V34, P274, DOI 10.1364/OL.34.000274; Kubler C, 2004, APPL PHYS LETT, V85, P3360, DOI 10.1063/1.1808232; Parrott EPJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3642002; Zmuidzinas J, 2004, P IEEE, V92, P1597, DOI 10.1109/JPROC.2004.833670; Miyamaru F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3436724; Nashima S, 2001, APPL PHYS LETT, V79, P3923, DOI 10.1063/1.1413498; Hebling J, 2002, OPT EXPRESS, V10, P1161, DOI 10.1364/OE.10.001161; Chen HT, 2011, LASER PHOTONICS REV, V5, P513, DOI 10.1002/lpor.201000043; Tani M, 2000, APPL PHYS LETT, V77, P1396, DOI 10.1063/1.1289914; Tani M, 1997, APPL OPTICS, V36, P7853, DOI 10.1364/AO.36.007853; Morikawa O, 2011, J APPL PHYS, V110, DOI 10.1063/1.3639296; Takano K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3654156; Wang KL, 2004, NATURE, V432, P376, DOI 10.1038/nature03040; Kondo T, 2003, JPN J APPL PHYS 2, V42, pL373, DOI 10.1143/JJAP.42.L373; Teppe F, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2005394; Takano K, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.016701; Hirori H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560062; Suzuki S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525834; WASCHKE C, 1993, PHYS REV LETT, V70, P3319, DOI 10.1103/PhysRevLett.70.3319; Dyakonova N, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191421; Andrews HL, 2004, PHYS REV SPEC TOP-AC, V7, DOI 10.1103/PhysRevSTAB.7.070701; Yu NF, 2010, NAT MATER, V9, P730, DOI [10.1038/nmat2822, 10.1038/NMAT2822]; Sekine N, 1999, APPL PHYS LETT, V74, P1006, DOI 10.1063/1.123437; Suizu K, 2010, OPT EXPRESS, V18, P3338, DOI 10.1364/OE.18.003338; Qin Q, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/7/075004; Shimano R, 2002, APPL PHYS LETT, V81, P199, DOI 10.1063/1.1492319; Hirori H, 2004, JPN J APPL PHYS 2, V43, pL1287, DOI 10.1143/JJAP.43.L1287; Nishizawa J, 2008, PHYS STATUS SOLIDI C, V5, P2802, DOI 10.1002/pssc.200779256; SAETA PN, 1993, APPL PHYS LETT, V63, P3482, DOI 10.1063/1.110127; ROSKOS HG, 1992, PHYS REV LETT, V68, P2216, DOI 10.1103/PhysRevLett.68.2216; Sizov F, 2010, OPTO-ELECTRON REV, V18, P10, DOI 10.2478/s11772-009-0029-4; Taniuchi T, 2004, J APPL PHYS, V95, P5984, DOI 10.1063/1.1713045; Knap W, 2004, APPL PHYS LETT, V85, P675, DOI 10.1063/1.1775034; Chen HT, 2006, NATURE, V444, P597, DOI 10.1038/nature05343; SUTO K, 1983, IEEE J QUANTUM ELECT, V19, P1251, DOI 10.1109/JQE.1983.1072030; ZHANG XC, 1993, APPL PHYS LETT, V62, P2003, DOI 10.1063/1.109514; Idehara T, 2006, INT J INFRARED MILLI, V27, P319, DOI 10.1007/s10762-006-9084-9; Kozuki K, 2011, OPT EXPRESS, V19, P24950, DOI 10.1364/OE.19.024950; KOMIYAMA S, 1991, OPT QUANT ELECTRON, V23, pS133, DOI 10.1007/BF00619762; Tani M, 1998, J APPL PHYS, V83, P2473, DOI 10.1063/1.367007; Hangyo M, 2005, INT J INFRARED MILLI, V26, P1661, DOI 10.1007/s10762-005-0288-1; Ito T, 2007, J OPT SOC AM B, V24, P1230, DOI 10.1364/JOSAB.24.001230; Liu JL, 2010, NAT PHOTONICS, V4, P627, DOI 10.1038/NPHOTON.2010.165; Hangyo M, 1996, APPL PHYS LETT, V69, P2122, DOI 10.1063/1.117175; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Komiyama S, 2011, IEEE J SEL TOP QUANT, V17, P54, DOI 10.1109/JSTQE.2010.2048893; Hosako I, 2007, P IEEE, V95, P1611, DOI 10.1109/JPROC.2007.898844; Dyakonov M, 1996, IEEE T ELECTRON DEV, V43, P380, DOI 10.1109/16.485650; Morikawa O, 2000, APPL PHYS LETT, V76, P1519, DOI 10.1063/1.126082; [Anonymous], 2006, OYO BUTURI, V75; Dreyhaupt A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1891304; Nishizawa J, 2008, INT J INFRARED MILLI, V29, P291, DOI 10.1007/s10762-007-9322-9; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; Takano K, 2011, OPT LETT, V36, P2665, DOI 10.1364/OL.36.002665; Kumar S, 2008, IEEE J SEL TOP QUANT, V14, P333, DOI 10.1109/JSTQE.2007.915510; Scheller M, 2010, OPT EXPRESS, V18, P27112, DOI 10.1364/OE.18.027112; Chan WL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3147221; Fukasawa Ryoichi, 2010, Oyo Buturi, V79; Hangyo M., 2005, BUNKO KENKYU, V54, P181; Hangyo M., 2005, Oyo Buturi, V74; Hattori T., 2009, INTRO NONLINEAR OPTI; Hirakawa K., 2006, Oyo Buturi, V75; Hirakawa Kazuhiko, 2010, Oyo Buturi, V79; Hirori H., 2012, OYO BUTURI, V81, P291; Hoffmann MC, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/8/083001; Hosako Iwao, 2010, Oyo Buturi, V79; Ishibashi T., 2001, Oyo Buturi, V70; Ito Hiromasa, 2010, Oyo Buturi, V79; Ito H., 2006, Oyo Buturi, V75; Jahangiri F., 2012, THESIS; Kado Yuichi, 2011, Oyo Buturi, V80; Kataoka T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3519480; Kawano Yukio, 2011, Oyo Buturi, V80; Kawase K., 2002, Oyo Buturi, V71; Kawase Kodo, 2008, Oyo Buturi, V77; Kitagishi K., 2012, OYO BUTURI, V81, P312; Kittel C., 2005, INTRODUCTION SOLID S; Kneubuhl F. K., 1980, INFRARED MILLIMETER, V3, P219; Komiyama S., 2006, Oyo Buturi, V75; Kumar S, 2011, IEEE J SEL TOP QUANT, V17, P38, DOI 10.1109/JSTQE.2010.2049735; Lee Y.-S., 2009, PRINCIPLES TERAHERTZ; Li D, 2012, NUCL INSTRUM METH A, V674, P20, DOI 10.1016/j.nima.2012.01.039; Lisauskas A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3140611; Minamide H., 2012, OYO BUTURI, V81, P284; Mitsuishi A, 2014, J INFRARED MILLIM TE, V35, P243, DOI 10.1007/s10762-013-0029-9; Mittleman D., 2003, SENSING TERAHERTZ RA; Moller K.D., 1971, FAR INFRARED SPECTRO; Nishizawa J., 2005, FUNDAMENTALS APPL TE; Oda N, 2010, CR PHYS, V11, P496, DOI 10.1016/j.crhy.2010.05.001; Oda N., 2012, OYO BUTURI, V81, P321; Ramian G., 2006, NUCL INSTRUM METH A, V557, P225; Sakaj Kiyomi, 2008, Oyo Buturi, V77; Sakai K., 2005, TERAHERTZ OPTOELECTR; Sakai K., 1983, REV INFRARED MILLIME, V1, P155; Sakai K., 2001, Oyo Buturi, V70; Sekine N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.057408; Tanigawa T., 2011, OPTICAL ALLIANCE FEB, P130; Terahertz Technology Forum, 2007, HDB TER TECHN; Tonouchi M., 2011, NEW TERAHERTZ IND; van der Meer AFG, 2004, NUCL INSTRUM METH A, V528, P8, DOI 10.1016/j.nima.2004.04.008; Wu T. K., 1995, FREQUENCY SELECTIVE; YARBOROU.JM, 1969, APPL PHYS LETT, V15, P102, DOI 10.1063/1.1652910; Yasui T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008379; Yatsugi K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3595270; Zhang XC, 2010, INTRODUCTION TO THZ WAVE PHOTONICS, P1, DOI 10.1007/978-1-4419-0978-7	151	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							120101	10.7567/JJAP.54.120101		16	Physics, Applied	Physics	CY1TU	WOS:000366191400001		
J	Honma, M; Uchida, E; Saito, H; Harada, T; Muto, S; Nose, T				Honma, Michinori; Uchida, Etsuo; Saito, Hiroo; Harada, Takeshi; Muto, Seiei; Nose, Toshiaki			Simple system for measuring optical rotation of glucose solution using liquid-crystal grating	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POLARIZATION GRATINGS; HIGH-EFFICIENCY; DIFFRACTION; POLARIMETER; HETERODYNE; DOMAIN	We demonstrate an optical system for measuring the concentrations of optically active media using liquid-crystal polarization gratings (LCPGs). The optical rotation angle is determined by measuring the intensities of two diffracted light beams from an LCPG combined with a quarter-wave plate (QWP). The intensity ratio is used to evaluate the optical rotation angle, minimizing the dependence on changes in light source intensity and wavelength and reducing the influence of temperature-drift-induced LC birefringence shifts. We demonstrate the system by measuring the concentration of a glucose-water solution. The measurement error caused by the slight wavelength dependence of the QWP's retardation is assessed numerically. (C) 2015 The Japan Society of Applied Physics	[Honma, Michinori; Nose, Toshiaki] Akita Prefectural Univ, Fac Syst Sci & Technol, Dept Elect & Informat Syst, Akita 0150055, Japan; [Uchida, Etsuo; Saito, Hiroo; Harada, Takeshi; Muto, Seiei] Muto Denshi Kogyo Ltd, Akita 0100341, Japan	Honma, M (reprint author), Akita Prefectural Univ, Fac Syst Sci & Technol, Dept Elect & Informat Syst, Akita 0150055, Japan.	mhonma@akita-pu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25390058]; Akita Prefecture Promotion of Industry-Academia-Government Cooperation Feasibility Study Assistance	This work was partially supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (No. 25390058), and by Akita Prefecture Promotion of Industry-Academia-Government Cooperation Feasibility Study Assistance (2012).	Kotova SP, 2002, OPT EXPRESS, V10, P1258, DOI 10.1364/OE.10.001258; Honma M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.062501; Crawford GP, 2005, J APPL PHYS, V98, DOI 10.1063/1.2146075; Marrucci L, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207993; TODOROV T, 1992, OPT LETT, V17, P358, DOI 10.1364/OL.17.000358; Shi L, 2008, J APPL PHYS, V104, DOI 10.1063/1.2966300; Kudenov MW, 2011, APPL OPTICS, V50, P2283, DOI 10.1364/AO.50.002283; HORI Y, 1979, IEEE T ELECTRON DEV, V26, P1734, DOI 10.1109/T-ED.1979.19678; Honma M, 2003, JPN J APPL PHYS 1, V42, P6992, DOI 10.1143/JJAP.42.6992; Chou C, 1997, JPN J APPL PHYS 1, V36, P356, DOI 10.1143/JJAP.36.356; Sarkissian H, 2006, MOL CRYST LIQ CRYST, V451, P1, DOI 10.1080/154214090959957; Nersisyan SR, 2009, OPT EXPRESS, V17, P1817, DOI 10.1364/OE.17.001817; Mitsui T, 1999, JPN J APPL PHYS 1, V38, P2152, DOI 10.1143/JJAP.38.2152; Chao JC, 2007, OPT EXPRESS, V15, P16702, DOI 10.1364/OE.15.016702; Ono H, 2003, J APPL PHYS, V94, P1298, DOI 10.1063/1.1587269; Chou C, 1998, APPL OPTICS, V37, P3553, DOI 10.1364/AO.37.003553; Pham TTH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.097002; Provenzano C, 2006, APPL OPTICS, V45, P3929, DOI 10.1364/AO.45.003929; Sarkissian H, 2006, OPT LETT, V31, P2248, DOI 10.1364/OL.31.002248; LOVE GD, 1994, OPT LETT, V19, P1170; Resler DP, 1996, OPT LETT, V21, P689, DOI 10.1364/OL.21.000689; Yang ZH, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4804596; Blinov LM, 2006, MOL CRYST LIQ CRYST, V449, P147, DOI 10.1080/15421400600583919; Wang X, 2000, APPL OPTICS, V39, P6545, DOI 10.1364/AO.39.006545; Presnyakov V, 2006, OPT EXPRESS, V14, P10558, DOI 10.1364/OE.14.010558; Honma M, 2004, APPL OPTICS, V43, P5193, DOI 10.1364/AO.43.005193; Provenzano C, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355456; Wood MFG, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2968198; Honma M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737945; Komanduri RK, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3197011; Culbreath C, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3669528; Honma M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.051702; Tabiryan NV, 2011, AIP ADV, V1, DOI 10.1063/1.3609965; Oh C, 2008, OPT LETT, V33, P2287, DOI 10.1364/OL.33.002287; Khan SA, 2004, OPT EXPRESS, V12, P868, DOI 10.1364/OPEX.12.000868; Provenzano C, 2010, OPT LETT, V35, P1822, DOI 10.1364/OL.35.001822; SATO S, 1979, JPN J APPL PHYS, V18, P1679, DOI 10.1143/JJAP.18.1679	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							122601	10.7567/JJAP.54.122601		6	Physics, Applied	Physics	CY1TU	WOS:000366191400008		
J	Kajita, S; Ohta, A; Ishida, T; Makihara, K; Yoshida, T; Ohno, N				Kajita, Shin; Ohta, Akio; Ishida, Tomoya; Makihara, Katsunori; Yoshida, Tomoko; Ohno, Noriyasu			Increase in the work function of W/WO3 by helium plasma irradiation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TUNGSTEN SURFACE; NANOSTRUCTURE; BOMBARDMENT; EXPOSURE; STATE	Helium plasma irradiation to tungsten leads to formation of helium clusters, helium bubbles, and fiberform nanostructures near the surface. In this study, tungsten samples exposed to helium plasmas are analyzed by X-ray photoelectron spectroscopy in detail. The W 4f spectra and valence band spectra show chemical composition and electronic state of the surface. It was found that significant differences were not identified on the electronic state between the helium plasma irradiated and pristine samples when the degree of oxidization was the same level. From a low kinetic energy cut-off of X-ray photoelectron spectrum, the work function of the samples was measured. It was found that helium plasma irradiation increased the work function by approximately 0.5 eV when WO3/W was higher than unity. The possible mechanism to arise the difference in the work function is discussed. (C) 2015 The Japan Society of Applied Physics	[Kajita, Shin] Nagoya Univ, Nagoya, Aichi 4648603, Japan; [Ohta, Akio; Ishida, Tomoya; Makihara, Katsunori; Ohno, Noriyasu] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Yoshida, Tomoko] Osaka City Univ, Adv Res Inst Nat Sci & Technol, Osaka 5588585, Japan	Kajita, S (reprint author), Nagoya Univ, Nagoya, Aichi 4648603, Japan.	kajita.shin@nagoya-u.jp	Kajita, Shin/Q-1020-2015		Japan Society for the Promotion of Science (JSPS) [15H04229]; NIFS collaborative research program [NIFS15KOAH032]	This work was supported in part by a Grant-in-Aid for Scientific Research (B) 15H04229 from the Japan Society for the Promotion of Science (JSPS) and NIFS collaborative research program (NIFS15KOAH032).	Takamura S, 2013, FUSION SCI TECHNOL, V63, P225; Nishijima D, 2011, FUSION SCI TECHNOL, V60, P1447; Xie FY, 2012, J ELECTRON SPECTROSC, V185, P112, DOI 10.1016/j.elspec.2012.01.004; Kajita S, 2007, NUCL FUSION, V47, P1358, DOI 10.1088/0029-5515/47/9/038; Grubbs ME, 2009, IEEE ELECTR DEVICE L, V30, P925, DOI 10.1109/LED.2009.2026717; Martynenko YV, 2012, PLASMA PHYS REP+, V38, P996, DOI 10.1134/S1063780X12110074; Anders A, 2008, SPRINGER SER ATOM OP, V50, P1, DOI 10.1007/978-0-387-79108-1_1; Tanuma S, 2011, SURF INTERFACE ANAL, V43, P689, DOI 10.1002/sia.3522; Bagus PS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126101; Krasheninnikov SI, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014040; Baldwin MJ, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035001; Kajita S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798597; CHEN YC, 1984, PHYS REV B, V30, P7317, DOI 10.1103/PhysRevB.30.7317; Li W, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1849135; Kajita S, 2013, J NUCL MATER, V442, pS515, DOI 10.1016/j.jnucmat.2012.12.046; Barengolts SA, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/12/125004; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095005; Kolesnychenko OY, 2000, PHYSICA B, V284, P1257, DOI 10.1016/S0921-4526(99)02519-3; de Respinis M, 2013, ACS APPL MATER INTER, V5, P7621, DOI 10.1021/am401936q; Kajita S, 2013, FUSION ENG DES, V88, P2842, DOI 10.1016/j.fusengdes.2013.05.014; Nishijima D, 2011, J NUCL MATER, V415, pS96, DOI 10.1016/j.jnucmat.2010.12.017; Ito AM, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014062; Kajita S, 2011, J NUCL MATER, V418, P152, DOI 10.1016/j.jnucmat.2011.06.026; Greiner MT, 2010, J PHYS CHEM C, V114, P19777, DOI 10.1021/jp108281m; Kajita S, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/02/025602; Kajita S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.085204; Faney T, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/1/013014; Park Y, 1996, APPL PHYS LETT, V68, P2699, DOI 10.1063/1.116313; Kim JH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826642; Greiner MT, 2012, ADV FUNCT MATER, V22, P4557, DOI 10.1002/adfm.201200615; Leung TC, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195408; Ohno N, 2013, J NUCL MATER, V438, pS879, DOI 10.1016/j.jnucmat.2013.01.190; Vida G, 2003, MICROSC MICROANAL, V9, P337, DOI 10.1017/S143192760303023X; Krasheninnikov SI, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/7/073019; Fall C. J., 2002, Physical Review B (Condensed Matter and Materials Physics), V65, DOI 10.1103/PhysRevB.65.045401; Irfan H., 2010, APPL PHYS LETT, V96; Kajita S, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/3/032002; Komori K., 2014, J SURF SCI NANOTECHN, V12, P343; Komori K., 2014, THESIS; Michaelides A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.246103; Miyazaki S., 2008, HYOMEN KAGAKU, V29, P84, DOI 10.1380/jsssj.29.84; Nishijima D., 2013, 14 INT C PLASM FAC M; Roman T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.156804; Takamura S., 2014, PLASMA FUSION RES, V9; Takamura S., 2006, PLASMA FUSION RES, V1, P51, DOI 10.1585/pfr.1.051; Takayama A, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AL03	46	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							126201	10.7567/JJAP.54.126201		6	Physics, Applied	Physics	CY1TU	WOS:000366191400020		
J	Kozawa, T				Kozawa, Takahiro			Optimum concentration ratio of photodecomposable quencher to acid generator in chemically amplified extreme ultraviolet resists	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRON-BEAM; LITHOGRAPHY; EFFICIENCY; AMPLIFICATION	In chemically amplified resists used for ionizing radiations such as an extreme ultraviolet radiation, thermalized electrons and protons play important roles in pattern formation. Photodecomposable quenchers are important for 11 nm half-pitch fabrication because they capture both thermalized electrons and protons. However, their effects are complicated for the same reason. In this study, the optimum concentration ratio of photodecomposable quenchers to acid generators in terms of the trade-off relationships between resolution, line width roughness (LWR), and sensitivity was theoretically investigated, assuming line-and-space patterns of 11nm half-pitch. To suppress LWR to less than 20% critical dimension (CD), the recommended total sensitizer concentration (the sum of acid generator and photodecomposable quencher concentrations) was in the range of 0.20-0.22nm(-3). The expected sensitivities were 30-40mJ cm(-2) when the resist performance of the latest chemically amplified resists was assumed. The optimum ratio of photodecomposable quencher concentration to the total sensitizer concentration was 0.55. (C) 2015 The Japan Society of Applied Physics	[Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Kozawa, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25246036]	This work was supported in part by a Grant-in-Aid for Scientific Research (Project No. 25246036) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Yamamoto H, 2005, JPN J APPL PHYS 1, V44, P5836, DOI 10.1143/JJAP.44.5836; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; USHIROGOUCHI T, 1995, P SOC PHOTO-OPT INS, V2438, P609, DOI 10.1117/12.210384; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; Kozawa T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.056502; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Fujii S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.116501; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; KOZAWA T, 1992, JPN J APPL PHYS 1, V31, P4301, DOI 10.1143/JJAP.31.4301; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; KINOSHITA H, 1989, J VAC SCI TECHNOL B, V7, P1648, DOI 10.1116/1.584507; Natsuda K, 2008, JPN J APPL PHYS, V47, P4932, DOI 10.1143/JJAP.47.4932; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Fujii S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.086502; Yamamoto H, 2004, JPN J APPL PHYS 2, V43, pL848, DOI 10.1143/JJAP.43.L848; Vogt BD, 2007, J VAC SCI TECHNOL B, V25, P175, DOI 10.1116/1.2429675; Thackeray J, 2013, J PHOTOPOLYM SCI TEC, V26, P605; Kozawa T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.036501; Kozawa T, 2006, J VAC SCI TECHNOL B, V24, pL27, DOI 10.1116/1.2393297; Kozawa T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2909275; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076505; Kozawa T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.016503; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.066508; Nalamasu O, 1998, J VAC SCI TECHNOL B, V16, P3716, DOI 10.1116/1.590396; Hirose R, 2007, JPN J APPL PHYS 2, V46, pL979, DOI 10.1143/JJAP.46.L979; Wurm S, 2007, JPN J APPL PHYS 1, V46, P6105, DOI 10.1143/JJAP.46.6105; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2007, JPN J APPL PHYS 2, V46, pL1143, DOI 10.1143/JJAP.46.L1143; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; Kozawa T, 2007, J VAC SCI TECHNOL B, V25, P2481, DOI 10.1116/1.2794063; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; Mitsuyasu M, 2015, J PHOTOPOLYM SCI TEC, V28, P119; Kozawa T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.016502; Chen S. F., 2012, P SOC PHOTO-OPT INS, V8325; Funato S., 1995, J PHOTOPOLYM SCI TEC, V8, P543, DOI 10.2494/photopolymer.8.543; Peeters R., 2014, EUV S; Pirati A, 2015, PROC SPIE, V9422, DOI 10.1117/12.2085912; Wurm S., 2014, EUV S; Yen A., 2014, EUV S	43	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							126501	10.7567/JJAP.54.126501		5	Physics, Applied	Physics	CY1TU	WOS:000366191400021		
J	Luong, MV; Cadatal-Raduban, M; Empizo, MJF; Arita, R; Minami, Y; Shimizu, T; Sarukura, N; Azechi, H; Pham, MH; Nguyen, HD; Kawazoe, Y				Mui Viet Luong; Cadatal-Raduban, Marilou; Empizo, Melvin John F.; Arita, Ren; Minami, Yuki; Shimizu, Toshihiko; Sarukura, Nobuhiko; Azechi, Hiroshi; Minh Hong Pham; Hung Dai Nguyen; Kawazoe, Yoshiyuki			Comparison of the electronic band structures of LiCaAlF6 and LiSrAlF6 ultraviolet laser host media from ab initio calculations	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ALL-SOLID-STATE; NONLINEAR-OPTICAL SUSCEPTIBILITIES; CE-DOPED LICAALF6; SINGLE-CRYSTAL; CZOCHRALSKI TECHNIQUE; CF4 ATMOSPHERE; GROWTH; ENERGY; HYPERPOLARIZABILITY; PERFORMANCE	We report the electronic structures and density of states (DOS) of perfect LiCAF and LiSAF crystals calculated from density functional theory (DFT) with local density approximation (LDA) using optimized lattice constants. DOS calculations reveal that the valence band is mainly derived from F 2p, thereby resulting to a very narrow valence band manifold. Meanwhile, the conduction band is mainly derived from Ca 4s or Sr 5s resulting to Sr having a broader band dispersion compared to Ca. Both fluoride compounds have indirect band gaps with LiCAF having a band gap of 8.02 eV and LiSAF a band gap of 7.92 eV. This is, to the best of our knowledge, the first report on the electronic structure of LiSAF calculated using DFT with LDA. Our results suggest that when doped with Ce3+, the shorter 5d-conduction band distance in Ce:LiSAF combined with the difficulty of growing high-purity crystals lead to the more pronounced excited state absorption (ESA) and solarization effect experimentally observed in Ce: LiSAF, limiting its potential as a laser material compared with Ce: LiCAF. (C) 2015 The Japan Society of Applied Physics	[Mui Viet Luong; Cadatal-Raduban, Marilou; Empizo, Melvin John F.; Arita, Ren; Minami, Yuki; Shimizu, Toshihiko; Sarukura, Nobuhiko; Azechi, Hiroshi; Minh Hong Pham] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Cadatal-Raduban, Marilou] Massey Univ, Inst Nat & Math Sci, Ctr Theoret Chem & Phys, Auckland 0632, New Zealand; [Cadatal-Raduban, Marilou; Minh Hong Pham] Osaka Univ, Inst Acad Initiat, Suita, Osaka 5650871, Japan; [Minh Hong Pham; Hung Dai Nguyen] Vietnam Acad Sci & Technol, Inst Phys, Hanoi, Vietnam; [Kawazoe, Yoshiyuki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kawazoe, Yoshiyuki] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan	Luong, MV (reprint author), Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan.	luong-vm@ile.osaka-u.ac.jp					Sarukura N, 1998, APPL OPTICS, V37, P6446, DOI 10.1364/AO.37.006446; Shimamura K, 2002, J ALLOY COMPD, V343, P204, DOI 10.1016/S0925-8388(02)00125-1; Yanagida T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.106401; Amaral JB, 2003, J PHYS-CONDENS MAT, V15, P2523, DOI 10.1088/0953-8984/15/17/308; VARSHNI YP, 1967, PHYSICA, V34, P149, DOI 10.1016/0031-8914(67)90062-6; Kirm M, 2005, NUCL INSTRUM METH A, V537, P291, DOI 10.1016/j.nima.2004.08.029; Reshak AH, 2013, J PHYS CHEM B, V117, P14141, DOI 10.1021/jp4077905; LAWSON JK, 1993, PHYS REV B, V47, P14003, DOI 10.1103/PhysRevB.47.14003; Sarukura N, 2007, OPT MATER, V30, P15, DOI 10.1016/j.optmat.2006.11.031; Shiran N, 2005, NUCL INSTRUM METH A, V537, P266, DOI 10.1016/j.nima.2004.08.023; Liu ZL, 1999, J NONLINEAR OPT PHYS, V8, P41, DOI 10.1142/S0218863599000047; Ono Y, 2001, J CRYST GROWTH, V229, P505, DOI 10.1016/S0022-0248(01)01218-0; Tyuterev VG, 2006, COMP MATER SCI, V38, P350, DOI 10.1016/j.commatsci.2005.08.012; Reshak AH, 2011, PHYS CHEM CHEM PHYS, V13, P2945, DOI 10.1039/c0cp01601b; Tran F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226401; Shimamura K, 2000, J CRYST GROWTH, V211, P302, DOI 10.1016/S0022-0248(99)00789-7; Shimamura K, 2001, J CRYST GROWTH, V223, P383, DOI 10.1016/S0022-0248(01)00593-0; Yoshikawa A, 2010, OPT MATER, V32, P845, DOI 10.1016/j.optmat.2010.04.032; Reshak AH, 2013, PHYS CHEM CHEM PHYS, V15, P18979, DOI 10.1039/c3cp53431f; MARSHALL CD, 1994, J OPT SOC AM B, V11, P2054, DOI 10.1364/JOSAB.11.002054; PINTO JF, 1995, ELECTRON LETT, V31, P2009, DOI 10.1049/el:19951395; Krupa JC, 1997, J ALLOY COMPD, V250, P287, DOI 10.1016/S0925-8388(96)02725-9; Liu Z, 1998, JPN J APPL PHYS 2, V37, pL1318, DOI 10.1143/JJAP.37.L1318; Bensalah A, 2001, J CRYST GROWTH, V231, P143, DOI 10.1016/S0022-0248(01)01440-3; Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258; Grzechnik A, 2004, J PHYS-CONDENS MAT, V16, P5769, DOI 10.1088/0953-8984/16/32/013; Bayramian AJ, 1996, J LUMIN, V69, P85, DOI 10.1016/0022-2313(96)00081-6; Davydyuk GE, 2013, PHYS CHEM CHEM PHYS, V15, P6965, DOI 10.1039/c3cp50836f; Du MH, 2012, J APPL PHYS, V112, DOI 10.1063/1.4770469; Kohanoff J., 2006, ELECT STRUCTURE CALC, P75, DOI 10.1017/CBO9780511755613.006; Moncorge R., 2002, ULTRAVIOLET SPECTROS; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Sakai M., 1999, LASERS ELECTROOPTICS, P497; Sarantopoulou E., 2001, VUV LASER SPECTROSCO; SCHAFFERS KI, 1991, ACTA CRYSTALLOGR C, V47, P18, DOI 10.1107/S0108270190006205; Yanagida T, 2012, KEY ENG MATER, V508, P224, DOI 10.4028/www.scientific.net/KEM.508.224	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							122602	10.7567/JJAP.54.122602		6	Physics, Applied	Physics	CY1TU	WOS:000366191400009		
J	Nagakubo, A; Ogi, H; Hirao, M				Nagakubo, Akira; Ogi, Hirotsugu; Hirao, Masahiko			Refractive index and extinction coefficient of Si at 400nm between 10 and 300K	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TEMPERATURE-DEPENDENCE; OPTICAL-CONSTANTS; ELEVATED-TEMPERATURES; DIELECTRIC FUNCTION; ELASTIC-CONSTANTS; SILICON; GERMANIUM; ELLIPSOMETRY; ABSORPTION; CRYSTALS	Optical properties of Si are important and widely studied. However, temperature dependence of the refractive index for visible light at low temperatures has not been measured. In this study, we measured the complex refractive index of Si at 400nm between 10 and 300K by picosecond ultrasound spectroscopy. The measured refractive index at room temperature agrees well with reported values, confirming the accuracy of our measurement, and we found that the refractive index at 10 K is smaller than reported values. (C) 2015 The Japan Society of Applied Physics	[Nagakubo, Akira; Ogi, Hirotsugu; Hirao, Masahiko] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Nagakubo, A (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.	akira.nagakubo@abc.me.es.osaka-u.ac.jp					DAUNOIS A, 1978, PHYS REV B, V18, P1824, DOI 10.1103/PhysRevB.18.1824; BRIGGS HB, 1950, PHYS REV, V77, P287, DOI 10.1103/PhysRev.77.287; Ogi H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134204; VERLEUR HW, 1968, J OPT SOC AM, V58, P1356, DOI 10.1364/JOSA.58.001356; THUTUPALLI GKM, 1977, J PHYS C SOLID STATE, V10, P467, DOI 10.1088/0022-3719/10/3/017; ASPNES DE, 1983, PHYS REV B, V27, P985, DOI 10.1103/PhysRevB.27.985; JELLISON GE, 1983, PHYS REV B, V27, P7466, DOI 10.1103/PhysRevB.27.7466; PHILIPP HR, 1963, PHYS REV, V129, P1550, DOI 10.1103/PhysRev.129.1550; LI HH, 1980, J PHYS CHEM REF DATA, V9, P561; PHILIPP HR, 1960, PHYS REV, V120, P37, DOI 10.1103/PhysRev.120.37; VUYE G, 1993, THIN SOLID FILMS, V233, P166, DOI 10.1016/0040-6090(93)90082-Z; Devos A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125208; SALZBERG CD, 1957, J OPT SOC AM, V47, P244, DOI 10.1364/JOSA.47.000244; ICENOGLE HW, 1976, APPL OPTICS, V15, P2348, DOI 10.1364/AO.15.002348; HALL JJ, 1967, PHYS REV, V161, P756, DOI 10.1103/PhysRev.161.756; JELLISON GE, 1986, J APPL PHYS, V60, P841, DOI 10.1063/1.337386; JELLISON GE, 1982, J APPL PHYS, V53, P3745, DOI 10.1063/1.331113; BATCHELDER DN, 1964, J CHEM PHYS, V41, P2324, DOI 10.1063/1.1726266; PRIMAK W, 1971, APPL OPTICS, V10, P759, DOI 10.1364/AO.10.000759; HARA H, 1966, J PHYS SOC JPN, V21, P1222, DOI 10.1143/JPSJ.21.1222; LEDBETTER H, 1994, PHYS STATUS SOLIDI B, V181, P81, DOI 10.1002/pssb.2221810109; Komma J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4738989; VILLA JJ, 1972, APPL OPTICS, V11, P2102, DOI 10.1364/AO.11.002102; LAUTENSCHLAGER P, 1987, PHYS REV B, V36, P4821, DOI 10.1103/PhysRevB.36.4821; Duquesne JY, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134205; CARDONA M, 1959, J PHYS CHEM SOLIDS, V8, P204, DOI 10.1016/0022-3697(59)90316-6; DASH WC, 1955, PHYS REV, V99, P1151, DOI 10.1103/PhysRev.99.1151; JELLISON GE, 1982, APPL PHYS LETT, V41, P180, DOI 10.1063/1.93454; MCSKIMIN HJ, 1953, J APPL PHYS, V24, P988, DOI 10.1063/1.1721449; Daly BC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174112; PHILIPP HR, 1972, J APPL PHYS, V43, P2835, DOI 10.1063/1.1661603; HULTHEN R, 1975, PHYS SCRIPTA, V12, P342, DOI 10.1088/0031-8949/12/6/008; Nagakubo A, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.07GA09; Tanigaki K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HB01; Varshni V. P., 1970, PHYS REV B, V2, P3952	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							128001	10.7567/JJAP.54.128001		3	Physics, Applied	Physics	CY1TU	WOS:000366191400024		
J	Rahman, MS; Islam, MA; Saha, BB; Nakagawa, T; Mizuno, S				Rahman, Md. Sazzadur; Islam, Md. Amirul; Saha, Bidyut Baran; Nakagawa, Takeshi; Mizuno, Seigi			Structure determination of the ordered (2 x 1) phase of NiSi surface alloy on Ni(111) using low-energy electron diffraction	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NI/SI(111) SYSTEM; GROWTH; SILICIDE; RECONSTRUCTION; SEGREGATION; MICROSCOPY; COVERAGE; KINETICS; EPITAXY; DEVICES	The (2 x 1) structure of the two-dimensional nickel silicide surface alloy on Ni(111) was investigated using quantitative low-energy electron diffraction analysis. The unit cell of the determined silicide structure contains one Si and one Ni atom, corresponding to a chemical formula of NiSi. The Si atoms adopt substitutional face-centered cubic hollow sites on the Ni(111) substrate. The Ni-Si bond lengths were determined to be 2.37 and 2.34 angstrom. Both the alloy surface and the underlying first layers of Ni atoms exhibit slight corrugation. The Ni-Si interlayer distance is smaller than the Ni-Ni interlayer distance, which indicates that Si atoms and underlying Ni atoms strongly interact. (C) 2015 The Japan Society of Applied Physics	[Rahman, Md. Sazzadur; Nakagawa, Takeshi; Mizuno, Seigi] Kyushu Univ, Dept Mol & Mat Sci, Kasuga, Fukuoka 8168580, Japan; [Rahman, Md. Sazzadur] Hajee Mohammad Danesh Sci & Technol Univ, Dept Telecommun & Elect Engn, Dinajpur 5200, Bangladesh; [Islam, Md. Amirul; Saha, Bidyut Baran] Kyushu Univ, Program Leading Grad Sch, Green Asia Educ Ctr, Kasuga, Fukuoka 8168580, Japan; [Saha, Bidyut Baran] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Rahman, MS (reprint author), Kyushu Univ, Dept Mol & Mat Sci, Kasuga, Fukuoka 8168580, Japan.	sazzad_043@yahoo.com; mizuno.seigi@kyudai.jp			JSPS KAKENHI [15H03677]; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST	This work was supported by JSPS KAKENHI Grant Number 15H03677 and by the Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST.	WILSON RJ, 1987, PHYS REV LETT, V58, P2575, DOI 10.1103/PhysRevLett.58.2575; VONKANEL H, 1992, MATER SCI REP, V8, P193, DOI 10.1016/0920-2307(92)90003-J; GOTHELID M, 1994, PHYS REV B, V50, P4470, DOI 10.1103/PhysRevB.50.4470; Oughaddou H, 2000, PHYS REV B, V62, P16653, DOI 10.1103/PhysRevB.62.16653; Gregoratti L, 1999, PHYS REV B, V59, P2018, DOI 10.1103/PhysRevB.59.2018; HSIEH YF, 1988, THIN SOLID FILMS, V162, P287, DOI 10.1016/0040-6090(88)90217-9; MIZUNO S, 1995, PHYS REV B, V52, P11658; Mukai R, 1995, THIN SOLID FILMS, V270, P567, DOI 10.1016/0040-6090(95)06936-4; Srivastava GP, 2012, APPL SURF SCI, V258, P8377, DOI 10.1016/j.apsusc.2012.03.166; OHGURO T, 1994, IEEE T ELECTRON DEV, V41, P2305, DOI 10.1109/16.337443; Chambon C, 2008, SURF SCI, V602, P2363, DOI 10.1016/j.susc.2008.04.038; DOLBAK AE, 1991, SURF SCI, V247, P32, DOI 10.1016/0039-6028(91)90192-U; Deng F, 1997, J APPL PHYS, V81, P8047, DOI 10.1063/1.365410; VANHOVE MA, 1993, SURF SCI REP, V19, P191, DOI 10.1016/0167-5729(93)90011-D; MEINEL K, 1989, PHYS STATUS SOLIDI A, V116, P47, DOI 10.1002/pssa.2211160106; EUGENE J, 1991, SURF SCI, V241, P1, DOI 10.1016/0039-6028(91)90204-6; LIU Y, 1990, SURF SCI, V240, P245, DOI 10.1016/0039-6028(90)90745-T; GIBSON JM, 1989, SURF SCI, V208, P317, DOI 10.1016/0039-6028(89)90006-X; Kinoda G, 2000, SURF SCI, V461, P67, DOI 10.1016/S0039-6028(00)00534-3; Chi DZ, 2001, J ELECTRON MATER, V30, P1483, DOI 10.1007/s11664-001-0162-4; Meunier I, 1999, SURF SCI, V422, P42, DOI 10.1016/S0039-6028(98)00868-1; Lalmi B, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245306; Rahman MS, 2015, SURF SCI, V642, P1, DOI 10.1016/j.susc.2015.07.024; Phaneuf RJ, 1998, SURF REV LETT, V5, P1179, DOI 10.1142/S0218625X98001511; GIORDANO H, 1993, SCRIPTA METALL MATER, V28, P257, DOI 10.1016/0956-716X(93)90573-B; Golias E, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075403; [Anonymous], 2015, APPL SURF SCI; Nash P., 1987, B ALLOY PHASE DIAGRA, V8, P6, DOI 10.1007/BF02868885; PENDRY JB, 1980, J PHYS C SOLID STATE, V13, P937, DOI 10.1088/0022-3719/13/5/024; Rahman MS, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.015502; Yao T., APPL SURF SCI, V104-105, P213	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							125701	10.7567/JJAP.54.125701		5	Physics, Applied	Physics	CY1TU	WOS:000366191400019		
J	Tanaka, K; Suhara, T				Tanaka, Keisuke; Suhara, Toshiaki			Fabrication of 0.7 mu m(2) ridge waveguide in ion-sliced LiNbO3 by proton-exchange accelerated chemical etching	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LITHIUM-NIOBATE; CRYSTAL; GENERATION; DEVICES; FILMS	We fabricated low-loss ridge waveguides of 1.0 x 0.7 mu m(2) cross-sectional area in ion-sliced LiNbO3 crystals by chemical etching accelerated in proton-exchanged regions. Strong light confinement was obtained at 1.55 mu m wavelength. The waveguides are effective in implementing efficient and compact nonlinear-optic wavelength conversion devices. (C) 2015 The Japan Society of Applied Physics	[Tanaka, Keisuke; Suhara, Toshiaki] Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Tanaka, K (reprint author), Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	ktanaka@ioe.eei.eng.osaka-u.ac.jp			JSPS; MEXT	This work was supported by Grants-in-Aid for Scientific Research from JSPS, and Creation of innovation Centres for Advanced interdisciplinary Research Areas Program, MEXT.	LAURELL F, 1992, J LIGHTWAVE TECHNOL, V10, P1606, DOI 10.1109/50.184899; CLARK DF, 1983, J APPL PHYS, V54, P6218, DOI 10.1063/1.331937; Levy M, 1998, APPL PHYS LETT, V73, P2293, DOI 10.1063/1.121801; Iwai M, 2003, APPL PHYS LETT, V83, P3659, DOI 10.1063/1.1623938; SUCHOSKI PG, 1988, OPT LETT, V13, P1050, DOI 10.1364/OL.13.001050; Poberaj G, 2009, OPT MATER, V31, P1054, DOI 10.1016/j.optmat.2007.12.019; Hu H, 2009, OPT EXPRESS, V17, P24261, DOI 10.1364/OE.17.024261; Kou R, 2011, OPT EXPRESS, V19, P11867, DOI 10.1364/OE.19.011867; Sugita T, 2004, ELECTRON LETT, V40, P1359, DOI 10.1049/el:20046010; Takaoka T, 2009, ELECTRON LETT, V45, P940, DOI 10.1049/el.2009.1693; SCHMIDT RV, 1974, APPL PHYS LETT, V25, P458, DOI 10.1063/1.1655547; LEE HJ, 1995, ELECTRON LETT, V31, P268, DOI 10.1049/el:19950195; REGENER R, 1985, APPL PHYS B-PHOTO, V36, P143, DOI 10.1007/BF00691779; Suhara T., 2003, WAVEGUIDE NONLINEAR; Tanaka K., 2013, 18 MICR C, pH68; Tanaka K., 2013, LASER KENKYU, V41, P1022	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							128002	10.7567/JJAP.54.128002		3	Physics, Applied	Physics	CY1TU	WOS:000366191400025		
J	Tashima, S; Ohnishi, M; Hugrass, W; Sugimoto, K; Sakaguchi, M; Osawa, H; Nishimura, H; Matsukuma, H				Tashima, Saya; Ohnishi, Masami; Hugrass, Waheed; Sugimoto, Keita; Sakaguchi, Masatugu; Osawa, Hodaka; Nishimura, Hiroaki; Matsukuma, Hiraku			Microwave discharge plasma production with resonant cavity for EUV mask inspection tool	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								A microwave-discharge-produced plasma source was developed to generate 13.5nm extreme ultraviolet (EUV) radiation for application as a mask inspection tool. The EUV radiation of a system with a high Q-factor (>3900) resonant cavity and a solid-state oscillator was studied. The gas pressure and microwave power dependences on the EUV radiation for transverse-magnetic mode TM010 and transverse-electric mode TE111 were determined. For the solid-state oscillator, the efficiency of the EUV radiation over the input power was 5.8 times higher than that for a magnetron. EUV radiation of 10mW/(2 pi sr) was observed under a gas pressure of 5 Pa and microwave power of 400W. We expect that more EUV power and a smaller plasma is generated when a magnetic field is applied to confirm the plasma and a facility is operated with an improved system to cool an entire cavity. (C) 2015 The Japan Society of Applied Physics	[Tashima, Saya; Ohnishi, Masami; Hugrass, Waheed; Sugimoto, Keita; Osawa, Hodaka] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan; [Sakaguchi, Masatugu] Furukawa Commun & Broadcasting Co Ltd, Yamato, Kanagawa 2420018, Japan; [Nishimura, Hiroaki; Matsukuma, Hiraku] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Tashima, S (reprint author), Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan.				Program for Creating Start-ups from Advanced Research and Technology by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Institute of laser Engineering, Osaka University [2014B1-03]	The study was supported by the Program for Creating Start-ups from Advanced Research and Technology by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also performed under the joint research of the Institute of laser Engineering, Osaka University (Grant No. 2014B1-03).	Ali L. A., 2000, J MICROWAVE POWER EE, V35, P242; MARTINELLI M, 1985, IEEE T MICROW THEORY, V33, P779, DOI 10.1109/TMTT.1985.1133126; Brandt DC, 2011, PROC SPIE, V7969, DOI 10.1117/12.882208; Lee SH, 2011, J KOREAN PHYS SOC, V59, P3542, DOI 10.3938/jkps.59.3542; Horne S. F., 2014, P INT WORKSH EUV SOF, P10; Knoll G. F., 1989, RAD DETECTION MEASUR, P754; Mori I., 2013, INT S EXTR ULTR LITH, P682; Suzuki K., 2009, P INT S EXTR ULTR LI, P117; Tashima S., 2014, JPS C P, V1; Tsoulfanidis N., 1983, MEASUREMENT DETECTIO; Yamazaki T., 2014, INT S EXTR ULTR LITH; Yoshioka M, 2011, PROC SPIE, V7969, DOI 10.1117/12.879386	12	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							126701	10.7567/JJAP.54.126701		6	Physics, Applied	Physics	CY1TU	WOS:000366191400023		
J	Yamakawa, H; Sakaguchi, T; Ahmed, M; Bakry, A; Koyama, F				Yamakawa, Hideaki; Sakaguchi, Takahiro; Ahmed, Moustafa; Bakry, Ahmed; Koyama, Fumio			Spatial-mode multiplexer/demultiplexer based on tapered hollow waveguide with lateral optical confinement	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								We propose and demonstrate a spatial-mode multi/demultiplexer based on a tapered hollow waveguide with lateral optical confinement. The fabricated device shows vertical radiation spots for different transverse-modes traveling along a tapered hollow waveguide. Both multiplexing and demultiplexing functions are presented, exhibiting a potential of spatial-mode multiplexing/demultiplexing hollow waveguide devices in compact fashion. (C) 2015 The Japan Society of Applied Physics	[Yamakawa, Hideaki; Sakaguchi, Takahiro; Koyama, Fumio] Tokyo Inst Technol, Photon Integrat Syst Res Ctr, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan; [Ahmed, Moustafa; Bakry, Ahmed; Koyama, Fumio] King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia	Yamakawa, H (reprint author), Tokyo Inst Technol, Photon Integrat Syst Res Ctr, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.	koyama@pi.titech.ac.jp			deanship of Scientific Research (DSR), King Abdulaziz University [20-130-35-RG]; KAU; Ministry of Education, Culture, Sports, Science and Technology of Japan [S22226008]	This work was funded by the deanship of Scientific Research (DSR), King Abdulaziz University, under Grant No. 20-130-35-RG. The authors, therefore, acknowledge with thanks DSR technical and financial support of KAU. This work was supported by a Grant-in-Aid for Scientific Research (S22226008) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Al Amin A., 2011, 16 OPT COMM C OECC, P415; Leuthold J, 1996, OPT LETT, V21, P836, DOI 10.1364/OL.21.000836; Saitoh F, 2010, OPT EXPRESS, V18, P4709, DOI 10.1364/OE.18.004709; Richardson DJ, 2010, SCIENCE, V330, P327, DOI 10.1126/science.1191708; Miura T, 2003, IEEE PHOTONIC TECH L, V15, P1240, DOI 10.1109/LPT.2003.816657; Dalir H, 2011, IEICE ELECTRON EXPR, V8, P684, DOI 10.1587/elex.8.684; Bagheri S., 2009, GROUP 4 PHOT GFP; Doerr C. R., 2011, 37 EUR C ECOC; Hanzawa N., 2011, OFC; Imamura A., 2011, 16 OPTOELECTRONICS C; Miura T., 2005, LAS EL SOC LEOS; Sakurai Y., 2006, OPT FIB COMM C OFC; Sakurai Y., 2005, OPT FIB COMM C OFC; Watanabe T., 2014, 40 EUR C ECOC; Yamakawa H., 2013, C LAS EL PAC RIM CLE; Yamakawa H., 2012, 23 IEEE INT SEM LAS; Yang W., 2011, LAS EL CLEO	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							120302	10.7567/JJAP.54.120302		3	Physics, Applied	Physics	CY1TU	WOS:000366191400003		
J	Yanagida, M				Yanagida, Masatoshi			The role of the bulk electrolyte layer in I-3(-)-ion transport in dye-sensitized solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NANOCRYSTALLINE TIO2; IONIC LIQUID; EFFICIENCY; PERFORMANCE; FILMS; COMPLEXES; GELATORS; CIRCUIT; CATION	The influence of I-3(-)-ion transport in the electrolyte solution of dye-sensitized solar cells (DSCs) on the cell properties was investigated on the bases of an ion transport model and measurements of the diffusion-limited current density and the time-dependent short-circuit photocurrent density (J(sc)). The bulk layer (BL) of the electrolyte must be thin to enhance the fill factor because a thick BL increases the series resistance in DSCs. In the case of a high-viscosity electrolyte, which is favored for long-term stability, the J(sc) becomes constant as a function of the light intensity. Slow ion diffusion induces a deficiency of I-3(-) near the counter electrode. Achieving a constant J(sc) depends on ion transport in the porous TiO2, which is slower compared to that in the BL. Therefore, a BL of sufficient thickness is needed as a repository for I-3(-) to compensate for the slow diffusion of I-3(-) in porous TiO2. (C) 2015 The Japan Society of Applied Physics	[Yanagida, Masatoshi] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050047, Japan	Yanagida, M (reprint author), Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050047, Japan.	YANAGIDA.Masatoshi@nims.go.jp			Precursory Research for Embryonic Science and Technology of Japan Science and Technology Agency; MEXT Program for Development of Environmental Technology Using Nano-technology	This work was supported in part by Precursory Research for Embryonic Science and Technology of Japan Science and Technology Agency, and by the MEXT Program for Development of Environmental Technology Using Nano-technology.	Matsui H, 2004, J PHOTOCH PHOTOBIO A, V164, P129, DOI 10.1016/j.jphotochem.2003.12.022; Honda M, 2013, J PHYS CHEM C, V117, P17033, DOI 10.1021/jp404572y; Zhang SF, 2011, PHYS CHEM CHEM PHYS, V13, P19310, DOI 10.1039/c1cp22832c; Yanagida M, 2006, J PHOTOCH PHOTOBIO A, V182, P288, DOI 10.1016/j.jphotochem.2006.06.010; Sakaguchi S, 2004, J PHOTOCH PHOTOBIO A, V164, P117, DOI 10.1016/j.jphotochem.2003.11.014; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Honda M, 2013, AIP ADV, V3, DOI 10.1063/1.4815973; Yanagida M, 2003, INORG CHIM ACTA, V351, P283, DOI 10.1016/S0020-1693(03)00116-6; Asano T, 2005, JPN J APPL PHYS 1, V44, P6776, DOI 10.1143/JJAP.44.6776; Nazeeruddin MK, 2001, J AM CHEM SOC, V123, P1613, DOI 10.1021/ja003299u; Wang ZS, 2008, CHEM MATER, V20, P3993, DOI 10.1021/cm8003276; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Papageorgiou N, 1996, SOL ENERG MAT SOL C, V44, P405, DOI 10.1016/S0927-0248(96)00050-5; Miyamoto K, 2006, CHEM LETT, V35, P336, DOI 10.1246/cl.2006.336; Han LY, 2004, APPL PHYS LETT, V84, P2433, DOI 10.1063/1.1690495; Yanagida M, 2010, SOL ENERG MAT SOL C, V94, P297, DOI 10.1016/j.solmat.2009.10.002; Yanagida M, 2013, ELECTROCHIM ACTA, V87, P309, DOI 10.1016/j.electacta.2012.09.049; Yanagida M, 2007, J PHYS CHEM C, V111, P201, DOI 10.1021/jp0606715; Hauch A, 2001, ELECTROCHIM ACTA, V46, P3457, DOI 10.1016/S0013-4686(01)00540-0; Zhang SF, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.042301; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; Yanagida M, 2002, NEW J CHEM, V26, P963, DOI 10.1039/b202975h; Yanagida M, 2006, ELECTROCHIM ACTA, V51, P3993, DOI 10.1016/j.electacta.2005.11.014; Nakabayashi S, 1996, J PHYS CHEM-US, V100, P714, DOI 10.1021/jp951235d; Kubo W, 2003, J PHYS CHEM B, V107, P4374, DOI 10.1021/jp034248x; Chiba Y, 2006, JPN J APPL PHYS 2, V45, pL638, DOI 10.1143/JJAP.45.L638; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Yang XD, 2013, ENERG ENVIRON SCI, V6, P54, DOI 10.1039/c2ee22998f; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P805, DOI 10.1002/pip.2637; Papageorgiou N, 1996, J ELECTROCHEM SOC, V143, P3099, DOI 10.1149/1.1837171; Kawano R, 2004, J PHOTOCH PHOTOBIO A, V164, P87, DOI 10.1016/j.jphotochem.2003.12.019; Honda M., 2014, E J SURF SCI NANOTEC, V12, P63; Honda M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4900640; Gorlov M, 2008, DALTON T, P2655, DOI 10.1039/b716419j; Murai S, 2003, CHEM COMMUN, P1534, DOI 10.1039/b302793g; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Shibata Y, 2003, CHEM COMMUN, P2730, DOI 10.1039/b305368g; Yanagida M, 2015, ADV NAT SCI-NANOSCI, V6, DOI 10.1088/2043-6262/6/1/015010; Yanagida M., 2014, P GRAND REN EN; Yanagida M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NE16; Yanagida M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/1/015006; Yanagida M., 2000, DALTON T, V16, P2817	42	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2015	54	12							124301	10.7567/JJAP.54.124301		5	Physics, Applied	Physics	CY1TU	WOS:000366191400012		
J	Chen, B; Imai, H; Li, SF; Jia, L; Umeda, J; Kondoh, K				Chen, Biao; Imai, Hisashi; Li, Shufeng; Jia, Lei; Umeda, Junko; Kondoh, Katsuyoshi			Crack Formation in Powder Metallurgy Carbon Nanotube (CNT)/Al Composites During Post Heat-Treatment	JOM			English	Article							MATRIX COMPOSITES; ALUMINUM	After the post heat-treatment (PHT) process of powder metallurgy carbon nanotubes (CNT)/Al composites, micro-cracks were observed in the composites, leading to greatly degraded mechanical properties. To understand and suppress the crack formation, an in situ observation of CNT/Al composites was performed at elevated temperatures. PHT was also applied to various bulk pure Al and CNT/Al composites fabricated under different processes. It was observed that the composites consolidated by hot-extrusion might form micro-cracks, but those consolidated by spark plasma sintering (SPS) showed no crack after PHT. A high-temperature SPS process before hot-extrusion was effective to prevent crack formation. The release of residual stress in severe plastic deformed (SPD) materials was responsible for the cracking phenomena during the PHT process. Furthermore, a good particle bonding was essential and effective to suppress cracks for SPD materials in the PHT process.	[Chen, Biao] Osaka Univ, Grad Sch Engn, Osaka 5650871, Japan; [Imai, Hisashi; Umeda, Junko; Kondoh, Katsuyoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan; [Li, Shufeng; Jia, Lei] Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China	Chen, B (reprint author), Osaka Univ, Grad Sch Engn, Osaka 5650871, Japan.	chen-b@jwri.osaka-u.ac.jp	Chen, Biao/A-8982-2015	Chen, Biao/0000-0002-6428-2639			Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543; Kondoh K, 2014, CARBON, V72, P15, DOI 10.1016/j.carbon.2014.01.013; Fugetsu B, 2005, CHEM LETT, V34, P1218, DOI 10.1246/cl.2005.1218; Shekhar S, 2011, J MATER RES, V26, P395, DOI 10.1557/jmr.2010.28; Terasaki H, 2013, METALL MATER TRANS A, V44A, P2683, DOI 10.1007/s11661-013-1610-5; Popov VN, 2004, MAT SCI ENG R, V43, P61, DOI 10.1016/j.mser.2003.10.001; Ci LJ, 2006, ACTA MATER, V54, P5367, DOI 10.1016/j.actamat.2006.06.031; Esawi AMK, 2009, MAT SCI ENG A-STRUCT, V508, P167, DOI 10.1016/j.msea.2009.01.002; Sauvage X, 2012, MAT SCI ENG A-STRUCT, V540, P1, DOI 10.1016/j.msea.2012.01.080; Chen B, 2014, ADV ENG MATER, V16, P972, DOI 10.1002/adem.201400232; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	DEC	2015	67	12					2887	2891		10.1007/s11837-014-1246-y		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	CX2QM	WOS:000365541700016		
J	Yoshiyama, K; Arita, H; Suzuki, J				Yoshiyama, Kazuyo; Arita, Hideko; Suzuki, Jinichi			The Effect of Aroma Hand Massage Therapy for People with Dementia	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; MINI-MENTAL-STATE; PSYCHOLOGICAL SYMPTOMS; PSYCHOSOCIAL INTERVENTIONS; NEUROPSYCHIATRIC INVENTORY; ALZHEIMERS-DISEASE; AGITATED BEHAVIORS; DOUBLE-BLIND; NPI-Q	Objectives: Clinical aromatherapy is a complementary therapy that may be very helpful for elderly dementia care. Aromatherapy may reduce the behavioral and psychological symptoms of dementia (BPSD), improve quality of care, and thus improve the quality of life for people with dementia. In this pilot study, aroma hand massage therapy was used for elderly patients in a medical institution in Japan. The study assessed the effectiveness and safety of clinical aromatherapy as part of routine integrative care among people with dementia in a clinical care setting. Interventions: The randomized, crossover pilot trials were performed among 14 patients with mild-to-moderate dementia older than age 65 years living in a nursing home in Nara, Japan. Participants were divided into two groups and offered, alternately, control therapy and clinical aromatherapy 3 times a week for the 4-week trials. The effects on BPSD and activities of daily living (ADLs) were evaluated quantitatively before and after the study and 4 weeks after the study ended as a follow-up. Observation records were also collected to obtain qualitative data. Results: The quantitative data showed that neither therapy significantly improved the BPSD or ADL results. The qualitative data were classified into four main categoriesmood, behavior, verbal communication, and nonverbal communicationreflecting the positive experiences of participants during both therapies. No harmful reactions or changes in medication occurred during the study. Conclusions: This pilot study demonstrated that clinical aromatherapy was clinically safe but did not lead to statistically significant improvements in BPSD or ADL among people with dementia. Further research on therapeutic effects is needed to develop high-quality care with clinical aromatherapy for elderly patients with dementia in Japan and to fully establish evidence for effective and safe practice in health care institutions.	[Yoshiyama, Kazuyo] Clin LEsprit Naturel, Nagoya, Aichi, Japan; [Arita, Hideko] Tenri Hlth Care Univ, Nara, Japan; [Suzuki, Jinichi] Publ Hlth Med Ctr Sagamihara City, Kanagawa, Japan	Yoshiyama, K (reprint author), Clin LEsprit Naturel, Kita Ku, 2-8-26-202 Ozone, Nagoya, Aichi, Japan.	lespritnaturel@gmail.com					Alzheimer's Disease International, 2013, POLICY BRIEF HEADS G; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Jimbo D, 2009, PSYCHOGERIATRICS, V9, P173, DOI 10.1111/j.1479-8301.2009.00299.x; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77; Matsumoto Naomi, 2006, Brain and Nerve (Tokyo), V58, P785; Behrman S, 2014, MATURITAS, V77, P305, DOI 10.1016/j.maturitas.2014.01.003; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P711; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922; Madhusoodanan Subramoniam, 2014, World J Psychiatry, V4, P72, DOI 10.5498/wjp.v4.i4.72; Lee MS, 2012, MATURITAS, V71, P257, DOI 10.1016/j.maturitas.2011.12.018; van der Linde RM, 2014, INT J GERIATR PSYCH, V29, P562, DOI 10.1002/gps.4037; Smallwood J, 2001, INT J GERIATR PSYCH, V16, P1010, DOI 10.1002/gps.473; Moniz-Cook E, 2003, BRIT MED J, V326, P661, DOI 10.1136/bmj.326.7390.661; Johannessen B, 2013, COMPLEMENT THER CLIN, V19, P209, DOI 10.1016/j.ctcp.2013.01.003; Ballard C, 2008, INT REV PSYCHIATR, V20, P396, DOI 10.1080/09540260802099968; Azermai M, 2012, AGEING RES REV, V11, P78, DOI 10.1016/j.arr.2011.07.002; Ballard CG, 2002, J CLIN PSYCHIAT, V63, P553; Posadzki Paul, 2012, Int J Risk Saf Med, V24, P147, DOI 10.3233/JRS-2012-0568; Lawrence V, 2012, BRIT J PSYCHIAT, V201, P344, DOI 10.1192/bjp.bp.111.101402; Kurz A, 2013, NERVENARZT, V84, P93, DOI 10.1007/s00115-012-3655-x; Burns A, 2011, DEMENT GERIATR COGN, V31, P158, DOI 10.1159/000324438; LAWTON MP, 1994, ALZ DIS ASSOC DIS, V8, P138, DOI 10.1097/00002093-199404000-00015; Asada Takashi, 2012, Rinsho Shinkeigaku, V52, P962; Bianchi AJ, 2015, REV MED INTERNE, V36, P31, DOI 10.1016/j.revmed.2014.09.008; Bowling A, 2015, AGING MENT HEALTH, V19, P13, DOI 10.1080/13607863.2014.915923; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P722; Cohen-Mansfield J, 1991, INSTRUCTION MANUAL C; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Forrester LT, 2014, COCHRANE DB SYST REV, V2; Fu CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-165; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hobart JC, 2001, NEUROLOGY, V57, P639; Homma A, 2002, JPN J GERIATR PSYCHI, V13, P831; Lake JH, 2007, COMPLEMENTARY ALTERN; Livingston G, 2014, BRIT J PSYCHIAT, V205, P436, DOI 10.1192/bjp.bp.113.141119; Monti DA, 2010, INTEGRATIVE PSYCHIAT; Pazyar N, 2013, GIORN ITAL DERMAT V, V148, P687; Senno N, 1997, FUNCTIONAL EVALUATIO; The Ministry in Health Labour and Welfare in Japan, 1993, DEGR IND DAIL LIV EL; Tsutsumida R, 2011, JPN J APPL PSYCHOL E, V10, P13; World Health Organisation, 1992, ICD 10 CLASS MENT BE	42	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	DEC 1	2015	21	12					759	765		10.1089/acm.2015.0158		7	Integrative & Complementary Medicine	Integrative & Complementary Medicine	CX4LO	WOS:000365672600005		
J	Matsumoto-Miyazaki, J; Miyazaki, N; Nishiwaki, A; Endo, J; Ushikoshi, H; Ohno, Y; Minatoguchi, S				Matsumoto-Miyazaki, Jun; Miyazaki, Nagisa; Nishiwaki, Ayuko; Endo, Junki; Ushikoshi, Hiroaki; Ohno, Yasushi; Minatoguchi, Shinya			Acupuncture Treatment for Dyspnea due to Combined Pulmonary Fibrosis and Emphysema: A Case Report	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article							WALK TEST; DISEASE; COPD	Objective: Combined idiopathic pulmonary fibrosis with pulmonary emphysema (CPFE) is a syndrome with a characteristic presentation of upper lobe emphysema and lower lobe fibrosis. Dyspnea on exertion (DOE) is a major symptom of CPFE. We report a patient with DOE due to CPFE who was successfully treated with acupuncture. Design: Case report. Case presentation: A 72-year-old Japanese man with a 4-year history of DOE was diagnosed with CPFE 2 years previously in another hospital. He received standard Western medicine treatment, which included bronchodilators. However, his DOE did not improve. Consequently, he visited our hospital for acupuncture treatment and received acupuncture treatment once a week for 1 year. Results: After 10 weeks of acupuncture treatment, the results of the 6-minute walk test (6-minute walking distance, 379m; lowest oxygen saturation, 86%; modified Borg dyspnea scale score: 2 units) were better than those at baseline (352m, 84%, 4 units, respectively). These values were sustained at both 30 weeks (470m, 88%, 1 unit) and 60 weeks (473m, 85%, 2 units). Serum interstitial biomarkers, Krebs von den Lungen and surfactant protein-D, decreased after commencement of acupuncture therapy. Conclusion: A patient with CPFE showed improvements in dyspnea scores, exercise tolerance, and serum biomarkers during a 1-year course of acupuncture treatment. Use of acupuncture might be an effective adjunct therapy in relieving DOE due to CPFE. A large, well-designed cohort study that includes patients with CPFE treated with acupuncture should be conducted.	[Matsumoto-Miyazaki, Jun; Miyazaki, Nagisa; Nishiwaki, Ayuko; Endo, Junki; Ohno, Yasushi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol & Respirol, Gifu 5011194, Japan; [Ushikoshi, Hiroaki] Gifu Univ Hosp, Adv Crit Care Ctr, Gifu, Japan	Matsumoto-Miyazaki, J (reprint author), Gifu Univ, Grad Sch Med, Dept Cardiol & Respirol, 1-1 Yanagido, Gifu 5011194, Japan.	jmiyamatsu@gmail.com					Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Suzuki M, 2008, J ALTERN COMPLEM MED, V14, P1097, DOI 10.1089/acm.2007.0786; Suzuki M, 2012, ACUPUNCT MED, V30, P96, DOI 10.1136/acupmed-2011-010112; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; BUIST AS, 1973, AM REV RESPIR DIS, V108, P1078; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Filshie J, 1996, PALLIATIVE MED, V10, P145, DOI 10.1177/026921639601000209; Papiris SA, 2013, EXPERT REV RESP MED, V7, P19, DOI [10.1586/ers.12.80, 10.1586/ERS.12.80]; Suzuki M, 2012, ARCH INTERN MED, V172, P878, DOI 10.1001/archinternmed.2012.1233; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chiba S, 2012, PULM MED, V2012; Cottin Vincent, 2013, Eur Respir Rev, V22, P153, DOI 10.1183/09059180.00000813; Coyle M, 2014, ALTERN THER HEALTH M, V20, P10; Dowman L, 2014, COCHRANE DB SYST REV, V10; Jones Alice Y M, 2011, Altern Ther Health Med, V17, P8; Li Rong, 2005, Zhongguo Zhen Jiu, V25, P790; McCarthy B, 2015, COCHRANE DB SYST REV, V2; Moffet Howard H, 2006, BMC Complement Altern Med, V6, P25, DOI 10.1186/1472-6882-6-25; Ries Andrew L, 2005, COPD, V2, P105; Suzuki Masao, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P289; World Health Organization, 2008, WHO STAND AC POINT L	22	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	DEC 1	2015	21	12					804	809		10.1089/acm.2015.0132		6	Integrative & Complementary Medicine	Integrative & Complementary Medicine	CX4LO	WOS:000365672600011		
J	Ogawa, H; Nishikawa, Y; Fujiwara, A; Takenaka, M; Wang, YC; Kanaya, T; Takata, M				Ogawa, Hiroki; Nishikawa, Yukihiro; Fujiwara, Akihiko; Takenaka, Mikihito; Wang, Yi-Chin; Kanaya, Toshiji; Takata, Masaki			Visualizing patterned thin films by grazing-incidence small-angle X-ray scattering coupled with computed tomography	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						grazing-incidence small-angle scattering; X-ray tomography; diffuse scattering; surface structure	NEUTRON-SCATTERING; BORN APPROXIMATION; COPOLYMERS	Images of the spatial distribution of nanostructures in thin films were successfully reconstructed by grazing-incidence small-angle X-ray scattering (GISAXS) coupled with computed tomography (CT) measurements. As a model sample of inhomogeneous thin films, a thin film was patterned with four characters (F, B, S and L) consisting of nanoparticles of gold (Au), platinum (Pt), Au/Pt and Pt/Au, respectively, on a silicon substrate. The characters each produced respective two-dimensional GISAXS images which reflect the nanoparticle structures and their correlations in the thin film. The application of the GISAXS-CT technique to the characteristic scattering GISAXS intensity of each component enables one to reconstruct the images of each character independently. Moreover, it was found that the patterned images could be reconstructed even from very weak scattered intensities at higher q positions and the diffuse intensities. These results indicate that the GISAXS-CT method is a powerful tool to obtain distinct reconstruction images detailing the particle size, shape and surface roughness.	[Ogawa, Hiroki; Kanaya, Toshiji] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Ogawa, Hiroki; Fujiwara, Akihiko; Takata, Masaki] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Nishikawa, Yukihiro] Kyoto Inst Technol, Fac Mat Sci & Engn, Kyoto 6068585, Japan; [Takenaka, Mikihito; Wang, Yi-Chin] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6158510, Japan; [Takenaka, Mikihito; Takata, Masaki] Riken SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Ogawa, H (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	ogawa@scl.kyoto-u.ac.jp	Fujiwara, Akihiko/F-3031-2015	Fujiwara, Akihiko/0000-0002-1319-388X	Ministry of Education, Science, Sports and Culture of Japan (MEXT) [15K17489]; Photon and Quantum Basic Research Coordinated Development Program from MEXT; GIGNO project of JASRI	This work was supported by Grant-in-Aid No. 15K17489 of the Ministry of Education, Science, Sports and Culture of Japan (MEXT) and the Photon and Quantum Basic Research Coordinated Development Program from MEXT, and the GIGNO project of JASRI. Synchrotron radiation GISAXS measurements were carried out at the first hutch of the Consortium of the Advanced Soft Material Beamline (FSBL) under proposal Nos. 2013A1871, 2013B1881 and 2014A1851.	Nishikawa Y, 2013, INT J POLYM MATER PO, V62, P295, DOI 10.1080/00914037.2012.664215; Lee B, 2005, MACROMOLECULES, V38, P3395, DOI 10.1021/ma048214e; Lu XH, 2013, J APPL CRYSTALLOGR, V46, P165, DOI 10.1107/S0021889812047887; Lee B, 2005, MACROMOLECULES, V38, P4311, DOI 10.1021/ma047562d; Junker M, 1997, MACROMOLECULES, V30, P2085, DOI 10.1021/ma9610469; Dalgliesh R, 2002, CURR OPIN COLLOID IN, V7, P244, DOI 10.1016/S1359-0294(02)00054-7; Schmidbauer M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115324; Metwalli E, 2008, LANGMUIR, V24, P4265, DOI 10.1021/la7038587; Schroer CG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196062; Okuda H, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/47/474003; Kuhlmann M, 2009, LANGMUIR, V25, P7241, DOI 10.1021/la901325y; SCHUBERT KV, 1991, J CHEM PHYS, V95, P8532, DOI 10.1063/1.461282; Busch P, 2007, MACROMOLECULES, V40, P630, DOI 10.1021/ma061695c; Stein GE, 2007, MACROMOLECULES, V40, P2453, DOI 10.1021/ma0625509; SINHA SK, 1988, PHYS REV B, V38, P2297, DOI 10.1103/PhysRevB.38.2297; Sinha SK, 1996, PHYSICA A, V231, P99, DOI 10.1016/0378-4371(96)00085-4; Ogawa H, 2013, POLYM J, V45, P109, DOI 10.1038/pj.2012.194; Busch P, 2006, J APPL CRYSTALLOGR, V39, P433, DOI 10.1107/S0021889806012337; Babonneau D, 2010, J APPL CRYSTALLOGR, V43, P929, DOI 10.1107/S0021889810020352; Herman G. T., 1980, IMAGE RECONSTRUCTION, p[1, 277]; Muller-Buschbaum P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/18/184111; RAMACHAN.GN, 1971, P NATL ACAD SCI USA, V68, P2236, DOI 10.1073/pnas.68.9.2236; Roe R.-J., 2000, METHODS XRAY NEUTRON	23	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	DEC	2015	48		6				1645	1650		10.1107/S1600576715016684		6	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CX5XC	WOS:000365774800007		
J	Shinohara, Y; Amemiya, Y				Shinohara, Yuya; Amemiya, Yoshiyuki			Effect of finite spatial coherence length on small-angle scattering	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						small-angle scattering; coherence; forward scattering; hierarchical structure	X-RAY-SCATTERING; SILICA	This study shows that forward scattering at the origin of reciprocal space contributes to the scattering intensity profiles of ultra-small-angle scattering. The forward scattering corresponds to a Fourier transform of the X-ray coherent volume on a sample. This contribution is usually ignored in the study of small-angle scattering, while it is fully considered in the fields of X-ray imaging, such as coherent X-ray diffraction imaging and X-ray ptychography. This effect is explicitly illustrated in the context of small-angle scattering, and the effect of a finite spatial coherence length on small-angle scattering is discussed.	[Shinohara, Yuya; Amemiya, Yoshiyuki] Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Shinohara, Y (reprint author), Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	yuya@k.u-tokyo.ac.jp					Bouty A, 2014, MACROMOLECULES, V47, P5365, DOI 10.1021/ma500582p; Suzuki A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.053903; Ilavsky J, 2002, REV SCI INSTRUM, V73, P1660, DOI 10.1063/1.1425387; Nugent KA, 2010, ADV PHYS, V59, P1, DOI 10.1080/00018730903270926; WOLF E, 1982, J OPT SOC AM, V72, P343, DOI 10.1364/JOSA.72.000343; Kishimoto H, 2014, J SYNCHROTRON RADIAT, V21, P1, DOI 10.1107/S1600577513023205; Thibault P, 2013, NATURE, V494, P68, DOI 10.1038/nature11806; Masunaga H, 2013, J APPL CRYSTALLOGR, V46, P577, DOI 10.1107/S0021889813002628; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P469, DOI 10.1107/S0021889809008802; Koga T, 2008, MACROMOLECULES, V41, P453, DOI 10.1021/ma0718671; Shinohara Y, 2007, J APPL CRYSTALLOGR, V40, pS397, DOI 10.1107/S0021889807011697; Kammler HK, 2004, LANGMUIR, V20, P1915, DOI 10.1021/la030155v; Baeza G. P., 2012, MACROMOLECULES, V46, P317; Feigin L, 1987, STRUCTURE ANAL SMALL; Glatter O, 1982, SMALL ANGLE XRAY SCA; Guinier A., 1955, SMALL ANGLE SCATTERI; Higgins J. S., 1994, POLYM NEUTRON SCATTE; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Roe R.-J., 2000, METHODS XRAY NEUTRON	19	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	DEC	2015	48		6				1660	1664		10.1107/S160057671501715X		5	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CX5XC	WOS:000365774800009		
J	Yang, AL; Sakata, O; Yamauchi, R; Kumara, LSR; Song, C; Katsuya, Y; Matsuda, A; Yoshimoto, M				Yang, Anli; Sakata, Osami; Yamauchi, Ryosuke; Kumara, L. S. R.; Song, Chulho; Katsuya, Yoshio; Matsuda, Akifumi; Yoshimoto, Mamoru			Atomic disorder of Li0.5Ni0.5O thin films caused by Li doping: estimation from X-ray Debye-Waller factors	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						atomic disorder; thin films; Li doping; Debye-Waller factors	CUBIC-CRYSTALS; TEMPERATURE; NIO; SEMICONDUCTORS; CONDUCTIVITY; FABRICATION	Cubic type room-temperature (RT) epitaxial Li0.5Ni0.5O and NiO thin films with [111] orientation grown on ultra-smooth sapphire (0001) substrates were examined using synchrotron-based thin-film X-ray diffraction. The 1 (1) over bar1 and 2 (2) over bar2 rocking curves including six respective equivalent reflections of the Li0.5Ni0.5O and NiO thin films were recorded. The RT B-1 factor, which appears in the Debye-Waller factor, of a cubic Li0.5Ni0.5O thin film was estimated to be 1.8 (4) angstrom(2) from its 1 (1) over bar1 and 2 (2) over bar2 reflections, even though the Debye model was originally derived on the basis of one cubic element. The corresponding Debye temperature is 281 (39) K. Furthermore, the B-2 factor in the pseudo-Debye-Waller factor is proposed. This parameter, which is evaluated using one reflection, was also determined for the Li0.5Ni0.5O thin film by treating Li0.5Ni0.5O and NiO as ideal NaCl crystal structures. A structural parameter for the atomic disorder is introduced and evaluated. This parameter includes the combined effects of thermal vibration, interstitial atoms and defects caused by Li doping using the two Debye-Waller factors.	[Yang, Anli; Sakata, Osami; Kumara, L. S. R.; Song, Chulho; Katsuya, Yoshio] Natl Inst Mat Sci, SPring 8, Synchrotron Xray Stn, Sayo, Hyogo 6795148, Japan; [Sakata, Osami] NIMS, Quantum Beam Unit, Synchrotron Xray Grp, Sayo, Hyogo 6795148, Japan; [Sakata, Osami; Yamauchi, Ryosuke; Matsuda, Akifumi; Yoshimoto, Mamoru] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Sakata, Osami; Song, Chulho] Natl Inst Mat Sci, Lithium Air Battery Specially Promoted Res Team, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan	Yang, AL (reprint author), Natl Inst Mat Sci, SPring 8, Synchrotron Xray Stn, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	alyang@semi.ac.cn; SAKATA.Osami@nims.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K04616]	The thin-film X-ray diffraction measurements were approved by the NIMS Synchrotron X-ray Station at SPring-8 under proposal Nos. 2011B4508, 2012A4505, 2012B4505 and 2014B4900. This work was also partly supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan [OS: Grants-in-Aid for Basic Research (C) No. 15K04616]. The authors are grateful to Dr K. Yokoyama, Dr S. Takeda, Professor Y. Kagoshima and Professor J. Matsui, University of Hyogo, for their technical contribution.	Guo W, 2013, MATER LETT, V92, P291, DOI 10.1016/j.matlet.2012.10.109; GOODENOUGH JB, 1958, J PHYS CHEM SOLIDS, V5, P107, DOI 10.1016/0022-3697(58)90136-7; Moulki H, 2012, ELECTROCHIM ACTA, V74, P46, DOI 10.1016/j.electacta.2012.03.123; Palatnikov MN, 2006, J CRYST GROWTH, V291, P390, DOI 10.1016/j.jcrysgro.2006.03.022; FREER R, 1981, J MATER SCI, V16, P3225, DOI 10.1007/BF00540337; Borca CN, 2000, APPL PHYS LETT, V77, P88, DOI 10.1063/1.126886; MURAKAMI T, 1953, J PHYS SOC JPN, V8, P36, DOI 10.1143/JPSJ.8.36; Yang AL, 2014, APPL SURF SCI, V320, P787, DOI 10.1016/j.apsusc.2014.09.154; Sakata O, 2004, APPL SURF SCI, V221, P450, DOI 10.1016/S0169-4332(03)00961-9; WATHORE TN, 1980, J MATER SCI, V15, P2927, DOI 10.1007/BF00550565; Dutta T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3499276; Chawla S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125204; SASAKI T, 1993, PHYSICA B, V185, P159, DOI 10.1016/0921-4526(93)90231-T; MATSUMURO A, 1990, J APPL PHYS, V68, P2719, DOI 10.1063/1.346446; Ohta H, 2003, APPL PHYS LETT, V83, P1029, DOI 10.1063/1.1598624; YOSHIMOTO M, 1995, APPL PHYS LETT, V67, P2615, DOI 10.1063/1.114313; Sakata O, 1997, ACTA CRYSTALLOGR A, V53, P781, DOI 10.1107/S0108767397008659; Shiraishi N, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.108001; CHIPMAN DR, 1963, J APPL PHYS, V34, P912, DOI 10.1063/1.1729559; KULKARNI RG, 1977, J APPL PHYS, V48, P1844, DOI 10.1063/1.323936; LONSDALE K, 1948, ACTA CRYSTALLOGR, V1, P142, DOI 10.1107/S0365110X48000387; HERBSTEIN FH, 1961, ADV PHYS, V10, P313, DOI 10.1080/00018736100101301; Garduno-Wilches I, 2013, INT J HYDROGEN ENERG, V38, P4213, DOI 10.1016/j.ijhydene.2013.01.122; Brown P. J., 2006, INT TABLES CRYSTALLO, P554, DOI 10.1107/97809553602060000600; Gazzara C. P., 1964, ADV XRAY ANAL, V7, P14; James R. W., 1962, OPTICAL PRINCIPLES D; McLaren VL, 2004, DALTON T, P3042, DOI 10.1039/b316396m; Pathak P. D., 1973, ACTA CRYSTALLOGR A, V29, P45, DOI 10.1107/S0567739473000100; Yamauchi R, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FF16	29	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	DEC	2015	48		6				1896	1900		10.1107/S1600576715020002		5	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CX5XC	WOS:000365774800035		
J	Abe, T; Kitaoka, Y; Kikuchi, DM; Takeda, K; Numata, O; Takemasa, T				Abe, Takaaki; Kitaoka, Yu; Kikuchi, Dale Manjiro; Takeda, Kohei; Numata, Osamu; Takemasa, Tohru			High-intensity interval training-induced metabolic adaptation coupled with an increase in Hif-1 alpha and glycolytic protein expression	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						anaerobic metabolism; gene regulation; Hif-1 alpha; high-intensity training; skeletal muscle introduction	HUMAN SKELETAL-MUSCLE; EXERCISE PERFORMANCE; OXIDATIVE-METABOLISM; SPRINT INTERVAL; FIBER TYPES; FATTY-ACID; HYPOXIA; ACTIVATION; ENZYMES; MECHANISM	It is known that repeated bouts of high-intensity interval training (HIIT) lead to enhanced levels of glycolysis, glycogenesis, and lactate transport proteins in skeletal muscle; however, little is known about the molecular mechanisms underlying these adaptations. To decipher the mechanism leading to improvement of skeletal muscle glycolytic capacity associated with HIIT, we examined the role of hypoxia-inducible factor-1 alpha (Hif-1 alpha), the major transcription factor regulating the expression of genes related to anaerobic metabolism, in the adaptation to HIIT. First, we induced Hif-1 alpha accumulation using ethyl 3,4-dihy-droxybenzoate (EDHB) to assess the potential role of Hif-1 alpha in skeletal muscle. Treatment with EDHB significantly increased the protein levels of Hif-1 alpha in gastrocnemius muscles, accompanied by elevated expression of genes related to glycolysis, glycogenesis, and lactate transport. Daily administration of EDHB for 1 wk resulted in elevated glycolytic enzyme activity in gastrocnemius muscles. Second, we examined whether a single bout of HIIT could induce Hif-1 alpha protein accumulation and subsequent increase in the expression of genes related to anaerobic metabolism in skeletal muscle. We observed that the protein levels of Hif-1 alpha and expression of the target genes were elevated 3 h after an acute bout of HIIT in gastrocnemius muscles. Last, we examined the effects of long-term HIIT. We found that long-term HIIT increased the basal levels of Hif-1 alpha as well as the glycolytic capacity in gastrocnemius muscles. Our results suggest that Hif-1 alpha is a key regulator in the metabolic adaptation to high-intensity training.	[Abe, Takaaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Kitaoka, Yu] Univ Tokyo, Dept Sports Sci, Meguro Ku, Tokyo, Japan; [Kikuchi, Dale Manjiro] Grad Univ Adv Studies, Dept Polar Sci, Tachikawa, Tokyo, Japan; [Takeda, Kohei; Takemasa, Tohru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Abe, Takaaki; Numata, Osamu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Takemasa, T (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.	takemasa@taiiku.tsukuba.ac.jp					Linossier MT, 1997, ACTA PHYSIOL SCAND, V161, P439, DOI 10.1046/j.1365-201X.1997.00244.x; Lindholm ME, 2014, AM J PHYSIOL-REG I, V307, pR248, DOI 10.1152/ajpregu.00036.2013; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; CADEFAU J, 1990, ACTA PHYSIOL SCAND, V140, P341, DOI 10.1111/j.1748-1716.1990.tb09008.x; Gohil K, 2012, AM J PHYSIOL-ENDOC M, V303, pE18, DOI 10.1152/ajpendo.00027.2012; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Lunde IG, 2011, J PHYSIOL-LONDON, V589, P1443, DOI 10.1113/jphysiol.2010.202762; Terada S, 2005, ACTA PHYSIOL SCAND, V184, P59, DOI 10.1111/j.1365-201X.2005.01423.x; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Terada S, 2001, J APPL PHYSIOL, V90, P2019; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; JACOBS I, 1987, MED SCI SPORT EXER, V19, P368; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; LO S, 1970, J APPL PHYSIOL, V28, P234; CHI MMY, 1983, AM J PHYSIOL, V244, pC276; SHONK CE, 1964, CANCER RES, V24, P709; Pisani DF, 2005, J GEN PHYSIOL, V126, P173, DOI 10.1085/jgp.200509265; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Takeda K, 2011, J NUTR SCI VITAMINOL, V57, P246, DOI 10.3177/jnsv.57.246; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Hoshino D, 2013, APPL PHYSIOL NUTR ME, V38, P326, DOI 10.1139/apnm-2012-0257; Hoshino D, 2012, AM J PHYSIOL-REG I, V302, pR373, DOI 10.1152/ajpregu.00183.2011; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Kasiganesan H, 2007, ACTA PHYSIOL, V190, P163, DOI 10.1111/j.1748-1716.2006.01676.x; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Pescador N., 2010, PLOS ONE, V5, P1; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447; Suzuki J, 2012, ADV EXERC SPORT PHYS, V18, P39; Wenger RH, 2005, SCI STKE, V2005, P12	33	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	DEC 1	2015	119	11					1297	1302		10.1152/japplphysiol.00499.2015		6	Physiology; Sport Sciences	Physiology; Sport Sciences	CX7UH	WOS:000365907800006		
J	Okushima, D; Poole, DC; Rossiter, HB; Barstow, TJ; Kondo, N; Ohmae, E; Koga, S				Okushima, Dai; Poole, David C.; Rossiter, Harry B.; Barstow, Thomas J.; Kondo, Narihiko; Ohmae, Etsuko; Koga, Shunsaku			Muscle deoxygenation in the quadriceps during ramp incremental cycling: Deep vs. superficial heterogeneity	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						time-resolved near-infrared spectroscopy; deep and superficial muscle; oxygen delivery; oxygen uptake	DIFFERENT FIBER TYPES; NEAR-INFRARED SPECTROSCOPY; PULMONARY O-2 UPTAKE; CENTRAL MOTOR DRIVE; BLOOD-FLOW; SKELETAL-MUSCLE; MAXIMAL EXERCISE; PERFUSION HETEROGENEITY; OXYGEN EXTRACTION; UPTAKE KINETICS	Muscle deoxygenation (i.e., deoxy[Hb + Mb]) during exercise assesses the matching of oxygen delivery ((Q) over dot(O2)) to oxygen utilization ((V) over dot(O2)). Until now limitations in near-infrared spectroscopy (NIRS) technology did not permit discrimination of deoxy[Hb + Mb] between superficial and deep muscles. In humans, the deep quadriceps is more highly vascularized and oxidative than the superficial quadriceps. Using high-power time-resolved NIRS, we tested the hypothesis that deoxygenation of the deep quadriceps would be less than in superficial muscle during incremental cycling exercise in eight males. Pulmonary (V) over dot(O2) was measured and muscle deoxy[Hb + Mb] was determined in the superficial vastus lateralis (VL), vastus medialis (VM), and rectus femoris (RF-s) and the deep rectus femoris (RF-d). deoxy[Hb + Mb] in RF-d was significantly less than VL at 70% (67.2 +/- 7.0 vs. 75.5 +/- 10.7 mu M) and 80% (71.4 +/- 11.0 vs. 79.0 +/- 15.4 mu M) of peak work rate (WRpeak), but greater than VL and VM at WRpeak (87.7 +/- 32.5 vs. 76.6 +/- 17.5 and 75.1 +/- 19.9 mu M). RF-s was intermediate at WRpeak (82.6 +/- 18.7 mu M). Total hemoglobin and myoglobin concentration and tissue oxygen saturation were significantly greater in RF-d than RF-s throughout exercise. The slope of deoxy[Hb + Mb] increase (proportional to (Q) over dot(O2)/(V) over dot(O2)) in VL and VM slowed markedly above 70% WRpeak, whereas it became greater in RF-d. This divergent deoxygenation pattern may be due to a greater population of slowt-witch muscle fibers in the RF-d muscle and the differential recruitment profiles and vascular and metabolic control properties of specific fiber populations within superficial and deeper muscle regions.	[Okushima, Dai; Koga, Shunsaku] Kobe Design Univ, Appl Physiol Lab, Kobe, Hyogo 6512196, Japan; [Poole, David C.; Barstow, Thomas J.] Kansas State Univ, Dept Kinesiol, Manhattan, KS 66506 USA; [Poole, David C.; Barstow, Thomas J.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Rossiter, Harry B.] Harbor Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst, Rehabil Clin Trials Ctr,Div Resp & Crit Care Phys, Torrance, CA USA; [Kondo, Narihiko] Kobe Univ, Kobe, Hyogo 657, Japan; [Ohmae, Etsuko] Hamamatsu Photon KK, Hamamatsu, Shizuoka, Japan	Koga, S (reprint author), Kobe Design Univ, Appl Physiol Lab, Nishi Ku, 8-1-1 Gakuennishi Machi, Kobe, Hyogo 6512196, Japan.	s-koga@kobe-du.ac.jp			Japan Society for the Promotion of Science [KAKENHI-15K16476, KAKENHI-24247046, -26560362]; United Kingdom (UK)-Japan Partnering Award from Biotechnology and Biological Sciences Research Council, UK [BB/I024798/1]	D. Okushima was supported by grants from the Japan Society for the Promotion of Science (KAKENHI-15K16476). S. Koga was supported by grants from the Japan Society for the Promotion of Science (KAKENHI-24247046 and -26560362). H. B. Rossiter and S. Koga were supported by a United Kingdom (UK)-Japan Partnering Award from Biotechnology and Biological Sciences Research Council, UK (BB/I024798/1).	Hamaoka T, 2000, J BIOMED OPT, V5, P102, DOI 10.1117/1.429975; Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; RICHARDSON RS, 1993, J APPL PHYSIOL, V75, P1911; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Heinonen I, 2007, J APPL PHYSIOL, V103, P2042, DOI 10.1152/japplphysiol.00567.2007; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; McAllister RM, 2003, J APPL PHYSIOL, V94, P1777, DOI 10.1152/japplphysiol.00901.2002; Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; DiMenna FJ, 2010, RESP PHYSIOL NEUROBI, V173, P138, DOI 10.1016/j.resp.2010.07.005; Heinonen I, 2010, J APPL PHYSIOL, V108, P378, DOI 10.1152/japplphysiol.00745.2009; Behnke BJ, 2011, AM J PHYSIOL-REG I, V301, pR783, DOI 10.1152/ajpregu.00205.2011; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Koga S, 2015, J APPL PHYSIOL, V118, P1435, DOI 10.1152/japplphysiol.01003.2014; Mortensen SP, 2005, J PHYSIOL-LONDON, V566, P273, DOI 10.1113/jphysiol.2005.086025; Harms CA, 1997, J APPL PHYSIOL, V82, P1573; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kalliokoski KK, 2000, EUR J APPL PHYSIOL, V83, P395, DOI 10.1007/s004210000267; Jones AM, 2004, EUR J APPL PHYSIOL, V91, P238, DOI 10.1007/s00421-003-0971-7; Boone J, 2012, EUR J APPL PHYSIOL, V112, P1143, DOI 10.1007/s00421-011-2068-z; Behnke BJ, 2003, J PHYSIOL-LONDON, V549, P597, DOI 10.1113/jphysiol.2002.035915; Adami A, 2015, J APPL PHYSIOL, V118, P1091, DOI 10.1152/japplphysiol.00918.2014; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Boone J, 2009, EUR J APPL PHYSIOL, V105, P851, DOI 10.1007/s00421-008-0969-2; Poole DC, 2011, ACTA PHYSIOL, V202, P293, DOI 10.1111/j.1748-1716.2010.02246.x; Laughlin MH, 2012, COMPR PHYSIOL, V2, P321, DOI 10.1002/cphy.c100048; Osawa T, 2011, MED SCI SPORT EXER, V43, P1406, DOI 10.1249/MSS.0b013e3182100261; Boone J, 2010, MED SCI SPORT EXER, V42, P935, DOI 10.1249/MSS.0b013e3181c0ecea; Koga S, 2012, J APPL PHYSIOL, V112, P26, DOI 10.1152/japplphysiol.00925.2011; Ferreira LF, 2007, J APPL PHYSIOL, V103, P1999, DOI 10.1152/japplphysiol.01414.2006; Murias JM, 2013, RESP PHYSIOL NEUROBI, V189, P530, DOI 10.1016/j.resp.2013.08.011; KNIGHT DR, 1992, J APPL PHYSIOL, V73, P1114; Spencer MD, 2012, EUR J APPL PHYSIOL, V112, P3349, DOI 10.1007/s00421-012-2323-y; Endo MY, 2007, AM J PHYSIOL-REG I, V293, pR812, DOI 10.1152/ajpregu.00028.2007; LEXELL J, 1983, ACTA PHYSIOL SCAND, V117, P115, DOI 10.1111/j.1748-1716.1983.tb07185.x; Kalliokoski KK, 2003, J APPL PHYSIOL, V94, P953, DOI 10.1152/japplphysiol.00731.2002; Reid RW, 2001, J APPL PHYSIOL, V90, P897; Vogiatzis I, 2009, J PHYSIOL-LONDON, V587, P3665, DOI 10.1113/jphysiol.2009.171694; Cannon DT, 2013, J APPL PHYSIOL, V115, P839, DOI 10.1152/japplphysiol.00510.2013; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Boone J, 2015, EUR J APPL PHYSIOL, V115, P57, DOI 10.1007/s00421-014-2991-x; Ijichi S, 2005, J BIOMED OPT, V10, P1; Spencer MD, 2014, J APPL PHYSIOL, V117, P1199, DOI 10.1152/japplphysiol.00060.2014; Vogiatzis I, 2015, J APPL PHYSIOL, V118, P783, DOI 10.1152/japplphysiol.00458.2014	44	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	DEC 1	2015	119	11					1313	1319		10.1152/japplphysiol.00574.2015		7	Physiology; Sport Sciences	Physiology; Sport Sciences	CX7UH	WOS:000365907800008		
J	Tsukiya, T; Mizuno, T; Takewa, Y; Tatsumi, E; Taenaka, Y				Tsukiya, Tomonori; Mizuno, Toshihide; Takewa, Yoshiaki; Tatsumi, Eisuke; Taenaka, Yoshiyuki			Preclinical study of a novel hydrodynamically levitated centrifugal pump for long-term cardiopulmonary support	JOURNAL OF ARTIFICIAL ORGANS			English	Article						ECMO; Centrifugal pump; Animal experiment; Hydrodynamic levitation	EXTRACORPOREAL MEMBRANE-OXYGENATION; CIRCULATORY SUPPORT; LIFE-SUPPORT; BLOOD PUMP; EXPERIENCE; SYSTEM; BRIDGE; HEMOCOMPATIBILITY; RECOVERY; DEVICES	An extracorporeal centrifugal blood pump with a hydrodynamically levitated impeller was developed for use in a durable extracorporeal membrane oxygenation (ECMO) system. The present study examined the biocompatibility of the blood pump during long-term use by conducting a series of 30-day chronic animal experiments. The ECMO system was used to produce a percutaneous venoarterial bypass between the venae cavae and carotid artery in adult goats. No anticoagulation or antiplatelet therapy was administered during the experiments. Three out of four animals survived for the scheduled 30-day period, and the blood pumps and membrane oxygenators both exhibited sufficient hydrodynamic performance and good antithrombogenicity, while one animal died of massive bleeding from the outflow cannulation site. The animals' plasma free hemoglobin had returned to within the normal range by 1 week after the surgical intervention, and their hemodynamic and biochemistry parameters remained within their normal ranges throughout the experiment. The explanted centrifugal blood pumps did not display any trace of thrombus formation. Based on the biocompatibility demonstrated in this study, the examined centrifugal blood pump, which includes a hydrodynamically levitated impeller, is suitable for use in durable ECMO systems.	[Tsukiya, Tomonori; Mizuno, Toshihide; Takewa, Yoshiaki; Tatsumi, Eisuke; Taenaka, Yoshiyuki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, Suita, Osaka 5658565, Japan	Tsukiya, T (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tsukiya@ncvc.go.jp; toshi@ncvc.go.jp			New Energy and Industrial Technology Development Organization as a Translational Research Project	This study received financial support from the New Energy and Industrial Technology Development Organization as a Translational Research Project.	John R, 2011, J THORAC CARDIOV SUR, V141, P932, DOI 10.1016/j.jtcvs.2010.03.046; Whitson BA, 2007, J HEART LUNG TRANSPL, V26, P345, DOI 10.1016/j.healun.2007.01.024; Bhama JK, 2009, J HEART LUNG TRANSPL, V28, P971, DOI 10.1016/j.healun.2009.04.015; Peek GJ, 2002, ASAIO J, V48, P480, DOI 10.1097/01.MAT.0000026348.66193.2F; Kashiwa K, 2012, J ARTIF ORGANS, V15, P207, DOI 10.1007/s10047-012-0632-x; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Fuehner T, 2012, AM J RESP CRIT CARE, V185, P763, DOI 10.1164/rccm.201109-1599OC; Paden ML, 2013, ASAIO J, V59, P202, DOI 10.1097/MAT.0b013e3182904a52; Tuzun E, 2007, TEX HEART I J, V34, P406; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Zimmermann AK, 2004, ASAIO J, V50, P193, DOI 10.1097/01.MAT.0000123638.41808.59; Thiara APS, 2007, PERFUSION-UK, V22, P323, DOI 10.1177/0267659107086270; Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9; Nishinaka T, 2002, ARTIF ORGANS, V26, P548, DOI 10.1046/j.1525-1594.2002.06886_3.x; Ochiai Y, 2001, ANN THORAC SURG, V72, P747, DOI 10.1016/S0003-4975(01)02892-2; Eya K, 1996, ASAIO J, V42, pM832; Kawakami H, 1997, ASAIO J, V43, pM490; van der Meer AL, 2003, ARTIF ORGANS, V27, P21; Hoashi T, 2000, J ARTIF ORGANS, V16, P267; Kusajima K, 2014, ARTIF ORGANS, V17, P99	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					300	306		10.1007/s10047-015-0842-0		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900002		
J	Sumikura, H; Nakayama, Y; Ohnuma, K; Kishimoto, S; Takewa, Y; Tatsumi, E				Sumikura, Hirohito; Nakayama, Yasuhide; Ohnuma, Kentaro; Kishimoto, Satoru; Takewa, Yoshiaki; Tatsumi, Eisuke			In vitro hydrodynamic evaluation of a biovalve with stent (tubular leaflet type) for transcatheter pulmonary valve implantation	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Pulmonary valve; Biovalve; Pulsatile circulation circuit; Autologous tissue; Hydrodynamic evaluation	AORTIC-VALVE; HEART-VALVE; REPLACEMENT; CONDUIT; PROSTHESIS; STENOSIS; MODEL; BODY	We have been developing an autologous heart valve-shaped tissue with a stent (stent-biovalve) for transcatheter pulmonary valve implantation (TPVI) using "in-body tissue architecture" technology. In this study, the hydrodynamic performance of a stent-biovalve with tubular leaflets was evaluated by changing its leaflet height in an in vitro test in order to determine the appropriate stent-biovalve form for the pulmonary valve. A specially designed, self-expandable, stent-mounted, cylindrical acrylic mold was placed in a dorsal subcutaneous pouch of goat, and the implant was extracted 2 months later. Only the cylindrical acrylic mold was removed from the implant, and a tubular hollow structure of membranous connective tissue impregnated with the stent strut was obtained. Half of tubular tissue was completely folded in half inwards, and 3 commissure parts were connected to form 3 leaflets, resulting in the preparation of a stent-biovalve with tubular leaflets (25-mm ID). The stent-biovalve with adjusting leaflet height (13, 14, 15, 17, 20, and 25 mm) was fixed to a specially designed pulsatile mock circulation circuit under pulmonary valve conditions using 37 A degrees C saline. The mean pressure difference and effective orifice area were better than those of the biological valve. The lowest and highest leaflet heights had a high regurgitation rate due to lack of coaptation or prevention of leaflet movement, respectively. The lowest regurgitation (ca. 11 %) was observed at a height of 15 mm. The leaflet height was found to significantly affect the hydrodynamics of stent-biovalves, and the existence of an appropriate leaflet height became clear.	[Sumikura, Hirohito; Ohnuma, Kentaro; Kishimoto, Satoru; Takewa, Yoshiaki; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, Suita, Osaka 5658565, Japan; [Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Suita, Osaka 5658565, Japan	Sumikura, H (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	sumikura@ri.ncvc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25670603]	The present study was supported by Grants-in-Aid for Challenging Exploratory Research (No. 25670603) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Kishimoto S, 2015, J ARTIF ORGANS, V18, P185, DOI 10.1007/s10047-015-0817-1; Funayama M, 2015, J ARTIF ORGANS, V18, P228, DOI 10.1007/s10047-015-0820-6; [Anonymous], 58402005E ISO; Sumikura H, 2014, ARTIF ORGANS, V38, P282, DOI 10.1111/aor.12173; Tokunaga S, 2010, J ARTIF ORGANS, V13, P77, DOI 10.1007/s10047-010-0507-y; Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0; Mizuno T, 2014, J BIOMED MATER RES B, V102, P1038, DOI 10.1002/jbm.b.33086; Sumikura H, 2013, J ARTIF ORGANS, V16, P138, DOI 10.1007/s10047-013-0687-3; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; Takewa Y, 2013, J ARTIF ORGANS, V16, P176, DOI 10.1007/s10047-012-0679-8; Huang PH, 2013, CARDIOL CLIN, V31, P337, DOI 10.1016/j.ccl.2013.05.009; Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046; Nakayama Y, 2015, J BIOMED MATER RES B, V103, P1, DOI 10.1002/jbm.b.33186	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					307	314		10.1007/s10047-015-0851-z		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900003		
J	Iwamoto, U; Hori, H; Takami, Y; Tokushima, Y; Shinzato, M; Yasutake, M; Kitaguchi, N				Iwamoto, Ushio; Hori, Hideo; Takami, Yoshihiro; Tokushima, Yasuo; Shinzato, Masanori; Yasutake, Mikitomo; Kitaguchi, Nobuya			A novel cell-containing device for regenerative medicine: biodegradable nonwoven filters with peripheral blood cells promote wound healing	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Nonwoven filter; Peripheral blood cells; Wound healing; FGF-7; TGF-beta 1	KERATINOCYTE GROWTH-FACTOR; MODEL	The efficacy of skin regeneration devices consisting of nonwoven filters and peripheral blood cells was investigated for wound healing. We previously found that human peripheral blood cells enhanced their production of growth factors, such as transforming growth factor beta 1 (TGF-beta 1) and vascular endothelial growth factor, when they were captured on nonwoven filters. Cells on biodegradable filters were expected to serve as a local supply of growth factors and cell sources when they were placed in wounded skin. Nonwoven filters made of biodegradable polylactic acid (PLA) were cut out as 13-mm disks and placed into cell-capturing devices. Mouse peripheral blood was filtered, resulting in PLA filters with mouse peripheral blood cells (m-PBCs) at capture rates of 65.8 +/- A 5.2 %. Then, the filters were attached to full-thickness surgical wounds in a diabetic db/db mouse skin for 14 days as a model of severe chronic wounds. The wound area treated with PLA nonwoven filters with m-PBCs (PLA/B+) was reduced to 8.5 +/- A 12.2 % when compared with day 0, although the non-treated control wounds showed reduction only to 60.6 +/- A 27.8 %. However, the PLA filters without m-PBCs increased the wound area to 162.9 +/- A 118.7 %. By histopathological study, the PLA/B+ groups more effectively accelerated formation of epithelium. The m-PBCs captured on the PLA filters enhanced keratinocyte growth factor (FGF-7) and TGF-beta 1 productions in vitro, which may be related to wound healing. This device is useful for regeneration of wounded skin and may be adaptable for another application.	[Iwamoto, Ushio; Yasutake, Mikitomo] Asahi Kasei Corp, Healthcare R&D Ctr, Tokyo, Japan; [Hori, Hideo; Kitaguchi, Nobuya] Fujita Hlth Univ, Sch Hlth Sci, Fac Clin Engn, Toyoake, Aichi 4701192, Japan; [Takami, Yoshihiro] Kyorin Univ, Sch Med, Dept Plast Surg, Tokyo, Japan; [Tokushima, Yasuo] Asahi Kasei Med Co Ltd, Therapeut Apheresis Div, Tokyo, Japan; [Shinzato, Masanori] Fujita Hlth Univ, Sch Hlth Sci, Fac Med Management & Informat Sci, Toyoake, Aichi 4701192, Japan	Hori, H (reprint author), Fujita Hlth Univ, Sch Hlth Sci, Fac Clin Engn, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	hori@fujita-hu.ac.jp; nkitaguc@fujita-hu.ac.jp			Asahi Kasei Corporation; JSPS KAKENHI [25410232]	The authors thank Ms. Mikiko Ariga of Asahi Kasei Fibers Corporation for providing the nonwoven filters. The authors thank Ms. Miwa Sakata, and Mr. Masaya Yamamoto, Kazuki Kawamura and Tomoya Oguri for their technical assistance. This work was partly supported by a research grant from Asahi Kasei Corporation and JSPS KAKENHI Grant Number 25410232.	TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Stroman PW, 1999, MAGNET RESON MED, V42, P210, DOI 10.1002/(SICI)1522-2594(199907)42:1<210::AID-MRM29>3.0.CO;2-Q; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513; Akita S, 2005, BURNS, V31, P855, DOI 10.1016/j.burns.2005.04.008; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Riedel K, 2007, ARCH MED RES, V38, P45, DOI 10.1016/j.arcmed.2006.04.010; Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x; RUBIN JS, 1995, CELL BIOL INT, V19, P399, DOI 10.1006/cbir.1995.1085; Jain R, 2013, BIOMATERIALS, V34, P340, DOI 10.1016/j.biomaterials.2012.09.055; STAIANOCOICO L, 1993, J EXP MED, V178, P865, DOI 10.1084/jem.178.3.865; Hori H, 2015, J ARTIF ORGANS, V18, P55, DOI 10.1007/s10047-014-0794-9; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Penn Jack W, 2012, Int J Burns Trauma, V2, P18; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Robson Martin C., 1997, Wound Repair and Regeneration, V5, P12, DOI 10.1046/j.1524-475X.1997.50106.x	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					315	321		10.1007/s10047-015-0845-x		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900004		
J	Iwai, R; Tsujinaka, T; Nakayama, Y				Iwai, Ryosuke; Tsujinaka, Takahiro; Nakayama, Yasuhide			Preparation of Biotubes with vascular cells component by in vivo incubation using adipose-derived stromal cell-exuding multi-microporous molds	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Vascular grafts; In vivo tissue engineering; Adipose-derived vascular stromal cells; Biotube; Vascular tissue	BODY TISSUE ARCHITECTURE; STEM-CELLS; PERITONEAL-CAVITY; ENDOTHELIAL-CELLS; IMPLANTATION; EXPRESSION; FIBROSIS; VITRO	Biotubes, prepared using in-body tissue architecture (IBTA) technology, have adequate mechanical properties and excellent biocompatibility for vascular grafts. However, they have thin walls, lack vascular constructing cells, and are composed of subcutaneous connective tissues consisting mainly of collagen and fibroblasts. This study aimed to prepare Biotubes with a vascular-like structure including an endothelial cell lining and a smooth muscle cell by IBTA using adipose-derived vascular stromal cell (ADSCs)-exuding specially designed multiporous tubes (outer diameter 5 mm, length 24 mm, pore size 500 mu m, pore number 180, cell number/tube > 3.0 x 10(6)). ADSCs were separated from rat subcutaneous fat, suspended in a Matrigel (TM) solution at 4 A degrees C, and then filled into the tubes. After the tubes were embedded into dorsal subcutaneous pouches of the same rats for 2 weeks, robust Biotubes with a wall thickness of > 600 mu m were formed surrounding the tubes. The luminal layer of the obtained Biotubes was dominated by the cells positive for an endothelial marker. Almost the entire intima, with a thickness of about 400 mu m, was occupied with cells positive for a smooth muscle marker. Both cells were derived from ADSCs. Biotube walls were constructed by fusing ADSC-derived vascular constructing cells exuded from the tubes and fibroblasts and collagen from the surrounding connective tissue. A robust Biotubes with vascular cells component, were formed after only 2 weeks of subcutaneous incubation of ADSCs-exuding multiporous tubes.	[Iwai, Ryosuke; Tsujinaka, Takahiro; Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Suita, Osaka 5658565, Japan	Nakayama, Y (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, 5-7-1 Fujishiro dai, Suita, Osaka 5658565, Japan.	ny@ncvc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23860078, B23360374]	This work was supported in part by Grant-in-Aid for Young Scientists (Start-up, Grant Number 23860078) and Scientific Research (B23360374) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Thrall RS, 1997, AM J PATHOL, V151, P1303; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Krawiec JT, 2012, BIOMATERIALS, V33, P3388, DOI 10.1016/j.biomaterials.2012.01.014; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Seki T, 2012, J SURG RES, V178, P63, DOI 10.1016/j.jss.2012.02.014; Arana M, 2013, ACTA BIOMATER, V9, P6075, DOI 10.1016/j.actbio.2012.12.014; Iwai R, 2013, BIOCONJUGATE CHEM, V24, P159, DOI 10.1021/bc300317e; Iwai R, 2013, BIOMATERIALS, V34, P9096, DOI 10.1016/j.biomaterials.2013.08.027; Campbell JH, 1999, CIRC RES, V85, P1173; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Zhang P, 2011, STEM CELLS DEV, V20, P977, DOI 10.1089/scd.2010.0152; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Watanabe T, 2010, J BIOMED MATER RES B, V92B, P236, DOI 10.1002/jbm.b.31510; Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379; Kriz J, 2012, AM J SURG, V203, P397; Nakayama Y, 2015, J BIOMED MATER RES B, V103, P1, DOI 10.1002/jbm.b.33186; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					322	329		10.1007/s10047-015-0848-7		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900005		
J	Sakiyama, R; Yamamoto, K; Ishimori, I; Yoshida, S; Akiba, T; Mineshima, M				Sakiyama, Ryoichi; Yamamoto, Kenichiro; Ishimori, Isamu; Yoshida, Satoshi; Akiba, Takashi; Mineshima, Michio			Performance evaluation of developed polysulfone membrane hemodiafilters, ABH-F and ABH-P, in post- and pre-dilution hemodiafiltration	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Hemodiafilter; Pre-dilution HDF; Post-dilution HDF; Clearance; TMP	HIGH-FLUX HEMODIALYSIS; ONLINE HEMODIAFILTRATION; MORTALITY; PHOSPHATE; REMOVAL	ABH-F and ABH-P have been developed for hemodiafiltration (HDF) therapy. In this study, we evaluated the solute removal characteristics of the hemodiafilters in a bovine blood in vitro study. The hemodiafilters were examined for 120 min at various filtration flow rates (Q (F)) (31.2-250 mL/min) under a constant blood flow rate of 250 mL/min and constant dialysate flow rates of 500/250 mL/min in pre-dilution HDF (pre-HDF) and post-dilution HDF (post-HDF). Creatinine clearance in pre-HDF was approximately 85 % of that in post-HDF because it was removed by molecular diffusion dominantly. The initial clearances of beta(2)-microglobulin and alpha(1)-microglobulin increased with Q (F) and these values slightly and steeply decreased with time due to membrane fouling. Under a same Q (F) of 62.5 mL/min, higher clearance values in post-HDF were obtained compared with those in pre-HDF. All clearance values of ABH-P were higher than those of ABH-F under the same Q (F). It seems that the ABH-P has a larger pore size of membrane than that in ABH-F. The creatinine and alpha(1)-microglobulin clearance values were obtained as highest at post-Q (F)62.5, the beta(2)-microglobulin clearance values and transmembrane pressure were obtained as highest at pre-Q (F)250. Large solute clearances such as alpha(1)-microglobulin and albumin decreased with time in all HDF experiments. Time decay of large solute clearance values was observed in the HDF modality that had a higher clearance of the solute at 5 min later after the start of experiment.	[Sakiyama, Ryoichi; Yamamoto, Kenichiro; Ishimori, Isamu; Yoshida, Satoshi; Mineshima, Michio] Tokyo Womens Med Univ, Dept Clin Engn, Shinjuku Ku, Tokyo 1628666, Japan; [Akiba, Takashi] Tokyo Womens Med Univ, Dept Blood Purificat, Tokyo, Japan	Sakiyama, R (reprint author), Tokyo Womens Med Univ, Dept Clin Engn, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	sakiyama@twmu.ac.jp			Asahikasei Medical, Tokyo, Japan	Michio Mineshima received a research grant from Asahikasei Medical, Tokyo, Japan. The other authors have no conflict of interest.	Kawanishi H, 2011, CONTRIB NEPHROL, V173, P36, DOI 10.1159/000328944; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Oates T, 2011, AM J NEPHROL, V33, P70, DOI 10.1159/000322834; Sakurai K, 2013, J ARTIF ORGANS, V16, P316, DOI 10.1007/s10047-013-0698-0; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Movilli E, 2011, NEPHROL DIAL TRANSPL, V26, P4032, DOI 10.1093/ndt/gfr179; Masakane I, 2011, CONTRIB NEPHROL, V173, P84, DOI 10.1159/000328959; Siriopol D, 2015, NEPHROL DIAL TRANSPL, V30, P294, DOI 10.1093/ndt/gfu347; Pedrini LA, 2011, NEPHROL DIAL TRANSPL, V26, P2617, DOI 10.1093/ndt/gfq761; Vilar E, 2009, CLIN J AM SOC NEPHRO, V4, P1944, DOI 10.2215/CJN.05560809; Wester L, 2000, GLYCOBIOLOGY, V10, P891, DOI 10.1093/glycob/10.9.891; Ward RA, 2000, J AM SOC NEPHROL, V11, P2344; ROCKEL A, 1986, KIDNEY INT, V30, P429, DOI 10.1038/ki.1986.202; Beerenhout CH, 2005, NEPHROL DIAL TRANSPL, V20, P1155, DOI 10.1093/ndt/gfh775; Sakiyama R, 2012, J ARTIF ORGANS, V15, P266, DOI 10.1007/s10047-012-0643-7; Lornoy W, 1998, AM J NEPHROL, V18, P105, DOI 10.1159/000013317; Bosch T, 1985, Contrib Nephrol, V46, P14; Sakiyama R, 2012, THERAPEUTICS ENG, V24, P20; Yamamoto Ken-ichiro, 2005, J Artif Organs, V8, P198, DOI 10.1007/s10047-005-0303-2	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					330	337		10.1007/s10047-015-0844-y		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900006		
J	Asakura, Y; Sapkota, A; Maruyama, O; Kosaka, R; Yamane, T; Takei, M				Asakura, Yuta; Sapkota, Achyut; Maruyama, Osamu; Kosaka, Ryo; Yamane, Takashi; Takei, Masahiro			Relative permittivity measurement during the thrombus formation process using the dielectric relaxation method for various hematocrit values	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Dielectric relaxation method; Thrombus detection; Thrombus formation; Red blood cell; Artificial heart	BLOOD; SPECTROSCOPY; ROULEAUX	The relative permittivity epsilon' and the dielectric loss epsilon aEuro(3) for various hematocrit values H for static bovine blood condition have been measured using the dielectric relaxation method to detect thrombosis in real time. The suitable measurement frequency f (m) ranged within 60 kHz to 1 MHz, and the relaxation frequency of red blood cells (RBCs) f (rc) was observed to be 2 MHz. In the f (m), the temporal change of normalized epsilon' exhibited a minimum (called as bottom point). The bottom point was observed to be exponentially shortened as H increased. This characteristic of the epsilon'* minimum is discussed from three viewpoints: during fibrin formation, direct thrombus formation, and rouleaux formation processes. epsilon'* during the fibrin formation process decreased over time, irrespective of f. However, epsilon'* in f (m) during the direct thrombus formation process and during the aggregation formation process increased immediately and rapidly over time. Therefore, the epsilon'* bottom point in f (m) might be the indication of micrometer-scale thrombus formation by RBC aggregation due to fibrin formation.	[Asakura, Yuta; Takei, Masahiro] Chiba Univ, Div Artificial Syst Sci, Grad Course Mech Engn, Inage Ku, Chiba 2638522, Japan; [Sapkota, Achyut] Kisarazu Coll, Natl Inst Technol, Dept Informat & Comp Engn, Kisarazu, Chiba 2920041, Japan; [Maruyama, Osamu; Kosaka, Ryo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan; [Yamane, Takashi] Kobe Univ, Grad Sch Engn, Dept Mech Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Sapkota, A (reprint author), Kisarazu Coll, Natl Inst Technol, Dept Informat & Comp Engn, 2-22-1 Kiyomidai Higashi, Kisarazu, Chiba 2920041, Japan.	sapkota@ieee.org			Japanese Society for Artificial Organs; Venture Business Laboratory; COE Start-up program (Chiba University); Asahi Glass Foundation, Japan;  [26750143];  [26630046]	This study was supported by the Yoshimi T.M.P Grant in 2012 of the Japanese Society for Artificial Organs, the Venture Business Laboratory and the COE Start-up program (Chiba University), Grant-in-Aid for Scientific Research for Young Researchers (26750143), Grant-in-Aid for Challenging Exploratory Research (26630046), and a research grant from Asahi Glass Foundation, Japan. The authors would like to thank Mr. Takuto Fuse (Chiba University, Division of Artificial Systems Science) for his generous help in conducting the experiments and constructive feedback during manuscript preparation and revision.	Wolf M, 2011, BBA-GEN SUBJECTS, V1810, P727, DOI 10.1016/j.bbagen.2011.05.012; Oshima S, 2009, ARTIF ORGANS, V33, P749, DOI 10.1111/j.1525-1594.2009.00891.x; Tamagawa M, 2009, ARTIF ORGANS, V33, P604, DOI 10.1111/j.1525-1594.2009.00782.x; Baskurt OK, 2010, IEEE T BIO-MED ENG, V57, P969, DOI 10.1109/TBME.2009.2036598; KAIBARA M, 1983, BIORHEOLOGY, V20, P583; Asami K, 2002, J NON-CRYST SOLIDS, V305, P268, DOI 10.1016/S0022-3093(02)01110-9; Irimajiri A, 1996, BBA-GEN SUBJECTS, V1290, P207, DOI 10.1016/0304-4165(96)00048-7; Noshiro M, 2007, IFMBE PROC, V17, P70; Affanni A, 2012, IEEE IMTC P, P1477; ASAKA K, 1990, J MEMBRANE SCI, V50, P71, DOI 10.1016/S0376-7388(00)80887-X; Asakura Y, 2013, T VISUAL SOC JPN, V33, P17; Hayashi Y, 2010, ANAL CHEM, V82, P9759; Park HJ, 2003, BIOSENS BIOELECTRON, V19, P321; Tamakawa M, 2010, ASME 2010 INT MECH E, DOI [10.1115/IMECE2010-38607, DOI 10.1115/IMECE2010-38607]; Yamane T, 2002, J ARTIF ORGANS, V5, P149, DOI 10.1007/s100470200027	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					346	353		10.1007/s10047-015-0847-8		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900008		
J	Arakawa, M; Yamaguchi, A; Nishimura, T; Itoh, S; Yuri, K; Kyo, S; Adachi, H				Arakawa, Mamoru; Yamaguchi, Atsushi; Nishimura, Takashi; Itoh, Satoshi; Yuri, Koichi; Kyo, Shunei; Adachi, Hideo			Nipro extra-corporeal left ventricular assist device fitting after left ventricular reconstruction with mitral valve plasty	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Left ventricular assist device; Left ventricular reconstruction; Severe heart failure; Cardiac low output syndrome	IDIOPATHIC DILATED CARDIOMYOPATHY; CONGESTIVE-HEART-FAILURE; SURGERY	Both left ventricular assist device and left ventricular reconstruction are treatment choices for severe heart failure conditions. Our institution performed a left ventricular assist device installation following a left ventricular reconstruction procedure on a 42-year-old male patient who presented with dilated cardiomyopathy and low cardiac output syndrome. A mitral valve plasty was used to correct the acute mitral valve regurgitation and we performed a Nipro extra-corporeal left ventricular assist device installation on post-operative day 14. Due to the left ventricular reconstruction that the patient had in a previous operation, we needed to attach an apical cuff on posterior apex, insert the inflow cannula with a large curve, and shift the skin insertion site laterally to the left. We assessed the angle between the cardiac longitudinal axis and the inflow cannula using computed tomography. The patient did not complain of any subjective symptoms of heart failure. Although Nipro extra-corporeal left ventricular assist device installation after left ventricular reconstruction has several difficulties historically, we have experienced a successful case.	[Arakawa, Mamoru; Yamaguchi, Atsushi; Itoh, Satoshi; Yuri, Koichi; Adachi, Hideo] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Omiya Ku, Saitama 3308503, Japan; [Nishimura, Takashi; Kyo, Shunei] Tokyo Metropolitan Geriatr Hosp, Dept Cardiac Surg, Tokyo 173, Japan	Arakawa, M (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	a_mamoru@mbn.nifty.com; yamaatsu@omiya.jichi.ac.jp					Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Nishimura T, 2014, J ARTIF ORGANS, V17, P211, DOI 10.1007/s10047-014-0779-8; Yamaguchi A, 2005, ANN THORAC SURG, V79, P456, DOI 10.1016/j.athoracsur.2004.07.045; Szalay ZA, 2003, EUR J CARDIO-THORAC, V23, P567, DOI 10.1016/S1010-7940(02)00864-3; Takeda K, 2008, ANN THORAC SURG, V85, P1339, DOI 10.1016/j.athoracsur.2007.12.065; Osaki S, 2009, J HEART LUNG TRANSPL, V28, P520, DOI 10.1016/j.healun.2009.02.004; Kyo S, 2012, J CARDIOL, V59, P101, DOI 10.1016/j.jjcc.2012.01.001; Horii T, 2006, ANN THORAC SURG, V82, P1349, DOI 10.1016/j.athoracsur.2006.04.077; Suma H, 2007, EUR J CARDIO-THORAC, V32, P912, DOI 10.1016/j.ejcts.2007.09.021; DOR V, 1989, THORAC CARDIOV SURG, V37, P11, DOI 10.1055/s-2007-1013899; Yoshioka D, 2012, CIRC J, V76, P372, DOI 10.1253/circj.CJ-11-0833; Fatullayev J, 2014, J ARTIF ORGANS, V17, P370, DOI 10.1007/s10047-014-0785-x; Garbade J, 2011, CIRC-HEART FAIL, V4, P14; Timms D, 2010, ARTIF ORGANS, V9, P714	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					361	364		10.1007/s10047-015-0837-x		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900011		
J	Akiyama, M; Hosoyama, K; Kumagai, K; Kawamoto, S; Saiki, Y				Akiyama, Masatoshi; Hosoyama, Katsuhiro; Kumagai, Kiichiro; Kawamoto, Shunsuke; Saiki, Yoshikatsu			Continuous flow left ventricular assist device implantation concomitant with aortic arch replacement and aortic valve closure in a patient with end-stage heart failure associated with bicuspid aortic valve	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Ventricular assist device; Concomitant surgeries; Aortic surgery; Bicuspid aortic valve	SUPPORT	Left ventricular assist device (LVAD) implantation has become an established treatment for patients with end-stage heart failure as a bridge to cardiac transplantation. During LVAD implantation, some patients require concomitant surgeries, including tricuspid valve repair, aortic valve repair or replacement, and patent foramen ovale closure. However, concomitant aortic surgeries are rare in patients requiring LVAD implantation. We successfully performed total arch replacement with an open distal technique, aortic valve closure, and continuous flow LVAD implantation simultaneously.	[Akiyama, Masatoshi; Hosoyama, Katsuhiro; Kumagai, Kiichiro; Kawamoto, Shunsuke; Saiki, Yoshikatsu] Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan	Akiyama, M (reprint author), Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Aoba Ku, 1-1Seiryo Cho, Sendai, Miyagi 9808574, Japan.	akiyamam@med.tohoku.ac.jp; yoshisaiki@med.tohoku.ac.jp					Segura AM, 2013, J HEART LUNG TRANSPL, V32, P1096, DOI 10.1016/j.healun.2013.07.007; Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004; Gregoric ID, 2007, TEX HEART I J, V34, P463; Takeda K, 2012, J ARTIF ORGANS, V15, P204, DOI 10.1007/s10047-012-0628-6	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					365	369		10.1007/s10047-015-0840-2		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900012		
J	Hoashi, T; Kagisaki, K; Moon, J; Takahashi, Y; Hayashi, T; Ichikawa, H				Hoashi, Takaya; Kagisaki, Koji; Moon, Jiyong; Takahashi, Yuzo; Hayashi, Teruyuki; Ichikawa, Hajime			Suspected cold agglutination during mild hypothermic pediatric open heart surgery: a report of two cases	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Pediatric; Cold agglutinin; Cardiopulmonary bypass	CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; AGGLUTINEMIA; CARDIOPLEGIA; MANAGEMENT	Cold agglutination was suspected in 2 pediatric open heart surgery cases during mild hypothermic cardiopulmonary bypass. The first patient was a 2-year-old boy with secundum atrial septal defect. Fifteen minutes after the initiation of mild hypothermic cardiopulmonary bypass, the inlet pressure of oxygenator suddenly elevated from 250 to over 500 mmHg, whereas outlet pressure was maintained. The blood flow rate decreased from 140 to 85 ml/kg/min. At that time, the arterial blood temperature was less than 32 A degrees C. Cold agglutinin was highly suspected, so patient was immediately warmed, and the inlet pressure of oxygenator decreased to 250 mmHg when the arterial blood temperature reached to 36 A degrees C. Second patient was a 3-year-old boy with secondary developed subvalvular pulmonary stenosis after the repair of double chambered right ventricle at 10 months of his age. Eighteen minutes after the initiation of mild hypothermic cardiopulmonary bypass, the inflow pressure suddenly elevated to 500 mmHg and transmission flow decreased to 55 ml/kg/min. Twenty-three minutes after warming, the pressure fell to a normal level and transmission flow was recovered. The operation continued with normo-thermic cardiopulmonary bypass and crystalloid cardioplegia. Both cases had no postoperative complications related to cold agglutinin such as myocardial infarction, cerebral infarction, or renal insufficiency.	[Hoashi, Takaya; Kagisaki, Koji; Moon, Jiyong; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Takahashi, Yuzo; Hayashi, Teruyuki] Natl Cerebral & Cardiovasc Ctr, Dept Clin Engn, Suita, Osaka, Japan	Hoashi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	thoashi@surg1.med.osaka-u.ac.jp; ichikawa@hp.ncvc.go.jp					BERREKLOUW E, 1982, ANN THORAC SURG, V33, P521; Ko W, 1996, J CARDIOVASC SURG, V37, P623; AGARWAL SK, 1995, ANN THORAC SURG, V60, P1143, DOI 10.1016/0003-4975(95)00501-B; LEE MC, 1989, ANN THORAC SURG, V47, P57; Kanemitsu S, 2010, J THORAC CARDIOV SUR, V140, pE73, DOI 10.1016/j.jtcvs.2010.06.030; SCHREIBER AD, 1977, NEW ENGL J MED, V296, P1490, DOI 10.1056/NEJM197706302962602; Mastrogiovanni G, 1996, ANN THORAC SURG, V62, P317, DOI 10.1016/0003-4975(96)88940-5; Barbara DW, 2013, J THORAC CARDIOV SUR, V146, P668, DOI 10.1016/j.jtcvs.2013.03.009; HEARNSBERGER J, 1993, J THORAC CARDIOV SUR, V106, P756; Donatelli F, 1995, Cardiovasc Surg, V3, P191, DOI 10.1016/0967-2109(95)90893-A	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					370	372		10.1007/s10047-015-0836-y		3	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900013		
J	Teshima, H; Ikebuchi, M; Sano, T; Kinugasa, Y; Tai, R; Irie, H				Teshima, Hideki; Ikebuchi, Masahiko; Sano, Toshikazu; Kinugasa, Yusuke; Tai, Ryuta; Irie, Hiroyuki			A reoperation of thrombosed On-X valve detected by multidetector-row computed tomography	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Multidetector-row computed tomography; Prosthetic valve thrombus; Mechanical valve	OBSTRUCTION; ECHOCARDIOGRAPHY; DYSFUNCTION; POSITION; PANNUS; TRIAL	A 62-year-old female patient underwent mitral valve replacement with a 31/33-mm On-X valve for ischemic mitral valve regurgitation. Three months later, transthoracic echocardiography incidentally showed a blocked leaflet with 6 mmHg of mean pressure gradient and 2.4 cm(2) of mitral valve orifice area. Transesophageal echocardiography could not detect thrombus. Electrocardiographically gated multidetector-row computed tomography (MDCT) clearly demonstrated a blocked leaflet in the close position and thrombus (2 cm in length, 0.4 cm(2) in area) attached onto the atrial aspect of the leaflet. These findings observed by MDCT were confirmed at reoperation. MDCT was useful diagnostic method for visualizing prosthetic valve thrombosis.	[Teshima, Hideki; Ikebuchi, Masahiko; Sano, Toshikazu; Kinugasa, Yusuke; Tai, Ryuta; Irie, Hiroyuki] Chikamori Hosp Heart Ctr, Cardiovasc Surg, Kochi 7808522, Japan	Teshima, H (reprint author), Chikamori Hosp Heart Ctr, Cardiovasc Surg, 1-1-16 Ohkawasuji, Kochi 7808522, Japan.	tesshiaby@chikamori.com			Kochi Organization for Medical Reformation and Renewal, Kochi, Japan	This work was supported in part by a Grant-in-Aid for Promoting a Board-Certified instructor, from Kochi Organization for Medical Reformation and Renewal, Kochi, Japan.	Al Habib HF, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2013.02.026; Teshima H, 2002, ARTIF ORGANS, V26, P460, DOI 10.1046/j.1525-1594.2002.06988.x; Feng ZG, 2002, ARTIF ORGANS, V26, P32, DOI 10.1046/j.1525-1594.2002.06833.x; Tong AT, 2004, J AM COLL CARDIOL, V43, P77, DOI 10.1016/j.jacc.2003.08.028; Ozkan M, 2013, JACC-CARDIOVASC IMAG, V6, P206, DOI 10.1016/j.jcmg.2012.10.016; Teshima H, 2014, J ARTIF ORGANS, V17, P162, DOI 10.1007/s10047-013-0751-z; Girard SE, 2001, J AM COLL CARDIOL, V37, P579, DOI 10.1016/S0735-1097(00)01113-X; Ueda T, 2013, CIRC J, V77, P418, DOI 10.1253/circj.CJ-12-0290; Tanis W, 2014, EUR HEART J-CARD IMG, V15, P119, DOI 10.1093/ehjci/jet127; Lengyel M, 2005, J HEART VALVE DIS, V14, P567; Bimbaum BA, 2007, RADIOLOGY, V242, P109; Honda J, 2009, JPN J CARDIOVASC SUR, V38, P114; Puskas J, 2014, J THORAC CARDIOV SUR, V147, P1202, DOI 10.1016/j.jtcvs.2014.01.004; Puskas J, 2014, J THORAC CARDIOVASC, V147, P1210, DOI [10.1016/ j. jtcvs. 2014.01.004 1210- 1211, DOI 10.1016/J.JTCVS.2014.01.004]; Smadi O, 2014, EUR HEART J-CARD IMG, V15, P142, DOI 10.1093/ehjci/jet059	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					373	376		10.1007/s10047-015-0850-0		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900014		
J	Saito, Y; Suzuki, Y; Goto, T; Daitoku, K; Minakawa, M; Fukuda, I				Saito, Yoshiaki; Suzuki, Yasuyuki; Goto, Takeshi; Daitoku, Kazuyuki; Minakawa, Masahito; Fukuda, Ikuo			Cardiac supporting device using artificial rubber muscle: preliminary study to active dynamic cardiomyoplasty	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Blood vessel prosthesis; Artificial muscle; Cardiac supporting		Dynamic cardiomyoplasty is a surgical treatment that utilizes the patient's skeletal muscle to support circulation. To overcome the limitations of autologous skeletal muscles in dynamic cardiomyoplasty, we studied the use of a wrapped-type cardiac supporting device using pneumatic muscles. Four straight rubber muscles (Fluidic Muscle, FESTO, Esslingen, Germany) were used and connected to pressure sensors, solenoid valves, a controller and an air compressor. The driving force was compressed air. A proportional-integral-derivative system was employed to control the device movement. An overflow-type mock circulation system was used to analyze the power and the controllability of this new device. The device worked powerfully with pumped flow against afterload of 88 mmHg, and the beating rate and contraction/dilatation time were properly controlled using simple software. Maximum pressure inside the ventricle and maximum output were 187 mmHg and 546.5 ml/min, respectively, in the setting of 50 beats per minute, a contraction/dilatation ratio of 1:2, a preload of 18 mmHg, and an afterload of 88 mmHg. By changing proportional gain, contraction speed could be modulated. This study showed the efficacy and feasibility of a pneumatic muscle for use in a cardiac supporting device.	[Saito, Yoshiaki; Suzuki, Yasuyuki; Daitoku, Kazuyuki; Minakawa, Masahito; Fukuda, Ikuo] Hirosaki Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Hirosaki, Aomori 0368562, Japan; [Goto, Takeshi] Hirosaki Univ, Sch Med & Hosp, Dept Clin Engn, Aomori, Japan	Saito, Y (reprint author), Hirosaki Univ, Sch Med, Dept Thorac & Cardiovasc Surg, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	yomusai12@yahoo.co.jp					Morales R, 2011, MED BIOL ENG COMPUT, V49, P1145, DOI 10.1007/s11517-011-0814-3; Almond CS, 2013, CIRCULATION, V127, P1702, DOI 10.1161/CIRCULATIONAHA.112.000685; Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095; Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034; Zhang H, 2010, IEEE ENG MED BIO, P3686; Carpentier A, 1991, CARDIOMYOPLASTY; FESTO AG & Co. KG, IN TECHN FLUID MUSCL	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					377	381		10.1007/s10047-015-0860-y		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900015		
J	Funayama, M; Furukoshi, M; Moriwaki, T; Nakayama, Y				Funayama, Marina; Furukoshi, Maya; Moriwaki, Takeshi; Nakayama, Yasuhide			Development of an in vivo tissue-engineered valved conduit (type S biovalve) using a slitted mold	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Biovalve; Connective tissue; In-body tissue architecture; Leaflet; Sinus of Valsalva	ARCHITECTURE TECHNOLOGY; AORTIC-VALVE; LEAFLET; BODY; MODEL	In autologous valved conduits (biovalves) using in-body tissue architecture, the limited area available for leaflet formation is a concern. In this study, we designed a novel biovalve mold with slits to enhance in vivo cell migration, regardless of size. As a control, the original mold without slits was used. When both types of molds were embedded into subcutaneous pouches in beagle dogs for 8 weeks, the outer surfaces of all molds were completely covered with connective tissue to form conduit tissue. In the molds without slits, the leaflet size was limited to half of the design. In contrast, in the mold with slits, the complete leaflet area was formed. Upon trimming excess peripheral tissues, removing the mold, and cutting the connective tissue formed at the slits, completely autologous connective tissue biovalves with the designed leaflet area were obtained as type S (diameter, 6-28 mm) biovalves. The slit structure customized to the mold was effective for allowing cells to enter, thereby facilitating cell migration and contributing to the successful preparation of reliable biovalves of various physiological sizes suitable for all clinical uses.	[Funayama, Marina; Furukoshi, Maya; Moriwaki, Takeshi; Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, Suita, Osaka 5658565, Japan	Funayama, M (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Div Med Engn & Mat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	funayama.marina@ncvc.go.jp; ny@ncvc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	The authors thank Ms. Manami Sone for technical support. This study was funded in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Hayashida K, 2008, J BIOMED MATER RES B, V86B, P1, DOI 10.1002/jbm.b.30981; Nakayama Y, 2009, J BIOMED MATER RES B, V91B, P813, DOI 10.1002/jbm.b.31460; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Stickler P, 2010, ACTA BIOMATER, V6, P2448, DOI 10.1016/j.actbio.2010.01.041; Sripathi VC, 2004, ANN THORAC SURG, V77, P844, DOI 10.1016/S0003-4975(03)01518-2; Mizuno T, 2014, J BIOMED MATER RES B, V102, P1038, DOI 10.1002/jbm.b.33086; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; Takewa Y, 2013, J ARTIF ORGANS, V16, P176, DOI 10.1007/s10047-012-0679-8; Kishi A, 2010, ARTIF ORGANS, V34, P1125, DOI 10.1111/j.1525-1594.2010.00997.x; Funayama M, 2015, J ARTIF ORGANS, DOI [10.1007/s1004701508206, DOI 10.1007/S1004701508206]; Funayama M, 2015, J ARTIF ORGANS, V18, P40, DOI 10.1007/s10047-014-0793-x; Nakayama Y, 2015, J BIOMED MATER RES B, V103, P1, DOI 10.1002/jbm.b.33186	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					382	386		10.1007/s10047-015-0856-7		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900016		
J	Munekage, M; Yatabe, T; Kitagawa, H; Takezaki, Y; Tamura, T; Namikawa, T; Hanazaki, K				Munekage, Masaya; Yatabe, Tomoaki; Kitagawa, Hiroyuki; Takezaki, Yuka; Tamura, Takahiko; Namikawa, Tsutomu; Hanazaki, Kazuhiro			An artificial pancreas provided a novel model of blood glucose level variability in beagles	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Artificial pancreas; Variability of blood glucose level; Beagle	ILL PATIENTS	Although the effects on prognosis of blood glucose level variability have gained increasing attention, it is unclear whether blood glucose level variability itself or the manifestation of pathological conditions that worsen prognosis. Then, previous reports have not been published on variability models of perioperative blood glucose levels. The aim of this study is to establish a novel variability model of blood glucose concentration using an artificial pancreas. We maintained six healthy, male beagles. After anesthesia induction, a 20-G venous catheter was inserted in the right femoral vein and an artificial pancreas (STG-22, Nikkiso Co. Ltd., Tokyo, Japan) was connected for continuous blood glucose monitoring and glucose management. After achieving muscle relaxation, total pancreatectomy was performed. After 1 h of stabilization, automatic blood glucose control was initiated using the artificial pancreas. Blood glucose level varied for 8 h, alternating between the target blood glucose values of 170 and 70 mg/dL. Eight hours later, the experiment was concluded. Total pancreatectomy was performed for 62 +/- A 13 min. Blood glucose swings were achieved 9.8 +/- A 2.3 times. The average blood glucose level was 128.1 +/- A 5.1 mg/dL with an SD of 44.6 +/- A 3.9 mg/dL. The potassium levels after stabilization and at the end of the experiment were 3.5 +/- A 0.3 and 3.1 +/- A 0.5 mmol/L, respectively. In conclusion, the results of the present study demonstrated that an artificial pancreas contributed to the establishment of a novel variability model of blood glucose levels in beagles.	[Munekage, Masaya; Kitagawa, Hiroyuki; Takezaki, Yuka; Namikawa, Tsutomu; Hanazaki, Kazuhiro] Kochi Med Sch, Dept Surg, Nankoku, Kochi 7838505, Japan; [Yatabe, Tomoaki; Tamura, Takahiko] Kochi Med Sch, Dept Anesthesiol & Intens Care Med, Nankoku, Kochi 7838505, Japan	Munekage, M (reprint author), Kochi Med Sch, Dept Surg, Oko Cho, Nankoku, Kochi 7838505, Japan.	m-munekage@kochi-u.ac.jp; yatabe@kochi-u.ac.jp			JSPS KAKENHI [26350504]	This work was supported by JSPS KAKENHI Grant Number 26350504.	Kono T, 2005, ARTIF ORGANS, V29, P83, DOI 10.1111/j.1525-1594.2004.29008.x; Buckley MS, 2010, CRIT CARE MED, V38, pS253, DOI 10.1097/CCM.0b013e3181dda0be; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Yatabe T, 2011, CRIT CARE MED, V39, P575, DOI 10.1097/CCM.0b013e318206b9ad; Yamashita K, 2008, ANESTH ANALG, V106, P160, DOI 10.1213/01.ane.0000296461.26492.3c	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2015	18	4					387	390		10.1007/s10047-015-0854-9		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CX6CN	WOS:000365788900017		
J	Kamio, Y; Haraguchi, H; Stickley, A; Ogino, K; Ishitobi, M; Takahashi, H				Kamio, Yoko; Haraguchi, Hideyuki; Stickley, Andrew; Ogino, Kazuo; Ishitobi, Makoto; Takahashi, Hidetoshi			Brief Report: Best Discriminators for Identifying Children with Autism Spectrum Disorder at an 18-Month Health Check-Up in Japan	JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS			English	Article						Autism spectrum disorder; Screening; Short form; Modified checklist for autism in toddlers (M-CHAT); Primary care settings	PERVASIVE DEVELOPMENTAL DISORDERS; FOLLOW-UP; YOUNG-CHILDREN; M-CHAT; TODDLERS; SCALE; RELIABILITY; VALIDITY; INFANTS; VERSION	To determine the best discriminative items for identifying young children with autism spectrum disorders (ASD), we conducted a secondary analysis using longitudinal cohort data that included the Japanese version of the 23-item modified checklist for autism in toddlers (M-CHAT-JV). M-CHAT-JV data at 18 months of age and diagnostic information evaluated at age 3 or later from 1851 Japanese children was used to isolate six highly discriminative items. Using data from two different community samples (n = 1851, n = 665) these items were shown to have comparable psychometric values with those of the full version. Our results suggest that these items might work as a short form screener for early identification of ASD in primary care settings where there are time constraints on screening.	[Kamio, Yoko; Haraguchi, Hideyuki; Stickley, Andrew; Ogino, Kazuo; Ishitobi, Makoto; Takahashi, Hidetoshi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Stickley, Andrew] Univ Tokyo, Dept Human Ecol, Grad Sch Med, Tokyo, Japan; [Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, Huddinge, Sweden; [Ogino, Kazuo] Tokyo Metropolitan Childrens Med Ctr, Dept Child & Adolescent Psychiat, Fuchu, Tokyo, Japan	Kamio, Y (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878553, Japan.	ykamio@ka2.so-net.ne.jp			RISTEX (Japan Science and Technology Agency) of Japan; Japanese Ministry of Health, Labor, and Welfare [H19-SHOGAI-008]	This work was funded by the RISTEX (Japan Science and Technology Agency) of Japan [Brain-Science and Education FY2004]; and the Japanese Ministry of Health, Labor, and Welfare [H19-SHOGAI-008]. We wish to thank all the participating families and assessment team, especially Naoko Inada, Miho Kuroda, Atsuko Miyake and Honami Yamaguchi for their contributions.	American Academy of Pediatrics Council on Children With Disabilities Section on Developmental and Behavioral Pediatrics, 2006, PEDIATRICS, V119, P1808; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Kleinman JM, 2008, J AUTISM DEV DISORD, V38, P827, DOI 10.1007/s10803-007-0450-9; Inada N, 2010, RES AUTISM SPECT DIS, V4, P605, DOI 10.1016/j.rasd.2009.12.003; Tsuchiya KJ, 2013, J AUTISM DEV DISORD, V43, P643, DOI 10.1007/s10803-012-1606-9; Inada N, 2011, RES AUTISM SPECT DIS, V5, P330, DOI 10.1016/j.rasd.2010.04.016; KURITA H, 1989, J AUTISM DEV DISORD, V19, P389, DOI 10.1007/BF02212937; Wong V, 2004, PEDIATRICS, V114, P166; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606; Kamio Y, 2014, J AUTISM DEV DISORD, V44, P194, DOI 10.1007/s10803-013-1864-1; Pandey J, 2008, AUTISM, V12, P513, DOI 10.1177/1362361308094503; Barton ML, 2012, J AUTISM DEV DISORD, V42, P1165, DOI 10.1007/s10803-011-1343-5; Khowaja MK, 2015, J AUTISM DEV DISORD, V45, P1797, DOI 10.1007/s10803-014-2339-8; Robins DL, 2014, PEDIATRICS, V133, P37, DOI 10.1542/peds.2013-1813; Dietz C, 2006, J AUTISM DEV DISORD, V36, P713, DOI 10.1007/s10803-006-0114-1; Robins DL, 2008, AUTISM, V12, P537, DOI 10.1177/1362361308094502; Stenberg N, 2014, PAEDIATR PERINAT EP, V28, P255, DOI 10.1111/ppe.12114; Chlebowski C, 2013, PEDIATRICS, V131, pE1121, DOI 10.1542/peds.2012-1525; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Koyama T., 2010, ANN REPORT RES SUPPO, P15; Kuroda M., 2013, ANNUAL REPORT OF RES, P31; Robins D. L., 2010, 9 INT M AUT RES PHIL; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Tatsuta N., 2013, J SPECIAL ED RES, V2, P17	24	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0162-3257	1573-3432		J AUTISM DEV DISORD	J. Autism Dev. Disord.	DEC	2015	45	12			SI		4147	4153		10.1007/s10803-015-2527-1		7	Psychology, Developmental	Psychology	CX0WD	WOS:000365417100038		
J	Kuge, T; Teramoto, H; Inui, M				Kuge, Takayuki; Teramoto, Haruhiko; Inui, Masayuki			AraR, an L-Arabinose-Responsive Transcriptional Regulator in Corynebacterium glutamicum ATCC 31831, Exerts Different Degrees of Repression Depending on the Location of Its Binding Sites within the Three Target Promoter Regions	JOURNAL OF BACTERIOLOGY			English	Article							OXYGEN-DEPRIVATION CONDITIONS; BACILLUS-SUBTILIS; IN-VIVO; METABOLIC PATHWAY; ESCHERICHIA-COLI; GENE-EXPRESSION; DNA LOOPS; PROTEIN; OPERATORS; REGULON	In Corynebacterium glutamicum ATCC 31831, a LacI-type transcriptional regulator AraR, represses the expression of L-arabinose catabolism (araBDA), uptake (araE), and the regulator (araR) genes clustered on the chromosome. AraR binds to three sites: one (BSB) between the divergent operons (araBDA and galM-araR) and two (BSE1 and BSE2) upstream of araE. L-Arabinose acts as an inducer of the AraR-mediated regulation. Here, we examined the roles of these AraR-binding sites in the expression of the AraR regulon. BSB mutation resulted in derepression of both araBDA and galM-araR operons. The effects of BSE1 and/or BSE2 mutation on araE expression revealed that the two sites independently function as the cis elements, but BSE1 plays the primary role. However, AraR was shown to bind to these sites with almost the same affinity in vitro. Taken together, the expression of araBDA and araE is strongly repressed by binding of AraR to a single site immediately downstream of the respective transcriptional start sites, whereas the binding site overlapping the -10 or -35 region of the galM-araR and araE promoters is less effective in repression. Furthermore, downregulation of araBDA and araE dependent on L-arabinose catabolism observed in the BSB mutant and the AraR-independent araR promoter identified within galM-araR add complexity to regulation of the AraR regulon derepressed by L-arabinose. IMPORTANCE Corynebacterium glutamicum has a long history as an industrial workhorse for large-scale production of amino acids. An important aspect of industrial microorganisms is the utilization of the broad range of sugars for cell growth and production process. Most C. glutamicum strains are unable to use a pentose sugar L-arabinose as a carbon source. However, genes for L-arabinose utilization and its regulation have been recently identified in C. glutamicum ATCC 31831. This study elucidates the roles of the multiple binding sites of the transcriptional repressor AraR in the derepression by L-arabinose and thereby highlights the complex regulatory feedback loops in combination with L-arabinose catabolism-dependent repression of the AraR regulon in an AraR-independent manner.	[Kuge, Takayuki; Teramoto, Haruhiko; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto, Japan; [Kuge, Takayuki; Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, Kyoto, Japan.	mmg-lab@rite.or.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was financially supported in part by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Kawaguchi H, 2008, APPL MICROBIOL BIOT, V77, P1053, DOI 10.1007/s00253-007-1244-x; Mota LJ, 2001, J BACTERIOL, V183, P4190, DOI 10.1128/JB.183.14.4190-4201.2001; SAHM H, 1995, FEMS MICROBIOL REV, V16, P243; Sasaki M, 2008, APPL MICROBIOL BIOT, V81, P691, DOI 10.1007/s00253-008-1703-z; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; Marushima K, 2009, J BACTERIOL, V191, P5930, DOI 10.1128/JB.00703-09; Semsey S, 2002, EMBO J, V21, P4349, DOI 10.1093/emboj/cdf431; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Bothast RJ, 1999, BIOTECHNOL PROGR, V15, P867, DOI 10.1021/bp990087w; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; KATZ L, 1971, J BACTERIOL, V107, P34; Okibe N, 2011, J MICROBIOL METH, V85, P155, DOI 10.1016/j.mimet.2011.02.012; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Kuge T, 2014, J BACTERIOL, V196, P2242, DOI 10.1128/JB.01655-14; Elander RT, 2009, CELLULOSE, V16, P649, DOI 10.1007/s10570-009-9308-y; TULLIUS TD, 1985, SCIENCE, V230, P679, DOI 10.1126/science.2996145; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3128.2006; JOHNSON CM, 1995, J BACTERIOL, V177, P3438; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; RHODES D, 1980, NATURE, V286, P573, DOI 10.1038/286573a0; Okino S, 2005, APPL MICROBIOL BIOT, V68, P475, DOI 10.1007/s00253-005-1900-y; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Kawaguchi H, 2009, APPL ENVIRON MICROB, V75, P3419, DOI 10.1128/AEM.02912-08; Sasaki M, 2009, APPL MICROBIOL BIOT, V85, P105, DOI 10.1007/s00253-009-2065-x; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Franco IS, 2007, NUCLEIC ACIDS RES, V35, P4755, DOI 10.1093/nar/gkm509; Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Fritz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089532; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Jojima T, 2013, CORYNEBACTERIUM GLUT, V23, P149; Miller J. H., 1972, EXPT MOL GENETICS; Teramoto H, 2013, CORYNEBACTERIUM GLUT, V23, P263; Yukawa H., 2007, AMINO ACID BIOSYNTHE, V5, P349, DOI [10.1007/7171_2006_066, DOI 10.1007/7171_2006_066]	37	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	DEC	2015	197	24					3788	3796		10.1128/JB.00314-15		9	Microbiology	Microbiology	CX3TX	WOS:000365623400006		
J	Nakai, R				Nakai, Ryo			Comparative politics and government of the Baltic states: Estonia, Latvia and Lithuania in the 21st century	JOURNAL OF BALTIC STUDIES			English	Book Review									[Nakai, Ryo] Rikkyo Univ, Tokyo 171, Japan	Nakai, R (reprint author), Rikkyo Univ, Tokyo 171, Japan.						AUERS D, 2015, COMP POLITICS GOVT B	1	0	0	ASSOC ADVANCEMENT BALTIC STUDIES INC	PORTLAND	3465 EAST BURNSIDE ST, PORTLAND, OR 97214-2050 USA	0162-9778	1751-7877		J BALTIC STUD	J. Baltic Stud.	DEC	2015	46	4					545	547				3	Area Studies; Humanities, Multidisciplinary	Area Studies; Arts & Humanities - Other Topics	CX7QB	WOS:000365896000008		
J	Sun, L; Nakamae, N; Ichikawa, N				Sun, Li; Nakamae, Naomi; Ichikawa, Naoki			The region from phenylalanine-28 to lysine-50 of a yeast mitochondrial ATPase inhibitor (IF1) forms an alpha-helix in solution	JOURNAL OF BIOENERGETICS AND BIOMEMBRANES			English	Article						ATP synthase; Mitochondrial ATPase inhibitor (IF1); Proline scanning mutagenesis; Alpha helix	PROLINE SCANNING MUTAGENESIS; ADENOSINE-TRIPHOSPHATASE; BOVINE IF1; PROTEIN; F-1-ATPASE; SEQUENCE; OVEREXPRESSION; PURIFICATION; SYNTHASE; SUBUNIT	A mitochondrial ATPase inhibitor, IF1, is a 63 amino acid residue protein that regulates the activity of ATP synthase (F1Fo-ATPase). In the present study, we constructed mutant IF1 proteins with proline residues inserted into a wide range of their primary structures to determine the location and function of alpha-helix in the protein. A total of 11 yeast IF1 protein mutants were expressed and purified. Proline insertions in the region 28-50 reduced alpha-helical contents, indicating that the region formed a helix in solution. Oligomer formation of proline mutants at the C-terminal 38-60 region was markedly reduced, indicating that the region is required for oligomerization of the protein. Proline mutants at the N-terminal 18-39 region did not inhibit F1Fo-ATPase, indicating that the region is required for ATPase inhibitory activity. Inhibition of a proline insertion mutant between residues 44 and 45 that lost a large portion of the alpha-helix was slower, although the maximal inhibition level of the mutant protein was comparable to that of wild-type IF1. The results suggest that the helix of yeast IF1 facilitates binding to F-1 by promoting initial interaction of the proteins.	[Sun, Li; Nakamae, Naomi; Ichikawa, Naoki] Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Sumiyoshi Ku, Osaka 5588585, Japan	Ichikawa, N (reprint author), Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	ichikawa@life.osaka-cu.ac.jp					Ichikawa N, 2006, J BIOENERG BIOMEMBR, V38, P93, DOI 10.1007/s10863-006-9009-2; Ando C, 2008, J BIOCHEM, V144, P547, DOI 10.1093/jb/mvn100; LEBOWITZ MS, 1993, ARCH BIOCHEM BIOPHYS, V301, P64, DOI 10.1006/abbi.1993.1115; Ichikawa N, 2004, PROTEIN EXPRES PURIF, V37, P97, DOI 10.1016/j.pep.2004.06.002; ICHIKAWA N, 1990, J BIOL CHEM, V265, P6274; Schulman BA, 1996, NAT STRUCT BIOL, V3, P682, DOI 10.1038/nsb0896-682; KLEIN G, 1980, BIOCHEMISTRY-US, V19, P2919, DOI 10.1021/bi00554a016; Ichikawa N, 2001, J BIOCHEM-TOKYO, V130, P687; Gordon-Smith DJ, 2001, J MOL BIOL, V308, P325, DOI 10.1006/jmbi.2001.4570; Ichikawa N, 1999, BIOSCI BIOTECH BIOCH, V63, P2225, DOI 10.1271/bbb.63.2225; Ichikawa N, 1998, J BIOCHEM-TOKYO, V124, P886; VANHEEKE G, 1993, BIOCHEMISTRY-US, V32, P10140, DOI 10.1021/bi00089a033; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Ichikawa N, 2003, J BIOENERG BIOMEMBR, V35, P399, DOI 10.1023/A:1027383629565; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Allen RJL, 1940, BIOCHEM J, V34, P858; Zanotti F, 2004, J BIOENERG BIOMEMBR, V36, P447, DOI 10.1023/B:JOBB.0000047327.68173.9b; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Nakagawa K, 2006, BIOCHEMISTRY-US, V45, P15468, DOI 10.1021/bi061420p; Bason JV, 2014, P NATL ACAD SCI USA, V111, P11305, DOI 10.1073/pnas.1411560111; Robinson GC, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120164; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; MATSUBARA H, 1981, J BIOCHEM-TOKYO, V90, P1159; Ichikawa N, 2002, J BIOCHEM, V132, P649; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P61; LOWRY OH, 1951, J BIOL CHEM, V193, P265	29	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0145-479X	1573-6881		J BIOENERG BIOMEMBR	J. Bioenerg. Biomembr.	DEC	2015	47	6					457	465		10.1007/s10863-015-9627-7		9	Biophysics; Cell Biology	Biophysics; Cell Biology	CX1GA	WOS:000365443300003		
J	Takeuchi, K; Arthanari, H; Shimada, I; Wagner, G				Takeuchi, Koh; Arthanari, Haribabu; Shimada, Ichio; Wagner, Gerhard			Nitrogen detected TROSY at high field yields high resolution and sensitivity for protein NMR	JOURNAL OF BIOMOLECULAR NMR			English	Article						Nitrogen detection; TROSY; High field magnet; Protein NMR; Amide back exchange; Deuteration	ALPHA DIRECT-DETECTION; BIOLOGICAL MACROMOLECULES; RESONANCE ASSIGNMENTS; SPECTROSCOPY; RELAXATION; INFORMATION; EXPRESSION; COUPLINGS; SEQUENCE; DYNAMICS	Detection of N-15 in multidimensional NMR experiments of proteins has sparsely been utilized because of the low gyromagnetic ratio (gamma) of nitrogen and the presumed low sensitivity of such experiments. Here we show that selecting the TROSY components of proton-attached N-15 nuclei (TROSY N-15(H)) yields high quality spectra in high field magnets (> 600 MHz) by taking advantage of the slow N-15 transverse relaxation and compensating for the inherently low N-15 sensitivity. The N-15 TROSY transverse relaxation rates increase modestly with molecular weight but the TROSY gain in peak heights depends strongly on the magnetic field strength. Theoretical simulations predict that the narrowest line width for the TROSY N-15(H) component can be obtained at 900 MHz, but sensitivity reaches its maximum around 1.2 GHz. Based on these considerations, a N-15-detected 2D H-1-N-15 TROSY-HSQC (N-15-detected TROSY-HSQC) experiment was developed and high-quality 2D spectra were recorded at 800 MHz in 2 h for 1 mM maltose-binding protein at 278 K (tau(c) similar to 40 ns). Unlike for H-1 detected TROSY, deuteration is not mandatory to benefit N-15 detected TROSY due to reduced dipolar broadening, which facilitates studies of proteins that cannot be deuterated, especially in cases where production requires eukaryotic expression systems. The option of recording N-15 TROSY of proteins expressed in H2O media also alleviates the problem of incomplete amide proton back exchange, which often hampers the detection of amide groups in the core of large molecular weight proteins that are expressed in D2O culture media and cannot be refolded for amide back exchange. These results illustrate the potential of N-15(H)-detected TROSY experiments as a means to exploit the high resolution offered by high field magnets near and above 1 GHz.	[Takeuchi, Koh; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350063, Japan; [Takeuchi, Koh] JST, PRESTO, Tokyo 1350063, Japan; [Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, Boston, MA 02115 USA; [Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Shimada, I (reprint author), Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350063, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp; gerhard_wagner@hms.harvard.edu			NIH [GM047467, AI37581, EB002026]; METI; JST, PRESTO	This work was supported by NIH Grants GM047467 and AI37581 to GW and by METI (Grant Name: development of core technologies for innovative drug development based upon IT) to IS. This work was also partly supported by JST, PRESTO to KT. Maintenance of NMR instruments was in part supported by NIH grant EB002026. We would like thanks Dominique Frueh, Wolfgang Bermel and Arthur Palmer for useful discussions. We would like to thank Ms. Misaki Imai for making the protein samples used in the paper.	Balayssac S, 2006, J AM CHEM SOC, V128, P15042, DOI 10.1021/ja0645436; Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b; Takeuchi K, 2010, J AM CHEM SOC, V132, P2945, DOI 10.1021/ja907717b; Hsu STD, 2009, J AM CHEM SOC, V131, P7222, DOI 10.1021/ja902307q; Gal M, 2011, J BIOMOL NMR, V51, P497, DOI 10.1007/s10858-011-9580-7; Banci L, 2004, J BIOMOL NMR, V28, P249, DOI 10.1023/B:JNMR.0000013703.30623.f7; Lohr F, 2003, J BIOMOL NMR, V25, P291, DOI 10.1023/A:1023084605308; Felli IC, 2009, CHEMPHYSCHEM, V10, P1356, DOI 10.1002/cphc.200900133; Vasos PR, 2006, J BIOMOL NMR, V36, P27, DOI 10.1007/s10858-006-9063-4; Keizers PHJ, 2007, J AM CHEM SOC, V129, P9292, DOI 10.1021/ja0725201; Morgan WD, 2000, J BIOMOL NMR, V17, P337, DOI 10.1023/A:1008313530207; Pervushin K, 2000, Q REV BIOPHYS, V33, P161, DOI 10.1017/S0033583500003619; Kupce E, 2003, PROG NUCL MAG RES SP, V42, P95, DOI 10.1016/S0079-6565(03)00022-0; Lee D, 2005, J BIOMOL NMR, V31, P273, DOI 10.1007/s10858-005-2361-4; PENG JW, 1991, J MAGN RESON, V95, P421, DOI 10.1016/0022-2364(91)90233-J; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Miyazawa-Onami M, 2013, J BIOMOL NMR, V57, P297, DOI 10.1007/s10858-013-9789-8; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Serber Z, 2001, CHEMBIOCHEM, V2, P247, DOI 10.1002/1439-7633(20010401)2:4<247::AID-CBIC247>3.3.CO;2-M; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Bermel W, 2003, J AM CHEM SOC, V125, P16423, DOI 10.1021/ja037676p; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Gardner KH, 1998, J AM CHEM SOC, V120, P11738, DOI 10.1021/ja982019w; Allen KN, 2010, CURR OPIN CHEM BIOL, V14, P247, DOI 10.1016/j.cbpa.2010.01.004; FUJIWARA T, 1988, J MAGN RESON, V77, P53, DOI 10.1016/0022-2364(88)90031-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Sastry M, 2011, J BIOMOL NMR, V50, P197, DOI 10.1007/s10858-011-9506-4; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; Bermel W, 2006, PROG NUCL MAG RES SP, V48, P25, DOI 10.1016/j.pnmrs.2005.09.002; Schanda P, 2006, J MAGN RESON, V178, P334, DOI 10.1016/j.jmr.2005.10.007; BOHLEN JM, 1993, J MAGN RESON SER A, V102, P293, DOI 10.1006/jmra.1993.1107; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Rovnyak D, 2004, J BIOMOL NMR, V30, P1, DOI 10.1023/B:JNMR.0000042946.04002.19; INAGAKI F, 1980, PROG NUCL MAG RES SP, V14, P67, DOI 10.1016/0079-6565(80)80004-5; Takeuchi K, 2010, J BIOMOL NMR, V47, P271, DOI 10.1007/s10858-010-9430-z; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Takeuchi K, 2008, J AM CHEM SOC, V130, P17210, DOI 10.1021/ja806956p; Kofuku Y, 2014, ANGEW CHEM INT EDIT, V53, P13376, DOI 10.1002/anie.201406603; Levy G. C., 1979, NITROGEN 15 NUCL MAG; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; Takeuchi K, 2012, RECENT DEV BIOMOLECU	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	DEC	2015	63	4					323	331		10.1007/s10858-015-9991-y		9	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CX6CT	WOS:000365789500001		
J	Yoshiura, C; Ueda, T; Kofuku, Y; Matsumoto, M; Okude, J; Kondo, K; Shiraishi, Y; Shimada, I				Yoshiura, Chie; Ueda, Takumi; Kofuku, Yutaka; Matsumoto, Masahiko; Okude, Junya; Kondo, Keita; Shiraishi, Yutaro; Shimada, Ichio			Elucidation of the CCR1-and CCR5-binding modes of MIP-1 alpha by application of an NMR spectra reconstruction method to the transferred cross-saturation experiments	JOURNAL OF BIOMOLECULAR NMR			English	Article						Membrane proteins; G-protein coupled receptors; Transferred cross-saturation; Nanodiscs; Sparse sampling; Surface plasmon resonance	CCR5 BINDING; CHEMOKINE; RECEPTOR; MIP-1-BETA; ACTIVATION; REDUNDANCY; COMPLEX	C-C chemokine receptor 1 (CCR1) and CCR5 are involved in various inflammation and immune responses, and regulate the progression of the autoimmune diseases differently. However, the number of residues identified at the binding interface was not sufficient to clarify the differences in the CCR1- and CCR5-binding modes to MIP-1 alpha, because the NMR measurement time for CCR1 and CCR5 samples was limited to 24 h, due to their low stability. Here we applied a recently developed NMR spectra reconstruction method, Conservation of experimental data in ANAlysis of FOuRier, to the amide-directed transferred cross-saturation experiments of chemokine receptors, CCR1 and CCR5, embedded in lipid bilayers of the reconstituted high density lipoprotein, and MIP-1 alpha. Our experiments revealed that the residues on the N-loop and beta-sheets of MIP-1 alpha are close to both CCR1 and CCR5, and those in the C-terminal helix region are close to CCR5. These results suggest that the genetic influence of the single nucleotide polymorphisms of MIP-1 alpha that accompany substitution of residues in the C-terminal helix region, E57 and V63, would provide clues toward elucidating how the CCR5-MIP-1 alpha interaction affects the progress of autoimmune diseases.	[Yoshiura, Chie; Ueda, Takumi; Kofuku, Yutaka; Matsumoto, Masahiko; Okude, Junya; Kondo, Keita; Shiraishi, Yutaro; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ueda, Takumi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Matsumoto, Masahiko] Japan Biol Informat Consortium, Koto Ku, Tokyo 1358073, Japan	Shimada, I (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI)	We are grateful to Drs. Masanori Osawa, Noritaka Nishida, and Koh Takeuchi for their helpful advice. This work was supported by a grant from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade and Industry (METI).	Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Laurence JS, 2001, BIOCHEMISTRY-US, V40, P4990, DOI 10.1021/bi002593w; Bondue A, 2002, BIOCHEMISTRY-US, V41, P13548, DOI 10.1021/bi026087d; Ueda T, 2014, Q REV BIOPHYS, V47, P143, DOI 10.1017/S0033583514000043; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Proudfoot AEI, 2010, EXPERT OPIN INV DRUG, V19, P345, DOI 10.1517/13543780903535867; Mahad DJ, 2004, J NEUROPATH EXP NEUR, V63, P262; Modi WS, 2006, AM J HUM GENET, V79, P120, DOI 10.1086/505331; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; O'Hayre M, 2010, EXPERT OPIN DRUG DIS, V5, P1109, DOI 10.1517/17460441.2010.525633; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f; Ueda T, 2015, J BIOMOL NMR, V62, P31, DOI 10.1007/s10858-015-9908-9; Devalaraja MN, 1999, TRENDS PHARMACOL SCI, V20, P151, DOI 10.1016/S0165-6147(99)01342-5; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	DEC	2015	63	4					333	340		10.1007/s10858-015-9992-x		8	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CX6CT	WOS:000365789500002		
J	Konuma, T; Harada, E; Sugase, K				Konuma, Tsuyoshi; Harada, Erisa; Sugase, Kenji			Extracting protein dynamics information from overlapped NMR signals using relaxation dispersion difference NMR spectroscopy	JOURNAL OF BIOMOLECULAR NMR			English	Article						Protein dynamics; Relaxation dispersion difference; Overlapped signal; Heme oxygenase-1	HUMAN HEME OXYGENASE-1; CHARACTERIZING CHEMICAL-EXCHANGE; ENZYME CATALYSIS; SH3 DOMAIN; STATES; PEROXIDASE; SEQUENCE; MOTIONS; BINDING	Protein dynamics plays important roles in many biological events, such as ligand binding and enzyme reactions. NMR is mostly used for investigating such protein dynamics in a site-specific manner. Recently, NMR has been actively applied to large proteins and intrinsically disordered proteins, which are attractive research targets. However, signal overlap, which is often observed for such proteins, hampers accurate analysis of NMR data. In this study, we have developed a new methodology called relaxation dispersion difference that can extract conformational exchange parameters from overlapped NMR signals measured using relaxation dispersion spectroscopy. In relaxation dispersion measurements, the signal intensities of fluctuating residues vary according to the Carr-Purcell-Meiboon-Gill pulsing interval, whereas those of non-fluctuating residues are constant. Therefore, subtraction of each relaxation dispersion spectrum from that with the highest signal intensities, measured at the shortest pulsing interval, leaves only the signals of the fluctuating residues. This is the principle of the relaxation dispersion difference method. This new method enabled us to extract exchange parameters from overlapped signals of heme oxygenase-1, which is a relatively large protein. The results indicate that the structural flexibility of a kink in the heme-binding site is important for efficient heme binding. Relaxation dispersion difference requires neither selectively labeled samples nor modification of pulse programs; thus it will have wide applications in protein dynamics analysis.	[Konuma, Tsuyoshi; Harada, Erisa; Sugase, Kenji] Suntory Fdn Life Sci, Bioorgan Res Inst, Mishima, Osaka 6188503, Japan	Sugase, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	sugase@sunbor.or.jp			MEXT of Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas for K. S. and a Grant-in-Aid for Young Scientists (B) for T. K. from the MEXT of Japan.	Sugase K, 2007, J AM CHEM SOC, V129, P13406, DOI 10.1021/ja0762238; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Gutmanas A, 2004, J MAGN RESON, V167, P107, DOI 10.1016/j.jmr.2003.12.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Sugase K, 2013, J BIOMOL NMR, V56, P275, DOI 10.1007/s10858-013-9747-5; Harada E, 2015, BIOMOL NMR ASSIGN, V9, P197, DOI 10.1007/s12104-014-9573-z; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/nchembio.1202, 10.1038/NCHEMBIO.1202]; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Angulo J, 2011, EUR BIOPHYS J BIOPHY, V40, P1357, DOI 10.1007/s00249-011-0749-5; Matsuki Y, 2011, J PHYS CHEM B, V115, P13740, DOI 10.1021/jp2081116; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Tugarinov V, 2004, J BIOMOL NMR, V30, P347, DOI 10.1007/s10858-005-1549-y; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Harada E, 2015, BIOCHEMISTRY-US, V53, P340; Popovic M, 2015, PROTEIN SCI, V4, P996	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	DEC	2015	63	4					367	373		10.1007/s10858-015-9995-7		7	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CX6CT	WOS:000365789500005		
J	Wakabayashi, H; Matsushima, M; Uwano, R; Watanabe, N; Oritsu, H; Shimizu, Y				Wakabayashi, Hidetaka; Matsushima, Masato; Uwano, Rimiko; Watanabe, Naoko; Oritsu, Hideyuki; Shimizu, Yoshitaka			Skeletal muscle mass is associated with severe dysphagia in cancer patients	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Article						Sarcopenia; Carcinoma; Sarcopenic dysphagia; Rehabilitation; Nutrition	OLDER-ADULTS; SARCOPENIC DYSPHAGIA; SWALLOWING FUNCTION; NUTRITIONAL-STATUS; PREVALENCE; REHABILITATION; MALNUTRITION; IMPACT; HEAD; COMPLICATIONS	Background The purpose of this study was to assess the association between skeletal muscle mass, activities of daily living (ADLs) and severe dysphagia in cancer patients. Methods A nested case-control study was performed in 111 consecutive cancer patients with dysphagia who were prescribed speech therapy. Skeletal muscle mass comprising the cross-sectional area of the left and right psoas muscles was assessed via abdominal computed tomography at the third lumbar vertebral level. ADLs were evaluated by the Barthel Index. The severity of dysphagia was assessed by the Food Intake Level Scale and was characterized by non-oral feeding or oral food intake at discharge. Univariate and logistic regression analyses were applied to examine the associations between dysphagia, skeletal muscle index (SMI) and ADLs. Results There were 86 men and 25 women (mean age, 70 years). The mean SMI was 5.68 +/- 1.74 cm(2)/m(2) in men and 4.43 +/- 1.21 cm(2)/m(2) in women. The median Barthel Index score was 20. Thirty-three patients were on non-oral feeding at discharge. The mean SMI did not differ significantly between non-oral feeding and oral food intake groups in t-test. The median Barthel Index score was lower in the non-oral feeding group in Mann-Whitney U test. Logistic regression analysis of the severity of dysphagia adjusted for age, sex, SMI, Barthel Index score, serum albumin, cancer type and stage, and vocal cord paralysis showed that SMI was associated independently with oral food intake at discharge. Barthel Index score showed a tendency to be associated with oral food intake. Conclusions Skeletal muscle mass is associated with severe dysphagia in cancer patients. ADLs show a tendency to be associated with severe dysphagia in cancer patients.	[Wakabayashi, Hidetaka; Uwano, Rimiko; Watanabe, Naoko; Oritsu, Hideyuki; Shimizu, Yoshitaka] Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami Ward, Yokohama, Kanagawa 2320024, Japan; [Wakabayashi, Hidetaka; Matsushima, Masato] Jikei Univ, Sch Med, Div Clin Epidemiol, Minato Ward, Tokyo 1050003, Japan	Wakabayashi, H (reprint author), Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami Ward, 4-57 Urafune Chou, Yokohama, Kanagawa 2320024, Japan.	noventurenoglory@gmail.com			Ministry of Education, Science, Culture, Sports, Science, and Technology of Japan [25350611]	This work was supported by a research Grant-in-Aid for Scientific Research C (no. 25350611) from the Ministry of Education, Science, Culture, Sports, Science, and Technology of Japan.	Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Otsuji H, 2015, WORLD J SURG, V39, P1494, DOI 10.1007/s00268-015-2988-6; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI [10.1016/S1470-2045(10)70218-7, 10.1016/51470-2045(10)70218-7]; Cabre M, 2010, AGE AGEING, V39, P39, DOI 10.1093/ageing/afp100; Denaro N, 2013, CLIN EXP OTORHINOLAR, V6, P117, DOI 10.3342/ceo.2013.6.3.117; Garcia-Peris P, 2007, CLIN NUTR, V26, P710, DOI 10.1016/j.clnu.2007.08.006; Shiozu H, 2015, J PHYS THER SCI, V27, P393, DOI 10.1589/jpts.27.393; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Wakabayashi H, 2015, GERIATR GERONTOL INT, V15, P410, DOI 10.1111/ggi.12283; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Heymsfield SB, 2014, J CACHEXIA SARCOPENI, V5, P9, DOI 10.1007/s13539-014-0130-5; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Hudson HM, 2000, DYSPHAGIA, V15, P31; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; Kortebein P, 2009, AM J PHYS MED REHAB, V88, P66, DOI 10.1097/PHM.0b013e3181838f70; Kojima A, 2014, AURIS NASUS LARYNX, V41, P294, DOI 10.1016/j.anl.2013.12.009; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Feng X, 2013, J GERONTOL A-BIOL, V68, P853, DOI 10.1093/gerona/gls225; Carrion S, 2014, CLIN NUTR, V34, P436; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Grant M M, 1995, Semin Oncol Nurs, V11, P266, DOI 10.1016/S0749-2081(05)80007-5; Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x; Jones KI, 2015, COLORECTAL DIS, V17, pO20, DOI 10.1111/codi.12805; Kuroda Y, 2014, INT J SPEECH-LANG PA, V2, P20; Maeda K, 2015, GERIATR GERONTOL INT, DOI [10.1111/ggi.12486, DOI 10.1111/GGI.12486]; Maeda K, 2015, DYSPHAGIA, V30, P80, DOI 10.1007/s00455-014-9577-y; MAHONEY F I, 1965, Md State Med J, V14, P61; Psutka SP, 2014, CANCER-AM CANCER SOC, V120, P2910, DOI 10.1002/cncr.28798; Rubenstein LZ, 2001, J GERONTOL A-BIOL, V56, pM366; Sobin L, 2009, TNM CLASSIFICATION M; VELDEE M S, 1992, Dysphagia, V7, P86, DOI 10.1007/BF02493439; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; Wakabayashi H., 2014, J FRAILTY AGING, V3, P97; Wakabayashi H, 2014, J CACHEXIA SARCOPENI, V5, P269, DOI 10.1007/s13539-014-0162-x; Wakabayashi H, 2015, J NUTR HEALTH AGING, DOI [10.1007/s12603-015-0481-4, DOI 10.1007/S12603-015-0481-4]; Wakabayashi H, 2011, GEN MED, V12, P69; Wakabayashi H, 2014, J REHABIL MED, V46, P277, DOI 10.2340/16501977-1258; Zalite I. O., 2015, Pancreatology, V15, P19, DOI 10.1016/j.pan.2014.11.006	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Caxhexia Sarcopenia Muscle	DEC	2015	6	4					351	357		10.1002/jcsm.12052		7	Medicine, General & Internal	General & Internal Medicine	CX2OP	WOS:000365536800013		
J	Hatanaka, M; Konishi, M; Ishida, J; Saito, M; Springer, J; Hatanaka, M				Hatanaka, Michiyoshi; Konishi, Masaaki; Ishida, Junnichi; Saito, Masakazu; Springer, Jochen; Hatanaka, Michiyoshi			Novel mechanism of ghrelin therapy for cachexia	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Letter									[Hatanaka, Michiyoshi; Konishi, Masaaki; Ishida, Junnichi; Saito, Masakazu; Springer, Jochen] Univ Med Ctr Gottingen UMG, Dept Cardiol & Pneumol, Innovat Clin Trials, Gottingen, Germany; [Hatanaka, Michiyoshi] Shionogi & Co Ltd, Discovery Res Lab Innovat Frontier Med, Osaka, Japan	Hatanaka, M (reprint author), Univ Med Ctr Gottingen UMG, Dept Cardiol & Pneumol, Innovat Clin Trials, Gottingen, Germany.	michiyoshi.hatanaka@shionogi.co.jp					Muller TD, 2010, J CACHEXIA SARCOPENI, V1, P159, DOI 10.1007/s13539-010-0012-4; Lenk K, 2013, J CACHEXIA SARCOPENI, V4, P63, DOI 10.1007/s13539-012-0085-3; Bourdel-Marchasson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108687; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Jose M, 2015, LANCET ONCOL, V16, P108; Kangawa K, 2010, J CACHEXIA SARCOPENI, V5, P261; Palus S, 2014, J CACHEXIA SARCOPENI, V5, P193, DOI 10.1007/s13539-014-0157-7; Pietra C, 2014, J CACHEXIA SARCOPENI, V5, P329, DOI 10.1007/s13539-014-0159-5; Sakai H, 2014, TOXICOL APPL PHARM, V278, P190, DOI 10.1016/j.taap.2014.05.001; Temel J, 2013, J CACHEXIA SARCOPENI, V4, P334, DOI [10.1007/s13539-013-0123-9, DOI 10.1007/S13539-013-0123-9]	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Caxhexia Sarcopenia Muscle	DEC	2015	6	4					393	393		10.1002/jcsm.12084		1	Medicine, General & Internal	General & Internal Medicine	CX2OP	WOS:000365536800018		
J	Okamura, T; Okada, M; Kikuchi, T; Wakizaka, H; Zhang, MR				Okamura, Toshimitsu; Okada, Maki; Kikuchi, Tatsuya; Wakizaka, Hidekatsu; Zhang, Ming-Rong			A C-11-labeled 1,4-dihydroquinoline derivative as a potential PET tracer for imaging of redox status in mouse brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						apocynin; dihydroquinoline; positron emission tomography; quinolinium cation; redox status	LONG-TERM POTENTIATION; OXIDATIVE STRESS; NADPH OXIDASE; IN-VIVO; SUPEROXIDE; DELIVERY; MICE; DIPHENYLENEIODONIUM; NEURODEGENERATION; CARDIOMYOPATHY	A disturbance in redox balance has been implicated in the pathogenesis of a number of diseases. This study sought to examine the feasibility of imaging brain redox status using a C-11-labeled dihydroquinoline derivative ([C-11]DHQ1) for positron emission tomography (PET). The lipophilic PET tracer [C-11]DHQ1 was rapidly oxidized to its hydrophilic form in mouse brain homogenate. The redox modulators diphenyleneiodonium and apocynin significantly reduced the initial velocity of [11C]DHQ1 oxidation, and apocynin also caused concentration-dependent inhibition of the initial velocity. Moreover, [C-11]DHQ1 readily entered the brain by diffusion after administration and underwent oxidation into the hydrophilic cationic form, which then slowly decreased. By contrast, apocynin treatment inhibited the in vivo oxidation of [C-11]DHQ1 to the hydrophilic cationic form, leading to a rapid decrease of radioactivity in the brain. Thus, the difference in the [C-11]DHQ1 kinetics reflects the alteration in redox status caused by apocynin. In conclusion, [C-11]DHQ1 is a potential PET tracer for imaging of redox status in the living brain.	[Okamura, Toshimitsu; Okada, Maki; Kikuchi, Tatsuya; Wakizaka, Hidekatsu; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan	Okamura, T (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	okamura@fml.nirs.go.jp			JSPS [25461895]	This work was partially supported by JSPS KAKENHI (25461895).	SUZUKI K, 1985, INT J APPL RADIAT IS, V36, P971, DOI 10.1016/0020-708X(85)90258-3; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066; Riganti C, 2006, TOXICOL APPL PHARM, V212, P179, DOI 10.1016/j.taap.2005.07.011; Thiels E, 2000, J NEUROSCI, V20, P7631; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U; Abe K, 2014, J CEREBR BLOOD F MET, V34, P1907, DOI 10.1038/jcbfm.2014.160; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Gao HM, 2003, J NEUROSCI, V23, P6181; Wang Q, 2006, BRAIN RES, V1090, P182, DOI 10.1016/j.brainres.2006.03.060; BODOR N, 1983, SCIENCE, V221, P65, DOI 10.1126/science.6857264; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; BREWSTER ME, 1989, J ORG CHEM, V54, P3721, DOI 10.1021/jo00276a039; PALOMINO E, 1989, J MED CHEM, V32, P622, DOI 10.1021/jm00123a020; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Bodor N, 2002, J DRUG TARGET, V10, P63, DOI 10.1080/1061186029000754; Klann E, 1998, J NEUROPHYSIOL, V80, P452; Droge W, 2002, PHYSIOL REV, V82, P47; STUEHR DJ, 1991, FASEB J, V5, P98; Chu WH, 2014, ORG BIOMOL CHEM, V12, P4421, DOI 10.1039/c3ob42379d; Nakamura M, 2012, CIRC RES, V111, P604, DOI 10.1161/CIRCRESAHA.111.247924; Lull ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020153; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Sies H, 1985, OXIDATIVE STRESS, P1	26	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2015	35	12					1930	1936		10.1038/jcbfm.2015.132		7	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CX7OI	WOS:000365891300004		
J	Suzuki, Y; Nagai, N; Yamakawa, K; Muranaka, Y; Hokamura, K; Umemura, K				Suzuki, Yasuhiro; Nagai, Nobuo; Yamakawa, Kasumi; Muranaka, Yoshinori; Hokamura, Kazuya; Umemura, Kazuo			Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain ischemia; endothelial endocytosis; tissue-type plasminogen activator; vascular endothelial growth factor; vascular permeability	RECEPTOR-RELATED PROTEIN; ARTERY OCCLUSION MODEL; LIPOPROTEIN RECEPTOR; SIGNALING PATHWAY; TPA; CELLS; ACCUMULATION; MODULATION; HEMORRHAGE; CROSSES	Recombinant tissue-type plasminogen activator (rt-PA) modulates cerebrovascular permeability and exacerbates brain injury in ischemic stroke, but its mechanisms remain unclear. We studied the involvement of vascular endothelial growth factor (VEGF)mediated endocytosis in the increase of blood-brain barrier (BBB) permeability potentiated by rt-PA after ischemic stroke. The rt-PA treatment at 4 hours after middle cerebral artery occlusion induced a transient increase in BBB permeability after ischemic stroke in mice, which was suppressed by antagonists of either low-density lipoprotein receptor families (LDLRs) or VEGF receptor-2 (VEGFR-2). In immortalized bEnd. 3 endothelial cells, rt-PA treatment upregulated VEGF expression and VEGFR-2 phosphorylation under ischemic conditions in an LDLR-dependent manner. In addition, rt-PA treatment increased endocytosis and transcellular transport in bEnd. 3 monolayers under ischemic conditions, which were suppressed by the inhibition of LDLRs, VEGF, or VEGFR-2. The rt-PA treatment also increased the endocytosis of endothelial cells in the ischemic brain region after stroke in mice. These findings indicate that rt-PA increased BBB permeability via induction of VEGF, which at least partially mediates subsequent increase in endothelial endocytosis. Therefore, inhibition of VEGF induction may have beneficial effects after thrombolytic therapy with rt-PA treatment after stroke.	[Suzuki, Yasuhiro] Ohu Univ, Sch Pharmaceut Sci, Koriyama, Fukushima 9638611, Japan; [Suzuki, Yasuhiro; Yamakawa, Kasumi; Hokamura, Kazuya; Umemura, Kazuo] Hamamatsu Univ Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4313192, Japan; [Nagai, Nobuo] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Anim Biosci, Nagahama, Japan; [Muranaka, Yoshinori] Hamamatsu Univ Sch Med, Ultrastruct Lab, Res Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan	Suzuki, Y (reprint author), Ohu Univ, Sch Pharmaceut Sci, 31-1 Misumido,Tomita Machi, Koriyama, Fukushima 9638611, Japan.	ya-suzuki@pha.ohu-u.ac.jp			JSPS [23790289]	This study was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) Number 23790289 to YS.	Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Dwyer J, 2011, ONCOGENE, V30, P190, DOI 10.1038/onc.2010.411; Lopez-Atalaya JP, 2007, STROKE, V38, P1036, DOI 10.1161/01.STR.0000258100.04923.84; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Ho VC, 2012, CIRCULATION, V126, P741, DOI 10.1161/CIRCULATIONAHA.112.091603; Nicole O, 2001, NAT MED, V7, P59; Suzuki Y, 2007, J THROMB HAEMOST, V5, P1732, DOI 10.1111/j.1538-7836.2007.02628.x; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; HERZ J, 1988, EMBO J, V7, P4119; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017; Suzuki Y, 2002, BRAIN RES, V945, P242, DOI 10.1016/S0006-8993(02)02806-8; Suzuki Y, 2011, BLOOD, V118, P3182, DOI 10.1182/blood-2011-05-353912; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Cai XF, 2006, J NAT PROD, V69, P1095, DOI 10.1021/np060081y; Kanazawa M, 2011, J CEREBR BLOOD F MET, V31, P1461, DOI 10.1038/jcbfm.2011.9; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; GARABEDIAN HD, 1988, THROMB RES, V50, P121, DOI 10.1016/0049-3848(88)90180-6; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Namiki A, 1995, J BIOL CHEM, V270, P31189; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Tang SC, 2012, INT J CANCER, V130, P223, DOI 10.1002/ijc.26000; Nagai N, 1999, CIRCULATION, V99, P2440; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Abumiya T, 2005, BRAIN RES, V1049, P95, DOI 10.1016/j.brainres.2005.05.011; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Suzuki Y, 2004, J THROMB HAEMOST, V2, P1617, DOI 10.1111/j.1538-7836.2004.00889.x; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; Horowitz A, 2012, CELL SIGNAL, V24, P1810, DOI 10.1016/j.cellsig.2012.05.007; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P863, DOI 10.1111/j.1432-1033.1994.00863.x; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Cattaneo MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029680; Hashimoto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023359	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2015	35	12					2021	2031		10.1038/jcbfm.2015.167		11	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CX7OI	WOS:000365891300014		
J	Schwartz, GJ; Gao, XB; Tsuruoka, S; Purkerson, JM; Peng, H; D'Agati, V; Picard, N; Eladari, D; Al-Awqati, Q				Schwartz, George J.; Gao, XiaoBo; Tsuruoka, Shuichi; Purkerson, Jeffrey M.; Peng, Hu; D'Agati, Vivette; Picard, Nicolas; Eladari, Dominique; Al-Awqati, Qais			SDF1 induction by acidosis from principal cells regulates intercalated cell subtype distribution	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CORTICAL COLLECTING TUBULE; METABOLIC-ACIDOSIS; KIDNEY; DUCT; PH; EXPRESSION; ALDOSTERONE; GROWTH; DIFFERENTIATION; TRANSPORTERS	The nephron cortical collecting duct (CCD) is composed of principal cells, which mediate Na, K, and water transport, and intercalated cells (ICs), which are specialized for acid-base transport. There are two canonical IC forms: acid-secreting alpha-ICs and HCO3-secreting beta-ICs. Chronic acidosis increases alpha-ICs at the expense of beta-ICs, thereby increasing net acid secretion by the CCD. We found by growth factor quantitative PCR array that acidosis increases expression of mRNA encoding SDF1 (or CXCL12) in kidney cortex and isolated CCDs from mouse and rabbit kidney cortex. Exogenous SDF1 or pH 6.8 media increased H+ secretion and decreased HCO3 secretion in isolated perfused rabbit CCDs. Acid-dependent changes in H+ and HCO3 secretion were largely blunted by AMD3100, which selectively blocks the SDF1 receptor CXCR4. In mice, diet-induced chronic acidosis increased alpha-ICs and decreased beta-ICs. Additionally, IC-specific Cxcr4 deletion prevented IC subtype alterations and magnified metabolic acidosis. SDF1 was transcriptionally regulated and a target of the hypoxia-sensing transcription factor HIF1 alpha. IC-specific deletion of Hifl alpha produced no effect on mice fed an acid diet, as alpha-ICs increased and beta-ICs decreased similarly to that observed in WT littermates. However, Hifla deletion in all CCD cells prevented acidosis-induced IC subtype distribution, resulting in more severe acidosis. Cultured principal cells exhibited an HIF1 alpha-dependent increase of Sdf1 transcription in response to media acidification. Thus, our results indicate that principal cells respond to acid by producing SDF1, which then acts on adjacent ICs.	[Schwartz, George J.; Purkerson, Jeffrey M.; Peng, Hu] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Gao, XiaoBo; Al-Awqati, Qais] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Tsuruoka, Shuichi] Jichi Med Sch, Dept Clin Pharmacol, Minami Kawachi, Tochigi, Japan; [D'Agati, Vivette] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Picard, Nicolas; Eladari, Dominique] Pads Cardiovasc Res Ctr PARCC, UMR S970, INSERM, Paris, France	Al-Awqati, Q (reprint author), Columbia Univ, Dept Med, 622 West 168th St,Room PH8E-111A, New York, NY 10032 USA.	qa1@cumc.columbia.edu			NIH [DK-20999, DK-050603]; Appel a projets generique from the Agence Nationale de la Recherche [ANR 14-CE12-0013-01/HYPERSCREEN]; CHLORBLOCK from the IDEX Sorbonne Paris Cite	This work was supported by NIH grants DK-20999 (to Q Al-Awqati) and DK-050603 (to G.J. Schwartz), and by grant ANR 14-CE12-0013-01/HYPERSCREEN Appel a projets generique 2014 from the Agence Nationale de la Recherche (to D. Eladari) and grant CHLORBLOCK from the IDEX Sorbonne Paris Cite (to D. Eladari).	Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Lotan D, 2008, PEDIATR NEPHROL, V23, P71, DOI 10.1007/s00467-007-0648-2; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Tsuruoka S, 1997, J CLIN INVEST, V99, P1420, DOI 10.1172/JCI119301; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; SCHWARTZ GJ, 1985, J CLIN INVEST, V75, P1638, DOI 10.1172/JCI111871; HOSTETTER TH, 1986, KIDNEY INT, V30, P509, DOI 10.1038/ki.1986.215; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Van Huyen JPD, 2008, J AM SOC NEPHROL, V19, P1965, DOI 10.1681/ASN.2007070781; Oliver JA, 2012, AM J PHYSIOL-RENAL, V302, pF1362, DOI 10.1152/ajprenal.00202.2011; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Al-Awqati Q, 2011, ANNU REV PHYSIOL, V73, P401, DOI 10.1146/annurev-physiol-012110-142253; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Al-Awqati Q, 2011, PHYSIOLOGY, V26, P266, DOI 10.1152/physiol.00008.2011; ALAWQATI Q, 1976, J CLIN INVEST, V58, P351, DOI 10.1172/JCI108479; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786/MCR-06-0103; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; Curthoys NP, 2014, CLIN J AM SOC NEPHRO, V9, P1627, DOI 10.2215/CJN.10391012; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; WEINER ID, 1990, J CLIN INVEST, V85, P274, DOI 10.1172/JCI114423; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Loniewski I, 2014, KIDNEY INT, V85, P529, DOI 10.1038/ki.2013.401; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; SILVER RB, 1992, J MEMBRANE BIOL, V125, P13; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002; Miller RL, 2009, KIDNEY INT, V75, P435, DOI 10.1038/ki.2008.569; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Cosson MA, 2009, MOL GENET METAB, V97, P172; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; Knowles Jonathan, 2005, Current Vascular Pharmacology, V3, P309, DOI 10.2174/157016105774329462; Lo YF, 2011, KIDNEY INT, V79, P730; Miller RL, 2006, AM J PHYSIOL-RENAL, V291, pF236, DOI 10.1152/ajprenal.00273.2005; Purkerson JM, 2014, AM J PHYSIOL-RENAL, V307, pF601, DOI 10.1152/ajprenal.00404.2013; Welsh-Bacic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025240; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wesson DE, 2011, AM J PHYSIOL-RENAL, V300, pF830, DOI 10.1152/ajprenal.00587.2010; Wiliam C, 2006, PFLUGERS ARCH, V451, P534	45	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	DEC	2015	125	12					4365	4374		10.1172/JCI80225		10	Medicine, Research & Experimental	Research & Experimental Medicine	CX6SI	WOS:000365831300008		
J	Kikuchi, J; Koyama, D; Wada, T; Izumi, T; Hofgaard, PO; Bogen, B; Furukawa, Y				Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Izumi, Tohru; Hofgaard, Peter O.; Bogen, Bjarne; Furukawa, Yusuke			Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma	JOURNAL OF CLINICAL INVESTIGATION			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; METHYLTRANSFERASE GENE EZH2; MESENCHYMAL STEM-CELLS; SUPPRESSES METHYLATION; HISTONE DEACETYLASES; IN-VITRO; EXPRESSION; BORTEZOMIB; ADHESION; GROWTH	Alterations in chromatin modifications, such as histone methylation, have been suggested as mediating chemotherapy resistance in several cancer types; therefore, elucidation of the epigenetic mechanisms that underlie drug resistance may greatly contribute to the advancement of cancer therapies. In the present study, we identified histone H3-lysine 27 (H3K27) as a critical residue for epigenetic modification in multiple myeloma. We determined that abrogation of drug-induced H3K27 hypermethylation is associated with cell adhesion-mediated drug resistance (CAM-DR), which is the most important form of drug resistance, using a coculture system to evaluate stroma cell adhesion-dependent alterations in multiple myeloma cells. Cell adhesion counteracted anticancer drug-induced hypermethylation of H3K27 via inactivating phosphorylation of the transcription regulator EZH2 at serine 21, leading to the sustained expression of antiapoptotic genes, including IGF1, B cell CLL/Iymphoma 2 (BCL2), and hypoxia inducible factor 1, alpha subunit (H/F1A). Pharmacological and genetic inhibition of the IGF-1R/P13K/AKT pathway reversed CAM-DR by promoting EZH2 dephosphorylation and H3K27 hypermethylation both in vitro and in refractory murine myeloma models. Together, our findings identify and characterize an epigenetic mechanism that underlies CAM-DR and suggest that kinase inhibitors to counteract EZH2 phosphorylation should be included in combination chemotherapy to increase therapeutic index.	[Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan; [Izumi, Tohru] Tochigi Canc Ctr, Div Hematol, Utsunomiya, Tochigi, Japan; [Hofgaard, Peter O.; Bogen, Bjarne] Oslo Univ Hosp, Inst Immunol, KG Jebsen Ctr Res Influenza Vaccines, N-0450 Oslo, Norway; [Bogen, Bjarne] Oslo Univ Hosp, Ctr Immune Regulat, Dept Immunol, N-0450 Oslo, Norway; Univ Oslo, Oslo, Norway	Furukawa, Y (reprint author), Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp			High-Tech Research Center Project for Private Universities: a Matching Fund Subsidy from MEXT; Japan Society for the Promotion of Science [25118721, 25461434, 26461438]; Japan Leukemia Research Fund; Yasuda Memorial Cancer Foundation; Takeda Science Foundation; Kano Foundation Research grant; Award in Aki's Memory; International Myeloma Foundation Japan	The authors are grateful to Kiyoshi Ando (Tokai University, Tokyo, Japan) for his technical advice regarding the establishment of the coculture system and Akiko Yonekura for her technical assistance. This work was supported in part by the High-Tech Research Center Project for Private Universities: a Matching Fund Subsidy from MEXT, Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grants 25118721, 25461434, and 26461438), and research grants from the Japan Leukemia Research Fund, the Yasuda Memorial Cancer Foundation, and the Takeda Science Foundation (to J. Kikuchi and Y. Furukawa). J. Kikuchi and Y. Furukawa received a Kano Foundation Research grant and the Award in Aki's Memory, respectively, from the International Myeloma Foundation Japan.	Yamaguchi H, 2014, CANCER RES TREAT, V46, P209, DOI 10.4143/crt.2014.46.3.209; Kikuchi J, 2014, INT J HEMATOL, V99, P726, DOI 10.1007/s12185-014-1573-3; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Cheng MF, 2009, HISTOL HISTOPATHOL, V24, P1105; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Sripayap P, 2014, ACTA HAEMATOL-BASEL, V132, P1, DOI 10.1159/000357213; De Schauwer C, 2011, THERIOGENOLOGY, V75, P1431, DOI 10.1016/j.theriogenology.2010.11.008; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Kawada H, 1999, EXP HEMATOL, V27, P904, DOI 10.1016/S0301-472X(99)00012-0; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109; Zeng XZ, 2011, CELL CYCLE, V10, P579, DOI 10.4161/cc.10.4.14722; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Sasaki H, 2008, ONCOGENE, V27, P2737, DOI 10.1038/sj.onc.1210926; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Kikuchi J, 2013, J BIOL CHEM, V288, P25593, DOI 10.1074/jbc.M113.480574; Koyama D, 2014, LEUKEMIA, V28, P1216, DOI 10.1038/leu.2013.366; Tai YT, 2003, CANCER RES, V63, P5850; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Hideshima T, 2011, INT J HEMATOL, V94, P344, DOI 10.1007/s12185-011-0917-5; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Chiron D, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.18; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Rahal R, 2014, NAT MED, V20, P87, DOI 10.1038/nm.3435; Riedel SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052398; Sashida G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5177; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Schwarzer R, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.37; Xie ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021583	49	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	DEC	2015	125	12					4375	4390		10.1172/JC180325		16	Medicine, Research & Experimental	Research & Experimental Medicine	CX6SI	WOS:000365831300009		
J	Masuda, M; Miyazaki-Anzai, S; Keenan, AL; Okamura, K; Kendrick, J; Chonchol, M; Offermanns, S; Ntambi, JM; Kuro-o, M; Miyazaki, M				Masuda, Masashi; Miyazaki-Anzai, Shinobu; Keenan, Audrey L.; Okamura, Kayo; Kendrick, Jessica; Chonchol, Michel; Offermanns, Stefan; Ntambi, James M.; Kuro-o, Makoto; Miyazaki, Makoto			Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity	JOURNAL OF CLINICAL INVESTIGATION			English	Article							STEAROYL-COA DESATURASE-1; CHRONIC KIDNEY-DISEASE; ENDOPLASMIC-RETICULUM STRESS; SOFT-TISSUE CALCIFICATION; SMOOTH-MUSCLE-CELLS; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; PHOSPHOLIPID-COMPOSITION; ARTERIAL CALCIFICATION; OXIDATIVE STRESS; MICE	Recent evidence indicates that saturated fatty acid-induced (SFA-induced) lipotoxicity contributes to the pathogenesis of cardiovascular and metabolic diseases; however, the molecular mechanisms that underlie SFA-induced lipotoxicity remain unclear. Here, we have shown that repression of stearoyl-CoA desaturase (SCD) enzymes, which regulate the intracellular balance of SFAs and unsaturated FAs, and the subsequent accumulation of SFAs in vascular smooth muscle cells (VSMCs), are characteristic events in the development of vascular calcification. We evaluated whether SMC-specific inhibition of SCD and the resulting SFA accumulation plays a causative role in the pathogenesis of vascular calcification and generated mice with SMC-specific deletion of both Scd1 and Scd2. Mice lacking both SCD1 and SCD2 in SMCs displayed severe vascular calcification with increased ER stress. Moreover, we employed shRNA library screening and radiolabeling approaches, as well as in vitro and in vivo lipidomic analysis, and determined that fully saturated phosphatidic acids such as 1,2-distearoyl-PA (18:0/18:0-PA) mediate SFA-induced lipotoxicity and vascular calcification. Together, these results identify a key lipogenic pathway in SMCs that mediates vascular calcification.	[Masuda, Masashi; Miyazaki-Anzai, Shinobu; Keenan, Audrey L.; Okamura, Kayo; Kendrick, Jessica; Chonchol, Michel; Miyazaki, Makoto] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Ntambi, James M.] Univ Wisconsin, Dept Biochem & Nutr Sci, Madison, WI USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, Shimotsuke, Tochigi, Japan; [Miyazaki, Makoto] Univ Colorado Denver, Div Endocrinol Diabet & Metab, Aurora, CO USA	Miyazaki, M (reprint author), 12700 E 17th Ave,C281 RC-2,Rm 7450, Aurora, CO 80045 USA.	makoto.miyazaki@ucdenver.edu			NIH [DK096030, HL117602, DK62388]; American Heart Association [13POST13820008]	The authors work was supported by grants, including NIH DK096030 and HL117602 to M. Miyazaki and DK62388 to J.M. Ntambi. M. Masuda received a fellowship from the American Heart Association (13POST13820008).	Geng YF, 2011, J BIOL CHEM, V286, P33701, DOI 10.1074/jbc.M111.269639; MARSH JB, 1962, BIOCHIM BIOPHYS ACTA, V60, P320, DOI 10.1016/0006-3002(62)90407-9; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Abedin M, 2006, CIRC RES, V98, P727, DOI 10.1161/01.RES.0000216009.68958.e6; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Miyazaki-Anzai S, 2010, CIRC RES, V106, P1807, DOI 10.1161/CIRCRESAHA.109.212969; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Wendel AA, 2013, J BIOL CHEM, V288, P27299, DOI 10.1074/jbc.M113.485219; Zhang CB, 2015, J BIOL CHEM, V290, P3519, DOI 10.1074/jbc.M114.602789; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Memon F, 2008, KIDNEY INT, V74, P566, DOI 10.1038/ki.2008.218; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Minville-Walz M, 2012, GENES NUTR, V7, P209, DOI 10.1007/s12263-011-0258-2; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/01.mol.0000073502.41685.c7; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Towler DA, 2013, CIRC RES, V113, P198, DOI 10.1161/CIRCRESAHA.113.300155; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; Brodeur MR, 2013, J VASC RES, V50, P430, DOI 10.1159/000354235; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Ting TC, 2011, J BIOL CHEM, V286, P23938, DOI 10.1074/jbc.M111.237065; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Miyazaki M, 2001, J BIOL CHEM, V276, P39455, DOI 10.1074/jbc.M106442200; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Anderson EK, 2012, ARTERIOSCL THROM VAS, V32, P1687, DOI 10.1161/ATVBAHA.112.250142; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Masuda M, 2010, BIOCHEM J, V429, P583, DOI 10.1042/BJ20100484; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Masuda M, 2012, J LIPID RES, V53, P1543, DOI 10.1194/jlr.M025981; Cheng SL, 2014, DIABETES, V63, P4326, DOI 10.2337/db14-0326; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Kageyama A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068197; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; Miyazaki-Anzai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108270; Miyazaki-Anzai S, 2014, J AM HEART ASSOC, V3; Tintut Yin, 2000, Circulation, V102, P2636; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013	71	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	DEC	2015	125	12					4544	4558		10.1172/JCI82871		15	Medicine, Research & Experimental	Research & Experimental Medicine	CX6SI	WOS:000365831300020		
J	Shigeto, M; Ramracheya, R; Tarasov, AI; Cha, CY; Chibalina, MV; Hastoy, B; Philippaert, K; Reinbothe, T; Rorsman, N; Salehi, A; Sones, WR; Vergari, E; Weston, C; Gorelik, J; Katsura, M; Nikolaev, VO; Vennekens, R; Zaccolo, M; Galione, A; Johnson, PRV; Kaku, K; Ladds, G; Rorsman, P				Shigeto, Makoto; Ramracheya, Reshma; Tarasov, Andrei I.; Cha, Chae Young; Chibalina, Margarita V.; Hastoy, Benoit; Philippaert, Koenraad; Reinbothe, Thomas; Rorsman, Nils; Salehi, Albert; Sones, William R.; Vergari, Elisa; Weston, Cathryn; Gorelik, Julia; Katsura, Masashi; Nikolaev, Viacheslav O.; Vennekens, Rudi; Zaccolo, Manuela; Galione, Antony; Johnson, Paul R. V.; Kaku, Kohei; Ladds, Graham; Rorsman, Patrik			GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation	JOURNAL OF CLINICAL INVESTIGATION			English	Article							GLUCAGON-LIKE PEPTIDE-1; PANCREATIC BETA-CELLS; TYPE-2 DIABETIC-PATIENTS; CATION CHANNEL TRPM4; PROTEIN-KINASE-C; ACTION-POTENTIALS; MOUSE ISLETS; RAT ISLETS; B-CELLS; GLUCOSE	Strategies aimed at mimicking or enhancing the action of the incretin hormone glucagon-like peptide 1 (GLP-1) therapeutically improve glucose-stimulated insulin secretion (GSIS); however, it is not clear whether GLP-1 directly drives insulin secretion in pancreatic islets. Here, we examined the mechanisms by which GLP-1 stimulates insulin secretion in mouse and human islets. We found that GLP-1 enhances GSIS at a half-maximal effective concentration of 0.4 pM. Moreover, we determined that GLP-1 activates PLC, which increases submembrane diacylglycerol and thereby activates PKC, resulting in membrane depolarization and increased action potential firing and subsequent stimulation of insulin secretion. The depolarizing effect of GLP-1 on electrical activity was mimicked by the PKC activator PMA, occurred without activation of PKA, and persisted in the presence of PKA inhibitors, the K-ATP channel blacker tolbutamide, and the L-type Ca2+ channel blacker isradipine; however, depolarization was abolished by lowering extracellular Na+. The PKC-dependent effect of GLP-1 on membrane potential and electrical activity was mediated by activation of NW-permeable TRPM4 and TRPM5 channels by mobilization of intracellular Ca2+ from thapsigargin-sensitive Ca2+ stores. Concordantly, GLP-1 effects were negligible in Trpm4 or Trpm5 KO islets. These data provide important insight into the therapeutic action of GLP-1 and suggest that circulating levels of this hormone directly stimulate insulin secretion by beta cells.	[Shigeto, Makoto; Ramracheya, Reshma; Tarasov, Andrei I.; Cha, Chae Young; Chibalina, Margarita V.; Hastoy, Benoit; Rorsman, Nils; Sones, William R.; Vergari, Elisa; Johnson, Paul R. V.; Rorsman, Patrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England; [Shigeto, Makoto; Cha, Chae Young; Reinbothe, Thomas; Salehi, Albert; Rorsman, Patrik] Univ Gothenburg, Metab Res Unit, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Shigeto, Makoto; Katsura, Masashi; Kaku, Kohei] Kawasaki Med Univ, Dept Diabet Endocrinol & Metab, Kurashiki, Okayama, Japan; [Tarasov, Andrei I.; Johnson, Paul R. V.; Rorsman, Patrik] Churchill Hosp, Oxford Natl Inst Hlth Res, Oxford OX3 7LE, England; [Philippaert, Koenraad; Vennekens, Rudi] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Ion Channel Res, Leuven, Belgium; [Rorsman, Nils; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Weston, Cathryn; Ladds, Graham] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiovasc Sci, London, England; [Nikolaev, Viacheslav O.] Univ Klinikum Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Zaccolo, Manuela] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Ladds, Graham] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	Rorsman, P (reprint author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Old Rd, Oxford OX3 7LE, England.	patrik.rorsman@drl.ox.ac.uk			Medical Research Council, Diabetes UK; Oxford Biomedical Research Centre; Wellcome Trust; Warwick Impact Fund; Biotechnology and Biological Sciences Research Council; Knut and Alice Wallenberg Foundation; Swedish Research Council; Kawasaki Medical School	We thank David Wiggins for excellent technical assistance. This work was supported by the Medical Research Council, Diabetes UK (to R. Ramracheya), Oxford Biomedical Research Centre (to A. Tarasov), the Wellcome Trust (Senior Investigator Awards to A. Galione and P. Rorsman), the Warwick Impact Fund (to C. Weston and G. Ladds), the Biotechnology and Biological Sciences Research Council (to G. Ladds), the Knut and Alice Wallenberg Foundation (to P. Rorsman), and the Swedish Research Council (to P. Rorsman). The initial stages of M. Shigeto's stay in Oxford were supported by a fellowship from Kawasaki Medical School.	FRIDOLF T, 1991, BIOCHEM BIOPH RES CO, V179, P701, DOI 10.1016/0006-291X(91)91429-G; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; Green BD, 2004, ARCH BIOCHEM BIOPHYS, V428, P136, DOI 10.1016/j.abb.2004.05.005; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Lopez-Delgado MI, 1998, ENDOCRINOLOGY, V139, P2811, DOI 10.1210/en.139.6.2811; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; GAO ZY, 1994, ENDOCRINOLOGY, V135, P191, DOI 10.1210/en.135.1.191; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Gopel SO, 1999, J GEN PHYSIOL, V114, P759, DOI 10.1085/jgp.114.6.759; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; VALVERDE I, 1993, ENDOCRINOLOGY, V132, P75, DOI 10.1210/en.132.1.75; Kato M, 1996, REGUL PEPTIDES, V62, P23, DOI 10.1016/0167-0115(95)00164-6; Shigeto M, 2008, J PHARMACOL SCI, V108, P274, DOI 10.1254/jphs.08090FP; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Hansen L, 1999, ENDOCRINOLOGY, V140, P5356, DOI 10.1210/en.140.11.5356; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; LAKE SP, 1989, DIABETES, V38, P143; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Hallbrink M, 2001, BBA-PROTEIN STRUCT M, V1546, P79, DOI 10.1016/S0167-4838(00)00270-3; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; Balas B, 2007, J CLIN ENDOCR METAB, V92, P1249, DOI 10.1210/jc.2006-1882; GOKE R, 1993, J BIOL CHEM, V268, P19650; Low JT, 2013, DIABETOLOGIA, V56, P2629, DOI 10.1007/s00125-013-3019-5; Bavec A, 2003, REGUL PEPTIDES, V111, P137, DOI 10.1016/S0167-0115(02)00282-3; Deacon CF, 2013, EXPERT OPIN PHARMACO, V14, P2047, DOI 10.1517/14656566.2013.824966; Rickels MR, 2009, J CLIN ENDOCR METAB, V94, P181, DOI 10.1210/jc.2008-1806; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Gall D, 1999, BIOPHYS J, V76, P2018; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Ahren B, 2007, BEST PRACT RES CL EN, V21, P517, DOI 10.1016/j.beem.2007.07.005; FRIDOLF T, 1991, DIABETES RES CLIN EX, V16, P185; Hoist J.J., 2007, PHYSIOL REV, V87, P1409; Hoist JJ, 2005, DIABETOLOGIA, V48, P612; Holz GGt, 1993, NATURE, V361, P362; Liman E R, 2007, Handb Exp Pharmacol, P287; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Reinbothe TM, 2014, ISLETS, V6, DOI 10.4161/isl.28095; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Ruas M, 2014, MOL CELL BIOL, V34, P3981, DOI 10.1128/MCB.00113-14; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vennekens R, 2007, Handb Exp Pharmacol, P269; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Zhang Q, 2014, J PHYSIOL-LONDON, V592, P4677, DOI 10.1113/jphysiol.2014.274209	63	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	DEC	2015	125	12					4714	4728		10.1172/JCI81975		15	Medicine, Research & Experimental	Research & Experimental Medicine	CX6SI	WOS:000365831300034		
J	Tsuzuki, Y				Tsuzuki, Yukihiro			Pricing Bounds on Quanto Options	JOURNAL OF DERIVATIVES			English	Article							BASKET OPTIONS; PRICES; STRATEGIES	This article proposes model-independent pricing bounds on quanto options and the corresponding replicating strategies, which are static strategies with portfolios consisting of plain vanilla options on the foreign asset and on the EX rate. Because they are model-independently derived, one can make profit without risk if quanto options are priced outside the bounds. Additionally, the pricing bounds can be improved if liquid quanto contracts, such as quanto forward contracts, are used for replication. Numerical examples compare our pricing bounds with the Black pricing formula and the same formula with an ad-hoc adjustment. It is found that prices produced by the Black formula with and without ad-hoc adjustments may be outside the model-independent pricing bounds, and that the pricing bounds with quanto forward contracts are substantially improved.	[Tsuzuki, Yukihiro] Univ Tokyo, Grad Sch Econ, Tokyo, Japan	Tsuzuki, Y (reprint author), Univ Tokyo, Grad Sch Econ, Tokyo, Japan.	yukihirotsuzuki@gmail.com					BREEDEN DT, 1978, J BUS, V51, P621, DOI 10.1086/296025; Laurence P, 2009, INSUR MATH ECON, V44, P35, DOI 10.1016/j.insmatheco.2008.09.007; Chung SL, 2008, J BANK FINANC, V32, P631, DOI 10.1016/j.jbankfin.2007.01.027; Hobson D, 2005, INSUR MATH ECON, V37, P553, DOI 10.1016/j.insmatheco.2005.05.010; Chen X, 2008, INSUR MATH ECON, V42, P1067, DOI 10.1016/j.insmatheco.2008.01.002; Dhaene J, 2002, INSUR MATH ECON, V31, P3, DOI 10.1016/S0167-6687(02)00134-8; Hobson D, 2005, QUANT FINANC, V5, P329, DOI 10.1080/14697680500151392; Avellaneda M., 1995, APPL MATH FINANCE, V2, P73, DOI 10.1080/13504869500000005; Baxter M., 1996, FINANCIAL CALCULUS I; Bennett M. N., 2004, J DERIV, V12, P26, DOI 10.3905/jod.2004.434535; Cherubini U., 2002, APPL MATH FINANCE, V9, P69, DOI 10.1080/13504860210136721a; Cheung K.C., 2013, AFI1377 KU LEUV FEB; Giese A., 2012, RISK, P67; Jackel P, 2010, QUANTO SKEW STOCHAST; Jackel P, 2009, QUANTO SKEW; Karatzas I., 1988, BROWNIAN MOTION STOC; Madan D., 1998, VOLATILITY NEW ESTIM; Niculescu C.P., 2013, ABSTR APPL ANAL, V219, P6393; Schoutens W., 2005, J DERIV, V12, P63, DOI 10.3905/jod.2005.479381; Touzi N., 2013, EXPLICIT MARTINGALE; Tsuzuki Y., 2013, INT J THEORETICAL AP, V16; Wang T.-H., 2003, APPL MATH FINANCE, V12, P253	22	0	0	INST INVESTOR INC	NEW YORK	225 PARK AVE SOUTH, NEW YORK, NY 10003 USA	1074-1240	2168-8524		J DERIV	J. Deriv.	WIN	2015	23	2					53	61				9	Business, Finance	Business & Economics	CX3WL	WOS:000365630100005		
J	Sato, M				Sato, Motoyuki			Near Range Radar and Its Application to Near Surface Geophysics and Disaster Mitigation	JOURNAL OF EARTH SCIENCE			English	Article						near range radar; GPR; GB-SAR; disaster mitigation; SAR processing; migration; multi-static radar		In this paper, we discuss about the near range radar applied to various environmental applications and disaster mitigation issues. Synthetic aperture radar (SAR) processing or migration is the key technology in near range radar imaging, which can be used in ground penetrating radar (GPR) and ground-based synthetic aperture radar (GB-SAR). We demonstrate some applications which include GPR for humanitarian demining, GPR for archaeological survey, GB-SAR for landslide monitoring and nondestructive inspection of wooden buildings. We also demonstrate a new array GPR system "Yakumo", which was used for archaeological survey for demonstration of advanced multi-static radar signal processing for better radar imaging.	[Sato, Motoyuki] Tohoku Univ, Ctr Northeast Asian Studies, Sendai, Miyagi 9808576, Japan	Sato, M (reprint author), Tohoku Univ, Ctr Northeast Asian Studies, Sendai, Miyagi 9808576, Japan.	sato@cneas.tohoku.ac.jp			JSPS [23246076]	This research has been achieved by "Development of Non-Destructive Inspection method for constructions by electromagnetic wave", the Commissioned Research of National Institute of Information and Communications Technology (NICT), Japan and JSPS Grant-in-Aid for Scientific Research (No. 23246076).	Grasmueck M, 2007, IEEE T GEOSCI REMOTE, V45, P130, DOI 10.1109/TGRS.2006.882253; Sato M., 2012, J KOREAN I ELECTROMA, V12, P56; Sato M., 2007, P SOC PHOTO-OPT INS, V6553; Sato M., 2010, 2010 INT C IND POS I, P974	4	0	0	CHINA UNIV GEOSCIENCES	BEIJING	29 XUEYUAN RD, BEIJING, 100083, PEOPLES R CHINA	1674-487X	1867-111X		J EARTH SCI-CHINA	J. Earth Sci.	DEC	2015	26	6					858	863		10.1007/s12583-015-0595-y		6	Geosciences, Multidisciplinary	Geology	CX8DY	WOS:000365934000013		
J	Kaneko, T; Kanazawa, T; Nishiguchi, M; Kikuyama, H; Tsutsumi, A; Uenishi, H; Kawabata, Y; Kawashige, S; Nishizawa, Y; Maruyama, S; Koh, J; Yoneda, H				Kaneko, Takao; Kanazawa, Tetsufumi; Nishiguchi, Masaki; Kikuyama, Hiroki; Tsutsumi, Atsushi; Uenishi, Hiroyuki; Kawabata, Yasuo; Kawashige, Seiya; Nishizawa, Yoshitaka; Maruyama, Souichiro; Koh, Jun; Yoneda, Hiroshi			Microarray Analysis of Human Blood During Electroconvulsive Therapy	JOURNAL OF ECT			English	Article						modified electroconvulsive therapy; mECT; microarray; catatonic schizophrenia; quantitative polymerase chain reaction; qPCR; AKT3; TCF7; PPP3R1; GADD45B; mRNA; gene expression	GENE-EXPRESSION; NEUROPEPTIDE-Y; MESSENGER-RNA; SCHIZOPHRENIA; STIMULATION; RAT; TCF7L2; ECT; DEPRESSION; MECHANISM	Introduction Electroconvulsive therapy (ECT) is currently regarded as a significant treatment option for intractable psychiatric disorders, such as catatonic schizophrenia or treatment-resistant depression; however, the underlying molecular mechanism for its therapeutic effect remains obscure. Methods Employing microarray analysis (Human Genome U133 Plus 2.0 Array; Affymetrix, United States) of cDNA derived from the peripheral blood of patients with catatonic schizophrenia (n = 5), we detected a significant change in 145 genes (0.68%) before and after modified ECT (mECT). Moreover, we performed quantitative polymerase chain reaction validation of genes that had previously been suggested to be functionally related to schizophrenia. Results Of 4 genes examined (AKT3, TCF7, PPP3R1, and GADD45B), only TCF7 was increased during the mECT procedure (P = 0.0025). Discussion This study describes the first attempt to uncover the molecular mechanism of mECT using a microarray assay of mRNA derived from peripheral blood, and our results suggest that the TCF family may play a role in the functional mechanism of mECT.	[Kaneko, Takao; Kanazawa, Tetsufumi; Nishiguchi, Masaki; Kikuyama, Hiroki; Tsutsumi, Atsushi; Kawabata, Yasuo; Kawashige, Seiya; Nishizawa, Yoshitaka; Maruyama, Souichiro; Koh, Jun; Yoneda, Hiroshi] Osaka Med Coll, Dept Neuropsychiat, Takatsuki, Osaka 5698686, Japan; [Kikuyama, Hiroki] Shin Abuyama Hosp, Takatsuki, Osaka, Japan; [Uenishi, Hiroyuki] Kansai Univ, Grad Sch Psychol, Suita, Osaka, Japan	Kanazawa, T (reprint author), Osaka Med Coll, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	psy052@poh.osaka-med.ac.jp					Alkelai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029228; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; Fochtmann LJ, 1998, J ECT, V14, P206; Sokol SY, 2011, CELL RES, V21, P1002, DOI 10.1038/cr.2011.86; Pompili M, 2013, SCHIZOPHR RES, V146, P1, DOI 10.1016/j.schres.2013.02.005; Kellner CH, 2012, AM J PSYCHIAT, V169, P1238, DOI 10.1176/appi.ajp.2012.12050648; Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Dyrvig M, 2014, GENE, V539, P8, DOI 10.1016/j.gene.2014.01.072; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Petrides G, 1996, CONVULSIVE THER, V12, P138; Zervas IM, 2012, WORLD J BIOL PSYCHIA, V13, P96, DOI 10.3109/15622975.2011.564653; ZACHRISSON O, 1995, MOL BRAIN RES, V31, P71, DOI 10.1016/0169-328X(95)00033-O; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Naylor P, 1996, MOL BRAIN RES, V35, P349, DOI 10.1016/0169-328X(95)00264-S; Newton SS, 2003, J NEUROSCI, V23, P10841; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Andrade C, 2008, J PSYCHIATR RES, V42, P837, DOI 10.1016/j.jpsychires.2007.08.009; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Mikkelsen JD, 2006, J PSYCHIAT RES, V40, P153, DOI 10.1016/j.jpsychires.2005.02.005; Bolwig TG, 2011, CAN J PSYCHIAT, V56, P13; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Balog Z, 2012, AM J PSYCHIAT, V169, P335, DOI 10.1176/appi.ajp.2011.11101562; Okabe T, 2010, BIOMED RES-TOKYO, V31, P287, DOI 10.2220/biomedres.31.287; Iacob E, 2014, DEPRESS RES TREAT, V2014; Qu HQ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-51; Savic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026897	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1095-0680	1533-4112		J ECT	J. ECT	DEC	2015	31	4					234	237		10.1097/YCT.0000000000000234		4	Behavioral Sciences; Psychiatry	Behavioral Sciences; Psychiatry	CX4RE	WOS:000365687200008		
J	Bolliger, DU; Mills, D; White, J; Kohyama, M				Bolliger, Doris U.; Mills, Daniel; White, Jeremy; Kohyama, Megumi			Japanese Students' Perceptions of Digital Game Use for English-Language Learning in Higher Education	JOURNAL OF EDUCATIONAL COMPUTING RESEARCH			English	Article						digital games; higher education; Japanese students; second language learning; student perceptions	TECHNOLOGY ACCEPTANCE MODEL; INFORMATION-TECHNOLOGY; BEHAVIORAL INTENTION; PERCEIVED USEFULNESS; SIMULATION GAMES; 2ND LIFE; PLAY; COMMUNITIES; EXPERIENCE; ATTITUDES	Researchers investigated perceptions of Japanese college students toward the use of digital games in English-language learning. The study was conducted at one large private university in Japan. Undergraduate students who were enrolled in 14 English-language courses were invited to complete a paper-based survey during class time. The survey included the following constructs: ease of use, learning opportunities, experience, preferences, and actual use. Participants were also invited to share potential advantages and disadvantages for digital game use in the classroom. Two hundred and twenty-two students completed the survey. Results indicate that most students viewed the potential integration and utilization of digital games as positive. However, some students expressed concern that the use of games may not be an effective or efficient method of learning.	[Bolliger, Doris U.] Univ Wyoming, Instruct Technol Program, Laramie, WY 82071 USA; [Mills, Daniel] Ritsumeikan Univ, English, Kusatsu, Shiga, Japan; [White, Jeremy] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Shiga, Japan; [Kohyama, Megumi] Ritsumeikan Univ, Kusatsu, Shiga, Japan	Bolliger, DU (reprint author), Univ Wyoming, Dept 3374, 1000 Univ Ave,ED 322, Laramie, WY 82071 USA.	dorisbolliger@gmail.com					Akoi K., 2010, WORLD ACAD SCI ENG T, V42, P698; Tao YH, 2009, COMPUT EDUC, V53, P929, DOI 10.1016/j.compedu.2009.05.009; Hsu CL, 2004, INFORM MANAGE-AMSTER, V41, P853, DOI 10.1016/j.im.2003.08.014; Venkatesh V, 2003, MIS QUART, V27, P425; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Sanchez RA, 2010, COMPUT HUM BEHAV, V26, P1632, DOI 10.1016/j.chb.2010.06.011; Young MF, 2012, REV EDUC RES, V82, P61, DOI 10.3102/0034654312436980; Lau SH, 2008, BRIT J EDUC TECHNOL, V39, P685, DOI 10.1111/j.1467-8535.2007.00770.x; Peterson M, 2010, RECALL, V22, P273, DOI 10.1017/S0958344010000169; Bourgonjon J, 2010, COMPUT EDUC, V54, P1145, DOI 10.1016/j.compedu.2009.10.022; Ha I, 2007, INFORM MANAGE-AMSTER, V44, P276, DOI 10.1016/j.im.2007.01.001; deHaan J, 2010, LANG LEARN TECHNOL, V14, P74; Papastergiou M, 2009, COMPUT EDUC, V52, P1, DOI 10.1016/j.compedu.2008.06.004; Hsu CL, 2007, COMPUT HUM BEHAV, V23, P1642, DOI 10.1016/j.chb.2005.09.001; Cha ES, 2007, J ADV NURS, V58, P386, DOI 10.1111/j.1365-2648.2007.04242.x; Bonanno P, 2008, BRIT J EDUC TECHNOL, V39, P97, DOI 10.1111/j.1467-8535.2007.00732.x; Wang FH, 2013, BRIT J EDUC TECHNOL, V44, P357, DOI 10.1111/j.1467-8535.2012.01334.x; Latchem C, 2008, BRIT J EDUC TECHNOL, V39, P610, DOI 10.1111/j.1467-8535.2007.00771.x; Oliver M, 2009, BRIT J EDUC TECHNOL, V40, P444, DOI 10.1111/j.1467-8535.2009.00948.x; WARSHAW PR, 1985, J EXP SOC PSYCHOL, V21, P213, DOI 10.1016/0022-1031(85)90017-4; Park SY, 2012, BRIT J EDUC TECHNOL, V43, P592, DOI 10.1111/j.1467-8535.2011.01229.x; Ranalli J, 2008, COMPUT ASSIST LANG L, V21, P441, DOI 10.1080/09588220802447859; ADAMS DA, 1992, MIS QUART, V16, P227, DOI 10.2307/249577; Warner CN, 2004, LANG LEARN TECHNOL, V8, P69; King WR, 2006, INFORM MANAGE-AMSTER, V43, P740, DOI 10.1016/j.im.2006.05.003; Ke FF, 2008, COMPUT EDUC, V51, P1609, DOI 10.1016/j.compedu.2008.03.003; Legris P, 2003, INFORM MANAGE-AMSTER, V40, P191, DOI 10.1016/S0378-7206(01)00143-4; Bandura A., 1997, SELF EFFICACY EXERCI; Bogdan R. C., 1998, QUALITATIVE RES ED I; Carless D., 2012, ONTASK, V2, P4; Carr D., 2008, HDB RES EFFECTIVE EL, P911, DOI 10.4018/978-1-59904-808-6.ch052; Chen Howard Hao-Jan, 2011, Edutainment Technologies. Educational Games and Virtual Reality/Augmented Reality Applications. Proceedings 6th International Conference on E-learning and Games, Edutainment 2011, DOI 10.1007/978-3-642-23456-9_31; Creswell J, 2014, RES DESIGN QUALITATI; Davies R., 2002, JAPANESE MIND UNDERS; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; De Jean J, 1999, GENDER ED, V11, P207, DOI DOI 10.1080/09540259920708; DeVellis RF, 2003, SCALE DEV THEORY APP; Entertainment Software Association, 2014, 2014 ESS FACTS COMP; Fishbein M., 1975, BELIEF ATTITUDE INTE; Flick U., 2006, INTRO QUALITATIVE RE; Gee JP, 2003, WHAT VIDEO GAMES HAVE TO TEACH US ABOUT LEARNING AND LITERACY, P1; Gefen D., 2000, J ASSOC INF SYST, V1, P1; Gravetter F. J., 2009, RES METHODS BEHAV SC; Han Kwang Hyun, 2006, Asia Pacific Journal of Information Systems, V16, P123; Lenhart A., 2008, ADULTS VIDEO GAMES; Mills D. J., 2014, COMPUTER ASSISTED LA, V15, P1; Ministry of Internal Affairs and Communications, 2014, WHIT PAP 2014 INF CO; Newzoo, 2015, GLOB REP US CHIN TAK; Peterson M., 2011, DIGITAL CULTURE ED, V3, P56; Peterson M., 2001, Computer Assisted Language Learning, V14, DOI 10.1076/call.14.5.443.5773; Rankin Y., 2006, EUROGRAPHICS, V25, P3; Rankin Y. A., 2009, P INT C FDN DIG GAM, V4, P161, DOI [10.1145/1536513.1536546, DOI 10.1145/1536513.1536546]; Rieber LP, 1996, ETR&D-EDUC TECH RES, V44, P43, DOI 10.1007/BF02300540; SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170; Shield L., 2003, LANGUAGE LEARNING ON, P97; Statista, 2015, NUMB VID GAM WORLDW; Teo T., 2011, TECHNOLOGY ACCEPTANC; Thorne S. L., 2008, MEDIATING DISCOURSE, P305; Tomlinson B., 2009, SIMULATION GAMING, V40, P645, DOI 10.1177/1046878109339969; Wang R., 2008, SURVEY PRACTICE, V1, P1; Warman P., 2013, 2013 MOBILE GAMES RE; Waters J. K., 2007, T H E J, V34, P26; World Health Organisation (WHO), 2014, GLOB HLTH OBS DAT RE	64	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0735-6331	1541-4140		J EDUC COMPUT RES	J. Educ. Comput. Res.	DEC	2015	53	3					384	408		10.1177/0735633115600806		25	Education & Educational Research	Education & Educational Research	CX4LG	WOS:000365671600003		
J	Shirakura, Y; Fukuoka, T				Shirakura, Yuki; Fukuoka, Toshio			MAN WITH SUDDEN NECK PAIN	JOURNAL OF EMERGENCY MEDICINE			English	Editorial Material							SPINAL EPIDURAL HEMATOMA		[Shirakura, Yuki; Fukuoka, Toshio] Kurashiki Cent Hosp, Dept Emergency Med, Emergency & Crit Care Ctr, Kurashiki, Okayama, Japan	Shirakura, Y (reprint author), Kurashiki Cent Hosp, Dept Emergency Med, Miwa 1-1-1, Kurashiki, Okayama, Japan.						Akimoto Tetsu, 2014, J Cent Nerv Syst Dis, V6, P15, DOI 10.4137/JCNSD.S13252; Groen RJM, 2004, ACTA NEUROCHIR, V146, P103, DOI 10.1007/s00701-003-0160-9; Liu Z, 2008, SURG NEUROL, V69, P253, DOI 10.1016/j.surneu.2007.02.019; Ito H, 2014, INTERNAL MED, V53, P57, DOI 10.2169/internalmedicine.53.1274; Liao CC, 2009, J NEUROSURG-SPINE, V11, P480, DOI 10.3171/2009.4.SPINE08904; Dinsmore AJ, 2005, J EMERG MED, V28, P423, DOI 10.1016/j.jemermed.2004.11.023; Matsumoto H, 2014, J SPINAL CORD MED, V35, P262	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2015	49	6					E199	E200		10.1016/j.jemermed.2015.06.017		2	Emergency Medicine	Emergency Medicine	CX0TC	WOS:000365408800010		
J	Kuroda, S; Takagi, S; Nakagaki, T; Ueda, T				Kuroda, Shigeru; Takagi, Seiji; Nakagaki, Toshiyuki; Ueda, Tetsuo			Allometry in Physarum plasmodium during free locomotion: size versus shape, speed and rhythm	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Cell locomotion; Scaling; Self-organization; Dimensional analysis; Spatial memory; Localization of locomotion machinery; Traveling wave	INTRACELLULAR ATP; CONTRACTION RHYTHM; POLYCEPHALUM; PATTERNS; OSCILLATIONS; MIGRATION; LIGHT	Physarum plasmodium is a giant unicellular organism whose length can vary by more than three orders of magnitude. Using plasmodia ranging in size from 100 mu m to 10 cm, we investigated the size dependency of their thickness distributions and locomotion speeds during free locomotion. (1) In the longitudinal direction, the organism is thickest close to the front, and decreases exponentially in thickness towards the rear. The slenderness ratio varies with body size according to a power law, such that large plasmodia are long and flat, whereas small plasmodia are short and thick. (2) The mean locomotion speed is proportional to the mean maximum thickness of the frontal part. By conducting a dimensional analysis, possible physical models are discussed. (3) The intrinsic period of the thickness oscillation, which is related to shuttle streaming (period 1-2 min), increases logarithmically with body size. (4) Various characteristics exhibit size-independent, long-period (20 +/- 10 min) oscillations, including speed, shape and intrinsic thickness oscillation period. These variations are closely coupled to formation of the entire cell shape, including undulation of thickness along the longitudinal axis and timing of branching of the frontal tip. Based on these experimental results and those reported previously, we propose a simple mathematical model for cell locomotion.	[Kuroda, Shigeru; Nakagaki, Toshiyuki; Ueda, Tetsuo] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Takagi, Seiji] Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan	Kuroda, S (reprint author), Hokkaido Univ, Res Inst Elect Sci, Kita Ku, N20W10, Sapporo, Hokkaido 0010020, Japan.	shigeru.kuroda@es.hokudai.ac.jp			Strategic Japanese-Swedish Research Cooperative Programme from JST; JSPS KAKENHI [26310202]; Mext Japan [25103006, 25111726]	This work was supported by the Strategic Japanese-Swedish Research Cooperative Programme from JST and by JSPS KAKENHI (grant no. 26310202), a Grant-in-Aid for Scientific Research on Innovative Areas 'Fluctuation and Structure' (no. 25103006) and 'Cross talk between moving cells and microenvironment' (no. 25111726) from Mext Japan.	Alexopoulos C., 1996, INTRO MYCOLOGY; Ueda K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021916; INOUYE K, 1979, PROTOPLASMA, V99, P289, DOI 10.1007/BF01275802; UEDA T, 1980, EUR J CELL BIOL, V23, P37; Matsumoto K, 2008, BIOPHYS J, V94, P2492, DOI 10.1529/biophysj.107.113050; Rodiek B, 2015, EUR BIOPHYS J BIOPHY, V44, P349, DOI 10.1007/s00249-015-1028-7; Rieu JP, 2005, BIOPHYS J, V89, P3563, DOI 10.1529/biophysj.104.056333; AKITAYA T, 1985, J GEN MICROBIOL, V131, P195; Coggin SJ, 1996, PROTOPLASMA, V194, P243, DOI 10.1007/BF01882031; ISHIGAMI M, 1987, J CELL BIOL, V105, P381, DOI 10.1083/jcb.105.1.381; MORI Y, 1986, PROTOPLASMA, V135, P31, DOI 10.1007/BF01277050; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; KAWAHARA T, 1983, PHYS LETT A, V97, P311, DOI 10.1016/0375-9601(83)90648-5; UEDA T, 1982, J THEOR BIOL, V97, P87, DOI 10.1016/0022-5193(82)90280-6; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; UEDA T, 1975, J GEN PHYSIOL, V65, P223, DOI 10.1085/jgp.65.2.223; Ashworth J., 1975, BIOL SLIME MOULDS; Barenblatt G, 2003, SCALING; Calder WA, 1996, SIZE FUNCTION LIFE H; de Gennes P. G., 2004, CAPILLARITY WETTING; Kamiya N., 1959, PROTOPLASMIC STRE 3A, V8, P1; Kessler D, 1982, CELL BIOL PHYSARUM D, V1, P145; McMahon T. A., 1983, SIZE LIFE; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband W.S., 1997, IMAGEJ; Rohlf F.J., 1994, BIOMETRY PRINCIPLES; SCHMIDT-NIELSEN K., 1984, SCALING WHY IS ANIMA; Shingleton A., 2010, NAT ED KNOWL, V1, P2; Takagi S., 2007, TOPOLOGICAL ASPECTS, P86, DOI 10.1142/9789812708687_0011; Ueda T., 2006, WORLD SCI LECT NOTES, V3, P221; Vouk V., 1910, SITZ KAIS ACAD WISS, V119, P853	31	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	DEC	2015	218	23					3729	3738		10.1242/jeb.124354		10	Biology	Life Sciences & Biomedicine - Other Topics	CX5PR	WOS:000365754900010		
J	Puneeta, P; Vijai, D; Yoo, HK; Matsui, H; Sakurai, Y				Puneeta, Pandey; Vijai, Dharmamony; Yoo, Hae-Kyun; Matsui, Hajime; Sakurai, Yasunori			Observations on the spawning behavior, egg masses and paralarval development of the ommastrephid squid Todarodes pacificus in a laboratory mesocosm	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Spawning behavior; Egg mass; Thermocline; Paralarvae; Todarodes pacificus	JAPANESE COMMON SQUID; ARTIFICIAL FERTILIZATION; EMBRYONIC-DEVELOPMENT; RHYNCHOTEUTHION PARALARVAE; OCTOPUS-VULGARIS; DOSIDICUS-GIGAS; DIGESTIVE-TRACT; CEPHALOPODA; BARTRAMII; TEMPERATURE	The spawning behavior of ommastrephid squids has never been observed under natural conditions. Previous laboratory observations of Japanese flying squid (Todarodes pacificus) suggest that prespawning females might rest on the continental shelf or slope before they ascend above the pycnocline to spawn, and that the egg masses might settle in the pycnocline. Here, two mesocosm experiments were conducted in a 300 m(3) tank that was 6 m deep to investigate this hypothesis. In the first experiment, a thermocline (2.5-3.5 m) was established in the tank by creating a thermally stratified (17-22 degrees C) water column. In the second experiment, the temperature was uniform (22 degrees C) at all depths. Prior to spawning, females did not rest on the tank floor. In the stratified water column, egg masses remained suspended in the thermocline, but in an unstratified water column, they settled on the tank bottom, collapsed and were infested by microbes, resulting in abnormal or nonviable embryos. Eleven females spawned a total of 18 egg masses (17-80 cm in diameter), indicating that females can spawn more than once when under stress. Paralarvae hatched at stage 30/31 and survived for up to 10 days, allowing us to observe the most advanced stage of paralarvae in captivity. Paralarvae survived after consumption of the inner yolk, suggesting they might have fed in the tank.	[Puneeta, Pandey; Vijai, Dharmamony; Yoo, Hae-Kyun; Matsui, Hajime; Sakurai, Yasunori] Hokkaido Univ, Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Puneeta, P (reprint author), Hokkaido Univ, Sch Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	puneeta83@gmail.com			Hokkaido University, Japan	This study was funded by Hokkaido University, Japan.	Vijai D, 2015, ZOOMORPHOLOGY, V134, P417, DOI 10.1007/s00435-015-0267-6; Arkhipkin AI, 2015, REV FISH SCI AQUAC, V23, P92, DOI 10.1080/23308249.2015.1026226; Bower JR, 1999, MAR BIOL, V135, P99, DOI 10.1007/s002270050606; Kidokoro H, 2008, FISHERIES SCI, V74, P553, DOI 10.1111/j.1444-2906.2008.01558.x; Villanueva R, 2011, J EXP MAR BIOL ECOL, V407, P54, DOI 10.1016/j.jembe.2011.07.012; Ohizumi H, 2000, MAR ECOL PROG SER, V200, P265, DOI 10.3354/meps200265; Sakurai Y, 2000, ICES J MAR SCI, V57, P24, DOI 10.1006/jmsc.2000.0667; Yoo HK, 2014, FISHERIES SCI, V80, P925, DOI 10.1007/s12562-014-0767-1; von Boletzky S, 1998, OCEANOGR MAR BIOL<D>, V36, P341; Shigeno S, 2001, ZOOL SCI, V18, P1011, DOI 10.2108/zsj.18.1011; Vidal EAG, 1998, B MAR SCI, V63, P305; Vijai D, 2015, MAR ECOL PROG SER, V529, P145, DOI 10.3354/meps11286; Yatsu A, 1999, FISHERIES SCI, V65, P904; Nishikawa H, 2014, FISH OCEANOGR, V23, P289, DOI 10.1111/fog.12064; Rosa AL, 2011, ICES J MAR SCI, V68, P1114, DOI 10.1093/icesjms/fsr037; IKEDA Y, 1993, INVERTEBR REPROD DEV, V23, P39, DOI 10.1080/07924259.1993.9672291; Kimura S, 2004, J MOLLUS STUD, V70, P117, DOI 10.1093/mollus/70.2.117; Bower JR, 1996, AM MALACOL BULL, V13, P65; Vidal EAG, 2002, B MAR SCI, V71, P915; O'Shea S, 2004, NEW ZEAL J ZOOL, V31, P161; Uchikawa K, 2009, FISHERIES SCI, V75, P317, DOI 10.1007/s12562-008-0036-2; VECCHIONE M, 1991, B MAR SCI, V49, P300; SAKURAI Y, 1995, VELIGER, V38, P185; ANDREWS PLR, 1983, J MAR BIOL ASSOC UK, V63, P109; Yamamoto Jun, 2012, Bulletin of the Japanese Society of Fisheries Oceanography, V76, P18; Tamura T, 2002, ICES J MAR SCI, V59, P516, DOI 10.1006/jmsc.2002.1199; Watanabe K, 1996, AM MALACOL BULL, V13, P73; Sakai M, 1998, S AFR J MARINE SCI, V20, P255; Staaf DJ, 2008, J MAR BIOL ASSOC UK, V88, P759, DOI 10.1017/S0025315408001422; Yamamoto J, 2002, B MAR SCI, V71, P987; Roura A, 2012, MAR BIOL, V159, P1335, DOI 10.1007/s00227-012-1914-9; Kishi MJ, 2009, J MARINE SYST, V78, P278, DOI 10.1016/j.jmarsys.2009.02.012; BALCH N, 1985, Vie et Milieu, V35, P243; Blake R. W., 1983, FISH LOCOMOTION; Bower J. R., 1997, THESIS; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Cheslin M. V., 1993, OCEANOLOGY, V33, P98; FAO, 2014, FAO YB FISH AQ SAT; Hamabe M., 1966, Bulletin of the Japan Sea Regional Fisheries Research Laboratory, V16, P13; Hamabe M., 1962, Bulletin of the Japan Sea Regional Fisheries Research Laboratory, V10, P1; Hamabe M., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P930; Harrop J, 2014, J NAT HIST, V48, P2501, DOI 10.1080/00222933.2014.937367; Ikeda Yuzuru, 1993, P179; Laptikhovsky V. V., 1990, BIOL MORYA, V3, P62; Nigmatullin Ch.M., 1994, Ruthenica, V4, P79; NIXON M, 1985, Vie et Milieu, V35, P255; O'DOR R K, 1985, Vie et Milieu, V35, P267; O'Dor R. K., 1985, NAFO SCI COUN STUDIE, V9, P69; O'Dor R. K., 1982, N ATL FISH ORG SCI C, V8, P1; Okutani T., 1968, Bulletin of the Tokai Regional Fisheries Research Laboratory, VNo. 55, P9; Okutani T., 1983, CEPHALOPOD LIFE CYCL, VI, P201; Sakurai Y., 2006, GLOBEC REPORT, V24, P33; Sakurai Y., 2015, PICES NEWSL, V23, P37; Sakurai Y., 2013, ADV SQUID BIOL ECO 2, P249; Soeda J., 1956, Bulletin of the Hokkaido Regional Fisheries Research Laboratory, VNo. 14, P1; Vijai D., 2015, THESIS; Villanueva R., 2014, CEPHALOPOD CULTURE, P479; WATANABE TAISUKE, 1965, BULL TOKAI REG FISH RES LAB, V43, P1	58	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	DEC	2015	218	23					3825	3835		10.1242/jeb.127670		11	Biology	Life Sciences & Biomedicine - Other Topics	CX5PR	WOS:000365754900021		
J	Ando, N; Kanzaki, R				Ando, Noriyasu; Kanzaki, Ryohei			A simple behaviour provides accuracy and flexibility in odour plume tracking - the robotic control of sensory-motor coupling in silkmoths	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Odour-source localization; Corollary discharge; Reafference; Chemotaxis; Optomotor response; Sensory-motor integration	FINE-SCALE STRUCTURE; MALE SILKWORM MOTH; BOMBYX-MORI; DROSOPHILA-MELANOGASTER; DESCENDING INTERNEURONS; PHEROMONE ORIENTATION; CONTROL MECHANISMS; FLIGHT CONTROL; SEX-PHEROMONE; FLYING MOTHS	Odour plume tracking is an essential behaviour for animal survival. A fundamental strategy for this is to move upstream and then across-stream. Male silkmoths, Bombyx mori, display this strategy as a preprogrammed sequential behaviour. They walk forward (surge) in response to the female sex pheromone and perform a zigzagging 'mating dance'. Though pre-programmed, the surge direction is modulated by bilateral olfactory input and optic flow. However, the nature of the interaction between these two sensory modalities and contribution of the resultant motor command to localizing an odour source are still unknown. We evaluated the ability of the silkmoth to localize an odour source under conditions of disturbed sensory-motor coupling, using a silkmoth-driven mobile robot. The significance of the bilateral olfaction of the moth was confirmed by inverting the olfactory input to the antennae, or its motor output. Inversion of the motor output induced consecutive circling, which was inhibited by covering the visual field of the moth. This suggests that the corollary discharge from the motor command and the reafference of self-generated optic flow generate compensatory signals to guide the surge accurately. Additionally, after inverting the olfactory input, the robot successfully tracked the odour plume by using a combination of behaviours. These results indicate that accurate guidance of the reflexive surge by integrating bilateral olfactory and visual information with innate pre-programmed behaviours increases the flexibility to track an odour plume even under disturbed circumstances.	[Ando, Noriyasu; Kanzaki, Ryohei] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Ando, N (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan.	ando@brain.imi.i.u-tokyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [22700197, 24650090]	This work was supported by the Japan Society for the Promotion of Science KAKENHI [grant numbers 22700197, 24650090 to N.A.].	Duistermars BJ, 2009, CURR BIOL, V19, P1301, DOI 10.1016/j.cub.2009.06.022; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; MARTIN H, 1965, NATURE, V208, P59, DOI 10.1038/208059a0; Kaissling KE, 1997, EXS, V84, P343; TOBIN TR, 1981, SCIENCE, V214, P1147, DOI 10.1126/science.214.4525.1147; Kramer E, 1997, INSECT PHEROMONE RESEARCH, P232; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Mishima T, 1999, J COMP PHYSIOL A, V184, P143, DOI 10.1007/s003590050314; Pansopha P, 2014, J EXP BIOL, V217, P1811, DOI 10.1242/jeb.090266; KANZAKI R, 1992, ZOOL SCI, V9, P515; Ando N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/1/016008; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; MURLIS J, 1981, PHYSIOL ENTOMOL, V6, P71, DOI 10.1111/j.1365-3032.1981.tb00262.x; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Takasaki T, 2012, J COMP PHYSIOL A, V198, P295, DOI 10.1007/s00359-011-0708-8; REEDER PB, 1980, ANIM BEHAV, V28, P831, DOI 10.1016/S0003-3472(80)80143-6; Loudon C, 2000, J EXP BIOL, V203, P2977; Kanzaki R, 1998, J COMP PHYSIOL A, V182, P267, DOI 10.1007/s003590050177; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; Gatellier L, 2004, J EXP BIOL, V207, P2487, DOI 10.1242/jeb.01035; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; BORST A, 1982, J COMP PHYSIOL, V147, P479; Chow DM, 2008, J EXP BIOL, V211, P2478, DOI 10.1242/jeb.018879; KENNEDY JS, 1974, SCIENCE, V184, P999, DOI 10.1126/science.184.4140.999; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464; Gaudry Q, 2013, NATURE, V493, P424, DOI 10.1038/nature11747; KENNEDY JS, 1983, PHYSIOL ENTOMOL, V8, P109, DOI 10.1111/j.1365-3032.1983.tb00340.x; Gaudry Q, 2012, CURR OPIN NEUROBIOL, V22, P216, DOI 10.1016/j.conb.2011.12.010; Wada S, 2005, J COMP NEUROL, V484, P168, DOI 10.1002/cne.20452; BAKER TC, 1988, J EXP BIOL, V137, P29; Willis MA, 2005, J EXP BIOL, V208, P721, DOI 10.1242/jeb.01418; Dickerson BH, 2014, J EXP BIOL, V217, P2301, DOI 10.1242/jeb.103770; TOBIN TR, 1986, J COMP PHYSIOL A, V158, P729, DOI 10.1007/BF00603831; OLBERG RM, 1983, J COMP PHYSIOL, V152, P297; Kanzaki R, 1996, ZOOL SCI, V13, P79, DOI 10.2108/zsj.13.79; WILLIS MA, 1987, J INSECT PHYSIOL, V33, P875, DOI 10.1016/0022-1910(87)90036-9; Catania KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2444; Emoto S., 2007, J ROBOTICS MECHATRON, V19, P436; Fujiwara T, 2014, J NEUROSCI, V34, P16581, DOI 10.1523/JNEUROSCI.2319-14.2014; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; HANGART.W, 1967, Z VERGL PHYSIOL, V57, P103, DOI 10.1007/BF00303068; HOLM S, 1979, SCAND J STAT, V6, P65; Kanzaki R., 2007, INTERNAT C SER, V1301, P7, DOI 10.1016/j.ics.2006.12.037; Kramer E., 1975, OLFACTION TASTE, V5, P329; Namiki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6919; Pinheiro J., 2013, R PACKAGE VERSION, P1; R Development Core Team, 2010, R LANG ENV STAT COMP; Therneau T.M., 2014, PACKAGE SURVIVAL ANA; van Breugel F, 2014, CURR BIOL, V24, P274, DOI 10.1016/j.cub.2013.12.023; Willis Mark A, 2008, Navigation. Journal of the Institute of Navigation, V55	54	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	DEC	2015	218	23					3845	3854		10.1242/jeb.124834		10	Biology	Life Sciences & Biomedicine - Other Topics	CX5PR	WOS:000365754900023		
J	Ford, BQ; Dmitrieva, JO; Heller, D; Chentsova-Dutton, Y; Grossmann, I; Tamir, M; Uchida, Y; Koopmann-Holm, B; Floerke, VA; Uhrig, M; Bokhan, T; Mauss, IB				Ford, Brett Q.; Dmitrieva, Julia O.; Heller, Daniel; Chentsova-Dutton, Yulia; Grossmann, Igor; Tamir, Maya; Uchida, Yukiko; Koopmann-Holm, Birgit; Floerke, Victoria A.; Uhrig, Meike; Bokhan, Tatiana; Mauss, Iris B.			Culture Shapes Whether the Pursuit of Happiness Predicts Higher or Lower Well-Being	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL			English	Article						happiness; well-being; culture	MEASUREMENT INVARIANCE; LIFE SATISFACTION; VALUING HAPPINESS; UNITED-STATES; SELF-ESTEEM; EMOTIONS; COLLECTIVISM; INDIVIDUALISM; COVARIANCE; VALIDATION	Pursuing happiness can paradoxically impair well-being. Here, the authors propose the potential down-sides to pursuing happiness may be specific to individualistic cultures. In collectivistic (vs. individualistic) cultures, pursuing happiness may be more successful because happiness is viewed-and thus pursued-in relatively socially engaged ways. In 4 geographical regions that vary in level of collectivism (United States, Germany, Russia, East Asia), we assessed participants' well-being, motivation to pursue happiness, and to what extent they pursued happiness in socially engaged ways. Motivation to pursue happiness predicted lower well-being in the United States, did not predict well-being in Germany, and predicted higher well-being in Russia and in East Asia. These cultural differences in the link between motivation to pursue happiness and well-being were explained by cultural differences in the socially engaged pursuit of happiness. These findings suggest that culture shapes whether the pursuit of happiness is linked with better or worse well-being, perhaps via how people pursue happiness.	[Ford, Brett Q.; Mauss, Iris B.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Dmitrieva, Julia O.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Heller, Daniel] Tel Aviv Univ, Sch Management, IL-69978 Tel Aviv, Israel; [Chentsova-Dutton, Yulia] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Grossmann, Igor] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Tamir, Maya] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Uchida, Yukiko] Kyoto Univ, Kokoro Res Ctr, Kyoto 6068501, Japan; [Koopmann-Holm, Birgit] Santa Clara Univ, Dept Psychol, Santa Clara, CA 95053 USA; [Floerke, Victoria A.] Tufts Univ, Dept Psychol, Medford, MA USA; [Uhrig, Meike] Univ Tubingen, Dept Media Studies, Tubingen, Germany; [Bokhan, Tatiana] Tomsk State Univ, Dept Psychol, Tomsk, Russia	Ford, BQ (reprint author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	brett.q.ford@berkeley.edu			Greater Good Science Center (Berkeley, CA); Affective Science Training Fellowship [5T32MH020006]	We thank Joshua Eng, Vivian Dzokoto, Shanmukh Kamble, Christie Napa-Scollon, Tatiana Panusheva, and Yen-chen Chang for their collaboration, and the Greater Good Science Center (Berkeley, CA) and Affective Science Training Fellowship (5T32MH020006) for research support to Brett Q. Ford.	Fernandez DR, 1997, J SOC PSYCHOL, V137, P43; Grossmann I, 2014, WIRES COGN SCI, V5, P1, DOI 10.1002/wcs.1267; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; Oishi S, 2013, PERS SOC PSYCHOL B, V39, P559, DOI 10.1177/0146167213480042; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P890, DOI 10.1037/0022-3514.91.5.890; Koopmann-Holm B, 2011, J CROSS CULT PSYCHOL, V42, P355, DOI 10.1177/0022022110362753; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Varnum MEW, 2010, CURR DIR PSYCHOL SCI, V19, P9, DOI 10.1177/0963721409359301; Matsumoto D, 1997, J CROSS CULT PSYCHOL, V28, P743, DOI 10.1177/0022022197286006; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Diener E, 1998, PSYCHOL INQ, V9, P33, DOI 10.1207/s15327965pli0901_3; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Harmon-Jones E, 2011, J PERS SOC PSYCHOL, V101, P1332, DOI 10.1037/a0024951; Suh EM, 2002, J PERS SOC PSYCHOL, V83, P1378, DOI 10.1037//0022-3514.83.6.1378; Fulmer CA, 2010, PSYCHOL SCI, V21, P1563, DOI 10.1177/0956797610384742; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Tsai JL, 2007, PERSPECT PSYCHOL SCI, V2, P242, DOI 10.1111/j.1745-6916.2007.00043.x; Diener E, 2009, SOC INDIC RES SER, V38, P71, DOI 10.1007/978-90-481-2352-0_4; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Grossmann I, 2012, J EXP PSYCHOL GEN, V141, P31, DOI 10.1037/a0023817; Diener E, 2005, PSYCHOL INQ, V16, P162, DOI 10.1207/s15327965pli1604_04; Helliwell JF, 2004, PHILOS T ROY SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Realo A, 1999, J SOC PSYCHOL, V139, P133; Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575; Mauss IB, 2012, EMOTION, V12, P908, DOI 10.1037/a0025299; Kitayama S, 2009, J PERS SOC PSYCHOL, V97, P236, DOI 10.1037/a0015999; McMahan EA, 2014, SOC INDIC RES, V119, P321, DOI 10.1007/s11205-013-0476-7; Mauss IB, 2011, EMOTION, V11, P807, DOI 10.1037/a0022010; Bastian B, 2014, EMOTION, V14, P639, DOI 10.1037/a0036466; Beck A. T., 1996, BECK DEPRESSION INVE; Brislin R. W, 1980, HDB CROSS CULTURAL P, V1, P389; Ford B. Q., 2014, LIGH DARK SIDES POSI, P363; Ford BQ, 2015, EMOTION, V15, P211, DOI 10.1037/emo0000048; Ford B. Q., 2014, J SOC CLIN PSYCHOL, V93, P891; Joshanloo M, 2014, J CROSS CULT PSYCHOL, V45, P246, DOI 10.1177/0022022113505357; Kuhnen U., 2001, J CROSS CULTURAL PSY, V32, P366, DOI [10.1177/0022022101032003007, DOI 10.1177/0022022101032003007]; Lama D., 1998, ART HAPPINESS HDB LI; Layous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051380; Lu Luo, 2004, J HAPPINESS STUD, V5, P269, DOI DOI 10.1007/S10902-004-8789-5; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Muthen L. K., 2015, MPLUS USERS GUIDE; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719, DOI 10.1037/0022-3514.69.4.719; Schooler J. W., 2003, PSYCHOL EC DECISIONS, P41	46	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0096-3445	1939-2222		J EXP PSYCHOL GEN	J. Exp. Psychol.-Gen.	DEC	2015	144	6					1053	1062		10.1037/xge0000108		10	Psychology, Experimental	Psychology	CX3QW	WOS:000365615200008		
J	Okamatsu-Ogura, Y; Tsubota, A; Ohygma, K; Nogusa, Y; Saito, M; Kimura, K				Okamatsu-Ogura, Yuko; Tsubota, Ayumi; Ohygma, Kana; Nogusa, Yoshihito; Saito, Masayuki; Kimura, Kazuhiro			Capsinoids suppress diet-induced obesity through uncoupling protein 1-dependent mechanism in mice	JOURNAL OF FUNCTIONAL FOODS			English	Article						Capsinoids; Uncoupling protein 1; Brown adipose tissue; White adipose tissue; Diet-induced obesity; Beige adipocytes	BROWN ADIPOSE-TISSUE; CAPSAICIN ANALOGS CAPSINOIDS; ENERGY-EXPENDITURE; ADULT HUMANS; SUBSTRATE UTILIZATION; PUNGENT PRINCIPLE; CAPSICUM FRUITS; FAT DEVELOPMENT; BEIGE FAT; METABOLISM	Capsinoids are less pungent capsaicin analogues that increase whole body energy expenditure and hence reduce fat. Several studies have suggested that capsinoids activate brown adipose tissue (BAT), a major site of adaptive thermogenesis, but the actual contribution of BAT and uncoupling protein 1 (UCP1), a thermogenic protein expressed in BAT, to the fat-reducing effect of capsinoids has not yet been determined. Here, we investigated the effect of capsinoids on high-fat diet (HFD)-induced obesity using wild-type (WT) and UCP1-deficient (KO) mice. Capsinoids feeding potently suppressed HFD-induced increase in body weight, adiposity, and fatty liver development in WT mice. In contrast, such effects of capsinoids were completely abolished in UCP1-KO mice. Moreover, capsinoids significantly increased UCP1 protein expression in BAT without its apparent induction in white adipose tissue (WAT) in WT mice. These results indicate that capsinoids suppress diet-induced obesity of mice through the UCP1 function in BAT but not in WAT. (C) 2015 Elsevier Ltd. All rights reserved.	[Okamatsu-Ogura, Yuko; Tsubota, Ayumi; Saito, Masayuki; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan; [Ohygma, Kana; Nogusa, Yoshihito] Ajinomoto Co Inc, Inst Innovat, Frontier Res Labs, Kanagawa, Japan	Okamatsu-Ogura, Y (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan.	y-okamatsu@vetmed.hokudai.ac.jp			Northern Advancement Center for Science & Technology of Hokkaido Japan, JSPS KAKENHI [26860684]	We thank Dr. L. Kozak (Pennington Biomedical Research Center) for providing us with UCP1-KO mice and Dr. T. Kawada (Kyoto University) for the kind gift of the anti-UCP1 antibody. This study is supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan, JSPS KAKENHI Grant Number 26860684.	Kawabata F, 2009, BIOSCI BIOTECH BIOCH, V73, P2690, DOI 10.1271/bbb.90555; Faraut B, 2009, INT J OBESITY, V33, P1348, DOI 10.1038/ijo.2009.182; KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250; Masuda Y, 2003, J APPL PHYSIOL, V95, P2408, DOI 10.1152/japplphysiol.00828.2002; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Kobata K, 1999, J NAT PROD, V62, P335, DOI 10.1021/np9803373; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ono K, 2011, J APPL PHYSIOL, V110, P789, DOI 10.1152/japplphysiol.00128.2010; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; KAWADA T, 1991, J AGR FOOD CHEM, V39, P651, DOI 10.1021/jf00004a004; Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Belza A, 2009, METABOLISM, V58, P1137, DOI 10.1016/j.metabol.2009.03.013; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2735, DOI 10.1271/bbb.65.2735; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; KAWADA T, 1986, J NUTR, V116, P1272; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Inoue N, 2007, BIOSCI BIOTECH BIOCH, V71, P380, DOI 10.1271/bbb.60341; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Lowell BB, 2000, NATURE, V404, P652; Kozak LP, 2014, BBA-MOL BASIS DIS, V1842, P370, DOI 10.1016/j.bbadis.2013.04.025; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ohyama K, 2015, AM J PHYSIOL-ENDOC M, V308, P315; Okamatsu-Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084229; Josse AR, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-65; Saito Masayuki, 2013, Diabetes Metab J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Okamatsu-Ogura Yuko, 2007, Obes Res Clin Pract, V1, P223, DOI 10.1016/j.orcp.2007.08.001; WATANABE T, 1988, AM J PHYSIOL, V255, pE23; Yoshioka M, 1998, BRIT J NUTR, V80, P503	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	DEC	2015	19		A				1	9		10.1016/j.jff.2015.09.005		9	Food Science & Technology	Food Science & Technology	CX3XZ	WOS:000365634100001		
J	Udomsin, O; Juengwatanatrakul, T; Yusakul, G; Putalun, W				Udomsin, Orapin; Juengwatanatrakul, Thaweesak; Yusakul, Gorawit; Putalun, Waraporn			Chromene stability: The most potent estrogenic compounds in White Kwao Krua (Pueraria candollei var mirifica) crude extract	JOURNAL OF FUNCTIONAL FOODS			English	Article						HPLC (high-performance liquid chromatography); Stability; Deoxymiroestrol; Miroestrol; Isomiroestrol; Pueraria candollei var. mirifica crude extract	PHYTOESTROGEN-RICH-HERB; LINKED-IMMUNOSORBENT-ASSAY; VAGINAL CORNIFICATION; URINARY GONADOTROPIN; BONE LOSS; MIROESTROL; DEOXYMIROESTROL; MONKEYS; CELLS; RATS	Pueraria candollei var. mirifica (PM) is a phytoestrogen-rich herb with rejuvenating qualities. Stability of chromenes, comprising deoxymiroestrol, miroestrol and isomiroestrol, in crude extract of PM was investigated. The effects of acid-base condition and temperature on stability of the chromene standard solution and the PM crude extract were analysed using gradient HPLC. The degradation of the chromenes in the extract was sensitive to high temperatures and strongly acidic or alkaline solutions. Specifically, deoxymiroestrol, which exhibited the highest estrogenic activity, can be easy degraded to miroestrol or isomiroestrol. However, chromene standard solution was stable in ethanol after storage for 360 days at 25 degrees C. The crude extract of PM in the solid form was stable when stored at -20 or 4 degrees C for 360 days. Therefore, the extract could be stored in the solid form at low temperatures. This method provides a system to simultaneously identify chromenes in crude extract of PM. (C) 2015 Elsevier Ltd. All rights reserved.	[Udomsin, Orapin; Putalun, Waraporn] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand; [Udomsin, Orapin; Putalun, Waraporn] Khon Kaen Univ, Natl Res Univ, Res Grp Pharmaceut Act Nat Prod Using Pharmaceut, Khon Kaen 40002, Thailand; [Juengwatanatrakul, Thaweesak] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Ubon Ratchathani 34190, Thailand; [Yusakul, Gorawit] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan	Putalun, W (reprint author), Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand.	waraporn@kku.ac.th			Khon Kaen University in Thailand [570803]	This work was supported by Khon Kaen University in Thailand [570803]. We would also like to thank Assoc. Prof. Dr. Chaiyo Chaichantipyuth, Faculty of Pharmaceutical Sciences, Chulalongkorn University, and Dr. Orawan Monthakantirat, Faculty of Pharmaceutical Sciences, Khon Kaen University, for supplying the purified chromene standards.	Yusakul G, 2011, FITOTERAPIA, V82, P203, DOI 10.1016/j.fitote.2010.09.009; Cherdshewasart W, 2007, J PHARMACEUT BIOMED, V43, P428, DOI 10.1016/j.jpba.2006.07.013; Chansakaow S, 2000, PLANTA MED, V66, P572, DOI 10.1055/s-2000-8603; Chansakaow S, 2000, J NAT PROD, V63, P173, DOI 10.1021/np990547v; Malaivijitnond S, 2006, J ETHNOPHARMACOL, V107, P354, DOI 10.1016/j.jep.2006.03.026; Chandeying Verapol, 2007, Journal of the Medical Association of Thailand, V90, P1720; Yusakul G, 2013, TALANTA, V114, P73, DOI 10.1016/j.talanta.2013.04.011; Sahoo N, 2010, FITOTERAPIA, V81, P462, DOI 10.1016/j.fitote.2010.02.001; Cherdshewasart W, 2008, J REPROD DEVELOP, V54, P63, DOI 10.1262/jrd.19002; Urasopon N, 2008, MATURITAS, V59, P137, DOI 10.1016/j.maturitas.2008.01.001; Bang MH, 2013, CHEM NAT COMPD+, V49, P443, DOI 10.1007/s10600-013-0634-9; Bilia AR, 2001, INT J PHARM, V213, P199, DOI 10.1016/S0378-5173(00)00660-8; Trisomboon H, 2007, J REPROD DEVELOP, V53, P395, DOI 10.1262/jrd.18079; JONES HE, 1961, J ENDOCRINOL, V22, P293, DOI 10.1677/joe.0.0220293; Suphrom N, 2014, J PHARM PHARMACOL, V66, P1282, DOI 10.1111/jphp.12216; Matsumura A, 2005, J STEROID BIOCHEM, V94, P431, DOI 10.1016/j.jsbmb.2004.12.041; Trisomboon H, 2007, ANIM SCI J, V78, P378, DOI 10.1111/j.1740-0929.2007.00450.x; Yusakul G, 2013, ANAL CHIM ACTA, V785, P104, DOI 10.1016/j.aca.2013.04.053; Cherdshewasart W, 2007, J REPROD DEVELOP, V53, P385, DOI 10.1262/jrd.18065; Pholphana N, 2004, PHYTOCHEM ANALYSIS, V15, P365, DOI 10.1002/pca.789; Yamaguchi M, 1998, BIOCHEM PHARMACOL, V55, P71, DOI 10.1016/S0006-2952(97)00402-4; Urasopon N, 2007, MATURITAS, V56, P322, DOI 10.1016/j.maturitas.2006.09.007; Sugimoto E, 2000, BIOCHEM PHARMACOL, V59, P471, DOI 10.1016/S0006-2952(99)00351-2; Anusamsoondhom S., 1931, REMEDY PAMPHLET KWAO; Bodner C. C., 2002, PUERARIA GENUS PUERA, P29; Chattuwatthana T., 2015, European Journal of Medicinal Plants, V5, P318; Cherdshewasart W., 2008, PHYTOMEDICINE INT J, V5, P38; International Conference on Harmonisation, 2003, INT C HARM INT C HAR; Khitkal B., 2009, SURANAREE J SCI TECH, V17, P27; Lamlertkittikul Surachai, 2004, Journal of the Medical Association of Thailand, V87, P33; Malaivijitnond Suchinda, 2012, Front Med, V6, P8, DOI 10.1007/s11684-012-0184-8; Muangman V, 2001, SIRIRAJ HOSP GAZ, V53, P300; Office of Agricultural Economic, 2007, ANN RES REP THAI HER	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	DEC	2015	19		A				269	277		10.1016/j.jff.2015.09.036		9	Food Science & Technology	Food Science & Technology	CX3XZ	WOS:000365634100025		
J	Yamashita, H; Kusudo, T; Takeuchi, T; Qiao, SL; Tsutsumiuchi, K; Wang, T; Wang, YX				Yamashita, Hitoshi; Kusudo, Tatsuya; Takeuchi, Tamaki; Qiao, Shanlou; Tsutsumiuchi, Kaname; Wang, Ting; Wang, Youxue			Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice	JOURNAL OF FUNCTIONAL FOODS			English	Article						Evodiamine; Ageing; Obesity; Insulin resistance; Adipose tissue	ACTIVATED PROTEIN-KINASE; LIFE-SPAN; UCP1-DEFICIENT MICE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; S6 KINASE; ENERGY; FAT; AGE; PHOSPHORYLATION	Evodiamine is a major alkaloid extracted from the fruit of Evodia fructus, which reduces diet-induced obesity in young animals. We investigated the effects of long-term dietary supplementation with evodiamine on obesity, insulin resistance and longevity in normal ageing mice. Twelve-month-old C57BL/6J male mice were fed with standard chow with or without 1 or 10 mg evodiamine per kg food and maintained until death. Supplementation with low dose evodiamine prevented body weight gain and improved glucose tolerance in the mice, in which increased AMPK phosphorylation and down-regulation of mTOR signalling responsible for regulating energy metabolism were detected in white adipose tissue. However, evodiamine supplementation did not increase lifespan, and the high dose evodiamine caused excessive reduction in body weight, which could have side effects in aged animals. Thus, evodiamine at a low dose (1 mg/kg food) prevents obesity and insulin resistance even when ingestion begins in middle age. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamashita, Hitoshi; Kusudo, Tatsuya; Takeuchi, Tamaki; Qiao, Shanlou] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Tsutsumiuchi, Kaname] Chubu Univ, Dept Biol Chem, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan; [Wang, Ting] Iwate Med Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Morioka, Iwate 0208505, Japan; [Wang, Youxue] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Yamashita, H (reprint author), Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan.	hyamashi@isc.chubu.ac.jp; youxue.wang@utsouthwestern.edu			Ministry of Health, Labour and Welfare [15C-8]; MEXT-Supported program for the Strategic Research Foundation at private universities [S1201007]	We thank Ms. Y. Yamashita, Y Kadokawa and Dr. J. Yao for technical assistance. This work was supported by a Research Grant (15C-8) for Longevity Sciences from the Ministry of Health, Labour and Welfare (to H.Y.), and by a grant (S1201007) from the MEXT-Supported program for the Strategic Research Foundation at private universities (to H.Y.). The early phase of this study was performed at the Department of Molecular Genetics in the National Institute for Longevity Sciences.	Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Wang YX, 2006, PFLUG ARCH EUR J PHY, V452, P363, DOI 10.1007/s00424-005-0036-3; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Kopelman PG, 2000, NATURE, V404, P635; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35001102; Kobayashi Y, 2001, PLANTA MED, V67, P628, DOI 10.1055/s-2001-17353; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Summers SA, 1998, BIOCHEM BIOPH RES CO, V246, P76, DOI 10.1006/bbrc.1998.8575; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; CHIOU WF, 1992, EUR J PHARMACOL, V215, P277, DOI 10.1016/0014-2999(92)90039-7; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Mattson MP, 2010, AGEING RES REV, V9, P69, DOI 10.1016/j.arr.2009.11.004; Wang T, 2009, FEBS LETT, V583, P3655, DOI 10.1016/j.febslet.2009.10.046; Ching LC, 2012, MOL MED, V18, P805, DOI 10.2119/molmed.2011.00461; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Schwarz NA, 2013, NUTR RES, V33, P1034, DOI 10.1016/j.nutres.2013.08.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ko HJ, 2015, J FUNCT FOODS, V17, P271, DOI 10.1016/j.jff.2015.05.033; Heo SK, 2009, J CELL BIOCHEM, V107, P123, DOI 10.1002/jcb.22109; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Wei J, 2013, ACTA PHYSIOL, V207, P299, DOI 10.1111/apha.12005; Yamashita H, 2014, CELL CYCLE, V13, P2801, DOI 10.4161/15384101.2014.954213; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Bak E. J., 2010, INT J OBESITY, V163, P250; Kim Y, 2015, J FUNCT FOODS, V12, P509, DOI 10.1016/j.jff.2014.12.004; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083264; Yoshizumi Masanori, 1997, Journal of Medical Investigation, V44, P79	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	DEC	2015	19		A				320	329		10.1016/j.jff.2015.09.032		10	Food Science & Technology	Food Science & Technology	CX3XZ	WOS:000365634100030		
J	Fujiwara, Y; Shiraishi, D; Yoshitomi, M; Ikeda, T; Mizuta, H; Takeya, M; Komohara, Y				Fujiwara, Yukio; Shiraishi, Daisuke; Yoshitomi, Makiko; Ikeda, Tsuyoshi; Mizuta, Hiroshi; Takeya, Motohiro; Komohara, Yoshihiro			Soyasapogenols contained in soybeans suppress tumour progression by regulating macrophage differentiation into the protumoural phenotype	JOURNAL OF FUNCTIONAL FOODS			English	Article						Soybean; Soyasapogenol; Macrophage; STAT3; Tumour cells	GLIOBLASTOMA CELL-PROLIFERATION; SIGNAL TRANSDUCER; POOR-PROGNOSIS; STRUCTURAL ELUCIDATION; HUMAN GLIOMAS; STAT3; CANCER; GROWTH; TRANSCRIPTION-3; ACTIVATION	Tumour-associated macrophages (TAMs) polarized to the protumoural M2 phenotype promote tumour proliferation and are considered to be a therapeutic target in patients with malignant tumours. In this study, we tried to identify natural compounds that inhibit TAM polarization into the M2 phenotype. We found that an extract of soybeans suppressed M2 polarization, and that soyasapogenols, major compounds contained in soybeans, significantly inhibited the M2 polarization and increased the secretion of IL-12 produced by M1 macrophages. Soyasapogenols suppressed the activation of STAT3 in both macrophages and tumour cells, and inhibited the proliferation of U373, SaOS2 and LM8 tumour cells. Furthermore, oral administration of soyasapogenol B significantly suppressed both subcutaneous tumour development and lung metastasis in a LM8 tumour-bearing mice. An anti-tumour immune response was also induced by the administration of soyasapogenol B. Therefore, soyasapogenols may represent new agents that can be used for the prevention and/or treatment of various malignant tumours. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujiwara, Yukio; Shiraishi, Daisuke; Yoshitomi, Makiko; Takeya, Motohiro; Komohara, Yoshihiro] Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Kumamoto 8608556, Japan; [Shiraishi, Daisuke; Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Dept Orthopaed Surg, Kumamoto 8608556, Japan; [Ikeda, Tsuyoshi] Sojo Univ, Fac Pharmaceut Sci, Ikeda, Kumamoto 8600082, Japan	Komohara, Y (reprint author), Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Dept Cell Pathol, Honjo 1-1-1, Kumamoto, Kumamoto 8608556, Japan.	ycomo@kumamoto-u.ac.jp			JSPS KAKENHI [25293089, 25460497, 25860501]; Takano Life Science Research Foundation; Fuji Foundation	We thank Dr. Koji Ohnishi, Mr. Takenobu Nakagawa, Mrs. Emi Kiyota and Ms. Yui Hayashida for their technical assistance. This work was supported by JSPS KAKENHI Grant Number 25293089, 25460497 and 25860501. This work was supported by Grant-in-Aid for Young Scientists from Takano Life Science Research Foundation and from Fuji Foundation for Protein Research.	Abou-Ghazal M, 2008, CLIN CANCER RES, V14, P8228, DOI 10.1158/1078-0432.CCR-08-1329; Ikeda T, 2005, BIOL PHARM BULL, V28, P1779, DOI 10.1248/bpb.28.1779; Fujiwara Y, 2011, ONCOL REP, V26, P1533, DOI 10.3892/or.2011.1454; Hasegawa H, 1998, PLANTA MED, V64, P696, DOI 10.1055/s-2006-957560; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; KUDOU S, 1992, BIOSCI BIOTECH BIOCH, V56, P142, DOI 10.1271/bbb.56.142; KUDOU S, 1991, AGR BIOL CHEM TOKYO, V55, P2227; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Duan HO, 2006, J BIOL CHEM, V281, P12451, DOI 10.1074/jbc.M600294200; Espinosa I, 2009, AM J PATHOL, V174, P2347, DOI 10.2353/ajpath.2009.081037; Mantovani A, 2003, TUMORI, V89, P459; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Kinjo J, 2000, BIOL PHARM BULL, V23, P887; Kamo S, 2014, NUTRITION, V30, P596, DOI 10.1016/j.nut.2013.10.017; Kong LY, 2010, CLIN CANCER RES, V16, P5722, DOI 10.1158/1078-0432.CCR-10-1693; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Fujiwara Y, 2011, CANCER SCI, V102, P206, DOI 10.1111/j.1349-7006.2010.01772.x; Horlad H, 2013, MOL NUTR FOOD RES, V57, P1046, DOI 10.1002/mnfr.201200610; Fujiwara Y, 2013, ONCOL LETT, V6, P1619, DOI 10.3892/ol.2013.1591; KUDOU S, 1993, BIOSCI BIOTECH BIOCH, V57, P546; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Clear AJ, 2010, BLOOD, V115, P5053, DOI 10.1182/blood-2009-11-253260; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Kida H, 1997, BIOL PHARM BULL, V20, P1274; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Gao L, 2010, INT J RADIAT ONCOL, V77, P1223, DOI 10.1016/j.ijrobp.2009.12.036; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Sica A., 2010, Experimental Oncology, V32, P153; Fuh B, 2009, BRIT J CANCER, V100, P106, DOI 10.1038/sj.bjc.6604793; Fujiwara Y, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/348539; Gordon S., 2003, NAT REV IMMUNOL, V3, P23, DOI DOI 10.1038/NRI978; Shimoyamada M. K. S., 1990, AGR BIOL CHEM TOKYO, V54, P71	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	DEC	2015	19		A				594	605		10.1016/j.jff.2015.09.055		12	Food Science & Technology	Food Science & Technology	CX3XZ	WOS:000365634100056		
J	Yoshimura, Y				Yoshimura, Yasuhiro			Optimal Fault-Tolerant Configurations of Control Moment Gyros	JOURNAL OF GUIDANCE CONTROL AND DYNAMICS			English	Article							RIGID SPACECRAFT; STABILIZATION; POINTS; SPHERE		[Yoshimura, Yasuhiro] Tokyo Metropolitan Univ, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan	Yoshimura, Y (reprint author), Tokyo Metropolitan Univ, Dept Aerosp Engn, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.	yyoshi@tmu.ac.jp			 [26820372]	This work was supported by Grants-in-Aid for Scientific Research (no. 26820372).	Tsiotras P, 2000, J ASTRONAUT SCI, V48, P337; Saff EB, 1997, MATH INTELL, V19, P5; Peake MJ, 2014, ENG ANAL BOUND ELEM, V40, P114, DOI 10.1016/j.enganabound.2013.11.020; Gui HC, 2013, CHINESE J AERONAUT, V26, P1218, DOI 10.1016/j.cja.2013.04.042; Morin P, 1997, IEEE T AUTOMAT CONTR, V42, P528, DOI 10.1109/9.566663; Thomson JJ, 1904, PHILOS MAG, V7, P237, DOI 10.1080/14786440409463107; Bhat SP, 2009, IEEE T AUTOMAT CONTR, V54, P585, DOI 10.1109/TAC.2008.2008324; KRISHNAN H, 1995, J GUID CONTROL DYNAM, V18, P256, DOI 10.2514/3.21378; Bayadi R., 2011, P 18 IFAC WORLD C MI, P13828, DOI 10.3182/20110828-6-it-1002.01313; CROUCH PE, 1984, IEEE T AUTOMAT CONTR, V29, P321, DOI 10.1109/TAC.1984.1103519; Kim Donghoon, 2013, J GUIDANCE CONTROL D, V36, P1855; Lakhbab H., 2012, APPL MATH SCI, V6, P1487; Leve F., 2009, AIAA AER C, DOI [10.2514/6.2009-1836, DOI 10.2514/6.2009-1836]; Noumi A., 2013, AIAA GUID NAV CONTR, DOI [10.2514/6.2013-5119, DOI 10.2514/6.2013-5119]; ORIOLO G, 1991, PROCEEDINGS OF THE 30TH IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-3, P2398, DOI 10.1109/CDC.1991.261620; Saleh J. H., 2011, SPACECRAFT RELIABILI, P71, DOI [10.1002/9781119994077.ch5, DOI 10.1002/9781119994077.CH5]; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Wichlund K. Y., 1995, Proceedings of the Third European Control Conference. ECC 95; Yoshikawa T., 1985, IEEE T ROBOTIC AUTOM, P1033, DOI [10.1109/ROBOT.1985.1087277, DOI 10.1109/ROBOT.1985.1087277]	19	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0731-5090	1533-3884		J GUID CONTROL DYNAM	J. Guid. Control Dyn.	DEC	2015	38	12					2460	2466		10.2514/1.G001249		7	Engineering, Aerospace; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CX5ML	WOS:000365745700019		
J	Isono, H; Mandal, G; Morita, T				Isono, Hiroshi; Mandal, Gautam; Morita, Takeshi			Thermodynamics of QCD from Sakai-Sugimoto model	JOURNAL OF HIGH ENERGY PHYSICS			English	Article						Gauge-gravity correspondence; Holography and quark-gluon plasmas; Phase Diagram of QCD	HOLOGRAPHIC QCD; QUANTUM CHROMODYNAMICS; FINITE-TEMPERATURE	Till date, the only consistent description of the deconfinement phase of the Sakai-Sugimoto model appears to be provided by the analysis of [1]. The current version of the analysis, however, has a subtlety regarding the monodromy of quarks around the Euclidean time circle. In this note, we revisit and resolve this issue by considering the effect of an imaginary baryon chemical potential on quark monodromies. With this ingredient, the proposal of [1] for investigating finite temperature QCD using holography is firmly established. Additionally, our technique allows a holographic computation of the free energy as a function of the imaginary chemical potential in the deconfinement phase; we show that our result agrees with the corresponding formula obtained from perturbative QCD, namely the Roberge-Weiss potential.	[Isono, Hiroshi] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Isono, Hiroshi] Chulalongkorn Univ, Fac Sci, Particle Phys Res Lab, Dept Phys, Bangkok 10330, Thailand; [Mandal, Gautam] Tata Inst Fundamental Res, Dept Theoret Phys, Mumbai 400005, Maharashtra, India; [Morita, Takeshi] Shizuoka Univ, Dept Phys, Suruga Ku, Shizuoka 4228529, Japan	Isono, H (reprint author), Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan.	hiroshi.isono81@gmail.com; mandal@theory.tifr.res.in; morita.takeshi@shizuoka.ac.jp			Iwanami Fujukai; JSPS [15K17643]	The authors would like to thank Yoshimasa Hidaka for discussions about imaginary chemical potential. The work of H. I. is supported by Iwanami Fujukai. The work of T. M. is supported in part by Grant-in-Aid for Scientific Research (No. 15K17643) from JSPS.	Aharony O, 1998, J HIGH ENERGY PHYS; GOCKSCH A, 1983, PHYS REV LETT, V50, P1099, DOI 10.1103/PhysRevLett.50.1099; Chen F, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.041901; Aharony O, 2007, ANN PHYS-NEW YORK, V322, P1420, DOI 10.1016/j.aop.2006.11.002; Kashiwa K, 2015, PHYS LETT B, V750, P282, DOI 10.1016/j.physletb.2015.09.036; ROBERGE A, 1986, NUCL PHYS B, V275, P734, DOI 10.1016/0550-3213(86)90582-1; EGUCHI T, 1982, PHYS REV LETT, V48, P1063, DOI 10.1103/PhysRevLett.48.1063; Aharony O, 2000, PHYS REP, V323, P183, DOI 10.1016/S0370-1573(99)00083-6; Sakai T, 2005, PROG THEOR PHYS, V113, P843, DOI 10.1143/PTP.113.843; Azuma T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.091603; Hanada M, 2015, NUCL PHYS B, V899, P631, DOI 10.1016/j.nuclphysb.2015.08.018; GREGORY R, 1994, NUCL PHYS B, V428, P399, DOI 10.1016/0550-3213(94)90206-2; Kim KY, 2013, J KOREAN PHYS SOC, V63, P1515, DOI 10.3938/jkps.63.1515; Kim Y, 2013, PROG PART NUCL PHYS, V68, P55, DOI 10.1016/j.ppnp.2012.09.002; Bergman O, 2007, J HIGH ENERGY PHYS; COLEMAN S, 1976, ANN PHYS-NEW YORK, V101, P239, DOI 10.1016/0003-4916(76)90280-3; Dasgupta K, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2015)122; Horigome N, 2007, J HIGH ENERGY PHYS; Itzhaki N, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.046004; Maldacena J, 2001, J HIGH ENERGY PHYS; Maldacena J.M., 1998, ADV THEOR MATH PHYS, V2, p[231, 1113], DOI DOI 10.1023/A:1026654312961; Mandal G, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2011)073; Morita T, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2015)047; Polyakov A. M., 1987, CONT CONCEPTS PHYS, V3; Rafferty J, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2011)087; Rebhan A, 2015, EPJ WEB CONF, V95, DOI 10.1051/epjconf/20159502005; Rozah M, 2008, J HIGH ENERGY PHYS; Sin SJ, 2007, J HIGH ENERGY PHYS; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI DOI 10.1016/S0370-1573(99)00083-6; WITTEN E, 1979, NUOVO CIMENTO A, V51, P325, DOI 10.1007/BF02776593; Witten E, 1998, J HIGH ENERGY PHYS; Yamada D, 2008, J HIGH ENERGY PHYS; Yee HU, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/04/029	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8479			J HIGH ENERGY PHYS	J. High Energy Phys.	DEC 1	2015		12							006	10.1007/JHEP12(2015)006		19	Physics, Particles & Fields	Physics	CX7HI	WOS:000365872400001		
J	Kawano, H; Nishijima, H; Morimoto, J; Hirota, F; Morita, R; Mouri, Y; Nishioka, Y; Matsumoto, M				Kawano, Hiroshi; Nishijima, Hitoshi; Morimoto, Junko; Hirota, Fumiko; Morita, Ryoko; Mouri, Yasuhiro; Nishioka, Yasuhiko; Matsumoto, Mitsuru			Aire Expression Is Inherent to Most Medullary Thymic Epithelial Cells during Their Differentiation Program	JOURNAL OF IMMUNOLOGY			English	Article							PROMISCUOUS GENE-EXPRESSION; DENDRITIC CELLS; SELF-TOLERANCE; THYMOCYTES; ESTABLISHMENT; AUTOIMMUNITY; ANTIGENS; REVEALS; STROMA	Aire in medullary thymic epithelial cells (mTECs) plays an important role in the establishment of self-tolerance. Because Aire(+) mTECs appear to be a limited subset, they may constitute a unique lineage(s) among mTECs. An alternative possibility is that all mTECs are committed to express Aire in principle, but Aire expression by individual mTECs is conditional. To investigate this issue, we established a novel Aire reporter strain in which endogenous Aire is replaced by the human AIRE-GFP-Flag tag (Aire/hAGF-knockin) fusion gene. The hAGF reporter protein was produced and retained very efficiently within mTECs as authentic Aire nuclear dot protein. Remarkably, snapshot analysis revealed that mTECs expressing hAGF accounted for >95% of mature mTECs, suggesting that Aire expression does not represent a particular mTEC lineage(s). We confirmed this by generating Aire/diphtheria toxin receptor-knockin mice in which long-term ablation of Aire(+) mTECs by diphtheria toxin treatment resulted in the loss of most mature mTECs beyond the proportion of those apparently expressing Aire. These results suggest that Aire expression is inherent to all mTECs but may occur at particular stage(s) and/or cellular states during their differentiation, thus accounting for the broad impact of Aire on the promiscuous gene expression of mTECs.	[Kawano, Hiroshi; Nishijima, Hitoshi; Morimoto, Junko; Hirota, Fumiko; Morita, Ryoko; Mouri, Yasuhiro; Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan; [Kawano, Hiroshi; Nishioka, Yasuhiko] Univ Tokushima, Inst Biomed Sci, Dept Resp Med & Rheumatol, Grad Sch, Tokushima 7708503, Japan; [Hirota, Fumiko; Morita, Ryoko; Matsumoto, Mitsuru] Japan Agcy Med Res & Development Core Res Evolut, Tokyo 1000004, Japan	Matsumoto, M (reprint author), Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	mitsuru@tokushima-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology (to M.M.).	Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Gillard GO, 2005, J EXP MED, V202, P15, DOI 10.1084/jem.20050976; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Nishikawa Y, 2014, J IMMUNOL, V192, P2585, DOI 10.4049/jimmunol.1302786; Hubert FX, 2008, J IMMUNOL, V180, P3824; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Dooley J, 2008, J IMMUNOL, V181, P5225; Tykocinski LO, 2010, P NATL ACAD SCI USA, V107, P19426, DOI 10.1073/pnas.1009265107; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Mouri Y, 2011, J IMMUNOL, V186, P5047, DOI 10.4049/jimmunol.1003533; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Alves NL, 2009, TRENDS IMMUNOL, V30, P468, DOI 10.1016/j.it.2009.07.010; Khan IS, 2014, J EXP MED, V211, P761, DOI 10.1084/jem.20131889; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jcm.20050693; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Matsumoto M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00210; Mouri Y, 2014, J IMMUNOL, V193, P4356, DOI 10.4049/jimmunol.1400389; Wang XP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00019	29	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2015	195	11					5149	5158		10.4049/jimmunol.1501000		10	Immunology	Immunology	CX3NP	WOS:000365606100011		
J	Tsuchimoto, Y; Asai, A; Tsuda, Y; Ito, I; Nishiguchi, T; Garcia, MC; Suzuki, S; Kobayashi, M; Higuchi, K; Suzuki, F				Tsuchimoto, Yusuke; Asai, Akira; Tsuda, Yasuhiro; Ito, Ichiaki; Nishiguchi, Tomoki; Garcia, Melanie C.; Suzuki, Sumihiro; Kobayashi, Makiko; Higuchi, Kazuhide; Suzuki, Fujio			M2b Monocytes Provoke Bacterial Pneumonia and Gut Bacteria-Associated Sepsis in Alcoholics	JOURNAL OF IMMUNOLOGY			English	Article							BLOOD MONONUCLEAR-CELLS; LIVER-DISEASE; IMMUNE-RESPONSES; APOPTOTIC CELLS; MACROPHAGE ACTIVATION; KLEBSIELLA-PNEUMONIAE; CHEMOKINE PRODUCTION; KUPFFER CELLS; HOST-DEFENSE; NOD MICE	Chronic alcohol consumption markedly impairs host antibacterial defense against opportunistic infections. gamma-irradiated NOD-SCID IL-2R gamma(null) mice inoculated with nonalcoholic PBMCs (control PBMC chimeras) resisted Klebsiella pneumonia and gut bacteriaassociated sepsis, whereas the chimeras created with alcoholic PBMCs (alcoholic PBMC chimeras) were very susceptible to these infections. M1 monocytes (IL-12(+)IL-10(-)CD163(-)CD14(+) cells), major effector cells in antibacterial innate immunity, were not induced by a bacterial Ag in alcoholic PBMC cultures, and M2b monocytes (CCL1(+)CD163(+)CD14(+) cells), which predominated in alcoholic PBMCs, were shown to be inhibitor cells on the Ag-stimulated monocyte conversion from quiescent monocytes to M1 monocytes. CCL1, which functions to maintain M2b macrophage properties, was produced by M2b monocytes isolated from alcoholic PBMCs. These M2b monocytes reverted to quiescent monocytes (IL-12(-)IL-10(-)CCL1(-)CD163(-)CD14(+) cells) in cultures supplemented with CCL1 antisense oligodeoxynucleotide, and the subsequent quiescent monocytes easily converted to M1 monocytes under bacterial Ag stimulation. Alcoholic PBMC chimeras treated with CCL1 antisense oligodeoxynucleotide were resistant against pulmonary infection by K. pneumoniae and sepsis stemming from enterococcal translocation. These results indicate that a majority of monocytes polarize to an M2b phenotype in association with alcohol abuse, and this polarization contributes to the increased susceptibility of alcoholics to gut and lung infections. Bacterial pneumonia and gut bacteria-associated sepsis, frequently seen in alcoholics, can be controlled through the polarization of macrophage phenotypes.	[Tsuchimoto, Yusuke; Asai, Akira; Tsuda, Yasuhiro; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan; [Ito, Ichiaki; Nishiguchi, Tomoki; Garcia, Melanie C.; Kobayashi, Makiko; Suzuki, Fujio] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Suzuki, Sumihiro] Univ N Texas, Hlth Sci Ctr, Dept Biostat, Ft Worth, TX 76107 USA	Suzuki, F (reprint author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	fsuzuki@utmb.edu					Katakura T, 2005, CLIN EXP IMMUNOL, V142, P419, DOI 10.1111/j.1365-2249.2005.02944.x; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Swanson GR, 2010, ALCOHOL, V44, P223, DOI 10.1016/j.alcohol.2009.10.019; Shigemitsu H, 2007, CURR OPIN PULM MED, V13, P192, DOI 10.1097/MCP.0b013e3280f629f0; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Maree AFM, 2008, J APPL PHYSIOL, V104, P157, DOI 10.1152/japplphysiol.00514.2007; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453; Asai A, 2012, J LEUKOCYTE BIOL, V92, P859, DOI 10.1189/jlb.0212107; PENNER E, 1978, CLIN EXP IMMUNOL, V34, P28; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Boe DM, 2009, J LEUKOCYTE BIOL, V86, P1097, DOI 10.1189/jlb.0209087; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Shellito JE, 2001, ALCOHOL CLIN EXP RES, V25, P872, DOI 10.1111/j.1530-0277.2001.tb02293.x; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; MORLAND H, 1988, ALCOHOL CLIN EXP RES, V12, P755, DOI 10.1111/j.1530-0277.1988.tb01340.x; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Zisman DA, 1998, ALCOHOL CLIN EXP RES, V22, P621, DOI 10.1111/j.1530-0277.1998.tb04303.x; Starkenburg S, 2001, ALCOHOL CLIN EXP RES, V25, P1221, DOI 10.1111/j.1530-0277.2001.tb02339.x; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boe DM, 2010, ALCOHOL CLIN EXP RES, V34, P1723, DOI 10.1111/j.1530-0277.2010.01259.x; Kobayashi M, 2012, J IMMUNOL, V189, P296, DOI 10.4049/jimmunol.1200350; Tsuda Y, 2008, J IMMUNOL, V180, P4133; Laso FJ, 1997, ALCOHOL CLIN EXP RES, V21, P1226, DOI 10.1097/00000374-199710000-00011; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Vergadi E, 2014, J IMMUNOL, V192, P394, DOI 10.4049/jimmunol.1300959; Ko WC, 2002, EMERG INFECT DIS, V8, P160; Pascual M, 2011, IMMUNOL CELL BIOL, V89, P716, DOI 10.1038/icb.2010.163; Bagby GJ, 1998, ALCOHOL CLIN EXP RES, V22, P1740, DOI 10.1097/00000374-199811000-00017; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Bhatty M, 2011, ALCOHOL, V45, P523, DOI 10.1016/j.alcohol.2011.02.305; Latif O, 2002, FRONT BIOSCI, V7, pA135, DOI 10.2741/latif; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Curtis BJ, 2013, ALCOHOL RES-CURR REV, V35, P97; Tabata T, 2002, J GASTROENTEROL, V37, P726, DOI 10.1007/s005350200118; Sester DP, 1999, J LEUKOCYTE BIOL, V66, P542; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Pan HN, 2006, ALCOHOL CLIN EXP RES, V30, P1615, DOI 10.1111/j.1530-0277.2006.00194.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Laso FJ, 2007, ALCOHOL CLIN EXP RES, V31, P846, DOI 10.1111/j.1530-0277.2007.00377.x; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; THOMAS HC, 1978, CLIN EXP IMMUNOL, V31, P150; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; Liu W, 2011, EXP MOL PATHOL, V91, P761, DOI 10.1016/j.yexmp.2011.08.003; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135; Bautista AP, 2002, FRONT BIOSCI, V7, pA117; Siggins RW, 2011, J IMMUNOL, V186, P4306, DOI 10.4049/jimmunol.1002885; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Jaurigue MM, 2014, WORLD J GASTROENTERO, V20, P2143, DOI 10.3748/wjg.v20.i9.2143; Dominguez-Santalla MJ, 2001, ALCOHOL CLIN EXP RES, V25, P1198, DOI 10.1111/j.1530-0277.2001.tb02336.x; Ohama H, 2015, AM J PATHOL, V185, P420, DOI 10.1016/j.ajpath.2014.09.022; Tuomisto S, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-40; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607	67	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2015	195	11					5169	5177		10.4049/jimmunol.1501369		9	Immunology	Immunology	CX3NP	WOS:000365606100013		
J	Weinstein, JR; Quan, Y; Hanson, JF; Colonna, L; Iorga, M; Honda, S; Shibuya, K; Shibuya, A; Elkon, KB; Moller, T				Weinstein, Jonathan R.; Quan, Yi; Hanson, Josiah F.; Colonna, Lucrezia; Iorga, Michael; Honda, Shin-ichiro; Shibuya, Kazuko; Shibuya, Akira; Elkon, Keith B.; Moeller, Thomas			IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fc alpha/mu Receptor	JOURNAL OF IMMUNOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNE-SYSTEM; STAPHYLOCOCCUS-AUREUS; APOPTOTIC CELLS; IMMUNOGLOBULIN G; CR3 CD11B/CD18; AMYLOID-BETA; MOUSE MODEL; ACTIVATION; RESPONSES	Microglia play an important role in receptor-mediated phagocytosis in the CNS. In brain abscess and other CNS infections, invading bacteria undergo opsonization with Igs or complement. Microglia recognize these opsonized pathogens by Fc or complement receptors triggering phagocytosis. In this study, we investigated the role of Fc alpha/mu R, the less-studied receptor for IgM and IgA, in microglial phagocytosis. We showed that primary microglia, as well as N9 microglial cells, express Fc alpha/mu R. We also showed that anti-Staphylococcus aureus IgM markedly increased the rate of microglial S. aureus phagocytosis. To unequivocally test the role of Fc alpha/mu R in IgM-mediated phagocytosis, we performed experiments in microglia from Fc alpha/mu R-/- mice. Surprisingly, we found that IgM-dependent phagocytosis of S. aureus was similar in microglia derived from wild-type or Fc alpha/mu R-/- mice. We hypothesized that IgM-dependent activation of complement receptors might contribute to the IgM-mediated increase in phagocytosis. To test this, we used immunologic and genetic inactivation of complement receptor 3 components (CD11b and CD18) as well as C3. IgM-, but not IgG-mediated phagocytosis of S. aureus was reduced in wild-type microglia and macrophages following preincubation with an anti-CD11b blocking Ab. IgM-dependent phagocytosis of S. aureus was also reduced in microglia derived from CD18(-/-) and C3(-/-) mice. Taken together, our findings implicate complement receptor 3 and C3, but not Fc alpha/mu R, in IgMmediated phagocytosis of S. aureus by microglia.	[Weinstein, Jonathan R.; Quan, Yi; Hanson, Josiah F.; Iorga, Michael; Moeller, Thomas] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Colonna, Lucrezia; Elkon, Keith B.] Univ Washington, Sch Med, Dept Med, Div Rheumatol, Seattle, WA 98195 USA; [Honda, Shin-ichiro; Shibuya, Kazuko; Shibuya, Akira] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Dept Immunol, Ibaraki 3058575, Japan	Weinstein, JR (reprint author), Univ Washington, Sch Med, Dept Neurol, Box 356465,1959 NE Pacific St, Seattle, WA 98195 USA.	jweinste@u.washington.edu			American Heart Association [0750078Z]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [F32AR065837]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS065008]	This work was supported by American Heart Association Grant-In-Aid 0750078Z (to T.M.), National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant F32AR065837 (to L.C.), and National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant NS065008 (to J.R.W.).	Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Shibuya A, 2000, NAT IMMUNOL, V1, P441, DOI 10.1038/80886; Weinstein JR, 2009, NEUROCHEM RES, V34, P445, DOI 10.1007/s11064-008-9803-9; GIULIAN D, 1986, J NEUROSCI, V6, P2163; RIGHI M, 1995, J NEUROCHEM, V64, P121; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Nakahara J, 2003, NEUROSCI LETT, V337, P73, DOI 10.1016/S0304-3940(02)01312-5; Wang XJ, 2007, NEUROCHEM INT, V50, P39, DOI 10.1016/j.neuint.2006.07.014; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Quan Y, 2009, NEUROSCI LETT, V464, P29, DOI 10.1016/j.neulet.2009.08.013; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Konat GW, 2006, J NEUROCHEM, V99, P1, DOI 10.1111/j.1471-4159.2006.04076.x; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; HUBER H, 1968, SCIENCE, V162, P1281, DOI 10.1126/science.162.3859.1281; Kim SJ, 2003, ANN NY ACAD SCI, V987, P68; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Feng XY, 2010, ATHEROSCLEROSIS, V208, P396, DOI 10.1016/j.atherosclerosis.2009.07.035; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; de Fougerolles AR, 2001, EUR J IMMUNOL, V31, P2189, DOI 10.1002/1521-4141(200107)31:7<2189::AID-IMMU2189>3.0.CO;2-V; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; Shibuya A, 2006, SPRINGER SEMIN IMMUN, V28, P377, DOI 10.1007/s00281-006-0050-3; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Honda S, 2009, P NATL ACAD SCI USA, V106, P11230, DOI 10.1073/pnas.0809917106; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; SHEN L, 1992, IMMUNOL RES, V11, P273, DOI 10.1007/BF02919133; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Pan WL, 2006, MICROBES INFECT, V8, P1209, DOI 10.1016/j.micinf.2005.11.009; Morgan D, 2009, CNS NEUROL DISORD-DR, V8, P7; Kielian T, 2002, J NEUROIMMUNOL, V130, P86, DOI 10.1016/S0165-5728(02)00216-3; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; WILSON RW, 1993, J IMMUNOL, V151, P1571; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1; Plow EF, 1997, J CLIN INVEST, V99, P1145, DOI 10.1172/JCI119267; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Cinco M, 2006, NEW MICROBIOL, V29, P193; Kinet JP, 2000, NAT IMMUNOL, V1, P371, DOI 10.1038/80805; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Baldwin AC, 2004, J NEUROIMMUNOL, V151, P24, DOI 10.1016/j.jneuroim.2004.02.002; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; EHLENBERGER AG, 1977, J EXP MED, V145, P357, DOI 10.1084/jem.145.2.357; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Gordon S., 2003, NAT REV IMMUNOL, V3, P23, DOI DOI 10.1038/NRI978; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008	53	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2015	195	11					5309	5317		10.4049/jimmunol.1401195		9	Immunology	Immunology	CX3NP	WOS:000365606100025		
J	Neoh, KB; Bong, LJ; Nguyen, MT; Nguyen, VT; Nguyen, HQ; Itoh, M; Kozan, O; Yoshimura, T				Neoh, Kok-Boon; Bong, Lee-Jin; My Thi Nguyen; Vuong Tan Nguyen; Huy Quoc Nguyen; Itoh, Masayuki; Kozan, Osamu; Yoshimura, Tsuyoshi			Termite diversity and complexity in Vietnamese agroecosystems along a gradient of increasing disturbance	JOURNAL OF INSECT CONSERVATION			English	Article						Macrotermitinae; Vegetation cover; Agricultural intensification; Ecosystem services; Biodiversity conservation; Soil-feeding termite	SOUTHEAST-ASIAN BIODIVERSITY; MBALMAYO-FOREST-RESERVE; COFFEE AGROECOSYSTEMS; TROPICAL FOREST; DIFFERING LEVELS; POPULATION-SIZE; ISOPTERA; MANAGEMENT; ASSEMBLAGES; ANTS	The rapid development of the Vietnamese coffee industry caused widespread deforestation, land degradation, desertification, and soil and water degradation in the late 1990s. However, little is known about the impact of intensification of coffee farming on arthropod diversity in Vietnamese coffee agroecosystems. We conducted an in-depth study of the termite presence in five land-uses along a gradient of increased land-use intensity in the Central Highlands of Vietnam: mixed deciduous forest (MF), secondary forest (SF), planted pine forest (PF), rubber plantation (RP), and coffee plantations (CP). The estimated number of termite species decreased along the land-use gradient. In coffee agroecosystems, the termite species richness was 20-50 % lower than that of the forested areas and monoculture rubber plantation. In terms of beta diversity, the termite faunal composition in CP was significantly separated from those of the other land-uses, in which the similarity was only 28.67 %. Litter depth, canopy cover, and wood basal area were positively associated with the termite communities present in MF and SF, whereas the termite community in PF was positively associated with soil bulk density, leaf litter, and understory vegetation. The ecological characteristics in RP and CP appeared to be negatively associated with wood basal area, leaf litter, and understory vegetation where well represented by Ancistrotermes pakistanicus (Ahmad). The sites also supported a few soil-feeding termites [e.g., Dicuspiditermes garthwaitei (Gardner), Pericapritermes latignathus (Holmgren), and Pseudocapritermes sinensis Ping and Xu in RP; only D. garthwaitei in CP].	[Neoh, Kok-Boon] Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan; [Neoh, Kok-Boon; Bong, Lee-Jin; Yoshimura, Tsuyoshi] Kyoto Univ, Lab Innovat Humanohabitabil, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan; [My Thi Nguyen; Vuong Tan Nguyen; Huy Quoc Nguyen] Inst Ecol & Works Protect, Hanoi, Vietnam; [Itoh, Masayuki; Kozan, Osamu] Kyoto Univ, Ctr Southeast Asian Studies, Sakyo Ku, Kyoto 6068501, Japan	Neoh, KB (reprint author), Natl Chung Hsing Univ, Dept Entomol, 250 Guoguang Rd, Taichung 40227, Taiwan.	neohkokboon@nchu.edu.tw			Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' - Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	We would like to thank Yoko Takematsu (Yamaguchi University) for assistance in identifying termite specimens and three anonymous reviewers whose comments greatly improved the manuscript. This study was supported by the Large-Scale Research Program 'Promoting the Study of Sustainable Humanosphere in Southeast Asia' funded by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), 2011-2016. K.-B.N. was an international research fellow of the Japan Society for the Promotion of Science and L.-J.B. was a mission researcher of the Research Institute for Sustainable Humonosphere, Kyoto University.	AHMAD MUZAFFER, 1965, BULL AMER MUS NATUR HIST, V131, P1; D'haeze D, 2005, AGR ECOSYST ENVIRON, V105, P59, DOI 10.1016/j.agee.2004.05.009; Jones DT, 2003, J APPL ECOL, V40, P380, DOI 10.1046/j.1365-2664.2003.00794.x; Eggleton P, 1998, OIKOS, V81, P525, DOI 10.2307/3546772; Chao A, 2000, STAT SINICA, V10, P227; [Anonymous], 1998, INVESTMENT PROJECT E; Briggs HM, 2013, ENVIRON ENTOMOL, V42, P1210, DOI 10.1603/EN13087; ROULAND C, 1991, COMP BIOCHEM PHYS A, V99, P657, DOI 10.1016/0300-9629(91)90146-4; Philpott SM, 2008, BIODIVERS CONSERV, V17, P1805, DOI 10.1007/s10531-007-9267-2; Brickle NW, 2002, BIOL CONSERV, V105, P189, DOI 10.1016/S0006-3207(01)00182-3; Jones DT, 2000, J APPL ECOL, V37, P191, DOI 10.1046/j.1365-2664.2000.00464.x; EGGLETON P, 1995, J TROP ECOL, V11, P85; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Urrutia-Escobar MX, 2013, ENVIRON ENTOMOL, V42, P194, DOI 10.1603/EN11084; D'haeze D, 2005, AGR WATER MANAGE, V73, P1, DOI 10.1016/j.agwat.2004.10.003; Gordon CE, 2009, BASIC APPL ECOL, V10, P246, DOI 10.1016/j.baae.2008.04.004; Hairiah K, 2006, FOREST ECOL MANAG, V224, P45, DOI 10.1016/j.foreco.2005.12.007; Vaessen T, 2011, J TROP FOR SCI, V23, P196; LEPAGE M, 1993, J TROP ECOL, V9, P303; Dibog L, 1999, B ENTOMOL RES, V89, P125; Teodoro AV, 2010, ENVIRON ENTOMOL, V39, P1744, DOI 10.1603/EN10092; Philpott SM, 2006, BIODIVERS CONSERV, V15, P139, DOI 10.1007/s10531-004-4247-2; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Davies RG, 1999, J APPL ECOL, V36, P946, DOI 10.1046/j.1365-2664.1999.00450.x; Marin L, 2013, ENVIRON ENTOMOL, V42, P204, DOI 10.1603/EN11223; Muriel SB, 2009, CONSERV BIOL, V23, P948, DOI 10.1111/j.1523-1739.2009.01213.x; Donovan SE, 2001, PEDOBIOLOGIA, V45, P1, DOI 10.1078/0031-4056-00063; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Takematsu Y, 2012, J NAT HIST, V46, P1079, DOI 10.1080/00222933.2011.651653; Okwakol MJN, 2000, AFR J ECOL, V38, P1, DOI 10.1046/j.1365-2028.2000.00189.x; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; Armbrecht I, 2005, CONSERV BIOL, V19, P897, DOI 10.1111/j.1523-1739.2005.00062.x; Eggleton P, 2002, AGR ECOSYST ENVIRON, V90, P189, DOI 10.1016/S0167-8809(01)00206-7; Beaudrot L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019777; Bryan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069679; Colwell RK, 2005, ESTIMATES STAT ESTIM; Dak Lak Statistical Department, 2002, STAT YB 2001; Evans TA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1257; FAO, 2014, FAOSTAT; Holt JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P389; Kon Thian-Woei, 2012, Pakistan Journal of Biological Sciences, V15, P108, DOI 10.3923/pjbs.2012.108.120; Muller D, 2003, LAND USE CHANGE CENT; Nguyen DK, 2007, FAUNA VIETNAM, V15; Nguyen Manh Ha, 2009, Oryx, V43, P129; Ponte S, 2004, STANDARDS SUSTAINABI; ter Braak CJF, 2012, CANOCO REFERENCE MAN; Umeh V. C., 1997, Insect Science and its Application, V17, P315; Vuong NT, 2012, P 9 PAC RIM TERM RES	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1366-638X	1572-9753		J INSECT CONSERV	J. Insect Conserv.	DEC	2015	19	6					1129	1139		10.1007/s10841-015-9828-8		11	Biodiversity Conservation; Entomology	Biodiversity & Conservation; Entomology	CX6CY	WOS:000365790000008		
J	Senoo, N; Miyoshi, N; Goto-Inoue, N; Minami, K; Yoshimura, R; Morita, A; Sawada, N; Matsuda, J; Ogawa, Y; Setou, M; Kamei, Y; Miura, S				Senoo, Nanami; Miyoshi, Noriyuki; Goto-Inoue, Naoko; Minami, Kimiko; Yoshimura, Ryoji; Morita, Akihito; Sawada, Naoki; Matsuda, Junichiro; Ogawa, Yoshihiro; Setou, Mitsutoshi; Kamei, Yasutomi; Miura, Shinji			PGC-1 alpha-mediated changes in phospholipid profiles of exercise-trained skeletal muscle	JOURNAL OF LIPID RESEARCH			English	Article						biochemical assays; fatty acid; lipidomics; mass spectrometry; molecular imaging; nuclear receptors; phospholipids/phosphatidylcholine; phospholipids/phosphatidylethanolamine; transcription factors; peroxisome proliferator-activated receptor gamma coactivator 1 alpha	FATTY-ACID-COMPOSITION; IMAGING MASS-SPECTROMETRY; DOCOSAHEXAENOIC ACID; MESSENGER-RNA; TRIACYLGLYCEROL SYNTHESIS; RECEPTOR ACTIVATION; INSULIN-RESISTANCE; COACTIVATOR PGC-1; CDNA CLONING; ACYLTRANSFERASE	Exercise training influences phospholipid fatty acid composition in skeletal muscle and these changes are associated with physiological phenotypes; however, the molecular mechanism of this influence on compositional changes is poorly understood. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), a nuclear receptor coactivator, promotes mitochondrial biogenesis, the fiber-type switch to oxidative fibers, and angiogenesis in skeletal muscle. Because exercise training induces these adaptations, together with increased PGC-1 alpha, PGC-1 alpha may contribute to the exercise-mediated change in phospholipid fatty acid composition. To determine the role of PGC-1 alpha, we performed lipidomic analyses of skeletal muscle from genetically modified mice that overexpress PGC-1 alpha in skeletal muscle or that carry KO alleles of PGC-1 alpha. We found that PGC-1 alpha affected lipid profiles in skeletal muscle and increased several phospholipid species in glycolytic muscle, namely phosphatidylcholine (PC) (18:0/22:6) and phosphatidylethanolamine (PE) (18:0/22:6). We also found that exercise training increased PC (18:0/22:6) and PE (18:0/22:6) in glycolytic muscle and that PGC-1 alpha was required for these alterations. Because phospholipid fatty acid composition influences cell permeability and receptor stability at the cell membrane, these phospholipids may contribute to exercise training-mediated functional changes in the skeletal muscle.	[Senoo, Nanami; Morita, Akihito; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka 4228526, Japan; [Miyoshi, Noriyuki] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Biochem Lab, Shizuoka 4228526, Japan; [Goto-Inoue, Naoko] Nihon Univ, Coll Bioresource Sci, Dept Marine Sci & Resources, Fujisawa, Kanagawa 2520880, Japan; [Minami, Kimiko; Yoshimura, Ryoji; Kamei, Yasutomi] Kyoto Prefectural Univ, Grad Sch Environm & Life Sci, Lab Mol Nutr, Sakyo Ku, Kyoto 6068522, Japan; [Sawada, Naoki] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Sawada, Naoki; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo 1138510, Japan; [Matsuda, Junichiro] Natl Inst Biomed Innovat Hlth & Nutr, Lab Anim Models Human Dis, Ibaraki, Osaka 5670085, Japan; [Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China	Kamei, Y (reprint author), Kyoto Prefectural Univ, Grad Sch Environm & Life Sci, Lab Mol Nutr, Sakyo Ku, Kyoto 6068522, Japan.	kamei@kpu.ac.jp; miura@u-shizuoka-ken.ac.jp	Miura, Shinji/K-6516-2013		Council for Science, Technology, and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion program (SIP) [14533567]; Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization, NARO; Tojuro Iijima Foundation for Food Science and Technology (Chiba, Japan); KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo) [26282184, 26560400, 25116712, 21300240]; Uehara Memorial Foundation (Tokyo, Japan); Kao Research Council for the Study of Healthcare Science (Tokyo, Japan) [A-31006]; University of Shizuoka Grant for Scientific and Educational Research	This study was supported by the Council for Science, Technology, and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion program (SIP, number 14533567); "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization, NARO); and the Tojuro Iijima Foundation for Food Science and Technology (Chiba, Japan). This study was also supported by Grants-in-Aid for Scientific Research (KAKENHI, numbers 26282184, 26560400, 25116712, and 21300240) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo), the Uehara Memorial Foundation (Tokyo, Japan), the Kao Research Council for the Study of Healthcare Science (Tokyo, Japan, number A-31006), and a University of Shizuoka Grant for Scientific and Educational Research.	Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; PAN DA, 1993, J NUTR, V123, P512; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Zaima N, 2011, J OLEO SCI, V60, P93, DOI 10.5650/jos.60.93; Eto M, 2014, BIOCHEM BIOPH RES CO, V443, P718, DOI 10.1016/j.bbrc.2013.12.043; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Baur LA, 1998, METABOLISM, V47, P106, DOI 10.1016/S0026-0495(98)90202-5; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Kano Y, 2014, J APPL PHYSIOL, V117, P163, DOI 10.1152/japplphysiol.00080.2014; MORGAN TE, 1969, AM J PHYSIOL, V216, P82; Helge JW, 1999, J NUTR, V129, P1636; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mitchell TW, 2010, INT J MOL SCI, V11, P3954, DOI 10.3390/ijms11103954; Andersson A, 2002, AM J CLIN NUTR, V76, P1222; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JC131785; Goto-Inoue N, 2009, J CHROMATOGR A, V1216, P7096, DOI 10.1016/j.chroma.2009.08.056; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Mitchell TW, 2004, J APPL PHYSIOL, V97, P1823, DOI 10.1152/japplphysiol.00344.2004; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; GREEN HJ, 1992, J APPL PHYSIOL, V72, P484; KENNEDY EP, 1961, FED PROC, V20, P934; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Andersson A, 2000, AM J PHYSIOL-ENDOC M, V279, pE744; Tuazon MA, 2012, METABOLISM, V61, P801, DOI 10.1016/j.metabol.2011.10.019; Ayre KJ, 1996, J NUTR, V126, P653; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432; VANROLLINS M, 1984, J LIPID RES, V25, P507; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Goto-Inoue N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03267; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Yamamoto H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-51	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	DEC	2015	56	12					2286	2296		10.1194/jlr.M060533		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CX6XA	WOS:000365843800006		
J	Furuhashi, M; Hiramitsu, S; Mita, T; Fuseya, T; Ishimura, S; Omori, A; Matsumoto, M; Watanabe, Y; Hoshina, K; Tanaka, M; Moniwa, N; Yoshida, H; Ishii, J; Miura, T				Furuhashi, Masato; Hiramitsu, Shinya; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Omori, Akina; Matsumoto, Megumi; Watanabe, Yuki; Hoshina, Kyoko; Tanaka, Marenao; Moniwa, Norihito; Yoshida, Hideaki; Ishii, Junnichi; Miura, Tetsuji			Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus	JOURNAL OF LIPID RESEARCH			English	Article						fatty acid binding protein 4; adipokine; adipocyte; glucagon-like peptide 1	ACID-BINDING PROTEIN; METABOLIC SYNDROME; PLASMA FATTY-ACID-BINDING-PROTEIN-4; LIPID-ACCUMULATION; ENDOTHELIAL-CELLS; 3T3-L1 ADIPOCYTES; RECEPTOR AGONISTS; HEART-DISEASE; AP2; ATHEROSCLEROSIS	Fatty acid binding protein 4 (FABP4), also known as adipocyte FABP or aP2, is secreted from adipocytes in association with lipolysis as a novel adipokine, and elevated serum FABP4 level is associated with obesity, insulin resistance, and atherosclerosis. However, little is known about the modulation of serum FABP4 level by therapeutic drugs. Sitagliptin (50 mg/day), a dipeptidyl peptidase 4 (DPP-4) inhibitor that increases glucagon-like peptide 1 (GLP-1), was administered to patients with type 2 diabetes (n = 24) for 12 weeks. Treatment with sitagliptin decreased serum FABP4 concentration by 19.7% (17.8 +/- 1.8 vs. 14.3 +/- 1.5 ng/ml, P < 0.001) and hemoglobin A1c without significant changes in adiposity or lipid variables. In 3T3-L1 adipocytes, sitagliptin or exendin-4, a GLP-1 receptor agonist, had no effect on short-term (2 h) secretion of FABP4. However, gene expression and long-term (24 h) secretion of FABP4 were significantly reduced by sitagliptin, which was not mimicked by exendin-4. Treatment with recombinant DPP-4 increased gene expression and long-term secretion of FABP4, and the effects were cancelled by sitagliptin. Furthermore, knockdown of DPP-4 in 3T3-L1 adipocytes decreased gene expression and long-term secretion of FABP4. In conclusion, sitagliptin decreases serum FABP4 level, at least in part, via reduction in the expression and consecutive secretion of FABP4 in adipocytes by direct inhibition of DPP-4.	[Furuhashi, Masato; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Omori, Akina; Matsumoto, Megumi; Watanabe, Yuki; Hoshina, Kyoko; Tanaka, Marenao; Moniwa, Norihito; Yoshida, Hideaki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Hiramitsu, Shinya] Hiramitsu Heart Clin, Minami Ku, Nagoya, Aichi 4570047, Japan; [Ishii, Junnichi] Fujita Hlth Univ, Sch Med, Dept Joint Res, Lab Clin Med, Toyoake, Aichi 47011, Japan	Furuhashi, M (reprint author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	furuhasi@sapmed.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Translational Research Network Program; Uehara Memorial Foundation; Senshin Medical Research Foundation; Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation; Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation; Naito Foundation Natural Science Scholarship; Suhara Memorial Foundation; Kondou Kinen Medical Foundation	M.F. has been supported by grants from the Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology (MEXT) Translational Research Network Program, Uehara Memorial Foundation, Senshin Medical Research Foundation, Japan Diabetes Foundation, Takeda Medical Research Foundation, Ono Medical Research Foundation, Takeda Science Foundation, Akiyama Life Science Foundation, Yamaguchi Endocrine Research Foundation, Naito Foundation Natural Science Scholarship, Suhara Memorial Foundation, and Kondou Kinen Medical Foundation. The authors declare no conflict of interest.	Apaijai N, 2013, BRIT J PHARMACOL, V169, P1048, DOI 10.1111/bph.12176; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Gao W, 2012, DRUG METAB DISPOS, V40, P990, DOI 10.1124/dmd.111.042291; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Kajimoto K, 2012, ENDOCRINOLOGY, V153, P5629, DOI 10.1210/en.2012-1456; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Satoh-Asahara N, 2013, METABOLISM, V62, P347, DOI 10.1016/j.metabol.2012.09.004; Karpisek M, 2007, EUR J CLIN INVEST, V37, P637, DOI 10.1111/j.1365-2362.2007.001835.x; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Das Siddhartha Shankar, 2014, Diabetes Metab Syndr Obes, V7, P185, DOI 10.2147/DMSO.S62610; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; GOKE R, 1993, J BIOL CHEM, V268, P19650; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Lee MYK, 2007, ARTERIOSCL THROM VAS, V27, P2443, DOI 10.1161/ATVBAHA.107.141705; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Cabré A, 2007, Atherosclerosis, V195, pe150, DOI 10.1016/j.atherosclerosis.2007.04.045; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Ertunc ME, 2015, J LIPID RES, V56, P423, DOI 10.1194/jlr.M055798; Furuhashi M., 2011, INT J INFLAM, V2011, DOI DOI 10.4061/2011/642612; Furuhashi M, 2015, HYPERTENS RES, V38, P252, DOI 10.1038/hr.2015.2; Furuhashi Masato, 2014, Clin Med Insights Cardiol, V8, P23, DOI 10.4137/CMC.S17067; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Mita T, 2015, OBESITY, V23, P359, DOI 10.1002/oby.20954; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Okazaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115429; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Rosmaninho-Salgado J, 2012, PEPTIDES, V37, P49, DOI 10.1016/j.peptides.2012.06.014; Tanaka Marenao, 2014, Nephron Clin Pract, V128, P345, DOI 10.1159/000368412	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	DEC	2015	56	12					2372	2380		10.1194/jlr.M059469		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CX6XA	WOS:000365843800013		
J	Furukawa, J; Sakai, S; Yokota, I; Okada, K; Hanamatsu, H; Kobayashi, T; Yoshida, Y; Higashino, K; Tamura, T; Igarashi, Y; Shinohara, Y				Furukawa, Jun-ichi; Sakai, Shota; Yokota, Ikuko; Okada, Kazue; Hanamatsu, Hisatoshi; Kobayashi, Takashi; Yoshida, Yasunobu; Higashino, Kenichi; Tamura, Tomohiro; Igarashi, Yasuyuki; Shinohara, Yasuro			Quantitative GSL-glycome analysis of human whole serum based on an EGCase digestion and glycoblotting method	JOURNAL OF LIPID RESEARCH			English	Article						glycolipids; gangliosides; mass spectrometry; lipidomics; diagnostic tools; biomarker; blood; glycomics; thin-layer chromatography; glycosphingolipid; endoglycoceramidase	TIME-OF-FLIGHT; MASS-SPECTROMETRY; HUMAN-PLASMA; GLYCOSPHINGOLIPIDS; GANGLIOSIDES; QUANTIFICATION; METABOLISM; DISORDERS	Glycosphingolipids (GSLs) are lipid molecules linked to carbohydrate units that form the plasma membrane lipid raft, which is clustered with sphingolipids, sterols, and specific proteins, and thereby contributes to membrane physical properties and specific recognition sites for various biological events. These bioactive GSL molecules consequently affect the pathophysiology and pathogenesis of various diseases. Thus, altered expression of GSLs in various diseases may be of importance for disease-related biomarker discovery. However, analysis of GSLs in blood is particularly challenging because GSLs are present at extremely low concentrations in serum/plasma. In this study, we established absolute GSL-glycan analysis of human serum based on endoglycoceramidase digestion and glycoblotting purification. We established two sample preparation protocols, one with and the other without GSL extraction using chloroform/methanol. Similar amounts of GSL-glycans were recovered with the two protocols. Both protocols permitted absolute quantitation of GSL-glycans using as little as 20 mu l of serum. Using 10 healthy human serum samples, up to 42 signals corresponding to GSL-glycan compositions could be quantitatively detected, and the total serum GSL-glycan concentration was calculated to be 12.1-21.4 mu M. We further applied this method to TLC-prefractionated serum samples. These findings will assist the discovery of disease-related biomarkers by serum GSL-glycomics.	[Furukawa, Jun-ichi; Yokota, Ikuko; Okada, Kazue; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Labs Med & Funct Glycom, Sapporo, Hokkaido 0010021, Japan; [Sakai, Shota; Hanamatsu, Hisatoshi; Igarashi, Yasuyuki] Hokkaido Univ, Grad Sch Adv Life Sci, Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Kobayashi, Takashi; Yoshida, Yasunobu; Higashino, Kenichi] Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido 0010021, Japan; [Tamura, Tomohiro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan	Furukawa, J (reprint author), Hokkaido Univ, Grad Sch Adv Life Sci, Labs Med & Funct Glycom, Sapporo, Hokkaido 0010021, Japan.	jfuru@sci.hokudai.ac.jp; yshinohara@sci.hokudai.ac.jp			Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work was supported, in part, by the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; KUNDU SK, 1985, ARCH BIOCHEM BIOPHYS, V238, P388, DOI 10.1016/0003-9861(85)90179-1; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Fuller M, 2014, ANAL BIOCHEM, V458, P20, DOI 10.1016/j.ab.2014.04.018; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; ITO M, 1986, J BIOL CHEM, V261, P14278; Naven TJP, 1996, RAPID COMMUN MASS SP, V10, P1361, DOI 10.1002/(SICI)1097-0231(199608)10:11<1361::AID-RCM642>3.0.CO;2-A; DAWSON G, 1976, J LIPID RES, V17, P125; Ishibashi Y, 2012, J LIPID RES, V53, P2242, DOI 10.1194/jlr.D028951; Inokuchi J, 2014, GLYCOCONJUGATE J, V31, P193, DOI 10.1007/s10719-013-9516-4; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Parry S, 2007, GLYCOBIOLOGY, V17, P646, DOI 10.1093/glycob/cwm024; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; PROKAZOVA NV, 1994, LIPIDS, V29, P1, DOI 10.1007/BF02537083; Huang QY, 2014, ANAL BIOCHEM, V455, P26, DOI 10.1016/j.ab.2014.03.014; SVENNERHOLM E, 1963, NATURE, V198, P688, DOI 10.1038/198688b0; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; SCHNEIDER JS, 1995, NEUROLOGY, V45, P1149; Miura Y, 2007, CHEM-EUR J, V13, P4797, DOI 10.1002/chem.200601872; NUDELMAN E, 1983, SCIENCE, V220, P509, DOI 10.1126/science.6836295; Fujitani N, 2011, J BIOL CHEM, V286, P41669, DOI 10.1074/jbc.M111.301796; Uematsu R, 2005, MOL CELL PROTEOMICS, V4, P1977, DOI 10.1074/mcp.M500203-MCP200; Hakomori S, 1973, Adv Cancer Res, V18, P265, DOI 10.1016/S0065-230X(08)60755-1; Kollewe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125339; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Nigam V. N., 1973, ADV CANCER RES, V17, P1, DOI 10.1016/S0065-230X(08)60530-8	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	DEC	2015	56	12					2399	2407		10.1194/jlr.D062083		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CX6XA	WOS:000365843800016		
J	Yudo, H; Yoshikawa, T				Yudo, Hartono; Yoshikawa, Takao			Buckling phenomenon for imperfect pipe under pure bending	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Imperfect pipe; Buckling moment; Oval deformation; Elastic buckling; Elasto-plastic buckling		The buckling phenomenon for imperfect pipe under bending has been investigated by nonlinear FEA, considering the effect of a cross sectional oval deformation by changing the variables of pipes, that is, L/D varying from 2.5 to 20, D/t varying from 50 to 200, and imperfection (delta (o)/t) varying from 0.05 to 0.5. As well as the elastic buckling, the elasto-plastic buckling was investigated. From the calculation results, the followings were found. The reduction of buckling moment due to imperfection is larger in short pipe than in long pipe. The effect of imperfection for pipes with large values of D/t is larger than those with small values of D/t if L/D of both pipes is same. The effects of imperfection for elastic analysis are larger than elasto-plastic analysis. The buckling moment reduces more by the imperfection of buckling mode than by that of oval mode.	[Yudo, Hartono] Kyushu Univ, Grad Sch Engn, Dept Maritime Engn, Fukuoka 812, Japan; [Yudo, Hartono] Diponegoro Univ, Fac Engn, Naval Architecture, Semarang, Indonesia; [Yoshikawa, Takao] Kyushu Univ, Fac Engn, Dept Marine Syst Engn, Fukuoka 812, Japan	Yudo, H (reprint author), Kyushu Univ, Grad Sch Engn, Dept Maritime Engn, Fukuoka 812, Japan.	hartono.yudo@kyudai.jp					Gere J.M., 1961, THEORY ELASTIC STABI; Ju G. T., 1992, J SOLIDS STRUCTURES, V29, P1143; Odland J, 1978, NORWEGIAN MARITIME R, V6, P2; Seide P, 1961, T ASME J APPL MECH, V28, P112; SUPERB, 1996, BUCKL COLL LIM STAT; Yudo H, 2014, J MAR SCI TECHNOL, V20, P94; Yudo H, 2012, P 26 AS TECHN EXCH A, P359	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2015	20	4					703	710		10.1007/s00773-015-0324-3		8	Engineering, Marine; Engineering, Civil	Engineering	CX5GH	WOS:000365729600010		
J	Ren, XY; Gao, YY; Mizutani, N				Ren, Xingyue; Gao, Yangyang; Mizutani, Norimi			Application of the numerical circular wave tank on the simulations of oblique and multi-directional waves	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Circular wave tank; Directional waves; Two-phase flow; Volume of fluid method; Cylindrical coordinates	ZONAL-EMBEDDED GRIDS; VOLUME; MAKER; CYLINDER; FLOW	To simulate the oblique and multi-direction waves, a numerical circular wave tank of implementing a finite volume method in three-dimensional cylindrical coordinates is developed based on the incompressible two-phase flow model in the present study. Both the oblique waves from an arbitrary direction and multi-directional waves reproduced by the integration of oblique waves are investigated using the circular wave tank. By comparing the numerical results with the theoretical ones, it is found that the proposed numerical wave tank can accurately reproduce oblique and multi-directional waves without the influence of the reflection waves. Numerical results of the wave diffraction around a vertical circular cylinder from different incident directions are also presented. The result shows that it is in good agreement with the theoretical and experimental results and it is interesting to note that the influence of the incident direction can be ignored on the performance of the circular wave tank.	[Ren, Xingyue; Mizutani, Norimi] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648602, Japan; [Gao, Yangyang] Zhejiang Univ, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China	Gao, YY (reprint author), Zhejiang Univ, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China.	yygao@zju.edu.cn					KRIEBEL DL, 1990, OCEAN ENG, V17, P345, DOI 10.1016/0029-8018(90)90029-6; Lin PZ, 1999, J WATERW PORT C-ASCE, V125, P207, DOI 10.1061/(ASCE)0733-950X(1999)125:4(207); Williams AN, 2000, OCEAN ENG, V27, P603, DOI 10.1016/S0029-8018(99)00016-5; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Losasso F, 2006, COMPUT FLUIDS, V35, P995, DOI 10.1016/j.compfluid.2005.01.006; Suh YK, 2006, INT J NUMER METH FL, V52, P263, DOI 10.1002/fld.1177; KRIEBEL DL, 1992, OCEAN ENG, V19, P75, DOI 10.1016/0029-8018(92)90048-9; Heyns JA, 2013, INT J NUMER METH FL, V71, P788, DOI 10.1002/fld.3694; Ubbink O, 1999, J COMPUT PHYS, V153, P26, DOI 10.1006/jcph.1999.6276; Choi J, 2009, COAST ENG, V56, P1043, DOI 10.1016/j.coastaleng.2009.06.009; HIRAISHI T, 1995, INT OFFSHORE POLAR E, P26; Chen L, 1999, J FLUID MECH, V387, P61, DOI 10.1017/S0022112099004449; Park JC, 2004, OCEAN ENG, V31, P1549, DOI 10.1016/j.oceaneng.2003.12.009; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Austin DI, 1982, P 18 INT C COAST ENG, P2079; DALRYMPLE RA, 1989, J HYDRAUL RES, V27, P23; Funke ER, 1987, TRHY021 NAT RES COUN; GASKELL PH, 1988, INT J NUMER METH FL, V8, P617, DOI 10.1002/fld.1650080602; Ito K, 1996, P 25 C COAST ENG, P443; Kravchenko AG, 1996, J COMPUT PHYS, V127, P412, DOI 10.1006/jcph.1996.0184; MacCamy RC, 1954, 69 US ARM CORPS ENG, V69; Naito S, 2006, P 16 INT OFFSH POL E; Nichols BD, 1980, LA8355; Tanaka M, 1994, P 24 INT C COAST ENG, P650	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2015	20	4					711	721		10.1007/s00773-015-0325-2		11	Engineering, Marine; Engineering, Civil	Engineering	CX5GH	WOS:000365729600011		
J	Wei, ZY; Hu, CH				Wei, Zhaoyu; Hu, Changhong			Experimental study on water entry of circular cylinders with inclined angles	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Water entry; Cavity; Inclined cylinders; Spin-induced lift and drag	IMPACT; SPHERES; EXIT; SURFACE	A series of experimental studies have been carried out on water entry of three-dimensional circular cylinders for low Froude numbers. In our previous paper (Wei and Hu J Mar Sci Technol, 1:1-13, 2014), the results on horizontal circular cylinders have been reported, describing several typical three-dimensional water entry phenomena and discussing the effect of length-to-diameter ratios. In this paper, the results on inclined circular cylinders are presented. The emphasis of the study is paid on the effect of inclined angles. The effects of density ratio and length-to-diameter ratio are also considered. Translational and rotational motions of the cylinder are obtained from the image analysis of the video records by a high-speed digital camera. The lift force, drag force and torque on the cylinder are then estimated using the cylinder motions. Both quantitative and qualitative analyses are carried out on the experimental results. The major observations of this study are: (1) the cylinder with lower inclined angle experiences larger maximum drag force; (2) due to initial impact, the cylinder moves along a curved trajectory in water as a result of spin-induced lift force; (3) the inclined angle also makes the surface of cylinder relatively more hydrophilic; (4) when the cavity collapses, a sudden change of the trajectories and forces appears due to the free surface impinging on the cylinder.	[Wei, Zhaoyu] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Hu, Changhong] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Hu, CH (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan.	hu@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		Research Institute for Applied Mechanics, Kyushu University	The authors would like to thank Research Institute for Applied Mechanics, Kyushu University for supporting this study. The authors would also like to acknowledge Mr. Makoto Yasunaga, Dr. Sueyoshi Makoto, and are grateful for their help in designing and installing the experimental setup.	Rosellini L, 2005, J FLUID MECH, V543, P137, DOI 10.1017/S0022112005006373; Enriquez OR, 2012, J FLUID MECH, V701, P40, DOI 10.1017/jfm.2012.130; Truscott TT, 2009, J FLUID MECH, V625, P135, DOI 10.1017/S0022112008005533; Piro DJ, 2013, J FLUID STRUCT, V37, P134, DOI 10.1016/j.jfluidstructs.2012.09.006; Enriquez OR, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3481432; MAY A, 1950, J APPL PHYS, V21, P1285, DOI 10.1063/1.1699592; MAY A, 1951, J APPL PHYS, V22, P1219, DOI 10.1063/1.1699831; Duez C, 2007, NAT PHYS, V3, P180, DOI 10.1038/nphys545; Sun H, 2006, APPL OCEAN RES, V28, P299, DOI 10.1016/j.apor.2007.02.002; MAY A, 1952, J APPL PHYS, V23, P1362, DOI 10.1063/1.1702076; MAY A, 1948, J APPL PHYS, V19, P1109, DOI 10.1063/1.1715027; Glasheen JW, 1996, PHYS FLUIDS, V8, P2078, DOI 10.1063/1.869010; Khabakhpasheva TI, 2013, J FLUID STRUCT, V36, P32, DOI 10.1016/j.jfluidstructs.2012.08.004; Techet AH, 2011, J FLUID STRUCT, V27, P716, DOI 10.1016/j.jfluidstructs.2011.03.014; Zhu X, 2007, J OFFSHORE MECH ARCT, V129, P253, DOI 10.1115/1.2199558; Lin MC, 1997, FLUID DYN RES, V19, P125, DOI 10.1016/S0169-5983(96)00033-0; ABELSON HI, 1970, J FLUID MECH, V44, P129, DOI 10.1017/S0022112070001738; Oliver JM, 2007, J FLUID MECH, V572, P59, DOI 10.1017/S002211200600276X; Cointe R, 1987, J OFFSHORE MECH ARCT, V109, P237, DOI DOI 10.1115/1.3257015; Epps BP, 2010, 3 MATH METH ENG INT; Greenhow M, 1983, 8319 MIT DEP OC ENG; GREENHOW M, 1988, APPL OCEAN RES, V10, P191, DOI 10.1016/S0141-1187(88)80003-8; May A, 1975, WATER ENTRY CAVITY R; Raffel M., 1998, PARTICLE IMAGE VELOC; RICHARDSON EG, 1948, P PHYS SOC LOND, V61, P352, DOI 10.1088/0959-5309/61/4/308; Truscott TT, 2013, ANNU REV FLUID MECH, V46, P355; Ueda Y, 2010, J VISUAL-JAPAN, V14, P7; von Karman T, 1929, 321 NACA TN; Wagner H, 1932, Z ANGEW MATH MECH, V12, P193, DOI 10.1002/zamm.19320120402; Wagner H, 1948, 1139 NACA TM; Wei ZY, 2014, J MAR SCI TECHNOL, V1, P1; Wei ZY, 2012, THEOR APPL MECH LETT, V2; Worthington AM, 1897, PHILOS T R SOC LON A, V189, P137, DOI 10.1098/rsta.1897.0005	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2015	20	4					722	738		10.1007/s00773-015-0326-1		17	Engineering, Marine; Engineering, Civil	Engineering	CX5GH	WOS:000365729600012		
J	Abdullah, E; Gotoh, K; Deguchi, J				Abdullah, Ezzarhan; Gotoh, Koji; Deguchi, Junichi			Comprehensive study of structural integrity of non-load-carrying fillet-welded joint effect with large gap size	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Welded joint with large gap; Non-load-carrying fillet-welded joint; Fatigue performance; CO2 gas shielded welding; Hot spot stress; Mechanical properties of a welded joint	CRUCIFORM JOINTS; FATIGUE-STRENGTH; GEOMETRY; LIFE; TOE	The structural integrity of the fillet-welded joint with large gap sizes made by semi-automatic CO2 gas shielded welding is investigated to suggest for the improvement of construction quality standards. An allowable limit on the gap size of welded joints is specified in many construction quality standards based on experimental and empirical results from the welded joints made by manual metal arc welding. Mechanical tests such as hardness, tensile, bending and fatigue were performed to confirm the welded specimen's quality. Macro observation and dye penetrants inspection were performed on the welded specimen face and weld toe area to verify if any defects are present. Obtained S-N curves from experimental results for the welded specimen with large gap present higher performance compared to the fatigue design S-N curves proposed by the International Institute of Welding (IIW) and UK-HSE.	[Abdullah, Ezzarhan] Kyushu Univ, Dept Civil & Struct Engn, Fukuoka 812, Japan; [Gotoh, Koji] Kyushu Univ, Dept Marine Syst Engn, Fukuoka 812, Japan; [Deguchi, Junichi] Oshima Shipbldg Co Ltd, Construct Dept, Prod Control Sect, Nagasaki, Japan	Gotoh, K (reprint author), Kyushu Univ, Dept Marine Syst Engn, Fukuoka 812, Japan.	gotoh@nams.kyushu-u.ac.jp			Malaysian Government (Public Service Department); Department of Occupational Safety and Health Malaysia	The first author gratefully acknowledged the Malaysian Government (Public Service Department), especially Department of Occupational Safety and Health Malaysia for their supports through scholarships provided. The authors also acknowledge Mr. Koji Murakami, senior technical staff of Kyushu University for the support during experimental work.	Nykanen T, 2007, ENG FRACT MECH, V74, P399, DOI 10.1016/j.engfracmech.2006.05.017; [Anonymous], 143452012 ISOTR IIW; Kainuma S, 2006, INT J FATIGUE, V28, P864, DOI 10.1016/j.ijfatigue.2005.10.004; Okayasu M, 2013, MAT SCI ENG A-STRUCT, V560, P643, DOI 10.1016/j.msea.2012.10.008; NGUYEN TN, 1995, ENG FRACT MECH, V51, P1; FERREIRA JAM, 1989, INT J FATIGUE, V11, P29; [Anonymous], 1984, 002 JSME; PANG HLJ, 1993, INT J FATIGUE, V15, P31, DOI 10.1016/0142-1123(93)90074-Z; Lee CH, 2009, ENG FAIL ANAL, V16, P849, DOI 10.1016/j.engfailanal.2008.07.004; MIKI C, 1993, INT J FATIGUE, V15, P133, DOI 10.1016/0142-1123(93)90007-D; ClassNK, 2013, RUL SURV CONSTR STEE; Health and Safety Executive (UK-HSE), 2012, STAT TECHN GUID INF; Hobbacher H, 2009, WELDING RES COUNCIL, V520; IACS No. 47-Rev. 5, 2010, SHIPB REP QUAL STAND; Japanese society of steel construction-JSSC, 2012, FAT DES REC STEEL ST; JSQS, 2010, JAP SHIPB QUAL STAND	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2015	20	4					752	764		10.1007/s00773-015-0328-z		13	Engineering, Marine; Engineering, Civil	Engineering	CX5GH	WOS:000365729600014		
J	Zhang, Y; Liu, TM; Zhao, SQ; Kuang, XL; Hussain, S; Lin, LY; Zeng, W; Peng, XH; Wang, ZC				Zhang, Yu; Liu, Tianmo; Zhao, Shuoqing; Kuang, Xinliang; Hussain, Shahid; Lin, Liyang; Zeng, Wen; Peng, Xianghe; Wang, Zhongchang			Hydrothermal synthesis of ZnO microcakes assembled by octahedrons and their gas-sensing property	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							GROWTH-MECHANISM; ONE-STEP; NANOSTRUCTURES; SENSORS; PERFORMANCE; NANOPARTICLES; FORMALDEHYDE; NANOWIRES; ARRAYS; HOLLOW	We report on the preparation of novel ZnO microcakes via a simple yet efficient hydrothermal approach. Three different ZnO microcakes are obtained by varying the amount of sodium hydroxide, and the influence of the sodium hydroxide on the growth of microcakes are discussed in order to elucidate growth mechanism of the microcakes. We also find that the microcakes are assembled by octahedrons and that the morphology is critical to tailoring the gas-sensing performance. Such octahedron-assembled ZnO microcakes show good gas-sensing properties to ethanol gas even at a low concentration.	[Zhang, Yu; Liu, Tianmo; Zhao, Shuoqing; Kuang, Xinliang; Hussain, Shahid; Lin, Liyang; Zeng, Wen] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China; [Zhang, Yu; Liu, Tianmo; Zhao, Shuoqing; Kuang, Xinliang; Hussain, Shahid; Zeng, Wen] Chongqing Univ, Natl Engn Res Ctr Mg Alloys, Chongqing 400044, Peoples R China; [Peng, Xianghe] Chongqing Univ, Chongqing Key Lab Heterogeneous Mat Mech, Chongqing 400044, Peoples R China; [Lin, Liyang; Wang, Zhongchang] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Liu, TM (reprint author), Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.	tmliu@cqu.edu.cn; zcwang@wpi-aimr.tohoku.ac.jp			National Natural Science Foundation of China [11332013]; Fundamental Research Funds for Central Universities [106112015CDJXY130013]; JSPS; CAS under Japan-China Scientific Cooperation Program; Shorai Foundation for Science and Technology;  [15H04114];  [15K14117]	The authors gratefully acknowledge the financial support to this work from the National Natural Science Foundation of China (Grant No. 11332013) and Fundamental Research Funds for Central Universities (Grant No. 106112015CDJXY130013). Z.C.W. thanks the financial support from the Scientific Research (B) (Grant No. 15H04114), Challenging Exploratory Research (Grant No. 15K14117), JSPS and CAS under Japan-China Scientific Cooperation Program, and the Shorai Foundation for Science and Technology.	Zeng W, 2012, SENSOR ACTUAT B-CHEM, V166, P141, DOI 10.1016/j.snb.2012.02.016; Guo WW, 2012, SENSOR ACTUAT B-CHEM, V166, P492, DOI 10.1016/j.snb.2012.02.093; Rao J, 2012, ACS APPL MATER INTER, V4, P5346, DOI 10.1021/am3012966; Qurashi A, 2015, RSC ADV, V5, P22570, DOI 10.1039/c4ra15497e; Guo WW, 2013, SENSOR ACTUAT B-CHEM, V178, P53, DOI 10.1016/j.snb.2012.12.073; Hussain S, 2014, MATER LETT, V128, P35, DOI 10.1016/j.matlet.2014.04.115; Guo WW, 2013, J MATER SCI-MATER EL, V24, P1764, DOI 10.1007/s10854-012-1009-x; Xu XB, 2012, CRYST GROWTH DES, V12, P4829, DOI 10.1021/cg3005773; Guo WW, 2014, CERAM INT, V40, P2295, DOI 10.1016/j.ceramint.2013.07.150; Jing ZH, 2008, ADV MATER, V20, P4547, DOI 10.1002/adma.200800243; Lian JB, 2011, CRYSTENGCOMM, V13, P4820, DOI 10.1039/c1ce05301a; Zhao JG, 2013, J ALLOY COMPD, V579, P45, DOI 10.1016/j.jallcom.2013.05.052; Chen Z, 2013, J ALLOY COMPD, V557, P274, DOI 10.1016/j.jallcom.2012.11.177; Dalvand R, 2015, MATER LETT, V146, P65, DOI 10.1016/j.matlet.2015.02.003; Zeng W, 2012, J MATER CHEM, V22, P3544, DOI 10.1039/c2jm15017d; Hussain S, 2014, MATER LETT, V118, P165, DOI 10.1016/j.matlet.2013.12.068; Gurlo A, 2011, NANOSCALE, V3, P154, DOI 10.1039/c0nr00560f; Xu F, 2012, APPL SURF SCI, V258, P8160, DOI 10.1016/j.apsusc.2012.05.014; Espinosa HD, 2012, ADV MATER, V24, P4656, DOI 10.1002/adma.201104810; Srivastava A, 2007, MATER CHEM PHYS, V105, P385, DOI 10.1016/j.matchemphys.2007.05.003; Wu WY, 2009, NANOSCALE RES LETT, V4, P513, DOI 10.1007/s11671-009-9271-4; Zeng W, 2009, SENSORS-BASEL, V9, P9029, DOI 10.3390/s91109029; Guo WW, 2011, MATER LETT, V65, P3384, DOI 10.1016/j.matlet.2011.07.059; Singh RC, 2008, SENSOR ACTUAT B-CHEM, V135, P352, DOI 10.1016/j.snb.2008.09.004; Sun ZP, 2006, NANOTECHNOLOGY, V17, P2266, DOI 10.1088/0957-4484/17/9/032; Zheng KB, 2010, MATER SCI ENG B-ADV, V166, P104, DOI 10.1016/j.mseb.2009.09.029; Zhao YY, 2015, NANOSCALE, V7, P1904, DOI 10.1039/c4nr06461e; Joshi RK, 2012, CHEM SOC REV, V41, P5285, DOI 10.1039/c2cs35089k; Xiao SS, 2014, J MATER SCI-MATER EL, V25, P5518, DOI 10.1007/s10854-014-2338-8; Santra PK, 2013, J AM CHEM SOC, V135, P877, DOI 10.1021/ja310737m; Guo WW, 2012, MATER LETT, V89, P5, DOI 10.1016/j.matlet.2012.08.055; Zhang Y., 2013, J MATER SCI-MATER EL, V25, P376	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	DEC	2015	26	12			SI		9529	9534		10.1007/s10854-015-3869-3		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CX2KP	WOS:000365525900035		
J	Zhang, FB; Saito, K; Tanaka, T; Nishio, M; Guo, QX				Zhang, Fabi; Saito, Katsuhiko; Tanaka, Tooru; Nishio, Mitsuhiro; Guo, Qixin			Electrical properties of Si doped Ga2O3 films grown by pulsed laser deposition	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							BETA-GA2O3 THIN-FILMS; ULTRAVIOLET PHOTODETECTORS; SINGLE-CRYSTALS; C-PLANE; CONDUCTIVITY; OXIDATION; EPITAXY; LAYERS	In order to investigate Si doping effect on the structure and properties of Ga2O3 thin films, films with different Si content were grown by pulsed laser deposition (PLD) on sapphire substrates at 500 A degrees C. Carrier density of 9.1 x 10(19) cm(-3) and conductivity of 2.0 S cm(-1) have been observed for 1.1 at.% Si-doped film. Further increase of the Si content leads to the decrease of the carrier density. Atomic force microscope and spectrophotometer show that the obtained films have very smooth surface and high transmittance. X-ray diffraction reveals that films with Si content lower than 4.1 at.% are of high (-201) oriented monoclinic structure. Our work shows that PLD is ideal candidate for growing conductive Si-doped beta-Ga2O3 films.	[Zhang, Fabi; Saito, Katsuhiko; Tanaka, Tooru; Nishio, Mitsuhiro; Guo, Qixin] Saga Univ, Synchrotron Light Applicat Ctr, Dept Elect & Elect Engn, Saga 8408502, Japan	Guo, QX (reprint author), Saga Univ, Synchrotron Light Applicat Ctr, Dept Elect & Elect Engn, Saga 8408502, Japan.	guoq@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors would like to thank Yuuki Okano for RHEED measurements. This work was partially supported by the Partnership Project for Fundamental Technology Researches of Ministry of Education, Culture, Sports, Science and Technology, Japan.	Cheng Y, 2013, J MATER SCI-MATER EL, V24, P5122, DOI 10.1007/s10854-013-1533-3; Suzuki N, 2014, J CRYST GROWTH, V401, P670, DOI [10.1016/j.jcrysgro.2014.02.051, 10.1016/j.jcrysgro.2014.02.0.51]; Zhang FB, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4900522; Takakura K, 2009, PHYSICA B, V404, P4854, DOI 10.1016/j.physb.2009.08.167; Villora EG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919728; Sasaki K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.086502; Chiang HQ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1843286; Tomm Y, 2001, SOL ENERG MAT SOL C, V66, P369, DOI 10.1016/S0927-0248(00)00196-3; Hosono H, 1996, J NON-CRYST SOLIDS, V203, P334, DOI 10.1016/0022-3093(96)00367-5; Oshima Y, 2015, J CRYST GROWTH, V410, P53, DOI [10.1016/j.jcrysgro.2014.10.038, 10.1016/j.crysgro.2014.10.038]; Ueda N, 1997, APPL PHYS LETT, V70, P3561, DOI 10.1063/1.119233; Zhang FB, 2014, J CRYST GROWTH, V387, P96, DOI 10.1016/j.jcrysgro.2013.11.022; Zhang F, 2014, SOLID STATE COMMUN, V186, P28, DOI 10.1016/j.scc.2014.01.024; Varley JB, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499306; Kozodoy P, 2000, J APPL PHYS, V87, P1832, DOI 10.1063/1.372098; Korhonen E, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922814; Aida H, 2008, JPN J APPL PHYS, V47, P8506, DOI 10.1143/JJAP.47.8506; GUPTA A, 1993, J APPL PHYS, V73, P7877, DOI 10.1063/1.353939; Shinohara D, 2008, JPN J APPL PHYS, V47, P7311, DOI 10.1143/JJAP.47.73111; Nakagomi S, 2012, J CRYST GROWTH, V349, P12, DOI 10.1016/j.jcrysgro.2012.04.006; Orita M, 2002, THIN SOLID FILMS, V411, P134, DOI 10.1016/S0040-6090(02)00202-X; Takakura K, 2012, PHYSICA B, V407, P2900, DOI 10.1016/j.physb.2011.08.061; Gaddy BE, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4878657; Lee SA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2374806; Zacherle T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235206; Tomm Y, 2000, J CRYST GROWTH, V220, P510, DOI 10.1016/S0022-0248(00)00851-4; Muller S, 2014, PHYS STATUS SOLIDI A, V211, P34, DOI 10.1002/pssa.201330025; HIRATANI M, 1995, J APPL PHYS, V78, P4258, DOI 10.1063/1.359888; Guo P, 2014, J MATER SCI-MATER EL, V25, P3629, DOI 10.1007/s10854-014-2066-0; Orita M, 2000, APPL PHYS LETT, V77, P4166, DOI 10.1063/1.1330559; Varley JB, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/33/334212; Kokubun Y, 2010, PHYS STATUS SOLIDI A, V207, P1741, DOI 10.1002/pssa.200983712; Irmscher K, 2011, J APPL PHYS, V110, DOI 10.1063/1.3642962; Gogova D, 2014, J CRYST GROWTH, V401, P665, DOI 10.1016/j.jcrysgro.2013.11.056; Oshima T, 2007, JPN J APPL PHYS 1, V46, P7217, DOI 10.1143/JJAP.46.7217; Sze S.M., 2006, PHYS SEMICONDUCTOR D, P369	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	DEC	2015	26	12			SI		9624	9629		10.1007/s10854-015-3627-6		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	CX2KP	WOS:000365525900046		
J	Tian, Y; Fujibayashi, S; Yamaguchi, S; Matsushita, T; Kokubo, T; Matsuda, S				Tian, Yi; Fujibayashi, Shunsuke; Yamaguchi, Seiji; Matsushita, Tomiharu; Kokubo, Tadashi; Matsuda, Shuichi			In vivo study of the early bone-bonding ability of Ti meshes formed with calcium titanate via chemical treatments	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							HEAT-TREATED TITANIUM; BIOACTIVE TITANIUM; ALKALI; METAL; IMPLANTS; OSSEOINTEGRATION; REPLACEMENT; TISSUE	Alkali and heat (AH) treatment forming sodium titanate has been shown to connect bioinert Ti metal and bone tissue. Artificial joints treated with this method have achieved extensive clinical application. Recently a new chemical treatment of Alkali-Calcium-Heat-Water (ACaHW) treatment forming calcium titanate was proposed. Notably, the apatite-forming ability of this treatment is greater than that of AH treatment, as verified in vitro. However, the early bone-bonding abilities of the two treatments have not been compared in vivo. To simulate clinical application, we treated a commercially pure Ti (Cp-Ti) mesh implant with AH or ACaHW. Then, using mechanical and histological methods, we compared the bone-bonding abilities of the two treatments early during the implantation process (2-4 weeks); untreated Cp-Ti mesh was used as a control. Because the mesh structure might influence bone-bonding ability, we compared these bonding abilities with values obtained at 4 and 8 weeks using a Cp-Ti implant with a plate structure. In the mesh group, histological comparisons at 2 and 3 weeks indicated that ACaHW treatment resulted in a bone-bonding ability similar to that of AH treatment; ACaHW exhibited a greater bonding ability than AH at 4 weeks. However, in tests of the plate group at later time points, such differences were not apparent. The results obtained here indicate that during the early stage of embedment, ACaHW treatment of Cp-Ti mesh implants yields a higher bone-bonding ability than AH treatment, thus providing a positive reference for future clinical applications.	[Tian, Yi; Fujibayashi, Shunsuke; Matsuda, Shuichi] Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Yamaguchi, Seiji; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Tian, Y (reprint author), Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	tianyittt1986@126.com					Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.0.CO;2-C; Kizuki T, 2013, J MATER SCI-MATER M, V24, P635, DOI 10.1007/s10856-012-4837-6; Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309; HUNGERFORD DS, 1993, ORTHOP CLIN N AM, V24, P617; Kusakabe H, 2004, BIOMATERIALS, V25, P2957, DOI 10.1016/j.biomaterials.2003.09.090; Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B; Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409; Hirota M, 2012, INT J ORAL MAX SURG, V41, P1304, DOI 10.1016/j.ijom.2011.12.035; Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.0.CO;2-M; Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x; Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540; [Anonymous], 2002, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-200202000-00007; LaPorte DM, 1999, ORTHOPEDICS, V22, P1154; Yamaguchi S, 2010, J MATER SCI-MATER M, V21, P439, DOI 10.1007/s10856-009-3904-0; NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.0.CO;2-F; Urban RM, 1996, J BONE JOINT SURG AM, V78A, P1068; Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026; So K, 2013, CLIN ORTHOP RELAT R, V471, P3847, DOI 10.1007/s11999-013-2945-3; Tanaka M, 2014, J MATER SCI-MATER M, V25, P635, DOI 10.1007/s10856-013-5101-4; Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6; Kizuki T, 2010, ACTA BIOMATER, V6, P2836, DOI 10.1016/j.actbio.2010.01.007; Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.0.CO;2-W; Kokubo Tadashi, 2015, Open Biomed Eng J, V9, P29, DOI 10.2174/1874120701509010029	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	DEC	2015	26	12								10.1007/s10856-015-5612-2		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CX5SC	WOS:000365761800007		
J	Iwasaki, K; Goto, Y; Katoh, T; Yamashita, T; Kaneko, S; Suga, H				Iwasaki, Kazuhiro; Goto, Yuki; Katoh, Takayuki; Yamashita, Taro; Kaneko, Shuichi; Suga, Hiroaki			A Fluorescent Imaging Probe Based on a Macrocyclic Scaffold That Binds to Cellular EpCAM	JOURNAL OF MOLECULAR EVOLUTION			English	Article						In vitro selection; Macrocyclic peptide; EpCAM; Fluorescent imaging probe; Cancer cell imaging	SELECTION-BASED DISCOVERY; ADHESION MOLECULE EPCAM; IN-VITRO SELECTION; EP-CAM; ANTIGEN EPCAM; IMMUNOTHERAPEUTIC TARGET; ANTITUMOR-ACTIVITY; EPITHELIAL-CELLS; STRUCTURAL BASIS; CARCINOMA-CELLS	Here, we report a fluorescent probe based on a macrocyclic peptide scaffold that specifically stains EpCAM-expressing MCF7 cells. The 14-mer macrocyclic peptide binding to the extracellular domain of EpCAM with a dissociation constant in the low nM range (1.7 nM) was discovered using the random non-standard peptide-integrated discovery system. Notably, this probe containing a fluorescence tag is less than 3000 Da in total and able to visualize nearly every live cell under high cell-density conditions, which was not achieved by the conventional mAb staining method. This suggests that the molecular probe based on the compact macrocyclic scaffold has great potentials as an imaging tool for the EpCAM biomarker as well as a delivery vehicle for drug conjugates.	[Iwasaki, Kazuhiro] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Goto, Yuki; Katoh, Takayuki; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1138654, Japan; [Yamashita, Taro; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Suga, Hiroaki] JST, CREST, Bunkyo Ku, Tokyo 1130033, Japan	Suga, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	hsuga@chem.s.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare; Japan Society for the Promotion of Science [24681047, 15K12739];  [7734]	We thank Drs. M. Ohuchi and T. Yoshitomi for supporting in the preparation of the manuscript. This work was supported by Ministry of Health, Labor and Welfare Grants-in-aid for Scientific Research programs from 2010 to 2012 to H. S., Y. T., and S. K., Grants-in-Aid for JSPS Fellows (7734) to K. I., and partly grants of Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (A) (24681047) to T. K., and Challenging Exploratory Research (15K12739) to Y. G.	Jung YK, 2014, CHEM COMMUN, V50, P12329, DOI 10.1039/c4cc03888f; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Linke R, 2010, MABS-AUSTIN, V2, P129; Armstrong A, 2003, CANCER BIOL THER, V2, P320, DOI 10.4161/cbt.2.4.451; Passioura T, 2014, ANNU REV BIOCHEM, V83, P727, DOI 10.1146/annurev-biochem-060713-035456; Stefan N, 2011, J MOL BIOL, V413, P826, DOI 10.1016/j.jmb.2011.09.016; Hussain S, 2006, MOL CANCER THER, V5, P3170, DOI 10.1158/1535-7163.MCT-06-0412; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Huls GA, 1999, NAT BIOTECHNOL, V17, P276; Zielonka S, 2014, J BIOTECHNOL, V191, P236, DOI 10.1016/j.jbiotec.2014.04.023; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Went P, 2005, AM J SURG PATHOL, V29, P83, DOI 10.1097/01.pas.0000.146028.70868.7a; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Shaunak S, 2006, NAT CHEM BIOL, V2, P312, DOI 10.1038/nchembio786; Subramanian N, 2014, CHEM COMMUN, V50, P11810, DOI 10.1039/c4cc02996h; Iwasaki K, 2012, ORG BIOMOL CHEM, V10, P5783, DOI 10.1039/c2ob25306b; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Martin-Killias P, 2011, CLIN CANCER RES, V17, P100, DOI 10.1158/1078-0432.CCR-10-1303; Morioka T, 2015, CURR OPIN CHEM BIOL, V26, P34, DOI 10.1016/j.cbpa.2015.01.023; Hristodorov D, 2014, MOL CANCER THER, V13, P2194, DOI 10.1158/1535-7163.MCT-13-0781; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Song YL, 2013, ANAL CHEM, V85, P4141, DOI 10.1021/ac400366b; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Deonarain MP, 2009, MABS, V1, P12; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI [10.1021/cb700233t, 10.1021/c6700233t]; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Guillemot JC, 2001, HISTOCHEM CELL BIOL, V116, P371, DOI 10.1007/s004180100329; Nochi T, 2004, CLIN IMMUNOL, V113, P326, DOI 10.1016/j.clim.2004.08.013; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Kratz H, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-17; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Hayashi Y, 2012, ACS CHEM BIOL, V7, P607, DOI 10.1021/cb200388k; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Ito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7373; Kwiatkowska-Borowczyk Eliza P, 2015, Contemp Oncol (Pozn), V19, pA52, DOI 10.5114/wo.2014.47129	44	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2844	1432-1432		J MOL EVOL	J. Mol. Evol.	DEC	2015	81	5-6			SI		210	217		10.1007/s00239-015-9710-z		8	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CX5AV	WOS:000365713700011		
J	Carrillo-Sepulveda, MA; Spitler, K; Pandey, D; Berkowitz, DE; Matsumoto, T				Carrillo-Sepulveda, Maria Alicia; Spitler, Kathryn; Pandey, Deepesh; Berkowitz, Dan E.; Matsumoto, Takayuki			Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Diabetes; High glucose; NF-kappa B; ROS; TLR4; Vascular smooth muscle cell	SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; TOLL-LIKE-RECEPTORS; ENDOTHELIUM-DEPENDENT RELAXATION; SPONTANEOUSLY HYPERTENSIVE-RATS; GLUCOSE-INDUCED PROLIFERATION; ANGIOTENSIN-II; MESENTERIC-ARTERIES; SIGNALING PATHWAYS; INSULIN-RESISTANCE	Hyperglycemia-induced reactive oxygen species (ROS) production plays a major role in the pathogenesis of diabetic vascular dysfunction. However, the underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a key component of innate immunity, is known to be activated during diabetes. Therefore, we hypothesize that hyperglycemia activates TLR4 signaling in vascular smooth muscle cells (VSMCs) that triggers ROS production and causes vascular dysfunction. Rat mesenteric VSMCs exposed to high glucose (25 mmol/l) increased TLR4 expression and activated TLR4 signaling via upregulation of myeloid differentiation factor 88 (MyD88). TLR4 inhibitor CLI-095 significantly attenuated elevated levels of ROS and nuclear factor-kappa B (NF-kappa B) activity in VSMCs exposed to high glucose. Mesenteric arteries from streptozotocin-induced diabetic rats treated with CLI-095 (2 mg/kg/day) intraperitoneally for 2 weeks exhibited reduced ROS generation and attenuated noradrenaline-induced contraction. These results suggest that hyperglycemia-induced ROS generation and NF-kappa B activation in VSMCs are at least, in part, mediated by TLR4 signaling. Therefore, strategies to block TLR4 signaling pathways pose a promising avenue to alleviate diabetic-induced vascular complications. High glucose-induced TLR4 activation in vascular smooth muscle cells. Inhibition of TLR4 attenuated high glucose-induced ROS production and NF-kappa B activity in VSMC. Suppression of TLR4 signaling attenuated mesenteric contraction in diabetic rat.	[Carrillo-Sepulveda, Maria Alicia] Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA; [Spitler, Kathryn] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Pandey, Deepesh; Berkowitz, Dan E.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Matsumoto, Takayuki] Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 1428501, Japan; [Carrillo-Sepulveda, Maria Alicia] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, Old Westbury, NY 11568 USA	Carrillo-Sepulveda, MA (reprint author), Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA.	mcarrill@nyit.edu			American Heart Association [13POST14690026, 13POST16810011]	This work was supported by research grants from American Heart Association to M.A. Carrillo-Sepulveda (13POST14690026) and D. Pandey (13POST16810011).	Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Schaeffer G, 2003, DIABETOLOGIA, V46, P773, DOI 10.1007/s00125-003-1091-y; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Devaraj S, 2009, DIABETOLOGIA, V52, P1665, DOI 10.1007/s00125-009-1394-8; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Matsumoto T, 2009, J PHARMACOL EXP THER, V329, P324, DOI 10.1124/jpet.108.148718; Yuen CY, 2012, CIRC RES, V111, pE55, DOI 10.1161/CIRCRESAHA.112.271361; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Miyagawa K, 2007, J HYPERTENS, V25, P415, DOI 10.1097/HJH.0b013e3280115b96; Bardal S, 2006, DIABETOLOGIA, V49, P811, DOI 10.1007/s00125-006-0151-5; Matsumoto T, 2007, AM J PHYSIOL-HEART C, V293, pH1480, DOI 10.1152/ajpheart.00229.2007; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Matsumoto T, 2007, FREE RADICAL BIO MED, V42, P993, DOI 10.1016/j.freeradbiomed.2006.12.028; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Srivastava P, 1998, PHARMACOL RES, V38, P265, DOI 10.1006/phrs.1998.0357; Kanie N, 2000, GEN PHARMACOL-VASC S, V35, P311, DOI 10.1016/S0306-3623(02)00115-5; Lin CC, 2010, FREE RADICAL BIO MED, V48, P240, DOI 10.1016/j.freeradbiomed.2009.10.047; Spitaler MM, 2002, DIABETOLOGIA, V45, P476, DOI 10.1007/s00125-002-0782-0; Beckman JA, 2013, EUR HEART J, V34, P2444, DOI 10.1093/eurheartj/eht142; Hernanz R, 2015, BRIT J PHARMACOL, V172, P3159, DOI 10.1111/bph.13117; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Quintela AM, 2012, FREE RADICAL BIO MED, V53, P730, DOI 10.1016/j.freeradbiomed.2012.05.045; Elms SC, 2013, DIABETOLOGIA, V56, P654, DOI 10.1007/s00125-012-2789-5; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Matsumoto T, 2012, PHARMACOL RES, V65, P537, DOI 10.1016/j.phrs.2012.02.004; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Asehnoune K, 2004, J IMMUNOL, V172, P2522; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Kassan M, 2013, DIABETES, V62, P2078, DOI 10.2337/db12-1374; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607; Wang YC, 2013, STROKE, V44, P2545, DOI 10.1161/STROKEAHA.113.001038; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Hattori Y, 2000, CARDIOVASC RES, V46, P188, DOI 10.1016/S0008-6363(99)00425-3; Sattar N, 2013, DIABETOLOGIA, V56, P686, DOI 10.1007/s00125-012-2817-5; Jeong IK, 2011, EXP MOL MED, V43, P684, DOI 10.3858/emm.2011.43.12.079; Touyz RM, 1996, J BIOL CHEM, V271, P24353; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Liu ZW, 2013, BIOL TRACE ELEM RES, V156, P262, DOI 10.1007/s12011-013-9857-7; Chan KC, 2012, CARDIOVASC THER, V30, P75, DOI 10.1111/j.1755-5922.2010.00226.x; Yamamoto M, 2002, J IMMUNOL, V169, P6668; Li HL, 2013, ATHEROSCLEROSIS, V228, P61, DOI 10.1016/j.atherosclerosis.2013.02.013; Ungvari Z, 2006, ANTIOXID REDOX SIGN, V8, P1121, DOI 10.1089/ars.2006.8.1121; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Schmidt L, 2015, PFLUG ARCH EUR J PHY, V467, P2361, DOI 10.1007/s00424-015-1688-2; Jialal I, 2012, CURR DIABETES REP, V12, P172, DOI 10.1007/s11892-012-0258-7; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Porter KE, 2013, CLIN SCI, V125, P167, DOI 10.1042/CS20120413; Kobayashi T, 2007, FREE RADICAL BIO MED, V43, P431, DOI 10.1016/j.freeradbiomed.2007.04.019; Lavrentyev EN, 2007, CIRC RES, V101, P455, DOI 10.1161/CIRCRESAHA.107.151852; Kobayashi T, 2008, BRIT J PHARMACOL, V155, P974, DOI 10.1038/bjp.2008.327; Park HS, 2004, J IMMUNOL, V173, P3589; Matsumoto T, 2009, J PHARMACOL SCI, V110, P326, DOI 10.1254/jphs.09116FP; Carrillo-Sepulveda MA, 2014, CELL PHYSIOL BIOCHEM, V34, P1497, DOI 10.1159/000366354; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Castillo-Hernandez Maria Carmen, 2010, Front Biosci (Elite Ed), V2, P441, DOI 10.2741/e103; Ganguly R, 2014, AM J PHYSL CELL PHYS, P02014; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Lv JL, 2015, BIOCHEM BIOPH RES CO, V459, P264, DOI 10.1016/j.bbrc.2015.02.096; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Mudaliar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108844; Sender V., 2014, COMMUN INTEGR BIOL, V7, DOI [10.4161/cib.29053, DOI 10.4161/cib.29053]; Sender V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059896; Sollinger D, 2014, CARDIOVASC RES, V101, P464, DOI 10.1093/cvr/cvt265; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Wu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094957; Zhang X, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-147	77	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	DEC	2015	93	12					1341	1354		10.1007/s00109-015-1318-7		14	Genetics & Heredity; Medicine, Research & Experimental	Genetics & Heredity; Research & Experimental Medicine	CX5BJ	WOS:000365715300006		
J	Nishiyama, A; Nakashima, K; Matsuba, A; Misono, M				Nishiyama, A.; Nakashima, K.; Matsuba, A.; Misono, M.			Doppler-free two-photon absorption spectroscopy of rovibronic transition of naphthalene calibrated with an optical frequency comb	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						High-resolution spectroscopy; Optical frequency comb; Doppler-free two-photon absorption; Polyatomic molecule	QUANTUM CASCADE LASER; LIFETIME MEASUREMENTS; VIBRONIC LEVELS; RESOLUTION; SPECTRA; CAVITY; SWEPT; BAND	We performed Doppler-free two-photon absorption spectroscopy of naphthalene using an optical frequency comb as a frequency reference. Rotationally resolved rovibronic spectra were observed, and absolute frequencies of the rovibronic transitions were determined with an uncertainty of several tens of kHz. The resolution and precision of our system are finer than the natural width of naphthalene. We assigned 1466 lines of the (Q(ka))Q(J) transition and calculated molecular constants. We attribute systematic spectral line shifts to the Coriolis interaction, and discuss the origin of the spectral linewidths. (C) 2015 Elsevier Inc. All rights reserved.	[Nishiyama, A.] Univ Electrocommun, Fac Informat & Engn, Chofu, Tokyo 1828585, Japan; [Nakashima, K.; Matsuba, A.; Misono, M.] Fukuoka Univ, Fac Sci, Jonan Ku, Fukuoka 8140180, Japan	Misono, M (reprint author), Fukuoka Univ, Fac Sci, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	m-misono@fukuoka-u.ac.jp					CHEN KM, 1977, OPT COMMUN, V23, P90, DOI 10.1016/0030-4018(77)90133-X; BOESL U, 1975, CHEM PHYS LETT, V31, P1, DOI 10.1016/0009-2614(75)80044-3; Pirali O, 2013, PHYS CHEM CHEM PHYS, V15, P10141, DOI [10.1039/c3cp44305a, 10.1039/c3crho44305a]; Judge RH, 2001, COMPUT PHYS COMMUN, V135, P293, DOI 10.1016/S0010-4655(00)00233-2; Yoshida K, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3122039; Misono M, 2002, J CHEM PHYS, V116, P162, DOI 10.1063/1.1421069; Knabe K, 2013, OPT EXPRESS, V21, P1020, DOI 10.1364/OE.21.001020; HANSCH TW, 1980, OPT COMMUN, V35, P441, DOI 10.1016/0030-4018(80)90069-3; Knabe K, 2012, OPT EXPRESS, V20, P12432, DOI 10.1364/OE.20.012432; Nishiyama A, 2014, OPT LETT, V39, P4923, DOI 10.1364/OL.39.004923; Okubo M, 2002, J CHEM PHYS, V116, P9293, DOI 10.1063/1.1473812; Nishiyama A, 2013, J OPT SOC AM B, V30, P2107, DOI 10.1364/JOSAB.30.002107; Del'Haye P, 2009, NAT PHOTONICS, V3, P529, DOI 10.1038/NPHOTON.2009.138; Buckingham GT, 2013, J PHYS CHEM A, V117, P10047, DOI 10.1021/jp400702p; Misono M, 2003, J CHEM PHYS, V118, P5422, DOI 10.1063/1.1554734; BECK SM, 1981, J CHEM PHYS, V74, P43, DOI 10.1063/1.440850; BOESL U, 1976, CHEM PHYS LETT, V42, P16, DOI 10.1016/0009-2614(76)80542-8; Giorgetta FR, 2010, NAT PHOTONICS, V4, P853, DOI 10.1038/nphoton.2010.228; Demtroder W., 2008, LASER SPECTROSCOPY; Kato H., 2000, DOPPLER FREE HIGH RE	20	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	DEC	2015	318						40	45		10.1016/j.jms.2015.09.010		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CX1MC	WOS:000365459300005		
J	Sugi, Y; Vinu, A				Sugi, Yoshihiro; Vinu, Ajayan			Shape-Selective Catalysis in the Alkylation of Naphthalene: Steric Interaction with the Nanospace of Zeolites	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Naphthalene; Zeolite; Pores and Channels; Shape-Selective Catalysis; beta,beta- and 2,6-Dialkylnaphthalene; Steric Restriction	LARGE-PORE ZEOLITES; 14-MEMBERED RING ZEOLITES.; LIQUID-PHASE ALKYLATION; EXTERNAL ACID SITES; H-BETA ZEOLITES; MORDENITE CATALYSTS; DEALUMINATED MORDENITE; TERT-BUTYLATION; ISOPROPYLATION; BIPHENYL	Steric interaction of reagents with nanospace of zeolites was studied in alkylation: isopropylation, sec-butylation, and tert-butylation of naphthalene (NP) over several large-pore zeolites to elucidate the mechanism of shape-selective catalysis. Selectivities for beta,beta- and 2,6-diallvInaphthalene (DAN) were influenced by the type of zeolite and bulkiness of alkylating agent. Shape-selective formation of beta,beta- and 2,6-diisopropylnaphthalene (DIPN) occurred only over H-mordenite (MOR) in the isopropylation of NP. Bulky alpha,alpha- and alpha,beta-DIPN are excluded because of steric restriction at their transition states by the MOR channels, resulting in the selective formation of beta,beta- and 2,6-DIPN. AFI (SSZ-24) gave also high selectivities for 2,6-DIPN, and CFI (CIT-5) and MSE (MCM-68) gave high selectivities for beta,beta-DIPN. The lower selectivities for 2,6-DIPN were observed over the zeolites, ATS (SSZ-55), IFR (SSZ-42), DON (UTD-1), SFH (SSZ-53), FAU (Y-zeolite), BEA (zeolite beta), and CON (CIT-1). Their channels allow the accommodation of bulky isomers, resulting in the catalysis under kinetic and/or thermodynamic controls. The selectivities for beta,beta- and 2,6-DAN were enhanced with the increase in bulkiness of alkylating agents: 1-butene for sec-butylation and 2-methylpropene for tert-butylation, even over zeolites with large pores and channels: the transition states of the least bulky isomers only fit the channels, and the other bulky isomers are excluded by steric restriction of the channels. However, tert-butylation over FAU, BEA, and CON had selectivities of around 50-60% for 2,6-DTBN, and almost 100% selectivities for beta,beta-DTBN. These zeolites cannot recognize the differences between 2,6- and 2,7-DTBN, but they can differentiate beta,beta-DTBN from the other isomers. The results indicate that the fitting of the least bulky isomers to zeolite channels, resulting in the exclusion of other bulky isomers, is a key for highly shape-selective catalysis.	[Sugi, Yoshihiro] Gifu Univ, Fac Engn, Dept Mat Sci & Technol, Gifu 5011193, Japan; [Sugi, Yoshihiro; Vinu, Ajayan] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia	Sugi, Y (reprint author), Gifu Univ, Fac Engn, Dept Mat Sci & Technol, Gifu 5011193, Japan.						Ahedi R. K., 2001, STUD SURF SCI CATAL, V135, P4096; Horniakova J, 2001, APPL CATAL A-GEN, V215, P235, DOI 10.1016/S0926-860X(01)00538-5; Brzozowski R, 2012, J CATAL, V292, P181, DOI 10.1016/j.jcat.2012.05.013; Brzozowski R, 2005, J CATAL, V232, P366, DOI 10.1016/j.jcat.2005.03.009; CSICSERY SM, 1984, ZEOLITES, V4, P202, DOI 10.1016/0144-2449(84)90024-1; Sugi Y, 2001, CATAL SURV JPN, V5, P43, DOI 10.1023/A:1012394525091; Kamalakar G, 1999, J MOL CATAL A-CHEM, V149, P283, DOI 10.1016/S1381-1169(99)00191-0; Bouvier C, 2010, J CATAL, V270, P60, DOI 10.1016/j.jcat.2009.12.005; Brzozowski R, 2010, APPL CATAL A-GEN, V377, P76, DOI 10.1016/j.apcata.2010.01.022; Takeuchi G, 1996, CATAL LETT, V41, P195, DOI 10.1007/BF00811490; Sugi Y, 1999, APPL CATAL A-GEN, V189, P251, DOI 10.1016/S0926-860X(99)00282-3; Tasi G, 2011, J CATAL, V279, P229, DOI 10.1016/j.jcat.2011.01.009; SUGI Y, 1994, CATAL TODAY, V19, P187, DOI 10.1016/0920-5861(94)85007-0; Sugi Y, 2008, B CHEM SOC JPN, V81, P897, DOI 10.1246/bcsj.81.897; Sugi Y, 2007, B CHEM SOC JPN, V80, P1418, DOI 10.1246/bcsj.80.1418; Brzozowski R, 2009, TOP CATAL, V52, P1001, DOI 10.1007/s11244-009-9240-2; Moreau P, 2001, J MOL CATAL A-CHEM, V168, P105, DOI 10.1016/S1381-1169(00)00482-9; MOREAU P, 1992, J ORG CHEM, V57, P5040, DOI 10.1021/jo00044a052; Anand R, 2003, APPL CATAL A-GEN, V249, P265, DOI 10.1016/S0926-860X(03)00204-7; Sugi Y, 2008, CATAL TODAY, V131, P413, DOI 10.1016/j.cattod.2007.10.060; Sugi Y, 2009, J MOL CATAL A-CHEM, V304, P22, DOI 10.1016/j.molcata.2009.01.018; Brzozowski R, 2007, CATAL COMMUN, V8, P1681, DOI 10.1016/j.catcom.2007.01.039; Brzozowski R, 1998, APPL CATAL A-GEN, V166, P21, DOI 10.1016/S0926-860X(97)00234-2; CHU SJ, 1994, IND ENG CHEM RES, V33, P3112, DOI 10.1021/ie00036a028; Moreau P, 2000, CATAL TODAY, V60, P235, DOI 10.1016/S0920-5861(00)00340-0; Maekawa H, 2008, J MOL CATAL A-CHEM, V279, P27, DOI 10.1016/j.molcata.2007.09.020; Kamalakar G, 2002, MICROPOR MESOPOR MAT, V52, P151, DOI 10.1016/S1387-1811(02)00280-9; Sugi Y, 2008, B CHEM SOC JPN, V81, P1166, DOI 10.1246/bcsj.81.1166; Ferino I, 1999, APPL CATAL A-GEN, V183, P303, DOI 10.1016/S0926-860X(99)00074-5; VENUTO PB, 1994, MICROPOROUS MATER, V2, P297, DOI 10.1016/0927-6513(94)00002-6; Sugi Y, 2007, B CHEM SOC JPN, V80, P2232, DOI 10.1246/bcsj.80.2232; Song CS, 1999, APPL CATAL A-GEN, V182, P175, DOI 10.1016/S0926-860X(99)00008-3; SAWA M, 1989, APPL CATAL, V53, P169, DOI 10.1016/S0166-9834(00)80019-6; Tasi G, 2001, J PHYS CHEM A, V105, P6513, DOI 10.1021/jp003428t; Sugi Y, 2010, J JPN PETROL INST, V53, P263, DOI 10.1627/jpi.53.263; Naiki H, 2011, MICROPOR MESOPOR MAT, V143, P383, DOI 10.1016/j.micromeso.2011.03.023; OLAH GA, 1976, J AM CHEM SOC, V98, P1839, DOI 10.1021/ja00423a032; Liu ZM, 1997, APPL CATAL A-GEN, V159, P305, DOI 10.1016/S0926-860X(97)00060-4; Shibata T, 2009, J MOL CATAL A-CHEM, V297, P80, DOI 10.1016/j.molcata.2008.09.016; KARGE HG, 1986, CHEM-ING-TECH, V58, P946, DOI 10.1002/cite.330581206; MOREAU P, 1992, J CATAL, V136, P487, DOI 10.1016/0021-9517(92)90078-V; Brzozowski R, 2011, J CATAL, V280, P137, DOI 10.1016/j.jcat.2011.01.017; HORSLEY JA, 1994, J CATAL, V147, P231, DOI 10.1006/jcat.1994.1134; GUISNET M, 1989, APPL CATAL, V54, P1, DOI 10.1016/S0166-9834(00)82350-7; Sugi Y, 2008, CATAL TODAY, V139, P242, DOI 10.1016/j.cattod.2008.09.007; BHATIA S, 1989, CATAL REV, V31, P431, DOI 10.1080/01614948909349937; Subrahmanyam C, 2005, J MOL CATAL A-CHEM, V226, P155, DOI 10.1016/j.molcata.2004.08.051; Sugi Y, 2011, KOREAN J CHEM ENG, V28, P409, DOI 10.1007/s11814-010-0382-5; Brzozowski R, 2002, J CATAL, V210, P313, DOI 10.1006/jcat.2002.3702; Buijs W, 2011, J CATAL, V279, P231, DOI 10.1016/j.jcat.2011.01.006; Buijs W, 2011, J CATAL, V280, P142, DOI 10.1016/j.jcat.2011.02.012; Colon G, 1998, APPL CATAL A-GEN, V168, P81, DOI 10.1016/S0926-860X(97)00346-3; Cuttrufello M. G., 2003, APPL CATAL A-GEN, V241, P91; Katayama A., 1991, J CHEM SOC CHEM COMM, V39; Kim J.-H., 1995, MICROPOROUS MATER, V5, P113; Lee H. S., 1989, CATAL LETT, V2, P243; Matsuda T., 1999, ACS SYM SER, V738, P282; Matsuzaki T., 1989, CHEM EXPRESS, V4, P413; Olah G. A., 1964, FRIEDEL CRAFTS RELAT, V2, p[XIV, XXII, XVII]; Song C., 1999, J JPN PETROL INST, V42, pC287; Sugi Y., 1997, CATALYSIS; Sugi Y, 2010, J CHIN CHEM SOC-TAIP, V57, P1; Sugi Y, 2014, J MOL CATAL A-CHEM, V395, P543, DOI 10.1016/j.molcata.2014.08.035	63	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	DEC	2015	15	12					9369	9381		10.1166/jnn.2015.11586		13	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CX2VN	WOS:000365555000005		
J	Chen, KC; Dutta, S; Yannauchi, Y; Alshehri, SM; Nguyen, MT; Yonezawa, T; Shen, KH; Wu, KCW				Chen, Kuan-Chou; Dutta, Saikat; Yannauchi, Yusuke; Alshehri, Saad M.; Mai Thanh Nguyen; Yonezawa, Tetsu; Shen, Kun-Hung; Wu, Kevin C. -W.			Mesoporous Europium-Doped Titania Nanoparticles (Eu-MTNs) for Luminescence-Based Intracellular Bio-Imaging	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Mesoporous; Titania; Europium; Bio-Imaging; Nanoparticles	THIN-FILMS; TIO2 NANOPARTICLES; IN-VITRO; PHOTOLUMINESCENCE; NANOCRYSTALS; COMPLEXES; Y2O3EU; WATER; OXIDE	Monodisperse and mesoporous europium (Eu)-doped titania nanoparticles (denoted as Eu-MTNs) were prepared by a co-synthesis method with the presence of a cationic surfactant (i.e., CTAB). A maximum loading amount of 8 mol% of Eu could be successfully incorporated into the framework of MTNs. The synthesized Eu-MTNs samples were characterized with X-ray diffraction (XRD) and scanning electron microscopy (SEM), with their luminescent property examined by photoluminescence (PL). Under ultraviolet irradiation, the Eu-MTNs samples exhibit several characteristic luminescence corresponding to D-5(0)-F-7(j) for Eu+3 ions, which can be attributed to the energy transfer from titania nanocrystallite to Eu3+ ions dispersed in amorphous mesoporous titania region. The potential intracellular bio-imaging application of the synthesized Eu-MTN nanoparticles was demonstrated with a breast cancer cell line (i.e., BT-20). High biocompatibility and strong luminescence of the Eu-MTNs show great potential in biomedical applications.	[Chen, Kuan-Chou] Taipei Med Univ, Dept Urol, Shuang Ho Hosp, Taipei 23561, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Sch Med, Dept Urol, Coll Med, Taipei 11031, Taiwan; [Dutta, Saikat; Wu, Kevin C. -W.] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan; [Yannauchi, Yusuke; Alshehri, Saad M.] King Saud Univ, Dept Chem, Coll Sci, Riyadh 11451, Saudi Arabia; [Yannauchi, Yusuke] Natl Inst Mat Sci, Res Ctr Mat Nanoarchitecton MANA, World Premier Int, Tsukuba, Ibaraki 3050044, Japan; [Mai Thanh Nguyen; Yonezawa, Tetsu] Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Shen, Kun-Hung] Chi Mei Med Ctr, Div Urol, Dept Surg, Tainan 701, Taiwan; [Wu, Kevin C. -W.] Natl Hlth Res Inst, Div Med Engn Res, Zhunan 350, Miaoli County, Taiwan	Shen, KH (reprint author), Chi Mei Med Ctr, Div Urol, Dept Surg, 901 Chung Hwa Rd, Tainan 701, Taiwan.				Chi-Mei Medical Center/Taipei Medical University [104CM-TMU-08]; Deanship of Scientific Research, King Saud University	This work was supported by the funding of Chi-Mei Medical Center/Taipei Medical University (104CM-TMU-08). The authors extend their appreciation to the Visiting Professor Program (VPP) supported by the Deanship of Scientific Research, King Saud University.	Julian B, 2005, NANOTECHNOLOGY, V16, P2707, DOI 10.1088/0957-4484/16/11/040; Vivero-Escoto JL, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/1/013003; Liao YT, 2012, APPL ENERG, V100, P75, DOI 10.1016/j.apenergy.2012.02.053; Hackenberg S, 2010, INT J ONCOL, V37, P1583, DOI 10.3892/ijo_00000812; Frindell KL, 2003, J SOLID STATE CHEM, V172, P81, DOI 10.1016/S0022-4596(02)00126-3; Sandoval S, 2012, CHEM MATER, V24, P4222, DOI 10.1021/cm302642g; Frindell KL, 2002, ANGEW CHEM INT EDIT, V41, P959, DOI 10.1002/1521-3773(20020315)41:6<959::AID-ANIE959>3.0.CO;2-M; Wakefield G, 2001, ADV MATER, V13, P1557, DOI 10.1002/1521-4095(200110)13:20<1557::AID-ADMA1557>3.0.CO;2-W; Malgras V, 2015, B CHEM SOC JPN, V88, P1171, DOI 10.1246/bcsj.20150143; Yin JB, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2712495; Tsuji E, 2014, J PHYS CHEM C, V118, P5406, DOI 10.1021/jp4126073; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Huang HS, 2013, SMALL, V9, P2520, DOI 10.1002/smll.201202786; Xin H, 2003, CHEM MATER, V15, P3728, DOI 10.1021/cm0344414; Kido J, 2002, CHEM REV, V102, P2357, DOI 10.1021/cr010448y; Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162; Nyk M, 2008, NANO LETT, V8, P3834, DOI 10.1021/nl802223f; Chen HW, 2011, CHEM COMMUN, V47, P8346, DOI 10.1039/c1cc12514a; Li JG, 2006, J PHYS CHEM B, V110, P1121, DOI 10.1021/jp0533291; Jeon S, 2003, CHEM MATER, V15, P1256, DOI 10.1021/cm0207402; Wu KCW, 2011, J MATER CHEM, V21, P8934, DOI 10.1039/c1jm10548e; Wu KCW, 2011, CHEM COMMUN, V47, P5232, DOI 10.1039/c1cc10659g; Dong H., 2015, CHEM REV, DOI [10.1021/acs.chemrev5b00091, DOI 10.1021/ACS.CHEMREV.5B00091]; Martinez-Rubio MI, 2001, LANGMUIR, V17, P7145, DOI 10.1021/la0105883; Sheih F. K., 2013, CHEM-EUR J, V19, P11139; Siant-Cricq P., 2013, J MATER CHEM B, V1, P2451; Wu K. C. W., 2012, J MATER CHEM, V22, P12510	27	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	DEC	2015	15	12					9802	9806		10.1166/jnn.2015.12329		5	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CX2VN	WOS:000365555000063		
J	Ontam, A; Khaorapapong, N; Ogawa, M				Ontam, Areeporn; Khaorapapong, Nithima; Ogawa, Makoto			Cadmium Telluride-Titanium Dioxide Nanocomposite for Photodegradation of Organic Substance	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Cadmium Telluride; Titanium Dioxide; Photodegradation; 4-Chlorophenol	TIO2; NANOPARTICLES; CDTE; 4-CHLOROPHENOL	Cadmium telluride-titanium dioxide nanocomposite was prepared by hydrothermal reaction of sot gel derived titanium dioxide and organically modified cadmium telluride. The crystallinity of titanium dioxide in the nanocomposite was higher than that of pure titanium dioxide obtained by the reaction under the same temperature and pressure conditions, showing that cadmium telluride induced the crystallization of titanium dioxide. Diffuse reflectance spectrum of the nanocomposite showed the higher absorption efficiency in the UV-visible region due to band-gap excitation of titanium dioxide. The nanocomposite significantly showed the improvement of photocatalytic activity for 4-chlorophenol with UV light.	[Ontam, Areeporn; Khaorapapong, Nithima] Khon Kaen Univ, Fac Sci, Dept Chem, Khon Kaen 40002, Thailand; [Ontam, Areeporn; Khaorapapong, Nithima] Khon Kaen Univ, Fac Sci, Ctr Excellence Innovat Chem, Khon Kaen 40002, Thailand; [Ogawa, Makoto] Waseda Univ, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan; [Ogawa, Makoto] Waseda Univ, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo 1698050, Japan	Khaorapapong, N (reprint author), Khon Kaen Univ, Fac Sci, Dept Chem, Khon Kaen 40002, Thailand.						Li JH, 2009, COORDIN CHEM REV, V253, P3015, DOI 10.1016/j.ccr.2009.07.017; Liu Y, 2010, J PHYS CHEM C, V114, P1641, DOI 10.1021/jp910500c; Mi L, 2008, APPL SURF SCI, V255, P2574, DOI 10.1016/j.apsusc.2008.07.150; Maurya A, 2011, MATER CHARACT, V62, P382, DOI 10.1016/j.matchar.2011.01.014; Zhang H, 2003, J PHYS CHEM B, V107, P8, DOI 10.1021/jp025910c; MATUSCHEK G, 1995, THERMOCHIM ACTA, V263, P23, DOI 10.1016/0040-6031(94)02389-6; Theurich J, 1996, LANGMUIR, V12, P6368, DOI 10.1021/la960228t; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; Lee JC, 2007, CRYST GROWTH DES, V7, P2588, DOI 10.1021/cg070588m; Seabold JA, 2008, CHEM MATER, V20, P5266, DOI 10.1021/cm8010666; Robert D, 2007, CATAL TODAY, V122, P20, DOI 10.1016/j.cattod.2007.01.060; Song YY, 2009, CHEM MATER, V21, P68, DOI 10.1021/cm801925j; Jun YW, 2006, B KOR CHEM SOC, V27, P961; Kang MG, 1999, J PHOTOCH PHOTOBIO A, V125, P119, DOI 10.1016/S1010-6030(99)00092-1; Luo BW, 2012, J ALLOY COMPD, V517, P192, DOI 10.1016/j.jallcom.2011.12.090; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Huerta-Ruelas J, 2000, JPN J APPL PHYS 1, V39, P1701, DOI 10.1143/JJAP.39.1701	17	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	DEC	2015	15	12					10041	10045		10.1166/jnn.2015.10611		5	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CX2VN	WOS:000365555000098		
J	Long, NV; Yang, Y; Teranishi, T; Thi, CM; Cao, Y; Nogami, M				Nguyen Viet Long; Yang, Yong; Teranishi, Toshiharu; Cao Minh Thi; Cao, Yanqin; Nogami, Masayuki			Biomedical Applications of Advanced Multifunctional Magnetic Nanoparticles	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Fe Nanoparticles; Fe Oxide Nanoparticles; Au Nanoparticles; Ag Nanoparticles; Pt Nanoparticles; Drug Delivery; Hyperthermia; Magnetic Resonance Imaging; Drug; Cancers; Tumors; Cancer Therapy	IRON-OXIDE NANOPARTICLES; NOBLE-METAL NANOPARTICLES; ENHANCED RAMAN-SCATTERING; DRUG-DELIVERY-SYSTEM; MRI CONTRAST AGENTS; IN-VIVO; SILVER NANOPARTICLES; THERAPEUTIC APPLICATIONS; BIOLOGICAL APPLICATIONS; CANCER-TREATMENT	In this review, we have presented the latest results and highlights on biomedical applications of a class of noble metal nanoparticles, such as gold, silver and platinum, and a class of magnetic nanoparticles, such as cobalt, nickel and iron. Their most important related compounds are also discussed for biomedical applications for treating various diseases, typically as cancers. At present, both physical and chemical methods have been proved very successful to synthesize, shape, control, and produce metal- and oxide-based homogeneous particle systems, e.g., nanoparticles and microparticles. Therefore, we have mainly focused on functional magnetic nanoparticles for nanomedicine because of their high bioadaptability to the organs inside human body. Here, bio-conjugation techniques are very crucial to link nanoparticles with conventional drugs, nanodrugs, biomolecules or polymers for biomedical applications. Biofunctionalization of engineered nanoparticles for biomedicine is shown respective to in vitro and in vivo analysis protocols that typically include drug delivery, hyperthermia therapy, magnetic resonance imaging (MRI), and recent outstanding progress in sweep imaging technique with Fourier transformation (SWIFT) MRI. The latter can be especially applied using magnetic nanoparticles, such as Co-, Fe-, Ni-based nanoparticles, alpha-Fe2O3, and Fe3O4 oxide nanoparticles for analysis and treatment of malignancies. Therefore, this review focuses on recent results of scientists, and related research on diagnosis and treatment methods of common and dangerous diseases by biomedical engineered nanoparticles. Importantly, nanosysems (nanoparticles) or microsystems (microparticles) or hybrid micronano systems are shortly introduced into nanomedicine. Here, Fe oxide nanoparticles ultimately enable potential and applicable technologies for tumor-targeted imaging and therapy. Finally, we have shown the latest aspects of the most important Fe-based particle systems, such as Fe, alpha-Fe2O3, Fe3O4, Fe-FexOy oxide core-shell nanoparticles, and CoFe2O4-MnFe2O4 core-shell nanoparticles for nanomedicine in the efficient treatment of large tumors at low cost in near future.	[Nguyen Viet Long; Yang, Yong; Cao, Yanqin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Nguyen Viet Long] Posts & Telecommun Inst Technol, Hanoi 100000, Vietnam; [Nguyen Viet Long; Teranishi, Toshiharu] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Cao Minh Thi] Ho Chi Minh City Univ Technol, Ho Chi Minh City 700000, Vietnam; [Nogami, Masayuki] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan	Long, NV (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.				Chinese Academy of Sciences (Visiting Fellowship for Researchers from Developing Countries) [2013FFGB0007]; China Postdoctoral Science Foundation from Shanghai Institute of Ceramics, Chinese Academy of Sciences [2014M551462]; National Natural Science Foundation of China [51471182]	We greatly thank and appreciate the financial supports and projects sponsored by Chinese Academy of Sciences (Visiting Fellowship for Researchers from Developing Countries, Grant No. 2013FFGB0007) and China Postdoctoral Science Foundation (No. 2014M551462) from Shanghai Institute of Ceramics, Chinese Academy of Sciences, and other Universities for our research on Novel Magnetic Nanoparticles for Catalysis, Biology and Medicine (Nanomedicine). This study was supported by a fund from the National Natural Science Foundation of China (No. 51471182).	Andra W., 2007, HDB MAGNETISM ADV MA, V4; Sun XL, 2012, NANO LETT, V12, P4859, DOI 10.1021/nl302358e; Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Reddy LH, 2012, CHEM REV, V112, P5818, DOI 10.1021/cr300068p; Chaudhuri RG, 2012, CHEM REV, V112, P2373, DOI 10.1021/cr100449n; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Mahmoudi M, 2012, CHEM REV, V112, P2323, DOI 10.1021/cr2002596; Sinha A, 2014, NANOMED-NANOTECHNOL, V10, P1003, DOI 10.1016/j.nano.2014.02.002; Chen TJ, 2008, J BIOMED MATER RES A, V87A, P165, DOI 10.1002/jbm.a.31752; Singh A, 2014, DRUG DISCOV TODAY, V19, P474, DOI 10.1016/j.drudis.2013.10.005; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Trinh TT, 2011, RSC ADV, V1, P100, DOI 10.1039/c1ra00012h; Long NV, 2014, RECENT PAT NANOTECH, V8, P52; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Long NV, 2013, J NANOSCI NANOTECHNO, V13, P4799, DOI 10.1166/jnn.2013.7570; Tonga GY, 2014, ADV MATER, V26, P359, DOI 10.1002/adma.201303001; del Burgo LS, 2014, NANOMED-NANOTECHNOL, V10, P905, DOI 10.1016/j.nano.2013.10.001; Long NV, 2012, J EXP NANOSCI, V7, P133, DOI 10.1080/17458080.2010.513017; Pham VB, 2013, INT J NANOTECHNOL, V10, P178, DOI 10.1504/IJNT.2013.053130; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Gao ZB, 2013, NANOMED-NANOTECHNOL, V9, P174, DOI 10.1016/j.nano.2012.06.003; Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064; Kim T, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/012001; Wang ZY, 2014, J MATER CHEM B, V2, P4748, DOI 10.1039/c4tb00342j; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Long NV, 2014, RSC ADV, V4, P8250, DOI 10.1039/c3ra46410e; Invernici G, 2011, RECENT PAT ANTI-CANC, V6, P58, DOI 10.2174/157489211793979990; Sun SH, 2002, J AM CHEM SOC, V124, P8204, DOI 10.1021/ja026501x; Huang YP, 2008, J MATER SCI, V43, P5390, DOI 10.1007/s10853-008-2793-9; Locatelli E, 2014, NANOMEDICINE-UK, V9, P839, DOI [10.2217/nnm.14.1, 10.2217/NNM.14.1]; Stone J, 2011, WIRES NANOMED NANOBI, V3, P100, DOI 10.1002/wnan.120; Liu WJ, 2014, CHEM ENG J, V236, P448, DOI 10.1016/j.cej.2013.10.062; Zhou ZJ, 2013, ACS NANO, V7, P3287, DOI 10.1021/nn305991e; Long NV, 2012, NEW J CHEM, V36, P1320, DOI 10.1039/c2nj40027h; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Herve K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465608; Klostergaard J, 2012, NANOMED-NANOTECHNOL, V8, pS37, DOI 10.1016/j.nano.2012.05.010; Yang Y, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/32/325701; Meng H, 2013, ACS NANO, V7, P994, DOI 10.1021/nn3044066; Safarik I, 2009, CHEM PAP, V63, P497, DOI 10.2478/s11696-009-0054-2; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Dykman L, 2012, CHEM SOC REV, V41, P2256, DOI 10.1039/c1cs15166e; Jenkins JT, 2013, NANOMED-NANOTECHNOL, V9, P356, DOI 10.1016/j.nano.2012.08.007; Doaga A, 2013, AIP CONF PROC, V1564, P123, DOI 10.1063/1.4832806; Teli MK, 2010, CURR PHARM DESIGN, V16, P1882; Jaganathan H, 2011, ACS APPL MATER INTER, V3, P1282, DOI 10.1021/am200086r; Chomoucka J, 2010, PHARMACOL RES, V62, P144, DOI 10.1016/j.phrs.2010.01.014; Thanh NTK, 2010, NANO TODAY, V5, P213, DOI 10.1016/j.nantod.2010.05.003; Doria G, 2012, SENSORS-BASEL, V12, P1657, DOI 10.3390/s120201657; Repko A, 2011, J NANOPART RES, V13, P5021, DOI 10.1007/s11051-011-0483-z; Ho D, 2011, ACCOUNTS CHEM RES, V44, P875, DOI 10.1021/ar200090c; Ryvolova M, 2012, SENSORS-BASEL, V12, P14792, DOI 10.3390/s121114792; Carenco S, 2014, ADV MATER, V26, P371, DOI 10.1002/adma.201303198; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Darton NJ, 2008, NANOMED-NANOTECHNOL, V4, P19, DOI 10.1016/j.nano.2007.11.001; Sahay G, 2010, BIOMATERIALS, V31, P923, DOI 10.1016/j.biomaterials.2009.09.101; Long NV, 2014, RSC ADV, V4, P6383, DOI 10.1039/c3ra45925j; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Poudyal N, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/4/043001; Markides H, 2012, J NANOMATER, DOI 10.1155/2012/614094; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Yang Y, 2008, SCRIPTA MATER, V58, P862, DOI 10.1016/j.scriptamat.2008.01.017; Liu G, 2013, SMALL, V9, P1533, DOI 10.1002/smll.201201531; Felice B, 2014, MAT SCI ENG C-MATER, V41, P178, DOI 10.1016/j.msec.2014.04.049; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Munger MA, 2014, NANOMED-NANOTECHNOL, V10, P1, DOI 10.1016/j.nano.2013.06.010; Long NV, 2011, J CRYST GROWTH, V320, P78, DOI 10.1016/j.jcrysgro.2011.02.006; Singh S, 2007, J NANOSCI NANOTECHNO, V7, P3048, DOI 10.1166/jnn.2007.922; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Dinarvand R, 2011, INT J NANOMED, V6, P877, DOI 10.2147/IJN.S18905; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202; Fantechi E, 2014, ACS NANO, V8, P4705, DOI 10.1021/nn500454n; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Cormode DP, 2013, NMR BIOMED, V26, P766, DOI 10.1002/nbm.2909; Long NV, 2011, ACTA MATER, V59, P2901, DOI 10.1016/j.actamat.2011.01.033; Zhang JJ, 2014, MAGN RESON MED, V71, P1982, DOI 10.1002/mrm.25181; Blanco-Andujar C, 2010, ANNU REP PROG CHEM A, V106, P553, DOI 10.1039/b920666n; Long NV, 2011, J NANOPART RES, V13, P5177, DOI 10.1007/s11051-011-0503-z; Soares PIP, 2012, RECENT PAT ANTI-CANC, V7, P64; Tomitaka A, 2011, J MAGN MAGN MATER, V323, P1398, DOI 10.1016/j.jmmm.2010.11.054; Long NV, 2014, COLLOID SURFACE A, V456, P184, DOI 10.1016/j.colsurfa.2014.05.001; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Chen H, 2009, ANGEW CHEM INT EDIT, V48, P9295, DOI 10.1002/anie.200903655; Kharisov BI, 2012, RSC ADV, V2, P9325, DOI 10.1039/c2ra20812a; Yildirimer L, 2011, NANO TODAY, V6, P585, DOI 10.1016/j.nantod.2011.10.001; Cao YQ, 2014, J NANOSCI NANOTECHNO, V14, P1194, DOI 10.1166/jnn.2014.9130; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Hung LY, 2014, NANOMED-NANOTECHNOL, V10, P819, DOI 10.1016/j.nano.2013.11.009; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Singh D, 2014, NANOMEDICINE-UK, V9, P469, DOI [10.2217/nnm.14.4, 10.2217/NMM.14.4]; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Calero M, 2014, NANOMED-NANOTECHNOL, V10, P733, DOI 10.1016/j.nano.2013.11.010; Locatelli E, 2014, CHEM COMMUN, V50, P7783, DOI 10.1039/c4cc01513d; Psimadas D, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/2/025101; Chatterjee K, 2014, ADV COLLOID INTERFAC, V209, P8, DOI 10.1016/j.cis.2013.12.008; Poon Z, 2011, NANOMED-NANOTECHNOL, V7, P201, DOI 10.1016/j.nano.2010.07.008; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Ung D, 2009, CRYSTENGCOMM, V11, P1309, DOI 10.1039/b823290n; Korzeniowska B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/44/442002; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Long NV, 2012, J EXP NANOSCI, V7, P426, DOI 10.1080/17458080.2010.543988; Baldi G, 2007, LANGMUIR, V23, P4026, DOI 10.1021/la063255k; Rizzitelli S, 2014, NANOMED-NANOTECHNOL, V10, P901, DOI 10.1016/j.nano.2014.03.012; Yang CG, 2008, NANOMED-NANOTECHNOL, V4, P318, DOI 10.1016/j.nano.2008.05.004; Shiba K, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/2/023002; Kobayashi N, 2015, MAGN RESON MED, V73, P1812, DOI 10.1002/mrm.25301; Tahara K, 2010, INT J PHARMACEUT, V392, P311, DOI 10.1016/j.ijpharm.2010.03.042; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Yin ZF, 2013, PHYS CHEM CHEM PHYS, V15, P4844, DOI 10.1039/c3cp43938k; Long NV, 2013, J NANOMATER, DOI 10.1155/2013/793125; Fan KL, 2012, NAT NANOTECHNOL, V7, P459, DOI [10.1038/nnano.2012.90, 10.1038/NNANO.2012.90]; Gehrke H, 2011, ARCH TOXICOL, V85, P799, DOI 10.1007/s00204-010-0636-3; Vogt C, 2010, J NANOPART RES, V12, P1137, DOI 10.1007/s11051-009-9661-7; Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1; Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f; Zhou X, 2014, NANOMED-NANOTECHNOL, V10, P889, DOI 10.1016/j.nano.2014.03.001; Qiang LH, 2014, COLLOID SURFACE A, V456, P62, DOI 10.1016/j.colsurfa.2014.04.058; Wong KKY, 2010, MEDCHEMCOMM, V1, P125, DOI 10.1039/c0md00069h; Betancourt-Galindo R., 2014, J NANOMATER, V2014; Binns C., 2003, INTRO NANOSCIENCE NA; Bullinger H., 2009, TECHNOLOGY GUIDE PRI; Chen Po C, 2008, Nanotechnol Sci Appl, V1, P45; Cornell R. M., 2003, IRON OXIDES STRUCTUR; Crespo P, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/48/484006; Devkota J, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862395; Dewi MR, 2014, AUST J CHEM, V67, P663, DOI 10.1071/CH13595; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Dwivedi M, 2014, J BIOMATER TISS ENG, V4, P198, DOI 10.1166/jbt.2014.1164; Freitas Jr R. A., 2003, NANOMEDICINE A, VIIA; Freitas Robert A Jr, 2005, Nanomedicine, V1, P2, DOI 10.1016/j.nano.2004.11.003; Gao JH, 2009, ACCOUNTS CHEM RES, V42, P1097, DOI 10.1021/ar9000026; Gao Z., 2003, NANOMED-NANOTECHNOL, V9, P174; Garwood M., 2014, SOC THERM MED ANN M; Hai T. H., 2011, INT J NANOTECHNOL, V8, P383, DOI 10.1504/IJNT.2011.038214; Hans M. L., 2006, NANOMATERIALS HDB; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hughes G. A., 2014, ADV DRUG DELIV REV, V1, P22; Hughes Gareth A, 2005, Nanomedicine, V1, P22, DOI 10.1016/j.nano.2004.11.009; Jain K. K., 2008, HDB NANOMEDICINE; Kawamura G., 2007, APPL PHYS LETT, V90; Kazem N-K, 2013, ASIAN PAC J CANCER P, V14, P6595; Kemp MM, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455104; Ketebu O., 2014, ADV SCI ENG MED, V6, P531; Kopwitthaya A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315101; Kosaka PM, 2014, NAT NANOTECHNOL, V9, P1047, DOI [10.1038/nnano.2014.250, 10.1038/NNANO.2014.250]; Kumar C. S. S. R., 2005, BIOFUNCTIONALIZATION, V1; lida H., 2007, J COLLOID INTERF SCI, V314, P274; Locatelli E, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2304-7; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Long N. V., 2010, ADV NAT SCI-NANOSCI, V1; Long N. V., 2014, CURR PHYS CHEM, V4, P1; Long NV, 2011, J ALLOY COMPD, V509, P7702, DOI 10.1016/j.jallcom.2011.04.031; Long N. V., 2012, J ADV MICROS RES, V7, P98; Long N. V., 2012, RECENT PAT MAT SCI, V5, P175; Long N. V., 2014, J ADV SCI ENG MED, V6, P1; Long NV, 2010, MATER CHEM PHYS, V124, P1193; Mandarano G, 2010, BIOMED IMAGING INTER, V6, pe13, DOI DOI 10.2349/BIIJ.6.2.E13; Mohammadi H., 2013, INT NANO LETT, V3, P28; Nann T., 2011, NANO BIOMED ENG, V3, P137; Nardon C, 2014, ANTICANCER RES, V34, P487; Nguyen X. P., 2012, ADV NAT SCI-NANOSCI, V3; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Peeples B, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2290-9; Reis Catarina Pinto, 2006, Nanomedicine-Nanotechnology Biology and Medicine, V2, P8, DOI 10.1016/j.nano.2005.12.003; Porcel E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085103; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Rajesh E. M., 2014, ADV SCI ENG MED, V6, P268; Sanvicens N, 2008, TRENDS BIOTECHNOL, V26, P425, DOI 10.1016/j.tibtech.2008.04.005; Singh D, 2014, NANOMEDICINE-UK, V9, P501, DOI 10.2217/NMM.14.5; Singh R., 2007, J BIOMED NANOTECHNOL, V7, P489; Singh S., 2014, ADV SCI ENG MED, V6, P688; Spielmann H., 2010, ALTERNATIVE TESTING; Teja A. S., 2009, CRYST GROWTH CHARACT, V55, P22; Thanh NTK, 2012, MAGNETIC NANOPARTICLES: FROM FABRICATION TO CLINICAL APPLICATIONS, P1, DOI 10.1201/b11760; Thuy P. T. H., 2013, INT J NANOTECHNOL, V10, P166; Tran D. L., 2010, ADV NAT SCI NANOSCI, V1; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Unger E. C., 1996, U.S. Patent, Patent No. 5580575; Vergoni V., 2009, NANOMEDICINE, V5, P369; Victor F. P., 2010, WO Patent, Patent No. [2010069941A1, 2010069941]; Xing X., 2010, ADV MATER, V11; Yih Tachung C, 2005, Nanomedicine, V1, P191, DOI 10.1016/j.nano.2005.04.001; Yu XW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5136; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhou Weilie, 2005, Nanomedicine, V1, P233, DOI 10.1016/j.nano.2005.06.005	191	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	DEC	2015	15	12					10091	10107		10.1166/jnn.2015.11691		17	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CX2VN	WOS:000365555000103		
J	Hashimoto, R; Koike, H; Takahashi, M; Ohyama, K; Kawagashira, Y; Iijima, M; Sobue, G				Hashimoto, Rina; Koike, Haruki; Takahashi, Mie; Ohyama, Ken; Kawagashira, Yuichi; Iijima, Masahiro; Sobue, Gen			Uncompacted Myelin Lamellae and Nodal Ion Channel Disruption in POEMS Syndrome	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Electron microscopy; Neuropathy; Node of Ranvier; POEMS syndrome; Sodium channel; Sural nerve biopsy	STEM-CELL TRANSPLANTATION; SECONDARY SEGMENTAL DEMYELINATION; EXPERIMENTAL ALLERGIC NEURITIS; CROW-FUKASE SYNDROME; PERIPHERAL NEUROPATHY; NERVE BIOPSY; FIBER LOSS; POLYNEUROPATHY; RANVIER; REMYELINATION	To elucidate the significance of uncompacted myelin lamellae (UML) and ion channel disruption at the nodes of Ranvier in the polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome, we evaluated sural nerve biopsy specimens from 33 patients with POEMS syndrome and from 7 control patients. Uncompacted myelin lamellae distribution was assessed by electron microscopy and immunofluorescence microscopy. In the POEMS patient biopsies, UML were seen more frequently in small versus large myelinated fibers. Paranodes and Schmidt-Lanterman incisures, where normal physiologic UM is located, were frequently associated with UM. Widening of the nodes of Ranvier (i.e. segmental demyelination) was not associated with UML. There was axonal hollowing with neurofilament condensation at Schmidt-Lanterman incisures with abnormal UML, suggesting axonal damage at those sites in the POEMS patient biopsies. Myelin sheath irregularity was conspicuous in large myelinated fibers and was associated with abnormally widened bizarrely shaped Schmidt-Lanterman incisures. Indirect immunofluorescent studies revealed abnormalities of sodium (pan sodium) and potassium (KCNQ2) channels, even at nonwidened nodes of Ranvier. Thus, UML was not apparently associated with segmental demyelination but seemed to be associated with axonal damage. These observations suggest that nodal ion channel disruption may be associated with functional deficits in POEMS syndrome patient nerves.	[Hashimoto, Rina; Koike, Haruki; Takahashi, Mie; Ohyama, Ken; Kawagashira, Yuichi; Iijima, Masahiro; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan	Sobue, G (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp			Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Dispenzieri A, 2004, BLOOD, V104, P3400, DOI 10.1182/blood-2004-05-2046; Vallat JM, 2011, ACTA NEUROPATHOL, V121, P313, DOI 10.1007/s00401-011-0804-4; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Kawagashira Y, 2010, J NEUROPATH EXP NEUR, V69, P1143, DOI 10.1097/NEN.0b013e3181fa44af; Rasband MN, 1999, J NEUROSCI, V19, P7516; OHI T, 1985, ANN NEUROL, V17, P255, DOI 10.1002/ana.410170306; Koike H, 2003, ANN NEUROL, V54, P19, DOI 10.1002/ana.10550; Ulzheimer JC, 2004, MOL CELL NEUROSCI, V25, P83, DOI 10.1016/j.mcn.2003.09.015; Kuwabara S, 2008, J NEUROL NEUROSUR PS, V79, P1255, DOI 10.1136/jnnp.2008.150177; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; VITAL C, 1994, ACTA NEUROPATHOL, V87, P302; Koike H, 2007, J NEUROPATH EXP NEUR, V66, P1027, DOI 10.1097/NEN.0b013e3181598294; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; SOBUE G, 1992, ACTA NEUROPATHOL, V84, P171; BUCHTHAL F, 1987, AM J ANAT, V180, P156, DOI 10.1002/aja.1001800205; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Renaud S, 2006, NEUROLOGY, V66, P742, DOI 10.1212/01.wnl.0000201193.00382.b3; BLUME G, 1995, NEUROLOGY, V45, P1577; Koike H, 2004, NEUROLOGY, V63, P129; Vallat JM, 2009, J NEUROPATH EXP NEUR, V68, P833, DOI 10.1097/NEN.0b013e3181af2b9c; Vital C, 2003, MUSCLE NERVE, V27, P253, DOI 10.1002/mus.10331; Fujinuma Y, 2012, J NEUROL SCI, V318, P131, DOI 10.1016/j.jns.2012.03.004; YOSHIKAWA H, 1991, J NEUROPATH EXP NEUR, V50, P649, DOI 10.1097/00005072-199109000-00009; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Craner MJ, 2003, BRAIN, V126, P1552, DOI 10.1093/brain/awg153; Kuwabara S, 2008, NEUROLOGY, V71, P1691, DOI 10.1212/01.wnl.0000323811.42080.a4; Kuwabara S, 2006, NEUROLOGY, V66, P105, DOI 10.1212/01.wnl.0000188757.38495.23; WAXMAN SG, 1985, SCIENCE, V228, P1502, DOI 10.1126/science.2409596; Novakovic SD, 1998, MUSCLE NERVE, V21, P1019, DOI 10.1002/(SICI)1097-4598(199808)21:8<1019::AID-MUS6>3.0.CO;2-B; Koike H, 2008, J NEUROL NEUROSUR PS, V79, P1171, DOI 10.1136/jnnp.2007.135681; DYCK PJ, 1981, ANN NEUROL, V9, P575, DOI 10.1002/ana.410090611; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Nasu S, 2012, J NEUROL NEUROSUR PS, V83, P476, DOI 10.1136/jnnp-2011-301706; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Koike H, 2001, NEUROLOGY, V56, P1727; KELLY JJ, 1983, NEUROLOGY, V33, P202; Sinisalo M, 2004, AM J HEMATOL, V76, P66, DOI 10.1002/ajh.20051; Dispenzieri A, 2003, BLOOD, V101, P2496, DOI 10.1182/blood-2002-07-2299; OHNISHI A, 1981, J NEUROL SCI, V51, P131, DOI 10.1016/0022-510X(81)90066-6; Mauermann ML, 2012, J NEUROL NEUROSUR PS, V83, P480, DOI 10.1136/jnnp-2011-301472; Cifuentes-Diaz C, 2011, PLOS ONE, V6; Dyck PJ GC, 1993, PERIPHERAL NEUROPATH, P514; Kimura J, 2003, PRINCIPLES PRACTICE; Kuwabara S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006828.pub2; NAKANISHI T, 1984, NEUROLOGY, V34, P712; NUKADA H, 1987, ANN NEUROL, V22, P311, DOI 10.1002/ana.410220306	46	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2015	74	12					1127	1136		10.1097/NEN.0000000000000257		10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CX3PB	WOS:000365610200002		
J	Nakanishi, K; Tanaka, N; Kamei, N; Hiramatsu, T; Ujigo, S; Sumiyoshi, N; Rikita, T; Takazawa, A; Ochi, M				Nakanishi, Kazuyoshi; Tanaka, Nobuhiro; Kamei, Naosuke; Hiramatsu, Takeshi; Ujigo, Satoshi; Sumiyoshi, Norihiko; Rikita, Takanori; Takazawa, Atsushi; Ochi, Mitsuo			Electrophysiological assessments of the motor pathway in diabetic patients with compressive cervical myelopathy	JOURNAL OF NEUROSURGERY-SPINE			English	Article						transcranial magnetic stimulation; motor evoked potentials; central motor conduction time; peripheral conduction time; corticospinal tract; F-wave; diabetes mellitus; cervical myelopathy; cervical	TRANSCRANIAL MAGNETIC STIMULATION; F-WAVE LATENCY; TRACT CONDUCTION BLOCK; SPONDYLOTIC MYELOPATHY; EVOKED-POTENTIALS; NERVE-CONDUCTION; CORTICOSPINAL TRACT; HEALTHY-SUBJECTS; SURGICAL-TREATMENT; LAMINOPLASTY	OBJECT The occurrence of compressive cervical myelopathy (CCM) increases in adults over 50 years of age. In addition, diabetes mellitus (DM) is a frequent comorbidity for people of this age and may impact the severity of CCM. The authors assessed motor pathway function in diabetic patients with CCM to investigate the correlation between electro-physiological parameters and clinical symptoms. METHODS Motor evoked potentials (MEPs) were measured from the abductor digiti minimi muscle (ADM) and the abductor hallucis muscle (AH) following transcranial magnetic stimulation, as were M- and F-waves following electrical stimulation of the ulnar and tibial nerves, in 22 patients with CCM and diabetes mellitus (DM) who had not experienced symptomatic diabetic neuropathy (CCM-DM group), in 92 patients with CCM alone (CCM group), and in 24 healthy adults (control group). The peripheral conduction time (PCT; measured from the ADM and AH) was calculated as follows: (M-wave latency + F-wave latency 1)/2. The central motor conduction time (CMCT; measured from the ADM and AH) was calculated by subtracting the PCT from the onset latency of the MEPs. The Japanese Orthopaedic Association (JOA) score for cervical myelopathy was obtained before and 1 year after surgery as a clinical outcome measure. RESULTS MEP, PCT, and CMCT parameters in the CCM-DM and CCM groups were significantly longer than those in the control group (p = 0.000-0.007). The PCTs in the CCM-DM group were significantly longer than those in the CCM group (p = 0.001-0.003). No significant differences were detected in the MEP and CMCT parameters between the CCM-DM and CCM groups (p = 0.080-1.000). The JOA score before surgery in the CCM-DM group was 10.7 +/- 2.0 points and was significantly lower than that in the CCM group (12.2 +/- 2.5 points, p = 0.015). In the CCM-DM group, JOA scores before surgery correlated with MEP-AH (r = -0.610, p = 0.012) and PCT-AH (r = -0.676, p = 0.004) values; but not with CMCT values, while the JOA scores were related to both MEP and CMCT parameters in the CCM group. The JOA scores improved to 13.8 +/- 2.2 points after surgery (p = 0.001) and correlated with MEP-AH (r = -0.667, p = 0.005) and PCT-AH (r = -0.611, p = 0.012) in the CCM-DM group. CONCLUSIONS The results suggest that MEP, PCT, and CMCT parameters each reveal abnormalities in the upper and lower motor neurons even in patients with DM. The results also show a prolonged PCT in CCM-DM patients, despite having no history of diabetic neuropathy. Corticospinal tract impairments are similar between CCM and CCM-DM patients, while the JOA score of the CCM-DM patients is lower than that in the CCM patients. The JOA score in CCM-DM patients may be influenced by additional impairments in peripheral nerves or other diabetic complications. These electro-physiological studies may be useful for screening motor pathway function for CCM in patients with DM.	[Nakanishi, Kazuyoshi; Tanaka, Nobuhiro; Kamei, Naosuke; Hiramatsu, Takeshi; Ujigo, Satoshi; Sumiyoshi, Norihiko; Rikita, Takanori; Takazawa, Atsushi; Ochi, Mitsuo] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthoped Surg, Integrated Hlth Sci, Hiroshima 7348551, Japan	Nakanishi, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthoped Surg, Integrated Hlth Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kazn@hiroshima-u.ac.jp			Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare [24592198]	Supported by the Grants-in-Aid for Scientific Research (Scientific Research C, Research Project Number: 24592198) from Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare.	Matsuda Y, 1999, SPINE, V24, P529, DOI 10.1097/00007632-199903150-00005; Ofuji A, 1998, J NEUROL SCI, V160, P26, DOI 10.1016/S0022-510X(98)00160-9; TAVY DLJ, 1994, MUSCLE NERVE, V17, P235, DOI 10.1002/mus.880170215; Kaneko K, 2001, CLIN NEUROPHYSIOL, V112, P1035, DOI 10.1016/S1388-2457(01)00533-8; Tobimatsu S, 1998, J NEUROL, V245, P256, DOI 10.1007/s004150050215; Machino M, 2014, SPINE, V39, P220, DOI 10.1097/BRS.0000000000000102; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; DILAZZARO V, 1992, ELECTROEN CLIN NEURO, V85, P311, DOI 10.1016/0168-5597(92)90107-M; FURBY A, 1992, J NEUROL, V239, P152, DOI 10.1007/BF00833916; Andersen H, 1997, MUSCLE NERVE, V20, P1296, DOI 10.1002/(SICI)1097-4598(199710)20:10<1296::AID-MUS12>3.0.CO;2-1; Puksa L, 2003, CLIN NEUROPHYSIOL, V114, P1079, DOI 10.1016/S1388-2457(03)00028-2; CLAUS D, 1990, MUSCLE NERVE, V13, P1125, DOI 10.1002/mus.880131207; DVORAK J, 1991, SPINE, V16, P955, DOI 10.1097/00007632-199108000-00016; [Anonymous], 1996, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-199602000-00018; DENOORDHOUT AM, 1991, NEUROLOGY, V41, P75; Nakanishi K, 2010, SPINE, V35, pE1593, DOI 10.1097/BRS.0b013e3181d9e7a4; KIMURA J, 1979, J NEUROL SCI, V42, P291, DOI 10.1016/0022-510X(79)90061-3; Jaskolski DJ, 1989, BRIT J NEUROSURG, V3, P541, DOI 10.3109/02688698909002845; Kaneko K, 1997, SPINE, V22, P636, DOI 10.1097/00007632-199703150-00012; Tanaka N, 2008, J SPINAL DISORD TECH, V21, P547, DOI 10.1097/BSD.0b013e31815c85bd; Hasegawa K, 2002, J SPINAL DISORD TECH, V15, P458; KIMURA J, 1974, NEUROLOGY, V24, P539; CONRAD B, 1975, J NEUROL, V210, P151, DOI 10.1007/BF00316242; Nakanishi K, 2014, J NEUROSURG-SPINE, V21, P210, DOI 10.3171/2014.4.SPINE13545; Pan H, 2014, MUSCLE NERVE, V49, P804, DOI 10.1002/mus.24127; Machino M, 2012, SPINE, V37, P667, DOI 10.1097/BRS.0b013e31823147c9; PANAYIOTOPOULOS CP, 1977, J NEUROL SCI, V31, P319, DOI 10.1016/0022-510X(77)90211-8; DORFMAN LJ, 1979, NEUROLOGY, V29, P38; Tanaka N, 2009, J NEUROSURG-SPINE, V11, P421, DOI 10.3171/2009.4.SPINE08584; KING D, 1976, J NEUROL NEUROSUR PS, V39, P538, DOI 10.1136/jnnp.39.6.538; HAYASHI H, 1988, SPINE, V13, P618; Lo YL, 2004, SPINE, V29, P1137, DOI 10.1097/00007632-200405150-00017; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Nakanishi K, 2006, CLIN NEUROPHYSIOL, V117, P623, DOI 10.1016/j.clinph.2005.11.010; ZAPPIA M, 1993, ELECTROEN CLIN NEURO, V89, P67, DOI 10.1016/0168-5597(93)90087-6; Nakanishi K, 2007, J NEUROL SCI, V256, P71, DOI 10.1016/j.jns.2007.02.009; Kohara N, 2000, DIABETOLOGIA, V43, P915, DOI 10.1007/s001250051469; Chistyakov AV, 2004, SPINE, V29, pE239, DOI 10.1097/01.BRS.0000127191.12310.FB; CHU NS, 1989, ELECTROEN CLIN NEURO, V74, P481, DOI 10.1016/0168-5597(89)90039-7; Jaiser SR, 2014, MUSCLE NERVE, V51, P706; Kimura J, 1984, ANN NEUROL, V16, P415; Naderi S, 1998, NEUROSURGERY, V43, P43, DOI 10.1097/00006123-199807000-00028; Takahashi J, 2008, SPINE, V33, pE15, DOI 10.1097/BRS.0b013e31815e5dae	43	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2015	23	6					707	714		10.3171/2015.3.SPINE141060		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CX0FI	WOS:000365371900005		
J	Oichi, T; Chikuda, H; Morikawa, T; Mori, H; Kitamura, D; Higuchi, J; Taniguchi, Y; Matsubayashi, Y; Oshima, Y; Tanaka, S				Oichi, Takeshi; Chikuda, Hirotaka; Morikawa, Teppei; Mori, Harushi; Kitamura, Daisuke; Higuchi, Junya; Taniguchi, Yuki; Matsubayashi, Yoshitaka; Oshima, Yasushi; Tanaka, Sakae			Concurrent spinal schwannoma and meningioma mimicking a single cervical dumbbell-shaped tumor: case report	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cervical spine; schwannoma; meningioma; pathology; oncology	HYPERPLASIA	Dumbbell-shaped tumors consisting of 2 different tumors are extremely rare. Herein, the authors present a case of concurrent spinal schwannoma and meningioma mimicking a single cervical dumbbell-shaped tumor. A 64-year-old man presented with a 5-year history of gradually exacerbating left occipital pain without clinical evidence of neurofibromatosis. Magnetic resonance imaging showed an extradural tumor along the left C-2 nerve root with a small intradural component. The tumor was approached via a C-1 hemilaminectomy. The intradural tumor was resected together with the extradural tumor after opening the dura meter. The intradural tumor was attached to the dura mater around the exit point of the C-2 nerve root. lntraoperative biopsy revealed that the extradural tumor was a schwannoma and that the intradural tumor was a meningioma. The dura mater adjacent to the tumor was then coagulated and resected. Postoperative pathological examination confirmed the same diagnoses with no evidence of continuity between the intra- and extradural components. The patient's postoperative clinical course was uneventful. Clinicians should be aware that cervical dumbbell-shaped tumors can consist of 2 different tumors.	[Oichi, Takeshi; Chikuda, Hirotaka; Kitamura, Daisuke; Higuchi, Junya; Taniguchi, Yuki; Matsubayashi, Yoshitaka; Oshima, Yasushi; Tanaka, Sakae] Tokyo Univ Hosp, Dept Orthoped Surg, Tokyo 1138655, Japan; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 1138655, Japan; [Mori, Harushi] Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan	Chikuda, H (reprint author), Tokyo Univ Hosp, Dept Orthoped Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	chikuda-tky@umin.ac.jp					Angiari P, 1987, Acta Neurol (Napoli), V9, P218; Kim DG, 1997, ACTA NEUROCHIR, V139, P1061, DOI 10.1007/BF01411561; El-Mahdy W, 1999, BRIT J NEUROSURG, V13, P550; SPENCER WH, 1979, OPHTHALMOLOGY, V86, P881; Kutz JW, 2009, SKULL BASE-INTERD AP, V19, P443, DOI 10.1055/s-0029-1220206; Nakamura M, 2012, SPINE, V37, pE617, DOI 10.1097/BRS.0b013e31824167f1; Nakamizo A, 2012, NEUROPATHOLOGY, V32, P190, DOI 10.1111/j.1440-1789.2011.01239.x; Ozawa H, 2007, J NEUROSURG-SPINE, V7, P587, DOI 10.3171/SPI-07/12/587; Perry A, 2005, BRAIN PATHOL, V15, P109; FEIGIN I, 1978, J NEUROPATH EXP NEUR, V37, P459, DOI 10.1097/00005072-197809000-00001; Brandwein-Gensler M, 2004, HEAD NECK-J SCI SPEC, V26, P637, DOI 10.1002/hed.20024; Dorizzi A, 1992, J Neurosurg Sci, V36, P173; SHUANGSH.S, 1971, J NEUROL SCI, V14, P277, DOI 10.1016/0022-510X(71)90217-6; ZIMMERMAN LE, 1980, BRIT J OPHTHALMOL, V64, P638, DOI 10.1136/bjo.64.8.638	14	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2015	23	6					784	787		10.3171/2015.3.SPINE141315		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CX0FI	WOS:000365371900015		
J	Ito, K; Aoyama, T; Horiuchi, T; Hongo, K				Ito, Kiyoshi; Aoyama, Tatsuro; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro			Utility of nonpenetrating titanium clips for dural closure during spinal surgery to prevent postoperative cerebrospinal fluid leakage	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cerebrospinal fluid leakage; dural closure; intradural lesion; nonpenetrating clips; spinal surgery; technique	FIBRIN GLUE; VASCULAR CLIPS; VENOUS REPAIR; SUTURE; ARTERIAL; ANASTOMOSIS; MESH	OBJECT The nonpenetrating titanium clip has been successfully used in peripheral arterial bypass surgery. The purpose of this study was to evaluate the leakage pressures and patterns of nonpenetrating titanium clips using a simple model that mimicked spinal surgery. In addition, the authors describe their surgical experience with these clips and the follow-up results in 31 consecutive patients. METHODS The authors compared nonpenetrating titanium clips and expanded polytetrafluoroethylene (ePTFE) sutures in relation to the water pressure that could be tolerated by sutured ePTFE sheets, and the leakage pressure patterns were determined. The changes in leakage pressures at 5 minutes, 30 minutes, and 12 hours were examined when the clips and sutures were used in combination with the mesh-and-glue technique in an in vitro study. Thirty-one patients underwent spinal intradural procedures using nonpenetrating titanium clips to suture the dura maters using the meshand-glue technique, involving fibrin glue and polyglycolic acid fibrin sheets. RESULTS A significant difference was apparent between the ePTFE suture group and the nonpenetrating titanium clip group, with the latter showing a leakage pressure that could be sustained and was 1508% higher than that of the former (p = 0.001). In relation to leakage patterns, the nonpenetrating titanium clips did not make any suture holes in the ePTFE sheet and fluid leakage occurred between the clips, whereas fluid leakage was associated with the pressure elevation that occurred at the suture holes made by the ePTFE sutures. Of the 31 patients who underwent spinal intradural procedures using nonpenetrating titanium clips, 1 (3.2%) experienced cerebrospinal fluid (CSF) leakage postoperatively. No other complications-for example, allergic reactions, adhesions, or infections-were encountered. CONCLUSIONS The interrupted placement of nonpenetrating titanium clips enables dural closure without creating any holes. These clips facilitate improvements in the initial leakage pressure and reduce postoperative CSF leakage following spinal surgery. The authors conclude that it is very beneficial to suture the spinal dura mater using nonpenetrating titanium clips given the anatomical characteristics of the spinal dura mater and the fact that the clips do not create suture holes.	[Ito, Kiyoshi; Aoyama, Tatsuro; Horiuchi, Tetsuyoshi; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan	Ito, K (reprint author), Shinshu Univ, Sch Med, Dept Neurosurg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kitoh@shinshu-u.ac.jp					SHAFFREY CI, 1990, NEUROSURGERY, V26, P207; Nagata K, 1999, NEUROL MED-CHIR, V39, P316, DOI 10.2176/nmc.39.316; KIRSCH WM, 1992, AM SURGEON, V58, P722; Nakajima S, 2001, NEUROSURGERY, V49, P117, DOI 10.1097/00006123-200107000-00018; KIRSCH WM, 1993, SKULL BASE SURG, V3, P171, DOI 10.1055/s-2008-1060582; Pikoulis E, 2000, J TRAUMA, V48, P292, DOI 10.1097/00005373-200002000-00016; ZHU YH, 1985, SURG FORUM, V36, P492; Leppaniemi A, 1997, J VASC SURG, V26, P24, DOI 10.1016/S0741-5214(97)70142-3; GASKILL DM, 1992, UROLOGY, V40, P191, DOI 10.1016/0090-4295(92)90526-3; Ducasse E, 2001, J MAL VASCUL, V26, P50; Yano S, 2007, SURG NEUROL, V67, P59, DOI 10.1016/j.surneu.2006.05.049; Palm SJ, 1999, NEUROSURGERY, V45, P875, DOI 10.1097/00006123-199910000-00029; Dimakakos PB, 1999, PHLEBOLOGY, V14, P65, DOI 10.1007/s005230050046; Protasoni M, 2011, J NEUROSURG, V114, P1723, DOI 10.3171/2010.12.JNS101732; LEVY DI, 1994, J NEUROSURG, V81, P947, DOI 10.3171/jns.1994.81.6.0947; Shibata T, 1998, VASCULAR SURG, V32, P315, DOI 10.1177/153857449803200403; Zeebregts C, 2001, BRIT J SURG, V88, P1201, DOI 10.1046/j.0007-1323.2001.01857.x; Hida K, 2006, SURG NEUROL, V65, P136, DOI 10.1016/j.surneu.2005.07.059; Shimizu T, 2004, SPINE SPINAL CORD, V17, P411; Standring S, 2008, GRAYS ANATOMY ANATOM	20	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2015	23	6					812	819		10.3171/2015.3.SPINE141215		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CX0FI	WOS:000365371900019		
J	Cao, XY; Ding, XF; Lu, YH; Zhu, P; Shoji, T				Cao, X. Y.; Ding, X. F.; Lu, Y. H.; Zhu, P.; Shoji, T.			Influences of Cr content and PWHT on microstructure and oxidation behavior of stainless steel weld overlay cladding materials in high temperature water	JOURNAL OF NUCLEAR MATERIALS			English	Article						Overlay cladding; Cr content; Post weld heat treatment (PWHT); Oxidation	REACTOR PRESSURE-VESSELS; STRESS-CORROSION CRACKING; OXIDE-FILM PROPERTIES; LOW-ALLOY STEEL; NEUTRON-IRRADIATION; CHROMIUM CONTENT; TRANSITION WELD; HEAT-TREATMENT; PASSIVE FILMS; 304-STAINLESS-STEEL	Influences of Cr content and post weld heat treatment (PWHT) on microstructure and oxidation behavior of stainless steel cladding materials in high temperature water were investigated. The amounts of metal oxidized and dissolved were estimated to compare the oxidation behaviors of cladding materials with different Cr contents and PWHT. The results indicated that higher Cr content led to formation of more ferrite content, and carbides were found along delta/gamma phase interface after PWHT. Higher Cr content enhanced the pitting resistance and compactness of the oxide film to reduce metal amount oxidized and dissolved, which mitigated the weight changes and the formation of Fe-rich oxides. PWHT promoted more and deeper pitting holes along the delta/gamma phase interface due to formation of carbides, which resulted in an increase in metal amount oxidized and dissolved, and were also responsible for more Fe-rich oxides and higher weight changes. (C) 2015 Elsevier B.V. All rights reserved.	[Cao, X. Y.; Ding, X. F.; Lu, Y. H.; Shoji, T.] Univ Sci & Technol Beijing, Natl Ctr Mat Serv Safety, Beijing 100083, Peoples R China; [Zhu, P.] Suzhou Nucl Power Res Inst Co Ltd, Suzhou 215004, Peoples R China; [Shoji, T.] Tohoku Univ, Fracture & Reliabil Res Inst, Aoba Ku, Sendai, Miyagi 9808579, Japan	Lu, YH (reprint author), Univ Sci & Technol Beijing, Natl Ctr Mat Serv Safety, 30 Xueyuan Rd, Beijing 100083, Peoples R China.	lu_yonghao@mater.ustb.edu.cn			National Energy Application Technology Research and Engineering Demonstration Project [NY20111201-1]; Important National Science & Technology Specific Projects of China [2011ZX06004-009]; 111 Project [B12012]	The authors acknowledge the financial support for the present work from National Energy Application Technology Research and Engineering Demonstration Project (NY20111201-1), Important National Science & Technology Specific Projects of China (2011ZX06004-009) and the 111 Project (Grant No. B12012).	Macdonald DD, 2010, ECS TRANSACTIONS, V28, P123, DOI 10.1149/1.3496427; Terachi T, 2008, J NUCL SCI TECHNOL, V45, P975, DOI 10.3327/jnst.45.975; Takeuchi T, 2014, J NUCL MATER, V449, P273, DOI 10.1016/j.jnucmat.2014.01.004; Takeuchi T, 2013, J NUCL MATER, V443, P266, DOI 10.1016/j.jnucmat.2013.07.035; ALLEN GC, 1988, OXID MET, V29, P391, DOI 10.1007/BF00666841; Takeuchi T, 2012, J NUCL MATER, V425, P60, DOI 10.1016/j.jnucmat.2011.12.004; Takeuchi T, 2014, J NUCL MATER, V452, P235, DOI 10.1016/j.jnucmat.2014.04.003; Hamm D, 2002, CORROS SCI, V44, P1009, DOI 10.1016/S0010-938X(01)00126-3; Liu XH, 2012, CORROS SCI, V65, P136, DOI 10.1016/j.corsci.2012.08.022; Xu J, 2012, ELECTROCHIM ACTA, V71, P219, DOI 10.1016/j.electacta.2012.03.148; Cheng XQ, 2011, ELECTROCHIM ACTA, V56, P5860, DOI 10.1016/j.electacta.2011.04.127; TAKALO T, 1979, METALL TRANS A, V10, P1173, DOI 10.1007/BF02811663; Sikora E, 1996, ELECTROCHIM ACTA, V41, P783, DOI 10.1016/0013-4686(95)00312-6; Kuang WJ, 2012, CORROS SCI, V63, P259, DOI 10.1016/j.corsci.2012.06.007; Abraham GJ, 2012, NUCL ENG DES, V243, P69, DOI 10.1016/j.nucengdes.2011.11.018; Lo IH, 2003, MAT SCI ENG A-STRUCT, V355, P137, DOI 10.1016/S0921-5093(03)00078-9; Kuang WJ, 2011, CORROS SCI, V53, P1107, DOI 10.1016/j.corsci.2010.12.008; Sun H, 2009, CORROS SCI, V51, P2840, DOI 10.1016/j.corsci.2009.08.006; Li GF, 2000, CORROS SCI, V42, P1005, DOI 10.1016/S0010-938X(99)00131-6; Abe H, 2012, J NUCL MATER, V424, P57, DOI 10.1016/j.jnucmat.2012.02.006; Cui Y, 2007, MATER DESIGN, V28, P324, DOI 10.1016/j.matdes.2005.05.022; Takeda Y, 2006, APPL SURF SCI, V252, P8580, DOI 10.1016/j.apsusc.2005.11.073; Gillemot F, 2007, INT J PRES VES PIP, V84, P469, DOI 10.1016/j.ijpvp.2007.04.004; Hamm D, 2002, CORROS SCI, V44, P1443, DOI 10.1016/S0010-938X(01)00147-0; Takeuchi T, 2011, J NUCL MATER, V415, P198, DOI 10.1016/j.jnucmat.2011.06.004; Dan T, 2010, CORROS SCI, V52, P1228, DOI 10.1016/j.corsci.2009.11.039; CHATTERJI S, 1995, CEMENT CONCRETE RES, V25, P299, DOI 10.1016/0008-8846(95)00013-5; Dickman R., 1984, SOLID STATE IONICS, V12, P1; Ding T. Y., 1982, T CHINA WELD I, V3, P37; Gao Xin, 2007, Corrosion Science and Protection Technology, V19; Gu X. N., 1986, PETRO CHEM EQUIP, V15, P10; Hamada I., 2002, NUCL ENG DES, V214, P05; krishnan R. U., 2014, MATER CHARACT, V93, P10; Li GF, 2001, CORROS SCI, V43, P1963, DOI 10.1016/S0010-938X(00)00182-7; Macdonald D. D., 1996, ELECTROCHIM ACTA, V56, P1761; [邱绍宇 Qiu Shaoyu], 2002, [原子能科学技术, Atomic Energy Science and Technology], V36, P193; Schaeffler A. L., 1949, MET PROG, V56, P380; Sheng Z. Q., 1990, NUCL POWER ENG, V11, P48; Zhang W. J., 1986, FOREIGN NUCL POWER, V1, P59; Zuo B., 2012, WELD TECHNOL, V41, P10	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		1				32	41		10.1016/j.jnucmat.2015.09.015		10	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MJ	WOS:000365602800003		
J	Chen, TY; Aydogan, E; Gigax, JG; Chen, D; Wang, J; Wang, XM; Ukai, S; Garner, FA; Shao, L				Chen, Tianyi; Aydogan, Eda; Gigax, Jonathan G.; Chen, Di; Wang, Jing; Wang, Xuemei; Ukai, S.; Garner, F. A.; Shao, Lin			Microstructural changes and void swelling of a 12Cr ODS ferritic-martensitic alloy after high-dpa self-ion irradiation	JOURNAL OF NUCLEAR MATERIALS			English	Article						ODS; Dual-phase; Ferritic-martensitic; Coherency; Ion irradiation; Void swelling; Microstructure stability; Nano-particle	DISPERSION-STRENGTHENED STEEL; CHANNEL ANGULAR EXTRUSION; FERRITIC/MARTENSITIC STEELS; MECHANICAL-PROPERTIES; NEUTRON-IRRADIATION; RADIATION-DAMAGE; OXIDE PARTICLES; PURE IRON; DEGREES-C; IN-SITU	A dual-phase 12Cr oxide-dispersion-strengthened (ODS) alloy, with improved corrosion and oxidation resistance exhibits promising void swelling resistance and microstructural stability under Fe2+ ion irradiation to 800 dpa at 475 degrees C. Dispersoids were originally present in both ferrite and tempered martensite grains, with the latter having a wider range of dispersoid sizes. In both phases dispersoids > 10 nm in diameter are incoherent with the matrix, while smaller dispersoids are coherent. During irradiation the larger incoherent dispersoids shrank and disappeared. Beyond 60 dpa dispersoids in both phases approached a near-identical equilibrium size of similar to 2-2.5 nm, which appears to be rather independent of local displacement rate. Grain morphology was found to be stable under irradiation. Compared to other ferritic-martensitic alloys, the ion-induced swelling of this alloy is quite low, arising from swelling resistance associated with both tempered martensite and dispersoids in both phases. Swelling in tempered martensite is an order of magnitude less than in the ferrite phase. (C) 2015 Published by Elsevier B.V.	[Chen, Tianyi; Gigax, Jonathan G.; Chen, Di; Wang, Xuemei; Garner, F. A.; Shao, Lin] Texas A&M Univ, Dept Nucl Engn, College Stn, TX 77843 USA; [Aydogan, Eda; Wang, Jing] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA; [Ukai, S.] Hokkaido Univ, Dept Mat Sci & Engn, Kita Ku, Sapporo, Hokkaido 0600808, Japan; [Garner, F. A.] Radiat Effects Consulting, Richland, WA 99354 USA	Shao, L (reprint author), Texas A&M Univ, Dept Nucl Engn, College Stn, TX 77843 USA.	lshao@tamu.edu			US Department of Energy, NEUP program [DE-NE0008297]	The research was supported by US Department of Energy, NEUP program, through grant no. DE-NE0008297. The authors acknowledge the Microscopy and Imaging Center (MIC) and Materials Characterization Facility (MCF) of Texas A&M University for instruments access.	Karak SK, 2013, METALL MATER TRANS A, V44A, P2884, DOI 10.1007/s11661-013-1627-9; Yamashita S, 2004, PHIL MAG LETT, V84, P525, DOI 10.1080/09500830412331303609; Garner FA, 2000, J NUCL MATER, V276, P123, DOI 10.1016/S0022-3115(99)00225-1; Gan J, 2008, JOM-US, V60, P24, DOI 10.1007/s11837-008-0003-5; Yamashita S, 2007, J NUCL MATER, V367, P202, DOI 10.1016/j.jnucmat.2007.03.145; Yazawa Y, 2004, ACTA MATER, V52, P3727, DOI 10.1016/j.actamat.2004.04.027; DUBUISSON P, 1993, J NUCL MATER, V205, P178, DOI 10.1016/0022-3115(93)90080-I; Klueh RL, 2007, J NUCL MATER, V371, P37, DOI 10.1016/j.jnucmat.2007.05.005; GARNER FA, 1983, J NUCL MATER, V117, P177, DOI 10.1016/0022-3115(83)90023-5; Hsiung LL, 2010, MATER LETT, V64, P1782, DOI 10.1016/j.matlet.2010.05.039; NES E, 1985, ACTA METALL MATER, V33, P11, DOI 10.1016/0001-6160(85)90214-7; Sencer BH, 2000, J NUCL MATER, V283, P164, DOI 10.1016/S0022-3115(00)00338-X; Allen TR, 2005, NUCL SCI ENG, V151, P305; Schaublin R, 2006, J NUCL MATER, V351, P247, DOI 10.1016/j.jnucmat.2006.02.005; Song M, 2014, ACTA MATER, V74, P285, DOI 10.1016/j.actamat.2014.04.034; Dvoriashin AM, 2004, J NUCL MATER, V329, P319, DOI 10.1016/j.jnucmat.2004.04.309; Mo K, 2014, J NUCL MATER, V455, P376, DOI 10.1016/j.jnucmat.2014.06.060; Chen Y, 2014, J NUCL MATER, V452, P321, DOI 10.1016/j.jnucmat.2014.05.046; Toloczko MB, 2014, J NUCL MATER, V453, P323, DOI 10.1016/j.jnucmat.2014.06.011; Allen TR, 2008, J NUCL MATER, V375, P26, DOI 10.1016/j.jnucmat.2007.11.001; Stoller RE, 2013, NUCL INSTRUM METH B, V310, P75, DOI 10.1016/j.nimb.2013.05.008; Certain AG, 2010, J NUCL MATER, V407, P2, DOI 10.1016/j.jnucmat.2010.07.002; Song M, 2013, J ALLOY COMPD, V577, P247, DOI 10.1016/j.jallcom.2013.04.198; Shao L, 2014, J NUCL MATER, V453, P176, DOI 10.1016/j.jnucmat.2014.06.002; Miller MK, 2006, J NUCL MATER, V351, P261, DOI [10.1016/j.jnucmat.2006.02.004, 10.1016/j.jucmat.2006.02.004]; McClintock DA, 2009, J NUCL MATER, V386-88, P307, DOI 10.1016/j.jnucmat.2008.12.104; [Anonymous], 2009, E52183 ASTM INT, V12.02; Ukai S, 2014, J NUCL MATER, V455, P700, DOI 10.1016/j.jnucmat.2014.09.038; Ohtsuka S, 2005, MATER TRANS, V46, P487, DOI 10.2320/matertrans.46.487; Ribis J, 2014, J NUCL MATER, V444, P314, DOI 10.1016/j.jnucmat.2013.10.010; RUSSELL KC, 1993, J NUCL MATER, V206, P129, DOI 10.1016/0022-3115(93)90120-N; He JC, 2014, J NUCL MATER, V455, P41, DOI 10.1016/j.jnucmat.2014.03.024; Yamamoto M, 2011, J NUCL MATER, V417, P237, DOI 10.1016/j.jnucmat.2010.12.250; Hsiung L, 2011, J NUCL MATER, V409, P72, DOI 10.1016/j.jnucmat.2010.09.014; Lescoat ML, 2014, ACTA MATER, V78, P328, DOI 10.1016/j.actamat.2014.06.060; Hayama AOF, 2004, MAT SCI ENG A-STRUCT, V371, P198, DOI 10.1016/j.msea.2003.11.052; Bryk V., P ACC APPL BRUG BELG, P1; Chen D., 2013, SCI REP, V3; Garner F., 1994, MAT SCI TECHNOLOGY A, P419; Garner F.A., 2015, 17 INT C ENV DEGR MA; Gigax JG, 2015, J NUCL MATER, V465, P343, DOI 10.1016/j.jnucmat.2015:05.025; Klueh R.L., 2001, HIGH CHROMIUM FERRIT; Miao YB, 2015, MAT SCI ENG A-STRUCT, V625, P146, DOI 10.1016/j.msea.2014.12.017; Smidt Jr F.A., 1976, STP ASTM, VSTP 611, P227; Smither RK, 1985, ANLFPPTM197; Ukai S., 2007, ENERGY MAT, V2; Ukai S., 2011, METAL CERAMIC POLYM; Was G. S., 2007, FUNDAMENTALS RAD MAT; Ziegler J.F., 2013, SRIM PROGRAM	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		1				42	49		10.1016/j.jnucmat.2015.09.016		8	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MJ	WOS:000365602800004		
J	Lin, YR; Ku, CS; Ho, CY; Chuang, WT; Kondo, S; Kai, JJ				Lin, Yan-Ru; Ku, Ching-Shun; Ho, Chun-Yu; Chuang, Wei-Tsung; Kondo, Sosuke; Kai, Ji-Jung			Irradiation-induced microstructural evolution and swelling of 3C-SiC (vol 459, pg 276, 2015)	JOURNAL OF NUCLEAR MATERIALS			English	Correction									[Lin, Yan-Ru; Kai, Ji-Jung] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan; [Lin, Yan-Ru; Ku, Ching-Shun; Chuang, Wei-Tsung] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Ho, Chun-Yu; Kai, Ji-Jung] Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu 30013, Taiwan; [Kondo, Sosuke] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Kai, Ji-Jung] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon 852, Hong Kong, Peoples R China	Kai, JJ (reprint author), City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon 852, Hong Kong, Peoples R China.						Lin YR, 2015, J NUCL MATER, V459, P276, DOI 10.1016/j.jnucmat.2015.01.040	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		1				393	393		10.1016/j.jnucmat.2015.08.024		1	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MJ	WOS:000365602800042		
J	Suzudo, T; Yamaguchi, M; Hasegawa, A				Suzudo, Tomoaki; Yamaguchi, Masatake; Hasegawa, Akira			Migration of rhenium and osmium interstitials in tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article						Kinetic Monte Carlo method; Rhenium and osmium in tungsten; Migration; Diffusivity; Radiation induced precipitates	NEUTRON-IRRADIATED TUNGSTEN; FIELD-ION MICROSCOPE; KINETIC MONTE-CARLO; W-RE ALLOYS; INDUCED PRECIPITATION; ALPHA-IRON; TRANSMUTATION; SIMULATION; STABILITY; ENERGY	Tungsten is expected to be a promising plasma-facing material for future fusion devices, but radiation-induced precipitation (RIP), which leads the material to hardening, is a concern at their practical use. One of the keys to accurate prediction of the emergence of RIP is migration of solute atoms, rhenium and osmium, that are produced by nuclear transmutation through irradiation. We conduct a series of numerical simulations using an atomic kinetic Monte Carlo method and investigate the migration of these solute atoms in the form of tungsten-rhenium and tungsten-osmium mixed dumbbells, considered to be the most efficient "carriers" of the solute atoms. We find that the low rotation energy barrier of these mixed dumbbells leading to three-dimensional migration greatly influences their diffusivities. The result also suggests that, although these dumbbells have three-dimensional motion, one cannot simply reduce their migration behavior to that of vacancy-like spherical objects. (C) 2015 Elsevier B.V. All rights reserved.	[Suzudo, Tomoaki; Yamaguchi, Masatake] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Tokai, Ibaraki 3191195, Japan; [Hasegawa, Akira] Tohoku Univ, Dept Quantum Sci & Energy Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Suzudo, T (reprint author), Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, 2-4 Shirane Shirakata, Tokai, Ibaraki 3191195, Japan.	suzudo.tomoaki@jaea.go.jp			JSPS KAKENHI [24561044, 15K06672]	T.S. and M.Y. are supported by JSPS KAKENHI Grant Number 24561044 to conduct this work. T.S. and A.H. are supported by JSPS KAKENHI Grant Number 15K06672 to conduct this work.	WILLIAMS RK, 1983, METALL TRANS A, V14, P655, DOI 10.1007/BF02643781; Marian J, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144102; WILSON KL, 1980, ACTA METALL MATER, V28, P89, DOI 10.1016/0001-6160(80)90043-7; CAUVIN R, 1981, PHYS REV B, V23, P3322, DOI 10.1103/PhysRevB.23.3322; Xu HX, 2012, J NUCL MATER, V423, P102, DOI 10.1016/j.jnucmat.2012.01.020; Krasnochtchekov P, 2007, JOM-US, V59, P46, DOI 10.1007/s11837-007-0054-z; Armstrong DEJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811825; RALPH B, 1963, PHILOS MAG, V8, P919, DOI 10.1080/14786436308214452; SIKKA VK, 1974, METALL TRANS, V5, P1514, DOI 10.1007/BF02646643; MATOLICH J, 1974, SCRIPTA METALL MATER, V8, P837, DOI 10.1016/0036-9748(74)90304-4; MARTIN G, 1980, PHYS REV B, V21, P2122, DOI 10.1103/PhysRevB.21.2122; HERSCHITZ R, 1985, NUCL INSTRUM METH B, V7-8, P137, DOI 10.1016/0168-583X(85)90544-0; Suzudo T, 2012, J NUCL MATER, V423, P40, DOI 10.1016/j.jnucmat.2012.01.014; Voter AF, 2007, NATO SCI SER II MATH, V235, P1; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Cottrell GA, 2006, FUSION SCI TECHNOL, V50, P89; Hasegawa A, 2011, J NUCL MATER, V417, P491, DOI 10.1016/j.jnucmat.2010.12.114; Barashev AV, 2005, PHILOS MAG, V85, P1539, DOI [10.1080/14786430500036348, 10.1080/1478643050036348]; Ebihara K, 2013, J NUCL MATER, V440, P627, DOI 10.1016/j.jnucmat.2013.05.066; Nemoto Y, 2000, J NUCL MATER, V283, P1144, DOI 10.1016/S0022-3115(00)00290-7; Tanno T, 2008, MATER TRANS, V49, P2259, DOI 10.2320/matertrans.MAW200821; Abe Y, 2012, FUSION SCI TECHNOL, V62, P139; Marian J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.094303; Fukuda M, 2012, MATER TRANS, V53, P2145, DOI 10.2320/matertrans.MBW201110; TAYLOR A, 1961, J LESS-COMMON MET, V3, P333, DOI 10.1016/0022-5088(61)90025-X; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Noda T, 1998, J NUCL MATER, V258, P934, DOI 10.1016/S0022-3115(98)00088-9; Rieth M., 2012, J NUCL MATER, V432, P482; Suzudo T., 2015, J NUCL MAT UNPUB; Suzudo T., 2011, PROG NUCL SCI TECHNO, V2, P56; Suzudo T, 2014, MODEL SIMUL MATER SC, V22, DOI 10.1088/0965-0393/22/7/075006	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		1				418	423		10.1016/j.jnucmat.2015.05.051		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MJ	WOS:000365602800049		
J	Oda, T; Zhu, DQ; Watanabe, Y				Oda, Takuji; Zhu, Deqiong; Watanabe, Yoshiyuki			Kinetic Monte Carlo simulation on influence of vacancy on hydrogen diffusivity in tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article						Hydrogen diffusivity; Tungsten; Kinetic Monte Carlo simulation; Vacancy	POLYCRYSTALLINE TUNGSTEN; TRANSPORT PARAMETERS; DEUTERIUM; TEMPERATURE; RETENTION; REACTOR; IRON; PERMEATION; SURFACE	Kinetic Mote Carlo (KMC) simulations are performed to quantify the influence of trap in hydrogen diffusivity in tungsten. As a typical trap, mono-vacancy is considered in the simulation. Experimental results reported by Frauenfelder are nicely reproduced when hydrogen concentration and trap concentration expected in the experiment are employed in the simulation. The effective diffusivity of hydrogen is evidently decreased by traps even at high temperatures like 1300 K. These results suggest that only high-temperature experimental data, which are not significantly affected by traps, should be fitted to, in order to derive the true hydrogen diffusivity from experiments. Therefore, we recommend D = 1.58 x 10(-7) exp(-0.25 eV/kT) m(2) s(-1) as the equation for hydrogen diffusion coefficient in tungsten, which was obtained by fitting only to experimental data at 1500-2400 K by Heinola and Ahlgren, rather than the most cited equation D = 4.1 x 10(-7) exp(-0.39 eV/kT) m(2) s(-1), which was obtained by fitting to all experimental data at 1100-2400 K including some data that should be affected by traps. (C) 2015 Elsevier B.V. All rights reserved.	[Oda, Takuji; Zhu, Deqiong] Seoul Natl Univ, Dept Nucl Engn, Seoul 151742, South Korea; [Watanabe, Yoshiyuki] Japan Atom Energy Agcy, Aomori 0393212, Japan	Oda, T (reprint author), Seoul Natl Univ, Dept Nucl Engn, 1 Gwanak Ro, Seoul 151742, South Korea.	oda@snu.ac.kr			National Research Foundation of Korea under Nuclear Fusion Basic Research program; BK 21 plus project; Center for Advanced Research in Fusion Reactor Engineering (CARFRE)	This research was supported by National Research Foundation of Korea under Nuclear Fusion Basic Research program. This research was also supported by BK 21 plus project and the Center for Advanced Research in Fusion Reactor Engineering (CARFRE). The calculations in this research were carried out using the HELIOS supercomputer system at the Computational Simulation Center of the International Fusion Research Center (IFERC-CSC) in Japan.	Ahlgren T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3298466; Shimada M, 2011, J NUCL MATER, V415, pS667, DOI 10.1016/j.jnucmat.2010.11.050; Matsuyama M, 2002, J NUCL MATER, V307, P729, DOI 10.1016/S0022-3115(02)01266-7; Esteban GA, 2001, J NUCL MATER, V295, P49, DOI 10.1016/S0022-3115(01)00486-X; You YW, 2013, AIP ADV, V3, DOI 10.1063/1.4789547; Liu YL, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/44/445504; Serra E, 1998, J NUCL MATER, V255, P105, DOI 10.1016/S0022-3115(98)00038-5; Nordlund K, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/22/224018; Ikeda T, 2011, J NUCL MATER, V415, pS684, DOI 10.1016/j.jnucmat.2010.12.007; Hayward E, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/42/425402; ANDERL RA, 1992, FUSION TECHNOL, V21, P745; Kimizuka H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094110; Alkhamees A, 2009, J NUCL MATER, V393, P508, DOI 10.1016/j.jnucmat.2009.07.012; Dubrovinsky LS, 1997, PHYS CHEM MINER, V24, P547, DOI 10.1007/s002690050070; STEPHENS JR, 1970, METALL TRANS, V1, P1293; MCNABB A, 1963, T METALL SOC AIME, V227, P618; Becquart CS, 2009, J NUCL MATER, V386-88, P109, DOI 10.1016/j.jnucmat.2008.12.085; Ikeda T, 2011, FUSION SCI TECHNOL, V60, P1463; Gilbert MR, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043005; Gasparyan YM, 2009, J NUCL MATER, V390-91, P606, DOI 10.1016/j.jnucmat.2009.01.172; White GK, 1997, INT J THERMOPHYS, V18, P1269, DOI 10.1007/BF02575261; Heinola K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094102; Zhou HB, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025016; Alimov VK, 2012, J NUCL MATER, V420, P519, DOI 10.1016/j.jnucmat.2011.11.003; ELEVELD H, 1994, J NUCL MATER, V212, P1421, DOI 10.1016/0022-3115(94)91062-6; Hatano Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073006; RASCH KD, 1980, PHILOS MAG A, V41, P91; Kong XS, 2013, J NUCL MATER, V433, P357, DOI 10.1016/j.jnucmat.2012.10.024; Ahlgren T, 2012, J NUCL MATER, V427, P152, DOI 10.1016/j.jnucmat.2012.04.031; Maisonneuve J, 2011, FUSION SCI TECHNOL, V60, P1507; Franzen P, 1997, J NUCL MATER, V241, P1082, DOI 10.1016/S0022-3115(96)00664-2; Lu GH, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/086001; Liu YL, 2009, J NUCL MATER, V390-91, P1032, DOI 10.1016/j.jnucmat.2009.01.277; ABDOU MA, 1986, FUSION TECHNOL, V9, P250; Liu YQ, 2010, J INSECT SCI, V10, P1, DOI [10.1673/031.010.14140, 10.1080/15313220903558520]; Fernandez N, 2015, ACTA MATER, V94, P307, DOI 10.1016/j.actamat.2015.04.052; Heinola K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.073409; Sorescu DC, 2005, CATAL TODAY, V105, P44, DOI 10.1016/j.cattod.2005.04.010; Tanabe T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014044; Roth J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/103001; Kurishita H, 2013, MATER TRANS, V54, P456, DOI 10.2320/matertrans.MG201209; Ferroni F, 2015, ACTA MATER, V90, P380, DOI 10.1016/j.actamat.2015.01.067; Terentyev D, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/4/042004; Yoshikawa T, 2012, J PHYS CHEM C, V116, P23113, DOI 10.1021/jp307660e; Nakamura H, 2003, J NUCL MATER, V313, P679, DOI 10.1016/S0022-3115(02)01383-1; Nishikawa M, 2010, FUSION ENG DES, V85, P987, DOI 10.1016/j.fusengdes.2009.11.007; Heinola K, 2013, J NUCL MATER, V438, pS1001, DOI 10.1016/j.jnucmat.2013.01.218; Heinola K, 2010, J APPL PHYS, V107, DOI 10.1063/1.3386515; Fukumoto M, 2009, J NUCL MATER, V390-91, P572, DOI 10.1016/j.jnucmat.2009.01.107; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Isobe K., 2013, J PLASMA FUSION RES, V10, P81; Jiang DE, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064102; Johnson D.F., 2011, J MATER RES, V25, P315; Luescher M., 1994, COMPUT PHYS COMMUN, V79, P100; Otsuka T, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014052; Schmid K, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896580	56	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		1				439	447		10.1016/j.jnucmat.2015.07.054		9	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MJ	WOS:000365602800052		
J	McMurray, JW; Hirooka, S; Murakami, T; Suzuki, K; White, JT; Voit, SL; Nelson, AT; Slone, BW; Besmann, TM; McClellan, KJ; Kato, M				McMurray, J. W.; Hirooka, S.; Murakami, T.; Suzuki, K.; White, J. T.; Voit, S. L.; Nelson, A. T.; Slone, B. W.; Besmann, T. M.; McClellan, K. J.; Kato, M.			Thermodynamic assessment of the oxygen rich U-Ce-O system	JOURNAL OF NUCLEAR MATERIALS			English	Article						UO2 +/- x; Uranium; Cerium; Oxygen; Compound energy formalism; Calphad; Oxygen potential; Phase equilibria	OXIDE; NONSTOICHIOMETRY; OXIDATION; BEHAVIOR; FUELS	A thermodynamic assessment of the U-Ce-O system was performed by combining the existing Calphad assessments of the U-O and Ce-O binaries. A compound energy formalism representation for the fluorite U1-yCeyO2 +/- x and a partially ionic two-sublattice liquid model for U-Ce-O melt were developed to describe the ternary solutions. Oxygen potentials for U1-yCeyO2 +/- x for 0.05, 0.20, 0.30, and 0.50 Ce metal fractions were measured from thermogravimetric analysis and used, along with other thermodynamic data reported in the literature, to optimize the adjustable parameters of the models for U1-yCeyO2 +/- x and the U-Ce-O ternary liquid. In addition, the thermochemical behavior of U1-yCeyO2 +/- x and U1-yPuyO2 +/- x was compared in order to assess the suitability of using Ce as a surrogate for Pu in MOX fuel. (C) 2015 Elsevier B.V. All rights reserved.	[McMurray, J. W.; Slone, B. W.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Hirooka, S.; Murakami, T.; Suzuki, K.; Kato, M.] Japan Atom Energy Agcy, Fuel Technol Dept, Plutonium Fuel Dev Ctr, Nucl Fuel Cycle Engn Labs, Tokai, Ibaraki 3191194, Japan; [White, J. T.; Voit, S. L.; Nelson, A. T.; McClellan, K. J.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Besmann, T. M.] Univ S Carolina, Coll Engn & Comp, Dept Mech Engn, Columbia, SC 29208 USA	McMurray, JW (reprint author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.	mcmurrayjw1@ornl.gov			US Department of Energy, Office of Nuclear Energy Fuel Cycle Technology Program	The authors would like to thank Ryan Cooper and Yan Zhou of Oak Ridge National Laboratory for helpful comments. The authors would also like to acknowledge John Dunwoody and Darrin Byler for assistance with sample preparation at LANL. The work was supported by the US Department of Energy, Office of Nuclear Energy Fuel Cycle Technology Program.	MARKIN TL, 1970, J INORG NUCL CHEM, V32, P77, DOI 10.1016/0022-1902(70)80450-X; Zinkevich M, 2007, PROG MATER SCI, V52, P597, DOI 10.1016/j.pmatsci.2006.09.002; Angle JP, 2014, J NUCL MATER, V454, P69, DOI 10.1016/j.jnucmat.2014.07.039; Gueneau C, 2011, J NUCL MATER, V419, P145, DOI 10.1016/j.jnucmat.2011.07.033; NAWADA HP, 1986, J NUCL MATER, V139, P19, DOI 10.1016/0022-3115(86)90159-5; REDLICH O, 1948, IND ENG CHEM, V40, P345, DOI 10.1021/ie50458a036; Krishnan RV, 2008, THERMOCHIM ACTA, V472, P95, DOI 10.1016/j.tca.2008.02.018; HILLERT M, 1985, METALL TRANS A, V16, P261; LINDEMER TB, 1988, J AM CERAM SOC, V71, P553, DOI 10.1111/j.1151-2916.1988.tb05919.x; Bale C, 2002, CALPHAD, V26, P189, DOI 10.1016/S0364-5916(02)00035-4; Brese RG, 2015, J NUCL MATER, V460, P5, DOI 10.1016/j.jnucmat.2015.01.047; Kvashnina KO, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.253002; DUCROUX R, 1981, J NUCL MATER, V97, P333, DOI 10.1016/0022-3115(81)90482-7; McMurray JW, 2014, J NUCL MATER, V452, P397, DOI 10.1016/j.jnucmat.2014.04.047; Konings RJM, 2010, J PHYS CHEM REF DATA, V39, DOI 10.1063/1.3474238; NAGARAJAN K, 1985, J NUCL MATER, V130, P242, DOI 10.1016/0022-3115(85)90313-7; Nelson AT, 2014, J AM CERAM SOC, V97, P3652, DOI 10.1111/jace.13170; Gueneau C, 2008, J NUCL MATER, V378, P257, DOI 10.1016/j.jnucmat.2008.06.013; ADAMSON MG, 1985, J NUCL MATER, V130, P349, DOI 10.1016/0022-3115(85)90323-X; ARONSON S, 1958, J CHEM PHYS, V29, P151, DOI 10.1063/1.1744415; LORENZELLI R, 1980, J NUCL MATER, V95, P290, DOI 10.1016/0022-3115(80)90371-2; ARITA Y, 1995, THERMOCHIM ACTA, V253, P1, DOI 10.1016/0040-6031(94)02020-O; MARKIN TL, 1970, J INORG NUCL CHEM, V32, P59, DOI 10.1016/0022-1902(70)80449-3; Gueneau C, 2002, J NUCL MATER, V304, P161, DOI 10.1016/S0022-3115(02)00878-4; NORRIS DIR, 1983, J NUCL MATER, V116, P184, DOI 10.1016/0022-3115(83)90101-0; [Anonymous], 2013, ACERS NIST PHASE EQU; Zinkevich M, 2006, SOLID STATE IONICS, V177, P989, DOI 10.1016/j.ssi.2006.02.044; TAGAWA H, 1981, B CHEM SOC JPN, V54, P138, DOI 10.1246/bcsj.54.138; Skala T, 2011, APPL SURF SCI, V257, P3682, DOI 10.1016/j.apsusc.2010.11.107; Blackburn P.E., 1972, ANL7877 REPT, P16; Brown R.C., 1975, THERMODYNAMIC INVEST; Haefling J., 1959, T MET SOC AIME, V215; Kang S.-H., 1998, KOR J CERAM SOC, V4, P78; Lee S.M., 2015, MEASUREMENT OX UNPUB; Lukas H.L., 2007, COMPUTATIONAL THERMO; McMurray JW, 2015, J NUCL MATER, V456, P142, DOI 10.1016/j.jnucmat.2014.09.031; Olander D.R., 1976, FUNDAMENTAL ASPECTS; Taylor J. R., 1997, INTRO ERROR ANAL STU; Valdez J.A., 2012, DRAFT REPORT MELT PO; Venkata-Krishnan R., 2006, THERMOCHIM ACTA, V440, P141, DOI 10.1016/j.tca.2005.11.005; Walker E A, 2008, Transactions of the American Nuclear Society, V98	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		2				588	600		10.1016/j.jnucmat.2015.10.008		13	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MR	WOS:000365603600015		
J	Nakamori, F; Ohishi, Y; Muta, H; Kurosaki, K; Fukumoto, K; Yamanaka, S				Nakamori, Fumihiro; Ohishi, Yuji; Muta, Hiroaki; Kurosaki, Ken; Fukumoto, Ken-ichi; Yamanaka, Shinsuke			Mechanical and thermal properties of bulk ZrB2	JOURNAL OF NUCLEAR MATERIALS			English	Article						Fuel debris; Zirconium diboride; Mechanical properties; Thermal properties; Vickers hardness; Fracture toughness	HOT-PRESSED ZRB2; ZIRCONIUM DIBORIDE; SOLID-SOLUTIONS; ELASTIC PROPERTIES; VICKERS HARDNESS; CARBON ADDITIONS; BORON-CARBIDE; TEMPERATURE; CERAMICS; CONDUCTIVITY	ZrB2 appears to have formed in the fuel debris at the Fukushima Daiichi nuclear disaster site, through the reaction between Zircaloy cladding materials and the control rod material B4C. Since ZrB2 has a high melting point of 3518 K, the ceramic has been widely studied as a heat-resistant material. Although various studies on the thermochemical and thermophysical properties have been performed for ZrB2, significant differences exist in the data, possibly due to impurities or the porosity within the studied samples. In the present study, we have prepared a ZrB2 bulk sample with 93.1% theoretical density by sintering ZrB2 powder. On this sample, we have comprehensively examined the thermal and mechanical properties of ZrB2 by the measurement of specific heat, ultrasonic sound velocities, thermal diffusivity, and thermal expansion. Vickers hardness and fracture toughness were also measured and found to be 13-23 GPa and 1.8-2.8 MPa m(0.5), respectively. The relationships between these properties were carefully examined in the present study. (C) 2015 Elsevier B.V. All rights reserved.	[Nakamori, Fumihiro; Ohishi, Yuji; Muta, Hiroaki; Kurosaki, Ken; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 565, Japan; [Fukumoto, Ken-ichi; Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Fukui, Japan	Ohishi, Y (reprint author), Osaka Univ, Grad Sch Engn, Suita, Osaka 565, Japan.	ohishi@ms.see.eng.osaka-u.ac.jp					Patel M, 2013, J EUR CERAM SOC, V33, P1615, DOI 10.1016/j.jeurceramsoc.2013.03.006; Boniecki M, 2007, J EUR CERAM SOC, V27, P1351, DOI 10.1016/j.jeurceramsoc.2006.05.055; WALLACE DC, 1960, PHYS REV, V120, P84, DOI 10.1103/PhysRev.120.84; Takano M, 2014, J NUCL SCI TECHNOL, V51, P859, DOI 10.1080/00223131.2014.912567; Fahrenholtz WG, 2007, J AM CERAM SOC, V90, P1347, DOI 10.1111/j.1551-2916.2007.01583.x; Guo SQ, 2009, J EUR CERAM SOC, V29, P787, DOI 10.1016/j.jeurceramsoc.2008.06.037; Jiang CL, 2014, APPL SURF SCI, V288, P324, DOI 10.1016/j.apsusc.2013.10.027; Dodd SP, 2002, J MATER SCI, V37, P2731, DOI 10.1023/A:1015825318086; Kulkarni NK, 2009, J NUCL MATER, V384, P81, DOI 10.1016/j.jnucmat.2008.10.015; Zimmermann JW, 2008, J AM CERAM SOC, V91, P1405, DOI 10.1111/j.1551-2916.2008.02268.x; Lonergan JM, 2014, J AM CERAM SOC, V97, P1689, DOI 10.1111/jace.12950; McClane DL, 2014, J AM CERAM SOC, V97, P1552, DOI 10.1111/jace.12893; WILEY DE, 1969, J LESS-COMMON MET, V18, P149, DOI 10.1016/0022-5088(69)90134-9; ANDERSON OL, 1963, J PHYS CHEM SOLIDS, V24, P909, DOI 10.1016/0022-3697(63)90067-2; Zhang LN, 2011, J AM CERAM SOC, V94, P2562, DOI 10.1111/j.1551-2916.2011.04411.x; Din SU, 1998, MATER CHEM PHYS, V53, P48, DOI 10.1016/S0254-0584(97)02057-9; Yamada K, 1998, J ALLOY COMPD, V271, P697, DOI 10.1016/S0925-8388(98)00190-X; Zapata-Solvas E, 2013, J EUR CERAM SOC, V33, P3467, DOI 10.1016/j.jeurceramsoc.2013.06.009; Yamanaka S, 1998, J ALLOY COMPD, V271, P549, DOI 10.1016/S0925-8388(98)00152-2; VANUITERT LG, 1977, MATER RES BULL, V12, P261, DOI 10.1016/0025-5408(77)90143-X; Lindemann FA, 1910, PHYS Z, V11, P609; Thompson MJ, 2012, J AM CERAM SOC, V95, P1077, DOI 10.1111/j.1551-2916.2011.05034.x; Chakraborty S, 2014, INT J REFRACT MET H, V46, P35, DOI 10.1016/j.ijrmhm.2014.05.004; Ivanovskii AL, 2013, INT J REFRACT MET H, V36, P179, DOI 10.1016/j.ijrmhm.2012.08.013; Zhu S, 2007, J AM CERAM SOC, V90, P3660, DOI 10.1111/j.1551-2916.2007.01936.x; Yamada K, 1997, J NUCL MATER, V247, P289, DOI 10.1016/S0022-3115(97)00076-7; Gong JH, 1999, J EUR CERAM SOC, V19, P2625, DOI 10.1016/S0955-2219(99)00043-6; BIRCH F, 1961, J GEOPHYS RES, V66, P2199, DOI 10.1029/JZ066i007p02199; TANAKA K, 1989, INT J ENG SCI, V27, P11, DOI 10.1016/0020-7225(89)90165-1; GIBBY RL, 1971, J NUCL MATER, V38, P163, DOI 10.1016/0022-3115(71)90040-7; Chakraborty S., 2014, INT J APPL CERAM TEC; Eucken A., 1940, Forschung auf dem Gebiete des Ingenieurwesens, V11, DOI 10.1007/BF02584103; Gronvold F., 1970, J CHEM THERMODYN, V2, P665, DOI DOI 10.1016/0021-9614(70)90042-X; Guo SQ, 2011, SCRIPTA MATER, V65, P1018, DOI 10.1016/j.scriptamat.2011.09.007; JUSTIN J F, 2011, ONERA J AEROSPACE LA, V3, P1; Kislyi P.S., 1962, SOV POWDER METALL, V1, P441; ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x; Liu M., 2013, JPN J MULTIPH FLOW, V27, P298; Loehman R., 2006, SAND20062925; Melendez-Martinez JJ, 2002, J EUR CERAM SOC, V22, P2543, DOI 10.1016/S0955-2219(02)00114-0; Asl MS, 2015, MAT SCI ENG A-STRUCT, V625, P385, DOI 10.1016/j.msea.2014.12.028; Stull D, 1971, JANAF THERMOCHEMICAL; Vajeeston P, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.045115; Yadhukulakrishnan GB, 2012, MAT SCI ENG A-STRUCT, V552, P125, DOI 10.1016/j.msea.2012.05.020; Yano K., 2013, INT NUCL FUEL CYCL C, V2, P1554	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	DEC	2015	467		2				612	617		10.1016/j.jnucmat.2015.10.024		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CX3MR	WOS:000365603600018		
J	Umeda, Y; Demura, Y; Morikawa, M; Anzai, M; Kadowaki, M; Ameshima, S; Tsuchida, T; Tsujikawa, T; Kiyono, Y; Okazawa, H; Ishizaki, T; Ishizuka, T				Umeda, Yukihiro; Demura, Yoshiki; Morikawa, Miwa; Anzai, Masaki; Kadowaki, Maiko; Ameshima, Shingo; Tsuchida, Tatsuro; Tsujikawa, Tetsuya; Kiyono, Yasushi; Okazawa, Hidehiko; Ishizaki, Takeshi; Ishizuka, Tamotsu			Prognostic Value of Dual-Time-Point F-18-FDG PET for Idiopathic Pulmonary Fibrosis	JOURNAL OF NUCLEAR MEDICINE			English	Article						fluorodeoxyglucose F-18; idiopathic pulmonary fibrosis; positron emission tomography; survival analysis	POSITRON-EMISSION-TOMOGRAPHY; STAGE LUNG-DISEASE; HEXOKINASE TRANSLOCATION; INTERSTITIAL PNEUMONIA; DIAGNOSIS; TRANSPLANTATION; TRIAL; DIFFERENTIATION; INFLAMMATION; PIRFENIDONE	The aim of this prospective study was to clarify whether dual-timepoint F-18-FDG PET imaging results are useful to predict long-term survival of idiopathic pulmonary fibrosis (IPF) patients. Methods: Fifty IPF patients underwent F-18-FDG PET examinations at 2 time points: 60 min (early imaging) and 180 min (delayed imaging) after F-18-FDG injection. The standardized uptake value (SUV) at each point and retention index value (RI-SUV) calculated from those were evaluated, and then the results were compared with overall and progressionfree survival. Results: A multivariate Cox proportional hazards model showed higher RI-SUV and higher extent of fibrosis score as independent predictors of shorter progression-free survival. The median progression-free survival for patients with negative RI-SUV was better than that for those with positive RI-SUV (27.9 vs. 13.3 mo, P = 0.0002). On the other hand, multivariate Cox analysis showed higher RI-SUV and lower forced vital capacity to be independent predictors of shorter overall survival. The 5-y survival rate for patients with negative RI-SUV was better than that for those with positive RI-SUV (76.8% vs. 14.3%, P = 0.00001). In addition, a univariate Cox model showed that positive RI-SUV as a binary variable was a significant indicator of mortality (hazard ratio, 7.31; 95% confidence interval, 2.64-20.3; P = 0.0001). Conclusion: Our results demonstrate that positive RI-SUV is strongly predictive of earlier deterioration of pulmonary function and higher mortality in patients with IPF.	[Umeda, Yukihiro; Morikawa, Miwa; Anzai, Masaki; Kadowaki, Maiko; Ameshima, Shingo; Ishizuka, Tamotsu] Univ Fukui, Dept Internal Med 3, Eiheiji, Fukui 9101193, Japan; [Demura, Yoshiki] Fukui Red Cross Hosp, Dept Resp Med, Fukui, Fukui, Japan; [Tsuchida, Tatsuro] Univ Fukui, Fac Med Sci, Dept Radiol, Eiheiji, Fukui 9101193, Japan; [Tsujikawa, Tetsuya; Kiyono, Yasushi; Okazawa, Hidehiko] Univ Fukui, Fac Med Sci, Biomed Imaging Res Ctr, Eiheiji, Fukui 9101193, Japan; [Ishizaki, Takeshi] Resp Dis Ctr, Northern Noto Area, Anamizu, Ishikawa, Japan	Umeda, Y (reprint author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, 23-3 Matsuoka Shimoaizuki, Eiheiji, Fukui 9101193, Japan.	umeda@u-fukui.ac.jp			scientific research program "Seeds of Advanced Medicine" of the University of Fukui Hospital, Japan	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This work was supported by a grant-in-aid from the scientific research program "Seeds of Advanced Medicine" of the University of Fukui Hospital, Japan. No other potential conflict of interest relevant to this article was reported.	American Thoracic Society, 2000, AM J RESP CRIT CARE, V161, P646; PEDLEY KC, 1993, BIOCHEM J, V291, P515; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Huang JB, 2002, CELL IMMUNOL, V218, P95, DOI 10.1016/S0008-8749(02)00582-8; Tsuchida T, 2011, HELL J NUCL MED, V14, P224; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2001, AM J RESP CRIT CARE, V164, P1025; Umeda Y, 2009, EUR J NUCL MED MOL I, V36, P1121, DOI 10.1007/s00259-009-1069-1; Ishimori T, 2002, J NUCL MED, V43, P658; El-Chemaly S, 2013, CHEST, V143, P1685, DOI 10.1378/chest.12-1359; Jegal Y, 2005, AM J RESP CRIT CARE, V171, P639, DOI 10.1164/rccm.200403-331OC; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Schuster DP, 2007, AM J PHYSIOL-LUNG C, V292, pL845, DOI 10.1152/ajplung.00350.2006; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; Umeda Y, 2011, RESPIROLOGY, V16, P713, DOI 10.1111/j.1440-1843.2011.01966.x; Meissner HH, 2006, RESPIRATION, V73, P197, DOI 10.1159/000088062; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; SVANHOLM H, 1989, APMIS, V97, P689; Mogulkoc N, 2001, AM J RESP CRIT CARE, V164, P103; Chen DL, 2009, AM J RESP CRIT CARE, V180, P533, DOI 10.1164/rccm.200904-0501OC; Demura Y, 2003, J NUCL MED, V44, P540; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; Kim IH, 2008, J MICROBIOL BIOTECHN, V18, P35; De Meester J, 2001, J HEART LUNG TRANSPL, V20, P518, DOI 10.1016/S1053-2498(01)00241-8; Win T, 2012, EUR J NUCL MED MOL I, V39, P521, DOI 10.1007/s00259-011-1986-7; Groves AM, 2009, J NUCL MED, V50, P538, DOI 10.2967/jnumed.108.057901; Azuma A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-143; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL	31	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC	2015	56	12					1869	1875		10.2967/jnumed.115.163360		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5EL	WOS:000365724800012		
J	Kanzaki, Y; Yamauchi, Y; Morita, H; Hayashi, M; Komori, T; Ukimura, A; Ishizaka, N				Kanzaki, Yumiko; Yamauchi, Yohei; Morita, Hideaki; Hayashi, Masuo; Komori, Tsuyoshi; Ukimura, Akira; Ishizaka, Nobukazu			Presence of Postsystolic Shortening Increases the Likelihood of Coronary Artery Disease: A Rest Electrocardiography-Gated Myocardial Perfusion SPECT Study	JOURNAL OF NUCLEAR MEDICINE			English	Article						coronary artery disease; scintigraphy; postsystolic shortening	LEFT-VENTRICULAR DYSSYNCHRONY; EMISSION COMPUTED-TOMOGRAPHY; ACUTELY ISCHEMIC-MYOCARDIUM; BUNDLE-BRANCH BLOCK; PHASE-ANALYSIS; MECHANICAL DYSSYNCHRONY; EJECTION FRACTION; PROGNOSTIC VALUE; RECOVERY; MOTION	Postsystolic shortening (PSS), which is a delayed myocardial contraction that occurs after end-systole, has been considered an important diagnostic index of myocardial ischemia. Recent technological advancements in quantitative gated SPECT (QGS) software enables the left ventricular (LV) regional analysis and may be useful for PSS measurement. The purpose of this study was to evaluate whether PSS at the resting condition determined by QGS is useful to identify patients with coronary artery disease. Methods: The study comprised 146 patients (mean age +/- SD, 71 +/- 8 y; 98 men) with normal LV wall motion (mean LV ejection fraction +/- SD, 72% +/- 9%) who underwent both coronary angiography and resting Tc-99m-tetrofosmin myocardial perfusion SPECT. The sum of the difference between post-end-systolic maximal LV thickening and end-systolic LV thickening, designated PSS index, was calculated from 17 LV myocardial segments using QGS. Results: The PSS index was significantly higher in patients with significant stenosis of the coronary artery than in the other patients (9.8 +/- 10.2 vs. 5.6 +/- 5.1; P < 0.01). A cutoff point of 6.0 of the PSS index had sensitivity, specificity, positive predictive value, and negative predictive values of 55%, 70%, 76%, and 47%, respectively, for the diagnosis of coronary artery disease. Multivariate logistic regression analysis demonstrated that a PSS index greater than 6.0 was an independent predictor for the presence of coronary artery disease (odds ratio, 2.46; 95% confidence interval, 1.1-5.4; P < 0.05). Conclusion: Among subjects with normal LV function, PSS index even in the resting condition determined using QGS may help to identify patients with coronary artery disease.	[Kanzaki, Yumiko; Yamauchi, Yohei; Morita, Hideaki; Ukimura, Akira; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Takatsuki, Osaka 5698686, Japan; [Hayashi, Masuo; Komori, Tsuyoshi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan	Kanzaki, Y (reprint author), Osaka Med Coll, Dept Cardiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	in3089@poh.osaka-med.ac.jp					Onishi T, 2009, CIRC J, V73, P125; Weidemann F, 2006, ULTRASOUND MED BIOL, V32, P53, DOI 10.1016/j.ultrasmedbio.2005.09.003; Chen J, 2011, J NUCL CARDIOL, V18, P685, DOI 10.1007/s12350-011-9392-x; Chen CC, 2012, EUR J NUCL MED MOL I, V39, P1904, DOI 10.1007/s00259-012-2208-7; Sharir T, 1999, CIRCULATION, V100, P1035; AlJaroudi W, 2012, J NUCL CARDIOL, V19, P63, DOI 10.1007/s12350-011-9463-z; Akincioglu C, 2005, J NUCL MED, V46, P1102; Uebleis C, 2013, J NUCL CARDIOL, V20, P253, DOI 10.1007/s12350-013-9673-7; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Smanio PEP, 1997, J AM COLL CARDIOL, V30, P1687, DOI 10.1016/S0735-1097(97)00363-X; Bijnens B, 2007, CIRCULATION, V116, P2453, DOI 10.1161/CIRCULATIONAHA.106.684357; Ryf S, 2006, J CARDIOV MAGN RESON, V8, P445, DOI 10.1080/10976640600599494; Bavelaar-Croon CDL, 2001, AM HEART J, V141, P383, DOI 10.1067/mhj.2001.112780; Germano G, 2007, J NUCL CARDIOL, V14, P433, DOI 10.1016/j.nuclcard.2007.06.008; Van Kriekinge SD, 2008, J NUCL MED, V49, P1790, DOI 10.2967/jnumed.108.055160; Hida S, 2012, CIRC J, V76, P1942, DOI 10.1253/circj.CJ-11-1392; Wang JW, 2005, CIRCULATION, V111, P2943, DOI 10.1161/CIRCULATIONAHA.104.482984; Pislaru C, 2002, J AM COLL CARDIOL, V40, P1487, DOI 10.1016/S0735-1097(02)02171-4; Uebleis C, 2012, EUR J NUCL MED MOL I, V39, P1561, DOI 10.1007/s00259-012-2157-1; AlJaroudi W, 2011, J NUCL CARDIOL, V18, P36, DOI 10.1007/s12350-010-9296-1; Dilsizian V, 2005, CIRCULATION, V112, P2169, DOI 10.1061/CIRCULATIONHA.104.530428; GERMANO G, 1995, J NUCL MED, V36, P2138; Henneman MM, 2007, J NUCL MED, V48, P1104, DOI 10.2967/jnumed.107.039925; Huang WS, 2014, J NUCL CARDIOL, V21, P1048, DOI 10.1007/s12350-014-9980-7; TAKAYAMA M, 1988, CIRCULATION, V78, P994; Asanuma T, 2009, JACC-CARDIOVASC IMAG, V2, P1253, DOI 10.1016/j.jcmg.2009.07.008; Kukulski T, 2003, J AM COLL CARDIOL, V41, P810, DOI 10.1016/S0735-1097(02)02934-0; Pazhenkottil AP, 2011, HEART, V97, P33, DOI 10.1136/hrt.2010.201566; Asanuma T, 2015, HEART, V101, P509, DOI 10.1136/heartjnl-2013-305403; Austen W G, 1975, Circulation, V51, P5	30	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC	2015	56	12					1889	1894		10.2967/jnumed.115.153791		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5EL	WOS:000365724800015		
J	Hosokawa, C; Ishii, K; Kimura, Y; Hyodo, T; Hosono, M; Sakaguchi, K; Usami, K; Shimamoto, K; Yamazoe, Y; Murakami, T				Hosokawa, Chisa; Ishii, Kazunari; Kimura, Yuichi; Hyodo, Tomoko; Hosono, Makoto; Sakaguchi, Kenta; Usami, Kimio; Shimamoto, Kenji; Yamazoe, Yuzuru; Murakami, Takamichi			Performance of C-11-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images	JOURNAL OF NUCLEAR MEDICINE			English	Article						C-11-PIB; positron emission tomography; binding potential; equivocal; white matter retention	POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DEMENTIA; CONSORTIUM; DIAGNOSIS; PATHOLOGY; CONSENSUS; C-11-PIB	The goal of this study was to clarify whether binding potential (BP) images using C-11-Pittsburgh compound B (C-11-PiB) and dynamic PET can reliably detect cortical amyloid deposits for patients whose C-11-PiB PET static images are ambiguous and whether visual ratings are affected by white matter retention. Methods: Static and BP images were constructed for 85 consecutive patients with cognitive impairment after C-11-PiB dynamic PET. Cortical uptake was visually assessed as positive, negative, or equivocal for both types of images. Quantitatively, the standardized uptake value ratio (SUVR) from the static image, the nondisplaceable BP from the dynamic image for mean gray matter uptake, and the ratio of gray matter uptake to white matter retention were compared among C-11-PiB-positive, C-11-PiB-equivocal, and C-11-PiB-negative groups. Results: Forty-three scans were visually assessed as C-11-PiB-positive in both the static and the BP images. Ten scans were C-11-PiB-equivocal in the static images. In 8 of them, the BP images were C-11-PiB-positive, whereas the other 2 were C-11-PiB-equivocal. Thirty-two scans were assessed as C-11-PiB-negative in the static images. In the BP images, 4 were C-11-PiB-positive and 2 were C-11-PiB-equivocal. The mean gray matter uptake of C-11-PiB in SUVR and nondisplaceable BP, respectively, showed statistically significant differences among the C-11-PiB-positive, C-11-PiB-equivocal, and C-11-PiB-negative groups. The ratio of gray matter uptake to white matter retention was lower in the BP images than static images from the C-11-PiB-negative and C-11-PiB-equivocal groups, whereas it was higher in the C-11-PiB-positive group. Conclusion: C-11-PiB PET BP images can clarify visual interpretation of clinical static C-11-PiB-equivocal images by reducing the interference of nonspecific white matter retention. We conclude that C-11-PiB-equivocal PET findings on static images reflect cortical amyloid deposits, which can be verified using BP images. Furthermore, quantitative assessments, such as SUVR and nondisplaceable BP, are of no use for correctly rating equivocal visual findings.	[Hosokawa, Chisa; Ishii, Kazunari; Hyodo, Tomoko; Hosono, Makoto; Murakami, Takamichi] Kinki Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan; [Hosokawa, Chisa; Hosono, Makoto; Sakaguchi, Kenta; Usami, Kimio; Shimamoto, Kenji; Yamazoe, Yuzuru; Murakami, Takamichi] Kinki Univ, Fac Med, Inst Adv Clin Med, Osaka 5898511, Japan; [Ishii, Kazunari] Kinki Univ Hosp, Neurocognit Disorders Ctr, Osaka, Japan; [Kimura, Yuichi] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan	Hosokawa, C (reprint author), Kinki Univ, Fac Med, Dept Radiol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	ch4111@gmail.com			JSPS KAKENHI [50534103]; 21st Century Research and Development Incentive Wages at Kinki University	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This study was supported in part by JSPS KAKENHI grant 50534103 and the 21st Century Research and Development Incentive Wages at Kinki University. No other potential conflicts of interest relevant to this article are reported.	Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Fodero-Tavoletti MT, 2009, J NUCL MED, V50, P198, DOI 10.2967/jnumed.108.057984; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Burack MA, 2010, NEUROLOGY, V74, P77, DOI 10.1212/WNL.0b013e3181c7da8e; MCKHANN G, 1984, NEUROLOGY, V34, P939; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; MIRRA SS, 1991, NEUROLOGY, V41, P479; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Neary D, 1998, NEUROLOGY, V51, P1546; Klumpers UMH, 2012, NUCL MED COMMUN, V33, P422, DOI [10.1097/MNM.0b013e3283505f7b, 10.1097/MNM.0b013e328350517b]; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; Leinonen V, 2008, ARCH NEUROL-CHICAGO, V65, P1304, DOI 10.1001/archneur.65.10.noc80013; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Rowe CC, 2013, J NUCL MED, V54, P880, DOI 10.2967/jnumed.112.114785; Zwan MD, 2014, J NUCL MED, V55, P1305, DOI 10.2967/jnumed.114.139121; Cohen AD, 2013, NEUROIMAGE, V71, P207, DOI 10.1016/j.neuroimage.2013.01.015; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Edison P, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt87; Hosokawa C, 2015, ANN NUCL MED, V29, P164, DOI 10.1007/s12149-014-0924-8	32	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC	2015	56	12					1910	1915		10.2967/jnumed.115.156414		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX5EL	WOS:000365724800018		
J	Murakami, K; Livingstone, MBE				Murakami, Kentaro; Livingstone, M. Barbara E.			Eating Frequency Is Positively Associated with Overweight and Central Obesity in US Adults	JOURNAL OF NUTRITION			English	Article						eating frequency; meal frequency; snack frequency; body mass index; waist circumference; epidemiology; NHANES; misreporting	MULTIPLE-PASS METHOD; MIDDLE-AGED MEN; BODY-MASS INDEX; ENERGY-INTAKE; WAIST CIRCUMFERENCE; PHYSICAL-ACTIVITY; PATTERNS; WOMEN; POPULATION; BMI	Background: Evidence of the association between eating frequency (EF) and adiposity is inconsistent. Objective: With the use of data from the NHANES 2003-2012, this cross-sectional study examined the associations between EF, meal frequency (MF), and snack frequency (SF) and overweight/obesity and central obesity. Methods: Dietary intake was assessed with the use of two 24-h dietary recalls in 18,696 US adults >= 20 y of age. All eating occasions providing >= 50 kcal of energy were divided into meals or snacks on the basis of contribution to energy intake (>= 15% or <15%), self-report, and time (0600-1000, 1200-1500, 1800-2100, or other). Multivariable logistic regression was used to compute ORs and 95% CIs. Results: When analyzed without adjustment for the ratio of energy intake to estimated energy requirement (EI:EER), all measures of EF, MF, and SF showed inverse or null associations. After adjustment for EI: EER, however, EF was positively associated with overweight/obesity (body mass index >= 25 kg/m(2)) and central obesity (waist circumference >= 102 cm in men and >= 88 cm in women). Compared with the lowest category (<= 3 times/d), the OR (95% CI) for overweight/obesity in the highest category (>= 5 times/d) was 1.54 (1.23, 1.93) in men (P-trend = 0.003) and 1.45 (1.17, 1.81) in women (P-trend = 0.001). The corresponding value for central obesity was 1.42 (1.15, 1.75) in men (P-trend = 0.002) and 1.29 (1.05, 1.59) in women (P-trend = 0.03). The self-report-based MF and time-based MF were positively associated with overweight/obesity, central obesity, or both, although MF based on energy contribution showed no associations. There were positive associations for all SF measures in men and for the energy-contribution-based SF in women. Conclusions: This cross-sectional study suggests that higher EF, MF, and SF are associated with an increased likelihood of overweight/obesity and central obesity in US adults. Prospective studies are needed to confirm the associations observed in this study.	[Murakami, Kentaro] Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Shiga, Japan; [Livingstone, M. Barbara E.] Univ Ulster, Northern Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland	Murakami, K (reprint author), Univ Shiga Prefecture, Sch Human Cultures, Dept Nutr, Shiga, Japan.	kenmrkm@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K16213]	This research was supported in part by the Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. 15K16213) (to KM).	Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Johnson GH, 2010, CRIT REV FOOD SCI, V50, P848, DOI 10.1080/10408390903572479; Ruidavets JB, 2002, INT J OBESITY, V26, P1476, DOI 10.1038/sj.ijo.0802143; Yannakoulia M, 2007, OBESITY, V15, P100, DOI 10.1038/oby.2007.503; Huang TTK, 2005, OBES RES, V13, P1205, DOI 10.1038/oby.2005.143; Drummond SE, 1998, INT J OBESITY, V22, P105, DOI 10.1038/sj.ijo.0800552; Conway JM, 2003, AM J CLIN NUTR, V77, P1171; Hartline-Grafton HL, 2010, OBESITY, V18, P736, DOI 10.1038/oby.2009.249; Duffey KJ, 2013, EUR J CLIN NUTR, V67, P868, DOI 10.1038/ejcn.2013.60; Duval K, 2008, AM J CLIN NUTR, V88, P1200, DOI 10.3945/ajcn.2008.26220; Mills JP, 2011, OBESITY, V19, P552, DOI 10.1038/oby.2010.265; Blanton CA, 2006, J NUTR, V136, P2594; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Ritchie LD, 2012, AM J CLIN NUTR, V95, P290, DOI 10.3945/ajcn.111.016881; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Summerbell CD, 1996, EUR J CLIN NUTR, V50, P513; Howarth NC, 2007, INT J OBESITY, V31, P675, DOI 10.1038/sj.ijo.0803456; McCrory MA, 2011, J NUTR, V141, P148, DOI 10.3945/jn.109.114991; van der Heijden AAWA, 2007, OBESITY, V15, P2463, DOI 10.1038/oby.2007.292; KANT AK, 1995, INT J OBESITY, V19, P468; Conway JM, 2004, J AM DIET ASSOC, V104, P595, DOI 10.1016/j.jada.2004.01.007; Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104; Berteus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI [10.1038/sj.ijo.0802950, 10.1038/sj.ijo..802950]; Centers for Disease Control and Prevention, NHANES RESP RAT POP; Centers for Disease Control and Prevention National Center for Health Statistics, CONT NHANES WEB TUT; Centers for Disease Control and Prevention National Center for Health Statistics., QUEST DAT REL DOC; Holmback I, 2010, BRIT J NUTR, V104, P1065, DOI 10.1017/S0007114510001753; Institute of Medicine, 2002, DIET REF INT EN CARB; Johnson CL, 1999, VITAL HLTH STAT, V161, P1; Kant AK, 2015, J ACAD NUTR DIET, V115, P50, DOI 10.1016/j.jand.2014.06.354; Livingstone MBE, 2003, J NUTR, V133, p895S; Luke A, 2003, BMC PUBLIC HEALTH, V11, P387, DOI DOI 10.1186/1471-2458-11-387; Marin-Guerrero AC, 2008, BRIT J NUTR, V100, P1142, DOI 10.1017/S0007114508966137; Murakami K, 2014, INT J OBESITY, V38, P1200, DOI 10.1038/ijo.2014.1; Smith KJ, 2012, BRIT J NUTR, V108, P1086, DOI 10.1017/S0007114511006398; Titan SMO, 2001, BRIT MED J, V323, P1286, DOI 10.1136/bmj.323.7324.1286; World Health Organization, 2000, WHO TECHN REP SER, V894; Zipf G, 2013, VITAL HLTH STAT, V56, P1	40	0	0	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3166	1541-6100		J NUTR	J. Nutr.	DEC	2015	145	12					2715	2724		10.3945/jn.115.219808		10	Nutrition & Dietetics	Nutrition & Dietetics	CX5DY	WOS:000365723300010		
J	Iida, Y; Kojima, A; Takatani, Y; Nakano, T; Sugimoto, H; Midorikawa, T; Ishii, M				Iida, Yosuke; Kojima, Atsushi; Takatani, Yusuke; Nakano, Toshiya; Sugimoto, Hiroyuki; Midorikawa, Takashi; Ishii, Masao			Trends in pCO(2) and sea-air CO2 flux over the global open oceans for the last two decades	JOURNAL OF OCEANOGRAPHY			English	Article						pCO(2) mapping; pCO(2) trend; CO2 flux; Gas exchange; Carbon cycle; Biogeochemistry	ANTHROPOGENIC CARBON-DIOXIDE; WESTERN EQUATORIAL PACIFIC; SURFACE OCEAN; SOUTHERN-OCEAN; NORTH PACIFIC; TROPICAL ATLANTIC; ATMOSPHERIC CO2; GAS-EXCHANGE; INDIAN-OCEAN; ARABIAN SEA	To date, millions of data for partial pressure of carbon dioxide in surface seawater (pCO(2)s) have been acquired from global oceans. However, pCO(2)s varies extremely both in space and time, and it is still necessary to fill in its spatiotemporal gaps to evaluate the changes in sea-air CO2 flux from regional to global scales. In the present study, we have analyzed the rates of pCO(2)s increase for the past decades, ranging from +1.21 A mu atm year(-1) in the western equatorial Pacific to +2.00 A mu atm year(-1) in the Southern Ocean, and developed algorithms to reconstruct global monthly pCO(2)s fields based on a quality-controlled database, Surface Ocean CO2 Atlas (SOCAT) version 2. The error of pCO(2)s algorithms is +/- 16.3 A mu atm. The mean annual global sea-air CO2 flux for the years 1990-2012 was estimated to be -1.76 PgC year(-1) (contemporary flux; a negative value indicates oceanic uptake). The uncertainty in this estimate is calculated to be 0.77 PgC year(-1) (44 %), i.e., 0.09 PgC year(-1) from our empirical method to interpolate/extrapolate pCO(2)s, and 0.67 PgC year(-1) from determination of the rates of pCO(2)s increase and the rest from gas transfer processes including wind speed (0.26 PgC year(-1)) and a scaling factor of piston velocity (0.26 PgC year(-1)). The decadal mean CO2 flux showed a trend toward increasing uptake from -1.67 PgC year(-1) for 1990-1999 to -1.92 PgC year(-1) for 2003-2012, due to growing uptake in the Pacific and Atlantic Oceans. However, these estimates of CO2 flux are sensitive to the rates of pCO(2)s increase used to constrain the long-term pCO(2)s change for each sub-region.	[Iida, Yosuke; Kojima, Atsushi; Takatani, Yusuke; Nakano, Toshiya; Sugimoto, Hiroyuki; Ishii, Masao] Japan Meteorol Agcy, Global Environm & Marine Dept, Chiyoda Ku, Tokyo 1008122, Japan; [Iida, Yosuke; Kojima, Atsushi; Takatani, Yusuke; Nakano, Toshiya; Sugimoto, Hiroyuki; Midorikawa, Takashi; Ishii, Masao] Meteorol Res Inst, Oceanog & Geochem Res Dept, Tsukuba, Ibaraki 3050052, Japan	Iida, Y (reprint author), Japan Meteorol Agcy, Global Environm & Marine Dept, Chiyoda Ku, 1-3-4 Otemachi, Tokyo 1008122, Japan.	iida-ysk@met.kishou.go.jp			Meteorological Research Institute; MEXT [24121003]	This work has been done on the basis of the SOCAT V2 database to evaluate rate of pCO<INF>2</INF>s increase and derive the algorithms for mapping pCO<INF>2</INF>s fields. The Surface Ocean CO<INF>2</INF> Atlas (SOCAT) is an international effort, supported by the International Ocean Carbon Coordination Project (IOCCP), the Surface Ocean Lower Atmosphere Study (SOLAS), and the Integrated Marine Biogeochemistry and Ecosystem Research program (IMBER), to deliver a uniformly quality controlled surface ocean CO<INF>2</INF> database. The many researchers and funding agencies responsible for the collection of data and quality control are thanked for their contributions to SOCAT. Authors acknowledge support from the Meteorological Research Institute's priority research fund for observation and diagnostic analysis of carbon cycle in the atmosphere and ocean, and MEXT Grant-in-Aid for Scientific Research on Innovative Areas No. 24121003.	Ishii M, 2002, DEEP-SEA RES PT II, V49, P1691, DOI 10.1016/S0967-0645(02)00007-3; OUDOT C, 1987, DEEP-SEA RES, V34, P1107, DOI 10.1016/0198-0149(87)90067-7; POISSON A, 1993, J GEOPHYS RES-OCEANS, V98, P22759, DOI 10.1029/93JC02501; INOUE HY, 1995, TELLUS B, V47, P391, DOI 10.1034/j.1600-0889.47.issue4.2.x; Ho DT, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006854; KEELING CD, 1960, TELLUS, V12, P200; Midorikawa T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051665; Iudicone D, 2011, BIOGEOSCIENCES, V8, P1031, DOI 10.5194/bg-8-1031-2011; Bates NR, 2014, OCEANOGRAPHY, V27, P126; Jiang CL, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002824; Kumar MD, 1996, J GEOPHYS RES-OCEANS, V101, P18121, DOI 10.1029/96JC01452; Lenton A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004095; Sabine CL, 2000, MAR CHEM, V72, P33, DOI 10.1016/S0304-4203(00)00064-5; TAKAHASHI T, 1961, J GEOPHYS RES, V66, P477, DOI 10.1029/JZ066i002p00477; Sasse TP, 2013, GEOPHYS RES LETT, V40, P1594, DOI 10.1002/grl.50342; Nakaoka S, 2006, TELLUS B, V58, P148, DOI 10.1111/j.1600-0889.2006.00178.x; Ishii M, 2009, DEEP-SEA RES PT II, V56, P591, DOI 10.1016/j.dsr2.2009.01.002; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P8292, DOI 10.1073/pnas.94.16.8292; Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Santana-Casiano JM, 2009, DEEP-SEA RES PT II, V56, P533, DOI 10.1016/j.dsr2.2008.12.010; Sweeney C, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002784; Bates NR, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002491; Takahashi T, 2014, MAR CHEM, V164, P95, DOI 10.1016/j.marchem.2014.06.004; Sarma VVSS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001062; KEELING CD, 1968, J GEOPHYS RES, V73, P4543, DOI 10.1029/JB073i014p04543; Lefevre N, 2010, TELLUS B, V62, P595, DOI 10.1111/j.1600-0889.2010.00475.x; Maki T, 2010, TELLUS B, V62, P797, DOI 10.1111/j.1600-0889.2010.00488.x; Inoue HY, 1996, GEOPHYS RES LETT, V23, P1781, DOI 10.1029/96GL01674; Lefevre N, 1998, J GEOPHYS RES-OCEANS, V103, P5623, DOI 10.1029/97JC02303; SARMIENTO JL, 1993, NATURE, V365, P697, DOI 10.1038/365697a0; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; Millero FJ, 1998, DEEP-SEA RES PT II, V45, P2225, DOI 10.1016/S0967-0645(98)00069-1; Naegler T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025408; Nakaoka S, 2013, BIOGEOSCIENCES, V10, P6093, DOI 10.5194/bg-10-6093-2013; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Rodenbeck C, 2014, BIOGEOSCIENCES, V11, P4599, DOI 10.5194/bg-11-4599-2014; Frolicher TL, 2013, GLOBAL BIOGEOCHEM CY, V27, P239, DOI 10.1002/gbc.20028; Naegler T, 2009, TELLUS B, V61, P372, DOI 10.1111/j.1600-0889.2008.00408.x; Fay AR, 2014, GEOPHYS RES LETT, V41, P6833, DOI 10.1002/2014GL061324; Metzl N, 1999, TELLUS B, V51, P849, DOI 10.1034/j.1600-0889.1999.t01-3-00008.x; Goyet C, 1998, DEEP-SEA RES PT I, V45, P609, DOI 10.1016/S0967-0637(97)00085-X; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Zeng J, 2014, J ATMOS OCEAN TECH, V31, P1838, DOI 10.1175/JTECH-D-13-00137.1; Takahashi T, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003074; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Schuster U, 2013, BIOGEOSCIENCES, V10, P607, DOI 10.5194/bg-10-607-2013; Wanninkhof R, 2013, BIOGEOSCIENCES, V10, P1983, DOI 10.5194/bg-10-1983-2013; Chierici M, 2012, REMOTE SENS ENVIRON, V119, P184, DOI 10.1016/j.rse.2011.12.020; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; Parard G, 2010, TELLUS B, V62, P636, DOI 10.1111/j.1600-0889.2010.00503.x; Olsen A, 2008, BIOGEOSCIENCES, V5, P535; Woolf DK, 2005, TELLUS B, V57, P87, DOI 10.1111/j.1600-0889.2005.00139.x; Ishii M, 2014, BIOGEOSCIENCES, V11, P709, DOI 10.5194/bg-11-709-2014; Schuster U, 2009, DEEP-SEA RES PT II, V56, P620, DOI 10.1016/j.dsr2.2008.12.011; Pfeil B, 2013, EARTH SYST SCI DATA, V5, P125, DOI 10.5194/essd-5-125-2013; Bates NR, 2012, BIOGEOSCIENCES, V9, P2509, DOI 10.5194/bg-9-2509-2012; Sallee JB, 2012, NAT GEOSCI, V5, P579, DOI [10.1038/ngeo1523, 10.1038/NGEO1523]; Atlas R, 2011, B AM METEOROL SOC, V92, P157, DOI 10.1175/2010BAMS2946.1; Fay AR, 2013, GLOBAL BIOGEOCHEM CY, V27, P541, DOI 10.1002/gbc.20051; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Ishii M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006831; Sarma VVSS, 2013, BIOGEOSCIENCES, V10, P7035, DOI 10.5194/bg-10-7035-2013; Lenton A, 2013, BIOGEOSCIENCES, V10, P4037, DOI 10.5194/bg-10-4037-2013; Park GH, 2010, TELLUS B, V62, P352, DOI 10.1111/j.1600-0889.2010.00498.x; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Browning T.J., 2015, FRONT MAR SCI MAR BI, V2, P14; Feldman GC, 2012, OCEAN COLOR WEB MODI; Feldman GC, 2010, OCEAN COLOR WEB SEAW; Feng M.Q, 2011, BOUND VALUE PROBL, V2011, P1; Gonzalez-Davila M, 2009, SEA SURFACE ATMOSPHE, DOI [10.3334/CDIAC/otg.TSM_ESTOC, DOI 10.3334/CDIAC/0TG.TSM_ESTOC]; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kurihara Y., 2006, WEATHER B, V73, ps1; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Liss PS, 1986, ROLE AIR SEA EXCHANG, P113; Murata A, 1996, J METEOROL RES, V48, P33; Stocker T. F., 2013, CLIMATE CHANGE 2013, p[1535, Cambridge], DOI DOI 10.1017/CBO9781107415324; Sugimoto H, 2012, METHOD ESTIMATING SE, V66, P32; Takahashi T, 2014, ORNLCDIAC160 USDA, DOI [10.3334/CDIAC/OTG.NDP088(V2013), DOI 10.3334/CDIAC/0TG.NDP088(V2013)]; Takahashi T, 2008, ORNLCDIAC152 DEP EN, P20; Tseng CM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049774; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Weiss R. F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	83	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2015	71	6					637	661		10.1007/s10872-015-0306-4		25	Oceanography	Oceanography	CX7IC	WOS:000365874400001		
J	Zhu, XH; Zhao, RX; Guo, XY; Long, Y; Ma, YL; Fan, XP				Zhu, Xiao-Hua; Zhao, Ruixiang; Guo, Xinyu; Long, Yu; Ma, Yun-Long; Fan, Xiaopeng			A long-term volume transport time series estimated by combining in situ observation and satellite altimeter data in the northern South China Sea	JOURNAL OF OCEANOGRAPHY			English	Article						Long-term time series of volume transport; Pressure-recording inverted echo sounder; Gravest empirical mode; Satellite altimeter; Seasonal variability; South China sea	MESOSCALE EDDIES; CIRCULATION; KUROSHIO; VARIABILITY; MODEL; EDDY	We deployed five pressure-recording inverted echo sounders (PIES) along a satellite altimeter track across the continental slope of the northern South China Sea (NSCS) from October 2012 to July 2014, and obtained a time series of volume transport (VTPIES) across the section from their records. Applying the empirical relationship between VTPIES and the satellite altimeter sea surface height anomaly difference across the section, we obtained a time series of volume transport (VTNSCS) over 22 years from 1992 to 2014. The VTNSCS shows a small mean value of -1.6 Sv (1 Sv = 10(6) m(3) s(-1)) (i.e., toward the southwest), but a significant seasonal reversal and mesoscale eddy induced fluctuations (-11.8 to 19.7 Sv). The monthly mean of VTNSCS over 22 years shows a maximum (3.6 Sv) in July and a minimum (-7.3 Sv) in December. This is the first long time series of volume transport for the NSCS based on in situ data.	[Zhu, Xiao-Hua; Zhao, Ruixiang; Guo, Xinyu; Long, Yu; Ma, Yun-Long; Fan, Xiaopeng] State Ocean Adm, Inst Oceanog 2, State Key Lab Satellite Ocean Environm Dynam, Hangzhou 310012, Zhejiang, Peoples R China; [Guo, Xinyu] Ehime Univ, Ctr Marine Environm Study, Matsuyama, Ehime 7908577, Japan; [Zhu, Xiao-Hua] Zhejiang Univ, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China	Zhu, XH (reprint author), State Ocean Adm, Inst Oceanog 2, State Key Lab Satellite Ocean Environm Dynam, 36 Baochubei Rd, Hangzhou 310012, Zhejiang, Peoples R China.	xhzhu@sio.org.cn			National Basic Research Program of China [2011CB403503]; National Natural Science Foundation of China [41276095, 41476020, 41276028, 41321004]; Scientific Research Fund of SIO [JT1402, JT1207]; State Key Laboratory of Satellite Ocean Environment Dynamics, Second Institute of Oceanography [SOEDZZ1403]; Global Change and Air-Sea Interaction [GASI-03-01-01-02]	This study is supported by the National Basic Research Program of China (2011CB403503), the National Natural Science Foundation of China (41276095, 41476020, 41276028, and 41321004), the Scientific Research Fund of SIO under grants JT1402 and JT1207, and the projects of State Key Laboratory of Satellite Ocean Environment Dynamics, Second Institute of Oceanography (SOEDZZ1403), and Global Change and Air-Sea Interaction (GASI-03-01-01-02). The Argo data are provided by China Argo Real-time Data Center (http://www.argo.gov.cn/argo-eng/index.asp). The HYCOM data are downloaded from http://hycom.org/. We thank the crew and participants of the R/V Shiyan-3 for their support during deployment cruise.	Chu XQ, 2014, J GEOPHYS RES-OCEANS, V119, P881, DOI 10.1002/2013JC009314; Qiu B, 1999, J PHYS OCEANOGR, V29, P2471, DOI 10.1175/1520-0485(1999)029<2471:SEFMOT>2.0.CO;2; Wang DX, 2013, J GEOPHYS RES-OCEANS, V118, P490, DOI 10.1029/2012JC008429; Fang GH, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006225; Imawaki S, 2001, GEOPHYS RES LETT, V28, P17, DOI 10.1029/2000GL011796; Wang Q, 2015, J GEOPHYS RES-OCEANS, V120, P517, DOI 10.1002/2014JC009814; Zhu XH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015867; Hu JY, 2010, J OCEANOGR, V66, P591; Wang GH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018532; Fang GH, 2012, ACTA OCEANOL SIN, V31, P1, DOI 10.1007/s13131-012-0231-y; Liu ZY, 2001, J PHYS OCEANOGR, V31, P272, DOI 10.1175/1520-0485(2001)031<0272:RDOSVI>2.0.CO;2; Fang WD, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2002JC001343; Wang DX, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026316; Andres M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004200; Kagimoto T, 1997, J PHYS OCEANOGR, V27, P403, DOI 10.1175/1520-0485(1997)027<0403:STVOTK>2.0.CO;2; Donohue KA, 2010, J ATMOS OCEAN TECH, V27, P507, DOI 10.1175/2009JTECHO686.1; Andres M, 2008, J OCEANOGR, V64, P937, DOI 10.1007/s10872-008-0077-2; Watts DR, 2001, J PHYS OCEANOGR, V31, P2186, DOI 10.1175/1520-0485(2001)031<2186:ATDGEM>2.0.CO;2; Fang GH, 2009, DYNAM ATMOS OCEANS, V47, P55, DOI 10.1016/j.dynatmoce.2008.09.003; Qu TD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028350; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Zhu XH, 2004, J OCEANOGR, V60, P953, DOI 10.1007/s10872-005-0004-8; Hsin YC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007714; Wu Chauron, 1998, J OCEANOGR, V54, P361, DOI DOI 10.1007/BF02742620; Wyrtki K, 1961, SCI RESULTS MARINE I, V2, P195; Yang Y., 1999, J OCEANOGR, V55, P609, DOI DOI 10.1023/A:1007892819134	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2015	71	6					663	673		10.1007/s10872-015-0305-5		11	Oceanography	Oceanography	CX7IC	WOS:000365874400002		
J	Tsuchiya, K; Sano, T; Kawasaki, N; Fukuda, H; Tomioka, N; Hamasaki, K; Tada, Y; Shimode, S; Toda, T; Imai, A				Tsuchiya, Kenji; Sano, Tomoharu; Kawasaki, Nobuyuki; Fukuda, Hideki; Tomioka, Noriko; Hamasaki, Koji; Tada, Yuya; Shimode, Shinji; Toda, Tatsuki; Imai, Akio			New radioisotope-free method for measuring bacterial production using [N-15(5)]-2'-deoxyadenosine and liquid chromatography mass spectrometry (LC-MS) in aquatic environments	JOURNAL OF OCEANOGRAPHY			English	Article						Bacterial production; Stable isotope; Liquid chromatography mass spectrometry (LC-MS); DNA synthesis; 2 '-deoxyadenosine	DISSOLVED ORGANIC-MATTER; THYMIDINE INCORPORATION; DEOXYRIBONUCLEOSIDE KINASES; LEUCINE INCORPORATION; TRITIATED-THYMIDINE; INCORPORATION RATES; PROTEIN-SYNTHESIS; WATERS; DNA; ASSEMBLAGES	This study proposed a non-radioactive quantitative measurement of bacterial production using stable isotope nitrogen-15-labeled deoxyadenosine ([N-15(5)]-2'-deoxyadenosine; N-15-dA) by liquid chromatography mass spectrometry (LC-MS). The method of preparing N-5-dA described in this study included incubation of seawater or lake water with N-15-dA for 5-24 h, filtration onto a membrane filter, DNA extraction, enzymatic hydrolysis of DNA to nucleosides and quantification of N-15-dA by LC-MS. In the DNA extraction, the silica beads method was examined first, but a large amount of salts and enzymatic inhibitors used in the method caused failure of subsequent procedures, such as enzymatic hydrolysis and LC-MS analysis. On the other hand, the magnetic beads method showed much better results for the extraction. The incorporation rate of N-15-dA was significantly positively correlated to that of tritium-labeled thymidine (H-3-TdR) in samples of coastal seawaters and lake waters. The average N-15-dA: H-3-TdR incorporation ratio for the seawater sample was 0.55 with 2.5 and 97.5 % confidence intervals of 0.51 and 0.58, respectively; the average ratio for the lake water sample was 0.28 with 2.5 and 97.5 % confidence intervals of 0.23 and 0.34, respectively. The results suggest that the N-15-dA method can be applied to the measurement of bacterial production in aquatic ecosystems, and that this method can accurately predict the DNA synthesis rates measured by the conventional method.	[Tsuchiya, Kenji; Toda, Tatsuki] Soka Univ, Fac Sci & Engn, Hachioji, Tokyo 1928577, Japan; [Sano, Tomoharu; Kawasaki, Nobuyuki; Tomioka, Noriko; Imai, Akio] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Kawasaki, Nobuyuki] Univ Selangor, Bestari Jaya 45600, Salangor, Malaysia; [Fukuda, Hideki; Hamasaki, Koji; Tada, Yuya] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Tada, Yuya] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Shimode, Shinji] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Tsuchiya, K (reprint author), Soka Univ, Fac Sci & Engn, 1-236 Tangi Machi, Hachioji, Tokyo 1928577, Japan.	ktsuchiya@soka.gr.jp			Japan Society for the Promotion of Science [2550019]; Japan Science Society	We thank Dr. Kazuhiro Iwasaki for valuable advice on DNA extraction, Dr. Shota Takumi for valuable advice on enzymatic DNA hydrolysis and Dr. Kazuaki Shutsubo for the use of his spectrometer. The data of DNA extraction efficiency of the Extrap Soil DNA Kit Plus ver.2 was supplied by Nippon Steel & Sumikin Eco-Tech Corporation. This research was partly supported by a Grant-in-Aid for Scientific Research (No. 2550019) from the Japan Society for the Promotion of Science and the Sasakawa Scientific Research Grant from The Japan Science Society.	Tinta T, 2012, FEMS MICROBIOL LETT, V331, P120, DOI 10.1111/j.1574-6968.2012.02565.x; INGRAM LO, 1972, J BACTERIOL, V112, P170; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; HOLLIBAUGH JT, 1980, LIMNOL OCEANOGR, V25, P172; ROBARTS RD, 1989, LIMNOL OCEANOGR, V34, P213; DAVIS CL, 1989, APPL ENVIRON MICROB, V55, P1267; Perez MT, 2010, ENVIRON MICROBIOL, V12, P74, DOI 10.1111/j.1462-2920.2009.02043.x; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599; Nohara K, 2011, ARCH TOXICOL, V85, P653, DOI 10.1007/s00204-010-0611-z; KARL DM, 1982, APPL ENVIRON MICROB, V44, P891; KIRCHMAN DL, 1988, MAR ECOL PROG SER, V45, P169, DOI 10.3354/meps045169; JEFFREY WH, 1990, APPL ENVIRON MICROB, V56, P1367; Imai A, 2003, WATER RES, V37, P4284, DOI 10.1016/S0043-1354(03)00310-5; Nelson CE, 2005, LIMNOL OCEANOGR-METH, V3, P211; FUHRMAN JA, 1980, APPL ENVIRON MICROB, V39, P1085; AULING G, 1982, EUR J BIOCHEM, V121, P365, DOI 10.1111/j.1432-1033.1982.tb05795.x; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Verdolino V, 2008, J PHYS CHEM B, V112, P16860, DOI 10.1021/jp8068877; DUCKLOW HW, 1992, ADV MICROB ECOL, V12, P113; Hamasaki K, 2006, J OCEANOGR, V62, P793, DOI 10.1007/s10872-006-0098-7; BLOEM J, 1989, APPL ENVIRON MICROB, V55, P1787; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; OGURA N, 1975, MAR BIOL, V31, P101, DOI 10.1007/BF00391622; PEDROSALIO C, 1989, MAR ECOL PROG SER, V55, P83, DOI 10.3354/meps055083; BRITTAIN AM, 1990, APPL ENVIRON MICROB, V56, P1245; Petit M, 1999, FRESHWATER BIOL, V42, P513, DOI 10.1046/j.1365-2427.1999.00500.x; Azam F, 1983, MAR ECOL PROG SER, V10, P275; Camargo APM, 2004, THESIS; Ebise S, 1987, JPN J LIMNOL, V48, pS85; Legendre P, 2001, MODEL 2 REGRESSION U; Robarts RD, 1993, ADV MICROB ECOL, P371; Steward CF, 1999, AQUAT MICROB ECOL, V19, P57; Tsuchiya Kenji, 2013, Plankton & Benthos Research, V8, P74; YuA Nemtseva, 2006, RUSSIAN J MAR BIOL, V32, P55	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2015	71	6					675	683		10.1007/s10872-015-0310-8		9	Oceanography	Oceanography	CX7IC	WOS:000365874400003		
J	Xiong, XR; Masuda, Y; Hashioka, T; Ono, T; Yamanaka, Y				Xiong, Xuanrui; Masuda, Yoshio; Hashioka, Taketo; Ono, Tsuneo; Yamanaka, Yasuhiro			Effect of seasonal change in gas transfer coefficient on air-sea CO2 flux in the western North Pacific	JOURNAL OF OCEANOGRAPHY			English	Article						Gas transfer coefficient; pCO(2); Air-sea CO2 flux; Ecosystem model; North Pacific; East Asian winter monsoon; Seasonal change	SURFACE OCEAN PCO(2); ECOSYSTEM MODEL; MARINE ECOSYSTEM; CARBON; NEMURO; WATERS	We used an eddy-permitting three-dimensional ocean ecosystem model and applied it in the western North Pacific to understand the seasonal variations and horizontal distributions of the air-sea CO2 flux and difference in the partial pressure between sea water and the atmosphere (a dagger pCO(2)). The high-resolution model reproduced the observed zonal belt of strong CO2 uptake in the mid-latitude (30-45A degrees N) western North Pacific including the Kuroshio extension and mixed water regions, which was difficult to show in previous coarse-resolution models. The East Asian winter monsoon, an important phenomenon in the western North Pacific, affects the seasonal CO2 air-sea gas exchange with a high (low) gas transfer coefficient in winter (summer). In the subtropical region, a dagger pCO(2) is negative in winter and positive in summer as a result of the temperature effect. Combination of seasonal change in gas transfer coefficient with a dagger pCO(2) suppresses CO2 release in the subtropical region, and vice versa in the subarctic region (i.e., suppresses CO2 uptake). That is, the East Asian winter monsoon in the western North Pacific contributes to the reduction of the annual CO2 flux through the seasonal change in the gas transfer coefficient, leading to an overall annual CO2 uptake in the subtropical region and CO2 release in the subarctic region.	[Xiong, Xuanrui; Masuda, Yoshio; Yamanaka, Yasuhiro] Hokkaido Univ, Grad Sch Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Xiong, Xuanrui] Chongqing Univ Posts & Telecommun, Sch Commun & Informat Engn, Chongqing 400065, Peoples R China; [Hashioka, Taketo; Yamanaka, Yasuhiro] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Environm Biogeochem Cycle Res Program, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Ono, Tsuneo] Natl Res Inst Fisheries Sci, Kanazawa Ku, Kanazawa, Kanagawa 2368648, Japan	Xiong, XR (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Kita Ku, N10W5, Sapporo, Hokkaido 0600810, Japan.	xiongxuanrui@ees.hokudai.ac.jp			Development of Mitigation and Adaptation Techniques to Global Warming project in the sectors of agriculture, forestry, and fisheries; Rotary Yoneyama Memorial Foundation; MEXT; Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)	The authors wish to thank Drs. Yukihiro Nojiri and Shin-ichiro Nakaoka for offering the observed pCO<INF>2</INF> data. We would like to thank Drs. Masahiko Fujii, Naosuke Okada, and Masahito Shigemitsu for their helpful comments. Xuanrui Xiong was supported by the Development of Mitigation and Adaptation Techniques to Global Warming project in the sectors of agriculture, forestry, and fisheries, and the Rotary Yoneyama Memorial Foundation. Taketo Hashioka was supported by the Grant-in-Aid for the Global COE Program from MEXT and Young Researcher Overseas Visits Program for Vitalizing Brain Circulation from the Japan Society for the Promotion of Science (JSPS). Yasuhiro Yamanaka was also supported by Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST).	INOUE HY, 1995, TELLUS B, V47, P391, DOI 10.1034/j.1600-0889.47.issue4.2.x; Zeng JY, 2002, DEEP-SEA RES PT II, V49, P5303, DOI 10.1016/S0967-0645(02)00192-3; Sasai Y, 2003, MAR CHEM, V81, P71, DOI 10.1016/S0304-4203(02)00140-8; Ishii M, 2001, MAR CHEM, V75, P17, DOI 10.1016/S0304-4203(01)00023-8; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P8292, DOI 10.1073/pnas.94.16.8292; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Sweeney C, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002784; Takamura TR, 2010, J METEOROL SOC JPN, V88, P883, DOI 10.2151/jmsj.2010-602; Valsala V, 2010, TELLUS B, V62, P821, DOI [10.1111/j.1600-0889.2010.00495.x, 10.1111/J.1600-0889.2010.00495.X]; Yamanaka Y, 2004, J OCEANOGR, V60, P227, DOI 10.1023/B:JOCE.0000038329.91976.7d; Kishi MJ, 2007, ECOL MODEL, V202, P12, DOI 10.1016/j.ecolmodel.2006.08.021; Nakaoka S, 2013, BIOGEOSCIENCES, V10, P6093, DOI 10.5194/bg-10-6093-2013; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Wanninkhof R, 2013, BIOGEOSCIENCES, V10, P1983, DOI 10.5194/bg-10-1983-2013; Fujii M, 2007, ECOL MODEL, V202, P52, DOI 10.1016/j.ecolmodel.2006.02.046; Hashioka T, 2007, ECOL MODEL, V202, P68, DOI 10.1016/j.ecolmodel.2006.05.038; Vichi M, 2011, CLIM DYNAM, V37, P1929, DOI 10.1007/s00382-011-1079-0; Hashioka T, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038912; Hasumi H, 2006, 25 CCSR; Najjar RG, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002857; Redfield A.C., 1963, SEA, V2, P26; Sakamoto TT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023384; Sakamoto TT, 2008, GEOPHYS MONOGR SER A, V177, P265; Takahashi T, 2001, ENCY OCEAN SCI, P400; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Weiss R. F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2015	71	6					685	701		10.1007/s10872-015-0313-5		17	Oceanography	Oceanography	CX7IC	WOS:000365874400004		
J	Hioki, N; Kuma, K; Morita, Y; Miura, D; Ooki, A; Tanaka, S; Onishi, H; Takatsu, T; Kobayashi, N; Kamei, Y				Hioki, Nanako; Kuma, Kenshi; Morita, Yuichiroh; Miura, Daichi; Ooki, Atsushi; Tanaka, Seiji; Onishi, Hiroji; Takatsu, Tetsuya; Kobayashi, Naoto; Kamei, Yoshihiko			Regeneration dynamics of iron and nutrients from bay sediment into bottom water of Funka Bay, Japan	JOURNAL OF OCEANOGRAPHY			English	Article						Iron cycling; Nutrients; Dissolved oxygen; Humic-like dissolved organic matter; Bay sediment; Funka Bay (Japan)	DISSOLVED ORGANIC-MATTER; ARCTIC COASTAL ENVIRONMENT; BERING-SEA SHELF; VERTICAL-DISTRIBUTION; ANOXIC SEDIMENT; NORTH PACIFIC; DENITRIFICATION; SEAWATER; OCEAN; ACCUMULATION	We studied iron remobilization and nutrient regeneration in bottom water of Funka Bay, Japan, bimonthly from August 2010 to December 2011. The bay basin (bottom depth, 92-96 m) is separated from the northwest Pacific Ocean at its mouth by a sill with a depth of 60 m. After a spring phytoplankton bloom during early March-early April, nutrients in bay bottom water tended to accumulate with time until August-September, and to increase gradually with depth during April-October, by the oxidative decomposition of settling particulate organic matter on the bay bottom. In contrast, the process of iron remobilization into bottom water of the bay is remarkably different from nutrient regeneration. The much higher concentrations of dissolved and total dissolvable iron near the bottom and the seasonally variable relationship between dissolved iron concentration and apparent oxygen utilization in bay bottom water likely reflect a balance between dissolved iron input and removal processes within the bay bottom water. The release of soluble Fe(II) from reducing bay sediments might induce the high concentrations of dissolved and total dissolvable iron in deep-bottom waters of Funka Bay and might be one of the most important sources of iron in Funka Bay. The upward transport of iron from the bay bottom to the surface water during the winter vertical mixing may play an important role in the supply of bioavailable iron for phytoplankton growth in the coastal waters.	[Hioki, Nanako; Kuma, Kenshi; Morita, Yuichiroh; Miura, Daichi; Ooki, Atsushi; Tanaka, Seiji; Onishi, Hiroji; Takatsu, Tetsuya; Kobayashi, Naoto; Kamei, Yoshihiko] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Kuma, K (reprint author), Hokkaido Univ, Fac Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	kuma@fish.hokudai.ac.jp			Hokusui Society Foundation, Sapporo; Ministry of Education, Culture, Sports, Science and Technology, Japan [22510001]	We thank K. Toya for technical assistance. We also thank the captain and crew of the R/V Ushio-Maru of Hokkaido University for their help in sampling. We are grateful to two reviewers for their constructive and helpful comments on this work. This study was supported partly by a grant for 2010-2011 FYs Research Projects from the Hokusui Society Foundation, Sapporo, and a grant for Scientific Research (no. 22510001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	OBATA H, 1993, ANAL CHEM, V65, P1524, DOI 10.1021/ac00059a007; Yoshikawa C, 2006, J MARINE SYST, V63, P49, DOI 10.1016/j.jmarsys.2006.05.008; Saitoh Y, 2008, J OCEANOGR, V64, P815, DOI 10.1007/s10872-008-0068-3; Inagaki Y, 2012, FISHERIES SCI, V78, P647, DOI 10.1007/s12562-012-0493-5; Chang BX, 2009, DEEP-SEA RES PT II, V56, P1339, DOI 10.1016/j.dsr2.2008.10.024; Chen M, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002160; Kudo I, 2000, MAR ECOL PROG SER, V193, P45, DOI 10.3354/meps193045; Hurst MP, 2010, CONT SHELF RES, V30, P467, DOI 10.1016/j.csr.2010.01.001; HAYASE K, 1988, MAR CHEM, V25, P373, DOI 10.1016/0304-4203(88)90117-X; Inagaki Y, 2014, FISHERIES SCI, V80, P725, DOI 10.1007/s12562-014-0761-7; Mordy CW, 2010, MAR CHEM, V121, P157, DOI 10.1016/j.marchem.2010.04.004; Takahashi D, 2005, CONT SHELF RES, V25, P1877, DOI 10.1016/j.csr.2005.06.009; Sasaki K, 2001, GEOCHEM J, V35, P295; Kitayama S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004754; Uchida R, 2013, J GEOPHYS RES-OCEANS, V118, P1257, DOI [1002/jgrc.20097, 10.1002/jgrc.20097]; Severmann S, 2010, GEOCHIM COSMOCHIM AC, V74, P3984, DOI 10.1016/j.gca.2010.04.022; Horak REA, 2013, DEEP-SEA RES PT II, V94, P95, DOI 10.1016/j.dsr2.2013.03.014; Homoky WB, 2012, MAR CHEM, V134, P59, DOI 10.1016/j.marchem.2012.03.003; DeVries T, 2014, NAT GEOSCI, V7, P890, DOI 10.1038/NGEO2300; Moore JK, 2008, BIOGEOSCIENCES, V5, P631; Yoshimura T, 2011, MAR CHEM, V126, P182, DOI 10.1016/j.marchem.2011.06.003; Kuma K, 2014, J OCEANOGR, V70, P377, DOI 10.1007/s10872-014-0239-3; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; STIGLIANI WM, 1988, ENVIRON MONIT ASSESS, V10, P245, DOI 10.1007/BF00395083; Kudo I, 2007, J OCEANOGR, V63, P791, DOI 10.1007/s10872-007-0067-9; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Lohan MC, 2008, ENVIRON SCI TECHNOL, V42, P6462, DOI 10.1021/es800144j; Kuma K, 1996, LIMNOL OCEANOGR, V41, P396; WATANABE Y, 1984, MAR CHEM, V15, P71, DOI 10.1016/0304-4203(84)90039-2; DEVOL AH, 1978, DEEP-SEA RES, V25, P137, DOI 10.1016/0146-6291(78)90001-2; MOPPER K, 1993, MAR CHEM, V41, P229, DOI 10.1016/0304-4203(93)90124-7; Bruland KW, 2001, BIOGEOCHEMISTRY IRON, P255; Hansen HP, 1999, METHODS SEAWATER ANA, P75, DOI DOI 10.1002/9783527613984.CH4; Hasegawa N, 1997, UMI SORA, V73, P113; HAYASE K, 1995, MAR CHEM, V48, P283, DOI 10.1016/0304-4203(94)00051-E; Hioki N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06775; Homoky WB, 2012, GEOLOGY, V37, P751; JOHNSON K. S, 2007, EOS T AGU, V88, P131, DOI [10.1029/2007EO110003, DOI 10.1029/2007E0110003]; Kudo I, 1999, J OCEANOGR, V55, P505, DOI 10.1023/A:1007887307322; MAITA Y, 1988, Journal of the Oceanographical Society of Japan, V44, P268, DOI 10.1007/BF02302569; Miyake Hideo, 1998, Memoirs of the Faculty of Fisheries Hokkaido University, V45, P36; Ohtani K, 1970, B FACULTY FISHERIES, V20, P303; OHTANI K, 1980, Bulletin of the Faculty of Fisheries Hokkaido University, V31, P84; Ohtani K, 1971, B FAC FISH HOKKAIDO, V22, P58; Parsons TR, 1984, MANUAL CHEM BIOL MET; Shinada Akiyoshi, 1999, Plankton Biology and Ecology, V46, P24; Tanaka K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05292	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2015	71	6					703	714		10.1007/s10872-015-0312-6		12	Oceanography	Oceanography	CX7IC	WOS:000365874400005		
J	Urakawa, LS; Kurogi, M; Yoshimura, K; Hasumi, H				Urakawa, L. Shogo; Kurogi, Masao; Yoshimura, Kei; Hasumi, Hiroyasu			Modeling low salinity waters along the coast around Japan using a high-resolution river discharge dataset	JOURNAL OF OCEANOGRAPHY			English	Article						River runoff; low salinity waters; coastal modeling; two-way nested-grid model system; ocean general circulation model	RECIRCULATING BULGE REGION; BUOYANT OUTFLOWS; OCEAN MODELS; SIMULATIONS; TRANSPORT; PLUME; ICE	The effect of river runoff on the salinity distribution in the coastal regions of Japan is investigated with a nested-grid model system. High-resolution river runoff data calculated by a hydrological cycle model are used in this study. Freshwater fluxes from rivers result in extremely low salinity waters along the coast of Japan. Fixed line observations conducted by prefectural fisheries research institutes show that such low salinity waters also exist in the real ocean. The use of the river runoff data noted above leads to reduction in root mean square errors (RMSEs) of sea surface salinity between observational data and the model result. The model experiments also show that freshwater inputs from large rivers can affect the salinity distribution far away from their mouths, which suggests that we should care about such rivers far away from the area of interest as well as local rivers. The experiment with runoff from non-Class-A rivers shows the smaller RMSE than the experiment without river runoff. Such small rivers also contribute a lot to improving reproducibility of the salinity distribution in the coastal areas. These results clearly show that precise data for river discharge are essential for realistic coastal modeling.	[Urakawa, L. Shogo; Yoshimura, Kei; Hasumi, Hiroyasu] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Kurogi, Masao] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan	Urakawa, LS (reprint author), Meteorol Res Inst, Oceanog & Geochem Res Dept, Tsukuba, Ibaraki 3050052, Japan.	surakawa@mri-jma.go.jp	Yoshimura, Kei/F-2041-2010		Tohoku Ecosystem-Associated Marine Sciences from Ministry of Education, Culture, Sports, Science, and Technology of Japan	The authors appreciate thoughtful and constructive comments from two anonymous reviewers, which significantly improve the quality of this paper. This study is supported by Tohoku Ecosystem-Associated Marine Sciences from Ministry of Education, Culture, Sports, Science, and Technology of Japan. The numerical experiments are conducted using the Fujitsu PRIMEHPC FX10 System (Oakleaf-FX, Oakbridge) in the Information Technology Center, the University of Tokyo. Authors would like to express heartfelt respects and gratitude to all public research institutes, including two institutes and one center cited in the text, which manage fixed line observation in the coastal regions of Japan.	Noh Y, 1999, J GEOPHYS RES-OCEANS, V104, P15621, DOI 10.1029/1999JC900068; Oki T, 1999, J METEOROL SOC JPN, V77, P235; Cherubin LM, 2014, PROG OCEANOGR, V127, P21, DOI 10.1016/j.pocean.2014.05.006; Ishizaki H, 1999, J ATMOS OCEAN TECH, V16, P1994, DOI 10.1175/1520-0426(1999)016<1994:ROTTOS>2.0.CO;2; Griffies SM, 2000, MON WEATHER REV, V128, P2935, DOI 10.1175/1520-0493(2000)128<2935:BFWASL>2.0.CO;2; Takikawa T, 2005, J PHYS OCEANOGR, V35, P1154, DOI 10.1175/JPO2742.1; Garvine RW, 2001, J MAR RES, V59, P193, DOI 10.1357/002224001762882637; Miyazawa Y, 2013, BIOGEOSCIENCES, V10, P2349, DOI 10.5194/bg-10-2349-2013; Yankovsky AE, 1997, J PHYS OCEANOGR, V27, P1386, DOI 10.1175/1520-0485(1997)027<1386:ASTFTF>2.0.CO;2; Avicola G, 2003, J MAR RES, V61, P411, DOI 10.1357/002224003322384870; Tsujino H, 2011, J OCEANOGR, V67, P449, DOI 10.1007/s10872-011-0050-3; Avicola G, 2003, J MAR RES, V61, P435, DOI 10.1357/002224003322384889; Yoshimura K, 2006, GLOBAL PLANET CHANGE, V51, P90, DOI 10.1016/j.gloplacha.2005.12.007; Miyazawa Y, 2012, OCEAN DYNAM, V62, P645, DOI 10.1007/s10236-011-0516-2; Whitney MM, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2003JC002261; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; Hickey BM, 1998, J GEOPHYS RES-OCEANS, V103, P10339, DOI 10.1029/97JC03290; Taniguchi M, 2002, HYDROL PROCESS, V16, P2115, DOI 10.1002/hyp.1145; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021880; Griffies SM, 2014, OCEAN MODEL, V78, P35, DOI 10.1016/j.ocemod.2014.03.004; Fong DA, 2002, J PHYS OCEANOGR, V32, P957, DOI 10.1175/1520-0485(2002)032<0957:TATOFI>2.0.CO;2; ROACH AT, 1995, J GEOPHYS RES-OCEANS, V100, P18443, DOI 10.1029/95JC01673; Komuro Y, 2012, J METEOROL SOC JPN, V90A, P213, DOI 10.2151/jmsj.2012-A11; Kurogi M, 2013, J GEOPHYS RES-OCEANS, V118, P1182, DOI 10.1002/jgrc.20123; Whitney MM, 2006, J PHYS OCEANOGR, V36, P3, DOI 10.1175/JPO2805.1; Antonov JI, 2010, NOAA ATLAS NESDIS 69, V2, P184; Danabasoglu G, 2014, OCEAN MODEL, V73, P76, DOI 10.1016/j.ocemod.2013.10.005; Hasumi H, 2006, 25 CCSR U TOK; Kurapov AL, 2011, J GEOPHYS RES, V116, P006; Large WG, 2004, TN460 STR NCAR; Leonard B, 1994, 106679 NASA; LEONARD BP, 1979, COMPUT METHOD APPL M, V19, P59, DOI 10.1016/0045-7825(79)90034-3; Locarnini R.A., 2010, NOAA ATLAS NESDIS, V68, P184; Naganuma Kosuke, 2000, Bulletin of the Japan Sea National Fisheries Research Institute, V50, P1; Nakada S., 2012, HYDROL RES LETT, V6, P47, DOI DOI 10.3178/HRL.6.47; Nishida Y., 2003, OCEANOGR JPN, V12, P487; Taniguchi M, 2000, J JPN SOC HYDROL WAT, V13, P476; Tanioka K, 1962, UMI TO SORA, V38, P90; Uda M, 1934, J IMP FISH EXP STA, V5, P191; Yokouchi Katsumi, 1998, Bulletin of Tohoku National Fisheries Research Institute, V60, P1; Yoshimura K., 2008, HYDROLOGICAL RES LET, V2, P22, DOI DOI 10.3178/HRL.2.22	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2015	71	6					715	739		10.1007/s10872-015-0314-4		25	Oceanography	Oceanography	CX7IC	WOS:000365874400006		
J	Tajima, K; Miyake, T; Koike, N; Hattori, T; Takahashi, H; Matsumoto, T; Fujita, K; Kuroda, M; Ito, N; Goto, H				Tajima, Kazuki; Miyake, Taku; Koike, Naohito; Hattori, Takaaki; Takahashi, Hiroki; Matsumoto, Tetsuya; Fujita, Koji; Kuroda, Masahiko; Ito, Norihiko; Goto, Hiroshi			Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							STAPHYLOCOCCUS-AUREUS KERATITIS; NEGATIVE BACTERIAL-INFECTIONS; CONTACT-LENS; ANTIMICROBIAL RESISTANCE; NOSOCOMIAL PNEUMONIA; CORNEAL ULCERS; RABBIT MODEL; ILL-PATIENTS; COLISTIN; PHARMACODYNAMICS	Purpose: To compare the efficacy of topical 1.5% and 0.5% levofloxacin (LVFX) for the treatment of multidrug-resistant Pseudomonas aeruginosa (MDRP) keratitis in rabbits. Methods: In a rabbit eye, we produced an MDRP keratitis model by excising a 2-mm circular disc of the cornea up to a depth of one-half of the stromal layer and inoculated an MDRP strain into the corneal concavity. Nine hours after inoculation and after confirming that MDRP keratitis had developed, we treated the eyes topically with 0.5% levofloxacin, 1.5% levofloxacin, or phosphate-buffered saline (PBS) every 6h until 57h postinfection. The infected eyes were evaluated by clinical score, histopathological examination, and viable bacterial count (colony forming units). Results: In the MDRP keratitis model, clinical score was significantly lower in 0.5% and 1.5% levofloxacin-treated groups than in PBS-treated group and was the lowest in 1.5% levofloxacin-treated group. Histopathological examination showed maintenance of corneal translucency and little influx of polymorphonuclear neutrophils in 1.5% levofloxacin-treated group. Viable bacterial count in the infected cornea was significantly lower in 0.5% levofloxacin-treated group compared with PBS-treated group, while no viable bacteria were detected in 1.5% levofloxacin-treated group. Conclusions: Using our MDRP keratitis model, we showed that topical 0.5% levofloxacin is not adequately effective, while 1.5% levofloxacin is efficacious in controlling MDRP keratitis.	[Tajima, Kazuki; Miyake, Taku; Hattori, Takaaki; Takahashi, Hiroki; Ito, Norihiko; Goto, Hiroshi] Tokyo Med Univ, Dept Ophthalmol, Tokyo 1600023, Japan; [Tajima, Kazuki] Keio Univ, Dept Surg, Tokyo, Japan; [Koike, Naohito; Matsumoto, Tetsuya] Tokyo Med Univ, Dept Microbiol, Tokyo 1600023, Japan; [Fujita, Koji; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1600023, Japan; [Ito, Norihiko] Tottori Univ, Univ Vet Med Ctr, Tottori 680, Japan	Tajima, K (reprint author), Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	tajima-k@hotmail.co.jp					Tajima K, 2013, VET OPHTHALMOL, V16, P240, DOI 10.1111/j.1463-5224.2012.01066.x; Prokosch V, 2012, GRAEF ARCH CLIN EXP, V250, P369, DOI 10.1007/s00417-011-1722-9; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; DRUSANO GL, 1993, ANTIMICROB AGENTS CH, V37, P483; Tajima K, 2014, J INFECT CHEMOTHER, V20, P343, DOI 10.1016/j.jiac.2013.10.015; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; JOHNSON MK, 1990, CURR EYE RES, V9, P1107, DOI 10.3109/02713689008997584; Andes D, 2002, ANTIMICROB AGENTS CH, V46, P1665, DOI 10.1128/AAC.46.6.1665-1670.2002; Drusano GL, 2004, J INFECT DIS, V189, P1590, DOI 10.1086/383320; CALLEGAN MC, 1992, INVEST OPHTH VIS SCI, V33, P3017; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Jain R, 2014, CORNEA, V33, P22, DOI 10.1097/ICO.0000000000000011; Cavanagh HD, 2010, CORNEA, V29, P1075, DOI 10.1097/ICO.0b013e3181d103bb; Keklikci U, 2008, JPN J OPHTHALMOL, V52, P357, DOI 10.1007/s10384-008-0577-z; Bukholm G, 2002, INFECT CONT HOSP EP, V23, P441, DOI 10.1086/502082; Aoki N, 2009, J ANTIMICROB CHEMOTH, V63, P534, DOI 10.1093/jac/dkn530; Yildiz EH, 2012, CORNEA, V31, P1097, DOI 10.1097/ICO.0b013e318221cee0; Dajcs JJ, 2000, INVEST OPHTH VIS SCI, V41, P1432; Cho YS, 2012, INFECTION, V40, P27, DOI 10.1007/s15010-011-0192-7; Schreiber W, 2003, INVEST OPHTH VIS SCI, V44, P2634, DOI 10.1167/iovs.02-1135; Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001; Lee SK, 2012, CLIN EXP OTORHINOLAR, V5, P17, DOI 10.3342/ceo.2012.5.1.17; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; FORREST A, 1993, ANTIMICROB AGENTS CH, V37, P1073; Romanowski EG, 2005, AM J OPHTHALMOL, V139, P867, DOI 10.1016/j.ajo.2005.01.021; Douglas MW, 2001, BURNS, V27, P131, DOI 10.1016/S0305-4179(00)00084-X; Walters T, 2010, CORNEA, V29, P263, DOI 10.1097/ICO.0b013e3181b55fce; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Kouda S, 2011, INFECTION, V39, P247, DOI 10.1007/s15010-011-0111-y; Michalopoulos AS, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-30; Naesens R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-317; Wei C, 2014, INVEST OPHTH VIS SCI, V55, P5890, DOI 10.1167/iovs.14-14235	32	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	DEC 1	2015	31	10					636	641		10.1089/jop.2015.0026		6	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	CX4TZ	WOS:000365694500009		
J	Park, J; Bain, P; Kusumi, T				Park, Joonha; Bain, Paul; Kusumi, Takashi			Nuclear Power and Japan's Collective Future: Understanding Beliefs About How Nuclear Policies Will Affect Society	JOURNAL OF PACIFIC RIM PSYCHOLOGY			English	Article						nuclear plants; Japan; collective future; beliefs about future society	PERCEIVED RISKS; CLIMATE-CHANGE; COMPETENCE; ACCEPTANCE; DIMENSIONS; ENERGY; PERCEPTIONS; ATTITUDES; ACCIDENT; WARMTH	Despite ongoing controversies regarding possible directions for the nuclear plants program throughout Japan since the Fukushima disaster, little has been researched about people's belief structure about future society and what may affect their attitudes toward different policy options. Beyond policy debates, the present study focused on how people see a future society according to the assumptions of different policy options. A total of 125 students at Japanese universities were asked to compare a future society with society today in which one of alternative policies was adopted (i.e., shutdown or expansion of nuclear reactors) in terms of characteristics of individuals and society in general. While perceived dangerousness of nuclear power predicted attitudes and behavioural intentions to make personal sacrifices for nuclear power policies, beliefs about the social consequences of the policies, especially on economic development and dysfunction, appeared to play stronger roles in predicting those measures. The importance of sociological dimensions in understanding how people perceive the future of society regarding alternative nuclear power policies, and the subtle discrepancies between attitudes and behavioural intentions, are discussed.	[Park, Joonha] Nagoya Univ Commerce & Business, Fac Commun, Nisshin, Japan; [Bain, Paul] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Kusumi, Takashi] Kyoto Univ, Grad Sch Educ, Kyoto, Japan	Park, J (reprint author), Nagoya Univ Commerce & Business, Fac Commun, Nagoya, Aichi, Japan.	jpark@nucba.ac.jp					Siegrist M, 2013, ENERG POLICY, V59, P112, DOI 10.1016/j.enpol.2012.07.051; HUGHEY JB, 1988, J APPL SOC PSYCHOL, V18, P880, DOI 10.1111/j.1559-1816.1988.tb01181.x; Butler C, 2011, ENVIRONMENT, V53, P3, DOI 10.1080/00139157.2011.623051; VANDERPLIGT J, 1984, ENERG POLICY, V12, P302, DOI 10.1016/0301-4215(84)90033-8; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; de Groot JIM, 2013, RISK ANAL, V33, P307, DOI 10.1111/j.1539-6924.2012.01845.x; Judd CM, 2005, J PERS SOC PSYCHOL, V89, P899, DOI 10.1037/0022-3514.89.6.899; Whitfield SC, 2009, RISK ANAL, V29, P425, DOI 10.1111/j.1539-6924.2008.01155.x; Bickerstaff K, 2008, PUBLIC UNDERST SCI, V17, P145, DOI 10.1177/0963662506066719; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; Pidgeon NF, 2008, GLOBAL ENVIRON CHANG, V18, P69, DOI 10.1016/j.gloenvcha.2007.09.005; MCDANIELS TL, 1988, RISK ANAL, V8, P457, DOI 10.1111/j.1539-6924.1988.tb00509.x; Bain PG, 2013, PERS SOC PSYCHOL B, V39, P523, DOI 10.1177/0146167213478200; Ajzen I, 2004, PERS SOC PSYCHOL B, V30, P1108, DOI 10.1177/0146167204264079; Bain P.G., 2015, NATURE CLIMATE CHANG, DOI [10.1038/nclimate2814, DOI 10.1038/NCLIMATE2814]; Bain P.G., 2012, NATURE CLIMATE CHANG; Chomsky N., 1999, RESONANCE, V4, P86, DOI 10.1007/BF02838732; DROTTZSJOBERG BM, 1990, J ENVIRON PSYCHOL, V10, P135, DOI 10.1016/S0272-4944(05)80124-0; Kovacs P., 2010, PUBLIC ATTITUDES NUC; Maniates M., 2010, ENV POLITICS SACRIFI, P313; Milfont T.L., 2014, PSICO, V45, P359; Park J., 2013, AS ASS SOC PSYCH YOG; Poortinga W., 2003, TECHNICAL REPORT; Prati G., 2012, ENVIRON BEHAV, V45, P782; Visschers VHM, 2013, RISK ANAL, V33, P333, DOI 10.1111/j.1539-6924.2012.01861.x	25	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1834-4909			J PAC RIM PSYCHOL	J. Pac. Rim Psychol.	DEC	2015	9	2			SI		78	85		10.1017/prp.2015.9		8	Psychology, Multidisciplinary	Psychology	CX6IP	WOS:000365804700004		
J	Wada, S; Shimizu, K; Inoguchi, H; Shimoda, H; Yoshiuchi, K; Akechi, T; Uchida, M; Ogawa, A; Fujisawa, D; Inoue, S; Uchitomi, Y; Matsushima, E				Wada, Saho; Shimizu, Ken; Inoguchi, Hironobu; Shimoda, Haruki; Yoshiuchi, Kazuhiro; Akechi, Tatsuo; Uchida, Megumi; Ogawa, Asao; Fujisawa, Daisuke; Inoue, Shinichirou; Uchitomi, Yosuke; Matsushima, Eisuke			The Association Between Depressive Symptoms and Age in Cancer Patients: A Multicenter Cross-Sectional Study	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Age; cancer; depression; oncology; somatic symptoms	COOPERATIVE-ONCOLOGY-GROUP; BREAST-CANCER; MENTAL-HEALTH; LUNG-CANCER; OLDER; PREVALENCE; ANXIETY; ADULTS; LIFE; SEVERITY	Context. There is controversy around the association between depressive symptoms and age in adult cancer patients. Objectives. The aim of this study was to evaluate the following hypotheses: 1) cancer patients' depressive symptoms decrease with age, and 2) in individuals aged 65 years or older, depressive symptoms increase because of the effect of somatic symptoms. Methods. We retrospectively analyzed a database of 356 cancer patients who were consecutively recruited in a previous multicenter cross-sectional study. Depressive symptoms were assessed by the Patient Health Questionnaire-9 (PHQ-9), and correlations with age and other factors were assessed by hierarchical multivariate regression analysis. Age was entered as the dependent variable in the first step, patient characteristics and cancer-related variables were entered in the second step, and somatic symptoms were entered in the last step. We analyzed this model for both the total sample and the subpopulation aged 65 years or older. Results. In the total sample, the PHQ-9score was significantly associated with lower age, fatigue, and shortness of breath(adjusted R-2 14.2%). In the subpopulation aged 65 years or older, no factor was associated with the PHQ-9 score (adjusted R-2 7.3%). Conclusion. The finding that depressive symptoms in cancer patients decreased with age was concordant with our first hypothesis, but the second hypothesis was not supported. Younger cancer patients were vulnerable to depressive symptoms and should be monitored carefully. Further studies using more representative samples are needed to examine in detail the association between depressive symptoms and age in older cancer patients. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Wada, Saho; Shimizu, Ken; Inoguchi, Hironobu] Natl Canc Ctr, Dept Psychooncol, Chuo Ku, Tokyo, Japan; [Wada, Saho; Matsushima, Eisuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Liaison Psychiat & Palliat Med, Bunkyo Ku, Tokyo, Japan; [Shimoda, Haruki] Univ Tokyo, Dept Mental Hlth, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Yoshiuchi, Kazuhiro] Univ Tokyo, Grad Sch Med, Dept Stress Sci & Psychosomat Med, Bunkyo Ku, Tokyo, Japan; [Shimoda, Haruki] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Mental Hlth Policy & Evaluat, Kodaira, Tokyo, Japan; [Akechi, Tatsuo] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan; [Akechi, Tatsuo; Uchida, Megumi] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan; [Ogawa, Asao; Fujisawa, Daisuke] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Psychooncol, Kashiwa, Chiba, Japan; [Ogawa, Asao; Fujisawa, Daisuke] Natl Canc Ctr Hosp East, Dept Psychooncol Serv, Kashiwa, Chiba, Japan; [Inoue, Shinichirou] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama, Okayama, Japan; [Uchitomi, Yosuke] Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tokyo 104, Japan	Shimizu, K (reprint author), Natl Canc Ctr, Dept Psychooncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo, Japan.	keshimiz@ncc.go.jp			Japanese Ministry of Health, Labour and Welfare [H22-033]	This work was supported in part by a Grant-in-Aid in Cancer Research, Clinical Cancer Research (grant number H22-033 to Dr. Shimizu), from the Japanese Ministry of Health, Labour and Welfare. The authors certify that they have no affiliations with or involvement in any organization or entity with any financial or nonfinancial interest in the subject matter or materials discussed in this manuscript. The authors declare no conflicts of interest.	Ahles TA, 2014, PSYCHO-ONCOLOGY, V23, P1382, DOI 10.1002/pon.3545; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Andreas S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-62; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Bouchardy C, 2007, J CLIN ONCOL, V25, P1858, DOI 10.1200/JCO.2006.10.4208; Giacalone A, 2013, SUPPORT CARE CANCER, V21, P2899, DOI 10.1007/s00520-013-1897-1; Walker J, 2008, J CLIN ONCOL, V26, P4725, DOI 10.1200/JCO.2007.11.8844; Dotan E, 2012, J NATL COMPR CANC NE, V10, P213; Kluthcovsky ACGC, 2012, SUPPORT CARE CANCER, V20, P1901, DOI 10.1007/s00520-011-1293-7; Bardwell WA, 2006, J CLIN ONCOL, V24, P2420, DOI 10.1200/JCO.2005.02.0081; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Sutin AR, 2013, JAMA PSYCHIAT, V70, P803, DOI 10.1001/jamapsychiatry.2013.193; Okuyama T, 2003, J PAIN SYMPTOM MANAG, V26, P1093, DOI 10.1016/j.jpainsymman.2003.05.003; Weir HK, 2003, J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Pallis AG, 2010, EUR J CANCER, V46, P1502, DOI 10.1016/j.ejca.2010.02.022; Reilly CM, 2013, SUPPORT CARE CANCER, V21, P1525, DOI 10.1007/s00520-012-1688-0; Nelson CJ, 2009, ONCOLOGIST, V14, P891, DOI 10.1634/theoncologist.2009-0059; Chang JA, 2009, SUPPORT CARE CANCER, V17, P1285, DOI 10.1007/s00520-009-0583-9; Avis NE, 2013, BREAST CANCER RES TR, V139, P199, DOI 10.1007/s10549-013-2513-2; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Walker J, 2013, ANN ONCOL, V24, P895, DOI 10.1093/annonc/mds575; Lange M, 2014, CANCER TREAT REV, V40, P810, DOI 10.1016/j.ctrv.2014.03.003; van der Lee ML, 2005, J CLIN ONCOL, V23, P6607, DOI 10.1200/JCO.2005.14.308; Kim JEE, 2009, J PAIN SYMPTOM MANAG, V37, P715, DOI 10.1016/j.jpainsymman.2008.04.018; Pan HH, 2012, EUR J ONCOL NURS, V16, P345, DOI 10.1016/j.ejon.2011.07.011; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23; Bunce D, 2012, J PSYCHIATR RES, V46, P1662, DOI 10.1016/j.jpsychires.2012.08.023; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Stommel M, 2004, HEALTH PSYCHOL, V23, P564, DOI 10.1037/0278-6133.23.6.564; Yancik R, 2004, SEMIN ONCOL, V31, P128, DOI 10.1053/j.seminoncol.2003.12.024; Lo C, 2010, J CLIN ONCOL, V28, P3084, DOI 10.1200/JCO.2009.26.9712; Shimizu K, 2012, ANN ONCOL, V23, P1973, DOI 10.1093/annonc/mds061; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Blank TO, 2008, CANCER-AM CANCER SOC, V112, P2569, DOI [10.1002/cncr.23444, 10.1002/cncr23444]; Cataldo JK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-6; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P4333, DOI 10.1002/cncr.28376; Cohen M, 2014, PSYCHO-ONCOLOGY, V23, P151, DOI 10.1002/pon.3383; Deshields T, 2006, PSYCHO-ONCOL, V15, P398, DOI 10.1002/pon.962; Ferrari AJ, 2013, PLOS MED, V11, P1; Fiske A, 2003, J GERONTOL B-PSYCHOL, V58, P320; Jolly TA, 2015, ONCOLOGIST, V20, P379, DOI 10.1634/theoncologist.2014-0247; Jonge P, 2006, PSYCHOSOMATICS, V47, P33; Mimura C, 2011, SHEISHINIGAKU, V53, P15; Mojtabai R, 2014, J AFFECT DISORD C, V174C, P556; Mystakidou K, 2015, PSYCHO-ONCOLOGY, V24, P311, DOI 10.1002/pon.3642; Parpa E, 2015, ARCH GERONTOL GERIAT, V60, P9, DOI 10.1016/j.archger.2014.09.008; Rao A, 2004, J NATL CANC I MONOGR, P150; Ravi P, 2014, UROL ONCOL-SEMIN ORI, V32, P1333, DOI 10.1016/j.urolonc.2014.05.005; Rodin G, 2007, PSYCHO-ONCOL, V16, P1080, DOI 10.1002/pon.1186; Rooney AG, 2013, J NEURO-ONCOL, V113, P49, DOI 10.1007/s11060-013-1088-4; Scheffold K, 2014, EUR J CANCER CARE, V23, P472, DOI 10.1111/ecc.12152; Trask Peter C, 2004, J Natl Cancer Inst Monogr, P80; Vehling S, 2014, PSYCHO-ONCOLOGY, V23, P283, DOI [10.1002/pon.3417, 10.1002/pon.3415]; Wefel JS, 2010, CANCER-AM CANCER SOC, V116, P3348, DOI 10.1002/cncr.25098	56	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	DEC	2015	50	6					768	777		10.1016/j.jpainsymman.2015.07.011		10	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CX7OH	WOS:000365891100004		
J	Natori, Y; Yoshizawa, H; Mizuno, H; Hayashi, A				Natori, Yuhei; Yoshizawa, Hidekazu; Mizuno, Hiroshi; Hayashi, Ayato			Preoperative transcutaneous electrical nerve stimulation for localizing superficial nerve paths	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Pen-type TENS; Tumor resection; Peripheral nerve; Nerve injury; Nerve path	PERCUTANEOUS ELECTRODE GUIDANCE; FACIAL-NERVE; PERIPHERAL-NERVES; REGIONAL ANESTHESIA; BRACHIAL-PLEXUS; 7 TESLA; PRELOCATION; BLOCK; MRI	During surgery, peripheral nerves are often seen to follow unpredictable paths because of previous surgeries and/or compression caused by a tumor. Iatrogenic nerve injury is a serious complication that must be avoided, and preoperative evaluation of nerve paths is important for preventing it. In this study, transcutaneous electrical nerve stimulation (TENS) was used for an in-depth analysis of peripheral nerve paths. This study included 27 patients who underwent the TENS procedure to evaluate the peripheral nerve path (17 males and 10 females; mean age: 59.9 years, range: 18-83 years) of each patient preoperatively. An electrode pen coupled to an electrical nerve stimulator was used for superficial nerve mapping. The TENS procedure was performed on patients' major peripheral nerves that passed close to the surgical field of tumor resection or trauma surgery, and intraoperative damage to those nerves was apprehensive. The paths of the target nerve were detected in most patients preoperatively. The nerve paths of 26 patients were precisely under the markings drawn preoperatively. The nerve path of one patient substantially differed from the preoperative markings with numbness at the surgical region. During surgery, the nerve paths could be accurately mapped preoperatively using the TENS procedure as confirmed by direct visualization of the nerve. This stimulation device is easy to use and offers highly accurate mapping of nerves for surgical planning without major complications. The authors conclude that TENS is a useful tool for noninvasive nerve localization and makes tumor resection a safe and smooth procedure. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Natori, Yuhei; Yoshizawa, Hidekazu; Mizuno, Hiroshi; Hayashi, Ayato] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138421, Japan	Hayashi, A (reprint author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ayhayasi@juntendo.ac.jp					Khan R, 2001, J BONE JOINT SURG BR, V83B, P1145, DOI 10.1302/0301-620X.83B8.12251; Christ S, 2012, ANESTH ANALG, V114, P1128, DOI 10.1213/ANE.0b013e3182468cc1; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; LAGRANGE PDP, 1978, BRIT J ANAESTH, V50, P965; Capdevila X, 2004, REGION ANESTH PAIN M, V29, P206, DOI 10.1016/j.rapm.2004.02.004; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; TERESI L, 1987, AM J ROENTGENOL, V148, P589; THIBAULT F, 1993, RADIOLOGY, V188, P701; Ishibashi M, 2010, NEURORADIOLOGY, V52, P1037, DOI 10.1007/s00234-010-0718-1; Urmey WF, 2002, REGION ANESTH PAIN M, V27, P261, DOI 10.1053/rapm.2002.31211; KAPRAL S, 1994, ANESTH ANALG, V78, P507; TERESI LM, 1987, AM J ROENTGENOL, V148, P995; Gray AT, 2006, ANESTHESIOLOGY, V104, P368, DOI 10.1097/00000542-200602000-00024; Agarwal CA, 2010, PLAST RECONSTR SURG, V125, P532, DOI 10.1097/PRS.0b013e3181c82e9d; Gregor K, 2015, MUSCLE NERVE, V51, P338; Keita F, 2013, PAIN CLINIC, V34, P343; Meisei T, 2003, J JPN SOC CRANIO MAX, V19, P220; Silva Paula Fabiana Sobral da, 2010, Arq Neuropsiquiatr, V68, P619, DOI 10.1590/S0004-282X2010000400026; Takehiko T, 2009, NEUROIMAGE, V44, P884; Tobias L, 2014, EXP EYE RES, V125, P89; Tomoki N, 2010, ANESTH RESUSC, V46, P23; van Egmond SL, 2014, OTOL NEUROTOL, V35, P725, DOI 10.1097/MAO.0000000000000276; Yosuke U, 2011, PAIN CLINIC, V32, P365	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	DEC	2015	68	12					1713	1718		10.1016/j.bjps.2015.08.018		6	Surgery	Surgery	CX7OA	WOS:000365890300021		
J	Hayashi, A; Komoto, M; Tanaka, R; Natori, Y; Matsumura, T; Horiguchi, M; Matsuda, N; Yoshizawa, H; Mizuno, H				Hayashi, Ayato; Komoto, Masakazu; Tanaka, Rica; Natori, Yuhei; Matsumura, Takashi; Horiguchi, Masatoshi; Matsuda, Norifumi; Yoshizawa, Hidekazu; Mizuno, Hiroshi			The availability of perifascial areolar tissue graft for deep cutaneous ulcer coverage	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Perifascial areolar tissue; Vacuum-assisted closure; Ulcer; Bone exposure; Tendon exposure; Deep cutaneous ulcer	VACUUM-ASSISTED-CLOSURE; ARTIFICIAL DERMIS; EXPOSED BONE; WOUNDS; SURGERY; DEFECTS	Soft tissue defects or skin ulcers associated with tendon or bone exposure located distally on the extremities are always difficult to treat. The introduction of the vacuum-assisted closure (VAC) and dermal templates has led to major changes in ulcer treatment strategies. However, it is necessary to find an alternative method to treat these defects when VAC is not available. Perifascial areolar tissue (PAT) is the loose connective tissue on the deep fascia that could be a candidate for repairing soft tissue defects or skin ulcers. Grafting PAT on the exposed bone or tendon, including a wide coverage of well-vascularized tissue surrounding the granulation tissue, can prepare the wound to be subsequently closed by a skin graft. In this study, the PAT was used in various situations and its optimal usage and outcomes were evaluated. A total of 13 PAT grafts were performed and were especially useful for covering narrow ulcers with narrow tendon exposure and filling fistula areas. In comparison to other cases, covering the exposed cortical bone ulcers seemed to be more difficult to perform. However, an option for these ulcers could be the exposure of bone marrow and usage of intraosseous blood flow. It was also possible for the simultaneous engraftment of PAT and skin in narrow areas and could be an alternative in cases of small concave ulcers or fistulae. The PAT graft is a simple and minimally invasive procedure that can be a good alternative when VAC is not available. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Hayashi, Ayato; Tanaka, Rica; Horiguchi, Masatoshi; Matsuda, Norifumi; Yoshizawa, Hidekazu; Mizuno, Hiroshi] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1138421, Japan; [Komoto, Masakazu; Matsumura, Takashi] Juntendo Univ, Dept Plast & Reconstruct Surg, Sizuoka Hosp, Shizuoka, Japan; [Natori, Yuhei] Kawasakinanbu Hosp, Dept Plast & Reconstruct Surg, Kawasaki, Kanagawa, Japan	Hayashi, A (reprint author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ayhayasi@juntendo.ac.jp					Eo S, 2011, INT WOUND J, V8, P261, DOI 10.1111/j.1742-481X.2011.00780.x; Helgeson MD, 2007, J ORTHOP TRAUMA, V21, P394, DOI 10.1097/BOT.0b013e318070c028; Koizumi T, 2013, J PLAST SURG HAND SU, V47, P276, DOI 10.3109/2000656X.2012.759955; Kang GCW, 2010, ANN PLAS SURG, V65, P70, DOI 10.1097/SAP.0b013e3181a72f77; Moiemen NS, 2001, PLAST RECONSTR SURG, V108, P93, DOI 10.1097/00006534-200107000-00015; Kamisasanuki T, 2014, GRAEF ARCH CLIN EXP, V252, P829, DOI 10.1007/s00417-014-2606-6; Brandi C, 2008, J PLAST RECONSTR AES, V61, P1507, DOI 10.1016/j.bjps.2007.09.036; Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426; Trop M, 2006, J TRAUMA, V61, P1267, DOI 10.1097/01.ta.0000241149.20000.55; DeFranzo AJ, 2001, PLAST RECONSTR SURG, V108, P1184, DOI 10.1097/00006534-200110000-00013; Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002; Hachiya A, 2010, ANN OTO RHINOL LARYN, V119, P707; Iorio ML, 2012, PLAST RECONSTR SURG, V130, p232S, DOI 10.1097/PRS.0b013e3182615703; Kouraba S, 2003, ANZ J SURG, P73; Milcheski Dimas A, 2014, Plast Reconstr Surg Glob Open, V2, pe170, DOI 10.1097/GOX.0000000000000108; Webb Lawrence X, 2002, J Am Acad Orthop Surg, V10, P303	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	DEC	2015	68	12					1743	1749		10.1016/j.bjps.2015.08.008		7	Surgery	Surgery	CX7OA	WOS:000365890300025		
J	Fuse, Y; Yamamoto, T				Fuse, Yuma; Yamamoto, Takumi			Diamond-shaped anastomosis for supermicrosurgical side-to-side lymphaticovenular anastomosis	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter									[Fuse, Yuma; Yamamoto, Takumi] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138654, Japan	Fuse, Y (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138654, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011; SHIOI K, 1984, Nagoya Journal of Medical Science, V46, P19; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, P1573, DOI 10.1016/j.bjps.2014.06.007	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	DEC	2015	68	12					E209	E210		10.1016/j.bjps.2015.08.033		2	Surgery	Surgery	CX7OA	WOS:000365890300008		
J	Oda, Y; Tadokoro, S; Takase, M; Kanahara, N; Watanabe, H; Shirayama, Y; Hashimoto, K; Iyo, M				Oda, Yasunori; Tadokoro, Shigenori; Takase, Masayuki; Kanahara, Nobuhisa; Watanabe, Hiroyuki; Shirayama, Yukihiko; Hashimoto, Kenji; Iyo, Masaomi			G protein-coupled receptor kinase 6/-arrestin 2 system in a rat model of dopamine supersensitivity psychosis	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Antipsychotic; dopamine D2 receptor (DRD2); dopamine; locomotor activity; radioligand binding assay; striatum	BETA-ARRESTIN; TARDIVE-DYSKINESIA; ONSET PSYCHOSIS; ANTIPSYCHOTICS; EXPRESSION; SCHIZOPHRENIA; HALOPERIDOL; ACTIVATION; OCCUPANCY; DISORDER	In humans, long-term antipsychotic treatment is known to induce movement disorders and a psychosis, called dopamine supersensitivity psychosis (DSP). The mechanism by which chronic administration of antipsychotic(s) causes DSP may be the treatment-induced up-regulation of dopamine D-2 receptors (DRD2). G protein-coupled receptor kinase 6 (GRK6) and beta-arrestin 2 (ARRB2) play important roles in the trafficking of DRD2 by phosphorylation and internalization. We investigated the effects of chronic continuous treatment with mini-pump-administered haloperidol (HAL) on the sensitivity of Wistar rats to dopamine, as measured by the locomotor response to methamphetamine (MAP) and the density of striatal DRD2. Chronic continuous treatment with HAL resulted in significantly higher locomotor response to MAP and significantly higher striatal DRD2 density compared with those in rats administered vehicle (VEH). Enzyme-linked immunosorbent assays revealed that striatal ARRB2 in DSP model rats tended to decrease in comparison with that in the VEH group. In addition, the ratio of GRK6/ARRB2 in DSP model rats was significantly higher than that in controls. Our results suggest that alterations of the GRK6 and ARRB2 system could induce both DRD2 up-regulation and impairment of the dopamine signaling pathway, resulting potentially in the development of DSP.	[Oda, Yasunori; Takase, Masayuki; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba 2608670, Japan; [Tadokoro, Shigenori] Shousin Kai Mobara Hosp, Dept Psychiat, Mobara, Japan; [Kanahara, Nobuhisa; Watanabe, Hiroyuki] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehabil, Chiba 2608670, Japan; [Shirayama, Yukihiko] Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Oda, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Psychiat, 1-8-1 Inohana, Chiba 2608670, Japan.	odayasunori@chiba-u.jp			Japan Society for the Promotion of Science (JSPS)	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS).	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Kane JM, 2007, J CLIN PSYCHIAT, V68, P27; [Anonymous], 2011, SCHIZOPHR B; Ahmed MR, 2008, J PHARMACOL EXP THER, V325, P276, DOI 10.1124/jpet.107.131987; Ibrahim IAAEH, 2012, J PHARMACOL SCI, V118, P408, DOI 10.1254/jphs.11R10CP; Inoue A, 1997, EUR J PHARMACOL, V321, P105, DOI 10.1016/S0014-2999(96)00920-X; Seeman P, 2013, PROG NEURO-PSYCHOPH, V46, P146, DOI 10.1016/j.pnpbp.2013.07.006; Ko F, 2006, SYNAPSE, V60, P141, DOI 10.1002/syn.20287; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Chouinard G, 2008, PSYCHOTHER PSYCHOSOM, V77, P69, DOI 10.1159/000112883; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; SEEMAN P, 1984, SCIENCE, V225, P728, DOI 10.1126/science.6147018; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Samaha AN, 2007, J NEUROSCI, V27, P2979, DOI 10.1523/JNEUROSCI.5416-06.2007; Moncrieff J, 2006, ACTA PSYCHIAT SCAND, V114, P3, DOI 10.1111/j.1600-0447.2006.00787.x; Hurle MA, 2001, J NEUROCHEM, V77, P486, DOI 10.1046/j.1471-4159.2001.00268.x; CHOUINARD G, 1986, PSYCHOPHARMACOL BULL, V22, P891; CHOUINARD G, 1991, SCHIZOPHR RES, V5, P21, DOI 10.1016/0920-9964(91)90050-2; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Raehal KM, 2009, DRUG ALCOHOL DEPEN, V104, P187, DOI 10.1016/j.drugalcdep.2009.04.011; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Kimura H, 2014, SCHIZOPHR RES, V155, P52, DOI 10.1016/j.schres.2014.02.022; KOHLER U, 1994, NEUROSCI LETT, V170, P99, DOI 10.1016/0304-3940(94)90248-8; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Seeman P, 2013, EUR NEUROPSYCHOPHARM, V23, P999, DOI 10.1016/j.euroneuro.2013.06.005; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; CHOUINARD G, 1978, AM J PSYCHIAT, V135, P1409; Huang NN, 1997, NEUROCHEM INT, V30, P277, DOI 10.1016/S0197-0186(96)00093-9; Iyo M, 2013, J CLIN PSYCHOPHARM, V33, P398, DOI 10.1097/JCP.0b013e31828ea95c; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; CHOUINARD G, 1988, J CLIN PSYCHOPHARM, V8, pS21; Erdtmann-Vourliotis M, 2001, Brain Res Mol Brain Res, V95, P129; Manago F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00301; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Lefkowitz Robert J, 2005, Science, V308, P512, DOI 10.1126/science.1109237; Watari Kenji, 2014, J Mol Signal, V9, P1, DOI 10.1186/1750-2187-9-1	43	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	DEC	2015	29	12					1308	1313		10.1177/0269881115593903		6	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CX5MC	WOS:000365744800010		
J	Endo, T; Osawa, K; Tatsumi, M; Ninomiya, K; Takahashi, K				Endo, Takatsugu; Osawa, Koji; Tatsumi, Mai; Ninomiya, Kazuaki; Takahashi, Kenji			Transport Properties of Various Ionic Liquids During Electrodialysis	JOURNAL OF SOLUTION CHEMISTRY			English	Article						Ionic liquid; Electrodialysis; Ion transport; Diffusion coefficient	EXCHANGE MEMBRANE; RECOVERY; DENSITY	We have measured changes in ionic liquid (IL) concentrations as functions of time for seven different imidazolium based ILs undergoing electrodialysis (ED). We also measured IL concentrations in the corresponding aqueous solutions, and subsequently estimated IL diffusion coefficients in each medium. All ILs were successfully transported from the aqueous solutions in the ED process; nevertheless, their transport behavior in the membranes differed significantly. Diffusion coefficients in the membranes were several hundred times smaller than those in aqueous solution; moreover, diffusion coefficients in the membranes showed stronger ion size dependence than that predicted by the Stokes-Einstein equation. This dependence was more prominent when the cation size was increased compared to that when the anion size was increased. This behavior can be attributed to the geometry of pores in the membranes. The average pore size in the membranes was estimated to be similar to 4 , which is comparable to the size of IL ions (2-4 ) used here and therefore slows down the ion migration of ILs, particularly the ions with larger ion size. Moreover, it is suggested that the cation exchange membranes have longer permeation paths for ions than the anion exchange membranes, which explains the slower diffusivity of the cation in the ED process.	[Endo, Takatsugu; Osawa, Koji; Tatsumi, Mai; Takahashi, Kenji] Kanazawa Univ, Fac Nat Syst, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Ninomiya, Kazuaki] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan	Takahashi, K (reprint author), Kanazawa Univ, Fac Nat Syst, Inst Sci & Engn, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ktkenji@staff.kanazawa-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) [2100040]; Center of Innovation Program from Japan Science and Technology Agency, JST	This study was supported in part by an Advanced Low Carbon Technology Research and Development Program (ALCA) (Grant number 2100040) and the Center of Innovation Program from Japan Science and Technology Agency, JST.	Himmler S, 2007, GREEN CHEM, V9, P935, DOI 10.1039/b617498a; Maki-Arvela P, 2010, IND CROP PROD, V32, P175, DOI 10.1016/j.indcrop.2010.04.005; Choi JH, 2001, J MEMBRANE SCI, V191, P225, DOI 10.1016/S0376-7388(01)00513-0; Bai L, 2013, SCI CHINA CHEM, V56, P1811, DOI 10.1007/s11426-013-5016-4; Trinh LTP, 2013, SEP PURIF TECHNOL, V120, P86, DOI 10.1016/j.seppur.2013.09.025; WESSELINGH JA, 1995, CHEM ENG J BIOCH ENG, V57, P75, DOI 10.1016/0923-0467(94)02932-6; Mier MP, 2008, SEP PURIF TECHNOL, V59, P197, DOI 10.1016/j.seppur.2007.06.015; Hossain MM, 2012, AUST J CHEM, V65, P1465, DOI 10.1071/CH12324; ITOH H, 1986, J MEMBRANE SCI, V27, P155, DOI 10.1016/S0376-7388(00)82052-9; Abels C, 2013, BIORESOURCE TECHNOL, V149, P58, DOI 10.1016/j.biortech.2013.09.012; Amarasekara AS, 2009, IND ENG CHEM RES, V48, P10152, DOI 10.1021/ie901047u; Meng H, 2008, J MEMBRANE SCI, V318, P1, DOI 10.1016/j.memsci.2008.02.020; Le XT, 2009, J MEMBRANE SCI, V340, P133, DOI 10.1016/j.memsci.2009.05.025; Li H, 2009, DESALINATION, V245, P349, DOI 10.1016/j.desal.2008.06.022; Parsons DF, 2009, J PHYS CHEM A, V113, P1141, DOI 10.1021/jp802984b; Wang XL, 2012, DESALINATION, V285, P205, DOI 10.1016/j.desal.2011.10.003; Meng H, 2011, DESALIN WATER TREAT, V34, P326, DOI 10.5004/dwt.2011.2884; Haerens K, 2012, SEP PURIF TECHNOL, V97, P90, DOI 10.1016/j.seppur.2012.02.017; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Firdaous L., 2005, SCAND C SIM MOD TRON; Frisch M. J., 2010, GAUSSIAN 09; GREGOR H P, 1968, Pure and Applied Chemistry, V16, P329, DOI 10.1351/pac196816020329; Haghighi M. S., 2013, RENEW SUST ENERG REV, V27, P77; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3	25	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0095-9782	1572-8927		J SOLUTION CHEM	J. Solut. Chem.	DEC	2015	44	12					2405	2415		10.1007/s10953-015-0409-y		11	Chemistry, Physical	Chemistry	CX5GJ	WOS:000365729800009		
J	Fujiwara, Y; Manabe, H; Sumida, T; Tanaka, N; Hamasaki, T				Fujiwara, Yasushi; Manabe, Hideki; Sumida, Tadayoshi; Tanaka, Nobuhiro; Hamasaki, Takahiko			Microscopic Posterior Transdural Resection of Cervical Retro-Odontoid Pseudotumors	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						microscopic spine surgery; transdural resection; cervical retro-odontoid pseudotumor	DISC HERNIATION; DISKECTOMY; LAMINOPLASTY	Retro-odontoid pseudotumors are noninflammatory masses formed posterior to the odontoid process. Because of their anatomy, the optimal surgical approach for resecting pseudotumors is controversial. Conventionally, 3 approaches are used: the anterior transoral approach, the lateral approach, and the posterior extradural approach; however, each approach has its limitations. The posterior extradural approach is the most common; however, it remains challenging due to severe epidural veins. Although regression of pseudotumors after fusion surgery has been reported, direct decompression and a pathologic diagnosis are ideal when the pseudotumor is large. We therefore developed a new microscopic surgical technique; transdural resection. After C1 laminectomy, the dorsal and ventral dura was incised while preserving the arachnoid. Removal of the pseudotumor was performed and both of the dura were repaired. The patient's clinical symptoms subsequently improved and the pathologic findings showed degenerative fibrocartilaginous tissue. In addition, no neurological deterioration, central spinal fluid leakage, or arachnoiditis was observed. Currently, the usefulness of the transdural approach has been reported for cervical and thoracic disk herniation. According to our results, the transdural approach is recommended for resection of retro-odontoid pseudotumors because it enables direct decompression of the spinal cord and a pathologic diagnosis.	[Fujiwara, Yasushi; Manabe, Hideki] Hiroshima City Asa Hosp, Dept Orthoped Surg, Asa Kita Ku, Hiroshima 7310293, Japan; [Tanaka, Nobuhiro] Hiroshima Univ, Dept Orthopaed Surg, Inst Biomed & Hlth Sci, Hiroshima 730, Japan	Fujiwara, Y (reprint author), Hiroshima City Asa Hosp, Dept Orthoped Surg, Asa Kita Ku, 2-1-1 Kabe Minami, Hiroshima 7310293, Japan.	ys.fujiwara@nifty.com					Coppes MH, 2012, EUR SPINE J, V21, P623, DOI 10.1007/s00586-011-1990-4; Kakutani K, 2013, EUR SPINE J, V22, P1119, DOI 10.1007/s00586-013-2681-0; Tanaka N, 2013, J NEUROSURG-SPINE, V18, P653, DOI 10.3171/2013.3.SPINE12673; Fujimoto Y, 2002, SPINE, V27, P715, DOI 10.1097/00007632-200204010-00008; Chikuda H, 2009, SPINE, V34, pE110, DOI 10.1097/BRS.0b013e31818acd27; Taylor AS, 1910, ANN SURG, V51, P529, DOI 10.1097/00000658-191004000-00010; FOX MW, 1994, NEUROSURGERY, V34, P634; Fox MW, 1994, NEUROSURGERY, V34, P641	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	DEC	2015	28	10					363	369		10.1097/BSD.0000000000000335		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX5AU	WOS:000365713600003		
J	Hirose, J; Taniwaki, T; Fujimoto, T; Okada, T; Nakamura, T; Usuku, K; Mizuta, H				Hirose, Jun; Taniwaki, Takuya; Fujimoto, Toru; Okada, Tatsuya; Nakamura, Takayuki; Usuku, Koichiro; Mizuta, Hiroshi			Validity of E-PASS System for Postoperative Morbidity of Spinal Surgery	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						spine; surgery; outcome; postoperative morbidity; risk score	STRESS E-PASS; PHYSIOLOGICAL ABILITY; SCORING SYSTEM; LUMBAR SPINE; GASTROINTESTINAL SURGERY; CLINICAL ARTICLE; SURGICAL AUDIT; HIP FRACTURE; COMPLICATIONS; MORTALITY	Study Design:A single-center retrospective cohort study.Objective:To evaluate the ability of the Estimation of Physiologic Ability and Surgical Stress (E-PASS) system to predict postoperative risk in patients scheduled for spinal surgery.Summary of Background Data:The E-PASS system is a surgical audit to predict postoperative morbidity and mortality in general surgery. It is currently not applied in patients with spinal disorders.Methods:The E-PASS system is comprised of a preoperative risk score (PRS), a surgical stress score (SSS), and a comprehensive risk score (CRS). The latter reflects both the PRS and SSS. We calculated the E-PASS scores for 275 consecutive patients who underwent spinal surgery and evaluated the relationship between the incidence of postoperative complications and each score of the E-PASS system and their ability to predict postoperative morbidity.Results:Postoperative complications developed in 31 patients (11.3%). All E-PASS scores were significantly higher in patients with postoperative complications and they were linearly correlated with the overall incidence of postoperative complications. In particular, PRS was correlated with complications at nonsurgical sites and SSS with surgical site complications. The area under the receiver operating characteristic curve (AUC) for PRS and SSS was higher in patients with complications at nonsurgical and surgical sites, respectively. The AUC for CRS exhibited good predictive power for both types of complication.Conclusions:The E-PASS system correctly predicted morbidity. The predictive ability of CRS was good for overall morbidity. The E-PASS system is useful for the accurate prediction of the risk for in-hospital morbidity in individual patients scheduled for spinal surgery.	[Hirose, Jun; Taniwaki, Takuya; Fujimoto, Toru; Okada, Tatsuya; Nakamura, Takayuki; Mizuta, Hiroshi] Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Kumamoto 8608556, Japan; [Usuku, Koichiro] Kumamoto Univ Hosp, Dept Med Informat Sci & Adm Planning, Kumamoto, Japan	Hirose, J (reprint author), Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hirojun-mk@umin.ac.jp					KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Nohara Y, 2004, J ORTHOP SCI, V9, P424, DOI 10.1007/s00776-004-0802-7; Harel R, 2013, J SPINAL DISORD TECH, V26, P183, DOI 10.1097/BSD.0b013e31823db361; Schoenfeld AJ, 2011, J BONE JOINT SURG AM, V93A, P1577, DOI 10.2106/JBJS.J.01048; Tang T, 2007, AM J SURG, V194, P176, DOI 10.1016/j.amjsurg.2006.10.032; DEYO RA, 1992, J BONE JOINT SURG AM, V74A, P536; Okabe H, 2011, J SURG ONCOL, V104, P641, DOI 10.1002/jso.21928; Howe CR, 2011, SPINE, V36, P1397, DOI 10.1097/BRS.0b013e3181f453e2; Campbell PG, 2011, J NEUROSURG-SPINE, V14, P16, DOI 10.3171/2010.9.SPINE10151; Hirose J, 2009, CLIN ORTHOP RELAT R, V467, P3327, DOI 10.1007/s11999-009-0915-6; Prytherch DR, 1998, BRIT J SURG, V85, P1217; Yamashita S, 2004, EUR SURG RES, V36, P249, DOI 10.1159/000078860; Hirose J, 2008, CLIN ORTHOP RELAT R, V466, P2833, DOI 10.1007/s11999-008-0377-2; Hashimoto D, 2010, J HEPATO-BIL-PAN SCI, V17, P132, DOI 10.1007/s00534-009-0116-4; Chen W, 2010, J CLIN NEUROSCI, V17, P567, DOI 10.1016/j.jocn.2009.09.020; Ramesh VJ, 2008, BRIT J NEUROSURG, V22, P275, DOI 10.1080/02688690701784905; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Kadono Y, 2010, J ORTHOP SCI, V15, P162, DOI 10.1007/s00776-009-1448-2; Vaidya R, 2009, SPINE, V34, P495, DOI 10.1097/BRS.0b013e318198c5f2; Patil CG, 2007, CANCER, V110, P625, DOI 10.1002/cncr.22819; Haga Y, 2011, ANN SURG, V253, P194, DOI 10.1097/SLA.0b013e3181f66199; Hashimoto D, 2010, SURG TODAY, V40, P632, DOI 10.1007/s00595-009-4112-8; Hammers R, 2010, J NEUROSURG, V112, P257, DOI 10.3171/2009.6.JNS081235; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Nasser R, 2010, J NEUROSURG-SPINE, V13, P144, DOI 10.3171/2010.3.SPINE09369; Li G, 2008, SPINE, V33, P1250, DOI 10.1097/BRS.0b013e3181714a44; Haga Y, 1999, SURG TODAY, V29, P219; Lee MJ, 2011, SPINE, V36, P1801, DOI 10.1097/BRS.0b013e318219d28d; Oka Y, 2005, WORLD J SURG, V29, P1029, DOI 10.1007/s00268-005-7719-y; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Haga Y, 2004, SURGERY, V135, P586, DOI 10.1016/j.surg.2003.11.012; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Jones HJS, 1999, BRIT J SURG, V86, P149; Raffo CS, 2006, SPINE, V31, P99, DOI 10.1097/01.brs.0000192678.25586.e5; Hirose J, 2008, ARCH ORTHOP TRAUM SU, V128, P1447, DOI 10.1007/s00402-007-0551-0; Rampersaud YR, 2006, SPINE, V31, P1503, DOI 10.1097/01.brs.0000220652.39970.c2; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	DEC	2015	28	10					E595	E600		10.1097/BSD.0000000000000056		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CX5AX	WOS:000365713900008		
J	Ben Ahmed, A; Ben Abdallah, A				Ben Ahmed, Achraf; Ben Abdallah, Abderazek			Hybrid silicon-photonic network-on-chip for future generations of high-performance many-core systems	JOURNAL OF SUPERCOMPUTING			English	Article						Hybrid silicon-photonic NoC; Energy-efficient; Non-blocking photonic switch; Contention-aware; Path configuration	RECONFIGURABLE MULTIRING NETWORK; INTERCONNECTION NETWORKS; ARBITRARY ROTATION; DIGITIZED IMAGES; MULTIPROCESSORS; ARCHITECTURE; ALGORITHM; DESIGN	Photonic networks-on-chip (PNoCs) promise significant advantages over their electronic counterparts. In particular, they offer a potentially disruptive technology solution with fundamentally low power dissipation that remains independent of capacity while providing ultra-high throughput and minimal access latency. In conventional hybrid-PNoC systems, several electrical control functions, such as path setup, acknowledgment and Tear-down are necessary for the end-to-end optical transfer. However, the circuit-switched nature of photonic interconnect directly affects the performance and power characteristics of on-chip communication. In this paper, we propose an energy-efficient and high-throughput hybrid silicon-photonic network-on-chip, named PHENIC, targeted for future generations of high-performance many-core systems. PHENIC is based on a smart contention-aware path-configuration algorithm and an energy-efficient non-blocking optical switch to further exploit the low energy proprieties of the PNoC systems. Through detailed simulation, we demonstrate that the proposed system has a better performance and low energy dissipation compared to conventional hybrid-PNoCs.	[Ben Ahmed, Achraf; Ben Abdallah, Abderazek] Univ Aizu, Grad Sch Comp Sci & Engn, Adapt Syst Lab, Aizu Wakamatsu, Fukushima 9658580, Japan	Ben Ahmed, A (reprint author), Univ Aizu, Grad Sch Comp Sci & Engn, Adapt Syst Lab, Aizu Wakamatsu, Fukushima 9658580, Japan.	achraf26@gmail.com; benab@u-aizu.ac.jp			University of Aizu Competitive Research Funding (CRF) [P-12-2014-2015]	This work is partially supported by the University of Aizu Competitive Research Funding (CRF), Ref. P-12-2014-2015. We wish to thank all anonymous reviewers for providing us useful comments and suggestions.	Adi C A D, 2010, Proceedings 2010 First International Conference on Networking and Computing (ICNC 2010), DOI 10.1109/IC-NC.2010.31; Aggarwal A, 1994, J ACM, V43, P973; Ben Ahmed A, 2014, J PARALLEL DISTR COM, V74, P2229, DOI 10.1016/j.jpdc.2014.01.002; Gu HX, 2009, DES AUT TEST EUROPE, P3; Hendry G, 2011, J PARALLEL DISTR COM, V71, P641, DOI 10.1016/j.jpdc.2010.09.009; BHANDARKAR SM, 1995, INT J PATTERN RECOGN, V9, P201, DOI 10.1142/S0218001495000110; Arabnia HR, 1996, J SUPERCOMPUT, V10, P243, DOI 10.1007/BF00130109; [Anonymous], 2012, P 62 C EL COMP TECHN; Pan Y, 2009, CONF PROC INT SYMP C, P429; Tan XF, 2014, J LIGHTWAVE TECHNOL, V32, P991, DOI 10.1109/JLT.2013.2296145; Morris RW, 2014, IEEE T COMPUT, V63, P243, DOI 10.1109/TC.2012.183; Chan J, 2012, J OPT COMMUN NETW, V4, P189, DOI 10.1364/JOCN.4.000189; Kahng AB, 2012, IEEE T VLSI SYST, V20, P191, DOI 10.1109/TVLSI.2010.2091686; Wang JH, 2013, 2013 IEEE 27TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P1571, DOI 10.1109/WAINA.2013.34; Beausoleil RG, 2008, SYMP HI PER INT, P182; Ye YY, 2013, IEEE T COMPUT AID D, V32, P584, DOI 10.1109/TCAD.2012.2228739; Petracca M, 2008, SYMP HI PER INT, P31; Shacham A, 2008, IEEE T COMPUT, V57, P1246, DOI 10.1109/TC.2008.78; Chan J, 2011, IEEE T COMPUT AID D, V30, P1507, DOI 10.1109/TCAD.2011.2157157; Wani MA, 2003, J SUPERCOMPUT, V25, P43, DOI 10.1023/A:1022804606389; ARABNIA HR, 1987, COMPUT J, V30, P425; BHANDARKAR SM, 1995, J PARALLEL DISTR COM, V24, P107, DOI 10.1006/jpdc.1995.1011; BHANDARKAR SM, 1995, PARALLEL COMPUT, V21, P1783, DOI 10.1016/0167-8191(95)00032-9; Arabnia HR, 1993, P 7 ANN INT HIGH PER, P349; Arabnia HR, 1987, INT J EUROGRAPH ASS, V6, P3, DOI DOI 10.1111/J.1467-8659.1987.TB00340.X; ARABNIA HR, 1990, J PARALLEL DISTR COM, V10, P188, DOI 10.1016/0743-7315(90)90028-N; Arabnia HR, 1995, IEEE P COMP COMM NET, P479; Arabnia HR, 1989, INT J EUROGRAPH ASS, V8, P3, DOI DOI 10.1111/J.1467-8659.1989.TB00448.X; Ben Abdallah A, 2006, P S SCI SOC TECHN, P4; Ben Abdallah A, 2013, MULTICORE SYSTEMS ON; Ben Ahmed A, 2015, IEEE INT C SYST MAN; Ben Ahmed A, 2015, P IEEE WORLD C INF T; Ben Ahmed A, 2015, P IEEE 9 INT S EMB M; Ben Ahmed A., 2013, P 14 INT C SCI TECHN, P1; Ben Ahmed A, 2013, J SUPERCOMPUT, V66-3, P1507; Benini L, 2006, NETWORKS CHIPS TECHN; Chan J, 2010, DES AUT TEST EUR C E, P691; Chen Z.P., 2013, CHINESE CONCRETE J, V10, P10; Hendry G, 2010, P INT C HIGH PERF CO, P1; Hendry Gilbert, 2010, Proceedings of the 18th IEEE Symposium on High Performance Interconnects (HOTI 2010), DOI 10.1109/HOTI.2010.12; Kirman K, 2010, P 15 ED ASPLOS ARCH, P15; Matsutani H, P 15 IEEE INT S HIGH, P367; Mori K, 2010, Proceedings of the 2010 International Conference on Broadband, Wireless Computing, Communication and Applications (BWCCA 2010), DOI 10.1109/BWCCA.2010.51; Pan Y, 2010, INT S HIGH PERF COMP, P1; Pasricha S, 2008, P AS S PAC C DES AUT, P789; Preston K, 2011, C LAS EL CLEO, P1; Shacham A, 2007, P 1 INT S NETW ON CH, P53; Sun C, 2012, P 6 IEEE ACM INT S N, P201; Vantrease D, 2008, P 35 INT S COMP ARCH, P153, DOI DOI 10.1109/ISCA.2008.35; Vantrease Dana, 2009, Proceedings of the 2009 42nd Annual IEEE/ACM International Symposium on Microarchitecture (MICRO 2009), DOI 10.1145/1669112.1669152; Wang H, 2007, P FRONT NAN PLASM; Ye YY, 2013, IEEE INT SYMP CIRC S, P321; Zhang L, 2012, P EUR SOL STAT DEV R, P282; Zhang X, 2010, P DAC 10, P156, DOI 10.1145/1837274.1837314	54	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8542	1573-0484		J SUPERCOMPUT	J. Supercomput.	DEC	2015	71	12					4446	4475		10.1007/s11227-015-1539-0		30	Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CW7NH	WOS:000365185400007		
J	Doi, T; Verghese, J; Shimada, H; Makizako, H; Tsutsumimoto, K; Hotta, R; Nakakubo, S; Suzuki, T				Doi, Takehiko; Verghese, Joe; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho; Suzuki, Takao			Motoric Cognitive Risk Syndrome: Prevalence and Risk Factors in Japanese Seniors	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Gait; cognition; dementia; lifestyle	WHITE-MATTER LESIONS; GERIATRIC DEPRESSION SCALE; OLDER-ADULTS; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; IMPAIRMENT; DEMENTIA; POPULATION; MEMORY; EXERCISE	Objectives: Motoric cognitive syndrome (MCR), a newly described predementia syndrome characterized by cognitive complaints and slow gait, is associated with increased risk of developing dementia. Due to the potential differences in health, behavioral, and lifestyle factors between races that can influence dementia risk, it is important to examine risk factors for MCR in different countries. This study aimed to report the prevalence as well as modifiable factors associated with MCR in Japanese communit-dwelling older adults. Design: A cross-sectional design. Setting: General community. Participants: A total of 9683 older adults (52% women, mean age: 73.6 years) participating in the National Center for Geriatrics and Gerontology Study of Geriatric Syndromes. Measurements: Participants were screened for presence of MCR at baseline. The association of selected modifiable risk factors (medical illness, depressive symptoms, and falls) and lifestyle variables (obesity, physical inactivity, smoking, and alcohol consumption) with MCR was examined using multivariate logistic regression analysis. Results: At cross-section, 619 participants met criteria for MCR, with an overall prevalence 6.4% (95% CI 5.9-6.9). A higher prevalence of MCR was seen with advancing age (P < .001), but there were no sex differences. Diabetes (adjusted odds ratio [OR] 1.47, P = .001), depressive symptoms (OR 3.57, P < .001), and falls (OR 1.45, P < .001) were associated with increased risk of MCR. Among the lifestyle factors, obesity (OR 1.26, P = .018) and physical inactivity (OR 1.57, P < .001) were associated with increased risk of MCR. Conclusion: MCR is common in the elderly Japanese population. The potentially modifiable risk and lifestyle factors identified for MCR should be further studied to develop interventions. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Doi, Takehiko; Makizako, Hyuma; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, Sect Hlth Promot, Obu, Aichi 4748511, Japan; [Doi, Takehiko] Japan Soc Promot Sci, Tokyo, Japan; [Doi, Takehiko; Verghese, Joe] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurol, Bronx, NY USA; [Verghese, Joe] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Shimada, Hiroyuki] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, Obu, Aichi 4748511, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Obu, Aichi 4748511, Japan; [Suzuki, Takao] JF Oberlin Univ, Grad Sch, Dept Gerontol, Tokyo, Japan	Doi, T (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan.	take-d@ncgg.go.jp			Health and Labour Sciences Research grants (Comprehensive Research on Aging and Health); National Center for Geriatrics and Gerontology, Japan [22-16];  [259435];  [23300205];  [15H05369]	This study was funded by Health and Labour Sciences Research grants (Comprehensive Research on Aging and Health); Grant-in-Aid for JSPS Fellows (259435); Grant-in-Aid for Scientific Research (B) (grant number 23300205); Grant-in-Aid for Young Scientists (A) (15H05369), and Research Funding for Longevity Sciences (22-16) from the National Center for Geriatrics and Gerontology, Japan.	Ogama N, 2014, J AM MED DIR ASSOC, V15, P36, DOI 10.1016/j.jamda.2013.11.004; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Liang KY, 2010, ANN NEUROL, V68, P311, DOI 10.1002/ana.22096; van Oijen M, 2007, ALZHEIMERS DEMENT, V3, P92, DOI 10.1016/j.jalz.2007.01.011; Biessels GJ, 2014, LANCET DIABETES ENDO, V2, P246, DOI 10.1016/S2213-8587(13)70088-3; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Zheng JJJ, 2012, J GERONTOL A-BIOL, V67, P1085, DOI 10.1093/gerona/gls063; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Chang KH, 2014, AGE, V36, P967, DOI 10.1007/s11357-013-9608-x; Nakamura K, 2013, PSYCHIAT CLIN NEUROS, V67, P517, DOI 10.1111/pcn.12098; Fujishima M, 2002, ANN NY ACAD SCI, V977, P1; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; Makizako H, 2015, J GERONTOL A-BIOL, V70, P480, DOI 10.1093/gerona/glu136; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Doi T, 2015, GERIATR GERONTOL INT, V15, P1073, DOI 10.1111/ggi.12407; Hajjar I, 2009, J GERONTOL A-BIOL, V64, P994, DOI 10.1093/gerona/glp075; Verghese J, 2014, NEUROLOGY, V83, P2278, DOI 10.1212/WNL.0000000000001084; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Verghese J, 2006, J AM GERIATR SOC, V54, P255, DOI 10.1111/j.1532-5415.2005.00580.x; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7; Zheng JJJ, 2011, STROKE, V42, P2086, DOI 10.1161/STROKEAHA.110.610360; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Iseki K, 2010, NEUROIMAGE, V49, P1659, DOI 10.1016/j.neuroimage.2009.09.023; Meguro K, 2012, PSYCHOGERIATRICS, V12, P226, DOI 10.1111/j.1479-8301.2012.00406.x; Chang T, 2014, PSYCHOGERIATRICS; Daviglus Martha L, 2010, NIH Consens State Sci Statements, V27, P1; Doi T, 2015, EXP GERONTOL, V62, P1, DOI 10.1016/j.exger.2014.12.011; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Shimada H, 2015, GERIATR GERONTOL INT; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483; The Examination Committee for Criteria of Metabolic Syndrome in Japan, 2005, J JPN SOC INTERN MED, V94; Tian Q, 2014, J GERONTOL A-BIOL, V69, P1284, DOI 10.1093/gerona/glt287	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	DEC 1	2015	16	12							UNSP 1103.e21	10.1016/j.jamda.2015.09.003		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CW9RG	WOS:000365335300020		
J	Uemura, K; Shimada, H; Makizako, H; Doi, T; Tsutsumimoto, K; Lee, S; Umegaki, H; Kuzuya, M; Suzuki, T				Uemura, Kazuki; Shimada, Hiroyuki; Makizako, Hyuma; Doi, Takehiko; Tsutsumimoto, Kota; Lee, Sangyoon; Umegaki, Hiroyuki; Kuzuya, Masafumi; Suzuki, Takao			Effects of Mild Cognitive Impairment on the Development of Fear of Falling in Older Adults: A Prospective Cohort Study	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Falls; cognitive decline; risk factors; elderly	ACTIVITY RESTRICTION; ALZHEIMERS-DISEASE; RISK-FACTORS; REDUCE FEAR; PREVALENCE; WOMEN; PEOPLE; PREVENTION; SYMPTOMS; GAIT	Objectives: The aim of this study was to determine whether mild cognitive impairment (MCI) affects the development of fear of falling (FoF) in older adults. Design: Prospective cohort study. Setting: The Obu Study for Health Promotion in the Elderly, Japan. Participants: A total of 1700 community-dwelling people aged 65 years or older without FoF at baseline participated. Measurements: FoF and related variables, such as physical function, self-rated health, depression, and total number of medication doses, were investigated at baseline. Participants also underwent cognitive tests and were divided into cognitive healthy and MCI. Fifteen months after the baseline measurements, we collected information about the status of FoF and fall incidence during the 15-month follow-up. Results: At the 15-month follow-up survey, 452 participants (26.5%) reported the development of FoF. Logistic regression analysis showed that MCI (odds ratio [95% CI] = 1.41 [1.07-1.87]) and a fall incident (3.00 [2.23-4.07]) during follow-up independently predicted the development of FoF, after controlling for demographic factors, physical function, self-rated health, and depression. The odds ratio for the development of FoF in participants with both MCI and a fall incident compared with those without them was 7.34 (4.06-13.3), after controlling for confounding factors. Conclusion: MCI predicts the new onset of FoF in older adults, especially when they have experience with falling. Aside from the risk of falling, it is suggested that individuals with MCI are an at-risk population for FoF and related negative consequences in terms of postfall syndrome. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Uemura, Kazuki] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4668550, Japan; [Shimada, Hiroyuki; Makizako, Hyuma; Doi, Takehiko; Tsutsumimoto, Kota; Lee, Sangyoon] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, Obu, Japan; [Doi, Takehiko] Japan Soc Promot Sci, Tokyo, Japan; [Umegaki, Hiroyuki; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Nagoya, Aichi 4668550, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Obu, Japan	Uemura, K (reprint author), Nagoya Univ, Inst Innovat Future Soc, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	uemura@coi.nagoya-u.ac.jp			Japanese Ministry of Health, Labour, and Welfare [B-3]; National Center for Geriatrics and Gerontology [22-16]	This work was funded by a grant from the Japanese Ministry of Health, Labour, and Welfare (Project for Optimizing Long-Term Care; B-3) and a grant from the National Center for Geriatrics and Gerontology (Research Funding for Longevity Sciences; 22-16).	Apostolova LG, 2008, DEMENT GERIATR COGN, V25, P115, DOI 10.1159/000112509; Murphy SL, 2003, J GERONTOL A-BIOL, V58, P943; Visschedijk J, 2013, J AM MED DIR ASSOC, V14, P218, DOI 10.1016/j.jamda.2012.10.013; Hauer KA, 2011, GERONTOLOGY, V57, P462, DOI 10.1159/000320054; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Uemura K, 2014, MATURITAS, V78, P62, DOI 10.1016/j.maturitas.2014.02.018; Aggarwal NT, 2006, ARCH NEUROL-CHICAGO, V63, P1763, DOI 10.1001/archneur.63.12.1763; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x; Monastero R, 2009, J ALZHEIMERS DIS, V18, P11, DOI 10.3233/JAD-2009-1120; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; James BD, 2011, AM J GERIAT PSYCHIAT, V19, P961, DOI 10.1097/JGP.0b013e318211c219; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Van der Mussele S, 2013, INT J GERIATR PSYCH, V28, P265, DOI 10.1002/gps.3820; Lach HW, 2005, PUBLIC HEALTH NURS, V22, P45, DOI 10.1111/j.0737-1209.2005.22107.x; Howland J, 1998, GERONTOLOGIST, V38, P549; Gallagher D, 2011, INT J GERIATR PSYCH, V26, P166, DOI 10.1002/gps.2509; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Gillespie SM, 2007, J AM MED DIR ASSOC, V8, P307, DOI 10.1016/j.jamda.2007.04.006; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Deshpande N, 2008, J AM GERIATR SOC, V56, P615, DOI 10.1111/j.1532-5415.2007.01639.x; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015; Larson EB, 2006, ANN INTERN MED, V144, P73; Gustafsson TM, 1998, AGE AGEING, V27, P585, DOI 10.1093/ageing/27.5.585; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Austin N, 2007, J AM GERIATR SOC, V55, P1598, DOI 10.1111/j.1532-5415.2007.01317.x; Salkeld G, 2000, BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Ayoubi F, 2015, J AM MED DIR ASSOC, V16, P14, DOI 10.1016/j.jamda.2014.06.020; Legters K, 2002, PHYS THER, V82, P264; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Tennsledt S, 1998, J GERONTOL B-PSYCHOL, V53, pP384	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	DEC 1	2015	16	12							UNSP 1104.e9	10.1016/j.jamda.2015.09.014		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CW9RG	WOS:000365335300022		
J	Doi, T; Shimada, H; Makizako, H; Tsutsumimoto, K; Hotta, R; Nakakubo, S; Suzuki, T				Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho; Suzuki, Takao			Mild Cognitive Impairment, Slow Gait, and Risk of Disability: A Prospective Study	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Cognitive function; mild cognitive impairment; mobility; disability; cognitive frailty	OLDER-ADULTS; INSTRUMENTAL ACTIVITIES; PHYSICAL PERFORMANCE; ALZHEIMERS-DISEASE; SPEED; DEMENTIA; ASSOCIATION; FRAILTY; CARE; PREVALENCE	Objectives: Mild cognitive impairment (MCI) may be a risk for disability, and co-occurrence of slow gait (SG) and MCI may increase this risk. Design: Prospective study. Setting: General community. Participants: The study included 3482 older adults (mean age: 71.4 years) without disability at baseline. Measurements: We collected information on demographic variables, measured gait speed and cognitive function to diagnose MCI at baseline. During the follow-up period, the incident disability was monitored. Participants were divided into groups without MCI and SG (control), with SG without MCI (SG), without SG and with MCI in single (sMCI) or multiple (mMCI) domains, and with SG and MCI in single (sMCI + SG) and multiple (mMCI + SG) domains. Results: During follow-up, 134 participants developed disability (mean follow-up: 29.4 months). The proportions of incident disability were higher in the MCI with SG, MCI, and SG groups, compared with the control group. SG [hazard ratio 2.27 (95% confidence interval: 1.38-3.73)], mMCI [2.56 (1.31-5.02)], sMCI + SG [2.46 (1.21-5.00)], and mMCI + SG [3.48 (1.79-6.76)] participants had risks for disability. Conclusions: Co-occurrence of SG and MCI in multiple domains has a higher risk of disability than each condition alone. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Doi, Takehiko; Shimada, Hiroyuki; Makizako, Hyuma; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, Obu, Japan; [Doi, Takehiko] Japan Soc Promot Sci, Tokyo, Japan; [Doi, Takehiko; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Japan	Doi, T (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, 7-430 Morioka Cho Obu, Aichi 4748511, Japan.	take-d@ncgg.go.jp			Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); Research Funding for Longevity Sciences [22-16];  [23300205];  [15H05369]	This work was supported by Health and Labor Sciences Research Grants (Comprehensive Research on Aging and Health); a Grant-in-Aid for Scientific Research (B) (grant number 23300205); a Grant-in-Aid for Young Scientists (A) (grant number 15H05369) and Research Funding for Longevity Sciences (22-16).	Brodaty H, 2013, ALZHEIMERS DEMENT, V9, P310, DOI 10.1016/j.jalz.2011.11.010; Doi T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-67; Purser JL, 2005, J AM GERIATR SOC, V53, P1966, DOI 10.1111/j.1532-5415.2005.53566.x; Sabbagh MN, 2010, CURR ALZHEIMER RES, V7, P280; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P439, DOI 10.1016/j.jalz.2013.09.008; Gill TM, 1996, J GERONTOL A-BIOL, V51, pM283; Whitson HE, 2011, J AM GERIATR SOC, V59, P207, DOI 10.1111/j.1532-5415.2010.03238.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Sanders JL, 2014, J GERONTOL A-BIOL, V69, P174, DOI 10.1093/gerona/glt088; Hausdorff JM, 2013, J GERONTOL A-BIOL, V68, P409, DOI 10.1093/gerona/glt002; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Solfrizzi V, 2013, ALZHEIMERS DEMENT, V9, P113, DOI 10.1016/j.jalz.2011.09.223; De Vriendt P, 2013, J NUTR HEALTH AGING, V17, P64, DOI 10.1007/s12603-012-0381-9; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Buchman AS, 2013, NEUROLOGY, V80, P2055, DOI 10.1212/WNL.0b013e318294b462; Rodakowski J, 2014, J AM GERIATR SOC, V62, P1347, DOI 10.1111/jgs.12878; Boisgontier MP, 2013, NEUROSCI BIOBEHAV R, V37, P1824, DOI 10.1016/j.neubiorev.2013.07.014; Waite LM, 2005, J NEUROL SCI, V229, P89, DOI 10.1016/j.jns.204.11.009; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Doi T, 2015, GERIATR GERONTOL INT, V15, P1073, DOI 10.1111/ggi.12407; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Fried LP, 1997, J AM GERIATR SOC, V45, P92; Doi T, 2015, NEUROBIOL AGING, V36, P942, DOI 10.1016/j.neurobiolaging.2014.10.035; Rist PM, 2014, NEUROLOGY, V82, P1543, DOI 10.1212/WNL.0000000000000357; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Annweiler C, 2013, J NEURAL TRANSM, V120, P1083, DOI 10.1007/s00702-012-0926-4; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Wadley VG, 2008, AM J GERIAT PSYCHIAT, V16, P416, DOI 10.1097/JGP.0b013e31816b7303; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Holtzer R, 2014, J GERONTOL A-BIOL, V69, P1375, DOI 10.1093/gerona/glu052; Pedersen MM, 2014, J GERONTOL A-BIOL, V69, P1511, DOI 10.1093/gerona/glu063; Shimada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002424; Sosa AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001170	53	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	DEC 1	2015	16	12					1082	1086		10.1016/j.jamda.2015.07.007		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CW9RG	WOS:000365335300014		
J	Shibata, A; Uemura, M; Hosokawa, M; Miyashita, K				Shibata, Ako; Uemura, Mariko; Hosokawa, Masashi; Miyashita, Kazuo			Formation of Acrolein in the Autoxidation of Triacylglycerols with Different Fatty Acid Compositions	JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY			English	Article						Fish oil oxidation; Flavor deterioration; Volatiles; Acrolein; Oxidative stability	LIPID OXIDATION; FISH OILS; THERMAL-DECOMPOSITION; MOLECULAR-MECHANISMS; VOLATILE COMPOUNDS; VEGETABLE-OILS; SENSORY IMPACT; PRODUCTS; TOXICITY; DISEASE	Fish, echium, linseed, and soybean oil triacyglycerols (TAGs) were oxidized at 50 or 60 A degrees C to determine the effect of the polyunsaturated fatty acid composition on the volatile product formation. The analysis of the oxygen consumption and total volatile formation demonstrated that the soybean oil TAG had the highest oxidative stability followed by linseed, echium, and fish oil TAGs. Our results were in agreement with the expected average number of bis-allylic positions of each TAG. Higher quantities of acrolein (2-propenal) and propanal were detected using the static headspace gas chromatography method at the early stages of oxidation of echium and fish oil TAGs; however, a considerable amount of propanal and only a small amount of acrolein were found in the oxidized linseed oil TAG. The peak area ratios of acrolein to propanal were 0.115, 0.569, and 2.554 after the 8-h oxidation of linseed, echium, and fish oil TAG, respectively, suggesting the preferential formation of acrolein, especially during the fish oil TAG oxidation. The acrolein quickly increased during the first stage of oxidation, but thereafter it either did not change or slightly decreased during the fish oil oxidation. Because fish oil induces flavor deterioration from the very early stage of the oxidation, the acrolein formation observed in the present study may be important for fish oil deterioration.	[Shibata, Ako; Uemura, Mariko; Hosokawa, Masashi; Miyashita, Kazuo] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Miyashita, K (reprint author), Hokkaido Univ, Fac Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	kmiya@fish.hokudai.ac.jp			Ministry of Agriculture, Forestry and Fisheries in Japan	This work was supported by "Scientific technique research promotion program from agriculture, forestry, fisheries and food industry" from the Ministry of Agriculture, Forestry and Fisheries in Japan.	American Oil Chemists' Society (AOCS), 1998, CD853; Dehaut A, 2014, J AGR FOOD CHEM, V62, P8014, DOI 10.1021/jf5021736; Sae-Leaw T, 2014, EUR J LIPID SCI TECH, V116, P885, DOI 10.1002/ejlt.201300381; Takeoka G, 1996, J AGR FOOD CHEM, V44, P654, DOI 10.1021/jf950430m; LoPachin RM, 2014, CHEM RES TOXICOL, V27, P1081, DOI 10.1021/tx5001046; Endo Y, 2013, J AM OIL CHEM SOC, V90, P959, DOI 10.1007/s11746-013-2242-z; Shibamoto T, 2006, J PHARMACEUT BIOMED, V41, P12, DOI 10.1016/j.jpba.2006.01.047; Serra A, 2014, MEAT SCI, V97, P504, DOI 10.1016/j.meatsci.2014.03.002; Narayan B, 2006, FOOD REV INT, V22, P291, DOI 10.1080/87559120600694622; Allayee H, 2009, J NUTRIGENET NUTRIGE, V2, P140, DOI 10.1159/000235562; Taneja A, 2012, ANNU REV FOOD SCI T, V3, P105, DOI 10.1146/annurev-food-022811-101130; Gomez-Cortes P, 2015, FOOD CHEM, V174, P310, DOI 10.1016/j.foodchem.2014.11.015; CHO SY, 1987, J AM OIL CHEM SOC, V64, P876, DOI 10.1007/BF02641498; HSIEH TCY, 1989, J AM OIL CHEM SOC, V66, P114, DOI 10.1007/BF02661797; Horiuchi M, 1998, J AGR FOOD CHEM, V46, P5232, DOI 10.1021/jf980482m; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; SNYDER JM, 1988, J AM OIL CHEM SOC, V65, P1617, DOI 10.1007/BF02912565; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; FRANKEL EN, 1993, J AM OIL CHEM SOC, V70, P767, DOI 10.1007/BF02542598; FRANKEL EN, 1981, LIPIDS, V16, P279, DOI 10.1007/BF02534950; KARAHADIAN C, 1989, J AM OIL CHEM SOC, V66, P953, DOI 10.1007/BF02682616; Venkateshwarlu G, 2004, J AGR FOOD CHEM, V52, P1635, DOI 10.1021/jf0351321; Shimajiri J, 2013, J AGR FOOD CHEM, V61, P7969, DOI 10.1021/jf401788j; Venkateshwarlu G, 2004, J AGR FOOD CHEM, V52, P311, DOI 10.1021/jf034833v; Aidos I, 2002, EUR J LIPID SCI TECH, V104, P808, DOI 10.1002/1438-9312(200212)104:12<808::AID-EJLT808>3.0.CO;2-J; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; HIRAYAMA T, 1989, EISEI KAGAKU, V35, P303; Jacobsen C, 1999, FETT-LIPID, V101, P484, DOI 10.1002/(SICI)1521-4133(199912)101:12<484::AID-LIPI484>3.0.CO;2-H; Jan F, 2008, MOL NUTR FOOD RES, V52, P7; KINSELLA JE, 1986, FOOD TECHNOL-CHICAGO, V40, P89; Miyashita K, 2014, EUR J LIPID SCI TECH, V116, P1268, DOI 10.1002/ejlt.201400114; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; Russ GL, 2010, BIOCHEM PHARMACOL, V235, P937; Sae-leaw T, 2014, EUR J LIPID SCI TECH, V116, P987	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-021X	1558-9331		J AM OIL CHEM SOC	J. Am. Oil Chem. Soc.	DEC	2015	92	11-12					1661	1670		10.1007/s11746-015-2732-2		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CX5TJ	WOS:000365765100013		
J	Sakai, N; Wada, T				Sakai, Norihiko; Wada, Takashi			T Helper 2 Cytokine Signaling in Bone Marrow-Derived Fibroblasts: A Target for Renal Fibrosis	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Editorial Material							FIBROCYTES; KIDNEY; INJURY; RECRUITMENT; CONTRIBUTE; DIFFERENTIATION; NEPHROPATHY; EXPRESSION; DISEASE; CELLS		[Sakai, Norihiko] Kanazawa Univ Hosp, Div Blood Purificat, Kanazawa, Ishikawa, Japan; [Sakai, Norihiko; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Fac Med, Dept Lab Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Wada, T (reprint author), Dept Lab Med, Div Nephrol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	twada@m-kanazawa.jp					Xia YF, 2013, HYPERTENSION, V62, P1129, DOI 10.1161/HYPERTENSIONAHA.113.01837; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Keeley EC, 2012, J HYPERTENS, V30, P1856, DOI 10.1097/HJH.0b013e32835639bb; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Xia YF, 2014, KIDNEY INT, V86, P327, DOI 10.1038/ki.2014.64; Reich B, 2013, KIDNEY INT, V84, P78, DOI 10.1038/ki.2013.84; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Liu LL, 2012, AM J NEPHROL, V36, P386, DOI 10.1159/000343283; Chesney J, 1998, J IMMUNOL, V160, P419; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Yukawa K, 2005, INT J MOL MED, V15, P225; BUCALA R, 1994, MOL MED, V1, P71; Chen JY, 2014, LAB INVEST, V94, P545, DOI 10.1038/labinvest.2014.43; Xia YF, 2014, ARTERIOSCL THROM VAS, V34, P1422, DOI 10.1161/ATVBAHA.113.303172; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; de Alba CG, 2015, AM J RESP CRIT CARE, V191, P427, DOI 10.1164/rccm.201407-1334OC; Giron-Michel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031624; Rivas-Caicedo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007066; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Takahashi T, 1996, CLIN EXP IMMUNOL, V104, P517, DOI 10.1046/j.1365-2249.1996.62768.x; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167; Yan JY, 2015, J AM SOC NEPHROL, V26, P3060, DOI 10.1681/ASN.2014070717	30	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	DEC	2015	26	12					2896	2898		10.1681/ASN.2015040469		3	Urology & Nephrology	Urology & Nephrology	CX1OR	WOS:000365466000003		
J	Wilhelmus, S; Alpers, CE; Cook, HT; Ferrario, F; Fogo, AB; Haas, M; Joh, K; Noel, LH; Seshan, SV; Bruijn, JA; Bajenna, IM				Wilhelmus, Suzanne; Alpers, Charles E.; Cook, H. Terence; Ferrario, Franco; Fogo, Agnes B.; Haas, Mark; Joh, Kensuke; Noel, Laure-Helene; Seshan, Surya V.; Bruijn, Jan A.; Bajenna, Ingeborg M.			The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIPHOSPHOLIPID SYNDROME NEPHROPATHY; RENAL VASCULAR-LESIONS; OXFORD CLASSIFICATION; NATURAL-HISTORY; CLINICAL COURSE; NEPHRITIS; GLOMERULONEPHRITIS; PATHOLOGY; PROGNOSIS	Over 10 years have passed since the latest revision of the histopathologic classification of lupus nephritis. This revision was a significant improvement compared with the previous version, mainly because of clearer and more concise definitions and the elimination of mixed subclasses. Despite these improvements, there are still some difficulties in the classification for lupus nephritis, many of which are in the definitions provided. In this review, we focus on the difficulties surrounding the evaluation of classes III and IV lesions, particularly the definitions of endocapillary and extracapillary proliferation, the use of the terms endocapillary proliferation and hypercellularity, the clinical relevance of segmental and global subdivision in class IV, and the value of distinguishing lesions that indicate activity and chronicity. Vascular and tubulointerstitial lesions are also discussed. Furthermore, we give an overview of the history of the classification to provide background on the origin and development of the definitions in lupus nephritis. The issues raised in this review as well as the suggestions for improvements may assist with a revision of the lupus nephritis classification in the near future.	[Wilhelmus, Suzanne; Bruijn, Jan A.; Bajenna, Ingeborg M.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Alpers, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Complement & Inflammat Res, London, England; [Ferrario, Franco] San Gerardo Hosp, Nephropathol Ctr, Monza, Italy; [Fogo, Agnes B.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Haas, Mark] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Joh, Kensuke] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Noel, Laure-Helene] French Natl Inst Hlth & Med Res, Necker Hosp, Dept Pathol, Paris, France; [Seshan, Surya V.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA	Wilhelmus, S (reprint author), Leiden Univ, Med Ctr, Dept Pathol, L1-Q,POB 9600, NL-2300 RC Leiden, Netherlands.	s.wilhelmus@lumc.nl					Hertig A, 2002, AM J KIDNEY DIS, V40, P1179, DOI 10.1053/ajkd.2002.36875; Dube GK, 2002, CLIN NEPHROL, V57, P120; SCHWARTZ MM, 1993, AM J KIDNEY DIS, V21, P374; Wu LH, 2013, KIDNEY INT, V83, P715, DOI 10.1038/ki.2012.409; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; SCHWARTZ MM, 1992, KIDNEY INT, V42, P743, DOI 10.1038/ki.1992.342; SCHWARTZ MM, 1987, KIDNEY INT, V32, P274, DOI 10.1038/ki.1987.203; ZIMMERMAN SW, 1975, LAB INVEST, V32, P665; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Haring CM, 2012, J AM SOC NEPHROL, V23, P149, DOI 10.1681/ASN.2011060558; Schwartz MM, 2008, NEPHROL DIAL TRANSPL, V23, P1298, DOI 10.1093/ndt/gfm775; ESDAILE JM, 1989, Q J MED, V72, P779; Furness PN, 2006, AM J SURG PATHOL, V30, P1030, DOI 10.1097/00000478-200608000-00015; Erre GL, 2014, RHEUMATOL INT, V34, P535, DOI 10.1007/s00296-013-2900-3; Najafi CC, 2001, KIDNEY INT, V59, P2156, DOI 10.1046/j.1523-1755.2001.0590062156.x; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Pollak VE, 1997, J AM SOC NEPHROL, V8, P1189; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Furness PN, 2003, AM J SURG PATHOL, V27, P805, DOI 10.1097/00000478-200306000-00012; Yokoyama H, 2004, KIDNEY INT, V66, P2382, DOI 10.1111/j.1523-1755.2004.66027.x; APPEL GB, 1994, J AM SOC NEPHROL, V4, P1499; WERNICK RM, 1993, ANN INTERN MED, V119, P805; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; BALDWIN DS, 1977, AM J MED, V62, P12, DOI 10.1016/0002-9343(77)90345-X; CORWIN HL, 1988, AM J NEPHROL, V8, P85, DOI 10.1159/000167563; BALDWIN DS, 1970, ANN INTERN MED, V73, P929; Salvatore SP, 2012, CLIN J AM SOC NEPHRO, V7, P914, DOI 10.2215/CJN.11751111; Daugas E, 2002, J AM SOC NEPHROL, V13, P42; MAGIL AB, 1988, KIDNEY INT, V34, P511, DOI 10.1038/ki.1988.211; APPEL GB, 1978, MEDICINE, V57, P371; POLLAK VE, 1964, J LAB CLIN MED, V63, P537; Kraft SW, 2005, J AM SOC NEPHROL, V16, P175; Hsieh C, 2011, ARTHRIT CARE RES, V63, P865, DOI 10.1002/acr.20441; MUEHRCKE RC, 1955, ANN RHEUM DIS, V14, P371, DOI 10.1136/ard.14.4.371; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; BANFI G, 1991, AM J KIDNEY DIS, V18, P240; AUSTIN HA, 1995, NEPHROL DIAL TRANSPL, V10, P1620; Yu F, 2010, KIDNEY INT, V77, P820, DOI 10.1038/ki.2010.13; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Bonsib SM, 2015, HEPTINSTALLS PATHOLO, P1; Churg J, 1982, RENAL DIS CLASSIFICA, P127; Churg J, 1995, RENAL DIS CLASSIFICA, P151; Dorland WAN, 2007, DORLANDS ILLUSTRATED; Miranda Juan M, 2009, Reumatol Clin, V5, P209, DOI 10.1016/j.reuma.2008.12.011; Wilhelmus S, 2015, CLIN J AM SOC NEPHRO, V10, P47, DOI 10.2215/CJN.03580414	45	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	DEC	2015	26	12					2938	2946		10.1681/ASN.2015040384		9	Urology & Nephrology	Urology & Nephrology	CX1OR	WOS:000365466000009		
J	Nakano, D; Doi, K; Kitamura, H; Kuwabara, T; Mori, K; Mukoyama, M; Nishiyama, A				Nakano, Daisuke; Doi, Kent; Kitamura, Hiroaki; Kuwabara, Takashige; Mori, Kiyoshi; Mukoyama, Masashi; Nishiyama, Akira			Reduction of Tubular Flow Rate as a Mechanism of Oliguria in the Early Phase of Endotoxemia Revealed by Intravital Imaging	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							ACUTE KIDNEY INJURY; ACUTE-RENAL-FAILURE; FLUID BALANCE; SEPSIS; MICE; INFLAMMATION; MORTALITY; SODIUM; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE	Urine output is widely used as a criterion for the diagnosis of AKI. Although several potential mechanisms of septic AKI have been identified, regulation of urine flow after glomerular filtration has not been evaluated. This study evaluated changes in urine flow in mice with septic AKI. The intratubular urine flow rate was monitored in real time by intravital imaging using two-photon laser microscopy. The tubular flow rate, as measured by freely filtered dye (FITC-inulin or Lucifer yellow), time-dependently declined after LPS injection. At 2 hours, the tubular flow rate was slower in mice injected with LPS than in mice injected with saline, whereas BP and GFR were similar in the two groups. Importantly, fluorophore-conjugated LPS selectively accumulated in the proximal tubules that showed reduced tubular flow at 2 hours and luminal obstruction with cell swelling at 24 hours. Delipidation of LPS or deletion of Toll-like receptor 4 in mice abolished these effects, whereas neutralization of TNF-alpha had little effect on LPS-induced tubular flow retention. Rapid intravenous fluid resuscitation within 6 hours improved the tubular flow rate only when accompanied by the dilation of obstructed proximal tubules with accumulated LPS. These findings suggest that LPS reduces the intratubular urine flow rate during early phases of endotoxemia through a Toll-like receptor 4-dependent mechanism, and that the efficacy of fluid resuscitation may depend on the response of tubules with LPS accumulation.	[Nakano, Daisuke; Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Miki, Kagawa 7610793, Japan; [Kitamura, Hiroaki] Kagawa Univ, Dept Anesthesiol, Miki, Kagawa 7610793, Japan; [Doi, Kent] Univ Tokyo, Univ Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Kuwabara, Takashige; Mukoyama, Masashi] Kyoto Univ, Dept Nephrol, Kyoto, Japan; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan	Nakano, D (reprint author), Kagawa Univ, Fac Med, Dept Pharmacol, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	dnakano@med.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23790299]	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23790299 to D.N.).	Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Wang W, 2002, AM J PHYSIOL-RENAL, V283, pF583, DOI 10.1152/ajprenal.00270.2001; Lu JCT, 2009, CLIN J AM SOC NEPHRO, V4, P1020, DOI 10.2215/CJN.05411008; Legrand M, 2011, INTENS CARE MED, V37, P1534, DOI 10.1007/s00134-011-2267-4; Joannidis M, 2005, CRIT CARE CLIN, V21, P239, DOI 10.1016/j.ccc.2004.12.005; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Patil NK, 2014, AM J PHYSIOL-RENAL, V306, pF734, DOI 10.1152/ajprenal.00643.2013; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; Mehta RL, 2011, INTENS CARE MED, V37, P241, DOI 10.1007/s00134-010-2089-9; DING HF, 1990, J MED MICROBIOL, V31, P95; Russell JA, 2000, CRIT CARE MED, V28, P3405, DOI 10.1097/00003246-200010000-00005; Prowle JR, 2014, NAT REV NEPHROL, V10, P37, DOI 10.1038/nrneph.2013.232; Negishi K, 2009, AM J PATHOL, V174, P1154, DOI 10.2353/ajpath.2009.080644; Srisawat N, 2010, BLOOD PURIFICAT, V29, P300, DOI 10.1159/000280099; Okusa MD, 2014, KIDNEY INT, V85, P39, DOI 10.1038/ki.2013.378; Wu LP, 2007, J AM SOC NEPHROL, V18, P1807, DOI 10.1681/ASN.2006121402; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Evans RG, 2013, CLIN EXP PHARMACOL P, V40, P106, DOI 10.1111/1440-1681.12031; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Gluba A, 2010, NAT REV NEPHROL, V6, P224, DOI 10.1038/nrneph.2010.16; Langenberg C, 2014, CRIT CARE MED, V42, pE58, DOI 10.1097/CCM.0b013e3182a639da; Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x; Kellum JA, 2008, CLIN J AM SOC NEPHRO, V3, P887, DOI 10.2215/CJN.04891107; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Nishioka S, 2014, KIDNEY INT, V85, P871, DOI 10.1038/ki.2013.496; Cunningham PN, 2004, J IMMUNOL, V172, P2629; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Cunningham PN, 2002, J IMMUNOL, V168, P5817; Blantz RC, 2012, AM J PHYSIOL-RENAL, V303, pF405, DOI 10.1152/ajprenal.00329.2011; Leelahavanichkul A, 2011, KIDNEY INT, V80, P1198, DOI 10.1038/ki.2011.261; Eadon MT, 2012, AM J PHYSIOL-RENAL, V303, pF821, DOI 10.1152/ajprenal.00023.2012; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Ikeda S, 2014, AM J PHYSIOL-RENAL, V306, pF744, DOI 10.1152/ajprenal.00474.2013; Lameire N, 2005, LANCET, V365, P417; Langenberg C, 2008, CRIT CARE, V12, DOI 10.1186/cc6823; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Sipos A, 2010, AM J PHYSIOL-RENAL, V299, pF1087, DOI 10.1152/ajprenal.00469.2009; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11682; Vanmassenhove J, 2013, CRIT CARE, V17, DOI 10.1186/cc13057	48	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	DEC	2015	26	12					3035	3044		10.1681/ASN.2014060577		10	Urology & Nephrology	Urology & Nephrology	CX1OR	WOS:000365466000018		
J	Kim, B; Takeuchi, A; Matsuoka, S; Lee, JH; Shin, YC; Han, DW				Kim, Bongju; Takeuchi, Ayako; Matsuoka, Satoshi; Lee, Jong Ho; Shin, Yong Cheol; Han, Dong-Wook			Inhibition of mitochondrial Na+-Ca2+ exchange by CGP-37157 attenuates BCR-mediated apoptosis in DT40 B lymphocytes	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Na+-Ca2+ exchange; CGP-37157; B lymphocytes; Apoptosis	CARDIAC MYOCYTES; CELL-DEATH; CALCIUM; CA2+; DISEASE; FATE	The antigen binding to the B cell receptor (BCR) induces a rise in cytoplasmic Ca2+ and initiates cell responses such as apoptosis, proliferation, and differentiation in B lymphocytes. We previously showed that the inhibition of mitochondrial Na+-Ca2+ exchange (NCXm) by 7-chloro-5- (2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one [CGP-37157] dose-dependently reduced BCR-mediated rise in cytoplasmic Ca2+ in DT40 B lymphocytes. However, the effect of CGP-37157 on BCR-mediated apoptosis is not yet fully understood. Here, we studied the effect of NCXm inhibition on BCR-mediated apoptosis in DT40 B lymphocytes. Apoptotic cells (Annexin V+ and PI - ) were increased by the BCR-stimulation while the treatment of cells with 20-mu M CGP-37157 attenuated the apoptosis induction. On the other hand, 24-hr treatments with 0.2 - 20 mu M CGP- 37157 without the BCR stimulation did not affect the apoptotic-cell population. In the NCLX (a gene encoding NCXm) knockout cells, although the apoptotic cells were increased in the control, the appearance of late apoptotic cells (Annexin V+ and PI+) was decreased by BCR stimulation when compared to the wild-type cells. Our findings suggest that the inhibition of NCXm attenuates BCR-mediated apoptosis in DT40 B lymphocytes.	[Kim, Bongju] Seoul Natl Univ, Clin Dent Res Inst, Dent Hosp, Seoul 03080, South Korea; [Takeuchi, Ayako; Matsuoka, Satoshi] Univ Fukui, Dept Integrat & Syst Physiol, Fac Med Sci, Fukui 9101193, Japan; [Lee, Jong Ho; Shin, Yong Cheol; Han, Dong-Wook] Pusan Natl Univ, Dept Cognomechatron Engn & Nanointegrated C BK21, Busan 46241, South Korea	Kim, B (reprint author), Seoul Natl Univ, Clin Dent Res Inst, Dent Hosp, Seoul 03080, South Korea.	bjkim@genome.tokushima-u.ac.jp; nanohan@pusan.ac.kr			Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists from the Physiological Society of Japan; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A2A2A02010181]	This work was supported by a Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists from the Physiological Society of Japan and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A2A2A02010181).	Vafiadaki E, 2009, PFLUG ARCH EUR J PHY, V457, P687, DOI 10.1007/s00424-008-0506-5; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; COX DA, 1993, J CARDIOVASC PHARM, V21, P595; BERS DM, 1993, CARDIOVASC RES, V27, P1772, DOI 10.1093/cvr/27.10.1772; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Nicolau SM, 2009, J PHARMACOL EXP THER, V330, P844, DOI 10.1124/jpet.109.154765; Kim B, 2012, J PHYSIOL-LONDON, V590, P459, DOI 10.1113/jphysiol.2011.222927; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411	14	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	DEC	2015	67	11					1915	1919		10.3938/jkps.67.1915		5	Physics, Multidisciplinary	Physics	CX6MX	WOS:000365816300004		
J	Asamura, H; Chansky, K; Crowley, J; Goldstraw, P; Rusch, VW; Vansteenkiste, JF; Watanabe, H; Wu, YL; Zielinski, M; Ball, D; Rami-Porta, R				Asamura, Hisao; Chansky, Kari; Crowley, John; Goldstraw, Peter; Rusch, Valerie W.; Vansteenkiste, Johan F.; Watanabe, Hirokazu; Wu, Yi-Long; Zielinski, Marcin; Ball, David; Rami-Porta, Ramon		Int Assoc Study Lung Canc Staging	The International Association for the Study of Lung Cancer Lung Cancer Staging Project Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Review						Lung cancer; Lung cancer staging; N component; N descriptors; Tumor; node; metastasis classification; Lymph node metastasis	FORTHCOMING 7TH EDITION; TNM CLASSIFICATION; PROPOSALS; REVISION	Introduction: Nodal status is considered to be one of the most reliable indicators of the prognosis in patients with lung cancer and thus is indispensable in determining the optimal therapeutic options. We sought to determine whether the current nodal (N) descriptors should be maintained or revised for the next edition (8th) of the International Lung Cancer Staging System. Methods: The new International Association for the Study of Lung Cancer lung cancer database was created from 94,708 patients diagnosed as having lung cancer between 1999 and 2010. Among these, 38,910 and 31,426 patients with non-small-cell lung carcinoma were available for an analysis of the clinical (c)N and pathological (p)N status, respectively. The anatomical location of lymph node involvement was defined by either the Naruke (for Japanese data) or American Thoracic Society (for non-Japanese data) nodal charts. Survival was calculated by the Kaplan-Meier method, and prognostic groups were assessed by a Cox regression analysis. Results: The current N0 to N3 descriptors for both the cN and pN status consistently separated prognostically distinct groups. The 5-year survival rates according to the cN and pN status were 60% and 75% (N0), 37% and 49% (N1), 23% and 36% (N2), and 9% and 20% (N3), respectively. The differences in survival between all neighboring nodal categories were highly significant for both the cN and pN status. With regard to pathological staging, additional analyses regarding the prognosis were performed by further dividing N1 into N1 at a single station (N1a) and N1 at multiple stations (N1b); N2 into N2 at a single station without N1 involvement (skip metastasis, N2a1), N2 at a single station with N1 involvement (N2a2), and N2 at multiple stations (N2b). The survival curves for N1b and N2a2 overlapped each other, and N2a1 had numerically a better prognosis than N1b, although the difference was not significant. Geographic difference in N-specific prognosis was observed for both c-settings and p-settings. This might have been because of the difference in the used nodal map, surgical technique, and pathologist's handling of the resected specimen. Conclusions: Current N descriptors adequately predict the prognosis and therefore should be maintained in the forthcoming staging system. Furthermore, we recommend that physicians record the number of metastatic lymph nodes (or stations) and to further classify the N category using new descriptors, such as N1a, N1b, N2a, N2b, and N3, for further testing.	[Asamura, Hisao] Keio Univ, Sch Med, Div Thorac Surg, Tokyo 1608582, Japan; [Chansky, Kari; Crowley, John] Canc Res & Biostat, Seattle, WA USA; [Goldstraw, Peter] Univ London Imperial Coll Sci Technol & Med, Acad Dept Thorac Surg, Royal Brompton Hosp, London, England; [Goldstraw, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Rusch, Valerie W.] Mem Sloan Kettering Canc Ctr, Thorac Serv, New York, NY 10021 USA; [Vansteenkiste, Johan F.] Univ Hosp KU Leuven, Resp Oncol Unit Pulmonol, Leuven, Belgium; [Watanabe, Hirokazu] Natl Canc Ctr, Dept Radiol, Tokyo, Japan; [Wu, Yi-Long] Guangdong Prov Peoples Hosp, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China; [Zielinski, Marcin] Pulm Hosp, Dept Thorac Surg, Zakopane, Poland; [Ball, David] Peter MacCallum Canc Ctr, Dept Radiotherapy, Melbourne, Vic, Australia; [Rami-Porta, Ramon] Univ Barcelona, Dept Thorac Surg, Hosp Univ Mutua Terrassa, Barcelona, Spain; [Rami-Porta, Ramon] CIBERES Lung Canc Grp, Barcelona, Spain	Asamura, H (reprint author), Keio Univ, Sch Med, Div Thorac Surg, Shinjuku Ku, 35 Schinanomachi, Tokyo 1608582, Japan.	hasamura@keio.jp			Johnson and Johnson; International Association of Study of Lung Cancer (IASLC); Genelux, Inc.; Eli Lily; Sanofi; Astra-Zeneca; Roche; Phizer; IASLC	Hisao Asamura has declared he currently receives payment for lectures from Johnson and Johnson. John Crowley has declared that his work is funded by the International Association of the Study of Lung Cancer (IASLC) and has received grants and support to travel from the IASLC. Valerie Rusch has declared that she currently receives the grants from Genelux, Inc. David Ball has declared on-going board memberships of Lilly Oncology, Astra-Zeneca, and Boeringer-Ingelheim. Yi-Long Wu has declared that he currently receives payment for lectures from Eli Lily, Sanofi, Astra-Zeneca, Roche, and Phizer.	American Joint Committee on Cancer, AJCC CANC STAG MAN; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Ramirez RA, 2012, J CLIN ONCOL, V30, P2823, DOI 10.1200/JCO.2011.39.2589; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; Saji H, 2013, CHEST, V143, P1618, DOI 10.1378/chest.12-0750; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; NARUKE T, 1978, J THORAC CARDIOV SUR, V76, P832; Wei SH, 2011, J THORAC ONCOL, V6, P310, DOI 10.1097/JTO.0b013e3181ff9b45; Rami-Porta R, 2014, J THORAC ONCOL, V9, P1618, DOI 10.1097/JTO.0000000000000334; UICC International Union Against Cancer, 2009, UICC INT UNION CANC	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2015	10	12					1675	1684		10.1097/JTO.0000000000000678		10	Oncology; Respiratory System	Oncology; Respiratory System	CX3DG	WOS:000365575100005		
J	Tanaka, K; Hida, T; Oya, Y; Oguri, T; Yoshida, T; Shimizu, J; Horio, Y; Hata, A; Kaji, R; Fujita, S; Sekido, Y; Kodaira, T; Kokubo, M; Katakami, N; Yatabe, Y				Tanaka, Kosuke; Hida, Toyoaki; Oya, Yuko; Oguri, Tomoyo; Yoshida, Tatsuya; Shimizu, Junichi; Horio, Yoshitsugu; Hata, Akito; Kaji, Reiko; Fujita, Shiro; Sekido, Yoshitaka; Kodaira, Takeshi; Kokubo, Masaki; Katakami, Nobuyuki; Yatabe, Yasushi			EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma	JOURNAL OF THORACIC ONCOLOGY			English	Article						EGFR mutation; Lung adenocarcinoma; Chemoradiation therapy; Locally advanced NSCLC	CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; KINASE DOMAIN; RAS ONCOGENE; GEFITINIB; CHEMORADIOTHERAPY; CHEMOTHERAPY; METAANALYSIS; RADIATION; ERLOTINIB	Background: Concurrent chemoradiation therapy (CRT) is the current standard of care for patients with locally advanced lung adenocarcinoma; however, little has been reported about the impact of epidermal growth factor receptor (EGFR) mutation on CRT efficacy. Methods: From 2006 to 2013, we retrospectively screened 104 unresectable stage III adenocarcinoma patients who were examined for EGFR mutation status and received definitive concurrent CRT consisting of platinum doublet chemotherapy in first-line setting and compared the clinical outcomes and recurrence patterns according to mutation status. Results: Among 104 patients, EGFR mutation was detected in 29 (28%). The overall response rate did not differ between EGFR-mutant and wild-type patients (72.4% versus 72.0%, p = 0.607). The median progression-free survival in concurrent CRT was significantly shorter in EGFR-mutant patients than in wild-type patients (9.8 [95% confidence interval, CI: 7.6-19.0] versus 16.5 [95% CI: 11.8-19.9] months, p = 0.041). The 2-year recurrence-free survival rate was 7.7% and 28.1% in EGFR-mutant and wild-type patients, respectively (p = 0.028). Distant metastases were more frequently identified as the first recurrence site in EGFR-mutant patients than in wild-type patients (76% versus 40%, p = 0.001). The brain was the most often affected site in EGFR-mutant patients (35%). However, locoregional recurrence was less common in EGFR-mutant patients than in the wild-type population (14% versus 35%, p = 0.027). Overall survival was similar between EGFR-mutant and wild-type patients (51.1 [95% CI: 28.2-70.2] versus 42.9 [95% CI: 35.3 to not available] months, p = 0.637). Among the EGFR wild-type population who were examined for Kras mutation, Kras-mutant patients had significantly worse overall survival than Kras wild-type patients (21.6 versus 49.8 months, p = 0.024). Conclusion: Concurrent CRT resulted in shorter progression-free survival in EGFR-mutant stage III adenocarcinoma patients than in wild-type patients, mainly because of distant metastasis relapse, regardless of better local control. Because of these distinct biological features, a different strategy, including EGFR-tyrosine kinase inhibitors for EGFR-mutant locally advanced adenocarcinoma patients receiving definitive CRT may be needed.	[Tanaka, Kosuke; Hida, Toyoaki; Oya, Yuko; Oguri, Tomoyo; Yoshida, Tatsuya; Shimizu, Junichi; Horio, Yoshitsugu] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan; [Tanaka, Kosuke; Sekido, Yoshitaka] Aichi Canc Ctr, Div Mol Oncol, Res Inst, Nagoya, Aichi 4648681, Japan; [Hata, Akito; Kaji, Reiko; Fujita, Shiro; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo, Japan; [Kodaira, Takeshi] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi 464, Japan; [Kokubo, Masaki] Kobe City Med Ctr Gen Hosp, Dept Radiat Oncol, Kobe, Hyogo, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan	Tanaka, K (reprint author), Aichi Canc Ctr, Dept Thorac Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	kosuke624t@gmail.com			National Cancer Center Research and Development Fund [26-A-4]	This study was supported in part by National Cancer Center Research and Development Fund (26-A-4).	Okamoto I, 2008, INT J CLIN ONCOL, V13, P112, DOI 10.1007/s10147-007-0754-y; Mak RH, 2011, ONCOLOGIST, V16, P886, DOI 10.1634/theoncologist.2011-0040; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Furuse K, 1999, J CLIN ONCOL, V17, P2692; Blackstock AW, 2007, J CLIN ONCOL, V25, P4146, DOI 10.1200/JCO.2007.12.6581; Akamatsu H, 2014, AM J CLIN ONCOL-CANC, V37, P144, DOI 10.1097/COC.0b013e31826e04f9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Ahn HK, 2013, LUNG CANCER, V79, P300, DOI 10.1016/j.lungcan.2012.11.010; Huncharek M, 1999, CARCINOGENESIS, V20, P1507, DOI 10.1093/carcin/20.8.1507; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Meng DQ, 2013, LUNG CANCER, V81, P1, DOI 10.1016/j.lungcan.2013.03.019; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Mamon HJ, 2005, J CLIN ONCOL, V23, P1530, DOI 10.1200/JCO.2005.04.123; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Li Fuhai, 2011, Zhongguo Fei Ai Za Zhi, V14, P715, DOI 10.3779/j.issn.1009-3419.2011.09.03; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Parkin DM, 2001, EJC SUPPL, V37, P4, DOI DOI 10.1016/S0959-8049(01)00267-2; Shin DY, 2014, J THORAC ONCOL, V9, P195, DOI 10.1097/JTO.0000000000000069; Yagishita S, 2015, INT J RADIAT ONCOL, V91, P140, DOI 10.1016/j.ijrobp.2014.08.344	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2015	10	12					1720	1725		10.1097/JTO.0000000000000675		6	Oncology; Respiratory System	Oncology; Respiratory System	CX3DG	WOS:000365575100012		
J	Paz-Ares, L; Hirsh, V; Zhang, L; de Marinis, F; Yang, JCH; Wakelee, HA; Seto, T; Wu, YL; Novello, S; Juhasz, E; Aren, O; Sun, Y; Schmelter, T; Ong, TJ; Pena, C; Smit, EF; Mok, TS				Paz-Ares, Luis; Hirsh, Vera; Zhang, Li; de Marinis, Filippo; Yang, James Chih-Hsin; Wakelee, Heather A.; Seto, Takashi; Wu, Yi-Long; Novello, Silvia; Juhasz, Erszebet; Aren, Osvaldo; Sun, Yan; Schmelter, Thomas; Ong, Teng Jin; Pena, Carol; Smit, Egbert F.; Mok, Tony S.			Monotherapy Administration of Sorafenib in Patients With Non-Small Cell Lung Cancer (MISSION) Trial A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens	JOURNAL OF THORACIC ONCOLOGY			English	Article						Non-small-cell lung cancer; Molecular targeted therapy; Sorafenib; KRAS mutation; EGFR mutation	RANDOMIZED-TRIAL; PROGNOSTIC VALUE; ERLOTINIB; MUTATIONS; THERAPY; NSCLC; VERISTRAT(R); BEVACIZUMAB; CARCINOMA; PLASMA	Introduction: Sorafenib monotherapy has shown benefits in phase II trials as third-/fourth-line treatment in patients with non-small-cell lung cancer (NSCLC). Methods: The phase III, multinational, double-blind, placebo-controlled Monotherapy admInistration of Sorafenib in patientS wIth nOn-small-cell luNg cancer (MISSION) trial randomized patients with advanced relapsed/refractory NSCLC, following two or three prior treatment regimens, to sorafenib 400 mg twice a day (n = 350) or matching placebo (n = 353) plus best supportive care. The primary end point was overall survival (OS); secondary end points included progression-free survival (PFS) and time to progression. Epidermal growth factor receptor and KRAS mutation status was analyzed in archival tumor and/or circulating tumor DNA from blood samples obtained during screening. Results: Median OS was similar in the sorafenib and placebo groups (8.2 versus 8.3 mo; hazard ratio [HR], 0.99; 95% confidence interval [CI], 0.84-1.17; p = 0.47). Median PFS (2.8 versus 1.4 mo; HR, 0.61; 95% CI, 0.51-0.72; p < 0.0001), and time to progression (2.9 versus 1.4 mo; HR, 0.54; 95% CI, 0.45-0.65; p < 0.0001) were significantly greater with sorafenib than with placebo. Among the 89 patients with epidermal growth factor receptor mutations, OS (13.9 versus 6.5 mo; HR, 0.48; 95% CI, 0.30-0.76; p = 0.002) and PFS (2.7 versus 1.4 mo; HR, 0.27; 95% CI, 0.16-0.46; p < 0.001) were significantly higher with sorafenib than placebo. PFS was significantly longer with sorafenib than placebo in patients with either wild-type or mutated KRAS, but OS was similar. Common drug-related adverse events were rash/desquamation, diarrhea, and fatigue, consistent with the safety profile of sorafenib. Conclusions: Third-/fourth-line sorafenib therapy did not significantly increase OS in patients with relapsed/refractory NSCLC, despite significantly increasing PFS.	[Paz-Ares, Luis] Univ Seville, CSIC, Inst Invest Biomed Sevilla, Hosp Univ Virgen Rocio, Seville, Spain; [Hirsh, Vera] McGill Univ, Dept Oncol, Ctr Hlth, Montreal, PQ, Canada; [Zhang, Li] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [de Marinis, Filippo] Azienda Osped S Camillo Forlanini, Pulm Oncol Unit 1, Rome, Italy; [Yang, James Chih-Hsin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Wakelee, Heather A.] Stanford Univ, Dept Med, Div Oncol, Ctr Canc, Stanford, CA 94305 USA; [Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Novello, Silvia] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Juhasz, Erszebet] Koranyi Natl Inst TB & Pulmonol I & XIV, Dept Pulmonol 14, Budapest, Hungary; [Aren, Osvaldo] Int Ctr Clin Studies, Unidad Oncol Tocac, Santiago, Chile; [Sun, Yan] Chinese Acad Med Sci, Canc Inst Hosp, Beijing 100730, Peoples R China; [Sun, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Schmelter, Thomas] Bayer Pharma AG, Berlin, Germany; [Ong, Teng Jin; Pena, Carol] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Smit, Egbert F.] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands; [Mok, Tony S.] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Paz-Ares, L (reprint author), Hosp Univ Doce Octubre, Med Oncol Serv, Av Cordoba KM 5, Madrid 28041, Spain.	lpazaresr@seom.org			Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals	This study was supported by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, An Amgen subsidiary. Editorial assistance was provided to the authors by BelMed Professional Resources, Inc. with funding by Bayer HealthCare Pharmaceuticals.	Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Gautschi O, 2013, LUNG CANCER, V79, P59, DOI 10.1016/j.lungcan.2012.10.006; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Lee JS, 2012, J CLIN ONCOL, V30, P1114, DOI 10.1200/JCO.2011.36.1709; Carbone DP, 2012, J THORAC ONCOL, V7, P1653, DOI 10.1097/JTO.0b013e31826c1155; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Blumenschein GR, 2009, J CLIN ONCOL, V27, P4274, DOI 10.1200/JCO.2009.22.0541; Amann JM, 2010, J THORAC ONCOL, V5, P169, DOI 10.1097/JTO.0b013e3181c8cbd9; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Langer CJ, 2013, CANCER TREAT REV, V39, P252, DOI 10.1016/j.ctrv.2012.05.003; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Carbone DP, 2010, LUNG CANCER, V69, P337, DOI 10.1016/j.lungcan.2009.11.019; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Kuiper JL, 2012, BRIT J CANCER, V107, P1820, DOI 10.1038/bjc.2012.470; Scagliotti G, 2010, J CLIN ONCOL, V28, P1835, DOI 10.1200/JCO.2009.26.1321; Wakelee HA, 2012, J THORAC ONCOL, V7, P1574, DOI 10.1097/JTO.0b013e31826149ba; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Smit EF, 2010, J THORAC ONCOL, V5, P719, DOI 10.1097/JTO.0b013e3181d86ebf; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Dingemans AMC, 2013, CLIN CANCER RES, V19, P743, DOI 10.1158/1078-0432.CCR-12-1779; Kato T, 2014, J CLIN ONCOL, V32; NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), 2013, NONSM CELL LUNG CANC	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2015	10	12					1745	1753		10.1097/JTO.0000000000000693		9	Oncology; Respiratory System	Oncology; Respiratory System	CX3DG	WOS:000365575100015		
J	Taguchi, K; Okada, A; Hamamoto, S; Iwatsuki, S; Naiki, T; Ando, R; Mizuno, K; Tozawa, K; Kohri, K; Yasui, T				Taguchi, Kazumi; Okada, Atsushi; Hamamoto, Shuzo; Iwatsuki, Shoichiro; Naiki, Taku; Ando, Ryosuke; Mizuno, Kentaro; Tozawa, Keiichi; Kohri, Kenjiro; Yasui, Takahiro			Proinflammatory and Metabolic Changes Facilitate Renal Crystal Deposition in an Obese Mouse Model of Metabolic Syndrome	JOURNAL OF UROLOGY			English	Article						kidney; nephrolithiasis; metabolic syndrome X; adipokines; macrophages	KIDNEY-STONE FORMATION; CALCIUM-OXALATE; MACROPHAGE ACTIVATION; EPITHELIAL-CELLS; TUBULAR CELLS; ADIPOCYTES; POLARIZATION; UROLITHIASIS; ASSOCIATION; RISK	Purpose: To clarify metabolic syndrome induced stone formation mechanisms we investigated the metabolic and immunohistochemical characteristics associated with renal crystal deposition using a model of mice with metabolic syndrome administered a high fat diet and ethylene glycol. Materials and Methods: Ob/Ob mice with Leptin gene deficiencies and metabolic syndrome related characteristics were compared with wild heterozygous lean mice. Four study groups were fed standard food and water (control group), a high fat diet and normal water (high fat diet group), 1% ethylene glycol and standard food (ethylene glycol group) or a high fat diet and 1% ethylene glycol (high fat diet plus ethylene glycol group). Blood, urine and kidney samples were taken after 14 days. Results: Ob/Ob mice in the high fat diet plus ethylene glycol group showed diffuse renal crystal depositions. Lean and Ob/Ob mice in the high fat diet plus ethylene glycol group showed significant excretion of urinary calcium oxalate crystals. Ob/Ob mice had significant hypercalciuria, hyperphosphaturia and hyperlipidemia, massive lipid fragments in tubular lumina and fat droplets in renal tubular cells. Ob/Ob mice in the high fat diet plus ethylene glycol group had markedly increased expression of osteopontin, monocyte chemoattractant protein-1, interleukin-6 and tumor necrosis factor-alpha. In Ob/Ob mice the number of proinflammatory macrophages was considerably elevated. Conclusions: We induced renal crystal deposition in mice with metabolic syndrome using a high fat diet and ethylene glycol. Increases in luminal mineral and lipid density, and proinflammatory adipocytokines and macrophages facilitated renal crystal formation in mice with metabolic syndrome.	[Taguchi, Kazumi; Okada, Atsushi; Hamamoto, Shuzo; Iwatsuki, Shoichiro; Naiki, Taku; Ando, Ryosuke; Mizuno, Kentaro; Tozawa, Keiichi; Kohri, Kenjiro; Yasui, Takahiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan	Okada, A (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	a-okada@med.nagoya-cu.ac.jp					Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; PIZZOLATO P, 1964, J HISTOCHEM CYTOCHEM, V12, P333; Kohri K, 2012, UROL RES, V40, P623, DOI 10.1007/s00240-012-0514-y; Okada A, 2007, UROL RES, V35, P89, DOI 10.1007/s00240-007-0082-8; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Torricelli FCM, 2014, J UROLOGY, V191, P667, DOI 10.1016/j.juro.2013.09.022; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Khan SR, 2010, J UROLOGY, V184, P1189, DOI 10.1016/j.juro.2010.04.065; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; Khan SR, 2009, UROL RES, V37, P169, DOI 10.1007/s00240-009-0201-9; Zuo L, 2014, J UROLOGY, V191, P1906, DOI 10.1016/j.juro.2014.01.013; Okada A, 2009, J BONE MINER RES, V24, P908, DOI [10.1359/jbmr.081245, 10.1359/JBMR.081245]; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Taguchi K, 2014, J AM SOC NEPHROL, V25, P1680, DOI 10.1681/ASN.2013060675; Antonelli JA, 2014, EUR UROL, V66, P724, DOI 10.1016/j.eururo.2014.06.036; Kohjimoto Y, 2013, AM J KIDNEY DIS, V61, P923, DOI 10.1053/j.ajkd.2012.12.028; Huang MY, 2005, KIDNEY INT, V68, P497, DOI 10.1111/j.1523-1755.2005.00427.x; Jeong IG, 2011, AM J KIDNEY DIS, V58, P383, DOI 10.1053/j.ajkd.2011.03.021; Umekawa T, 2002, KIDNEY INT, V61, P105, DOI 10.1046/j.1523-1755.2002.00106.x; Lieske JC, 2014, J AM SOC NEPHROL, V25, P211, DOI 10.1681/ASN.2013111189; Bobulescu IA, 2008, AM J PHYSIOL-RENAL, V294, pF1315, DOI 10.1152/ajprenal.00550.2007; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fujii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061343; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; Ichikawa J, 2014, UROLITHIASIS, V42, P17, DOI 10.1007/s00240-013-0612-5; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Okada A, 2010, J BONE MINER RES, V25, P2425, DOI 10.1002/jbmr.158	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	DEC	2015	194	6					1787	1796		10.1016/j.juro.2015.07.083		10	Urology & Nephrology	Urology & Nephrology	CX8WT	WOS:000365985900095		
J	Chen, TH; Aure, WE; Cruz, EI; Malbas, FF; Teng, HJ; Lu, LC; Kim, KS; Tsuda, Y; Shu, PY				Chen, Tien-Huang; Aure, Wilfredo E.; Irlandez Cruz, Estrella; Malbas, Fedelino F., Jr.; Teng, Hwa-Jen; Lu, Liang-Chen; Kim, Kyeong Soon; Tsuda, Yoshio; Shu, Pei-Yun			Avian Plasmodium infection in field-collected mosquitoes during 2012-2013 in Tarlac, Philippines	JOURNAL OF VECTOR ECOLOGY			English	Article						Avian malaria parasite; Culicidae; Philippines	MULTIPLE LINEAGES; MALARIA PARASITES; ISLANDS; JAPAN; PREVALENCE; BIRDS	Global warming threatens to increase the spread and prevalence of mosquito-transmitted diseases. Certain pathogens may be carried by migratory birds and transmitted to local mosquito populations. Mosquitoes were collected in the northern Philippines during bird migration seasons to detect avian malaria parasites as well as for the identification of potential vector species and the estimation of infections among local mosquito populations. We used the nested PCR to detect the avian malaria species. Culex vishnui (47.6%) was the most abundant species collected and Cx. tritaeniorhynchus (13.8%) was the second most abundant. Avian Plasmodium parasites were found in eight mosquito species, for which the infection rates were between 0.5% and 6.2%. The six Plasmodium genetic lineages found in this study included P. juxtanucleare -GALLUS02, Tacy7 (Donana04), CXBIT01, Plasmodium species LIN2 New Zealand, and two unclassified lineages. The potential mosquito vectors for avian Plasmodium parasites in the Philippines were Cq. crassipes, Cx. fuscocephala, Cx. quinquefasciatus, Cx. sitiens, Cx. vishnui, and Ma. Uniformis; two major genetic lineages, P. juxtanucleare and Tacy7, were identified.	[Chen, Tien-Huang; Teng, Hwa-Jen; Lu, Liang-Chen; Shu, Pei-Yun] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Aure, Wilfredo E.; Irlandez Cruz, Estrella] Res Inst Trop Med, Dept Med Entomol, Muntinlupa, Metro Manila, Philippines; [Malbas, Fedelino F., Jr.] Res Inst Trop Med, Vet Res Dept, Muntinlupa, Metro Manila, Philippines; [Kim, Kyeong Soon] Tottori Univ, Fac Agr, Joint Dept Vet Med, Tottori 680, Japan; [Tsuda, Yoshio] Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, Tokyo 1628640, Japan	Teng, HJ (reprint author), Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, 6 Linsen S Rd, Taipei, Taiwan.	hjteng@cdc.gov.tw			National Institute of Infectious Diseases, Japan	We thank Cheo Lin, Ching-lin Su, and Yu-Yu Chen for mosquito collections. This work was supported by an international collaboration grant from the National Institute of Infectious Diseases, Japan.	Allen D., 2006, Forktail, V22, P57; Ejiri H, 2009, PARASITOL RES, V105, P629, DOI 10.1007/s00436-009-1434-9; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Silva-Iturriza A, 2012, PARASITOL INT, V61, P650, DOI 10.1016/j.parint.2012.07.003; Levin II, 2013, CONSERV BIOL, V27, P1366, DOI 10.1111/cobi.12127; Kim KS, 2009, J MED ENTOMOL, V46, P1230; Braile TM, 2013, FORKTAIL, P140; Nabeshima T, 2009, J GEN VIROL, V90, P827, DOI 10.1099/vir.0.007617-0; Ejiri H, 2008, J VET MED SCI, V70, P1205, DOI 10.1292/jvms.70.1205; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Jourdain E, 2007, EMERG INFECT DIS, V13, P365; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Fallon S. M., 2005, AM NAT, V165, P465; Oliveros Carl, 2008, Check List, V4, P137; Valkiunas G, 2005, AVIAN MALARIA PARASI	17	0	0	SOC VECTOR ECOLOGY	CORONA	1966 COMPTON AVE, CORONA, CA 92881 USA	1081-1710	1948-7134		J VECTOR ECOL	J. Vector Ecol.	DEC	2015	40	2					386	392		10.1111/jvec.12178		7	Entomology	Entomology	CX5DF	WOS:000365721100023		
J	Tanaka, S; Seki, M; Miki, T; Shigematsu, I; Kanayama, K				Tanaka, Soichi; Seki, Masako; Miki, Tsunehisa; Shigematsu, Ichinori; Kanayama, Kozo			Solute diffusion into cell walls in solution-impregnated wood under conditioning process I: effect of relative humidity on solute diffusivity	JOURNAL OF WOOD SCIENCE			English	Article						Impregnated wood; Conditioning; Relative humidity; Solute diffusivity; Solvent evaporation		This study focused on solute diffusing into cell walls in solution-impregnated wood under conditioning. The purpose of this paper was to clarify the effect of relative humidity (RH) of the conditioning on solute diffusivity in the impregnated wood. Water evaporation, swelling, and shrinkage of wood samples impregnated with an aqueous solution of polyethylene glycol (PEG) polymer were examined under conditioning at an RH of 11, 32, 55, or 80 % followed by drying under vacuum. Dried samples were observed using a micro-focus X-ray computed tomography instrument. The total amount of PEG polymer diffusing into cell walls during conditioning increased with RH. Theoretical interpretation indicated that this was caused by an increase in polymer (solute) diffusivity as the amount of water (solvent) in samples increased. Temporal variability of the evaporation rate of water and of the swelling rate of the sample also were examined. Solute diffusivity, which was similar at each RH at the beginning of conditioning, decreased during conditioning; this decrease was greater at lower RH values due to a higher evaporation rate.	[Tanaka, Soichi; Kanayama, Kozo] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan; [Tanaka, Soichi; Kanayama, Kozo] Natl Inst Adv Ind Sci & Technol, Mat Res Inst Sustainable Dev, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Seki, Masako; Miki, Tsunehisa; Shigematsu, Ichinori] Natl Inst Adv Ind Sci & Technol, Struct Mat Res Inst, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Tanaka, S (reprint author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan.	soichi_tanaka@rish.kyoto-u.ac.jp					Watanabe H, 2015, J WOOD SCI, V61, P171, DOI 10.1007/s10086-014-1458-3; Jeremic D, 2007, WOOD SCI TECHNOL, V41, P597, DOI 10.1007/s00226-006-0120-7; INOUE M, 1993, MOKUZAI GAKKAISHI, V39, P181; Jeremic D, 2009, CELLULOSE, V16, P339, DOI 10.1007/s10570-008-9255-z; Matsuda Y, 2015, J WOOD SCI, V61, P128, DOI 10.1007/s10086-014-1457-4; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Jeremic D, 2009, WOOD SCI TECHNOL, V43, P317, DOI 10.1007/s00226-008-0233-2; Furuno T., 1978, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V24, P287; Ishimaru Y, 1993, MOKUZAIHOZON, V19, P204; Kitani Y, 1970, MOKUZAI GAKKAISHI, V16, P326; Ogura T, 1951, RINGYOSHIKENJYOHOKOK, V51, P61; Sadoh T, 1973, B KYOTO U FOR, V45, P227; Schneider VA, 1969, HOLZ ROH WERKST, V27, P209; Schneider VA, 1970, HOLZ ROH WERKST, V28, P20; Skaar C, 1988, WOOD WATER RELATIONS, P198; Stamm A. J., 1964, Forest Products Journal, V14, P403; Stamm A. J., 1956, Forest Products Journal, V6, P201; Stamm A. J., 1959, Forest Products Journal, V9, P375; Tanaka S, 2014, P 9 C SUST DEV EN WA; Tanaka S, 2015, J SOC MAT SCI JPN, V64, P369; TARKOW HAROLD, 1966, FOREST PROD J, V16, P61	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					543	551		10.1007/s10086-015-1503-x		9	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800001		
J	Takada, M; Saka, S				Takada, Masatsugu; Saka, Shiro			Comparative study on topochemistry of delignification from Japanese cedar and Japanese beech by hydrothermal treatment	JOURNAL OF WOOD SCIENCE			English	Article						Japanese cedar; Japanese beech; Hydrothermal treatment; Topochemistry; Delignification	HOT-COMPRESSED WATER; LIGNIN-DERIVED PRODUCTS; LIGNOCELLULOSIC BIOMASS; BIRCH WOOD; HYDROLYSIS; EDXA	The difference in decomposition behavior of lignin from Japanese cedar (Cryptomeria japonica) as softwood and Japanese beech (Fagus crenata) as hardwood treated by hot-compressed water was investigated. The obtained residual lignin was then evaluated by the alkaline nitrobenzene oxidation analysis, the relative proportion of ether type linkages had decreased for both species as the hot-compressed water treatment was prolonged. Furthermore, the microscopic observation of the residual lignin indicated that lignin in tracheid cell walls was removed to a greater extent than that in middle lamella in Japanese cedar. Similarly in Japanese beech, lignin in fiber cell walls was removed more extensively, with middle lamella lignin remaining after two-step treatment. Such observation was supported by a result obtained from the methoxyl content analysis per C-9 unit of the residual lignin. Based on these lines of evidence, lignin in middle lamella must be rich in condensed type, and these differences between softwood and hardwood can be attributed to the intrinsic characteristics of the original lignin and its topochemistry in woods.	[Takada, Masatsugu; Saka, Shiro] Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Saka, S (reprint author), Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	saka@energy.kyoto-u.ac.jp			JST (ALCA) project "Ethanol Production with Acetic Acid Fermentation from Lignocellulosics"	This work has been done as part of the JST (ALCA) project "Ethanol Production with Acetic Acid Fermentation from Lignocellulosics" The authors gratefully acknowledge all the support.	WHITING P, 1982, WOOD SCI TECHNOL, V16, P261; Sakaki T, 2002, IND ENG CHEM RES, V41, P661, DOI 10.1021/ie010614s; Yamauchi K, 2013, J WOOD SCI, V59, P149, DOI 10.1007/s10086-012-1313-3; Ehara K, 2002, J WOOD SCI, V48, P320, DOI 10.1007/BF00831354; Rogalinski T, 2008, J SUPERCRIT FLUID, V47, P54, DOI 10.1016/j.supflu.2008.05.003; SAKA S, 1982, WOOD SCI TECHNOL, V16, P139; Aguayo MG, 2014, HOLZFORSCHUNG, V68, P623, DOI 10.1515/hf-2013-0190; Mou HY, 2014, J AGR FOOD CHEM, V62, P3619, DOI 10.1021/jf500582w; SAKA S, 1988, HOLZFORSCHUNG, V42, P149, DOI 10.1515/hfsg.1988.42.3.149; Ando H, 2000, IND ENG CHEM RES, V39, P3688, DOI 10.1021/ie0000257; Biziks V, 2013, WOOD SCI TECHNOL, V47, P717, DOI 10.1007/s00226-013-0531-1; Lu X, 2009, J WOOD SCI, V55, P367, DOI 10.1007/s10086-009-1040-6; Koch G, 2003, HOLZFORSCHUNG, V57, P611, DOI 10.1515/HF.2003.092; Phaiboonsilpa N, 2010, J WOOD SCI, V56, P331, DOI 10.1007/s10086-009-1099-0; Baker SM, 1996, HOLZFORSCHUNG, V50, P573; Chen CL, 1992, METHODS LIGNIN CHEM, P33; Dence C. W., 1992, METHODS LIGNIN CHEM, P33; Milagres AMF, 2010, ROUTES CELLULOSIC ET, P53; Mondonca R, 2004, WOOD SCI TECHNOL, V38, P567; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Rohbein M, 2010, WOOD SCI TECHNOL, V44, P435; Sarkanen KV, 1971, LIGNINS OCCURRENCE F, P43; Takada M, 2015, J WOOD SCI, V61, P299, DOI 10.1007/s10086-015-1464-0; Whiting P, 1981, J WOOD CHEM TECHNOL, V1, P111, DOI 10.1080/02773818108085108	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					602	607		10.1007/s10086-015-1501-z		6	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800008		
J	Matsushita, Y; Ko, C; Aoki, D; Hashigaya, S; Yagami, S; Fukushima, K				Matsushita, Yasuyuki; Ko, Chisato; Aoki, Dan; Hashigaya, Shota; Yagami, Sachie; Fukushima, Kazuhiko			Enzymatic dehydrogenative polymerization of monolignol dimers	JOURNAL OF WOOD SCIENCE			English	Article						Enzymatic dehydrogenative polymerization; Lignification; Monolignol; Dimer; Reaction kinetics	SINAPYL ALCOHOL; CELL-WALL; LIGNIN; PEROXIDASE; OXIDATION; LIGNIFICATION; ARABIDOPSIS; HETEROGENEITY; BIOSYNTHESIS; ENHANCEMENT	The structure and biosynthesis of lignin are not yet fully understood, especially the step following the initial dimerization of monolignol. Liquid chromatograph mass spectrometer (LC-MS) was used to analyze the consumption rates of monolignol dimers formed by beta-O-4, beta-5, and beta-beta couplings between coniferyl alcohols in efforts to understand the activity of monolignol dimers in enzymatic dehydrogenative polymerization. We investigated the reaction kinetics in single-component and mixed-component reaction systems containing one and two species of the dimers, respectively. A difference was observed between the consumption rates of the three dimers we tested, and the consumption rate of one dimer in the single-component reaction was different from that in a mixed-component reaction. In qualitative LC-MS analyses, coniferyl alcohol oligomers were detected in the reaction products. Some monolignol tetramers were formed by 5-5 and 5-O-4 coupling between the dimers. The results of this work suggested that monolignol dimers with beta-5 and beta-beta linkages could function as radical mediators in enzyme-catalyzed polymerization.	[Matsushita, Yasuyuki; Ko, Chisato; Aoki, Dan; Hashigaya, Shota; Yagami, Sachie; Fukushima, Kazuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Matsushita, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	ysmatsu@agr.nagoya-u.ac.jp					Stevanic JS, 2009, HOLZFORSCHUNG, V63, P497, DOI 10.1515/HF.2009.094; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; van Parijs FRD, 2010, PLANT PHYSIOL, V153, P1332, DOI 10.1104/pp.110.154468; QUIDEAU S, 1994, HOLZFORSCHUNG, V48, P12, DOI 10.1515/hfsg.1994.48.1.12; Sangha AK, 2014, J PHYS CHEM B, V118, P164, DOI 10.1021/jp411998t; TERASHIMA N, 1988, WOOD SCI TECHNOL, V22, P259; Sangha AK, 2012, J PHYS CHEM B, V116, P4760, DOI 10.1021/jp2122449; Akerholm M, 2003, HOLZFORSCHUNG, V57, P459, DOI 10.1515/HF.2003.069; Yamasaki H, 1998, FEBS LETT, V422, P377, DOI 10.1016/S0014-5793(98)00048-9; Grabber JH, 2003, J AGR FOOD CHEM, V51, P4984, DOI 10.1021/jf030027c; Fournand D, 2003, PHYTOCHEMISTRY, V62, P139, DOI 10.1016/S0031-9422(02)00573-3; Demont-Caulet N, 2010, PHYTOCHEMISTRY, V71, P1673, DOI 10.1016/j.phytochem.2010.06.011; Ostergaard L, 2000, PLANT MOL BIOL, V44, P231, DOI 10.1023/A:1006442618860; FERGUS BJ, 1970, HOLZFORSCHUNG, V24, P113, DOI 10.1515/hfsg.1970.24.4.113; FREUDENBERG K, 1959, NATURE, V183, P1152, DOI 10.1038/1831152a0; Russell WR, 2006, BIOMACROMOLECULES, V7, P268, DOI 10.1021/bm050636o; Yue FX, 2012, CHEM-EUR J, V18, P16402, DOI 10.1002/chem.201201506; TAKAHAMA U, 1995, PHYSIOL PLANTARUM, V93, P61, DOI 10.1034/j.1399-3054.1995.930110.x; Peura M, 2006, BIOMACROMOLECULES, V7, P1521, DOI 10.1021/bm050722o; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; HEPLER PK, 1970, AM J BOT, V57, P85, DOI 10.2307/2440382; ADLER E, 1977, WOOD SCI TECHNOL, V11, P169; Nielsen KL, 2001, BIOCHEMISTRY-US, V40, P11013, DOI 10.1021/bi010661o; BLINKOVSKY AM, 1993, J POLYM SCI POL CHEM, V31, P1839, DOI 10.1002/pola.1993.080310722; Wang C, 2013, BIOMACROMOLECULES, V14, P3964, DOI 10.1021/bm401084h; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Takahama U, 1996, PLANT CELL PHYSIOL, V37, P499; Onnerud H, 2003, HOLZFORSCHUNG, V57, P377, DOI 10.1515/HF.2003.056; FUKUSHIMA K, 1991, HOLZFORSCHUNG, V45, P87, DOI 10.1515/hfsg.1991.45.2.87; Kobayashi T, 2005, J WOOD SCI, V51, P607, DOI 10.1007/s10086-005-0702-2; RIDE JP, 1975, PHYSIOL PLANT PATHOL, V5, P125, DOI 10.1016/0048-4059(75)90016-8; Shigematsu M, 2006, J WOOD SCI, V52, P128, DOI 10.1007/s10086-005-0737-4; Aoyama W, 2002, J WOOD SCI, V48, P497, DOI 10.1007/BF00766646; Takahama U, 1997, PLANT CELL PHYSIOL, V38, P456; Shigematsu M, 2008, J WOOD SCI, V54, P308, DOI 10.1007/s10086-008-0955-7; Barakat A, 2007, PLANTA, V225, P267; Barcelo AR, 1997, INT REV CYTOL, V176, P87, DOI 10.1016/S0074-7696(08)61609-5; FREUDENBERG K, 1952, CHEM BER-RECL, V85, P1181, DOI 10.1002/cber.19520851213; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Takabe K, 1981, MOKUZAI GAKKAISHI, V27, P813; Terashima N, 1979, MOKUZAI GAKKAISHI, V25, P595	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					608	619		10.1007/s10086-015-1513-8		12	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800009		
J	Kayo, C; Watanabe, C; Sasaki, T; Kumagai, S; Noda, R; Hashimoto, S				Kayo, Chihiro; Watanabe, Chiaki; Sasaki, Takanobu; Kumagai, Seiki; Noda, Ryu; Hashimoto, Seiji			Life cycle greenhouse gas emissions of woodchip-paved walkways using tsunami salt-damaged wood: examination in Otsuchi, Iwate Prefecture	JOURNAL OF WOOD SCIENCE			English	Article						Life cycle assessment (LCA); Paving materials; Tsunami salt-damaged wood; Adhesive; Energy use	BALANCE; ENERGY; PRODUCTS; IMPACTS	A life cycle assessment of greenhouse gas (GHG: CO2, CH4, N2O) emissions for woodchip-paved walkways using tsunami salt-damaged wood was conducted in Otsuchi, Iwate Prefecture. The GHG emissions for woodchip-paved walkways from the raw material procurement process to the construction process were 2.62 kg-CO2-eq/m(2)/year. Of these, most were for the raw material procurement process (88 %), with the production process accounting for 7 %, the transportation process < 1 %, and the construction process 4 %. In the raw material procurement process, almost all of the GHG emissions were related to raw materials for adhesive. On the other hand, in the disposal process, use of disposed chips as energy (heat supply) in place of heavy oil obtained GHG emission reductions of 2.42 kg-CO2-eq/m(2)/year. With these taken into account, the net GHG emissions of the woodchip-paved walkway were reduced to 0.20 kg-CO2-eq/m(2)/year. We found that using a woodchip-paved walkway to replace an asphalt-paved walkway could reduce GHG emissions by 1.45 kg-CO2-eq/m(2)/year, and replacing an artificial turf walkway could reduce GHG emissions by 1.61 kg-CO2-eq/m(2)/year. However, achieving these reductions depends upon maintaining the woodchip pavement for at least 2 years and using the disposed chips as energy.	[Kayo, Chihiro] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Environm Conservat, Fuchu, Tokyo 1838509, Japan; [Watanabe, Chiaki; Sasaki, Takanobu] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan; [Kumagai, Seiki] Woody Sannai Co Ltd, Yokote, Akita 0191108, Japan; [Noda, Ryu] Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Hashimoto, Seiji] Ritsumeikan Univ, Coll Sci & Engn, Dept Environm Syst Engn, Kusatsu, Shiga 5258577, Japan	Kayo, C (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Environm Conservat, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	kayoc@cc.tuat.ac.jp; chiaki@iwt.akita-pu.ac.jp; taka@iwt.akita-pu.ac.jp; kumagai@woodyland.jp; noda.ryu.008@m.kyushu-u.ac.jp; shashimo@fc.ritsumei.ac.jp			Toyota Foundation; MEXT KAKENHI Grant [25282115, 15H02863]; JSPS KAKENHI Grant [26870181]	In conducting this research, the authors were assisted greatly by the people of the Otsuchi Town Hall, the NPO Kirikiri Koku, Ikarigawaseikan Co., Ltd., and the Warabikko Shopping District. The authors would like to express heartfelt gratitude for their assistance. This work was supported by the Toyota Foundation, MEXT KAKENHI Grant No. 25282115 and No. 15H02863, and JSPS KAKENHI Grant No. 26870181.	Kayo C, 2011, J WOOD SCI, V57, P234, DOI 10.1007/s10086-010-1167-5; Petersen AK, 2005, FOREST POLICY ECON, V7, P249, DOI 10.1016/S1389-9341(03)00063-7; Whittaker C, 2011, BIOMASS BIOENERG, V35, P4581, DOI 10.1016/j.biombioe.2011.07.001; Micales JA, 1997, INT BIODETER BIODEGR, V39, P145, DOI 10.1016/S0964-8305(97)83389-6; Hitoe K, 2013, MOKUZAI GAKKAISHI, V59, P269; Kayo C, 2011, J IND ECOL, V15, P122, DOI 10.1111/j.1530-9290.2010.00308.x; Upton B, 2008, BIOMASS BIOENERG, V32, P1, DOI 10.1016/j.biombioe.2007.07.001; [Anonymous], 2013, 14067 ISOTS, P52; Aoyama T, 2007, CONSTR RECYCL, V38, P13; Forestry Agency of Japan, 2014, 2012 WOOD MAT DEM SU; Garcia SG, 2011, SCI TOTAL ENVIRON, V410-411, P16; Inter-disciplinary committee on the increased use of wood in civil engineering, 2010, 2009 REP INT DISC ST, P73; IPCC, 2013, IPCC 5 ASS REP CLIM; Japan Environmental Management Association for Industry, 2014, MILCA; Japan Wood Energy Co. Ltd., 2012, WOOD BIOMASS BOILER; Kayo C, 2015, J WOOD SCI, V61, P70, DOI 10.1007/s10086-014-1434-y; Kayo C, 2012, LIFE ENV, V1, P36; Kubo H, 2008, CONSTR TECH RES CTR, V21, P66; Ministry of Finance Japan, 2015, MIN ORD CONC US LIF; Ministry of Land Infrastructure Transport and Tourism Japan, 2012, 2010 NAT NET FLOW CA; National Institute for Land and Infrastructure Management Ministry of Land Infrastructure Transport and Tourism Japan, 2012, LIF CYCL ASS SOC CAP; Noda R, 2014, J WOOD SCI, V60, P461, DOI 10.1007/s10086-014-1423-1; Otsuchi town, 2014, 2014 OTSUCHI TOWN DI; Takeda T, 2009, PAVEMENT, V44, P11; The Task Team on Disaster Waste Management and Reconstruction in Japan Society of Material Cycles and Waste Management, 2012, STRAT SEPAR TREATM D; Watanabe C, 2013, P ANN C I SOC SAF SC, V32, P59; Ximenes F, 2015, WASTE MANAGE, V41, P101	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					620	629		10.1007/s10086-015-1502-y		10	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800010		
J	Kobayashi, K; Akada, M; Torigoe, T; Imazu, S; Sugiyama, J				Kobayashi, Kayoko; Akada, Masanori; Torigoe, Toshiyuki; Imazu, Setsuo; Sugiyama, Junji			Automated recognition of wood used in traditional Japanese sculptures by texture analysis of their low-resolution computed tomography data	JOURNAL OF WOOD SCIENCE			English	Article						Wood identification; Pattern recognition; Texture analysis; Gray-level co-occurrence matrix; X-ray computer tomography	CLASSIFICATION	The identification of wood species used in the cultural artifacts is important in terms of their preservation and inheritance. However, a nondestructive method is required, and wood samples must be partly cut off in conventional methods such as microscopy. In this study, we constructed a novel system for wood identification using image recognition of X-ray computed tomography images of eight major species used in Japanese wooden sculptures. Texture analyses of the computed tomography images were carried out using the gray-level co-occurrence matrix, from which 15 textural features were calculated. The k-nearest-neighbor algorithm combined with cross validation was applied for classification and evaluation of the system. Input datasets with a variation in image qualities (resolution, gray level, and image size) were investigated using this novel system, and the accuracy was greater than 98 % when the input images had a certain quality level. Although there are still technical problems to be overcome, progress in the development of automated identification is extremely encouraging in that such an approach has the potential to make a valuable contribution in adding scientific species notion to the artifacts; otherwise, only the literal documents are available.	[Kobayashi, Kayoko; Sugiyama, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan; [Akada, Masanori; Imazu, Setsuo] Natl Museum Kyushu, Dazaifu, Fukuoka 8180118, Japan; [Torigoe, Toshiyuki] Nara Natl Museum, Nara, Nara 6308213, Japan	Kobayashi, K (reprint author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan.	kayoko_kobayashi@rish.kyoto-u.ac.jp			Japan Society for the Promotion of Science [25252033, 22300309]	The authors thank Mr. Ken'ichiro Yano, a sculptor, for providing the wood samples and valuable discussion in the early stage of this project. The authors also appreciate Ms. Izumi Kanai and Mr. Hajime Sorimachi for their enthusiasm and continuous technical support. This study was inspired by the pioneering master's thesis by Mr. Maekawa, Graduate School of Informatics, Kyoto University. This study was fully supported by Grants-in-Aid for Scientific Research (Grant Numbers 25252033 and 22300309) from the Japan Society for the Promotion of Science.	Albregtsen F, 1995, TECHNICAL NOTE; Pan S, 2011, COMPUT ELECTRON AGR, V75, P250, DOI 10.1016/j.compag.2010.11.010; Martins J, 2013, MACH VISION APPL, V24, P567, DOI 10.1007/s00138-012-0417-5; Yuliastuti E, 2013, PROCEEDINGS OF 2013 3RD INTERNATIONAL CONFERENCE ON INSTRUMENTATION CONTROL AND AUTOMATION (ICA 2013), P198; Schimleck LR, 1996, APPITA J, V49, P319; [Anonymous], 2014, IEEE INT C SIGN PROC; Yusof R, 2013, COMPUT ELECTRON AGR, V93, P68, DOI 10.1016/j.compag.2013.01.007; [Anonymous], 2010, 12 INT C COMP MOD SI, DOI DOI 10.1109/UKSIM.2010.61; Horikawa Y, 2015, J WOOD SCI, V61, P251, DOI 10.1007/s10086-015-1462-2; Bremananth R, 2009, Proceedings of the 2009 International Conference on Advances in Recent Technologies in Communication and Computing. ARTCom 2009, DOI 10.1109/ARTCom.2009.10; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hermanson JC, 2011, IAWA J, V32, P233; Mizuno S, 2010, J ARCHAEOL SCI, V37, P2842, DOI 10.1016/j.jas.2010.06.022; Bordese M, 2013, BIOPS IMAGE PROCESSI; Filho PLP, 2010, 20 INT C PATT REC IC, P4178, DOI [10.1109/ICPR.2010.1015, DOI 10.1109/ICPR.2010.1015]; IAWA Committee, 1989, IAWA B, V10, P219, DOI 10.1163/22941932-90000496; Khalid M, 2008, INT J SIMUL SYST SCI, V9, P9; Khalid M, 2011, P 2 IEEE INT C INSTR, P6; Martins JG, 2015, MACH VISION APPL, V26, P279, DOI 10.1007/s00138-015-0659-0; R Core Team, 2014, R LANG ENV STAT COMP; Richter HG, 2004, IAWA B, V1, P1; Venables W. N., 2002, MODERN APPL STAT S; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076101; Watanabe K, 2011, JPN J HIST BOT, V19, P117	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					630	640		10.1007/s10086-015-1507-6		11	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800011		
J	Miyoshi, Y; Furutani, M; Ishihara, M; Tai, S; Furuta, Y; Kawai, S				Miyoshi, Yuka; Furutani, Mariko; Ishihara, Mayuko; Tai, Shunichi; Furuta, Yuzo; Kawai, Shuichi			Technological development for the control of humidity conditioning performance of slit materials made from Japanese cedar	JOURNAL OF WOOD SCIENCE			English	Article						Humidity conditioning performance; Slit material; Heat treatment temperature; Japanese cedar	WOOD	For the purpose of technology development to control the humidity conditioning performance of slit material made from Japanese cedar, the effects of the groove shape of slit samples, air convection, and heat treatment on moisture adsorption and desorption properties were studied. The results obtained are as follows. The moisture adsorption and desorption rates of slit samples were increased with increase of end grain area of them. However, the moisture adsorption and desorption rates were not increased with increase of depth of concave, although the end grain area was increased. On the other hand, reduced rates of the slit samples with deep concave were increased by air convection. The increase ratios of moisture adsorption and desorption rates were larger in samples with deep concave. Equilibrium moisture content was decreased with increase of heat treatment temperature. Pore volume of micropores smaller than 0.6 nm was decreased with increases of heat treatment temperature. Compromise position of processing condition for slit material should be sought considering production and labor costs, drying conditions, and installation environment in addition to results obtained in this study.	[Miyoshi, Yuka; Tai, Shunichi; Furuta, Yuzo] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Furutani, Mariko] Hokushin Co Ltd, Kishiwada, Osaka 5968521, Japan; [Ishihara, Mayuko] Seiki Co Ltd, Nakagyo Ku, Kyoto, Kyoto 6040857, Japan; [Kawai, Shuichi] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ku, Kyoto 6068306, Japan	Miyoshi, Y (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyo118mint@yahoo.co.jp			RISH (Research Institute for Sustainable Humanosphere)	This study was supported by "The mission research" and "The development of new area" grant funded by RISH (Research Institute for Sustainable Humanosphere). The authors would like to appreciate the members of the projects.	Morooka T, 2007, J WOOD SCI, V53, P192, DOI 10.1007/s10086-006-0848-6; Obataya E, 2000, MOKUZAI GAKKAISHI, V46, P77; Kojiro K, 2008, J WOOD SCI, V54, P202, DOI 10.1007/s10086-007-0943-3; NORIMOTO M, 1990, MOKUZAI GAKKAISHI, V36, P341; Kobayashi S, 1994, S 9 DIG SIGN PROC C3, P265; Maki F, 1981, WOOD IND, V36, P476; Ohata T, 2012, RES REP SHIMANE I IN, V48, P16; Society The Japan Wood Research, 2011, STRUCT OF WOOD, P37; Tsujino Y, 2000, GLOB ENV RES, V4, P89; Tsumura T, 2006, SUMM ANN M ARCH I JA, P1003; Tsumura T, 2007, SUMM ANN M ARCH I JA, P1055	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					641	646		10.1007/s10086-015-1512-9		6	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800012		
J	Ogawa, K; Sasaki, Y; Yamasaki, M				Ogawa, Keita; Sasaki, Yasutoshi; Yamasaki, Mariko			Theoretical modeling and experimental study of Japanese "Watari-ago" joints (vol 61, pg 481, 2015)	JOURNAL OF WOOD SCIENCE			English	Correction									[Ogawa, Keita; Sasaki, Yasutoshi; Yamasaki, Mariko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan	Sasaki, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan.	ysasaki@nagoya-u.jp					Ogawa K, 2015, J WOOD SCI, V61, P481, DOI 10.1007/s10086-015-1498-3	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	DEC	2015	61	6					647	647		10.1007/s10086-015-1509-4		1	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CX4ZX	WOS:000365710800013		
J	Nakai, A; Pyae, A; Luimula, M; Hongo, S; Vuola, H; Smed, J				Nakai, Akihito; Pyae, Aung; Luimula, Mika; Hongo, Satoshi; Vuola, Hannu; Smed, Jouni			Investigating the effects of motion-based Kinect game system on user cognition	JOURNAL ON MULTIMODAL USER INTERFACES			English	Article						Skeletal motion interface; Usability test; Kansei engineering; Serious game		Kinect, which is useful as a multimodal input device, offers multiple features such as voice recognition, facial tracking, object recognition, and gesture recognition. Games with such human-centred, interactive interfaces create an environment that bridges between artificial and natural cognitive capabilities, enabling them to work together more efficiently. This study specifically examines a usability evaluation method that uses Kansei engineering knowledge to identify and remedy difficulties related to user interface development. As a practical application of the suggested evaluation method, we used a particular serious game, "The Glider," a prototype developed by Serious Games Finland. It exploits Kinect as its game controller. Serious games are usually aimed at promoting specific effects that can be achieved through playing the game. However, such effects can also present tradeoffs in terms of usability. Controlling motions in "The Glider" has been developed in close cooperation with medical doctors, physiotherapists, and patients in terms of well-being and light exercise. However, modulating the difficulty balance and usability of the game is also a very important aspect of game development. As described in this paper, our goal is to evaluate the control motion of the game from a usability perspective. Evaluation consists of state and appearance observations conducted with 12 Japanese subjects. Observed data were tagged into several categories to quantize their behaviours and speeches, and were analysed using both cognitive bias evaluation and statistical evaluation. Results show that difficulties for subjects in control motions of the game were curved out, which is a key to balancing usability and difficulty while maintaining the genuine purpose of the serious game.	[Nakai, Akihito] Tohoku Univ, Elect Commun Res Inst, Aoba Ward, Sendai, Miyagi, Japan; [Pyae, Aung; Luimula, Mika] Turku Univ Appl Sci, Turku, Finland; [Hongo, Satoshi] Sendai Natl Coll Technol, Natori, Miyagi, Japan; [Vuola, Hannu] Serious Games Finland, Helsinki, Finland; [Pyae, Aung; Smed, Jouni] Univ Turku, Turku, Finland	Nakai, A (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ward, 2-1-1 Katahira, Sendai, Miyagi, Japan.	nakai@ais.riec.tohoku.ac.jp; aung.pyae@turkuamk.fi; mika.luimula@turkuamk.fi; hongo@sendai-nct.ac.jp; hannu.vuola@seriousgames.fi; jouni.smed@utu.fi					Allan O, 2012, P AVI 12 INT C ADV V, P324; Anderson F., 2010, ANNU REV CYBERTHERAP, V8, P181; Biswas KK, 2011, P 5 INT C AUT ROB AP; Buchenau M, 2000, S DES INT SYST 2000, P424; Burke JW, 2010, INT C SER DIS VIRT R; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; Chao S, 2012, P 4 INT C INT MULT C, P55; Choh N, 2008, P ACE 08 2008 INT C, P395, DOI 10.1145/1501750.1501844; Csapo A, 2012, ACTA POLYTECH HUNG, V9, P85105; Huotari K, 2012, P 16 INT AC MINDTREK, P17; Kaiho H, PROTOCOL ANAL WHAT W, P249; KEIO Univ. Fukuda Lab, ERG GUID WAY STUD KA, P354; Leo KH, 2010, P ICREATE 10 4 INT C; Levy L, 2009, GAME DEV ESSENTIALS; Matsuguma H, 2011, ASIA DIGITAL ART DES; NAGAMACHI M, 1995, INT J IND ERGONOM, V15, P3, DOI 10.1016/0169-8141(94)00052-5; Pranav M, 2009, CHI EA 09 EXTENDED A, P4111; Pyae A, 2013, P 7 ANN INT C COMP G, P151; Shiizuka H, 2011, INTELLIGENT DECISION, P329; Theng YL, 2012, P CHI12 ACM NEW YORK, P691; Thibaut W, 2011, P SA 11 SIGGRAPH AS; Wu D, 2012, P MM 12 20 ACM INT C, P1303; Xia L, 2011, INT WORKSH HUM ACT U	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1783-7677	1783-8738		J MULTIMODAL USER IN	J. Multimodal User Interfaces	DEC	2015	9	4					403	411		10.1007/s12193-015-0197-0		9	Computer Science, Artificial Intelligence; Computer Science, Cybernetics	Computer Science	CX1FK	WOS:000365441700014		
J	Tachibana, Y; Mae, T; Shino, K; Kanamoto, T; Sugamoto, K; Yoshikawa, H; Nakata, K				Tachibana, Yuta; Mae, Tatsuo; Shino, Konsei; Kanamoto, Takashi; Sugamoto, Kazuomi; Yoshikawa, Hideki; Nakata, Ken			Morphological changes in femoral tunnels after anatomic anterior cruciate ligament reconstruction	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						ACL; Anatomic; Tunnel enlargement; Cross-sectional area; Graft; Tunnel morphology; Knee	HAMSTRING TENDON GRAFTS; BONE TUNNEL; DOUBLE-BUNDLE; ACL RECONSTRUCTION; TIBIAL TUNNEL; SINGLE-BUNDLE; ENLARGEMENT; FIXATION; MOTION; REPLACEMENT	Few studies investigated the enlargement inside the tunnel as well as the morphological change at the aperture after anterior cruciate ligament (ACL) reconstruction, whereas the tunnel enlargement has been well documented. The purposes were to evaluate the change in the cross-sectional area along the femoral tunnel and to morphologically clarify the enlargement at the femoral tunnel aperture after anatomic triple-bundle (ATB) ACL reconstruction. The study included 15 patients with unilateral ACL rupture. ATB ACL reconstruction was performed using semitendinosus tendon autografts. Three-dimensional computer models of the femur and bone tunnels were reconstructed from computed tomography images obtained 3 weeks and 1 year postoperatively. The cross-sectional area at the aperture as well as inside the tunnel was compared between the two periods. Likewise, the location of tunnel walls and center in the tunnel footprint were evaluated. The cross-sectional area enlarged by 22.7 % for anteromedial/intermediate graft (P = 0.002) and 28.6 % for posterolateral graft (P = 0.002) at the aperture, while decreased by 36.2 % at 10 mm from the aperture for anteromedial/intermediate graft (P = 0.004). Both the anterior and posterior walls shifted anteriorly, while the distal wall shifted distally in both tunnels. Consequently, the center in the footprint significantly shifted anteriorly (4.9-6.6 %) and distally (2.2-2.6 %) in both tunnels. The femoral tunnel enlargement occurred at the aperture after ATB ACL reconstruction, but did not occur in the middle of the femoral tunnel. The morphology at the aperture changed with time after surgery as the tunnel walls translated anteriorly and distally. Case series, Level IV.	[Tachibana, Yuta; Mae, Tatsuo; Kanamoto, Takashi; Yoshikawa, Hideki; Nakata, Ken] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; [Shino, Konsei] Yukioka Hosp, Sports Orthopaed Surg Ctr, Kita Ku, Osaka, Osaka 5300021, Japan; [Sugamoto, Kazuomi] Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, Suita, Osaka 5650871, Japan	Mae, T (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	ta-mae@umin.ac.jp					Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Segawa H, 2001, KNEE SURG SPORT TR A, V9, P206, DOI 10.1007/s001670100201; Tsuda E, 2002, ARTHROSCOPY, V18, P960, DOI 10.1053/jars.2002.36112; Oka K, 2010, CLIN ORTHOP RELAT R, V468, P2410, DOI 10.1007/s11999-010-1283-y; Kim JG, 2013, AM J SPORT MED, V41, P2512, DOI 10.1177/0363546513500626; Drogset JO, 2006, AM J SPORT MED, V34, P1164, DOI 10.1177/0363546505285384; Kawaguchi Y, 2011, KNEE SURG SPORT TR A, V19, P1249, DOI 10.1007/s00167-011-1455-7; Thomas NP, 2005, AM J SPORT MED, V33, P1701, DOI 10.1177/0363546505276759; Tomita F, 2001, ARTHROSCOPY, V17, P461, DOI 10.1053/jars.2001.24059; Choi NH, 2012, AM J SPORT MED, V40, P383, DOI 10.1177/0363546511425883; Rodeo SA, 2006, AM J SPORT MED, V34, P1790, DOI 10.1177/0363546506290059; FAHEY M, 1994, AM J SPORT MED, V22, P410, DOI 10.1177/036354659402200318; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Andriacchi TP, 2005, J BIOMECH, V38, P293, DOI 10.1016/j.jbiomech.2004.02.010; Mae T, 2013, ARTHROSCOPY, V29, P213, DOI 10.1016/j.arthro.2012.08.012; Kato Y, 2012, ARTHROSCOPY, V28, P247, DOI 10.1016/j.arthro.2011.07.019; Lee YS, 2012, KNEE SURG SPORT TR A, V20, P2243, DOI 10.1007/s00167-011-1874-5; Wilson TC, 2004, AM J SPORT MED, V32, P543, DOI 10.1177/0363546504263151; Tanaka Y, 2012, KNEE SURG SPORT TR A, V20, P95, DOI 10.1007/s00167-011-1551-8; Siebold R, 2007, ARTHROSCOPY, V23, P291, DOI 10.1016/j.arthro.2007.01.006; Segawa H, 2003, AM J SPORT MED, V31, P444; Jarvela T, 2008, ARTHROSCOPY, V24, P1349, DOI 10.1016/j.arthro.2008.07.018; Webster KE, 2001, KNEE SURG SPORT TR A, V9, P86, DOI 10.1007/s001670100191; Siebold R, 2008, ARTHROSCOPY, V24, P137, DOI 10.1016/j.arthro.2007.11.013; Buelow JU, 2002, KNEE SURG SPORT TR A, V10, P80, DOI 10.1007/s00167-001-0267-6; Yasuda K, 2006, ARTHROSCOPY, V22, P240, DOI 10.1016/j.arthro.2005.12.017; Iwahashi T, 2008, KNEE SURG SPORT TR A, V16, P167, DOI 10.1007/s00167-007-0456-z; Forsythe B, 2010, J BONE JOINT SURG AM, V92A, P1418, DOI 10.2106/JBJS.I.00654; Papageorgiou CD, 2001, AM J SPORT MED, V29, P620; Fujie H, 2011, KNEE SURG SPORT TR A, V19, pS47, DOI 10.1007/s00167-011-1513-1; Silva A, 2010, KNEE SURG SPORT TR A, V18, P1189, DOI 10.1007/s00167-010-1046-z; Siebold R, 2010, ARTHROSCOPY, V26, P1066, DOI 10.1016/j.arthro.2009.12.019; Fauno P, 2005, ARTHROSCOPY, V21, P1337, DOI 10.1016/j.arthro.2005.08.023; Simonian PT, 2000, ARTHROSCOPY, V16, P707, DOI 10.1053/jars.2000.4635; MARKOLF KL, 1990, J BONE JOINT SURG AM, V72A, P557; Mae T, 2010, ARTHROSCOPY, V26, P214, DOI 10.1016/j.arthro.2009.07.016; Berg EE, 2001, ARTHROSCOPY, V17, P189, DOI 10.1053/jars.2001.20958; Otsubo H, 2012, KNEE SURG SPORT TR A, V20, P127, DOI 10.1007/s00167-011-1576-z; Vadala A, 2007, KNEE SURG SPORT TR A, V15, P365, DOI 10.1007/s00167-006-0219-2; Taketomi S, 2014, ARTHROSCOPY, V30, P701, DOI 10.1016/j.arthro.2014.02.016; Hantes ME, 2004, ARTHROSCOPY, V20, P572, DOI 10.1016/j.arthro.2004.04.069; Clatworthy MG, 1999, KNEE SURG SPORT TR A, V7, P138, DOI 10.1007/s001670050138; Yamakado K, 2002, ARTHROSCOPY, V18, P82, DOI 10.1053/jars.2002.25966; Araki D, 2014, AM J SPORT MED, V42, P2234, DOI 10.1177/0363546514540274; Bedi Asheesh, 2009, HSS J, V5, P51, DOI 10.1007/s11420-008-9096-1; Bernard M, 1997, Am J Knee Surg, V10, P14; Höher J, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P231, DOI 10.1007/s001670050105; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; L'Insalata J C, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P234, DOI 10.1007/s001670050056; Lee YS, 2014, KNEE SURG SPORT TR A, V22, P2033, DOI 10.1007/s00167-013-2597-6; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; Norwood L A, 1979, Am J Sports Med, V7, P23, DOI 10.1177/036354657900700106; Shino K, 2005, OPER TECH ORTHOP, V15, P130, DOI 10.1053/j.oto.2004.10.012; Xu Yan, 2011, Arthroscopy, V27, P923, DOI 10.1016/j.arthro.2011.02.020	54	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2015	23	12					3591	3600		10.1007/s00167-014-3252-6		10	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CX5BN	WOS:000365715800020		
J	Mochizuki, T; Sato, T; Tanifuji, O; Kobayashi, K; Yamagiwa, H; Watanabe, S; Koga, Y; Omori, G; Endo, N				Mochizuki, Tomoharu; Sato, Takashi; Tanifuji, Osamu; Kobayashi, Koichi; Yamagiwa, Hiroshi; Watanabe, Satoshi; Koga, Yoshio; Omori, Go; Endo, Naoto			Unicompartmental knee arthroplasty cannot restore the functional flexion axis of a living knee to normal	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Functional flexion axis; Unicompartmental knee arthroplasty; Osteoarthritis and normal knees; 3D to 2D registration; Clinical epicondylar axis; Vertical translation	IN-VIVO DETERMINATION; 10-YEAR FOLLOW-UP; TRANSEPICONDYLAR AXIS; EPICONDYLAR AXIS; KINEMATICS; OSTEOARTHRITIS; ALIGNMENT; SYSTEM; PROGRESSION; ANTEROPOSTERIOR	The purpose of this study was to investigate the hypothesis that a medial unicompartmental knee arthroplasty might restore the functional flexion axis of a knee to normal. The flexion axis can be indirectly identified by tracking the vertical translation of anatomic landmarks that basically move around the flexion axis during a knee motion. If a unicompartmental knee could help restore the normal flexion axis, the anatomic landmarks after the arthroplasty would show the vertical translation similar to those of normal knees during a knee flexion. While performing a squatting motion, the kinematics of 17 knees were determined before and after a medial unicompartmental arthroplasty to calculate the vertical translation of a clinical epicondylar axis, using a three- to two-dimensional registration technique through a single-plane fluoroscopic system incorporating a biplanar static radiography. The results were compared with a normal data, and a statistical analysis including a two-way repeated-measured analysis of variance was performed. For the medial end, from 10A degrees to 100A degrees knee flexion, normal, osteoarthritic, and unicompartmental knees had the average superior vertical translation of 7.3 +/- A 4.2, 4.3 +/- A 7.2, and 2.4 +/- A 3.1 mm, respectively, with statistical significance between normal and unicompartmental knees (p < 0.001). The vertical translation did not return to normal post-implantation. A unicompartmental knee could not reproduce the normal flexion axis. As for clinical relevance, the changes of the implant design and surgical procedure may be necessary to obtain the normal flexion axis reproducing a normal motion. IV.	[Mochizuki, Tomoharu; Sato, Takashi; Watanabe, Satoshi; Koga, Yoshio] Niigata Med Ctr, Dept Orthopaed Surg, Niigata, Niigata, Japan; [Mochizuki, Tomoharu; Tanifuji, Osamu; Yamagiwa, Hiroshi; Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Dept Orthoped Surg, Niigata, Niigata, Japan; [Mochizuki, Tomoharu] Niigata Prefectural Cent Hosp, Dept Orthopaed Surg, Joetsu, Niigata, Japan; [Kobayashi, Koichi] Niigata Univ, Sch Med, Dept Hlth Sci, Niigata, Niigata, Japan; [Omori, Go] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Niigata, Japan	Mochizuki, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Dept Orthoped Surg, Niigata, Niigata, Japan.	tommochi121710@gmail.com					Becker R, 2013, KNEE SURG SPORT TR A, V21, P2427, DOI 10.1007/s00167-012-2157-5; Blaha JD, 2004, J ARTHROPLASTY, V19, P22, DOI 10.1016/j.arth.2004.04.002; Blaha JD, 2003, CLIN ORTHOP RELAT R, P25; Tanifuji O, 2011, J ORTHOP SCI, V16, P710, DOI 10.1007/s00776-011-0149-9; Mochizuki T, 2013, J ORTHOP SCI, V18, P54, DOI 10.1007/s00776-012-0322-9; Tanifuji O, 2013, KNEE SURG SPORT TR A, V21, P2301, DOI 10.1007/s00167-012-2010-x; Berger RA, 1999, CLIN ORTHOP RELAT R, P50; Eckhoff DG, 2005, J BONE JOINT SURG AM, V87A, P71, DOI 10.2106/JBJS.E.00440; Brandt KD, 2008, RHEUM DIS CLIN N AM, V34, P531, DOI 10.1016/j.rdc.2008.05.011; [Anonymous], 1993, CLIN ORTHOPAEDICS; Patil S, 2005, J BONE JOINT SURG AM, V87A, P332, DOI 10.2106/JBJS.C.01467; Mochizuki T, 2014, J ORTHOP SCI, V19, P451, DOI 10.1007/s00776-014-0536-0; Argenson JNA, 2002, J BONE JOINT SURG AM, V84A, P2235; Asano T, 2005, J ARTHROPLASTY, V20, P1060, DOI 10.1016/j.arth.2004.08.005; Kobayashi K, 2009, J BIOMECH, V42, P2818, DOI 10.1016/j.jbiomech.2009.08.022; Most E, 2004, J BIOMECH, V37, P1743, DOI 10.1016/j.jbiomech.2004.01.025; Brouwer GM, 2007, ARTHRITIS RHEUM, V56, P1204, DOI 10.1002/art.22515; Sato T, 2004, J ARTHROPLASTY, V19, P620, DOI 10.1016/j.arth.2003.12.063; HOLLISTER AM, 1993, CLIN ORTHOP RELAT R, P259; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Yoshino N, 2001, J ARTHROPLASTY, V16, P493, DOI 10.1054/arth.2001.23621; Argenson JNA, 2002, J ARTHROPLASTY, V17, P1049, DOI 10.1054/arth.2002.34527; Akizuki S, 2009, J ARTHROPLASTY, V24, P963, DOI 10.1016/j.arth.2008.06.013; Cerejo R, 2002, ARTHRITIS RHEUM, V46, P2632, DOI 10.1002/art.10530; Blaha JD, 2002, ORTHOPEDICS, V25, P963; Colle F, 2012, KNEE SURG SPORT TR A, V20, P552, DOI 10.1007/s00167-011-1604-z; Churchill DL, 1998, CLIN ORTHOP RELAT R, P111; Haaker P, 1990, INT J CARDIAC IMAGIN, V6, P36; Kobayashi K, 2009, J JPN SOC EXP MECH, V9, P162; Mochizuki T, 2013, KNEE SURG SPORT TR A, V22, P1911	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2015	23	12					3736	3742		10.1007/s00167-014-3296-7		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CX5BN	WOS:000365715800039		
J	Muneta, T; Koga, H; Nakamura, T; Horie, M; Watanabe, T; Yagishita, K; Sekiya, I				Muneta, Takeshi; Koga, Hideyuki; Nakamura, Tomomasa; Horie, Masafumi; Watanabe, Toshifumi; Yagishita, Kazuyoshi; Sekiya, Ichiro			A new behind-remnant approach for remnant-preserving double-bundle anterior cruciate ligament reconstruction compared with a standard approach	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Anterior cruciate ligament reconstruction; Anterior cruciate ligament anatomy; Remnant preserving; Femoral tunnel creation; Behind-remnant approach	FEMORAL TUNNEL PLACEMENT; ANATOMIC RECONSTRUCTION; ATTACHMENT; PRESERVATION; LOCATION	To introduce a new behind-remnant approach for double-bundle (DB) anterior cruciate ligament (ACL) reconstruction and to compare the femoral tunnel positions of anteromedial (AM) and posterolateral (PL) bundles between the new and standard procedures by a three-dimensional computed tomography (3D-CT). During DB ACL reconstruction, two approaches for femoral tunnel creation were consecutively practiced from 2010 to 2012. The patients were evaluated retrospectively as a cohort study. A total of 200 primary ACL reconstructions have been performed using a transtibial approach. One approach was a standard approach from the front in which the ACL remnant was peeled off from the attachment, and two guide wires were inserted based on anatomic bony landmarks (standard group). The other approach was a new behind-remnant approach in which the ACL remnant was kept untouched and two guide wires were inserted at the posterior margin of the direct ACL insertion (behind-remnant group). The position of the AM and PL femoral tunnels was expressed on a 3D-CT reconstructive image using the quadrant method with a statistical analysis. The depth of the AM center was 24 +/- A 6 % (mean and standard deviation) in the standard group and 22 +/- A 5 % in the behind-remnant group. The height of the AM tunnel center was 22 +/- A 8 % in the standard group and 31 +/- A 8 % in the behind-remnant group. The depth of the PL tunnel center was 32 +/- A 6 % in the standard group and 35 +/- A 5 % in the behind-remnant group. The height of the PL tunnel center was 47 +/- A 9 % in the standard group and 55 +/- A 7 % in the behind-remnant group. The AM and PL femoral tunnels in both groups were created within the normal anatomic footprint of the previous studies. The behind-remnant approach created a significantly lower femoral tunnel for both AM (p = 0.000) and PL tunnels (p = 0.000). The depth of both AM and PL tunnels was not significantly different between the two groups (n.s.). The new behind-remnant procedure is technically simple and reproducible as a remnant-preserving ACL reconstruction. Cohort study, Level III.	[Muneta, Takeshi; Koga, Hideyuki; Nakamura, Tomomasa; Horie, Masafumi; Watanabe, Toshifumi; Yagishita, Kazuyoshi; Sekiya, Ichiro] Tokyo Med & Dent Univ, Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Muneta, Takeshi] Tokyo Med & Dent Univ, Grad Sch, Dept Joint Surg & Sports Med, Bunkyo Ku, Tokyo 1138519, Japan	Muneta, T (reprint author), Tokyo Med & Dent Univ, Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	muneta.orj@tmd.ac.jp					Ahn JH, 2014, ARTHROSC TECH, V20, pe175; Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Mochizuki T, 2006, ARTHROSCOPY, V22, P356, DOI 10.1016/j.arthro.2005.09.020; Yasuda K, 2012, ARTHROSCOPY, V28, P343, DOI 10.1016/j.arthro.2011.08.305; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Sasaki N, 2012, ARTHROSCOPY, V28, P1135, DOI 10.1016/j.arthro.2011.12.021; Yamamoto Y, 2004, AM J SPORT MED, V32, P1825, DOI 10.1177/0363546504263947; Nakamae A, 2010, ARTHROSCOPY, V26, P1577, DOI 10.1016/j.arthro.2010.04.076; Yasuda K, 2004, ARTHROSCOPY, V20, P1015, DOI 10.1016/j.arthro.2004.08.010; Muneta T, 2013, KNEE SURG SPORT TR A, V21, P906, DOI 10.1007/s00167-012-2023-5; Wu B, 2013, ARTHROSCOPY, V29, P1362, DOI 10.1016/j.arthro.2013.05.010; Kerner S, 2007, J CLIN PERIODONTOL, V34, P969, DOI 10.1111/j.1600-051X.2007.01137.x; Tsukada H, 2008, J ORTHOP SCI, V13, P122, DOI 10.1007/s00776-007-1203-5; Maeda S, 2011, ARTHROSCOPY, V27, P1203, DOI 10.1016/j.arthro.2011.03.080; Mochizuki T, 2014, KNEE SURG SPORT TR A, V22, P336, DOI 10.1007/s00167-013-2404-4; Papalia R, 2012, BRIT MED BULL, V104, P91, DOI 10.1093/bmb/ldr053; Forsythe B, 2010, J BONE JOINT SURG AM, V92A, P1418, DOI 10.2106/JBJS.I.00654; Inoue M, 2010, KNEE SURG SPORT TR A, V18, P1176, DOI 10.1007/s00167-009-0989-4; Colombet P, 2006, ARTHROSCOPY, V22, P984, DOI 10.1016/j.arthro.2006.04.102; Bernard M, 1997, Am J Knee Surg, V10, P14; Horie M, 2013, KNEE SURG SPORTS TRA; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; Muneta T, 2011, SPORTS MED ARTHROSC, V28, P15; Ochi M, 2011, SPORTS MED ARTHROSC, V5, P30; Zantop T, 2008, AM J SPORT MED, V36, P678, DOI 10.1177/0363546508314414	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2015	23	12					3743	3749		10.1007/s00167-014-3300-2		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CX5BN	WOS:000365715800040		
J	Shukuya, T; Yamanaka, T; Seto, T; Daga, H; Goto, K; Saka, H; Sugawara, S; Takahashi, T; Yokota, S; Kaneda, H; Kawaguchi, T; Nagase, S; Oguri, T; Iwamoto, Y; Nishimura, T; Hattori, Y; Nakagawa, K; Nakanishi, Y; Yamamoto, N				Shukuya, Takehito; Yamanaka, Takeharu; Seto, Takashi; Daga, Haruko; Goto, Koichi; Saka, Hideo; Sugawara, Shunichi; Takahashi, Toshiaki; Yokota, Soichiro; Kaneda, Hiroyasu; Kawaguchi, Tomoya; Nagase, Seisuke; Oguri, Tetsuya; Iwamoto, Yasuo; Nishimura, Takashi; Hattori, Yoshihiro; Nakagawa, Kazuhiko; Nakanishi, Yoichi; Yamamoto, Nobuyuki		West Japan Oncology Grp	Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial	LANCET ONCOLOGY			English	Article							1ST-LINE THERAPY; III TRIAL; CANCER; CHEMOTHERAPY; GEMCITABINE; CARBOPLATIN; PACLITAXEL; BEVACIZUMAB; COMBINATION; PLACEBO	Background The combination of nedaplatin, a cisplatin derivative, and docetaxel showed promising activity for advanced squamous cell lung carcinoma in a previous phase 1-2 study. We compared nedaplatin plus docetaxel with cisplatin plus docetaxel in patients with previously untreated advanced or relapsed squamous cell lung carcinoma to determine effects on overall survival. Methods We did a randomised, open-label, phase 3 study at 53 institutions in Japan. Eligibility criteria included pathologically proven squamous cell lung cancer with stage IIIB/IV or postoperative recurrence, age 20-74 years, Eastern Cooperative Oncology Group performance status of 0-1, no previous chemotherapy or recurrence more than a year after previous adjuvant chemotherapy, and adequate organ function. Patients were randomly assigned (1: 1) to 100 mg/m(2) nedaplatin and 60 mg/m(2) docetaxel intravenously, or 80 mg/m(2) cisplatin and 60 mg/m(2) docetaxel, every 3 weeks for four to six cycles (at the treating oncologist's discretion). Randomisation was done centrally at the West Japan Oncology Group data centre via a computer-generated allocation sequence with dynamic minimisation that balanced stage (IIIB/IV or postoperative recurrent), sex, and institution. The primary endpoint was overall survival in the modified intention-to-treat population (ie, all patients who were randomly assigned and met the inclusion criteria). Safety analyses were done in all randomly assigned patients who received at least one dose of the study regimen. This trial is registered with the UMIN Clinical Trials Registry, number UMIN000002015, and is closed to new participants. Findings Between July 6, 2009, and July 26, 2012, 355 patients were randomly assigned. 349 patients were included in the modified intention-to-treat analysis (177 in the nedaplatin group and 172 in the cisplatin group). Overall survival was significantly longer in the nedaplatin group (median 13.6 months, 95% CI 11.6-15.6) than in the cisplatin group (11.4 months, 10.2-12.2; hazard ratio 0.81, 95% CI 0.65-1.02; p=0.037, one-sided stratified log-rank test). Grade 3 or worse nausea (seven of 177 patients in the nedaplatin group and 25 of 175 in the cisplatin group), fatigue (six vs 20), hyponatraemia (24 vs 53), and hypokalaemia (four vs 15) were more frequent in the cisplatin group than in the nedaplatin group, whereas grade 3 or worse leucopenia (98 vs 77), neutropenia (146 vs 123), and thrombocytopenia (16 vs none) were more frequent in the nedaplatin group than in the cisplatin group. Treatment-related deaths occurred in four and three patients in nedaplatin and cisplatin groups, respectively. Interpretation Overall survival was significantly longer with nedaplatin plus docetaxel than with cisplatin plus docetaxel, and the regimens had different safety profiles. Nedaplatin plus docetaxel could be a new treatment option for advanced or relapsed squamous cell lung cancer.	[Shukuya, Takehito] Juntendo Univ, Dept Resp Med, Tokyo, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa, Japan; [Seto, Takashi] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; [Daga, Haruko] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Chiba, Japan; [Saka, Hideo] Natl Hosp Org, Nagoya Med Ctr, Dept Resp Med & Med Oncol, Nagoya, Aichi, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Yokota, Soichiro] Natl Hosp Org, Toneyama Natl Hosp, Dept Resp Med, Osaka, Japan; [Kaneda, Hiroyasu; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Kawaguchi, Tomoya] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka 558, Japan; [Nagase, Seisuke] Tokyo Med Univ, Dept Thorac Surg, Tokyo 1608402, Japan; [Oguri, Tetsuya] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan; [Iwamoto, Yasuo] Hiroshima City Hosp, Dept Med Oncol, Hiroshima, Japan; [Nishimura, Takashi] Kyoto Katsura Hosp, Dept Resp Med, Kyoto, Japan; [Hattori, Yoshihiro] Hyogo Canc Ctr, Dept Thorac Oncol, Kobe, Hyogo, Japan; [Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 812, Japan; [Yamamoto, Nobuyuki] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan	Yamamoto, N (reprint author), Wakayama Med Univ, Dept Internal Med 3, 811-1 Kimiidera, Wakayama, Wakayama 6418509, Japan.	nbyamamo@wakayama-med.ac.jp			West Japan Oncology Group, a non-profit organisation; Sanofi	This study was done and funded by the West Japan Oncology Group, a non-profit organisation. This study was also partly supported by Sanofi. We thank the patients and their families for their support and participation in this trial. We thank the data managers and other supporting staff of the West Japan Oncology Group, especially Kaori Mori and Shinichiro Nakamura.	Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Gandara DR, 2009, J CLIN ONCOL, V27, P3540, DOI 10.1200/JCO.2008.20.8793; Thatcher N, 2015, LANCET ONCOL, V16, P763, DOI 10.1016/S1470-2045(15)00021-2; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Ellis LM, 2014, J CLIN ONCOL, V32, P1277, DOI 10.1200/JCO.2013.53.8009; Jin JH, 2009, J THORAC ONCOL, V4, P1017, DOI 10.1097/JTO.0b013e3181add9c7; Gao GH, 2012, INT J CANCER, V131, pE822, DOI 10.1002/ijc.27396; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Kenmotsu H, 2015, CANCER SCI, V106, P497, DOI 10.1111/cas.12647; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Yamamoto N, 2009, CANCER CHEMOTH PHARM, V65, P79, DOI 10.1007/s00280-009-1006-9; Kubota K, 2004, J CLIN ONCOL, V22, P254, DOI 10.1200/JCO.2004.06.114; FUKUDA M, 1990, CANCER CHEMOTH PHARM, V26, P393, DOI 10.1007/BF02994087; Socinski MA, 2012, J CLIN ONCOL, V30, P2055, DOI 10.1200/JCO.2011.39.5848; Naito Y, 2011, ANN ONCOL, V22, P2471, DOI 10.1093/annonc/mdq781; Furuse K, 1992, Gan To Kagaku Ryoho, V19, P879; Japan Lung Cancer Society, GUID TREATM LUNG CAN; Meza R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121323; Nakajima O, 1994, JPN J LUNG CANC, V34, P313; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Ota K, 1992, Gan To Kagaku Ryoho, V19, P855; Shimada Muneaki, 2013, Cancer Manag Res, V5, P67, DOI 10.2147/CMAR.S35785; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI 10.1056/NEJMoa1408440; The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, EFF GUID STAT PRINC; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2015	16	16					1630	1638		10.1016/S1470-2045(15)00305-8		9	Oncology	Oncology	CX6IF	WOS:000365803700058		
J	Moriyama, T; Metzger, ML; Wu, G; Nishii, R; Qian, MX; Devidas, M; Yang, WJ; Cheng, C; Cao, XY; Quinn, E; Raimondi, S; Gastier-Foster, JM; Raetz, E; Larsen, E; Martin, PL; Bowman, WP; Winick, N; Komada, Y; Wang, SG; Edmonson, M; Xu, H; Mardis, E; Fulton, R; Pui, CH; Mullighan, C; Evans, WE; Zhang, JH; Hunger, SP; Relling, MV; Nichols, KE; Loh, ML; Yang, JJ				Moriyama, Takaya; Metzger, Monika L.; Wu, Gang; Nishii, Rina; Qian, Maoxiang; Devidas, Meenakshi; Yang, Wenjian; Cheng, Cheng; Cao, Xueyuan; Quinn, Emily; Raimondi, Susana; Gastier-Foster, Julie M.; Raetz, Elizabeth; Larsen, Eric; Martin, Paul L.; Bowman, W. Paul; Winick, Naomi; Komada, Yoshihiro; Wang, Shuoguo; Edmonson, Michael; Xu, Heng; Mardis, Elaine; Fulton, Robert; Pui, Ching-Hon; Mullighan, Charles; Evans, William E.; Zhang, Jinghui; Hunger, Stephen P.; Relling, Mary V.; Nichols, Kim E.; Loh, Mignon L.; Yang, Jun J.			Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study	LANCET ONCOLOGY			English	Article							CHILDRENS ONCOLOGY GROUP; MINIMAL RESIDUAL DISEASE; SEQUENCING DATA; VARIANTS; SUSCEPTIBILITY; MUTATIONS; REARRANGEMENT; RELAPSE; THROMBOCYTOPENIA; MECHANISMS	Background Hereditary predisposition is rarely suspected for childhood acute lymphoblastic leukaemia (ALL). Recent reports of germline ETV6 variations associated with substantial familial clustering of haematological malignancies indicated that this gene is a potentially important genetic determinant for ALL susceptibility. Our aims in this study were to comprehensively identify ALL predisposition variants in ETV6 and to determine the extent to which they contributed to the overall risk of childhood ALL. Methods Whole-exome sequencing of an index family with several cases of ALL was done to identify causal variants for ALL predisposition. Targeted sequencing of ETV6 was done in children from the Children's Oncology Group and St Jude Children's Research Hospital front-line ALL trials. Patients were included in this study on the basis of their enrolment in these clinical trials and the availability of germline DNA. ETV6 variant genotypes were compared with non-ALL controls to define ALL-related germline risk variants. ETV6 variant function was characterised bioinformatically and correlated with clinical and demographic features in children with ALL. Findings We identified a novel non-sense ETV6 variant (p.Arg359X) with a high penetrance in an index family. Subsequent targeted sequencing of ETV6 in 4405 childhood ALL cases identified 31 exonic variants (four non-sense, 21 missense, one splice site, and five frameshift variants) that were potentially related to ALL risk in 35 cases (1%). 15 (48%) of 31 ALL-related ETV6 variants clustered in the erythroblast transformation specific domain and were predicted to be highly deleterious. Children with ALL-related ETV6 variants were significantly older at leukaemia diagnosis than those without (10.2 years [IQR 5.3-13.8] vs 4.7 years [3.0-8.7]; p=0.017). The hyperdiploid leukaemia karyotype was highly over-represented in ALL cases harbouring germline ETV6 risk variants compared with the wildtype group (nine [64%] of 14 cases vs 538 [27%] of 2007 cases; p=0.0050). Interpretation Our findings indicated germline ETV6 variations as the basis of a novel genetic syndrome associated with predisposition to childhood ALL. The development of recommendations for clinical interventions and surveillance for individuals harbouring ALL-related ETV6 variants are needed.	[Moriyama, Takaya; Nishii, Rina; Qian, Maoxiang; Yang, Wenjian; Evans, William E.; Relling, Mary V.; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Metzger, Monika L.; Quinn, Emily; Pui, Ching-Hon; Nichols, Kim E.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Wu, Gang; Wang, Shuoguo; Edmonson, Michael; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Cheng, Cheng; Cao, Xueyuan] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Raimondi, Susana; Pui, Ching-Hon; Mullighan, Charles] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Pui, Ching-Hon; Mullighan, Charles; Evans, William E.; Relling, Mary V.; Yang, Jun J.] St Jude Childrens Res Hosp, Ctr Comprehens Canc, Hematol Malignancies Program, Memphis, TN 38105 USA; [Moriyama, Takaya; Komada, Yoshihiro] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie, Japan; [Nishii, Rina] Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Tokyo, Japan; [Devidas, Meenakshi] Univ Florida, Coll Med Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Raetz, Elizabeth] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Larsen, Eric] Maine Childrens Canc Program, Scarborough, ME USA; [Martin, Paul L.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Bowman, W. Paul] Cook Childrens Med Ctr, Ft Worth, TX USA; [Winick, Naomi] Univ Texas SW Med Ctr Dallas, Pediat Hematol Oncol, Dallas, TX 75390 USA; [Xu, Heng] Sichuan Univ, Dept Lab Med, Natl Key Lab Biotherapy, Ctr Biotherapy & Canc Ctr,West China Hosp, Chengdu 610064, Peoples R China; [Mardis, Elaine; Fulton, Robert] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Loh, Mignon L.] Univ Calif San Francisco, Benioff Childrens Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Loh, Mignon L.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Yang, JJ (reprint author), St Jude Childrens Res Hosp, Hematol Malignancies Program, Pharmaceut Sci, MS313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	jun.yang@stjude.org			US National Institutes of Health [CA21765, CA98543, CA114766, CA98413, CA180886, CA180899, GM92666, GM115279, GM097119]; American Lebanese Syrian Associated Charities; American Society of Hematology Scholar Award; Order of St Francis Foundation; Study-Abroad Scholarship of Mie Prefecture, Japan	This work was supported by the US National Institutes of Health (grant numbers CA21765, CA98543, CA114766, CA98413, CA180886, CA180899, GM92666, GM115279, and GM097119) and the American Lebanese Syrian Associated Charities. JJY is supported by the American Society of Hematology Scholar Award and by the Order of St Francis Foundation, and TM is supported by the Study-Abroad Scholarship of Mie Prefecture, Japan. We thank the patients and parents who participated in the St Jude Children's Research Hospital and COG protocols included in this study, the clinicians and research staff at St Jude Children's Research Hospital and COG institutions, and Jeanette Pullen (University of Mississippi, Jackson, MS, USA) and Andrew Carroll (University of Alabama, Birmingham, AL, USA) for assistance in the classification of patients with ALL; and Mark Shriver (Pennsylvania State University, University Park, PA, USA) for sharing SNP genotype data of the Native American references.	Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stanulla M, 2009, SEMIN HEMATOL, V46, P52, DOI 10.1053/j.seminhematol.2008.09.007; Pritchard JK, 2000, GENETICS, V155, P945; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Fernandez CA, 2015, BLOOD, V126, P69, DOI 10.1182/blood-2015-02-628800; Alpar D, 2015, LEUKEMIA, V29, P839, DOI 10.1038/leu.2014.322; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Kinlen L, 2011, BRIT J CANCER, V104, P12, DOI 10.1038/sj.bjc.6605982; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Hemminki K, 2002, LEUKEMIA, V16, P297, DOI 10.1038/sj.leu.2402351; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Moriyama T, 2015, BLOOD, V125, P3988, DOI 10.1182/blood-2014-12-580001; Bhojwani D, 2012, LEUKEMIA, V26, P265, DOI 10.1038/leu.2011.227; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Noetzli L, 2015, NAT GENET, V47, P535, DOI 10.1038/ng.3253; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Guidez F, 2000, BLOOD, V96, P2557; Borowitz MJ, 2015, BLOOD, V126, P964, DOI 10.1182/blood-2015-03-633685; Kharazmi E, 2012, BRIT J HAEMATOL, V159, P585, DOI 10.1111/bjh.12069; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Edmonson MN, 2011, BIOINFORMATICS, V27, P865, DOI 10.1093/bioinformatics/btr032; Pui CH, 1998, BLOOD, V92, P411; De Soumya, 2014, J Mol Biol, V426, P1390, DOI 10.1016/j.jmb.2013.11.031; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Moorman AV, 2014, BLOOD, V124, P1434, DOI 10.1182/blood-2014-03-562918; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Topka S, GERMLINE ETV6 MUTATI; Xu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8553; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177	55	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2015	16	16					1659	1666		10.1016/S1470-2045(15)00369-1		8	Oncology	Oncology	CX6IF	WOS:000365803700061		
J	Matsuoka, A; Maeda, O; Ando, Y				Matsuoka, Ayumu; Maeda, Osamu; Ando, Yuichi			TRIBE study: are all three cytotoxic drugs crucial?	LANCET ONCOLOGY			English	Letter							ADVANCED COLORECTAL-CANCER; FOLFIRI PLUS BEVACIZUMAB; 1ST-LINE TREATMENT; OPEN-LABEL; SURVIVAL		[Matsuoka, Ayumu; Maeda, Osamu; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668550, Japan	Matsuoka, A (reprint author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668550, Japan.	ayumu0611@med.nagoya-u.ac.jp	MAEDA, Osamu/Q-1016-2015				Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Cremolini C, 2015, LANCET ONCOL, V16, P1306, DOI 10.1016/S1470-2045(15)00122-9	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2015	16	16					CP15	CP15				1	Oncology	Oncology	CX6IF	WOS:000365803700002		
J	Honda, K; Gyawali, B; Ando, Y				Honda, Kazunori; Gyawali, Bishal; Ando, Yuichi			Survival of patients with metastatic breast cancer with or without locoregional therapy	LANCET ONCOLOGY			English	Letter									[Honda, Kazunori; Gyawali, Bishal; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668550, Japan	Honda, K (reprint author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668550, Japan.	kh99081@med.nagoya-u.ac.jp					Badwe R, 2015, LANCET ONCOL, V16, P1380, DOI 10.1016/S1470-2045(15)00135-7	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2015	16	16					E586	E586				1	Oncology	Oncology	CX6IF	WOS:000365803700013		
J	Kawata, S; Noguchi, K; Suzuki, T; Karino, T; Barada, D; Ogoyski, AI; Ma, YY				Kawata, S.; Noguchi, K.; Suzuki, T.; Karino, T.; Barada, D.; Ogoyski, A. I.; Ma, Y. Y.			Uniformity of fuel target implosion in heavy ion fusion	LASER AND PARTICLE BEAMS			English	Article						Heavy-ion beam; Hot-spot dynamics; Implosion uniformity; Inertial confinement fusion; Non-uniformity mitigation	INERTIAL CONFINEMENT FUSION; RAYLEIGH-TAYLOR INSTABILITY; DYNAMIC STABILIZATION; DRIVEN; BEAM; SYMMETRY; ENERGY; PLASMA; GAIN	In inertial confinement fusion the target implosion non-uniformity is introduced by a driver beams' illumination non-uniformity, a fuel target alignment error in a fusion reactor, the target fabrication defect, etc. For a steady operation of a fusion power plant the target implosion should be robust against the implosion non-uniformities. In this paper the requirement for the implosion uniformity is first discussed. The implosion uniformity should be less than a few percent. A study on the fuel hotspot dynamics is also presented and shows that the stagnating plasma fluid provides a significant enhancement of vorticity at the final stage of the fuel stagnation. Then non-uniformity mitigation mechanisms of the heavy-ion beam (HIB) illumination are also briefly discussed in heavy ion inertial fusion (HIF). A density valley appears in the energy absorber, and the large-scale density valley also works as a radiation energy confinement layer, which contributes to a radiation energy smoothing. In HIF a wobbling HIB illumination was also introduced to realize a uniform implosion. In the wobbling HIBs illumination, the illumination non-uniformity oscillates in time and space on a HIF target. The oscillating-HIB energy deposition may contribute to the reduction of the HIBs' illumination non-uniformity by its smoothing effect on the HIB illumination non-uniformity and also by a growth mitigation effect on the Rayleigh-Taylor instability.	[Kawata, S.; Noguchi, K.; Suzuki, T.; Karino, T.; Barada, D.; Ma, Y. Y.] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan; [Kawata, S.; Barada, D.; Ma, Y. Y.] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan; [Ogoyski, A. I.] Tech Univ Varna, Dept Phys, Ulitska, Varna, Bulgaria	Kawata, S (reprint author), Utsunomiya Univ, Grad Sch Engn, Yohtoh 7-1-2, Utsunomiya, Tochigi 3218585, Japan.	kwt@cc.utsunomiya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Center for Optical Research and Education, Utsunomiya University Japan (CORE); program of High-End Foreign Expert in China; ASian core program for High energy density science Using intense LAser photons (ASHULA) project; Japan-US fusion collaboration program; ILE, Osaka University	The work was partly supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Society for the Promotion of Science (JSPS), Center for Optical Research and Education, Utsunomiya University Japan (CORE), the program of High-End Foreign Expert in China, ASian core program for High energy density science Using intense LAser photons (ASHULA) project, Japan-US fusion collaboration program, and ILE, Osaka University. The authors also appreciate Prof. Yongtao Zhao and Prof. Dieter Hoffmann, the Chairmen of the 20th International Symposium on Heavy-Ion Inertial Fusion (HIF2014) for their perfect organization of HIF2014, Prof. K. Tanaka in Osaka University and Friends in US Heavy Ion Fusion Virtual National Laboratory for their fruitful discussions and supports.	KAWATA S, 1993, LASER PART BEAMS, V11, P757; Miyazawa K, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2140684; SKUPSKY S, 1983, J APPL PHYS, V54, P3662, DOI 10.1063/1.332599; Someya T, 2004, PHYS REV SPEC TOP-AC, V7, DOI 10.1103/PhysRevSTAB.7.044701; Logan BG, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2950303; Basko MM, 2004, PHYS PLASMAS, V11, P1577, DOI 10.1063/1.1650352; Petzoldt RW, 1998, FUSION TECHNOL, V34, P831; Piriz AR, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3633487; Abarzhi SI, 2010, PHILOS T R SOC A, V368, P1809, DOI 10.1098/rsta.2010.0020; Piriz AR, 2003, PLASMA PHYS CONTR F, V45, P1733, DOI 10.1088/0741-3335/45/9/311; Piriz AR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017501; Piriz AR, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026317; Kawata S, 2009, NUCL INSTRUM METH A, V606, P152, DOI 10.1016/j.nima.2009.03.188; Park HS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.055001; Hurricane OA, 2014, NATURE, V506, P343, DOI 10.1038/nature13008; Ogoyski AI, 2010, COMPUT PHYS COMMUN, V181, P1332, DOI 10.1016/j.cpc.2010.03.016; WEIBEL ES, 1959, PHYS REV LETT, V2, P83, DOI 10.1103/PhysRevLett.2.83; BODNER SE, 1974, PHYS REV LETT, V33, P761, DOI 10.1103/PhysRevLett.33.761; TAKABE H, 1985, PHYS FLUIDS, V28, P3676, DOI 10.1063/1.865099; TROYON F, 1971, PHYS FLUIDS, V14, P2069, DOI 10.1063/1.1693294; EMERY MH, 1982, PHYS REV LETT, V48, P253, DOI 10.1103/PhysRevLett.48.253; WOLF GH, 1970, PHYS REV LETT, V24, P444, DOI 10.1103/PhysRevLett.24.444; ARNOLD RC, 1987, REP PROG PHYS, V50, P559, DOI 10.1088/0034-4885/50/5/002; KAWATA S, 1984, J PHYS SOC JPN, V53, P3416, DOI 10.1143/JPSJ.53.3416; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; BETTI R, 1993, PHYS REV LETT, V71, P3131, DOI 10.1103/PhysRevLett.71.3131; ARNOLD RC, 1982, NUCL INSTRUM METHODS, V199, P557, DOI 10.1016/0167-5087(82)90157-0; Someya T, 2006, LASER PART BEAMS, V24, P359, DOI 10.1017/S0263034606060526; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; Kawata S, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3680617; Atzeni S., 2004, PHYS INERTIAL FUSION; Bodner S., 1981, J FUSION ENERG, V1, P221, DOI 10.1007/BF01050355; Boris J. P., 1977, Comments on Plasma Physics and Controlled Fusion, V3; Ertel H., 1942, METEOROL Z, V59, P277; Kawata S., 2013, NUCL INSTRUM METH A, V733, P211; Lifshitz E.M., 1959, FLUID MECH; Qin H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.254801; Someya T, 2006, THESIS	38	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	DEC	2015	33	4					591	599		10.1017/S026303461500066X		9	Physics, Applied	Physics	CX5HC	WOS:000365731700001		
J	Kondo, K; Yokozuka, T; Oguri, Y				Kondo, Kotaro; Yokozuka, Tomohiro; Oguri, Yoshiyuki			Well-defined atomic hydrogen target driven by electromagnetic shock wave for stopping power measurement	LASER AND PARTICLE BEAMS			English	Article						Electromagnetic shock tube; Heavy-ion fusion; Stopping power	IONS; IGNITION; PLASMA	The precise estimation of stopping power is crucial to predict the beam energy loss in the target for heavy-ion fusion and heavy-ion-driven high-energy density physics experiments. The electromagnetic shock wave has been proposed to generate a well-defined atomic hydrogen target for the stopping power measurement with dissociation effects. We measured the angular distribution profile of the discharge plasma and the plasma velocity in the electromagnetic shock tube by high-speed framing cameras. To improve the uniformity of the discharge plasma and the velocity, an external magnetic field was applied in the electromagnetic shock tube. The plasma velocity was up to approximately 40 km/s for an initial hydrogen gas pressure of 100 Pa and the velocity decreased with the initial pressure and the propagation length. The framing cameras showed that angular distributions of the discharge plasmas were not uniform and the initial angular distributions were important for the development of plasma profiles. The interaction of the plasma with the external magnetic field was estimated using the ratio of the plasma dynamic pressure to the magnetic pressure. The estimations offer more magnetic fields to improve the discharge uniformity due to the interaction.	[Kondo, Kotaro; Yokozuka, Tomohiro; Oguri, Yoshiyuki] Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Tokyo 1528550, Japan	Kondo, K (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, 2-12-1 N1-14 Ookayama, Tokyo 1528550, Japan.	kotaro@nr.titech.ac.jp			NSF-JSPS program	This work was supported by NSF-JSPS program. We would like to thank S. Fujioka at Osaka University for NSF-JSPS program and N. Tsuruoka at Tokyo Institute of Technology for his support in preparation of the experimental apparatus.	Alfven H., 1960, Journal of Nuclear Energy. C. Plasma Physics, Accelerators, Thermonuclear Research, V1, DOI 10.1016/0368-3281(60)90002-4; Zwicknagel G, 1998, NUCL INSTRUM METH A, V415, P680, DOI 10.1016/S0168-9002(98)00448-3; Kondo K, 2014, NUCL INSTRUM METH A, V733, P1, DOI 10.1016/j.nima.2013.05.105; Grisham LR, 2004, PHYS PLASMAS, V11, P5727, DOI 10.1063/1.1806137; Hasegawa J, 2009, NUCL INSTRUM METH A, V606, P205, DOI 10.1016/j.nima.2009.03.102; Paul H, 2006, NUCL INSTRUM METH B, V247, P166, DOI 10.1016/j.nimb.2006.01.059; Kondo K, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2179409; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Ogawa M, 2000, LASER PART BEAMS, V18, P647, DOI 10.1017/S0263034600184083; Zwicknagel G, 2009, LASER PART BEAMS, V27, P399, DOI 10.1017/S0263034609000524; Roth M, 2001, PHYS REV LETT, V86, P436, DOI 10.1103/PhysRevLett.86.436; Kondo K., 2015, J PHYS C SE IN PRESS	12	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	DEC	2015	33	4					679	683		10.1017/S0263034615000087		5	Physics, Applied	Physics	CX5HC	WOS:000365731700010		
J	Yang, ZH; Inoue, S; Taniguchi, Y; Miyahara, H; Iwasaki, Y; Takeo, J; Sakaue, H; Nakaya, Y				Yang, Zhi-Hong; Inoue, Seika; Taniguchi, Yasuko; Miyahara, Hiroko; Iwasaki, Yusuke; Takeo, Jiro; Sakaue, Hiroshi; Nakaya, Yutaka			Long-term dietary supplementation with saury oil attenuates metabolic abnormalities in mice fed a high-fat diet: combined beneficial effect of omega-3 fatty acids and long-chain monounsaturated fatty acids	LIPIDS IN HEALTH AND DISEASE			English	Article							INSULIN-RESISTANCE; EICOSAPENTAENOIC ACID; HDL-CHOLESTEROL; C57BL/6J MICE; RISK-FACTORS; OBESITY; DISEASE; EXPRESSION; ADIPOSITY; TISSUE	Background: Pacific saury is a common dietary component in East Asia. Saury oil contains considerable levels of n-3 unsaturated fatty acids (PUFA) and long-chain monounsaturated fatty acids (LCMUFA) with aliphatic tails longer than 18 carbons. In our previous study, consumption of saury oil for 4 to 6 wk improved insulin sensitivity and the plasma lipid profile in mice. However, the long-term effects of saury oil on metabolic syndrome (MetS) risk factors remain to be demonstrated. In the current study, we examined the long-term effects of saury oil on mice fed a high-fat diet, and compared the effect of n-3 PUFA EPA and LCMUFA on MetS risk factor in diet-induced obese mice. Methods and Results: In Experiment 1, male C57BL/6 J mice were fed either a 32 % lard diet (control) or a diet containing 22 % lard plus 10 % saury oil (saury oil group) for 18 weeks. Although no differences were found in body weight and energy expenditure between the control and saury oil groups, the saury oil diet decreased plasma insulin, non-HDL cholesterol, hepatic steatosis, and adipocyte size, and altered levels of mRNA transcribed from genes involved in insulin signaling and inflammation in adipose tissue. Organ and plasma fatty acid profile analysis revealed that consumption of saury oil increased n-3 PUFA and LCMUFA (especially n-11 LCMUFA) levels in multiple organs, and decreased the fatty acid desaturation index (C16:1/C16:0; C18:1/C18:0) in liver and adipose tissue. In Experiment 2, male C57BL/6 J mice were fed a 32 % lard diet (control), a diet containing 28 % lard plus 4 % EPA (EPA group), or a diet containing 20 % lard plus 12 % LCMUFA concentrate (LCMUFA group) for 8 weeks. EPA or LCMUFA intake increased organ levels of EPA and LCMUFA, respectively. Consumption of EPA reduced plasma lipid levels and hepatic lipid deposition, and decreased the fatty acid desaturation index in liver and adipose tissue. Consumption of LCMUFA decreased plasma non-HDL cholesterol, improved hyperinsulinemia, and decreased the fatty acid desaturation index in adipose tissue. EPA accumulated mainly in liver, and LCMUFA (especially n-11 LCMUFA) accumulated mainly in white adipose tissue, suggesting their possible individual biological effects for improving MetS. Conclusion: Our results suggest that saury oil-mediated improvement of metabolic syndrome in diet-induced obese mice may possibly be due to a combined effect of n-3 PUFA and LCMUFA.	[Yang, Zhi-Hong; Miyahara, Hiroko; Iwasaki, Yusuke; Takeo, Jiro] Nippon Suisan Kaisha, Cent Res Lab, Hachioji, Tokyo 1920991, Japan; [Yang, Zhi-Hong] NHLBI, Lipoprot Metab Sect, Cardiopulm Branch, NIH, Bethesda, MD 20892 USA; [Inoue, Seika; Taniguchi, Yasuko; Sakaue, Hiroshi; Nakaya, Yutaka] Univ Tokushima, Grad Sch Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan	Yang, ZH (reprint author), Nippon Suisan Kaisha, Cent Res Lab, 32-3 Nanakuni 1 Chome, Hachioji, Tokyo 1920991, Japan.	zhihong.yang@nih.gov					Poudyal H, 2015, PROG LIPID RES, V59, P172, DOI 10.1016/j.plipres.2015.07.002; Yang ZH, 2011, J AGR FOOD CHEM, V59, P7482, DOI 10.1021/jf201496h; Sondermeijer BM, 2013, EUR J CLIN INVEST, V43, P1009, DOI 10.1111/eci.12129; Yang ZH, 2011, LIPIDS, V46, P425, DOI 10.1007/s11745-011-3553-1; Dobrzyn P, 2015, PROG LIPID RES, V57, P1, DOI 10.1016/j.plipres.2014.11.003; Mori T, 2007, J NUTR, V137, P2629; Howell G, 2009, BBA-MOL CELL BIOL L, V1791, P1190, DOI 10.1016/j.bbalip.2009.08.008; Vessby B, 2013, BRIT J NUTR, V110, P871, DOI 10.1017/S0007114512005934; FOLCH J, 1957, J BIOL CHEM, V226, P497; Schaefer JR, 2011, CURR PHARM DESIGN, V17, P852, DOI 10.2174/138161211795428849; le Morvan V, 2002, LIPIDS, V37, P767, DOI 10.1007/s11745-002-0959-2; [Anonymous], 2001, JAMA, V285, P2486; Scicchitano P, 2014, J FUNCT FOODS, V6, P11, DOI 10.1016/j.jff.2013.12.006; Kien CL, 2014, AM J CLIN NUTR, V99, P436, DOI 10.3945/ajcn.113.070557; Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001; [Anonymous], 2014, FOOD NUTR RES, DOI DOI 10.3402/FNR.V58.25145; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Abeywardena Mahinda Y., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P232; LEPAGE G, 1986, J LIPID RES, V27, P114; Abete I, 2011, NUTR METAB CARDIOVAS, V21, pB1, DOI 10.1016/j.numecd.2011.05.001; CHILDS MT, 1990, AM J CLIN NUTR, V52, P632; Dillard A, 2013, LIPIDS, V48, P1177, DOI 10.1007/s11745-013-3840-0; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; OTA T, 1980, MAR ECOL PROG SER, V3, P11, DOI 10.3354/meps003011; LeMieux MJ, 2015, J NUTR, V145, P411, DOI 10.3945/jn.114.202952; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Galic S, 2011, MOL CELL ENDOCRINOL, V316, P129; Namayandeh Seyedeh Mahdieh, 2013, Int J Prev Med, V4, P1059; Oliveira A. C. M., 2005, Journal of Aquatic Food Product Technology, V14, P73, DOI 10.1300/J030v14n01_07; Pedersen David J, 2015, Mol Metab, V4, P507, DOI 10.1016/j.molmet.2015.04.003; Sato A, 2010, DIABETES, V9, P2495; Vinknes KJ, 2013, OBESITY, V21, P294; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138; Yang ZH, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-16	38	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-511X			LIPIDS HEALTH DIS	Lipids Health Dis.	DEC 1	2015	14								155	10.1186/s12944-015-0161-8		13	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CX2ZB	WOS:000365564200001		
J	Wang, J; Morikawa, H; Kawaguchi, T				Wang, Jian; Morikawa, Hidenori; Kawaguchi, Tetsuo			Experimental and analytical investigations of bonding ultrahigh strength fibre concrete panels on reinforced concrete structures with low concrete strength	MAGAZINE OF CONCRETE RESEARCH			English	Article							RC BEAMS	A large number of aging reinforced concrete (RC) bridges have become huge potential safety hazards. Due to poor design and/or construction, some of these old RC bridges do not even meet basic safety requirements such as shear capacity. This paper presents a new shear strengthening technique of bonding ultrahigh strength fibre reinforced concrete (UFC) panels onto the ends of girders of aging RC bridges. This technique has many attractive characteristics, such as outstanding durability, workability, efficiency and reliability. To investigate the effect UFC strengthening has on the shear resisting mechanism and bond-slip properties of rebars embedded in RC beams, experiments and finite-element analyses were conducted. The experimental results show that both the shear resisting capacity and the bond-slip properties of rebars improved when UFC panels were applied. Analytical results from the modified bond-slip model show good agreement with the experimental results in terms of load-deflection and crack patterns.	[Wang, Jian; Morikawa, Hidenori] Kobe Univ, Dept Civil Engn, Kobe, Hyogo 657, Japan; [Kawaguchi, Tetsuo] Taiheiyo Cement Corp, Ctr Res & Dev, Chiba, Japan	Wang, J (reprint author), Kobe Univ, Dept Civil Engn, Kobe, Hyogo 657, Japan.						Iskhakov I, 2013, MATER DESIGN, V44, P216, DOI 10.1016/j.matdes.2012.07.041; Oehlers DJ, 2001, COMPOS PART A-APPL S, V32, P1345, DOI 10.1016/S1359-835X(01)00089-6; Martinola G, 2010, CEMENT CONCRETE COMP, V32, P731, DOI 10.1016/j.cemconcomp.2010.07.001; Wang J, 2015, MAG CONCRETE RES, V67, P718, DOI 10.1680/macr.14.00331; Chao SH, 2009, ACI STRUCT J, V106, P897; Behloul M, 2007, P INT RILEM WORKSH H, P213; CEB-FIP, 1993, MOD COD 1990; JSCE (Japan Society of Civil Engineers), 2004, REC DES CONSTR ULTR; JSCECC (Japan Society of Civil Engineers Concrete Committee, 2007, STAND SPEC CONCR STR, P39; Kohno F, 2014, P JAPAN CONCRETE I, V36, P1237; Manie J, 2010, DIANA USERS MANUAL R; Shima H., 1987, P SOC CIVIL ENG, V378, P165; Wang J, 2013, P CONCRETE STRUCTURE, V13, P389; Wang J, 2013, P JAPAN CONCRETE I, V35, P1381; Wang J, 2012, J NANOMATER, V2012, P1; Wang J, 2013, P 3 INT C SUST CONST, Ve291; Wirojjanapirom P, 2013, P 3 INT C SUST CONST, Ve35, P1	17	0	0	ICE PUBLISHING	WESTMINISTER	INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND	0024-9831	1751-763X		MAG CONCRETE RES	Mag. Concr. Res.	DEC	2015	67	24					1329	1339		10.1680/macr.15.00026		11	Construction & Building Technology; Materials Science, Multidisciplinary	Construction & Building Technology; Materials Science	CX3OF	WOS:000365607800004		
J	Nakayama, T; Nishie, A; Yoshiura, T; Asayama, Y; Ishigami, K; Kakihara, D; Obara, M; Honda, H				Nakayama, Tomohiro; Nishie, Akihiro; Yoshiura, Takashi; Asayama, Yoshiki; Ishigami, Kousei; Kakihara, Daisuke; Obara, Makoto; Honda, Hiroshi			Balanced MR cholangiopancreatography with motion-sensitized driven-equilibrium (MSDE) preparation: Feasibility and optimization of imaging parameters	MAGNETIC RESONANCE IMAGING			English	Article						MRCP; MSDE; MRI; Balanced SSFP	MAGNETIC-RESONANCE; CHOLANGIOGRAPHY; TRUEFISP; PITFALLS; SEQUENCE; IMAGES; ACID	Purpose: To show the feasibility of motion-sensitized driven-equilibrium-balanced magnetic resonance cholangiopancreatography and to determine the optimal velocity encoding (VENC) value. Materials and methods: Sixteen healthy volunteers underwent MRI study using a 1.5-T clinical unit and a 32-channel body array coil. For each volunteer, images were obtained using the following seven respiratory-triggered sequences: (1) balanced magnetic resonance cholangiopancreatography without motion-sensitized driven-equilibrium, and (2)-(7) balanced magnetic resonance cholangiopancreatography with motion-sensitized driven-equilibrium, with VENC = 1, 3, 5, 7, 9 and infinity cm/s for the x-, y-, and z-directions, respectively. Quantitative evaluation was obtained by measuring the maximum signal intensity of the common hepatic duct, portal vein, liver tissue including visible peripheral vessels, and liver tissue excluding visible peripheral vessels that were evaluated. We compared the contrast ratios of portal vein/common hepatic duct, liver tissue including visible peripheral vessels/common hepatic duct and liver tissue excluding visible peripheral vessels/common hepatic duct among the five finite sequences (VENC = 1, 3, 5, 7, and 9 cm/s). Statistical comparisons were performed using the t-test for paired data with the Bonferroni correction. Results: Suppression of blood vessel signals was achieved with motion-sensitized driven-equilibrium sequences. We found the optimal VENC values to be either 3 or 5 cm/s with the best suppression of relative vessel signals to bile ducts. At a lower VENC value (1 cm/s), the bile duct signal was reduced, presumably due to minimal biliary flow. Conclusion: The feasibility of motion-sensitized driven-equilibrium-balanced magnetic resonance cholangiopancreatography was suggested. The optimal VENC value was considered to be either 3 or 5 cm/s. The clinical usefulness of this new magnetic resonance cholangiopancreatography sequence needs to be verified by further studies. (C) 2015 Elsevier Inc. All rights reserved.	[Nakayama, Tomohiro; Nishie, Akihiro; Yoshiura, Takashi; Asayama, Yoshiki; Ishigami, Kousei; Kakihara, Daisuke; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Obara, Makoto] Philips Elect Japan, Minato Ku, Tokyo 1088507, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp					Lee MG, 1997, RADIOLOGY, V202, P663; Ringe KI, 2010, RADIOLOGY, V255, P451, DOI 10.1148/radiol.10091130; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Irie H, 1998, RADIOLOGY, V206, P379; Sugita R, 2003, AM J ROENTGENOL, V180, P467; Hekimoglu K, 2008, J DIGEST DIS, V9, P162, DOI 10.1111/j.1751-2980.2008.00339.x; Nakamura Y, 2009, MAGN RESON MED SCI, V8, P143; Reinhold C, 1998, RADIOLOGY, V209, P435; Fuchs F, 2003, EUR J RADIOL, V46, P28, DOI 10.1016/S0720-048X(02)00330-3; Pavone P, 1997, AM J ROENTGENOL, V169, P807; Krause D, 2002, J COMPUT ASSIST TOMO, V26, P541, DOI 10.1097/01.RCT.0000029048.35986.E9; Barish MA, 1999, NEW ENGL J MED, V341, P258, DOI 10.1056/NEJM199907223410407; Nguyen TD, 2008, J MAGN RESON IMAGING, V28, P1092, DOI 10.1002/jmri.21568; Huang TY, 2002, MAGNET RESON MED, V48, P684, DOI 10.1002/mrm.10260; Koktzoglou I, 2007, J CARDIOV MAGN RESON, V9, P33, DOI 10.1080/10976640600843413; Watanabe Y, 1999, RADIOGRAPHICS, V19, P415; Holzknecht N, 1998, RADIOLOGY, V206, P657; Kim KA, 2010, RADIOLOGY, V256, P475, DOI 10.1148/radiol.10091774; Irie H, 2001, RADIOGRAPHICS, V21, P23; Nagao E, 2011, AM J NEURORADIOL, V32, P664, DOI 10.3174/ajnr.A2343; Hoppel BE, 2001, P 9 ANN M ISMRM GLAS; Ichikawa T., 2002, P 10 ANN M ISMRM HON; Toouli J, 1996, Gastroenterologist, V4, P44; TORSOLI A, 1988, ENDOSCOPY, V20, P166, DOI 10.1055/s-2007-1018169	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	DEC	2015	33	10					1219	1223		10.1016/j.mri.2015.07.003		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX8EG	WOS:000365934800004		
J	Kanoto, M; Sugai, Y; Hosoya, T; Toyoguchi, Y; Konno, Y; Watarai, F; Ito, T; Watanabe, T; Kakehata, S				Kanoto, Masafumi; Sugai, Yukio; Hosoya, Takaaki; Toyoguchi, Yuuki; Konno, Yoshihiro; Watarai, Fumika; Ito, Tsukasa; Watanabe, Tomoo; Kakehata, Seiji			Detectability and anatomical correlation of middle ear cholesteatoma using fused thin slice non-echo planar imaging diffusion-weighted image and magnetic resonance cisternography (FTS-nEPID)	MAGNETIC RESONANCE IMAGING			English	Article						Cholesteatoma; MRI; Non-EPI DWIs; MR cisternography	RECURRENT CHOLESTEATOMA; DIAGNOSTIC-ACCURACY; SINGLE-SHOT; MRI; SURGERY; BONE	Cholesteatomas show high intensity in diffusion-weighted imaging (DWI). We performed fused thin slice non-echo planar imaging (EPI) DWI and magnetic resonance cisternography (FTS-nEPID) for cholesteatoma patients to increase the detectability of FTS-nEPID for cholesteatoma. The subjects are 77 consecutive patients who underwent FTS-nEPID as a preoperative study (mean age: 53.3 +/- 21.8, 47 men and 30 women). Otorhinolaryngologists performed the operations. We anatomically classified the middle ear into four portions. A radiologist evaluated the images for cholesteatoma and assessed the anatomical invasive range in four portions using only FTS-nEPID. We classified large cholesteatomas that invaded more than three portions and small ones that invaded less than two portions based on the results obtained from surgery, and calculated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). For all cholesteatomas with an existing diagnosis, the sensitivity, specificity, PPV, and NPV were 71%, 70%, 94%, and 27%, respectively. In anatomical evaluation, the sensitivity, specificity, PPV, and NPV were 49%, 85%, 77%, and 64%, respectively. For large cholesteatomas with an existing diagnosis, the sensitivity was 86%. In anatomical evaluation, the sensitivity, specificity, PPV, and NPV were 51%, 57%, 88%, and 18%, respectively. For small cholesteatomas with an existing diagnosis, the sensitivity, specificity, PPV, and NPV were 59%, 78%, 92%, and 30%, respectively. In anatomical evaluation, the sensitivity, specificity, PPV, and NPV were 40%, 85%, 60%, and 71%, respectively. FTS-nEPID may be useful for diagnosing cholesteatomas. Further research is needed for anatomical evaluation because there were many false-negative results. (C) 2015 Elsevier Inc. All rights reserved.	[Kanoto, Masafumi; Sugai, Yukio; Hosoya, Takaaki; Toyoguchi, Yuuki; Watarai, Fumika] Yamagata Univ, Fac Med, Dept Diagnost Radiol, Yamagata 9909585, Japan; [Konno, Yoshihiro] Yamagata Univ, Dept Diagnost Radiol, Fac Med, Yamagata 9909585, Japan; [Ito, Tsukasa; Watanabe, Tomoo; Kakehata, Seiji] Yamagata Univ, Fac Med, Dept Otolaryngol Head & Neck Surg, Yamagata 9909585, Japan	Kanoto, M (reprint author), Yamagata Univ, Fac Med, Dept Diagnost Radiol, Iida Nishi 2-2-2, Yamagata 9909585, Japan.	mkanoto@med.id.yamagata-u.ac.jp; ysugai@med.id.yamagata-u.ac.jp; thosoya@med.id.yamagata-u.ac.jp; c-elegans_0201g@mail.goo.ne.jp; k_hiro_0805@yahoo.co.jp; fumikawatarai@yahoo.co.jp; tuito@med.id.yamagata-u.ac.jp; watanatm@med.id.yamagata-u.ac.jp; seijik06@gmail.com			Global COE program of the Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid from the Global COE program of the Japan Society for the Promotion of Science.	Alvo A, 2014, AM J NEURORADIOL, V35, P1820, DOI 10.3174/ajnr.A3952; Liu W, 2014, INT J CLIN EXP PATHO, V7, P709; Aikele P, 2003, AM J ROENTGENOL, V181, P261; Vercruysse JP, 2006, EUR RADIOL, V16, P1461, DOI 10.1007/s00330-006-0160-2; De Foer B, 2006, AM J NEURORADIOL, V27, P1480; Dremmen MHG, 2012, AM J NEURORADIOL, V33, P439, DOI 10.3174/ajnr.A2824; Barath K, 2011, AM J NEURORADIOL, V32, P221, DOI 10.3174/ajnr.A2052; Fitzek C, 2002, J MAGN RESON IMAGING, V15, P636, DOI 10.1002/jmri.10118; De Foer B, 2010, NEURORADIOLOGY, V52, P785, DOI 10.1007/s00234-010-0742-1; Yamashita K, 2011, AM J NEURORADIOL, V32, P1915, DOI 10.3174/ajnr.A2651; Plouin-Gaudon I, 2010, ARCH OTOLARYNGOL, V136, P878, DOI 10.1001/archoto.2010.151; De Foer B, 2010, RADIOLOGY, V255, P866, DOI 10.1148/radiol.10091140; Sharifian H, 2012, J MED IMAG RADIAT ON, V56, P398, DOI 10.1111/j.1754-9485.2012.02377.x; Stasolla A, 2004, OTOL NEUROTOL, V25, P879, DOI 10.1097/00129492-200411000-00005; Khemani S, 2011, CLIN RADIOL, V66, P760, DOI 10.1016/j.crad.2010.12.019; Dubrulle F, 2006, RADIOLOGY, V238, P604, DOI 10.1148/radiol.2381041649; Ilica AT, 2012, DIAGN INTERV RADIOL, V18, P153, DOI 10.4261/1305-3825.DIR.4246-11.3; Khemani S, 2011, CLIN OTOLARYNGOL, V36, P306, DOI 10.1111/j.1749-4486.2011.02332.x; Lehmann P, 2009, AM J NEURORADIOL, V30, P423, DOI 10.3174/ajnr.A1352; Lincot J, 2015, J NEURORADIOLOGY, V42, P193, DOI 10.1016/j.neurad.2014.02.003; Lingam Ravi K, 2013, Radiology, V269, P504, DOI 10.1148/radiol.13130065; Presutti L, 2014, ACTA OTORHINOLARYNGO, V34, P153; Velthuis S, 2014, J LARYNGOL OTOL, P1	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	DEC	2015	33	10					1253	1257		10.1016/j.mri.2015.08.007		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX8EG	WOS:000365934800008		
J	Kato, K; Arai, Y; Ikoma, K; Nakagawa, S; Inoue, H; Kan, H; Matsuki, T; Fujiwara, H; Kubo, T				Kato, Kammei; Arai, Yuji; Ikoma, Kazuya; Nakagawa, Shuji; Inoue, Hiroaki; Kan, Hiroyuki; Matsuki, Tomohiro; Fujiwara, Hiroyoshi; Kubo, Toshikazu			Early postoperative cartilage evaluation by magnetic resonance imaging using T-2 mapping after arthroscopic partial medial meniscectomy	MAGNETIC RESONANCE IMAGING			English	Article						T-2 mapping; Arthroscopic meniscectomy; Articular cartilage; Cartilage evaluation	ARTICULAR-CARTILAGE; IN-VIVO; FEMORAL CARTILAGE; MRI; KNEE; T2; OSTEOARTHRITIS; CONTRAST; PROTOCOL; T-1-RHO	Purpose: This study was performed to quantitatively evaluate postoperative changes in cartilage by T-2 mapping after arthroscopic partial medial meniscectomy. Material and Methods: The study enrolled 17 patients with 20 knees that underwent arthroscopic partial medial meniscectomy. MRI was performed preoperatively and at six months postoperatively, with subjects evaluated by T-2 mapping of the central part of the medial condyle of the femur in the sagittal plane. Regions of interest (ROIs) were set at 10 points between the point of intersection of the anatomical axis of the femur and the articular surface of the medial condyle and posterior area approximately 90 degrees to the anatomical axis. Pre- and postoperative T-2 values at each ROI were evaluated. Results: Postoperative T-2 values were significantly longer than preoperative values at approximately 20, 30, 40, and 50 degrees to the anatomical axis of the femur. The maximum change between pre- and postoperative T-2 values was +6.65% at 30 degrees to the anatomical axis. Conclusions: Mechanical stress at positions approximately 20, 30, 40, and 50 degrees relative to the anatomical axis of the femur increased soon after arthroscopic medial meniscectomy. These findings indicate the start of degeneration, via disorganization of collagen arrays, of the articular cartilage and increased water content. (C) 2015 Published by Elsevier Inc.	[Kato, Kammei; Arai, Yuji; Ikoma, Kazuya; Nakagawa, Shuji; Inoue, Hiroaki; Kan, Hiroyuki; Matsuki, Tomohiro; Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Dept Orthopaed, Grad Sch Med Sci, Kyoto 6028566, Japan	Arai, Y (reprint author), Kyoto Prefectural Univ Med, Dept Orthopaed, Grad Sch Med Sci, Kamigyo Ku, 465 Kajiicho, Kyoto 6028566, Japan.	yarai89046@nike.eonet.ne.jp					Jazrawi LM, 2011, J AM ACAD ORTHOP SUR, V19, P420; Menezes NM, 2004, MAGNET RESON MED, V51, P503, DOI 10.1002/mrm.10710; Mosher TJ, 2001, AM J ROENTGENOL, V177, P665; Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012; Newbould RD, 2012, J MAGN RESON IMAGING, V35, P1422, DOI 10.1002/jmri.23598; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118; Kim T, 2014, SKELETAL RADIOL, V43, P947, DOI 10.1007/s00256-014-1872-z; Hesper T, 2014, SKELETAL RADIOL, V43, P1429, DOI 10.1007/s00256-014-1852-3; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887; Yang N, 2009, ANN BIOMED ENG, V37, P2360, DOI 10.1007/s10439-009-9781-3; Burstein D, 2001, MAGNET RESON MED, V45, P36, DOI 10.1002/1522-2594(200101)45:1<36::AID-MRM1006>3.0.CO;2-W; Eckstein F, 2011, ANN RHEUM DIS, V70, P1223, DOI 10.1136/ard.2010.141382; Bydder M, 2007, J MAGN RESON IMAGING, V25, P290, DOI 10.1002/jmri.20850; Liess C, 2002, OSTEOARTHR CARTILAGE, V10, P907, DOI 10.1053/joca.2002.0847; Tsushima H, 2012, RHEUMATOL INT, V32, P2867, DOI 10.1007/s00296-011-2140-3; Andreisek G, 2014, INVEST RADIOL, V49, P57, DOI 10.1097/RLI.0b013e3182a574e1; Nieminen MT, 2001, MAGN RESON MED, V46, P487, DOI 10.1002/mrm.1218; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; Gold GE, 2004, AM J ROENTGENOL, V183, P343; Wirth W, 2011, OSTEOARTHR CARTILAGE, V19, P74, DOI 10.1016/j.joca.2010.10.022; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Kijowski R, 2013, RADIOLOGY, V267, P503, DOI 10.1148/radiol.12121413; ROSENBERG TD, 1988, J BONE JOINT SURG AM, V70A, P1479; Shiomi T, 2012, OSTEOARTHR CARTILAGE, V20, P1383, DOI 10.1016/j.joca.2012.07.015; Nishioka H, 2012, J MAGN RESON IMAGING, V35, P147, DOI 10.1002/jmri.22811; Fox Alice J S, 2012, Sports Health, V4, P340; Kotam H, 2004, ORTHOP SURG, V55-5, P522; Sanchis M, 1998, ARTHROSCOPY, V4, P206; Sorimachi T, 2010, JPN J JOINT DIS, V29, P79; Stoller DW, 2007, MAGNETIC RESONANCE I, P382; Takayama Y, 2011, P 19 ANN M ISMRM, P3213	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	DEC	2015	33	10					1274	1280		10.1016/j.mri.2015.08.002		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX8EG	WOS:000365934800011		
J	Sugimori, H; Fujima, N; Suzuki, Y; Hamaguchi, H; Sakata, M; Kudo, K				Sugimori, Hiroyuki; Fujima, Noriyuki; Suzuki, Yuriko; Hamaguchi, Hiroyuki; Sakata, Motomichi; Kudo, Kohsuke			Evaluation of cerebral blood flow using multi-phase pseudo continuous arterial spin labeling at 3-tesla	MAGNETIC RESONANCE IMAGING			English	Article						Arterial spin labeling; Cerebral blood flow; Multi-phase pseudo continuous arterial spin labeling; Arterial transit time	PERFUSION MRI; EFFICIENCY	Purpose: Arterial spin labeling (ASL) methods have been widely used for evaluation of cerebral blood flow (CBF) by magnetic resonance imaging. However, ASL methods require setting of the post labeling delay (PLD) time for obtaining images. As the hemodynamic status cannot be estimated in each patient, the resultant quantitative values of blood flow may not be accurate. The multi-phase pseudo continuous arterial spin labeling (pCASL) method can be used to obtain images at various time-points. The purpose of this study was to create the transit-time maps for correcting the delayed blood flow and evaluate CBF using the transit-time maps obtained by the multi-phase pCASL method. Materials and Methods: Twelve patients who underwent both 3.0-tesla magnetic resonance imaging (MRI) and single photon emission computed tomography with iodine-123-N-isopropyl-p-iodoamphetamine (123I-IMP) were investigated. This study was approved by the institutional review board of our institution. MRI acquisitions included PLD time-fixed (1525 ms) and multi-phase pCASL sequences. The transit-time maps were calculated from multi-phase pCASL images by software. The transit-time maps were applied to PLD-fixed pCASL images pixel by pixel, for calculating the CBF value corrected for peak blood transit time. Regions of interest were drawn on the brain. IMP-CBF, ASL-CBF (default and corrected) and transit time were measured for each segment. Results: Twelve patients and 264 segments were investigated. The mean IMP-CBF, ASL-CBF (default, corrected) and transit time were 28.4, 23.0, 29.6, [ml/min/100 g] and 1977.5 [ms], respectively. There were no significant differences between IMP-CBF and ASL-CBF (corrected). Conclusion: CBF values can be corrected by using the transit-time maps obtained using the multi-phase pCASL method. (C) 2015 Elsevier Inc. All rights reserved.	[Sugimori, Hiroyuki; Hamaguchi, Hiroyuki] Hokkaido Univ Hosp, Dept Radiol Technol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Fujima, Noriyuki; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Suzuki, Yuriko] Philips Elect Japan, Minato Ku, Tokyo 1088507, Japan; [Sakata, Motomichi] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Sugimori, H (reprint author), Hokkaido Univ Hosp, Dept Radiol Technol, Kita Ku, North 14,West 5, Sapporo, Hokkaido 0608648, Japan.	sugimori@huhp.hokudai.ac.jp; fujima@med.hokudai.ac.jp; yuriko.suzuki@philips.com; hhummer@huhp.hokudai.ac.jp; moto@hs.hokudai.ac.jp; kkudo@huhp.hokudai.ac.jp					Garcia DM, 2005, MAGNET RESON MED, V54, P366, DOI 10.1002/mrm.20556; Chalela JA, 2000, STROKE, V31, P680; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Wang R, 2014, EUR RADIOL, V24, P1135, DOI 10.1007/s00330-014-3098-9; Silva AC, 1999, MAGNET RESON MED, V42, P425, DOI 10.1002/(SICI)1522-2594(199909)42:3<425::AID-MRM3>3.0.CO;2-S; IIDA H, 1994, J NUCL MED, V35, P2019; Khalili-Mahani N, 2011, J CEREBR BLOOD F MET, V31, P1321, DOI 10.1038/jcbfm.2010.234; Petersen ET, 2006, BRIT J RADIOL, V79, P688, DOI 10.1259/bjr/67705974; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Golay X, 2005, MAGNET RESON MED, V53, P15, DOI 10.1002/mrm.20338; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Kim SG, 1997, MAGNET RESON MED, V37, P425, DOI 10.1002/mrm.1910370321; St. Lawrence K. S., 2005, Magnetic Resonance in Medicine, V53, P425, DOI 10.1002/mrm.20364; Sugimori Hiroyuki, 2013, Radiol Phys Technol, V6, P86, DOI 10.1007/s12194-012-0173-2; Wang DJ, 2013, NEUROIMAGE-CLIN, V6, P1	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	DEC	2015	33	10					1338	1344		10.1016/j.mri.2015.07.016		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX8EG	WOS:000365934800019		
J	Badolo, A; Bando, H; Traore, A; Ko-Ketsu, M; Guelbeogo, WM; Kanuka, H; Ranson, H; Sagnon, N; Fukumoto, S				Badolo, Athanase; Bando, Hironori; Traore, Alphonse; Ko-Ketsu, Mami; Guelbeogo, Wamdaogo Moussa; Kanuka, Hirotaka; Ranson, Hilary; Sagnon, N'Fale; Fukumoto, Shinya			Detection of G119S ace-1(R) mutation in field-collected Anopheles gambiae mosquitoes using allele-specific loop-mediated isothermal amplification (AS-LAMP) method	MALARIA JOURNAL			English	Article						Insecticide; Resistance; Ace1-R; LAMP; Malaria; Mosquito	MULTIPLE INSECTICIDE RESISTANCE; WESTERN BURKINA-FASO; RAPID IDENTIFICATION; PYRETHROID RESISTANCE; MALARIA; AFRICA; VECTORS; PARASITES	Background: Malaria vectors have developed resistance to the four families of insecticides available for public health purposes. For example, the kdr mutation is associated with organochlorines and pyrethroids resistance. It is of particular concern that organophosphate and carbamate resistance associated with the G119S ace-1(R) mutation has recently increased in West Africa in extent and frequency, and is now spreading through the Anopheles gambiae malaria vector population. There is an urgent need to improve resistance management using existing insecticides and new tools to quickly assess resistance level for rapid decision-making. Methods: DNA extracted from field-collected mosquitoes was used to develop the method. Specific primers were designed manually to match the mutation region and an additional mismatched nucleotide in the penultimate position to increase specificity. Other primers used are common to both wild and mutant types. The allele specific (AS)-LAMP method was compared to the PCR restriction fragment length polymorphism (PCR-RFLP) and real-time PCR (RT-PCR) methods using the genomic DNA of 104 field-collected mosquitoes. Results: The primers designed for LAMP were able to distinguish between the wild type (ace-1(S)) and mutated type allele (ace-1(R)). Detection time was 50 min for the wild type homozygous and 64 min for the heterozygous. No amplification of the resistant allele took place within the 75-min test period when using the wild type primers. For the ace-1(R) resistant type, detection time was 51 min for the resistant homozygous and 55 min for the heterozygous. No amplification of the wild type allele took place within the 75-min test period when using the resistant type primers. Gel electrophoresis of LAMP products confirmed that amplification was primer-DNA specific, i.e., primers could only amplify their target specific DNA. AS-LAMP, PCR-RFLP, and RT-PCR showed no significant difference in the sensitivity and specificity of their ace-1(R) detection ability. Conclusions: The AS-LAMP method could detect the ace-1(R) mutation within 60 min, which is faster than conventional PCR-RFLP. This method may be used to quickly detect the ace-1(R) mutation for rapid decision-making, even in less well-equipped laboratories.	[Badolo, Athanase; Bando, Hironori; Ko-Ketsu, Mami; Fukumoto, Shinya] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Badolo, Athanase; Traore, Alphonse; Guelbeogo, Wamdaogo Moussa; Sagnon, N'Fale] CNRFP, Ouagadougou 01, Burkina Faso; [Badolo, Athanase] Univ Ouagadougou, Lab Entomol Fondamentale & Appl, Ouagadougou 03, Burkina Faso; [Kanuka, Hirotaka] Jikei Univ, Sch Med, Dept Trop Med, Tokyo 1058461, Japan; [Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Badolo, A (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan.	a.badolo@gmail.com; fukumoto@obihiro.ac.jp			Japan International Cooperation Agency (JICA); Japanese Ministry of Education, Science, Sports, Culture and Technology; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) [A70588]	This study was supported in part by a grant from the Japan International Cooperation Agency (JICA) to AB and SF, and Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, Culture and Technology to SF and HK. This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) through the grant A70588 to HR.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; Bass C, 2010, PESTIC BIOCHEM PHYS, V96, P80, DOI 10.1016/j.pestbp.2009.09.004; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Aonuma H, 2008, BIOCHEM BIOPH RES CO, V376, P671, DOI 10.1016/j.bbrc.2008.09.061; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Weetman D, 2015, MOL ECOL, V24, P2656, DOI 10.1111/mec.13197; Thera MA, 2012, ANNU REV MED, V63, P345, DOI 10.1146/annurev-med-022411-192402; Bonizzoni M, 2009, AM J TROP MED HYG, V81, P1030, DOI 10.4269/ajtmh.2009.09-0333; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Perera N, 2009, J VIROL METHODS, V156, P32, DOI 10.1016/j.jviromet.2008.10.023; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Aonuma H, 2010, EXP PARASITOL, V125, P179, DOI 10.1016/j.exppara.2009.12.023; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Aonuma H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-15; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-227; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; MR4, 2014, METH AN RES; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; TmCGoV Control, 2011, PLOS MED, V8; Toe KH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1342-6; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; WHO, 2013, WORLD MALARIA REPORT 2013, P1	30	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 1	2015	14								477	10.1186/s12936-015-0968-9		8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CX6FB	WOS:000365795500004		
J	Fujii, T; Watanabe, K; Nishihara, C; Obuchi, M; Ohba, H				Fujii, T.; Watanabe, K.; Nishihara, C.; Obuchi, M.; Ohba, H.			The giant brown alga Sargassum carpophyllum on a nearshore coral reef in Okinawa Island, Japan	MARINE BIODIVERSITY			English	Editorial Material									[Fujii, T.] Univ Ryukyus, Dept Sci & Engn, Nishihara, Okinawa 9030213, Japan; [Watanabe, K.] Okinawa Natl Coll Technol, Nago, Okinawa 9052192, Japan; [Obuchi, M.] Biol Inst Kuroshio, Kochi 7880333, Japan; [Ohba, H.] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan	Fujii, T (reprint author), Univ Ryukyus, Dept Sci & Engn, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	takumagnum0213@hotmail.co.jp					Shimabukuro Hiromori, 2006, Japanese Journal of Phycology, V54, P85; Mattio L, 2009, J PHYCOL, V45, P1374, DOI 10.1111/j.1529-8817.2009.00760.x; Luning K, 1990, SEAWEEDS THEIR ENV B, P527; SILVA P.C., 1996, U CALIFORNIA PUBLICA, V79, P1	4	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1867-1616	1867-1624		MAR BIODIVERS	Mar. Biodivers.	DEC	2015	45	4					603	604		10.1007/s12526-014-0280-x		2	Biodiversity Conservation; Marine & Freshwater Biology	Biodiversity & Conservation; Marine & Freshwater Biology	CX7HU	WOS:000365873600005		
J	Hirose, M; Hirose, E; Kiyomoto, M				Hirose, Mamiko; Hirose, Euichi; Kiyomoto, Masato			Identification of five species of Dendrodoris (Mollusca: Nudibranchia) from Japan, using DNA barcode and larval characters	MARINE BIODIVERSITY			English	Article						18S rRNA; COI; DNA barcode; Sea slug; Veliger larva	PHYLOGENETIC INFERENCE; MOLECULAR PHYLOGENY; ATLANTIC-OCEAN; OPISTHOBRANCHIA; GASTROPODA; SEA; REDESCRIPTION; POLYCERIDAE; DORIDOIDEA; CHECKLIST	Species of the genus Dendrodoris are defined as "radula-less" dorids (Nudibranchia: Doridina: Porostomata: Dendrodorididae). These sea slugs are colorful nudibranchs distributed across the world's oceans. Because of color variations and anatomical similarities, species discrimination has been disputed in several Dendrodoris species. We determined the partial mitochondrial COI gene sequences and 18S rRNA gene sequences of five Dendrodoris species (D. arborescens, D. denisoni, D. guttata, D. nigra, and D. rubra) and Doriopsilla miniata in Japan to clarify the species identity of each dendrodorid species. We examined a total of 50 specimens from the intertidal zone at 10 sites in four regions along the Pacific coast of Japan. Partial COI gene sequences significantly differed among the six species. Although six partial 18S rRNA gene sequences were obtained for the six species, sequences differed little among species and did not clarify details of the Dendrodoris phylogeny. We also described the morphological features of veliger larvae of three Dendrodoris species. (D. arborescens, D. guttata, and D. rubra) The veligers of D. arborescens had a brown-pigmented, cup-shaped shell, and its foot was not retracted into the shell. In contrast, the veligers of D. guttata and D. rubra had a transparent, coiled shell with an operculum. Mean shell lengths of D. arborescens, D. rubra, and D. guttata were 171.5 +/- 8.0, 172.8 +/- 4.9, and 222.3 +/- 15.2 mu m, respectively. The present molecular analysis and larval characteristics indicated that each of the six species is a distinct species.	[Hirose, Mamiko; Kiyomoto, Masato] Ochanomizu Univ, Marine & Coastal Res Ctr, Tateyama, Chiba 2940301, Japan; [Hirose, Euichi] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan	Hirose, M (reprint author), Ochanomizu Univ, Marine & Coastal Res Ctr, Tateyama, Chiba 2940301, Japan.	hirose.mamiko@ocha.ac.jp			Nippon Foundation; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from University of the Ryukyus	We thank Dr. Masami Obuchi (Biological Institute of Kuroshio, Kochi), Dr. Gen Hamanaka (Marine and Coastal Research Center, Ochanomizu University), Dr. Ryota Suwa (Seto Marine Biological Laboratory, Kyoto University), Dr. Hiroyuki Tachikawa (Natural History Museum and Institute, Chiba), Dr. Yusuke Yamana (Wakayama Prefectural Museum of Natural History), and Dr. Kensuke Yanagi (Coastal Branch of Natural History Museum and Institute, Chiba) for providing the specimens used in this study. This study was performed as a project of the Educational Cooperative-utilization Site by the Ministry of Education, Culture, Sports, Science & Technology in Japan, and partly supported by the Nippon Foundation and the International Research Hub Project for Climate Change and Coral Reef/Island Dynamics from University of the Ryukyus.	Brodie Gilianne D., 2006, Records of the Western Australian Museum, P119; Sachidhanandam U, 2000, RAFFLES B ZOOL, P513; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Brodie GD, 1997, J MOLLUS STUD, V63, P407, DOI 10.1093/mollus/63.3.407; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pola M, 2012, ZOOL J LINN SOC-LOND, V165, P311, DOI 10.1111/j.1096-3642.2012.00816.x; Ornelas-Gatdula E, 2012, ZOOL SCR, V41, P374, DOI 10.1111/j.1463-6409.2012.00538.x; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; Turner LM, 2008, ZOOL SCR, V37, P23, DOI 10.1111/j.1463-6409.2007.00310.x; Krug PJ, 2013, MOL PHYLOGENET EVOL, V69, P1101, DOI 10.1016/j.ympev.2013.07.009; Brodie GD, 2004, ZOOTAXA, P1; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Wagele H, 2003, SM S COMP E, P185; Yonow N, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.197.1728; Thollesson M, 2000, MOL PHYLOGENET EVOL, V16, P161, DOI 10.1006/mpev.2000.0789; Ohnheiser LT, 2013, ZOOL J LINN SOC-LOND, V167, P273, DOI 10.1111/zoj.12000; Pola M, 2006, ANN ZOOL FENN, V43, P52; Pola M, 2007, MOL PHYLOGENET EVOL, V43, P726, DOI 10.1016/j.ympev.2007.02.003; Britton T, 2007, MATH MED BIOL, V24, P401, DOI 10.1093/imammb/dqm008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Bhave Vishal, 2011, Journal of the Bombay Natural History Society, V108, P172; Brodie Gilianne D., 2005, Molluscan Research, V25, P37; Apte Deepak, 2010, Journal of the Bombay Natural History Society, V107, P14; Baba K, 1949, OPISTHOBRANCHIA SAGA; BARASH A, 1986, Spixiana, V9, P117; Behrens David W., 2004, Proceedings of the California Academy of Sciences, V55, P408; Bergh R, 1876, REISEN ARCHIPEL PHIL, V2, P377; Collingwood Cuthbert, 1881, Transactions of the Linnean Society, V(2), P123; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GOHAR H. A. F., 1967, PUBL MAR BIOL STA AL GHARDAQA, V14, P31; Gosliner TM, 2008, INDOPACIFIC NUDIBRAN; Jobb G, 2008, TREEFINDER VER; Kelaart EF, 1858, J ROY ASIATIC SOC, V3, P84; Maas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053889; Nakano R, 2004, OPISTHOBRANCHS JAPAN; Nakano R, 2011, KUROSHIO BIOSPH, V7, P1; Okutani T, 2001, MARINE MOLLUSKS JAPA; Patel BK, 2013, RES J MARINE SCI, V1, P10; Rasband W.S., 1997, IMAGEJ; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSE R A, 1985, Journal of the Malacological Society of Australia, V7, P75; Ruppell E, 1828, ATLAS REISE NORDLICH, P15; Stimpson W, 1855, P ACAD NAT SCI PHILA, V7, P375; Swofford D, 2003, PAUP 4 0B7A PHYLOGEN; Valdes A, 1996, J MOLLUS STUD, V62, P1, DOI 10.1093/mollus/62.1.1; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022; WoRMS Editorial Board, 2014, WORLD REGISTER MARIN; YOUNG D K, 1969, Malacologia, V9, P421	48	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1867-1616	1867-1624		MAR BIODIVERS	Mar. Biodivers.	DEC	2015	45	4					769	780		10.1007/s12526-014-0288-2		12	Biodiversity Conservation; Marine & Freshwater Biology	Biodiversity & Conservation; Marine & Freshwater Biology	CX7HU	WOS:000365873600031		
J	Gon, Y				Gon, Yasuro			Dirichlet series constructed from periods of automorphic forms	MATHEMATISCHE ZEITSCHRIFT			English	Article						Periods of automorphic forms; Dirichlet series of Selberg type	SELBERG ZETA-FUNCTIONS	We consider certain Dirichlet series of Selberg type, constructed from periods of automorphic forms. We study analytic properties of these Dirichlet series and show that they have analytic continuation to the whole complex plane.	[Gon, Yasuro] Kyushu Univ, Fac Math, Fukuoka 8190395, Japan	Gon, Y (reprint author), Kyushu Univ, Fac Math, Fukuoka 8190395, Japan.	ygon@math.kyushu-u.ac.jp			JSPS [26400017, 23540020]	This work was partially supported by JSPS Grant-in-Aid for Scientific Research (C) No. 23540020 and (C) No. 26400017.	Kurokawa N, 2004, COMMUN MATH PHYS, V247, P447, DOI 10.1007/s00220-004-1065-z; KATOK S, 1985, INVENT MATH, V80, P469, DOI 10.1007/BF01388727; Hashimoto Y, 2005, LETT MATH PHYS, V73, P59, DOI 10.1007/s11005-005-6784-3; Fischer J., 1987, LECT NOTES MATH, V1253; Gon Y., 2003, J RAMANUJAN MATH SOC, V18, P257; Lebedev NN, 1972, SPECIAL FUNCTIONS TH; Tsuzuki Masao, 2002, ASIAN J MATH, V6, P227	7	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	DEC	2015	281	3-4					747	773		10.1007/s00209-015-1506-8		27	Mathematics	Mathematics	CW3WJ	WOS:000364922700007		
J	Koike, T				Koike, Takayuki			Toward a higher codimensional Ueda theory	MATHEMATISCHE ZEITSCHRIFT			English	Article						Flat line bundles; Ueda's theory; The blow-up of the three dimensional projective space at eight points		Ueda's theory is a theory on a flatness criterion around a smooth hypersurface of a certain type of topologically trivial holomorphic line bundles. We propose a codimension two analogue of Ueda's theory. As an application, we give a sufficient condition for the anti-canonical bundle of the blow-up of the three dimensional projective space at 8 points to be non semi-ample however admit a smooth Hermitian metric with semi-positive curvature.	[Koike, Takayuki] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Koike, T (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	tkoike@ms.u-tokyo.ac.jp			KAKENHI [25-2869]; Program for Leading Graduate Schools, MEXT, Japan	The author would like to give heartful thanks to his supervisor Prof. Shigeharu Takayama whose comments and suggestions were of inestimable value for my study. He also thanks Prof. Tetsuo Ueda and Prof. Yoshinori Gongyo for helpful comments and warm encouragements. He is supported by the Grant-in-Aid for Scientific Research (KAKENHI No. 25-2869) and the Grant-in-Aid for JSPS fellows. This work is supported by the Program for Leading Graduate Schools, MEXT, Japan.	GRAUERT H, 1962, MATH ANN, V146, P331, DOI 10.1007/BF01441136; KODAIRA K, 1959, AM J MATH, V81, P477, DOI 10.2307/2372752; Totaro B, 2009, AM J MATH, V131, P1815; Siegel CL, 1942, ANN MATH, V43, P607, DOI 10.2307/1968952; Brunella M., 2010, RIV MAT U PARMA, V1, P441; Camacho C., 2003, MONOGRAFIAS I MATEMA, V35; Koike T., ANN I FOURI IN PRESS; Koike T., KYOTO J MAT IN PRESS; Laufer H.B., 1971, ANN MATH STUD, V71; Lesieutre J., ARXIV14104467; Neeman A., 1989, AM MATH SOC, V81; Rossi H., 1969, LECT MOD ANAL APPL, V103, P10, DOI 10.1007/BFb0099982; Ueda T., 1983, MATH KYOTO U, V22, P583	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	DEC	2015	281	3-4					967	991		10.1007/s00209-015-1516-6		25	Mathematics	Mathematics	CW3WJ	WOS:000364922700017		
J	Takahashi, R				Takahashi, Ryosuke			Asymptotic stability for Kahler-Ricci solitons	MATHEMATISCHE ZEITSCHRIFT			English	Article						Fano manifold; Kahler-Ricci soliton; Balanced metric	SCALAR CURVATURE; EINSTEIN METRICS; UNIQUENESS; MANIFOLDS; ENERGY	Let X be a Fano manifold. We say that a hermitian metric on with positive curvature is a Kahler-Ricci soliton if it satisfies the equation for some holomorphic vector field . The candidate for a vector field is uniquely determined by the holomorphic structure of X up to conjugacy, hence depends only on the holomorphic structure of X. We introduce a sequence of holomorphic vector fields which approximates and fits to the quantized settings. Moreover, we also discuss about the existence and convergence of the quantized Kahler-Ricci solitons attached to the sequence .	[Takahashi, Ryosuke] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Takahashi, R (reprint author), Nagoya Univ, Grad Sch Math, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	m11036a@math.nagoya-u.ac.jp			 [25-3077]	The author would like to express his gratitude to Professor Ryoichi Kobayashi for his advice on this article, and to the referee for useful suggestions that helped him to improve the original manuscript. The author is supported by Grant-in-Aid for JSPS Fellows Number 25-3077.	Donaldson SK, 2009, PURE APPL MATH Q, V5, P571; Boucksom S, 2010, ACTA MATH-DJURSHOLM, V205, P199, DOI 10.1007/s11511-010-0054-7; Donaldson SK, 2001, J DIFFER GEOM, V59, P479; Futaki A, 2004, INT J MATH, V15, P967, DOI 10.1142/S0129167X04002612; Mabuchi T, 2009, OSAKA J MATH, V46, P115; FUJIKI A, 1978, INVENT MATH, V44, P225, DOI 10.1007/BF01403162; Tian G, 2015, COMMUN PUR APPL MATH, V68, P1085, DOI 10.1002/cpa.21578; Ono H, 2012, ANN I FOURIER, V62, P1265; Berman R, 2010, INVENT MATH, V181, P337, DOI 10.1007/s00222-010-0248-9; Mabuchi T, 2011, OSAKA J MATH, V48, P845; Tian G, 2000, ACTA MATH-DJURSHOLM, V184, P271, DOI 10.1007/BF02392630; Tian G, 2002, COMMENT MATH HELV, V77, P297, DOI 10.1007/s00014-002-8341-3; Berman RJ, 2013, PUBL MATH-PARIS, P179, DOI 10.1007/s10240-012-0046-6; Berman R.J., ARXIV14018264; Chen XX, 2015, J AM MATH SOC, V28, P235; Chen X., ARXIV14056797; Takahashi R., ARXIV14104891	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	DEC	2015	281	3-4					1021	1034		10.1007/s00209-015-1518-4		14	Mathematics	Mathematics	CW3WJ	WOS:000364922700019		
J	Banerjee, D; Tanaka, H; Iizuka, H				Banerjee, Debasish; Tanaka, Hiroya; Iizuka, Hideo			NULL-SPOT CONTROL OF MAGNETIC FIELD ENABLED BY MANIPULATING CURRENT DISTRIBUTION IN METALLIC LOOP ARRAY	MICROWAVE AND OPTICAL TECHNOLOGY LETTERS			English	Article						active circuits; arrays; magnetic fields	DESIGN; PLATES	Loading a capacitor into a metallic loop allows one to tune the resonance frequency of the induced current on the loop and enhance the current amplitude for the normally incident magnetic field. We show that in an array of variable-capacitor-loadedlo ops, a null spot of the magnetic field generated some distance away can be moved laterally and crossed the array by manipulating current amplitude of each loop via the variable capacitor. We develop an analytic model for expressing the curl of the current source on the loop by using the delta function so that the magnetic field behavior in the vicinity of the array is characterized together with physical insight. Moreover, the control of a null spot is explained by the decomposition of the curl of current sources. The concept of a null-spot control is crucial for manipulating the kilohertz/megahertz magnetic field. (C) 2015 Wiley Periodicals, Inc.	[Banerjee, Debasish] Toyota Motor Engn & Mfg North Amer, Toyota Res Inst, Ann Arbor, MI 48105 USA; [Tanaka, Hiroya; Iizuka, Hideo] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Banerjee, D (reprint author), Toyota Motor Engn & Mfg North Amer, Toyota Res Inst, Ann Arbor, MI 48105 USA.	debasish.banerjee@tema.toyota.com					Grbic A, 2008, SCIENCE, V320, P511, DOI 10.1126/science.1154753; Merlin R, 2007, SCIENCE, V317, P927, DOI 10.1126/science.1143884; Boyvat M, 2012, PROG ELECTROMAGN RES, V126, P303, DOI 10.2528/PIER12022010; Dede EM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737003; Grbic A, 2008, IEEE T ANTENN PROPAG, V56, P3159, DOI 10.1109/TAP.2008.929436; Tanaka H, 2012, IEEE ANTENN WIREL PR, V11, P1088, DOI 10.1109/LAWP.2012.2218091; Lee J, 2012, FINITE ELEM ANAL DES, V58, P44, DOI 10.1016/j.finel.2012.04.007; van Wyk JD, 2005, IEEE T POWER ELECTR, V20, P523, DOI 10.1109/TPEL.2005.846553; Goleman K, 2005, IEEE T MAGN, V41, P4084, DOI 10.1109/TMAG.2005.855193; [Anonymous], 2011, FELP US MAN SUIT 6 1; Banerjee D, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3629992; Gao F, 2014, IEEE T MICROW THEORY, V62, P481, DOI 10.1109/TMTT.2014.2299763; Tanaka H, 2013, IEEE T MAGN, V49, P5682, DOI 10.1109/TMAG.2013.2275391; Wakatsuchi H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.245501; BUTLER CM, 1982, IEEE T ANTENN PROPAG, V30, P755, DOI 10.1109/TAP.1982.1142839; Celozzi S., 2008, ELECTROMAGNETIC SHIE	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0895-2477	1098-2760		MICROW OPT TECHN LET	Microw. Opt. Technol. Lett.	DEC	2015	57	12					2891	2895		10.1002/mop.29455		6	Engineering, Electrical & Electronic; Optics	Engineering; Optics	CX0LT	WOS:000365388800044		
J	Cao, QF; Yamamoto, J; Isobe, T; Tateno, S; Murase, Y; Chen, YX; Handa, H; Yamaguchi, Y				Cao, Qing-Fu; Yamamoto, Junichi; Isobe, Tomoyasu; Tateno, Shumpei; Murase, Yuki; Chen, Yexi; Handa, Hiroshi; Yamaguchi, Yuki			Characterization of the Human Transcription Elongation Factor Rtf1: Evidence for Nonoverlapping Functions of Rtf1 and the Paf1 Complex (vol 35, pg 3459, 2015)	MOLECULAR AND CELLULAR BIOLOGY			English	Correction									[Cao, Qing-Fu; Yamamoto, Junichi; Isobe, Tomoyasu; Tateno, Shumpei; Murase, Yuki; Chen, Yexi; Yamaguchi, Yuki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Handa, Hiroshi] Tokyo Med Univ, Dept Nanoparticle Translat Res, Tokyo 1608402, Japan	Cao, QF (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.						Cao QF, 2015, MOL CELL BIOL, V35, P3459, DOI 10.1128/MCB.00601-15	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	DEC	2015	35	23					4093	4093		10.1128/MCB.00914-15		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CX5BF	WOS:000365714900013		
J	Asanoma, K; Liu, G; Yamane, T; Miyanari, Y; Takao, T; Yagi, H; Ohgami, T; Ichinoe, A; Sonoda, K; Wake, N; Kato, K				Asanoma, Kazuo; Liu, Ge; Yamane, Takako; Miyanari, Yoko; Takao, Tomoka; Yagi, Hiroshi; Ohgami, Tatsuhiro; Ichinoe, Akimasa; Sonoda, Kenzo; Wake, Norio; Kato, Kiyoko			Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells	MOLECULAR AND CELLULAR BIOLOGY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FACTOR DEC2; PANCREATIC-CANCER; BREAST-CANCER; E-BOX; INDEPENDENT MECHANISMS; ENDOMETRIAL CANCER; STRA13 EXPRESSION; PROXIMAL PROMOTER; TGF-BETA	BHLHE40 and BHLHE41 (BHLHE40/41) are basic helix-loop-helix type transcription factors that play key roles in multiple cell behaviors. BHLHE40/41 were recently shown to be involved in an epithelial-to-mesenchymal transition (EMT). However, the precise mechanism of EMT control by BHLHE40/41 remains unclear. In the present study, we demonstrated that BHLHE40/41 expression was controlled in a pathological stage-dependent manner in human endometrial cancer (HEC). Our in vitro assays showed that BHLHE40/41 suppressed tumor cell invasion. BHLHE40/41 also suppressed the transcription of the EMT effectors SNAI1, SNAI2, and TWIST1. We identified the critical promoter regions of TWIST1 for its basal transcriptional activity. We elucidated that the transcription factor SP1 was involved in the basal transcriptional activity of TWIST1 and that BHLHE40/41 competed with SP1 for DNA binding to regulate gene transcription. This study is the first to report the detailed functions of BHLHE40 and BHLHE41 in the suppression of EMT effectors in vitro. Our results suggest that BHLHE40/41 suppress tumor cell invasion by inhibiting EMT in tumor cells. We propose that BHLHE40/41 are promising markers to predict the aggressiveness of each HEC case and that molecular targeting strategies involving BHLHE40/41 and SP1 may effectively regulate HEC progression.	[Asanoma, Kazuo; Yamane, Takako; Miyanari, Yoko; Yagi, Hiroshi; Ohgami, Tatsuhiro; Ichinoe, Akimasa; Sonoda, Kenzo; Kato, Kiyoko] Kyushu Univ, Dept Obstet & Gynecol, Fac Med Sci, Fukuoka 812, Japan; [Liu, Ge; Wake, Norio] Kyushu Univ, Res Ctr Environm & Dev Med Sci, Fukuoka 812, Japan; [Takao, Tomoka] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Asanoma, K (reprint author), Kyushu Univ, Dept Obstet & Gynecol, Fac Med Sci, Fukuoka 812, Japan.	asanoma@med.kyushu-u.ac.jp			JSPS KAKENHI grant [26462529]; Takeda Science Foundation; Foundation for the Advancement of Clinical Medicine	This work was supported by JSPS KAKENHI grant number 26462529, the Takeda Science Foundation, and the Foundation for the Advancement of Clinical Medicine (funds to K.A.).	Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Shi XH, 2011, WORLD J GASTROENTERO, V17, P2037, DOI 10.3748/wjg.v17.i15.2037; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.271714999; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Martin B, 1999, NUCLEIC ACIDS RES, V27, P3402, DOI 10.1093/nar/27.17.3402; Li YX, 2011, BREAST CANCER RES TR, V128, P667, DOI 10.1007/s10549-010-1083-9; Qian YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084015; Li D, 2013, ONCOGENE, V32, P4950, DOI 10.1038/onc.2012.509; Wu YY, 2012, INT J ONCOL, V41, P1337, DOI 10.3892/ijo.2012.1559; Yunokawa M, 2007, ONCOL REP, V17, P871; Preusser M, 2005, HISTOL HISTOPATHOL, V20, P1173; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Villamarin S, 2002, BIOCHEM PHARMACOL, V63, P1251, DOI 10.1016/S0006-2952(02)00865-1; Park YK, 2012, MOL CELLS, V33, P575, DOI 10.1007/s10059-012-0002-9; Wu YY, 2012, BIOMED RES-TOKYO, V33, P75; Allred DC, 1998, MODERN PATHOL, V11, P155; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Li YX, 2004, BIOCHEM J, V382, P895; Zhu Y, 2013, CANCER SCI, V104, P1052, DOI 10.1111/cas.12176; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Hsiao SP, 2009, BIOCHEM J, V422, P343, DOI 10.1042/BJ20090072; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Hamaguchi H, 2004, BIOCHEM J, V382, P43; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Azmi S, 2004, J BIOL CHEM, V279, P52643, DOI 10.1074/jbc.M409188200; Wong VCL, 2011, BRIT J CANCER, V104, P841, DOI 10.1038/bjc.2011.25; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Inaguma S, 2013, CANCER RES, V73, P7313, DOI 10.1158/0008-5472.CAN-13-2008; Yamada K, 2005, FRONT BIOSCI, V10, P3151, DOI 10.2741/1772; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Liu Y, 2013, TUMOR BIOL, V34, P1641, DOI 10.1007/s13277-013-0697-z; Sato F, 2012, INT J MOL MED, V30, P495, DOI 10.3892/ijmm.2012.1037; Asanoma K, 2012, J BIOL CHEM, V287, P2257, DOI 10.1074/jbc.M111.287128; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Liu Y, 2013, INT J MOL MED, V31, P855, DOI 10.3892/ijmm.2013.1279; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Hu T, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0135-8; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Rossner M J, 1997, Mol Cell Neurosci, V10, P460; Suzuki M, 2014, BIOCHEM BIOPH RES CO, V455, P390, DOI 10.1016/j.bbrc.2014.11.030; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041862	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	DEC	2015	35	24					4096	4109		10.1128/MCB.00678-15		14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CX5BL	WOS:000365715500001		
J	Ikura, M; Furuya, K; Matsuda, S; Matsuda, R; Shima, H; Adachi, J; Matsuda, T; Shiraki, T; Ikura, T				Ikura, Masae; Furuya, Kanji; Matsuda, Shun; Matsuda, Ryo; Shima, Hiroki; Adachi, Jun; Matsuda, Tomonari; Shiraki, Takuma; Ikura, Tsuyoshi			Acetylation of Histone H2AX at Lys 5 by the TIP60 Histone Acetyltransferase Complex Is Essential for the Dynamic Binding of NBS1 to Damaged Chromatin	MOLECULAR AND CELLULAR BIOLOGY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; MRE11-RAD50-NBS1 COMPLEX; HOMOLOGOUS RECOMBINATION; GENOME STABILITY; SYNDROME GENE; LIVING CELLS; MDC1; PHOSPHORYLATION; GAMMA-H2AX	The association and dissociation of DNA damage response (DDR) factors with damaged chromatin occurs dynamically, which is crucial for the activation of DDR signaling in a spatiotemporal manner. We previously showed that the TIP60 histone acetyltransferase complex acetylates histone H2AX, to facilitate H2AX exchange at sites of DNA damage. However, it remained unclear how the acetylation of histone H2AX by TIP60 is related to the DDR signaling. We found that the acetylation but not the phosphorylation of H2AX is essential for the turnover of NBS1 on damaged chromatin. The loss of H2AX acetylation at Lys 5 by TIP60 in cells disturbed the accumulation of NBS1 at sites of DNA damage. Although the phosphorylation of H2AX is also reportedly required for the retention of NBS1 at damage sites, our data indicated that the acetylation-dependent NBS1 turnover by TIP60 on damaged chromatin restricts the dispersal of NBS1 foci from the sites of DNA damage. These findings indicate the importance of the acetylation-dependent dynamic binding of NBS1 to damaged chromatin, created by histone H2AX exchange, for the proper accumulation of NBS1 at DNA damage sites.	[Ikura, Masae; Matsuda, Ryo; Ikura, Tsuyoshi] Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Regulatory Network, Kyoto 606, Japan; [Furuya, Kanji] Kyoto Univ, Ctr Radiat Biol, Dept Radiat Syst, Kyoto 606, Japan; [Matsuda, Shun; Matsuda, Tomonari] Kyoto Univ, Res Ctr Environm Qual Management, Lab Environm Qual Management, Otsu, Shiga, Japan; [Shima, Hiroki] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan; [Adachi, Jun] Natl Inst Biomed Innovat, Ibaraki, Osaka, Japan; [Shiraki, Takuma] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan	Ikura, T (reprint author), Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Regulatory Network, Kyoto 606, Japan.	ikurat@house.rbc.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ikura T, 2003, FRONT BIOSCI, V8, pS149, DOI 10.2741/1013; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; NIWA H, 1991, GENE, V108, P193; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Gospodinov A, 2013, DNA REPAIR, V12, P800, DOI 10.1016/j.dnarep.2013.07.006; Walter J, 2003, J MICROSC-OXFORD, V209, P71, DOI 10.1046/j.1365-2818.2003.01117.x; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Iijima K, 2004, CHROMOSOMA, V113, P53, DOI 10.1007/s00412-004-0298-0; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Swygert SG, 2014, BBA-GENE REGUL MECH, V1839, P728, DOI 10.1016/j.bbagrm.2014.02.013; van Attikum H, 2005, CELL CYCLE, V4, P1011; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI [10.2217/epi.09.22, 10.2217/EP1.09.22]; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Altmeyer M, 2013, CURR OPIN GENET DEV, V23, P156, DOI 10.1016/j.gde.2012.11.001; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Tobias F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057953	43	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	DEC	2015	35	24					4147	4157		10.1128/MCB.00757-15		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CX5BL	WOS:000365715500005		
J	Tanaka, Y; Yano, H; Ogasawara, S; Yoshioka, S; Imamura, H; Okamoto, K; Tsuneoka, M				Tanaka, Yuji; Yano, Hirohisa; Ogasawara, Sachiko; Yoshioka, Sho-ichi; Imamura, Hiromi; Okamoto, Kengo; Tsuneoka, Makoto			Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell Proliferation	MOLECULAR AND CELLULAR BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; POLYMERASE-I TRANSCRIPTION; BREAST-CANCER; TOR PATHWAY; TIF-IA; HISTONE; GROWTH; KDM2A; PHOSPHORYLATION; TARGETS	Environmental conditions control rRNA transcription. Previously, we found that serum and glucose deprivation induces KDM2A-mediated H3K36me2 demethylation in the rRNA gene (rDNA) promoter and reduces rRNA transcription in the human breast cancer cell line MCF-7. However, the molecular mechanism and biological significance are still unclear. In the present study, we found that glucose starvation alone induced the KDM2A-dependent reduction of rRNA transcription. The treatment of cells with 2-deoxy-D-glucose, an inhibitor of glycolysis, reduced rRNA transcription and H3K36me2 in the rDNA promoter, both of which were completely dependent on KDM2A in low concentrations of 2-deoxy-D-glucose, that is, mild starvation conditions. The mild starvation induced these KDM2A activities through AMP-activated kinase (AMPK) but did not affect another AMPK effector of rRNA transcription, TIF-IA. In the triple-negative breast cancer cell line MDA-MB-231, the mild starvation also reduced rRNA transcription in a KDM2A-dependent manner. We detected KDM2A in breast cancer tissues irrespective of their estrogen receptor, progesterone receptor, and HER2 status, including triple-negative cancer tissues. In both MCF-7 and MDA-MB-231 cells, mild starvation reduced cell proliferation, and KDM2A knockdown suppressed the reduction of cell proliferation. These results suggest that under mild glucose starvation AMPK induces KDM2A-dependent reduction of rRNA transcription to control cell proliferation.	[Tanaka, Yuji; Yoshioka, Sho-ichi; Okamoto, Kengo; Tsuneoka, Makoto] Takasaki Univ Hlth & Welf, Lab Mol & Cellular Biol, Fac Pharm, Takasaki, Gumma, Japan; [Yano, Hirohisa; Ogasawara, Sachiko] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan	Tsuneoka, M (reprint author), Takasaki Univ Hlth & Welf, Lab Mol & Cellular Biol, Fac Pharm, Takasaki, Gumma, Japan.	tsuneoka@takasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) KAKENHI [21570204, 23770209, 23114721, 25840011]	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant-in-Aid for Scientific Research C, 21570204 and 23770209; Grants-in-Aid for Young Scientists 23114721 and 25840011).	Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Stavropoulos P, 2007, EXPERT OPIN THER TAR, V11, P809, DOI 10.1517/14728222.11.6.809; Weindruch R, 2001, J GERONTOL A-BIOL, V56, P20; Cheng ZJ, 2014, GENE DEV, V28, P1758, DOI 10.1101/gad.246561.114; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Kustatscher G, 2007, CURR OPIN CHEM BIOL, V11, P628, DOI 10.1016/j.cbpa.2007.09.011e; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Allred DC, 1998, MODERN PATHOL, V11, P155; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Chedin S, 2007, CELL CYCLE, V6, P11, DOI 10.4161/cc.6.1.3649; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Wu A, 2005, J BIOL CHEM, V280, P2863, DOI 10.1074/jbc.M406138200; Tanaka Y, 2014, CELL STRUCT FUNCT, V39, P79; Theriault RL, 2013, J NATL COMPR CANC NE, V11, P753; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Klaus A, 2012, J PROTEOMICS, V75, P3304, DOI 10.1016/j.jprot.2012.03.040; Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; Tuerk RD, 2007, J PROTEOME RES, V6, P3266, DOI 10.1021/pr070160a; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Ishizaki H, 2007, PATHOL INT, V57, P672, DOI 10.1111/j.1440-1827.2007.02156.x; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Kawakami E., 2014, MECH DEVELOP, V135, P31, DOI DOI 10.1016/J.M0D.2014.10.001; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Tanaka Yuji, 2013, Seikagaku, V85, P852; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	DEC	2015	35	24					4170	4184		10.1128/MCB.00579-15		15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CX5BL	WOS:000365715500007		
J	Ichihashi, N; Aita, T; Motooka, D; Nakamura, S; Yomo, T				Ichihashi, Norikazu; Aita, Takuyo; Motooka, Daisuke; Nakamura, Shota; Yomo, Tetsuya			Periodic Pattern of Genetic and Fitness Diversity during Evolution of an Artificial Cell-Like System	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						RNA; experimental evolution; diversity; fitness landscape; next-generation sequencer	BENEFICIAL MUTATIONS; RNA; REPLICATION; POPULATION; SELECTION; FATE	Genetic and phenotypic diversity are the basis of evolution. Despite their importance, however, little is known about how they change over the course of evolution. In this study, we analyzed the dynamics of the adaptive evolution of a simple evolvable artificial cell-like system using single-molecule real-time sequencing technology that reads an entire single artificial genome. We found that the genomic RNA population increases in fitness intermittently, correlating with a periodic pattern of genetic and fitness diversity produced by repeated diversification and domination. In the diversification phase, a genomic RNA population spreads within a genetic space by accumulating mutations until mutants with higher fitness are generated, resulting in an increase in fitness diversity. In the domination phase, the mutants with higher fitness dominate, decreasing both the fitness and genetic diversity. This study reveals the dynamic nature of genetic and fitness diversity during adaptive evolution and demonstrates the utility of a simplified artificial cell-like system to study evolution at an unprecedented resolution.	[Ichihashi, Norikazu; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan; [Ichihashi, Norikazu; Aita, Takuyo; Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Osaka, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	Yomo, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan.	yomo@ist.osaka-u.ac.jp					Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Bansho Y, 2012, CHEM BIOL, V19, P478, DOI 10.1016/j.chembiol.2012.01.019; EDWARDS AWF, 1994, BIOL REV, V69, P443, DOI 10.1111/j.1469-185X.1994.tb01247.x; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hayden EJ, 2014, J MOL EVOL, V78, P101, DOI 10.1007/s00239-013-9604-x; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Jimenez JI, 2013, P NATL ACAD SCI USA, V110, P14984, DOI 10.1073/pnas.1307604110; Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5; Barrick J E, 2009, Cold Spring Harb Symp Quant Biol, V74, P119, DOI 10.1101/sqb.2009.74.018; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Wagner A., 2005, ROBUSTNESS EVOLVABIL	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	DEC	2015	32	12					3205	3214		10.1093/molbev/msv189		10	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CX2ED	WOS:000365507300014		
J	Shimojo, D; Onodera, K; Doi-Torii, Y; Ishihara, Y; Hattori, C; Miwa, Y; Tanaka, S; Okada, R; Ohyama, M; Shoji, M; Nakanishi, A; Doyu, M; Okano, H; Okada, Y				Shimojo, Daisuke; Onodera, Kazunari; Doi-Torii, Yukiko; Ishihara, Yasuharu; Hattori, Chinatsu; Miwa, Yukino; Tanaka, Satoshi; Okada, Rina; Ohyama, Manabu; Shoji, Masanobu; Nakanishi, Atsushi; Doyu, Manabu; Okano, Hideyuki; Okada, Yohei			Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells	MOLECULAR BRAIN			English	Article						Human embryonic stem cells; Human induced pluripotent stem cells; Motor neurons; Long-term culture of motor neurons; Lentiviral reporter	WNT/BETA-CATENIN PATHWAY; PROGENITOR CELLS; PRECURSOR CELLS; IPS CELLS; IN-VITRO; DISEASE; PROLIFERATION; MAINTENANCE; AGGREGATION; GENERATION	Background: Human pluripotent stem cells (hPSCs) are being applied in regenerative medicine and for the in vitro modeling of human intractable disorders. In particular, neural cells derived from disease specific human induced pluripotent stern cells (hiPSCs) established from patients with neurological disorders have been used as in vitro disease models to recapitulate in vivo pathogenesis because neural cells cannot be usually obtained from patients themselves. Results: In this study, we established a rapid, efficient, and simple method for efficiently deriving motor neurons from hPSCs that is useful for pathophysiological analysis and the development of drugs to treat motor neuron diseases. Treatment with GSK3I3 inhibitors during the initial phase of differentiation in combination with dual SMAD inhibition was sufficient to induce PAX6(+) and SOX1(+) neural progenitors within 1 week, and subsequent treatment with retinoic acid (RA) and purmorphamine, which activates sonic hedgehog (SHH) signaling, resulted in the highly efficient induction of HB9(+) and ISL-1(+) motor neurons within 2 weeks. After 4 weeks of monolayer differentiation in motor neuron maturation medium, hPSC-derived motor neurons were shown to mature, displaying larger somas and clearer staining for the mature motor neuron marker choline acetyltransferase (ChAT). Moreover, hPSC-derived motor neurons were able to form neuromuscular junctions with human myotubes in vitro and induced acetylcholine receptor (AChR) clustering, as detected by Alexa 555 conjugated a-Bungarotoxin (o-BTX), suggesting that these hPSC-derived motor neurons formed functional contacts with skeletal muscles. This differentiation system is simple and is reproducible in several hiPSC clones, thereby minimizing clonal variation among hPSC clones. We also established a system for visualizing motor neurons with a lentiviral reporter for HB9 (HB9(e438)::Venus). The specificity of this reporter was confirmed through immunocytochemistry and quantitative RT-PCR analysis of high positive fractions obtained via fluorescence activated cell sorting (PACS), suggesting its applicability for motor neuron specific analysis. Conclusions: Our motor neuron differentiation system and lentivirus-based reporter system for motor neurons facilitate the analysis of disease specific hiPSCs for motor neuron diseases.	[Shimojo, Daisuke; Onodera, Kazunari; Doi-Torii, Yukiko; Tanaka, Satoshi; Okada, Rina; Doyu, Manabu; Okada, Yohei] Aichi Med Univ, Sch Med, Dept Neurol, Nagakute, Aichi 4801195, Japan; [Shimojo, Daisuke; Ishihara, Yasuharu; Hattori, Chinatsu; Miwa, Yukino; Okano, Hideyuki; Okada, Yohei] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Onodera, Kazunari] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan; [Tanaka, Satoshi] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Nagoya, Aichi 4668550, Japan; [Okada, Rina] Jikei Univ, Sch Med, Div Regenerat Med, Tokyo 1058461, Japan; [Ohyama, Manabu] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan; [Shoji, Masanobu; Nakanishi, Atsushi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, Fujisawa, Kanagawa 2518555, Japan	Okano, H (reprint author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.	hidokano@a2.keio.jp; yohei@aichi-med-u.ac.jp			Kanrinmaru-Project at Keio University; Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Program for Intractable Disease Research disease-specific IPS Cells from the Japan Science and Technology Agency (JST); AMED	We. are grateful to Dr. Hirofumi Suemori for providing KhEs1 hESCs, Dr. Shinya Yamanaka for 201B7 hiPSCs, Dr. Wack Akamatsu for supporting IPSC establishment, Dr. Steven Goldman for the IHB9<SUP>e438</SUP> enhancer element, Dr. Hiroyuki Miyoshi for lentiviral vectors, and Drs Hiroki Shinkai, Satoshi Niwa, Kazuko Kondoh, and Ayako Suzuki for technical and administrative assistance. We are also grateful to the members of the Okano and Okada laboratories for their encouragement and kind support. This work was supported by the Kanrinmaru-Project at Keio University; grants from the Practical Research; Project for intractable Diseases of the Ministry of Health, Labour and Welfare (MHLW) and the Japan Agency for Medical Research and development (AMED); a Grant-in-Aid for Scientific Research (B); and a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS) to YO. This work was also supported by a Grant-in-Aid for Scientific Research in Innovative Areas (Foundation of Synapse Neurocircuit Pathology to YO; a Brain Protein Aging and Dementia Control to YO and HO) from the JSPS and the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Project for the Realization al Regenerative Medicine and Support for the Core Institutes for IPS cell research from the MEXT; a grant from the Program for Intractable Disease Research disease-specific IPS Cells from the Japan Science and Technology Agency (JST) and AMED to HO; and a Grant-in-Ad for JSPS Fellows to DS.	Hashimoto N, 2006, BIOCHEM BIOPH RES CO, V348, P1383, DOI 10.1016/j.bbrc.2006.08.006; Otaegi G, 2011, J NEUROSCI, V31, P809, DOI 10.1523/JNEUROSCI.4330-10.2011; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Ohta E, 2015, HUM MOL GENET, V24, P4879, DOI 10.1093/hmg/ddv212; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Surmacz B, 2012, STEM CELLS, V30, P1875, DOI 10.1002/stem.1166; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Nihei Y, 2013, J BIOL CHEM, V288, P8043, DOI 10.1074/jbc.M112.408211; Nakano T, 2005, DEV BIOL, V283, P474, DOI 10.1016/j.ydbio.2005.04.017; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI [10.1016/j.mod.2007.11.004, 10.1016/j.mbd.2007.11.004]; Chen X, 2014, CELL PHYSIOL BIOCHEM, V34, P1109, DOI 10.1159/000366325; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Naujok Ortwin, 2014, BMC Res Notes, V7, P273, DOI 10.1186/1756-0500-7-273; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853	35	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-6606			MOL BRAIN	Mol. Brain	DEC 1	2015	8								79	10.1186/s13041-015-0172-4		15	Neurosciences	Neurosciences & Neurology	CX3AS	WOS:000365568500001		
J	Hu, CW; Hsu, CL; Wang, YC; Ishihama, Y; Ku, WC; Huang, HC; Juan, HF				Hu, Chia-Wei; Hsu, Chia-Lang; Wang, Yu-Chao; Ishihama, Yasushi; Ku, Wei-Chi; Huang, Hsuan-Cheng; Juan, Hsueh-Fen			Temporal Phosphoproteome Dynamics Induced by an ATP Synthase Inhibitor Citreoviridin	MOLECULAR & CELLULAR PROTEOMICS			English	Article							METAL-OXIDE CHROMATOGRAPHY; UNFOLDED PROTEIN RESPONSE; LIVER HEPG2 CELLS; BETA-SUBUNIT; ENDOTHELIAL-CELLS; EXTRACELLULAR ATP; HSP90 INHIBITION; PROSTATE-CANCER; BREAST-CANCER; PHOSPHORYLATION	Citreoviridin, one of toxic mycotoxins derived from fungal species, can suppress lung cancer cell growth by inhibiting the activity of ectopic ATP synthase, but has limited effect on normal cells. However, the mechanism of citreoviridin triggering dynamic molecular responses in cancer cells remains unclear. Here, we performed temporal phosphoproteomics to elucidate the dynamic changes after citreoviridin treatment in cells and xenograft model. We identified a total of 829 phosphoproteins and demonstrated that citreoviridin treatment affects protein folding, cell cycle, and cytoskeleton function. Furthermore, response network constructed by mathematical modeling shows the relationship between the phosphorylated heat shock protein 90 and mitogen-activated protein kinase signaling pathway. This work describes that citreoviridin suppresses cancer cell growth and mitogen-activated protein kinase/extracellular signal-regulated kinase signaling by site-specific dephosphorylation of HSP90AB1 on Serine 255 and provides perspectives in cancer therapeutic strategies.	[Hu, Chia-Wei; Juan, Hsueh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 106, Taiwan; [Hsu, Chia-Lang; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 106, Taiwan; [Wang, Yu-Chao] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan; [Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Ku, Wei-Chi] Fu Jen Catholic Univ, Sch Med, New Taipei City 242, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 106, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 106, Taiwan	Huang, HC (reprint author), Natl Yang Ming Univ, Inst Biomed Informat, 155,Sect 2,Linong St, Taipei 11221, Taiwan.	hsuancheng@ym.edu.tw; yukijuan@ntu.edu.tw		JUAN, HSUEH-FEN/0000-0003-4876-3309	National Taiwan University Cutting-Edge Steering Research Project [NTU-CESRP-103R7602C3]; National Science Council of Taiwan [NSC 102-2628-B-002-041-MY3, NSC 102-2627-B-002-002, NSC 102-2311-B-010-004]	This work was supported by the National Taiwan University Cutting-Edge Steering Research Project (NTU-CESRP-103R7602C3) and the National Science Council of Taiwan (NSC 102-2628-B-002-041-MY3, NSC 102-2627-B-002-002, NSC 102-2311-B-010-004).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; GAUSE EM, 1981, J BIOL CHEM, V256, P557; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Chang HY, 2012, CANCER RES, V72, P4696, DOI 10.1158/0008-5472.CAN-12-0567; Deshpande M, 2012, INT J ONCOL, V41, P219, DOI 10.3892/ijo.2012.1431; Lim YP, 2005, CLIN CANCER RES, V11, P3163, DOI 10.1158/1078-0432.CCR-04-2243; NISHIE K, 1988, RES COMMUN CHEM PATH, V59, P31; Chiu TL, 2010, INT J MOL MED, V25, P231, DOI 10.3892/ijmm_00000335; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Wu HM, 2010, COMPUT STAT DATA AN, V54, P767, DOI 10.1016/j.csda.2008.09.029; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Huang TC, 2008, J PROTEOME RES, V7, P1433, DOI 10.1021/pr700742h; Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y; Cornford PA, 2000, CANCER RES, V60, P7099; Wang WJ, 2012, CLIN EXP MED, V12, P3, DOI 10.1007/s10238-011-0133-x; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Xing SL, 2011, CELL BIOL INT, V35, P81, DOI 10.1042/CBI20090441; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Mowery YM, 2008, CANCER BIOL THER, V7, P1836, DOI 10.4161/cbt.7.11.7155; Lu CW, 2013, BIOCHEM PHARMACOL, V85, P1246, DOI 10.1016/j.bcp.2013.02.003; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Kim BW, 2004, EXP MOL MED, V36, P476; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Liu YN, 2015, TOXICON, V95, P30, DOI 10.1016/j.toxicon.2014.12.014; Harsha HC, 2010, MOL ONCOL, V4, P482, DOI 10.1016/j.molonc.2010.09.004; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Palumbo AM, 2011, MASS SPECTROM REV, V30, P600, DOI 10.1002/mas.20310; Almeida MI, 2012, FOOD ADDIT CONTAM A, V29, P694, DOI 10.1080/19440049.2011.651750; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Hu CW, 2012, J PROTEOME RES, V11, P5362, DOI 10.1021/pr300582p; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Tanaka K, 2013, CLIN CANCER RES, V19, P3856, DOI 10.1158/1078-0432.CCR-12-3167; Wang YX, 2015, TOXINS, V7, P3030, DOI 10.3390/toxins7083030; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; LINNETT PE, 1978, BIOCHEM J, V170, P503; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Kenan DJ, 2005, J BIOENERG BIOMEMBR, V37, P461, DOI 10.1007/s10863-005-9492-x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Sun SQ, 2010, MED HYPOTHESES, V74, P841, DOI 10.1016/j.mehy.2009.11.043; Scaltriti M, 2012, CLIN CANCER RES, V18, P4508, DOI 10.1158/1078-0432.CCR-11-2138; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Ito T, 2000, GENE DEV, V14, P1899; Chang HY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.504; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Hou HF, 2015, TOXICOL IND HEALTH, V31, P193, DOI 10.1177/0748233713483194; Hou HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125956; Johansson R., 1993, SYSTEM MODELING IDEN; Liu F, 2012, J INEQUAL APPL, V2012, P1; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Wang YC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-20; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070642; Zhao WL, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-92	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	1535-9476	1535-9484		MOL CELL PROTEOMICS	Mol. Cell. Proteomics	DEC	2015	14	12					3284	3298		10.1074/mcp.M115.051383		15	Biochemical Research Methods	Biochemistry & Molecular Biology	CX3ZN	WOS:000365638100015		
J	Miyagi, R; Akiyama, N; Osada, N; Takahashi, A				Miyagi, Ryutaro; Akiyama, Noriyoshi; Osada, Naoki; Takahashi, Aya			Complex patterns of cis-regulatory polymorphisms in ebony underlie standing pigmentation variation in Drosophila melanogaster	MOLECULAR ECOLOGY			English	Article						allele-specific expression level; amplicon sequencing; cis-regulatory variation; linkage disequilibrium; melanin biosynthesis	QUANTITATIVE TRAIT LOCI; THORACIC TRIDENT PIGMENTATION; AFFECTING WING SHAPE; CONTROLLING BRISTLE SCORE; GENETIC REFERENCE PANEL; CHROMOSOME SECTIONS; NATURAL VARIATION; EVOLUTION; POPULATIONS; NUMBER	Pigmentation traits in adult Drosophila melanogaster were used in this study to investigate how phenotypic variations in continuous ecological traits can be maintained in a natural population. First, pigmentation variation in the adult female was measured at seven different body positions in 20 strains from the Drosophila melanogaster Genetic Reference Panel(DGRP) originating from a natural population in North Carolina. Next, to assess the contributions of cis-regulatory polymorphisms of the genes involved in the melanin biosynthesis pathway, allele-specific expression levels of four genes were quantified by amplicon sequencing using a 454 GS Junior. Among those genes, ebony was significantly associated with pigmentation intensity of the thoracic segment. Detailed sequence analysis of the gene regulatory regions of this gene indicated that many different functional cis-regulatory alleles are segregating in the population and that variations outside the core enhancer element could potentially play important roles in the regulation of gene expression. In addition, a slight enrichment of distantly associated SNP pairs was observed in the similar to 10kb cis-regulatory region of ebony, which suggested the presence of interacting elements scattered across the region. In contrast, sequence analysis in the core cis-regulatory region of tan indicated that SNPs within the region are significantly associated with allele-specific expression level of this gene. Collectively, the data suggest that the underlying genetic differences in the cis-regulatory regions that control intraspecific pigmentation variation can be more complex than those of interspecific pigmentation trait differences, where causal genetic changes are typically confined to modular enhancer elements.	[Miyagi, Ryutaro; Akiyama, Noriyoshi; Takahashi, Aya] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Osada, Naoki] Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 4118540, Japan; [Osada, Naoki] SOKENDAI Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Takahashi, Aya] Tokyo Metropolitan Univ, Res Ctr Genom & Bioinformat, Hachioji, Tokyo 1920397, Japan	Takahashi, A (reprint author), Tokyo Metropolitan Univ, Dept Biol Sci, Minamiosawa 1-1, Hachioji, Tokyo 1920397, Japan.	ayat@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank the Bloomington Stock Center for fly stocks and Koichiro Tamura for valuable discussions. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; SHRIMPTON AE, 1988, GENETICS, V118, P445; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Wagner S, 2007, J COMP NEUROL, V500, P601, DOI 10.1002/cne.21138; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Zimmerman E, 2000, GENETICS, V155, P671; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Borycz J, 2002, J NEUROSCI, V22, P10549; Kopp A, 1997, DEVELOPMENT, V124, P3715; Parkash R, 2008, FLY, V2, P111; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Nuzhdin SV, 1999, GENETICS, V153, P1317; Mackay TFC, 2005, PHILOS T ROY SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; SHRIMPTON AE, 1988, GENETICS, V118, P437; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Kopp A, 2003, GENETICS, V163, P771; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Takahashi A, 2005, GENETICS, V170, P709, DOI 10.1534/genetics.104.036483; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Weber K, 1999, GENETICS, V153, P773; Gurganus MC, 1999, GENETICS, V152, P1585; Weber K, 2001, GENETICS, V159, P1045; Takahashi A, 2013, GENES GENET SYST, V88, P165; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Munjal AK, 1997, GENET SEL EVOL, V29, P601, DOI 10.1051/gse:19970505; Ordway AJ, 2014, DEV BIOL, V392, P431, DOI 10.1016/j.ydbio.2014.05.023; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Telonis-Scott M, 2011, MOL ECOL, V20, P2100, DOI 10.1111/j.1365-294X.2011.05089.x; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; LONG AD, 1995, GENETICS, V139, P1273; CLARK AG, 1991, P NATL ACAD SCI USA, V88, P9823, DOI 10.1073/pnas.88.21.9823; DAVID JR, 1985, GENET SEL EVOL, V17, P211, DOI 10.1186/1297-9686-17-2-211; Takahashi A, 2011, MOL ECOL, V20, P4277, DOI 10.1111/j.1365-294X.2011.05260.x; Morgan TH, 1919, J GEN PHYSIOL, V1, P639, DOI 10.1085/jgp.1.6.639; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; Mezey JG, 2005, GENETICS, V169, P2101, DOI 10.1534/genetics.104.0369988; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; Bastide H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0179-y; Bastide H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003534; Bickel RD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001275; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Dembeck LM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005163; Gavin BA, 2007, PLOS GENET, V3, P2358, DOI 10.1371/journal.pgen.0030206; Johnson WC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005279; Lachaise D, 1988, HIST BIOGEOGRAPHY DR; Parkash Ravi, 2009, Journal of Insect Science (Tucson), V9, P1, DOI 10.1673/031.009.4901; R Core Team, 2014, R LANG ENV STAT COMP; Suvorov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083547; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/S0065-2660(08)60008-5	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	DEC	2015	24	23					5829	5841		10.1111/mec.13432		13	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CX5QK	WOS:000365756900008		
J	Park, YJ; Nishikawa, T; Minami, M; Nemoto, K; Iwasaki, T; Matsushima, K				Park, Young-Jun; Nishikawa, Tomotaro; Minami, Mineo; Nemoto, Kazuhiro; Iwasaki, Tomohiro; Matsushima, Kenichi			A low-pungency S3212 genotype of Capsicum frutescens caused by a mutation in the putative aminotransferase (p-AMT) gene	MOLECULAR GENETICS AND GENOMICS			English	Article						Capsicum frutescens; Capsinoid; Putative aminotransferase; Low-pungency; Deletion mutation	NONPUNGENT CAPSAICINOID ANALOGS; CH-19 SWEET; PEPPER; CAPSINOIDS; BIOSYNTHESIS; ANNUUM; ACCUMULATION; HUMANS; TRAIT	The purpose of this study was to identify the genetic mechanism underlying capsinoid biosynthesis in S3212, a low-pungency genotype of Capsicum frutescens. Screening of C. frutescens accessions for capsaicinoid and capsiate contents by high-performance liquid chromatography revealed that low-pungency S3212 contained high levels of capsiate but no capsaicin. Comparison of DNA coding sequences of pungent (T1 and Bird Eye) and low-pungency (S3212) genotypes uncovered a significant 12-bp deletion mutation in exon 7 of the p-AMT gene of S3212. In addition, p-AMT gene transcript levels in placental tissue were positively correlated with the degree of pungency. S3212, the low-pungency genotype, exhibited no significant p-AMT transcript levels, whereas T1, one of the pungent genotypes, displayed high transcript levels of this gene. We therefore conclude that the deletion mutation in the p-AMT gene is related to the loss of pungency in placental tissue and has given rise to the low-pungency S3212 C. frutescens genotype. C. frutescens S3212 represents a good natural source of capsinoids. Finally, our basic characterization of the uncovered p-AMT gene mutation should contribute to future studies of capsinoid biosynthesis in Capsicum.	[Park, Young-Jun; Minami, Mineo; Nemoto, Kazuhiro; Iwasaki, Tomohiro; Matsushima, Kenichi] Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan; [Nishikawa, Tomotaro] Natl Insitute Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan	Matsushima, K (reprint author), Shinshu Univ, Grad Sch Agr, 8304 Minami Minowa, Nagano 3994598, Japan.	matuken@shinshu-u.ac.jp			MEXT; Shimizu Sumio Research Fund, Shinshu Foundation for Promotion of Agricultural and Forest Science	We express our sincere thanks to Dr. Yoshiyuki Tanaka (Okayama University) for helpful comments on this manuscript. This research was supported by MEXT Project 'Basic research for creation of agricultural innovation by cooperation between the faculty of technology and the faculty of agriculture, Shinshu University' and Shimizu Sumio Research Fund, Shinshu Foundation for Promotion of Agricultural and Forest Science.	Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010; Lang YQ, 2009, PLANT J, V59, P953, DOI 10.1111/j.1365-313X.2009.03921.x; Blum E, 2003, THEOR APPL GENET, V108, P79, DOI 10.1007/s00122-003-1405-y; Kawabata F, 2006, BIOSCI BIOTECH BIOCH, V70, P2824, DOI 10.1271/bbb.60206; Tanaka Y, 2010, J AGR FOOD CHEM, V58, P1761, DOI 10.1021/jf903282r; Macho A, 2003, EUR J NUTR, V42, P2, DOI 10.1007/s00394-003-0394-6; Rosa A, 2002, J AGR FOOD CHEM, V50, P7396, DOI [10.1021/jf020431w, 10.1021/fj020431w]; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Luo XJ, 2011, EUR J PHARMACOL, V650, P1, DOI 10.1016/j.ejphar.2010.09.074; Kirschbaum-Titze P, 2002, J AGR FOOD CHEM, V50, P1260, DOI 10.1021/jf010527a; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Tanaka Y, 2010, J AGR FOOD CHEM, V58, P11762, DOI 10.1021/jf1019642; IWAI K, 1979, AGR BIOL CHEM TOKYO, V43, P2493; Haramizu S, 2011, BIOSCI BIOTECH BIOCH, V75, P95, DOI 10.1271/bbb.100577; Saritnum O, 2008, J JPN SOC HORTIC SCI, V77, P265, DOI 10.2503/jjshs1.77.265; Han K, 2013, MOL BREEDING, V31, P537, DOI 10.1007/s11032-012-9811-y; Tanaka Y, 2009, J AGR FOOD CHEM, V57, P5407, DOI 10.1021/jf900634s; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Onuki K, 2011, BIOSCI BIOTECH BIOCH, V65, P2735; Rozen S, 2000, Methods Mol Biol, V132, P365	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	DEC	2015	290	6					2217	2224		10.1007/s00438-015-1071-1		8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CX0ZF	WOS:000365425300014		
J	Someya, T; Kaltenbrunner, M; Yokota, T				Someya, Takao; Kaltenbrunner, Martin; Yokota, Tomoyuki			Ultraflexible organic electronics	MRS BULLETIN			English	Article						devices; electronic material; semiconducting; sensor	FIELD-EFFECT TRANSISTORS; ACTIVE-MATRIX DISPLAYS; THIN-FILM TRANSISTORS; LARGE-AREA; STRETCHABLE ELECTRONICS; ELASTIC CONDUCTORS; IN-VIVO; POLYMER; DEVICES; CIRCUITS	In this article, we review recent research progress on ultraflexible organic thin-film devices and their emerging applications. We describe progress on devices such as organic thin-film transistors, organic photovoltaic cells, and organic light-emitting diodes that are manufactured on ultrathin plastic films with micrometer-scale thicknesses. These ultraflexible organic devices have been utilized to realize new applications, including wearable and biomedical devices.	[Someya, Takao; Yokota, Tomoyuki] Univ Tokyo, Sch Engn, Dept Elect & Elect Engn, Tokyo 1138654, Japan; [Someya, Takao; Yokota, Tomoyuki] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Tokyo, Japan; [Kaltenbrunner, Martin] Johannes Kepler Univ Linz, Soft Matter Phys Dept, Linz, Austria	Someya, T (reprint author), Univ Tokyo, Sch Engn, Dept Elect & Elect Engn, Tokyo 1138654, Japan.	someya@ee.t.u-tokyo.ac.jp; martin.kaltenbrunner@jku.at; yokota@ntech.t.u-tokyo.ac.jp					Yamamoto T, 2007, J AM CHEM SOC, V129, P2224, DOI 10.1021/ja068429z; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/nphoton.2013.188, 10.1038/NPHOTON.2013.188]; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Suga T, 2009, ADV MATER, V21, P1627, DOI 10.1002/adma.200803073; Cantatore E, 2007, IEEE J SOLID-ST CIRC, V42, P84, DOI 10.1109/JSSC.2006.886556; Baude PF, 2003, APPL PHYS LETT, V82, P3964, DOI 10.1063/1.1579554; Jung M, 2010, IEEE T ELECTRON DEV, V57, P571, DOI 10.1109/TED.2009.2039541; Andersson P, 2002, ADV MATER, V14, P1460, DOI 10.1002/1521-4095(20021016)14:20<1460::AID-ADMA1460>3.0.CO;2-S; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kato Y, 2007, IEEE T ELECTRON DEV, V54, P202, DOI 10.1109/TED.2006.888678; Heikenfeld J, 2011, J SOC INF DISPLAY, V19, P129, DOI 10.1889/JSID19.2.129; Kato Y, 2010, IEEE T ELECTRON DEV, V57, P995, DOI 10.1109/TED.2010.2044278; Jeon J, 2013, ADV MATER, V25, P850, DOI 10.1002/adma.201204082; Sekitani T, 2008, P NATL ACAD SCI USA, V105, P4976, DOI 10.1073/pnas.0708340105; Park JS, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3159832; Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/nmat3755, 10.1038/NMAT3755]; Suo Z, 1999, APPL PHYS LETT, V74, P1177, DOI 10.1063/1.123478; Sekitani T, 2010, NAT MATER, V9, P1015, DOI [10.1038/nmat2896, 10.1038/NMAT2896]; Gleskova H, 1999, APPL PHYS LETT, V75, P3011, DOI 10.1063/1.125174; Fukuda K, 2011, ADV FUNCT MATER, V21, P4019, DOI 10.1002/adfm.201101050; Ma MM, 2013, SCIENCE, V339, P186, DOI 10.1126/science.1230262; Liang JJ, 2013, NAT PHOTONICS, V7, P817, DOI 10.1038/NPHOTON.2013.242; Reeder J, 2014, ADV MATER, V26, P4967, DOI 10.1002/adma.201400420; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169; Subramanian V, 2005, P IEEE, V93, P1330, DOI 10.1109/JPROC.2005.850305; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Voit W, 2010, ADV FUNCT MATER, V20, P162, DOI 10.1002/adfm.200901409; Campana A, 2014, ADV MATER, V26, P3874, DOI 10.1002/adma.201400263; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Myny K, 2012, IEEE J SOLID-ST CIRC, V47, P284, DOI 10.1109/JSSC.2011.2170635; Arias AC, 2004, APPL PHYS LETT, V85, P3304, DOI 10.1063/1.1801673; Steudel S, 2005, NAT MATER, V4, P597, DOI 10.1038/nmat1434; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/nmat2459, 10.1038/NMAT2459]; Noda M, 2011, J SOC INF DISPLAY, V19, P316, DOI 10.1889/JSID19.4.316; Someya T, 2005, IEEE T ELECTRON DEV, V52, P2502, DOI 10.1109/TED.2005.857935; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Fukushima T, 2005, ANGEW CHEM INT EDIT, V44, P2410, DOI 10.1002/anie.200462318; Hu LB, 2009, P NATL ACAD SCI USA, V106, P21490, DOI 10.1073/pnas.0908858106; Vanfleteren J, 2012, MRS BULL, V37, P254, DOI 10.1557/mrs.2012.48; Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Fuketa H, 2014, IEEE T BIOMED CIRC S, V8, P824, DOI 10.1109/TBCAS.2014.2314135; Sekitani T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868868; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Hu LB, 2010, ACS NANO, V4, P5843, DOI 10.1021/nn1018158; Halik M, 2004, NATURE, V431, P963, DOI 10.1038/nature02987; Mabeck JT, 2006, ANAL BIOANAL CHEM, V384, P343, DOI 10.1007/s00216-005-3390-2; Bansal A. K., ADV MAT; Bao ZN, 1997, CHEM MATER, V9, P1299, DOI 10.1021/cm9701163; Crawford GP, 2005, WILEY-SID SER DISPL, P1, DOI 10.1002/0470870508; Fuketa H., 2015, IEEE INT SOL STAT CI; Fukuda K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5147; Gao L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5938; Graz IM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3570661; Ji Yongsung, 2013, Nat Commun, V4, P2707, DOI 10.1038/ncomms3707; Jin D. -U., 2009, SID INT S, V40, P983, DOI 10.1889/1.3256964; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2573; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3133; Kim RH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4583; Klauk H., 2006, ORGANIC ELECT MAT MA; Klauk H., 2012, ORGANIC ELECT; Knopfmacher O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3954; Libanori R., 2012, NAT COMMUN, V3, P2281; Lochner CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6745; Matsubara R., 2012, SID S, V43, P419, DOI [10.1002/j.2168-0159.2012.tb05805.x, DOI 10.1002/J.2168-0159.2012.TB05805.X]; Matsuhisa N., 2015, NAT COMMUN, V6, P8461, DOI [10.1038/ncomms9461, DOI 10.1038/NCOMMS9461]; Mulla MY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7010; Park IJ, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/10/105019; Pushparaj V. L., 2007, P NATL ACAD SCI USA, V104, P13574, DOI [10.1073/pnas.0706508104, DOI 10.1073/PNAS.0706508104]; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Sekitani T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2115075; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Someya T., 2012, STRETCHABLE ELECT; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Steudel S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2202243; Suzuki K., 2009, P IDW, V16, P1581; Takamiya M., 2007, IEEE J SOLID-ST CIRC, V42, P1, DOI [10.1109/JSSC.2006.889391, DOI 10.1109/JSSC.2006.889391]; Wong WS, 2009, ELECTRON MATER SCI T, P143, DOI 10.1007/978-0-387-74363-9_6; Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329; Xu S., 2012, NAT COMMUN, V4, P1543; Zhao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5293	90	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0883-7694	1938-1425		MRS BULL	MRS Bull.	DEC	2015	40	12					1130	1137		10.1557/mrs.2015.277		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CX5LY	WOS:000365744400013		
J	Sakamoto, M; Nakajima, T; Alexandrova, T				Sakamoto, Mizuki; Nakajima, Tatsuo; Alexandrova, Todorka			Enhancing values through virtuality for intelligent artifacts that influence human attitude and behavior	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Persuasion; Intelligent artifacts; Values; Virtuality; Fictionality; Ideological messages; Transmedia storytelling; Internet of things; Gamification	MODEL	Embodied interaction technologies allow us to enhance physical artifacts surrounding us by adding an information layer to the artifacts. The information layer that we call virtual forms presents dynamically generated visual information representing virtual objects and creatures that influence human attitude and behavior. The focus of our research is to develop intelligent artifacts enhanced with virtual forms that influence human attitude and behavior. To suggest some ways to develop such artifacts that harmoniously integrate virtual forms into them, based on our experience with three case studies presented in the paper, we propose a value-based analysis framework, which allows us to discuss and consider some good-design implications for the design of the enhanced intelligent artifacts. We also present design implications to apply the value-based analysis framework to analyze and enhance one of intelligent artifact. Finally, our experience suggests that incorporating fictionality is a promising direction for the designing of intelligent artifacts with ideological messages intended to influence people's attitude and behavior.	[Sakamoto, Mizuki; Nakajima, Tatsuo; Alexandrova, Todorka] Waseda Univ, Dept Comp Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Nakajima, T (reprint author), Waseda Univ, Dept Comp Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	tatsuo@dcl.cs.waseda.ac.jp					Boztepe S, 2007, INT J DES, V1, P55; Lockton D, 2010, APPL ERGON, V41, P382, DOI 10.1016/j.apergo.2009.09.001; Lehdonvirta V, 2009, ELECTRON COMMER RES, V9, P97, DOI 10.1007/s10660-009-9028-2; Nakajima T, 2013, PERS UBIQUIT COMPUT, V17, P107, DOI 10.1007/s00779-011-0469-y; Yamabe T, 2013, MULTIMED TOOLS APPL, V62, P259, DOI 10.1007/s11042-011-0979-7; Kim WC, 2005, CALIF MANAGE REV, V47, P105; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38; Ardenne P., 2009, AC DC CONT ART CONT; Arrasvuori J., 2011, P DES PLEAS PROD INT; Baudrillard J, 1994, SIMULACRA SIMULATION; Beyer H, 1999, CONTEXTUAL DESIGN; Bogost I, 2010, NEWSGAMES JOURNALISM; Friedman B, 2006, ADV MANAG INFORM SYS, V5, P348; Cagan C, 2002, CREATING BREAKTHROUG; Cockton G., 2006, P NORDICHI 2006, P165, DOI 10.1145/1182475.1182493; Consolvo S., 2006, P INT C HUM FACT COM; Dena C., 2009, THESIS; Deterding S., 2011, P AC MINDTR C; Dewey J, 1987, ART EXPERIENCE; Djajadiningrat T., 2002, P DIS 02 ACM, P285; Dunne A, 2013, SPECULATIVE EVERYTHI; Dunne Lucy, 2010, SMART CLOTHING PRACT, V2, P41; Ehn P, 1993, PARTICIPATORY DESIGN, P41; Fogg BJ, 2002, PERSUASIVE TECHNOLOG; Fredrikson B, 2009, POSITIVITY TOP NOTCH; Fuad-Luka A, 2009, DESIGN ACTIVISM BEAU; Fujinami K., 2005, P 2 INT WORKSH UB IN, P335; Fujinami K., 2005, P 3 INT C PERV COMP, P137; Fulton SJ, 2005, THOUGHTLESS ACTS; Gilmore J. H., 1999, EXPERIENCE EC WORK I; Goffman Erving, 1974, FRAME ANAL ESSAY ORG; Hakknas L., 2001, J PERSONAL UBIQUITOU, V5; Hara K, 2011, JAPANESE DESIGN AEST; Hassenzahl M., 2006, USER EXPERIENCE RES, P91; Hekler E., 2013, P CHI 2013; Huizinga J., 1955, HOMOLUDENS STUDY PLA; IDEO, 2003, IDEO METH CARDS 51 W; Ishii H., 1997, P SIGCHI C HUM FACT, P234, DOI DOI 10.1145/258549.258715; Iwata T., 2011, Proceedings of the 2011 IEEE 17th International Conference on Embedded and Real-Time Computing Systems and Applications (RTCSA 2011), DOI 10.1109/RTCSA.2011.43; Jordan P., 2002, DESIGNING PLEASURABL; Jull J, 2005, HALF REAL VIDEO GAME; Kahneman D., 2012, THINKING FAST SLOW; Kawsar F., 2008, P 10 INT C UB COMP, P282, DOI 10.1145/1409635.1409673; Kawsar F., 2005, P 2005 JOINT C SMART, P141, DOI 10.1145/1107548.1107587; Krippendorff K, 2005, SEMANTIC TURN NEW FD; Lehdonvirta V., 2011, KNOWLEDGE MAP VIRTUA; Lehdonvirta V, 2009, PUBLICATIONS TURKU A, V11; Marzano S, 2003, NEW EVERYDAY VIEW AM; Maslow A. H., 1970, MOTIVATION PERSONALI; Mattila A. S., 2000, J SERV RES-US, V3, P35, DOI 10.1177/109467050031003; McGonigal J., 2011, REALITY IS BROKEN WH; Montola M, 2009, PERVASIVE GAMES THEO; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1162/PRES.16.4.337; Petersen M.G., 2004, P 5 C DES INT SYST, P269, DOI 10.1145/1013115.1013153; Reeves B, 1998, MEDIA EQUATION PEOPL; Ritterfeld U., 2009, SERIOUS GAMES MECH E; Ruppel M.N., 2012, THESIS; Ruth M., 2007, PRODUCT EXPERIENCE H; Sakamoto M., 2013, P INT C MOB UB MULT; Sakamoto M., 2014, P 6 INT C SOC COMP S; Sakamoto M., 2014, 6 INT C CROSS CULT D; Sakamoto M., 2014, INT J HYBRID INFORM, V7; Sakamoto M., 2013, P 6 INT C ADV COMP H; Sakamoto M., 2014, P 25 INT C DAT EXP S; Sakamoto M., 2014, P INT C INT POL POL; Sakamoto M., 2014, INT J SMART HOME, V8; Sakamoto M., 2014, P 2 INT C DISTR AMB; Schwartz B., 2005, PARADOX CHOICE WHY M; Schwarz N, 2006, SOCIAL PSYCHOL HDB B; Sengers P, 2006, P 6 C DES INT SYST, P99, DOI DOI 10.1145/1142405.1142422; Szulborski D, 2005, THIS IS NOT GAME GUI; Thaler R. H., 2009, NUDGE IMPROVING DECI; Todd PM, 2007, EUR J OPER RES, V177, P1417; Wright P, 2010, EXPERIENCE CTR DESIG; Zuckerman O., 2014, PERSONAL UBIQUITOUS, V18	75	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	DEC	2015	74	24					11537	11568		10.1007/s11042-014-2250-5		32	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CX1HG	WOS:000365446600026		
J	Warabi, Y; Takahashi, T; Isozaki, E				Warabi, Yoko; Takahashi, Toshiyuki; Isozaki, Eiji			Progressive cerebral atrophy in neuromyelitis optica	MULTIPLE SCLEROSIS JOURNAL			English	Article						Multiple sclerosis; neuromyelitis optica; secondary progressive; progressive cerebral atrophy; inflammation; axonal degeneration; anti-aquaporin-4 antibody; astrocyte	DEGENERATION; MYELOPATHY	We report two cases of neuromyelitis optica patients with progressive cerebral atrophy. The patients exhibited characteristic clinical features, including elderly onset, secondary progressive tetraparesis and cognitive impairment, abnormally elevated CSF protein and myelin basic protein levels, and extremely highly elevated serum anti-AQP-4 antibody titer. Because neuromyelitis optica pathology cannot switch from an inflammatory phase to the degenerative phase until the terminal phase, neuromyelitis optica rarely appears as a secondary progressive clinical course caused by axonal degeneration. However, severe intrathecal inflammation and massive destruction of neuroglia could cause a secondary progressive clinical course associated with cerebral atrophy in neuromyelitis optica patients.	[Warabi, Yoko; Isozaki, Eiji] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan; [Takahashi, Toshiyuki] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Takahashi, Toshiyuki] Natl Yonezawa Hosp, Dept Neurol, Yonezawa, Yamagata, Japan	Warabi, Y (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	youko_warabi@tmhp.jp					Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yanagawa K, 2009, NEUROLOGY, V73, P1628, DOI 10.1212/WNL.0b013e3181c1deb9; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Kim JS, 2010, MULT SCLER, V16, P1255, DOI 10.1177/1352458510377907; Popescu BFG, 2010, NEUROLOGY, V75, P2103, DOI 10.1212/WNL.0b013e318200d80c; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Katz JD, 2000, ARCH NEUROL-CHICAGO, V57, P355, DOI 10.1001/archneur.57.3.355; Irwin DJ, 2014, NEUROLOGY, V83, P502, DOI 10.1212/WNL.0000000000000668; Blanc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033878; Caroppo P, 2014, JAMA NEUROL, V71, P1562, DOI 10.1001/jamaneurol.2014.1316; Fujihara K, 2012, CLIN EXP NEUROIMMUNO, V3, P58; Gelfand Jeffrey M, 2014, Neurol Neuroimmunol Neuroinflamm, V1, pe34, DOI 10.1212/NXI.0000000000000034; Wingerchuk D. M., 2015, NEUROLOGY, V85, P1	14	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	DEC	2015	21	14					1872	1875		10.1177/1352458515600246		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX3PR	WOS:000365611900093		
J	Brilot-Turville, F; Ramanathan, S; Tea, F; Merheb, V; Kira, J; Dale, R; Reddel, S; Prelog, K; Barnett, M; Parratt, J; Nosadini, M				Brilot-Turville, Fabienne; Ramanathan, Sudarshini; Tea, Fiona; Merheb, Vera; Kira, Jun-ichi; Dale, Russell; Reddel, Stephen; Prelog, Kristina; Barnett, Michael; Parratt, John; Nosadini, Marguerita			Investigating the clinical phenotype and epitope associated with MOG autoantibody in human demyelinating disorders	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract	MS Research Australia Progress in MS Research Conference	OCT 29-30, 2015	Melbourne, AUSTRALIA			Antibody MOG epitope optic neuritis			[Brilot-Turville, Fabienne; Ramanathan, Sudarshini; Tea, Fiona; Merheb, Vera; Dale, Russell; Nosadini, Marguerita] Univ Sydney, Kids Res Inst, Childrens Hosp Westmead, Neuroimmunol Grp, Sydney, NSW 2006, Australia; [Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Reddel, Stephen; Barnett, Michael] Univ Sydney, Brain & Mind Ctr, Sydney, NSW 2006, Australia; [Prelog, Kristina] Childrens Hosp Westmead, Sydney, NSW, Australia; [Parratt, John] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	DEC	2015	21	14				OP 4.3	NP8	NP9				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX3PR	WOS:000365611900021		
J	Tamura, Y; Hane, K				Tamura, Yosuke; Hane, Kazuhiro			AlN Nanowall Structures Grown on Si (111) Substrate by Molecular Beam Epitaxy	NANOSCALE RESEARCH LETTERS			English	Article						AlN; Nanostructure; Nanowall; MBE; Si substrate; Epitaxial growth; XRD	GAN NANONETWORK; SCHOTTKY DIODE; SAPPHIRE; QUALITY; FILMS; MBE	AlN nanowall structures were grown on Si (111) substrate using molecular beam epitaxy at substrate temperature of 700 degrees C with N/Al flux ratios ranging from 50 to 660. A few types of other AlN nanostructures were also grown under the nitrogen-rich conditions. The AlN nanowalls were ranged typically 60-120 nm in width and from 190 to 470 nm in length by changing N/Al flux ratio. The AlN nanowall structures grown along the c-plane consisted of AlN (0002) crystal with full-width at half maximum of the rocking curve about 5000 arcsec.	[Tamura, Yosuke; Hane, Kazuhiro] Tohoku Univ, Grad Sch Engn, Dept Nanomech, Aoba Ku, Sendai, Miyagi 980, Japan	Tamura, Y (reprint author), Tohoku Univ, Grad Sch Engn, Dept Nanomech, Aoba Ku, 6-6-01 Aramaki Aza Aoba, Sendai, Miyagi 980, Japan.	y.tamura@hane.mech.tohoku.ac.jp			Japan Society for the Promotion of Science	The authors would like to thank Y. Kanamori and T. Sasaki for discussion. Y. Tamura appreciates the Research Fellow of Japan Society for the Promotion of Science for the financial support.	Taniyasu Y, 2006, NATURE, V441, P325, DOI 10.1038/nature04760; Nechaev DV, 2013, J CRYST GROWTH, V378, P319, DOI 10.1016/j.jcrysgro.2012.12.080; Li XH, 2015, J CRYST GROWTH, V414, P76, DOI 10.1010/j.jcysgro.2014.10.007; Kesaria M, 2011, MATER RES BULL, V46, P1811, DOI 10.1016/j.materresbull.2011.07.043; Zhong AH, 2014, SENSOR ACTUAT A-PHYS, V209, P52, DOI 10.1016/j.sna.2014.01.014; EAGLESHAM DJ, 1991, APPL PHYS LETT, V59, P685, DOI 10.1063/1.105365; Yasutake K, 1998, J VAC SCI TECHNOL A, V16, P2140, DOI 10.1116/1.581321; Lei WW, 2009, CRYST GROWTH DES, V9, P1489, DOI 10.1021/cg800965p; Kesaria M, 2011, CRYST GROWTH DES, V11, P4900, DOI 10.1021/cg200749w; Yamano K, 2015, J CRYST GROWTH, V425, P316, DOI 10.1016/j.jcrysgro.2015.02.051; Kishino K, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/22/225602; SAXLER A, 1994, APPL PHYS LETT, V64, P339, DOI 10.1063/1.111168; Schenk HPD, 1999, MAT SCI ENG B-SOLID, V59, P84, DOI 10.1016/S0921-5107(98)00328-6; Kishino K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.031001; Zhang F, 2012, VACUUM, V86, P833, DOI 10.1016/j.vacuum.2011.02.012; Zhong AH, 2014, INT J HYDROGEN ENERG, V39, P8564, DOI 10.1016/j.ijhydene.2014.03.120; Wu Q, 2003, J MATER CHEM, V13, P2024, DOI 10.1039/b303987k; Ishizawa S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.055001; Eom D, 2015, CRYST GROWTH DES, V15, P1242, DOI 10.1021/cg5016274; Kuo SY, 2015, J MATER SCI-MATER EL, V26, P4285, DOI 10.1007/s10854-015-2980-9; Ebling DG, 1999, J CRYST GROWTH, V201, P411, DOI 10.1016/S0022-0248(98)01364-5; Rodriguez PEDS, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803017; Fan ZY, 1999, MAT SCI ENG B-SOLID, V67, P80, DOI 10.1016/S0921-5107(99)00213-5; Zhao S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08332; Zhong AH, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-686; Zhong AH, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JE13	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1556-276X			NANOSCALE RES LETT	Nanoscale Res. Lett.	DEC 1	2015	10								460	10.1186/s11671-015-1178-7		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CX5SM	WOS:000365762800002		
J	Zhao, WR; Weng, GE; Wang, JY; Zhang, JY; Liang, HW; Sekiguchi, T; Zhang, BP				Zhao, Wan-Ru; Weng, Guo-En; Wang, Jian-Yu; Zhang, Jiang-Yong; Liang, Hong-Wei; Sekiguchi, Takashi; Zhang, Bao-Ping			Enhanced Light Emission due to Formation of Semi-polar InGaN/GaN Multi-quantum Wells	NANOSCALE RESEARCH LETTERS			English	Article						Semi-polar; InGaN/GaN multi-quantum wells; Cathodoluminescence; Photoluminescence	MULTIPLE-QUANTUM WELLS; FIELD; LAYERS	InGaN/GaN multi-quantum wells (MQWs) are grown on (0001) sapphire substrates by metal organic chemical vapor deposition (MOCVD) with special growth parameters to form V-shaped pits simultaneously. Measurements by atomic force microscopy (AFM) and transmission electron microscopy (TEM) demonstrate the formation of MQWs on both (0001) and (1 (1) over bar 01) side surface of the V-shaped pits. The latter is known to be a semi-polar surface. Optical characterizations together with theoretical calculation enable us to identify the optical transitions from these MQWs. The layer thickness on (1 (1) over bar 01) surface is smaller than that on (0001) surface, and the energy level in the (1 (1) over tilde 01) semi-polar quantum well (QW) is higher than in the (0001) QW. As the sample temperature is increased from 15 K, the integrated cathodoluminescence (CL) intensity of (0001) MQWs increases first and then decreases while that of the (1 (1) over bar 01) MQWs decreases monotonically. The integrated photoluminescence (PL) intensity of (0001) MQWs increases significantly from 15 to 70 K. These results are explained by carrier injection from (1 (1) over bar 01) to (0001) MQWs due to thermal excitation. It is therefore concluded that the emission efficiency of (0001) MQWs at high temperatures can be greatly improved due to the formation of semi-polar MQWs.	[Zhao, Wan-Ru; Zhang, Jiang-Yong; Zhang, Bao-Ping] Xiamen Univ, Dept Elect Engn, Xiamen 361005, Peoples R China; [Weng, Guo-En] Xiamen Univ, Dept Phys, Xiamen 361005, Peoples R China; [Wang, Jian-Yu] Nanjing Univ, Sch Elect Sci & Engn, Nanjing 210093, Jiangsu, Peoples R China; [Liang, Hong-Wei] Dalian Univ Technol, Sch Phys & Optoelect Engn, Dalian 116024, Peoples R China; [Sekiguchi, Takashi] Natl Inst Mat Sci, World Premier Int WPI Ctr Mat Nanoarchitecton MAN, Tsukuba, Ibaraki 3050044, Japan	Liang, HW (reprint author), Dalian Univ Technol, Sch Phys & Optoelect Engn, Dalian 116024, Peoples R China.	hwliang@dlut.edu.cn; bzhang@xmu.edu.cn			National Natural Science Foundation of China [61274052, 11474235]; Fundamental Research Funds for the Central Universities [2013121024]; Key Lab of Nanodevices and Nanoapplications, Suzhou Institute of Nano-Tech and Nano-Bionics of Chinese Academy of Sciences [14ZS02]; Opened Fund of the State Key Laboratory on Integrated Optoelectronics [IOSKL2014KF08]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61274052, 11474235), the Fundamental Research Funds for the Central Universities (Grant No. 2013121024), the Key Lab of Nanodevices and Nanoapplications, Suzhou Institute of Nano-Tech and Nano-Bionics of Chinese Academy of Sciences (Grant No. 14ZS02), and the Opened Fund of the State Key Laboratory on Integrated Optoelectronics No. IOSKL2014KF08.	Nam OH, 1997, APPL PHYS LETT, V71, P2638, DOI 10.1063/1.120164; Narayanan V, 2001, APPL PHYS LETT, V78, P1544, DOI 10.1063/1.1352699; Yu ET, 1997, APPL PHYS LETT, V71, P2794, DOI 10.1063/1.120138; LESTER SD, 1995, APPL PHYS LETT, V66, P1249, DOI 10.1063/1.113252; Jho YD, 2001, APPL PHYS LETT, V79, P1130, DOI 10.1063/1.1396315; Tsai CC, 2002, APPL PHYS LETT, V80, P3718, DOI 10.1063/1.1480108; Ambacher O, 2002, J PHYS-CONDENS MAT, V14, P3399, DOI 10.1088/0953-8984/14/13/302; Nardelli MB, 1997, APPL PHYS LETT, V71, P3135, DOI 10.1063/1.120269; Wang HN, 2012, OPT EXPRESS, V20, P3932, DOI 10.1364/OE.20.003932; Bemardini F, 2000, APPL SURF SCI, V166, P23; Dupuis RD, 2007, APPL PHYS LETT, V91; Hinckley J, 2009, APPL PHYS LETT, V95; Hinze P, 2005, PHYS REV LETT, V95; Jiang FY, 2014, APPL PHYS LETT, V104; Kim ST, 2013, APPL PHYS LETT, V102; Kneissl M, 2012, SEMICOND SCI TECH, V27; Speck JS, 2006, J APPL PHYS, V100; Tansu N, 2007, APPL PHYS LETT, V91; Wang JX, 2013, CHINESE PHYS LETT, V30; Weng GE, 2013, FUNCT MATER LETT, V6	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1556-276X			NANOSCALE RES LETT	Nanoscale Res. Lett.	DEC 1	2015	10								459	10.1186/s11671-015-1171-1		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CX5SM	WOS:000365762800001		
J	Paulsen, JD; Demery, V; Santangelo, CD; Russell, TP; Davidovitch, B; Menon, N				Paulsen, Joseph D.; Demery, Vincent; Santangelo, Christian D.; Russell, Thomas P.; Davidovitch, Benny; Menon, Narayanan			Optimal wrapping of liquid droplets with ultrathin sheets	NATURE MATERIALS			English	Article							THIN; PARTICLES; BUBBLES; STRESS	Elastic sheets offer a path to encapsulating a droplet of one fluid in another that is different from that of traditional molecular or particulate surfactants(1). In wrappings of fluids by sheets of moderate thickness with petals designed to curl into closed shapes(2,3), capillarity balances bending forces. Here, we show that, by using much thinner sheets, the constraints of this balance can be lifted to access a regime of high sheet bendability that brings three major advantages: ultrathin sheets automatically achieve optimally efficient shapes that maximize the enclosed volume of liquid for a fixed area of sheet; interfacial energies and mechanical properties of the sheet are irrelevant within this regime, thus allowing for further functionality; and complete coverage of the fluid can be achieved without special sheet designs. We propose and validate a general geometric model that captures the entire range of this new class of wrapped and partially wrapped shapes.	[Paulsen, Joseph D.; Demery, Vincent; Santangelo, Christian D.; Davidovitch, Benny; Menon, Narayanan] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Paulsen, Joseph D.; Russell, Thomas P.] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA; [Russell, Thomas P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Russell, Thomas P.] Tohoku Univ, WPI AIMR, Aoba Ku, Sendai, Miyagi 9808577, Japan	Paulsen, JD (reprint author), Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA.	paulsenj@umass.edu; vdemery@umass.edu		Paulsen, Joseph/0000-0001-6048-456X	W. M. Keck Foundation	We thank M. Juszkiewicz for early contributions to this work and O. Agam for helpful discussions. Funding from the W. M. Keck Foundation is gratefully acknowledged.	Holmes DP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.038303; Davidovitch B, 2011, P NATL ACAD SCI USA, V108, P18227, DOI 10.1073/pnas.1108553108; King H, 2012, P NATL ACAD SCI USA, V109, P9716, DOI 10.1073/pnas.1201201109; Subramaniam AB, 2005, NATURE, V438, P930, DOI 10.1038/438930a; Pak I, 2008, AM MATH MON, V115, P443; Gao LC, 2008, LANGMUIR, V24, P9183, DOI 10.1021/la8014578; Schroll RD, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.014301; Chen LQ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492834; PAULSEN WH, 1994, AM MATH MON, V101, P953, DOI 10.2307/2975161; Reis PM, 2010, SOFT MATTER, V6, P5705, DOI 10.1039/c0sm00895h; Witten TA, 2007, REV MOD PHYS, V79, P643, DOI 10.1103/RevModPhys.79.643; Jamin T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.204503; Cui MM, 2013, SCIENCE, V342, P460, DOI 10.1126/science.1242852; Pocivavsek L, 2008, SCIENCE, V320, P912, DOI 10.1126/science.1154069; Guo XY, 2009, P NATL ACAD SCI USA, V106, P20149, DOI 10.1073/pnas.0907390106; Vella D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.014301; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Pineirua M, 2010, SOFT MATTER, V6, P4491, DOI 10.1039/c0sm00004c; Aharoni H, 2010, NAT MATER, V9, P993, DOI [10.1038/nmat2893, 10.1038/NMAT2893]; Huang J, 2007, SCIENCE, V317, P650, DOI 10.1126/science.1144616; Diamant H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.164302; Pak I, 2010, J NONLINEAR MATH PHY, V17, P145, DOI 10.1142/S140292511000057X; Antkowiak A, 2011, P NATL ACAD SCI USA, V108, P10400, DOI 10.1073/pnas.1101738108; Brakke K., 1992, EXP MATH, V1, P141, DOI DOI 10.1080/10586458.1992.10504253; Chopin J, 2015, J ELASTICITY, V119, P137, DOI 10.1007/s10659-014-9498-x; Py C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156103; Taylor G. I., 1963, SCI PAPERS GI TAYLOR, V3, P26; Zoueshtiagh F, 2014, SOFT MATTER, V10, P9403, DOI 10.1039/c4sm01648c	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	DEC	2015	14	12					1206	1209				4	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CX6VE	WOS:000365839000016		
J	Tada, T; Zhang, YZ; Koyama, T; Tobiume, M; Tsunetsugu-Yokota, Y; Yamaoka, S; Fujita, H; Tokunaga, K				Tada, Takuya; Zhang, Yanzhao; Koyama, Takayoshi; Tobiume, Minoru; Tsunetsugu-Yokota, Yasuko; Yamaoka, Shoji; Fujita, Hideaki; Tokunaga, Kenzo			MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; E3 UBIQUITIN LIGASE; COMPLEX CLASS-I; CELL-SURFACE; PERSISTENT INFECTION; ANTIGEN PRESENTATION; DOWN-REGULATION; NEF PROTEIN; VPU PROTEIN; T-CELLS	Membrane-associated RING-CH 8 (MARCH8) is one of 11 members of the recently discovered MARCH family of RING (really interesting new gene)-finger E3 ubiquitin ligases(1,2). MARCH8 downregulates several host transmembrane proteins, including major histocompatibility complex (MHC)-II, CD86, interleukin (IL)-1 receptor accessory protein, TNFrelated apoptosis-inducing ligand (TRAIL) receptor 1 and the transferrin receptor(3-7). However, its physiological roles remain largely unknown. Here we identify MARCH8 as a novel antiviral factor. The ectopic expression of MARCH8 in virusproducing cells does not affect levels of lentivirus production, but it does markedly reduce viral infectivity. MARCH8 blocks the incorporation of HIV-1 envelope glycoprotein into virus particles by downregulating it from the cell surface, probably through their interaction, resulting in a substantial reduction in the efficiency of viral entry. The inhibitory effect of MARCH8 on vesicular stomatitis virus G-glycoprotein is even more remarkable, suggesting a broad-spectrum inhibition of enveloped viruses by MARCH8. Notably, the endogenous expression of MARCH8 is high in monocyte-derived macrophages and dendritic cells, and MARCH8 knockdown or knockout in macrophages significantly increases the infectivity of virions produced by these cells. Our findings thus indicate that MARCH8 is highly expressed in terminally differentiated myeloid cells, and that it is a potent antiviral protein that targets viral envelope glycoproteins and reduces their incorporation into virions.	[Tada, Takuya; Zhang, Yanzhao; Koyama, Takayoshi; Tobiume, Minoru; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Zhang, Yanzhao; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan; [Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Tokunaga, K (reprint author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	tokunaga@nih.go.jp			Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS) [H24-005, H24-008, H25-010]; Japan Society for the Promotion of Science (KAKENHI) [26460086]; Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS); Japan Foundation for AIDS Prevention; Otsuka Toshimi Foundation Scholarship	We are grateful to F. Barre-Sinoussi for critical reading of the manuscript. We thank D. Trono (Ecole Polytechnique Federale de Lausanne, Switzerland, for pWPI; pLVTHM; and pMDLg/pRRE), M.D. Miller (Merck, USA, for pMM310), K. Tomonaga (Kyoto University, Japan, for pBDV-G), Y. Koyanagi (Kyoto University, Japan, for pJRFL); R.H. Silverman and B. Dong (US National Institutes of Health (NIH) AIDS Research and Reference Program, for VP62/pcDNA3.1) F. Zhang (Massachusetts Institute of Technology, USA, for lentiCRISPR-v2), A. Adachi (the University of Tokushima, Japan, for pGL-AN-.Env+Luc), Y. Ishizaka (National Center for Global Health and Medicine, Japan, for 8D1), K. Ikuta (Osaka University, Japan, for 4H4), F. Maldarelli and K. Strebel (US NIH AIDS Research and Reference Program, for anti-Vpu rabbit serum), and T. Sata (Toyama Institute of Health, Japan, for Nu24). This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS project no. H24-005, H24-008 and H25-010 to K.T.), the Japan Society for the Promotion of Science (KAKENHI 26460086 to H.F.), the Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS) (to K.T.). T.T. is a recipient of a Research Resident Fellowship from the Japan Foundation for AIDS Prevention. Y.Z. is a recipient of the Otsuka Toshimi Foundation Scholarship.	Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; MALDARELLI F, 1993, J VIROL, V67, P5056; Yang HC, 2009, P NATL ACAD SCI USA, V106, P6321, DOI 10.1073/pnas.0809536106; NIWA H, 1991, GENE, V108, P193; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; SHIBATA R, 1990, J VIROL, V64, P742; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Nakai-Murakami C, 2007, ONCOGENE, V26, P477, DOI 10.1038/sj.onc.1209831; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; Kitagawa Y, 2008, VIROLOGY, V373, P171, DOI 10.1016/j.virol.2007.11.033; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; NAIDU YM, 1988, J VIROL, V62, P4691; Nomaguchi M, 2014, MICROBES INFECT, V16, P695, DOI 10.1016/j.micinf.2014.06.004; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Adachi A, 1987, J Virol, V61, P209; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; OTAKE K, 1994, J IMMUNOL, V153, P5826; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Pham HM, 2004, J VIROL, V78, P13072, DOI 10.1128/JVI.78.23.13072-13081.2004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Lapaque Nicolas, 2009, J Biol Chem, V284, P7007, DOI 10.1074/jbc.M805736200; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Daito T, 2011, J VIROL, V85, P12170, DOI 10.1128/JVI.05554-11; Koyama T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-21; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Mashiba M, 2014, CELL HOST MICROBE, V16, P722, DOI 10.1016/j.chom.2014.10.014; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tokarev A, 2011, CELL LOGIST, V1, P90, DOI DOI 10.4161/CL.1.3.16708; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8961.2003	55	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1502	+		10.1038/nm.3956		10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	WOS:000366008700022		
J	Li, XJ; Toyohira, Y; Horisita, T; Satoh, N; Takahashi, K; Zhang, H; Iinuma, M; Yoshinaga, Y; Ueno, S; Tsutsui, M; Sata, T; Yanagihara, N				Li, Xiaojia; Toyohira, Yumiko; Horisita, Takafumi; Satoh, Noriaki; Takahashi, Keita; Zhang, Han; Iinuma, Munekazu; Yoshinaga, Yukari; Ueno, Susumu; Tsutsui, Masato; Sata, Takeyoshi; Yanagihara, Nobuyuki			Ikarisoside A inhibits acetylcholine-induced catecholamine secretion and synthesis by suppressing nicotinic acetylcholine receptor-ion channels in cultured bovine adrenal medullary cells	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						Adrenal medulla; Catecholamine secretion; Epimedium; Flavonoids; Ikarisoside A; Nicotinic acetylcholine receptor	B SIGNALING PATHWAYS; RAW 264.7 CELLS; CHROMAFFIN CELLS; TYROSINE-HYDROXYLASE; NEUROACTIVE STEROIDS; FLAVONOL GLYCOSIDES; CA-45 INFLUX; NA+ CHANNELS; NA-22 INFLUX; MODULATION	Ikarisoside A is a natural flavonol glycoside derived from plants of the genus Epimedium, which have been used in Traditional Chinese Medicine as tonics, antirheumatics, and aphrodisiacs. Here, we report the effects of ikarisoside A and three other flavonol glycosides on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells. We found that ikarisoside A (1-100 mu M), but not icariin, epimedin C, or epimedoside A, concentration-dependently inhibited the secretion of catecholamines induced by acetylcholine, a physiological secretagogue and agonist of nicotinic acetylcholine receptors. Ikarisoside A had little effect on catecholamine secretion induced by veratridine and 56 mM K+. Ikarisoside A (1-100 mu M) also inhibited Na-22(+) influx and Ca-45(2+) influx induced by acetylcholine in a concentration-dependent manner similar to that of catecholamine secretion. In Xenopus oocytes expressing alpha 3 beta 4 nicotinic acetylcholine receptors, ikarisoside A (0.1-100 mu M) directly inhibited the current evoked by acetylcholine. It also suppressed C-14-catecholamine synthesis and tyrosine hydroxylase activity induced by acetylcholine at 1-100 mu M and 10-100 mu M, respectively. The present findings suggest that ikarisoside A inhibits acetylcholine-induced catecholamine secretion and synthesis by suppression of nicotinic acetylcholine receptor-ion channels in bovine adrenal medullary cells.	[Li, Xiaojia; Toyohira, Yumiko; Takahashi, Keita; Yoshinaga, Yukari; Yanagihara, Nobuyuki] Univ Occupat & Environm Hlth, Dept Pharmacol, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Horisita, Takafumi; Sata, Takeyoshi] Univ Occupat & Environm Hlth, Dept Anesthesiol, Sch Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Satoh, Noriaki] Univ Occupat & Environm Hlth, Shared Use Res Ctr, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Zhang, Han] Tianjin Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med, Tianjin, Peoples R China; [Iinuma, Munekazu] Gifu Pharmaceut Univ, Dept Pharmacognosy, Gifu 502, Japan; [Ueno, Susumu] Univ Occupat & Environm Hlth, Dept Occupat Toxicol, Inst Ind Ecol Sci, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Tsutsui, Masato] Univ Ryukyus, Fac Med, Dept Pharmacol, Nishihara, Okinawa 90301, Japan	Yanagihara, N (reprint author), Univ Occupat & Environm Hlth, Dept Pharmacol, Sch Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yanagin@med.uoeh-u.ac.jp			Japan Society for Promotion of Science [23617035, 23617036, 23590159, 26350170]	This work was supported, in part, by Grant-in-Aid (23617035, 23617036, 23590159, and 26350170) for Scientific Research (C) from the Japan Society for the Promotion of Science.	TSUTSUI M, 1994, MOL PHARMACOL, V46, P1041; Lu MF, 2013, BIOCHEM BIOPH RES CO, V434, P701, DOI 10.1016/j.bbrc.2013.04.035; Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Lai XQ, 2013, INT IMMUNOPHARMACOL, V16, P41, DOI 10.1016/j.intimp.2013.03.025; YANAGIHARA N, 1987, BIOCHEM PHARMACOL, V36, P3823, DOI 10.1016/0006-2952(87)90444-8; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; WEILMALHERBE H, 1952, BIOCHEM J, V51, P311; LENA C, 1993, TRENDS NEUROSCI, V16, P181, DOI 10.1016/0166-2236(93)90150-K; Bobrovskaya L, 1998, J NEUROCHEM, V70, P2565; Kajiwara K, 2002, J PHARMACOL EXP THER, V302, P212, DOI 10.1124/jpet.302.1.212; Ueno S, 2004, FEBS LETT, V566, P213, DOI 10.1016/j.febslet.2004.04.030; Choi HJ, 2010, EUR J PHARMACOL, V636, P28, DOI 10.1016/j.ejphar.2010.03.023; Zhang H, 2010, J NEUROCHEM, V114, P1030, DOI 10.1111/j.1471-4159.2010.06840.x; WADA A, 1984, NEUROSCI LETT, V47, P75, DOI 10.1016/0304-3940(84)90389-6; Horishita T, 2008, J PHARMACOL EXP THER, V326, P270, DOI 10.1124/jpet.108.138370; Yanagihara N, 1996, J BIOL CHEM, V271, P17463; CRIADO M, 1992, NEUROCHEM RES, V17, P281, DOI 10.1007/BF00966671; WADA A, 1985, N-S ARCH PHARMACOL, V328, P273, DOI 10.1007/BF00515553; WADA A, 1985, NEUROSCIENCE, V15, P283, DOI 10.1016/0306-4522(85)90135-6; MIZUNO M, 1988, CHEM PHARM BULL, V36, P3487; Toyohira Y, 2005, N-S ARCH PHARMACOL, V371, P107, DOI 10.1007/s00210-005-1020-3; Shinohara Y, 2007, BIOCHEM PHARMACOL, V74, P1608, DOI 10.1016/j.bcp.2007.08.013; CamposCaro A, 1997, J NEUROCHEM, V68, P488; DOUGLAS WW, 1961, NATURE, V192, P1087, DOI 10.1038/1921087b0; Choi HJ, 2008, EUR J PHARMACOL, V601, P171, DOI 10.1016/j.ejphar.2008.09.032; Chen WF, 2011, BRIT J NUTR, V105, P180, DOI 10.1017/S0007114510003247; YANAGIHARA N, 1979, FEBS LETT, V105, P296, DOI 10.1016/0014-5793(79)80633-X; Pintado AJ, 2000, BRIT J PHARMACOL, V130, P1893, DOI 10.1038/sj.bjp.0703519; GARCIAGUZMAN M, 1995, EUR J NEUROSCI, V7, P647, DOI 10.1111/j.1460-9568.1995.tb00668.x; Kuroda M, 2000, PLANTA MED, V66, P575, DOI 10.1055/s-2000-8611; Ren ZL, 2012, J PHARMACOL SCI, V120, P139, DOI 10.1254/jphs.12R06CP; Dou JP, 2006, ANAL SCI, V22, P449, DOI 10.2116/analsci.22.449; Lopez MG, 1998, P NATL ACAD SCI USA, V95, P14184, DOI 10.1073/pnas.95.24.14184; Lambert JJ, 2001, BRAIN RES REV, V37, P68, DOI 10.1016/S0165-0173(01)00124-2; Liu M, 2007, ENDOCRINOLOGY, V148, P5348, DOI 10.1210/en.2007-0073; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; DOUGLAS WW, 1963, J PHYSIOL-LONDON, V167, P288; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Westfall TC, 2011, GOODMAN GILMANS PHAR, P277; Yanagihara N, 2014, J PHARMACOL SCI, V124, P123, DOI 10.1254/jphs.13R17CP; Zhou Jian, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1783	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	DEC	2015	388	12					1259	1269		10.1007/s00210-015-1161-y		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX6DJ	WOS:000365791100003		
J	Wybo, WAM; Boccalini, D; Torben-Nielsen, B; Gewaltig, MO				Wybo, Willem A. M.; Boccalini, Daniele; Torben-Nielsen, Benjamin; Gewaltig, Marc-Oliver			A Sparse Reformulation of the Green's Function Formalism Allows Efficient Simulations of Morphological Neuron Models	NEURAL COMPUTATION			English	Article							FREQUENCY-DOMAIN RESPONSES; RATIONAL APPROXIMATION; ARBITRARY GEOMETRY; DENDRITIC TREES; COMPUTATION; SYSTEMS	We prove that when a class of partial differential equations, generalized from the cable equation, is defined on tree graphs and the inputs are restricted to a spatially discrete, well chosen set of points, the Green's function (GF) formalism can be rewritten to scale asO(n) with the number n of inputs locations, contrary to the previously reported O(n(2)) scaling. We show that the linear scaling can be combined with an expansion of the remaining kernels as sums of exponentials to allow efficient simulations of equations from the aforementioned class. We furthermore validate this simulation paradigm on models of nerve cells and explore its relation with more traditional finite difference approaches. Situations in which a gain in computational performance is expected are discussed.	[Wybo, Willem A. M.; Gewaltig, Marc-Oliver] EPFL, Blue Brain Project, Brain Mind Inst, CH-1202 Geneva, Switzerland; [Boccalini, Daniele] Ecole Polytech Fed Lausanne, Math Inst Geometry & Applicat, Chair Geometry, CH-1015 Lausanne, Switzerland; [Torben-Nielsen, Benjamin] Okinawa Inst Sci & Technol, Computat Neurosci Unit, Okinawa 19191, Japan	Wybo, WAM (reprint author), EPFL, Blue Brain Project, Brain Mind Inst, CH-1202 Geneva, Switzerland.	willem.wybo@epfl.ch; daniele.boccalini@epfl.ch; btorbennielsen@gmail.com; marc-oliver.gewaltig@epfl.ch			European Union [269921, 604102]; EPFL Blue Brain Project Fund; ETH Board	We thank Luc Guyot for many insightful comments on this letter. The research leading to these results has received funding from the European Union, Seventh Framework Programme (FP7/2007-2013) under grant agreements 269921 (BrainScaleS) and 604102 (The HUMAN BRAIN PROJECT) as well as funding from the EPFL Blue Brain Project Fund and the ETH Board to the Blue Brain Project.	Bressloff PC, 1997, INT J MOD PHYS B, V11, P2343, DOI 10.1142/S0217979297001209; Lubich C, 2002, SIAM J SCI COMPUT, V24, P161, DOI 10.1137/S1064827501388741; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; ABBOTT LF, 1991, BIOL CYBERN, V66, P49, DOI 10.1007/BF00196452; Rotter S, 1999, BIOL CYBERN, V81, P381, DOI 10.1007/s004220050570; KOCH C, 1985, J NEUROSCI METH, V12, P303, DOI 10.1016/0165-0270(85)90015-9; Agmon-Snir H, 1998, NATURE, V393, P268; Wybo WAM, 2013, BIOL CYBERN, V107, P685, DOI 10.1007/s00422-013-0568-0; Hendrickx W, 2006, IEEE T POWER SYST, V21, P441, DOI 10.1109/TPWRS.2005.860905; BUTZ EG, 1974, BIOPHYS J, V14, P661; MOORE JW, 1978, BIOPHYS J, V21, P147; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; KOCH C, 1984, BIOL CYBERN, V50, P15, DOI 10.1007/BF00317936; Gustavsen B, 1999, IEEE T POWER DELIVER, V14, P1052, DOI 10.1109/61.772353; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Schoen A, 2012, NEURAL COMPUT, V24, P3126, DOI 10.1162/NECO_a_00366; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Carnevale NT, 2006, NEURON BOOK; Caudron Quentin, 2012, J Math Neurosci, V2, P11, DOI 10.1186/2190-8567-2-11; Coombes A. S., 2007, BIOL CYBERN, V97, P137; HINES M, 1984, INT J BIOMED COMPUT, V15, P69, DOI 10.1016/0020-7101(84)90008-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; Horn R. A., 2012, MATRIX ANAL; Koch C., 1998, BIOPHYSICS COMPUTATI; Laudanski J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003775; Silver A., 2010, NAT REV NEUROSCI, V11, P474, DOI [10.1038/nrn2864, DOI 10.1038/NRN2864]; Stakgold I, 1967, BOUNDARY VALUE PROBL; Torben-Nielsen B, 2014, NEUROINFORMATICS, V12, P619, DOI 10.1007/s12021-014-9232-7; Torben-Nielsen B, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00128; Tuckwell H.C., 1988, INTRO THEORETICAL NE	34	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	DEC	2015	27	12					2587	2622		10.1162/NECO_a_00788		36	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CX4MJ	WOS:000365674700004		
J	Naitou, K; Mamerto, TP; Pustovit, RV; Callaghan, B; Rivera, LR; Chan, AJ; Ringuet, MT; Pietra, C; Furness, JB				Naitou, K.; Mamerto, T. P.; Pustovit, R. V.; Callaghan, B.; Rivera, L. R.; Chan, A. J.; Ringuet, M. T.; Pietra, C.; Furness, J. B.			Site and mechanism of the colokinetic action of the ghrelin receptor agonist, HM01	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						defecation; ghrelin; ghrelin receptors	GROWTH-HORMONE SECRETAGOGUE; LUMBOSACRAL DEFECATION CENTER; RATS; NEURONS; STIMULATION; CONSTIPATION; VOLUNTEERS; EXPRESSION; APPETITE; MOTILITY	BackgroundIt has been recently demonstrated that the ghrelin receptor agonist, HM01, caused defecation in rats that were treated to provide a model for the constipation of Parkinson's disease. HM01 significantly increased fecal output and increased Fos activity in neurons of the hypothalamus and hindbrain, but not in the spinal defecation center. Other ghrelin agonists act on the defecation center. MethodsReceptor pharmacology was examined in ghrelin receptor (GHSR1a) transfected cells. Anesthetized rats were used to investigate sites and mechanisms of action. Key ResultsHM01 activated rat GHSR1a at nanomolar concentrations and was antagonized by the GHSR1a antagonist, YIL781. HM01, intravenous, was potent to activate propulsive colorectal contractions. This was prevented by pelvic nerve section and by intravenous YIL781, but not by spinal cord section rostral to the defecation centers. Direct intrathecal application of HM01 to the defecation center at spinal level L6-S1 initiated propulsive contractions of the colorectum. Conclusions & InferencesHM01 stimulates GHSR1a receptors on neurons in the lumbosacral defecation centers to cause propulsive contractions and emptying of the colorectum. It has greater potency when given systemically, compared with other GHSR1a agonists.	[Naitou, K.; Mamerto, T. P.; Pustovit, R. V.; Callaghan, B.; Rivera, L. R.; Chan, A. J.; Ringuet, M. T.; Furness, J. B.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Naitou, K.] Gifu Univ, United Grad Sch Vet Sci, Dept Vet Basic Sci, Physiol Lab, Gifu, Japan; [Pietra, C.] Helsinn Res & Preclin Dept, Lugano, Switzerland; [Furness, J. B.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	Furness, JB (reprint author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia.	j.furness@unimelb.edu.au			Transport Accident Commission of Victoria through the Institute for Safety, Compensation and Recovery Research; National Health and Medical Research Council of Australia [1005811]; Japan Public-Private Partnership Student Study Abroad Program (TOBITATE! Young Ambassador Program) from the Japan Student Services Organization (JASSO); NHMRC	The work was supported by the Transport Accident Commission of Victoria through the Institute for Safety, Compensation and Recovery Research, and by a grant from the National Health and Medical Research Council of Australia (grant number 1005811). KN was supported by the Japan Public-Private Partnership Student Study Abroad Program (TOBITATE! Young Ambassador Program) from the Japan Student Services Organization (JASSO). LRR was supported by an NHMRC early career fellowship.	Naitou K, 2015, NEUROGASTROENT MOTIL, V27, P147, DOI 10.1111/nmo.12492; Vizzard MA, 2000, CELL TISSUE RES, V299, P9, DOI 10.1007/s004410050002; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Bron R, 2013, J COMP NEUROL, V521, P2680, DOI 10.1002/cne.23309; White HK, 2009, J CLIN ENDOCR METAB, V94, P1198, DOI 10.1210/jc.2008-0632; Callaghan B, 2012, AM J PHYSIOL-HEART C, V303, pH1011, DOI 10.1152/ajpheart.00418.2012; Ferens DM, 2011, SPINAL CORD, V49, P1036, DOI 10.1038/sc.2011.60; Shafton AD, 2009, NEUROGASTROENT MOTIL, V21, P71, DOI 10.1111/j.1365-2982.2008.01176.x; Tebbe JJ, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-5; Hirayama H, 2010, NEUROGASTROENT MOTIL, V22, P1124, DOI 10.1111/j.1365-2982.2010.01553.x; Ferens DM, 2010, NEUROSCIENCE, V166, P671, DOI 10.1016/j.neuroscience.2010.01.001; Callaghan B, 2014, BRIT J PHARMACOL, V171, P1275, DOI 10.1111/bph.12527; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Tebbe JJ, 2005, J NEUROENDOCRINOL, V17, P570, DOI 10.1111/j.1365-2826.2005.01340.x; Callaghan B, 2014, PHARMACOL REV, V66, P984, DOI 10.1124/pr.113.008433; Bogeski G, 2005, NEUROGASTROENT MOTIL, V17, P262, DOI 10.1111/j.1365-2982.2004.00605.x; Garcia JM, 2009, GROWTH HORM IGF RES, V19, P267, DOI 10.1016/j.ghir.2008.12.003; Shimizu Y, 2006, J PHYSIOL-LONDON, V576, P329, DOI 10.1113/jphysiol.2006.116160; Ejskjaer N, 2010, NEUROGASTROENT MOTIL, V22, P1069, DOI 10.1111/j.1365-2982.2010.01519.x; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Esler WP, 2007, ENDOCRINOLOGY, V148, P5175, DOI 10.1210/en.2007-0239; Pustovit RV, 2015, NEUROGASTROENT MOTIL, V27, P610, DOI 10.1111/nmo.12517; Broad J, 2015, EUR J PHARMACOL, V752, P34; Camilleri M, 2015, NEUROGASTROENT MOTIL, V27, P324, DOI 10.1111/nmo.12490; Charoenthongtrakul S, 2009, J PHARMACOL EXP THER, V329, P1178, DOI 10.1124/jpet.108.150193; Ellis AG, 2015, SPINAL CORD, V53, P103, DOI 10.1038/sc.2014.218; Karasawa H, 2014, NEUROGASTROENT MOTIL, V26, P1771, DOI 10.1111/nmo.12459; lesRoux CW, 2005, J CLIN ENDOCR METAB, V90, P4521; Pustovit RV, 2014, NEUROGASTROENT MOTIL, V26, P264, DOI 10.1111/nmo.12259; Sanger GJ, 2014, NEUROGASTROENT MOTIL, V26, P149, DOI 10.1111/nmo.12300	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	DEC	2015	27	12					1764	1771		10.1111/nmo.12688		8	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	CX4OA	WOS:000365679000008		
J	Ogihara, K; Savory, N; Abe, K; Yoshida, W; Arakawa, M; Asahi, M; Kamohara, S; Ikebukuro, K				Ogihara, Kazumasa; Savory, Nasa; Abe, Koichi; Yoshida, Wataru; Arakawa, Mitsuru; Asahi, Masahiko; Kamohara, Seika; Ikebukuro, Kazunori			Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen	NUCLEIC ACID THERAPEUTICS			English	Article							AFFINITY IGE RECEPTOR; MAJOR ALLERGEN; POLLEN; SELECTION	Japanese cedar pollinosis is one of the most prevalent allergies in Japan. Reducing the allergen content of pollen plays a major role in the alleviation of allergy symptoms. Aptamers, oligonucleotides with an affinity for specific molecules, have great potential for reducing allergic activity. In this study, we report that the anti-Cry j 2 aptamers, CJ2-04 and CJ2-08, inhibited allergen-antibody reactions between Cry j 2, one of the major allergens in Japanese cedar pollen, and immunoglobulin E in serum collected from a patient with Japanese cedar pollinosis. In addition, the suppression of Ca2+ mobilization in basophils, which is related to degranulation, was observed in samples preincubated with either of these DNA aptamers. This study indicates that anti-Cry j 2 aptamers may inhibit allergen-antibody reactions and suppress the induction of Japanese cedar pollinosis, possibly leading to a novel external defense against this and other types of allergens.	[Ogihara, Kazumasa; Savory, Nasa; Abe, Koichi; Ikebukuro, Kazunori] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Ogihara, Kazumasa; Arakawa, Mitsuru; Asahi, Masahiko; Kamohara, Seika] DHC Corp, Tokyo, Japan; [Yoshida, Wataru] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo, Japan	Ikebukuro, K (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	ikebu@cc.tuat.ac.jp			Low-Carbon Research Network Japan (LCnet); Japan Society for the Promotion of Science (JSPS)	This study was supported by a grant from the Low-Carbon Research Network Japan (LCnet) to K. Ikebukuro. N. Savory was supported by the Japan Society for the Promotion of Science (JSPS). The authors appreciate Prof. Hata of the National Center for Child Health and Development for assistance with collecting a blood sample from a patient with Japanese cedar pollinosis. The authors would like to dedicate this article to celebrate the 20th anniversary of the Department of Biotechnology and Life Science at Tokyo University of Agriculture and Technology.	Low SY, 2009, BIOCHEM BIOPH RES CO, V386, P544, DOI 10.1016/j.bbrc.2009.06.089; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; HASHIMOTO M, 1995, CLIN EXP ALLERGY, V25, P848, DOI 10.1111/j.1365-2222.1995.tb00027.x; Ogihara K, 2015, BIOSENS BIOELECTRON, V63, P159, DOI 10.1016/j.bios.2014.07.030; Tran DT, 2010, MOLECULES, V15, P1127, DOI 10.3390/molecules15031127; SAKAGUCHI M, 1990, ALLERGY, V45, P309, DOI 10.1111/j.1398-9995.1990.tb00501.x; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Tran DT, 2013, BIOSENS BIOELECTRON, V43, P245, DOI 10.1016/j.bios.2012.12.022; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Miyaji K, 2013, J CLIN IMMUNOL, V33, P977, DOI 10.1007/s10875-013-9880-7; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Takahashi Y, 2008, J INVEST ALLERG CLIN, V18, P382; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Baba K, 2008, PROG MED, V28, P2001; Kedzierski S, 2013, BIOPROCESS J, V11, P46; Nadal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035253; Nakamura S, 2004, JAPANESE J PALYNOLOG, V50, P15; Okubo Kimihiro, 2008, Allergol Int, V57, P205, DOI 10.2332/allergolint.R-08-164; Wang Q., 2008, EAROZORU KENKYU, V23, P120	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2159-3337	2159-3345		NUCLEIC ACID THER	Nucl. Acid Ther.	DEC 1	2015	25	6					311	316		10.1089/nat.2015.0539		6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Research & Experimental Medicine	CX2MB	WOS:000365529900004		
J	Yagi, S; Aihara, K; Fukuda, D; Takashima, A; Bando, M; Hara, T; Nishimoto, S; Ise, T; Kusunose, K; Yamaguchi, K; Tobiume, T; Iwase, T; Yamada, H; Soeki, T; Wakatsuki, T; Shimabukuro, M; Akaike, M; Sata, M				Yagi, Shusuke; Aihara, Ken-ichi; Fukuda, Daiju; Takashima, Akira; Bando, Mika; Hara, Tomoya; Nishimoto, Sachiko; Ise, Takayuki; Kusunose, Kenya; Yamaguchi, Koji; Tobiume, Takeshi; Iwase, Takashi; Yamada, Hirotsugu; Soeki, Takeshi; Wakatsuki, Tetsuzo; Shimabukuro, Michio; Akaike, Masashi; Sata, Masataka			Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome (vol 14, 111, 2015)	NUTRITION JOURNAL			English	Correction									[Yagi, Shusuke; Fukuda, Daiju; Takashima, Akira; Bando, Mika; Hara, Tomoya; Ise, Takayuki; Kusunose, Kenya; Yamaguchi, Koji; Tobiume, Takeshi; Iwase, Takashi; Yamada, Hirotsugu; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Aihara, Ken-ichi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Hematol Endocrinol & Metab, Tokushima 7708503, Japan; [Nishimoto, Sachiko] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Nutr & Metab, Tokushima 7708503, Japan; [Shimabukuro, Michio] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiodiabet Med, Tokushima 7708503, Japan; [Akaike, Masashi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Med Educ, Tokushima 7708503, Japan	Yagi, S (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cardiovasc Med, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	syagi@tokushima-u.ac.jp					Yagi S, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0102-4	1	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2891			NUTR J	Nutr. J.	DEC 1	2015	14								121	10.1186/s12937-015-0112-2		2	Nutrition & Dietetics	Nutrition & Dietetics	CX6WJ	WOS:000365842100001		
J	Sugimoto, S; Nakajima, H; Kosaka, K; Hosoi, H				Sugimoto, Satoru; Nakajima, Hisakazu; Kosaka, Kitaro; Hosoi, Hajime			Review: Miglitol has potential as a therapeutic drug against obesity	NUTRITION & METABOLISM			English	Review						Miglitol; Obesity; Brown adipose tissue; Incretin hormones; Bile acid metabolism	BROWN ADIPOSE-TISSUE; GLUCAGON-LIKE PEPTIDE-1; ENERGY-EXPENDITURE; JAPANESE PATIENTS; MIXED MEAL; PLASMA; RATS; POLYPEPTIDE; INHIBITION; METABOLISM	The number of obese patients has increased annually worldwide. Therefore, there is a strong need to develop a new effective and safe anti-obesity drug. Miglitol is an alpha-glucosidase inhibitor (aGI) that is commonly used as an anti-diabetic drug, and there is growing evidence that it also has anti-obesity effects. Miglitol has been shown to reduce body weight and ameliorate insulin resistance in both clinical trials with adult patients and in rodent models of obesity. Although the specific mechanism of action of this effect remains unclear, some mechanisms have been suggested through experimental results. Miglitol has been shown to inhibit adipogenesis of white adipocytes in vitro, activate brown adipose tissue (BAT) in mice, influence bile acid metabolism in mice, and regulate the secretion of incretin hormones in humans. Among these results, we consider that BAT activation is likely the definitive mediator of miglitol's anti-obesity effect. A unique advantage of miglitol is that it is already used as an anti-diabetic drug with no severe side effects, whereas many of the anti-obesity drugs developed to date have been withdrawn because of their severe side effects. Miglitol is currently used clinically in a limited number of countries. In this review, we provide an overview of the state of research on miglitol for obesity treatment, emphasizing that it warrants more detailed attention. Overall, we demonstrate that miglitol shows good potential as a therapeutic for the treatment of obesity. Thus, we believe that further investigations of how it exerts its anti-obesity effect will likely contribute to the development of a new class of safe and effective drugs against obesity.	[Sugimoto, Satoru] Ayabe Municipal Hosp, Dept Pediat, Ayabe City, Kyoto 6230011, Japan; [Sugimoto, Satoru; Nakajima, Hisakazu; Kosaka, Kitaro; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kamikyo Ku, Kyoto, Kyoto 6028566, Japan	Sugimoto, S (reprint author), Ayabe Municipal Hosp, Dept Pediat, 20-1 Otsuka, Ayabe City, Kyoto 6230011, Japan.	satoru-s@koto.kpu-m.ac.jp					Kaku H, 2012, HORM METAB RES, V44, P312, DOI 10.1055/s-0032-1304563; Campbell LK, 2000, ANN PHARMACOTHER, V34, P1291; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Shrivastava A, 2013, LIPIDS, V48, P597, DOI 10.1007/s11745-012-3753-3; Ahr HJ, 1997, ARZNEIMITTEL-FORSCH, V47, P734; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; DEBOUNO JF, 1993, GEN PHARMACOL, V24, P509, DOI 10.1016/0306-3623(93)90339-Y; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Sasaki T, 2013, ENDOCR J, V60, P1117, DOI 10.1507/endocrj.EJ13-0333; Nathan PJ, 2011, CNS NEUROSCI THER, V17, P490, DOI 10.1111/j.1755-5949.2010.00172.x; Hayes MR, 2011, OBESITY, V19, P1342, DOI 10.1038/oby.2011.50; Dolgin E, 2012, NAT MED, V18, P843, DOI 10.1038/nm0612-843; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Narita T, 2012, DIABETES OBES METAB, V14, P283, DOI 10.1111/j.1463-1326.2011.01526.x; Mikada A, 2014, DIABETES RES CLIN PR, V106, P538, DOI 10.1016/j.diabres.2014.09.040; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Patel D, 2015, METABOLISM, V64, P1376, DOI 10.1016/j.metabol.2015.08.001; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Lee A, 2002, DIABETES OBES METAB, V4, P329, DOI 10.1046/j.1463-1326.2002.00219.x; Nirogi RVS, 2006, ARZNEIMITTEL-FORSCH, V56, P328; Sell H, 2004, INT J BIOCHEM CELL B, V36, P2098, DOI 10.1016/j.biocel.2004.04.003; KINGMA PJ, 1992, DIABETES CARE, V15, P478, DOI 10.2337/diacare.15.4.478; Fernandez-Marcos P. J., 2011, AM J CLIN NUTR, V93, p884S, DOI [10.3945/ajcn.110.001917, DOI 10.3945/AJCN.110.001917]; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Marken L Van, 2009, NEW ENGL J MED, V360, P1500, DOI DOI 10.1056/NEJM0A0808718); Hamade Y, 2013, METABOLISM, V62, P734, DOI 10.1016/j.metabol.2012.10.015; Shimabukuro M, 2012, INT J CARDIOL, V167, P2108; Sugihara H, 2014, J DIABETES INVEST, V5, P206, DOI 10.1111/jdi.12135; Sugimoto S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-14; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	31	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-7075			NUTR METAB	Nutr. Metab.	DEC 1	2015	12								51	10.1186/s12986-015-0048-8		7	Nutrition & Dietetics	Nutrition & Dietetics	CX3AF	WOS:000365567200001		
J	Ichikawa, Y; Watanabe, M				Ichikawa, Yuta; Watanabe, Mamoru			The daily food intake of Pantala flavescens females from foraging swarms estimated by the faeces excreted (Odonata: Libellulidae)	ODONATOLOGICA			English	Article						Dragonfly; Anisoptera; feeding activity; flier; foraging flight; hand-feeding method; metabolism; percher; swarming	SYMPETRUM-INFUSCATUM SELYS; PACHYDIPLAX-LONGIPENNIS ODONATA; FOREST GAPS; BODY-SIZE; DRAGONFLIES; BEHAVIOR; ANISOPTERA; NUMBER; ENERGY; METABOLISM	Pantala flavescens migrates to Japan every spring, where the population rapidly increases until autumn. Adults often form swarms above open grasslands for foraging. Little has been reported on the daily food intake in P. flavescens, probably due to the difficulty of observing foraging behaviour. We captured females from foraging swarms and kept them alive in the laboratory, and the faeces excreted were collected each 24-hour-period after capture. Faeces excreted within 24 hours after capture were typically dark brown, formed in oval pellets, including a lot of fragments of cuticle, which must have been derived from the prey. The total dry weight of faeces was 8.00 mg on average. The size of the subsequent faeces decreased, and the colour changed to reddish brown and detectable cuticle fragments were no longer present, suggesting that most of the indigestible parts had been excreted within 24 hours after feeding. When a female was handfed a single sheep blowfly, 4.51 mg of faeces were excreted within 24 hours after feeding, while a starved female excreted 2.23 mg. The daily food intake of a female was estimated to be about 14 mg, corresponding to about 185 small prey insects. Therefore, the mass flight of P. flavescens might affect populations of small insects in the open landscape in Japan.	[Ichikawa, Yuta; Watanabe, Mamoru] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Watanabe, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	watanabe@kankyo.envr.tsukuba.ac.jp					ANHOLT BR, 1991, CAN J ZOOL, V69, P1156, DOI 10.1139/z91-164; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505; May ML, 2002, J INSECT BEHAV, V15, P765, DOI 10.1023/A:1021171306468; Kato Kenta, 2011, Japanese Journal of Entomology (New Series), V14, P177; Richardson JML, 1997, OIKOS, V79, P477, DOI 10.2307/3546890; Plaistow S, 1999, ANIM BEHAV, V58, P659, DOI 10.1006/anbe.1999.1171; MAY ML, 1979, J EXP BIOL, V83, P79; ANHOLT BR, 1992, OIKOS, V65, P428, DOI 10.2307/3545559; YUVAL B, 1993, J INSECT BEHAV, V6, P333, DOI 10.1007/BF01048114; Watanabe M, 2011, ODONATOLOGICA, V40, P317; Suhling F, 2004, HYDROBIOLOGIA, V528, P75, DOI 10.1007/s10750-004-3047-8; Koch K, 2005, CAN J ZOOL, V83, P1631, DOI 10.1139/Z05-163; Iwasaki H, 2009, JPN J APPL ENTOMOL Z, V53, P165, DOI 10.1303/jjaez.2009.165; Arai Y, 2012, GRACILE, V72, P32; ARAI Y., 2007, MYSTERY RED DRAGONFL; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Baird JM, 1997, J INSECT BEHAV, V10, P655, DOI 10.1007/BF02765385; BANKS MJ, 1987, J ANIM ECOL, V56, P815, DOI 10.2307/4950; BENNETTOVA B, 1981, J INSECT PHYSIOL, V27, P403, DOI 10.1016/0022-1910(81)90019-6; Chowdhury S.H., 1986, Annals of Entomology (Dehra Dun), V4, P1; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORBET P S, 1984, Odonatologica, V13, P81; DUMONT H J, 1991, Odonatologica, V20, P45; FRIED CS, 1983, ECOL ENTOMOL, V8, P283, DOI 10.1111/j.1365-2311.1983.tb00509.x; Hashimoto H, 1969, Kontyu, V37, P305; Hawking J. H., 1994, Odonatologica, V23, P63; Higashi K., 1978, JIBP SYNTH, V18, P199; HIGASHI K., 1973, REP EBINO BIOL LAB K, V1, P119; Hirake T, 2012, GRACILE, V72, P42; Ichikawa Y, 2014, ZOOL SCI, V31, P721, DOI 10.2108/zs140116; Iwata N, 2009, TOMBO, V51, P29; May M.L., 1984, Advances in Odonatology, V2, P95; Moore N. W., 1993, Odonatologica, V22, P71; NEVILLE AC, 1983, J INSECT PHYSIOL, V29, P211, DOI 10.1016/0022-1910(83)90087-2; Oehme Hans, 1999, Libellula, V18, P79; SAMWAYS MJ, 1989, J ENTOMOL SOC S AFR, V52, P326; Tyagi B.K., 1995, Notulae Odonatologicae, V4, P92; WATANABE M., 2015, ECOLOGY OF ODONATA; WATANABE M., 1999, JPN J BIOL ED, V39, P65	39	0	0	SOC INT ODONATOLOGICA	BILTHOVEN	PO BOX 256, 3720 AG BILTHOVEN, NETHERLANDS	0375-0183			ODONATOLOGICA	Odonatologica	DEC 1	2015	44	3					375	389				15	Entomology	Entomology	CX6UK	WOS:000365837000006		
J	Shinoda, M; Takeda, M; Honda, K; Maruno, M; Katagiri, A; Satoh-Kuriwada, S; Shoji, N; Tsuchiya, M; Iwata, K				Shinoda, Masamichi; Takeda, Mamoru; Honda, Kuniya; Maruno, Mitsuru; Katagiri, Ayano; Satoh-Kuriwada, Shizuko; Shoji, Noriaki; Tsuchiya, Masahiro; Iwata, Koichi			Involvement of peripheral artemin signaling in tongue pain: possible mechanism in burning mouth syndrome	PAIN			English	Article						Burning mouth syndrome; Artemin; Transient receptor potential vanilloid 1	CAPSAICIN RECEPTOR TRPV1; IRRITABLE-BOWEL-SYNDROME; SMALL FIBER NEUROPATHY; ROOT GANGLION NEURONS; FACTOR FAMILY-MEMBER; SENSORY NEURONS; NERVE INJURY; TEMPOROMANDIBULAR-JOINT; THERMAL HYPERALGESIA; TRIGEMINAL GANGLION	Burning mouth syndrome is characterized by altered sensory qualities, namely tongue pain hypersensitivity. We found that the mRNA expression of Artemin (Artn) in the tongue mucosa of patients with burning mouth syndrome was significantly higher than that of control subjects, and we developed a mouse model of burning mouth syndrome by application of 2,4,6-trinitrobenzene sulfonic acid (TNBS) diluted with 50% ethanol to the dorsum of the tongue. TNBS treatment to the tongue induced persistent, week-long, noninflammatory tongue pain and a significant increase in Artn expression in the tongue mucosa and marked tongue heat hyperalgesia. Following TNBS treatment, the successive administration of the transient receptor potential vanilloid 1 (TRPV1) antagonist SB366791 or neutralizing anti-Artn antibody completely inhibited the heat hyperalgesia. The number of glial cell line-derived neurotrophic factor family receptor alpha 3 (GFR alpha 3)-positive and TRPV1-positive trigeminal ganglion (TG) neurons innervating the tongue significantly increased following TNBS treatment and was significantly reduced by successive administration of neutralizing anti-Artn antibody. The capsaicin-induced current in TG neurons innervating the tongue was enhanced following TNBS treatment and was inhibited by local administration of neutralizing anti-Artn antibody to the tongue. These results suggest that the overexpression of Artn in the TNBS-treated tongue increases the membrane excitability of TG neurons innervating the tongue by increasing TRPV1 sensitivity, which causes heat hyperalgesia. This model may be useful for the study of tongue pain hypersensitivity associated with burning mouth syndrome.	[Shinoda, Masamichi; Honda, Kuniya; Katagiri, Ayano; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 1018310, Japan; [Takeda, Mamoru] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Lab Food & Physiol Sci, Sagamihara, Kanagawa, Japan; [Honda, Kuniya] Nihon Univ, Sch Dent, Dept Complete Denture Prosthodont, Tokyo 1018310, Japan; [Satoh-Kuriwada, Shizuko; Shoji, Noriaki; Tsuchiya, Masahiro] Tohoku Univ, Grad Sch Dent, Div Oral Diag, Sendai, Miyagi 980, Japan; [Tsuchiya, Masahiro] Tohoku Fukushi Univ, Sendai, Miyagi, Japan	Shinoda, M (reprint author), Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, 1-8-13 Kandasurugadai, Tokyo 1018310, Japan.	shinoda.masamichi@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Nihon University Multidisciplinary Research Grant; Japanese Society for Promotion of Science [24593064]	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology-Supported Program for the Strategic Research Foundation at Private Universities, 2013 to 2017, Nihon University Multidisciplinary Research Grant for 2013, Grant-in-Aid for Scientific Research (C, 24593064) from the Japanese Society for Promotion of Science.	Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Onoda K, 2011, LARYNGOSCOPE, V121, P2592, DOI 10.1002/lary.22368; Gold MS, 2003, J NEUROSCI, V23, P158; Elitt CM, 2008, BRAIN RES, V1230, P80, DOI 10.1016/j.brainres.2008.06.119; Lopez-Jornet P, 2010, MED ORAL PATOL ORAL, V15, pE562, DOI 10.4317/medoral.15.e562; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Yilmaz Z, 2007, J CLIN NEUROSCI, V14, P864, DOI 10.1016/j.jocn.2006.09.002; Shinoda M, 2005, PAIN, V116, P42, DOI 10.1016/j.pain.2005.03.042; Lippoldt EK, 2013, J NEUROSCI, V33, P12543, DOI 10.1523/JNEUROSCI.5765-12.2013; Lauria G, 2005, PAIN, V115, P332, DOI 10.1016/j.pain.2005.03.028; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Jankowski MP, 2012, J NEUROSCI, V32, P17869, DOI 10.1523/JNEUROSCI.3148-12.2012; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Opree A, 2000, J NEUROSCI, V20, P6289; Takeda M, 2006, NEUROSCIENCE, V138, P621, DOI 10.1016/j.neuroscience.2005.11.024; Boucher Y, 2013, EUR J NEUROSCI, V38, P2812, DOI 10.1111/ejn.12282; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Mills CD, 2013, EUR J PAIN, V17, P469, DOI 10.1002/j.1532-2149.2012.00202.x; Jankowski MP, 2009, J NEUROSCI, V29, P1636, DOI 10.1523/JNEUROSCI.3474-08.2009; Wu ZZ, 2013, PAIN, V154, P2130, DOI 10.1016/j.pain.2013.06.040; Shim B, 2007, PAIN, V128, P40, DOI 10.1016/j.pain.2006.08.023; Takeda M, 2004, NEUROSCIENCE, V123, P491, DOI 10.1016/j.neuroscience.2003.09.022; Lauria G, 2005, CURR OPIN NEUROL, V18, P591, DOI 10.1097/01.wco.0000177330.35147.70; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Sugiyo S, 2009, EXP BRAIN RES, V196, P229, DOI 10.1007/s00221-009-1842-1; Spanemberg Juliana Cassol, 2014, Oral Health Dent Manag, V13, P418; Yiangou Y, 2007, J NEUROL NEUROSUR PS, V78, P218; Varga A, 2005, NEUROSCI LETT, V385, P137, DOI 10.1016/j.neulet.2005.05.015; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Caterina MJ, 1997, NATURE, V389, P816; Schobel N, 2012, PHYSIOL BEHAV, V107, P368, DOI 10.1016/j.physbeh.2012.09.004; Fukuoka T, 2002, PAIN, V99, P111, DOI 10.1016/S0304-3959(02)00067-2; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Majorana A, 2006, J ORAL PATHOL MED, V35, P423; Bennett DLH, 2000, J NEUROSCI, V20, P427; Jankowski MP, 2010, J NEUROSCI, V30, P16272, DOI 10.1523/JNEUROSCI.2195-10.2010; Akbar A, 2008, GUT, V57, P923, DOI 10.1136/gut.2007.138982; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005; Chan CLH, 2003, LANCET, V361, P385, DOI 10.1016/S0140-6736(03)12392-6; Drossman DA, 1997, GASTROENTEROLOGY, V112, P2120, DOI 10.1053/gast.1997.v112.agast972120; Walega DR, 2014, J ORAL FACIAL PAIN H, V28, P171, DOI 10.11607/ofph.1165; Honda K, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-75; Katagiri A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-23; Liu MG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-258; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sun A, 2013, J ORAL PATHOL MED, V42, P649, DOI 10.1111/jop.12101; Yoshida N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-41; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	DEC	2015	156	12					2528	2537		10.1097/j.pain.0000000000000322		10	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CX3KS	WOS:000365598300018		
J	Kothari, SF; Baad-Hansen, L; Oono, Y; Svensson, P				Kothari, Simple Futarmal; Baad-Hansen, Lene; Oono, Yuka; Svensson, Peter			Somatosensory assessment and conditioned pain modulation in temporomandibular disorders pain patients	PAIN			English	Article						Temporomandibular disorders (TMD); Somatosensory function; Quantitative sensory testing (QST); Conditioned pain modulation (CPM); Endogenous pain inhibitory systems	EXPERIMENTALLY EVOKED PAIN; JOINT PAIN; TMD PAIN; C-FIBERS; SENSITIVITY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; ABNORMALITIES; QUESTIONNAIRE; METAANALYSIS	The pathophysiology and underlying pain mechanisms of temporomandibular disorders (TMD) are poorly understood. The aims were to assess somatosensory function at the temporomandibular joints (TMJs) and to examine whether conditioned pain modulation (CPM) differs between TMD pain patients (n=34) and healthy controls (n=34). Quantitative sensory testing was used to assess the somatosensory function. Z-scores were calculated for patients based on reference data. Conditioned pain modulation was tested by comparing pressure pain thresholds (PPTs) before, during, and after the application of painful and nonpainful cold stimuli. Pressure pain thresholds were measured at the most painful TMJ and thenar muscle (control). Data were analyzed with analyses of variance. Most (85.3%) of the patients exhibited at least 1 or more somatosensory abnormalities at the most painful TMJ with somatosensory gain with regard to PPT and punctate mechanical pain stimuli, and somatosensory loss with regard to mechanical detection and vibration detection stimuli as the most frequent abnormalities. There was a significant CPM effect (increased PPT) at both test sites during painful cold application in healthy controls and patients (P < 0.001). There was no significant difference in the relative CPM effect during painful cold application between groups (P = 0.227). In conclusion, somatosensory abnormalities were commonly detected in TMD pain patients and CPM effects were similar in TMD pain patients and healthy controls.	[Kothari, Simple Futarmal; Baad-Hansen, Lene; Svensson, Peter] Aarhus Univ, Dept Dent, Sect Orofacial Pain & Jaw Funct, DK-8000 Aarhus C, Denmark; [Kothari, Simple Futarmal; Baad-Hansen, Lene; Svensson, Peter] Tokyo Med & Dent Univ, SCON, Tokyo, Japan; [Oono, Yuka] Tokyo Med & Dent Univ, Dept Anesthesiol & Clin Physiol, Div Oral Hlth Sci, Tokyo, Japan; [Svensson, Peter] Karolinska Inst, Dept Dent Med, Huddinge, Sweden	Kothari, SF (reprint author), Aarhus Univ, Dept Dent, Sect Orofacial Pain & Jaw Funct, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.	simple.futarmal@odont.au.dk			Danish Arthritis Association; Lundbeck foundation [905908]	This study was funded by the Danish Arthritis Association and Lundbeck foundation, Project 905908.	Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Lobbezoo F, 2004, J OROFAC PAIN, V18, P181; Wylde V, 2012, RHEUMATOLOGY, V51, P535, DOI 10.1093/rheumatology/ker343; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Garrett PH, 2013, J OROFAC PAIN, V27, P142, DOI 10.11607/jop.943; DREWES AM, 1993, CLIN J PAIN, V9, P80, DOI 10.1097/00002508-199306000-00002; Orstavik K, 2006, J NEUROSCI, V26, P11287, DOI 10.1523/JNEUROSCI.2659-06.2006; Maixner W, 1995, PAIN, V63, P341, DOI 10.1016/0304-3959(95)00068-2; Cairns BE, 2010, J ORAL REHABIL, V37, P391, DOI 10.1111/j.1365-2842.2010.02074.x; Baad-Hansen L, 2013, PAIN, V154, P1287, DOI 10.1016/j.pain.2013.04.005; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Ashina S, 2005, EUR J NEUROL, V12, P543, DOI 10.1111/j.1468-1331.2005.01023.x; Pfau DB, 2012, CURR PAIN HEADACHE R, V16, P199, DOI 10.1007/s11916-012-0261-3; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; Greenspan JD, 2011, J PAIN, V12, pT61, DOI 10.1016/j.jpain.2011.08.006; Kothari SF, 2012, J OROFAC PAIN, V26, P225; Sarlani E, 2003, PAIN, V102, P221, DOI 10.1016/S0304-3959(03)00095-2; Maixner W, 1998, PAIN, V76, P71, DOI 10.1016/S0304-3959(98)00028-1; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; KREGEL KC, 1992, J PHYSIOL-LONDON, V454, P359; Hansdottir R, 2004, J OROFAC PAIN, V18, P108; Eliav E, 2003, PAIN, V104, P481, DOI 10.1016/S0304-3959(03)00077-0; Visscher CM, 2004, J OROFAC PAIN, V18, P214; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Chen H, 2013, J PAIN, V14, P983, DOI 10.1016/j.jpain.2013.03.011; Sarlani E, 2007, J OROFAC PAIN, V21, P309; Ayesh EE, 2007, J DENT RES, V86, P1187; Lewis GN, 2012, J PAIN, V13, P936, DOI 10.1016/j.jpain.2012.07.005; Pigg M, 2010, PAIN, V148, P220, DOI 10.1016/j.pain.2009.10.024; Park JW, 2010, INT J ORAL MAX SURG, V39, P968, DOI 10.1016/j.ijom.2010.06.003; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Wang K, 2004, J OROFAC PAIN, V18, P33; Vernal R, 2008, ARCH ORAL BIOL, V53, P910, DOI 10.1016/j.archoralbio.2008.04.004; King CD, 2009, PAIN, V143, P172, DOI 10.1016/j.pain.2008.12.027; Edwards RR, 2009, EUR J PAIN, V13, P1043, DOI 10.1016/j.ejpain.2008.12.007; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; de Siqueira SRDT, 2013, OR SURG OR MED OR PA, V115, pE37, DOI 10.1016/j.oooo.2013.02.014; Serra J, 2009, PAIN, V147, P46, DOI 10.1016/j.pain.2009.07.028; Svensson P, 2001, PAIN, V92, P399, DOI 10.1016/S0304-3959(01)00284-6; Bendixen KH, 2012, J OROFAC PAIN, V26, P191; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Ayesh EE, 2008, PAIN, V137, P286, DOI 10.1016/j.pain.2007.09.004; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Hubscher M, 2013, PAIN, V154, P1497, DOI 10.1016/j.pain.2013.05.031; Drobek W, 2001, Clin Oral Investig, V5, P185, DOI 10.1007/s007840100125; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Fernandez-de-las-Penas C, 2009, J PAIN, V10, P1170, DOI 10.1016/j.jpain.2009.04.017; HAGBERG C, 1990, Journal of Craniomandibular Disorders, V4, P120; Hu WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110528; Kjogx H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01421; Nahman-Averbuch H, 2013, SCAND J PAIN, V4, P10; Okeson Jeffrey P, 2011, Dent Clin North Am, V55, P105, DOI 10.1016/j.cden.2010.08.007; Oono Y, 2014, EXP BRAIN RES, V232, P3111, DOI 10.1007/s00221-014-3997-7; Reid Kevin I., 1994, Journal of Orofacial Pain, V8, P258; Svensson Peter, 1995, Journal of Orofacial Pain, V9, P347	59	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	DEC	2015	156	12					2545	2555		10.1097/j.pain.0000000000000325		11	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CX3KS	WOS:000365598300020		
J	Akechi, T; Okuyama, T; Uchida, M; Sugano, K; Kubota, Y; Ito, Y; Sakamoto, N; Kizawa, Y				Akechi, Tatsuo; Okuyama, Toru; Uchida, Megumi; Sugano, Koji; Kubota, Yosuke; Ito, Yoshinori; Sakamoto, Nobuhiro; Kizawa, Yoshiyuki			Assessing medical decision making capacity among cancer patients: Preliminary clinical experience of using a competency assessment instrument	PALLIATIVE & SUPPORTIVE CARE			English	Article						Cancer; Decision making; Informed consent; Psychiatric co-morbidity	JAPAN	Object: This study investigates the usefulness of the Structured Interview for Competency and Incompetency Assessment Testing and Ranking Inventory (SICIATRI) for cancer patients, which is a structured interview that assesses a patient's competency in clinical practice. Methods: The SICIATRI, originally developed to measure patients' competency to give informed consent, were administered referred cancer patients who needed for assessing medical decision making capacity. The usefulness of the SICIATRI was investigated retrospectively. Recommendation for modification of the SICIATRI for cancer patients if applicable were made by the research team. Results: Among the 433 cancer patients referred for psychiatric consultation, 12 were administered the SICIATRI and all of the administration were conducted without big problems. All patients were 60 years or older. The most common purpose for competency evaluation was to analyze patients' understanding of the anti-cancer treatment proposed by oncologists, followed by their refusal of the treatment. Half of the patients (n = 6) were diagnosed with delirium and three among them were judged as having the most impaired status of a patient's competency. Two patients (17%) were diagnosed with major depression and another two (17%) were mental retardation and each one patient was diagnosed with dementia and past history of alcohol dependence. Among 6 patients without delirium 5 subjects including a dementia patient were judged as fully competent. Total of 5 small potential modifications of the SICIATRI for its use with Japanese cancer patients were recommended. Significance of results: Our experience suggests that the SICIATRI is a useful instrument for psycho-oncology clinical practice.	[Akechi, Tatsuo; Okuyama, Toru; Uchida, Megumi; Sugano, Koji; Kubota, Yosuke; Ito, Yoshinori] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi 4678601, Japan; [Akechi, Tatsuo; Okuyama, Toru; Uchida, Megumi; Ito, Yoshinori; Sakamoto, Nobuhiro] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan; [Sugano, Koji] Juntendo Univ, Div Resp Med, Fac Med, Tokyo, Japan; [Sakamoto, Nobuhiro] Nagoya City Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Nagoya, Aichi 4678601, Japan; [Kizawa, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Palliat Med, Kobe, Hyogo, Japan	Akechi, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Mizuho Ku, Mizuho Cho, Nagoya, Aichi 4678601, Japan.	takechi@med.nagoya-cu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology and a Grant-in-Aid for Cancer Research from the Japanese Ministry of Health, Labour and Welfare.	Clark JA, 2001, J CLIN ONCOL, V19, P72; Lepping P, 2011, BRIT J PSYCHIAT, V199, P355, DOI 10.1192/bjp.bp.111.094938; KNOWLES FE, 1994, GEN HOSP PSYCHIAT, V16, P119, DOI 10.1016/0163-8343(94)90055-8; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Ruhnke GW, 2000, CHEST, V118, P1172, DOI 10.1378/chest.118.4.1172; Akechi T, 2012, J AM GERIATR SOC, V60, P271, DOI 10.1111/j.1532-5415.2012.03895.x; Minagawa H, 1996, CANCER, V78, P1131, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.3.CO;2-J; Tomoda A, 1997, J CLIN PSYCHOL, V53, P443, DOI 10.1002/(SICI)1097-4679(199708)53:5<443::AID-JCLP4>3.0.CO;2-O; Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023; Akechi T, 2003, INT J PSYCHIAT CLIN, V7, P101, DOI [10.1080/13651500310001923, 10.1080/1651500310001923]; Tamburini M, 2000, SUPPORT CARE CANCER, V8, P223, DOI 10.1007/s005200050289; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; DEROGATIS LR, 1983, JAMA-J AM MED ASSOC, V249, P751, DOI 10.1001/jama.249.6.751; Kitamura T., 2012, JAPANESE J CLIN PSYC, V15, P1751	14	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1478-9515	1478-9523		PALLIAT SUPPORT CARE	Palliat. Support Care	DEC	2015	13	6					1529	1533		10.1017/S1478951513000588		5	Health Policy & Services	Health Care Sciences & Services	CX4JG	WOS:000365665500003		
J	Nagashima-Nishimaki, M; Taniyama, K; Minami, H; Takebayashi, M				Nagashima-Nishimaki, Miyuki; Taniyama, Kiyomi; Minami, Hanae; Takebayashi, Minoru			The effect of a pathology clinic on the mental state and adjustment of patients with breast cancer	PALLIATIVE & SUPPORTIVE CARE			English	Article						Breast cancer; Pathology clinic; Mental adjustment; Anxiety; Coping style	SCALE	Objective: In this study, we examine whether a pathology clinic, conducted by pathologists, a novel medical tool that provides an explanation for the diagnosis of a cancer, can influence the mental state and adjustment of breast cancer patients. Method: We created a paper-based questionnaire and interviewed targeted breast cancer patients, who had undergone radical surgery, before and after they visited the clinic. Results: We found that there may be increased motivation for treatment, a greater sense of reassurance, and reduced anxiety (as indicated by the Hospital Anxiety and Depression Scale (HADS)) in the group that attended the clinic. Significance of Results: Our results suggest that visiting the pathology clinic may reduce anxiety over the short term. On the other hand, Mental Adjustment to Cancer (MAC) Anxious Preoccupation scores were significantly higher in this group as well, both before and after attendance, compared to the group that did not attend. The attending group may have reduced anxiety by such actions as collecting medical data on the cause of their anxiety and adopting healthier behaviors. Our findings suggest that appropriate emotional support and provision of medical information are very important in dealing with patient anxiety.	[Nagashima-Nishimaki, Miyuki; Minami, Hanae; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Dept Psychiat, Hiroshima 7370023, Japan; [Taniyama, Kiyomi; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Hiroshima 7370023, Japan	Takebayashi, M (reprint author), Natl Hosp Org, Kure Med Ctr, Dept Psychiat, 3-1 Aoyama, Hiroshima 7370023, Japan.	mtakebayashi@kure-nh.go.jp					Kugaya A, 1998, JPN J CLIN ONCOL, V28, P333, DOI 10.1093/jjco/28.5.333; Fujimori M, 2007, PSYCHO-ONCOL, V16, P617, DOI 10.1002/pon.1102; Davidson R, 2005, PSYCHO-ONCOL, V14, P187, DOI 10.1002/pon.834; Akechi T, 2001, BREAST CANCER RES TR, V65, P195, DOI 10.1023/A:1010661530585; WATSON M, 1988, PSYCHOL MED, V18, P203; Matsuoka Y, 2002, BREAST CANCER RES TR, V76, P117, DOI 10.1023/A:1020572505095; Holstein J. A., 1995, ACTIVE INTERVIEW QUA, V37; Kvale S., 1996, INTERVIEWS INTRO QUA; Lofland J., 1995, ANAL SOCIAL SETTINGS; Taniyama K., 2012, RANGSIT J ARTS SCI, V2, P73; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	11	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1478-9515	1478-9523		PALLIAT SUPPORT CARE	Palliat. Support Care	DEC	2015	13	6					1615	1621		10.1017/S1478951515000395		7	Health Policy & Services	Health Care Sciences & Services	CX4JG	WOS:000365665500012		
J	Ichikura, K; Matsuda, A; Kobayashi, M; Noguchi, W; Matsushita, T; Matsushima, E				Ichikura, Kanako; Matsuda, Ayako; Kobayashi, Mika; Noguchi, Wataru; Matsushita, Toshiko; Matsushima, Eisuke			Breaking bad news to cancer patients in palliative care: A comparison of national cross-sectional surveys from 2006 and 2012	PALLIATIVE & SUPPORTIVE CARE			English	Article						Breaking bad news; Truth disclosure; Palliative care; End of life; Life expectancy	OF-LIFE CARE; COMMUNICATION; DISCLOSURE; DIAGNOSIS; JAPAN; ONCOLOGISTS; PREFERENCES; INFORMATION; PHYSICIANS; PROGNOSIS	Objective: Most cancer patients experience the time when a doctor must "break the bad news" to them, a time when it is necessary for patients to call upon their self-determination to aid in the battle with cancer. The purpose of our study was to clarify the percentage of times doctors deliver bad news to patients at the end of life in each of four different situations, and to define the most common recipients of this bad news. We compare these results for two timepoints: 2006 and 2012. Methods: The study had a national cross-sectional design consisting of self-completed questionnaires sent to all hospitals that provide cancer care. We mailed them to hospital directors in January and February of 2012, requesting a reply. The results of the same survey in 2006 were employed as a point for comparison. Results: A total of 1224 questionnaireswere returned during 2012. 1499 responses collected in 2006 were employed as reference data. Some hospital characteristics had changed over that interval; however, the new data obtained were representative for patients being treated in Japanese cancer care hospitals. In hospitals with 300-499, there were significant differences between 2006 and 2012 in the providing information about ("disclosure of cancer diagnosis," "therapeutic options for treatment," and "a life-prolonging treatment"). In addition, the likelihood of doctors delivering bad news to patients and family members (as opposed to family members only) at the end of life increased from 2006 to 2012. Significance of Results: Our results suggest that the overall incidence of bad news being disclosed has increased, especially in hub medical institutions for cancer care. Advanced treatment options or domestic legislation may have influenced the frequency or type of bad news.	[Ichikura, Kanako; Matsushima, Eisuke] Tokyo Med & Dent Univ, Sect Liaison Psychiat & Palliat Med, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan; [Ichikura, Kanako] Japan Soc Promot Sci, Tokyo, Japan; [Matsuda, Ayako] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Kobayashi, Mika] Toho Univ, Educ & Res Support Ctr, Tokyo, Japan; [Noguchi, Wataru] Keio Univ, Grad Sch Media Andn Governance, Yokohama, Kanagawa, Japan; [Matsushita, Toshiko] Yokohama City Univ, Grad Sch Med, Dept Nursing, Yokohama, Kanagawa, Japan	Matsushima, E (reprint author), Tokyo Med & Dent Univ, Sect Liaison Psychiat & Palliat Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	em.lppm@tmd.ac.jp			Health Labour Sciences Research Grant [H16-Medical-General-001]	This study was supported by a 2006 Health Labour Sciences Research Grant (H16-Medical-General-001). We state that we have no conflicts of interest to declare. We are grateful to Kenji Hayashi and Tomoko Kodama at the National Institutes of Public Health for their helpful advice about research planning. We also thank all the participants who completed questionnaires.	Ngo-Metzger Q, 2008, AM FAM PHYSICIAN, V77, P167; Kawakami S, 2001, ARCH GERONTOL GERIAT, V33, P29, DOI 10.1016/S0167-4943(01)00099-1; Seo M, 2000, PALLIATIVE MED, V14, P105, DOI 10.1191/026921600676888353; Horikawa N, 1999, GEN HOSP PSYCHIAT, V21, P368, DOI 10.1016/S0163-8343(99)00026-2; Fujimori M, 2005, PSYCHO-ONCOLOGY, V14, P1043, DOI 10.1002/pon.917; Miyata H, 2005, J MED ETHICS, V31, P447, DOI 10.1136/jme.2003.007302; Morita T, 2004, ANN ONCOL, V15, P1551, DOI 10.1093/annonc/mdh386; Hirai K, 2006, J PAIN SYMPTOM MANAG, V31, P140, DOI 10.1016/j.jpainsymman.2005.06.012; Gao W, 2010, EUR J CANCER, V46, P2036, DOI 10.1016/j.ejca.2010.03.033; Akabayashi A, 1999, LANCET, V354, P1263, DOI 10.1016/S0140-6736(99)02802-0; Cherny NI, 2011, PSYCHO-ONCOLOGY, V20, P1269, DOI 10.1002/pon.1853; Fujimori M, 2014, J CLIN ONCOL, V32, P2166, DOI 10.1200/JCO.2013.51.2756; Fetters MD, 1998, J CLIN ETHIC, V9, P132; Tang ST, 2006, CANCER INVEST, V24, P360, DOI 10.1080/07357900600705284; Saito S, 1996, FAM PROCESS, V35, P239, DOI 10.1111/j.1545-5300.1996.00239.x; Rogg L, 2010, PSYCHO-ONCOLOGY, V19, P1221, DOI 10.1002/pon.1691; Mackenzie LJ, 2013, PSYCHO-ONCOLOGY, V22, P2720, DOI 10.1002/pon.3337; Kaplowitz SA, 2002, HEALTH COMMUN, V14, P221, DOI 10.1207/S15327027HC1402_4; Mack JW, 2012, ANN INTERN MED, V156, P204, DOI 10.7326/0003-4819-156-3-201202070-00008; Arbabi Mohammad, 2010, Iran J Psychiatry, V5, P128; BUCKMAN R, 1984, BRIT MED J, V288, P1597; Committee Reviewing Medical Problems of the Japanese Society for General Hospital Psychiatry, 2012, JAPANESE J GEN HOSP, V24, P59; Cripe Larry D, 2012, J Palliat Med, V15, P99, DOI 10.1089/jpm.2011.0249; Fujimori M., 2013, PALLIAT SUPPORT CARE, V12, P379; International Agency for Research on Cancer; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Japanese Society for Palliative Medicine, 2008, PEACE PROJ; Kumar Milind, 2009, Indian J Palliat Care, V15, P61, DOI 10.4103/0973-1075.53533; Matsushima E., 2008, J JAPANESE ASS MED L, V24, P45; Ministry of Health Labour and Welfare, 2007, GUID DEC MAK PROC EN; Ministry of Health Labour and Welfare, 2013, INT REL INF PUBL HLT; Ministry of Health Labour and Welfare, 2011, JAP WHIT PAP POP POP; Ministry of Health Labour and Welfare, 2007, BAS PLAN PROM CANC C; Ministry of Health Labour andWelfare, 2012, BAS PLAN PROM CANC C; National Cancer Center of Japan, 2006, CANC CONTR INF SERV; OECD (Organisation for Economic Co-operation and Development), 2013, HLTH DAT 2013; Pang A, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-35; R Development Core Team, 2011, R LANG ENV STAT COMP	37	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1478-9515	1478-9523		PALLIAT SUPPORT CARE	Palliat. Support Care	DEC	2015	13	6					1623	1630		10.1017/S147895151500005X		8	Health Policy & Services	Health Care Sciences & Services	CX4JG	WOS:000365665500013		
J	Ishida, M; Onishi, H; Toyama, H; Tsutsumi, C; Endo, C; Tanahashi, I; Takahashi, T; Uchitomi, Y				Ishida, Mayumi; Onishi, Hideki; Toyama, Hiroaki; Tsutsumi, Chizuko; Endo, Chieko; Tanahashi, Iori; Takahashi, Takao; Uchitomi, Yosuke			Missing memories of death: Dissociative amnesia in the bereaved the day after a cancer death	PALLIATIVE & SUPPORTIVE CARE			English	Article						Bereavement; Dissociation; Retrograde amnesia; Cancer; Defense mechanism	RISK-FACTORS; GRIEF	Objective: The death of a loved one is one of the most stressful events of life, and such stress affects the physical and psychological well-being of the bereaved. Dissociative amnesia is characterized by an inability to recall important autobiographical information. Dissociative amnesia in the bereaved who have lost a loved one to cancer has not been previously reported. We discuss herein the case of a patient who developed dissociative amnesia the day after the death of here beloved husband. Method: A 38-year-old woman was referred for psychiatric consultation because of restlessness and abnormal behavior. Her 44-year-old husband had died of pancreatic cancer the day before the consultation. On the day of the death, she looked upset and began to hyperventilate. The next day, she behaved as if the deceased were still alive, which embarrassed her family. At her initial psychiatric consultation, she talked and behaved as if her husband was still alive and in the hospital. Results: Her psychiatric features fulfilled the DSM-V criteria for dissociative amnesia. The death of her husband had been very traumatic for her and was considered to have been one of the causes of this dissociation. Significance of Results: This report adds to the list of psychiatric symptoms in the bereaved who have lost a loved one to cancer. In an oncology setting, we should consider the impact of death, the concomitant defense mechanisms, and the background of the families.	[Ishida, Mayumi; Onishi, Hideki; Toyama, Hiroaki; Tsutsumi, Chizuko; Endo, Chieko; Tanahashi, Iori] Saitama Med Univ, Int Med Ctr, Dept Psychooncol, Hidaka City, Saitama 3501298, Japan; [Takahashi, Takao] Saitama Med Univ, Int Med Ctr, Dept Palliat Med, Hidaka City, Saitama 3501298, Japan; [Uchitomi, Yosuke] Natl Canc Ctr, Innovat Ctr Support Palliat & Psychosocial Care, Tokyo 104, Japan	Ishida, M (reprint author), Saitama Med Univ, Int Med Ctr, Dept Psychooncol, 1397-1 Yamane, Hidaka City, Saitama 3501298, Japan.	mayumi_i@saitama-med.ac.jp			Ministry of Health, Labour, and Welfare; Japan Society for the Promotion of Science KAKENHI [25510009]	This study was supported by a grant-in-aid from the Ministry of Health, Labour, and Welfare, and the Japan Society for the Promotion of Science KAKENHI (grant-in-aid for scientific research) No. 25510009.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Buckley T, 2009, INTERN MED J, V39, P370, DOI [10.1111/j.1445-5994.2009.01879.x, 10.1111/j.1445-5994.2008.01879.x]; Ishida M, 2012, JPN J CLIN ONCOL, V42, P506, DOI 10.1093/jjco/hys051; Rousseau P, 2000, J CLIN ONCOL, V18, P3998; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616; Vos MS, 2007, PSYCHO-ONCOLOGY, V16, P12, DOI 10.1002/pon.1051; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Erlangsen A, 2004, AGE AGEING, V33, P378, DOI 10.1093/ageing/afh128; Zisook S, 2009, WORLD PSYCHIATRY, V8, P67; Grimby A, 2009, AM J HOSP PALLIAT ME, V26, P8, DOI 10.1177/1049909107310140; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kaplan H.I., 1995, KAPLAN SADOCKS COMPR	12	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1478-9515	1478-9523		PALLIAT SUPPORT CARE	Palliat. Support Care	DEC	2015	13	6					1787	1790		10.1017/S1478951515000541		4	Health Policy & Services	Health Care Sciences & Services	CX4JG	WOS:000365665500030		
J	Feng, H; Gupta, B; Wang, ML; Zheng, WQ; Zheng, L; Zhu, XT; Yang, YM; Fang, Q; Luo, EJ; Fan, Q; Tsuboi, T; Cao, YM; Cui, LW				Feng, Hui; Gupta, Bhavna; Wang, Meilian; Zheng, Wenqi; Zheng, Li; Zhu, Xiaotong; Yang, Yimei; Fang, Qiang; Luo, Enjie; Fan, Qi; Tsuboi, Takafumi; Cao, Yaming; Cui, Liwang			Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China	PARASITES & VECTORS			English	Article						Plasmodium vivax; Transmission blocking vaccine; pvs48/45; Genetic polymorphism; Positive selection	MALARIA PARASITES; SEQUENCE POLYMORPHISMS; REDUCING ANTIBODIES; SURFACE-PROTEINS; HENAN PROVINCE; FALCIPARUM; PFS48/45; PFS230; GAMETOCYTE; EVOLUTION	Background: The male gamete fertilization factor P48/45 in malaria parasites is a prime transmission-blocking vaccine (TBV) candidate. Efforts to develop antimalarial vaccines are often thwarted by genetic diversity of the target antigens. Here we evaluated the genetic diversity of Pvs48/45 gene in global Plasmodium vivax populations. Methods: We determined 200 Pvs48/45 sequences collected from temperate and subtropical parasite populations in China. Population genetic and evolutionary analyses were performed to determine the levels of genetic diversity, potential signature of selection, and population differentiation. Results: Analysis of the Pvs48/45 sequences from 200 P. vivax parasites collected in a temperate and a tropical region revealed a low level of genetic diversity (pi = 0.0012) with 14 single nucleotide polymorphisms, of which 11 were nonsynonymous. Analysis of 344 Pvs48/45 sequences from nine worldwide P. vivax populations detected a total of 38 haplotypes, of which 13 haplotypes were present only once. Multiple tests for selection confirmed a signature of positive selection on Pvs48/45 with selection skewed to the second cysteine domain. Haplotype network analysis and Wright's fixation index showed large geographical differentiation with the presence of continent-or region-specific mutations in this gene. Conclusions: Pvs48/45 displays low levels of genetic diversity with the presence of region-specific mutations. Some of the mutations may be potential epitope targets based on their positions in the predicted structure, highlighting the need for future evaluation of these mutations in designing Pvs48/45-based TBV.	[Feng, Hui; Zheng, Li; Zhu, Xiaotong; Cao, Yaming; Cui, Liwang] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang, Liaoning, Peoples R China; [Gupta, Bhavna; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Wang, Meilian; Zheng, Wenqi; Luo, Enjie] China Med Univ, Coll Basic Med Sci, Dept Microbiol & Parasitol, Shenyang, Liaoning, Peoples R China; [Yang, Yimei] Dali Med Coll, Coll Basic Med Sci, Dept Parasitol, Dali, Yunnan, Peoples R China; [Fang, Qiang] Bengbu Med Coll, Dept Parasitol, Bengbu, Anhui, Peoples R China; [Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan	Cao, YM (reprint author), China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang, Liaoning, Peoples R China.	ymcao@mail.cmu.edu.cn; luc2@psu.edu			NIAID, National Institutes of Health [U19 AI089672, R01 AI099611]	The work was supported by NIAID, National Institutes of Health (U19 AI089672 and R01 AI099611).	Alonso PL, 2011, PLOS MED, V8; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Baird JK, 1999, MED CLIN N AM, V83, P923; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Drakeley CJ, 2006, PARASITE IMMUNOL, V28, P185, DOI 10.1111/j.1365-3024.2005.00818.x; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; Arevalo-Herrera M, 2010, HUM VACCINES, V6, P124; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Jones S, 2015, J INFECTION, V71, P117, DOI 10.1016/j.jinf.2015.03.007; NEI M, 1986, MOL BIOL EVOL, V3, P418; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; Woo MK, 2013, MEM I OSWALDO CRUZ, V108, P359, DOI 10.1590/S0074-02762013000300015; Tachibana M, 2011, CLIN VACCINE IMMUNOL, V18, P1343, DOI 10.1128/CVI.05104-11; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Tsuboi T, 1998, MOL MED, V4, P772; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu BL, 2006, AM J TROP MED HYG, V74, P564; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; TAJIMA F, 1989, GENETICS, V123, P585; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Templeton TJ, 1999, MOL BIOCHEM PARASIT, V101, P223, DOI 10.1016/S0166-6851(99)00066-3; Conway DJ, 2001, MOL BIOCHEM PARASIT, V115, P145, DOI 10.1016/S0166-6851(01)00278-X; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Baird JK, 1997, LANCET, V350, P1855, DOI 10.1016/S0140-6736(05)63676-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.moibiopara.2007.07.008; Doi M, 2011, VACCINE, V29, P4308, DOI 10.1016/j.vaccine.2011.04.028; Sleigh AC, 1998, B WORLD HEALTH ORGAN, V76, P265; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Tachibana M, 2012, VACCINE, V30, P1807, DOI 10.1016/j.vaccine.2012.01.003; Battle KE, 2012, ADV PARASIT, V80, P1, DOI 10.1016/B978-0-12-397900-1.00001-3; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.0528.x; Arevalo-Herrera M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119335; Baird JK, 1997, LANCET, V350, P6; Barry AE, 2009, PLOS ONE, V4; Bousema T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014114; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-68; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Feng H., 2011, CHINA PARASIT VECTOR, V4, P224; Forero-Rodriguez J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-58; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gholizadeh S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-137; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002404; Kang JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-144; Tachibana M, 2015, VACCINE, V33, P1901, DOI 10.1016/j.vaccine.2015.03.008; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; WHO, 2013, WORLD MALARIA REPORT 2013, P1; [周水森 ZHOU Shuisen], 2007, [中国寄生虫学与寄生虫病杂志, Chinese Journal of Parasitology & Parasitic Diseases], V25, P439	56	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 1	2015	8								615	10.1186/s13071-015-1232-4		11	Parasitology	Parasitology	CX2DP	WOS:000365505900006		
J	Masugi, Y; Tanese, K; Emoto, K; Yamazaki, K; Effendi, K; Funakoshi, T; Mori, M; Sakamoto, M				Masugi, Yohei; Tanese, Keiji; Emoto, Katsura; Yamazaki, Ken; Effendi, Kathryn; Funakoshi, Takeru; Mori, Mariko; Sakamoto, Michiie			Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma	PATHOLOGY INTERNATIONAL			English	Article						adenylate cyclase-associated protein; CAP2; malignant melanoma; prognosis	MULTISTAGE HEPATOCARCINOGENESIS; HEPATOCELLULAR-CARCINOMA; REGULATED EXPRESSION; CELL-PROLIFERATION; CANCER; CAP1; MIGRATION; DYNAMICS; METASTASIS; MECHANISMS	Malignant melanoma is one of the lethal malignant tumors worldwide. Previously we reported that adenylate cyclase-associated protein 2 (CAP2), which is a well-conserved actin regulator, was overexpressed in hepatocellular carcinoma; however, CAP2 expression in other clinical cancers remains unclear. The aim of the current study was to clarify the clinicopathological significance of CAP2 overexpression in malignant melanoma. Immunohistochemical analyses revealed that many melanoma cells exhibited diffuse cytoplasmic expression of CAP2, whereas no normal melanocytes showed detectable immunostaining for CAP2. A high level of CAP2 expression was seen in 14 of 50 melanomas and was significantly correlated with greater tumor thickness and nodular melanoma subtypes. In addition, a high level of CAP2 expression was associated with poor overall survival in univariate and multivariate analyses. For 13 patients, samples of primary and metastatic melanoma tissue were available: four patients exhibited higher levels of CAP2 expression in metastatic tumor compared to the primary site, whereas no patient showed lower levels of CAP2 expression in metastatic melanomas. Our findings show that CAP2 overexpression is a novel prognostic marker in malignant melanoma and that CAP2 expression seems to increase stepwise during tumor progression, suggesting the involvement of CAP2 in the aggressive behavior of malignant melanoma.	[Masugi, Yohei; Tanese, Keiji; Emoto, Katsura; Yamazaki, Ken; Effendi, Kathryn; Sakamoto, Michiie] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Tanese, Keiji; Funakoshi, Takeru; Mori, Mariko] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan	Sakamoto, M (reprint author), Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	msakamot@z5.keio.jp			JSPS [26293081]	We are grateful to Hiroshi Suzuki for technical assistance with immunohistochemistry. This work was supported by JSPS Grant-in-Aid for Scientific Research (B) Grant number 26293081.	Effendi K, 2013, EXP CELL RES, V319, P35, DOI 10.1016/j.yexcr.2012.09.013; Kirfel G, 2004, EUR J CELL BIOL, V83, P717, DOI 10.1078/0171-9335-00421; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Shibata R, 2006, CLIN CANCER RES, V12, P5363, DOI 10.1158/1078-0432.CCR-05-2245; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; Liu YH, 2014, PATHOL RES PRACT, V210, P169, DOI 10.1016/j.prp.2013.11.011; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/j.cub.2003.11.051; Sakamoto M, 2010, JPN J CLIN ONCOL, V40, P891, DOI 10.1093/jjco/hyq099; Balch CM, 2001, J CLIN ONCOL, V19, P3635; Tan M, 2013, ONCOL REP, V30, P1639, DOI 10.3892/or.2013.2607; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hua MH, 2015, INT J MOL MED, V35, P941, DOI 10.3892/ijmm.2015.2089; Leboit PE, 2006, WHO CLASSIFICATION T; Li M, 2013, JPN J CLIN ONCOL, V43, P856, DOI 10.1093/jjco/hyt093; Liu XC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0878-7; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Sobin L, 2009, TNM CLASSIFICATION M	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2015	65	12					627	634		10.1111/pin.12351		8	Pathology	Pathology	CX6WX	WOS:000365843500001		
J	Nakazawa, T; Nobusawa, S; Ikota, H; Kuwano, H; Takeyoshi, I; Yokoo, H				Nakazawa, Takuro; Nobusawa, Sumihito; Ikota, Hayato; Kuwano, Hiroyuki; Takeyoshi, Izumi; Yokoo, Hideaki			Wide expression of ZEB1 in sarcomatous component of spindle cell carcinoma of the esophagus	PATHOLOGY INTERNATIONAL			English	Article						epithelial-mesenchymal transition; esophagus; spindle cell carcinoma; TP53; ZEB1	EPITHELIAL-MESENCHYMAL TRANSITION; SQUAMOUS CARCINOMA; MONOCLONAL ORIGIN; E-CADHERIN; P53 GENE; TRANSCRIPTION FACTORS; TP53 MUTATION; CARCINOSARCOMA; TUMOR; CANCER	The pathogenesis of sarcomatous component in spindle cell carcinoma (SpCC) of the esophagus is unclear. To investigate the involvement of epithelial-mesenchymal transition (EMT) in sarcomatous differentiation, we performed immunohistochemistry for Slug, Twist, ZEB1, and ZEB2, transcription factors associated with EMT and E-cadherin, in 14 cases of SpCC of the esophagus. In order to verify the neoplastic nature of sarcomatous components, TP53 mutation status and protein expression were examined in each case. Nuclear ZEB1 expression was extensive in the sarcomatous component, greater than invasive front of carcinoma components (P < 0.0001). Membranous E-cadherin expression was mostly lost in sarcomatous cells in all cases (P < 0.0001). The p53 expression pattern was almost concordant between the two areas in all cases. TP53 mutation analysis revealed that seven cases harbored identical mutations in both components. One case had mutations only in the sarcomatous component. It is noteworthy that none of them harbored mutation in exon 5, unlike conventional esophageal squamous cell carcinoma. These findings show that ZEB1 are widely expressed in the sarcomatous area of SpCC of the esophagus, suggesting the involvement of EMT. The avoidance of exon 5 in terms of TP53 mutation may also be a feature of the tumor.	[Nakazawa, Takuro; Nobusawa, Sumihito; Ikota, Hayato; Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 3718511, Japan; [Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718511, Japan; [Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gunma 3718511, Japan	Nakazawa, T (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	ntakuro3@yahoo.co.jp					Yokobori T, 2013, CANCER SCI, V104, P48, DOI 10.1111/cas.12030; Madan AK, 2001, J GASTROINTEST SURG, V5, P414, DOI 10.1016/S1091-255X(01)80071-8; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; MARTIN MR, 1977, ARCH PATHOL LAB MED, V101, P604; Kojc N, 2009, VIRCHOWS ARCH, V454, P549, DOI 10.1007/s00428-009-0771-5; Amatya VJ, 2004, PATHOL INT, V54, P803, DOI 10.1111/j.1440-1827.2004.01759.x; Holst VA, 1997, AM J SURG PATHOL, V21, P801, DOI 10.1097/00000478-199707000-00008; OOI A, 1986, ACTA PATHOL JAPON, V36, P151; Kashiwabara K, 2001, PATHOL RES PRACT, V197, P41, DOI 10.1078/0344-0338-00006; TAKUBO K, 1982, HUM PATHOL, V13, P503, DOI 10.1016/S0046-8177(82)80036-1; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Matsumoto T, 2004, HUM PATHOL, V35, P322, DOI 10.1016/j.humpath.2003.02.001; ENRILE FT, 1973, CANCER, V31, P1197, DOI 10.1002/1097-0142(197305)31:5<1197::AID-CNCR2820310523>3.0.CO;2-9; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Nakagawa S, 1999, DIGEST DIS SCI, V44, P905, DOI 10.1023/A:1026640009829; ODA H, 1995, CANCER RES, V55, P658; Iwaya T, 2006, DIS ESOPHAGUS, V19, P48, DOI 10.1111/j.1442-2050.2006.00538.x; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Iwaya T, 1997, GASTROENTEROLOGY, V113, P973, DOI 10.1016/S0016-5085(97)70194-X; Handra-Luca A, 2001, HISTOPATHOLOGY, V39, P125, DOI 10.1046/j.1365-2559.2001.01174.x; Jin Z, 2003, INT J GYNECOL PATHOL, V22, P368, DOI 10.1097/01.pgp.0000092134.88121.56; Armstrong AB, 2009, MODERN PATHOL, V22, P113, DOI 10.1038/modpathol.2008.176; Conant JL, 2011, J CLIN PATHOL, V64, P1088, DOI 10.1136/jclinpath-2011-200216; Lien HC, 2004, J PATHOL, V204, P131, DOI 10.1002/path.1624; BATTIFORA H, 1976, CANCER, V37, P2275, DOI 10.1002/1097-0142(197605)37:5<2275::AID-CNCR2820370518>3.0.CO;2-3; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Egashira A, 2007, CANCER SCI, V98, P1152, DOI 10.1111/j.1349-7006.2007.00524.x; Sano A, 2009, ANTICANCER RES, V29, P3375; Ansari-Lari MA, 2002, AM J SURG PATHOL, V26, P1024, DOI 10.1097/01.PAS.0000018104-32686.56; IYOMASA S, 1990, JPN J CLIN ONCOL, V20, P99; Lauwers GY, 1998, HUM PATHOL, V29, P863, DOI 10.1016/S0046-8177(98)90458-0; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; LINDER J, 1987, HUM PATHOL, V18, P692, DOI 10.1016/S0046-8177(87)80240-X; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; TALBERT JL, 1963, J THORAC CARDIOV SUR, V45, P1; Lee JS, 2004, VIRCHOWS ARCH, V444, P194, DOI 10.1007/s00428-003-0953-5; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; Kounelis S, 1998, HUM PATHOL, V29, P82, DOI 10.1016/S0046-8177(98)90394-X; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Paniz-Mondolfi A, 2014, VIRCHOWS ARCH, V465, P339, DOI 10.1007/s00428-014-1628-0; Kawano T, 1996, PATHOL INT, V46, P38; Matsubara D, 2014, PATHOL INT, V64, P560, DOI 10.1111/pin.12214; Montgomery E, 2010, WHO CLASSIFICATION T, P18; Sasaki K, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-158; Sobin L, 2009, TNM CLASSIFICATION M	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2015	65	12					635	643		10.1111/pin.12354		9	Pathology	Pathology	CX6WX	WOS:000365843500002		
J	Ohtani, H; Mori-Shiraishi, K; Nakajima, M; Ueki, H				Ohtani, Haruo; Mori-Shiraishi, Kazuko; Nakajima, Morio; Ueki, Hamaichi			Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis	PATHOLOGY INTERNATIONAL			English	Article						anti-tumor immunity; invasive breast cancer; lymphocyte-predominant breast cancer; tumor-infiltrating lymphocytes	TUMOR-INFILTRATING LYMPHOCYTES; INTERNATIONAL EXPERT CONSENSUS; CD8(+) T-LYMPHOCYTES; PROGNOSTIC-FACTOR; PRIMARY THERAPY; NEOADJUVANT CHEMOTHERAPY; GASTRIC-CARCINOMA; HIGHLIGHTS; PREDICTORS; EXPRESSION	Lymphocyte-predominant breast cancer (LPBC) defined by the density of stromal lymphocytes shows favorable behavior. However, considerable distribution heterogeneity of lymphocytes is a major problem. The present study defined LPBC by the proportion of lymphocyte-rich stroma with the cut-off values of 30, 50, and 75%, and clinicopathologically analyzed mainly LPBC (area>30%) defined by the cut-off value of 30%. LPBCs (area>30%), 39 cases in total, were composed mainly of triple-negative and HER2(+)/ER- subtypes, without any luminal A-like subtype. LPBCs were composed predominantly of histological grade 3 tumors, without any grade 1 lesions. Multivariate analyses on 477 consecutive tumors revealed that ER-negativity and grade 3 status associated significantly with LPBC. LPBC (area>30%) showed better disease-free survival than grade-matched controls, and it was a good indicator of complete pathological remission after pre-operative chemotherapy. Patients with LPBC with the cut-off value of 50% and that of 75% showed 100% disease-free survival. These results demonstrated the validity of our definition of LPBC. Our data also suggest that de-differentiated cancers without TILs could be regarded as high-grade cancer without lymphocyte-mediated responses. In conclusion, the definition of LPBC by the proportion of lymphoid stroma is useful for prognostication of high grade breast cancer in routine diagnosis.	[Ohtani, Haruo] Mito Saiseikai Gen Hosp, Dept Pathol, Mito, Ibaraki 3114198, Japan; [Ohtani, Haruo] Natl Hosp Org, Mito Med Ctr, Dept Pathol, Ibaraki, Japan; [Mori-Shiraishi, Kazuko; Nakajima, Morio; Ueki, Hamaichi] Natl Hosp Org, Mito Med Ctr, Dept Surg, Ibaraki, Japan	Ohtani, H (reprint author), Mito Saiseikai Gen Hosp, Dept Pathol, 3-3-10 Futabadai, Mito, Ibaraki 3114198, Japan.	311serenity@gmail.com			National Hospital Organization Collaborative Clinical Research Grants, Japan	The present study was supported by National Hospital Organization Collaborative Clinical Research Grants, Japan. The corresponding author is grateful to the late Dr. Lloid J. Old, Ludwig Institute for Cancer Research, New York for his encouragements. Technical assistance by Mr. H. Tajima and Mr. Y. Kurabe is greatly acknowledged.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Naito Y, 1998, CANCER RES, V58, P3491; Mauri D, 2005, J NATL CANCER I, V97, P188; Ohtani H, 2009, J PATHOL, V217, P21, DOI 10.1002/path.2448; Nakano O, 2001, CANCER RES, V61, P5132; Matkowski R, 2009, ANTICANCER RES, V29, P2445; Saiki Y, 1996, LAB INVEST, V75, P67; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Yamaguchi R, 2012, HUM PATHOL, V43, P1688, DOI 10.1016/j.humpath.2011.12.013; Nawaz S, 2015, MODERN PATHOL, V28, P766, DOI 10.1038/modpathol.2015.37; Yakirevich E, 1999, MODERN PATHOL, V12, P1050; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Baker K, 2011, HISTOPATHOLOGY, V58, P1107, DOI 10.1111/j.1365-2559.2011.03846.x; Buzdar AU, 2007, CLIN CANCER RES, V13, P228, DOI 10.1158/1078-0432.CCR-06-1345; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Barnes L, 2005, WHO CLASSIFICATION T, P88; Chirieac LR, 2015, WHO CLASSIFICATION T, P95; Jacquemier J, 2012, WHO CLASSIFICATION T, P46; Japan Breast Cancer Society, 2013, CLIN PRACT GUID BREA; Kato T, 2014, INT J CLIN EXP PATHO, V7, P7967; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Liakou Chrysoula I, 2007, Cancer Immun, V7, P10; Loi S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24720; Oble Darryl A, 2009, Cancer Immun, V9, P3; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Sobin L, 2009, TNM CLASSIFICATION M; Tavassoli F.A., 2003, WHO CLASSIFICATION T; Uppaluri Ravindra, 2008, Cancer Immun, V8, P16; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2015	65	12					644	651		10.1111/pin.12355		8	Pathology	Pathology	CX6WX	WOS:000365843500003		
J	Eladl, AE; Satou, A; Elsayed, AA; Suzuki, Y; Shimizu-Kohno, K; Kato, S; Tomita, A; Kinoshita, T; Nakamura, S; Asano, N				Eladl, Ahmed E.; Satou, Akira; Elsayed, Ahmed Ali; Suzuki, Yuka; Shimizu-Kohno, Kei; Kato, Seiichi; Tomita, Akihiro; Kinoshita, Tomohiro; Nakamura, Shigeo; Asano, Naoko			Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages	PATHOLOGY INTERNATIONAL			English	Article						CD68; CD163; nodular lymphocyte predominant Hodgkin lymphoma; tissue associated macrophages	B-CELL LYMPHOMA; TUMOR-ASSOCIATED MACROPHAGES; EUROPEAN TASK-FORCE; STUDY-GROUP GHSG; DIFFERENTIAL-DIAGNOSIS; MALIGNANT-LYMPHOMA; PROGNOSTIC IMPACT; DISEASE; VARIANT; FEATURES	Clinicopathological features of 25 nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) patients in Japan were analysed. To investigate the clinicopathological significance of tissue associated macrophages (TAM) in NLPHL, CD68 and CD163 expression were investigated. The median age at onset was 56 years (range: 6-82 years) with male predominance (64%). All patients presented with lymph node enlargement with predilection for cervical LNs. Seven cases (28%) had mediastinal lesion and four (16%) had extranodal involvement. Most cases (76%) presented with early clinical stages. After median follow up of 44 months, both of overall and progression free survival rates were 95%. The presence of >5% CD68+ TAM in NLPHL was significantly associated with older age at diagnosis (median, 71 vs 52.5 years; P=0.048), lower hemoglobin level (33.3% vs 0%; P=0.037) and lower CR rate after initial treatment (42.9% vs 91.7%; P=0.038). The presence of >5% CD163+ TAM was significantly correlated with presence of B symptoms (40% vs 0%; P=0.036). In conclusion, NLPHL is rare among Japanese and appears to present at an older age than among Western patients. In our series, the presence of >5% CD68+ TAM in NLPHL was associated with lower CR rate, but with no impact on patients' survival.	[Eladl, Ahmed E.; Satou, Akira; Elsayed, Ahmed Ali; Suzuki, Yuka; Shimizu-Kohno, Kei; Kato, Seiichi; Nakamura, Shigeo] Nagoya Univ, Dept Pathol & Lab Med, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Tomita, Akihiro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Kinoshita, Tomohiro] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Asano, Naoko] Nagano Prefectural Suzaka Hosp, Dept Mol Diagnost, Suzaka, Japan; [Eladl, Ahmed E.; Elsayed, Ahmed Ali] Mansoura Univ, Fac Med, Dept Pathol, Mansoura, Egypt	Eladl, AE (reprint author), Nagoya Univ Hosp, Dept Pathol & Lab Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ah_eladl@hotmail.com	Nakamura, Shigeo/I-1571-2012				Advani RH, 2013, BLOOD, V122, P4182, DOI 10.1182/blood-2013-07-453241; AK N., 2008, CURR HEMATOL MALIG R, V3, P119; Anagnostopoulos I, 2000, BLOOD, V96, P1889; Chihara D, 2014, BRIT J HAEMATOL, V164, P536, DOI 10.1111/bjh.12659; Jackson C, 2010, ANN ONCOL, V21, P2061, DOI 10.1093/annonc/mdq063; Klein JL, 2014, AM J CLIN PATHOL, V141, P381, DOI 10.1309/AJCP61TLMXLSLJYS; Nogova L, 2008, J CLIN ONCOL, V26, P434, DOI 10.1200/JCO.2007.11.8869; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Miura Y, 2011, TOHOKU J EXP MED, V224, P151, DOI 10.1620/tjem.224.151; de Jong D, 2006, ANN ONCOL, V17, P141, DOI 10.1093/annonc/mdj037; Asano N, 2005, AM J SURG PATHOL, V29, P1284, DOI 10.1097/01.pas.0000173238.17331.6b; Drakos E, 2009, AM J SURG PATHOL, V33, P1725, DOI 10.1097/PAS.0b013e3181b27765; Fan Z, 2003, AM J SURG PATHOL, V27, P1346, DOI 10.1097/00000478-200310000-00007; Nam-Cha SH, 2008, AM J SURG PATHOL, V32, P1252, DOI 10.1097/PAS.0b013e318165b0d6; Lee MY, 2005, HAEMATOL-HEMATOL J, V90, P1703; Hartmann S, 2013, INT J CANCER, V133, P2609, DOI 10.1002/ijc.28273; MASON DY, 1994, AM J SURG PATHOL, V18, P526, DOI 10.1097/00000478-199405000-00014; Wlodarska I, 2003, BLOOD, V101, P706, DOI 10.1182/blood-2002-05-1592; REGULA DP, 1988, NEW ENGL J MED, V318, P214, DOI 10.1056/NEJM198801283180404; Al-Mansour M, 2010, J CLIN ONCOL, V28, P793, DOI 10.1200/JCO.2009.24.9516; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Cotta CV, 2011, HISTOPATHOLOGY, V59, P1194, DOI 10.1111/j.1365-2559.2011.04054.x; Marafioti T, 1997, NEW ENGL J MED, V337, P453, DOI 10.1056/NEJM199708143370703; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Biasoli I, 2010, CANCER-AM CANCER SOC, V116, P631, DOI 10.1002/cncr.24819; Harris NL, 2013, MODERN PATHOL, V26, pS57, DOI 10.1038/modpathol.2012.182; Nakatsuka S, 2006, INT J HEMATOL, V83, P391, DOI 10.1532/IJH97.05184; Diehl V, 1999, J CLIN ONCOL, V17, P776; Churchill HRO, 2010, HUM PATHOL, V41, P1726, DOI 10.1016/j.humpath.2010.05.010; Achten R, 2003, HAEMATOLOGICA, V88, P1431; Huang JZ, 2004, LEUKEMIA LYMPHOMA, V45, P1551, DOI 10.1080/1042819031000149421; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Sohani AR, 2011, AM J SURG PATHOL, V35, P1666, DOI 10.1097/PAS.0b013e31822832de; Fanale MA, 2010, ASH ANN M, V116, P2812; Friedman Debra L, 2006, J Natl Compr Canc Netw, V4, P249; Hancock SL, 1996, SEMIN RADIAT ONCOL, V6, P225, DOI 10.1016/S1053-4296(96)80018-X; Hartmann S, 2013, BLOOD, V122, P4246, DOI 10.1182/blood-2013-07-515825; Hartmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078812; Hartmann S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-332; Hartmann S, 2014, BRIT J HAEMATOL, V167, P238, DOI 10.1111/bjh.12997; Komohara Y, 2015, PATHOL INT, V65, P170, DOI 10.1111/pin.12259; Lymphoma Study Group of Japanese Pathologists, 2000, LYMPHOMA STUDY GROUP, V50, P696; National Comprehensive Cancer Network, NCCN PRACT GUID ONC; Poppema GD, 2008, NODULAR LYMPHOCYTE P, P323; Xing KH, 2014, BLOOD, V123, P3567, DOI 10.1182/blood-2013-12-541078	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2015	65	12					652	660		10.1111/pin.12357		9	Pathology	Pathology	CX6WX	WOS:000365843500004		
J	Tajima, S; Takanashi, Y; Koda, K; Fukayama, M				Tajima, Shogo; Takanashi, Yusuke; Koda, Kenji; Fukayama, Masashi			Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs	PATHOLOGY INTERNATIONAL			English	Article						extranodal lung; lymphoproliferative disorder; methotrexate; NK; T-cell lymphoma; rheumatoid arthritis	EPSTEIN-BARR-VIRUS; RHEUMATOID-ARTHRITIS; DISEASE; NASAL; RISK; REGRESSION; INFECTION; THERAPY	Patients having rheumatoid arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (LPD). Epstein-Barr virus (EBV) sometimes contributes to the development of MTX-associated LPD. Herein, we report the case of a 64-year-old Japanese woman with RA who showed complications of EBV-positive MTX-associated LPD. This case is exceedingly rare in that the LPD was confined to the lungs and its subclassification was extranodal NK/T-cell lymphoma. Only four cases of extranodal NK/T-cell lymphoma in the setting of MTX-associated LPD have ever been reported in the English language literature, only one of which was an extranasal NK/T-cell lymphoma, similar to our case. Extranasal NK/T-cell lymphomas show more aggressive behavior than nasal NK/T-cell lymphomas, possibly reflected by the considerable re-exacerbation of the lesions in only two months after the cessation of MTX in our case. However, the SMILE regimen (steroid, methotrexate, ifosfamide, l-asparaginase, and etoposide) was able to suppress tumor growth in this case.	[Tajima, Shogo; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan; [Takanashi, Yusuke] Fujieda Municipal Gen Hosp, Dept Chest Surg, Shizuoka, Japan; [Koda, Kenji] Fujieda Municipal Gen Hosp, Dept Pathol, Shizuoka, Japan	Tajima, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	stajima-tky@umin.ac.jp					Souza TA, 2007, J IMMUNOL, V179, P3153; Terroso G, 2014, ACTA REUMATOL PORT, V39, P77; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P1433, DOI 10.1002/art.22579; Lee J, 2005, EUR J CANCER, V41, P1402, DOI 10.1016/j.ejca.2005.03.010; Imokawa S, 2000, EUR RESPIR J, V15, P373, DOI 10.1034/j.1399-3003.2000.15b25.x; Kameda T, 2014, ARTHRIT CARE RES, V66, P1302, DOI 10.1002/acr.22306; Hoshida Y, 2007, J RHEUMATOL, V34, P322; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Salloum E, 1996, J CLIN ONCOL, V14, P1943; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Georgescu L, 1999, DRUG SAFETY, V20, P475, DOI 10.2165/00002018-199920060-00002; Isobe Y, 2004, CANCER RES, V64, P2167, DOI 10.1158/0008-5472.CAN-03-1562; Yamaguchi M, 2012, INT J HEMATOL, V96, P562, DOI 10.1007/s12185-012-1189-4; Kojima M, 2006, PATHOL RES PRACT, V202, P679, DOI 10.1016/j.prp.2006.05.007; Ichikawa A, 2013, EUR J HAEMATOL, V91, P20, DOI 10.1111/ejh.12116; Kondo S, 2013, VIRCHOWS ARCH, V462, P399, DOI 10.1007/s00428-013-1389-1; Gaulard P, 2008, WHO CLASSIFICATION T, P350; vansEde AE, 1998, SEMIN ARTHRITIS RHEU, V27, P277	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2015	65	12					661	665		10.1111/pin.12346		5	Pathology	Pathology	CX6WX	WOS:000365843500005		
J	Sato, A; Kawasaki, T; Kashiwaba, M; Ishida, K; Nagashima, Y; Moritani, S; Ichihara, S; Sugai, T				Sato, Ayaka; Kawasaki, Tomonori; Kashiwaba, Masahiro; Ishida, Kazushige; Nagashima, Yoji; Moritani, Suzuko; Ichihara, Shu; Sugai, Tamotsu			Glycogen-rich clear cell carcinoma of the breast showing carcinomatous lymphangiosis and extremely aggressive clinical behavior	PATHOLOGY INTERNATIONAL			English	Letter									[Sato, Ayaka; Kawasaki, Tomonori; Sugai, Tamotsu] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Morioka, Iwate 020, Japan; [Kashiwaba, Masahiro; Ishida, Kazushige] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Nagashima, Yoji] Tokyo Womens Med Univ Hosp, Dept Surg Pathol, Tokyo, Japan; [Moritani, Suzuko; Ichihara, Shu] Natl Hosp Org, Nagoya Med Ctr, Dept Pathol, Aichi, Japan	Sato, A (reprint author), Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Morioka, Iwate 020, Japan.						HULL MT, 1986, AM J SURG PATHOL, V10, P553, DOI 10.1097/00000478-198608000-00005; HAYES MMM, 1995, AM J SURG PATHOL, V19, P904, DOI 10.1097/00000478-199508000-00005; Ma XM, 2014, BREAST J, V20, P166, DOI 10.1111/tbj.12231; Han JH, 2003, ARCH PATHOL LAB MED, V127, P1330; TOIKKANEN S, 1991, HUM PATHOL, V22, P81, DOI 10.1016/0046-8177(91)90066-X; HULL MT, 1981, CANCER, V48, P2003, DOI 10.1002/1097-0142(19811101)48:9<2003::AID-CNCR2820480916>3.0.CO;2-Q; Govender D, 2002, AM J SURG PATHOL, V26, P670, DOI 10.1097/00000478-200205000-00014; Kuwabara H, 1997, J CLIN PATHOL, V50, P700, DOI 10.1136/jcp.50.8.700; Coyne JD, 2004, HISTOPATHOLOGY, V44, P580, DOI 10.1111/j.1365-2559.2004.01891.x; Eusebi V, 2012, WHO CLASSIFICATION T, P71	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	DEC	2015	65	12					674	676		10.1111/pin.12321		3	Pathology	Pathology	CX6WX	WOS:000365843500008		
J	Ouchi-Uchiyama, M; Sasahara, Y; Kikuchi, A; Goi, K; Nakane, T; Ikeno, M; Noguchi, Y; Uike, N; Miyajima, Y; Matsubara, K; Koh, K; Sugita, K; Imaizumi, M; Kure, S				Ouchi-Uchiyama, Meri; Sasahara, Yoji; Kikuchi, Atsuo; Goi, Kumiko; Nakane, Takaya; Ikeno, Mitsuru; Noguchi, Yasushi; Uike, Naokuni; Miyajima, Yuji; Matsubara, Kousaku; Koh, Katsuyoshi; Sugita, Kanji; Imaizumi, Masue; Kure, Shigeo			Analyses of Genetic and Clinical Parameters for Screening Patients With Inherited Thrombocytopenia With Small or Normal-Sized Platelets	PEDIATRIC BLOOD & CANCER			English	Article						ITP; molecular genetics; platelet disorders; thrombocytopenia	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; ALDRICH-SYNDROME PROTEIN; THROMBOPOIETIN-RECEPTOR; RUNX1 MUTATIONS; MALIGNANCY; PEDIGREES; ANKRD26; FPD/AML; WASP	Background. Childhood thrombocytopenias include immune thrombocytopenic purpura (ITP) and inherited thrombocytopenia; the former is caused by autoantibodies to platelets, whereas the latter can be distinguished by platelet size and underlying genetic mutations. Due to limited methods for the definite diagnosis of ITP, genetic and clinical parameters are required for diagnosing inherited thrombocytopenias with small or normal-sized platelets. Procedure. In total, 32 Japanese patients with thrombocytopenia with small or normal-sized platelets from 29 families were enrolled. All the patients were under 20 years of age, with family histories of early-onset thrombocytopenia and/or poor response to conventional therapies for ITP. Genotypes and clinical parameters were retrospectively evaluated according to the disease type. Results. Twelve cases of inherited thrombocytopenia were observed. We identified chromosomal deletions within the WASP gene in two patients with Wiskott-Aldrich syndrome; a missense mutation in a patient with X-linked thrombocytopenia; and mutations in the RUNX1 gene of five patients with familial platelet disorder with propensity to acute myelogenous leukemia, and in the ANKRD26 gene of four patients with autosomal dominant thrombocytopenia-2. All 12 carried germline mutations, three of which were de novo. Furthermore, we observed significantly elevated serum thrombopoietin (TPO) levels and dysplasia of megakaryocytes in patients carrying the RUNX1 and ANKRD26 mutations. Conclusions. Genetic analyses and detection of TPO levels and dysmegakaryopoiesis were clinically useful for screening patients with inherited thrombocytopenias, irrespective of the family history. We hypothesize that the WASP, RUNX1, and ANKRD26 genes are important for normal TPO signaling and the network underlying thrombopoiesis. Pediatr Blood (C) 2015 Wiley Periodicals, Inc.	[Ouchi-Uchiyama, Meri; Sasahara, Yoji; Kikuchi, Atsuo; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 9808575, Japan; [Ouchi-Uchiyama, Meri; Imaizumi, Masue] Miyagi Childrens Hosp, Dept Hematol & Oncol, Sendai, Miyagi, Japan; [Goi, Kumiko; Nakane, Takaya; Sugita, Kanji] Univ Yamanashi, Dept Pediat, Kofu, Yamanashi, Japan; [Ikeno, Mitsuru] Juntendo Univ, Sch Med, Dept Pediat & Adolescent Med, Tokyo 113, Japan; [Noguchi, Yasushi] Japanese Red Cross, Narita Hosp, Dept Pediat, Chiba, Japan; [Uike, Naokuni] Natl Hosp Org, Kyushu Canc Ctr, Dept Hematol, Fukuoka, Japan; [Miyajima, Yuji] Anjoh Kosei Hosp, Dept Pediat, Anjo, Aichi, Japan; [Matsubara, Kousaku] Nishi Kobe Med Ctr, Dept Pediat, Kobe, Hyogo, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan	Sasahara, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Pediat, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ysasahara@med.tohoku.ac.jp			Japan Society for the Promotion of Science [26461562]; Ministry of Health, Labor, and Welfare, Japan	Grant sponsor: Japan Society for the Promotion of Science; Grant number: 26461562; Grant sponsor: Ministry of Health, Labor, and Welfare, Japan	Looi CY, 2014, INT IMMUNOL, V26, P341, DOI 10.1093/intimm/dxt072; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; Jalagadugula G, 2010, BLOOD, V116, P6037, DOI 10.1182/blood-2010-06-289850; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; Kawai S, 2002, J IMMUNOL METHODS, V260, P195, DOI 10.1016/S0022-1759(01)00549-X; Noris P, 2013, BLOOD, V122, P1987, DOI 10.1182/blood-2013-04-499319; Watanabe Y, 2013, J ALLERGY CLIN IMMUN, V132, P648, DOI 10.1016/j.jaci.2013.03.046; Noris P, 2013, BRIT J HAEMATOL, V162, P112, DOI 10.1111/bjh.12349; Pecci A, 2013, INT J HEMATOL, V98, P34, DOI 10.1007/s12185-013-1351-7; Kappers-Klunne MC, 2001, BRIT J HAEMATOL, V115, P1004, DOI 10.1046/j.1365-2141.2001.03184.x; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Schnittger S, 2011, BLOOD, V117, P2348, DOI 10.1182/blood-2009-11-255976; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Ballmaier M, 2009, BRIT J HAEMATOL, V146, P3, DOI 10.1111/j.1365-2141.2009.07706.x; Bluteau D, 2012, BLOOD, V120, P2708, DOI 10.1182/blood-2012-04-422337; van den Oudenrijn S, 2000, BRIT J HAEMATOL, V110, P441, DOI 10.1046/j.1365-2141.2000.02175.x; Thompson AA, 2000, NAT GENET, V26, P397, DOI 10.1038/82511; Bluteau D, 2014, J CLIN INVEST, V124, P580, DOI 10.1172/JCI71861; Kurata Y, 2001, AM J CLIN PATHOL, V115, P656; Albert MH, 2010, BLOOD, V115, P3231, DOI 10.1182/blood-2009-09-239087; Ballmaier M, 2011, SEMIN THROMB HEMOST, V37, P673, DOI 10.1055/s-0031-1291377; Buchbinder David, 2014, Appl Clin Genet, V7, P55, DOI 10.2147/TACG.S58444; Kwan SP, P NATL ACAD SCI US, V92, P4706; Noris P, 2014, BLOOD, V124, pE4, DOI 10.1182/blood-2014-03-564328; Yoshimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5770; Zhang MY, 2015, NAT GENET, V47, P180, DOI 10.1038/ng.3177	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	DEC	2015	62	12					2082	2088		10.1002/pbc.25668		7	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CX0UN	WOS:000365412600006		
J	Al-Kzayer, LFY; Sakashita, K; Al-Jadiry, MF; Al-Hadad, SA; Ghali, HH; Uyen, LTN; Liu, TT; Matsuda, K; Abdulkadhim, JMH; Al-Shujairi, TA; Matti, ZIIK; Sughayer, MA; Rihani, R; Madanat, FF; Inoshita, T; Kamata, M; Koike, K				Al-Kzayer, Lika'a Fasih Y.; Sakashita, Kazuo; Al-Jadiry, Mazin Faisal; Al-Hadad, Salma Abbas; Ghali, Hasanein Habeeb; Uyen, Le T. N.; Liu, Tingting; Matsuda, Kazuyuki; Abdulkadhim, Jaafar M. H.; Al-Shujairi, Tariq Abadi; Matti, Zead Ismael I. K.; Sughayer, Maher A.; Rihani, Rawad; Madanat, Faris F.; Inoshita, Toshi; Kamata, Minoru; Koike, Kenichi			Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia	PEDIATRIC BLOOD & CANCER			English	Article						ALL; AML; Arab Asian children; FTA; MLL-rearrangement; RAS	ACUTE MYELOID-LEUKEMIA; FLT3; EXPOSURE; THERAPY; RELAPSE; PTPN11; IMPACT; CARDS; IRAQ; KIT	Background. KRAS and NRAS gene mutations are frequently observed in childhood leukemia. The objective of this study was to determine the frequency of RAS mutations and the association between RAS mutations and other genetic aberrations in Arab Asian children with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). Methods. Diagnostic samples of 485 patients (<18 years) with acute leukemia from Iraq and Jordan were obtained, using Flinders Technology Associates filter papers. Polymerase chain reaction and direct sequencing were performed in Japan. Results. RAS mutations were detected in 86/ 318 (27%) of ALL cases and 35/ 167 (21%) of AML cases. The frequency of NRAS mutation was similar to that of KRAS mutation in ALL. Two RAS mutations were detected in nine patients. Among 264 Iraqi patients with ALL, RAS mutation was significantly associated with lower initial white blood cell count. Of 57 patients with chimeric transcripts, only two patients with either TEL-AML1 or E2A-PBX1 had KRAS mutation. The frequency of NRAS mutation was four times higher than that of KRAS mutation in AML. FAB-M4 and M5 subsets were associated with RAS mutation. Among 134 Iraqi patients with AML, 18 patients had RAS mutations and other genetic aberrations. In particular, 9 of 25 (36%) with MLL-rearrangement had RAS mutations. Conclusion. The prevalence of oncogenic RAS mutations was higher among Arab Asian children than in other countries. RAS mutations in AML were found to coexist with other genetic aberrations, particularly MLL rearrangement. (C) 2015 Wiley Periodicals, Inc.	[Al-Kzayer, Lika'a Fasih Y.; Sakashita, Kazuo; Uyen, Le T. N.; Liu, Tingting; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Al-Jadiry, Mazin Faisal; Al-Hadad, Salma Abbas; Ghali, Hasanein Habeeb] Univ Baghdad, Baghdad Med City, Coll Med, Dept Pediat, Baghdad, Iraq; [Al-Jadiry, Mazin Faisal; Al-Hadad, Salma Abbas; Ghali, Hasanein Habeeb] Childrens Welf Teaching Hosp, Baghdad Med City, Dept Pediat Oncol, Baghdad, Iraq; [Matsuda, Kazuyuki] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Abdulkadhim, Jaafar M. H.; Al-Shujairi, Tariq Abadi; Matti, Zead Ismael I. K.] Cent Teaching Hosp Children, Dept Pediat Oncol, Baghdad, Iraq; [Sughayer, Maher A.] King Hussein Canc Ctr, Dept Pathol, Amman, Jordan; [Rihani, Rawad; Madanat, Faris F.] King Hussein Canc Ctr, Dept Pediat, Amman, Jordan; [Inoshita, Toshi] Japan Iraq Med Network, Tokyo, Japan; [Kamata, Minoru] Japan Chernobyl Fdn, Matsumoto, Nagano, Japan	Sakashita, K (reprint author), Shinshu Univ, Sch Med, Dept Pediat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	sakasita@shinshu-u.ac.jp			Japan Chernobyl Foundation (JCF); NGO (non-governmental organization), Matsumoto, Nagano, Japan	Grant sponsor: Japan Chernobyl Foundation (JCF); Grant sponsor: NGO (non-governmental organization), Matsumoto, Nagano, Japan	Barletta E, 2004, CARCINOGENESIS, V25, P749, DOI 10.1093/carcin/bgh057; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; NEUBAUER A, 1994, BLOOD, V83, P1603; Kuchenbauer F, 2006, BRIT J HAEMATOL, V134, P616, DOI 10.1111/j.1365-2141.2006.06229.x; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Al-Kzayer LFY, 2012, PEDIATR BLOOD CANCER, V59, P461, DOI 10.1002/pbc.24055; Rithidech KN, 1996, BLOOD CELL MOL DIS, V22, P271, DOI 10.1006/bcmd.1996.0110; Byrne JL, 1998, BRIT J HAEMATOL, V100, P256; Case M, 2008, CANCER RES, V68, P6803, DOI [10.1158/0008-5472.CAN-08-0101, 10.1158/0008-5472/CAN-08-0101]; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Perentesis JP, 2004, LEUKEMIA, V18, P685, DOI 10.1038/sj.leu.2403272; Kamada N, 1999, J RADIAT RES, V40, P155; Liang DC, 2006, CANCER, V106, P950, DOI 10.1002/cncr.21687; TAYLOR JA, 1992, J NATL CANCER I, V84, P1626, DOI 10.1093/jnci/84.21.1626; KUBO K, 1993, JPN J CANCER RES, V84, P379; Al-Kzayer LFY, 2014, ANN HEMATOL, V93, P949, DOI 10.1007/s00277-014-2007-2; Al-Kzayer LFY, 2014, PEDIATR BLOOD CANCER, V61, P1980, DOI 10.1002/pbc.25151; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Beaupre DM, 1999, J CLIN ONCOL, V17, P1071; Shu XO, 2004, CANCER EPIDEM BIOMAR, V13, P1230; Paulsson K, 2008, GENE CHROMOSOME CANC, V47, P26, DOI 10.1002/gcc.20502; Testi AM, 2006, HAEMATOL-HEMATOL J, V91, P509; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Shih LY, 2008, LEUKEMIA, V22, P303, DOI 10.1038/sj.leu.2404995; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Sano H, 2012, INT J HEMATOL, V95, P509, DOI 10.1007/s12185-012-1033-x; Wiemels JL, 2005, LEUKEMIA, V19, P415, DOI 10.1038/sj.leu.2403641; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Yamamoto T, 2006, LEUKEMIA RES, V30, P1085, DOI 10.1016/j.leukres.2006.02.004; Wiemels JL, 2010, BLOOD CELL MOL DIS, V45, P186, DOI 10.1016/j.bcmd.2010.07.007; Knight Thomas, 2014, Front Oncol, V4, P160, DOI 10.3389/fonc.2014.00160; Osaka Mitsuhiko, 1997, Leukemia (Basingstoke), V11, P393	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	DEC	2015	62	12					2157	2161		10.1002/pbc.25683		5	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CX0UN	WOS:000365412600017		
J	Nakamura, Y; Hagino, I; Nakajima, H; Aoki, M				Nakamura, Yuki; Hagino, Ikuo; Nakajima, Hiromichi; Aoki, Mitsuru			Staged Biventricular Repair-Oriented Strategy in Borderline Biventricular Repair Candidates with Ventricular Septal Defect	PEDIATRIC CARDIOLOGY			English	Article						Biventricular repair; Single-ventricle repair; Hypoplastic left ventricle; Left ventricle development; Straddling atrioventricular valve	OUTLET RIGHT VENTRICLE; SURGICAL-MANAGEMENT; PULMONARY-ATRESIA; MORTALITY; STENOSIS; HEARTS; VALVE	Although borderline biventricular repair (BVR) candidates unsuitable for primary BVR are often subjected to single-ventricle repair (SVR), some of them reach BVR by staged strategy. We evaluated our staged BVR-oriented strategy in borderline BVR candidates with ventricular septal defect (VSD) in whom a BVR/SVR decision was deferred beyond the neonatal period. Forty-two patients were treated with the approach between 1991 and 2012. They had been followed toward BVR until it was judged impossible. Outcomes, time course toward definitive repair (DR: BVR, SVR, or 1 + 1/2 ventricle repair), and hemodynamics were reviewed. A total of 57 palliative surgeries were performed before BVR or bidirectional Glenn (BDG), namely procedures to control pulmonary blood flow in 40, to improve mixing in 5, and to promote left ventricle (LV) growth in 5. LV growth was achieved in four patients. There were three cardiac deaths. Except for four awaiting patients, 19 reached BVR (50 %), 11 patients were converted to other than BVR, and 28 patients achieved DR (74 %) at the median age of 30.9 months. Cardiac cath before BVR or BDG performed at the median age of 22.5 months revealed well-preserved pulmonary vasculature with the median pulmonary artery pressure of 14 mmHg, except three patients unsuitable for SVR. In conclusion, our staged BVR-oriented strategy required longer time course and more complex palliative surgeries compared with a simple SVR strategy. Leaving open the possibility of a late crossover to an SVR pathway is mandatory when adopting staged BVR-oriented strategy in these complex patients.	[Nakamura, Yuki; Hagino, Ikuo; Aoki, Mitsuru] Chiba Children Hosp, Dept Cardiovasc Surg, Midori Ku, Chiba 2660007, Japan; [Nakajima, Hiromichi] Chiba Children Hosp, Dept Pediat Cardiol, Midori Ku, Chiba 2660007, Japan	Nakamura, Y (reprint author), Chiba Children Hosp, Dept Cardiovasc Surg, Midori Ku, 579-1 Heta, Chiba 2660007, Japan.	yukicvs@gmail.com					Matsuhisa H, 2013, ANN THORAC SURG, V96, P891, DOI 10.1016/j.athoracsur.2013.05.013; Freedom RM, 1998, ANN THORAC SURG, V66, P641, DOI 10.1016/S0003-4975(98)00620-1; Delius RE, 1996, J THORAC CARDIOV SUR, V112, P1561, DOI 10.1016/S0022-5223(96)70015-6; Anderson RH, 1998, ANN THORAC SURG, V66, P621, DOI 10.1016/S0003-4975(98)00579-7; Ashburn DA, 2004, J THORAC CARDIOV SUR, V127, P1000, DOI 10.1016/j.jtcvs.2003.11.057; Tweddell JS, 2009, ANN THORAC SURG, V88, P1291, DOI 10.1016/j.athoracsur.2009.05.076; Aeba R, 2000, ANN THORAC SURG, V69, P130, DOI 10.1016/S0003-4975(99)01315-6; Serraf A, 1996, J THORAC CARDIOV SUR, V111, P527, DOI 10.1016/S0022-5223(96)70304-5; Silverman NH, 1998, ANN THORAC SURG, V66, P634, DOI 10.1016/S0003-4975(98)00573-6; Karamlou T, 2013, J THORAC CARDIOV SUR, V145, P1018, DOI 10.1016/j.jtcvs.2012.11.092; NAKAZAWA M, 1976, CIRCULATION, V53, P884; Lunze FI, 2013, AM J CARDIOL, V112, P1207, DOI 10.1016/j.amjcard.2013.06.016; TABRY IF, 1979, J THORAC CARDIOV SUR, V77, P191; Hickey EJ, 2012, J THORAC CARDIOV SUR, V144, P409, DOI 10.1016/j.jtcvs.2011.09.076; Aotsuka H, 1995, ACTA PAEDIATR JAPON, V99, P1756; Emani Sitaram M, 2013, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V16, P37, DOI 10.1053/j.pcsu.2013.01.003; Hickey EJ, 2007, J THORAC CARDIOV SUR, V134, P1429, DOI 10.1016/j.jtcvs.2007.07.052; Ikeda H, 2004, ACTA CARDIOL PAEDIAT, V20, P423; Nakamura Y, 2015, ANN THORAC SURG, V99, P312, DOI 10.1016/j.athoracsur.2014.02.074	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	DEC	2015	36	8					1712	1721		10.1007/s00246-015-1221-6		10	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CW9HW	WOS:000365310800021		
J	Grammaticos, B; Ramani, A; Willox, R; Mase, T; Satsuma, J				Grammaticos, B.; Ramani, A.; Willox, R.; Mase, T.; Satsuma, J.			Singularity confinement and full-deautonomisation: A discrete integrability criterion	PHYSICA D-NONLINEAR PHENOMENA			English	Article						Mapping; Integrability; Deautonomisation; Singularity; Degree growth; Algebraic entropy	PAINLEVE EQUATIONS; ALGEBRAIC ENTROPY; SYSTEMS; MAPPINGS; DYNAMICS; SPACE	We present a new approach to singularity confinement which makes it an efficient and reliable discrete integrability detector. Our method is based on the full-deautonomisation procedure, which consists in analysing non-autonomous extensions of a given discrete system obtained by adding terms that are initially absent, but whose presence does not alter the singularity pattern. A justification for this approach is given through an algebro-geometric analysis. We also introduce the notions of early and late confinement. While the former is a confinement that may exist already for the autonomous system, the latter corresponds to a singularity pattern longer than that of the autonomous case. Late confinement will be shown to play an important role in the singularity analysis of systems with non-trivial gauge freedom, for which the existence of an undetected gauge in conjunction with a sketchy analysis, might lead to erroneous conclusions as to their integrability. An algebro-geometric analysis of the role of late confinement in this context is also offered. This novel type of singularity confinement analysis will be shown to allow for the exact calculation of the algebraic entropy of a given mapping. (C) 2015 Elsevier B.V. All rights reserved.	[Grammaticos, B.] Univ Paris 07, IMNC, F-91406 Orsay, France; [Grammaticos, B.] Univ Paris 11, CNRS, UMR 8165, F-91406 Orsay, France; [Ramani, A.] Ecole Polytech, Ctr Phys Theor, CNRS, F-91128 Palaiseau, France; [Willox, R.; Mase, T.] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; [Satsuma, J.] Musashino Univ, Dept Engn Math, Tokyo 1358181, Japan	Grammaticos, B (reprint author), Univ Paris 07, IMNC, Bat 440, F-91406 Orsay, France.	grammaticos@univ-paris-diderot.fr			Japan Society for the Promotion of Science (JSPS), through the JSPS grant: KAKENHI [15K04893]; JSPS [25-3088]; Graduate School of Mathematical Sciences of the University of Tokyo through its Program for Leading Graduate Schools, MEXT, Japan	RW would like to acknowledge support from the Japan Society for the Promotion of Science (JSPS), through the JSPS grant: KAKENHI Grant Number 15K04893. TM would also like to acknowledge support from JSPS through the Grant-in-Aid for Scientific Research 25-3088 and he wishes to thank the Graduate School of Mathematical Sciences of the University of Tokyo for support extended through its Program for Leading Graduate Schools, MEXT, Japan.	Ramani A, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/42/425201; Hietarinta J, 1998, PHYS REV LETT, V81, P325, DOI 10.1103/PhysRevLett.81.325; Viallet CM, 2008, INT J GEOM METHODS M, V5, P1373; Ramani A, 1996, PHYSICA A, V228, P160, DOI 10.1016/0378-4371(95)00439-4; Sakai H, 2001, COMMUN MATH PHYS, V220, P165, DOI 10.1007/s002200100446; Bellon MP, 1999, COMMUN MATH PHYS, V204, P425, DOI 10.1007/s002200050652; Hietarinta J, 2000, CHAOS SOLITON FRACT, V11, P29, DOI 10.1016/S0960-0779(98)00266-5; GRAMMATICOS B, 1991, PHYS REV LETT, V67, P1825, DOI 10.1103/PhysRevLett.67.1825; Halburd RG, 2005, J PHYS A-MATH GEN, V38, pL263, DOI 10.1088/0305-4470/38/16/L01; Hartshorne R., 1997, ALGEBRAIC GEOMETRY; Hone ANW, 2007, SYMMETRY INTEGR GEOM, V3, DOI 10.3842/SIGMA.2007.022; Kanki M., 2015, PREPRINT; Kruskal MD, 2000, REGUL CHAOTIC DYN, V5, P273, DOI 10.1070/RD2000v005n03ABEH000149; Mase T., 2014, PREPRINT; Painleve P, 1902, ACTA MATH-DJURSHOLM, V25, P1, DOI 10.1007/BF02419020; Ramani A, 2015, J PHYS A-MATH THEOR, V48, DOI 10.1088/1751-8113/48/11/11FT02; Ramani A, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/38/385201; Takenawa T, 2001, J PHYS A-MATH GEN, V34, P10533, DOI 10.1088/0305-4470/34/48/317; VESELOV AP, 1992, COMMUN MATH PHYS, V145, P181, DOI 10.1007/BF02099285	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2789	1872-8022		PHYSICA D	Physica D	DEC 1	2015	313						11	25		10.1016/j.physd.2015.09.006		15	Mathematics, Applied; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CX0HV	WOS:000365378400002		
J	Arai, K; Ohtsuki, Y				Arai, Kenta; Ohtsuki, Yukiyoshi			Reduced-dynamics approach for optimally designing unitary transformations	PHYSICAL REVIEW A			English	Article							DEUTSCH-JOZSA ALGORITHM; POLAR-MOLECULES; QUANTUM; PULSES; QUBIT	Quantum optimal control is a powerful tool for designing a pulse that executes a specified gate, i.e., a unitary transformation in quantum computation. If we consider qubits characterized by different spectroscopic properties, we may design a pulse that executes a specified gate on a specified qubit (S qubit) with the inclusion of neighboring qubits (B qubits) but does not explicitly include the other qubits. In this situation, first we introduce sets of reduced time-evolution operators associated with the S and B qubits. Then, we apply quantum optimal control to these sets to design optimal pulses that could selectively execute the specified gate on the S qubit while actively removing the effects of the pulse on the B qubits, which would lead to a scalable pulse-design procedure. The present pulse design is applied to the quantum computation proposed by DeMille with the aim of executing the Hadamard and controlled-NOT gates on the S qubits while actively suppressing the pulse-induced population transitions of the B qubit states. The numerical results illustrate high fidelity even after introducing the extra qubits that are not included in the pulse design.	[Arai, Kenta; Ohtsuki, Yukiyoshi] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	Ohtsuki, Y (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	ohtsuki@m.tohoku.ac.jp			JSPS KAKENHI Grant [15K05373]; Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy, Kyoto University [ZE27B-7]	We acknowledge stimulating discussions with Prof. H. Kono. This work was supported in part by JSPS KAKENHI Grant No. 15K05373 and also by the Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy, Kyoto University (Grant No. ZE27B-7).	Zhao MY, 2006, J CHEM PHYS, V125, DOI 10.1063/1.222039; Palao JP, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.188301; Cheng TW, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2164457; Machnes S, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022305; Troppmann U, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1881112; Jaouadi A, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812317; Ohtsuki Y, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/045002; Tsubouchi M, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052326; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; PEIRCE AP, 1988, PHYS REV A, V37, P4950, DOI 10.1103/PhysRevA.37.4950; Wei Q, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3567486; Ohtsuki Y, 2005, CHEM PHYS LETT, V404, P126, DOI 10.1016/j.cplett.2005.01.080; Tesch CM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157901; Ndong M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043424; [Anonymous], 2001, PHYS REV A; Korff BMR, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2141615; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Ohtsuki Y, 1999, J CHEM PHYS, V110, P9825, DOI 10.1063/1.478036; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Babikov D, 2004, J CHEM PHYS, V121, P7577, DOI 10.1063/1.1791635; Sugny D, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.042325; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Tesch CM, 2004, J CHEM PHYS, V121, P12158, DOI 10.1063/1.1818131; Zhu J, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4774058; KOSLOFF R, 1989, CHEM PHYS, V139, P201, DOI 10.1016/0301-0104(89)90012-8; WARREN WS, 1993, SCIENCE, V259, P1581, DOI 10.1126/science.259.5101.1581; Blum K., 1996, DENSITY MATRIX THEOR; Mermin N. D., 2007, QUANTUM COMPUTER SCI; Nielsen M A, 2000, QUANTUM COMPUTATION; Palao JP, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.062308; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Reich DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12430	33	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1050-2947	1094-1622		PHYS REV A	Phys. Rev. A	DEC 1	2015	92	6							062302	10.1103/PhysRevA.92.062302		12	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	CX5VW	WOS:000365771600003		
J	Huh, JH				Huh, Jong-Hoon			Multiplicative noise effects on electroconvection in controlling additive noise by a magnetic field	PHYSICAL REVIEW E			English	Article							NEMATIC LIQUID-CRYSTALS; ELECTROHYDRODYNAMIC CONVECTION; STOCHASTIC RESONANCE; EXTERNAL NOISE; DRIVEN; INSTABILITIES; FLUCTUATIONS; PATTERNS; ONSET	We report multiplicative noise-induced threshold shift of electroconvection (EC) in the presence of a magnetic field H. Controlling the thermal fluctuation (i.e., additive noise) of the rodlike molecules of nematic liquid crystals by H, the EC threshold is examined at various noise levels [characterized by their intensity and cutoff frequency (f(c))]. For a sufficiently strong H (i.e., ignorable additive noise), a modified noise sensitivity characterizing the shift problem is in good agreement with experimental results for colored as well as white noise (f(c) -> infinity); until now, there was a large deviation for (sufficiently) colored noises. The present study shows that H provides us with ideal conditions for studying the corresponding Carr-Helfrich theory considering pure multiplicative noise.	[Huh, Jong-Hoon] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Dept Mech Informat Sci & Technol, Fukuoka 8208502, Japan	Huh, JH (reprint author), Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Dept Mech Informat Sci & Technol, Fukuoka 8208502, Japan.				JSPS KAKENHI [15K05215]	This study was partly supported by JSPS KAKENHI Grant No. 15K05215.	GARCIAOJALVO J, 1993, PHYS REV LETT, V71, P1542, DOI 10.1103/PhysRevLett.71.1542; Jia Y, 2000, PHYS REV E, V62, P1869, DOI 10.1103/PhysRevE.62.1869; KAI S, 1979, J PHYS SOC JPN, V47, P1379, DOI 10.1143/JPSJ.47.1379; REHBERG I, 1991, PHYS REV LETT, V67, P596, DOI 10.1103/PhysRevLett.67.596; Buka A, 2007, PHYS REP, V448, P115, DOI 10.1016/j.physrep.2007.02.013; Behn U, 1998, PHYS REV E, V58, P2047, DOI 10.1103/PhysRevE.58.2047; KAI S, 1989, J STAT PHYS, V54, P1133, DOI 10.1007/BF01044707; John T, 1999, PHYS REV LETT, V83, P749, DOI 10.1103/PhysRevLett.83.749; HORSTHEMKE W, 1985, PHYS REV A, V31, P1123, DOI 10.1103/PhysRevA.31.1123; Zaikin AA, 1998, PHYS REV E, V58, P4355, DOI 10.1103/PhysRevE.58.4355; Ning LJ, 2007, PHYSICA A, V382, P415, DOI 10.1016/j.physa.2007.04.027; KAWAKUBO T, 1981, J PHYS SOC JPN, V50, P1451, DOI 10.1143/JPSJ.50.1451; Huh JH, 1999, J PHYS SOC JPN, V68, P1567, DOI 10.1143/JPSJ.68.1567; Blinov L. M., 1983, ELECTROOPTICAL MAGNE; Brand H., 1980, J PHYS SOC JPN, V48, P1382; DUBOISVI.E, 1971, J PHYS-PARIS, V32, P305, DOI 10.1051/jphys:01971003204030500; Huh JH, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.083601; Huh JH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.025302; Huh JH, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.083601; Huh JH, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066304; Huh JH, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.063601; Huh JH, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.033001; Huh JH, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.104602; John T, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046229; John T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056307; Ridolfi L., 2011, NOISE INDUCED PHENOM; Smith I. W., 1975, J PHYS-PARIS, V36, pC1	27	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1539-3755	1550-2376		PHYS REV E	Phys. Rev. E	DEC 1	2015	92	6							062504	10.1103/PhysRevE.92.062504		4	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	CX7HF	WOS:000365872100008		
J	Fukuda, K; Kawaguchi, D; Aihara, T; Ogasa, MY; Miki, NH; Haishi, T; Umebayashi, T				Fukuda, Kenji; Kawaguchi, Daichi; Aihara, Tomo; Ogasa, Mayumi Y.; Miki, Naoko H.; Haishi, Tomoyuki; Umebayashi, Toshihiro			Vulnerability to cavitation differs between current-year and older xylem: non-destructive observation with a compact magnetic resonance imaging system of two deciduous diffuse-porous species	PLANT CELL AND ENVIRONMENT			English	Article						annual ring; drought; embolism; MRI; water relations; xylem transport	STRESS-INDUCED CAVITATION; CRYOSCANNING ELECTRON-MICROSCOPY; RESOLUTION COMPUTED-TOMOGRAPHY; MANDSHURICA VAR JAPONICA; OPEN VESSEL ARTIFACT; PINE WILT DISEASE; WATER-STRESS; HYDRAULIC CONDUCTIVITY; WOODY-PLANTS; EMBOLISM REPAIR	Development of xylem embolism during water stress in two diffuse-porous hardwoods, Katsura (Cercidiphyllum japonicum) and Japanese white birch (Betula platyphylla var. japonica), was observed non-destructively under a compact magnetic resonance imaging (MRI) system in addition to conventional quantitation of hydraulic vulnerability to cavitation from excised stem segments. Distribution of white and dark areas in MR images corresponded well to the distribution of water-filled/embolized vessels observed by cryo-scanning electron microscopy in both species. Water-filled vessels were observed in MR images as white areas in Katsura and as white dots in Japanese white birch, respectively, and embolisms could be detected as a change to dark areas. The increase in the relative embolized area (REA: %) in the cross-sectional area of total xylem during water stress, which was estimated from the binarized MR images, was consistent with the hydraulic vulnerability curves of these species. From the non-destructive MRI observations, cavitation induced by water stress was shown to develop earlier in 1- or 2-year-old xylem than in the current-year xylem in both species; that is, the vulnerability to cavitation differs between vessels in the current-year xylem and those in older annual rings. Development of xylem embolism during water stress in two diffuse-porous hardwoods, Katsura (Cercidiphyllum japonicum) and Japanese white birch (Betula platyphylla var. japonica), was observed nondestructively under a compact magnetic resonance imaging (MRI) system in addition to conventional quantitation of hydraulic vulnerability to cavitation from excised stem segments. The increase in the relative embolized area estimated from the binarized MR images was consistent with the hydraulic vulnerability curves of these species. From the MRI observations, cavitation induced by water stress was shown to develop earlier in 1- or 2-year-old xylem than in the current-year xylem in the both species; i.e., the vulnerability to cavitation differs between vessels in the current-year xylem and those in older annual rings.	[Fukuda, Kenji; Kawaguchi, Daichi; Ogasa, Mayumi Y.; Umebayashi, Toshihiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwa, Chiba 2778563, Japan; [Aihara, Tomo; Miki, Naoko H.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Haishi, Tomoyuki] MR Technol Inc, Tsukuba, Ibaraki 3058573, Japan	Fukuda, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwa, Chiba 2778563, Japan.	fukuda@k.u-tokyo.ac.jp			KAKEN [23248022]	We thank Dr. Natsumaro Kutsuna, Laboratory of Plant Cell Biology and Totipotency, Department of Frontier Biology, Graduate School of Frontier Sciences, the University of Tokyo, for his helpful comments on the image analysis. We thank Dr. Tamio Akema, Forest and Forest Products Research Institute, for providing the pressure chamber for xylem pressure measurements. We also thank for Mr. Kazuma Togashi, MR Technology Inc., for providing technical support during the MRI experiments. We also thank to Dr. Michelle Holbrook and the anonymous reviewers for their helpful comments. This study was supported by KAKEN (No. 23248022).	Alder NN, 1997, J EXP BOT, V48, P665, DOI 10.1093/jxb/48.3.665; Hacke UG, 2003, PLANT CELL ENVIRON, V26, P303, DOI 10.1046/j.1365-3040.2003.00962.x; Clearwater MJ, 2003, PLANT CELL ENVIRON, V26, P1205, DOI 10.1046/j.1365-3040.2003.01042.x; Choat B, 2005, PLANT CELL ENVIRON, V28, P1082, DOI 10.1111/j.1365-3040.2005.01336.x; Hacke UG, 2006, TREE PHYSIOL, V26, P689; Cochard H, 2013, J EXP BOT, V64, P4779, DOI 10.1093/jxb/ert193; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; COCHARD H, 1992, PLANT PHYSIOL, V100, P205, DOI 10.1104/pp.100.1.205; Melcher PJ, 2001, OECOLOGIA, V126, P182, DOI 10.1007/s004420000519; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Zwieniecki MA, 2003, J EXP BOT, V54, P1399, DOI 10.1093/jxb/erg144; TYREE MT, 1988, PLANT PHYSIOL, V88, P574, DOI 10.1104/pp.88.3.574; Choat B, 2003, PLANT PHYSIOL, V131, P41, DOI 10.1104/pp.014100; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Utsumi Y, 1998, PLANT PHYSIOL, V117, P1463, DOI 10.1104/pp.117.4.1463; Ogasa M, 2010, TREE PHYSIOL, V30, P608, DOI 10.1093/treephys/tpq011; Cochard H, 2005, PHYSIOL PLANTARUM, V124, P410, DOI 10.1111/j.1399-3054.2005.00526.x; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; Tobin MF, 2013, PLANT BIOLOGY, V15, P496, DOI 10.1111/j.1438-8677.2012.00678.x; TYREE MT, 1986, PHYSIOL PLANTARUM, V66, P397, DOI 10.1111/j.1399-3054.1986.tb05941.x; Umebayashi T, 2011, PLANT PHYSIOL, V156, P943, DOI 10.1104/pp.110.170282; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; Utsumi Y, 1999, PLANT PHYSIOL, V121, P897, DOI 10.1104/pp.121.3.897; Bush SE, 2008, OECOLOGIA, V156, P13, DOI 10.1007/s00442-008-0966-5; Kaufmann I, 2009, NEW PHYTOL, V184, P245, DOI 10.1111/j.1469-8137.2009.02919.x; Bush SE, 2010, TREE PHYSIOL, V30, P1545, DOI 10.1093/treephys/tpq096; Salleo S, 1996, NEW PHYTOL, V132, P47, DOI 10.1111/j.1469-8137.1996.tb04507.x; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; SALLEO S, 1992, PLANT CELL ENVIRON, V15, P491, DOI 10.1111/j.1365-3040.1992.tb01001.x; Ogasa M, 2014, TREES-STRUCT FUNCT, V28, P461, DOI 10.1007/s00468-013-0963-0; Utsumi Y, 1996, IAWA J, V17, P113; CROMBIE DS, 1985, AUST J PLANT PHYSIOL, V12, P445; Sperry JS, 2012, PLANT CELL ENVIRON, V35, P601, DOI 10.1111/j.1365-3040.2011.02439.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Jacobsen AL, 2007, J ECOL, V95, P171, DOI 10.1111/j.1365-2745.2006.01186.x; Cochard H, 2010, PLANT CELL ENVIRON, V33, P1543, DOI 10.1111/j.1365-3040.2010.02163.x; SPERRY JS, 1990, PLANT CELL ENVIRON, V13, P427, DOI 10.1111/j.1365-3040.1990.tb01319.x; Utsuzawa S, 2005, PHYTOPATHOLOGY, V95, P737, DOI 10.1094/PHYTO-95-0737; Zwieniecki MA, 2001, SCIENCE, V291, P1059, DOI 10.1126/science.1057175; ZIMMERMANN MH, 1981, CAN J BOT, V59, P1882; Melcher PJ, 2003, PLANT PHYSIOL, V131, P1775, DOI 10.1104/pp.102.012856; Martin-StPaul NK, 2014, TREE PHYSIOL, V34, P894, DOI 10.1093/treephys/tpu059; Hacke UG, 2001, PLANT PHYSIOL, V125, P779, DOI 10.1104/pp.125.2.779; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Sperry J, 2013, PLANT CELL ENVIRON, V36, P1916, DOI 10.1111/pce.12148; Holbrook NM, 2001, PLANT PHYSIOL, V126, P27, DOI 10.1104/pp.126.1.27; McElrone AJ, 2012, NEW PHYTOL, V196, P661, DOI 10.1111/j.1469-8137.2012.04244.x; Loepfe L, 2007, J THEOR BIOL, V247, P788, DOI 10.1016/j.jtbi.2007.03.036; Sano Y, 2011, ANN BOT-LONDON, V107, P953, DOI 10.1093/aob/mcr042; Utsumi Y, 2003, PLANT PHYSIOL, V131, P1826, DOI 10.1104/pp.102.014795; Lu YY, 2010, PHYSIOL PLANTARUM, V140, P246, DOI 10.1111/j.1399-3054.2010.01397.x; Melcher PJ, 2012, METHODS ECOL EVOL, V3, P685, DOI 10.1111/j.2041-210X.2012.00204.x; Ogasa M, 2013, TREE PHYSIOL, V33, P335, DOI 10.1093/treephys/tpt010; Jacobsen AL, 2012, NEW PHYTOL, V194, P982, DOI 10.1111/j.1469-8137.2012.04118.x; Dang HZ, 2014, J ARID LAND, V6, P612, DOI 10.1007/s40333-014-0007-7; Lee SJ, 2008, ANN BOT-LONDON, V101, P595, DOI 10.1093/aob/mcm312; Umebayashi T, 2008, IAWA J, V29, P247; Urli M, 2013, TREE PHYSIOL, V33, P672, DOI 10.1093/treephys/tpt030; Torres-Ruiz JM, 2012, PHYSIOL PLANTARUM, V146, P129, DOI 10.1111/j.1399-3054.2012.01619.x; Salleo S, 2004, PLANT CELL ENVIRON, V27, P1065, DOI 10.1111/j.1365-3040.2004.01211.x; Phillips N, 1996, PLANT CELL ENVIRON, V19, P983, DOI 10.1111/j.1365-3040.1996.tb00463.x; Cochard H, 2015, PLANT CELL ENVIRON, V38, P201, DOI 10.1111/pce.12391; Dixon H. H., 1894, ANN BOT, V8, P468; CERMAK J, 1992, TREE PHYSIOL, V10, P367; Fukuda K., 2007, TREE PHYSIOL, V26, P969; Itoh T., 1996, WOOD RES TECH NOTES, V32, P66; Itoh T, 1995, WOOD RES TECH NOTES, V31, P81; KOZLOWSKI THEODORE T., 1961, FOREST SCI, V7, P177; Melcher PJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00368; SPERRY JS, 1991, J EXP BOT, V42, P1399, DOI 10.1093/jxb/42.11.1399; SPERRY JS, 1988, PLANT PHYSIOL, V88, P581, DOI 10.1104/pp.88.3.581; Suuronen J. -P., 2013, PLANT METHODS, V9, P1; Torres-Ruiz JM, 2014, PHYSIOL PLANTARUM, V152, P465, DOI 10.1111/ppl.12185; Trifilo P, 2014, TREE PHYSIOL, V34, P109, DOI 10.1093/treephys/tpt119; Tyree MT, 2002, XYLEM STRUCTURE ASCE; Umebayashi T., 2010, TREES-STRUCT FUNCT, V3, P571; Wheeler J. K., 2013, PLANT CELL ENVIRON, V36, P1916; Zwieniecki M. A., 2013, FRONT PLANT SCI, V4, P1	80	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	DEC	2015	38	12					2508	2518		10.1111/pce.12510		11	Plant Sciences	Plant Sciences	CX6EV	WOS:000365794900003		
J	Sugiura, D; Betsuyaku, E; Terashima, I				Sugiura, Daisuke; Betsuyaku, Eriko; Terashima, Ichiro			Manipulation of the hypocotyl sink activity by reciprocal grafting of two Raphanus sativus varieties: its effects on morphological and physiological traits of source leaves and whole-plant growth	PLANT CELL AND ENVIRONMENT			English	Article						biomass allocation; leaf mass per area; non-structural carbohydrates; photosynthetic rate; relative growth rate; sink activity	NET ASSIMILATION RATE; PHOTOSYNTHETIC CAPACITY; STORAGE ROOT; BIOMASS ALLOCATION; ELEVATED CO2; LEAF MASS; N CONTENT; AREA; RADISH; SHOOT	To reveal whether hypocotyl sink activities are regulated by the aboveground parts, and whether physiology and morphology of source leaves are affected by the hypocotyl sink activities, we conducted grafting experiments using two Raphanus sativus varieties with different hypocotyl sink activities. Comet (C) and Leafy (L) varieties with high and low hypocotyl sink activities were reciprocally grafted and resultant plants were called by their scion and stock such as CC, LC, CL and LL. Growth, leaf mass per area (LMA), total non-structural carbohydrates (TNCs) and photosynthetic characteristics were compared among them. Comet hypocotyls in CC and LC grew well regardless of the scions, whereas Leafy hypocotyls in CL and LL did not. Relative growth rate was highest in LL and lowest in CC. Photosynthetic capacity was correlated with Rubisco (ribulose 15-bisphosphate carboxylase/oxygenase) content but unaffected by TNC. High C/N ratio and accumulation of TNC led to high LMA and structural LMA. These results showed that the hypocotyl sink activity was autonomously regulated by hypocotyl and that the down-regulation of photosynthesis was not induced by TNC. We conclude that the change in the sink activity alters whole-plant growth through the changes in both biomass allocation and leaf morphological characteristics in R. sativus.	[Sugiura, Daisuke; Betsuyaku, Eriko; Terashima, Ichiro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Betsuyaku, Eriko; Terashima, Ichiro] CREST, Kawaguchi, Saitama 3320012, Japan	Sugiura, D (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	daisuke.sugiura@gmail.com			CREST (Creation of essential technologies to utilize carbon dioxide as a resource through the enhancement of plant productivity and the exploitation of plant products);  [21114007]	We greatly thank the members of Laboratory of Plant Ecology in The University of Tokyo for their valuable comments on the early draft and for technical assistance. This study was supported by a Grant-in Aid for Scientific Research on Innovative Areas (21114007) and CREST (Creation of essential technologies to utilize carbon dioxide as a resource through the enhancement of plant productivity and the exploitation of plant products).	Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tateno M, 1988, FUNCT ECOL, V2, P89, DOI 10.2307/2389465; Bernacchi CJ, 2001, PLANT CELL ENVIRON, V24, P253, DOI 10.1046/j.1365-3040.2001.00668.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Araya T, 2008, PLANT CELL ENVIRON, V31, P50, DOI 10.1111/j.1365-3040.2007.01736.x; Kasai M, 2008, PHYSIOL PLANTARUM, V134, P216, DOI 10.1111/j.1399-3054.2008.01105.x; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Bertin N, 1999, NEW PHYTOL, V143, P53, DOI 10.1046/j.1469-8137.1999.00436.x; Araya T, 2006, PLANT CELL PHYSIOL, V47, P644, DOI 10.1093/pep/pcj033; Theobald JC, 1998, PLANT PHYSIOL, V118, P945, DOI 10.1104/pp.118.3.945; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; SAGE RF, 1989, PLANT PHYSIOL, V89, P590, DOI 10.1104/pp.89.2.590; Takahashi I, 2012, PLANT BIOTECHNOL-NAR, V29, P447, DOI 10.5511/plantbiotechnology.12.1002a; Usuda H, 1998, PLANT CELL PHYSIOL, V39, P1; Miyazawa SI, 2011, J EXP BOT, V62, P2787, DOI 10.1093/jxb/erq454; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Usuda H, 1999, PLANT CELL PHYSIOL, V40, P1210; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; Usuda H, 1999, PLANT CELL PHYSIOL, V40, P369; Nakano H, 1997, PLANT PHYSIOL, V115, P191; Osone Y, 2005, FUNCT ECOL, V19, P460, DOI 10.1111/j.1365-2435.2005.00970.x; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Hara M, 2009, PLANT FOOD HUM NUTR, V64, P188, DOI 10.1007/s11130-009-0129-9; Miyashita A, 2014, FUNCT ECOL, V28, P1321, DOI 10.1111/1365-2435.12290; Takagi D, 2014, PLANT CELL PHYSIOL, V55, P333, DOI 10.1093/pcp/pcu007; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; GOLDSCHMIDT EE, 1992, PLANT PHYSIOL, V99, P1443, DOI 10.1104/pp.99.4.1443; Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x; RAPOPORT HF, 1985, CROP SCI, V25, P1079; Li B, 1999, ECOL RES, V14, P255, DOI 10.1046/j.1440-1703.1999.143298.x; MAKINO A, 1986, AGR BIOL CHEM TOKYO, V50, P1911; Jung B, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2014.1; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; KRAPP A, 1995, PLANTA, V195, P313; SAWADA S, 1990, PLANT CELL PHYSIOL, V31, P697; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; THORNE GN, 1964, ANN BOT-LONDON, V28, P499; Adams WW, 2013, PHOTOSYNTH RES, V117, P31, DOI 10.1007/s11120-013-9849-7; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Chapin I. I. I. F. S., 1990, ANNU REV ECOL SYST, V21, P423; Mizokami Y., 2014, PLANT CELL ENVIRON, V38, P388; SHEEN J, 1994, PHOTOSYNTH RES, V39, P427, DOI 10.1007/BF00014596; Shimakawa G, 2013, BIOSCI BIOTECH BIOCH, V77, P1655, DOI 10.1271/bbb.130186; YOKOI Y, 1976, BOT MAG TOKYO, V89, P1, DOI 10.1007/BF02489530	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	DEC	2015	38	12					2629	2640		10.1111/pce.12573		12	Plant Sciences	Plant Sciences	CX6EV	WOS:000365794900013		
J	Miyajima, T; Nishiyama, K; Satake, M; Tsuji, T				Miyajima, Toru; Nishiyama, Kenji; Satake, Munekazu; Tsuji, Takayuki			Synthesis and process development of polyether polyol with high primary hydroxyl content using a new propoxylation catalyst	POLYMER JOURNAL			English	Review								We have developed a novel class of propylene oxide-based polyether polyol (PPG) with up to 70% higher primary hydroxyl content, which is produced through a Lewis acid-mediated propoxylation reaction using a specific borane catalyst. Conventional PPGs produced via anionic ring-opening polymerization have secondary hydroxyls, resulting in poor reactivity in urethane formation. To overcome the poor reactivity, ethylene oxide (EO) is often added to the terminal hydroxyls of conventional PPGs. However, this modification decreases the humidity resistance of the resulting polymer. In contrast, our new PPG has enhanced primary hydroxyl content with little or no added EO, thereby achieving a good balance between reactivity and hydrophobicity. As a result, the new polyol has important advantages, such as enhanced durability, energy and resource conservation, and environmental load reduction for a broad area of polyurethane applications. In addition, we developed an innovative continuous process that uses tube reactors in combination with film evaporators for by-product removal. This review focuses on key technological innovations in process development and examples of the practical applications of the new PPG.	[Miyajima, Toru] SDP Global Co Ltd, Div Res, Kyoto 6050995, Japan; [Nishiyama, Kenji; Tsuji, Takayuki] Sanyo Chem Ind Ltd, Urethane Raw Mat Res Dept, Kyoto, Japan; [Satake, Munekazu] Sanyo Chem Ind Ltd, Intellectual Properties Dept, Kyoto, Japan	Miyajima, T (reprint author), SDP Global Co Ltd, Div Res, Higashiyama Ku, 11-1 Ikkyo Nomoto Cho, Kyoto 6050995, Japan.	t.miyajima@sdp-g.com					Penczek S, 2007, PROG POLYM SCI, V32, P247, DOI 10.1016/j.progpolymsci.2007.01.002; Erker G, 2005, DALTON T, P1883, DOI 10.1039/b503688g; Herold R.J., 1973, ADV CHEM SER, V128, P208; Miyajima T., 2012, P C 2012 POL TECHN C; Nishiyama K., 2002, P 4 JOINT RES M JAP, P89; Nishiyama K., 2013, P C 2013 POL TECHN C; PARKER RE, 1959, CHEM REV, V59, P737, DOI 10.1021/cr50028a006; Sanders J.H., 1962, POLYURETHANES CHEM T; SMITH JG, 1984, SYNTHESIS-STUTTGART, P629	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2015	47	12					771	778		10.1038/pj.2015.64		8	Polymer Science	Polymer Science	CX9TG	WOS:000366047900001		
J	Ichikawa, I; Sugizaki, T; Akasaka, S; Asai, S				Ichikawa, Isao; Sugizaki, Toshio; Akasaka, Shuichi; Asai, Shigeo			Quantitative analysis of the phase-separated structure and mechanical properties of acrylic copolymer/epoxy thermosetting resin composites	POLYMER JOURNAL			English	Article							SPINODAL DECOMPOSITION; SILICA PARTICLES; PULSED NMR; CRYSTALLIZATION; POLYMER	The effects of thermal curing reactivity on the phase-separated structures of acrylic copolymer/epoxy thermosetting resin composites containing various accelerator amounts were investigated to elucidate their phase separation behavior. These composites exhibited a sea-island structure, in which the island size decreased as the amount of accelerator increased. The island diameter distribution was represented as a lognormal plot. Island formation is explained by the law of proportionate effect. As observed during the last stage of phase separation via spinodal decomposition, small domains formed prior to coalescing. The effects of material composition on the phase structures and mechanical properties of acrylic copolymer/epoxy thermosetting resin composites were also examined. The morphologies varied depending on the components, and in particular, the total island area fractions and fracture surface shapes after the tensile tests differed. A small fraction of island area resulted in a lower fracture surface roughness and higher mechanical strength, indicating that in stronger composites, many epoxy components remained in the acrylic copolymer-rich sea phases. In addition, the destruction of resin composites was propagated through phase boundaries because the network formation states of the sea and island phases do not significantly differ.	[Ichikawa, Isao; Sugizaki, Toshio] LINTEC Corp, Struct Anal Lab, Saitama, Japan; [Ichikawa, Isao; Akasaka, Shuichi; Asai, Shigeo] Tokyo Inst Technol, Dept Chem & Mat Sci, Tokyo 1528550, Japan	Asai, S (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, 2-12-1-S8-43 Ookayama, Tokyo 1528550, Japan.	asai.s.aa@m.titech.ac.jp					TANAKA H, 1985, J CHEM PHYS, V82, P4326, DOI 10.1063/1.448824; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Nunes SP, 1996, J MEMBRANE SCI, V111, P93, DOI 10.1016/0376-7388(95)00281-2; NAKAMURA Y, 1993, POLYMER, V34, P3220, DOI 10.1016/0032-3861(93)90394-P; [Anonymous], 22 JEDEC; OHNAGA T, 1994, POLYMER, V35, P3774, DOI 10.1016/0032-3861(94)90561-4; Kishi H, 2011, POLYMER, V52, P760, DOI 10.1016/j.polymer.2010.12.025; COLBECK SC, 1987, ACTA METALL MATER, V35, P1583, DOI 10.1016/0001-6160(87)90105-2; Nakamura Y, 2011, J ADHES SCI TECHNOL, V25, P2703, DOI 10.1163/016942411X556079; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; TANAKA H, 1986, J CHEM PHYS, V85, P6197, DOI 10.1063/1.451850; YAMANAKA K, 1989, POLYMER, V30, P1839, DOI 10.1016/0032-3861(89)90355-8; Shimizu K, 2007, POLYMER, V48, P4226, DOI 10.1016/j.polymer.2007.05.005; SHIRAISHI T, 1992, POLYMER, V33, P2975, DOI 10.1016/0032-3861(92)90084-A; Nagai S, 2008, NIHON REOROJI GAKK, V36, P99, DOI 10.1678/rheology.36.99; LEE WI, 1982, J COMPOS MATER, V16, P510; Iwakura T., 2006, E J SOFT MAT, V2, P13, DOI 10.2324/ejsm.2.13; Landau L. D., 1970, THEORY ELASTICITY CO, V7; POWLES JG, 1963, P PHYS SOC LOND, V82, P6, DOI 10.1088/0370-1328/82/1/303; Rasband W.S., 1997, IMAGEJ; YAMANAKA K, 1989, POLYMER, V30, P662, DOI 10.1016/0032-3861(89)90151-1	21	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2015	47	12					779	788		10.1038/pj.2015.68		10	Polymer Science	Polymer Science	CX9TG	WOS:000366047900002		
J	Higaki, Y; Nishida, J; Takenaka, A; Yoshimatsu, R; Kobayashi, M; Takahara, A				Higaki, Yuji; Nishida, Jin; Takenaka, Ai; Yoshimatsu, Rika; Kobayashi, Motoyasu; Takahara, Atsushi			Versatile inhibition of marine organism settlement by zwitterionic polymer brushes	POLYMER JOURNAL			English	Article							SELF-ASSEMBLED MONOLAYERS; TRANSFER RADICAL POLYMERIZATION; POLYELECTROLYTE BRUSH; ANTIFOULING COATINGS; POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); PROTEIN ADSORPTION; FOULING RELEASE; BARNACLE CEMENT; CROSS-LINKING; SURFACE	The anti-fouling character of polymer brushes against marine organisms was investigated by performing settlement tests with barnacle cypris larvae and mussel larvae in their adhesion period, as well as a marine bacteria colonization test. The settlement behavior of the marine organisms was carefully observed during the assays to obtain insight into the anti-fouling character. Zwitterionic poly(phosphobetaine) brushes and poly(sulfobetaine) brushes exhibited excellent anti-fouling characteristics for both macro-and micro-organisms, whereas poly(quaternary ammonium cation) brushes allowed mussel larvae settlement and bacteria adhesion. Regardless of the surface free energy and chain mobility, all of the hydrophobic polymer brushes showed poor anti-fouling character for the marine organisms tested. The surface charge and hydration state in saline seawater appear to be important factors in the versatile anti-fouling performance of zwitterionic polyelectrolyte brushes.	[Higaki, Yuji; Nishida, Jin; Takenaka, Ai; Yoshimatsu, Rika; Kobayashi, Motoyasu; Takahara, Atsushi] Japan Sci & Technol Agcy JST, ERATO Takahara Soft Interfaces Project, Fukuoka, Japan; [Higaki, Yuji; Takahara, Atsushi] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8190395, Japan; [Higaki, Yuji; Takahara, Atsushi] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Higaki, Y (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	y-higaki@cstf.kyushu-u.ac; takahara@cstf.kyushu-u.ac.jp			Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency, JST [AS2511206M]	We are grateful to Dr Kamiya (Sessile Research Corp.) for assistance with the marine organism settlement tests and helpful discussions. We appreciate Dr Kevin L. White's assistance with English editing. This research was partially supported by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (No. AS2511206M), Japan Science and Technology Agency, JST.	Aldred N, 2009, FUNCTIONAL SURFACES IN BIOLOGY: ADHESION RELATED PHENOMENA, VOL 2, P43, DOI 10.1007/978-1-4020-6695-5_3; Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v; Kamino K, 2010, J ADHESION, V86, P96, DOI 10.1080/00218460903418139; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Murakami D, 2013, LANGMUIR, V29, P16093, DOI 10.1021/la404133e; Kikuchi M, 2012, POLYM J, V44, P121, DOI 10.1038/pj.2011.116; Morisaki H, 1999, MICROBIOL-SGM, V145, P2797; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5; Yang WJ, 2014, PROG POLYM SCI, V39, P1017, DOI 10.1016/j.progpolymsci.2014.02.002; Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i; Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957; Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020; Kobayashi M, 2013, SOFT MATTER, V9, P5138, DOI 10.1039/c3sm27700c; Liu XL, 2012, ADV MATER, V24, P3401, DOI 10.1002/adma.201200797; MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337; Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Schilp S, 2009, LANGMUIR, V25, P10077, DOI 10.1021/la901038g; Zhulina EB, 2012, SOFT MATTER, V8, P9376, DOI 10.1039/c2sm25863c; Adamczyk Z, 1999, ADV COLLOID INTERFAC, V83, P137, DOI 10.1016/S0001-8686(99)00009-3; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959; Dunlop IE, 2012, LANGMUIR, V28, P3187, DOI 10.1021/la204655h; Kitano H, 2011, COLLOID SURFACE B, V88, P455, DOI 10.1016/j.colsurfb.2011.07.029; Lu QY, 2012, BIOMATERIALS, V33, P1903, DOI 10.1016/j.biomaterials.2011.11.021; Xu H, 2013, SOFT MATTER, V9, P1967, DOI 10.1039/c2sm26994e; Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u; Zhang Z, 2009, LANGMUIR, V25, P13516, DOI 10.1021/la901957k; Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i; Hester JF, 1999, MACROMOLECULES, V32, P1643, DOI 10.1021/ma980707u; Xie LY, 2011, POLYMER, V52, P3738, DOI 10.1016/j.polymer.2011.06.033; Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k; Kamino K, 2010, BIOFOULING, V26, P755, DOI 10.1080/08927014.2010.514335; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Aldred N, 2010, BIOFOULING, V26, P673, DOI 10.1080/08927014.2010.506677; Brady RF, 2001, PROG ORG COAT, V43, P188, DOI 10.1016/S0300-9440(01)00180-1; Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a; Bhushan B, 2012, LANGMUIR, V28, P1698, DOI 10.1021/la2043729; Kobayashi M, 2014, ACS APPL MATER INTER, V6, P20365, DOI 10.1021/am505906h; Ohshima H, 1995, ADV COLLOID INTERFAC, V62, P189, DOI 10.1016/0001-8686(95)00279-Y; Kobayashi M, 2012, LANGMUIR, V28, P7212, DOI 10.1021/la301033h; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Nishida J, 2013, ACS MACRO LETT, V2, P112, DOI 10.1021/mz300524q; Terayama Y, 2011, MACROMOLECULES, V44, P104, DOI 10.1021/ma102223y; Guo SF, 2014, ACS APPL MATER INTER, V6, P13667, DOI 10.1021/am503147m; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Kobayashi M, 2014, J BIOMAT SCI-POLYM E, V25, P1673, DOI 10.1080/09205063.2014.952992; Ohkubo Y., 2012, SESSILE ORGANISM, V29, P41; Quintana R, 2014, COLLOID SURFACE B, V120, P118, DOI 10.1016/j.colsurfb.2014.04.012; Tsujii Y., 2006, ADV POLYM SCI, V63, P1	53	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2015	47	12					811	818		10.1038/pj.2015.77		8	Polymer Science	Polymer Science	CX9TG	WOS:000366047900006		
J	Murakami, T				Murakami, Teruo			Hydrogels in Biomedical Use	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Editorial Material									[Murakami, Teruo] Kyushu Univ, Res Ctr Adv Biomech, Fukuoka 812, Japan	Murakami, T (reprint author), Kyushu Univ, Res Ctr Adv Biomech, Fukuoka 812, Japan.							0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	DEC	2015	229	12			SI		825	827		10.1177/0954411915616528		3	Engineering, Biomedical	Engineering	CX4MM	WOS:000365675000001		
J	Suzuki, A; Sasaki, S				Suzuki, Atsushi; Sasaki, Saori			Swelling and mechanical properties of physically crosslinked poly(vinyl alcohol) hydrogels	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Poly(vinyl alcohol); physically crosslinked gel; microcrystallites; swelling ratio; mechanical strength; elution behavior; biomedical use	VOLUME PHASE-TRANSITION; MOLECULAR-WEIGHT DISTRIBUTION; NATURAL SYNOVIAL JOINTS; PVA CAST GELS; POLYMER GELS; POLYVINYL-ALCOHOL; CARTILAGE REPLACEMENT; DIMETHYL-SULFOXIDE; MIXED-SOLVENTS; ATR-FTIR	Physically crosslinked poly(vinyl alcohol) gels are versatile biomaterials due to their excellent biocompatibility. In the past decades, physically crosslinked poly(vinyl alcohol) and poly(vinyl alcohol)-based hydrogels have been extensively studied for biomedical applications. However, these materials have not yet been implemented due to their mechanical strength. Physically crosslinked poly(vinyl alcohol) gels consist of a swollen amorphous network of poly(vinyl alcohol) physically crosslinked by microcrystallites. Although the mechanical properties can be improved to some extent by controlling the distribution of microcrystallites on the nano- and micro-scales, enhancing the mechanical properties while maintaining high water content remains very difficult. It may be technologically impossible to significantly improve the mechanical properties while keeping the gel's high water absorbance ability using conventional fabrication methods. Physical and chemical understandings of the swelling and mechanical properties of physically crosslinked poly(vinyl alcohol) gels are considered here; some promising strategies for their practical applications are presented. This review focuses more on the recent studies on swelling and mechanical properties of poly(vinyl alcohol) hydrogels, prepared using only poly(vinyl alcohol) and pure water with no other chemicals, as potential biomedical materials.	[Suzuki, Atsushi; Sasaki, Saori] Yokohama Natl Univ, Res Inst Environm & Informat Sci, Dept Mat Sci, Yokohama, Kanagawa 2408501, Japan	Suzuki, A (reprint author), Yokohama Natl Univ, Res Inst Environm & Informat Sci, Dept Mat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	asuzuki@ynu.ac.jp			Japan Society for the Promotion of Science [Kaken: 23000011]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Grant-in-Aid for Specially Promoted Research of Japan Society for the Promotion of Science (Kaken: 23000011).	Praptowidodo VS, 2005, J MOL STRUCT, V739, P207, DOI 10.1016/j.molstruc.2004.04.035; Valentin JL, 2009, MACROMOLECULES, V42, P263, DOI 10.1021/ma802172g; Otsuka E, 2009, J APPL POLYM SCI, V114, P10, DOI 10.1002/app.30546; Otsuka E, 2011, J POLYM SCI POL PHYS, V49, P96, DOI 10.1002/polb.22161; Lee J, 2008, POLYM TEST, V27, P360, DOI 10.1016/j.polymertesting.2007.12.005; Takahashi N, 2003, POLYMER, V44, P4075, DOI 10.1016/S0032-3861(03)00390-2; Thomas BH, 2009, J MECH BEHAV BIOMED, V2, P588, DOI 10.1016/j.jmbbm.2008.08.001; Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q; Doi M, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.052001; Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010; Hirashima Y, 2005, MACROMOLECULES, V38, P9280, DOI 10.1021/ma051081s; Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036; Young TH, 2002, J MEMBRANE SCI, V210, P349, DOI 10.1016/S0376-7388(02)00413-1; HIROTSU S, 1987, J CHEM PHYS, V87, P1392, DOI 10.1063/1.453267; SUZUKI Y, 1992, J CHEM PHYS, V97, P3808, DOI 10.1063/1.462962; Ikeuchi K, 2007, P I MECH ENG J-J ENG, V221, P301, DOI 10.1243/13506501JET214; PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704; Otsuka E, 2009, PROG COLL POL SCI S, V136, P121, DOI 10.1007/2882_2009_17; MAMADA A, 1990, MACROMOLECULES, V23, P1517, DOI 10.1021/ma00207a046; TANAKA T, 1981, SCI AM, V244, P124; Suzuki A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364893; Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145; Otsuka E, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012043; Murakami T, 2015, TRIBOL INT, V89, P19, DOI 10.1016/j.triboint.2014.12.013; KLONOWSKI W, 1985, J APPL PHYS, V58, P2883, DOI 10.1063/1.335836; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246; SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0; Otsuka E, 2010, SOFT MATTER, V6, P6155, DOI 10.1039/c0sm00757a; OHMINE I, 1982, J CHEM PHYS, V77, P5725, DOI 10.1063/1.443780; Nishinari K, 2009, PROG COLL POL SCI S, V136, P87, DOI 10.1007/2882_2009_12; Murakami T, 1998, P I MECH ENG H, V212, P23, DOI 10.1243/0954411981533791; Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3; Hirokawa Y, 1999, MACROMOLECULES, V32, P7093, DOI 10.1021/ma990437v; Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P; TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820; AN Y, 1995, POLYMER, V36, P2297, DOI 10.1016/0032-3861(95)95310-W; TANAKA T, 1987, NATURE, V325, P796, DOI 10.1038/325796a0; Tanaka S, 2007, POLYM J, V39, P397, DOI 10.1295/polymj.PJ2006149; HIROTSU S, 1989, J PHYS SOC JPN, V58, P1508, DOI 10.1143/JPSJ.58.1508; Flory PI, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; Nakamura T, 2001, J BIOMED MATER RES, V56, P289, DOI 10.1002/1097-4636(200108)56:2<289::AID-JBM1097>3.0.CO;2-W; Sasaki S, 2012, J APPL POLYM SCI, V126, pE233, DOI 10.1002/app.36919; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Doi Y, 2005, LANGMUIR, V21, P5285, DOI 10.1021/la050453n; Bodugoz-Senturk H, 2008, BIOMATERIALS, V29, P141, DOI 10.1016/j.biomaterials.2007.09.015; HIROTSU S, 1994, PHASE TRANSIT, V47, P183, DOI 10.1080/01411599408200347; Zhang L, 2012, SOFT MATTER, V8, P10439, DOI 10.1039/c2sm26102b; Bispo VM, 2010, J BIOMED NANOTECHNOL, V6, P166, DOI 10.1166/jbn.2010.1110; TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602; MATSUO ES, 1994, MACROMOLECULES, V27, P6791, DOI 10.1021/ma00101a018; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; Zan J, 2006, J APPL POLYM SCI, V101, P1892, DOI 10.1002/app.23613; TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467; Hassan CM, 2000, ADV POLYM SCI, V153, P37; LI Y, 1992, ANNU REV MATER SCI, V22, P243; Ricciardi R, 2004, MACROMOLECULES, V37, P9510, DOI 10.1021/ma048418v; Otsuka E, 2012, SOFT MATTER, V8, P8129, DOI 10.1039/c2sm25513h; HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200; Suzuki A, 2001, J CHEM PHYS, V114, P5012, DOI 10.1063/1.1350576; OSADA Y, 1987, ADV POLYM SCI, V82, P1; DUSEK K, 1968, J POLYM SCI A2, V6, P1209, DOI 10.1002/pol.1968.160060701; Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v; Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694; Suzuki A, 1997, J CHEM PHYS, V107, P5179, DOI 10.1063/1.474880; Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032; Sasaki S, 2013, REACT FUNCT POLYM, V73, P878, DOI 10.1016/j.reactfunctpolym.2013.01.010; Suzuki A, 1997, MACROMOLECULES, V30, P2350, DOI 10.1021/ma961598r; Li JY, 2014, J MATER CHEM B, V2, P6708, DOI 10.1039/c4tb01194e; Yoshii F, 1999, RADIAT PHYS CHEM, V55, P133, DOI 10.1016/S0969-806X(98)00318-1; Kudo S, 2010, J POLYM SCI POL PHYS, V48, P1978, DOI 10.1002/polb.22076; AMIYA T, 1987, MACROMOLECULES, V20, P1162, DOI 10.1021/ma00171a050; Sasaki S, 2014, POLYM BULL, V71, P2383, DOI 10.1007/s00289-014-1196-0; Yamaue T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041402; BASTIDE J, 1988, MACROMOLECULES, V21, P2647, DOI 10.1021/ma00186a058; MURAKAMI T, 1990, JSME INT J III-VIB C, V33, P465; Doi Y, 2005, LANGMUIR, V21, P9420, DOI 10.1021/la0512502; Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792; Huggins ML, 1942, J PHYS CHEM-US, V46, P151, DOI 10.1021/j150415a018; Cai SQ, 2011, J MECH PHYS SOLIDS, V59, P2259, DOI 10.1016/j.jmps.2011.08.008; Kanaya T, 2012, POLYM J, V44, P83, DOI 10.1038/pj.2011.88; SUZUKI A, 1993, ADV POLYM SCI, V110, P199; Finch CA, 1997, POLYVINYL ALCOHOL DE; Flory P. J., 1953, PRINCIPLE POLYM CHEM; Heskins M.a.G.J.E., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; Hyon SH, 1987, US Patent, Patent No. [4, 663, 358, 4663358]; Klein J., 2013, FRICTION, V1, P1, DOI DOI 10.1007/S40544-013-0001-7; Koyano T, 1998, J BIOMED MATER RES, V39, P486; KUKHARCH.MM, 1972, VYSOKOMOL SOEDIN S B, V14, P843; Lozinsky VI, 2014, ADV POLYM SCI, V263, P1, DOI 10.1007/978-3-319-05846-7_1; Murakami T, 2014, P I MECH ENG J-J ENG, V228, P1099, DOI 10.1177/1350650114530273; Nakano Y, 2014, SCI TECHNOLOGY HDB G; Nambu M, 1982, Japanese Patent Kokai, Patent No. [57/130543, 57130543]; Noh T, 2015, J APPL POLYM SCI, V136, P121; PEPPAS NA, 1975, MAKROMOL CHEM, V176, P3433; Sakai N, 2012, TRIBOL INT, V45, P225; Sasaki S, MACR S IN PRESS; Sasaki S, POLYM ADVAN TECHNOL, DOI [10.1002/pat.3643, DOI 10.1002/PAT.3643]; Sato H, 2007, J APPL POLYM SCI, V105, P3811, DOI 10.1002/app.26626; STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A; Suzuki A, ENCY BIOCOLLOID BIOI; Tanaka K., 2000, MOL RECOGNITION MINI	102	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	DEC	2015	229	12			SI		828	844		10.1177/0954411915615469		17	Engineering, Biomedical	Engineering	CX4MM	WOS:000365675000002		
J	Nonoyama, T; Gong, JP				Nonoyama, Takayuki; Gong, Jian Ping			Double-network hydrogel and its potential biomedical application: A review	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Double-network hydrogel; molecular stent technology; artificial cartilage	HIGH MECHANICAL STRENGTH; HIGH-TOUGHNESS; ARTIFICIAL CARTILAGE; FLOW-CONTROL; CRACK TIPS; IN-VIVO; GELS; DESIGN; ENTANGLEMENT; HYSTERESIS	Double-network hydrogels are one of the most promising candidates as artificial soft supporting tissues owing to their excellent mechanical performance, water storage capability, and biocompatibility. A double-network hydrogel consists of two contrasting polymer networks: rigid and brittle first network and soft and ductile second network. To satisfy this double-network requirement, polyelectrolyte and neutral polymer are suitable as the first and the second networks, respectively. Combination of these two networks gives rise to extraordinarily tough double-network hydrogel as a result of substantial internal fracture of the brittle first network at large deformation, which contributes to the energy dissipation. Therefore, the first network serves as the sacrificial bonds to toughen the material. The double-network principle is universal and many kinds of double-network hydrogels composed of various chemical species have been developed. Moreover, a molecular stent technology has been developed to synthesize the double-network hydrogels using neutral polymer network as the brittle first network. The sulfonic double-network hydrogel was found to induce spontaneous hyaline cartilage regeneration in vivo.	[Nonoyama, Takayuki; Gong, Jian Ping] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Gong, JP (reprint author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Kita 10 Nishi 8, Sapporo, Hokkaido 0600810, Japan.	gong@mail.sci.hokudai.ac.jp					Tsukeshiba H, 2005, J PHYS CHEM B, V109, P16304, DOI 10.1021/jp052419n; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Gong JP, 2000, J PHYS CHEM B, V104, P9904, DOI 10.1021/jp0014418; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Tanaka Y, 2005, J PHYS CHEM B, V109, P11559, DOI 10.1021/jp0500790; Azuma C, 2007, J BIOMED MATER RES A, V81A, P373, DOI 10.1002/jbm.a.31043; Hagiwara Y, 2010, CELLULOSE, V17, P93, DOI 10.1007/s10570-009-9357-2; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Nakajima T, 2011, J POLYM SCI POL PHYS, V49, P1246, DOI 10.1002/polb.22293; Na YH, 2004, MACROMOLECULES, V37, P5370, DOI 10.1021/ma049506i; Nakajima T, 2009, MACROMOLECULES, V42, P2184, DOI 10.1021/ma802148p; Gong J, 1998, J CHEM PHYS, V109, P8062, DOI 10.1063/1.477453; Tanabe Y, 2008, J MATER SCI-MATER M, V19, P1379, DOI 10.1007/s10856-007-3255-7; Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b; Yu QM, 2009, MACROMOLECULES, V42, P3852, DOI 10.1021/ma900622s; Eddington DT, 2004, ADV DRUG DELIVER REV, V56, P199, DOI 10.1016/j.addr.2003.08.013; CHEN GH, 1995, MACROMOL RAPID COMM, V16, P175, DOI 10.1002/marc.1995.030160304; Chen YM, 2009, SOFT MATTER, V5, P1804, DOI 10.1039/b818586g; Kitamura N, 2011, AM J SPORT MED, V39, P1160, DOI 10.1177/0363546511399383; Yasuda K, 2009, MACROMOL BIOSCI, V9, P307, DOI 10.1002/mabi.200800223; Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y; Huang M, 2007, MACROMOLECULES, V40, P6658, DOI 10.1021/ma062482q; Arakaki K, 2010, J BIOMED MATER RES A, V93A, P1160, DOI 10.1002/jbm.a.32613; Liang SM, 2009, CHEM COMMUN, P7518, DOI 10.1039/b916581a; Sashinami H, 2006, BIOCHEM BIOPH RES CO, V351, P1005, DOI 10.1016/j.bbrc.2006.10.146; Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197; Yoshida R, 1997, ADV MATER, V9, P175, DOI 10.1002/adma.19970090219; TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Nakajima T, 2010, POLYM CHEM-UK, V1, P693, DOI 10.1039/c0py00031k; Hu J, 2011, MACROMOLECULES, V44, P7775, DOI 10.1021/ma2016248; Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X; Nakajima T, 2012, ADV FUNCT MATER, V22, P4426, DOI 10.1002/adfm.201200809; Chen YM, 2005, BIOMATERIALS, V26, P4588, DOI 10.1016/j.bomaterials.2004.11.025; Yang W, 2008, ADV MATER, V20, P4499, DOI 10.1002/adma.200801396; Haque MA, 2010, ADV MATER, V22, P5110, DOI 10.1002/adma.201002509; Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x; Na YH, 2006, MACROMOLECULES, V39, P4641, DOI 10.1021/ma060568d; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/nmat3713, 10.1038/NMAT3713]; Zhao Y, 2014, ADV MATER, V26, P436, DOI 10.1002/adma.201303387; Wu ZL, 2011, B CHEM SOC JPN, V84, P1295, DOI 10.1246/bcsj.20110201; Haque MA, 2011, MACROMOLECULES, V44, P8916, DOI 10.1021/ma201653t; Tanaka Y, 2008, MACROMOL RAPID COMM, V29, P1514, DOI 10.1002/marc.200800227; ATHANASIOU KA, 1991, J ORTHOPAED RES, V9, P330, DOI 10.1002/jor.1100090304; Derossi JD, 1991, POLYM GELS FUNDAMENT; Fung Y.-C., 1993, BIOMECHANICS MECH PR; Kawauchi Yasunori, 2009, Journal of Physics: Conference Series, V184, DOI 10.1088/1742-6596/184/1/012016; Peppas NA, 1987, HYDROGELS MED PHARM	59	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	DEC	2015	229	12			SI		853	863		10.1177/0954411915606935		11	Engineering, Biomedical	Engineering	CX4MM	WOS:000365675000004		
J	Murakami, T; Yarimitsu, S; Nakashima, K; Sakai, N; Yamaguchi, T; Sawae, Y; Suzuki, A				Murakami, Teruo; Yarimitsu, Seido; Nakashima, Kazuhiro; Sakai, Nobuo; Yamaguchi, Tetsuo; Sawae, Yoshinori; Suzuki, Atsushi			Biphasic and boundary lubrication mechanisms in artificial hydrogel cartilage: A review	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Biphasic lubrication; boundary lubrication; artificial hydrogel cartilage; hydrogels; adaptive multimode lubrication; biotribology	ADAPTIVE MULTIMODE LUBRICATION; INTERSTITIAL FLUID PRESSURIZATION; NATURAL SYNOVIAL JOINTS; TOTAL HIP-ARTHROPLASTY; ARTICULAR-CARTILAGE; HYDRATION LUBRICATION; POLYVINYL-ALCOHOL; ADSORBED FILM; KNEE-JOINT; GEL LAYER	Various studies on the application of artificial hydrogel cartilage to cartilage substitutes and artificial joints have been conducted. It is expected in clinical application of artificial hydrogel cartilage that not only soft-elastohydrodynamic lubrication but biphasic, hydration, gel-film and boundary lubrication mechanisms will be effective to sustain extremely low friction and minimal wear in daily activities similar to healthy natural synovial joints with adaptive multimode lubrication. In this review article, the effectiveness of biphasic lubrication and boundary lubrication in hydrogels in thin film condition is focused in relation to the structures and properties of hydrogels. As examples, the tribological behaviors in three kinds of poly(vinyl alcohol) hydrogels with high water content are compared, and the importance of lubrication mechanism in biomimetic artificial hydrogel cartilage is discussed to extend the durability of cartilage substitute.	[Murakami, Teruo; Yarimitsu, Seido] Kyushu Univ, Res Ctr Adv Biomech, Fukuoka 8190395, Japan; [Nakashima, Kazuhiro; Yamaguchi, Tetsuo; Sawae, Yoshinori] Kyushu Univ, Fac Engn, Dept Mech Engn, Fukuoka 8190395, Japan; [Sakai, Nobuo] Kyushu Inst Technol, Grad Sch Engn, Dept Appl Sci Integrated Syst Engn, Kitakyushu, Fukuoka 804, Japan; [Suzuki, Atsushi] Yokohama Natl Univ, Dept Mat Sci, Yokohama, Kanagawa 240, Japan; [Suzuki, Atsushi] Yokohama Natl Univ, Res Inst Environm & Informat Sci, Yokohama, Kanagawa 240, Japan; [Yarimitsu, Seido] Tokyo Metropolitan Univ, Fac Syst Design, Tokyo 158, Japan	Murakami, T (reprint author), Kyushu Univ, Res Ctr Adv Biomech, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	tmura@mech.kyushu-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI: 23000011]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank the financial support for main part in this review article given by the Grant-in-Aid for Specially Promoted Research of Japan Society for the Promotion of Science (KAKENHI: 23000011).	Kobayashi M, 2010, MATERIALS, V3, P2753, DOI 10.3390/ma3042753; Blum MM, 2013, WEAR, V301, P201, DOI 10.1016/j.wear.2012.11.042; Murakami T, 2011, P I MECH ENG J-J ENG, V225, P1174, DOI 10.1177/1350650111415756; Otsuka E, 2009, J APPL POLYM SCI, V114, P10, DOI 10.1002/app.30546; Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; Nakashima K, 2005, JSME INT J C-MECH SY, V48, P555, DOI 10.1299/jsmec.48.555; JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228; Ikeuchi K, 2007, P I MECH ENG J-J ENG, V221, P301, DOI 10.1243/13506501JET214; ORFORD CR, 1985, HISTOCHEM J, V17, P223, DOI 10.1007/BF01003221; Tomita N, 1999, J BIOMED MATER RES, V48, P474; Moro T, 2014, J ORTHOP RES, V32, P369, DOI 10.1002/jor.22526; Suciu AN, 2003, J BIOMECH ENG-T ASME, V125, P425, DOI 10.1115/1.1589505; Otsuka E, 2009, PROG COLL POL SCI S, V136, P121, DOI 10.1007/2882_2009_17; Sakai N, 2012, TRIBOL INT, V46, P225, DOI 10.1016/j.triboint.2011.03.016; Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021; Otsuka E, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012043; Murakami T, 2009, P I MECH ENG J-J ENG, V223, P287, DOI 10.1243/13506501JET536; Murakami T, 2015, TRIBOL INT, V89, P19, DOI 10.1016/j.triboint.2014.12.013; Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246; Yarimitsu S, 2010, J JPN SOC TRIBOLOGIS, V55, P489; Murakami T, 1998, P I MECH ENG H, V212, P23, DOI 10.1243/0954411981533791; Murakami T, 2012, P I MECH ENG J-J ENG, V226, P827, DOI 10.1177/1350650112451377; Zappone B, 2007, BIOPHYS J, V92, P1693, DOI 10.1529/biophysj.106.088799; Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167; Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199; SWANN DA, 1981, ARTHRITIS RHEUM, V24, P22, DOI 10.1002/art.1780240104; Higaki H, 1997, JSME INT J C-MECH SY, V40, P776; KIRK TB, 1993, J ORTHOP RHEUMATOL, V6, P21; Pawaskar SS, 2007, P I MECH ENG J-J ENG, V221, P165, DOI 10.1243/13506501JET241; Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416; Oonishi H, 2001, J BIOMED MATER RES, V58, P167, DOI 10.1002/1097-4636(2001)58:2<167::AID-JBM1003>3.0.CO;2-A; Sardinha VM, 2013, WEAR, V301, P218, DOI 10.1016/j.wear.2012.11.054; WALKER PS, 1968, ANN RHEUM DIS, V27, P512, DOI 10.1136/ard.27.6.512; Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035; MURAKAMI T, 1993, TRIBOLOGY S, V25, P673, DOI 10.1016/S0167-8922(08)70420-6; Kosukegawa H, 2015, TRIBOL INT, V82, P407, DOI 10.1016/j.triboint.2014.05.029; Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q; Oral E, 2011, INT ORTHOP, V35, P215, DOI 10.1007/s00264-010-1161-y; UNSWORTH A, 1975, ANN RHEUM DIS, V34, P277, DOI 10.1136/ard.34.4.277; Hassan CM, 2000, ADV POLYM SCI, V153, P37; Parkes M, 2015, TRIBOL INT, V89, P9, DOI 10.1016/j.triboint.2014.11.024; MANSOUR JM, 1977, J LUBRIC TECH-T ASME, V99, P163; Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694; Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02; Nakashima K, 2007, TRIBOL LETT, V26, P145, DOI 10.1007/s11249-006-9185-6; Yarimitsu S, 2009, TRIBOL INT, V42, P1615, DOI 10.1016/j.triboint.2008.11.005; Ateshian GA, 1997, J BIOMECH ENG-T ASME, V119, P81, DOI 10.1115/1.2796069; Zywiel MG, 2011, CLIN ORTHOP RELAT R, V469, P1536, DOI 10.1007/s11999-010-1658-0; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; MURAKAMI T, 1990, JSME INT J III-VIB C, V33, P465; Kurokawa T, 2005, LANGMUIR, V21, P8643, DOI 10.1021/la050635h; Katta J, 2008, MED ENG PHYS, V30, P1349, DOI 10.1016/j.medengphy.2008.09.004; Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0; Higaki H, 1998, P I MECH ENG H, V212, P337, DOI 10.1243/0954411981534114; HILLS BA, 1989, J RHEUMATOL, V16, P82; Arakaki K, 2010, J BIOMED MATER RES A, V91, P1160; Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02; Dowson D., 1967, P I MECH ENG, V181, P45; Dowson D, 1989, P IMECHE C CHANG ROL, P1; Dowson D, 1986, ENG MED, V15, P65; Higaki H, 1996, JPN J TRIBOL, V40, P691; Ikeuchi K., 1995, LUBRICANTS LUBRICATI, P65; Klein J., 2013, FRICTION, V1, P1, DOI DOI 10.1007/S40544-013-0001-7; Komoto T, 1984, SEN-I GAKKAISHI, V40, P53; Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P8; Mabuchi K, 1986, J JPN SOC ORTHOP BIO, V8, P101; McCutchen CW, 1962, WEAR, V5, P1, DOI 10.1016/0043-1648(62)90176-X; Medley J B, 1984, Eng Med, V13, P137; Mihalko WM, 2014, CLIN ORTHOP RELAT R, V472, P3747, DOI 10.1007/s11999-014-3816-2; Mow VC, 1990, BIOMECHANICS DIARTHR, V1, P215; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73; Murakami T, ENCY BIOCOLLOID BIOI; Murakami T, 2014, P I MECH ENG J-J ENG, V228, P1099, DOI 10.1177/1350650114530273; Murakami T, 2000, TRIBOL SER, V38, P317; Murakami T, 2013, FRICTION, V1, P150; Murakami T, 1999, TRIBOLOGY S, V36, P737; Murakami T, 2013, ENCY TRIBOLOGY, P3854; Murakami T, 1997, ELASTOHYDRODYNAMICS, P383; Nakashima K, 2000, P INT TRIB C NAG, V2, P1537; Nambu M, 1982, Japanese Patent Kokai, Patent No. [57/130543, 130543]; Omata S, 2015, BIOSURF BIOTRIBOL, V1, P71; PasqualiRonchetti I, 1997, J STRUCT BIOL, V120, P1, DOI 10.1006/jsbi.1997.3908; Sakai N, 2012, BIOMECHANISMS, V21, P251; Sasada T., 2000, J JAPANESE SOC CLIN, V21, P17; Suzuki A, 2013, EXT WORLD TRIB C KYO; Suzuki A, ENCY BIOCOLLOID BIOI; Unsworth A, 1989, P IMECHE INT C CHANG, P715; Yamaguchi T, 2012, JAST C MUR 16 18 SEP, P1992; Yarimitsu S, 2008, TRIBOL ONLINE, V3, P238, DOI 10.2474/trol.3.238; Yarimitsu S, 2013, J BIOMECH SCI ENG, V8, P257; Yarimitsu S, 2014, 2 INT C BIOTR TOR 11	94	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	DEC	2015	229	12			SI		864	878		10.1177/0954411915611160		15	Engineering, Biomedical	Engineering	CX4MM	WOS:000365675000005		
J	Ando, H; Matsuzawa, Y				Ando, Hiroshi; Matsuzawa, Yasumichi			The Weyl-von Neumann theorem and Borel complexity of unitary equivalence modulo compacts of self-adjoint operators	PROCEEDINGS OF THE ROYAL SOCIETY OF EDINBURGH SECTION A-MATHEMATICS			English	Article						Weyl-von Neumann theorem; self-adjoint operators; turbulence		The Weyl-von Neumann theorem asserts that two bounded self-adjoint operators A, B on a Hilbert space H are unitarily equivalent modulo compacts, i. e. uAu* + K = B for some unitary u is an element of U(H) and compact self-adjoint operator K, if and only if A and B have the same essential spectrum: sigma(ess)(A) = sigma(ess)(B). We study, using methods from descriptive set theory, the problem of whether the above Weyl-von Neumann result can be extended to unbounded operators. We show that if H is separable infinite dimensional, the relation of unitary equivalence modulo compacts for bounded self-adjoint operators is smooth, while the same equivalence relation for general self-adjoint operators contains a dense G(delta)-orbit but does not admit classification by countable structures. On the other hand, the apparently related equivalence relation A similar to B double left right arrow there exists u is an element of U(H) [u(A-i)-(1)u*-(B-i)(-1) is compact] is shown to be smooth.	[Ando, Hiroshi] Erwin Schrodinger Int Inst Math Phys, A-1090 Vienna, Austria; [Matsuzawa, Yasumichi] Shinshu Univ, Fac Educ, Dept Math, Nagano 3808544, Japan	Ando, H (reprint author), Chiba Univ, Dept Math & Informat, Inage Ku, 1-33 Yayoicha, Chiba 2638522, Japan.	hiroando@s.chiba-u.ac.jp; myasu@shinshu-u.ac.jp			EPDI/JSPS/IHES (Erwin Schrodinger Institute); Kyoto University GCOE Program	We thank Professor Asao Arai for communicating to us his proof of lemma 3.10, Professors Alexander Kechris, Uffe Haagerup, Asger Tornquist and Todor Tsankov for useful comments and pointing us towards the literature. We also thank the anonymous referee for numerous valuable suggestions on the organization of the paper that made the paper more readable. H.A. is supported by an EPDI/JSPS/IHES Fellowship (affiliated to the Erwin Schrodinger Institute) and part of the work was done during his visit to the University of Copenhagen. He is grateful to the Kyoto University GCOE Program, from which he received financial support for travelling to attend the workshop 'Set theory and C*-algebras' at the American Institute of Mathematics in 2012, which motivated the present work.	Akhiezer N. I., 1961, THEORY LINEAR OPERAT; FILLMORE PA, 1971, ADV MATH, V7, P254, DOI 10.1016/S0001-8708(71)80006-3; Kothe G, 1936, MATH Z, V41, P137, DOI 10.1007/BF01180408; Weyl H, 1910, MATH ANN, V68, P220, DOI 10.1007/BF01474161; Latrach K, 2005, STUD MATH, V171, P207, DOI 10.4064/sm171-3-1; Kerr D, 2010, P LOND MATH SOC, V100, P459, DOI 10.1112/plms/pdp036; BERG ID, 1971, T AM MATH SOC, V160, P365, DOI 10.2307/1995812; Kechris AS, 2001, ERGOD THEOR DYN SYST, V21, P1459; Dougherty R, 1999, T AM MATH SOC, V351, P1835, DOI 10.1090/S0002-9947-99-02261-8; Sasyk R, 2009, J FUNCT ANAL, V256, P2710, DOI 10.1016/j.jfa.2008.11.010; Choksi JR, 1998, CAN MATH BULL, V41, P137, DOI 10.4153/CMB-1998-021-4; CHRISTEN.JP, 1971, MATH ANN, V195, P17, DOI 10.1007/BF02059413; Conway J. B., 1999, COURSE OPERATOR THEO; Conway J. B., 1990, COURSE FUNCTIONAL AN; Dixmier J., 1949, J MATH PURE APPL, V28, P321; Dixmier J., 1949, B SOC MATH FRANCE, V77, P11; Farah I., 2013, INT MATH RES NOTICES, P5796; Gao S, 2009, MONOGR TXB PURE APPL, V293, P3; Hjorth G., 2000, MATH SURVEYS MONOGRA, V75; Kato T., 1957, P JAPAN ACAD, V33, P260, DOI 10.3792/pja/1195525063; Kechris A. S., 2003, LONDON MATH SOC LECT, V262, P115; KECHRIS A.S., 1996, CLASSICAL DESCRIPTIV; Kuroda S., 1958, P JAPAN ACAD, V34, P11; Lassner G., 1976, REP MATH PHYS, V9, P157, DOI 10.1016/0034-4877(76)90051-3; Oliveira C. R., 2009, PROGR MATH PHYS, V54; Reed M., 1981, METHODS MODERN MATH, VI; Rosenblum M., 1957, PAC J MATH, V7, P997; SCHMUDGEN K., 2010, GRADUATE TEXTS MATH, V265; SIMON B, 1995, ANN MATH, V141, P131, DOI 10.2307/2118629; von Neumann J., 1935, ACTUALITES SCI IND, V229; Weyl H., 1909, REND CIRC MAT PALERM, V27, P373	31	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0308-2105	1473-7124		P ROY SOC EDINB A	Proc. R. Soc. Edinb. Sect. A-Math.	DEC	2015	145	6					1115	1144		10.1017/S0308210515000293		30	Mathematics, Applied; Mathematics	Mathematics	CX4PU	WOS:000365683600001		
J	Bai, YW; Tashiro, S; Nagatoishi, S; Suzuki, T; Yan, DK; Liu, RH; Tsumoto, K; Bartlam, M; Yamamoto, T				Bai, Yuwei; Tashiro, Shinya; Nagatoishi, Satoru; Suzuki, Toru; Yan, Dongke; Liu, Ruihua; Tsumoto, Kouhei; Bartlam, Mark; Yamamoto, Tadashi			Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach	PROTEIN & CELL			English	Letter							TOB; PHOSPHORYLATION; DEADENYLATION		[Bai, Yuwei; Suzuki, Toru; Yan, Dongke; Liu, Ruihua; Bartlam, Mark] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Bai, Yuwei; Suzuki, Toru; Yan, Dongke; Liu, Ruihua; Bartlam, Mark] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Tashiro, Shinya; Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Yamamoto, Tadashi] Grad Univ, Okinawa Inst Sci & Technol, Cell Signal Unit, Kunigami, Okinawa 9040412, Japan	Tsumoto, K (reprint author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tsumoto@ims.u-tokyo.ac.jp; bartlam@nankai.edu.cn					Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Iwanaga K, 2003, CANCER LETT, V202, P71, DOI 10.1016/j.canlet.2003.08.019; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Ito Y, 2005, CANCER LETT, V220, P237, DOI 10.1016/j.canlet.2004.08.017; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Giannetti AM, 2008, J MED CHEM, V51, P574, DOI 10.1021/jm700952v; Yang X, 2008, NUCLEIC ACIDS RES, V36, P6872, DOI 10.1093/nar/gkn825; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Jia SJ, 2007, DEV DYNAM, V236, P913, DOI 10.1002/dvdy.21092; Suzuki T, 2012, J BIOL CHEM, V287, P40256, DOI 10.1074/jbc.M112.353805; Ezzeddine N, 2012, MOL CELL BIOL, V32, P1089, DOI 10.1128/MCB.06370-11; Pfaff Samuel J, 2015, Methods Mol Biol, V1278, P587, DOI 10.1007/978-1-4939-2425-7_39; Doidge R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051331	15	0	0	HIGHER EDUCATION PRESS	BEIJING	NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA	1674-800X	1674-8018		PROTEIN CELL	Protein Cell	DEC	2015	6	12					924	928		10.1007/s13238-015-0225-6		5	Cell Biology	Cell Biology	CX2GJ	WOS:000365514600011		
J	Nagata, T; Suzuki, F; Teo, AR				Nagata, Toshihiko; Suzuki, Futoshi; Teo, Alan R.			Generalized social anxiety disorder: A still-neglected anxiety disorder 3 decades since Liebowitz's review	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						generalized; social anxiety disorder; taijin kyofusho; under-recognition; undertreatment	RANDOMIZED CONTROLLED-TRIAL; AVOIDANT PERSONALITY-DISORDER; NATIONAL-COMORBIDITY-SURVEY; MENTAL-HEALTH SURVEY; DSM-III-R; COGNITIVE-BEHAVIORAL THERAPY; VENLAFAXINE EXTENDED-RELEASE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; 12-MONTH PREVALENCE	In the 3 decades since Liebowitz's review of a neglected anxiety disorder,' controversy and challenges have remained in the study of social anxiety disorder (SAD). This review examines evidence around the classification and subtyping of SAD, focusing on generalized SAD. Substantial discrepancies and variation in definition, epidemiology, assessment, and treatment of generalized SAD exist as the international literature on it has grown. In East Asian cultures in particular, study of taijin kyofusho has been important to a broadened conceptualization of SAD into generalized SAD. Despite important progress with biological and other studies, many challenges in the understanding of generalized SAD will remain in the years to come.	[Nagata, Toshihiko] Mental Hlth Clin Dr Nagata Nanba, Osaka 5420076, Japan; [Suzuki, Futoshi] Nagoya Univ Hosp, Dept Child & Adolescent Psychiat, Aichi, Japan; [Teo, Alan R.] VA Portland Hlth Care Syst, Portland, OR USA; [Teo, Alan R.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Nagata, T (reprint author), Mental Hlth Clin Dr Nagata Nanba, Chuo Ku, SAN EI Midosuji Bldg 3F,3-5-8 Nanba, Osaka 5420076, Japan.	toshi@nanba-nagata.com					American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Nagata T, 2000, PSYCHIAT RES, V94, P239, DOI 10.1016/S0165-1781(00)00157-8; Van Ameringen MA, 2001, AM J PSYCHIAT, V158, P275, DOI 10.1176/appi.ajp.158.2.275; Narrow WE, 2002, ARCH GEN PSYCHIAT, V59, P115, DOI 10.1001/archpsyc.59.2.115; Asakura S, 2007, INT J NEUROPSYCHOPH, V10, P263, DOI 10.1017/S1461145706006602; Kitanishi K, 1995, PSYCHIAT CLIN NEUROS, V49, P245, DOI 10.1111/j.1440-1819.1995.tb01896.x; El-Gabalawy R, 2010, J ANXIETY DISORD, V24, P244, DOI 10.1016/j.janxdis.2009.11.003; Hudson JL, 2000, BEHAV MODIF, V24, P102, DOI 10.1177/0145445500241006; Seedat S, 2004, J CLIN PSYCHIAT, V65, P244; Distel MA, 2008, BEHAV GENET, V38, P24, DOI 10.1007/s10519-007-9182-z; Kerns CE, 2013, DEPRESS ANXIETY, V30, P709, DOI 10.1002/da.22067; Wagner R, 2006, J ANXIETY DISORD, V20, P363, DOI 10.1016/j.janxdis.2005.02.003; Kim J, 2008, DEPRESS ANXIETY, V25, P601, DOI 10.1002/da.20345; Heinrichs N, 2006, BEHAV RES THER, V44, P1187, DOI 10.1016/j.brat.2005.09.006; Schutters SIJ, 2010, INT CLIN PSYCHOPHARM, V25, P302, DOI 10.1097/YIC.0b013e32833a4d71; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Bogels SM, 2010, DEPRESS ANXIETY, V27, P168, DOI 10.1002/da.20670; Dalrymple KL, 2008, J NERV MENT DIS, V196, P639, DOI 10.1097/NMD.0b013e318181353b; Wagner KD, 2004, ARCH GEN PSYCHIAT, V61, P1153, DOI 10.1001/archpsyc.61.11.1153; Beesdo K, 2007, ARCH GEN PSYCHIAT, V64, P903, DOI 10.1001/archpsyc.64.8.903; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Liebowitz MR, 1999, J CLIN PSYCHIAT, V60, P22; BRUCH MA, 1994, J ANXIETY DISORD, V8, P155, DOI 10.1016/0887-6185(94)90013-2; March JS, 2007, BIOL PSYCHIAT, V62, P1149, DOI 10.1016/j.biopsych.2007.02.025; Galbraith T, 2014, J ANXIETY DISORD, V28, P57, DOI 10.1016/j.janxdis.2013.11.009; Heimberg RG, 2014, DEPRESS ANXIETY, V31, P472, DOI 10.1002/da.22231; Liebowitz MR, 2005, J CLIN PSYCHIAT, V66, P238; Lampe L, 2003, PSYCHOL MED, V33, P637, DOI 10.1017/S0033291703007621; Pollack MH, 2014, AM J PSYCHIAT, V171, P44, DOI 10.1176/appi.ajp.2013.12101353; Mennin DS, 2002, J ANXIETY DISORD, V16, P661, DOI 10.1016/S0887-6185(02)00134-2; Stein DJ, 2009, ANN CLIN PSYCHIATRY, V21, P109; Stein MB, 1999, AM J PSYCHIAT, V156, P756; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; LEVIN AP, 1993, J ANXIETY DISORD, V7, P207, DOI 10.1016/0887-6185(93)90003-4; Pande AC, 2004, J CLIN PSYCHOPHARM, V24, P141, DOI 10.1097/01.jcp.0000117423.05703.e7; TAKAHASHI T, 1989, COMPR PSYCHIAT, V30, P45, DOI 10.1016/0010-440X(89)90117-X; Gureje O, 2006, BRIT J PSYCHIAT, V188, P465, DOI 10.1192/bjp.188.5.465; Pande AC, 1999, J CLIN PSYCHOPHARM, V19, P341, DOI 10.1097/00004714-199908000-00010; Muehlbacher M, 2005, J CLIN PSYCHOPHARM, V25, P580, DOI 10.1097/01.jcp.0000186871.04984.8d; MARKS IM, 1966, AM J PSYCHIAT, V123, P218; Nagata T, 2013, INT J SOC PSYCHIATR, V59, P73, DOI 10.1177/0020764011423184; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733; Heimberg RG, 1998, ARCH GEN PSYCHIAT, V55, P1133, DOI 10.1001/archpsyc.55.12.1133; Spitzer RL, 2008, J NERV MENT DIS, V196, P356, DOI 10.1097/NMD.0b013e3181710950; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1351; Stein MB, 1998, AM J PSYCHIAT, V155, P90; [Anonymous], 2004, ACTA PSYCHIAT SCAN S; Ravindran LN, 2009, J CLIN PSYCHOPHARM, V29, P561, DOI 10.1097/JCP.0b013e3181bf6303; Baldwin D, 1999, BRIT J PSYCHIAT, V175, P120, DOI 10.1192/bjp.175.2.120; Lader M, 2004, DEPRESS ANXIETY, V19, P241, DOI 10.1002/da.20014; Vorcaro CMR, 2004, INT J SOC PSYCHIATR, V50, P216, DOI 10.1177/0020764004043131; Zimmerman M, 2003, J PSYCHIAT RES, V37, P325, DOI 10.1016/S0022-3956(03)00020-7; Nagata T, 2003, INT J PSYCHIAT CLIN, V7, P107, DOI 10.1080/13651500310000690; Randall CL, 2001, ALCOHOL CLIN EXP RES, V25, P210, DOI 10.1111/j.1530-0277.2001.tb02201.x; Zhang W, 2005, J PSYCHOPHARMACOL, V19, P551, DOI 10.1177/0269881105056526; Kleinknecht RA, 1997, J ANXIETY DISORD, V11, P157, DOI 10.1016/S0887-6185(97)00004-2; Fouche JP, 2013, HUM PSYCHOPHARM CLIN, V28, P102, DOI 10.1002/hup.2281; Stein DJ, 2010, DEPRESS ANXIETY, V27, P390, DOI 10.1002/da.20639; Kendler KS, 2001, ARCH GEN PSYCHIAT, V58, P257, DOI 10.1001/archpsyc.58.3.257; Stein MB, 2005, PSYCHOPHARMACOLOGY, V177, P280, DOI 10.1007/s00213-004-1957-9; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Knappe S, 2011, J PSYCHIATR RES, V45, P111, DOI 10.1016/j.jpsychires.2010.05.002; DAVIDSON JRT, 1993, J CLIN PSYCHOPHARM, V13, P423; Davidson JRT, 2004, ARCH GEN PSYCHIAT, V61, P1005, DOI 10.1001/archpsyc.61.10.1005; Bromet EJ, 2005, SOC PSYCH PSYCH EPID, V40, P681, DOI 10.1007/s00127-005-0927-9; Kashdan TB, 2010, CURR DIR PSYCHOL SCI, V19, P47, DOI 10.1177/0963721409359280; Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590; Burstein M, 2011, J AM ACAD CHILD PSY, V50, P870, DOI 10.1016/j.jaac.2011.06.005; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1080/j.1440-1614.2006.01903.x; Heimberg RG, 2000, EUR PSYCHIAT, V15, P29, DOI 10.1016/S0924-9338(00)00213-3; McTeague LM, 2012, DEPRESS ANXIETY, V29, P264, DOI 10.1002/da.21891; Tillfors M, 2001, BEHAV RES THER, V39, P289, DOI 10.1016/S0005-7967(00)00003-6; MANNUZZA S, 1995, ARCH GEN PSYCHIAT, V52, P230; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; ROBINS E, 1970, AM J PSYCHIAT, V126, P983; Blanco C, 2010, ARCH GEN PSYCHIAT, V67, P286, DOI 10.1001/archgenpsychiatry.2010.11; DeFife JA, 2013, JAMA PSYCHIAT, V70, P140, DOI 10.1001/jamapsychiatry.2013.270; GREENBERG D, 1983, BRIT J PSYCHIAT, V143, P526, DOI 10.1192/bjp.143.5.526; Koyama A, 2010, PSYCHIAT RES, V176, P69, DOI 10.1016/j.psychres.2008.10.019; Cho MJ, 2007, J NERV MENT DIS, V195, P203, DOI 10.1097/01.nmd.0000243826.40732.45; Leichsenring F, 2013, AM J PSYCHIAT, V170, P759, DOI 10.1176/appi.ajp.2013.12081125; Stein MB, 2010, J CLIN PSYCHIAT, V71, P627, DOI 10.4088/JCP.08m04949gre; Wakefield JC, 2005, CAN J PSYCHIAT, V50, P317; Stein DJ, 2010, CURR PSYCHIAT REP, V12, P471, DOI 10.1007/s11920-010-0140-8; HOFMANN SG, 1995, BEHAV RES THER, V33, P567, DOI 10.1016/0005-7967(94)00072-R; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; Vaishnavi S, 2007, PROG NEURO-PSYCHOPH, V31, P1464, DOI 10.1016/j.pnpbp.2007.06.027; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; Stein MB, 1998, JAMA-J AM MED ASSOC, V280, P708, DOI 10.1001/jama.280.8.708; Boone ML, 1999, J ANXIETY DISORD, V13, P271, DOI 10.1016/S0887-6185(99)00004-3; Kasper S, 2005, BRIT J PSYCHIAT, V186, P222, DOI 10.1192/bjp.186.3.222; Barnett SD, 2002, J PSYCHOPHARMACOL, V16, P365; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Cox BJ, 2008, BEHAV RES THER, V46, P477, DOI 10.1016/j.brat.2008.01.011; Bruhl AB, 2014, NEUROSCI BIOBEHAV R, V47, P260, DOI 10.1016/j.neubiorev.2014.08.003; ANDREWS G, 1990, BRIT J PSYCHIAT, V157, P6, DOI 10.1192/bjp.157.1.6; Blanco C, 2013, INT J NEUROPSYCHOPH, V16, P235, DOI 10.1017/S1461145712000119; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Liebowitz MR, 2002, J CLIN PSYCHIAT, V63, P66; Stein MB, 2000, ARCH GEN PSYCHIAT, V57, P1046, DOI 10.1001/archpsyc.57.11.1046; Allgulander C, 1999, ACTA PSYCHIAT SCAND, V100, P193, DOI 10.1111/j.1600-0447.1999.tb10845.x; Montgomery SA, 1998, J AFFECT DISORDERS, V50, pS17, DOI 10.1016/S0165-0327(98)00093-7; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Nagata T, 2006, DEPRESS ANXIETY, V23, P168, DOI 10.1002/da.20153; Kessler RC, 1998, AM J PSYCHIAT, V155, P613; Allgulander C, 2004, HUM PSYCHOPHARM CLIN, V19, P387, DOI 10.1002/hup.602; Chartrand H, 2011, CAN J BEHAV SCI, V43, P89, DOI 10.1037/a0022435; Merikangas KR, 1999, BIOL PSYCHIAT, V46, P1523, DOI 10.1016/S0006-3223(99)00172-9; Hook JN, 2002, CLIN PSYCHOL-SCI PR, V9, P379, DOI 10.1093/clipsy/9.4.379; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; Rickels K, 2004, J CLIN PSYCHOPHARM, V24, P488, DOI 10.1097/01.jcp.0000138764.31106.60; LIEBOWITZ MR, 1985, ARCH GEN PSYCHIAT, V42, P729; KATZELNICK DJ, 1995, AM J PSYCHIAT, V152, P1368; Marques L, 2012, J ANXIETY DISORD, V26, P665, DOI 10.1016/j.janxdis.2012.05.004; Silberman EK, 2014, AM J PSYCHIAT, V171, P795, DOI 10.1176/appi.ajp.2014.14010048; [Anonymous], 2011, CIMA SCI J; HEIMBERG RG, 1990, J NERV MENT DIS, V178, P172, DOI 10.1097/00005053-199003000-00004; Keshavan MS, 2005, AM J PSYCHIAT, V162, P102, DOI 10.1176/appi.ajp.162.1.102; CRASKE MG, 1991, CLIN PSYCHOL REV, V11, P599, DOI 10.1016/0272-7358(91)90006-G; Stein DJ, 2002, J CLIN PSYCHIAT, V63, P152; CHEN XY, 1995, DEV PSYCHOPATHOL, V7, P337; Liebowitz MR, 2005, ARCH GEN PSYCHIAT, V62, P190, DOI 10.1001/archpsyc.62.2.190; Bogels SM, 2014, DEPRESS ANXIETY, V31, P363, DOI 10.1002/da.22246; Cox BJ, 2009, DEPRESS ANXIETY, V26, P354, DOI 10.1002/da.20475; Katzelnick DJ, 2001, AM J PSYCHIAT, V158, P1999, DOI 10.1176/appi.ajp.158.12.1999; Capps D., 1999, SOCIAL PHOBIA ALLEVI, P127; Choy Yujuan, 2008, Depress Anxiety, V25, P230, DOI 10.1002/da.20295; Crome E, 2014, AUST NZ J PSYCHIAT, V49, P227; Florescu S, 2009, MANAGEMENT HLTH, V13, P23; Hofmann Stefan G, 2010, Depress Anxiety, V27, P1073, DOI 10.1002/da.20771; Hofmann S G, 1999, Depress Anxiety, V9, P15, DOI 10.1002/(SICI)1520-6394(1999)9:1<15::AID-DA2>3.0.CO;2-6; Kasahara Y, 1972, FEAR EYE TO EYE CONF; Kawakami N., 2014, JAPANESE PSYCHIAT EP; KIRMAYER LJ, 1991, J NERV MENT DIS, V179, P19, DOI 10.1097/00005053-199101000-00005; Moynihan R, 2006, PLOS MED, V3, P425, DOI 10.1371/journal.pmed.0030191; Nagata T, 2004, SEISHIN IGAKU, V46, P141; Okano Ken-Ichiro, 1994, Bulletin of the Menninger Clinic, V58, P323; Sim K, 2007, BRIT J CLIN PHARMACO, V63, P431, DOI 10.1111/j.1365-2125.2006.02780.x; Stein MB, 1995, MODIFIED VERSION STR; Stemberger Ruth Townsley, 1995, Journal of Abnormal Psychology, V104, P526, DOI 10.1037/0021-843X.104.3.526; vansVliet IM, 1994, PSYCHOPHARMACOLOGY B, V115, P128; Wilson EO, 1984, BIOPHILIA; Yamashita I., 1977, TAIJIN KYOFU	147	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	2015	69	12					724	740		10.1111/pcn.12327		17	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CX6LV	WOS:000365813400001		
J	Omachi, Y; Ito, K; Arima, K; Matsuda, H; Nakata, Y; Sakata, M; Sato, N; Nakagome, K; Motohashi, N				Omachi, Yoshie; Ito, Kimiteru; Arima, Kunimasa; Matsuda, Hiroshi; Nakata, Yasuhiro; Sakata, Masuhiro; Sato, Noriko; Nakagome, Kazuyuki; Motohashi, Nobutaka			Clinical impact of C-11-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						[C-11]Pittsburgh compound-B positron emission tomography; Alzheimer's disease; diagnosis; mild cognitive impairment; National Institute on Aging-Alzheimer's Association	BRAIN PERFUSION SPECT; LEWY BODY DISEASES; NATIONAL INSTITUTE; ASSOCIATION WORKGROUPS; AMYLOID-BETA; CRITERIA; PET; GUIDELINES; RECOMMENDATIONS; DEPOSITION	AimsThe purpose of this study was to evaluate the clinical impact of addition of [C-11]Pittsburgh compound-B positron emission tomography (C-11-PiB PET) on routine clinical diagnosis of Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI), and to assess diagnostic agreement between clinical criteria and research criteria of the National Institute on Aging-Alzheimer's Association. MethodsThe diagnosis in 85 patients was made according to clinical criteria. Imaging examinations, including both magnetic resonance imaging and single-photon emission computed tomography/computed tomography to identify neuronal injury (NI), and C-11-PiB PET to identify amyloid were performed, and all subjects were re-categorized according to the research criteria. ResultsAmong 40 patients with probable AD dementia (ProAD), 37 were NI-positive, 29 were C-11-PiB-positive, and 27 who were both NI- and C-11-PiB-positive were categorized as having ProAD dementia with a high level of evidence of the AD pathophysiological process'. Among 20 patients with possible AD dementia (PosAD), 17 were NI-positive, and six who were both NI- and C-11-PiB-positive were categorized as having PosAD with evidence of the AD pathophysiological process'. Among 25 patients with MCI, 18 were NI-positive, 13 were C-11-PiB-positive, and 10 who were both NI- and C-11-PiB-positive were categorized as having MCI due to AD-high likelihood'. ConclusionsDiagnostic concordance between clinical criteria and research criteria may not be high in this study. C-11-PiB PET may be of value in making the diagnosis of dementia and MCI in cases with high diagnostic uncertainty.	[Omachi, Yoshie; Arima, Kunimasa; Sakata, Masuhiro; Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 1878551, Japan; [Ito, Kimiteru; Nakata, Yasuhiro; Sato, Noriko] Natl Ctr Neurol & Psychiat, Dept Radiol, Kodaira, Tokyo 1878551, Japan; [Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Kodaira, Tokyo 1878551, Japan; [Motohashi, Nobutaka] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropsychiat, Kofu, Yamanashi, Japan	Omachi, Y (reprint author), Natl Ctr Neurol & Psychiat, Dept Psychiat, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878551, Japan.	oomachi-tjo@umin.ac.jp			 [24791363]	The authors gratefully thank Yoshikazu Ishizuka and Yoko Ishikubo of the National Center of Neurology and Psychiatry for their skillful technical assistance. We certify that we have no conflicts of interest to declare in relation to this study. This work was supported by a Grant-in-Aid for Young Scientists (B) (24791363). The study sponsor had no role in the study design, data collection, data analysis, data interpretation, manuscript writing, or the decision to submit the manuscript for publication.	Lowe VJ, 2013, NEUROLOGY, V80, P2130, DOI 10.1212/WNL.0b013e318295d6cf; Gomperts SN, 2012, MOVEMENT DISORD, V27, P965, DOI 10.1002/mds.25048; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P107, DOI 10.1007/s00401-006-0156-7; MCKHANN G, 1984, NEUROLOGY, V34, P939; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Takeuchi J, 2012, DEMENT GERIATR COGN, V34, P112, DOI 10.1159/000341577; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Neary D, 1998, NEUROLOGY, V51, P1546; Villain N, 2012, BRAIN, V135, P2126, DOI 10.1093/brain/aws125; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Khachaturian ZS, 2011, ALZHEIMERS DEMENT, V7, P253, DOI 10.1016/j.jalz.2011.04.003; Sanchez-Juan P, 2014, NEUROLOGY, V82, P230, DOI 10.1212/WNL.0000000000000032; Rosen RF, 2010, ACTA NEUROPATHOL, V119, P221, DOI 10.1007/s00401-009-0583-3; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; ROMAN GC, 1993, NEUROLOGY, V43, P250; Bacskai BJ, 2007, ARCH NEUROL-CHICAGO, V64, P431, DOI 10.1001/archneur.64.3.431; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kogure D, 2000, J NUCL MED, V41, P1155; Vandenberghe R, 2013, CURR OPIN NEUROL, V26, P646, DOI 10.1097/WCO.0000000000000036; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Cairns NJ, 2009, ARCH NEUROL-CHICAGO, V66, P1557, DOI 10.1001/archneurol.2009.279; Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349; Leinonen V, 2008, ARCH NEUROL-CHICAGO, V65, P1304, DOI 10.1001/archneur.65.10.noc80013; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; BRAAK H, 1987, NEUROSCI LETT, V76, P124, DOI 10.1016/0304-3940(87)90204-7; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Knopman DS, 2001, NEUROLOGY, V56, P1143; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Ossenkoppele R, 2013, ALZHEIMERS DEMENT, V9, P414, DOI 10.1016/j.jalz.2012.07.003; Shimada H, 2013, MOVEMENT DISORD, V28, P169, DOI 10.1002/mds.25286; Driscoll I, 2012, ACTA NEUROPATHOL, V124, P823, DOI 10.1007/s00401-012-1025-1; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ito K, 2014, INT J GERIATR PSYCH, V29, P1079, DOI 10.1002/gps.4102; Katoh S, 1991, JPN J GERIATR PSYCHI, V11, P1339; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI 10.1016/j.jalz.2011.09.172	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	2015	69	12					741	751		10.1111/pcn.12326		11	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CX6LV	WOS:000365813400002		
J	Yoshino, A; Okamoto, Y; Doi, M; Horikoshi, M; Oshita, K; Nakamura, R; Otsuru, N; Yoshimura, S; Tanaka, K; Takagaki, K; Jinnin, R; Yamashita, H; Kawamoto, M; Yamawaki, S				Yoshino, Atsuo; Okamoto, Yasumasa; Doi, Mitsuru; Horikoshi, Masaru; Oshita, Kyoko; Nakamura, Ryuji; Otsuru, Naofumi; Yoshimura, Shinpei; Tanaka, Keisuke; Takagaki, Koki; Jinnin, Ran; Yamashita, Hidehisa; Kawamoto, Masashi; Yamawaki, Shigeto			Effectiveness of group cognitive behavioral therapy for somatoform pain disorder patients in Japan: A preliminary non-case-control study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						chronic pain; cognitive behavioral therapy; pain catastrophizing; somatic symptom disorder; somatoform pain disorder	RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; LOW-BACK-PAIN; DEPRESSION; HEALTH; VALIDATION; QUESTIONNAIRE; PREDICTORS; INVENTORY; VERSION	AimsSomatoform pain disorder is associated with psychosocial dysfunction, and psychotherapies, such as cognitive behavioral therapy (CBT), are thought to provide useful interventions to address such dysfunction as well as the pain itself. However, little is known about whether CBT for somatoform pain disorder is effective, including the long-term course of the illness, in non-Western populations. We therefore tailored such a program based on an existing CBT protocol and examined its effectiveness in Japan. MethodsThirty-four Japanese participants (22 women; mean age=52.5 years) enrolled in a weekly 12-session group treatment, with 32 completing both wait-list and treatment conditions. The primary outcome measure was pain intensity. Secondary outcome measures included pain characteristics, as measured by pain catastrophizing and psychometric evaluations, including depression, anxiety, and quality of life. The patients were followed up for 12 months after treatment. ResultsWe found that pain intensity, anxiety, depressive symptoms, and social functioning all significantly improved after treatment compared with the wait-list period, and the improvements in pain intensity, depressive symptoms, and social functioning were sustained at 12 months following the completion of CBT. There were strong positive correlations (P<0.01) among pre- and post-treatment changes in the affective dimension of pain, depression, anxiety, and pain catastrophizing. ConclusionsThese results show that the present CBT program was effective for Japanese patients with somatoform pain disorder and that gains were maintained over the long term. More work is needed to further clarify the effects of CBT interventions on somatoform symptoms, particularly in Japan.	[Yoshino, Atsuo; Okamoto, Yasumasa; Takagaki, Koki; Jinnin, Ran; Yamashita, Hidehisa; Yamawaki, Shigeto] Hiroshima Univ, Grad Sch Biomed Sci, Dept Psychiat & Neurosci, Div Frontier, Hiroshima 7348551, Japan; [Doi, Mitsuru] Hiroshima Univ, Dept Dent Anesthesiol, Hiroshima 7348551, Japan; [Oshita, Kyoko; Nakamura, Ryuji; Kawamoto, Masashi] Hiroshima Univ, Dept Anesthesiol & Crit Care, Hiroshima 7348551, Japan; [Otsuru, Naofumi] Hiroshima Univ, Bioenvironm Adaptat Sci, Hiroshima 7348551, Japan; [Tanaka, Keisuke] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 7348551, Japan; [Horikoshi, Masaru] Natl Ctr Neurol & Psychiat, Natl Ctr Cognit Behav Therapy & Res, Tokyo, Japan; [Yoshimura, Shinpei] Otemon Gakuin Univ, Dept Psychol, Osaka, Japan	Yoshino, A (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Psychiat & Neurosci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yoshino@hiroshima-u.ac.jp			KAKENHI [24390284, 15K19730]; Ministry of Health, Labour and Welfare	This study was supported by KAKENHI Grant Number 24390284 and 15K19730, and by a grant for Comprehensive Research on Disability Health and Welfare, Ministry of Health, Labour and Welfare. The authors report no conflicts of interest.	Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; SPECKENS AEM, 1995, BRIT MED J, V311, P1328; Saariaho AS, 2013, GEN HOSP PSYCHIAT, V35, P239, DOI 10.1016/j.genhosppsych.2012.11.011; Vendrig AA, 1999, J BEHAV MED, V22, P217, DOI 10.1023/A:1018716406511; Deale A, 1997, AM J PSYCHIAT, V154, P408; Lackner JM, 2004, PSYCHOSOM MED, V66, P435, DOI 10.1097/01.psy.0000126195.82317.46; McCracken LM, 2002, SPINE, V27, P2564, DOI 10.1097/01.BRS.0000032130.45175.66; Arimura T, 2012, PAIN MED, V13, P541, DOI 10.1111/j.1526-4637.2012.01333.x; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; DRAGUNS JG, 1971, J NERV MENT DIS, V152, P3, DOI 10.1097/00005053-197101000-00002; Borsbo B, 2008, J REHABIL MED, V40, P562, DOI 10.2340/16501977-0207; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Kroenke K, 2007, PSYCHOSOM MED, V69, P881, DOI 10.1097/PSY.0b013e31815b00c4; Koelen JA, 2014, BRIT J PSYCHIAT, V204, P12, DOI 10.1192/bjp.bp.112.121830; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Yoshino A, 2013, NEUROIMAGE-CLIN, V2, P782, DOI 10.1016/j.nicl.2013.06.001; JENSEN MP, 1994, J CONSULT CLIN PSYCH, V62, P172, DOI 10.1037/0022-006X.62.1.172; Iwata N, 2000, J CLIN PSYCHOL, V56, P793, DOI 10.1002/(SICI)1097-4679(200006)56:6<793::AID-JCLP8>3.0.CO;2-4; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; HARKAPAA K, 1991, PAIN, V46, P35, DOI 10.1016/0304-3959(91)90031-R; Thorn BE, 2007, J PAIN, V8, P938, DOI 10.1016/j.jpain.2007.06.010; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037//1040-3590.7.4.524; Moreno S, 2013, PSYCHOSOM MED, V75, P600, DOI 10.1097/PSY.0b013e31829a8904; Petrak F, 2003, EUR J PAIN, V7, P463, DOI 10.1016/S1090-3801(03)00014-4; Beck A. T., 1996, BECK DEPRESSION INVE; Cohen J., 1988, STAT POWER ANAL BEHA; First MB, 2012, STRUCTURED CLIN INTE; Loeser J., 2001, PAIN MALIGNANT DIS; Lofland KR, 1997, INT J REHABILITATION, V3, P221, DOI 10.1023/B:IJRH.0000008153.61553.60; Matsubara T, 2010, J PHYS THER, V1, P49; Matsunaga M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-22; Nelson H. E., 1982, NATL ADULT READING T; Ono Y, 2000, TRANSCULT PSYCHIATRY, V37, P219, DOI 10.1177/136346150003700204; Otis JD, 2007, MANAGING CHRONIC PAI; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Spielberger C., 1983, MANUAL STATE TRAIT A; Thorn BE, 2004, COGNITIVE THERAPY CH; World Health Organisation, 1992, ICD 10 CLASS MENT BE; Yoshino A, 2014, PSYCHIAT RES-NEUROIM, V221, P246, DOI 10.1016/j.pscychresns.2013.12.006	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	2015	69	12					763	772		10.1111/pcn.12330		10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CX6LV	WOS:000365813400004		
J	Hagiya, K; Sumiyoshi, T; Kanie, A; Pu, SH; Kaneko, K; Mogami, T; Oshima, S; Niwa, S; Inagaki, A; Ikebuchi, E; Kikuchi, A; Yamasaki, S; Iwata, K; Nakagome, K				Hagiya, Kumiko; Sumiyoshi, Tomiki; Kanie, Ayako; Pu, Shenghong; Kaneko, Koichi; Mogami, Tamiko; Oshima, Sachie; Niwa, Shin-ichi; Inagaki, Akiko; Ikebuchi, Emi; Kikuchi, Akiko; Yamasaki, Syudo; Iwata, Kazuhiko; Nakagome, Kazuyuki			Facial expression perception correlates with verbal working memory function in schizophrenia	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						facial emotion perception; neurocognition; schizophrenia; social cognition; working memory	GENERALIZED POOR PERFORMANCE; SOCIAL COGNITION; EMOTION RECOGNITION; JAPANESE VERSION; NEUROCOGNITIVE FUNCTION; IMPROVE COGNITION; BATTERY; DEFICIT; SYMPTOMATOLOGY; IMPAIRMENT	AimsFacial emotion perception is considered to provide a measure of social cognition. Numerous studies have examined the perception of emotion in patients with schizophrenia, and the majority has reported impaired ability to recognize facial emotion perception. We aimed to investigate the correlation between facial expression recognition and other domains of social cognition and neurocognition in Japanese patients with schizophrenia. MethodsParticipants were 52 patients with schizophrenia and 53 normal controls with no history of psychiatric diseases. All participants completed the Hinting Task and the Social Cognition Screening Questionnaire. The Brief Assessment of Cognition in Schizophrenia was administered only to the patients. Facial emotion perception measured by the Facial Emotion Selection Test (FEST) was compared between the patients and normal controls. ResultsPatients performed significantly worse on the FEST compared to normal control subjects. The FEST total score was significantly positively correlated with scores of the Brief Assessment of Cognition in Schizophrenia attention subscale, Hinting Task, Social Cognition Screening Questionnaire Verbal Working Memory and Metacognition subscales. Stepwise multiple regression analysis revealed that verbal working memory function was positively related to the facial emotion perception ability in patients with schizophrenia. ConclusionsThese results point to the concept that facial emotion perception and some types of working memory use common cognitive resources. Our findings may provide implications for cognitive rehabilitation and related interventions in schizophrenia.	[Hagiya, Kumiko; Sumiyoshi, Tomiki; Kanie, Ayako; Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 1878553, Japan; [Kikuchi, Akiko] Natl Ctr Neurol & Psychiat, Dept Forens Psychiat, Kodaira, Tokyo 1878553, Japan; [Inagaki, Akiko] Univ Tokyo, Grad Sch Med, Dept Psychiat Nursing, Tokyo, Japan; [Inagaki, Akiko; Ikebuchi, Emi] Teikyo Univ, Sch Med, Dept Neuropsychiat, Tokyo 173, Japan; [Yamasaki, Syudo] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 113, Japan; [Hagiya, Kumiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neuropsychiat, Kofu, Yamanashi, Japan; [Pu, Shenghong; Kaneko, Koichi] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neuropsychiat, Tottori 680, Japan; [Mogami, Tamiko] Tottori Univ, Grad Sch Med Sci, Dept Clin Psychol, Tottori 680, Japan; [Oshima, Sachie; Niwa, Shin-ichi] Fukushima Med Univ, Dept Neuropsychiat, Fukushima, Japan; [Iwata, Kazuhiko] Osaka Psychiat Med Ctr, Dept Psychiat, Osaka, Japan	Hagiya, K (reprint author), Natl Ctr Neurol & Psychiat, Dept Psychiat, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan.	hagiya@ncnp.go.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	NCNP [21-1, 27-1]; Health and Labour Sciences Research Grants for Comprehensive Research on Disability, Health, and Welfare [H24-Seishin-Ippan-002, H26-Seishin-Ippan-011]; Japan Society for the Promotion of Science [26461761]	This study was supported by Intramural Research Grants for Neurological and Psychiatric Disorders of NCNP (21-1 and 27-1), Health and Labour Sciences Research Grants for Comprehensive Research on Disability, Health, and Welfare (H24-Seishin-Ippan-002 and H26-Seishin-Ippan-011), and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (26461761). There are no conflicts of interest for any of the authors of this paper. No author has any possible financial gain for the findings presented here.	Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Turetsky BI, 2007, SCHIZOPHR RES, V94, P253, DOI 10.1016/j.schres.2007.05.001; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; KERR SL, 1993, J ABNORM PSYCHOL, V102, P312, DOI 10.1037/0021-843X.102.2.312; Smith MJ, 2014, SCHIZOPHRENIA BULL, V40, P824, DOI 10.1093/schbul/sbt084; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Salem JE, 1996, J ABNORM PSYCHOL, V105, P480, DOI 10.1037/0021-843X.105.3.480; Kohler CG, 2000, BIOL PSYCHIAT, V48, P127, DOI 10.1016/S0006-3223(00)00847-7; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Lysaker PH, 2014, PSYCHIAT RES, V219, P79, DOI 10.1016/j.psychres.2014.05.004; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Savla GN, 2013, SCHIZOPHRENIA BULL, V39, P979, DOI 10.1093/schbul/sbs080; Roberts DL, 2011, SCHIZOPHRENIA BULL, V37, P280; Green MF, 2005, SCHIZOPHRENIA BULL, V31, P882, DOI 10.1093/schbul/sbi049; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Mu YG, 2012, NEURO-ONCOLOGY, V14, P81, DOI 10.1093/neuonc/nos215; Kee KS, 1998, PSYCHIAT RES, V81, P57, DOI 10.1016/S0165-1781(98)00083-3; Mueser KT, 1996, J ABNORM PSYCHOL, V105, P271, DOI 10.1037/0021-843X.105.2.271; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Meyer MB, 2009, SCHIZOPHR RES, V110, P173, DOI 10.1016/j.schres.2009.03.015; Bryson G, 1997, PSYCHIAT RES, V71, P105, DOI 10.1016/S0165-1781(97)00050-4; Gonzalez-Garrido AA, 2007, INT J PSYCHOPHYSIOL, V65, P141, DOI 10.1016/j.ijpsycho.2007.04.005; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ventura J, 2013, SCHIZOPHRENIA BULL, V39, P102, DOI 10.1093/schbul/sbr067; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; SCHNEIDER F, 1995, SCHIZOPHR RES, V17, P67, DOI 10.1016/0920-9964(95)00031-G; Shiraishi Y, 2011, PERCEPT MOTOR SKILL, V113, P409, DOI 10.2466/02.13.15.27.PMS.113.5.409-420; Kanie A, 2014, PSYCHIAT CLIN NEUROS, V68, P701, DOI 10.1111/pcn.12181; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sb1029; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Green Michael F, 2006, J Clin Psychiatry, V67, pe12; Kaneda Y, 2013, SEISHIN IGAKU CLIN P, V55, P167	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	2015	69	12					773	781		10.1111/pcn.12329		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CX6LV	WOS:000365813400005		
J	Suppasri, A; Goto, K; Muhari, A; Ranasinghe, P; Riyaz, M; Affan, M; Mas, E; Yasuda, M; Imamura, F				Suppasri, Anawat; Goto, Kazuhisa; Muhari, Abdul; Ranasinghe, Prasanthi; Riyaz, Mahmood; Affan, Muzailin; Mas, Erick; Yasuda, Mari; Imamura, Fumihiko			A Decade After the 2004 Indian Ocean Tsunami: The Progress in Disaster Preparedness and Future Challenges in Indonesia, Sri Lanka, Thailand and the Maldives	PURE AND APPLIED GEOPHYSICS			English	Article						2004 Indian Ocean tsunami; reconstruction; disaster preparedness; disaster risk reduction	FIELD SURVEY; PAKARANG CAPE; EARTHQUAKE; REDUCTION; SUMATRA; HAZARD; RECONSTRUCTION; EDUCATION; PROVINCE; COAST	The 2004 Indian Ocean tsunami was one of the most devastating tsunamis in world history. The tsunami caused damage to most of the Asian and other countries bordering the Indian Ocean. After a decade, reconstruction has been completed with different levels of tsunami countermeasures in most areas; however, some land use planning using probabilistic tsunami hazard maps and vulnerabilities should be addressed to prepare for future tsunamis. Examples of early-stage reconstruction are herein provided alongside a summary of some of the major tsunamis that have occurred since 2004, revealing the tsunami countermeasures established during the reconstruction period. Our primary objective is to report on and discuss the vulnerabilities found during our field visits to the tsunami-affected countries-namely, Indonesia, Sri Lanka, Thailand and the Maldives. For each country, future challenges based on current tsunami countermeasures, such as land use planning, warning systems, evacuation facilities, disaster education and disaster monuments are explained. The problem of traffic jams during tsunami evacuations, especially in well-known tourist areas, was found to be the most common problem faced by all of the countries. The readiness of tsunami warning systems differed across the countries studied. These systems are generally sufficient on a national level, but local hazards require greater study. Disaster reduction education that would help to maintain high tsunami awareness is well established in most countries. Some geological evidence is well preserved even after a decade. Conversely, the maintenance of monuments to the 2004 tsunami appears to be a serious problem. Finally, the reconstruction progress was evaluated based on the experiences of disaster reconstruction in Japan. All vulnerabilities discussed here should be addressed to create long-term, disaster-resilient communities.	[Suppasri, Anawat; Goto, Kazuhisa; Mas, Erick; Yasuda, Mari; Imamura, Fumihiko] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Muhari, Abdul] Minist Marine Affairs & Fisheries, Jakarta, Indonesia; [Ranasinghe, Prasanthi] Lanka Hydraul Inst Ltd, Moratuwa, Sri Lanka; [Riyaz, Mahmood] Maldives Energy & Environm Co, Male, Maldives; [Affan, Muzailin] Syiah Kuala Univ, Fac Math & Nat Sci, Banda Aceh, Indonesia	Suppasri, A (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan.	suppasri@irides.tohoku.ac.jp			Reconstruction Agency of the Government of Japan; Tokio Marine & Nichido Fire Insurance Co., Ltd. through IRIDeS, Tohoku University	Dr. Anawat Suppasri would like to express sincere gratitude to ADRC for supporting his trip to the Maldives and to TMD and RIMES for their local support. Dr. Prasanthi Ranasinghe would like to convey her gratitude to the Lanka Hydraulic Institute Ltd (LHI) for providing literature that contributed to the Sri Lankan section. This research was funded by the Reconstruction Agency of the Government of Japan and Tokio Marine & Nichido Fire Insurance Co., Ltd. through IRIDeS, Tohoku University. The authors greatly appreciate Dr. Hermann M. Fritz, guest editor, two anonymous reviewers and Joshua Macabuag from University College London for valuable comments on the entire paper.	AMATEUR SEISMIC CENTER (ASC), 2005, M8 7 NIAS SIM EARTHQ; Liu PLF, 2005, SCIENCE, V308, P1595, DOI 10.1126/science.1110730; Hill EM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009159; Fritz HM, 2006, EARTHQ SPECTRA, V22, pS137, DOI 10.1193/1.2201973; Kuwata Y, 2010, J EARTHQ TSUNAMI, V4, P73, DOI 10.1142/S1793431110000789; Takada S, 2010, J EARTHQ TSUNAMI, V4, P83, DOI 10.1142/S1793431110000777; Fritz HM, 2006, EARTHQ SPECTRA, V22, pS219, DOI 10.1193/1.2201972; Borrero JC, 2009, GEOPHYS J INT, V178, P180, DOI 10.1111/j.1365-246X.2008.04058.x; Mikami T, 2014, NAT HAZARDS, V71, P851, DOI 10.1007/s11069-013-0936-z; [Anonymous], 2010, TELEGRAPH; Lauterjung J, 2010, NAT HAZARD EARTH SYS, V10, P641; Okal EA, 2008, GEOPHYS J INT, V172, P995, DOI 10.1111/j.1365-246X.2007.03674.x; Suppasri A, 2012, J EARTHQ TSUNAMI, V6, DOI 10.1142/S1793431112500108; Goto K, 2011, GEOMORPHOLOGY, V127, P107, DOI 10.1016/j.geomorph.2010.12.011; [Anonymous], 2007, BBC NEWS; Goto K, 2007, SEDIMENT GEOL, V202, P821, DOI 10.1016/j.sedgeo.2007.09.004; Goto Y, 2010, J EARTHQ TSUNAMI, V4, P115, DOI 10.1142/S1793431110000728; Monecke K, 2008, NATURE, V455, P1232, DOI 10.1038/nature07374; Murao O, 2010, J EARTHQ TSUNAMI, V4, P51, DOI 10.1142/S1793431110000765; Burbidge D, 2008, PURE APPL GEOPHYS, V165, P2059, DOI 10.1007/s00024-008-0421-x; Stein S, 2005, NATURE, V434, P581, DOI 10.1038/434581a; Jankaew K, 2008, NATURE, V455, P1228, DOI 10.1038/nature07373; Munch U, 2011, NAT HAZARD EARTH SYS, V11, P765, DOI 10.5194/nhess-11-765-2011; Stein S, 2007, B SEISMOL SOC AM, V97, pS279, DOI 10.1785/0120050617; [Anonymous], 2012, ALJAZEERA NEWS; Yanagisawa H, 2009, ESTUAR COAST SHELF S, V81, P27, DOI 10.1016/j.ecss.2008.10.001; Ranasinghe DPL, 2013, COAST ENG, V81, P67, DOI 10.1016/j.coastaleng.2013.07.004; Goto K, 2012, EARTH PLANETS SPACE, V64, P923, DOI 10.5047/eps.2011.08.019; Riyaz M, 2010, J EARTHQ TSUNAMI, V4, P135, DOI 10.1142/S1793431110000704; Lovholt F, 2006, NAT HAZARD EARTH SYS, V6, P979; Wijetunge JJ, 2009, OCEAN ENG, V36, P960, DOI 10.1016/j.oceaneng.2009.06.002; Diposaptono S, 2013, GEOPHYS J INT, V194, P1625, DOI 10.1093/gji/ggt175; Hyndman J, 2009, NORSK GEOGR TIDSSKR, V63, P89, DOI 10.1080/00291950802712178; Satake K, 2013, PURE APPL GEOPHYS, V170, P1567, DOI 10.1007/s00024-012-0536-y; Goff J, 2006, EARTHQ SPECTRA, V22, pS155, DOI 10.1193/1.2205897; Siripong A, 2010, J EARTHQ TSUNAMI, V4, P61, DOI 10.1142/S1793431110000716; ASIAN DEVELOPMENT BANK (ADB), 2005, JAP BANK INT COOP WO; BAUMAN P., 2007, J PEACEBUILDING DEV, V3, P6; BORRERO J. C., 2006, EARTHQ SPECTRA, V22, P93; Borrero JC, 2011, PURE APPL GEOPHYS, V168, P1075, DOI 10.1007/s00024-010-0218-6; CH2MHILL and LANKA HYDRAULIC INSTITUTE LTD, 2006, MAIN REP FISH HARB R, P1; Disaster Prevention Research Institute (DPRI), 2004, HDB DIS PREV SCI; Enia J., 2008, J PUBLIC INT AFFAIRS, V19, P7; FRANCO G., 2013, OBSERVATIONS RECOVER; GEIST E., 2009, SOUND WAVES COAS DEC; Goto Y., 2012, J DISASTER RES, V7, P92; GOTO Y., 2012, RESPONSE PEOPLE BAND; IMAMURA F., 2008, J EARTHQ TSUNAMI, V3, P59; Jaffe B.E., 2006, EARTHQ SPECTRA, V22, P105; KHAZAI B., 2006, EARTHQ SPECTRA, V22, P829; KUHN R., 2009, TSUNAMI CONFLICT SRI; KUWATA Y., 2011, POSTTSUNAMI LIFELINE; LATIEF H., 2008, INT C TSUN WARN ICTW; MINISTRY OF ENVIRONMENT ENERGY and WATER, 2007, NAT AD PROGR ACT; MUHARI A., 2014, CANCEL TSUNAMI WARNI; NOAA National Geophysical Data Center (NGDC), 2014, TSUN EV DAT; OAK RIDGE NATIONAL LABORATORY, 2006, LANDSCAN 2006; Okal EA, 2006, EARTHQ SPECTRA, V22, pS203, DOI 10.1193/1.2202647; Okal EA, 2006, EARTHQ SPECTRA, V22, pS241, DOI 10.1193/1.2209190; Okal EA, 2006, EARTHQ SPECTRA, V22, pS263, DOI 10.1193/1.2202646; Pariatmono, 2012, J DISASTER RES, V7, P102; Ruangrassamee A, 2006, EARTHQ SPECTRA, V22, P377; SAMEK J.H., 2004, ASSESSMENT IMPACT DE; SUPPASRI A., 2010, THESIS; Suppasri A. Muhari, 2012, J NATURAL DISASTER S, V34, P19; Synolakis C., 2006, EARTHQ SPECTRA, V22, P67; TOMITA T., 2011, FIELD SURVEY 2010 ME; UDO K., 2013, J JAPAN SOC CIVIL B2, V69, pI1391; US GEOLOGICAL SURVEY (USGS), 2007, MAGN 8 5 SO SUM IND; US GEOLOGICAL SURVEY (USGS), 2005, M8 7 NO SUM EARTHQ 2; US GEOLOGICAL SURVEY (USGS), 2012, M8 6 M8 2 NO SUM IND; Weiss R, 2006, EARTHQ SPECTRA, V22, pS235, DOI 10.1193/1.2201970; WIJAYARATNA N., 2006, P INT C TSUN STORM S; YASUDA M., 2014, P INT SEM 10 YEARS C	74	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2015	172	12			SI		3313	3341		10.1007/s00024-015-1134-6		29	Geochemistry & Geophysics	Geochemistry & Geophysics	CX5BR	WOS:000365716200004		
J	Mas, E; Koshimura, S; Imamura, F; Suppasri, A; Muhari, A; Adriano, B				Mas, Erick; Koshimura, Shunichi; Imamura, Fumihiko; Suppasri, Anawat; Muhari, Abdul; Adriano, Bruno			Recent Advances in Agent-Based Tsunami Evacuation Simulations: Case Studies in Indonesia, Thailand, Japan and Peru	PURE AND APPLIED GEOPHYSICS			English	Article							MODELS; MITIGATION; AREA	As confirmed by the extreme tsunami events over the last decade (the 2004 Indian Ocean, 2010 Chile and 2011 Japan tsunami events), mitigation measures and effective evacuation planning are needed to reduce disaster risks. Modeling tsunami evacuations is an alternative means to analyze evacuation plans and possible scenarios of evacuees' behaviors. In this paper, practical applications of an agent-based tsunami evacuation model are presented to demonstrate the contributions that agent-based modeling has added to tsunami evacuation simulations and tsunami mitigation efforts. A brief review of previous agent-based evacuation models in the literature is given to highlight recent progress in agent-based methods. Finally, challenges are noted for bridging gaps between geoscience and social science within the agent-based approach for modeling tsunami evacuations.	[Mas, Erick; Koshimura, Shunichi; Imamura, Fumihiko; Suppasri, Anawat] Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Sendai, Miyagi 980, Japan; [Muhari, Abdul] Minist Marine Affairs & Fisheries, Jakarta, Indonesia; [Adriano, Bruno] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan	Mas, E (reprint author), Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Sendai, Miyagi 980, Japan.	mas@irides.tohoku.ac.jp			SATREPS Peru project; CREST project of JST; IRIDeS grant;  [25242035]	This research was financially supported by Grant-in-Aid for Scientific Research (Project numbers: 25242035), SATREPS Peru project, CREST project of JST, and IRIDeS grant. In addition, we offer a special thanks to the two anonymous reviewers and the editor in charge of this paper from whom we have received valuable comments that improved the quality of this publication.	ABUSTAN M. S., 2012, P COASTAL ENG JSCE, V3, P56; [Anonymous], 2006, CTR ADV SPATIAL ANAL; Lammel G, 2010, PEDESTRIAN AND EVACUATION DYNAMICS 2008, P171, DOI 10.1007/978-3-642-04504-2_13; Suppasri A, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500052; Wijerathne MLL, 2013, PROCEDIA COMPUT SCI, V18, P1515, DOI 10.1016/j.procs.2013.05.319; Gierlach E, 2010, RISK ANAL, V30, P1539, DOI 10.1111/j.1539-6924.2010.01451.x; Synolakis CE, 2006, PHILOS T R SOC A, V364, P2231, DOI 10.1098/rsta.2006.1824; Gonzalez-Riancho P, 2013, NAT HAZARD EARTH SYS, V13, P3249, DOI 10.5194/nhess-13-3249-2013; LACHMAN R, 1961, SCIENCE, V133, P1405, DOI 10.1126/science.133.3462.1405; Bird DK, 2009, NAT HAZARD EARTH SYS, V9, P1307; Simonovic SP, 2005, NAT HAZARDS, V34, P25, DOI 10.1007/s11069-004-0785-x; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Muhari A, 2011, NAT HAZARD EARTH SYS, V11, P3107, DOI 10.5194/nhess-11-3107-2011; Vorst HCM, 2010, PROCEDIA ENGINEER, V3, P15, DOI 10.1016/j.proeng.2010.07.004; Bernard EN, 2006, PHILOS T R SOC A, V364, P1989, DOI 10.1098/rsta.2006.1809; CHARKNOL T., 2006, IATSS RES, V30, P83; Clerveaux V., 2008, SCI TSUNAMI HAZARDS, V27, P48; DEWI R. S., 2012, J INTEGRATED DISASTE, V2, P1, DOI [10.5595/idrim.2012.0023, DOI 10.5595/IDRIM.2012.0023]; DUNIN-KEPLICZ B., 2010, TEAMWORK MULTIAGENT, P246; FRASER S., 2012, TSUNAMI EVACUATION L, P1; FREIRE S., 2012, P INT C NTMS IST TUR, P1; FUJIOKA M., 2002, J ARCHITECTURE PLANN, V562, P231; Goto Y., 2012, J DISASTER RES, V7, P92; HELBING D., 2011, DO AGENT BASED SIMUL, P1; HELBING D., 2010, SOCIAL SIMULATION IN; HOPPE M., 2009, 25 GTZGITEWS; IMAMURA F., 2012, J DISASTER RES, V7; IMAMURA F., 2001, J JAPAN SOC NATURAL, V20, P183; Japan Meteorological Agency (JMA), 2013, LESS LEARN TSUN DIS, P1; JOHNSTON K. M., 2013, AGENT ANAL, P1; KATADA T., 2006, T JAPAN SOC CIVIL D, V62, P250; KATADA T., 2005, P JAPAN SOC CIVIL EN, V789, P93; Katada Toshitaka, 2004, RES J SOCIAL ENG, V2, P199; KATO S., 2009, J JAPAN SOC CIVIL B2, V65, P1316, DOI [10.2208/kaigan.65.1316, DOI 10.2208/KAIGAN.65.1316]; KENNEDY W.G., 2012, AGENT BASED MODELS G, P1; KIETPAWPAN M., 2008, SIMULATION APPROACH; LIU R., 2014, J INF TECHNOL, V19, P336; Mas E., 2012, J NATURAL DISASTER S, V34, P41; MAS E., 2013, 10 INT C URB EARTHQ, P1; MAS E., 2011, 25 IUGG GEN ASS INT; MAS E., 2013, J DISASTER RES, V8, P285; MEGURO K., 2005, PRODUCTION RES, V57, P343; Muhari A., 2011, J NAT DISASTER SCI, V34, P91; MUNADI K., 2012, P 2 ANN INT C SYIAH, P254; MURAKAMI H., 2012, 15 WORLD C EARTHQ EN, P1; NGUYEN T. N. A., 2012, SIMULATION EMERGENCY, P1; NGUYEN T. N. A., 2012, AAMAS 2011 WORKSH, P371; NOZAWA S., 2006, GEOGRAPHICAL INFORM, V15, P483; Oikawa Y, 2000, J CIV ENG INF PROCES, V9, P129; Ormerod P, 2009, LECT NOTES ARTIF INT, V5466, P130, DOI 10.1007/978-3-642-01109-2_10; Pan X., 2007, AI SOC, V22, P113, DOI DOI 10.1186/1471-2105-6-228; Park S, 2012, NAT HAZARDS, V63, P891, DOI 10.1007/s11069-012-0196-3; Pulido N., 2013, J DISAST RES, V8, P235; RAND W., 2006, VERIFICATION VALIDAT, P1; SAITO T., 1990, J JAPAN SOC NATURAL, V9, P49; SAITO T., 2004, 13 WORLD C EARTHQ EN, P1; Shendarkar A, 2006, Proceedings of the 2006 Winter Simulation Conference, Vols 1-5, P545, DOI 10.1109/WSC.2006.323128; SHUTO N., 2009, P 6 INT WORKSH COAST, P1; SUGIMOTO T., 2003, NAT HAZARDS, V2035, P585; SUPPASRI A., 2014, DAMAGE RECONSTRUCTIO; SUPPASRI A., 2010, THESIS; Suppasri A, 2012, PURE APPL GEOPHYS, V170, P993; Suzuki T., 2005, JAPAN SOC NAT DISAST, V23, P521; TAKAGI H., 2014, ANN M TOH BRANCH TEC, V3, P2011; USUZAWA H., 1997, ANN M TOH BRANCH TEC, P430; Watanabe K., 2009, J ARCHIT PLANN AIJ, V74, P627; WATTS JM, 1987, FIRE SAFETY J, V12, P237, DOI 10.1016/0379-7112(87)90008-7; Wood NJ, 2013, NAT HAZARDS, V65, P1603, DOI 10.1007/s11069-012-0434-8; WRAY R. E., 2003, BEHAV REPRESENTATION, P1; YAMAZAKI F., 2013, J DISASTER RES, V8, P224	70	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2015	172	12			SI		3409	3424		10.1007/s00024-015-1105-y		16	Geochemistry & Geophysics	Geochemistry & Geophysics	CX5BR	WOS:000365716200008		
J	Baba, T; Takahashi, N; Kaneda, Y; Ando, K; Matsuoka, D; Kato, T				Baba, Toshitaka; Takahashi, Narumi; Kaneda, Yoshiyuki; Ando, Kazuto; Matsuoka, Daisuke; Kato, Toshihiro			Parallel Implementation of Dispersive Tsunami Wave Modeling with a Nesting Algorithm for the 2011 Tohoku Tsunami	PURE AND APPLIED GEOPHYSICS			English	Article						2011 Tohoku tsunami; Boussinesq model; Dispersion; Soliton fission; Parallel computation	PACIFIC COAST; EARTHQUAKE; SLIP; INUNDATION; PROPAGATION; EQUATIONS; JAPAN	Because of improvements in offshore tsunami observation technology, dispersion phenomena during tsunami propagation have often been observed in recent tsunamis, for example the 2004 Indian Ocean and 2011 Tohoku tsunamis. The dispersive propagation of tsunamis can be simulated by use of the Boussinesq model, but the model demands many computational resources. However, rapid progress has been made in parallel computing technology. In this study, we investigated a parallelized approach for dispersive tsunami wave modeling. Our new parallel software solves the nonlinear Boussinesq dispersive equations in spherical coordinates. A variable nested algorithm was used to increase spatial resolution in the target region. The software can also be used to predict tsunami inundation on land. We used the dispersive tsunami model to simulate the 2011 Tohoku earthquake on the Supercomputer K. Good agreement was apparent between the dispersive wave model results and the tsunami waveforms observed offshore. The finest bathymetric grid interval was 2/9 arcsec (approx. 5 m) along longitude and latitude lines. Use of this grid simulated tsunami soliton fission near the Sendai coast. Incorporating the three-dimensional shape of buildings and structures led to improved modeling of tsunami inundation.	[Baba, Toshitaka; Takahashi, Narumi; Kaneda, Yoshiyuki; Ando, Kazuto; Matsuoka, Daisuke] Japan Agcy Marine Earth Sci & Technol, Yokohama Inst Earth Sci, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Kato, Toshihiro] NEC Corp Ltd, Minato Ward, Tokyo 1088001, Japan	Baba, T (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minami Jyousanjima Cho, Tokushima 7708506, Japan.	baba.toshi@tokushima-u.ac.jp			Science and Technology Research Partnership for Sustainable Development	Dr Hong Kie Thio, Dr Phil Cummins, and Dr David Burbidge kindly provided us with the URSGA tsunami software. The wave flume experimental data was provided by the Central Research Institute of the Electric Power Industry. The 2011 Tohoku tsunami data for the GPS buoy were provided by the Ministry of Land, Infrastructure, Transport and Tourism, and DART data came from the Pacific Marine Environmental Laboratory. The DEM and 3D building data were provided by the Geospatial Information Authority of Japan. The digital data of the initial sea-surface displacement of the 2011 Tohoku tsunami were provided by Dr Tatsuhiko Saito. Comments from Dr Takayuki Miyoshi and Dr Takane Hori were very useful for improving the manuscript. We thank anonymous reviewers for constructive comments. This research was implemented in the Strategic Programs for Innovative Research, Field 3, and was also partially supported by the Science and Technology Research Partnership for Sustainable Development. Some figures were prepared by use of Generic Mapping Tools (WESSEL and SMITH 1998), Seismic Analysis Code (GOLDSTEIN et al. 2007), and ArcGIS.	Aida I., 1978, Journal of Physics of the Earth, V26; Maeda T, 2011, EARTH PLANETS SPACE, V63, P803, DOI 10.5047/eps.2011.06.005; Shao GF, 2011, EARTH PLANETS SPACE, V63, P559, DOI 10.5047/eps.2011.06.028; Zhou H, 2011, NAT HAZARD EARTH SYS, V11, P2677, DOI 10.5194/nhess-11-2677-2011; Tsushima H, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008877; Madsen PA, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004932; Son S, 2011, OCEAN MODEL, V38, P96, DOI 10.1016/j.ocemod.2011.02.007; Matsuyama M, 2007, PURE APPL GEOPHYS, V164, P617, DOI 10.1007/s00024-006-0177-0; Nishimura T, 2011, EARTH PLANETS SPACE, V63, P631, DOI 10.5047/eps.2011.06.025; Kirby JT, 2013, OCEAN MODEL, V62, P39, DOI 10.1016/j.ocemod.2012.11.009; Saito T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006884; Jakeman JD, 2010, OCEAN DYNAM, V60, P1115, DOI 10.1007/s10236-010-0312-4; Goto K, 2012, EARTH PLANETS SPACE, V64, P1247, DOI 10.5047/eps.2012.02.007; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Lovholt F, 2012, NAT HAZARD EARTH SYS, V12, P1017, DOI 10.5194/nhess-12-1017-2012; Roeber V, 2010, COAST ENG, V57, P407, DOI 10.1016/j.coastaleng.2009.11.007; Hayashi Y, 2011, EARTH PLANETS SPACE, V63, P809, DOI 10.5047/eps.2011.06.042; Grilli ST, 2013, PURE APPL GEOPHYS, V170, P1333, DOI 10.1007/s00024-012-0528-y; Ito T, 2011, EARTH PLANETS SPACE, V63, P627, DOI 10.5047/eps.2011.06.023; Suito H, 2011, EARTH PLANETS SPACE, V63, P615, DOI 10.5047/eps.2011.06.053; Sitanggang KI, 2005, INT J NUMER METH FL, V49, P57, DOI 10.1002/fld.985; Ammon CJ, 2011, EARTH PLANETS SPACE, V63, P693, DOI 10.5047/eps.2011.05.015; Saito T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049089; Baba T, 2014, TSUNAMI EVENTS LESSO, V35, P89, DOI DOI 10.1007/978-94-007-7269-4_; CERJAN C, 1985, GEOPHYSICS, V50, P705, DOI 10.1190/1.1441945; Goldstein P., 2007, SAC SEISMIC ANAL COD; Horillo J., 2006, MAR GEOD, V29, P149; Imamura F., 2011, TSUNAMI SIMULATION 2; Iwase H., 2005, THESIS; Japan Society of Civil Engineers, 2002, TSUN ASS METH NUCL P; Kido Y., 2011, JAP GEOSC UN M; Mori N, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500015; Murashima Y., 2012, J JAPAN SOC CIVIL EN, V68; Murashima Y., 2010, J JAPAN SOC CIVIL EN, V66, P201; Peregrine H., 1972, WAVES BEACHES RESULT, P95; W. H. Press, 1986, NUMERICAL RECIPES; Satake K, 2002, INT HDB EARTHQUAKE A, V81A, P437, DOI 10.1016/S0074-6142(02)80231-5; Shigihara Y., 2006, J DISASTER RES, V1, P142; Shuto N., 1985, COASTAL ENG JAPAN JS, V28, P255; Takagawa T., 2012, J JAPAN SOC CIVIL EN, p[68, I_311]; WESSEL P, 1998, EOS T AGU, V0079; Yagi Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048701	42	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2015	172	12			SI		3455	3472		10.1007/s00024-015-1049-2		18	Geochemistry & Geophysics	Geochemistry & Geophysics	CX5BR	WOS:000365716200011		
J	Sozdinler, CO; Yalciner, AC; Zaytsev, A; Suppasri, A; Imamura, F				Sozdinler, Ceren Ozer; Yalciner, Ahmet Cevdet; Zaytsev, Andrey; Suppasri, Anawat; Imamura, Fumihiko			Investigation of Hydrodynamic Parameters and the Effects of Breakwaters During the 2011 Great East Japan Tsunami in Kamaishi Bay	PURE AND APPLIED GEOPHYSICS			English	Article						Tsunami; inundation; current velocity; water surface elevation; flow depth; Froude number; tsunami damage; dynamic tsunami input; march 11 2011 Great East Japan Tsunami	TOHOKU EARTHQUAKE	The March 2011 Great East Japan Tsunami was one of the most disastrous tsunami events on record, affecting the east coast of Japan to an extreme degree. Extensive currents combined with flow depths in inundation zones account for this devastating impact. Video footage taken by the eyewitnesses reveals the destructive effect and dragging capability of strong tsunami currents along the coast. This study provides a numerical modeling study in Kamaishi Bay, calculating the damage inflicted by tsunami waves on structures and coastlines in terms of the square of the Froude number Fr (2) ; and also other calculated hydrodynamic parameters, such as the distribution of instantaneous flow depths, maximum currents and water surface elevations that occurred during this catastrophic tsunami. Analyses were performed by using the tsunami numerical modeling code NAMI DANCE with nested domains at a higher resolution. The effect of the Kamaishi breakwater on the tsunami inundation distance and coastal damage was tested by using the conditions of "with breakwater," "without breakwater," and "damaged breakwater." Results show that the difference between the hydrostatic pressure on the seaward side of the breakwater and the leeward side of the breakwater is quite high, clarifying conditions contributing to failure of the breakwater. Lower water surface elevations were calculated in the case of a breakwater existing at the entrance, a partly valid condition for the damaged breakwater case. The results are different for current velocities and in the "with breakwater" condition due to the concentration of energy through the breakwater gaps.	[Sozdinler, Ceren Ozer] Bogazici Univ, Kandilli Observ, Dept Geophys, TR-34684 Istanbul, Turkey; [Sozdinler, Ceren Ozer] Earthquake Res Inst, TR-34684 Istanbul, Turkey; [Yalciner, Ahmet Cevdet] Middle E Tech Univ, Ocean Engn Res Ctr, Dept Civil Engn, TR-06800 Ankara, Turkey; [Zaytsev, Andrey] Russian Acad Sci, Far Eastern Branch, Special Res Bur Automat Marine Res, Yuzhno Sakhalinsk 693013, Russia; [Zaytsev, Andrey] Nizhnii Novgorod State Tech Univ, Nizhnii Novgorod 603950, Russia; [Suppasri, Anawat; Imamura, Fumihiko] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, Sendai, Miyagi 9800845, Japan	Sozdinler, CO (reprint author), Bogazici Univ, Kandilli Observ, Dept Geophys, TR-34684 Istanbul, Turkey.	ceren.ozer@boun.edu.tr; yalciner@metu.edu.tr; aizaytsev@mail.ru; suppasri@irides.tohoku.ac.jp; imamura@irides.tohoku.ac.jp			Scientific and Technological Research Council of Turkey (TUBITAK) [108Y227]; European Commission	The authors would like to acknowledge the partial support of the Scientific and Technological Research Council of Turkey (TUBITAK) research grant no: 108Y227, "Model Development and Risk Analysis for Tsunamis in the Black Sea and Mediterranean (MORAT)" and by European Commission-funded research project "Tsunami Risk ANd Strategies For the European Region (TRANSFER)." The authors also acknowledge the precious colleagues from PARI who provided the Kamaishi GPS buoy tsunami wave record.	Ozer C, 2011, PURE APPL GEOPHYS, V168, P2083, DOI 10.1007/s00024-011-0290-6; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Yalciner AC, 2007, OCEAN ENG, V34, P747, DOI 10.1016/j.oceaneng.2006.05.016; Koketsu K, 2011, EARTH PLANET SC LETT, V310, P480, DOI 10.1016/j.epsl.2011.09.009; Zahibo N, 2003, NAT HAZARD EARTH SYS, V3, P367; Leelawat N, 2014, NAT HAZARDS, V73, P449, DOI 10.1007/s11069-014-1081-z; Suppasri A, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500088; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Suppasri A, 2013, PURE APPL GEOPHYS, V170, P993, DOI 10.1007/s00024-012-0511-7; Yalciner AC, 2002, MAR GEOL, V190, P445, DOI 10.1016/S0025-3227(02)00358-4; Arikawa T., 2013, P 6 CIV ENG C AS REG; Arikawa T., 2009, J DISASTER RES, V4, P377; Arikawa T, 2012, P 33 INT C COAST ENG; Asakura R., 2000, P COASTAL ENG JSCE, V47, P911; Charvet I., 2014, STOCH ENV RES RISK A, DOI [10.1193/053013EQS138M, DOI 10.1193/053013EQS138M]; Coastal Engineering Committee Japan, 2011, TSUN HEIGHT DISTR; Fujima K., 2009, P 6 INT WORKSH COAST, P61; Geospatial Information Authority Japan, 2011, TSUN IN MAP; Goto C., 1997, MANUAL GUIDES, V35, P4; Imamura F., 2011, 2011 E JAPAN PACIFIC; Imamura F., 2001, TSUNAMI MODELLING MA; Imamura F., 1995, NUMERICAL METHOD T 2; Imamura F., 1989, TSUNAMI NUMERICAL SI; Iwate-Miyagi-Fukushima Province Japan, 2011, OBS TSUN IW MIYAG FU; Koizumi T., 2011, UNESCO IOC TSUN CIV; Koshimura S., 2009, J DISASTER RES, V4, P404; KURKIN A.A., 2003, IZVESTIA, V4, P126; NAMI DANCE, 2011, MAN NUM COD NAMI DAN; Onishi N, 2011, NEW YROK TIMES; Ozer C, 2012, THESIS; Ozer C., 2008, P 7 INT C COAST PROT; Ozer Sozdinler C., 2014, J PURE APPL GEOPHYS, V2014, DOI [10.1007/s00024-014-0947-z, DOI 10.1007/S00024-014-0947-Z]; Shuto N., 1990, COASTAL ENG JAPAN, V33, P173; Shuto N., 2009, Journal of Disaster Research, V4, P462; Suppasri A., 2011, JST JICA RISTEK INDO; Takahashi S., 2011, URGENT SURVEY 2011 G; Yalciner A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002113; Yalciner A.C., 2010, P 32 INT C COAST ENG; Yalciner A.C., 2003, NATO SCI SERIES; Yalciner A.C., 2001, INT TSUN S ITS 2001, P557; Zaitsev A., 2008, P 7 INT C COAST PORT; Zaitsev A.I., 2002, APPL MATH MECH, V3, P27	42	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	DEC	2015	172	12			SI		3473	3491		10.1007/s00024-015-1051-8		19	Geochemistry & Geophysics	Geochemistry & Geophysics	CX5BR	WOS:000365716200012		
J	Ono, T; Nakamura, T; Azami, Y; Yamaguchi, H; Hayashi, Y; Suzuki, M; Hatayama, Y; Tsukiyama, I; Hareyama, M; Kikuchi, Y; Nemoto, K				Ono, Takashi; Nakamura, Tatsuya; Azami, Yusuke; Yamaguchi, Hisashi; Hayashi, Yuichiro; Suzuki, Motohisa; Hatayama, Yoshiomi; Tsukiyama, Iwao; Hareyama, Masato; Kikuchi, Yasuhiro; Nemoto, Kenji			Clinical results of proton beam therapy for twenty older patients with esophageal cancer	RADIOLOGY AND ONCOLOGY			English	Article						proton therapy; aged; esophageal neoplasms; radiotherapy	SQUAMOUS-CELL CARCINOMA; 3-DIMENSIONAL CONFORMAL RADIATION; INVOLVED-FIELD IRRADIATION; DEFINITIVE CHEMORADIOTHERAPY; THORACIC ESOPHAGUS; NODAL IRRADIATION; PROSPECTIVE TRIAL; CHEMOTHERAPY; RADIOTHERAPY; PATTERNS	Background. In an aging society, increasing number of older patients are diagnosed with esophageal cancer. The purpose of this study was to assess the clinical efficacy and safety of proton beam therapy for older patients with esophageal cancer. Patients and methods. Older patients (age: >= 65 years) newly diagnosed with esophageal cancer between January 2009 and June 2013 were enrolled in this study. All patients underwent either proton beam therapy alone or proton beam therapy with initial X-ray irradiation. Toxicities were evaluated using the Common Terminology Criteria for Adverse Events version 4.0. Results. Twenty patients were eligible for this study and all completed the treatment. The median age was 78 years (range: 65-89 years) and the median follow-up time was 26.5 months (range: 6-62 months). Seven patients had lymph node metastases and 10 had stage II/III cancer. The median dose of proton beam therapy was 72.6 Gy relative biological dose effectiveness (RBE) (range: 66-74.8 Gy [RBE]) for proton beam therapy alone and 33 Gy (RBE) (range: 30.8-39.6 Gy [RBE]; total dose range: 66.8-75.6 Gy [RBE]) for proton beam therapy with initial X-ray irradiation. The 2-year overall survival rate was 81.8% (95% confidence interval [CI]: 62.4%-100%), and the 2-year local control rate was 89.4% (95% CI: 75.5%-100%). Grade 2 or 3 toxicities occurred in some cases; however, no grade 4 or 5 toxicity was observed. Conclusions. High-dose (66-75.6 Gy [RBE]) proton beam therapy without chemotherapy was an efficacious and safe treatment for older patients with esophageal cancer.	[Ono, Takashi; Nakamura, Tatsuya; Azami, Yusuke; Yamaguchi, Hisashi; Hayashi, Yuichiro; Suzuki, Motohisa; Hatayama, Yoshiomi; Tsukiyama, Iwao; Hareyama, Masato; Kikuchi, Yasuhiro] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, Koriyama, Fukushima 9638052, Japan; [Nemoto, Kenji] Yamagata Univ, Fac Med, Dept Radiat Oncol, Yamagata 990, Japan	Ono, T (reprint author), Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan.	abc1123513@gmail.com					Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Lin SH, 2012, INT J RADIAT ONCOL, V83, pE345, DOI 10.1016/j.ijrobp.2012.01.003; Zhang XL, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-64; Isacsson U, 1998, INT J RADIAT ONCOL, V41, P441, DOI 10.1016/S0360-3016(98)00047-9; Mizumoto M, 2010, STRAHLENTHER ONKOL, V186, P482, DOI 10.1007/s00066-010-2079-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kawashima M, 2006, INT J RADIAT ONCOL, V64, P1112, DOI 10.1016/j.irobp.2005.09.027; Zhao KL, 2010, INT J RADIAT ONCOL, V76, P446, DOI 10.1016/j.ijrobp.2009.02.078; Nishimura Y, 2009, RADIOTHER ONCOL, V92, P260, DOI 10.1016/j.radonc.2008.12.012; Blanchard EM, 2011, J THORAC ONCOL, V6, P115, DOI 10.1097/JTO.0b013e3181fbebfd; Uno T, 2004, ANTICANCER RES, V24, P2483; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Pan XN, 2009, INT J RADIAT ONCOL, V73, P601, DOI 10.1016/j.ijrobp.2008.09.042; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Zhang X, 2008, INT J RADIAT ONCOL, V72, P278, DOI 10.1016/j.ijrobp.2008.05.014; Sugahara S, 2005, INT J RADIAT ONCOL, V61, P76, DOI 10.1016/j.ijrobp.2004.04.003; Kawaguchi Y, 2011, JPN J CLIN ONCOL, V41, P1007, DOI 10.1093/jjco/hyr069; Mizumoto M, 2011, INT J RADIAT ONCOL, V81, pE601, DOI 10.1016/j.ijrobp.2011.02.041; Smith GL, 2009, INT J RADIAT ONCOL, V74, P482, DOI 10.1016/j.ijrobp.2008.08.046; Ariga H, 2009, INT J RADIAT ONCOL, V75, P348, DOI 10.1016/j.ijrobp.2009.02.086; Nemoto K, 2000, INT J RADIAT ONCOL, V46, P921, DOI 10.1016/S0360-3016(99)00485-X; Ji K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-200; Liu MN, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-142; Shohei K, 2003, CLIN CANCER RES, V9, P3571	25	0	0	ASSOC RADIOLOGY & ONCOLOGY	LJUBLJANA	INST ONCOLOGY, ZALOSKA CESTA 2, LJUBLJANA, 1000, SLOVENIA	1318-2099	1581-3207		RADIOL ONCOL	Radiol. Oncol.	DEC	2015	49	4					371	378		10.1515/raon-2015-0034		8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CX6GY	WOS:000365800400009		
J	Kasahara, N; Imai, H; Kaira, K; Mori, K; Wakuda, K; Ono, A; Taira, T; Kenmotsu, H; Harada, H; Naito, T; Murakami, H; Endo, M; Nakajima, T; Yamada, M; Takahashi, T				Kasahara, Norimitsu; Imai, Hisao; Kaira, Kyoichi; Mori, Keita; Wakuda, Kazushige; Ono, Akira; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Harada, Hideyuki; Naito, Tateaki; Murakami, Haruyasu; Endo, Masahiro; Nakajima, Takashi; Yamada, Masanobu; Takahashi, Toshiaki			Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy	RADIOLOGY AND ONCOLOGY			English	Article						chemoradiotherapy; limited-stage disease small cell lung cancer; overall survival; post-progression survival; progression-free survival	PHASE-III TRIAL; TUMOR RESPONSE; POSTPROGRESSION SURVIVAL; CHEMOTHERAPY; METAANALYSIS; TOPOTECAN; 2ND-LINE; THERAPY; TIME	Background. The effects of first-line chemoradiotherapy on overall survival (OS) may be confounded by subsequent lines of therapy in patients with limited-stage disease small cell lung cancer (LD-SCLC). Therefore, we aimed to determine the relationships between progression-free survival (PFS), post-progression survival (PPS) and OS after first-line chemoradiotherapy in LD-SCLC patients. Patients and methods. We retrospectively analyzed 71 LD-SCLC patients with performance status (PS) 0-2 who received first-line chemoradiotherapy and had disease recurrence between September 2002 and March 2013 at Shizuoka Cancer Center (Shizuoka, Japan). We determined the correlation between PFS and OS and between PPS and OS at the individual level. In addition, we performed univariate and multivariate analyses to identify significant prognostic factors of PPS. Results. OS is more strongly correlated with PPS (Spearman's r = 0.86, R-2 = 0.72, p < 0.05) than PFS (Spearman's r = 0.46, R-2 = 0.38, p < 0.05). In addition, the response to second-line treatments, the presence of distant metastases at recurrence and the number of additional regimens after first-line chemoradiotherapy were significant independent prognostic factors for PPS. Conclusions. PPS has more impact on OS than PFS in recurrent LD-SCLC patients with good PS at beginning of the treatment. Moreover, treatments administered after first-line chemoradiotherapy may affect their OS. However, larger multicenter studies are needed to validate these findings.	[Kasahara, Norimitsu; Imai, Hisao; Kaira, Kyoichi; Wakuda, Kazushige; Ono, Akira; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Nagaizumi, Shizuoka 4118777, Japan; [Harada, Hideyuki] Shizuoka Canc Ctr, Div Radiat Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Kasahara, Norimitsu; Imai, Hisao; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan; [Kaira, Kyoichi] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Gunma, Japan	Imai, H (reprint author), Shizuoka Canc Ctr, Div Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	m06701014@gunma-u.ac.jp					American Cancer Society, 2014, CANC FACTS FIG 2014; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Ebi N, 1997, JPN J CLIN ONCOL, V27, P166, DOI 10.1093/jjco/27.3.166; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Soria JC, 2010, ANN ONCOL, V21, P2324, DOI 10.1093/annonc/mdq204; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Johnson KR, 2006, LANCET ONCOL, V7, P741, DOI 10.1016/S1470-2045(06)70800-2; GIACCONE G, 1988, J CLIN ONCOL, V6, P1264; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Hayashi H, 2012, ANN ONCOL, V23, P1537, DOI 10.1093/annonc/mdr487; Hayashi H, 2013, CLIN LUNG CANCER, V14, P261, DOI 10.1016/j.cllc.2012.09.006; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Foster NR, 2011, CANCER-AM CANCER SOC, V117, P1262, DOI 10.1002/cncr.25526; Hotta K, 2009, J THORAC ONCOL, V4, P311, DOI 10.1097/JTO.0b013e3181989bd2; von Pawel J, 1999, J CLIN ONCOL, V17, P658; WARDE P, 1992, J CLIN ONCOL, V10, P890; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Imai H, 2015, ANN THORAC MED, V10, P61, DOI 10.4103/1817-1737.146885; Imai H, 2014, NEOPLASMA, V61, P233, DOI 10.4149/neo_2014_030; National Cancer Institute, 2014, SMALL CELL LUNG CANC	22	0	0	ASSOC RADIOLOGY & ONCOLOGY	LJUBLJANA	INST ONCOLOGY, ZALOSKA CESTA 2, LJUBLJANA, 1000, SLOVENIA	1318-2099	1581-3207		RADIOL ONCOL	Radiol. Oncol.	DEC	2015	49	4					409	415		10.1515/raon-2015-0037		7	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CX6GY	WOS:000365800400014		
J	Matsuoka, M; Zhang, JL				Matsuoka, Masaya; Zhang, Jinlong			Preface	RESEARCH ON CHEMICAL INTERMEDIATES			English	Editorial Material									[Matsuoka, Masaya] Osaka Prefecture Univ, Sakai, Osaka 591, Japan; [Zhang, Jinlong] E China Univ Sci & Technol, Shanghai 200237, Peoples R China	Matsuoka, M (reprint author), Osaka Prefecture Univ, Sakai, Osaka 591, Japan.	matsumac@chem.osakafu-u.ac.jp; jlzhang@ecust.edu.cn						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9385	9386		10.1007/s11164-015-1967-8		2	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300019		
J	Inamura, K; Kagami, N; Shirakawa, T; Eura, S; Watabe, M				Inamura, Kazuhiro; Kagami, Narinobu; Shirakawa, Toshiyuki; Eura, Shinya; Watabe, Mitsunori			Improvement in hydrocracking activity of heavy oil upgrading catalyst by modifications to some specific properties of Y-zeolite	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		Heavy oil upgrading; Hydrocracking (HYC); HDS; Zeolite; Modifications	CRACKING; SULFIDE	We have been developing zeolite catalysts for fixed-bed resid hydrodesulfurization (HDS) units. The catalysts, named R-HYC, show high resid hydrocracking (HYC) activity by increasing middle distillates and concurrently decreasing bottom fuel oil. To meet refinery demands for lower catalyst cost and improved HYC activity, the newest R-HYC has been developed as R-HYC12, showing more than twofold improved HYC activity compared with the previous R-HYC10, by means of modifications to some specific properties of Y-zeolite. A new sequence combining the developed R-HYC12 with the other, hydrodemetallization (HDM) and HDS catalysts has been proposed to achieve the best resid HDS unit performance.	[Inamura, Kazuhiro] Idemitsu Kosan Co Ltd, Mfg & Technol Dept, Sodegaura, Chiba 2990293, Japan; [Kagami, Narinobu] Idemitsu Kosan Co Ltd, Technol & Engn Ctr, Sodegaura, Chiba 2990293, Japan; [Shirakawa, Toshiyuki] Idemitsu Kosan Co Ltd, Adv Technol Res Labs, Sodegaura, Chiba 2990293, Japan; [Eura, Shinya; Watabe, Mitsunori] JGC Catalysts & Chem Ltd, Kitakyushu Operat Ctr, Kitakyushu, Fukuoka 8080027, Japan	Inamura, K (reprint author), Abu Dhabi Oil Refining Co TAKREER, Takreer Res Ctr, POB 3593, Abu Dhabi, U Arab Emirates.	kazuhiro.inamura@idemitsu.com					Chal R, 2011, CHEMCATCHEM, V3, P67, DOI 10.1002/cctc.201000158; HIDAKA S, 1988, APPL CATAL, V43, P57, DOI 10.1016/S0166-9834(00)80900-8; Katada N, 2004, J MOL CATAL A-CHEM, V211, P119, DOI 10.1016/j.molcata.2003.10.001; Inamura K, 2011, CATAL TODAY, V164, P204, DOI 10.1016/j.cattod.2010.10.082; INAMURA K, 1993, J CATAL, V142, P274, DOI 10.1006/jcat.1993.1207; Tomiyama T, 2011, CHEM LETT, V40, P49, DOI 10.1246/cl.2011.49; Suzuki K, 2007, J PHYS CHEM C, V111, P894, DOI 10.1021/jp065054v; Hohnholt J.F., 1993, NPRA ANN M; Inamura K., 2013, [No title captured], Patent No. [JP 2013212449, 2013212449]; LACEY PMC, 1954, J APPL CHEM, V4, P257; Okamoto Y, 2014, B CHEM SOC JPN, V87, P20, DOI 10.1246/bcsj.20130204; Toulhoat H, 2013, IFP ENERG NOUV PUBL, P1; Yamamoto T., 1991, 13 WORLD PETR C, P223	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9451	9461		10.1007/s11164-015-1970-0		11	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300023		
J	Kitagawa, M; Misu, S; Ichikawa, J; Matsuhashi, H				Kitagawa, Michiko; Misu, Sayaka; Ichikawa, Jun; Matsuhashi, Hiromi			Preparation of active MgO by short-time thermal decomposition of Mg(OH)(2)	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		MgO; Solid base; Thermal treatment; Crystal structure; Active sites	SOLID BASE CATALYSTS; SURFACES; SITES; OXIDE	In the preparation of MgO, Mg(OH)(2) was placed in a muffle furnace maintained at a desired temperature for rapid increase to the activation temperature and for short-time heating. The MgO obtained showed a higher activity for the retro-aldol reaction of diacetone alcohol and larger surface area in comparison with that prepared by conventional procedures. Among the prepared catalysts, MgO heated at 673 K for 20 min showed the highest activity. The prepared MgO has a wide and thin plate shape with a small crystal size. The surface area of MgO decreased monotonously with increase in heating time and temperature. Further thermal treatment produced a decrease in catalytic activity. After that, the activity was regenerated by a long-time thermal treatment. The change in crystal morphology and exposed surface crystal plane of MgO by thermal treatment is discussed.	[Kitagawa, Michiko] RIKEN, Wako, Saitama 3510198, Japan; [Misu, Sayaka; Ichikawa, Jun; Matsuhashi, Hiromi] Hokkaido Univ, Hakodate, Hokkaido 0408567, Japan	Matsuhashi, H (reprint author), Hokkaido Univ, I-2 Hachiman Cho, Hakodate, Hokkaido 0408567, Japan.	m-kitagawa@riken.jp; matsuhashi.hiromi@h.hokkyodai.ac.jp					Das PS, 2014, CERAM INT, V40, P6365, DOI 10.1016/j.ceramint.2013.10.139; Sutradhar N, 2011, J PHYS CHEM C, V115, P12308, DOI 10.1021/jp2022314; GREEN J, 1983, J MATER SCI, V18, P637, DOI 10.1007/BF00745561; ONISHI H, 1987, SURF SCI, V191, P479; KLABUNDE KJ, 1987, J AM CHEM SOC, V109, P1111, DOI 10.1021/ja00238a020; Chiesa M, 2005, J PHYS CHEM B, V109, P7314, DOI 10.1021/jp044783c; Plass R, 1998, SURF SCI, V414, P26, DOI 10.1016/S0039-6028(98)00438-5; Coluccia S., 1981, STUDIES SURFACE SCI, V7, P1160; Hattori H, 2001, APPL CATAL A-GEN, V222, P247, DOI 10.1016/S0926-860X(01)00839-0; Tanabe K., 1989, NEW SOLID ACIDS BASE, P29	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9463	9473		10.1007/s11164-015-1971-z		11	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300024		
J	Ikuta, Y; Nagai, Y; Takahashi, N				Ikuta, Yasuhiro; Nagai, Yasutaka; Takahashi, Naoki			New semi-empirical computational analysis of catalytic reactions for automobile	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		Reaction analysis; Semi-empirical computational analysis; Exhaust gas catalyst	CFSO-BEBO CALCULATIONS; TRANSITION D-METALS; BOND ORDER; MOLECULAR ADSORPTION; SURFACE-REACTIONS; NITRIC-OXIDE; PLATINUM 111; ENERGY; NO; CO	Reaction profiles of diatomic molecules, , and NO, on a transition -metal surface were semi-empirically calculated using a new approach based on a bond-energy bond-order (BEBO) model. The BEBO model could be a useful relation for describing reaction configurations. In this work, we introduce a new semi-empirical model which combines density functional theory (DFT)-based interaction parameters with the empirical Miyazaki BEBO model and demonstrate that our model could also be used successfully in previous DFT calculation results. The predictions calculated using this model, such as adsorption energies and adsorption geometries of incoming gas molecules, are close to previous experimental and theoretical results. In particular, the most remarkable point is that previous DFT calculation results and experimental results are available to our procedure. In other words, our model could be extremely simple but powerful.	[Ikuta, Yasuhiro; Nagai, Yasutaka; Takahashi, Naoki] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Ikuta, Y (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	e1500@mosk.tytlabs.co.jp					KORDESCH ME, 1986, SURF SCI, V175, pL687, DOI 10.1016/0039-6028(86)90075-0; WEINBERG WH, 1974, SURF SCI, V41, P312, DOI 10.1016/0039-6028(74)90311-2; MIYAZAKI E, 1976, SURF SCI, V57, P755, DOI 10.1016/0039-6028(76)90361-7; Wartnaby CE, 1996, J PHYS CHEM-US, V100, P12483, DOI 10.1021/jp953624d; BORG HJ, 1994, J CHEM PHYS, V101, P10052, DOI 10.1063/1.467994; Herron JA, 2012, SURF SCI, V606, P1670, DOI 10.1016/j.susc.2012.07.003; Sellers H, 1996, SURF SCI, V356, P209, DOI 10.1016/0039-6028(96)01354-4; Shustorovich E, 2003, SURF SCI, V527, P137, DOI 10.1016/S0039-6028(03)00013-X; Ford DC, 2005, SURF SCI, V587, P159, DOI 10.1016/j.susc.2005.04.028; BRENNAN D, 1960, PROC R SOC LON SER-A, V256, P81, DOI 10.1098/rspa.1960.0094; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Zhdanov VP, 1996, CATAL LETT, V40, P197, DOI 10.1007/BF00815282; Sutton JE, 2013, J CATAL, V297, P202, DOI 10.1016/j.jcat.2012.10.009; RAMSIER RD, 1994, SURF SCI, V320, P209, DOI 10.1016/0039-6028(94)90310-7; BRODEN G, 1976, SURF SCI, V59, P593, DOI 10.1016/0039-6028(76)90038-8; NIIYAMA H, 1975, J CATAL, V38, P238, DOI 10.1016/0021-9517(75)90084-6; MIYAZAKI E, 1978, SURF SCI, V71, P741, DOI 10.1016/0039-6028(78)90460-0; MIYAZAKI E, 1980, J CATAL, V65, P84, DOI 10.1016/0021-9517(80)90280-8; WICKHAM DT, 1991, SURF SCI, V243, P83, DOI 10.1016/0039-6028(91)90347-U; WHITE JA, 1994, PHYS REV B, V50, P4954, DOI 10.1103/PhysRevB.50.4954; Shustorovich E, 1998, SURF SCI REP, V31, P5; Blowers P, 1998, J PHYS CHEM A, V102, P9957, DOI 10.1021/jp9829243; WEINBERG WH, 1973, SURF SCI, V39, P206, DOI 10.1016/0039-6028(73)90104-0; WEINBERG WH, 1973, J CATAL, V28, P459, DOI 10.1016/0021-9517(73)90139-5; Mavrikakis M, 2002, J CHEM PHYS, V117, P6737, DOI 10.1063/1.1507104; Hammer B, 1999, PHYS REV B, V59, P7413, DOI 10.1103/PhysRevB.59.7413; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; PAULING L, 1947, J AM CHEM SOC, V69, P542, DOI 10.1021/ja01195a024; WEINBERG WH, 1975, J CATAL, V40, P268, DOI 10.1016/0021-9517(75)90254-7; BOND GC, 1966, DISCUSS FARADAY SOC, P200, DOI 10.1039/df9664100200; Johnston H.S., 1966, GAS PHASE REACTION R; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9475	9484		10.1007/s11164-015-1972-y		10	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300025		
J	Kanega, R; Ogihara, H; Yamanaka, I				Kanega, Ryoichi; Ogihara, Hitoshi; Yamanaka, Ichiro			Electrosynthesis of diphenyl carbonate catalyzed by Pd2+/0 (in situ NHC) redox catalyst promoted at Au anode	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		Diphenyl carbonate; Pd electrocatalyst; Au anode; Graphene support	PD-CARBENE COMPLEXES; OXIDATIVE CARBONYLATION; GOLD NANOPARTICLES; PHENOL; ELECTROCARBONYLATION; SILICA	The effects of Au anodes on electrochemical carbonylation of phenol with CO (1 atm) to diphenyl carbonate (DPC) catalyzed by Pd (in situ NHC) electrocatalyst were studied under galvanostatic electrolysis conditions. Au supported on carbon materials (Au/carbon) were effective anodes for oxidation of the homogeneous Pd electrocatalyst. Various carbon materials, Vulcan XC-72 carbon black (XC72), activate carbon, Ketjenblack, and graphene nanoplatelets (graphene-1, -2, -3) were tested as a support for Au. The Au/graphene-3 was the most effective anode for DPC formation. Effects of Au loadings and reducing agents (H-2 and NaBH4) on the reactivity of the Au/graphene-3 anode for the DPC formation were studied and the materials were characterized using XRD spectroscopy and TEM analysis. These experimental facts indicated that small Au particles on the surface of graphene were superior for the DPC synthesis by the Pd (in situ NHC) electrocatalyst.	[Kanega, Ryoichi; Yamanaka, Ichiro] Tokyo Inst Technol, Dept Appl Chem, Tokyo 1528552, Japan; [Ogihara, Hitoshi; Yamanaka, Ichiro] Tokyo Inst Technol, Dept Chem & Mat Sci, Tokyo 1528552, Japan	Yamanaka, I (reprint author), Tokyo Inst Technol, Dept Appl Chem, Tokyo 1528552, Japan.	yamanaka@cms.titech.ac.jp					Fan GZ, 2006, APPL ORGANOMET CHEM, V20, P656, DOI 10.1002/aoc.1062; Haruta M, 2002, CATTECH, V6, P102, DOI 10.1023/A:1020181423055; Murayama T, 2012, J PHYS CHEM C, V116, P10607, DOI 10.1021/jp300809s; Kanega R, 2014, TOP CATAL, V57, P995, DOI 10.1007/s11244-014-0262-z; Vavasori A, 1999, J MOL CATAL A-CHEM, V139, P109, DOI 10.1016/S1381-1169(98)00190-3; Fan GZ, 2007, J MOL CATAL A-CHEM, V267, P34, DOI 10.1016/j.molcata.2006.11.010; HALLGREN JE, 1981, J ORGANOMET CHEM, V204, P135, DOI 10.1016/S0022-328X(00)82481-X; Kanega R, 2013, ACS CATAL, V3, P389, DOI 10.1021/cs300725j; Ishii H, 2000, CATAL LETT, V65, P57, DOI 10.1023/A:1019044600244; Gong JL, 2007, APPL CATAL A-GEN, V316, P1, DOI 10.1016/j.apcata.2006.09.006; Guo HX, 2013, ADV MATER RES-SWITZ, V750-752, P1292, DOI 10.4028/www.scientific.net/AMR.750-752.1292; Okuyama K, 2003, J MOL CATAL A-CHEM, V203, P21, DOI 10.1016/S1381-1169(03)00281-4; Ronchin L, 2009, J MOL CATAL A-CHEM, V298, P23, DOI 10.1016/j.molcata.2008.09.028; Murayama T, 2010, CHEM LETT, V39, P418, DOI 10.1246/cl.2010.418; Song HY, 2000, J MOL CATAL A-CHEM, V154, P243, DOI 10.1016/S1381-1169(99)00392-1; Ishida T, 2008, J COLLOID INTERF SCI, V323, P105, DOI 10.1016/j.jcis.2008.02.046; Takagi M, 1998, J MOL CATAL A-CHEM, V129, pL1, DOI 10.1016/S1381-1169(97)00188-X; Xue W, 2005, CATAL COMMUN, V6, P431, DOI 10.1016/j.catcom.2005.03.013; Murayama T, 2011, ELECTROCHIM ACTA, V56, P2926, DOI 10.1016/j.electacta.2010.12.087; Hersh N., 1990, J APPL POLYM SCI, V41, P1033; Okuyam K, 2003, GREEN CHEM, V5, P563, DOI 10.1039/b304878k	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9497	9508		10.1007/s11164-015-1975-8		12	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300027		
J	Yamaguchi, S; Okuwa, T; Wada, H; Yamaura, H; Yahiro, H				Yamaguchi, Syuhei; Okuwa, Takahisa; Wada, Hiroki; Yamaura, Hiroyuki; Yahiro, Hidenori			Cyanosilylation of benzaldehyde with TMSCN over perovskite-type oxide catalyst prepared by thermal decomposition of heteronuclear cyano complex precursors	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		Perovskite-type oxide; Cyano complex; Cyanosilylation	NANOSIZED LAFEO3 POWDERS; ENANTIOSELECTIVE CYANOSILYLATION; STRUCTURAL-CHARACTERIZATION; OXIDATION REACTIONS; MIXED OXIDES; ALDEHYDES; EFFICIENT; KETONES; ION; NO	The perovskite-type oxide catalyst, SmFeO3, prepared by decomposition method of heteronuclear cyano complex precursor (CN method) was applied to liquid-phase organic reaction, cyanosilylation of benzaldehyde with TMSCN. The maximum catalytic activity per catalyst weight was achieved at 800 A degrees C of calcination temperature in CN method and it was found that the catalytic activity was strongly related to the crystallinity of SmFeO3 catalyst. The catalytic reaction performed in the presence of pyridine and 2,6-di-tert-butylpyridine suggests that the catalytically active sites are the Bronsted acid sites formed on the SmFeO3 catalyst. The catalytic activity of SmFeO3 catalyst prepared by CN method was much higher than those of acid catalysts: SiO2-Al2O3 and Amberlyst.	[Yamaguchi, Syuhei; Okuwa, Takahisa; Wada, Hiroki; Yamaura, Hiroyuki; Yahiro, Hidenori] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan	Yahiro, H (reprint author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan.	hyahiro@ehime-u.ac.jp					Gosavi PV, 2010, MATER CHEM PHYS, V119, P324, DOI 10.1016/j.matchemphys.2009.09.005; Giannakas AE, 2006, APPL CATAL A-GEN, V309, P254, DOI 10.1016/j.apcata.2006.05.016; North M, 2004, TETRAHEDRON, V60, P10383, DOI 10.1016/j.tet.2004.08.085; Teraoka Y, 1998, J CHEM SOC FARADAY T, V94, P1887, DOI 10.1039/a800872h; Rida K, 2007, APPL CATAL A-GEN, V327, P173, DOI 10.1016/j.apcata.2007.05.015; Kurono N, 2005, J ORG CHEM, V70, P6530, DOI 10.1021/jo050791t; Asamoto M, 2011, CATAL TODAY, V175, P534, DOI 10.1016/j.cattod.2011.04.048; Ogasawara Y, 2009, CHEM-EUR J, V15, P4343, DOI 10.1002/chem.200802536; Li W, 2004, MATER LETT, V58, P365, DOI 10.1016/S0167-577X(03)00502-0; Traversa E, 1998, J MATER RES, V13, P1335, DOI 10.1557/JMR.1998.0189; Sadaoka Y, 1996, J ALLOY COMPD, V240, P51, DOI 10.1016/0925-8388(96)02300-6; Baleizao C, 2004, TETRAHEDRON, V60, P10461, DOI 10.1016/j.tet.2004.08.077; Bell RJ, 2000, SOLID STATE IONICS, V131, P211, DOI 10.1016/S0167-2738(00)00668-8; WANG J, 1995, B CHEM SOC JPN, V68, P1226, DOI 10.1246/bcsj.68.1226; ZHANG HM, 1987, CHEM LETT, P665, DOI 10.1246/cl.1987.665; Karimi B, 2004, ORG LETT, V6, P4813, DOI 10.1021/ol0482083; Kim SS, 2007, APPL ORGANOMET CHEM, V21, P368, DOI 10.1002/aoc.1204; Yuasa M, 2007, CATAL TODAY, V126, P313, DOI 10.1016/j.cattod.2007.06.006; Ishihara T, 2003, J CATAL, V220, P104, DOI 10.1016/S0021-9517(03)00265-3; Fetterly BM, 2005, TETRAHEDRON LETT, V46, P8061, DOI 10.1016/j.tetlet.2005.09.032; Zhao Z, 1996, APPL CATAL B-ENVIRON, V8, P281, DOI 10.1016/0926-3373(95)00067-4; Rossetti I, 2001, APPL CATAL B-ENVIRON, V33, P345, DOI 10.1016/S0926-3373(01)00194-1; Aono H, 2001, J AM CERAM SOC, V84, P341; Ryu DH, 2004, J AM CHEM SOC, V126, P8106, DOI 10.1021/ja0475959; Traversa E, 1998, MATER RES BULL, V33, P673, DOI 10.1016/S0025-5408(98)00044-0; Asamoto M, 2009, CATAL SURV ASIA, V13, P221, DOI 10.1007/s10563-009-9079-3; Sadaoka Y, 1998, J ALLOY COMPD, V278, P135, DOI 10.1016/S0925-8388(98)00602-1; Asamoto M, 2009, TOP CATAL, V52, P823, DOI 10.1007/s11244-009-9233-1; Mori M, 2008, CATAL TODAY, V139, P125, DOI 10.1016/j.cattod.2008.08.014; Asamoto M, 2012, CATAL TODAY, V185, P230, DOI 10.1016/j.cattod.2011.09.023; Popa M, 2002, SOLID STATE IONICS, V154, P437, DOI 10.1016/S0167-2738(02)00480-0; Royer S, 2005, APPL CATAL A-GEN, V282, P273, DOI 10.1016/j.apcata.2004.12.018; Gregory RJH, 1999, CHEM REV, V99, P3649, DOI 10.1021/cr9902906; Tsuchida K, 2004, SENSOR MATER, V16, P171; GALLAGHER PK, 1977, J AM CERAM SOC, V60, P28, DOI 10.1111/j.1151-2916.1977.tb16086.x; MATUURA Y, 1993, J MATER CHEM, V3, P767, DOI 10.1039/jm9930300767; MIZUNO N, 1989, J CHEM SOC CHEM COMM, P316, DOI 10.1039/c39890000316; NAKAMURA T, 1980, NIPPON KAGAKU KAISHI, P1679; NITADORI T, 1988, B CHEM SOC JPN, V61, P621, DOI 10.1246/bcsj.61.621; Sadaoka Y, 1996, CHEM LETT, P177, DOI 10.1246/cl.1996.177; Sakamoto M., 1997, J CERAM SOC JPN, V105, P693; Shibasaki M., 2008, ACID CATALYSIS MODER, V2, P671; Teraoka Y, 2000, CHEM LETT, P1202, DOI 10.1246/cl.2000.1202	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9551	9560		10.1007/s11164-015-1980-y		10	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300031		
J	Tsukada, S; Wada, K; Miura, H; Hosokawa, S; Abe, R; Inoue, M				Tsukada, Shinji; Wada, Kenji; Miura, Hiroki; Hosokawa, Saburo; Abe, Ryu; Inoue, Masashi			Phosphine-stabilized, oxide-supported rhodium catalysts for highly efficient silylative coupling reactions	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		Supported catalyst; Rhodium; Ceria; Zirconia; Phosphine-modification; Vinylsilane; Styrenes; Silylative coupling	C-H BONDS; RUTHENIUM CATALYSTS; SILOXIDE COMPLEX; KEY STEP; VINYLSILANES; ACTIVATION; OLEFINS; STYRENE	Oxide-supported rhodium catalysts with excellent activity in silylative coupling reactions have been developed. Reductive pretreatment of the catalysts in the presence of 0.5 equiv triphenylphosphine under a hydrogen atmosphere enhanced and stabilized the catalytic activity. Of the catalysts examined, ceria-supported rhodium had the highest activity in the homo-coupling of vinylsilanes to bis(silyl)ethenes at 170 A degrees C. A zirconia-supported catalyst selectively gave E-1-aryl-2-silylethenes by cross-coupling of vinylsilanes with styrenes at 130 A degrees C, and a high turnover frequency of > 8200 h(-1) was achieved at 170 A degrees C. Spectroscopic studies revealed that well-dispersed surface rhodium(I) species predominantly formed on ceria or zirconia were transformed into rhodium hydride species, which are believed to be responsible for the high activity. These catalysts were recyclable without loss of activity, and leaching of rhodium species from the catalysts was not observed.	[Tsukada, Shinji; Miura, Hiroki; Abe, Ryu; Inoue, Masashi] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Kyoto 6158510, Japan; [Wada, Kenji] Kagawa Univ, Dept Med Chem, Grad Sch Med, Kagawa 7610793, Japan; [Miura, Hiroki] Tokyo Metropolitan Univ, Dept Urban Environm Sci, Hachioji, Tokyo 1920397, Japan; [Miura, Hiroki; Hosokawa, Saburo] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Nishikyo Ku, Kyoto 6158245, Japan	Wada, K (reprint author), Kagawa Univ, Dept Med Chem, Grad Sch Med, 1750-1 Ikenobe,Miki Cho, Kagawa 7610793, Japan.	wadaken@med.kagawa-u.ac.jp					Weck M, 2007, INORG CHEM, V46, P1865, DOI 10.1021/ic061898h; WAKATSUKI Y, 1995, J ORGANOMET CHEM, V500, P349, DOI 10.1016/0022-328X(95)00525-U; Marciniec B, 1998, CATAL LETT, V55, P125, DOI 10.1023/A:1019006206468; Marciniec B, 2000, ORGANOMETALLICS, V19, P1677, DOI 10.1021/om990881m; Sheldon RA, 1999, APPL CATAL A-GEN, V189, P163, DOI 10.1016/S0926-860X(99)00274-4; Marciniec B, 2000, INORG CHEM COMMUN, V3, P371, DOI 10.1016/S1387-7003(00)00089-7; Wada K, 2011, CATAL SURV ASIA, V15, P1, DOI 10.1007/s10563-010-9104-6; Miura H, 2010, CHEMCATCHEM, V2, P1223, DOI 10.1002/cctc.201000144; Marciniec B, 2008, ANGEW CHEM INT EDIT, V47, P541, DOI 10.1002/anie.200704362; Marciniec B, 2001, ORGANOMETALLICS, V20, P3423, DOI 10.1021/om0100683; Marciniec B, 2011, DALTON T, V40, P5073, DOI 10.1039/c0dt01631d; Marciniec B, 1999, INORG CHEM COMMUN, V2, P581, DOI 10.1016/S1387-7003(99)00150-1; Wada K, 2013, J JPN PETROL INST, V56, P69; Marciniec B, 2002, ORGANOMETALLICS, V21, P3263, DOI 10.1021/om0200611; Miura H, 2010, CHEM-EUR J, V16, P4186, DOI 10.1002/chem.200903564; Crabtree RH, 2005, ORGANOMETALLIC CHEMISTRY OF THE TRANSITION METALS, 4TH EDITION, P1, DOI 10.1002/0471718769; Ishiyama T, 2001, CHEM LETT, P1082; KAESZ HD, 1972, CHEM REV, V72, P231, DOI 10.1021/cr60277a003; Kaneda K., SYNLETT, V7, P999; Mise T, 1998, CHEM COMMUN, P699, DOI 10.1039/a800293b; Moulder F., 1992, HDB XRAY PHOTOELECTR; Pawluc P., 2010, EUR J ORG CHEM, V2, P219; Smith MD, 2003, CHEM COMMUN, P2652, DOI 10.1039/b308465e; Trost BM, 2002, ACCOUNTS CHEM RES, V35, P695, DOI 10.1021/ar010068z; WAKATSUKI Y, 1991, J CHEM SOC CHEM COMM, P703, DOI 10.1039/c39910000703	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9575	9586		10.1007/s11164-015-1983-8		12	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300033		
J	Hodoshima, S; Motomiya, A; Wakamatsu, S; Kanai, R; Yagi, F				Hodoshima, Shinya; Motomiya, Azusa; Wakamatsu, Shuhei; Kanai, Ryuichi; Yagi, Fuyuki			Catalytic cracking of light-naphtha over MFI-zeolite/metal-oxide composites for efficient propylene production	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article; Proceedings Paper	7th Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT)	JUN 01-06, 2014	Kyoto, JAPAN	Catalysis Soc Japan		Efficient propylene production; Light-naphtha cracking; Fe-Ga-Al-MFI-zeolite; Zeolite/metal-oxide composites	AROMATIC-HYDROCARBONS; ZSM-5; TRANSFORMATION; CONVERSION; PROPANE	The proprietary cracking catalysts for producing propylene efficiently from light-naphtha were developed in the present study in order to meet future demand for propylene and utilize various light paraffinic hydrocarbons (e.g., light-naphtha derived from crude oil, condensates recovered from natural gas and GTL-naphtha). The composite catalysts, consisting of Al-MFI zeolites containing two kinds of heteroatom (Fe, Ga) and metal oxides (e.g., aluminum oxide), were employed for n-hexane cracking at around 550 A degrees C. Since these catalysts reduced acid strength by Fe atoms and accelerated dehydrogenation for paraffinic hydrocarbons by Ga atoms, selective production of propylene was accomplished by suppressing formation of aromatics under mild conditions, resulting in the high propylene yields (18-31 wt%). Moreover, catalytic activities were maintained for ca. 80 h in cracking of n-hexane without dilution, suggesting that the energy-saving process for propylene production from light-naphtha could be realized in the fixed-bed operation by using the present catalysts.	[Hodoshima, Shinya; Motomiya, Azusa; Wakamatsu, Shuhei; Kanai, Ryuichi; Yagi, Fuyuki] Chiyoda Corp, Ctr Res & Dev, Kanagawa Ku, Yokohama, Kanagawa 2210022, Japan	Hodoshima, S (reprint author), Chiyoda Corp, Ctr Res & Dev, Kanagawa Ku, 3-13 Moriya Cho, Yokohama, Kanagawa 2210022, Japan.	hodoshima.shinya@chiyodacorp.com					Albright L.F., 1983, PYROLYSIS THEORY IND, P319; GIANNETTO G, 1994, CATAL REV, V36, P271, DOI 10.1080/01614949408013926; Corma A, 2012, APPL CATAL A-GEN, V417, P220, DOI 10.1016/j.apcata.2011.12.044; Chatterjee A, 1998, MICROPOR MESOPOR MAT, V21, P421, DOI 10.1016/S1387-1811(98)00051-1; INUI T, 1984, J CATAL, V90, P366, DOI 10.1016/0021-9517(84)90266-5; Konno H, 2012, J JPN PETROL INST, V55, P267, DOI 10.1627/jpi.55.267; Corma A, 2012, APPL CATAL A-GEN, V421, P121, DOI 10.1016/j.apcata.2012.02.008; KITAGAWA H, 1986, J CATAL, V101, P12, DOI 10.1016/0021-9517(86)90223-X; OKADO H, 1988, APPL CATAL, V41, P121, DOI 10.1016/S0166-9834(00)80387-5; Hodoshima S., 2013, 7 INT S AC BAS CAT 1; Yoshimura Y, 2000, CATAL SURV JPN, V4, P157	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	DEC	2015	41	12			SI		9615	9626		10.1007/s11164-015-2023-4		12	Chemistry, Multidisciplinary	Chemistry	CX5LO	WOS:000365743300036		
J	Yamamoto, N; Miyashita, T; Takaki, S; Goto, T				Yamamoto, Natsuhiro; Miyashita, Tetsuya; Takaki, Shunsuke; Goto, Takahisa			Effects of Breathing Pattern on Oxygen Delivery Via a Nasal or Pharyngeal Cannula	RESPIRATORY CARE			English	Article						nasal cannula; pharyngeal cannula; oxygen delivery; simulation study	GASES	BACKGROUND: During sedation for upper gastrointestinal endoscopy, oxygen delivery via a nasal cannula is often necessary. However, the influences of the oxygen delivery route and breathing pattern on the F-IO2 have not been thoroughly investigated. The aim of this simulation study was to investigate the difference in the F-IO2 with a pharyngeal cannula versus nasal cannula during high- or low-tidal volume (V-T) ventilation and open- or closed-mouth breathing. METHODS: Six healthy volunteers were asked to breathe using 2 patterns of ventilation (high or low V-T) via a sealed face mask connected to an endotracheal tube that was retrogradely inserted into the trachea of a mannequin. The mannequin also had a pharyngeal or nasal cannula inserted into the pharynx or attached to the nose, through which oxygen (2 or 5 L/min) was delivered. The mouth of the mannequin was kept open or closed by packing. We measured the F-IO2 of every breath for 1 min at each setting. RESULTS: During low-and high-V-T ventilation, the F-IO2 was highest at a flow of 5 L/min with a pharyngeal cannula. Oxygen delivery was higher with the pharyngeal cannula compared with the nasal cannula at all settings. Differences in flow did not result in significant differences in the F-IO2 with high- and low-V-T ventilation. At a flow of 5 L/min via a pharyngeal cannula, open-mouth breathing resulted in a significantly higher F-IO2 compared with closed-mouth breathing. Conclusions: A pharyngeal cannula provided a higher F-IO2 compared with a nasal cannula at the same oxygen flow. Open-mouth breathing resulted in a higher F-IO2 compared with closed-mouth breathing when 5 L/min oxygen was delivered via a pharyngeal cannula. The breathing pattern did not affect the F-IO2 in this study.	[Yamamoto, Natsuhiro; Miyashita, Tetsuya; Takaki, Shunsuke; Goto, Takahisa] Yokohama City Univ Med, Dept Anesthesiol, Yokohama, Kanagawa 2360004, Japan	Miyashita, T (reprint author), Yokohama City Univ Med, Dept Anesthesiol, 3-9 Fukuura Kanazawa, Yokohama, Kanagawa 2360004, Japan.	yushukyo@gmail.com					American Thoracic Society/European Respiratory Society Task Force, 2004, STAND DIAGN MAN PAT; Gross JL, 2012, MINERVA ANESTESIOL, V78, P496; KORY RC, 1962, JAMA-J AM MED ASSOC, V179, P767; Markovitz GH, 2010, RESP CARE, V55, P453; CHALON J, 1979, ANESTHESIOLOGY, V50, P195, DOI 10.1097/00000542-197903000-00005; Parke R, 2009, BRIT J ANAESTH, V103, P886, DOI 10.1093/bja/aep280; Eastwood GM, 2004, ANAESTH INTENS CARE, V32, P670; CHALON J, 1972, ANESTHESIOLOGY, V37, P338, DOI 10.1097/00000542-197209000-00010; Smart JA, 2000, BRIT J ANAESTH, V84, P735; GOODMAN NW, 1987, BRIT J ANAESTH, V59, P1497, DOI 10.1093/bja/59.12.1497; GREEN ID, 1967, BRIT MED J, V3, P593; Denaut M, 1974, Curr Med Res Opin, V2, P611; O'Reilly Nugent A, 2014, RESPIROLOGY, V19, P538; Wettstein Richard B, 2005, Respir Care, V50, P604	14	0	0	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	DEC	2015	60	12					1804	1809		10.4187/respcare.04173		6	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CX5QX	WOS:000365758400015		
J	Blair, D; Ju, L; Zhao, CN; Wen, LQ; Chu, Q; Fang, Q; Cai, RG; Gao, JR; Lin, XC; Liu, D; Wu, LA; Zhu, ZH; Reitze, DH; Arai, K; Zhang, F; Flaminio, R; Zhu, XJ; Hobbs, G; Manchester, RN; Shannon, RM; Baccigalupi, C; Gao, W; Xu, P; Bian, X; Cao, ZJ; Chang, ZJ; Dong, P; Gong, XF; Huang, SL; Ju, P; Luo, ZR; Qiang, LE; Tang, WL; Wan, XY; Wang, Y; Xu, SN; Zang, YL; Zhang, HP; Lau, YK; Ni, WT				Blair David; Ju Li; Zhao ChunNong; Wen LinQing; Chu Qi; Fang Qi; Cai RongGen; Gao JiangRui; Lin XueChun; Liu Dong; Wu Ling-An; Zhu ZongHong; Reitze, David H.; Arai Koji; Zhang Fan; Flaminio Raffaele; Zhu XingJiang; Hobbs George; Manchester, Richard N.; Shannon, Ryan M.; Baccigalupi Carlo; Gao Wei; Xu Peng; Bian Xing; Cao ZhouJian; Chang ZiJing; Dong Peng; Gong XueFei; Huang ShuangLin; Ju Peng; Luo ZiRen; Qiang Li'E; Tang WenLin; Wan XiaoYun; Wang Yue; Xu ShengNian; Zang YunLong; Zhang HaiPeng; Lau Yun-Kau; Ni Wei-Tou			Gravitational wave astronomy: the current status	SCIENCE CHINA-PHYSICS MECHANICS & ASTRONOMY			English	Review						gravitational waves; ground based detectors; pulsar timing; spaced based detectors; CMB	PULSAR TIMING ARRAY; BLACK-HOLE BINARIES; 12-AXIS VIBRATION ISOLATION; TIME-DELAY INTERFEROMETRY; 2-PHOTON QUANTUM OPTICS; MILLISECOND PULSAR; THERMAL NOISE; LOW-FREQUENCY; MECHANICAL LOSS; ADVANCED LIGO	In the centenary year of Einstein's General Theory of Relativity, this paper reviews the current status of gravitational wave astronomy across a spectrum which stretches from attohertz to kilohertz frequencies. Sect. 1 of this paper reviews the historical development of gravitational wave astronomy from Einstein's first prediction to our current understanding the spectrum. It is shown that detection of signals in the audio frequency spectrum can be expected very soon, and that a north-south pair of next generation detectors would provide large scientific benefits. Sect. 2 reviews the theory of gravitational waves and the principles of detection using laser interferometry. The state of the art Advanced LIGO detectors are then described. These detectors have a high chance of detecting the first events in the near future. Sect. 3 reviews the KAGRA detector currently under development in Japan, which will be the first laser interferometer detector to use cryogenic test masses. Sect. 4 of this paper reviews gravitational wave detection in the nanohertz frequency band using the technique of pulsar timing. Sect. 5 reviews the status of gravitational wave detection in the attohertz frequency band, detectable in the polarisation of the cosmic microwave background, and discusses the prospects for detection of primordial waves from the big bang. The techniques described in sects. 1-5 have already placed significant limits on the strength of gravitational wave sources. Sects. 6 and 7 review ambitious plans for future space based gravitational wave detectors in the millihertz frequency band. Sect. 6 presents a roadmap for development of space based gravitational wave detectors by China while sect. 7 discusses a key enabling technology for space interferometry known as time delay interferometry.	[Blair David; Ju Li; Zhao ChunNong; Wen LinQing; Chu Qi; Fang Qi; Zhu XingJiang] Univ Western Australia, Sch Phys, Crawley, WA 6009, Australia; [Cai RongGen] Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100190, Peoples R China; [Gao JiangRui] Shanxi Univ, Sch Phys & Elect Engn, Taiyuan 030006, Peoples R China; [Lin XueChun] Chinese Acad Sci, Inst Semicond, Lab All Solid State Light Sources, Beijing 100083, Peoples R China; [Liu Dong] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Zhejiang, Peoples R China; [Wu Ling-An] Chinese Acad Sci, Inst Phys, Lab Opt Phys, Beijing 100190, Peoples R China; [Zhu ZongHong; Zhang Fan] Beijing Normal Univ, Dept Astron, Gravitat Wave & Cosmol Lab, Beijing 100875, Peoples R China; [Reitze, David H.; Arai Koji] CALTECH, LIGO Lab, Pasadena, CA 91125 USA; [Reitze, David H.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [Zhang Fan] Univ Virginia, Dept Phys, Morgantown, WV 26506 USA; [Flaminio Raffaele] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Zhu XingJiang; Hobbs George; Manchester, Richard N.; Shannon, Ryan M.] CSIRO Astron & Space Sci, Epping, NSW 1710, Australia; [Shannon, Ryan M.] Curtin Univ, Int Ctr Radio Astron Res, Bentley, WA 6102, Australia; [Baccigalupi Carlo] SISSA, Astrophys Sect, I-34136 Trieste, Italy; [Gao Wei; Xu Peng; Bian Xing; Cao ZhouJian; Dong Peng; Gong XueFei; Xu ShengNian; Zang YunLong; Lau Yun-Kau] Chinese Acad Sci, Acad Math & Syst Sci, Inst Appl Math, Beijing 100190, Peoples R China; [Gao Wei; Bian Xing; Zang YunLong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Xu Peng; Dong Peng; Lau Yun-Kau] Chinese Acad Sci, Morningside Ctr Math, Beijing 100190, Peoples R China; [Cao ZhouJian] Chinese Acad Sci, State Key Lab Sci & Engn Comp, Acad Math & Syst Sci, Beijing 100190, Peoples R China; [Chang ZiJing; Wang Yue; Lau Yun-Kau] Henan Univ, Dept Math, Kaifeng 475001, Peoples R China; [Huang ShuangLin; Zhang HaiPeng] Capital Normal Univ, Dept Math, Beijing 100089, Peoples R China; [Ju Peng; Qiang Li'E] Changan Univ, Dept Geophys, Coll Geol Engn & Geomat, Xian 710054, Peoples R China; [Luo ZiRen] Leibniz Univ Hannover, QUEST Ctr Quantum Engn & Space Time Res, D-30167 Hannover, Germany; [Luo ZiRen] Max Planck Inst Gravitat Phys, Albert Einstein Inst, D-30167 Hannover, Germany; [Tang WenLin] Beijing Aerosp Control Ctr, Aerosp Flight Dynam Lab, Beijing 100094, Peoples R China; [Wan XiaoYun] Qian Xuesen Lab Launch Vehicle Technol, Beijing 100094, Peoples R China; [Ni Wei-Tou] Tsing Hua Univ, Dept Phys, Ctr Gravitat & Cosmol, Hsinchu 30013, Peoples R China	Blair, D (reprint author), Univ Western Australia, Sch Phys, Crawley, WA 6009, Australia.	david.blair@uwa.edu.au; lin-qing.wen@uwa.edu.au; fnzhang@bnu.edu.cn; reitze@ligo.caltech.edu; fnzhang@bnu.edu.cn; raffaele.flaminio@nao.ac.jp; xingjiang.zhu@uwa.edu.au; bacci@sissa.it; lau@amss.ac.cn; weitou@gmail.com			Kavli Institute for Theoretical Physics, China; US National Science Foundation [PHY-0757058]; National Natural Science Foundation of China [11443008, 11503003, 11305255, 11171329, 41404019]; Returned Overseas Chinese Scholars Foundation grant; Fundamental Research Funds for the Central Universities [2015KJJCB06]; Australian Research Council; National Space Science Center, Chinese Academy of Sciences [XDA04070400, XDA04077700]	The authors thank the Kavli Institute for Theoretical Physics, China for funding the Next Detectors for Gravitational Astronomy Program, and for their hospitality. Sect. 2 is based on DR's talks given during the course of this program. DR and KA are supported by the US National Science Foundation (Grant No. PHY-0757058), FZ is supported by the National Natural Science Foundation of China (Grant Nos. 11443008 and 11503003), a Returned Overseas Chinese Scholars Foundation grant, and Fundamental Research Funds for the Central Universities (Grant No. 2015KJJCB06). XZ, LW and GH acknowledge funding support from the Australian Research Council. This work was supported by the National Space Science Center, Chinese Academy of Sciences (Grant Nos. XDA04070400 and XDA04077700). Prof. HU WenRui's effort to promote GW detection in space in China motivated our study in the first place. We are also grateful to Prof. ZHANG ShuangNan for his support throughout the course of our work. Professors YAU ShingTung and YANG Lo have been very supportive and the Morningside Center of Mathematics provides a very conductive research environment to carry out the study. Partial supports from the National Natural Science Foundation of China (Grant Nos. 11305255, 11171329 and 41404019).	Aasi J, ARXIV13040670 VIRGO; Abernathy M, 2010, CLASSICAL QUANT GRAV; Accadia T, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/P03012; Acernese F., 2012, ASTROPART PHYS, V33, P182; Adam R., ARXIV14095738 PLANCK; Adam R., 2015, ARXIV150201582 PLANC; Adam R, ARXIV150201588 PLANC; AdeP A R, 2014, PHYS REV LETT, V112; AdeP A R, 2014, ASTROPHYS J, V794, P171; Adhikari R X, 2014, REV MOD PHYS, V86, P1265; Amstrong J W, 1999, ASTROPHYS J, V527, P814; Burgay M, 2003, NATURE, V426, P531, DOI 10.1038/nature02124; Pshirkov MS, 2010, MON NOT R ASTRON SOC, V402, P417, DOI 10.1111/j.1365-2966.2009.15887.x; Hirose E, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.062003; Harry GM, 2006, APPL OPTICS, V45, P1569, DOI 10.1364/AO.45.001569; Matteucci F, 2014, MON NOT R ASTRON SOC, V438, P2177, DOI 10.1093/mnras/stt2350; Martin IW, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/15/155012; LOUDON R, 1981, PHYS REV LETT, V47, P815, DOI 10.1103/PhysRevLett.47.815; Yi SX, 2014, MON NOT R ASTRON SOC, V445, P1245, DOI 10.1093/mnras/stu1826; Enoki M, 2007, PROG THEOR PHYS, V117, P241, DOI 10.1143/PTP.117.241; Hensley JM, 1999, REV SCI INSTRUM, V70, P2735, DOI 10.1063/1.1149838; Arun KG, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/9/094027; SCHUMAKER BL, 1985, PHYS REV A, V31, P3093, DOI 10.1103/PhysRevA.31.3093; Ju L, 2011, INT J MOD PHYS D, V20, P2087, DOI 10.1142/S0218271811020226; ROMANI RW, 1983, ASTROPHYS J, V265, pL35, DOI 10.1086/183953; CIUFOLINI I, 1989, INT J MOD PHYS A, V4, P3083, DOI 10.1142/S0217751X89001266; Tong ML, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/3/035001; Hobbs G, 2006, CHINESE J ASTRON AST, V6, P169; Oslowski S, 2011, MON NOT R ASTRON SOC, V418, P1258, DOI 10.1111/j.1365-2966.2011.19578.x; Liu K, 2014, MON NOT R ASTRON SOC, V443, P3752, DOI 10.1093/mnras/stu1420; WINKLER W, 1991, PHYS REV A, V44, P7022, DOI 10.1103/PhysRevA.44.7022; Braginsky VB, 1999, PHYS LETT A, V264, P1, DOI 10.1016/S0375-9601(99)00785-9; BLANDFORD R, 1984, J ASTROPHYS ASTRON, V5, P369, DOI 10.1007/BF02714466; Lentati L, 2015, MON NOT R ASTRON SOC, V453, P2576, DOI 10.1093/mnras/stv1538; Hobbs G, 2012, MON NOT R ASTRON SOC, V427, P2780, DOI 10.1111/j.1365-2966.2012.21946.x; SAULSON PR, 1990, PHYS REV D, V42, P2437, DOI 10.1103/PhysRevD.42.2437; HELLINGS RW, 1983, ASTROPHYS J, V265, pL39, DOI 10.1086/183954; Uchiyama T, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/22/224005; HEWISH A, 1968, NATURE, V217, P709, DOI 10.1038/217709a0; Harry GM, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084006; Plissi MV, 1998, REV SCI INSTRUM, V69, P3055, DOI 10.1063/1.1149054; Arai K, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/20/204020; Strain KA, 2003, APPL OPTICS, V42, P1244, DOI 10.1364/AO.42.001244; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; Lawrence R, 2004, OPT LETT, V29, P2635, DOI 10.1364/OL.29.002635; Barish BC, 1999, PHYS TODAY, V52, P44, DOI 10.1063/1.882861; Ellis JA, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224004; HELLO P, 1990, J PHYS-PARIS, V51, P1267, DOI 10.1051/jphys:0199000510120126700; Oslowski S, 2013, MON NOT R ASTRON SOC, V430, P416, DOI 10.1093/mnras/sts662; Somiya K, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/12/124007; Gretarsson AM, 2000, AIP CONF PROC, V523, P306; Hirose E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.102004; VILENKIN A, 1981, PHYS LETT B, V107, P47, DOI 10.1016/0370-2693(81)91144-8; Wang G, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/6/065011; Vacher R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214205; Newell DB, 1997, REV SCI INSTRUM, V68, P3211, DOI 10.1063/1.1148269; Grote H, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084003; Deng XH, 2011, MON NOT R ASTRON SOC, V414, P50, DOI 10.1111/j.1365-2966.2010.17913.x; MEERS BJ, 1988, PHYS REV D, V38, P2317, DOI 10.1103/PhysRevD.38.2317; Weisberg JM, 2010, ASTROPHYS J, V722, P1030, DOI 10.1088/0004-637X/722/2/1030; Braginsky VB, 2008, ASTRON LETT+, V34, P558, DOI 10.1134/S1063773708080070; Rosado PA, 2015, MON NOT R ASTRON SOC, V451, P2417, DOI 10.1093/mnras/stv1098; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; WEBER J, 1960, PHYS REV, V117, P306, DOI 10.1103/PhysRev.117.306; You XP, 2007, MON NOT R ASTRON SOC, V378, P493, DOI 10.1111/j.1365-2966.2007.11617.x; Jenet FA, 2005, ASTROPHYS J, V625, pL123, DOI 10.1086/431220; Seto N, 2009, MON NOT R ASTRON SOC, V400, pL38, DOI 10.1111/j.1745-3933.2009.00758.x; Sakakibara Y, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/15/155011; RAJAGOPAL M, 1995, ASTROPHYS J, V446, P543, DOI 10.1086/175813; Finn LS, 2010, ASTROPHYS J, V718, P1400, DOI 10.1088/0004-637X/718/2/1400; Keith MJ, 2013, MON NOT R ASTRON SOC, V429, P2161, DOI 10.1093/mnras/sts486; Aso Y, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043007; Sesana A, 2013, MON NOT R ASTRON SOC, V433, pL1, DOI 10.1093/mnrasl/slt034; Liao AC, 2002, INT J MOD PHYS D, V11, P1075, DOI 10.1142/S021827180200258X; Aston SM, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/23/235004; Ravi V, 2014, MON NOT R ASTRON SOC, V442, P56, DOI 10.1093/mnras/stu779; Lentati L, 2014, MON NOT R ASTRON SOC, V437, P3004, DOI 10.1093/mnras/stt2122; Belczynski K, 2002, ASTROPHYS J, V572, P407, DOI 10.1086/340304; Kramer M, 2006, SCIENCE, V314, P97, DOI 10.1126/science.1132305; Flaminio R, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084030; Zhu XJ, 2014, MON NOT R ASTRON SOC, V444, P3709, DOI 10.1093/mnras/stu1717; Cole GD, 2013, NAT PHOTONICS, V7, P644, DOI [10.1038/nphoton.2013.174, 10.1038/NPHOTON.2013.174]; STINEBRING DR, 1990, PHYS REV LETT, V65, P285, DOI 10.1103/PhysRevLett.65.285; Sudou H, 2003, SCIENCE, V300, P1263, DOI 10.1126/science.1082817; Abbott BP, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/7/076901; CAVES CM, 1985, PHYS REV A, V31, P3068, DOI 10.1103/PhysRevA.31.3068; Penn SD, 2006, PHYS LETT A, V352, P3, DOI 10.1016/j.physleta.2005.11.046; Vigeland SJ, 2014, MON NOT R ASTRON SOC, V440, P1446, DOI 10.1093/mnras/stu312; KOCHANEK CS, 1993, ASTROPHYS J, V417, pL17, DOI 10.1086/187083; Wang G, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/4/049501; Lyne AG, 2004, SCIENCE, V303, P1153, DOI 10.1126/science.1094645; Jaffe AH, 2003, ASTROPHYS J, V583, P616, DOI 10.1086/345443; Zhu XJ, 2013, MON NOT R ASTRON SOC, V431, P882, DOI 10.1093/mnras/stt207; Barriga P, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3250841; Wyithe JSB, 2003, ASTROPHYS J, V590, P691, DOI 10.1086/375187; Siemens X, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.105001; Lommen AN, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224001; Zhao W, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.124012; TAYLOR JH, 1982, ASTROPHYS J, V253, P908, DOI 10.1086/159690; Champion DJ, 2010, ASTROPHYS J LETT, V720, pL201, DOI 10.1088/2041-8205/720/2/L201; Marka S, 2002, CLASSICAL QUANT GRAV, V19, P1605, DOI 10.1088/0264-9381/19/7/351; Shannon RM, 2014, MON NOT R ASTRON SOC, V443, P1463, DOI 10.1093/mnras/stu1213; Sesana A, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224014; Amaro-Seoane P, 2010, MON NOT R ASTRON SOC, V402, P2308, DOI 10.1111/j.1365-2966.2009.16104.x; Bender PL, 1997, CLASSICAL QUANT GRAV, V14, P1439, DOI 10.1088/0264-9381/14/6/008; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Everitt CWF, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.221101; Gair J, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.082001; Cornish NJ, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224005; Wang JB, 2015, MON NOT R ASTRON SOC, V446, P1657, DOI 10.1093/mnras/stu2137; Degallaix J, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/18/185010; Accadia T, 2011, J LOW FREQ NOISE V A, V30, P63, DOI 10.1260/0263-0923.30.1.63; de Vine G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.211103; Nichols DA, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.124014; Coles W, 2011, MON NOT R ASTRON SOC, V418, P561, DOI 10.1111/j.1365-2966.2011.19505.x; MIZUNO J, 1993, PHYS LETT A, V175, P273, DOI 10.1016/0375-9601(93)90620-F; Harry GM, 2007, CLASSICAL QUANT GRAV, V24, P405, DOI 10.1088/0264-9381/24/2/008; Edwards RT, 2006, MON NOT R ASTRON SOC, V372, P1549, DOI 10.1111/j.1365-2966.2006.10870.x; Zheng W, 2009, CHINESE PHYS B, V18, P3597, DOI 10.1088/1674-1056/18/8/077; Lee KJ, 2014, MON NOT R ASTRON SOC, V441, P2831, DOI 10.1093/mnras/stu664; HULSE RA, 1975, ASTROPHYS J, V195, pL51, DOI 10.1086/181708; Astone P, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.022001; Jenet FA, 2006, ASTROPHYS J, V653, P1571, DOI 10.1086/508702; Harry GM, 2002, CLASSICAL QUANT GRAV, V19, P897, DOI 10.1088/0264-9381/19/5/305; NARAYAN R, 1992, PHILOS T ROY SOC A, V341, P151, DOI 10.1098/rsta.1992.0090; Takami K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.091104; BERTOTTI B, 1983, MON NOT R ASTRON SOC, V203, P945; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Kramer M, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224009; Hong T, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.082001; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; Mingarelli CMF, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.062005; Ciufolini I, 2004, NATURE, V431, P958, DOI 10.1038/nature03007; Lee KJ, 2011, MON NOT R ASTRON SOC, V414, P3251, DOI 10.1111/j.1365-2966.2011.18622.x; VINET JY, 1988, PHYS REV D, V38, P433, DOI 10.1103/PhysRevD.38.433; Weiss R, 1999, REV MOD PHYS, V71, pS187, DOI 10.1103/RevModPhys.71.S187; Penn SD, 2003, CLASSICAL QUANT GRAV, V20, P2917, DOI 10.1088/0264-9381/20/13/334; Giaime J, 1996, REV SCI INSTRUM, V67, P208, DOI 10.1063/1.1146573; Stinebring D, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224006; Kondratiev NM, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.022001; Ju L, 2000, REP PROG PHYS, V63, P1317, DOI 10.1088/0034-4885/63/9/201; KASPI VM, 1994, ASTROPHYS J, V428, P713, DOI 10.1086/174280; Rowan S, 2005, PHYS LETT A, V347, P25, DOI 10.1016/j.physleta.2005.06.055; Yardley DRB, 2010, MON NOT R ASTRON SOC, V407, P669, DOI 10.1111/j.1365-2966.2010.16949.x; RAWLEY LA, 1987, SCIENCE, V238, P761, DOI 10.1126/science.238.4828.761; van Haasteren R, 2010, MON NOT R ASTRON SOC, V401, P2372, DOI 10.1111/j.1365-2966.2009.15885.x; Ju L, 2004, CLASSICAL QUANT GRAV, V21, pS887, DOI 10.1088/0264-9381/21/5/077; Taylor SR, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.084001; Hild S, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/1/015003; Nan RD, 2011, INT J MOD PHYS D, V20, P989, DOI 10.1142/S0218271811019335; Cella G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3652857; Ravi V, 2015, MON NOT R ASTRON SOC, V447, P2772, DOI 10.1093/mnras/stu2659; Ni WT, 2010, MOD PHYS LETT A, V25, P922, DOI 10.1142/S0217732310000071; Favata M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.024002; CALLEN HB, 1951, PHYS REV, V83, P34, DOI 10.1103/PhysRev.83.34; Hobbs G, 2009, MON NOT R ASTRON SOC, V394, P1945, DOI 10.1111/j.1365-2966.2009.14391.x; Affeldt C, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/22/224002; Ade PAR, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.101301; Quinlan F, 2013, NAT PHOTONICS, V7, P290, DOI [10.1038/nphoton.2013.33, 10.1038/NPHOTON.2013.33]; Ni WT, 1997, P SOC PHOTO-OPT INS, V3116, P105, DOI 10.1117/12.293329; Ballardin G, 2001, REV SCI INSTRUM, V72, P3643, DOI 10.1063/1.1392338; Hobbs G, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084013; Sakakibara Y, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/22/224003; Hobbs G, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224007; Abbott R, 2002, CLASSICAL QUANT GRAV, V19, P1591, DOI 10.1088/0264-9381/19/7/349; Ferdman RD, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084014; Verbiest JPW, 2009, MON NOT R ASTRON SOC, V400, P951, DOI 10.1111/j.1365-2966.2009.15508.x; CHRISTENSEN N, 1992, PHYS REV D, V46, P5250, DOI 10.1103/PhysRevD.46.5250; Shannon RM, 2010, ASTROPHYS J, V725, P1607, DOI 10.1088/0004-637X/725/2/1607; Sanidas SA, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.122003; Boylan-Kolchin M, 2009, MON NOT R ASTRON SOC, V398, P1150, DOI 10.1111/j.1365-2966.2009.15191.x; Dhurandhar SV, 2013, ADV SPACE RES, V51, P198, DOI 10.1016/j.asr.2012.09.017; McLaughlin MA, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224008; Harms J, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/18/185011; van Haasteren R, 2011, MON NOT R ASTRON SOC, V414, P3117, DOI 10.1111/j.1365-2966.2011.18613.x; Braginsky VB, 2003, PHYS LETT A, V312, P244, DOI 10.1016/S0375-9601(03)00473-0; Evans M, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.102003; Sesana A, 2009, MON NOT R ASTRON SOC, V394, P2255, DOI 10.1111/j.1365-2966.2009.14499.x; Braginsky VB, 2004, PHYS LETT A, V324, P345, DOI 10.1016/j.physleta.2004.02.066; Dumas JC, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3250861; Mingarelli CMF, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.081104; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Gong XF, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/9/094012; DETWEILER S, 1979, ASTROPHYS J, V234, P1100, DOI 10.1086/157593; FOSTER RS, 1990, ASTROPHYS J, V361, P300, DOI 10.1086/169195; Chen D, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/22/224001; Damour T, 2000, PHYS REV LETT, V85, P3761, DOI 10.1103/PhysRevLett.85.3761; Wen ZL, 2009, ASTROPHYS J, V692, P511, DOI 10.1088/0004-637X/692/1/511; Abadie J, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/17/173001; Belczynski K, 2007, ASTROPHYS J, V662, P504, DOI 10.1086/513562; CLOHESSY WH, 1960, J AEROSP SCI, V27, P653; Yardley DRB, 2011, MON NOT R ASTRON SOC, V414, P1777, DOI 10.1111/j.1365-2966.2011.18517.x; Evans K, 2012, J PHYS CONF SER, V371, DOI 10.1088/1742-6596/371/1/012058; GIAZOTTO A, 1989, PHYS REP, V182, P365, DOI 10.1016/0370-1573(89)90087-2; MASHHOON B, 1989, PHYS REV D, V39, P2825, DOI 10.1103/PhysRevD.39.2825; Zhu XJ, 2015, MON NOT R ASTRON SOC, V449, P1650, DOI 10.1093/mnras/stv381; Ponslet ER, 1998, P SOC PHOTO-OPT INS, V3327, P432, DOI 10.1117/12.310705; Demorest PB, 2011, MON NOT R ASTRON SOC, V416, P2821, DOI 10.1111/j.1365-2966.2011.19230.x; Babak S, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.044034; Bassiri R, 2013, ACTA MATER, V61, P1070, DOI 10.1016/j.actamat.2012.10.009; DAVIS MM, 1985, NATURE, V315, P547, DOI 10.1038/315547a0; van Haasteren R, 2013, MON NOT R ASTRON SOC, V428, P1147, DOI 10.1093/mnras/sts097; Anselmi A., 2010, SDRPAI0668 THAL AL S; Arzoumanian Z, ARXIV150105343V1; Arzoumanian Z, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/141; Aufmuth P, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/202; Bender P L., 2004, CQGRA, V21, P1203; Bender P L, 2005, ESA, P33; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Bianchini F, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/1/64; Blair D., 2005, DETECTION GRAVITATIO; Blair D, 2015, SCI CHINA PHYS MECH, V58, DOI 10.1007/s11433-015-5747-7; Blair D, 2006, TEACH SCI, V52, P30; Boughn S, 1973, P IAU C GRAV RAD GRA; BRAGINSKY VB, 1987, NATURE, V327, P123, DOI 10.1038/327123a0; Braginskii V B, 1980, ZH EKSP TEOR FIZ, V31, P444; Braginsky V B, 1999, QUANTUM MEASUREMENT; Chen D, 2015, THESIS; Chu Q, 2012, J PHYS CONF SER, V363, DOI 10.1088/1742-6596/363/1/012023; Ciufolini I, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12133-8; Cordes JM, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/54; Cordes J M, ARXIV150308491V1; Cordes J M, ARXIV10103785V1; Cutler C, 2002, P GR16 C GEN REL GRA; Demorest PB, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/94; Deng X., 2014, PHYS REV D, V0; Dick G J, 2008, IPN PROGR REPORT, V42, P175; Dolch T, 2014, ASTROPHYS J, V794, DOI [10.1088/0004-637X/794/1/21, 10.1088/0004637X/794/1/21]; Dooley KL, 2015, J PHYS CONF SER, V610, DOI 10.1088/1742-6596/610/1/012015; Dooley K. L., 2015, Journal of Physics: Conference Series, V610, DOI 10.1088/1742-6596/610/1/012012; Driggers JC, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.102001; Einstein A, 1997, COLLECTED PAPERS A E; Einstein A, 1918, SITZBER K PREUSS AKA, P154; Einstein A., 1918, GRAVITATIONSWELLEN; Einstein A, 1915, SITZBER K PREUSS AKA, P844; Einstein A., 1916, SITZUNGSBERICHTE KON; Einstein A, 1916, SITZBER K PREUSS AKA, P688; Ellis JA, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/175; ESTABROOK FB, 1975, GEN RELAT GRAVIT, V6, P439, DOI 10.1007/BF00762449; Farmer A J, 2002, BAAS, V34, P1225; Freise A, 2010, LIVING REV RELATIV, V13; Gao W., 2015, GRACE FOLLOW ON CHIN; Gong XF, 2015, J PHYS CONF SER, V610, DOI 10.1088/1742-6596/610/1/012011; Grote H., 2003, MAKING IT WORK 2 GEN; Gruber T., 2014, EARTH SYSTEM MASS TR; Harry G, 2012, OPTICAL COATINGTHE; Hawking S, 1989, 300 YEARS GRAVITATIO; Hertz H R., 1887, ANN PHYS CHEM, V267, P421, DOI 10.1002/andp.18872670707; Hobbs G, ARXIV14070435V1; Jenet FA, 2004, ASTROPHYS J, V606, P799, DOI 10.1086/383020; Jennrich O, 2011, ESASRE201119; Keisler R, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/151; Khalaidovski A, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/10/105004; Kulier A, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/178; Kumar R, 2015, P 11 AM C G IN PRESS; Kuroda K, 2015, INT J MOD PHYS D, V24; Lau Y K., 2014, XDA04070400 CHIN AC; Lazio TJ, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224011; Lee HM, 2015, SCI CHINA PHYS MECH, V58, DOI 10.1007/s11433-015-5740-1; Levin Y., PHYS REV D, V57, P659; Liao A C, 2002, PUBLICATIONS YUNNAN, V3, P88; Lorimer D. R., 2005, HDB PULSAR ASTRONOMY; Luck H, 2010, J PHYS CONF SER, V228, DOI 10.1088/1742-6596/228/1/012012; Luck H, 2006, CLASSICAL QUANT GRAV, V23, pS71, DOI 10.1088/0264-9381/23/8/S10; Hobbs G, 2010, MON NOT R ASTRON SOC, V402, P1027, DOI 10.1111/j.1365-2966.2009.15938.x; Ma YQ, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/1/015003; Madison DR, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/141; Manchester RN, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/22/224010; MANCHESTER RN, 2013, PUBLICATIONS ASTRONO, V0030; Matichard F, 2015, PRECIS ENG, V40, P273, DOI 10.1016/j.precisioneng.2014.09.010; Matichard F, 2015, PRECIS ENG, V40, P287, DOI 10.1016/j.precisioneng.2014.11.010; Maxwell J C., 1865, PHILOS T R SOC; McLaughlin M A., ARXIV14094579V2; McWilliams ST, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/156; Misner Ch W, 1973, GRAVITATION; Mizuno J., 1995, COMP OPTICAL CONFIGU; Naess S, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/10/007; Nawrodt Ronny, 2008, Journal of Physics: Conference Series, V122, DOI 10.1088/1742-6596/122/1/012008; Ni W T, 2003, ADV SPACE RES, V32, P1437, DOI 10.1016/S0273-1177(03)90359-0; PHINNEY ES, 1991, ASTROPHYS J, V380, pL17, DOI 10.1086/186163; Pitkin M, 2011, LIVING REV RELATIV, V14; Ravi V, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/84; Rickles D, 1957, 1957 CHAP HILL C; Romani R W., 1989, ADV SCI I ASI C, V262, P113; Sathyaprakash BS, 2009, LIVING REV RELATIV, V12; Saulson P., 1994, FUNDAMENTALS INTERFE; Sazhin M. V., 1979, Soviet Astronomy, V22; SCHIFF LI, 1960, P NATL ACAD SCI USA, V46, P871, DOI 10.1073/pnas.46.6.871; Shannon RM, 2013, SCIENCE, V342, P334, DOI 10.1126/science.1238012; Shoemaker D., LIGOT0900288V3; Sneeuw N., 2000, THESIS; Taylor S, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.104028; Taylor S R, 2015, PHYS REV LETT, V15; The Virgo Collaboration, 2009, VIR027A09; The Virgo Collaboration, 2012, VIR0128A12; Thorne K S., 1995, PARTICLE NUCL ASTROP, P160; Thorne K S., 1988, NEAR ZERO NEW FRONTI, P573; Thorne K S, 1987, 300 YEARS GRAVITATIO; Tinto M, 2014, LIVING REV RELATIV, V17; Tsubono K, 1997, GRAVITATIONAL WAVE D, P117; WAHLQUIST H, 1987, GEN RELAT GRAVIT, V19, P1101, DOI 10.1007/BF00759146; Wang G, 2012, CHINESE ASTRON ASTR, V36, P211; Wang Gang, 2015, Chinese Physics B, V24, DOI 10.1088/1674-1056/24/5/059501; [王娜 Wang Na], 2014, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V44, P783; Wang Y, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/96; Weber J., 1961, GEN RELATIVITY GRAVI; Weiss R., 1972, TECHNICAL REPORT; Wen LQ, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.082001; Wheeler J., 1995, GRAVITATION INERTIA; Xu P, 2015, PREPRINT; Xu P, 2015, J GEOD GEOD IN PRESS	312	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7348	1869-1927		SCI CHINA PHYS MECH	Sci. China-Phys. Mech. Astron.	DEC	2015	58	12							120402	10.1007/s11433-015-5748-6		41	Physics, Multidisciplinary	Physics	CX6NI	WOS:000365817400003		
J	Kuba, M; Matsuzaka, T; Matsumori, R; Saito, R; Kaga, N; Taka, H; Ikehata, K; Okada, N; Kikuchi, T; Ohno, H; Han, SI; Takeuchi, Y; Kobayashi, K; Iwasaki, H; Yatoh, S; Suzuki, H; Sone, H; Yahagi, N; Arakawa, Y; Fujimura, T; Nakagawa, Y; Yamada, N; Shimano, H				Kuba, Motoko; Matsuzaka, Takashi; Matsumori, Rie; Saito, Ryo; Kaga, Naoko; Taka, Hikari; Ikehata, Kei; Okada, Naduki; Kikuchi, Takuya; Ohno, Hiroshi; Han, Song-Iee; Takeuchi, Yoshinori; Kobayashi, Kazuto; Iwasaki, Hitoshi; Yatoh, Shigeru; Suzuki, Hiroaki; Sone, Hirohito; Yahagi, Naoya; Arakawa, Yoji; Fujimura, Tsutomu; Nakagawa, Yoshimi; Yamada, Nobuhiro; Shimano, Hitoshi			Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-/-) mouse model	SCIENTIFIC REPORTS			English	Article							FATTY LIVER-DISEASE; BILE-ACID COMPOSITION; NONALCOHOLIC STEATOHEPATITIS; HEPATIC INFLAMMATION; INSULIN-RESISTANCE; DEFICIENT MICE; OBESE MICE; CHOLESTEROL; STEATOSIS; PATHWAYS	Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) that can develop into liver cirrhosis and cancer. Elongation of very long chain fatty acids (ELOVL) family member 6 (Elovl6) is a microsomal enzyme that regulates the elongation of C12-16 saturated and monounsaturated fatty acids (FAs). We have previously shown that Elovl6 plays an important role in the development of hepatic insulin resistance and NASH by modifying FA composition. Recent studies have linked altered hepatic cholesterol homeostasis and cholesterol accumulation to the pathogenesis of NASH. In the present study, we further investigated the role of Elovl6 in the progression of lithogenic diet (LD)-induced steatohepatitis. We showed that the absence of Elovl6 suppresses hepatic lipid accumulation, plasma total cholesterol and total bile acid (BA) levels in LDL receptor-deficient (Ldlr(-/-)) mice challenged with a LD. The absence of Elovl6 also decreases hepatic inflammation, oxidative stress and liver injury, but increases the formation of cholesterol crystals in the less dilated gallbladder. These findings suggest that Elovl6-mediated changes in hepatic FA composition, especially oleic acid (C18:1n-9), control handling of hepatic cholesterol and BA, which protects against hepatotoxicity and steatohepatitis, but promotes gallstone formation in LD-fed Ldlr(-/-) mice.	[Kuba, Motoko; Matsuzaka, Takashi; Matsumori, Rie; Saito, Ryo; Okada, Naduki; Kikuchi, Takuya; Ohno, Hiroshi; Han, Song-Iee; Takeuchi, Yoshinori; Kobayashi, Kazuto; Iwasaki, Hitoshi; Yatoh, Shigeru; Suzuki, Hiroaki; Yahagi, Naoya; Nakagawa, Yoshimi; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Kaga, Naoko; Taka, Hikari; Fujimura, Tsutomu] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Prote & Biomol Sci, Tokyo 1138421, Japan; [Ikehata, Kei; Arakawa, Yoji] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Sone, Hirohito] Niigata Univ, Fac Med, Dept Internal Med, Niigata 9518510, Japan	Matsuzaka, T (reprint author), Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	t-matsuz@md.tsukuba.ac.jp; hshimano@md.tsukuba.ac.jp			Program to Disseminate Tenure Tracking System from the Ministry of Science, Education, Culture, and Technology of Japan; Kowa Life Science Foundation; Suzuken Memorial Foundation International;  [21390275];  [22117502];  [21689025]	The authors thank Katsuko Okubo, Yuko Tamai and Chizuko Fukui for technical assistance. The authors also thank Dr. Tappei Takada (University of Tokyo) for discussion and helpful suggestions. This work was supported by Grants-in-Aid for Scientific Research 21390275 (to H. S.), 22117502 (to H. S.), 21689025 (to T. M.) and Program to Disseminate Tenure Tracking System (to T. M.) from the Ministry of Science, Education, Culture, and Technology of Japan, the Kowa Life Science Foundation (to T. M.) and the Suzuken Memorial Foundation International (to T. M.).	Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Yasutake K, 2009, SCAND J GASTROENTERO, V44, P471, DOI 10.1080/00365520802588133; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Amaro A, 2010, GASTROENTEROLOGY, V139, P149, DOI 10.1053/j.gastro.2010.03.039; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Sarwar N, 2010, LANCET, V375, P1634; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Watanabe S, 2012, J TOXICOL SCI, V37, P105; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Wouters K, 2010, FEBS LETT, V584, P1001, DOI 10.1016/j.febslet.2010.01.046; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x; MacDonald MLE, 2008, J LIPID RES, V49, P217, DOI 10.1194/jlr.M700478-JLR200; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Saito R, 2011, ARTERIOSCL THROM VAS, V31, P1973, DOI 10.1161/ATVBAHA.110.221663; Sturm E, 2005, J HEPATOL, V42, P102, DOI 10.1016/j.jhep.2004.09.019; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Beilke LD, 2009, DRUG METAB DISPOS, V37, P1035, DOI 10.1124/dmd.108.023317; Lake AD, 2013, TOXICOL APPL PHARM, V268, P132, DOI 10.1016/j.taap.2013.01.022; Matsuzaka T, 2002, J LIPID RES, V43, P911; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Campion SN, 2008, AM J PHYSIOL-GASTR L, V295, pG294, DOI 10.1152/ajpgi.00541.2007; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x; Crosignani A, 2007, CLIN CHIM ACTA, V382, P82, DOI 10.1016/j.cca.2007.03.025; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Wang DQH, 1996, J LIPID RES, V37, P606; Cherrington NJ, 2004, DRUG METAB DISPOS, V32, P734, DOI 10.1124/dmd.32.7.734; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Everhart JE, 2010, HEPATOLOGY, V51, P1491, DOI 10.1002/hep.23659; Usui S, 2002, J LIPID RES, V43, P805; Moschetta A, 2001, J LIPID RES, V42, P1273; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Tang N, 2014, BIOCHEM BIOPH RES CO, V450, P318, DOI 10.1016/j.bbrc.2014.05.113	49	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 1	2015	5								17604	10.1038/srep17604		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CX4DQ	WOS:000365649200002		
J	Tanabe, S; Nakanishi, T; Ishihara, Y; Nakashima, R				Tanabe, Susumu; Nakanishi, Toshimichi; Ishihara, Yoshiro; Nakashima, Rei			Millennial-scale stratigraphy of a tide-dominated incised valley during the last 14kyr: Spatial and quantitative reconstruction in the Tokyo Lowland, central Japan	SEDIMENTOLOGY			English	Article						Delta; estuary; fluvial; sea-level change; Tone River; Younger Dryas	SEA-LEVEL RISE; GLACIAL MAXIMUM; HOLOCENE EVOLUTION; CLIMATE-CHANGE; YOUNGER DRYAS; KANTO PLAIN; MODEL; CALIBRATION; SEDIMENT; SYSTEMS	Spatial and quantitative analysis of infilling processes of the tide-dominated incised valleys beneath the Tokyo Lowland during the last 14kyr was undertaken by using data from 18 sediment cores, 467 radiocarbon dates and 6100 borehole logs. The post-Last Glacial Maximum valley fills consist of braided river, meandering river, estuary, spit and delta systems in ascending order. The boundary between the estuary and delta systems is regarded as the maximum flooding surface. The maximum flooding surface beneath the Tokyo Lowland is dated at 8ka in the Arakawa Valley and 7ka in the Nakagawa Valley. This age difference is due to the migration of the Tone River from the Arakawa Valley to the Nakagawa Valley at 5ka, and suggests that the widely held view that the global initiation of deltas coincided with the abrupt rise of sea-level at 9 to 8ka is true only where there has been steady sediment supply from major rivers. The meandering river system is dominated by sheet-like sands that were deposited during lateral migration of channels during the Younger Dryas and isolated vertical sands within muds that reflect vertical aggradation of channels before and after the Younger Dryas. The transition between these channel geometries is controlled by a threshold sea-level rise of 4 to 7mmyr(-1). Before migration of the Tone River at 5ka, the tide-dominated bay in the Nakagawa Valley was filled by upward-fining laterally accreting muds. The muds accreted from the margin to the axis of the bay. Such lateral accretion of suspended particles derived from outside the bay has been documented in other tide-dominated coastal environments and is probably common in other similar settings. After the migration of the Tone River, the bay was filled by upward-coarsening deltaic sediments.	[Tanabe, Susumu; Nakashima, Rei] AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Nakanishi, Toshimichi; Ishihara, Yoshiro] Fukuoka Univ, Jonan Ku, Fukuoka 8140180, Japan	Tanabe, S (reprint author), AIST, Geol Survey Japan, Cent 7,Higashi 1-1-1, Tsukuba, Ibaraki 3058567, Japan.	s.tanabe@aist.go.jp					Amorosi Alessandro, 2014, Global and Planetary Change, V112, DOI 10.1016/j.gloplacha.2013.10.007; Hori K, 2002, J SEDIMENT RES, V72, P884, DOI 10.1306/052002720884; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Hijma MP, 2011, SEDIMENTOLOGY, V58, P1453, DOI 10.1111/j.1365-3091.2010.01222.x; Hori K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031029; Storms JEA, 2005, SEDIMENT GEOL, V180, P149, DOI 10.1016/j.sedgeo.2005.08.003; Muscheler R, 2008, NAT GEOSCI, V1, P263, DOI 10.1038/ngeo128; DALRYMPLE RW, 1992, J SEDIMENT PETROL, V62, P1130; Bard E, 2010, SCIENCE, V327, P1235, DOI 10.1126/science.1180557; Tanabe S, 2010, QUATERNARY SCI REV, V29, P3956, DOI 10.1016/j.quascirev.2010.09.018; Hanebuth TJJ, 2012, SEDIMENT GEOL, V261, P108, DOI 10.1016/j.sedgeo.2012.03.014; Chabangborn A, 2014, BOREAS, V43, P220, DOI 10.1111/bor.12032; ALLEN GP, 1993, J SEDIMENT PETROL, V63, P378; Aslan A, 1999, INT AS SED, V28, P193, DOI 10.1002/9781444304213.ch15; STUIVER M, 1993, RADIOCARBON, V35, P35; [Anonymous], 2013, J GEOL SOC JPN, DOI DOI 10.5575/geosoc.2013.0007; Tanabe S, 2006, SEDIMENT GEOL, V187, P29, DOI 10.1016/j.sedgeo.2005.12.004; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; Tanabe S, 2013, MAR GEOL, V336, P33, DOI 10.1016/j.margeo.2012.11.006; Okuno J, 2014, QUATERNARY SCI REV, V91, P42, DOI 10.1016/j.quascirev.2014.03.010; Vis GJ, 2009, SEDIMENT GEOL, V221, P19, DOI 10.1016/j.sedgeo.2009.07.010; Blum M, 2013, EARTH-SCI REV, V116, P128, DOI 10.1016/j.earscirev.2012.09.003; Ishihara T, 2012, GEOMORPHOLOGY, V147, P49, DOI 10.1016/j.geomorph.2011.08.022; Chen HW, 2010, J ASIAN EARTH SCI, V39, P192, DOI 10.1016/j.jseaes.2010.02.009; KAIZUKA S, 1977, QUATERNARY RES, V8, P32, DOI 10.1016/0033-5894(77)90055-2; Blum MD, 2000, SEDIMENTOLOGY, V47, P2, DOI 10.1046/j.1365-3091.2000.00008.x; Morehead MD, 2003, GLOBAL PLANET CHANGE, V39, P95, DOI 10.1016/S0921-8181(03)00019-5; Rodriguez AB, 2010, QUATERNARY SCI REV, V29, P3983, DOI 10.1016/j.quascirev.2010.10.004; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; BOYD R, 1992, SEDIMENT GEOL, V80, P139, DOI 10.1016/0037-0738(92)90037-R; Syvitski JP, 1998, COMPUT GEOSCI, V24, P51, DOI 10.1016/S0098-3004(97)00083-6; DAVIS RA, 1984, MAR GEOL, V60, P313, DOI 10.1016/0025-3227(84)90155-5; Yoneda M, 2004, NUCL INSTRUM METH B, V223, P116, DOI 10.1016/j.nimb.2004.04.026; Tjallingii R, 2014, J QUATERNARY SCI, V29, P581, DOI 10.1002/jqs.2731; Anderson JB, 2014, MAR GEOL, V352, P348, DOI 10.1016/j.margeo.2013.12.008; Tornqvist TE, 2012, NAT GEOSCI, V5, P601, DOI [10.1038/ngeo1536, 10.1038/NGEO1536]; Austermann J, 2013, NAT GEOSCI, V6, P553, DOI 10.1038/NGEO1859; Berendsen H. J. A., 2001, PALEOGEOGRAPHIC DEV; Bhattacharya J.P., 1992, FACIES MODELS RESPON, P157; Editorial Committee of Story of N-value, 1998, STOR OF N VAL; ENDO K, 1989, Quaternary Research (Tokyo), V28, P61; Farnsworth K.A., 2011, RIVER DISCHARGE COAS; GoodbredJr S. L.., 2012, PRINCIPLES TIDAL SED, P129; Institute of Earthquake and Volcano Geology AIST, 2014, ACT FAULT DAT JAP; Iseki H, 1975, J TOKYO GEOGR SOC, V84, P1; Iseya F, 1989, SEDIMENTARY FACIES A, P113; Ishihara Y., 2013, J GEOL SOC JPN, V119, P554, DOI DOI 10.5575/geosoc.2013.0019; Kaizuka S, 1987, J GEOGR, V96, P51; Kubo Y., 2006, J GEOL SOC JAPAN, V112, P719; Makinouchi T., 2001, J GEOL SOC JPN, V107, P283; Matsuda I, 1993, GEOMORPHOLOGY GEOLOG, P67; Menier D, 2006, SEPM SPEC PUBL, V85, P37; Miall A.D., 1992, FACIES MODELS RESPON, P119; Nakanishi T., 2011, B GEOL SURV JAPAN, V62, P47; Nakanishi T., 2011, B GEOLOGICAL SURVEY, V62, P3; Nakashima R., 2006, MEM GEOL SOC JAPAN, V59, P19; National Astronomical Observatory, 2009, CHRON SCI TABL RIK N; Okutani T, 2000, MARINE MOLLUSKS JAPA; Reimer PJ, 2009, RADIOCARBON, V51, P1111; Reineck H.E., 1980, DEPOSITIONAL SEDIMEN, DOI second; Stuiver M., 2012, CALIB 6 1; Suzuki Masaaki, 1993, Quaternary Research (Tokyo), V32, P195; Ta T.K.O., 2005, SEPM SPECIAL PUBLICA, V83, P453; Tanabe S., 2008, B GEOL SURV JAPAN, V59, P509; Tanabe S., 2010, J GEOL SOC JAPAN, V116, P85; Tanabe S., 2012, J GEOL SOC JPN, V118, P1, DOI DOI 10.5575/geosoc.2011.0020; Tanabe S, 2013, J TOKYO GEOGR SOC, V122, P949; Tanabe S., 2008, B GEOL SURV JAPAN, V59, P497; TORNQVIST TE, 1993, J SEDIMENT PETROL, V63, P683; Uehara K., 1999, PROGRAM ABSTRACTS 19, V29, P112; Uehara K., 2013, IAS SPEC PUBL, V44, P311; van dersSpek A. J. F., 1992, MAR GEOL, V80, P185; vansWagoner J. C., 1988, SEPM SPEC PUBL, V42, P39; Zaitlin BA, 1994, SEPM SPECIAL PUBLICA, V51, P45	74	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0037-0746	1365-3091		SEDIMENTOLOGY	Sedimentology	DEC	2015	62	7								10.1111/sed.12204		37	Geology	Geology	CX5DD	WOS:000365720900003		
J	Hara, N; Chijiiwa, M; Yara, M; Ishida, Y; Ogiwara, Y; Inazu, M; Kuroda, M; Karlsson, M; Sjovall, F; Elmer, E; Uchino, H				Hara, Naomi; Chijiiwa, Miyuki; Yara, Miki; Ishida, Yusuke; Ogiwara, Yukihiko; Inazu, Masato; Kuroda, Masahiko; Karlsson, Michael; Sjovall, Fredrik; Elmer, Eskil; Uchino, Hiroyuki			METABOLOMIC ANALYSES OF BRAIN TISSUE IN SEPSIS INDUCED BY CECAL LIGATION REVEAL SPECIFIC REDOX ALTERATIONS-PROTECTIVE EFFECTS OF THE OXYGEN RADICAL SCAVENGER EDARAVONE	SHOCK			English	Article						Encephalopathy; mitochondria; oxidative stress; radical scavenger; sepsis	MITOCHONDRIAL PERMEABILITY TRANSITION; SEPTIC ENCEPHALOPATHY; AQUEOUS-SOLUTION; NITRIC-OXIDE; COMPLEX-I; DYSFUNCTION; GLUTATHIONE; HYDROXYL; STATE; INHIBITION	The pathophysiology of sepsis-associated encephalopathy (SAE) is complex and remains incompletely elucidated. Dysregulated reactive oxygen species (ROS) production and mitochondrial-mediated necrotic-apoptotic pathway have been proposed as part of the pathogenesis. The present study aimed at analyzing the preventive effect of the free radical scavenger edaravone on sepsis-induced brain alterations. Sepsis was induced by cecal ligation and puncture (CLP) and the mice were divided into three groupsCLP vehicle (CLPV), CLP and edaravone (MCI-186, 3-methyl-1-phenyl-2-pyrazolin-5-one) (CLPE), and sham-operated (Sham). Mice in CLPV and CLPE were injected with saline or edaravone intraperitoneally at a dose of 10mg/kg twice daily. The treatments were initiated 4 days prior to the surgical procedure. Mortality, histological changes, electron microscopy (EM), and expression of Bcl-2 family genes (Bcl-2 and Bax) were analyzed in selected brain regions. CLPE showed significant improvement in survival compared with CLPV 18h postinduction of sepsis (P<0.05). At the same time point, pathohistological analysis also showed marked reduction of neuronal cell death in both parietal cortex and hippocampus in the CLPE (P<0.05). RT-PCR and immunoblotting directed at the Bcl-2 family revealed increased Bax mRNA levels in hippocampus at 12h in CLPV as well as an increased Bax/Bcl-2 protein ratio, changes that were significantly suppressed in CLPE. In conclusion, our study suggests that sepsis induced by cecal ligation alters cerebral redox status and supports a proapoptotic phenotype. The free radical scavenger edavarone reduces mortality of septic mice and protects against sepsis-induced neuronal cell death.	[Hara, Naomi; Chijiiwa, Miyuki; Yara, Miki; Ishida, Yusuke; Ogiwara, Yukihiko; Uchino, Hiroyuki] Tokyo Med Univ, Dept Anesthesiol, Tokyo 1680023, Japan; [Inazu, Masato] Tokyo Med Univ, Inst Med Sci, Tokyo 1680023, Japan; [Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1680023, Japan; [Karlsson, Michael; Sjovall, Fredrik; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Med, Lund, Sweden	Uchino, H (reprint author), Tokyo Med Univ, Dept Anesthesiol, Shinjyuku Ku, 6-7-1 Nishishinjuku, Tokyo 1680023, Japan.	h-uchi@tokyo-med.ac.jp	Karlsson, Michael/F-7554-2015	Karlsson, Michael/0000-0002-7247-2133	NeuroVive Pharmaceutical AB;  [26462348]	This work was financially supported by Grant-in-Aid for Scientific Research (Grant Number 26462348). MK and EE have equity interests in and/or have received salary support from in NeuroVive Pharmaceutical AB, a public company developing pharmaceuticals in the field of mitochondrial medicine. This project was however not initiated or supported by NeuroVive Pharmaceutical AB. The remaining authors declare no financial or commercial conflicts of interest.	Zhan RZ, 1996, SHOCK, V6, P293, DOI 10.1097/00024382-199610000-00012; Pytel P, 2009, CURR OPIN NEUROL, V22, P283, DOI 10.1097/WCO.0b013e32832b3101; Tajima S, 2008, RESPIROLOGY, V13, P646, DOI 10.1111/j.1440-1843.2008.01322.x; Roychoudhury S, 1996, MOL CELL BIOCHEM, V159, P95, DOI 10.1007/BF00420911; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; NISHI H, 1989, STROKE, V20, P1236; Dal-Pizzol F, 2014, REV BRAS PSIQUIATR, V36, P251, DOI 10.1590/1516-4446-2013-1233; Crouser ED, 2004, CRIT CARE MED, V32, P478, DOI 10.1097/01.CCM.0000109449.99160.81; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Kato S, 2009, SHOCK, V32, P586, DOI 10.1097/SHK.0b013e3181a2b886; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177; Voehringer DW, 1999, FREE RADICAL BIO MED, V27, P945, DOI 10.1016/S0891-5849(99)00174-4; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Watanabe T, 2004, YAKUGAKU ZASSHI, V124, P99, DOI 10.1248/yakushi.124.99; Pandharipande P, 2007, INTENS CARE MED, V33, P1726, DOI 10.1007/s00134-007-0687-y; Mezyk SP, 1996, RADIAT RES, V145, P102, DOI 10.2307/3579203; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Lipinski B, 2011, OXID MED CELL LONGEV, DOI 10.1155/2011/809696; Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; SJOBERG L, 1982, RADIAT RES, V89, P255, DOI 10.2307/3575771; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Jiao L, 2011, NEUROSCIENCE, V182, P177, DOI 10.1016/j.neuroscience.2011.01.017; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI [10.1097/CCM.0b013e3181760c4b, 10.1097/CCM0b013e3181760c4b]; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Arrigo AP, 1999, FREE RADICAL BIO MED, V27, P936, DOI 10.1016/S0891-5849(99)00175-6; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Flierl MA, 2010, CRIT CARE, V14, DOI 10.1186/cc9035; Iacobone Emanuele, 2009, Crit Care Med, V37, pS331, DOI 10.1097/CCM.0b013e3181b6ed58; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Yokoo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051539	35	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	DEC	2015	44	6					578	584		10.1097/SHK.0000000000000465		7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CX4LZ	WOS:000365673700010		
J	Koyanagi, A; Stickley, A				Koyanagi, Ai; Stickley, Andrew			The Association between Sleep Problems and Psychotic Symptoms in the General Population: A Global Perspective	SLEEP			English	Article						low- and middle-income countries; psychotic experience; sleep disturbance; multi-country; population-based; prevalence	COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE EPISODES; WORLD HEALTH SURVEY; PERSECUTORY DELUSIONS; PERSISTENT INSOMNIA; DIAGNOSIS; COUNTRIES; STRESS; RISK	Study Objectives: To assess the prevalence of sleep problems and their association with psychotic symptoms using a global database. Design: Community-based cross-sectional study. Setting: Data were analyzed from the World Health Organization's World Health Survey (WHS), a population-based survey conducted in 70 countries between 2002 and 2004. Patients or Participants: 261,547 individuals aged >= 18 years from 56 countries. Interventions: N/A. Measurements and Results: The presence of psychotic symptoms in the past 12 months was established using 4 questions pertaining to positive symptoms from the psychosis screening module of the Composite International Diagnostic Interview. Sleep problems referred to severe or extreme sleep problems in the past 30 days. Multivariable logistic regression was used to estimate the associations. The overall prevalence of sleep problems was 7.6% and ranged from 1.6% (China) to 18.6% (Morocco). Sleep problems were associated with significantly higher odds for at least one psychotic symptom in the vast majority of countries. In the pooled sample, after adjusting for demographic factors, alcohol consumption, smoking, and chronic medical conditions, having sleep problems resulted in an odds ratio (OR) for at least one psychotic symptom of 2.41 (95% confidence interval [CI] 2.18-2.65). This OR was 1.59 (1.40-1.81) when further adjusted for anxiety and depression. Conclusions: A strong association between sleep problems and psychotic symptoms was observed globally. These results have clinical implications and serve as a basis for future studies to elucidate the causal association between psychotic symptoms and sleep problems.	[Koyanagi, Ai] Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Res & Dev Unit, Barcelona, Spain; [Koyanagi, Ai; Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change SCOHOST, Huddinge, Sweden; [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Stickley, Andrew] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo, Japan; [Stickley, Andrew] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Child & Adolescent Mental Hlth, Kodaira, Tokyo, Japan	Koyanagi, A (reprint author), Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Res & Dev Unit, Dr Antoni Pujadas 42, Barcelona, Spain.	a.koyanagi@pssjd.org			ISCIII-General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF);  [CP13/00150]	This was not an industry supported study. Dr. Koyanagi was supported by the Miguel Servet contract financed by the CP13/00150 project, integrated into the National R + D + I and funded by the ISCIII-General Branch Evaluation and Promotion of Health Research-and the European Regional Development Fund (ERDF). The authors have indicated no financial conflicts of interest.	Abad Vivien C, 2005, Dialogues Clin Neurosci, V7, P291; Freeman D, 2011, PSYCHOL MED, V41, P923, DOI 10.1017/S0033291710001546; Moreno C, 2013, WORLD PSYCHIATRY, V12, P251, DOI 10.1002/wps.20070; Freeman D, 2011, SCHIZOPHR RES, V132, P135, DOI 10.1016/j.schres.2011.08.012; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Monti JM, 2005, INT REV PSYCHIATR, V17, P247, DOI 10.1080/09540260500104516; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Loerbroks A, 2012, INT J EPIDEMIOL, V41, P1436, DOI 10.1093/ije/dys123; Freeman D, 2012, SOC PSYCH PSYCH EPID, V47, P1195, DOI 10.1007/s00127-011-0433-1; Winsper C, 2014, INT REV PSYCHIATR, V26, P189, DOI 10.3109/09540261.2014.881330; Freeman D, 2010, J PSYCHIATR RES, V44, P1021, DOI 10.1016/j.jpsychires.2010.03.018; Pillai V, 2014, SLEEP, V37, P1199, DOI 10.5665/sleep.3838; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Nuevo R, 2012, SCHIZOPHRENIA BULL, V38, P475, DOI 10.1093/schbul/sbq099; Freeman D, 2009, SCHIZOPHR RES, V108, P280, DOI 10.1016/j.schres.2008.12.001; Hepworth C, 2011, J NERV MENT DIS, V199, P653, DOI 10.1097/NMD.0b013e318229cfa8; Sateia MJ, 2004, LANCET, V364, P1959, DOI 10.1016/S0140-6736(04)17480-1; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Mondelli V, 2014, EPIDEMIOL PSYCH SCI, V23, P215, DOI 10.1017/S204579601400033X; Petrovsky N, 2014, J NEUROSCI, V34, P9134, DOI 10.1523/JNEUROSCI.0904-14.2014; Myers E, 2011, J BEHAV THER EXP PSY, V42, P330, DOI 10.1016/j.jbtep.2011.02.004; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Nuevo R, 2011, J CLIN PSYCHIAT, V72, P1592, DOI 10.4088/JCP.10m06801; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; Cifuentes M, 2008, SOC SCI MED, V67, P529, DOI 10.1016/j.socscimed.2008.04.003; Freeman D, 2014, SOC PSYCH PSYCH EPID, V49, P1179, DOI 10.1007/s00127-014-0928-7; Freeman D, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-214; Koyanagi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114742; National Institutes of Health, 2005, NIH STAT OF THE SCI; Peraala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018566; Soosay I, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-229; Tjepkema Michael, 2005, Health Rep, V17, P9; Wong KO, 2013, PULM MED, V2013; World Health Organization, 2002, INT GUID MON ALC CON; Yung AR, 1996, SCHIZOPHR B, V22, P353	38	1	1	AMER ACAD SLEEP MEDICINE	WESTCHESTER	ONE WESTBROOK CORPORATE CTR, STE 920, WESTCHESTER, IL 60154 USA	0161-8105	1550-9109		SLEEP	Sleep	DEC 1	2015	38	12					1875	1885		10.5665/sleep.5232		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX3RH	WOS:000365616300011		
J	Yamada, T; Hara, K; Shojima, N; Yamauchi, T; Kadowaki, T				Yamada, Tomohide; Hara, Kazuo; Shojima, Nobuhiro; Yamauchi, Toshimasa; Kadowaki, Takashi			Daytime Napping and the Risk of Cardiovascular Disease and All-Cause Mortality: A Prospective Study and Dose-Response Meta-Analysis	SLEEP			English	Article						napping; siesta; cardiovascular disease; all-cause mortality; meta-analysis	CORONARY-HEART-DISEASE; SLEEP DURATION; NIGHTTIME SLEEP; SIESTA; NAP; POPULATION; EPIDEMIOLOGY; PREDICTORS; STATEMENT; HEALTH	Study Objectives: To summarize evidence about the association between daytime napping and the risk of cardiovascular disease and all-cause mortality, and to quantify the potential dose-response relation. Design: Meta-analysis of prospective cohort studies. Methods and Results: Electronic databases were searched for articles published up to December 2014 using the terms nap, cardiovascular disease, and all-cause mortality. We selected well-adjusted prospective cohort studies reporting risk estimates for cardiovascular disease and all-cause mortality related to napping. Eleven prospective cohort studies were identified with 151,588 participants (1,625,012 person-years) and a mean follow-up period of 11 years (60% women, 5,276 cardiovascular events, and 18,966 all-cause deaths). Pooled analysis showed that a long daytime nap (>= 60 min/day) was associated with a higher risk of cardiovascular disease (rate ratio [RR]: 1.82 [1.22-2.71], P = 0.003, I-2 = 37%) compared with not napping. All-cause mortality was associated with napping for = 60 min/day (RR: 1.27 [1.11-1.45], P < 0.001, I-2 = 0%) compared with not napping. In contrast, napping for < 60 min/day was not associated with cardiovascular disease (P = 0.98) or all-cause mortality (P = 0.08). Meta-analysis demonstrated a significant J-curve dose-response relation between nap time and cardiovascular disease (P for non-linearity = 0.01). The RR initially decreased from 0 to 30 min/day. Then it increased slightly until about 45 min/day, followed by a sharp increase at longer nap times. There was also a positive linear relation between nap time and all-cause mortality (P for non-linearity = 0.97). Conclusions: Nap time and cardiovascular disease may be associated via a J-curve relation. Further studies are needed to confirm the efficacy of a short nap.	[Yamada, Tomohide; Hara, Kazuo; Shojima, Nobuhiro; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138654, Japan	Shojima, N (reprint author), 7-3-1 Hongo, Tokyo 1138655, Japan.	nshojima-tky@umin.ac.jp					Altman DG, 2003, BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Orsini N, 2006, STATA J, V6, P40; Bursztyn M, 2013, SLEEP MED, V14, P3, DOI 10.1016/j.sleep.2012.09.010; Jung KI, 2013, SLEEP MED, V14, P12, DOI 10.1016/j.sleep.2012.06.004; Tanabe N, 2010, INT J EPIDEMIOL, V39, P233, DOI 10.1093/ije/dyp327; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Gillberg M, 1996, SLEEP, V19, P570; Naska A, 2007, ARCH INTERN MED, V167, P296, DOI 10.1001/archinte.167.3.296; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19; Zaregarizi M, 2007, J APPL PHYSIOL, V103, P1332, DOI 10.1152/japplphysiol.00474.2007; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Cappuccio FP, 2010, SLEEP, V33, P585; Bursztyn M, 2002, SLEEP, V25, P187; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Egger M, 1997, BRIT MED J, V315, P629; Lan TY, 2007, SLEEP, V30, P1105; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008; Burazeri G, 2003, SLEEP, V26, P578; Cairns BJ, 2012, BRIT J CANCER, V107, P527, DOI 10.1038/bjc.2012.291; Bursztyn M, 1999, ARCH INTERN MED, V159, P1582, DOI 10.1001/archinte.159.14.1582; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Leng Y, 2014, AM J EPIDEMIOL, V179, P1115, DOI 10.1093/aje/kwu036; Hayashi M, 1999, INT J PSYCHOPHYSIOL, V32, P173, DOI 10.1016/S0167-8760(99)00009-4; TRICHOPOULOS D, 1987, LANCET, V2, P269; Stang A, 2012, SLEEP, V35, P1705, DOI 10.5665/sleep.2248; Spiegel K, 2004, ANN INTERN MED, V141, P846; Bursztyn M, 2005, SLEEP, V28, P345; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cohen-Mansfield J, SLEEP, V35, P1003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Gale CR, 2014, CIRCULATION, V129, P186, DOI 10.1161/CIRCULATIONAHA.113.002065; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; [International Classification of Diseases (ICD) World Health Organization (WHO)], INT CLASS DIS ICD; Liberati A, 2009, ANN INTERN MED, V151, pW65; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; Wells G, NEWCASTLE OTTAWA SCA	41	0	0	AMER ACAD SLEEP MEDICINE	WESTCHESTER	ONE WESTBROOK CORPORATE CTR, STE 920, WESTCHESTER, IL 60154 USA	0161-8105	1550-9109		SLEEP	Sleep	DEC 1	2015	38	12					1945	1953		10.5665/sleep.5246		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX3RH	WOS:000365616300018		
J	Arita, A; Sasanabe, R; Hasegawa, R; Nomura, A; Hori, R; Mano, M; Konishi, N; Shiomi, T				Arita, Aki; Sasanabe, Ryujiro; Hasegawa, Rika; Nomura, Atsuhiko; Hori, Reiko; Mano, Mamiko; Konishi, Noriyuki; Shiomi, Toshiaki			Risk factors for automobile accidents caused by falling asleep while driving in obstructive sleep apnea syndrome	SLEEP AND BREATHING			English	Article						Automobile accidents; Obstructive sleep apnea; Epworth sleepiness sale; Falling asleep; Risk factors	JAPANESE PATIENTS; DRIVERS; RECOMMENDATIONS; HYPERTENSION; ASSOCIATION; PERFORMANCE; CRASHES; SOCIETY	Purpose We examined the risk factors for automobile accidents caused by falling asleep while driving in subjects with obstructive sleep apnea syndrome (OSAS). Methods We asked licensed drivers with history of snoring and excessive daytime sleepiness who had undergone polysomnography (PSG) at the Department of Sleep Medicine/Sleep Disorders Center at Aichi Medical University Hospital to complete the questionnaires on accidents caused by falling asleep while driving. As a subjective measure of sleepiness, we used the Epworth sleepiness scale (ESS). Based on PSG results, 2387 subjects diagnosed with OSAS were divided into three groups according to apnea-hypopnea index (AHI): mild-to-moderate (5 a parts per thousand currency signaEuro parts per thousand AHI < 30), severe (30 a parts per thousand currency signaEuro parts per thousand AHI < 60), and very severe (AHI a parts per thousand yenaEuro parts per thousand 60). We performed univariate and multivariate logistic regression on variables that might explain falling asleep at the wheel. Results We compared results between each group and simple snorers (394 subjects with AHI < 5) and found the group with very severe OSAS reported significantly higher rates of driving when drowsy and having accidents in the past 5 years due to falling asleep. Conclusions Our multivariate analysis suggests that scores on the ESS and patient-reported frequency of feeling drowsy while regular driving and working are related to automobile accidents caused by falling asleep while driving.	[Arita, Aki; Sasanabe, Ryujiro; Hasegawa, Rika; Nomura, Atsuhiko; Hori, Reiko; Mano, Mamiko; Konishi, Noriyuki; Shiomi, Toshiaki] Aichi Med Univ, Dept Sleep Med, Sch Med, Nagakute, Aichi 4801195, Japan	Sasanabe, R (reprint author), Aichi Med Univ, Dept Sleep Med, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	sasanabe@aichi-med-u.ac.jp					Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Parati G, 2012, J HYPERTENS, V30, P633, DOI 10.1097/HJH.0b013e328350e53b; BONNET MH, 1986, PSYCHOPHYSIOLOGY, V23, P263, DOI 10.1111/j.1469-8986.1986.tb00630.x; Banks S, 2005, SLEEP, V28, P1381; George CFP, 1999, SLEEP, V22, P790; Tregear S, 2010, SLEEP, V33, P1373; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Sasanabe R, 2006, HYPERTENS RES, V29, P315, DOI 10.1291/hypres.29.315; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; [Anonymous], 2007, J CLIN SLEEP MED, DOI DOI 10.5664/JCSM.2172; Shiomi T, 2002, PSYCHIAT CLIN NEUROS, V56, P333, DOI 10.1046/j.1440-1819.2002.01004.x; Otake K, 2009, INTERNAL MED, V48, P1863, DOI 10.2169/internalmedicine.48.2465; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; FINDLEY L, 1995, CHEST, V108, P619, DOI 10.1378/chest.108.3.619; Kapur VK, 2005, SLEEP, V28, P472; Komada Y, 2009, TOHOKU J EXP MED, V219, P11, DOI 10.1620/tjem.219.11; Ellen RL, 2006, J CLIN SLEEP MED, V15, P193; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540; National Police Agency working papers, 2007, NATL POLICY AGENCY W; Rechtshaffen A, 1968, MANUAL STANDARDIZED; Redelmeier DA, 2012, NEW ENGL J MED, V367, P1228, DOI 10.1056/NEJMsa1114310; Flemons WW, 1999, SLEEP, V22, P667; Stepanski EJ, 2002, SLEEP, V25, P268	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	DEC	2015	19	4					1229	1234		10.1007/s11325-015-1145-7		6	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CX5LZ	WOS:000365744500016		
J	Imai, Y; Tanaka, N; Usui, Y; Takahashi, N; Kurohane, S; Takei, Y; Takata, Y; Yamashina, A				Imai, Yasuko; Tanaka, Nobuhiro; Usui, Yasuhiro; Takahashi, Nori; Kurohane, Saiko; Takei, Yasuyoshi; Takata, Yoshifumi; Yamashina, Akira			Severe obstructive sleep apnea increases left atrial volume independently of left ventricular diastolic impairment	SLEEP AND BREATHING			English	Article						Obstructive sleep apnea; Left atrial volume; Diastolic function; Echocardiography	HEART-FAILURE; CARDIOVASCULAR OUTCOMES; OBESITY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DYSFUNCTION; FIBRILLATION; DIAMETER; DISEASE; HEALTH	Purpose Severe obstructive sleep apnea (OSA) directly impairs left ventricular (LV) diastolic function. Left atrial volume index (LAVI), an independent predictor of future cardiovascular events, is also related to OSA severity. This study aimed to assess whether OSA is associated with an increase in LAVI independently of LV diastolic function. Methods Two hundred six OSA patients (apnea hypopnea index, AHI a parts per thousand yenaEuro parts per thousand 5/h) without cardiac disease, hypertension, and diabetes were enrolled. They underwent overnight fully attended polysomnography and 2-dimensional echocardiography in order to estimate LA volumes and LV diastolic function which was assessed by the ratio of transmitral early diastolic flow velocity to late diastolic flow velocity (E/A), deceleration time, and mitral annular velocity (e') which was derived from tissue Doppler imaging. Patients were divided into two groups based on AHI, namely, group M (5 a parts per thousand currency signaEuro parts per thousand AHI < 30/h) and group S (AHI a parts per thousand yenaEuro parts per thousand 30/h). Results The LAVI value in group S was significantly larger than that in group M (20 +/- 5 vs. 23 +/- 5 mL/m(2), P < 0.001). E/A in group S was significantly lower than that in group M (P < 0.001), whereas the ratio of E to e' (E/e') in group S was significantly higher than that in group M (P < 0.001). AHI showed a statistically significant correlation with LAVI (P < 0.001). On multivariate linear regression analysis, severe OSA was independently related with LAVI even after adjusting for age, sex, systolic blood pressure, body mass index, and measurements of LV diastolic function (P = 0.04). Conclusions Severe OSA itself might directly increase LAVI, independently of LV diastolic function.	[Imai, Yasuko; Tanaka, Nobuhiro; Usui, Yasuhiro; Takahashi, Nori; Kurohane, Saiko; Takei, Yasuyoshi; Takata, Yoshifumi; Yamashina, Akira] Tokyo Med Univ, Dept Cardiol, Shinjuku Ku, Tokyo 1600023, Japan	Takata, Y (reprint author), Tokyo Med Univ, Dept Cardiol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	takatamd@gb3.so-net.ne.jp					Rossi VA, 2013, EUR RESPIR J, V41, P1439, DOI 10.1183/09031936.00128412; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Kizer JR, 2006, AM HEART J, V151, P412, DOI 10.1016/j.ahj.2005.04.031; Aurigemma GP, 2009, CIRC-CARDIOVASC IMAG, V2, P282, DOI 10.1161/CIRCIMAGING.108.826602; Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; Kim SM, 2012, J CARDIOL, V60, P475, DOI 10.1016/j.jjcc.2012.07.007; Iwasaki Y, 2012, HEART RHYTHM, V9, P1409, DOI 10.1016/j.hrthm.2012.03.024; Usui Y, 2012, SLEEP BREATH, V16, P677, DOI 10.1007/s11325-011-0557-2; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; Douglas PS, 2003, J AM COLL CARDIOL, V42, P1206, DOI 10.1016/S0735-1097(03)00956-2; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lakhani M, 2011, CARDIOL REV, V19, P1, DOI 10.1097/CRD.0b013e3181f877d2; Ayalon N, 2014, AM J CARDIOL, V114, P838, DOI 10.1016/j.amjcard.2014.06.013; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Kim SH, 2008, AM J CARDIOL, V101, P1663, DOI 10.1016/j.amjcard.2008.01.056; Takei Y, 2009, AM J HYPERTENS, V22, P763, DOI 10.1038/ajh.2009.79; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Oliveira W, 2009, HEART, V95, P1872, DOI 10.1136/hrt.2009.173625; Stritzke J, 2009, J AM COLL CARDIOL, V54, P1982, DOI 10.1016/j.jacc.2009.07.034; Pritchett AM, 2003, J AM COLL CARDIOL, V41, P1036, DOI 10.1016/S0935-1097(02)02981-9; Young T, 2008, SLEEP, V31, P1071; Jaroch J, 2014, BLOOD PRESSURE, V29, P1; Oliveira W, 2008, J AM SOC ECHOCARDIOG, V21, P1355, DOI 10.1016/j.echo.2008.09.007; Flemons WW, 1999, SLEEP, V22, P667; Usui Y, 2013, SLEEP MED, V2, P155	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1520-9512	1522-1709		SLEEP BREATH	Sleep Breath.	DEC	2015	19	4					1249	1255		10.1007/s11325-015-1153-7		7	Clinical Neurology; Respiratory System	Neurosciences & Neurology; Respiratory System	CX5LZ	WOS:000365744500019		
J	Bossert, W; Suzumura, K				Bossert, Walter; Suzumura, Kotaro			Expected utility without full transitivity	SOCIAL CHOICE AND WELFARE			English	Article							COMPLETENESS AXIOM; RATIONAL CHOICE; NONTRANSITIVE PREFERENCES; DECISION; UNCERTAINTY; REGRET; RISK	We generalize the classical expected-utility criterion by weakening transitivity to Suzumura consistency. In the absence of full transitivity, reflexivity and completeness no longer follow as a consequence of the system of axioms employed and a richer class of rankings of probability distributions results. This class is characterized by means of standard expected-utility axioms in addition to Suzumura consistency. An important feature of some members of our new class is that they allow us to soften the negative impact of so-called paradoxes that involve preference reversals without abandoning the expected-utility framework altogether.	[Bossert, Walter] Univ Montreal, Dept Econ, Montreal, PQ H3C 3J7, Canada; [Bossert, Walter] Univ Montreal, CIREQ, Montreal, PQ H3C 3J7, Canada; [Suzumura, Kotaro] Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, Tokyo 1698050, Japan	Bossert, W (reprint author), Univ Montreal, Dept Econ, POB 6128, Montreal, PQ H3C 3J7, Canada.	walter.bossert@videotron.ca; ktr.suzumura@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [22000001]; Fonds de Recherche sur la Societe et la Culture of Quebec; Social Sciences and Humanities Research Council of Canada	We thank Clemens Puppe, an associate editor and a referee for their valuable comments on an earlier version of the paper. Financial support from a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan for the Project on Economic Analysis of Intergenerational Issues (grant number 22000001), the Fonds de Recherche sur la Societe et la Culture of Quebec, and the Social Sciences and Humanities Research Council of Canada is gratefully acknowledged.	SEN A, 1969, REV ECON STUD, V36, P381, DOI 10.2307/2296434; Rabin M, 1998, J ECON LIT, V36, P11; FISHBURN PC, 1982, J MATH PSYCHOL, V26, P31, DOI 10.1016/0022-2496(82)90034-7; TVERSKY A, 1990, J ECON PERSPECT, V4, P201; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; SUZUMURA K, 1976, ECONOMICA, V43, P381, DOI 10.2307/2553273; LUCE RD, 1956, ECONOMETRICA, V24, P178, DOI 10.2307/1905751; AUMANN RJ, 1962, ECONOMETRICA, V30, P445, DOI 10.2307/1909888; FISHBURN PC, 1988, ECONOMETRICA, V56, P1221, DOI 10.2307/1911365; Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; BELL DE, 1982, OPER RES, V30, P961, DOI 10.1287/opre.30.5.961; SUZUMURA K, 1978, REV ECON STUD, V45, P329, DOI 10.2307/2297347; AUMANN RJ, 1964, ECONOMETRICA, V32, P210, DOI 10.2307/1913746; Dubra J, 2004, J ECON THEORY, V115, P118, DOI 10.1016/S0022-0531(03)00166-2; FISHBURN PC, 1972, ANN MATH STAT, V43, P1648, DOI 10.1214/aoms/1177692397; FISHBURN PC, 1971, ANN MATH STAT, V42, P572, DOI 10.1214/aoms/1177693407; Bossert W, 2005, ECONOMICA, V72, P185, DOI 10.1111/j.0013-0427.2005.00410.x; Aumann RJ, 2000, COLLECTED PAPERS, V1; Bossert W, 2010, CONSISTENCY CHOICE R; Camerer C., 1995, HDB EXPT EC, P587; FISHBURN PC, 1991, J RISK UNCERTAINTY, V4, P113, DOI 10.1007/BF00056121; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kreps David, 1988, NOTES THEORY CHOICE; Luce R. D., 1957, GAMES DECISIONS; Machina MJ, 1983, F UTILITY RISK THEOR, P263; Morgenstern O., 1947, THEORY GAMES EC BEHA; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Szpilrajn E, 1930, FUND MATH, V16, P386; Thrall RM, 1954, DECISION PROCESSES, P181; von Neumann J., 1944, THEORY GAMES EC BEHA	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	DEC	2015	45	4					707	722		10.1007/s00355-015-0876-5		16	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CX5AA	WOS:000365711200003		
J	Tachikawa, H; Iyama, T				Tachikawa, Hiroto; Iyama, Tetsuji			Structures and electronic states of halogen-terminated graphene nano-flakes	SOLID STATE SCIENCES			English	Article						Carbon nano-material; DFT; Band gap; Graphene flake; Functionalized graphene	ORBITAL-MOLECULAR DYNAMICS; FLUORINATED GRAPHENE; DIFFUSION DYNAMICS; LITHIUM BATTERIES; LI ION; NANORIBBONS; SURFACE; CATHODE; CARBON; C-60	Halogen-functionalized graphenes are utilized as electronic devices and energy materials. In the present paper, the effects of halogen-termination of graphene edge on the structures and electronic states of graphene flakes have been investigated by means of density functional theory (DFT) method. It was found that the ionization potential (Ip) and electron affinity of graphene (EA) are blue-shifted by the halogen termination, while the excitation energy is red-shifted. The drastic change showed a possibility as electronic devices such as field-effect transistors. The change of electronic states caused by the halogen termination of graphene edge was discussed on the basis of the theoretical results. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Tachikawa, Hiroto; Iyama, Tetsuji] Hokkaido Univ, Grad Sch Engn, Div Mat Chem, Sapporo, Hokkaido 0608628, Japan	Iyama, T (reprint author), Hokkaido Univ, Grad Sch Engn, Div Mat Chem, Sapporo, Hokkaido 0608628, Japan.	iyama@frontier.hokudai.ac.jp			JSPS KAKENHI Grant [15K05371]; MEXT KAKENHI Grant [25108004]	The author acknowledges partial support from JSPS KAKENHI Grant Number 15K05371 and MEXT KAKENHI Grant Number 25108004.	Lee SS, 2013, J PHYS CHEM C, V117, P5407, DOI 10.1021/jp310826d; Tachikawa H, 2008, J PHYS CHEM C, V112, P10193, DOI 10.1021/jp800398y; Delabarre C, 2006, CARBON, V44, P2543, DOI 10.1016/j.carbon.2006.05.013; Ueta A, 2012, J PHYS CHEM LETT, V3, P246, DOI 10.1021/jz201496q; Tachikawa H, 2006, J PHYS CHEM B, V110, P20445, DOI 10.1021/jp0616031; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Stine R, 2012, LANGMUIR, V28, P7957, DOI 10.1021/la301091f; Ohura T, 2015, ENVIRON POLLUT, V196, P331, DOI 10.1016/j.envpol.2014.10.028; Sun Y, 2013, J POWER SOURCES, V241, P168, DOI 10.1016/j.jpowsour.2013.04.093; Tachikawa H, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4906944; Kang B, 2009, NATURE, V458, P190, DOI 10.1038/nature07853; Tachikawa H, 2007, J PHYS CHEM C, V111, P13087, DOI 10.1021/jp072451c; Tachikawa H, 2015, SOLID STATE SCI, V48, P141, DOI 10.1016/j.solidstatesciences.2015.08.002; Robinson JT, 2010, NANO LETT, V10, P3001, DOI 10.1021/nl101437p; Bon SB, 2009, CHEM MATER, V21, P3433, DOI 10.1021/cm901039j; Tachikawa H, 2011, J PHYS CHEM C, V115, P20406, DOI 10.1021/jp204608s; Yang HC, 2011, J PHYS CHEM C, V115, P16844, DOI 10.1021/jp204573z; Cheng SH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205435; Osuna S, 2010, J PHYS CHEM C, V114, P3340, DOI 10.1021/jp908887n; Leenaerts O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195436; Hu CH, 2013, J PHYS CHEM C, V117, P3572, DOI 10.1021/jp3103113; KIMURA K, 1965, MOL PHYS, V9, P117, DOI 10.1080/00268976500100141; Tang SB, 2011, J PHYS CHEM C, V115, P16644, DOI 10.1021/jp204880f; Boukhvalov DW, 2010, PHYSICA E, V43, P199, DOI 10.1016/j.physe.2010.07.015; Frisch MJ, 2009, GAUSSIAN 09 REVISION; Klintenberg M., 2010, PHYS REV B, V81; Tachikawa H., 2015, PHYS STATUS SOLIDI C, V12, P1; Tachikawa H., 2014, SOLID STATE SCI, V2, P41; Withers F., 2010, PHYS REV B, V82; Zhang Y., 2013, J POWER SOURCES, V24, P517	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	DEC	2015	50						91	96		10.1016/j.solidstatesciences.2015.10.016		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CX6MT	WOS:000365815900014		
J	Brun, AS; Browning, MK; Dikpati, M; Hotta, H; Strugarek, A				Brun, A. S.; Browning, M. K.; Dikpati, M.; Hotta, H.; Strugarek, A.			Recent Advances on Solar Global Magnetism and Variability	SPACE SCIENCE REVIEWS			English	Review						Sun; Magnetism; Dynamo; Solar constant; Torsional Oscillations; Field parity; MHD instabilities	FLUX-TRANSPORT DYNAMO; STELLAR RADIATION ZONES; SUNS MERIDIONAL CIRCULATION; ROTATING SPHERICAL-SHELL; MAIN-SEQUENCE EVOLUTION; BABCOCK-LEIGHTON MODEL; POLAR FIELD REVERSAL; DIFFERENTIAL ROTATION; CONVECTION ZONE; IRRADIANCE VARIATIONS	We discuss recent observational, theoretical and numerical progress made in understanding the solar global magnetism and its short and long term variability. We discuss the physical process thought to be at the origin of the solar magnetic field and its 22-yr cycle, namely dynamo action, and the nonlinear interplay between convection, rotation, radiation and magnetic field, yielding modulations of the solar constant or of the large scale flows such as the torsional oscillations. We also discuss the role of the field parity and dynamo families in explaining the complex multipolar structure of the solar global magnetic field. We then present some key MHD processes acting in the deep radiative interior and discuss the probable topology of a primordial field there. Finally we summarize how helioseismology has contributed to these recent advances and how it could contribute to resolving current unsolved problems in solar global dynamics and magnetism.	[Brun, A. S.; Strugarek, A.] Univ Paris 07, CEA Saclay, CNRS, AIM,CEA, F-91191 Gif Sur Yvette, France; [Browning, M. K.] Univ Exeter, Phys & Astron, Exeter EX4 4QL, Devon, England; [Dikpati, M.] HAO NCAR, Boulder, CO USA; [Hotta, H.] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Brun, AS (reprint author), Univ Paris 07, CEA Saclay, CNRS, AIM,CEA, Bat 709, F-91191 Gif Sur Yvette, France.	sacha.brun@cea.fr; browning@astro.ex.ac.uk; dikpati@hao.ucar.edu; hotta.h@eps.s.u-tokyo.ac.jp; antoine.strugarek@cea.fr			NASA LWS [NNX08AQ34G]; ERC STARS2 project; French national program on Sun-Earth relationships (INSU/PNST); CNES Sun-Heliosphere program; UK STFC [ST/J001627/1STFC]; ISSI Bern; National Science Foundation	We acknowledge critical comments on solar global magnetism and dynamo by Prof. H.C. Spruit. We thank two anonymous referees for detailed and constructive comments. One of us (A.S.B) thanks the University of Kyoto, RIMS and Professors M. Yamada, K. Shibata, H. Isobe and S. Takehiro for their kind invitation in Fall 2013 during which this paper was finished. This work is partially supported by the NASA LWS grant NNX08AQ34G, by the ERC STARS2 project, by the French national program on Sun-Earth relationships (INSU/PNST) and by CNES Sun-Heliosphere program, and by a Consolidated Grant by the UK STFC (ST/J001627/1STFC). We acknowledge the support from ISSI Bern, for our participation in the workshop. The National Center for Atmospheric Research is sponsored by the National Science Foundation.	Abreu JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035442; Acheson D., 1978, SOL PHYS, V62; Miesch MS, 2006, ASTROPHYS J, V641, P618, DOI 10.1086/499621; Hale GE, 1925, ASTROPHYS J, V62, P270, DOI 10.1086/142933; Jiang J, 2010, ASTROPHYS J, V717, P597, DOI 10.1088/0004-637X/717/1/597; LEIGHTON RB, 1969, ASTROPHYS J, V156, P1, DOI 10.1086/149943; Dikpati M, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/4; Howe R, 2006, SOL PHYS, V235, P1, DOI 10.1007/s11207-006-0117-2; McClintock BH, 2013, SOL PHYS, V287, P215, DOI 10.1007/s11207-013-0338-0; MCFADDEN PL, 1991, J GEOPHYS RES-SOLID, V96, P3923, DOI 10.1029/90JB02275; MALKUS WVR, 1975, J FLUID MECH, V67, P417; Petrelis F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.144503; Strugarek A, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/189; Bonanno A, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/52; Nakano T, 2002, ASTROPHYS J, V573, P199, DOI 10.1086/340587; Dikpati M, 2006, ASTROPHYS J, V649, P498, DOI 10.1086/506314; Moss D, 2000, MON NOT R ASTRON SOC, V315, P521, DOI 10.1046/j.1365-8711.2000.03452.x; Brun AS, 2007, ASTRON NACHR, V328, P329, DOI 10.1002/asna.200610739; Miesch MS, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/2/L26; PITTS E, 1985, MON NOT R ASTRON SOC, V216, P139; Garaud P, 2009, ASTROPHYS J, V704, P1, DOI 10.1088/0004-637X/704/1/1; Nandy D, 2011, NATURE, V471, P80, DOI 10.1038/nature09786; Ossendrijver M, 2003, ASTRON ASTROPHYS REV, V11, P287, DOI 10.1007/s00159-003-0019-3; Weber MA, 2013, SOL PHYS, V287, P239, DOI 10.1007/s11207-012-0093-7; Karak BB, 2012, SOL PHYS, V278, P137, DOI 10.1007/s11207-012-9928-5; Miyahara H, 2004, SOL PHYS, V224, P317, DOI 10.1007/s11207-005-6501-5; Berdyugina SV, 2006, ASTRON ASTROPHYS, V445, P703, DOI 10.1051/0004-6361:20053454; Dikpati M, 2009, ASTROPHYS J, V692, P1421, DOI 10.1088/0004-637X/692/2/1421; Braithwaite J, 2004, NATURE, V431, P819, DOI 10.1038/nature02934; PALLA F, 1993, ASTROPHYS J, V418, P414, DOI 10.1086/173402; Haigh JD, 2010, NATURE, V467, P696, DOI 10.1038/nature09426; Tobias SM, 2009, SPACE SCI REV, V144, P77, DOI 10.1007/s11214-008-9442-0; Tobias SM, 2001, ASTROPHYS J, V549, P1183, DOI 10.1086/319448; Brun AS, 2006, ASTRON ASTROPHYS, V457, P665, DOI 10.1051/0004-6361:20053908; Brun AS, 2002, ASTROPHYS J, V570, P865, DOI 10.1086/339228; Choudhuri AR, 2009, RES ASTRON ASTROPHYS, V9, P953, DOI 10.1088/1674-4527/9/9/001; Basu S, 2010, ASTROPHYS J, V717, P488, DOI 10.1088/0004-637X/717/1/488; Bolduc C, 2012, SOL PHYS, V279, P383, DOI 10.1007/s11207-012-0019-4; Demoulin P, 2009, ADV SPACE RES, V43, P1013, DOI 10.1016/j.asr.2008.12.004; Goel A, 2009, RES ASTRON ASTROPHYS, V9, P115, DOI 10.1088/1674-4527/9/1/010; Hathaway DH, 2009, SPACE SCI REV, V144, P401, DOI 10.1007/s11214-008-9430-4; Moss D, 2003, ASTRON ASTROPHYS, V403, P693, DOI 10.1051/0004-6361:20030431; Beer J, 1998, SOL PHYS, V181, P237, DOI 10.1023/A:1005026001784; Spruit HC, 2003, SOL PHYS, V213, P1, DOI 10.1023/A:1023202605379; Yeates AR, 2008, ASTROPHYS J, V673, P544, DOI 10.1086/524352; Zahn JP, 1997, ASTRON ASTROPHYS, V322, P320; Dikpati M, 2001, ASTROPHYS J, V559, P428, DOI 10.1086/322410; Hughes DW, 2011, MON NOT R ASTRON SOC, V414, pL45, DOI 10.1111/j.1745-3933.2011.01053.x; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Ball WT, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118702; Thompson MJ, 2003, ANNU REV ASTRON ASTR, V41, P599, DOI 10.1146/annurev.astro.41.011802.094848; Rempel M, 2006, ASTROPHYS J, V647, P662, DOI 10.1086/505170; Rudiger G, 2012, MON NOT R ASTRON SOC, V425, P2267, DOI 10.1111/j.1365-2966.2012.21569.x; Kopp G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045777; Acevedo-Arreguin LA, 2013, MON NOT R ASTRON SOC, V434, P720, DOI 10.1093/mnras/stt1065; Solanki SK, 2006, REP PROG PHYS, V69, P563, DOI 10.1088/0034-4885/69/3/R02; Hao J, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L27; Padoan P, 2011, IAU SYMP P SERIES, V271, P187, DOI 10.1017/S1743921311017601; Rudiger G, 1997, ASTRON NACHR, V318, P273, DOI 10.1002/asna.2113180504; Kapyla PJ, 2010, ASTRON NACHR, V331, P73, DOI 10.1002/asna.200911252; Leonhardt R, 2007, EARTH PLANET SC LETT, V253, P172, DOI 10.1016/j.epsl.2006.10.025; Frohlich C, 2012, SURV GEOPHYS, V33, P453, DOI 10.1007/s10712-011-9168-5; Benevolenskaya EE, 2004, ASTRON ASTROPHYS, V428, pL5, DOI 10.1051/0004-6361:200400092; SOKOLOFF D, 1994, ASTRON ASTROPHYS, V288, P293; Bonanno A, 2002, ASTRON ASTROPHYS, V390, P673, DOI 10.1051/0004-6361:20020590; Dikpati M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025221; Fox P, 2004, GEOPH MONOG SERIES, V141, P141; Gilman PA, 1997, ASTROPHYS J, V484, P439, DOI 10.1086/304330; Frohlich C, 1998, GEOPHYS RES LETT, V25, P4377, DOI 10.1029/1998GL900157; Foukal P, 2006, NATURE, V443, P161, DOI 10.1038/nature05072; Tobias SM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.125003; Unruh YC, 2000, SPACE SCI REV, V94, P145, DOI 10.1023/A:1026758904332; Cameron RH, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219914; Duez V, 2011, ASTRON NACHR, V332, P983, DOI 10.1002/asna.201111610; Domingo V, 2009, SPACE SCI REV, V145, P337, DOI 10.1007/s11214-009-9562-1; BABCOCK HW, 1961, ASTROPHYS J, V133, P572, DOI 10.1086/147060; Charbonnel C, 2005, SCIENCE, V309, P2189, DOI 10.1126/science.1116849; Do Cao O, 2011, ASTRON NACHR, V332, P907, DOI 10.1002/asna.201111623; Forgacs-Dajka E, 2002, ASTRON ASTROPHYS, V389, P629, DOI 10.1051/0004-6361:20020586; Karak BB, 2010, ASTROPHYS J, V724, P1021, DOI 10.1088/0004-637X/724/2/1021; Spruit HC, 2002, ASTRON ASTROPHYS, V381, P923, DOI 10.1051/0004-6361:20011465; BABCOCK HD, 1959, ASTROPHYS J, V130, P364, DOI 10.1086/146726; Crutcher RM, 2009, ASTROPHYS J, V692, P844, DOI 10.1088/0004-637X/692/1/844; Kapyla PJ, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/41; Lean J, 1997, ANNU REV ASTRON ASTR, V35, P33, DOI 10.1146/annurev.astro.35.1.33; Beaudoin P, 2013, SOL PHYS, V282, P335, DOI 10.1007/s11207-012-0150-2; WANG YM, 1991, ASTROPHYS J, V383, P431, DOI 10.1086/170800; Palmer MA, 2004, ADV SPACE RES, V34, P343, DOI 10.1016/j.asr.2003.02.039; Spruit HC, 2012, PROG THEOR PHYS SUPP, P185; Cattaneo F, 2009, MON NOT R ASTRON SOC, V395, pL48, DOI 10.1111/j.1745-3933.2009.00639.x; Frohlich C, 2000, SPACE SCI REV, V94, P15, DOI 10.1023/A:1026765712084; Garaud P, 2008, MON NOT R ASTRON SOC, V391, P1239, DOI 10.1111/j.1365-2966.2008.13930.x; Mitra-Kraev U, 2007, ASTRON NACHR, V328, P1009, DOI 10.1002/asna.200710873; SPIEGEL EA, 1992, ASTRON ASTROPHYS, V265, P106; Brun AS, 2004, ASTROPHYS J, V614, P1073, DOI 10.1086/423835; Dikpati M, 2004, ASTROPHYS J, V601, P1136, DOI 10.1086/380508; Dikpati M, 2007, SOL PHYS, V245, P1, DOI 10.1007/s11207-007-9016-4; Brown BP, 2010, ASTROPHYS J, V711, P424, DOI 10.1088/0004-637X/711/1/424; Zahn JP, 2007, ASTRON ASTROPHYS, V474, P145, DOI 10.1051/0004-6361:20077653; Tobias SM, 2002, ASTRON NACHR, V323, P417, DOI 10.1002/1521-3994(200208)323:3/4<417::AID-ASNA417>3.0.CO;2-U; Spruit HC, 1999, ASTRON ASTROPHYS, V349, P189; Charbonneau P, 2000, ASTROPHYS J, V543, P1027, DOI 10.1086/317142; Garaud P, 2002, MON NOT R ASTRON SOC, V329, P1, DOI 10.1046/j.1365-8711.2002.04961.x; Mason J, 2008, MON NOT R ASTRON SOC, V391, P467, DOI 10.1111/j.1365-2966.2008.13918.x; Sule A, 2005, ASTRON ASTROPHYS, V437, P1061, DOI 10.1051/0004-6361:20042086; Rightmire-Upton L, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/1/L14; DSILVA S, 1993, ASTRON ASTROPHYS, V272, P621; WRIGHT GAE, 1973, MON NOT R ASTRON SOC, V162, P339; Dikpati M, 2010, ASTROPHYS J, V722, P774, DOI 10.1088/0004-637X/722/1/774; Hathaway DH, 2010, SCIENCE, V327, P1350, DOI 10.1126/science.1181990; Ilonidis S, 2011, SCIENCE, V333, P993, DOI 10.1126/science.1206253; Dikpati M, 2005, ASTROPHYS J, V635, pL193, DOI 10.1086/499626; GILMAN PA, 1981, ASTROPHYS J SUPPL S, V46, P211, DOI 10.1086/190743; Covas E, 2005, ASTRON ASTROPHYS, V429, P657, DOI 10.1051/0004-6361:20041741; Pap JM, 2003, LECT NOTES PHYS, V599, P129; SPIEGEL EA, 1980, NATURE, V287, P616, DOI 10.1038/287616a0; Lockwood M, 2012, SURV GEOPHYS, V33, P503, DOI 10.1007/s10712-012-9181-3; Gellert M, 2008, ASTRON ASTROPHYS, V479, pL33, DOI 10.1051/0004-6361:20077781; Warnecke J, 2012, SOL PHYS, V280, P299, DOI 10.1007/s11207-012-0108-4; KURUCZ RL, 1993, PHYS SCRIPTA, VT47, P110, DOI 10.1088/0031-8949/1993/T47/017; Schrijver CJ, 2001, ASTROPHYS J, V551, P1099, DOI 10.1086/320237; Clette F, 2012, J SPACE WEATHER SPAC, V2, DOI 10.1051/swsc/2012007; WANG YM, 1991, ASTROPHYS J, V375, P761, DOI 10.1086/170240; Forgacs-Dajka E, 2004, ASTRON ASTROPHYS, V413, P1143, DOI 10.1051/0004-6361:20031569; BRANDENBURG A, 1992, ASTRON ASTROPHYS, V265, P328; Gizon L, 2010, ANNU REV ASTRON ASTR, V48, P289, DOI 10.1146/annurev-astro-082708-101722; Chatterjee P, 2004, ASTRON ASTROPHYS, V427, P1019, DOI 10.1051/0004-6361:20041199; Charbonneau P, 2013, J PHYS CONF SER, V440, DOI 10.1088/1742-6596/440/1/012014; Ulrich RK, 2010, ASTROPHYS J, V725, P658, DOI 10.1088/0004-637X/725/1/658; Bushby PJ, 2006, MON NOT R ASTRON SOC, V371, P772, DOI 10.1111/j.1365-2966.2006.10706.x; Giles PM, 1997, NATURE, V390, P52, DOI 10.1038/36294; Dasi-Espuig M, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014301; Stein RF, 2006, ASTROPHYS J, V642, P1246, DOI 10.1086/501445; Hotta H, 2010, ASTROPHYS J, V709, P1009, DOI 10.1088/0004-637X/709/2/1009; Browning MK, 2007, ASTRON NACHR, V328, P1100, DOI 10.1002/asna.200710849; Petrovay K, 2002, SOL PHYS, V205, P39, DOI 10.1023/A:1013833709489; Spruit H, 2000, SPACE SCI REV, V94, P113, DOI 10.1023/A:1026742519353; Asplund M, 2004, ASTRON ASTROPHYS, V417, P751, DOI 10.1051/0004-6361:20034328; Jouve L, 2009, ASTROPHYS J, V701, P1300, DOI 10.1088/0004-637X/701/2/1300; TAYLER RJ, 1973, MON NOT R ASTRON SOC, V161, P365; Tobias SM, 1997, ASTRON ASTROPHYS, V322, P1007; Brun AS, 2009, SPACE SCI REV, V144, P151, DOI 10.1007/s11214-008-9454-9; Cheung MCM, 2010, ASTROPHYS J, V720, P233, DOI 10.1088/0004-637X/720/1/233; Haber DA, 2002, ASTROPHYS J, V570, P855, DOI 10.1086/339631; LABONTE BJ, 1982, SOL PHYS, V75, P161, DOI 10.1007/BF00153469; Hughes DW, 2013, J FLUID MECH, V717, P395, DOI 10.1017/jfm.2012.584; Strugarek A, 2011, ASTRON NACHR, V332, P891, DOI 10.1002/asna.201111613; Hathaway DH, 1996, ASTROPHYS J, V460, P1027, DOI 10.1086/177029; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; GUBBINS D, 1993, PHYS EARTH PLANET IN, V75, P225, DOI 10.1016/0031-9201(93)90003-R; Thuillier G, 2012, SOL PHYS, V277, P245, DOI 10.1007/s11207-011-9912-5; Garaud P, 2008, ASTROPHYS J, V674, P498, DOI 10.1086/524837; MARKEY P, 1973, MON NOT R ASTRON SOC, V163, P77; PARKER EN, 1993, ASTROPHYS J, V408, P707, DOI 10.1086/172631; Krivova NA, 2007, ASTRON ASTROPHYS, V467, P335, DOI 10.1051/0004-6361:20066725; Dikpati M, 1999, ASTROPHYS J, V518, P508, DOI 10.1086/307269; Howe R, 2009, ASTROPHYS J LETT, V701, pL87, DOI 10.1088/0004-637X/701/2/L87; Brandenburg A, 2005, ASTROPHYS J, V625, P539, DOI 10.1086/429584; Jouve L, 2008, ASTRON ASTROPHYS, V483, P949, DOI 10.1051/0004-6361:20078351; Jouve L, 2007, ASTRON ASTROPHYS, V474, P239, DOI 10.1051/0004-6361:20077070; Stein RF, 1998, ASTROPHYS J, V499, P914, DOI 10.1086/305678; Vorontsov SV, 2002, SCIENCE, V296, P101, DOI 10.1126/science.1069190; GLATZMAIER GA, 1985, ASTROPHYS J, V291, P300, DOI 10.1086/163069; Schou J, 1998, ASTROPHYS J, V505, P390, DOI 10.1086/306146; Braithwaite J, 2006, ASTRON ASTROPHYS, V450, P1077, DOI 10.1051/0004-6361:20041980; Gough DO, 1998, NATURE, V394, P755, DOI 10.1038/29472; Petrovay K, 2010, SPACE SCI REV, V155, P371, DOI 10.1007/s11214-010-9657-8; Beck JG, 1998, NATURE, V394, P653, DOI 10.1038/29245; Brun AS, 2007, ASTRON NACHR, V328, P1137, DOI 10.1002/asna.200710846; Hotta H, 2010, ASTROPHYS J LETT, V714, pL308, DOI 10.1088/2041-8205/714/2/L308; Pevtsov AA, 2003, ASTROPHYS J, V598, P1387, DOI 10.1086/378944; Vogler A, 2005, ASTRON ASTROPHYS, V429, P335, DOI 10.1051/0004-6361:20041507; Gallet B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.035302; Guerrero G, 2008, ASTRON ASTROPHYS, V485, P267, DOI 10.1051/0004-6361:200809351; Jouve L, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/4; Belucz B., 2013, ASTROPHYS J, V777, P1, DOI [10.1088/0004-637X/777/1, DOI 10.1088/0004-637X/777/1]; Biskamp D., 1993, CAMBRIDGE MONOGRAPHS; Braithwaite J, 2008, MON NOT R ASTRON SOC, V386, P1947, DOI 10.1111/j.1365-2966.2008.13218.x; Braithwaite J, 2009, MON NOT R ASTRON SOC, V397, P763, DOI 10.1111/j.1365-2966.2008.14034.x; Brown BP, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/69; Brown B.P., 2009, THESIS; Browning M. K., 2006, APJ, V648, P157, DOI [10.1086/507869, DOI 10.1086/507869]; Brun A.S., 2013, COMMUNICATION; Bullard E., 1954, Philosophical Transactions of the Royal Society of London. Series A (Mathematical and Physical Sciences), V247, DOI 10.1098/rsta.1954.0018; Cattaneo F., 1999, ASTROPHYS J LETT, V515, P39; Charbonneau P., 2005, LIVING REV SOL PHYS, V2, P2, DOI DOI 10.12942/LRSP-2010-3; Choudhuri A. R., 1995, ASTRON ASTROPHYS, V303, P29; Choudhuri AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.131103; Cowling T.G., 1953, SUN, P532; DeRosa ML, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/96; Dikpati M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044143; Dikpati M, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/20; Duez V., 2010, APJ, V724, P34; Ermolli I., 2012, ATMOS CHEM PHYS DISC, V12, P24557, DOI [10.5194/acpd-12-24557-2012, DOI 10.5194/ACPD-12-24557-2012]; Ferraro V.C.A., 1937, Monthly Notices of the Royal Astronomical Society, V97; Fontenla JM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016032; Gastine T, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219799; Ghizaru M., 2010, ASTROPHYS J LETT, V715, P133, DOI [10.1088/2041-8205/715/2/L133, DOI 10.1088/2041-8205/715/2/L133]; GILMAN PA, 1983, ASTROPHYS J SUPPL S, V53, P243, DOI 10.1086/190891; Gizon L., 2005, LIVING REV SOL PHYS, V2, P6, DOI [10.12942/lrsp-2005-6, DOI 10.12942/LRSP-2005-6]; Hernandez IG, 2010, ASTROPHYS J LETT, V713, pL16, DOI 10.1088/2041-8205/713/1/L16; Hathaway DH, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/84; Hathaway DH, 2010, LIVING REV SOL PHYS, V7; Hazra G., 2013, IS DEEP ONE CELL MER; Howard R., 1980, ASTROPHYS J LETT, V239, P33, DOI 10.1086/183286; Howe R., 2013, ASTROPHYS J LETT, V767, P20, DOI DOI 10.1088/2041-8205/767/1/L20; Howe R, 2009, LIVING REV SOL PHYS, V6; Joos M, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118730; Jouve L, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/31; Kapyla P. J., 2012, ASTROPHYS J LETT, V755, P22, DOI [10.1088/2041-8205/755/1/L22, DOI 10.1088/2041-8205/755/1/L22]; Karak B.B., 2012, SOL PHYS; Komm R, 2013, SOL PHYS, V287, P85, DOI 10.1007/s11207-012-0073-y; Komm R, 2011, J PHYS CONF SER, V271, DOI 10.1088/1742-6596/271/1/012065; Kosovichev AG, 2008, ASTROPHYS J LETT, V688, pL115, DOI 10.1086/595619; Lesieur M, 2008, FLUID MECH APPL, V84, P1; Li J, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/115; Livermore PW, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3313930; Maunder E.W., 1904, MNRAS, V64, P747; Mininni P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046302; Moffatt H. K., 1978, MAGNETIC FIELD GENER; MORENOINSERTIS F, 1983, ASTRON ASTROPHYS, V122, P241; Nelson NJ, 2014, SOL PHYS, V289, P441, DOI 10.1007/s11207-012-0221-4; Nelson NJ, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/73; Pap J.M., 2003, WASHINGTON DC AM GEO, V141; Petrovay K, 2010, LIVING REV SOL PHYS, V7; Pevtsov A.A., 2001, ASTROPHYS J LETT, V549, P261, DOI [10.1086/319179, DOI 10.1086/319179]; Piddington J. H., 1971, Proceedings of the Astronomical Society of Australia, V2; Pinto RF, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/55; Pinto RF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/72; Racine E, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/46; Rogers TM, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/12; Rudiger G, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/302; Schmutz W., 2012, ANN REPORT 2011 WORL; Schunker H., 2013, ASTRON ASTROPHYS; Schussler M., 1994, ASTRON ASTROPHYS, V281, P69; Shiota D, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/157; Spruit H.C., 2011, THE SUN THE SOLAR WI, P39; STEENBEC.M, 1966, Z NATURFORSCH PT A, VA 21, P369; Strugarek A., 2011, ASTRON ASTROPHYS, V532, P34; Brun AS, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/79; Usoskin IG, 2013, LIVING REV SOL PHYS, V10, DOI 10.12942/lrsp-2013-1; Yeates AR, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015611; Vazquez-Semadeni E, 2011, MON NOT R ASTRON SOC, V414, P2511, DOI 10.1111/j.1365-2966.2011.18569.x; Weber MA, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/11; Wood TS, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/47; Wood TS, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/99; Zhao J., 2013, ASTROPHYS J LETT, V774, P29, DOI DOI 10.1088/2041-8205/774/2/L29	247	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	DEC	2015	196	1-4					101	136		10.1007/s11214-013-0028-0		36	Astronomy & Astrophysics	Astronomy & Astrophysics	CX5PT	WOS:000365755100005		
J	Sekii, T; Appourchaux, T; Fleck, B; Turck-Chieze, S				Sekii, Takashi; Appourchaux, Thierry; Fleck, Bernhard; Turck-Chieze, Sylvaine			Future Mission Concepts for Helioseismology	SPACE SCIENCE REVIEWS			English	Review						Sun; Helioseismology; Space missions	TIME-DISTANCE HELIOSEISMOLOGY; DYNAMICS-OBSERVATORY SDO; MICHELSON DOPPLER IMAGER; SOLAR OPTICAL TELESCOPE; CONVECTION ZONE; FLOWS BENEATH; SOHO MISSION; OSCILLATIONS; HINODE; SUN	Future space-mission concepts currently discussed in the helioseismology community are reviewed. One popular idea is to observe the Sun from high latitudes, to explore the polar regions as well as to probe the deep interior using stereoscopic techniques, by combining observations from high latitudes with observations from within the ecliptic plane. Another idea is to stay within the ecliptic plane but still aim for stereoscopic helioseismology for deep layers. A new instrument and a novel mission concept for studying the solar core regions are also discussed.	[Sekii, Takashi] NAOJ, Div Solar & Plasma Astrophys, Mitaka, Tokyo 1818588, Japan; [Appourchaux, Thierry] Univ Paris 11, Inst Astrophys Spatiale, CNRS UMR8617, Orsay, France; [Fleck, Bernhard] NASA, ESA Sci Operat Dept, GSFC, Greenbelt, MD 20771 USA; [Turck-Chieze, Sylvaine] CEA DSM IRFU, CE Saclay, F-91191 Gif Sur Yvette, France	Sekii, T (reprint author), NAOJ, Div Solar & Plasma Astrophys, Mitaka, Tokyo 1818588, Japan.	sekii@solar.mtk.nao.ac.jp; Thierry.Appourchaux@ias.u-psud.fr; bfleck@esa.nascom.nasa.gov; Sylvaine.Turck-Chieze@cea.fr					Appourchaux T, 2009, EXP ASTRON, V23, P491, DOI 10.1007/s10686-008-9131-8; GREC G, 1980, NATURE, V288, P541, DOI 10.1038/288541a0; Geppert U, 2011, ADV SPACE RES, V48, P1695, DOI 10.1016/j.asr.2010.09.016; CLAVERIE A, 1979, NATURE, V282, P591, DOI 10.1038/282591a0; Lindsey C, 2000, SCIENCE, V287, P1799, DOI 10.1126/science.287.5459.1799; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Zhao JW, 2010, ASTROPHYS J, V708, P304, DOI 10.1088/0004-637X/708/1/304; Macdonald M, 2006, J SPACECRAFT ROCKETS, V43, P960, DOI 10.2514/1.16408; Domingo V, 1995, SOL PHYS, V162, P1, DOI 10.1007/BF00733425; Sekii T, 2007, PUBL ASTRON SOC JPN, V59, pS637; Couvidat S, 2003, ASTROPHYS J, V597, pL77, DOI 10.1086/379698; Norton AA, 2006, SOL PHYS, V239, P69, DOI 10.1007/s11207-006-0279-y; Nagashima K, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/2/L17; McNamara P, 2008, CLASSICAL QUANT GRAV, V25, DOI 10.1088/0264-9381/25/11/114034; Frohlich C, 1995, SOL PHYS, V162, P101, DOI 10.1007/BF00733428; Appourchaux T, 2010, ASTRON ASTROPHYS REV, V18, P197, DOI 10.1007/s00159-009-0027-z; Turck-Chieze S, 2008, ASTRON NACHR, V329, P521, DOI 10.1002/asna.200710989; Hathaway DH, 2010, SCIENCE, V327, P1350, DOI 10.1126/science.1181990; Ilonidis S, 2011, SCIENCE, V333, P993, DOI 10.1126/science.1206253; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Kosovichev AG, 1997, ASTROPHYS J, V482, pL207, DOI 10.1086/310708; Turck-Chieze S, 2009, EXP ASTRON, V23, P1017, DOI 10.1007/s10686-008-9111-z; Miesch MS, 2007, ASTROPHYS J SUPPL S, V168, P337, DOI 10.1086/509880; Garcia RA, 2007, SCIENCE, V316, P1591, DOI 10.1126/science.1140598; Gizon L, 2010, ANNU REV ASTRON ASTR, V48, P289, DOI 10.1146/annurev-astro-082708-101722; Giles PM, 1997, NATURE, V390, P52, DOI 10.1038/36294; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Appourchaux T, 2009, EXP ASTRON, V23, P1079, DOI 10.1007/s10686-008-9107-8; Garcia RA, 2005, ASTRON ASTROPHYS, V442, P385, DOI 10.1051/0004-6361:20052779; Haber DA, 2002, ASTROPHYS J, V570, P855, DOI 10.1086/339631; Gabriel AH, 1995, SOL PHYS, V162, P61, DOI 10.1007/BF00733427; Turck-Chieze S, 2006, ADV SPACE RES, V38, P1812, DOI 10.1016/j.asr.2005.09.033; Mitra-Kraev U, 2008, ASTRON ASTROPHYS, V481, pL1, DOI 10.1051/0004-6361:20079042; Duvall TL, 1997, SOL PHYS, V170, P63, DOI 10.1023/A:1004907220393; Vorontsov SV, 2002, SCIENCE, V296, P101, DOI 10.1126/science.1069190; Schou J, 1998, ASTROPHYS J, V505, P390, DOI 10.1086/306146; Zhao JW, 2001, ASTROPHYS J, V557, P384, DOI 10.1086/321491; Howe R, 2000, ASTROPHYS J, V533, pL163, DOI 10.1086/312623; Schou J, 2012, SOL PHYS, V275, P229, DOI 10.1007/s11207-011-9842-2; Appourchaux T, 2013, ASTR SOC P, V478, P125; Baker D., 2012, SOLAR SPACE PHYS SCI; Danzmann K., 2003, ADV SPACE RES, V32, P1233, DOI DOI 10.1016/S0273-1177(03)90323-1; Domingo V., 1982, SCI823 ESA, P1982; Domingo V., 1984, Memorie della Societa Astronomica Italiana, V55; Fleck B., 1995, SOLAR PHYS, V162; Huber M.C.E., 1996, ESA B, V86, P25; Liewer P.C., 2011, SOLAR POLAR IMAGER C; Simoniello R., 2012, ASTRON ASTROPHYS, V539, P135; Strong K., 2011, 4PI GLOBAL UNDERSTAN; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4; Turck-Chieze S, 2001, ASTROPHYS J, V555, pL69, DOI 10.1086/321726; Turck-Chieze S, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/086901; Vandenbussche F., 1999, ESA B, V97, P37; Velli M., 2011, SAFARI SOLAR ACTIVIT; Vourlidas A., 2011, MISSION SUN EARTH L5; Yoshikawa M., 2010, LUN PLAN I SCI C LUN, V41, P2746	58	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	DEC	2015	196	1-4					285	302		10.1007/s11214-015-0142-2		18	Astronomy & Astrophysics	Astronomy & Astrophysics	CX5PT	WOS:000365755100011		
J	Grebowsky, J; Fast, K; Talaat, E; Combi, M; Crary, F; England, S; Ma, Y; Mendillo, M; Rosenblatt, P; Seki, K; Stevens, M; Withers, P				Grebowsky, J.; Fast, K.; Talaat, E.; Combi, M.; Crary, F.; England, S.; Ma, Y.; Mendillo, M.; Rosenblatt, P.; Seki, K.; Stevens, M.; Withers, P.			Science Enhancements by the MAVEN Participating Scientists	SPACE SCIENCE REVIEWS			English	Review						Mars; Aeronomy; Thermosphere; Ionosphere magnetosphere MAVEN mission	KELVIN-HELMHOLTZ INSTABILITY; CO2 ICE CLOUDS; UPPER-ATMOSPHERE; MAGNETIC-FIELD; SOLAR-WIND; MARTIAN IONOSPHERE; HYBRID SIMULATION; RADAR SOUNDINGS; MARS EXPRESS; PICKUP IONS	NASA implemented a Participating Scientist Program and released a solicitation for the Mars Atmosphere and Volatile EvolutioN mission (MAVEN) proposals on February 14, 2013. After a NASA peer review panel evaluated the proposals, NASA Headquarters selected nine on June 12, 2013. The program's intent is to enhance the science return from the mission by including new investigations that broaden and/or complement the baseline investigations, while still addressing key science goals. The selections cover a broad range of science investigations. Included are: a patching of a 3D exosphere model to an improved global ionosphere-thermosphere model to study the generation of the exosphere and calculate the escape rates; the addition of a focused study of upper atmosphere variability and waves; improvement of a multi-fluid magnetohydrodynamic model that will be adjusted according to MAVEN observations to enhance the understanding of the solar-wind plasma interaction; a global study of the state of the ionosphere; folding MAVEN measurements into the Mars International Reference Ionosphere under development; quantification of atmospheric loss by pick-up using ion cyclotron wave observations; the reconciliation of remote and in situ observations of the upper atmosphere; the application of precise orbit determination of the spacecraft to measure upper atmospheric density and in conjunction with other Mars missions improve the static gravity field model of Mars; and an integrated ion/neutral study of ionospheric flows and resultant heavy ion escape. Descriptions of each of these investigations are given showing how each adds to and fits seamlessly into MAVEN mission science design.	[Grebowsky, J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Fast, K.; Talaat, E.] NASA, Headquarters, Washington, DC 20546 USA; [Combi, M.] Univ Michigan, Ann Arbor, MI 48109 USA; [Crary, F.] Univ Colorado, Boulder, CO 80303 USA; [England, S.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Ma, Y.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Mendillo, M.; Withers, P.] Boston Univ, Boston, MA 02215 USA; [Rosenblatt, P.] Royal Observ Belgium, Brussels, Belgium; [Seki, K.] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Stevens, M.] Naval Res Lab, Div Space Sci, Washington, DC 20375 USA	Grebowsky, J (reprint author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	joseph.m.grebowsky@nasa.gov			NASA's MAVEN Participating Scientist Program	Support from NASA's MAVEN Participating Scientist Program is acknowledged for all the studies.	Fritts DC, 2006, J ATMOS SOL-TERR PHY, V68, P247, DOI 10.1016/j.jastp.2005.04.010; Krasnopolsky VA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001809; Li L, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016249; Valeille A, 2010, ICARUS, V206, P28, DOI 10.1016/j.icarus.2009.04.036; England SL, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003998; Mendillo M, 2013, GEOPHYS RES LETT, V40, P5361, DOI 10.1002/2013GL057631; Chassefiere E, 2004, PLANET SPACE SCI, V52, P1039, DOI 10.1016/j.pss.2004.07.002; Toth G, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011126; Vincendon M, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003827; Fox JL, 2014, ICARUS, V228, P375, DOI 10.1016/j.icarus.2013.10.014; Mazarico E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033388; Rosenblatt P, 2012, ICARUS, V217, P831, DOI 10.1016/j.icarus.2011.06.019; Stevens MH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013225; Toth G, 2012, J COMPUT PHYS, V231, P870, DOI 10.1016/j.jcp.2011.02.006; HARNED DS, 1982, J COMPUT PHYS, V47, P452, DOI 10.1016/0021-9991(82)90094-8; Konopliv AS, 2011, ICARUS, V211, P401, DOI 10.1016/j.icarus.2010.10.004; Lammer H, 2006, SPACE SCI REV, V122, P189, DOI 10.1007/s11214-006-7018-4; Li L, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013850; Clancy RT, 1998, GEOPHYS RES LETT, V25, P489, DOI 10.1029/98GL00114; Huddleston DE, 2000, ADV SPACE RES-SERIES, V26, P1513, DOI 10.1016/S0273-1177(00)00091-0; Forbes JM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001582; Bailey SM, 2007, J ATMOS SOL-TERR PHY, V69, P1407, DOI 10.1016/j.jastp.2007.02.008; Spiga A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050343; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Bougher SW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024059; Ma YJ, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010367; Mendillo M, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016865; Halekas JS, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016590; Brain DA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023126; Beuthe M, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003976; Nagy AF, 2001, J GEOPHYS RES-SPACE, V106, P21565, DOI 10.1029/2001JA000007; Terada N, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013937; Withers P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053193; Brain D, 2010, ICARUS, V206, P139, DOI 10.1016/j.icarus.2009.06.030; Gurnett DA, 2005, SCIENCE, V310, P1929, DOI 10.1126/science.1121868; Leisner JS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024875; Bertucci C, 2005, J ATMOS SOL-TERR PHY, V67, P1797, DOI 10.1016/j.jastp.2005.04.007; Fang XH, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014929; Bougher SW, 2008, SPACE SCI REV, V139, P107, DOI 10.1007/s11214-008-9401-9; Creasey JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027583; Montmessin F, 2006, ICARUS, V183, P403, DOI 10.1016/j.icarus.2006.03.015; Delva M, 2011, SPACE SCI REV, V162, P5, DOI 10.1007/s11214-011-9828-2; Terada N, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009224; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; Yamauchi M, 2006, SPACE SCI REV, V126, P239, DOI 10.1007/s11214-006-9090-1; Liemohn MW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031806; Morgan DD, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013313; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002944; Rosenblatt P, 2008, PLANET SPACE SCI, V56, P1043, DOI 10.1016/j.pss.2008.02.004; Ma YJ, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009293; Mendillo M, 2013, PLANET SPACE SCI, V86, P117, DOI 10.1016/j.pss.2013.08.010; HUDDLESTON DE, 1992, J GEOPHYS RES-SPACE, V97, P12217, DOI 10.1029/92JA00726; Mitchell DL, 2001, J GEOPHYS RES-PLANET, V106, P23419, DOI 10.1029/2000JE001435; Marty JC, 2009, PLANET SPACE SCI, V57, P350, DOI 10.1016/j.pss.2009.01.004; Medvedev AS, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003848; Valeille A, 2010, ICARUS, V206, P18, DOI 10.1016/j.icarus.2008.08.018; Terada N, 2009, ASTROBIOLOGY, V9, P55, DOI 10.1089/ast.2008.0250; SWIFT DW, 1995, GEOPHYS RES LETT, V22, P311, DOI 10.1029/94GL03082; Carlsson E, 2006, ICARUS, V182, P320, DOI 10.1016/j.icarus.2005.09.020; Withers P, 2009, ADV SPACE RES, V44, P277, DOI 10.1016/j.asr.2009.04.027; Curry SM, 2013, J GEOPHYS RES-SPACE, V118, P554, DOI 10.1029/2012JA017665; Fox JL, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010380; Yagi M, 2012, ICARUS, V221, P682, DOI 10.1016/j.icarus.2012.07.022; Medvedev AS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050852; Valeille A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003388; Boesswetter A, 2010, PLANET SPACE SCI, V58, P2031, DOI 10.1016/j.pss.2010.10.003; Penz T, 2004, PLANET SPACE SCI, V52, P1157, DOI 10.1016/j.pss.2004.06.001; SHINAGAWA H, 1992, J GEOPHYS RES-PLANET, V97, P1027; Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Siskind DE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033742; NAGY AF, 1988, GEOPHYS RES LETT, V15, P433, DOI 10.1029/GL015i005p00433; Shizgal BD, 1996, REV GEOPHYS, V34, P483, DOI 10.1029/96RG02213; Dubinin E, 2011, SPACE SCI REV, V162, P173, DOI 10.1007/s11214-011-9831-7; Brain DA, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2000JA000416; Creasey JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024037; Valeille A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003389; Harnett EM, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011724; Manning CV, 2011, ICARUS, V212, P131, DOI 10.1016/j.icarus.2010.11.028; Bougher S.W., 2009, GEOPHYS RES LETT, V37; Bougher S.W., 2014, J GEOPHYS RES UNPUB; Chamberlain J. W., 1987, THEORY PLANETARY ATM; Clancy RT, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002805; Coates AJ, 2004, ADV SPACE RES-SERIES, V33, P1977, DOI 10.1016/j.asr.2003.06.029; Cowee M., 2012, J GEOPHYS RES, V117; Cowee M., 2007, J GEOPHYS RES, V112, P6230; Delamere P.A., 2009, J GEOPHYS RES, V114, P3220; Espley J.R., 2003, J GEOPHYS RES, V110; HANSON WB, 1988, J GEOPHYS RES, V93, P7538, DOI 10.1029/JA093iA07p07538; Hanson W. B., 1977, Journal of Geophysical Research, V82, DOI 10.1029/JS082i028p04351; Kaula W.M., 1966, THEORY SATELLITE GEO; Lee Y., 2014, J GEOPHYS RES UNPUB; Liehmohn M.W., 2006, ICARUS, V182, P383; Lundin R, 2011, SPACE SCI REV, V162, P309, DOI 10.1007/s11214-011-9811-y; Lundin R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039341; Ma YJ, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016657; Ma YJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029208; Maattanen A., 2013, COMP CLIMATOLOGY TER, P393, DOI [10.2458/azu_uapress_9780816530595-chi6, DOI 10.2458/AZU_UAPRESS_9780816530595-CHI6]; Matsumoto Y, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014637; Matta M, 2013, J GEOPHYS RES-SPACE, V118, P2681, DOI 10.1002/jgra.50104; McConnochie TH, 2010, ICARUS, V210, P545, DOI 10.1016/j.icarus.2010.07.021; Najib D, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016272; Nier A. O., 1977, Journal of Geophysical Research, V82, DOI 10.1029/JS082i028p04341; Schunk R., 2009, IONOSPHERES; Terada K., 2014, DCSM SIMULATIO UNPUB; Tokar R.L., 2008, GEOPHYS RES LETT, V33	105	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	DEC	2015	195	1-4					319	355		10.1007/s11214-014-0080-4		37	Astronomy & Astrophysics	Astronomy & Astrophysics	CX5GI	WOS:000365729700012		
J	Ostrovidov, S; Shi, XT; Sadeghian, RB; Salehi, S; Fujie, T; Bae, H; Ramalingam, M; Khademhosseini, A				Ostrovidov, Serge; Shi, Xuetao; Sadeghian, Ramin Banan; Salehi, Sahar; Fujie, Toshinori; Bae, Hojae; Ramalingam, Murugan; Khademhosseini, Ali			Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy	STEM CELL REVIEWS AND REPORTS			English	Article						Muscle; DMD; Muscular dystrophy; Stem cells; Tissue engineering; Scaffold	FUNCTIONAL SKELETAL-MUSCLE; SIDE POPULATION CELLS; SATELLITE CELLS; GENE-THERAPY; IN-VIVO; MYOBLAST DIFFERENTIATION; PROGENITOR CELLS; GROWTH-FACTORS; SELF-RENEWAL; INTRAMUSCULAR TRANSPLANTATION	Skeletal muscle tissue engineering is one of the important ways for regenerating functionally defective muscles. Among the myopathies, the Duchenne muscular dystrophy (DMD) is a progressive disease due to mutations of the dystrophin gene leading to progressive myofiber degeneration with severe symptoms. Although current therapies in muscular dystrophy are still very challenging, important progress has been made in materials science and in cellular technologies with the use of stem cells. It is therefore useful to review these advances and the results obtained in a clinical point of view. This article focuses on the differentiation of stem cells into myoblasts, and their application in muscular dystrophy. After an overview of the different stem cells that can be induced to differentiate into the myogenic lineage, we introduce scaffolding materials used for muscular tissue engineering. We then described some widely used methods to differentiate different types of stem cell into myoblasts. We highlight recent insights obtained in therapies for muscular dystrophy. Finally, we conclude with a discussion on stem cell technology. We discussed in parallel the benefits brought by the evolution of the materials and by the expansion of cell sources which can differentiate into myoblasts. We also discussed on future challenges for clinical applications and how to accelerate the translation from the research to the clinic in the frame of DMD.	[Ostrovidov, Serge; Sadeghian, Ramin Banan; Salehi, Sahar; Ramalingam, Murugan; Khademhosseini, Ali] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Shi, Xuetao] S China Univ Technol, Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510640, Guangdong, Peoples R China; [Shi, Xuetao] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China; [Fujie, Toshinori] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo 1628480, Japan; [Bae, Hojae; Khademhosseini, Ali] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea; [Ramalingam, Murugan] Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Biomed Engn,Dept Med,Biomat Innovat Res Ctr, Boston, MA 02139 USA; [Khademhosseini, Ali] MIT, Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia	Khademhosseini, A (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	alik@mit.edu			World Premier International Research Center Initiative (WPI), MEXT, Japan	This work was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan.	Al-Zaidy S, 2014, PEDIATR NEUROL, V51, P607, DOI 10.1016/j.pediatrneurol.2014.08.002; Liao IC, 2008, CELL MOL BIOENG, V1, P133, DOI 10.1007/s12195-008-0021-y; Nguyen D, 2009, LAB CHIP, V9, P3338, DOI 10.1039/b914091c; Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411; Rouger K, 2011, AM J PATHOL, V179, P2501, DOI 10.1016/j.ajpath.2011.07.022; Liu XH, 2009, BIOMATERIALS, V30, P4094, DOI 10.1016/j.biomaterials.2009.04.024; Liu J, 2013, ACTA BIOMATER, V9, P4688, DOI 10.1016/j.actbio.2012.08.009; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Holzwarth JM, 2011, J MATER CHEM, V21, P10243, DOI 10.1039/c1jm10522a; Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Wakabayashi M, 2010, TISSUE ENG PT A, V16, P3251, DOI 10.1089/ten.TEA.2009.0678; Abdel-Hamid H, 2012, CURR OPIN NEUROL, V25, P604, DOI 10.1097/WCO.0b013e328357f44c; Boldrin L, 2008, CELL TRANSPLANT, V17, P577; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Mosqueira M, 2013, MED RES REV, V33, P1174, DOI 10.1002/med.21279; Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233; Dingal PCDP, 2014, CURR OPIN BIOTECH, V28, P46, DOI [10.1016/j.copbio.2013.11.003, 10.1016/j.cophio.2013.11.003]; Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755; Ostrovidov S, 2013, MICRO AND NANOTECHNOLOGIES IN ENGINEERING STEM CELLS AND TISSUES, P52; Patenaude M, 2014, MACROMOL RAPID COMM, V35, P598, DOI 10.1002/marc.201300818; Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004; Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Quenneville SP, 2007, MOL THER, V15, P431, DOI 10.1038/sj.mt.6300047; Chan V, 2015, LAB CHIP, V15, P2258, DOI 10.1039/c5lc00222b; HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504; Meregalli M, 2013, FEBS J, V280, P4251, DOI 10.1111/febs.12083; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; KONIECZNY SF, 1984, CELL, V38, P791, DOI 10.1016/0092-8674(84)90274-5; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Sakurai H, 2009, STEM CELL RES, V3, P157, DOI 10.1016/j.scr.2009.08.002; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Pek YS, 2008, NAT NANOTECHNOL, V3, P671, DOI 10.1038/nnano.2008.270; Rask F, 2010, J BIOMED MATER RES A, V95A, P105, DOI 10.1002/jbm.a.32808; Jank BJ, 2015, BIOMATERIALS, V61, P246, DOI 10.1016/j.biomaterials.2015.04.051; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; McKeon-Fischer KD, 2011, J TISSUE ENG REGEN M, V5, P560, DOI 10.1002/term.348; Preynat-Seauve O, 2011, STEM CELL ENGINEERING: PRINCIPLES AND APPLICATIONS, P181, DOI 10.1007/978-3-642-11865-4_8; Manning J, 2015, J MUSCLE RES CELL M, V36, P155, DOI 10.1007/s10974-015-9406-4; Jakob F, 2012, CELL TISSUE RES, V347, P725, DOI 10.1007/s00441-011-1237-z; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/nmat2732, 10.1038/NMAT2732]; Annabi N, 2013, BIOCHEM ENG J, V77, P110, DOI 10.1016/j.bej.2013.05.006; Gawlik KI, 2014, AM J PATHOL, V184, P740, DOI 10.1016/j.ajpath.2013.11.017; Fishman JM, 2013, TISSUE ENG PART B-RE, V19, P503, DOI [10.1089/ten.TEB.2013.0120, 10.1089/ten.teb.2013.0120]; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Kingham E, 2013, ACS NANO, V7, P1867, DOI 10.1021/nn3037094; Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b; Carrow JK, 2015, MACROMOL CHEM PHYS, V216, P248, DOI 10.1002/macp.201400427; Galvez BG, 2006, J CELL BIOL, V174, P231; Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.TEA.2012.0181, 10.1089/ten.tea.2012.0181]; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Ramon-Azcon J, 2013, ADV MATER, V25, P4028, DOI 10.1002/adma.201301300; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95; Roca Isart, 2015, J Clin Med, V4, P243, DOI 10.3390/jcm4020243; Neal D, 2015, TISSUE ENG PT A, V21, P1848, DOI [10.1089/ten.TEA.2014.0317, 10.1089/ten.tea.2014.0317]; Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Ravichandran R, 2014, MACROMOL BIOSCI, V14, P515, DOI 10.1002/mabi.201300407; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l; Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007; Riboldi SA, 2008, J BIOMED MATER RES A, V84A, P1094, DOI 10.1002/jbm.a.31534; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Ku SH, 2013, BIOMATERIALS, V34, P2017, DOI 10.1016/j.biomaterials.2012.11.052; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L; Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004; Zatz M, 2015, NEUROMUSCULAR DISORD, V25, P371, DOI 10.1016/j.nmd.2015.02.007; Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9; Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/nmat3058, 10.1038/NMAT3058]; Ziv K, 2014, BIOMATERIALS, V35, P3736, DOI 10.1016/j.biomaterials.2014.01.029; Neuman S, 2001, GENE, V263, P17, DOI 10.1016/S0378-1119(00)00584-9; Chaudhuri B, 2014, MATER LETT, V126, P109, DOI 10.1016/j.matlet.2014.04.008; Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/nmat3937, 10.1038/NMAT3937]; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Liu GH, 2013, BIOMATERIALS, V34, P1311, DOI 10.1016/j.biomaterials.2012.10.038; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Ding K, 2013, CELL BIOL INT, V37, P977, DOI 10.1002/cbin.10123; Vieira NM, 2015, NEUROMUSCULAR DISORD, V25, P363, DOI 10.1016/j.nmd.2015.02.012; Dixon JE, 2014, P NATL ACAD SCI USA, V111, P5580, DOI 10.1073/pnas.1319685111; Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037; Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f; Wang L, 2014, MOL THER, V22, P1441, DOI 10.1038/mt.2014.78; Skuk D, 2010, MOL THER, V18, P1689, DOI 10.1038/mt.2010.128; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Leung M, 2013, BIOMACROMOLECULES, V14, P4207, DOI 10.1021/bm4009843; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063; Rohwedel J, 1998, EXP CELL RES, V239, P214, DOI 10.1006/excr.1997.3903; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Neal D, 2014, LAB CHIP, V14, P1907, DOI 10.1039/c4lc00023d; Berry SE, 2007, REGEN MED, V2, P275, DOI 10.2217/17460751.2.3.275; Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L; Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Mukherjee S, 2013, MICRO AND NANOTECHNOLOGIES IN ENGINEERING STEM CELLS AND TISSUES, P27; Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044; Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371; Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Hosoyama T, 2014, STEM CELL TRANSL MED, V3, P564, DOI 10.5966/sctm.2013-0143; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Torrente Y, 2007, CELL TRANSPLANT, V16, P563; Xiao Y, 2015, METHODS, V84, P44, DOI 10.1016/j.ymeth.2015.04.025; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Dang LTH, 2014, BIOMATERIALS, V35, P7786, DOI 10.1016/j.biomaterials.2014.05.018; Quattrocelli M, 2010, CELL DEATH DIFFER, V17, P1222, DOI 10.1038/cdd.2009.160; Quattrocelli M, 2011, J PATHOL, V223, P593, DOI 10.1002/path.2845; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032; GIBSON AJ, 1995, J CELL SCI, V108, P207; Fujie T, 2013, NANO LETT, V13, P3185, DOI 10.1021/nl401237s; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110; Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078; Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011; Aviss KJ, 2010, EUR CELLS MATER, V19, P193; Messina G, 2009, STEM CELLS, V27, P157, DOI 10.1634/stemcells.2008-0503; Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Skuk D, 2014, CELL TRANSPLANT, V23, P13, DOI 10.3727/096368912X661337; Skuk D, 2014, MOL THER, V22, P897, DOI 10.1038/mt.2014.57; Darabi R, 2011, STEM CELL REV REP, V7, P948, DOI 10.1007/s12015-011-9258-2; Constantin B, 2014, BBA-BIOMEMBRANES, V1838, P635, DOI 10.1016/j.bbamem.2013.08.023; Hutmacher DW, 2012, CELL TISSUE RES, V347, P485, DOI 10.1007/s00441-012-1357-0; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Azzabi Zouraq F., 2013, REGENERATIVE MED TIS, DOI [10.5772/55739, DOI 10.5772/55739]; Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155; Barberi T, 2005, PLOS MED, V2, P161, DOI DOI 10.1371/J0URNAL.PMED.0020161]; Berardi E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00119; Biswadeep C., 2015, BIOFABRICATION, V7; Braun R., 2014, AM J PHYS MED REHABI, V93, P97; Chen W., 2014, J TISSUE ENG REGEN M, DOI [10.1002/term.1914, DOI 10.1002/TERM.1914]; Darabi R., 2013, J STEM CELL RES THER, V3; Dolatshahi-Pirouz Alireza, 2011, J Funct Biomater, V2, P88, DOI 10.3390/jfb2030088; Evans CH, 2015, NAT REV RHEUMATOL, V11, P234, DOI 10.1038/nrrheum.2015.28; Filareto A., 2012, J STEM CELL RES THER, V10, pS10, DOI [10.4172/2157-7633.S10-001, DOI 10.4172/2157-7633.S10-001]; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Fu X, 2015, CELL MOL LIFE SCI, V72, P1663, DOI 10.1007/s00018-014-1819-5; Fuoco C., 2014, FRONT PHYSIOL, V5, P1; Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062; Fuoco C., 2012, SKELET MUSCLE, V2, P1; Garcia-Parra P., 2013, TISSUE ENG PART C-ME, V20, P28; Gilbert P. M., SCIENCE, V329, P1078; Ginn S.L., 2012, J GENE MED, V15, P65, DOI DOI 10.1002/JGM.2698; Goyenvalle A, 2015, NAT MED, V21, P270, DOI 10.1038/nm.3765; Hoshiya H., 2008, MOL THER, V17, P309; Hwang Y., 2014, SCI REP, V4, P1; Jarmin S, 2014, EXPERT OPIN BIOL TH, V14, P209, DOI 10.1517/14712598.2014.866087; Ju YM, 2014, ACTA BIOMATER, V10, P4332, DOI 10.1016/j.actbio.2014.06.022; Kajhoj T. Q., 2015, J MOL GENETIC MED, V9; Klymiuk N., 2011, REPROD FERT DEVELOP, V24, P231; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Li HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064923; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Meregalli M., 2014, FRONT PHYSIOL, V5, P1; Miyagoe-Suzuki Y., 2012, MUSCULAR DYSTROPHY, DOI [10.5772/30769, DOI 10.5772/30769]; Onopiuk M, 2015, ARCH BIOCHEM BIOPHYS, V569, P1, DOI 10.1016/j.abb.2015.01.025; Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.TEB.2013.0534, 10.1089/ten.teb.2013.0534]; Ostrovidov S., 2014, NANOSCIENCE NANOTECH; Penton CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054553; Pozzobon M., 2014, FRONT AGING NEUROSCI, V6, P1; Ramalingam M., 2012, TISSUE ENG PRINCIPLE, P1; Reis LA, 2015, CIRC-HEART FAIL, V8, P333, DOI 10.1161/CIRCHEARTFAILURE.114.001881; Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010; Sa S., 2012, J DEV BIOL TISSUE EN, V5, P12; Sa S, 2012, STEM CELL REV REP, V8, P1120, DOI 10.1007/s12015-012-9403-6; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063016; Schuurman W., 2011, BIOFABRICATION, V3, P1; Shi XT, 2015, ADV FUNCT MATER, V25, P2250, DOI 10.1002/adfm.201404531; Sicari B. M., 2013, ANAT REC, V297, P51; Sicari BM, 2014, SCI TRANSL MED, V6, P234, DOI DOI 10.1126/SCITRANSLMED.3008085; Singh VK, 2015, FRONT CELL DEV BIOL, V3, P1; Sun W., J TISSUE EN IN PRESS, DOI [10.1002/term.1868, DOI 10.1002/TERM.1868]; Sundararaghavan H. G., 2009, MACROMOL BIOSCI, V10, P265; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; TEDESCO FS, 2012, SCI TRANSL MED, V0140; Tedesco FS, 2015, CHROMOSOME RES, V23, P135, DOI 10.1007/s10577-014-9460-6; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wang X, 2008, JOVE-J VIS EXP, V17, P825; Zatti Susi, 2014, Mol Ther Methods Clin Dev, V1, P1, DOI 10.1038/mtm.2013.1	212	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1550-8943	1558-6804		STEM CELL REV REP	Stem Cell Rev. Rep.	DEC	2015	11	6					866	884		10.1007/s12015-015-9618-4		19	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	CX1JA	WOS:000365451300008		
J	Takabayashi, K; Hamatani, Y; Yamashita, Y; Takagi, D; Unoki, T; Ishii, M; Iguchi, M; Masunaga, N; Ogawa, H; Esato, M; Chun, YH; Tsuji, H; Wada, H; Hasegawa, K; Abe, M; Lip, GYH; Akao, M				Takabayashi, Kensuke; Hamatani, Yasuhiro; Yamashita, Yugo; Takagi, Daisuke; Unoki, Takashi; Ishii, Mitsuru; Iguchi, Moritake; Masunaga, Nobutoyo; Ogawa, Hisashi; Esato, Masahiro; Chun, Yeong-Hwa; Tsuji, Hikari; Wada, Hiromichi; Hasegawa, Koji; Abe, Mitsuru; Lip, Gregory Y. H.; Akao, Masaharu			Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation The Fushimi Atrial Fibrillation Registry	STROKE			English	Article						atrial fibrillation; embolism; registries; risk factors; stroke	AF REGISTRY; ORAL ANTICOAGULATION; RISK STRATIFICATION; PREDICTING STROKE; OUTCOMES; GUIDELINES; DURATION; THERAPY; PATTERN; PROJECT	Background and Purpose-There is controversy on the relationship of the type of atrial fibrillation (AF) to stroke. Although several studies show that patients with paroxysmal AF (PAF) have a stroke risk similar to those with persistent or permanent AF, recent studies suggest that PAF is associated with a lower rate of stroke. Limited data on stroke risk associated with PAF are evident in Asian populations. Methods-The Registry Study of Atrial Fibrillation Patients in Fushimi-ku (Fushimi AF Registry) is a community-based survey of patients with AF in Fushimi-ku, Kyoto, Japan. Patients were categorized into 2 types of AF: PAF or sustained (persistent or permanent) AF. We compared clinical events between PAF (n=1588) and sustained AF (n=1716). Results-Patients with PAF were younger, had less comorbidities, and received oral anticoagulants (OAC) less commonly. A lower risk of stroke/systemic embolism during follow-up period in the patients with PAF was consistently observed (non-OAC users: hazard ratio, 0.45; 95% confidence intervals, 0.27-0.75; P<0.01 and OAC users: hazard ratio, 0.59; 95% confidence interval, 0.35-0.93; P=0.03). The composite end point of stroke/systemic embolism/all-cause mortality was also lower in PAF, whether among OAC users (hazard ratio, 0.77; 95% confidence interval, 0.59-0.99; P=0.046) or non-OAC users (hazard ratio, 0.59; 95% confidence interval, 0.46-0.75; P<0.01). On multivariate analysis, PAF was an independent predictor of lower stroke/systemic embolism risk. Conclusions-In this large cohort of Japanese patients with AF, PAF was independently associated with lower incidence of stroke/systemic embolism than sustained AF. This may aid decision making for anticoagulation, especially in those patients with AF with few stroke risk factors.	[Takabayashi, Kensuke; Hamatani, Yasuhiro; Yamashita, Yugo; Takagi, Daisuke; Unoki, Takashi; Ishii, Mitsuru; Iguchi, Moritake; Masunaga, Nobutoyo; Ogawa, Hisashi; Abe, Mitsuru; Akao, Masaharu] Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Kyoto 6128555, Japan; [Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto 6128555, Japan; [Esato, Masahiro; Chun, Yeong-Hwa] Ijinkai Takeda Gen Hosp, Dept Arrhythmia, Kyoto, Japan; [Tsuji, Hikari] Tsuji Clin, Kyoto, Japan; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Akao, M (reprint author), Natl Hosp Org, Kyoto Med Ctr, Dept Cardiol, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	akao@kuhp.kyoto-u.ac.jp			Boehringer Ingelheim; Bayer Healthcare; Pfizer; Bristol-Myers Squibb; Astellas Pharma; AstraZeneca; Daiichi-Sankyo; Novartis Pharma; MSD; Sanofi-Aventis; Takeda Pharmaceutical	Dr Akao received research grants from Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi-Sankyo, Novartis Pharma, MSD, Sanofi-Aventis, and Takeda Pharmaceutical and has been on the speakers bureau for Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, and Bayer Healthcare. Dr Lip has served as a consultant or advisory board for Bayer/Jensen, Astellas, Merck, Sanofi, BMS/Pfizer, Biotronik, Medtronic, Portola, Boehringer Ingelheim, Microlife, and Daiichi-Sankyo and has been on the speakers bureau for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo. The other authors report no conflicts.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; [Anonymous], 2014, CIRC J, V78, P1997; Capucci A, 2005, J AM COLL CARDIOL, V46, P1913, DOI 10.1016/j.jacc.2005.07.044; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Camm AJ, 2012, EUROPACE, V14, P1385, DOI 10.1093/europace/eus305; Banerjee A, 2013, INT J CARDIOL, V167, P2682, DOI 10.1016/j.ijcard.2012.06.118; Hamatani Y, 2015, CIRC J, V79, P1009, DOI 10.1253/circj.CJ-14-1245; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; Boriani G, 2011, STROKE, V42, P1768, DOI 10.1161/STROKEAHA.110.609297; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Nieuwlaat R, 2008, EUR HEART J, V29, P915, DOI 10.1093/eurheartj/ehn101; Friberg L, 2010, EUR HEART J, V31, P967, DOI 10.1093/eurheartj/ehn599; Boriani G, 2014, EUR HEART J, V35, P508, DOI 10.1093/eurheartj/eht491; CORBALAN R, 1992, AM HEART J, V124, P149, DOI 10.1016/0002-8703(92)90933-M; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Al-Khatib SM, 2013, EUR HEART J, V34, P2464, DOI 10.1093/eurheartj/eht135; PETERSEN P, 1986, STROKE, V17, P622; Inoue H, 2014, CIRC J, V78, P2388, DOI 10.1253/circj.CJ-14-0507; Kannel WB, 1998, AM J CARDIOL, V82, P2, DOI DOI 10.1016/; National Clinical Guideline Center (UK) Atrial Fibrillation, 2014, NAT I HLTH CLIN EX G; Steinberg BA, 2015, EUR HEART J, V36, P288, DOI 10.1093/eurheartj/ehu359; Vanassche T, 2015, EUR HEART J, V36, P281, DOI 10.1093/eurheartj/ehu307	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	DEC	2015	46	12					3354	3361		10.1161/STROKEAHA.115.010947		8	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CX2NS	WOS:000365534400003		
J	Iwanaga, J; Saga, T; Tabira, Y; Watanabe, K; Yamaki, K				Iwanaga, Joe; Saga, Tsuyoshi; Tabira, Yoko; Watanabe, Koichi; Yamaki, Koh-ichi			Contrast imaging study of the horseshoe kidney for transplantation	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Horseshoe kidney; Isthmus; Contrast imaging technique; Urinary collecting system; Transplantation	RENAL-ARTERIES	In the surgical setting, horseshoe kidneys (HKs) may be a cause for confusion because of their complicated morphology, especially in the vicinity of the vascular and urinary collecting systems around the isthmus of the HK. In the patients with HK, analysis of the anatomical structure of the isthmus is both useful and necessary. The aim of this study is to observe the vascular and collecting system of the HK using anatomical and contrast imaging technique, then make use of the knowledge for clinical anatomy. A HK voluntarily donated post-mortem to our department in 2013 by an 80-year-old woman was dissected. The gross anatomy of this HK was reported. In this study, we additionally analyzed this kidney using micro-computed tomography with both colored and colorless contrast media after the kidney was made transparent. Contrast imaging clearly revealed that each of the five renal arteries, including the three surplus renal arteries, entering the HK distributed blood to different regions. Neither side of the urinary collecting system crossed the midline of the isthmus. Two surplus renal veins emerged from the HK and two ureters descended dorsal to the isthmus. These observations show that gross anatomical observation and contrast imaging of the HK can provide very important surgical information. Our results can contribute to both better understanding of fundamental knowledge and progress in the surgery of HKs such as in the setting of biopsy and transplantation.	[Iwanaga, Joe; Saga, Tsuyoshi; Tabira, Yoko; Watanabe, Koichi; Yamaki, Koh-ichi] Kurume Univ, Sch Med, Dept Anat, Kurume, Fukuoka 8300011, Japan	Iwanaga, J (reprint author), Kurume Univ, Sch Med, Dept Anat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	iwanaga_jyou@med.kurume-u.ac.jp					Sato A, 2011, CIRC J, V75, P2759, DOI 10.1253/circj.CJ-11-1159; Natsis K, 2014, SURG RADIOL ANAT, V36, P517, DOI 10.1007/s00276-013-1229-7; Satyapal KS, 2001, SURG RADIOL ANAT, V23, P33, DOI 10.1007/s00276-001-0033-y; Narita Hirokazu, 2012, Okajimas Folia Anatomica Japonica, V89, P7; Stroosma OB, 2001, J UROLOGY, V166, P2039, DOI 10.1016/S0022-5347(05)65501-2; Farman F, 1968, HDB UROLOGIE FUSION, P66; Foster JT, 2013, CASE REP TRANSPLANT, V2013, DOI [10.1155/2013/852127, DOI 10.1155/2013/852127]; Iwanaga J, 2014, KURUME IGAKUKAI ZASS, V77, P57; Sienko J, 2013, TRANSPL P, V46, P2923	9	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	DEC	2015	37	10					1267	1271		10.1007/s00276-015-1501-0		5	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	CX1JE	WOS:000365451700017		
J	Ohashi, M; Saka, M; Katayama, H; Okinaka, K; Morita, S; Fukagawa, T; Katai, H				Ohashi, Masaki; Saka, Makoto; Katayama, Hiroshi; Okinaka, Keiji; Morita, Shinji; Fukagawa, Takeo; Katai, Hitoshi			A Prospective Cohort Study To Evaluate the Feasibility of Intraoperative Antimicrobial Prophylaxis in Open Gastrectomy for Gastric Cancer	SURGICAL INFECTIONS			English	Article							SURGICAL-WOUND INFECTION; ANTIBIOTIC-PROPHYLAXIS; NOSOCOMIAL INFECTIONS; SITE INFECTIONS; POVIDONE-IODINE; SURGERY; CHLORHEXIDINE; PREVENTION; ANTISEPSIS; TRIAL	Background: The optimal duration of antimicrobial prophylaxis (AMP) in patients undergoing gastric cancer surgery remains debatable. The aim of this prospective cohort study was to evaluate the feasibility of intraoperative AMP in comparison with conventional AMP in patients undergoing elective open gastrectomy. Methods: The duration of AMP was shortened in two six-monthly stages in patients undergoing open gastrectomy for gastric cancer, and the incidences of surgical site infections (SSIs) and remote infections (RIs) were surveyed. In the first stage (September 2004 to February 2005), the patients received four intravenous injections of cefazolin 1g at 12-h intervals starting from 30min before surgery (conventional AMP). In the second stage (March 2005 to August 2005), the patients received the same agent at three-h intervals starting 30min before surgery and continuing until the end of the operation (intraoperative AMP). Results: A total of 423 patients were enrolled, including 202 patients operated on in the first stage of cancer and 221 patients operated on in the second stage. The patient characteristics in the two stages were well balanced. There was no significant difference in the incidence of SSIs (10.4% vs. 8.1%; odds ratio [OR], 0.764; 95% confidence interval [CI] 0.395-1.480; p=0.528) or RIs (7.9% vs. 5.9%; OR 0.727; 95% CI 0.340-1.551; p=0.525) between the two stages. There were no serious adverse events related to the AMP. The treatment effects on the SSIs were similar in all subgroups of patients analyzed. There was no appreciable difference in the trend in the causative pathogens of the SSIs and RIs between the two stages. Conclusions: Intraoperative and conventional AMP were associated with similar incidences of SSIs and RIs. Intraoperative AMP appears to be feasible and sufficient in patients undergoing open gastrectomy for gastric cancer.	[Ohashi, Masaki; Saka, Makoto; Katayama, Hiroshi; Morita, Shinji; Fukagawa, Takeo; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo 1040045, Japan; [Okinaka, Keiji] Natl Canc Ctr, Div Gen Internal Med, Tokyo 1040045, Japan	Ohashi, M (reprint author), Natl Canc Ctr, Gastr Surg Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	o-masaki@mvi.biglobe.ne.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Swenson BR, 2009, INFECT CONT HOSP EP, V30, P964, DOI 10.1086/605926; Haga N, 2012, INT SURG, V97, P169, DOI 10.9738/CC91.1; Mohri Y, 2007, BRIT J SURG, V94, P683, DOI 10.1002/bjs.5837; Katai H, 2003, BRIT J SURG, V90, P850, DOI 10.1002/bjs.4106; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; Imamura H, 2012, LANCET INFECT DIS, V12, P381, DOI 10.1016/S1473-3099(11)70370-X; Weist K, 2002, INFECT CONT HOSP EP, V23, P127, DOI 10.1086/502021; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Ahn HS, 2011, GASTRIC CANCER, V14, P178, DOI 10.1007/s10120-011-0012-x; POULSEN KB, 1994, EPIDEMIOL INFECT, V113, P283; Harbarth S, 2000, CIRCULATION, V101, P2916; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; KREISEL D, 1995, ARCH SURG-CHICAGO, V130, P989; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; POULSEN KB, 1995, BRIT J SURG, V82, P208, DOI 10.1002/bjs.1800820222; Morita S, 2008, BRIT J SURG, V95, P1131, DOI 10.1002/bjs.6295; Noorani A, 2010, BRIT J SURG, V97, P1614, DOI 10.1002/bjs.7214; Sekimoto M, 2004, INT J QUAL HEALTH C, V16, P367, DOI 10.1093/intqhc/mzh066; Furukawa K, 1999, SURG TODAY, V29, P701; Kim ES, 2012, INFECT CONT HOSP EP, V33, P572, DOI 10.1086/665728; Polk HC, 2000, AM SURGEON, V66, P105; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; CRUSE P, 1981, REV INFECT DIS, V3, P734; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Sobin L, 2009, TNM CLASSIFICATION M	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964	1557-8674		SURG INFECT	Surg. Infect.	DEC 1	2015	16	6					833	839		10.1089/sur.2015.021		7	Infectious Diseases; Surgery	Infectious Diseases; Surgery	CX2MK	WOS:000365530800026		
J	Wang, YF; Kuramitsu, Y; Kitagawa, T; Tokuda, K; Baron, B; Akada, J; Nakamura, K				Wang, Yufeng; Kuramitsu, Yasuhiro; Kitagawa, Takao; Tokuda, Kazuhiro; Baron, Byron; Akada, Junko; Nakamura, Kazuyuki			The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX	TARGETED ONCOLOGY			English	Article							RIBONUCLEOTIDE REDUCTASE; ANTIEPILEPTIC DRUG; ACTIVATION; TRANILAST; PHOSPHORYLATION; RECOMBINATION; CHEMOTHERAPY; COMBINATION; ABROGATION; RADIATION	Gemcitabine (GEM) remains a major chemotherapeutic drug for pancreatic cancer, but resistance to GEM has been a big problem, as its response rate has been decreasing year by year. The effect of the histone deacetylase inhibitor (HDAI) valproic acid (VPA) was compared with tranilast and RI-1 as a combinatorial treatment with GEM in four pancreatic cancer cell lines, BxPC-3, PK45p, MiaPaCa-2 and PK59. Cell viability assays were carried out to check the cytotoxic effects, western blotting was carried out for DNA repair mechanisms, and localization was determined by immunofluorescence. The sensitization factors (i.e., the fold ratio of cell viability for GEM/GEM plus drug) reveal that VPA increases the cytotoxic sensitization to GEM at approximately 2.7-fold, 1.2-fold, 1.5-fold and 2.2-fold in BxPC-3, MiaPaCa-2, PK-45p and PK-59 cell lines, respectively. Moreover, GEM induces activation of the DNA repair protein H2AX proportional to the dosage. Interestingly, however, this effect can be abrogated by VPA. These results indicate that VPA enhances GEM-induced cytotoxicity in GEM-resistant pancreatic cancer cells, possibly through inhibition of DNA damage signaling and repair. Our study suggests VPA as a potential therapeutic agent for combinatorial treatment with GEM in pancreatic cancer.	[Wang, Yufeng; Kuramitsu, Yasuhiro; Kitagawa, Takao; Tokuda, Kazuhiro; Baron, Byron; Akada, Junko; Nakamura, Kazuyuki] Yamguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, Ube, Yamaguchi 7558505, Japan; [Nakamura, Kazuyuki] Tokuyama Med Assoc, Ctr Clin Labs, Shunan, Japan	Kuramitsu, Y (reprint author), Yamguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	climates@yamaguchi-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24501352]	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (NO. 24501352 to Yasuhiro Kuramitsu). Immunoblot detection by LAS-1000 and plasmid construction were done at the Gene Research Center of Yamaguchi University.	Mori-Iwamoto S, 2008, MOL MED REP, V1, P429; Koga H, 2012, INT J ONCOL, V40, P679, DOI 10.3892/ijo.2011.1237; Nie L, 1996, MOL PHARMACOL, V50, P763; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; Chen XF, 2009, CANCER BIOTHER RADIO, V24, P689, DOI 10.1089/cbr.2009.0629; HUANG P, 1991, CANCER RES, V51, P6110; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; Kwan P, 2001, EPILEPSIA, V42, P1255, DOI 10.1046/j.1528-1157.2001.04501.x; Kuramitsu Y, 2012, ANTICANCER RES, V32, P2295; Schuchmann M, 2006, ONCOL REP, V15, P227; Noguchi H, 2009, ENDOCR J, V56, P245; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Kamrava M, 2008, INT J RADIAT ONCOL, V72, pS211, DOI 10.1016/j.ijrobp.2008.06.1542; Ziauddin MF, 2006, NEOPLASIA, V8, P446, DOI 10.1593/neo.05823; Greenblatt DY, 2008, ANN SURG, V247, P1036, DOI 10.1097/SLA.0b013e3181758d0e; BAKER CH, 1991, J MED CHEM, V34, P1879, DOI 10.1021/jm00110a019; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Spiecker M, 2002, MOL PHARMACOL, V62, P856, DOI 10.1124/mol.62.4.856; Cincarova L, 2013, EXPERT OPIN INV DRUG, V22, P1535, DOI 10.1517/13543784.2013.853037; Mitsuno M, 2010, INT J ONCOL, V36, P341, DOI 10.3892/ijo_00000505; Taba K, 2011, CHEMOTHERAPY, V57, P12, DOI 10.1159/000321019; Matthews DJ, 2007, CELL CYCLE, V6, P104, DOI 10.4161/cc.6.1.3699; Vitale G, 2012, BIOTECHNOL ADV, V30, P169, DOI 10.1016/j.biotechadv.2011.08.001; Lampen A, 1999, TOXICOL APPL PHARM, V160, P238, DOI 10.1006/taap.1999.8770; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Masoudi A, 2008, ANTICANCER RES, V28, P2437; Cheng YC, 2007, LEUKEMIA RES, V31, P1403, DOI 10.1016/j.leukres.2007.03.012; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Stamatopoulos B, 2009, LEUKEMIA, V23, P2281, DOI 10.1038/leu.2009.176; Candelaria M, 2010, EUR J GYNAECOL ONCOL, V31, P386; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Mackenzie GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061532; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Trapp O, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00019	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1776-2596	1776-260X		TARGET ONCOL	Target. Oncol.	DEC	2015	10	4					575	581		10.1007/s11523-015-0370-0		7	Oncology	Oncology	CX5VJ	WOS:000365770300012		
J	Hirabaru, M; Kuroki, T; Adachi, T; Kitasato, A; Ono, S; Tanaka, T; Matsushima, H; Sakai, Y; Soyama, A; Hidaka, M; Yamanouchi, K; Takatsuki, M; Okano, T; Eguchi, S				Hirabaru, Masataka; Kuroki, Tamotsu; Adachi, Tomohiko; Kitasato, Amane; Ono, Shinichiro; Tanaka, Takayuki; Matsushima, Hajime; Sakai, Yusuke; Soyama, Akihiko; Hidaka, Masaaki; Yamanouchi, Kosho; Takatsuki, Mitsuhisa; Okano, Teruo; Eguchi, Susumu			A Method for Performing Islet Transplantation Using Tissue-Engineered Sheets of Islets and Mesenchymal Stem Cells	TISSUE ENGINEERING PART C-METHODS			English	Article							HUMAN ADIPOSE-TISSUE; STROMAL CELLS; BONE-MARROW; ENDOTHELIAL-CELLS; HEME OXYGENASE-1; IN-VIVO; METABOLIC FUNCTION; DIABETES-MELLITUS; CULTURE SURFACES; SECRETION	Mesenchymal stem cells (MSCs) are known to have a protective effect on islet cells. Cell sheets developed using tissue engineering help maintain the function of the cells themselves. This study describes a tissue engineering approach using islets with MSC sheets to improve the therapeutic effect of islet transplantation. MSCs were obtained from Fischer 344 rats and engineered into cell sheets using temperature-responsive culture dishes. The islets obtained from Fischer 344 rats were seeded onto MSC sheets, and the islets with MSC sheets were harvested by low-temperature treatment after coculture. The functional activity of the islets with MSC sheets was confirmed by a histological examination, insulin secretion assay, and quantification of the levels of cytokines. The therapeutic effects of the islets with MSC sheets were investigated by transplanting the sheets at subcutaneous sites in severe combined immunodeficiency (SCID) mice with streptozotocin-induced diabetes. Improvement of islet function and viability was shown in situ on the MSC sheet, and the histological examination showed that the MSC sheet maintained adhesion factor on the surface. In the recipient mice, normoglycemia was maintained for at least 84 days after transplantation, and neovascularization was observed. These results demonstrated that islet transplantation in a subcutaneous site would be possible by using the MSC sheet as a scaffold for islets.	[Hirabaru, Masataka; Kuroki, Tamotsu; Adachi, Tomohiko; Kitasato, Amane; Ono, Shinichiro; Tanaka, Takayuki; Matsushima, Hajime; Sakai, Yusuke; Soyama, Akihiko; Hidaka, Masaaki; Yamanouchi, Kosho; Takatsuki, Mitsuhisa; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan; [Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo, Japan	Eguchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp					Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Shimizu H, 2009, BIOMATERIALS, V30, P5943, DOI 10.1016/j.biomaterials.2009.07.042; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Wang YJ, 2009, BIOCHEM BIOPH RES CO, V390, P1309, DOI 10.1016/j.bbrc.2009.10.143; Kim JS, 2012, J CONTROL RELEASE, V162, P382, DOI 10.1016/j.jconrel.2012.07.018; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Forte A, 2008, J CELL PHYSIOL, V217, P789, DOI 10.1002/jcp.21559; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; LEOW CK, 1995, DIABETOLOGIA, V38, P1014, DOI 10.1007/BF00402170; Lee DY, 2006, AM J TRANSPLANT, V6, P1820, DOI 10.1111/j.1600-6143.2006.01414.x; Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835; Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515; Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x; Emamaullee JA, 2005, DIABETES, V54, P2541, DOI 10.2337/diabetes.54.9.2541; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Chan TM, 2014, CELL TRANSPLANT, V23, P541, DOI 10.3727/096368914X678409; Fumimoto Y, 2009, TISSUE ENG PART C-ME, V15, P437, DOI 10.1089/ten.tec.2008.0555; Aksu AE, 2008, CLIN IMMUNOL, V127, P348, DOI 10.1016/j.clim.2008.02.003; Liu DZ, 2013, J SURG RES, V183, P450, DOI 10.1016/j.jss.2012.12.044; Okamoto T, 2011, ANN TRANSPL, V16, P114; Jiang M, 2008, J CELL BIOCHEM, V103, P321, DOI 10.1002/jcb.21416; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Nasr IW, 2005, J IMMUNOL, V174, P6161; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; Chan TM, 2014, STEM CELLS, V32, P1989, DOI 10.1002/stem.1693; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1002/stem.20080742, 10.1634/stemcells.stemcells.2008-0742]; Cheng Ying, 2005, Hepatobiliary Pancreat Dis Int, V4, P203; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Lin HP, 2015, CELL TRANSPLANT, V24, P521, DOI 10.3727/096368915X686977; Sakai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070970	50	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	DEC 1	2015	21	12					1205	1215		10.1089/ten.tec.2015.0035		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CX2MC	WOS:000365530000001		
J	Lu, S; Lam, J; Trachtenberg, JE; Lee, EJ; Seyednejad, H; van den Beucken, JJJP; Tabata, Y; Kasper, FK; Scott, DW; Wong, ME; Jansen, JA; Mikos, AG				Lu, Steven; Lam, Johnny; Trachtenberg, Jordan E.; Lee, Esther J.; Seyednejad, Hajar; van den Beucken, Jeroen J. J. P.; Tabata, Yasuhiko; Kasper, F. Kurtis; Scott, David W.; Wong, Mark E.; Jansen, John A.; Mikos, Antonios G.			Technical Report: Correlation Between the Repair of Cartilage and Subchondral Bone in an Osteochondral Defect Using Bilayered, Biodegradable Hydrogel Composites	TISSUE ENGINEERING PART C-METHODS			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; GROWTH-FACTOR; TREATING OSTEOARTHRITIS; RABBIT MODEL; KNEE JOINTS; IN-VIVO; DELIVERY; ARCHITECTURE; STRATEGIES	The present work investigated correlations between cartilage and subchondral bone repair, facilitated by a growth factor-delivering scaffold, in a rabbit osteochondral defect model. Histological scoring indices and microcomputed tomography morphological parameters were used to evaluate cartilage and bone repair, respectively, at 6 and 12 weeks. Correlation analysis revealed significant associations between specific cartilage indices and subchondral bone parameters that varied with location in the defect (cortical vs. trabecular region), time point (6 vs. 12 weeks), and experimental group (insulin-like growth factor-1 only, bone morphogenetic protein-2 only, or both growth factors). In particular, significant correlations consistently existed between cartilage surface regularity and bone quantity parameters. Overall, correlation analysis between cartilage and bone repair provided a fuller understanding of osteochondral repair and can help drive informed studies for future osteochondral regeneration strategies.	[Lu, Steven; Lam, Johnny; Trachtenberg, Jordan E.; Lee, Esther J.; Seyednejad, Hajar; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA; [van den Beucken, Jeroen J. J. P.; Jansen, John A.] Radboudumc, Dept Biomat, Nijmegen, Netherlands; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan; [Kasper, F. Kurtis] Univ Texas Houston, Sch Dent, Dept Orthodont, Houston, TX USA; [Scott, David W.] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Wong, Mark E.] Univ Texas Houston, Dept Oral & Maxillofacial Surg, Sch Dent, Houston, TX USA	Mikos, AG (reprint author), Rice Univ, Dept Bioengn, 6500 Main St,MS 142, Houston, TX 77030 USA.	mikos@rice.edu			National Institutes of Health [R01-AR048756]	This work was supported by the National Institutes of Health (R01-AR048756). The authors acknowledge the technical assistance of Ms. Natasja van Dijk with the histological preparation of specimens and Mr. Brian C. Dawson with micro-CT evaluation. The authors would also like to thank the registered veterinary technicians at the University of Texas Health Science Center for their support during the animal procedures.	Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.TEB.2012.0138, 10.1089/ten.teb.2012.0138]; Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205; Qiu YS, 2003, OSTEOARTHR CARTILAGE, V11, P810, DOI 10.1016/S1063-4584(03)00164-X; Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x; Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; [Anonymous], 1986, CLIN ORTHOPAEDICS; Orth P, 2013, EUR CELLS MATER, V25, P299; Baker-LePain JC, 2012, BONE, V51, P197, DOI 10.1016/j.bone.2012.01.008; Mansell JP, 2007, NAT CLIN PRACT RHEUM, V3, P306, DOI 10.1038/ncprheum0505; Orth P, 2012, OSTEOARTHR CARTILAGE, V20, P1161, DOI 10.1016/j.joca.2012.06.008; Lam J, 2015, ADV DRUG DELIVER REV, V84, P123, DOI [10.1016/j.addr.2014.06.006, 10.1016/j.addr.2014.06.005]; Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452; Lu S, 2014, BIOMATERIALS, V35, P8829, DOI 10.1016/j.biomaterials.2014.07.006; Funck-Brentano T, 2011, CYTOKINE GROWTH F R, V22, P91, DOI 10.1016/j.cytogfr.2011.04.003; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388; Orth P, 2013, OSTEOARTHR CARTILAGE, V21, P614, DOI 10.1016/j.joca.2013.01.008; SERINK MT, 1977, ACTA ORTHOP SCAND, V48, P250; Karsdal MA, 2008, OSTEOARTHR CARTILAGE, V16, P638, DOI 10.1016/j.joca.2008.01.014; Kim K, 2013, J CONTROL RELEASE, V168, P166, DOI 10.1016/j.jconrel.2013.03.013; Mukaka MM, 2012, MALAWI MED J, V24, P69; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Lam J, 2014, OSTEOARTHR CARTILAGE, V22, P1291, DOI 10.1016/j.joca.2014.06.035; Tokuhara Y, 2010, INT ORTHOP, V34, P761, DOI 10.1007/s00264-009-0818-x; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/; Zhang WJ, 2014, BIOMED RES INT, DOI 10.1155/2014/746138; de Vries-van Melle ML, 2014, TISSUE ENG PT A, V20, P23, DOI [10.1089/ten.TEA.2013.0080, 10.1089/ten.tea.2013.0080]; Goldring SR, 2012, ARTHRITIS RES THER, V14; Hickey Derrick G, 2003, Am J Orthop (Belle Mead NJ), V32, P70; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; Lajeunesse Daniel, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS34; RADIN EL, 1978, CLIN ORTHOP RELAT R, P288	34	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	DEC 1	2015	21	12					1216	1225		10.1089/ten.tec.2015.0117		10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CX2MC	WOS:000365530000002		
J	Baba, R; Onodera, T; Momma, D; Matsuoka, M; Hontani, K; Elmorsy, S; Endo, K; Todoh, M; Tadano, S; Iwasaki, N				Baba, Rikiya; Onodera, Tomohiro; Momma, Daisuke; Matsuoka, Masatake; Hontani, Kazutoshi; Elmorsy, Sameh; Endo, Kaori; Todoh, Masahiro; Tadano, Shigeru; Iwasaki, Norimasa			A Novel Bone Marrow Stimulation Technique Augmented by Administration of Ultrapurified Alginate Gel Enhances Osteochondral Repair in a Rabbit Model	TISSUE ENGINEERING PART C-METHODS			English	Article							ARTICULAR-CARTILAGE DEFECTS; FULL-THICKNESS DEFECTS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; MICROFRACTURE TECHNIQUE; KNEE ARTHROSCOPIES; SUBCHONDRAL BONE; CHONDRAL DEFECTS; IN-VIVO; DIFFERENTIATION; TRANSPLANTATION	Cartilage injuries are a common health problem resulting in the loss of daily activities. Bone marrow stimulation technique, one of the surgical techniques for the cartilage injuries, is characterized by technical simplicity and less invasiveness. However, it has been shown to result in fibrous or fibrocartilaginous repair with inferior long-term results. This study focused on using ultrapurified alginate gel (UPAL gel) as an adjuvant scaffold in combination with a bone marrow stimulation technique. The objective of this study was to assess the efficacy of a bone marrow stimulation technique augmented by UPAL gel in a rabbit osteochondral defect model. To achieve this goal, three experimental groups were prepared as follows: defects without intervention, defects treated with a bone marrow stimulation technique, and defects treated with a bone marrow stimulation technique augmented by UPAL gel. The macroscopic and histological findings of the defects augmented by UPAL gel improved significantly more than those of the others at 16 weeks postoperatively. The combination technique elicited hyaline-like cartilage repair, unlike bone marrow stimulation technique alone. This combination procedure has the potential of improving clinical outcomes after use of a bone marrow stimulation technique for articular cartilage injuries.	[Baba, Rikiya; Onodera, Tomohiro; Momma, Daisuke; Matsuoka, Masatake; Hontani, Kazutoshi; Elmorsy, Sameh; Endo, Kaori; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 0608638, Japan; [Todoh, Masahiro; Tadano, Shigeru] Hokkaido Univ, Fac Engn, Div Human Mech Syst & Design, Sapporo, Hokkaido 0608638, Japan	Onodera, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tomozou@med.hokudai.ac.jp			Newly Extended Technology Transfer Program (NexTEP) of the Japan Science and Technology Agency (JST)	This work is supported, in part, by the Newly Extended Technology Transfer Program (NexTEP) of the Japan Science and Technology Agency (JST). The authors are especially thankful to Mr. Shimizu (Mochida Pharmaceutical Co. Ltd.) for material preparations.	Anders Sven, 2013, Open Orthop J, V7, P133, DOI 10.2174/1874325001307010133; MITCHELL N, 1976, J BONE JOINT SURG AM, V58, P230; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532; Steadman JR, 1999, ORTHOPADE, V28, P26; Hamanishi M, 2013, J ORTHOP SCI, V18, P627, DOI 10.1007/s00776-013-0379-0; Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015; Mierisch CM, 2002, ARTHROSCOPY, V18, P892, DOI 10.1053/jars.2002.36117; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Changoor A, 2011, OSTEOARTHR CARTILAGE, V19, P126, DOI 10.1016/j.joca.2010.10.010; Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1; Igarashi T, 2010, J BIOMED MATER RES A, V94A, P844, DOI 10.1002/jbm.a.32762; Breinan HA, 1997, J BONE JOINT SURG AM, V79A, P1439; Dorotka R, 2005, OSTEOARTHR CARTILAGE, V13, P655, DOI 10.1016/j.joca.2005.04.001; Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135; Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033; Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3; Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040; MATSUSUE Y, 1993, ARTHROSCOPY, V9, P318, DOI 10.1016/S0749-8063(05)80428-1; Case ND, 2003, TISSUE ENG, V9, P587, DOI 10.1089/107632703768247296; Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008; Hiraki Y, 2001, OSTEOARTHR CARTILAGE, V9, pS102, DOI 10.1053/joca.2001.0451; van Susante JLC, 1999, BIOMATERIALS, V20, P1167, DOI 10.1016/S0142-9612(97)00190-7; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Mandelbaum BR, 1998, AM J SPORT MED, V26, P853; Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8; Dai LH, 2014, AM J SPORT MED, V42, P583, DOI 10.1177/0363546513518415; Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345; Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001; Mithoefer K, 2006, AM J SPORT MED, V34, P1413, DOI 10.1177/0363546506288240; PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618; Sukegawa A, 2012, TISSUE ENG PT A, V18, P934, DOI [10.1089/ten.TEA.2011.0380, 10.1089/ten.tea.2011.0380]; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345; Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1; Chen HM, 2011, AM J SPORT MED, V39, P1731, DOI 10.1177/0363546511403282; ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017; Poole R, 2010, OSTEOARTHR CARTILAGE, V18, pS10, DOI 10.1016/j.joca.2010.05.027; Wei XC, 1997, J BIOMED MATER RES, V34, P63, DOI 10.1002/(SICI)1097-4636(199701)34:1<63::AID-JBM9>3.0.CO;2-L; Behrens P, 2005, ARTHROSKOPIE, V18, P193, DOI 10.1007/s00142-005-0316-0; Efe T, 2012, KNEE SURG SPORT TR A, V20, P1911, DOI 10.1007/s00167-011-1777-5; Goyal D, 2013, ARTHROSCOPY, V29, P1579, DOI 10.1016/j.arthro.2013.05.027; Hunter W, 1743, PHILOS T R SOC LOND, V42, P514; Ross K. A., 2013, CARTILAGE, V4, P111; Siclari A., 2013, KNEE SURG SPORT TR A, V22, P1225	47	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	DEC 1	2015	21	12					1263	1273		10.1089/ten.tec.2015.0128		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CX2MC	WOS:000365530000007		
J	Yang, X; Wang, DP; Ma, Y; Xu, XG; Zhu, Z; Wang, XJ; Deng, HY; Li, CC; Chen, M; Tong, J; Yamanaka, K; An, Y				Yang, Xu; Wang, Dapeng; Ma, Yuan; Xu, Xiguo; Zhu, Zhen; Wang, Xiaojuan; Deng, Hanyi; Li, Chunchun; Chen, Min; Tong, Jian; Yamanaka, Kenzo; An, Yan			Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Antioxidant response; Arsenite; Carcinogenesis; HBE cells; Nrf2	FACTOR-KAPPA-B; GENE-EXPRESSION; CANCER-CELLS; HUMAN KERATINOCYTES; OXIDATIVE STRESS; DRUG-RESISTANCE; PROSTATE-CANCER; LUNG-CANCER; GROWTH; ROS	Long-term exposure to arsenite leads to human lung cancer, but the underlying mechanisms of carcinogenesis remain obscure. The transcription factor of nuclear factor-erythroid-2 p45-related factor (Nrf2)-mediated antioxidant response represents a critical cellular defense mechanism and protection against various diseases. Paradoxically, emerging data suggest that the constitutive activation of Nrf2 is associated with cancer development, progression and chemotherapy resistance. However, the role of Nrf2 in the occurrence of cancer induced by long-term arsenite exposure remains to be fully understood. By establishing transformed human bronchial epithelial (HBE) cells via chronic low-dose arsenite treatment, we showed that, in acquiring this malignant phenotype, continuous low level of ROS and sustained enhancement of Nrf2 and its target antioxidant enzyme levels were observed in the later-stage of arsenite-induced cell transformation. The downregulation of Keap1 level may be responsible for the over-activation of Nrf2 and its target enzymes. To validate these observations, Nrf2 was knocked down in arsenite-transformed HBE cells by SiRNA transfection, and the levels of Nrf2 and its target antioxidant enzymes, ROS, cell proliferation, migration, and colony formation were determined following these treatments. Results showed that blocked Nrf2 expression significantly reduced Nrf2 and its target antioxidant enzyme levels, restored ROS levels, and eventually suppressed cell proliferation, migration, and colony formation of the transformed cells. In summary, the results of the study strongly suggested that the continuous activation of Nrf2 and its target antioxidant enzymes led to the over-depletion of intracellular ROS levels, which contributed to arsenite-induced HBE cell transformation. (C) 2015 Elsevier Inc. All rights reserved.	[Yang, Xu; Wang, Dapeng; Ma, Yuan; Xu, Xiguo; Zhu, Zhen; Wang, Xiaojuan; Deng, Hanyi; Li, Chunchun; Chen, Min; Tong, Jian; An, Yan] Soochow Univ, Coll Med, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Dept Toxicol,Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China; [Wang, Dapeng] Guizhou Med Univ, Sch Publ Hlth, Dept Toxicol, Guiyang, Guizhou, Peoples R China; [Yamanaka, Kenzo] Nihon Univ, Sch Pharm, Lab Environm Toxicol & Carcinogenesis, Chiba, Japan	An, Y (reprint author), 199 Renal Rd Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China.	dranyan@126.com			National Natural Science Foundation of China [81573173]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20123201110012]; Graduate innovation project of Jiangsu Province [ZY32007613]; National Natural Science Foundation of China (NSFC) [Q3126982]; Projects of key International Cooperation and Exchanges [NSFC 81020108028]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (81573173); the Research Fund for the Doctoral Program of Higher Education of China (RFDP), (20123201110012); the Graduate innovation project of Jiangsu Province (ZY32007613); the Pre-Research of National Natural Science Foundation of China (NSFC) research grant (Q3126982); the Projects of key International Cooperation and Exchanges (NSFC 81020108028) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Duyndam MCA, 2001, J BIOL CHEM, V276, P48066, DOI 10.1074/jbc.M106282200; Zhao R, 2012, ENVIRON HEALTH PERSP, V120, P583, DOI 10.1289/ehp.1104580; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Chang QS, 2010, CANCER RES, V70, P5127, DOI 10.1158/0008-5472.CAN-10-0007; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Achanzar WE, 2002, J NATL CANCER I, V94, P1888; Kitchin KT, 2010, CHEM RES TOXICOL, V23, P327, DOI 10.1021/tx900343d; Li YA, 2010, ENVIRON HEALTH PERSP, V118, P936, DOI 10.1289/ehp.0901677; Fu JQ, 2010, ENVIRON HEALTH PERSP, V118, P864, DOI 10.1289/ehp.0901608; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361; REDDEL RR, 1988, CANCER RES, V48, P1904; Wang L, 2012, ARCH TOXICOL, V86, P879, DOI 10.1007/s00204-012-0845-z; Demizu Y, 2008, ANTIOXID REDOX SIGN, V10, P951, DOI 10.1089/ars.2007.1871; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Yamanaka K, 2009, LIFE SCI, V84, P627, DOI 10.1016/j.lfs.2009.02.008; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Surdu S, 2013, INT J CANCER, V133, P2182, DOI 10.1002/ijc.28216; Li B, 2013, ENVIRON TOXICOL, V28, P401, DOI 10.1002/tox.20731; BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Gilbert-Diamond D, 2013, ENVIRON HEALTH PERSP, V121, P1154, DOI 10.1289/ehp.1206178; COX AD, 1994, METHOD ENZYMOL, V238, P277; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Xu Y, 2012, ARCH TOXICOL, V86, P947, DOI 10.1007/s00204-012-0810-x; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Cho HY, 2002, AM J RESP CELL MOL, V26, P175; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Chain C.W., 2004, ENV HLTH PERSPECT, V112, P1704; IARC, 2012, ARS MET FIBR DUSTS R, V100 C, P36; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Watson J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120144; Wen G., 2007, MOL MED, V14, P2	56	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	DEC 1	2015	289	2					231	239		10.1016/j.taap.2015.09.020		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CX1NC	WOS:000365461900011		
J	Usui, S; Koketsu, Y				Usui, Shiho; Koketsu, Yuzo			Climatic factors associated with reproductive performance in English Berkshire pigs and crossbred pigs between Landrace and Large White raised in a subtropical climate region of Japan	TROPICAL ANIMAL HEALTH AND PRODUCTION			English	Article						Berkshire pigs; Climatic factors; Reproductive performance; Swine	HEAT-STRESS; SOWS; TEMPERATURE; TOLERANCE; TRAITS; BORN	Our objective was to characterize Berkshire female pigs associated with climatic factors by examining the interactions between two pig groups (pure English Berkshire females and crossbred females between Landrace and Large White) for reproductive performance in a humid subtropical zone. We analyzed 63,227 first-service records of 11,992 females in 12 herds. Climate data were obtained from four weather stations located close to the herds. Mean daily maximum temperatures (Tmax) and daily average relative humidity (ARH) for different time periods around servicing and farrowing of each female were coordinated with that female's reproductive performance data. Multilevel mixed-effects models were applied to the data. There were two-way interactions between the pig groups and either Tmax or ARH for weaning-to-first-mating interval (WMI) and number of total pigs born (TPB; P < 0.05). The WMI in Berkshire sows increased by 0.64 days as Tmax increased from 20 to 30 A degrees C (P < 0.05), whereas in crossbred sows it only increased by 0.09 days over the same Tmax range. In contrast, WMI in Berkshire sows only increased by 0.01 days as ARH increased from 60 to 80 % (P < 0.05), whereas in crossbred sows it increased by 0.32 days. In Berkshire females, TPB decreased by 0.3 pigs as Tmax increased from 20 to 30 A degrees C (P < 0.05), whereas that in crossbred females decreased by 0.4 pigs (P < 0.05). Therefore, we recommend producers apply advanced cooling systems for Berkshire females.	[Usui, Shiho; Koketsu, Yuzo] Meiji Univ, Sch Agr, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Koketsu, Y (reprint author), Meiji Univ, Sch Agr, Tama Ku, Higashi Mita 1-1-1, Kawasaki, Kanagawa 2148571, Japan.	koket001@isc.meiji.ac.jp			Meiji University	The authors gratefully thank the swine producers for their cooperation in providing valuable data for use in this study. We also thank Dr. I. McTaggart for his critical review of this manuscript. This work was supported by the Research Project Grant from Meiji University.	Bertoldo MJ, 2012, REPROD FERT DEVELOP, V24, P822, DOI 10.1071/RD11249; Iida R, 2014, J ANIM SCI, V92, P4180, DOI [10.2527/jas.2014-7636, 10.2527/jas2014-7636]; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Tomiyama M, 2009, J ANIM SCI, V87, P1613, DOI 10.2527/jas.2008-1214; Bloemhof S, 2008, J ANIM SCI, V86, P3330, DOI 10.2527/jas.2008-0862; Koketsu Y, 1996, J ANIM SCI, V74, P2875; Bloemhof S, 2013, J ANIM SCI, V91, P2667, DOI 10.2527/jas.2012-5902; Usui S, 2015, TROP ANIM HEALTH PRO, V47, P479, DOI 10.1007/s11250-014-0739-6; Suriyasomboon A, 2006, THERIOGENOLOGY, V65, P606, DOI 10.1016/j.theriogenology.2005.06.005; Freitas MS, 2006, LIVEST SCI, V105, P223, DOI 10.1016/j.livsci.2006.06.011; Tummaruk P, 2010, J AGR SCI, V148, P421, DOI 10.1017/S0021859610000110; Koketsu Y, 1997, THERIOGENOLOGY, V47, P1445, DOI 10.1016/S0093-691X(97)00135-0; Hansen PJ, 2001, THERIOGENOLOGY, V55, P91, DOI 10.1016/S0093-691X(00)00448-9; Hoving LL, 2011, LIVEST SCI, V140, P124, DOI 10.1016/j.livsci.2011.02.019; Dohoo I.R., 2009, VET EPIDEMIOLOGIC RE; Littell R.C., 2006, SAS SYSTEM MIXED MOD; McMullen L.K., 2006, BERKSHIRE SWINE PROD; PEEL M. C., 2007, HYDROL EARTH SYST SC, V4, P439, DOI DOI 10.5194/HESSD-4-439-2007; Sasaki Y, 2014, ANIM SCI J, V85, P213, DOI 10.1111/asj.12140	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-4747	1573-7438		TROP ANIM HEALTH PRO	Trop. Anim. Health Prod.	DEC	2015	47	8					1547	1552		10.1007/s11250-015-0896-2		6	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CX5MP	WOS:000365746300014		
J	Tefera, G; Tegegne, F; Mekuriaw, Y; Melaku, S; Tsunekawa, A				Tefera, Gebru; Tegegne, Firew; Mekuriaw, Yeshambel; Melaku, Solomon; Tsunekawa, Atsushi			Effects of different forms of white lupin (Lupinus albus) grain supplementation on feed intake, digestibility, growth performance and carcass characteristics of Washera sheep fed Rhodes grass (Chloris gayana) hay-based diets	TROPICAL ANIMAL HEALTH AND PRODUCTION			English	Article						Carcass characteristics; Digestibility; Dryland; Growth; Rhodes grass; White lupin; Washera sheep	LACTATING DAIRY-COWS; PROTEIN-SUPPLEMENT; NUTRITIONAL-VALUE; BODY-WEIGHT; WHEAT BRAN; MEAL; SEEDS; CONCENTRATE; MIXTURES; QUALITY	Protein is the major limiting nutrient in feeding ruminants especially in dryland areas. Thus, looking for locally available protein sources such as white lupin (Lupinus albus) grain is commendable. The objective of this experiment was to determine effects of supplementation of different forms of white lupin grain (WLG) on feed and nutrient intake, digestibility, growth and carcass characteristics. Twenty-five yearling male Washera sheep with initial body weight (BW) of 16.26 +/- 1.41 kg (mean +/- SD) were used. Animals were blocked into five based on their initial BW and were randomly assigned to one of the following five dietary treatments: Rhodes grass (Chloris gayana) hay (RGH) alone (T-1) or supplemented with 300 g (on dry matter (DM) basis) raw WLG (T-2) or raw soaked and dehulled WLG (T-3) or roasted WLG (T-4) or raw soaked WLG (T-5). Supplementation with WLG significantly improved total DM and nutrient intake (P < 0.001), nutrient digestibility (P < 0.01), and average daily gain (ADG) and feed conversion efficiency (FCE) (P < 0.001). Carcass quality parameters were significantly (P < 0.001) higher for supplemented sheep. However, the difference in carcass quality parameters among supplemented groups was not significant (P > 0.05). It is concluded that roasting white lupin grain can lead to a better feed and nutrient intake and consequently better carcass quality. White lupin grain can be recommended not only for maintenance but also for optimum performance of ruminants.	[Tefera, Gebru] Koga Irrigat & Watershed Management Project, Bahir Dar, Ethiopia; [Tegegne, Firew; Mekuriaw, Yeshambel] Bahir Dar Univ, Dept Anim Prod & Technol, Bahir Dar, Ethiopia; [Tegegne, Firew; Tsunekawa, Atsushi] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Melaku, Solomon] Haramaya Univ, Sch Anim & Range Sci, Dire Dawa, Ethiopia	Tegegne, F (reprint author), Bahir Dar Univ, Dept Anim Prod & Technol, POB 79, Bahir Dar, Ethiopia.	firewtegegne@alrc.tottori-u.ac.jp			Koga irrigation project	The first author would like to acknowledge Koga irrigation project for granting the research budget and Haramaya University for availing laboratory facilities.	Abate D., 2008, TROPICAL ANIMAL PROD, V41, P579; Diaz MT, 2002, SMALL RUMINANT RES, V43, P257, DOI 10.1016/S0921-4488(02)00016-0; Bishaw F, 2008, TROP ANIM HEALTH PRO, V40, P597, DOI 10.1007/s11250-008-9138-1; Yeheyis L, 2012, EXP AGR, V48, P414, DOI 10.1017/S0014479712000026; Pisarikova B, 2008, VET MED-CZECH, V53, P124; BRENES A, 1993, POULTRY SCI, V72, P2281; Yu P, 2002, ASIAN AUSTRAL J ANIM, V15, P974; KUNG L, 1991, J ANIM SCI, V69, P3398; WATKINS BA, 1987, POULTRY SCI, V66, P1798; FREER M, 1984, ANIM FEED SCI TECH, V11, P87, DOI 10.1016/0377-8401(84)90014-2; RAHMA EH, 1984, J AGR FOOD CHEM, V32, P1026, DOI 10.1021/jf00125a020; Yeheyis L, 2012, TROP ANIM HEALTH PRO, V44, P1255, DOI 10.1007/s11250-011-0066-0; Melaku S, 2004, LIVEST PROD SCI, V89, P253, DOI 10.1016/j.livprodsci.2004.01.003; Tafa A, 2010, TROP ANIM HEALTH PRO, V42, P677, DOI 10.1007/s11250-009-9475-8; ROBINSON PH, 1993, ANIM FEED SCI TECH, V43, P275, DOI 10.1016/0377-8401(93)90083-V; SMITH GH, 1986, AUST J EXP AGR, V26, P1, DOI 10.1071/EA9860001; Muzquiz M, 2012, PHYTOCHEM REV, V11, P227, DOI 10.1007/s11101-012-9233-9; Hagos T, 2009, TROP ANIM HEALTH PRO, V41, P599, DOI 10.1007/s11250-008-9230-6; Sujak A, 2006, FOOD CHEM, V98, P711, DOI 10.1016/j.foodchem.2005.06.036; Bahr M, 2014, LWT-FOOD SCI TECHNOL, V59, P587, DOI 10.1016/j.lwt.2014.05.026; GUILLAUME B, 1987, J DAIRY SCI, V70, P2339; AOAC (Association of Official Analytical Chemists), 1990, OFF METH CHEM AN; ARC (Agricultural Research Council), 1980, NUTR REQ RUM LIV TEC; Bediye S., 1989, 6 I AGR RES; Bediye S., 2007, 73 ETH I AGR RES; Bogale S., 2008, Tropical and Subtropical Agroecosystems, V8, P107; Carr J.R., 1976, NUTR ABSTRACTS REV, V46, P751; Clotter J.A., 1985, 49 FAO AN PROD HLTH; Degu A, 2009, ANIM FEED SCI TECH, V148, P214, DOI 10.1016/j.anifeedsci.2008.03.014; Denekew Y., 2004, THESIS; Takele Feyera, 2011, Pakistan Journal of Nutrition, V10, P1013; Food and Agricultural Organization of the United Nations, 2011, ETH COUNTR PROGR FRA; Gebregiorgis F., 2012, TROPICAL ANIMAL HLTH, V43, P511; Gebretsadik G., 2011, LIVESTOCK RES RURAL, V23; Gereslassie Z., 2009, E AFRICAN J SCI, V3, P37; Hailu A, 2011, LIVEST RES RURAL DEV, V23, P8; Legesse G., 2008, THESIS; Massae E. E., 1992, SMALL RUMINANT RES D, P401; McDonald P., 2002, ANIMAL NUTR; Mekuriaw Y., 2012, Pakistan Journal of Nutrition, V11, P322; Mulu M, 2005, THESIS; National Research Council - NRC, 1985, NUTR REQ SHEEP; Norton B.W, 2003, NUTR VALUE TREE LEGU; SAS (Statistical Analysis System), 2000, SAS STAT GUID PERS C; Silano V., 1981, IMPROVEMENT NUTR QUA; Simachew G., 2009, THESIS; Tegegne F., 2010, FEED RESOURCES ASSES; Tekletsadik E., 2008, THESIS; Tolera A, 2007, FEED RESOURCES PRODU; Van Soest PJ, 1994, NUTR ECOLOGY RUMINAN; Van Soest P.J., 1985, ANAL FORAGE FIBROUS; WARDO (Mecha Woreda Agricultural and Rural Development Office), 2009, WARDO ANN REP; Yeheyis L., 2010, LIVESTOCK RES RURAL, V22; Yeheyis L., 2011, Z NATURFORSCH, V6, P403	54	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-4747	1573-7438		TROP ANIM HEALTH PRO	Trop. Anim. Health Prod.	DEC	2015	47	8					1581	1590		10.1007/s11250-015-0901-9		10	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CX5MP	WOS:000365746300019		
J	Carpenter, C; Sidney, J; Kolla, R; Nayak, K; Tomiyama, H; Tomiyama, C; Padilla, OA; Rozot, V; Ahamed, SF; Ponte, C; Rolla, V; Antas, PR; Chandele, A; Kenneth, J; Laxmi, S; Makgotlho, E; Vanini, V; Ippolito, G; Kazanova, AS; Panteleev, AV; Hanekom, W; Mayanja-Kizza, H; Lewinsohn, D; Saito, M; McElrath, MJ; Boom, WH; Goletti, D; Gilman, R; Lyadova, IV; Scriba, TJ; Kallas, EG; Murali-Krishna, K; Sette, A; Arlehamn, CSL				Carpenter, Chelsea; Sidney, John; Kolla, Ravi; Nayak, Kaustuv; Tomiyama, Helena; Tomiyama, Claudia; Padilla, Oscar A.; Rozot, Virginie; Ahamed, Syed F.; Ponte, Carlos; Rolla, Valeria; Antas, Paulo R.; Chandele, Anmol; Kenneth, John; Laxmi, Seetha; Makgotlho, Edward; Vanini, Valentina; Ippolito, Giuseppe; Kazanova, Alexandra S.; Panteleev, Alexander V.; Hanekom, Willem; Mayanja-Kizza, Harriet; Lewinsohn, David; Saito, Mayuko; McElrath, M. Juliana; Boom, W. Henry; Goletti, Delia; Gilman, Robert; Lyadova, Irina V.; Scriba, Thomas J.; Kallas, Esper G.; Murali-Krishna, Kaja; Sette, Alessandro; Arlehamn, Cecilia S. Lindestam			A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents	TUBERCULOSIS			English	Article						Tuberculosis; T cell antigen; Vaccine; CD4	PPD-POSITIVE ADULTS; LATENT TUBERCULOSIS; VACCINATED INFANTS; BCG VACCINE; IMMUNOGENICITY; PROTECTION; RESPONSES; M72/AS01; IMMUNITY; INFECTION	We compared T cell recognition of 59 prevalently recognized Mycobacterium tuberculosis (MTB) antigens in individuals latently infected with MTB (LTBI), and uninfected individuals with previous BCG vaccination, from nine locations and populations with different HLA distribution, MTB exposure rates, and standards of TB care. This comparison revealed similar response magnitudes in diverse LTBI and BCG-vaccinated cohorts and significant correlation between responses in LTBIs from the USA and other locations. Many antigens were uniformly recognized, suggesting suitability for inclusion in vaccines targeting diverse populations. Several antigens were similarly immunodominant in LTBI and BCG cohorts, suggesting applicability for vaccines aimed at boosting BCG responses. The panel of MTB antigens will be valuable for characterizing MTB-specific CD4 T cell responses irrespective of ethnicity, infecting MTB strains and BCG vaccination status. Our results illustrate how a comparative analysis can provide insight into the relative immunogenicity of existing and novel vaccine candidates in LTBIs. (C) 2015 Elsevier Ltd. All rights reserved.	[Carpenter, Chelsea; Sidney, John; Kolla, Ravi; Sette, Alessandro; Arlehamn, Cecilia S. Lindestam] La Jolla Inst Allergy & Immunol, Dept Vaccine Discovery, La Jolla, CA 92037 USA; [Nayak, Kaustuv; Chandele, Anmol; Murali-Krishna, Kaja] Int Ctr Genet Engn & Biotechnol, ICGEB Emory Vaccine Ctr, New Delhi 110067, India; [Tomiyama, Helena; Tomiyama, Claudia; Padilla, Oscar A.; Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Rozot, Virginie; Makgotlho, Edward; Hanekom, Willem; Scriba, Thomas J.] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Rozot, Virginie; Makgotlho, Edward; Hanekom, Willem; Scriba, Thomas J.] Univ Cape Town, Dept Pediat & Child Hlth, ZA-7925 Cape Town, South Africa; [Ahamed, Syed F.; Kenneth, John] St Johns Natl Acad Sci, St Johns Res Inst, Div Infect Dis, Bangaluru 560034, Karnataka, India; [Ponte, Carlos; Rolla, Valeria; Antas, Paulo R.] Fiocruz MS, Inst Oswaldo Cruz, Clin Immunol Lab, BR-21045900 Rio De Janeiro, Brazil; [Laxmi, Seetha] St Johns Natl Acad Hlth Sci, St Johns Med Coll Hosp, Dept Transfus Med & Immunohematol, Bangaluru 560034, Karnataka, India; [Vanini, Valentina; Ippolito, Giuseppe; Goletti, Delia] Natl Inst Infect Dis, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Kazanova, Alexandra S.; Panteleev, Alexander V.; Lyadova, Irina V.] Cent TB Res Inst, Fed State Budgetary Sci Inst, Dept Immunol, Moscow, Russia; [Mayanja-Kizza, Harriet] Makerere Univ, Fac Med, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Lewinsohn, David] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Saito, Mayuko; Gilman, Robert] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Saito, Mayuko; Gilman, Robert] Univ Peruana Caytano Hereida, Lima, Peru; [Saito, Mayuko] Tohoku Univ, Dept Virol, Sendai, Miyagi 980, Japan; [McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, TB Res Unit, Cleveland, OH 44106 USA; [Murali-Krishna, Kaja] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Murali-Krishna, Kaja] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Arlehamn, CSL (reprint author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	cecilia@lji.org			National Institutes of Health [HHSN272200900044C, HHSN266200700022C/NO1-AI-70022, R37AI052731]; IOC/FIOCRUZ [CNPq research fellowship] [PQ-2-Brazil]; Italian Ministry of Health [Ricerca Corrente]; Bill and Melinda Gates Foundation [OPP1066265]; HIV Vaccine Trials Network [RAMP scholarship]; Russian Science Foundation [15-15-00136]	This work was supported by the National Institutes of Health [contract HHSN272200900044C to A.S., contract HHSN266200700022C/NO1-AI- 70022 to W.H.B, grant R37AI052731 to E.G.K]: the IOC/FIOCRUZ [CNPq research fellowship PQ-2-Brazil to P.R.A.]: The Italian Ministry of Health [Ricerca Corrente to D.G.], the Bill and Melinda Gates Foundation [OPP1066265 to T.J.S.], and the HIV Vaccine Trials Network [RAMP scholarship to O.A.P.], the Russian Science Foundation [15-15-00136 to I.V.L.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Von Eschen K, 2009, HUM VACCINES, V5, P475; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Paul S, 2015, J IMMUNOL METHODS, V422, P28, DOI 10.1016/j.jim.2015.03.022; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Kaufmann SHE, 2013, SEMIN IMMUNOL, V25, P172, DOI 10.1016/j.smim.2013.04.006; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Karp CL, 2015, IMMUNOL REV, V264, P363, DOI 10.1111/imr.12270; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Harboe M, 1996, INFECT IMMUN, V64, P16; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Spertini F, 2013, TUBERCULOSIS, V93, P179, DOI 10.1016/j.tube.2012.10.011; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Montoya J, 2013, J CLIN IMMUNOL, V33, P1360, DOI 10.1007/s10875-013-9949-3; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Ritz N, 2008, FEMS MICROBIOL REV, V32, P821, DOI 10.1111/j.1574-6976.2008.00118.x; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Gorak-Stolinska P, 2006, VACCINE, V24, P5726, DOI 10.1016/j.vaccine.2006.04.037; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; COLDITZ GA, 1995, PEDIATRICS, V96, P29; McKinney DM, 2013, IMMUNOGENETICS, V65, P357, DOI 10.1007/s00251-013-0684-y; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Copin R, 2014, VACCINE, V32, P5998, DOI 10.1016/j.vaccine.2014.07.113; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, P95, DOI DOI 10.1186/1471-2148-6-95; Idoko OT, 2014, TUBERCULOSIS, V94, P564, DOI 10.1016/j.tube.2014.07.001; Arlehamn CSL, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018465; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Sutherland JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074080; Vijayalakshmi V, 1995, Indian Pediatr, V32, P979; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	50	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1472-9792			TUBERCULOSIS	Tuberculosis	DEC	2015	95	6					713	721		10.1016/j.tube.2015.07.001		9	Immunology; Microbiology; Respiratory System	Immunology; Microbiology; Respiratory System	CX3UZ	WOS:000365626300012		
J	Iwai, H; Kato-Miyazawa, M; Kirikae, T; Miyoshi-Akiyama, T				Iwai, Hiroki; Kato-Miyazawa, Masako; Kirikae, Teruo; Miyoshi-Akiyama, Tohru			CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): A publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates	TUBERCULOSIS			English	Letter						CASTB; M. tuberculosis complex; Whole-genome sequencing; Next-generation sequencers			[Iwai, Hiroki; Kato-Miyazawa, Masako; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Dept Infect Dis, Shinjuku Ku, Tokyo 1628655, Japan; [Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Pathogen Microbe Lab, Shinjuku Ku, Tokyo 1628655, Japan	Miyoshi-Akiyama, T (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	takiyam@ri.ncgm.go.jp					Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Mitarai S, 2012, J CLIN MICROBIOL, V50, P884, DOI 10.1128/JCM.05638-11; Rad ME, 2003, EMERG INFECT DIS, V9, P838; Fitzgibbon MM, 2013, EUROSURVEILLANCE, V18, P24; Kato-Miyazawa M, 2015, CLIN MICROBIOL INFEC, V21, p[248, e1]; Leekitcharoenphon P, 2012, BMC GENOMICS S7, V13	8	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1472-9792			TUBERCULOSIS	Tuberculosis	DEC	2015	95	6					843	844		10.1016/j.tube.2015.09.002		2	Immunology; Microbiology; Respiratory System	Immunology; Microbiology; Respiratory System	CX3UZ	WOS:000365626300029		
J	Nakashima, Y; Iijima, T; Sugita, Y				Nakashima, Yusuke; Iijima, Takumi; Sugita, Yoichi			Surround-contingent motion aftereffect	VISION RESEARCH			English	Article						Adaptation; Motion aftereffect; Contingent aftereffect; Reference frame	SACCADIC EYE-MOVEMENTS; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; MACAQUE MONKEY; AREA MT; COLOR; ADAPTATION; DETECTORS; DIRECTION; SENSITIVITY	We investigated whether motion aftereffects (MAE) can be contingent on surroundings. Random dots moving leftward and rightward were presented in alternation. Moving dots were surrounded by an open circle or an open square. After prolonged exposure to these stimuli, MAE were found to be contingent upon the surrounding frames: dots moving in a random direction appeared moving leftward when surrounded by the frame that was presented in conjunction with rightward motion. The effect lasted for 24 h and was observed when adapter and test stimuli were presented not only retinotopically, but also at the same spatiotopic position. Furthermore, the effect was observed even when the adapter and test stimuli were presented at different retinotopic and spatiotopic positions as long as they were presented in the same hemi-field. These results indicate that MAE would be influenced not only by the stimulus features, but also by their surroundings, and they suggest that the surround-contingent MAE might be mediated in the higher stage of the motion processing pathway. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakashima, Yusuke; Iijima, Takumi; Sugita, Yoichi] Waseda Univ, Dept Psychol, Shinjuku Ku, Tokyo 1628644, Japan	Nakashima, Y (reprint author), Waseda Univ, Dept Psychol, Shinjuku Ku, 1-24-1 Toyama, Tokyo 1628644, Japan.	tngchhoff@asagi.waseda.jp			Japan Society for the Promotion of Science (JSPS) [25245069]	This work was supported by Grant-in-Aid for Scientific Research (25245069), Japan Society for the Promotion of Science (JSPS).	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106; Zimmermann E, 2013, CURR BIOL, V23, pR193, DOI 10.1016/j.cub.2013.01.065; Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Durgin FH, 1996, PERCEPT PSYCHOPHYS, V58, P207, DOI 10.3758/BF03211876; ANSTIS SM, 1974, PERCEPTION, V3, P153, DOI 10.1068/p030153; Wenderoth P, 2008, VISION RES, V48, P1949, DOI 10.1016/j.visres.2008.06.013; Mather G, 2012, NEUROPSYCHOLOGIA, V50, P153, DOI 10.1016/j.neuropsychologia.2011.11.013; MAY JG, 1976, SCIENCE, V192, P145, DOI 10.1126/science.1257760; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; Beck C, 2010, J PHYSIOL-PARIS, V104, P61, DOI 10.1016/j.jphysparis.2009.11.005; SHARPE LT, 1991, PERCEPT PSYCHOPHYS, V49, P434, DOI 10.3758/BF03212177; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; HEPLER N, 1968, SCIENCE, V162, P376, DOI 10.1126/science.162.3851.376; Meng X, 2006, VISION RES, V46, P3681, DOI 10.1016/j.visres.2006.05.012; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; POPPEL E, 1986, NATURE, V320, P523, DOI 10.1038/320523a0; SILLITO AM, 1995, NATURE, V378, P492; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; FAVREAU OE, 1972, SCIENCE, V176, P78, DOI 10.1126/science.176.4030.78; POTTS MJ, 1975, VISION RES, V15, P1225; LOOMIS JM, 1973, PERCEPTION, V2, P425, DOI 10.1068/p020425; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; HELD R, 1971, SCIENCE, V174, P314, DOI 10.1126/science.174.4006.314; Turi M, 2012, P ROY SOC B-BIOL SCI, V279, P3091, DOI 10.1098/rspb.2012.0637; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; MURCH GM, 1974, VISION RES, V14, P1181, DOI 10.1016/0042-6989(74)90214-4; EDWARDS M, 1993, PERCEPTION, V22, P1013, DOI 10.1068/p221013; Snowden RJ, 1997, CURR BIOL, V7, P717, DOI 10.1016/S0960-9822(06)00329-0; Price NSC, 2004, VISION RES, V44, P1971, DOI 10.1016/j.visres.2004.04.001; Barlow H. B., 1990, VISION CODING EFFICI, P363; BLAKEMOR.C, 1972, EXP BRAIN RES, V15, P439; Braddick O., 1978, HDB SENSORY PHYSL, V8, P3; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; Ezzati A, 2008, J VISION, V8, DOI 10.1167/8.14.23; Hein E, 2012, J VISION, V12, DOI 10.1167/12.7.16; Kaufman L., 1979, PERCEPTION WORLD TRA; Knapen T, 2009, J VISION, V9, DOI 10.1167/9.5.16; LAMME VAF, 1995, J NEUROSCI, V15, P1605; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127; Mayhew E. W., 1972, PERCEPT PSYCHOPHYS, V12, P77; MCCOLLOU.C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; Nakashima Y., 2014, J VISION, V14, P1; Nishida S, 2011, J VISION, V11, P1, DOI DOI 10.1167/11.5.11; Pavan A., 2013, J VISION, V13, p[16, 1], DOI 10.1167/13.6.16; RAYMOND JE, 1994, VISION RES, V34, P1029, DOI 10.1016/0042-6989(94)90007-8; Stromeyer C F 3rd, 1972, Am J Psychol, V85, P227; Von Grunau Michael, 1992, Spatial Vision, V6, P303, DOI 10.1163/156856892X00145; Yoshimoto S, 2014, J VISION, V14, DOI 10.1167/14.1.10	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	DEC	2015	117						9	15		10.1016/j.visres.2015.09.010		7	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CX2WQ	WOS:000365557900002		
J	Seya, Y; Shinoda, H; Nakaura, Y				Seya, Yasuhiro; Shinoda, Hiroyuki; Nakaura, Yoshiya			Up-down asymmetry in vertical vection	VISION RESEARCH			English	Article						Vection; Optokinetic nystagmus; Directional asymmetries	SELF-MOTION PERCEPTION; OCULAR FOLLOWING RESPONSES; OPTOKINETIC AFTER-NYSTAGMUS; LINEAR-VECTION; FOREGROUND MOTION; INVERTED VECTION; FLOW PATTERNS; ERECT MAN; MONKEY; DIRECTION	To investigate whether up-down asymmetry similar to that reported in vertical optokinetic nystagmus (OM), that is, larger OKN responses for upward motion than for downward motion, would appear in vertical vection, we conducted three experiments. In all three experiments, participants viewed a vertically moving random-dot pattern. In Experiments I and 2, participants reported vection using a joystick. After each trial, they were also asked to rate the vection magnitude experienced during the stimulus presentation. In Experiment 3, eye movements and vection magnitude (rated after each trial) in response to the stimulus were measured. The results of Experiment 1 showed larger vection magnitude for the upward motion of the stimulus than for the downward motion of it. However, vection onset latency did not change much with stimulus motion direction. Experiment 2 revealed that the up-down asymmetry in vection manifested progressively during the latter part of the stimulus presentation period. Experiment 3 showed clear up-down asymmetry in both OKN and vection magnitude. These results not only indicate that up-down asymmetry similar to that reported in vertical OKN appears in vertical vection, but they also support the notion that the mechanisms underlying vection and OKN are closely related to each other. (C) 2015 Elsevier Ltd. All rights reserved.	[Seya, Yasuhiro; Shinoda, Hiroyuki; Nakaura, Yoshiya] Ritsumeikan Univ, Dept Human & Comp Intelligence, Shiga 5258577, Japan	Seya, Y (reprint author), Ritsumeikan Univ, Dept Human & Comp Intelligence, 1-1-1 Noji Higashi, Shiga 5258577, Japan.	yseya@fc.ritsumei.ac.jp			 [25870916];  [15K00216]	This research was supported by Grants-in-Aid for Young Scientists (B) 25870916 to Y.S. and for Scientific Research (C) 15K00216 to H.S.	Nakamura S, 2004, VISION RES, V44, P1951, DOI 10.1016/j.visres.2004.03.004; MILES FA, 1986, J NEUROPHYSIOL, V56, P1381; Ohtani Y, 1997, VISION RES, V37, P765, DOI 10.1016/S0042-6989(96)00242-8; WAESPE W, 1986, EXP BRAIN RES, V65, P49; Nakamura S, 2003, VISION RES, V43, P745, DOI 10.1016/S0042-6989(03)00081-6; Seya Y, 2015, ATTEN PERCEPT PSYCHO, V77, P220, DOI 10.3758/s13414-014-0734-z; Knapp CM, 2008, INVEST OPHTH VIS SCI, V49, P581, DOI 10.1167/iovs.07-0773; OHMI M, 1986, EXP BRAIN RES, V63, P387; Ito H, 2003, PERCEPT PSYCHOPHYS, V65, P874, DOI 10.3758/BF03194821; LOTT LA, 1993, PERCEPTION, V22, P527, DOI 10.1068/p220527; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; BRANDT T, 1974, EXP BRAIN RES, V21, P337; MILES FA, 1986, J NEUROPHYSIOL, V56, P1321; VANDENBERG AV, 1988, EXP BRAIN RES, V70, P597; COHEN B, 1977, J PHYSIOL-LONDON, V270, P321; Sasaki K, 2012, PERCEPTION, V41, P875, DOI 10.1068/p7215; SCHOR C, 1981, VISION RES, V21, P985, DOI 10.1016/0042-6989(81)90002-X; Nakamura S, 1999, PERCEPTION, V28, P893, DOI 10.1068/p2939; KAWANO K, 1986, J NEUROPHYSIOL, V56, P1355; MURASUGI CM, 1989, EXP BRAIN RES, V77, P183; TELFORD L, 1993, PERCEPT PSYCHOPHYS, V53, P682, DOI 10.3758/BF03211744; LEPECQ JC, 1995, PERCEPTION, V24, P435, DOI 10.1068/p240435; Seno T, 2010, VISION RES, V50, P1131, DOI 10.1016/j.visres.2010.03.020; Seno T, 2011, ATTEN PERCEPT PSYCHO, V73, P1467, DOI 10.3758/s13414-011-0129-3; Giannopulu I, 1998, PERCEPTION, V27, P363, DOI 10.1068/p270363; Garbutt S, 2003, INVEST OPHTH VIS SCI, V44, P3833, DOI 10.1167/iovs-03-0066; Seno T, 2013, COGNITION, V126, P115, DOI 10.1016/j.cognition.2012.08.009; Lepecq JC, 1999, PERCEPTION, V28, P63, DOI 10.1068/p2749; BRANDT T, 1973, EXP BRAIN RES, V16, P476; Bubka A, 2007, AVIAT SPACE ENVIR MD, V78, P383; TAKAHASHI M, 1978, ORL J OTO-RHINO-LARY, V40, P43; Seno T, 2009, EXP BRAIN RES, V192, P221, DOI 10.1007/s00221-008-1575-6; MATSUO V, 1984, EXP BRAIN RES, V53, P197; EDWARDS M, 1993, PERCEPTION, V22, P1013, DOI 10.1068/p221013; Flanagan MB, 2002, AVIAT SPACE ENVIR MD, V73, P1067; Seno T, 2011, PERCEPTION, V40, P747, DOI 10.1068/p7018; BALL K, 1980, PERCEPTION, V9, P317, DOI 10.1068/p090317; Nakamura S, 2000, VISION RES, V40, P2915, DOI 10.1016/S0042-6989(00)00149-8; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; HECKMANN T, 1991, PERCEPTION, V20, P285, DOI 10.1068/p200285; Seya Y, 2007, VIS COGN, V15, P491, DOI 10.1080/13506280600777718; Duncker K., 1938, SOURCE BOOK GESTALT, P161, DOI 10.1037/11496-012; Ebenholtz S. M., 2001, OCULOMOTOR SYSTEMS P; Fischer MH, 1930, J PSYCHOL NEUROL, V41, P273; HOWARD IP, 1994, PERCEPTION, V23, P745, DOI 10.1068/p230745; Ito H., 2004, J PHYSL ANTHR APPL H, V65, P307; KANO C, 1991, Ecological Psychology, V3, P241, DOI 10.1207/s15326969eco0303_3; Knapp Christopher M, 2013, Strabismus, V21, P37, DOI 10.3109/09273972.2012.762532; Mach E., 1959, ANAL SENSATIONS RELA; Naito T, 2010, VISION RES, V50, P1862, DOI 10.1016/j.visres.2010.06.007; Nakamura S, 1998, PERCEPT MOTOR SKILL, V87, P667; Seya Y, 2014, I-PERCEPTION, V5, P630, DOI 10.1068/i0671	52	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	DEC	2015	117						16	24		10.1016/j.visres.2015.10.013		9	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CX2WQ	WOS:000365557900003		
J	Nakashima, R; Fang, Y; Hatori, Y; Hiratani, A; Matsumiya, K; Kuriki, I; Shioiri, S				Nakashima, Ryoichi; Fang, Yu; Hatori, Yasuhiro; Hiratani, Akinori; Matsumiya, Kazumichi; Kuriki, Ichiro; Shioiri, Satoshi			Saliency-based gaze prediction based on head direction	VISION RESEARCH			English	Article						Gaze prediction; Head direction; Eye-head coordination; Saliency map	VISUAL-ATTENTION; DYNAMIC SCENES; EYE-MOVEMENTS; VIEWING TASK; CENTER BIAS; COORDINATION; SHIFTS; OBSERVERS; AMPLITUDE; SELECTION	Despite decades of attempts to create a model for predicting gaze locations by using saliency maps, a highly accurate gaze prediction model for general conditions has yet to be devised. In this study, we propose a gaze prediction method based on head direction that can improve the accuracy of any model. We used a probability distribution of eye position based on head direction (static eye-head coordination) and added this information to a model of saliency-based visual attention. Using empirical data on eye and head directions while observers were viewing natural scenes, we estimated a probability distribution of eye position. We then combined the relationship between eye position and head direction with visual saliency to predict gaze locations. The model showed that information on head direction improved the prediction accuracy. Further, there was no difference in the gaze prediction accuracy between the two models using information on head direction with and without eye-head coordination. Therefore, information on head direction is useful for predicting gaze location when it is available. Furthermore, this gaze prediction model can be applied relatively easily to many daily situations such as during walking. (C) 2015 Elsevier Ltd. All rights reserved.	Tohoku Univ, Sendai, Miyagi 9808577, Japan; Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Nakashima, R (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	one.island.one@gmail.com			Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST), Japan; Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University, Japan	This study was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST), Japan, and by the Cooperative Research Project of the Research Institute of Electrical Communication (RIEC) at Tohoku University, Japan.	Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Chamveha I, 2013, COMPUT VIS IMAGE UND, V117, P1502, DOI 10.1016/j.cviu.2013.06.005; Oommen BS, 2004, EXP BRAIN RES, V155, P9, DOI 10.1007/s00221-003-1694-z; Kimura A, 2013, IEICE T INF SYST, VE96D, P562, DOI 10.1587/transinf.E96.D.562; ZANGEMEISTER WH, 1981, EXP NEUROL, V71, P76, DOI 10.1016/0014-4886(81)90072-8; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Frintrop S, 2011, COMPUTER ANALYSIS OF HUMAN BEHAVIOR, P69, DOI 10.1007/978-0-85729-994-9_4; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; TWEED D, 1995, J NEUROPHYSIOL, V73, P766; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Ehinger KA, 2009, VIS COGN, V17, P945, DOI 10.1080/13506280902834720; Freedman EG, 2008, EXP BRAIN RES, V190, P369, DOI 10.1007/s00221-008-1504-8; Greene MR, 2012, VISION RES, V62, P1, DOI 10.1016/j.visres.2012.03.019; Goossens HHLM, 1997, EXP BRAIN RES, V114, P542, DOI 10.1007/PL00005663; Freedman EG, 2005, EXP BRAIN RES, V167, P557, DOI 10.1007/s00221-005-0051-9; Hiratani A, 2013, 2013 SECOND IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION (ACPR 2013), P783, DOI 10.1109/ACPR.2013.183; Freedman EG, 2000, EXP BRAIN RES, V131, P22, DOI 10.1007/s002219900296; Nakashima R, 2012, VIS COGN, V20, P265, DOI 10.1080/13506285.2012.658102; Bindemann M, 2010, VISION RES, V50, P2577, DOI 10.1016/j.visres.2010.08.016; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Thumser ZC, 2008, EXP BRAIN RES, V191, P419, DOI 10.1007/s00221-008-1534-2; Cecala AL, 2008, VISION RES, V48, P149, DOI 10.1016/j.visres.2007.10.029; Dunham DN, 1997, INT J PSYCHOPHYSIOL, V27, P171, DOI 10.1016/S0167-8760(97)00054-8; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Fang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121035; Fang Y., 2015, ITE T MEDIA TECHNOLO, V3, P149; FULLER JH, 1992, EXP BRAIN RES, V92, P152; Kleiner M., 2007, PERCEPTION, V36; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kubota H., 2012, P S EY TRACK RES APP, P333; Nakashima R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124367; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092284; Nakazawa M., 2014, IPSJ T COMPUTER VISI, V6, P63; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peters R. J., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383337; Smith TJ, 2013, J VISION, V13, DOI 10.1167/13.8.16; Tatler B. W., 2007, J VISION, V7, P1; Tseng PH, 2009, J VISION, V9, DOI 10.1167/9.7.4; Yarbus A.L., 1967, EYE MOVEMENTS VISION	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	DEC	2015	117						59	66		10.1016/j.visres.2015.10.001		8	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CX2WQ	WOS:000365557900008		
J	Leu, JS; Hsu, KC; Song, T				Leu, Jenq-Shiou; Hsu, Kun-Che; Song, Tian			Enhancing the Presence Service Efficiency of Internet Protocol Multimedia Subsystem-Based Web Services	WIRELESS PERSONAL COMMUNICATIONS			English	Article						Internet protocol multimedia subsystem; Next-generation network (NGN); Presence service (PS); Web service	IMS	Over the past decade, voice-over-Internet protocol technologies and multimedia services for mobile devices have become a major trend of mobile networks because of the pervasiveness of handheld devices and the increased availability of advanced cellular networks worldwide. Next-generation network solutions, such as Internet protocol multimedia subsystems (IMS), offer considerable potential for providing various multimedia services. However, current IMS users have been developed separately based on various operating systems or devices. This study adopted a web-based IMS user and deployed a gateway between IMS users and an IMS network. Users can access IMS services by employing any device equipped with a web browser which supports a web real-time communication application programming interface. Since more real-time messaging services have exploited presence services (PSs) to issue user status information, a high number of status messages are generated. Instead of using the extensible markup language (XML) format to exchange presence data in PSs, this study adopted JavaScript object notation (JSON), which has a more compact and lightweight format for reducing the message volume and delay. This study evaluated the system performance based on XML and JSON data formats under realistic conditions. The results show that adopting JSON can effectively reduce the message volume and delay by approximately 40 and 54 %, respectively.	[Leu, Jenq-Shiou; Hsu, Kun-Che] Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan; [Song, Tian] Univ Tokushima, Dept Elect & Elect Engn, Tokushima 770, Japan	Leu, JS (reprint author), Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan.	jsleu@mail.ntust.edu.tw; M10102111@mail.ntust.edu.tw			Ministry of Science and Technology, Taiwan [MOST-103-2221-E-011-112]	The authors gratefully acknowledge the support by the Ministry of Science and Technology, Taiwan, under grant MOST-103-2221-E-011-112.	Islam S, 2013, IEEE NETWORK, V27, P37, DOI 10.1109/MNET.2013.6423190; Bellavista P, 2009, IEEE WIREL COMMUN, V16, P16, DOI 10.1109/MWC.2009.5109460; Loreto S, 2012, IEEE INTERNET COMPUT, V16, P68, DOI 10.1109/MIC.2012.115; Foschini L, 2011, IEEE COMMUN MAG, V49, P50, DOI 10.1109/MCOM.2011.6069709; Singh K, 2013, IEEE COMMUN MAG, V51, P28, DOI 10.1109/MCOM.2013.6495757; El Barachi M, 2013, 2013 IEEE CONSUMER COMMUNICATIONS AND NETWORKING CONFERENCE (CCNC), P892, DOI 10.1109/CCNC.2013.6488580; Calhoun P., 2003, 3588 IETF RFC; Camarillo G., 2006, 3G IP MULTIMEDIA SUB; Nurseitov N, 2009, CAINE, V2009, P157	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0929-6212	1572-834X		WIRELESS PERS COMMUN	Wirel. Pers. Commun.	DEC	2015	85	4					2319	2331		10.1007/s11277-015-2907-z		13	Telecommunications	Telecommunications	CX5GL	WOS:000365730000038		
J	Honna, N				Honna, Nobuyuki			world and sociolinguistics	WORLD ENGLISHES			English	Book Review									[Honna, Nobuyuki] Aoyama Gakuin Univ, Tokyo 1508366, Japan	Honna, N (reprint author), Aoyama Gakuin Univ, 4-4-25 Shibuya Ku, Tokyo 1508366, Japan.	n-honna@jcom.home.ne.jp					INOUE I, 2013, WORLD SOCIOLINGUISTI	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0883-2919	1467-971X		WORLD ENGLISH	World Englishes	DEC	2015	34	4					708	710		10.1111/weng.12181		3	Linguistics; Language & Linguistics	Linguistics	CX1BA	WOS:000365430000011		
J	Kohjimoto, Y; Hagino, K; Ogawa, T; Inagaki, T; Kitamura, S; Nishihata, M; Iba, A; Matsumura, N; Hara, I				Kohjimoto, Yasuo; Hagino, Keizo; Ogawa, Takatoshi; Inagaki, Takeshi; Kitamura, Shinji; Nishihata, Masaya; Iba, Akinori; Matsumura, Nagahide; Hara, Isao			Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial	WORLD JOURNAL OF UROLOGY			English	Article						Ureteral stone; Medical expulsive therapy; Naftopidil; alpha-Blockers	PLACEBO-CONTROLLED TRIAL; TAMSULOSIN; EFFICACY; METAANALYSIS; MANAGEMENT; FACILITATE; ANTAGONIST; PASSAGE	A multicenter, double-blind, randomized, controlled trial was conducted to determine the efficacy of naftopidil as medical expulsive therapy (MET) for patients with distal ureteral stones. Ninety-two patients presenting with a single distal ureteral stone a parts per thousand currency sign10 mm were randomly assigned to receive either naftopidil (75 mg of naftopidil once in the morning and placebo twice a day) or flopropione (80 mg three times a day). The primary end point was time to stone expulsion calculated by the Kaplan-Meier method. Secondary end points were the percentages of patients who required analgesics, hospital admission, and surgery, the number of working days lost to the disease, and treatment safety. Overall, three patients were excluded from the final analysis. No significant differences were noted in age, stone size, and stone side between the treatment arms. The median time to stone expulsion was 8 days [95 % confidence interval (CI), 3-16] for the naftopidil group, and this was significantly less than the 18 days (95 % CI, 11 to not reached) for the flopropione group (p = 0.03). On multivariate Cox regression analysis, the hazard of expulsion was 1.8-fold higher for the naftopidil group than for the flopropione group after adjustment for age, sex, stone side, and stone size. No significant differences were noted in the secondary end points. The administration of naftopidil significantly improved time to stone expulsion in patients with distal ureteral stones a parts per thousand currency sign10 mm. We believe that this is the first multicenter, double-blind, randomized, controlled trial demonstrating the efficacy of naftopidil for MET.	[Kohjimoto, Yasuo; Iba, Akinori; Matsumura, Nagahide; Hara, Isao] Wakayama Med Univ, Dept Urol, Wakayama 6418509, Japan; [Hagino, Keizo] Rinku Gen Med Ctr, Dept Urol, Osaka, Japan; [Ogawa, Takatoshi] Kainan Iryou Ctr, Dept Urol, Wakayama, Japan; [Inagaki, Takeshi] Kinan Hosp, Dept Urol, Wakayama, Japan; [Kitamura, Shinji] Kitamura Urol & Internal Clin, Wakayama, Japan; [Nishihata, Masaya] Kishiwada Tokushukai Hosp, Dept Urol, Osaka, Japan	Kohjimoto, Y (reprint author), Wakayama Med Univ, Dept Urol, 811-1 Kimiidera, Wakayama 6418509, Japan.	ykohji@wakayama-med.ac.jp					Parsons JK, 2007, J UROLOGY, V177, P983, DOI 10.1016/j.juro.2006.10.023; Zhou SG, 2011, WORLD J UROL, V29, P767, DOI 10.1007/s00345-011-0739-3; Itoh Y, 2007, INT J UROL, V14, P749, DOI 10.1111/j.1442-2042.2007.01812.x; Vincendeau S, 2010, ARCH INTERN MED, V170, P2021, DOI 10.1001/archinternmed.2010.447; Hollingsworth JM, 2006, LANCET, V368, P1171, DOI 10.1016/S0140-6736(06)69474-9; Abdel-Meguid TA, 2010, CAN J UROL, V17, P5178; Lu JL, 2012, UROL RES, V40, P757, DOI 10.1007/s00240-012-0498-7; Lu ZP, 2012, UROL INT, V89, P107, DOI 10.1159/000338909; Kaneko T, 2010, INT J UROL, V17, P462, DOI 10.1111/j.1442-2042.2010.02499.x; Hermanns T, 2009, EUR UROL, V56, P407, DOI 10.1016/j.eururo.2009.03.076; Ohgaki K, 2010, SCAND J UROL NEPHROL, V44, P420, DOI 10.3109/00365599.2010.497769; Takei R, 1999, JPN J PHARMACOL, V79, P447, DOI 10.1254/jjp.79.447; FERNBACH SK, 1993, PEDIATR RADIOL, V23, P478, DOI 10.1007/BF02012459; Sun XH, 2009, J UROLOGY, V181, P1716, DOI 10.1016/j.juro.2008.11.118; Al-Ansari A, 2010, UROLOGY, V75, P4, DOI 10.1016/j.urology.2009.09.073; Fan B, 2013, INT J UROL, V20, P818, DOI 10.1111/iju.12048; Ferre RM, 2009, ANN EMERG MED, V54, P432, DOI 10.1016/j.annemergmed.2008.12.026; Seitz C, 2009, EUR UROL, V56, P455, DOI 10.1016/j.eururo.2009.06.012; Kumar Santosh, 2013, Korean J Urol, V54, P311, DOI 10.4111/kju.2013.54.5.311; MALIN J M JR, 1970, British Journal of Urology, V42, P171, DOI 10.1111/j.1464-410X.1970.tb10018.x; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Ohkawa M, 1977, HINYOKIKA KIYO, V23, P403	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	DEC	2015	33	12					2125	2129		10.1007/s00345-015-1556-x		5	Urology & Nephrology	Urology & Nephrology	CX1ZK	WOS:000365494300029		
J	Suzuki, T				Suzuki, Tsutomu			Treatment of Cancer Pain and Medical Narcotics	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						cancer pain; narcotics; morphine; psychological dependence	UNRESECTABLE PANCREATIC-CANCER; ENDOGENOUS BETA-ENDORPHIN; INDUCED PLACE PREFERENCE; VENTRAL TEGMENTAL AREA; KAPPA-OPIOID SYSTEM; NEUROPATHIC PAIN; MORPHINE; SUPPRESSION; INVOLVEMENT; ACTIVATION	The World Health Organization has reported that when morphine is used to control pain in cancer patients, psychological dependence is not a major concern. Our studies were undertaken to ascertain the modulation of psychological dependence on morphine under a chronic pain-like state in rats. Morphine induced a dose-dependent place preference. We found that inflammatory and neuropathic pain-like states significantly suppressed the morphine-induced rewarding effect. In an inflammatory pain-like state, the suppressive effect was significantly recovered by treatment with a k-opioid receptor antagonist. In addition, in vivo microdialysis studies clearly showed that the morphine-induced increase in the extracellular levels of dopamine (DA) in the nucleus accumbens (N.Acc.) was significantly decreased in rats pretreated with formalin. This effect was in turn reversed by the microinjection of a specific dynorphin A antibody into the N.Acc. These findings suggest that the inflammatory pain-like state may have caused the sustained activation of the k-opioidergic system within the N.Acc., resulting in suppression of the morphine-induced rewarding effect in rats. On the other hand, we found that attenuation of the morphine-induced place preference under neuropathic pain may result from a decrease in the morphine-induced DA release in the N.Acc with a reduction in the mu-opioid receptor-mediated G-protein activation in the ventral tegmental area (VTA). Moreover, nerve injury results in the continuous release of endogenous beta-endorphin to cause the dysfunction of mu-opioid receptors in the VTA. This paper also provides a review to clarify misunderstandings of opioid analgesic use to control pain in cancer patients.	[Suzuki, Tsutomu] Hoshi Univ, Dept Toxicol, Shinagawa Ku, Tokyo 1428501, Japan	Suzuki, T (reprint author), Hoshi Univ, Dept Toxicol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	suzuki@hoshi.ac.jp					Narita M, 2001, PHARMACOL THERAPEUT, V89, P1, DOI 10.1016/S0163-7258(00)00099-1; Ozaki S, 2002, J NEUROCHEM, V82, P1192, DOI 10.1046/j.1471-4159.2002.01071.x; Narita M, 2005, NEUROPSYCHOPHARMACOL, V30, P111, DOI 10.1038/sj.npp.1300527; Niikura K, 2010, TRENDS PHARMACOL SCI, V31, P299, DOI 10.1016/j.tips.2010.04.003; Martin TJ, 2007, ANESTHESIOLOGY, V106, P312, DOI 10.1097/00000542-200702000-00020; SHIR Y, 1990, NEUROSCI LETT, V115, P62, DOI 10.1016/0304-3940(90)90518-E; SUZUKI T, 1990, PSYCHOPHARMACOLOGY, V102, P438, DOI 10.1007/BF02247122; Suzuki T, 1998, LIFE SCI, V64, pPL1, DOI 10.1016/S0024-3205(98)00537-2; Wong GY, 2004, JAMA-J AM MED ASSOC, V291, P1092, DOI 10.1001/jama.291.9.1092; Duthey B, 2014, J PAIN SYMPTOM MANAG, V47, P283, DOI 10.1016/j.jpainsymman.2013.03.015; Suzuki T, 1996, LIFE SCI, V59, P1667, DOI 10.1016/0024-3205(96)00498-5; Ozaki S, 2003, NEUROSCIENCE, V116, P89, DOI 10.1016/S0306-4522(02)00699-1; SUZUKI T, 1991, EUR J PHARMACOL, V205, P85; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Niikura K, 2008, NEUROSCI LETT, V433, P54, DOI 10.1016/j.neulet.2007.12.042; Ozaki S, 2004, J NEUROCHEM, V88, P1389, DOI 10.1046/j.1471-4159.2003.02272.x; Niikura K, 2008, NEUROSCI LETT, V435, P257, DOI 10.1016/j.neulet.2008.02.059; FUNADA M, 1993, NEUROPHARMACOLOGY, V32, P1315; LILLEMOE KD, 1993, ANN SURG, V217, P447, DOI 10.1097/00000658-199305010-00004; Funada M., 1995, ANN PSYCHIAT, V5, P223; Japanese Society for Palliative Medicine, 2014, CLIN GUID CANC PAIN, P29; Japanese Society of Pharmaceutical Palliative Care and Science, 2014, TXB PHARM PALL MED, P20; Suzuki E., 2014, PHARM MED, V32, P115; Takeda F., 1986, PAIN CLINIC, V1, P83; Wade CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079239; WHO, 1996, CANC PAIN REL; Yodogawa Christian Hospital, 2008, PALL CAR MAN; Yomiya K, 2011, CLIN PEARLS PALLIATI, P56; Yomiya K, 2013, GANTOTSUKANNWA NO KU, P1	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1325	1334				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000001		
J	Suzuki, T				Suzuki, Tokiko			Hetero-oligomerization and Functional Interaction between Purinergic Receptors Expressed in Platelets to Regulate Platelet Shape Change	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						purinergic receptor; heterooligomer; ADP; adenosine; platelet shape change	INTERNATIONAL UNION; ADENOSINE RECEPTOR; P2Y(1) RECEPTORS; A(1); PHARMACOLOGY; UPDATE; A(2A); MICE	Adenosine and its precursors, ATP and ADP, exert various physiological effects via binding to purinergic receptors. We previously used co-immunoprecipitation, bioluminescence resonance energy transfer (BRET) and immunoelectron microscopy to demonstrate the hetero-oligomerization of purinergic receptor subtypes. Furthermore, pharmacological studies found significant changes in receptor-mediated signaling in human embryonic kidney (HEK) 293T cells co-transfected with these receptors. These findings suggest that heterodimers of purinergic receptors may have distinct pharmacological profiles, possibly due to dimerization-induced conformational changes, further suggesting that heterodimerization may be employed to "fine-tune" purinergic receptor signaling. Adenosine A(2A) receptor (A(2A)R), P2Y(1) receptor (P2Y(1)R) and P2Y(12) receptor (P2Y(12)R) are predominantly expressed on human platelets. ADP activates human platelets by stimulating both P2Y(1)R and P2Y(12)R, which act sequentially and in concert to achieve complete platelet aggregation. In contrast, adenosine stimulates Gs-coupled A(2A)R, followed by activativation of adenylate cyclase, leading to an increase in intracellular cAMP levels, which potently inhibits platelet activation. We examined the hetero-oligomerization and functional interactions of A(2A)R, P2Y(1)R, and P2Y(12)R. In HEK293T cells triply expressing all three receptors, hetero-oligomerization was observed among the three receptors. Additionally, P2Y(1)R agonist-evoked Ca2+ signaling was significantly inhibited by co-treatment with an A(2A)R antagonist in HEK293T cells. In human platelets, we identified endogenous A(2A)R/P2Y(1)R and A(2A)R/P2Y(12)R heterodimers. We also observed functional Ca2+-signaling-related cross-talk similar to those found in HEK293T cells, and found that they appeared to affect platelet shape. These results collectively suggest that intermolecular signal transduction and specific conformational changes occur among components of the hetero-oligomers formed by these three receptors.	[Suzuki, Tokiko] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, Sendai, Miyagi 9808578, Japan	Suzuki, T (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	tokikosu@med.u-toyama.ac.jp					Akgün Eyup, 2013, Proc Natl Acad Sci U S A, V110, P11595, DOI 10.1073/pnas.1305461110; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Suzuki T, 2013, METHOD ENZYMOL, V521, P239, DOI 10.1016/B978-0-12-391862-8.00013-2; Nakata H, 2010, J RECEPT SIG TRANSD, V30, P337, DOI 10.3109/10799893.2010.509729; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yoshioka K, 2001, P NATL ACAD SCI USA, V98, P7617, DOI 10.1073/pnas.121587098; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Ledent C, 1997, NATURE, V388, P674; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Suzuki T, 2011, FEBS LETT, V585, P3978, DOI 10.1016/j.febslet.2011.10.050; Yoshioka K, 2002, FEBS LETT, V531, P299, DOI 10.1016/S0014-5793(02)03540-8; Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Suzuki T, 2006, BIOCHEM BIOPH RES CO, V351, P559, DOI 10.1016/j.bbrc.2006.10.075; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Goggs R, 2015, BIOCHEM J, V466, P431, DOI 10.1042/BJ20141404; Cattaneo M, 2001, HAEMATOLOGICA, V86, P346; Yoshioka K, 2002, FEBS LETT, V523, P147, DOI 10.1016/S0014-5793(02)02965-4; Namba Kazunori, 2010, BMC Res Notes, V3, P323, DOI 10.1186/1756-0500-3-323	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1335	1340				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000002		
J	Minami, A				Minami, Akira			Multidimensional Analysis of Hippocampal Excitatory Neurotransmission and Development of Analytical Tools for Glycans	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						sialidase; histochemical imaging probe; hippocampus; memory; BTP3-Neu5Ac; BTP4-Neu5Ac	CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; POLYSIALIC ACID; SIALIDASE ACTIVITY; GANGLIOSIDE SIALIDASE; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; NEURAMINIDASE ACTIVITY; MAMMALIAN SIALIDASES; EXPRESSION PATTERNS	Sialidase removes sialic acid residues from sialoglycoconjugates such as glycoproteins and glycolipids. Since sialic acid plays crucial roles in synaptic plasticity and memory in the hippocampus, the regulation of sialyl signaling by sialidase is also necessary for neural functions. However, since mammalian sialidase activity is remarkably weak, it has been difficult to detect sialidase activity in mammalian tissues. Determination of the distribution of sialidase activity in living mammalian tissues would provide much valuable information for understanding the roles of sialidase in physiological functions. Therefore, we synthesized a novel benzothiazolylphenol-based sialic acid derivative (BTP-Neu5Ac) as a fluorescent sialidase substrate. After cleavage of BTP-Neu5Ac, which is water soluble and shows little fluorescence, with sialidase, the water-insoluble fluorophore benzothiazolylphenol (BTP) released from BTP-Neu5Ac stains tissue and shows bright fluorescence. BTP-Neu5Ac can visualize sialidase activity in brain tissue with high levels of sensitivity and specificity. The sialidase expression level is markedly high in various human cancers such as colon, renal, prostate, and ovarian cancers. BTP-Neu5Ac can detect human colon cancers sensitively. Thus, BTP-Neu5Ac is useful not only for physiological research but also as a cancer probe. BTP-Neu5Ac is now being used in virology research. In this review, methods for histochemical imaging of sialidase activity and the role of sialidase in hippocampal memory are described based on the author's study of multidimensional analysis of hippocampal excitatory neurotransmission and development of analytical tools for glycans, which was awarded a prize by the Tokai branch of the Pharmaceutical Society of Japan.	[Minami, Akira] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, Shizuoka 4228526, Japan	Minami, A (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	aminami@u-shizuoka-ken.ac.jp					MIYAGI T, 1984, EUR J BIOCHEM, V141, P75, DOI 10.1111/j.1432-1033.1984.tb08159.x; Ha KT, 2004, MOL CELLS, V17, P267; Isaeva E, 2011, PHARMACOL REP, V63, P840; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Boyzo A, 2003, BRAIN RES, V964, P211, DOI 10.1016/S0006-8993(02)03985-9; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; RAMIREZ OA, 1990, BRAIN RES, V506, P291, DOI 10.1016/0006-8993(90)91264-H; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Hoffman KB, 1997, BRAIN RES, V753, P309, DOI 10.1016/S0006-8993(96)01468-0; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Takahashi T, 2014, J VIROL METHODS, V209, P136, DOI 10.1016/j.jviromet.2014.09.010; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Miyagi T, 2012, ADV EXP MED BIOL, V749, P257, DOI 10.1007/978-1-4614-3381-1_17; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Nomura H, 2006, ONCOL RES, V16, P289; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Saito M, 2002, HISTOCHEM CELL BIOL, V117, P453, DOI 10.1007/s00418-002-0399-x; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Rodriguez JA, 2001, J NEUROSCI, V21, P8387; Isaeva E, 2010, EUR J NEUROSCI, V32, P1889, DOI 10.1111/j.1460-9568.2010.07468.x; Fujii I, 1993, Bioorg Med Chem, V1, P147, DOI 10.1016/S0968-0896(00)82112-4; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Otsubo T, 2013, BIOORG MED CHEM LETT, V23, P2245, DOI 10.1016/j.bmcl.2013.01.043; Seki T, 1998, J NEUROSCI, V18, P3757; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Furuse H, 1998, EXP BRAIN RES, V123, P307, DOI 10.1007/s002210050573; CORFIELD AP, 1981, BIOCHEM J, V197, P293; SEKI T, 1993, J NEUROSCI, V13, P2351; Jung WR, 2008, NEUROSCI LETT, V439, P220, DOI 10.1016/j.neulet.2008.05.020; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Fukushima K, 2015, FEBS LETT, V589, P1278, DOI 10.1016/j.febslet.2015.03.036; WIERASZKO A, 1985, BRAIN RES, V345, P159, DOI 10.1016/0006-8993(85)90847-9; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Takano M, 2014, VIROLOGY, V464, P206, DOI 10.1016/j.virol.2014.04.005; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Bonten EJ, 2009, J BIOL CHEM, V284, P28430, DOI 10.1074/jbc.M109.031419; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kurebayashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04877; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Taguchi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131061; Takahashi T, 2014, BIOL PHARM BULL, V37, P1668	53	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1341	1348				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000003		
J	Shimizu, K				Shimizu, Kahori			Development and Characterization of a Novel Adenovirus Vector Exhibiting MicroRNA-mediated Suppression of the Leaky Expression of Adenovirus Genes	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						adenovirus vector; leaky expression; microRNA; gene therapy; hepatotoxicity	TRANSGENE EXPRESSION; THERAPY; MICE; E1; REPLICATION; PROTEINS; MOUSE; E2A	Replication-incompetent adenovirus (Ad) vectors have gained attention as gene delivery vehicles. Theoretically, no Ad genes should be expressed following transduction; however, Ad genes are expressed from the vector genome, leading to induction of cellular immunity against Ad proteins and Ad protein-induced toxicity. To suppress the leaky expression of Ad genes, a microRNA (miRNA) -regulated gene expression system was utilized. We developed novel Ad vectors by incorporating targeted sequences of miR-122a or miR-142-3p, which exhibit liver- or spleen-specific expression, respectively, in the 3'-untranslated region (UTR) of the E2A, E4, or pIX genes. These Ad vectors easily grew to high titers comparable to those of a conventional Ad vector in conventional human embryonic kidney 293 cells. The leaky expression of these Ad genes in mouse organs was significantly suppressed by 2- to 100-fold in an miRNA-dependent manner, compared with a conventional Ad vector, by the insertion of the miRNA-targeted sequences. Notably, the Ad vector carrying the miR-122a-targeted sequences into the 3'-UTR of the E4 gene (Ad-E4-122aT) expressed 1.5- to 34-fold higher and longer-term transgene expression and more than 20-fold lower levels of all the Ad early and late genes examined in the liver compared with a conventional Ad vector. miR-122a-mediated suppression of E4 gene expression in the liver significantly reduced the hepatotoxicity that an Ad vector causes via both adaptive and non-adaptive immune responses. Ad-E4-122aT would be a promising framework for efficient gene delivery due to its ability to mediate higher and longer-term transgene expression and lower hepatotoxicity than a conventional Ad vector.	[Shimizu, Kahori] Osaka Ohtani Univ, Fac Pharm, Biochem Lab, Tondabayashi, Osaka 5848540, Japan	Shimizu, K (reprint author), Osaka Ohtani Univ, Fac Pharm, Biochem Lab, 3-11-1 Nishikiori Kita, Tondabayashi, Osaka 5848540, Japan.	simizukaho@osaka-ohtani.ac.jp					Gao GP, 1996, J VIROL, V70, P8934; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Weitzman MD, 2005, FRONT BIOSCI, V10, P1106, DOI 10.2741/1604; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Dedieu JF, 1997, J VIROL, V71, P4626; O'Connor RJ, 2000, J VIROL, V74, P5819, DOI 10.1128/JVI.74.13.5819-5824.2000; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Armentano D, 1997, J VIROL, V71, P2408; Tauber B, 2001, GENE, V278, P1, DOI 10.1016/S0378-1119(01)00722-3; Gorziglia MI, 1996, J VIROL, V70, P4173; Shimizu K, 2011, MOL PHARMACEUT, V8, P1430, DOI 10.1021/mp200121z; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; Gorziglia MI, 1999, J VIROL, V73, P6048; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Wang Q, 1997, GENE THER, V4, P393, DOI 10.1038/sj.gt.3300404; WEINBERG DH, 1986, J VIROL, V57, P833; Vellinga J, 2005, J GEN VIROL, V86, P1581, DOI 10.1099/vir.0.80877-0; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Shimizu Kahori, 2014, Mol Ther Methods Clin Dev, V1, P14035, DOI 10.1038/mtm.2014.35	24	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1349	1356				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000004		
J	Hino, N				Hino, Nobumasa			A Method for Protein Photo-cross-linking in Living Cells Facilitating Analysis of Physiological Interactions of Proteins	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						photo-cross-linking; non-natural amino acid; expanded genetic code; protein-protein interaction	SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; MAMMALIAN-CELLS; GENETIC-CODE; ESCHERICHIA-COLI; STRUCTURAL BASIS; RECEPTOR; BINDING; SYSTEM	In living cells, most proteins form complexes with other proteins to exert their functions. Since protein functions are regulated in response to changes in the cellular environment, the components of the complexes can vary; therefore, proteins often interact in a weak and transient manner. To capture such labile protein interactions, we have developed a method for photo-cross-linking of proteins directly interacting in mammalian cells; this method involves expansion of the genetic code and site-specific incorporation of photoreactive amino acids into proteins. Upon cross-linking, protein complexes are stabilized by a covalent bond and can be readily isolated from cell extracts without the problems usually associated with simple affinity purification methods such as co-immunoprecipitation. Photo-cross-linkers have another benefit: they react exclusively with molecules within a range defined by the linker length. This property becomes useful for determining the binding interface of two proteins because the linkers can be introduced in a site-directed manner with our method. In this review, we first describe the expansion of the genetic code of mammalian cells for the incorporation of non-natural amino acids into proteins. Then, we introduce our recent applications and developments of the cross-linking method: identification of intracellular binding partners of the signaling protein growth factor receptor binding protein 2; analysis of the binding between membrane proteins on the cell surface; and a novel photoreactive amino acid that enables wide-ranging photo-cross-linking.	[Hino, Nobumasa] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Hino, N (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	hino@phs.osaka-u.ac.jp					Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Hino N, 2006, NAT PROTOC, V1, P2957, DOI 10.1038/nprot.2006.424; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Markham K, 2007, ANAL BIOANAL CHEM, V389, P461, DOI 10.1007/s00216-007-1385-x; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P11803, DOI 10.1073/pnas.1309584110; Shen B, 2011, STEM CELLS, V29, P1231, DOI 10.1002/stem.679; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Hino N, 2012, METHODS MOL BIOL, V794, P215, DOI 10.1007/978-1-61779-331-8_13; Janzen DM, 2004, NUCLEIC ACIDS RES, V32, P4491, DOI 10.1093/nar/gkh791; Schmied WH, 2014, J AM CHEM SOC, V136, P15577, DOI 10.1021/ja5069728; Mukai T, 2010, PROTEIN SCI, V19, P440, DOI 10.1002/pro.322; Yanagisawa T, 2012, MOL BIOSYST, V8, P1131, DOI 10.1039/c2mb05321g; Hara-Yokoyama M, 2012, STRUCTURE, V20, P1585, DOI 10.1016/j.str.2012.06.017; Kusano S, 2012, PROTEIN SCI, V21, P850, DOI 10.1002/pro.2072; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Dumas A, 2015, CHEM SCI, V6, P50, DOI 10.1039/c4sc01534g; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022	24	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1357	1363				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000005		
J	Ohtani, K; Hidaka, T; Marubashi, K; Takagi, H; Kamimura, N				Ohtani, Kazuya; Hidaka, Takashi; Marubashi, Koichi; Takagi, Hirokazu; Kamimura, Naoki			Practical Use Evaluation of Aluminum Packaging for Medicinal Products Based on Universal Design	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Universal Design; aluminum packaging; practical use evaluation; usability; pharmacist		Many pharmacists have requested optimization of aluminum packaging of medicinal products in terms of usability. To improve operational efficiency of aluminum packaging, we used Universal Design (UD) -based approach, which enables products to be used properly and consistently regardless of users. The UD-pack used in this research is composed of a film that can be easily opened and torn linear. Here, we compared the UD-pack to conventional aluminum packaging by evaluating the practical use of each under the cooperation of 24 pharmacists. Following opening and removal of contents of one sample for both types of packaging, monitors were asked which type was easier to use in each case. Also, monitors were to repeat the opening and removal of contents of five samples in a row, and were asked the same question. Monitors were recorded by digital camera to measure the time required to finish the procedure for five samples in a row. After opening one sample, approximately 83% of monitors preferred the UD-pack, and after opening five samples, all (100%) preferred the UD-pack. Regarding the time required for opening five samples and removing the contents measured by analyzing the recorded video, the UD-pack significantly reduced the time required for all monitors. The average time ratio of the UD-pack to conventional aluminum packaging was approximately 59%, and no significant difference was observed between male and female pharmacists. Our results indicate the UD-pack improves ease of opening and removal of contents and increases efficiency of dispensing in a clinical setting compared with conventional aluminum packaging.	[Ohtani, Kazuya; Hidaka, Takashi; Marubashi, Koichi; Takagi, Hirokazu] Astellas Pharma Inc, Pharmaceut Res & Technol Labs, Packaging Res, Yaizu, Shizuoka 4250072, Japan; [Ohtani, Kazuya; Kamimura, Naoki] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan	Ohtani, K (reprint author), Astellas Pharma Inc, Pharmaceut Res & Technol Labs, Packaging Res, 180 Ozumi, Yaizu, Shizuoka 4250072, Japan.	kazuya.ohtani@astellas.com					Mace R., 1985, DESIGNERS W, V33, P147; Okiyama S., 1995, PLASTIC FILM; Sakurai S., 2005, IYAKUHINHOUSOU NI KA, P137; Sawada S., 2013, JPI J, V5, P62; Sugihara M., 1984, IYAKUHIN NO HOUSOUSE; Takaike T., 2013, JPI J, V10, P40; Tanaka T., 1985, JPI J ADDITIONAL VOL, P42; Universal Design Kenkyu-kai, 2008, HUM ENG UN DES	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1365	1369				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000006		
J	Takaya, K; Ohtani, M; Nozawa, A; Manabe, H; Yamamura, Y; Ohno, Y; Akabane, Y; Ishii, H				Takaya, Kanami; Ohtani, Michiteru; Nozawa, Akane; Manabe, Haruka; Yamamura, Yoshikazu; Ohno, Yoshiko; Akabane, Yoshifumi; Ishii, Hiroyuki			Improvement of the Convenience of White Petrolatum	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						white petrolatum; melting point; yield value; consistency; moisturizing effect	ADHERENCE; PSORIASIS; THERAPY	White petrolatum is frequently used as an oleaginous base, but has a drawback of poor usability. In this trial, white petrolatum was prepared at a lower melting point to improve its usability. Characteristic pharmaceutical values such as melting point, yield, and consistency were compared between a conventional product and ophthalmic white petrolatum. Usability was compared by administering a survey questionnaire and evaluating the comparable moisturizing effect by conductivity in humans. The melting point and yield value of the improved product were significantly lower compared with other white petrolatum products. In the survey, the improved product was rated excellent in five criteria. On a scale of 1 to 5, the average values for the five criteria for the improved product were 4.7, while the conventional product and ophthalmic white petrolatum were rated 3.0 and 3.5, respectively. No difference in moisturizing effect was observed among all petrolatums after application, from day 1 to day 14. In conclusion, the improved white petrolatum demonstrated better usability, and the moisturizing effect was equivalent to conventional product, suggesting that the use of this improved product may lead to improved adherence.	[Takaya, Kanami; Ohtani, Michiteru; Nozawa, Akane; Manabe, Haruka; Yamamura, Yoshikazu] Tokyo Teishin Hosp, Dept Hosp Pharm, Chiyoda Ku, Tokyo 1028798, Japan; [Ohno, Yoshiko; Akabane, Yoshifumi; Ishii, Hiroyuki] Nikko Rica Corp, Chiyoda Ku, Tokyo 1010043, Japan	Takaya, K (reprint author), Tokyo Teishin Hosp, Dept Hosp Pharm, Chiyoda Ku, 2-14-23 Fujimi, Tokyo 1028798, Japan.	ktakaya@tth-japanpost.jp					Aizawa M., 1983, FRAGRANCE J, V62, P24; Feldman SR, 2007, J AM ACAD DERMATOL, V57, P81, DOI 10.1016/j.jaad.2007.04.005; Zaghloul SS, 2004, ARCH DERMATOL, V140, P408, DOI 10.1001/archderm.140.4.408; Brown KK, 2006, J AM ACAD DERMATOL, V55, P607, DOI 10.1016/j.jaad.2005.12.021; Serup J, 2006, ACTA DERM-VENEREOL, V86, P193, DOI 10.2340/00015555-0073; Hodari KT, 2006, J DERMATOL TREAT, V17, P136, DOI 10.1080/09546630600688515; Balkrishnan R, 2003, J AM ACAD DERMATOL, V49, P651, DOI 10.1067/S0190-9622(03)00912-5; Kawashima M., 2007, J JOCD, V61, P563; Kawashima M., 2007, JPN J DERMATOL, V117, P275; Nakagawa H., 2005, JPN J DERMATOL, V115, P1449; Nozawa A., 2012, JPN J DERMATOL, V122, P371; Ogita Y., 2007, JPN J PHARM HLTH CAR, V33, P613; Tagami H., 1980, JPN J DERMATOL, V90, P445; Takano M., 1981, KONNICHI NO HIFUGAIY, P172	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1371	1375				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000007		
J	Yamaguchi, T; Tanaka, M; Tanaka, A; Miyauchi, Y; Araki, H; Namba, H				Yamaguchi, Takumi; Tanaka, Mamoru; Tanaka, Akihiro; Miyauchi, Yoshirou; Araki, Hiroaki; Namba, Hiroyuki			Necessity of Disaster Medical Instructions in Pharmaceutical Education, and a Discussion of the Details of These Instructions	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						disaster medical instruction; pharmaceutical education; model core curriculum		Since the Great East Japan Earthquake, the Ministry of Health, Labour, and Welfare, municipalities, and medical organizations have made various revisions to medical systems employed at the time of a disaster. To educate pharmacists who can contribute to medical teams conducting healthcare activities at the time of disasters, there is a need to develop disaster medical instructions in pharmaceutical education. However, the "Model Core Curriculum for Pharmaceutical Education", a new curriculum, contains little disaster medical care education. In the present study, in cooperation with the Ehime Society of Hospital Pharmacists and Ehime Pharmaceutical Association, we surveyed pharmacists living in Ehime Prefecture in order to investigate their views regarding the necessity of disaster medical instructions in pharmaceutical education, and what they considered essential to be taught. Our subjects considered that there is a strong need for teaching disaster medical instruction in college. In addition, they regarded all of the 16 investigated items concerning disaster medical instruction as highly necessary. Factor analysis led to the classification of these items into "disaster medical activities performed by pharmacists" and "responses to secondary issues in affected areas". On the basis of this classification, we established specific goals. Disaster medical instructions should be taught as a part of pharmaceutical education in college. However, to develop these instructions, it is important for universities to cooperate with local pharmaceutical and hospital pharmacist associations, as it is difficult for universities to teach such instructions independently.	[Yamaguchi, Takumi; Namba, Hiroyuki] Matsuyama Univ, Ctr Clin Pharm, Matsuyama, Ehime 7908578, Japan; [Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki] Ehime Univ Hosp, Div Pharma, Toon, Ehime 7910295, Japan; [Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki] Ehime Soc Hosp Pharmacists, Toon, Ehime 7910295, Japan; [Miyauchi, Yoshirou] Ehime Pharmaceut Assoc, Matsuyama, Ehime 7900003, Japan	Yamaguchi, T (reprint author), Matsuyama Univ, Ctr Clin Pharm, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan.	tyamagu@cc.matsuyama-u.ac.jp					Nomura Ayumi, 2010, Acta Medica Nagasakiensia, V55, P41; Yamaguchi T, 2013, YAKUGAKU ZASSHI, V133, P1249; Cabinet Office Government of Japan, NANK TOR KYOD TAIS; Ehime Prefecture Department of Health and Welfare, IR KAT YOUR; Etani T., 2012, J OTOLARYNGOLOGY JAP, V115, P430; Harufuji Y., 2009, J J DISAST MED, V14, P338; Infectious Disease Surveillance Center, INFECT AGENTS SURVEI; Ishii N., 2009, J J DISAST MED, V14, P12; Itoh K., 2014, J JPN SOC EMER MED, V17, P229; Itoh K., 2013, J J DISAST MED, V18, P394; Japan Medical Associasion, 2011 JMAT NIK SAIG I; Japan Pharmaceutical Association, REP ACT GREAT E JAP; Kawai M., 2013, J J DISAST MED, V18, P69; Kawashima T., 2013, JAPANESE J INTENSIVE, V37, P173; Kondou Y., 2013, J J DISAST MED, V18, P291; Matsuda K., 2013, PSYCHIAT NEUROL JAP, V115, P520; Ministry of Health Labour and Welfare, SAIG NO AR NI KANS H; Ministry of Health Labour and Welfare, SAIG NIOK SHOK NO KY; Ministry of Health Labour and Welfare, SAIG NITS; Naito M., 2009, J J DISAST MED, V14, P338; National Center for Global Health and Medicine, SHIZ NIOK AK HOK SHI; Shinsawa K., 2014, NIIGATA MED J, V128, P323; Sugamata M., 2007, J URBAN SCI, V1, P63; The Pharmaceutical Society of Japan, MOD COR CURR PHARM E; Watanabe A., 2013, J J DISAST MED, V18, P296	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1377	1386				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000008		
J	Takano, Y; Hanya, M; Tatematsu, M; Nakamura, C; Abe, K; Fujisaki, K; Kamei, H				Takano, Yusuke; Hanya, Manako; Tatematsu, Michiko; Nakamura, Chikako; Abe, Keiko; Fujisaki, Kazuhiko; Kamei, Hiroyuki			Qualitative Research to Investigate the Needs of Pharmacists and Drug Therapy of Cancer Patients	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						cancer patient; pharmacist; grounded theory method; qualitative research; need		We performed a survey of cancer patients' needs for drug treatment and support from pharmacists during treatment and evaluated the support that cancer patients can expect from community pharmacists in the future. The patients consisted of 16 members of the Cancer Patient Association in Aichi prefecture who underwent chemotherapy. The results of a semistructured group interview were qualitatively analyzed using the grounded theory method. Patients undergoing chemotherapy had high hopes for its effectiveness but were worried about side effects and medical costs. To overcome these problems, they hoped for a decrease in the economic burden, compassionate-use system, and development of novel drugs. The patients had anxiety because the side effects of chemotherapy often caused physical and psychological damage. Despite patients' confusion, pharmacists sometimes did not give adequate explanations to them. The patients expected more from pharmacists regarding medication support and hoped for a system allowing continuous side effect monitoring and consultation without hesitation. For patients undergoing cancer chemotherapy who are confused regarding side effects, pharmacists should understand the patient explanatory model and become more involved with patients as partners in treatment.	[Takano, Yusuke; Hanya, Manako; Tatematsu, Michiko; Kamei, Hiroyuki] Meijo Univ, Fac Pharm, Tenpaku Ku, Nagoya, Aichi 4688503, Japan; [Nakamura, Chikako] Social Welf Corp Shinseikai, Takasaki, Gunma 3703347, Japan; [Abe, Keiko] Nagoya Univ Hosp, Nursing Career Support Off, Showa Ku, Nagoya, Aichi 4668600, Japan; [Fujisaki, Kazuhiko] Gifu Univ, Med Educ Dev Ctr, Gifu 5011194, Japan	Hanya, M (reprint author), Meijo Univ, Fac Pharm, Tenpaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	manako@meijo-u.ac.jp					Amioka K, 2004, YAKKYOKU, V55, P1551; [Anonymous], 2013, IDONONIPPON, V72, P26; Ishimoto K, 2004, YAKUGAKU ZASSHI, V124, P149, DOI 10.1248/yakushi.124.149; Takagi M, 2011, YAKUGAKU ZASSHI, V131, P45, DOI 10.1248/yakushi.131.45; Kawaguchi T, 2012, BIOL PHARM BULL, V35, P59; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Bond C, 2010, CONCORDANCE PARTNERS, P11; Editorial Department, 2010, PHARM MONTHLY, V52, P1670; Editorial Department, 2008, IDONONIPPON, V67, P174; Fujii T., 2010, J JPN SOC HOSP PHARM, V46, P1377; Fujisaki K, 2006, PHARM MONTHLY, V48, P501; Harikae H., 2008, JPN J PHARM HLTH CAR, V34, P156; Hayakawa M, 2014, PHARM MONTHLY, V56, P892; Horii N., 2009, JAPANESE J OCCUPATIO, V57, P118; Hosaka T., 2001, YAKKYOKU, V52, P2033; Imamura M., 2015, JPN J PHARM HLTH CAR, V41, P254; Kikuchi M., 2013, PHARM MONTHLY, V55, P2185; Koinuma N., 2007, GERIATRIC MED, V45, P577; Kubota K., 2007, J JPN SOC HOSP PHARM, V43, P387; Machida I., 2003, JAPANESE J PALLIATIV, V5, P284; Machida I, 2006, PHARM MONTHLY, V48, P507; Matsuda Y., 2013, PHARM MONTHLY, V55, P2162; Ministry of Health, 2012, VIT STAT; Miura A., 2009, MIE NURSING J, V11, P53; Nakano S, 2005, J THERPAY, V87, P1579; Saiki-Craighill S, 2013, SHITSUTEKIKENKYUHOU, P2; Takase H, 2008, GANKANJA NO KOKORO N, P1; Tatematsu M., 2014, JPN J PHARM PALLIAT, V7, P13; Yamada Y., 2009, CANC BOARD NYUGAN, V2, P139	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1387	1395				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000009		
J	Yajima, R; Imaoka, F; Wako, T; Kuroda, Y; Matsumoto, K; Kizu, J; Katayama, S				Yajima, Ryo; Imaoka, Futa; Wako, Tetsuya; Kuroda, Yuko; Matsumoto, Kazuaki; Kizu, Junko; Katayama, Shiro			Basic Studies on the Stability of Flavored Oral Solutions of Rebamipide	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						stomatitis; rebamipide; flavor; sodium alginate; stability	RATS	Stomatitis frequently occurs during chemotherapy and radiotherapy for cancer. Because of its pharmacological properties including anti-inflammatory activity and stimulatory effects on endogenous prostaglandin synthesis, rebamipide has been suggested as a potentially effective treatment against stomatitis. In the present study we tested the stability of oral rebamipide solutions prepared in our hospital pharmacy using sodium alginate as a thickener to increase retention of this agent in the oral cavity, and the addition of different flavoring mixtures intended for use in enteral diets to reduce the bitterness of rebamipide and sodium alginate. Samples of oral rebamipide solution prepared with 13 kinds of flavoring and sodium alginate were evaluated in terms of their appearance, redispersibility, pH, viscosity, and rebamipide content immediately after preparation and 1, 3, 7, and 10 days after storage at room temperature under ambient light or in a cool, dark place. After 10 days of storage, favorable stability was observed in four sample solutions supplemented with green apple, pineapple, yogurt, and tomato flavoring mixtures intended for use in Elental (R) diets. These oral solutions may have potential clinical application.	[Yajima, Ryo; Wako, Tetsuya; Katayama, Shiro] Nippon Med Coll Hosp, Sect Pharmaceut Serv, Bunkyo Ku, Tokyo 1138603, Japan; [Yajima, Ryo; Imaoka, Futa; Kuroda, Yuko; Matsumoto, Kazuaki; Kizu, Junko] Keio Univ, Fac Pharm, Div Pract Pharm, Minato Ku, Tokyo 1058512, Japan	Yajima, R (reprint author), Nippon Med Coll Hosp, Sect Pharmaceut Serv, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	r-yajima@nms.ac.jp					KLEINE A, 1993, DIGEST DIS SCI, V38, P1441, DOI 10.1007/BF01308601; Ukeda H, 1996, J JPN SOC FOOD SCI, V43, P569; OGINO K, 1992, EUR J PHARMACOL, V212, P9, DOI 10.1016/0014-2999(92)90065-C; Daigo K., 1983, JPN PHARMACOL THER, V11, P401; Hanawa T., 2012, PHARM MONTHLY, V54, P141; Kabeya M., 2011, JPN J CANC CHEMOTHER, V38, P1133; Kawai M., 1993, J CHEM SOC JAPAN CHE, V1993, P1184; Kohri Naonori, 2001, Yakuzaigaku, V61, P34; Miyajima C., 2009, SEN-I GAKKAISHI, V65, P444; Nabeta I., 2010, J JPN SOC HOSP PHARM, V46, P1629; Suda N., 2005, JPN J PHARM HLTH CAR, V31, P355; Sugawa R., 2012, J JPN SOC HOSP PHARM, V48, P1217; Sugisaki T., 2011, JPN J CANC CHEMOTHER, V38, P783; Takano R., 2009, JPN J PHARM HLTH CAR, V35, P247; Wako Y., 1990, B LAB FOOD TECHNOLOG, V1, P8; Yasuda T., 2011, J ORAL MAXILLOFAC RE, V2, pe3	16	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1397	1402				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000010		
J	Inose, R; Takahashi, K; Nishikawa, T; Nagayama, K				Inose, Ryo; Takahashi, Katsuyuki; Nishikawa, Takeshi; Nagayama, Katsuya			Analysis of Factors Influencing the Development of Hypomagnesemia in Patients Receiving Cetuximab Therapy for Head and Neck Cancer	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						cetuximab; hypomagnesemia; cisplatin; head and neck cancer	SQUAMOUS-CELL CARCINOMA; CHEMOTHERAPY PLUS CETUXIMAB; PHASE-II; JAPANESE PATIENTS; RADIOTHERAPY	Cetuximab was approved in Japan as the only clinically available molecular targeted drug for the treatment of head and neck cancer. Hypomagnesemia associated with cetuximab is considered one of the most serious adverse events. However, the factors influencing the development of hypomagnesemia are not clear, although the drug was previously approved for the treatment of patients with colorectal cancer. Thus, we studied the factors involved in the development of hypomagnesemia in patients receiving cetuximab therapy for head and neck cancer. Patients' background data and laboratory values before starting cetuximab therapy did not affect the development of hypomagnesemia. Among patients who had never been treated with cisplatin (NT group), 36.4% developed hypomagnesemia. In contrast, all patients who had previously been treated with cisplatin (T group) developed hypomagnesemia (p=0.034). Magnesium is reabsorbed by transient receptor potential subfamily melastatin 6 (TRPM6) in the distal convoluted tubule. The expression level of TRPM6 is controlled by the epidermal growth factor (EGF) pathway. Cetuximab is an EGF receptor inhibitor and reduces the expression of TRPM6. Additionally, recent studies have shown that the expression of TRPM6 is reduced by cisplatin. Therefore, we considered that the serum magnesium level was cumulatively reduced by cetuximab and cisplatin. In conclusion, the T group was more likely to develop hypomagnesemia than the NT group, and therefore the serum magnesium level in the T group requires careful monitoring so that magnesium supplementation can be provided to patients when the level decreases.	[Inose, Ryo; Takahashi, Katsuyuki; Nishikawa, Takeshi; Nagayama, Katsuya] Osaka City Univ Hosp, Dept Pharm, Abeno Ku, Osaka 5450051, Japan	Takahashi, K (reprint author), Osaka City Univ Hosp, Dept Pharm, Abeno Ku, 1-5-7 Asahi Machi, Osaka 5450051, Japan.	k.taka@med.osaka-cu.ac.jp					Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Okano S, 2013, JPN J CLIN ONCOL, V43, P476, DOI 10.1093/jjco/hyt030; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Yoshino T, 2013, JPN J CLIN ONCOL, V43, P524, DOI 10.1093/jjco/hyt034; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Bonner J.A., 2000, J CLIN ONCOL, V18, P47; Demizu M., 2013, JPN J CANC CHEMOTHER, V40, P897; Hashizume N., 1997, JAPANESE SOC INTERNA, V86, P1857; Ikari Akira, 2013, Seikagaku, V85, P574; Japanese Society of Medical Oncology, 2012, SHINR, P336; Ledeganck KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057016; Nakamoto E., 2011, JPN J PHARM HLTH CAR, V37, P403	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2015	135	12					1403	1407				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CX4UE	WOS:000365695000011		
J	Doi, T				Doi, Toshiyuki			Poiseuille flow and thermal transpiration of a rarefied gas between parallel plates II: effect of nonuniform surface properties in the longitudinal direction	ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK			English	Article						Boltzmann equation; Rarefied gas flow; Channel flow; Accommodation coefficient	BOLTZMANN-EQUATION; KINETIC-THEORY; CREEP	Poiseuille flow and thermal transpiration of a rarefied gas between two parallel plates are studied for the situation that one of the walls is a Maxwell-type boundary with a periodic distribution of the accommodation coefficient in the longitudinal direction. The flow behavior is studied numerically based on the Bhatnager-Gross-Krook-Welander model of the Boltzmann equation. The solution is sought in a superposition of a linear and a periodic functions in the longitudinal coordinate. The numerical solution is provided over a wide range of the mean free path and the parameters characterizing the distribution of the accommodation coefficient. Due to the nonuniform surface properties in the longitudinal direction, the flow is nonparallel, and a deviation in the pressure and the temperature of the gas from those of the conventional parallel flow is observed. An energy transfer between the gas and the walls arises. The mass flow rate of the gas is approximated by a formula consisting of the data of one-dimensional flows; however, a non-negligible disagreement is observed in Poiseuille flow when the amplitude of the variation of the accommodation coefficient is sufficiently large. The validity of the present approach is confirmed by a direct numerical analysis of a flow through a long channel.	[Doi, Toshiyuki] Tottori Univ, Grad Sch Engn, Dept Appl Math & Phys, Tottori 6808552, Japan	Doi, T (reprint author), Tottori Univ, Grad Sch Engn, Dept Appl Math & Phys, Tottori 6808552, Japan.	doi@damp.tottori-u.ac.jp					Abramowitz M, 1965, HDB MATH FUNCTIONS; KANKI T, 1973, PHYS FLUIDS, V16, P594, DOI 10.1063/1.1694393; Kosuge S, 2008, EUR J MECH B-FLUID, V27, P444, DOI 10.1016/j.euromechflu.2007.08.002; NIIMI H, 1971, J PHYS SOC JPN, V30, P572, DOI 10.1143/JPSJ.30.572; CHU CK, 1965, PHYS FLUIDS, V8, P12, DOI 10.1063/1.1761077; Sharipov F, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3156011; Doi T, 2015, J FLUID ENG-T ASME, V137, DOI 10.1115/1.4030490; Doi T, 2015, Z ANGEW MATH PHYS, V66, P1805, DOI 10.1007/s00033-014-0454-1; Chen CC, 2007, COMMUN PUR APPL MATH, V60, P147, DOI 10.1002/cpa.20167; Takata S, 2011, J FLUID MECH, V669, P242, DOI 10.1017/S0022112010005021; Sharipov F, 2008, MICROFLUID NANOFLUID, V4, P363, DOI 10.1007/s10404-007-0185-0; [Anonymous], 2013, U.S. Patent, Patent No. [20130017413 A1, 20130017413]; Doi T, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4002441; Doi T, 2012, VACUUM, V86, P1541, DOI 10.1016/j.vacuum.2012.02.034; LOYALKA SK, 1971, J CHEM PHYS, V55, P4497, DOI 10.1063/1.1676780; BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511; Sharipov F, 2002, EUR J MECH B-FLUID, V21, P113, DOI 10.1016/S0997-7546(01)01160-8; CERCIGNANI C, 1963, J APPL PHYS, V34, P3509, DOI 10.1063/1.1729249; Sharipov F, 1998, J PHYS CHEM REF DATA, V27, P657; Doi T, 2010, Z ANGEW MATH PHYS, V61, P811, DOI 10.1007/s00033-009-0055-6; WELANDER P, 1954, ARK FYS, V7, P507; Veijola T, 1998, SENSOR ACTUAT A-PHYS, V66, P83, DOI 10.1016/S0924-4247(97)01732-9; Doi T, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4026926; Cercignani C, 2004, PHYS FLUIDS, V16, P3426, DOI 10.1063/1.1764700; LOYALKA SK, 1974, PHYS FLUIDS, V17, P1053, DOI 10.1063/1.1694820; Scherer CS, 2009, Z ANGEW MATH PHYS, V60, P70, DOI 10.1007/s00033-008-7084-4; LOYALKA SK, 1975, J CHEM PHYS, V63, P4054, DOI 10.1063/1.431847; Cercignani C, 2004, TRANSPORT THEOR STAT, V33, P545, DOI 10.1081/TT-200053939; Doi T, 2012, Z ANGEW MATH PHYS, V63, P1091, DOI 10.1007/s00033-012-0213-0; Doi T, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/6/065503; Cercignani C., 2006, SLOW RAREFIED FLOWS; Cercignani C., 1963, RAREFIED GAS DYN, VII, P92; Hardt S., 2014, B AM PHYS SOC, V59, P444; CERCIGNA.C, 1971, TRANSPORT THEOR STAT, V1, P101, DOI 10.1080/00411457108231440; OHWADA T, 1989, PHYS FLUIDS A-FLUID, V1, P2042, DOI 10.1063/1.857478; Sone Y., 2007, MOL GAS DYNAMICS; Sone Y., 1990, J VAC SOC JPN, V33, P92	37	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0044-2275	1420-9039		Z ANGEW MATH PHYS	Z. Angew. Math. Phys.	DEC	2015	66	6					3405	3423		10.1007/s00033-015-0580-4		19	Mathematics, Applied	Mathematics	CX5MT	WOS:000365746800025		
J	Tanemura, M; Matsumoto, T				Tanemura, Masaharu; Matsumoto, Takeo			Density of the p2gg-4c1 packing of ellipses (II)	ZEITSCHRIFT FUR KRISTALLOGRAPHIE-CRYSTALLINE MATERIALS			English	Article						p2gg-2a2; p2gg-4c1; packing of ellipses; reduce; simultaneous nonlinear equations		As the second paper of the series, the first of which was published in 1997 (M. Tanemura, T. Matsumoto, Density of the p2gg-4c1 packing of ellipses (I). Z. Kristallogr. 1997, 212, 637), the p2gg-4c1(b) packing of identical ellipses where four ellipses are included in the rectangular unit cell and where every ellipse has six contacting neighbors, is discussed. It is shown here that the p2gg-4c1( b) packing of ellipses does not exceed the maximum density rho = pi / root 12 through numerical computations and series expansions. It is also shown that the p2gg-2a2 packing of ellipses has the similar properties and that it is considered as a special case of p2gg-4c1(b) packing. The method of computing the density for every parameter values of aspect ratio and tilt angle is given.	[Tanemura, Masaharu] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Matsumoto, Takeo] Kanazawa Univ, Dept Earth Sci, Fac Sci, Kanazawa, Ishikawa 9201192, Japan	Tanemura, M (reprint author), Inst Stat Math, Midori Cho 10-3, Tachikawa, Tokyo 1908562, Japan.	tanemura@ism.ac.jp					Delaney G, 2005, PHIL MAG LETT, V85, P89, DOI 10.1080/09500830500080763; Tanemura M, 1997, Z KRISTALLOGR, V212, P637, DOI 10.1524/zkri.1997.212.9.637; MATSUMOTO T, 1995, Z KRISTALLOGR, V210, P585, DOI 10.1524/zkri.1995.210.8.585; TANEMURA M, 1992, Z KRISTALLOGR, V198, P89, DOI 10.1524/zkri.1992.198.1-2.89; Donev A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.255506; Grunbaum B., 1987, TILINGS PATTERNS, P700; MATSUMOT.T, 1968, Z KRISTALLOGR KRIST, V126, P170, DOI 10.1524/zkri.1968.126.1-3.170; MATSUMOT.T, 1966, Z KRISTALLOGR KRIST, V123, P401, DOI 10.1524/zkri.1966.123.6.401; Nowacki W., 1948, SCHWEIZ MINER PETROG, V28, P502; Wilson A. J. C., 1995, INT TABLES CRYSTALLO, VC	10	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	2194-4946	2196-7105		Z KRIST-CRYST MATER	Z. Krist.-Cryst. Mater.	DEC	2015	230	12			SI		709	718		10.1515/zkri-2015-1880		10	Crystallography	Crystallography	CX7GN	WOS:000365870300004		
J	Chen, GX; Sieber, WK; Lincoln, JE; Birdsey, J; Hitchcock, EM; Nakata, A; Robinson, CF; Collins, JW; Sweeney, MH				Chen, Guang X.; Sieber, W. Karl; Lincoln, Jennifer E.; Birdsey, Jan; Hitchcock, Edward M.; Nakata, Akinori; Robinson, Cynthia F.; Collins, James W.; Sweeney, Marie H.			NIOSH national survey of long-haul truck drivers: Injury and safety	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Long-haul truck drivers; Truck driver safety; Truck driver injury; Risk factor; Survey; Hours of service	VEHICLE DRIVERS; UNITED-STATES; RISK-FACTORS; SEVERITIES; PASSENGERS; ACCIDENTS; FATIGUE; WORKERS; CRASH	Approximately 1,701,500 people were employed as heavy and tractor-trailer truck drivers in the United States in 2012. The majority of them were long-haul truck drivers (LHTDs). There are limited data on occupational injury and safety in LHTDs, which prompted a targeted national survey. The National Institute of Occupational Safety and Health conducted a nationally representative survey of 1265 LHTDs at 32 truck stops across the contiguous United States in 2010. Data were collected on truck crashes, near misses, moving violations, work-related injuries, work environment, safety climate, driver training, job satisfaction, and driving behaviors. Results suggested that an estimated 2.6% of LHTDs reported a truck crash in 2010,35% reported at least one crash while working as an LHTD, 24% reported at least one near miss in the previous 7 days, 17% reported at least one moving violation ticket and 4.7% reported a non-crash injury involving days away from work in the previous 12 months. The majority (68%) of non-crash injuries among company drivers were not reported to employers. An estimate of 73% of LHTDs (16% often and 58% sometimes) perceived their delivery schedules unrealistically tight; 24% often continued driving despite fatigue, bad weather, or heavy traffic because they needed to deliver or pick up a load at a given time; 4.5% often drove 10 miles per hours or more over the speed limit; 6.0% never wore a seatbelt; 36% were often frustrated by other drivers on the road; 35% often had to wait for access to a loading dock; 37% reported being noncompliant with hours-of-service rules (10% often and 27% sometimes); 38% of LHTDs perceived their entry-level training inadequate; and 15% did not feel that safety of workers was a high priority with their management. This survey brings to light a number of important safety issues for further research and interventions, e.g., high prevalence of truck crashes, injury underreporting, unrealistically tight delivery schedules, noncompliance with hours-of-service rules, and inadequate entry-level training. Published by Elsevier Ltd.	[Chen, Guang X.; Lincoln, Jennifer E.; Collins, James W.] NIOSH, Ctr Dis Control & Prevent, Div Safety Res, Morgantown, WV 26505 USA; [Sieber, W. Karl; Birdsey, Jan; Robinson, Cynthia F.; Sweeney, Marie H.] NIOSH, Ctr Dis Control & Prevent, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA; [Hitchcock, Edward M.] NIOSH, Ctr Dis Control & Prevent, Div Appl Res & Technol, Cincinnati, OH 45226 USA; [Nakata, Akinori] Univ Occupat & Environm Hlth, Fukuoka, Japan	Chen, GX (reprint author), NIOSH, Ctr Dis Control & Prevent, Div Safety Res, 1095 Willowdale Rd,MS-1811, Morgantown, WV 26505 USA.	gchen@cdc.gov; wks1@cdc.gov; axi5@cdc.gov; afq8@cdc.gov; ekh2@cdc.gov; nakataa@health.uoeh-u.ac.jp; cfr2@cdc.gov; joc4@cdc.gov; mhs2@cdc.gov			National Institute for Occupational Safety and Health; Federal Motor Carrier Safety Administration, U.S. Department of Transportation	This work was supported by the National Institute for Occupational Safety and Health with partial funding from the Federal Motor Carrier Safety Administration, U.S. Department of Transportation. We wish to thank Albert Alvarez, William Bannister, Paul Beatty, Dale Belman, Michael Belzer, Rebecca Brewster, LaMont Byrd, Gerald Donaldson, Eric Garshick, Jenny Guarino, Jeffrey Hickman, Gerald Krueger, Scott Madar, Anne McCartt, Stephanie Pratt, Michael Quinlan, Roger Rosa, John Sestito, Aaron Sussell, Martin Walker, Thomas Weakley, Ann Williamson, and Eric Wood for their helpful comments and/or guidance in development of our survey questionnaire and manuscript. We particularly wish to thank the participating truck stops and drivers without whom this data collection would not have been possible. Westat Inc. provided data collection and statistical support.	AAA Foundation for Traffic Safety, 2015, DROWS DRIV; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Rodriguez DA, 2006, IND LABOR RELAT REV, V59, P205; Khorashadi A, 2005, ACCIDENT ANAL PREV, V37, P910, DOI 10.1016/j.aap.2005.04.009; Bunn TL, 2012, ACCIDENT ANAL PREV, V47, P140, DOI 10.1016/j.aap.2011.10.008; Quinlan M, 1999, INT J LAW PSYCHIAT, V22, P491, DOI 10.1016/S0160-2527(99)00023-0; Zohar D, 2010, ACCIDENT ANAL PREV, V42, P1517, DOI 10.1016/j.aap.2009.12.019; McCartt AT, 2008, TRAFFIC INJ PREV, V9, P201, DOI 10.1080/15389580802040287; Hanowski RJ, 2009, ACCIDENT ANAL PREV, V41, P268, DOI 10.1016/j.aap.2008.11.007; Apostolopoulos Y, 2010, AAOHN J, V58, P285, DOI 10.3928/08910162-20100625-01; Sabbagh-Ehrlich S, 2005, INJURY PREV, V11, P110, DOI 10.1136/ip.2004.007682; Birdsey J, 2010, AAOHN J, V58, P473, DOI 10.3928/08910162-20101018-01; Bunn TL, 2009, TRAFFIC INJ PREV, V10, P266, DOI 10.1080/15389580902857622; Hanowski RJ, 2007, ACCIDENT ANAL PREV, V39, P1140, DOI 10.1016/j.aap.2007.02.011; Chen GX, 2014, AM J IND MED, V57, P800, DOI 10.1002/ajim.22320; Heaton K, 2008, AAOHN J, V56, P379; Bunn TL, 2005, ACCIDENT ANAL PREV, V37, P862, DOI 10.1016/j.aap.2005.04.004; Morrow PC, 2004, J SAFETY RES, V35, P59, DOI 10.1016/j.jsr.2003.07.004; Bunn T, 2013, J SAFETY RES, V44, P51, DOI 10.1016/j.jsr.2012.09.003; ASRS, 2014, AV SAF REP SYST; ATRI, 2011, PRED TRUCK CRASH INV; Belman D., 2004, SAILORS CONCRETE SEA; Belzer M., 2012, US HOUS REPR COMM SM; Belzer M., 2002, PAYING SAFETY EC ANA; Bigelow P.I., 2012, RESEARCH ON THE HEAL, P95; Blanco M., 2008, DTFH6101C0049; Blincoe L., 2002, 809446 DOT HS; BLS, 2014, OCC OUTL HDB; BLS, 2014, NONF OCC INJ ILLN RE; BLS, 2013, TABL 5 OCC MOST JOB; BLS, 2014, SURV OCC INJ ILLN SO; BLS, 2012, PERS WORK HOURS WORK; Boyle L.N., 2010, SAFETY CLIMATE COMME; Brady J.E., 2009, AM J EPIDEMIOL, V170, P775; Brodie Lisa, 2009, Accid Anal Prev, V41, P557, DOI 10.1016/j.aap.2009.02.005; CDC, 2015, DISTR DRIV; Chen GX, 2015, MMWR-MORBID MORTAL W, V64, P217; Chen G.X., 2004, T J COMMER VEH, V113, P360; DOT, 2013, BTS REL FREIGHT TRAN; FMCSA, 2010, FMCSARRA12023 US DEP; FMCSA, 2014, LARG TRUCK BUS CRASH; FMCSA, 2007, LARG TRUCK CRASH CAU; FMCSA, 2014, POCK GUID LARG TRUCK; Gilbertson J, 2005, USING NEAR MISS DATA; Hickman JS, 2015, J SAFETY RES, V52, P59, DOI 10.1016/j.jsr.2014.12.004; Hickman J.S., 2010, DTMC7507D00006 FED M; House of Representatives, 2008, HIDD TRAG UND WORKPL; Knipling R.R., 2004, COMMERCIAL TRUCK BUS, V4; Mayhew C., 2006, EMPL RELAT, V28, P212, DOI 10.1108/01425450610661216; McKinnon R.C., 2012, SAFETY MANAGEMENT NE; Murray D., 2006, PREDICTING TRUCK CRA; NHTSA, 2014, 812016 DOT HS; NIOSH, 2002, QUAL WORKL QUEST; NIOSH, 2009, NAT OCC RES AG NORA; NIOSH, 2013, WORK REL MOT VEH CRA; Quinlan M., 2008, REMUNERATION SAFETY; Rust K F, 1996, Stat Methods Med Res, V5, P283, DOI 10.1177/096228029600500305; Saltzman G.M., 2007, TRUCK DRIVER OCCUPAT; SAS Institute, 2011, STAT AN SYST V 9 2; Sieber WK, 2014, AM J IND MED, V57, P615, DOI 10.1002/ajim.22293; Stevenson M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-162	61	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	DEC	2015	85						66	72		10.1016/j.aap.2015.09.001		7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CW3IG	WOS:000364884800007		
J	Fujii, HA; Sugimoto, Y; Watanabe, T; Kusagaya, T				Fujii, H. A.; Sugimoto, Y.; Watanabe, T.; Kusagaya, T.			Tethered actuator for vibration control of space structures	ACTA ASTRONAUTICA			English	Article; Proceedings Paper	65th International Astronautical Congress (IAC)	SEP 29-OCT 03, 2014	Toronto, CANADA	Canadian Aeronaut & Space Inst, Int Astronaut Assoc		SSPS; Vibration control; Micro-tension actuator; Tether; Flexible leverage	MISSION-FUNCTION CONTROL; EULER-BERNOULLI BEAM; SLEW MANEUVER; DYNAMIC-SYSTEMS	Effectiveness of a micro-tension actuator for vibration control of such flexible space structures as the tethered space solar power satellites is experimentally studied on the ground. A flexible leverage is employed as the micro-tension actuator in order to control the microtension of tether. The flexible leverage is connected through a tether to the flexible beam as an experimental model of the flexible solar panel with the low first modal frequency of order 1 Hz. The nonlinearity of the flexible tether is taken into account for the vibration control since the tether becomes ineffective when it slacks, i.e., when it is tension-free. The feedback controller is designed by means of the Mission Function control algorithm. Flexural rigidity of the flexible leverage plays an important role in the vibration suppression and is studied experimentally to shed light on the effectiveness of the leverages with five different kinds of rigidity. The experimental results show not only the effect of the flexural rigidity of the flexible leverage on the control performance of the vibration suppression but also the importance of selection of the rigidity to control the vibration of tethered flexible space structures through the microtension of tethers in space. (C) 2015 IAA. Published by Elsevier Ltd. All rights reserved.	[Fujii, H. A.] TMIT, Res Ctr, Tokyo 1110032, Japan; [Sugimoto, Y.] Japan Aerosp Explorat Agcy, Tokyo, Japan; [Watanabe, T.] Teikyo Univ, Tokyo, Tochigi 3208551, Japan; [Kusagaya, T.] Tokyo Metropolitan Coll Ind Technol, Tokyo 1160003, Japan	Fujii, HA (reprint author), TMIT, Res Ctr, Tokyo 1110032, Japan.	tmit@pa2.so-net.ne.jp; sugimoto.yohei@jaxa.jp; nabetake@ase.teikyo-u.ac.jp; kusagaya@acp.metro-cit.ac.jp					Sekikawa K, 2004, ADV ASTRONAUT SCI, V117, P231; Tadikonda SSK, 1995, J VIB ACOUST, V117, P452, DOI 10.1115/1.2874478; Fujii HA, 2003, J ASTRONAUT SCI, V51, P249; BANERJEE AK, 1990, J GUID CONTROL DYNAM, V13, P221, DOI 10.2514/3.20540; FUJII H, 1989, J GUID CONTROL DYNAM, V12, P858, DOI 10.2514/3.20492; YANG B, 1992, J SOUND VIB, V156, P425, DOI 10.1016/0022-460X(92)90737-I; Sasaki S, 2007, ACTA ASTRONAUT, V60, P153, DOI 10.1016/j.actaastro.2006.07.010; Yuan K, 1997, J SOUND VIB, V204, P795, DOI 10.1006/jsvi.1997.0982; Tadi M, 2006, COMPUT METHOD APPL M, V195, P133, DOI 10.1016/j.cma.2005.01.012; Kar IN, 2000, IEEE-ASME T MECH, V5, P23; Yang JB, 2004, J SOUND VIB, V274, P863, DOI 10.1016/S0022-460X(03)00611-4; MORGUL O, 1992, IEEE T AUTOMAT CONTR, V37, P639, DOI 10.1109/9.135504; Okubo S, 2004, STRUCT MULTIDISCIP O, V26, P183, DOI 10.1007/s00158-003-0338-z; Kristiansen R, 2009, J GUID CONTROL DYNAM, V32, P1022, DOI 10.2514/1.42574; FUJII H, 1991, J GUID CONTROL DYNAM, V14, P986, DOI 10.2514/3.20740; Balas M. J., 1979, Journal of Guidance and Control, V2, DOI 10.2514/3.55869; Fan J., 2013, IPSI BGD INTERNET RE, V9, P28; Fujii H.A., 2003, P AIAA GUID NAV CONT; Fujii H.A., 2010, P IFAC S AUT CONTR A; Howell J., 1998, SPACE SOLAR POWER CO; Kane T. R., 1987, AIAA J GUIDANCE CONT, V10, P139; Kojima Y., 2008, P 26 INT S SPAC TECH; Kusagaya T., 2010, T JPN SOC AERONAUT S, V8; Lapidus L., 1999, NUMERICAL SOLUTION P; Mankins J.C., 2008, P 6 INT EN CONV ENG; Minagawa Y., 2008, P 26 INT S SPAC TECH; Sekikawa K., 2003, P 10 INT SPAC C PAC; Senda K., 2002, P 18 ISAS S SPAC STR; Tanaka D., 2012, P AS PAC INT S AER T; YANG B, 1991, J APPL MECH-T ASME, V58, P189, DOI 10.1115/1.2897147; Yano Y., 2011, P 28 INT S SPAC TECH	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	DEC	2015	117						55	63		10.1016/j.actaastro.2015.07.029		9	Engineering, Aerospace	Engineering	CW2BZ	WOS:000364797400006		
J	Yoshimitsu, T; McKenna-Lawlor, S; Candel, D; Ninomiya, K; Contant, JM				Yoshimitsu, Tetsuo; McKenna-Lawlor, Susan; Candel, Danielle; Ninomiya, Keiken; Contant, Jean-Michel			IAA multilingual space dictionary, current status and future prospects	ACTA ASTRONAUTICA			English	Article; Proceedings Paper	65th International Astronautical Congress (IAC)	SEP 29-OCT 03, 2014	Toronto, CANADA	Canadian Aeronaut & Space Inst, Int Astronaut Assoc		Astronautical terminology		Terminology is a key issue for a better understanding among people using various languages. Since 1986, when the International Academy of Astronautics (IAA) multilingual terminology database committee on astronautics was formed, the committee and its successor IAA study groups on the IAA multilingual space dictionary have made a continuous effort to construct a multilingual dictionary database on astronautical terms. In 2002, the dictionary was computerized using a database server and some recent internet technologies. The database is accessible from all over the world via the internet. You can search for terms at your home and office using a web browser installed on the computer with an internet connection. Since then, the number of terms and languages included in the database has increased. The current version includes about 3500 terms in 22 languages. The flexibility of the database enables the addition and the revision of new terms without much effort. The computerization has also demonstrated another possibility to utilize the database. When total of four paper books about the multilingual space terminology were published on the 50th anniversary of IAA in 2010, one of the lexicon books was edited by a computer program which accessed to the database. In this paper, the authors present the current status of the IAA multilingual database as well as the future possibilities on the utilization of the database. (C) 2015 IAA. Published by Elsevier Ltd. All rights reserved.	[Yoshimitsu, Tetsuo] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci ISAS, Tokyo, Japan; [McKenna-Lawlor, Susan] Space Technol Ireland Ltd, Dublin, Ireland; [Candel, Danielle] Univ Paris 07, F-75221 Paris 05, France; [Ninomiya, Keiken] ISAS JAXA, Sagamihara, Kanagawa, Japan; [Contant, Jean-Michel] Int Acad Astronaut IAA, Paris, France	Yoshimitsu, T (reprint author), Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci ISAS, Tokyo, Japan.	kikko@nnl.isas.jaxa.jp					Almar Ivan, 2012, ENLISH HUNGARIAN SPA; Almar I, 2002, ACTA ASTRONAUT, V50, P65, DOI 10.1016/S0094-5765(01)00191-6; Matsukata J, 2002, ACTA ASTRONAUT, V50, P95, DOI 10.1016/S0094-5765(01)00197-7; [Anonymous], 2002, ACTA ASTRONAUT, V50, P65; Harijono Djojodihardjo H.R., 2010, ENGLISH INDONESIAN S; IAA Multilingual Terminology Data Base Committee, 2002, LAST WORD DICT 53 IN; Kinyua Meshack, 2014, 65 INT ASTR C; McKenna-Lawlor Susan, 2010, ENGLISH IRISH LEXICO; Ninomiya K., 2011, 62 INT ASTR C; Ninomiya Keiken, 2010, SPACE LEXICON ENGLIS; Viljoen Christo, 2011, ENGLISH AFRIKAANS AF; Yoshimitsu T., 2002, 53 INT ASTR C; Yoshimitsu Tetsuo, 2012, 63 INT ASTR C NAPL 1; Zhuang Fenggan, 2010, ENGLISH CHINESE FREN	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	DEC	2015	117						64	72		10.1016/j.actaastro.2015.07.031		9	Engineering, Aerospace	Engineering	CW2BZ	WOS:000364797400007		
J	Takeuchi, S; Sugimura, T; Miyano, M; Kimura, T				Takeuchi, Satoru; Sugimura, Toshihide; Miyano, Makoto; Kimura, Teruo			De novo formation and rupture of proximal anterior cerebral artery aneurysm associated with middle cerebral artery occlusion	ACTA NEUROLOGICA BELGICA			English	Letter						De novo; Aneurysm; Subarachnoid haemorrhage; Middle cerebral artery occlusion			[Takeuchi, Satoru] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; [Sugimura, Toshihide; Miyano, Makoto; Kimura, Teruo] Dohtoh Neurosurg Hosp, Dept Neurosurg, Kitami, Hokkaido, Japan	Takeuchi, S (reprint author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s.takeuchi@room.ocn.ne.jp					Arnaout OM, 2012, NEUROSURGERY, V71, pE764, DOI 10.1227/NEU.0b013e31825fd169; Inui Y, 2006, NEUROL MED-CHIR, V46, P32, DOI 10.2176/nmc.46.32; SUZUKI M, 1992, J NEUROSURG, V76, P455, DOI 10.3171/jns.1992.76.3.0455	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2015	115	4					743	745		10.1007/s13760-015-0477-1		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CW8RB	WOS:000365265800047		
J	Zeka, B; Hastermann, M; Hochmeister, S; Kogl, N; Kaufmann, N; Schanda, K; Mader, S; Misu, T; Rommer, P; Fujihara, K; Illes, Z; Leutmezer, F; Sato, DK; Nakashima, I; Reindl, M; Lassmann, H; Bradl, M				Zeka, Bleranda; Hastermann, Maria; Hochmeister, Sonja; Koegl, Nikolaus; Kaufmann, Nathalie; Schanda, Kathrin; Mader, Simone; Misu, Tatsuro; Rommer, Paulus; Fujihara, Kazuo; Illes, Zsolt; Leutmezer, Fritz; Sato, Douglas Kazutoshi; Nakashima, Ichiro; Reindl, Markus; Lassmann, Hans; Bradl, Monika			Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS	ACTA NEUROPATHOLOGICA			English	Article						CNS inflammation; Neuromyelitis optica; T cells; Aquaporin 4; ENMO	MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; INTERSTITIAL FLUID; MOUSE MODEL; ACTIVATION; DISEASE	In neuromyelitis optica (NMO), astrocytes become targets for pathogenic aquaporin 4 (AQP4)-specific antibodies which gain access to the central nervous system (CNS) in the course of inflammatory processes. Since these antibodies belong to a T cell-dependent subgroup of immunoglobulins, and since NMO lesions contain activated CD4(+) T cells, the question arose whether AQP4-specific T cells might not only provide T cell help for antibody production, but also play an important role in the induction of NMO lesions. We show here that highly pathogenic, AQP4-peptide-specific T cells exist in Lewis rats, which recognize AQP4(268-285) as their specific antigen and cause severe panencephalitis. These T cells are re-activated behind the blood-brain barrier and deeply infiltrate the CNS parenchyma of the optic nerves, the brain, and the spinal cord, while T cells with other AQP4-peptide specificities are essentially confined to the meninges. Although AQP4(268-285)-specific T cells are found throughout the entire neuraxis, they have NMO-typical "hotspots" for infiltration, i.e. periventricular and periaqueductal regions, hypothalamus, medulla, the dorsal horns of spinal cord, and the optic nerves. Most remarkably, together with NMO-IgG, they initiate large astrocyte-destructive lesions which are located predominantly in spinal cord gray matter. We conclude that the processing of AQP4 by antigen presenting cells in Lewis rats produces a highly encephalitogenic AQP4 epitope (AQP4(268-285)), that T cells specific for this epitope are found in the immune repertoire of normal Lewis rats and can be readily expanded, and that AQP4(268-285)-specific T cells produce NMO-like lesions in the presence of NMO-IgG.	[Zeka, Bleranda; Hastermann, Maria; Koegl, Nikolaus; Kaufmann, Nathalie; Lassmann, Hans; Bradl, Monika] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, A-1090 Vienna, Austria; [Hochmeister, Sonja] Med Univ Graz, Dept Neurol, A-8036 Graz, Austria; [Schanda, Kathrin; Mader, Simone; Reindl, Markus] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria; [Misu, Tatsuro; Fujihara, Kazuo; Sato, Douglas Kazutoshi; Nakashima, Ichiro] Tohoku Univ, Grad Sch Med, Dept Neurol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Rommer, Paulus; Leutmezer, Fritz] Med Univ Vienna, Univ Hosp Neurol, A-1090 Vienna, Austria; [Illes, Zsolt] Univ Southern Denmark, Dept Neurol, DK-5000 Odense, Denmark; [Sato, Douglas Kazutoshi] Univ Sao Paulo, Dept Neurol, Fac Med, BR-01246903 Sao Paulo, Brazil	Bradl, M (reprint author), Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	monika.bradl@meduniwien.ac.at	Sato, Douglas/F-2508-2013; 	Sato, Douglas/0000-0002-7695-6020; Bradl, Monika/0000-0003-2239-1586	Austrian Science Fund [P25240-B24, I916-B13]; Else Kroner-Fresenius-Stiftung [2013_A283]; Austrian Ministery of Science, Research and Economy (BIGWIG-MS); Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Austrian Science Fund [Grant Numbers P25240-B24 to MB and I916-B13 (International Programme, Eugene Devic European Network) to HL and MR], by the Else Kroner-Fresenius-Stiftung (Grant Number 2013_A283 to MB), by the Austrian Ministery of Science, Research and Economy (BIGWIG-MS to HL and MR), and by Grants-in-aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan to KF and TM. We thank Dr. Dagoberto Callegaro for sample collection, Marianne Leisser, Ulrike Kock and Angela Kury for excellent technical assistance, Verena Berg and Madhura Modak for assistance at the beta-counter, and the Core Facility Flow Cytometry, Medical University of Vienna.	Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Mues M, 2013, NAT MED, V19, P778, DOI 10.1038/nm.3180; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Verkman AS, 2011, ACTA PHARMACOL SIN, V32, P702, DOI 10.1038/aps.2011.27; Arellano B, 2012, ARCH NEUROL-CHICAGO, V69, P1125, DOI 10.1001/archneurol.2012.1300; Pohl M, 2011, ACTA NEUROPATHOL, V122, P21, DOI 10.1007/s00401-011-0824-0; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Aboul-Enein F, 2004, J NEUROPATH EXP NEUR, V63, P1284; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; AMOR S, 1994, J IMMUNOL, V153, P4349; Ratelade J, 2013, ACTA NEUROPATHOL, V126, P699, DOI 10.1007/s00401-013-1172-z; Hochmeister S, 2008, AM J PATHOL, V173, P1669, DOI 10.2353/ajpath.2008.080234; Storch MK, 1998, BRAIN PATHOL, V8, P681; LASSMANN H, 1988, ACTA NEUROPATHOL, V75, P566; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Wauben MHM, 1997, INT IMMUNOL, V9, P281, DOI 10.1093/intimm/9.2.281; Kaab G, 1996, EUR J IMMUNOL, V26, P981, DOI 10.1002/eji.1830260504; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P18625, DOI 10.1073/pnas.0705033104; Tuohy VK, 1999, J EXP MED, V189, P1033, DOI 10.1084/jem.189.7.1033; Matiello M, 2013, JAMA NEUROL, V70, P1118, DOI 10.1001/jamaneurol.2013.3124; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Matsuya N, 2011, INT IMMUNOL, V23, P565, DOI 10.1093/intimm/dxr056; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Fujihara K, 2012, CLIN EXP NEUROIMMUNO, V3, P58; Jones MV, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0207-1; Kalluri SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016083; Kitic M, 2013, ACTA NEUROPATHOL COM, V1, P1; Nelson PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015050; Paxinos G., 1998, RAT BRAIN STEREOTAXI; Pohl Maria, 2013, Acta Neuropathol Commun, V1, P85, DOI 10.1186/2051-5960-1-85	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2015	130	6					783	798		10.1007/s00401-015-1501-5		16	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CW9FU	WOS:000365304900003		
J	Akagi, R; Tanaka, J; Shikiba, T; Takahashi, H				Akagi, Ryota; Tanaka, Jun; Shikiba, Tomofumi; Takahashi, Hideyuki			Muscle hardness of the triceps brachii before and after a resistance exercise session: a shear wave ultrasound elastography study	ACTA RADIOLOGICA			English	Article						Shear wave ultrasound elastography; shear modulus; elbow extensors; muscle thickness	ECCENTRIC EXERCISE; GASTROCNEMIUS-MUSCLE; RAPID ADAPTATION; SKELETAL-MUSCLE; DAMAGE; MEN; VOLUME; WOMEN; YOUNG; SIZE	Background: Muscle hardness indicates muscle condition, and its measurement before and after resistance exercise is essential for preventing resistance training-induced muscle injury. Purpose: To investigate muscle hardness of the triceps brachii (TB) before and immediately after a resistance exercise session involving the elbow extensors. Material and Methods: In 18 young men, muscle hardness of the long head of TB was measured at 50%, 60%, and 70% point along the length of the upper arm from the acromial process of the scapula to the lateral epicondyle of the humerus by using shear wave ultrasound elastography. At the same sites, muscle thickness of the long head of TB was also measured by ultrasonography. Resistance exercise was performed using a dumbbell with a mass adjusted to 80% of the one-repetition maximum. Results: Although the exercise-induced increase in muscle hardness was significant at all the regions, muscle hardness was significantly higher at 70% of the upper arm length than at the other regions before and after resistance exercise. The exercise-induced increase in muscle thickness was also significant, but the relative changes in muscle hardness before and after resistance exercise were not correlated with the corresponding relative changes in muscle thickness at each region. These results indicate the small effect of exercise-induced muscle swelling on exercise-induced changes in muscle hardness. Conclusion: We suggest that muscle damage and/or injury, particularly at the distal region of TB, should be carefully considered to safely perform resistance exercise.	[Akagi, Ryota; Tanaka, Jun; Shikiba, Tomofumi] Shibaura Inst Technol, Coll Syst Engn & Sci, Saitama, Saitama 3378570, Japan; [Akagi, Ryota; Takahashi, Hideyuki] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan	Akagi, R (reprint author), Shibaura Inst Technol, Coll Syst Engn & Sci, Minuma Ku, 307 Fukasaku, Saitama, Saitama 3378570, Japan.	rakagi12@sic.shibaura-it.ac.jp			MEXT/JSPS KAKENHI Grant [24700689]; Nakatomi Foundation	This study was partly supported by MEXT/JSPS KAKENHI Grant Number 24700689 (Grant-in-Aid for Young Scientists (B)) and the Nakatomi Foundation.	Abe T, 1997, J Gravit Physiol, V4, pS10; Akagi R, 2013, SCAND J MED SCI SPOR; PLOUTZSNYDER LL, 1995, AM J PHYSIOL-REG I, V269, pR536; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008; Melnyk JA, 2009, EUR J APPL PHYSIOL, V105, P929, DOI 10.1007/s00421-008-0979-0; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Wakahara T, 2010, AM J HUM BIOL, V22, P55, DOI 10.1002/ajhb.20951; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Kraemer WJ, 2004, MED SCI SPORT EXER, V36, P674, DOI 10.1249/01.MSS.0000121945.36635.61; Wakahara T, 2012, EUR J APPL PHYSIOL, V112, P1569, DOI 10.1007/s00421-011-2121-y; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Maher RM, 2013, ARCH PHYS MED REHAB, V94, P2146, DOI 10.1016/j.apmr.2013.04.021; Singh MAF, 1999, AM J PHYSIOL-ENDOC M, V277, pE135; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; SIPILA S, 1991, MUSCLE NERVE, V14, P527, DOI 10.1002/mus.880140607; Miyatani M, 2004, EUR J APPL PHYSIOL, V91, P264, DOI 10.1007/s00421-003-0974-4; Nosaka K, 2002, J STRENGTH COND RES, V16, P117; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381; McHugh MP, 1999, SPORTS MED, V27, P157, DOI 10.2165/00007256-199927030-00002; SIPILA S, 1993, MUSCLE NERVE, V16, P294, DOI 10.1002/mus.880160309; Morisada M, 2006, EUR J APPL PHYSIOL, V97, P681, DOI 10.1007/s00421-006-0225-6; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012; Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; MAIR J, 1995, INT J SPORTS MED, V16, P352, DOI 10.1055/s-2007-973019; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Fischer AA, 1987, CLIN J PAIN, V3, P23, DOI 10.1097/00002508-198703010-00005; Kawakami Y, 1995, EUR J APPL PHYSIOL O, V72, P37, DOI 10.1007/BF00964112	30	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	DEC	2015	56	12					1487	1493		10.1177/0284185114559765		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CX0PX	WOS:000365400200012		
J	Phasomkusolsil, S; Pantuwattana, K; Tawong, J; Khongtak, W; Kertmanee, Y; Monkanna, N; Klein, TA; Kim, HC; McCardle, PW				Phasomkusolsil, Siriporn; Pantuwattana, Kanchana; Tawong, Jaruwan; Khongtak, Weeraphan; Kertmanee, Yossasin; Monkanna, Nantaporn; Klein, Terry A.; Kim, Heung-Chul; McCardle, Patrick W.			The relationship between wing length, blood meal volume, and fecundity for seven colonies of Anopheles species housed at the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand	ACTA TROPICA			English	Article						Anopheles; Blood meal volume; Wing length; Feeding duration; Oviposition	REPUBLIC-OF-KOREA; AEDES-AEGYPTI; REPRODUCTIVE SUCCESS; DIPTERA-CULICIDAE; CULEX-NIGRIPALPUS; FEEDING SUCCESS; MALARIA VECTORS; SIZE VARIATION; BODY-SIZE; MOSQUITO	Established colonies of Anopheles campestris, Anopheles cracens, Anopheles dirus, Anopheles kleini, Anopheles minimus, Anopheles sawadwongporni, and Anopheles sinensis are maintained at the Armed Forces Research Institute of Medical Sciences (AFRIMS). Females were provided blood meals on human blood containing citrate as an anticoagulant using an artificial membrane feeder. The mean wing length, used as an estimate of body size, for each species was compared to blood-feeding duration (time), blood meal volume, and numbers of eggs oviposited. Except for An. campestris and An. cracens, there were significant interspecies differences in wing length. The mean blood meal volumes (mm(3)) of An. kleini and An. sinensis were significantly higher than the other 5 species. For all species, the ratios of unfed females weights/blood meal volumes were similar (range: 0.76-0.88), except for An. kleini (1.08) and An. cracens (0.52), that were significantly higher and lower, respectively. Adult females were allowed to feed undisturbed for 1, 3, and 5 mm intervals before blood feeding was interrupted. Except for An. cam pestris and An. sawadwongporni, the number of eggs oviposited were significantly higher for females that fed for 3 min when compared to those that only fed for 1 min. This information is critical to better understand the biology of colonized Anopheles spp. and their role in the transmission of malaria parasites as they relate to the relative size of adult females, mean volumes of blood of engorged females for each of the anopheline species, and the effect of blood feeding duration on specific blood meal volumes and fecundity. (C) 2015 Elsevier B.V. All rights reserved.	[Phasomkusolsil, Siriporn; Pantuwattana, Kanchana; Tawong, Jaruwan; Khongtak, Weeraphan; Kertmanee, Yossasin; Monkanna, Nantaporn; McCardle, Patrick W.] US Army Med Component, Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok 10400, Thailand; [Klein, Terry A.] Publ Hlth Command Reg Pacific, Camp Zama, Japan; [Kim, Heung-Chul] 168th Multifunct Med Battal, Med Detachment 5, APO, AP 96205 USA	Phasomkusolsil, S (reprint author), US Army Med Component, Armed Forces Res Inst Med Sci, Dept Entomol, 315-6 Ratchawithi Rd, Bangkok 10400, Thailand.	siripornp@afrims.org			U.S. Army Medical and Material Command, Fort Detrick, MD; Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; Public Health Command Region-Pacific, Camp Zama, Japan; 65th Medical Brigade, Yongsan US Army Garrison, Seoul, Korea	Funding for this project was partially provided by the U.S. Army Medical and Material Command, Fort Detrick, MD, the Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD, the Public Health Command Region-Pacific, Camp Zama, Japan, and the 65th Medical Brigade, Yongsan US Army Garrison, Seoul, Korea. The views expressed in this paper are those of the authors and do not represent the position and/or reflect the official policy of the Department of the Army, the Department of Defense or the U.S. Government.	Amir A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-81; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839; Rueda LM, 2005, ZOOTAXA, P1; Phasomkusolsil S, 2014, SE ASIAN J TROP MED, V45, P40; Shannon RC, 1941, J ECON ENTOMOL, V34, P300; Foley DH, 2009, J MED ENTOMOL, V46, P680, DOI 10.1603/033.046.0336; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; EDMAN JD, 1971, ANN ENTOMOL SOC AM, V64, P513; Bevins SN, 2007, J MED ENTOMOL, V44, P945, DOI 10.1603/0022-2585(2007)44[945:EAAOAR]2.0.CO;2; Muenworn V, 2009, J VECTOR ECOL, V34, P62, DOI [10.1111/j.1948-7134.2009.00008.x, 10.3376/038.034.0108]; Chadee DD, 2002, J VECTOR ECOL, V27, P172; EDMAN JD, 1974, J PARASITOL, V60, P874, DOI 10.2307/3278923; KELLY R, 1992, J AM MOSQUITO CONTR, V8, P386; PACKER MJ, 1989, ECOL ENTOMOL, V14, P297, DOI 10.1111/j.1365-2311.1989.tb00960.x; EDMAN JD, 1984, CONDOR, V86, P91, DOI 10.2307/1367358; Strickman D, 2003, AM J TROP MED HYG, V68, P209; KLEIN TA, 1987, J AM MOSQUITO CONTR, V3, P165; EDMAN JD, 1975, ENTOMOL EXP APPL, V18, P261; NAYAR JK, 1975, J MED ENTOMOL, V12, P99; Lee WJ, 2007, J MED ENTOMOL, V44, P1086, DOI 10.1603/0022-2585(2007)44[1086:AKAPAA]2.0.CO;2; Koella JC, 1996, J MED ENTOMOL, V33, P261; HARAMIS LD, 1983, MOSQ NEWS, V43, P77; MOLYNEUX M, 1993, BRIT MED J, V306, P1175; Foley DH, 2008, J MED ENTOMOL, V45, P852, DOI 10.1603/0022-2585(2008)45[852:PDOTSI]2.0.CO;2; RENSHAW M, 1994, MED VET ENTOMOL, V8, P179, DOI 10.1111/j.1365-2915.1994.tb00161.x; BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; COLLESS D H, 1960, Ann Trop Med Parasitol, V54, P475; Dodd C S, 1995, J R Army Med Corps, V141, P151; Garnham P.C.C., 1966, MALARIA PARASITES OT, P1114; Guinan D.M., 1986, CAN J ZOOL, V65, P1587; JEFFERY GEOFFREY M., 1956, EXPTL PARASITOL, V5, P371, DOI 10.1016/0014-4894(56)90021-2; KERSHAW W. E., 1955, ANN TROP MED AND PARASITOL, V49, P203; KITTHAWEE S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P128; Lehane M.J., 2005, BIOL BLOOD SUCKING I, P84, DOI 10.1017/CBO9780511610493.007; NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61; NASCI RS, 1990, J MED ENTOMOL, V27, P716; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Ow Yang C.K., 1963, MOSQ NEWS, V23, P34; Phasomkusolsil S, 2014, J AM MOSQUITO CONTR, V30, P1, DOI 10.2987/13-6390.1; Roitberg BD, 2003, BEHAV ECOL, V14, P736, DOI 10.1093/beheco/arg055; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; WOKE PAUL A., 1956, ANN ENT SOC AMER, V49, P435	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	DEC	2015	152						220	227		10.1016/j.actatropica.2015.09.021		8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CW5SW	WOS:000365057900032		
J	Ono, T; Takaoka, A; Morita, Y; Do, LTK; Tanihara, F; Taniguchi, M; Otoi, T				Ono, Tetsushi; Takaoka, Asako; Morita, Yasuhiro; Do, Lanh Thi Kim; Tanihara, Fuminori; Taniguchi, Masayasu; Otoi, Takeshige			EFFECTS OF DIBUTYRYL CYCLIC ADENOSINE MONOPHOSPHATE AND HUMAN CHORIONIC GONADOTROPIN ON THE FORMATION OF ANTRAL FOLLICLE-LIKE STRUCTURES BY BOVINE CUMULUS-OOCYTE COMPLEXES	ACTA VETERINARIA HUNGARICA			English	Article						Antrum-like structures; cAMP; cumulus cells; gap junction; follicular formation	IN-VITRO; STIMULATING-HORMONE; MEIOTIC MATURATION; MAMMALIAN OOCYTES; COLLAGEN GELS; GROWTH; GRANULOSA; HYPOXANTHINE; STEROIDS; CULTURE	This study evaluated the effect of dibutyryl cyclic adenosine monophosphate (dbcAMP) and human chorionic gonadotropin (hCG) on the formation of antral follicle-like structures (AFLSs) and on the meiotic status of bovine cumulus-oocyte complexes (COCs) embedded in collagen gel. Supplementation with dbcAMP increased the mean diameter of AFLSs during days 4-8 of culture compared with that of control COCs, irrespective of the concentration of dbcAMP used (0.5-2.0 mM). When the embedded COCs were cultured for 8 days with hCG, the diameters of AFLSs after 4 days of culture tended to be lower in the supplemented COCs than in the control COCs without hCG, irrespective of the concentration used (1-100 IU/mL). Supplementation with 10 IU/mL hCG increased the concentrations of anti-Mullerian hormone but not progesterone and oestradiol in the culture medium after 4 days of culture. Almost all oocytes collected from AFLSs had resumed meiosis by the end of culture, irrespective of supplementation of dbcAMP and hCG. These results indicate that although dbcAMP had a positive effect on AFLS formation and development, supplementation with hCG was detrimental. Moreover, hCG supplementation did not influence the luteinisation of granulosa cells in the AFLS for 4 days after the start of culture.	[Ono, Tetsushi; Takaoka, Asako; Morita, Yasuhiro; Do, Lanh Thi Kim; Tanihara, Fuminori; Taniguchi, Masayasu; Otoi, Takeshige] Yamaguchi Univ, Lab Anim Reprod, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan	Otoi, T (reprint author), Yamaguchi Univ, Lab Anim Reprod, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan.	otoi@tokushima-u.ac.jp					Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732; ANDERSON E, 1976, J CELL BIOL, V71, P680, DOI 10.1083/jcb.71.2.680; EVANS G, 1981, BIOL REPROD, V25, P673, DOI 10.1095/biolreprod25.4.673; Spears N, 1998, J REPROD FERTIL, V113, P19; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; HARTSHORNE GM, 1994, HUM REPROD, V9, P1003; DEKEL N, 1988, ANN NY ACAD SCI, V541, P211, DOI 10.1111/j.1749-6632.1988.tb22258.x; Demeestere I, 2005, REPRODUCTION, V130, P147, DOI 10.1530/rep.1.00648; Murray AA, 2008, MOL HUM REPROD, V14, P75, DOI 10.1093/molehr/gam092; CROSBY IM, 1985, J EXP ZOOL, V234, P307, DOI 10.1002/jez.1402340217; Roth Z, 2005, REPRODUCTION, V129, P235, DOI 10.1530/rep.1.00394; Cortvrindt R, 1998, HUM REPROD, V13, P1292, DOI 10.1093/humrep/13.5.1292; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; BROWER PT, 1981, DEV BIOL, V86, P373, DOI 10.1016/0012-1606(81)90195-0; Shen XJ, 1998, ZYGOTE, V6, P47; Hirao Y, 2012, J REPROD DEVELOP, V58, P167, DOI 10.1262/jrd.2011-052; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237; Monniaux D, 2008, BIOL REPROD, V79, P387, DOI 10.1095/biolreprod.107.065847; ABELL CW, 1973, J CELL BIOL, V59, P549, DOI 10.1083/jcb.59.3.549; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; CARROLL J, 1991, J REPROD FERTIL, V92, P197; Harada M, 1997, THERIOGENOLOGY, V48, P743, DOI 10.1016/S0093-691X(97)00298-7; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Monniaux D, 2013, REPROD FERT DEVELOP, V25, P1, DOI 10.1071/RD12270; Miyano T, 2005, J REPROD DEVELOP, V51, P169, DOI 10.1262/jrd.16014; Abakushina EV, 2011, REPROD DOMEST ANIM, V46, P423, DOI 10.1111/j.1439-0531.2010.01684.x; KOLENA J, 1972, ENDOCRINOLOGY, V90, P1543; DOWNS SM, 1985, P NATL ACAD SCI USA, V82, P454, DOI 10.1073/pnas.82.2.454; Fauser BCJM, 1997, ENDOCR REV, V18, P71, DOI 10.1210/er.18.1.71	30	0	0	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	0236-6290	1588-2705		ACTA VET HUNG	Acta Vet. Hung.	DEC	2015	63	4					485	498		10.1556/004.2015.045		14	Veterinary Sciences	Veterinary Sciences	CW9XL	WOS:000365351400008		
J	Suzuki, N; Tagashira, Y; Heist, BS; Tsuda, N; Watanuki, S; Tani, S; Honda, H				Suzuki, Noriko; Tagashira, Yasuaki; Heist, Brian S.; Tsuda, Naonori; Watanuki, Satoshi; Tani, Shoichiro; Honda, Hitoshi			Not Just Another Flare: Acute Polyarthritis in Rheumatoid Arthritis	AMERICAN JOURNAL OF MEDICINE			English	Editorial Material							MENINGOCOCCAL DISEASE; NEISSERIA-MENINGITIDIS		[Suzuki, Noriko; Tagashira, Yasuaki; Tsuda, Naonori; Honda, Hitoshi] Tokyo Metropolitan Tama Gen Med Ctr, Div Infect Dis, Tokyo, Japan; [Tagashira, Yasuaki; Tsuda, Naonori; Honda, Hitoshi] Tokyo Metropolitan Tama Gen Med Ctr, Dept Infect Prevent, Tokyo, Japan; [Heist, Brian S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Watanuki, Satoshi] Tokyo Metropolitan Tama Gen Med Ctr, Dept Rheumat Dis, Tokyo, Japan; [Tani, Shoichiro] Mitsui Mem Hosp, Dept Orthoped Surg, Tokyo 101, Japan	Honda, H (reprint author), Tokyo Metropolitan Tama Gen Med Ctr, Div Infect Dis, 2-8-29 Musashidai, Fuchu, Tokyo 1838524, Japan.	hondah@hotmail.com					Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; PINALS RS, 1994, NEW ENGL J MED, V330, P769, DOI 10.1056/NEJM199403173301108; SCHAAD UB, 1980, REV INFECT DIS, V2, P880; HARCUP C, 1983, ARTHRITIS RHEUM, V26, P1409, DOI 10.1002/art.1780261116; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Molnar-Kimber KL, 2012, MED HYPOTHESES, V78, P123, DOI 10.1016/j.mehy.2011.10.006; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; DUBOST JJ, 1993, MEDICINE, V72, P296; Bookstaver P Brandon, 2009, South Med J, V102, P438, DOI 10.1097/SMJ.0b013e31819ba3c0; Goedvolk CA, 2003, ARCH DIS CHILD, V88, P927, DOI 10.1136/adc.88.10.927; Michel Michael D, 2013, West J Emerg Med, V14, P165, DOI 10.5811/westjem.2012.10.12906	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	DEC	2015	128	12					E1	E3		10.1016/j.amjmed.2015.08.002		3	Medicine, General & Internal	General & Internal Medicine	CW8QQ	WOS:000365264700001		
J	Suzuki, S; Hirota, Y; Noda, K; Ohira, Y; Ikusaka, M				Suzuki, Shingo; Hirota, Yusuke; Noda, Kazutaka; Ohira, Yoshiyuki; Ikusaka, Masatomi			Orchialgia Presenting with Lower Quadrant Pain in Sitting	AMERICAN JOURNAL OF MEDICINE			English	Letter							CHRONIC TESTICULAR PAIN		[Suzuki, Shingo; Hirota, Yusuke; Noda, Kazutaka; Ohira, Yoshiyuki; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba, Chiba 2608677, Japan	Suzuki, S (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608677, Japan.	shngszkthk@yahoo.co.jp					Granitsiotis P, 2004, EUR UROL, V45, P430, DOI 10.1016/j.eururo.2003.11.004; Kumar P, 2010, UROL INT, V84, P125, DOI 10.1159/000277587; Quallich SA, 2013, AM J MENS HEALTH, V7, P402, DOI 10.1177/1557988313476732; Heidelbaugh Joel J, 2010, J Fam Pract, V59, P330	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	DEC	2015	128	12					E27	E27		10.1016/j.amjmed.2015.08.008		1	Medicine, General & Internal	General & Internal Medicine	CW8QQ	WOS:000365264700011		
J	Kashimura, Y; Chida, K				Kashimura, Yasuhiro; Chida, Koichi			Nuclear Reactor Accident Fallout Artifacts: Unusual Black Spots on Digital Radiographs	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						black spot; cesium; computed radiography; conventional digital x-ray examination; Fukushima Daiichi nuclear power plant accident; Great East Japan Earthquake; cesium; radioactive material	EARTHQUAKE; RADIATION; TSUNAMI; RADIOLOGY	OBJECTIVE. The Fukushima nuclear power plant accident resulted in the discharge of radioactive particulate material into the atmosphere. Consequently, several hospitals in Japan have observed black spots on x-ray computed radiography (CR) images caused by particulate radioactive fallout. CONCLUSION. These black spots have no effect on human health. To reduce the influence of black spots on CR images, we need to erase latent images on imaging plates (IPs) immediately before clinical use and read the IPs soon after the x-ray examination. Alternatively, the contaminated felt of a cassette can be cleaned or exchanged, if possible.	[Kashimura, Yasuhiro; Chida, Koichi] Tohoku Univ, Grad Sch Med, Dept Radiol Technol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kashimura, Yasuhiro] Iwaki Kyoritsu Gen Hosp, Iwaki, Fukushima, Japan; [Chida, Koichi] Tohoku Univ, Int Res Inst Disaster Sci, Div Disaster Med Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan	Chida, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Radiol Technol, Aoba Ku, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan.	chida@med.tohoku.ac.jp			Japan Society for the Promotion of Science [24300179]	Supported in part by a Grant-in-Aid for Scientific Research (No. 24300179) from the Japan Society for the Promotion of Science.	Christodouleas JP, 2011, NEW ENGL J MED, V364, P2334, DOI 10.1056/NEJMra1103676; Liu Q, 2011, RADIOLOGY, V261, P329, DOI 10.1148/radiol.11110924; Chida K, 2009, AM J ROENTGENOL, V193, P1680, DOI 10.2214/AJR.09.2747; Boehm BO, 2011, NEW ENGL J MED, V365, P676, DOI 10.1056/NEJMc1104982; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Shibahara S, 2011, TOHOKU J EXP MED, V223, P305, DOI 10.1620/tjem.223.305; Shibahara S, 2012, TOHOKU J EXP MED, V226, P1, DOI 10.1620/tjem.226.1; Ehara S, 2011, AM J ROENTGENOL, V197, pW549, DOI 10.2214/AJR.11.7004; Auffermann WF, 2015, AM J ROENTGENOL, V204, P44, DOI 10.2214/AJR.14.14041; Ministry of Education Culture Sports Science and Technology (MEXT) Japan, 2011, RES AIRB MON MIN ED; Steinhauser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057760	11	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	DEC	2015	205	6					1240	1243		10.2214/AJR.15.14557		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW9LO	WOS:000365320400026		
J	Yamaguchi, R; Makino, Y; Chiba, F; Torimitsu, S; Yajima, D; Shinozaki, T; Iwase, H				Yamaguchi, Rutsuko; Makino, Yohsuke; Chiba, Fumiko; Torimitsu, Suguru; Yajima, Daisuke; Shinozaki, Tomohiro; Iwase, Hirotaro			Fluid-Fluid Level and Pericardial Hyperdense Ring Appearance Findings on Unenhanced Postmortem CT Can Differentiate Between Postmortem and Antemortem Pericardial Hemorrhage	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						autopsy; cardiac tamponade; hemopericardium; MDCT; postmortem diagnosis	BASIC LIFE-SUPPORT; COMPUTED-TOMOGRAPHY; SUDDEN-DEATH; CADAVERIC BLOOD; CARDIOPULMONARY-RESUSCITATION; CARDIAC-TAMPONADE; ANEURYSM RUPTURE; VIRTUAL AUTOPSY; TRAUMA PATIENTS; PREDICTS CAUSE	OBJECTIVE. The objective of this study was to determine whether selected postmortem unenhanced CT findings can discriminate between antemortem and postmortem pericardial hemorrhage. MATERIALS AND METHODS. Thirty-one consecutive cases of postmortem CT followed by autopsy identifying at least 50 mL of hemorrhaged blood were reviewed. Seven cases were classified as postmortem pericardial hemorrhage secondary to chest compression (postmortem group), and 24 cases were classified as antemortem pericardial hemorrhage secondary to disease or trauma (antemortem group), on the basis of autopsy findings. Postmortem CT findings of pericardial hemorrhage were classified as stratification comprising upper low-density and lower high-density areas (i.e., fluid-fluid level) and a high-density concentric ring (i.e., pericardial hyperdense ring). Diagnostic values for detecting antemortem or postmortem pericardial hemorrhage using this classification system, along with attenuation (in Hounsfield units) of pericardial hemorrhage lesions and the presence or absence of flattened heart sign on postmortem CT, were measured. RESULTS. There were statistically significant differences in fluid-fluid level and pericardial hyperdense ring between the postmortem and antemortem groups (p < 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of fluid-fluid level for detecting postmortem pericardial hemorrhage were 86%, 96%, 86%, and 100%, respectively. The mean attenuation of pericardial hemorrhage lesions differed statistically significantly between the groups (p = 0.004). The presentation of the flattened heart sign did not differ statistically significantly between the groups (p = 0.681). CONCLUSION. Fluid-fluid level and pericardial hyperdense ring on postmortem CT, combined with attenuation, are useful for differentiating between antemortem and postmortem pericardial hemorrhage secondary to chest compression.	[Yamaguchi, Rutsuko; Makino, Yohsuke; Chiba, Fumiko; Torimitsu, Suguru; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yamaguchi, Rutsuko; Makino, Yohsuke; Chiba, Fumiko; Torimitsu, Suguru; Yajima, Daisuke; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chiba, Japan; [Makino, Yohsuke] Chiba Univ, Dept Forens Radiol & Imaging, Educ & Res Ctr Legal Med, Chiba, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Yamaguchi, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	rymgch@m.u-tokyo.ac.jp					Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Burke M, 2012, FORENSIC SCI MED PAT, V8, P367, DOI 10.1007/s12024-012-9347-9; Jackowski C, 2006, INT J LEGAL MED, V120, P233, DOI 10.1007/s00414-005-0023-4; Le Blanc-Louvry I, 2013, EUR RADIOL, V23, P1829, DOI 10.1007/s00330-013-2779-0; Takahashi N, 2012, EUR RADIOL, V22, P152, DOI 10.1007/s00330-011-2248-6; Ishikawa N, 2013, J FORENSIC LEG MED, V20, P1075, DOI 10.1016/j.jflm.2013.09.026; Levy AD, 2006, RADIOLOGY, V240, P522, DOI 10.1148/radiol.2402050972; Miller AC, 2014, RESUSCITATION, V85, P724, DOI 10.1016/j.resuscitation.2014.01.028; TAKEICHI S, 1984, AM J FOREN MED PATH, V5, P223, DOI 10.1097/00000433-198409000-00006; TAKEICHI S, 1986, AM J FOREN MED PATH, V7, P35, DOI 10.1097/00000433-198603000-00007; Federle MP, 2007, AM J ROENTGENOL, V188, P1324, DOI 10.2214/AJR.05.1911; Restrepo CS, 2007, RADIOGRAPHICS, V27, P1595, DOI 10.1148/rg.276065002; Filograna L, 2015, RADIOL MED, V120, P723, DOI 10.1007/s11547-015-0517-1; Filograna L, 2014, LEGAL MED-TOKYO, V16, P247, DOI 10.1016/j.legalmed.2014.05.005; Day CM, 2011, AM J ROENTGENOL, V196, pW166, DOI 10.2214/AJR.10.4446; Shojania KG, 2008, NEW ENGL J MED, V358, P873, DOI 10.1056/NEJMp0707996; Parizel PM, 2001, EUR RADIOL, V11, P1770; TAKEICHI S, 1985, AM J FOREN MED PATH, V6, P25, DOI 10.1097/00000433-198503000-00006; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Iwase H, 2010, J FORENSIC SCI, V55, P1509, DOI 10.1111/j.1556-4029.2010.01465.x; Hanneman K, 2014, J CARDIOVASC COMPUT, V8, P149, DOI 10.1016/j.jcct.2013.12.017; Filograna L, 2013, FORENSIC SCI INT, V228, pE76, DOI 10.1016/j.forsciint.2013.01.039; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Ross S, 2008, AM J ROENTGENOL, V190, P1380, DOI 10.2214/AJR.07.3082; Hoke RS, 2004, RESUSCITATION, V63, P327, DOI 10.1016/j.resuscitation.2004.05.019; Kasahara S, 2012, LEGAL MED-TOKYO, V14, P239, DOI 10.1016/j.legalmed.2012.03.007; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; GOLDSTEIN L, 1989, AM J ROENTGENOL, V152, P739; Gold MM, 2008, J COMPUT ASSIST TOMO, V32, P72, DOI 10.1097/rct.0b013e31815b3ebf; Palmiere C, 2012, FORENSIC SCI INT, V222, P33, DOI 10.1016/j.forsciint.2012.04.031; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; KRISCHER JP, 1987, CHEST, V92, P287, DOI 10.1378/chest.92.2.287; Poulsen K, 2007, FORENSIC SCI INT, V171, P190, DOI 10.1016/j.forsciint.2006.05.041; Shiotani S, 2002, J COMPUT ASSIST TOMO, V26, P892, DOI 10.1097/00004728-200211000-00006; Hellevuo H, 2013, RESUSCITATION, V84, P760, DOI 10.1016/j.resuscitation.2013.02.015; HernandezLuyando L, 1996, EUR J RADIOL, V23, P250, DOI 10.1016/S0720-048X(96)00781-4; Hoey BA, 2007, J TRAUMA, V63, P979, DOI 10.1097/TA.0b013e318154011f; Schreiber M, 2007, J TRAUMA, V63, P985; O'Donnell C, 2007, Forensic Sci Med Pathol, V3, P226, DOI 10.1007/s12024-007-9006-8; Sakamoto N, 2009, JPN J ACUTE MED, V33, P985; Shiotani Seiji, 2004, Radiat Med, V22, P405	41	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	DEC	2015	205	6					W568	W577		10.2214/AJR.15.14808		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW9LO	WOS:000365320400002		
J	Kurita, T; Morita, K; Sato, S				Kurita, Tadayoshi; Morita, Koji; Sato, Shigehito			The Influence of Hypovolemia and Fluid Resuscitation During Hemorrhagic Shock on Apneic Oxygen Desaturation After Preoxygenation in a Swine Model	ANESTHESIA AND ANALGESIA			English	Article							ACUTE KIDNEY INJURY; PHARMACODYNAMIC ANALYSIS; METABOLIC-RESPONSE; PROPOFOL; ANEMIA; VENTILATION; ISOFLURANE; ANESTHESIA	BACKGROUND: Patients experiencing major bleeding often require both aggressive fluid resuscitation and rapid sequence tracheal intubation. The influence of hemorrhage-induced hypovolemia, and/or subsequent fluid resuscitation, on the time until critical oxygen desaturation is not well described. We studied the time to oxygen desaturation in a pig model of hemorrhage shock and colloid resuscitation. METHODS: After anesthetic induction with isoflurane, 9 swine (mean SD = 25.3 0.6 kg) were studied with the use of a stepwise hemorrhage and fluid resuscitation model with 4 sequential stages: 600 mL hemorrhage, 600 mL hydroxyethyl starch infusion, a further 600 mL hemorrhage, and a second 600 mL hydroxyethyl starch infusion. At each stage, after 5 minutes of mechanical ventilation with 100% oxygen, we induced apnea and measured the time to oxygen desaturation (oxygen saturation [Spo(2)] <70%). Hemodynamic and blood gas variables were recorded, and the cerebral and peripheral tissue oxygenation indices were recorded by near-infrared spectroscopy. RESULTS: The times +/- SD to Spo(2) <70% at each stage were 136 +/- 41 (baseline), 147 +/- 41 (hemorrhage), 131 +/- 38 (resuscitation), 147 +/- 38 (repeat hemorrhage), and 134 +/- 36 seconds (repeat resuscitation). The mean differences in times before and after hemorrhage were 11.2 (6.5 to 16.0, P = 0.0052) and 16.0 (11.0 to 21.0, P < 0.0001), respectively. Pao(2) before and after apneic desaturation (at Spo(2) < 70%) was not different between stages. On the basis of tissue oxygenation index findings, hypovolemia decreased oxygen consumption, and fluid resuscitation recovered this parameter. CONCLUSIONS: In patients with acute hemorrhagic shock, a hypovolemic state increases the duration of apnea until critical oxygen desaturation. Clinicians should thus consider the relationship between fluid resuscitation and time to desaturation when performing tracheal intubation in such patients.	[Kurita, Tadayoshi; Morita, Koji; Sato, Shigehito] Hamamatsu Univ Sch Med, Dept Anesthesiol & Intens Care, Hamamatsu, Shizuoka 4313192, Japan	Kurita, T (reprint author), Hamamatsu Univ Sch Med, Dept Anesthesiol & Intens Care, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	tadkur@hama-med.ac.jp					WARNER MA, 1993, ANESTHESIOLOGY, V78, P56, DOI 10.1097/00000542-199301000-00010; Ickx BE, 2000, ANESTHESIOLOGY, V93, P1011, DOI 10.1097/00000542-200010000-00024; Heier T, 2001, ANESTHESIOLOGY, V94, P754, DOI 10.1097/00000542-200105000-00011; Morris J, 2001, ANAESTHESIA, V56, P1090, DOI 10.1046/j.1365-2044.2001.01962.x; Hare GMT, 2003, J APPL PHYSIOL, V94, P2058, DOI 10.1152/japplphysiol.00931.2002; Baraka A, 2000, CAN J ANAESTH, V47, P1144; Kurita T, 2003, BRIT J ANAESTH, V91, P871, DOI 10.1093/bja/aeg259; Yamamoto K, 1999, CAN J ANAESTH, V46, P1150; Ishikawa S, 2012, ANESTH ANALG, V114, P1256, DOI 10.1213/ANE.0b013e31824e2d20; Pehbock D, 2010, ANESTHESIOLOGY, V113, P593, DOI 10.1097/ALN.0b013e3181e73f07; Kurita T, 2011, BRIT J ANAESTH, V107, P719, DOI 10.1093/bja/aer233; HOLT JP, 1968, AM J PHYSIOL, V215, P704; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Kurita T, 2005, ANESTHESIOLOGY, V103, P1189, DOI 10.1097/00000542-200512010-00013; van Bommel J, 2002, ANESTHESIOLOGY, V97, P660, DOI 10.1097/00000542-200209000-00021; Mort TC, 2005, CRIT CARE MED, V33, P2672, DOI 10.1097/01.CCM.0000187131.67594.9E; Johnson KB, 2004, ANESTHESIOLOGY, V101, P647, DOI 10.1097/00000542-200409000-00013; Yoshitani K, 2007, ANESTHESIOLOGY, V106, P458, DOI 10.1097/00000542-200703000-00009; Johnson KB, 2003, ANESTHESIOLOGY, V99, P409, DOI 10.1097/00000542-200308000-00023; Hand WR, 2015, ANESTH ANALG, V120, P619, DOI 10.1213/ANE.0000000000000374; Kurita Tadayoshi, 2007, Anesth Analg, V105, P1639; Sun NN, 2014, ADV EXP MED BIOL, V812, P217, DOI 10.1007/978-1-4939-0620-8_29	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	DEC	2015	121	6					1555	1561		10.1213/ANE.0000000000000979		7	Anesthesiology	Anesthesiology	CX2BD	WOS:000365499000003		
J	Miura, T; Kita, A; Okamura, Y; Aki, T; Matsumura, Y; Tajima, T; Kato, J; Nakashimada, Y				Miura, Toyokazu; Kita, Akihisa; Okamura, Yoshiko; Aki, Tsunehiro; Matsumura, Yukihiko; Tajima, Takahisa; Kato, Junichi; Nakashimada, Yutaka			Effect of Salinity on Methanogenic Propionate Degradation by Acclimated Marine Sediment-Derived Culture	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Methane production; Acetogenesis; Salt tolerance; Marine sediments; Microbial community; Propionate degraders; Methanogens	ANAEROBIC-DIGESTION; MICROBIAL COMMUNITIES; METHANE PRODUCTION; SODIUM INHIBITION; BROWN-ALGAE; SP-NOV; FERMENTATION; REACTORS; SLUDGE; BATCH	Degradation of propionate under high salinity is needed for biomethane production from salt-containing feedstocks. In this study, marine sediment-derived culture was evaluated to determine the effect of salinity on methanogenic propionate degradation. Microbes in marine sediments were subjected to fed-batch cultivation on propionate for developing acclimatized cultures. The rate of propionate degradation increased eightfold during 10 rounds of cultivation. Microbial community composition was determined through pyrosequencing of 16S rRNA gene amplicons after 10 rounds of cultivation. Taxa analysis was conducted for the reads obtained by pyrosequencing. Known propionate degraders were undetectable in the acclimated culture. Comparison of bacterial taxa in the original sediment with those in the acclimated culture revealed that the populations of four bacterial taxa were significantly increased during acclimation. Methanolobus was the predominant archaea genus in the acclimated culture. The propionate degradation rate of the acclimated culture was not affected by salinity of up to equivalent of 1.9 % NaCl. The rate decreased at higher salinity levels and was more than 50 % of the maximum rate even at equivalent of 4.3 % NaCl.	[Miura, Toyokazu; Kita, Akihisa; Okamura, Yoshiko; Aki, Tsunehiro; Tajima, Takahisa; Kato, Junichi; Nakashimada, Yutaka] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398530, Japan; [Matsumura, Yukihiko] Hiroshima Univ, Inst Engn, Div Energy & Environm Engn, Hiroshima 7398527, Japan; [Miura, Toyokazu; Kita, Akihisa; Okamura, Yoshiko; Aki, Tsunehiro; Tajima, Takahisa; Nakashimada, Yutaka] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Nakashimada, Y (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan.	nyutaka@hiroshima-u.ac.jp	Aki, Tsunehiro/B-6719-2012	Aki, Tsunehiro/0000-0001-9753-2043	Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST)	This work was supported by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST).	LIU YT, 1991, BIORESOURCE TECHNOL, V35, P271, DOI 10.1016/0960-8524(91)90124-3; Kendall MM, 2006, FEMS MICROBIOL LETT, V262, P107, DOI 10.1111/j.1574-6968.2006.00380.x; Miura T, 2014, BIORESOURCE TECHNOL, V169, P362, DOI 10.1016/j.biortech.2014.07.013; MAWSON AJ, 1991, WATER RES, V25, P1549, DOI 10.1016/0043-1354(91)90187-U; Li YF, 2015, APPL MICROBIOL BIOT, V99, P969, DOI 10.1007/s00253-014-6036-5; SCHRAMM W, 1984, HYDROBIOLOGIA, V116, P282, DOI 10.1007/BF00027685; Ras Monique, 2011, Bioresour Technol, V102, P200, DOI 10.1016/j.biortech.2010.06.146; Jard G, 2012, CHEM ENG J, V209, P513, DOI 10.1016/j.cej.2012.08.010; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Wu SY, 2011, APPL ENVIRON MICROB, V77, P830, DOI 10.1128/AEM.01539-10; Mottet A, 2014, BIORESOURCE TECHNOL, V158, P300, DOI 10.1016/j.biortech.2014.02.055; Ito T, 2012, BIORESOURCE TECHNOL, V123, P599, DOI 10.1016/j.biortech.2012.07.108; Ma JX, 2009, WATER RES, V43, P3239, DOI 10.1016/j.watres.2009.04.046; Stams AJM, 2012, WATER SCI TECHNOL, V66, P352, DOI 10.2166/wst.2012.192; Gao YH, 2014, BIORESOURCE TECHNOL, V153, P245, DOI 10.1016/j.biortech.2013.11.077; FEIJOO G, 1995, ENZYME MICROB TECH, V17, P180, DOI 10.1016/0141-0229(94)00011-F; Abildgaard L, 2004, INT J SYST EVOL MICR, V54, P393, DOI 10.1099/ijs.0.02820-0; Ma JX, 2009, BIORESOURCE TECHNOL, V100, P3477, DOI 10.1016/j.biortech.2009.02.060; Sakai S, 2012, INT J SYST EVOL MICR, V62, P1389, DOI 10.1099/ijs.0.035048-0; MCCARTY PL, 1986, ENVIRON SCI TECHNOL, V20, P1200, DOI 10.1021/es00154a002; RINZEMA A, 1988, ENZYME MICROB TECH, V10, P24, DOI 10.1016/0141-0229(88)90094-4; Miura T, 2015, BIORESOURCE TECHNOL, V187, P275, DOI 10.1016/j.biortech.2015.03.142; Plugge CM, 2011, FRONT MICROBIOL, V2, P1	23	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	DEC	2015	177	7					1541	1552		10.1007/s12010-015-1834-5		12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CW7GH	WOS:000365165500013		
J	Shimazaki, Y; Takatsu, Y				Shimazaki, Youji; Takatsu, Yoko			Combined Method of Immunoaffinity Membrane Within Tubes and MALDI-TOF MS for Capturing and Analyzing Amyloid Beta	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						MALDI-TOFMS; Amyloid beta; Thioflavin Tassay; Micro-space	CEREBROSPINAL-FLUID; IMMOBILIZED AVIDIN; ELECTROPHORESIS; CHROMATOGRAPHY	Amyloid beta 1-40 peptide was specifically isolated and analyzed from human plasma spiked with amyloid beta using a combined method of biotinylated anti-amyloid beta antibody binding to membrane-immobilized avidin (immunoaffinity membrane) and matrix-assisted laser desorption /ionization time-of-flight mass spectrometry (MALDI-TOF MS). A solution of 10 mu L containing 13.6 ng to 2.9 mu g of amyloid beta peptide was examined in this method. After the isolated amyloid beta peptide from the spiked human plasma containing 2.9 mu g of amyloid beta peptide was incubated in the presence of trifluoroacetic acid, fibrillization of the peptides was observed using a thioflavin T assay. Furthermore, an immunoaffinity membrane present on the inner wall of a tube (diameter 2 mm) captured the amyloid beta peptide from the spiked human plasma. Our results indicate that the combination of the immunoaffinity membrane procedure and MALDI-TOF MS can be used to capture and analyze the target antigens such as amyloid beta in micro-spaces.	[Shimazaki, Youji] Ehime Univ, Grad Sch Sci & Engn Sci, Dept Biol & Chem, Matsuyama, Ehime 7908577, Japan; [Takatsu, Yoko] Ehime Univ, Fac Sci, Matsuyama, Ehime 7908577, Japan	Shimazaki, Y (reprint author), Ehime Univ, Grad Sch Sci & Engn Sci, Dept Biol & Chem, Matsuyama, Ehime 7908577, Japan.	shimazaki.yoji.my@ehime-u.ac.jp			JSPS KAKENHI [25410145]	This work was supported by JSPS KAKENHI Grant Number 25410145. The mass analysis of amyloid beta was carried out on a MALDI-TOF MS (Voyager-DE PRO) at the Applied Protein Research Laboratory.	Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Shimazaki Y, 2012, PROTEIN EXPRES PURIF, V83, P177, DOI 10.1016/j.pep.2012.03.017; Chaves AR, 2013, J CHROMATOGR B, V928, P37, DOI 10.1016/j.jchromb.2013.03.016; Verwey NA, 2009, J IMMUNOL METHODS, V348, P57, DOI 10.1016/j.jim.2009.06.011; Shimazaki Y, 2013, CLIN CHIM ACTA, V425, P48, DOI 10.1016/j.cca.2013.07.004; Karoor S, 2003, BIOTECHNOL BIOENG, V81, P134, DOI 10.1002/bit.10555; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Shimazaki Y, 2014, J CHROMATOGR B, V972, P53, DOI 10.1016/j.jchromb.2014.09.021; Shimazaki Y, 2012, ANAL BIOCHEM, V422, P55, DOI 10.1016/j.ab.2011.12.023; Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015; Kawashima N., 2013, NEUROSCI RES, V76, P169; Ortiz-Martin L, 2015, ELECTROPHORESIS, V36, P962, DOI 10.1002/elps.201400374	12	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	DEC	2015	177	7					1565	1571		10.1007/s12010-015-1837-2		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CW7GH	WOS:000365165500015		
J	Nakato, T; Nakano, Y; Mouri, E				Nakato, Teruyuki; Nakano, Yusuke; Mouri, Emiko			Effects of sol-gel transition of clay colloids on the spectroscopic behavior of cationic dye adsorbed on the clay particles	APPLIED CLAY SCIENCE			English	Article						Clay colloid; Laponite; Sol-gel transition; Rhodamine; Fluorescence	ANGLE NEUTRON-SCATTERING; RHODAMINE 6G; AQUEOUS SUSPENSIONS; INORGANIC NANOSHEETS; SPECTRAL PROPERTIES; LAYERED SILICATES; METHYLENE-BLUE; LAPONITE-B; DISPERSIONS; MONTMORILLONITE	Colloidal systems of smectite-type clay minerals have been examined as heterogeneous media of photofunctional molecules. However, behavior of the photoactive molecules adsorbed on the colloidal clay particles has not been systematically investigated in relation to the sol-gel transition of the clay colloids. We investigated effects of the sol-gel transition on the spectroscopic behavior of a cationic rhodamine dye adsorbed on the colloidal particles of synthetic hectorite (Laponite). The adsorbed dye indicated shift of the absorption and emission wavelengths occurring within a few days independent of the sol-gel transition, as well as increase in the fluorescence intensity that took place synchronously to the gelation occurring in a much longer time range dependent on the clay concentration. Observations of the sol-gel transition by fluidity loss at a macroscopic scale and alteration of the profile of autocorrelation function measured by dynamic light scattering (DLS) indicated that the former technique established the completion of the arrest of clay particles but the latter one tended to detect the beginning of the gelation. The increase in the fluorescence intensity of the dye started at the timing similar to that of the commencement of the sol-gel transition indicated by DLS. (C) 2015 Elsevier B.V. All rights reserved.	[Nakato, Teruyuki; Nakano, Yusuke; Mouri, Emiko] Kyushu Inst Technol, Dept Appl Chem, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Nakato, T (reprint author), Kyushu Inst Technol, Dept Appl Chem, Tobata Ku, 1-1 Sensui Cho, Kitakyushu, Fukuoka 8048550, Japan.	nakato@che.kyutech.ac.jp			JSPS KAKENHI grant [26620195, 15H03878]	This work was supported by JSPS KAKENHI grant numbers 26620195 and 15H03878.	Jabbari-Farouji S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.065701; ARBELOA FL, 1995, LANGMUIR, V11, P3211; GHOSH PK, 1984, J PHYS CHEM-US, V88, P5519, DOI 10.1021/j150667a012; ten Brinke AJW, 2007, SOFT MATTER, V3, P1145, DOI 10.1039/b704742h; Michot LJ, 2009, LANGMUIR, V25, P127, DOI 10.1021/la801894a; Czimerova A, 2011, J COLLOID INTERF SCI, V357, P322, DOI 10.1016/j.jcis.2011.01.069; Mourchid A, 1995, FARADAY DISCUSS, V101, P275, DOI 10.1039/fd9950100275; Paineau E, 2013, LIQ CRYST REV, V1, P110, DOI 10.1080/21680396.2013.842130; YARIV S, 1990, J CHEM SOC FARADAY T, V86, P1593, DOI 10.1039/ft9908601593; OGAWA M, 1992, J PHYS CHEM-US, V96, P8116, DOI 10.1021/j100199a054; Bujdak J, 2012, J COLLOID INTERF SCI, V388, P15, DOI 10.1016/j.jcis.2012.08.020; Suzuki Y, 2011, J PHYS CHEM C, V115, P20653, DOI 10.1021/jp203809b; Kroon M, 1996, PHYS REV E, V54, P6541, DOI 10.1103/PhysRevE.54.6541; RAMSAY JDF, 1993, J CHEM SOC FARADAY T, V89, P4207, DOI 10.1039/ft9938904207; Mourchid A, 1998, LANGMUIR, V14, P4718, DOI 10.1021/la980117p; Bujdak J, 2004, J PHYS CHEM B, V108, P4470, DOI 10.1021/jp037607x; Ishida Y, 2014, J PHYS CHEM C, V118, P20466, DOI 10.1021/jp506766t; Bonn D, 1999, LANGMUIR, V15, P7534, DOI 10.1021/la990167+; Eguchi M, 2013, J PHYS CHEM C, V117, P9245, DOI 10.1021/jp400645d; Ishida Y, 2012, ACS APPL MATER INTER, V4, P811, DOI 10.1021/am201465a; Czimerova A, 2004, J COLLOID INTERF SCI, V274, P126, DOI 10.1016/j.jcis.2003.10.025; Mourchid A, 1998, PHYS REV E, V57, pR4887, DOI 10.1103/PhysRevE.57.R4887; ESTEVEZ MJT, 1993, LANGMUIR, V9, P3629; Arbeloa FL, 2006, CHEM MATER, V18, P1407, DOI 10.1021/cm051518a; Rao KV, 2011, ANGEW CHEM INT EDIT, V50, P1179, DOI 10.1002/anie.201006270; ESTEVEZ MJT, 1995, J COLLOID INTERF SCI, V171, P439, DOI 10.1006/jcis.1995.1200; Xie LM, 2009, J AM CHEM SOC, V131, P9890, DOI 10.1021/ja9037593; DIJKSTRA M, 1995, PHYS REV LETT, V75, P2236, DOI 10.1103/PhysRevLett.75.2236; Bujdak J, 2002, J COLLOID INTERF SCI, V247, P494, DOI 10.1006/jcis.2001.8140; Ruzicka B, 2011, SOFT MATTER, V7, P1268, DOI 10.1039/c0sm00590h; Jabbari-Farouji S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061402; Arbeloa FL, 2007, J PHOTOCH PHOTOBIO C, V8, P85, DOI 10.1016/j.jphotochemrev.2007.03.003; Pignon F, 1997, PHYS REV E, V56, P3281, DOI 10.1103/PhysRevE.56.3281; Nicolai T, 2001, EUR PHYS J E, V5, P221, DOI 10.1007/s101890170077; NAKAMURA T, 1986, J PHYS CHEM-US, V90, P641, DOI 10.1021/j100276a032; Sasai R, 2002, LANGMUIR, V18, P6578, DOI 10.1021/la020183y; Suzuki Y, 2012, CHEM-ASIAN J, V7, P1170, DOI 10.1002/asia.201200049; Shalkevich A, 2007, LANGMUIR, V23, P3570, DOI 10.1021/la062996i; Umemura Y, 2002, J AM CHEM SOC, V124, P992, DOI 10.1021/ja016005t; VILLEMURE G, 1985, CAN J CHEM, V63, P1139, DOI 10.1139/v85-193; Arbeloa FL, 1997, CLAY MINER, V32, P97; Bujdak J, 2003, PHYS CHEM CHEM PHYS, V5, P4680, DOI 10.1039/b305699f; GRAUER Z, 1984, CAN J CHEM, V62, P1889, DOI 10.1139/v84-324; OGAWA M, 1995, CHEM REV, V95, P399, DOI 10.1021/cr00034a005; Shinozaki R, 2004, LANGMUIR, V20, P7583, DOI 10.1021/la049354k; Nakato T, 2012, J PHYS CHEM C, V116, P8562, DOI 10.1021/jp2118899; Tudisca V, 2012, RSC ADV, V2, P11111, DOI 10.1039/c2ra21486e; Jonsson B, 2008, LANGMUIR, V24, P11406, DOI 10.1021/la801118v; DELLAGUARDIA RA, 1983, J PHYS CHEM-US, V87, P3550, DOI 10.1021/j100241a037; ESTEVEZ MJT, 1994, CLAY MINER, V29, P105; AVERY RG, 1986, J COLLOID INTERF SCI, V109, P448, DOI 10.1016/0021-9797(86)90322-X; Zitnan M, 2009, LANGMUIR, V25, P6800, DOI 10.1021/la9006795; Takagi S, 2006, J PHOTOCH PHOTOBIO C, V7, P104, DOI 10.1016/j.jphotochemrev.2006.04.002; Takagi S, 2013, LANGMUIR, V29, P2108, DOI 10.1021/la3034808; ESTEVEZ MJT, 1994, J COLLOID INTERF SCI, V162, P412; Ooka C, 2003, APPL CATAL B-ENVIRON, V41, P313, DOI 10.1016/S0926-3373(02)00169-8; Pignon F, 1997, PHYS REV LETT, V79, P4689, DOI 10.1103/PhysRevLett.79.4689; Levitz P, 2000, EUROPHYS LETT, V49, P672, DOI 10.1209/epl/i2000-00203-9; Auerbach SM, 2004, HDB LAYERED MAT; Bonn D., 2002, PHYS REV LETT, V89; Brandenburg U., 1988, Applied Clay Science, V3, P263, DOI 10.1016/0169-1317(88)90033-6; Jabbari-Farouji S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061405; Jacobs KY, 1999, J COLLOID INTERF SCI, V220, P103, DOI 10.1006/jcis.1999.6513; Marques FAD, 2015, SOFT MATTER, V11, P466, DOI 10.1039/c4sm02010c; Nakato T., 2013, CLAY SCI, V17, P23; RAND B, 1980, J CHEM SOC FARAD T 1, V76, P225, DOI 10.1039/f19807600225; Ruzicka B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.258301; Shichi T., 2000, J PHOTOCH PHOTOBIO C, V1, P113, DOI 10.1016/S1389-5567(00)00008-3; Tanaka H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021402; Tanaka H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031404; Theng BKG, 1974, CHEM CLAY ORGANIC RE; van Olphen H., 1991, CLAY COLLOID CHEM	72	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-1317	1872-9053		APPL CLAY SCI	Appl. Clay Sci.	DEC	2015	118						29	37		10.1016/j.clay.2015.138.032		9	Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy	Chemistry; Materials Science; Mineralogy	CW5SH	WOS:000365056400004		
J	Yin, YH; Mizokami, S; Aikawa, K				Yin, Yanhong; Mizokami, Shoshi; Aikawa, Kohei			Compact development and energy consumption: Scenario analysis of urban structures based on behavior simulation	APPLIED ENERGY			English	Article						Energy consumption; Compact development; Urban structure; Consumption behavior	EMPIRICAL-ANALYSIS; CO2 EMISSIONS; FORM; CITIES; IMPACT; REQUIREMENTS; MOBILITY; DENSITY; TRAVEL	This study investigates the relationship between compact development and energy consumption by simulating individual consumption behaviors in monocentric and polycentric urban structures in Kumamoto in 2030. A model is developed to estimate individual consumption behaviors and demand of mobility goods and non-mobility goods at micro level. By considering the economic factor of income, the energy consumption is calculated based on demand of goods under Business as usual scenario, Central Core City scenario, and Multi-pole structure scenario. Results indicate the urban structure influences individual consumption behaviors and energy consumption. Increased consumption of the non-mobility goods and mass transit trips is shown in Central Core City scenario and the Multi-pole structure scenario. Monocentric urban structures as shown in Central Core City scenario show less effect on energy consumption than the polycentric urban structure in Multi-pole structure scenario. The findings suggest that the multi-pole urban structure is a better choice for compact development in Kumamoto based on less energy consumption. The method in this study provides a new approach to analyze the influence of urban structure on energy consumption at micro level. Findings give good suggestions for planning policy making regarding to compact development in Kumamoto. (C) 2015 Elsevier Ltd. All rights reserved.	[Yin, Yanhong] Ningbo Univ, Fac Maritime & Transportat, Ningbo 315211, Zhejiang, Peoples R China; [Yin, Yanhong] Ningbo Univ Subctr, Natl Traff Management Engn & Technol Res Ctr, Ningbo 315211, Zhejiang, Peoples R China; [Mizokami, Shoshi] Kumamoto Univ, Dept Civil & Environm Engn, Kumamoto 8608555, Japan; [Aikawa, Kohei] Obayashi Corp, Minato Ku, Tokyo 1070062, Japan	Yin, YH (reprint author), Ningbo Univ, Fac Maritime & Transportat, 818 Fenghua Rd, Ningbo 315211, Zhejiang, Peoples R China.	yinyanhong@nbu.edu.cn; smizo@gpo.kumamoto-u.ac.jp			Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; National Science Foundation of China (NSFC) [41301171]; K.C. Wong Magna Fund in Ningbo University; key discipline of "Transportation planning and management" in Ningbo city	The work is funded by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The paper was also supported by the National Science Foundation of China (NSFC) (41301171). It is also supported by K.C. Wong Magna Fund in Ningbo University and the project of "Subsidy stimulation mechanism and the influence on the operation of bus companies" sponsored by the key discipline of "Transportation planning and management" in Ningbo city.	Gaigne C, 2012, J URBAN ECON, V72, P123, DOI 10.1016/j.jue.2012.04.001; [Anonymous], INC DAT KUM; Grazi F, 2008, ENERG J, V29, P97; Zhang CG, 2012, ENERG POLICY, V49, P488, DOI 10.1016/j.enpol.2012.06.048; Camagni R, 2002, ECOL ECON, V40, P199, DOI 10.1016/S0921-8009(01)00254-3; Lenzen M, 2004, ECOL ECON, V49, P375, DOI 10.1016/j.ecolecon.2004.01.019; Yao YL, 2011, ENRGY PROCED, V5, P895, DOI 10.1016/j.egypro.2011.03.158; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Jabareen YR, 2006, J PLAN EDUC RES, V26, P38, DOI 10.1177/0739456X05285119; Lee S, 2014, ENERG POLICY, V68, P534, DOI 10.1016/j.enpol.2014.01.024; Van der Laan L, 1998, REG STUD, V32, P235; Chau CK, 2015, APPL ENERG, V143, P395, DOI 10.1016/j.apenergy.2015.01.023; Dujardin S, 2014, ENERG BUILDINGS, V68, P779, DOI 10.1016/j.enbuild.2012.10.059; Bouchair A, 2013, ENRGY PROCED, V42, P493, DOI 10.1016/j.egypro.2013.11.050; Yamagata Y, 2013, APPL ENERG, V112, P1466, DOI 10.1016/j.apenergy.2013.01.061; Chen HY, 2008, HABITAT INT, V32, P28, DOI 10.1016/j.habitatint.2007.06.005; Brownstone D, 2009, J URBAN ECON, V65, P91, DOI 10.1016/j.jue.2008.09.002; Wiedenhofer D, 2013, ENERG POLICY, V63, P696, DOI 10.1016/j.enpol.2013.07.035; Lenzen M, 1998, ENERGY, V23, P497, DOI 10.1016/S0360-5442(98)00020-6; [Anonymous], PRIC LAND FRONT MAJ; [Anonymous], RUNN FAR UN CAR TRIP; Liu XC, 2012, ENERG POLICY, V46, P359, DOI 10.1016/j.enpol.2012.03.070; Schwanen T, 2004, URBAN STUD, V41, P579, DOI 10.1080/0042098042000178690; Yin YH, 2013, ENERG POLICY, V61, P909, DOI 10.1016/j.enpol.2013.06.054; Bulkeley H, 2003, CITIES CLIMATE CHANG; Burton E, 2004, COMPACT CITY SUSTAIN; Cervero R, 2010, ENVIRON PLANN A, V42, P400, DOI 10.1068/a4236; Crane R, 2000, J PLAN LIT, V5, P3; Feng Z, 2010, ENERGY, V36, P656; Guy S, 2000, ACHIEVING SUSTAINABL; Kanemoto Y, 2006, MICROECONOMIC MODELI; Lo Alex YH, 2012, LAND USE POLICY, V29, P577; Newman Peter, 1999, SUSTAINABILITY CITIE; Westerink J, 2013, EUR PLAN STUD, V21, P473, DOI 10.1080/09654313.2012.722927	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0306-2619	1872-9118		APPL ENERG	Appl. Energy	DEC 1	2015	159						449	457		10.1016/j.apenergy.2015.09.005		9	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CW3GV	WOS:000364880900040		
J	Nagata, Y; Ohtsubo, Y; Tsuda, M				Nagata, Yuji; Ohtsubo, Yoshiyuki; Tsuda, Masataka			Properties and biotechnological applications of natural and engineered haloalkane dehalogenases	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Haloalkane dehalogenase; Environmental pollutant; Halogenated compound; Hydrolase; Protein engineering; Bacterial genome; Protein evolution	SPHINGOMONAS-PAUCIMOBILIS UT26; XANTHOBACTER-AUTOTROPHICUS GJ10; SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; GAMMA-HEXACHLOROCYCLOHEXANE; BETA-HEXACHLOROCYCLOHEXANE; HETEROLOGOUS EXPRESSION; BIOCHEMICAL-CHARACTERIZATION; DELTA-HEXACHLOROCYCLOHEXANE	Haloalkane dehalogenases (HLDs) convert halogenated compounds to corresponding alcohols, halides, and protons. They belong to alpha/beta-hydrolases, and their principal catalytic mechanism is S(N)2 nucleophilic substitution followed by the addition of water. Since HLDs generally have broad and different substrate specificities, they have various biotechnological applications. HLDs have previously been believed to be present only in bacterial strains that utilize xenobiotic halogenated compounds, and three archetypal HLDs, i.e., DhlA, DhaA, and LinB, have been intensively investigated by biochemical, structural, and computational analyses. Furthermore, by using the resulting data and target-selected random mutagenesis approaches, these HLDs have been successfully engineered to improve their substrate specificities and activities. In addition, important insights into protein evolution have been obtained by studying these HLDs. At the same time, the genome and metagenome information has revealed that HLD homologues are widely distributed in many bacterial strains, including ones that have not been reported to degrade halogenated compounds. Some of these cryptic HLD homologues have been experimentally confirmed to be "true" HLDs with unique substrate specificities and enantioselectivities. Although their biological functions and physiological roles remain mysterious, these potential HLDs are considered promising materials for the development of new biocatalysts.	[Nagata, Yuji; Ohtsubo, Yoshiyuki; Tsuda, Masataka] Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, Sendai, Miyagi 9808577, Japan	Nagata, Y (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Environm Life Sci, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	aynaga@ige.tohoku.ac.jp			JSPS KAKENHI [22380047, 25292043]	This work was partly supported by JSPS KAKENHI grant number 22380047 and 25292043.	Mena-Benitez GL, 2008, PLANT PHYSIOL, V147, P1192, DOI 10.1104/pp.108.119008; Sykora J, 2014, NAT CHEM BIOL, V10, P428, DOI 10.1038/nchembio.1502; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; Dravis BC, 2000, BIOTECHNOL BIOENG, V69, P235, DOI 10.1002/1097-0290(20000805)69:3<235::AID-BIT1>3.0.CO;2-D; NAGATA Y, 1993, J BACTERIOL, V175, P6403; Bohac M, 2002, BIOCHEMISTRY-US, V41, P14272, DOI 10.1021/bi026427v; Bosma T, 2002, APPL ENVIRON MICROB, V68, P3582, DOI 10.1128/AEM.68.7.3582-3587.2002; PRIES F, 1994, J BIOL CHEM, V269, P17490; Poelarends GJ, 1999, J BACTERIOL, V181, P2050; Chaloupkova R, 2014, ACTA CRYSTALLOGR D, V70, P1884, DOI 10.1107/S1399004714009018; Hladilkova J, 2013, J PHYS CHEM B, V117, P14329, DOI 10.1021/jp409040u; Devi-Kesavan LS, 2003, J AM CHEM SOC, V125, P1532, DOI 10.1021/ja026955u; Floor RJ, 2014, CHEMBIOCHEM, V15, P1659, DOI 10.1002/cbic.201402128; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Koudelakova T, 2013, BIOTECHNOL J, V8, P32, DOI 10.1002/biot.201100486; Sharir-Ivry A, 2015, CHEM-EUR J, V21, P7159, DOI 10.1002/chem.201406236; Ohana RF, 2009, PROTEIN EXPRES PURIF, V68, P110, DOI 10.1016/j.pep.2009.05.010; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Gehret JJ, 2012, PROTEIN SCI, V21, P239, DOI 10.1002/pro.2009; Bala K, 2012, ENVIRON SCI TECHNOL, V46, P4051, DOI 10.1021/es204143x; Kumar A, 2014, PROTEIN EXPRES PURIF, V99, P10, DOI 10.1016/j.pep.2014.03.003; Hasan K, 2011, APPL ENVIRON MICROB, V77, P1881, DOI 10.1128/AEM.02109-10; Holloway P, 1998, BIOTECHNOL BIOENG, V59, P520, DOI 10.1002/(SICI)1097-0290(19980820)59:4<520::AID-BIT16>3.0.CO;2-D; Swanson PE, 1999, CURR OPIN BIOTECH, V10, P365, DOI 10.1016/S0958-1669(99)80066-4; KAWASAKI H, 1992, J GEN MICROBIOL, V138, P1317; Lahoda M, 2014, ACTA CRYSTALLOGR D, V70, P209, DOI 10.1107/S1399004713026254; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Janssen DB, 2004, CURR OPIN CHEM BIOL, V8, P150, DOI 10.1016/j.cpba.2004.02.012; Nagata Y, 2003, APPL ENVIRON MICROB, V69, P2349, DOI 10.1128/AEM.69.4.2349-2355.2003; Fielman KT, 2001, ENVIRON TOXICOL CHEM, V20, P738, DOI 10.1897/1551-5028(2001)020<0738:PISAAS>2.0.CO;2; Drienovska I, 2012, APPL ENVIRON MICROB, V78, P4995, DOI 10.1128/AEM.00485-12; Novak HR, 2014, FEBS LETT, V588, P1616, DOI 10.1016/j.febslet.2014.02.056; FETZNER S, 1994, MICROBIOL REV, V58, P641; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Dvorak P, 2014, ENVIRON SCI TECHNOL, V48, P6859, DOI 10.1021/es500396r; Heeb NV, 2013, CHEMOSPHERE, V90, P1911, DOI 10.1016/j.chemosphere.2012.10.019; STUCKI G, 1994, APPL MICROBIOL BIOT, V42, P167; Kretz KA, 2004, METHOD ENZYMOL, V388, P3; Chaloupkova R, 2011, FEBS J, V278, P2728, DOI 10.1111/j.1742-4658.2011.08203.x; Mazumdar PA, 2008, BBA-PROTEINS PROTEOM, V1784, P351, DOI 10.1016/j.bbapap.2007.10.014; Wu J, 2007, APPL MICROBIOL BIOT, V73, P1097, DOI 10.1007/s00253-006-0579-z; Gray KA, 2003, ADV APPL MICROBIOL, V52, P1, DOI 10.1016/S0065-2164(03)01001-3; Jesenska A, 2009, APPL ENVIRON MICROB, V75, P5157, DOI 10.1128/AEM.00199-09; Hesseler M, 2011, APPL MICROBIOL BIOT, V91, P1049, DOI 10.1007/s00253-011-3328-x; Uchida E, 2005, ENVIRON SCI TECHNOL, V39, P7671, DOI 10.1021/es0506814; Jesenska A, 2005, APPL ENVIRON MICROB, V71, P6736, DOI 10.1128/AEM.71.11.6736-6745.2005; SENOO K, 1989, SOIL SCI PLANT NUTR, V35, P79; TARDIF G, 1991, APPL ENVIRON MICROB, V57, P1853; Daniel L, 2015, J CHEM INF MODEL, V55, P54, DOI 10.1021/ci500486y; Prokop Zbynek, 2006, Biotechnology Journal, V1, P1370, DOI 10.1002/biot.200600166; KEUNING S, 1985, J BACTERIOL, V163, P635; Kurumbang NP, 2014, ACS SYNTH BIOL, V3, P172, DOI 10.1021/sb400147n; Ito M, 2007, ARCH MICROBIOL, V188, P313, DOI 10.1007/s00203-007-0251-8; Heeb NV, 2012, ENVIRON SCI TECHNOL, V46, P6566, DOI 10.1021/es2046487; Fetzner S, 1998, APPL MICROBIOL BIOT, V50, P633; Widersten M, 1998, PROTEIN EXPRES PURIF, V13, P389, DOI 10.1006/prep.1998.0913; Koudelakova T, 2011, BIOCHEM J, V435, P345, DOI 10.1042/BJ20101405; Damborsky J, 2001, ENVIRON TOXICOL CHEM, V20, P2681, DOI 10.1897/1551-5028(2001)020<2681:SSRFHD>2.0.CO;2; Pikkemaat MG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.8.e35; Westerbeek A, 2011, ACS CATAL, V1, P1654, DOI 10.1021/cs2003565; James CA, 2009, CURR OPIN BIOTECH, V20, P237, DOI 10.1016/j.copbio.2009.02.014; Tratsiak K, 2013, ACTA CRYSTALLOGR F, V69, P683, DOI 10.1107/S1744309113012979; Fortova A, 2013, BIOCHIMIE, V95, P2091, DOI 10.1016/j.biochi.2013.07.025; Trincone A, 2011, MAR DRUGS, V9, P478, DOI 10.3390/md9040478; Jesenska A, 2002, APPL ENVIRON MICROB, V68, P3724, DOI 10.1128/AEM.68.8.3724-3730.2002; Sato Y, 2005, APPL ENVIRON MICROB, V71, P4372, DOI 10.1128/AEM.71.8.4372-4379.2005; Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185; Okai M, 2013, J BACTERIOL, V195, P2642, DOI 10.1128/JB.02020-12; Liu DS, 2012, ACS NANO, V6, P11080, DOI 10.1021/nn304793z; JANSSEN DB, 1989, J BACTERIOL, V171, P6791; Marek J, 2000, BIOCHEMISTRY-US, V39, P14082, DOI 10.1021/bi001539c; Nagata Y, 2007, APPL MICROBIOL BIOT, V76, P741, DOI 10.1007/s00253-007-1066-x; Sharma P, 2006, APPL ENVIRON MICROB, V72, P5720, DOI 10.1128/AEM.00192-06; Newman J, 1999, BIOCHEMISTRY-US, V38, P16105, DOI 10.1021/bi9913855; Schober M, 2013, TRENDS BIOTECHNOL, V31, P468, DOI 10.1016/j.tibtech.2013.05.005; Mattow J, 2001, ELECTROPHORESIS, V22, P2936, DOI 10.1002/1522-2683(200108)22:14<2936::AID-ELPS2936>3.0.CO;2-S; Schanstra JP, 1996, J BIOL CHEM, V271, P14747; Wu J, 2007, ENVIRON MICROBIOL, V9, P2331, DOI 10.1111/j.1462-2920.2007.01350.x; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.3.CO;2-D; Liskova V, 2015, CHEMCATCHEM, V7, P648, DOI 10.1002/cctc.201402792; Prokop Z, 2010, ANGEW CHEM INT EDIT, V49, P6111, DOI 10.1002/anie.201001753; SAHU SK, 1990, APPL ENVIRON MICROB, V56, P3620; Chaloupkova R, 2003, J BIOL CHEM, V278, P52622, DOI 10.1074/jbc.M306762200; Kotik M, 2012, J MICROBIOL METH, V88, P212, DOI 10.1016/j.mimet.2011.11.013; STUCKI G, 1995, ENVIRON SCI TECHNOL, V29, P2339, DOI 10.1021/es00009a028; Bosma T, 2003, BIOCHEMISTRY-US, V42, P8047, DOI 10.1021/bi026907m; Koudelakova T, 2013, ANGEW CHEM INT EDIT, V52, P1959, DOI 10.1002/anie.201206708; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707; Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g; Samin G, 2014, APPL ENVIRON MICROB, V80, P5467, DOI 10.1128/AEM.01620-14; Hasan K, 2013, FEBS J, V280, P3149, DOI 10.1111/febs.12238; Chovancova E, 2007, PROTEINS, V67, P305, DOI 10.1002/prot.21313; Janssen DB, 2001, CURR OPIN BIOTECH, V12, P254, DOI 10.1016/S0958-1669(00)00208-1; Bidmanova S, 2010, ANAL BIOANAL CHEM, V398, P1891, DOI 10.1007/s00216-010-4083-z; Shurki A, 2002, J AM CHEM SOC, V124, P4097, DOI 10.1021/ja012230z; van Leeuwen JGE, 2012, CHEMBIOCHEM, V13, P137, DOI 10.1002/cbic.201100579; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; Schanstra JP, 1996, BIOCHEMISTRY-US, V35, P5624, DOI 10.1021/bi952904g; Bosma T, 1999, APPL ENVIRON MICROB, V65, P4575; Naested H, 1999, PLANT J, V18, P571, DOI 10.1046/j.1365-313X.1999.00477.x; Bakermans C, 2003, ENVIRON MICROBIOL, V5, P321, DOI 10.1046/j.1462-2920.2003.00419.x; Poelarends GJ, 2000, J BACTERIOL, V182, P2725, DOI 10.1128/JB.182.10.2725-2731.2000; Vetter W, 2006, REV ENVIRON CONTAM T, V188, P1, DOI 10.1007/978-0-387-32964-2_1; Prokop Z, 2003, J BIOL CHEM, V278, P45094, DOI 10.1074/jbc.M307056200; Wijma HJ, 2014, J CHEM INF MODEL, V54, P2079, DOI 10.1021/ci500126x; Monincova M, 2007, APPL ENVIRON MICROB, V73, P2005, DOI 10.1128/AEM.02416-06; Campbell DW, 2006, BIOTECHNOL LETT, V28, P883, DOI 10.1007/s10529-006-9014-x; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530; Chan WY, 2010, MICROB BIOTECHNOL, V3, P107, DOI 10.1111/j.1751-7915.2009.00155.x; Nagata Y, 2005, APPL ENVIRON MICROB, V71, P2183, DOI 10.1128/AEM.71.4.2183-2185.2005; Jesenska A, 2000, APPL ENVIRON MICROB, V66, P219; Guan LJ, 2014, APPL MICROBIOL BIOT, V98, P8573, DOI 10.1007/s00253-014-5751-2; Kurihara T, 2008, CHEM REC, V8, P67, DOI 10.1002/tcr.20141; Bidmanova S, 2013, BIODEGRADATIVE BACTE, P155; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Fibinger MP, 2015, APPL MICROB IN PRESS; FRANKEN SM, 1991, EMBO J, V10, P1297; Kulakova AN, 1997, MICROBIOL-SGM, V143, P109; Kumar A, 2015, WORLD J MIC IN PRESS; Li AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089144; Moriuchi R, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0072-5; Pandey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103632	124	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	23					9865	9881		10.1007/s00253-015-6954-x		17	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CW7IL	WOS:000365171600002		
J	Nojiri, M; Hibi, M; Shizawa, H; Horinouchi, N; Yasohara, Y; Takahashi, S; Ogawa, J				Nojiri, Masutoshi; Hibi, Makoto; Shizawa, Hiroaki; Horinouchi, Nobuyuki; Yasohara, Yoshihiko; Takahashi, Satomi; Ogawa, Jun			Imidase catalyzing desymmetric imide hydrolysis forming optically active 3-substituted glutaric acid monoamides for the synthesis of gamma-aminobutyric acid (GABA) analogs	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Imidase; 3-substituted glutarimide; Desymmetrization; Bacterial screening; GABA synthesis; Stereoselective hydrolysis	CYCLIC IMIDES; METABOLISM; PREGABALIN; BACLOFEN	The recent use of optically active 3-substituted gamma-aminobutyric acid (GABA) analogs in human therapeutics has identified a need for an efficient, stereoselective method of their synthesis. Here, bacterial strains were screened for enzymes capable of stereospecific hydrolysis of 3-substituted glutarimides to generate (R)-3-substituted glutaric acid monoamides. The bacteria Alcaligenes faecalis NBRC13111 and Burkholderia phytofirmans DSM17436 were discovered to hydrolyze 3-(4-chlorophenyl) glutarimide (CGI) to (R)-3-(4-chlorophenyl) glutaric acid monoamide (CGM) with 98.1 % enantiomeric excess (e.e.) and 97.5 % e.e., respectively. B. phytofirmans DSM17436 could also hydrolyze 3-isobutyl glutarimide (IBI) to produce (R)-3-isobutyl glutaric acid monoamide (IBM) with 94.9 % e.e. BpIH, an imidase, was purified from B. phytofirmans DSM17436 and found to generate (R)-CGM from CGI with specific activity of 0.95 U/mg. The amino acid sequence of BpIH had a 75 % sequence identity to that of allantoinase from A. faecalis NBRC13111 (AfIH). The purified recombinant BpIH and AfIH catalyzed (R)-selective hydrolysis of CGI and IBI. In addition, a preliminary investigation of the enzymatic properties of BpIH and AfIH revealed that both enzymes were stable in the range of pH 6-10, with an optimal pH of 9.0, stable at temperatures below 40 A degrees C, and were not metalloproteins. These results indicate that the use of this class of hydrolase to generate optically active 3-substituted glutaric acid monoamide could simplify the production of specific chiral GABA analogs for drug therapeutics.	[Nojiri, Masutoshi; Yasohara, Yoshihiko] Kaneka Corp, Biotechnol Dev Labs, Takasago, Hyogo 6768688, Japan; [Hibi, Makoto; Takahashi, Satomi] Kyoto Univ, Grad Sch Agr, Ind Microbiol, Sakyo Ku, Kyoto 6068502, Japan; [Shizawa, Hiroaki; Horinouchi, Nobuyuki; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Ogawa, J (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	ogawa@kais.kyoto-u.ac.jp			 [26660064]	This work was partially supported by grants-in-aid for Scientific Research of Japan (no. 26660064 to J. Ogawa).	Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; Ogawa J, 1997, EUR J BIOCHEM, V243, P322, DOI 10.1111/j.1432-1033.1997.0322a.x; Ogawa J, 1996, APPL ENVIRON MICROB, V62, P3814; Nojiri M, 2013, J APPL MICROBIOL, V115, P1127, DOI 10.1111/jam.12309; Soong CL, 2001, J MOL CATAL B-ENZYM, V12, P61, DOI 10.1016/S1381-1177(00)00204-6; Lal R, 2009, J PHARMACOL EXP THER, V330, P911, DOI 10.1124/jpet.108.149773; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Ogawa J, 2000, APPL MICROBIOL BIOT, V54, P331; Hoekstra MS, 1997, ORG PROCESS RES DEV, V1, P26, DOI 10.1021/op9600320; Chavan AB, 2009, ORG PROCESS RES DEV, V13, P812, DOI 10.1021/op900064x; Hampson DR, 2011, BIOCHEM PHARMACOL, V81, P1078, DOI 10.1016/j.bcp.2011.02.005; Tassone DM, 2007, CLIN THER, V29, P26, DOI 10.1016/j.clinthera.2007.1.013; CHENEVERT R, 1994, CAN J CHEM, V72, P2312, DOI 10.1139/v94-294; Caira MR, 1997, J CHEM SOC PERK T, V2, P763; Scott BM, 2003, J BACTERIOL, V185, P126	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	23					9961	9969		10.1007/s00253-015-6812-x		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CW7IL	WOS:000365171600008		
J	Yuliana, T; Ebihara, K; Suzuki, M; Shimonaka, C; Amachi, S				Yuliana, Tri; Ebihara, Kyota; Suzuki, Mio; Shimonaka, Chie; Amachi, Seigo			A novel enzyme-based antimicrobial system comprising iodide and a multicopper oxidase isolated from Alphaproteobacterium strain Q-1	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Multicopper oxidase; Iodide; Antimicrobial system; Sporicidal activity; Povidone-iodine	BRINES	Alphaproteobacterium strain Q-1 produces an extracellular multicopper oxidase (IOX), which catalyzes iodide (I-) oxidation to form molecular iodine (I-2). In this study, the antimicrobial activity of the IOX/iodide system was determined. Both Gram-positive and Gram-negative bacteria tested were killed completely within 5 min by 50 mU mL(-1) of IOX and 10 mM iodide. The sporicidal activity of the system was also tested and compared with a common iodophor, povidone-iodine (PVP-I). IOX (300 mU mL(-1)) killed Bacillus cereus, B. subtilis, and Geobacillus stearothermophilus spores with decimal reduction times of 2.58, 7.62, and 40.9 min, respectively. However, 0.1 % PVP-I killed these spores with much longer decimal reduction times of 5.46, 38.0, and 260 min, respectively. To evaluate the more superior sporicidal activity of the IOX system over PVP-I, the amount of free iodine (non-complexed I-2) was determined by an equilibrium dialysis technique. The IOX system included more than 40 mg L-1 of free iodine, while PVP-I included at most 25 mg L-1 free iodine. Our results suggest that the new enzyme-based antimicrobial system is effective against a wide variety of microorganisms and bacterial spores, and that its strong biocidal activity is due to its high free iodine content, which is probably maintained by re-oxidation of iodide released after oxidation of cell components by I-2.	[Yuliana, Tri; Ebihara, Kyota; Suzuki, Mio; Shimonaka, Chie; Amachi, Seigo] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Yuliana, Tri] Padjadjaran State Univ, Dept Food Technol, Bandung 45363, Indonesia	Amachi, S (reprint author), Chiba Univ, Grad Sch Hort, 648 Matsudo, Matsudo, Chiba 2718510, Japan.	amachi@faculty.chiba-u.jp			Japan Foundation for Applied Enzymology; JSPS KAKENHI [20780049]; Institute of Fermentation, Osaka, Japan	This work was partially supported by grants from the Japan Foundation for Applied Enzymology, JSPS KAKENHI (20780049), and the Institute of Fermentation, Osaka, Japan, to S. A.	Hansen EH, 2003, APPL ENVIRON MICROB, V69, P4611, DOI 10.1128/AEM.69.8.4611-4617.2003; Muramatsu Y, 2001, EARTH PLANET SC LETT, V192, P583, DOI 10.1016/S0012-821X(01)00483-6; Fuglsang CC, 1995, TRENDS FOOD SCI TECH, V6, P390, DOI 10.1016/S0924-2244(00)89217-1; Atemnkeng MA, 2006, INT J PHARM, V317, P161, DOI 10.1016/j.ijpharm.2006.03.013; TAKIKAWA K, 1978, CHEM PHARM BULL, V26, P874; Suzuki M, 2012, APPL ENVIRON MICROB, V78, P3941, DOI 10.1128/AEM.00084-12; Amachi S, 2005, MICROBIAL ECOL, V49, P547, DOI 10.1007/s00248-004-0056-0; Hickey J, 1997, J PHARM PHARMACOL, V49, P1195; Cooper Rose A, 2007, Int Wound J, V4, P124, DOI 10.1111/j.1742-481X.2007.00314.x; Ehara A, 2014, GENOME ANNOUNC, V2; Gottardi W., 1983, Disinfection, sterilization and preservation, P183; Sakuma A, 2005, FUNCTION APPL IODINE, P15	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	23					10011	10018		10.1007/s00253-015-6862-0		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CW7IL	WOS:000365171600012		
J	Ali, MP; Kato, T; Park, EY				Ali, M. P.; Kato, Tatsuya; Park, Enoch Y.			Improved insecticidal activity of a recombinant baculovirus expressing spider venom cyto-insectotoxin	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Cyto-insectotoxin; Recombinant baculovirus; Pathogenicity; Cytotoxicity; Bombyx mori	AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; SILKWORM LARVAE; PEPTIDES; TOXIN; CHANNELS; PROTEIN; BLOCK; GENE; CONSTRUCTION	Baculoviruses have a long history of safe use as specific, environmentally friendly insecticides that provide alternatives to chemical pesticides for controlling insect pests. However, their use has been limited by several factors, particularly their slow pathogenicity. In this study, we constructed a recombinant Bombyx mori nucleopolyhedrovirus (BmNPV) and an Autographa californica multiple nucleopolyhedrovirus (AcMNPV) that expressed an insect-specific cyto-insectotoxin (Cit1a) from the venom of the central Asian spider Lachesana tarabaevi. Cit1a is a comparatively long linear cytolytic molecule that contains a predicted alpha-helix structure composed of two short membrane-acting antimicrobial peptides (MAMPs) that are joined together in a "head-to-tail" shape. Cit1a fused to polyhedrin gene (polh) (polh-cit1a) was expressed in the nuclei as polyhedra in silkworm larvae, Bm5 and Sf9 cells. An early death of Bm5 and Sf9 cells by recombinant BmNPV/Polh-Cit1a and AcMNPV/Polh-Cit1a was observed compared with control viruses that lacked the toxin gene. The infected cells showed a loss of cytoplasm, membrane integrity, and structural changes, suggesting that recombinant baculovirus-infected cells were killed by the necrosis caused by Cit1a. In addition, the BmNPV/Polh-Cit1a showed a significant reduction in the median lethal time (LT50) against silkworm larvae compared with those of control BmNPV that lacked the cit1a gene.	[Ali, M. P.; Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Biotechnol Lab,Suruga Ku, Shizuoka 4228529, Japan; [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka 4228529, Japan	Park, EY (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Biotechnol Lab,Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	panna_ali@yahoo.com; kato.tatsuya@shizuoka.ac.jp; park.enoch@shizuoka.ac.jp			Shizuoka University Corporation Environmental Leaders Program (ELSU), Japan	MPA was supported by Shizuoka University Corporation Environmental Leaders Program (ELSU), Japan.	Hiyoshi M, 2007, J VIROL METHODS, V144, P91, DOI 10.1016/j.jviromet.2007.04.005; Shim HJ, 2013, APPL ENVIRON MICROB, V79, P141, DOI 10.1128/AEM.02781-12; MINTZ IM, 1993, NEUROPHARMACOLOGY, V32, P1161, DOI 10.1016/0028-3908(93)90010-Z; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI 10.1042/bj20071123; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Hong HK, 2000, ARCH VIROL, V145, P2351, DOI 10.1007/s007050070025; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Ali MP, 2014, APPL MICROBIOL BIOT, V98, P6973, DOI 10.1007/s00253-014-5728-1; Choi Jae Young, 2008, Journal of Asia-Pacific Entomology, V11, P155, DOI 10.1016/j.aspen.2008.07.005; Inceoglu AB, 2001, PEST MANAG SCI, V57, P981, DOI 10.1002/ps.393; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Harrison RL, 2010, TOXINS, V2, P935, DOI 10.3390/toxins2050935; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191; SMITH GE, 1983, J VIROL, V45, P215; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Vorontsova OV, 2011, BIOCHIMIE, V93, P227, DOI 10.1016/j.biochi.2010.09.016; Chang JH, 2003, J INVERTEBR PATHOL, V84, P30, DOI 10.1016/S0022-2011(03)00121-6; Sanguinetti MC, 1997, MOL PHARMACOL, V51, P491; MINTZ IM, 1994, J NEUROSCI, V14, P2844; Lazarev VN, 2011, ANTIMICROB AGENTS CH, V55, P5367, DOI 10.1128/AAC.00449-11; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; Ardisson-Araujo DMP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084404; El-Menofy W, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-7; Gramkow AW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-143; Kato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064007; Kato T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-55; Osman G, 2012, AFR J BIOTECHNOL, V15, P11678; Szewczyk B, 2006, BIOTECHNOL ADV, V24, P143, DOI 10.1016/j.biotechadv.2005.09.001	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2015	99	23					10261	10269		10.1007/s00253-015-6846-0		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CW7IL	WOS:000365171600033		
J	Kiba, T; Kanbara, K; Ban, I; Kato, F; Kawashima, S; Saka, Y; Yamamoto, K; Nishiyama, J; Mizuno, Y; Abe, T; Fukunaga, M				Kiba, Tadashi; Kanbara, Kenji; Ban, Ikumi; Kato, Fumie; Kawashima, Sadanobu; Saka, Yukie; Yamamoto, Kazumi; Nishiyama, Junji; Mizuno, Yasuyuki; Abe, Tetsuya; Fukunaga, Mikihiko			Saliva Amylase as a Measure of Sympathetic Change Elicited by Autogenic Training in Patients with Functional Somatic Syndromes	APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK			English	Article						Autogenic training; Dysregulation of the autonomic nervous system; Functional somatic syndrome; Salivary amylase; Sympathetic activity	SECRETORY IMMUNITY; TENSION HEADACHES; NERVOUS ACTIVITY; STRESS-RESPONSE; ALPHA-AMYLASE; FOLLOW-UP; FIBROMYALGIA; ANXIETY; DEFINITION; RELAXATION	The aim of this study was to discuss the effect of autogenic training (AT) on patients with functional somatic syndrome (FSS) using salivary amylase, the skin temperature of the finger, subjective severity of symptoms, and psychological characteristics as measures. We assessed 20 patients with FSS and 23 healthy controls before and after AT. Baseline levels of salivary amylase prior to an AT session were significantly higher in the FSS group than in the control group. However, this difference was not significant after AT. The skin temperature of the finger increased after AT in both the FSS and control groups. AT contributed to the improvement of somatic symptoms in patients with FSS. Our results regarding psychological characteristics suggest that mood disturbances are deeply involved in the pathology of FSS. Individuals with FSS exhibited elevated levels of sympathetic activity compared with healthy controls. Our data indicates that AT eased dysregulation of the autonomic nervous system in patients with FSS. Thus, salivary amylase may be a useful index of change induced by AT in patients with FSS.	[Kiba, Tadashi; Kanbara, Kenji; Ban, Ikumi; Kato, Fumie; Kawashima, Sadanobu; Saka, Yukie; Yamamoto, Kazumi; Nishiyama, Junji; Mizuno, Yasuyuki; Abe, Tetsuya; Fukunaga, Mikihiko] Kansai Med Univ, Dept Psychosomat Med, Hirakata, Osaka, Japan; [Yamamoto, Kazumi] Nishi Kyoto Hosp, Dept Psychosomat Med, Nishikyo Ku, Kyoto, Japan	Kiba, T (reprint author), Kansai Med Univ, Dept Psychosomat Med, 2-5-1 Shinmachi, Hirakata, Osaka, Japan.	tadashi_kiba@yahoo.co.jp					ACOG Practice Bulletin, 2001, INT J GYNECOL OBSTET, V73, P183; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Palanisamy K, 2012, J PHYS THER SCI, V24, P1341; Zsombok T, 2003, HEADACHE, V43, P251, DOI 10.1046/j.1526-4610.2003.03049.x; Noto Y, 2005, ANESTH ANALG, V101, P1873, DOI 10.1213/01.ANE.0000184196.60838.8D; Mitani S, 2006, J PSYCHOSOM RES, V60, P439, DOI 10.1016/j.jpsychores.2005.09.005; Barsky AJ, 1999, ANN INTERN MED, V130, P910; Yamaguchi M, 2006, J INT MED RES, V34, P152; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Blanchard EB, 2005, APPL PSYCHOPHYS BIOF, V30, P53, DOI 10.1007/s10484-005-2173-z; Kanji N, 2006, COMPLEMENT THER MED, V14, P144, DOI 10.1016/j.ctim.2006.03.001; Yamaguchi Masaki, 2007, Folia Pharmacologica Japonica, V129, P80, DOI 10.1254/fpj.129.80; SPEIRS RL, 1974, ARCH ORAL BIOL, V19, P747, DOI 10.1016/0003-9969(74)90161-7; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Christensen SS, 2015, J PSYCHOSOM RES, V78, P363, DOI 10.1016/j.jpsychores.2014.12.005; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; COLLET L, 1986, PAIN, V25, P205, DOI 10.1016/0304-3959(86)90094-1; Keel PJ, 1998, CLIN J PAIN, V14, P232, DOI 10.1097/00002508-199809000-00010; Kanbara K, 2004, APPL PSYCHOPHYS BIOF, V29, P255, DOI 10.1007/s10484-004-0386-1; Kanbara K, 2007, PSYCHOSOM MED, V69, P158, DOI 10.1097/PSY.0b013e3180312cac; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P549, DOI 10.1016/S0022-3999(01)00224-0; Tak LM, 2011, BIOL PSYCHOL, V87, P183, DOI 10.1016/j.biopsycho.2011.02.002; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Stetter F, 2002, APPL PSYCHOPHYS BIOF, V27, P45, DOI 10.1023/A:1014576505223; SPINHOVEN P, 1992, GEN HOSP PSYCHIAT, V14, P408, DOI 10.1016/0163-8343(92)90008-X; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Shinozaki M, 2010, APPL PSYCHOPHYS BIOF, V35, P189, DOI 10.1007/s10484-009-9125-y; ZITMAN FG, 1992, J PSYCHOSOM RES, V36, P219, DOI 10.1016/0022-3999(92)90086-H; Tak LM, 2010, J PSYCHOSOM RES, V68, P461, DOI 10.1016/j.jpsychores.2009.12.004; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Mutsuura H, 2009, APPL PSYCHOPHYS BIOF, V34, P291, DOI 10.1007/s10484-009-9110-5; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Fink P, 2007, PSYCHOSOM MED, V69, P30, DOI 10.1097/PSY.0b013e31802e46eb; Grillon C, 2007, BIOL PSYCHIAT, V62, P1183, DOI 10.1016/j.biopsych.2007.06.007; Okifuji A, 2002, APPL PSYCHOPHYS BIOF, V27, P129, DOI 10.1023/A:1016243710507; Last AR, 2009, AM FAM PHYSICIAN, V79, P1067; Bosch JA, 1996, PSYCHOSOM MED, V58, P374; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Veen G, 2013, PSYCHIAT RES, V208, P41, DOI 10.1016/j.psychres.2013.03.012; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; VANDYCK R, 1991, INT J CLIN EXP HYP, V39, P6, DOI 10.1080/00207149108409615; FUKUDA K, 1994, ANN INTERN MED, V121, P953; Fukunaga M., 1997, JAPANESE J PSYCHOSOM, V37, P511; Kanbara Kenji, 2009, Nihon Rinsho, V67, P1669; Hatta H., 1998, JPN J PSYCHOSOM MED, V38, P309; Ichinose M., 2010, JAPANESE J BIOFEEDBA, V37, P109; Ioannou S, 2014, PSYCHOPHYSIOLOGY, V51, P951, DOI 10.1111/psyp.12243; Irie M., 1996, JAPANESE J PSYCHOSOM, V36, P299; Kasai H., 2012, JAPANESE J PSYCHOSOM, V52, P12; Kiba T., 2013, JAPANESE J PSYCHOSOM, V53, P670; Koike Y., 1979, OTORHINO LARYNGOLOGI, V72, P1499; Komai G., 2003, JAPANESE J PSYCHOSOM, V43, P839; Luthe W., 1969, AUTOGENIC THERAPY; Matsuoka Y., 2012, JAPANESE J PSYCHOSOM, V52, P32; Mizuno Y., 2001, JAPANESE J MED ELECT, V39, P234; Murakami M., 2009, T JAPANEASE SOC MED, V47, P166; Nakao M., 2001, JPN J PSYCHOSOM MED, V41, P539; Oka T., 1993, JAPANESE J PSYCHOSOM, V33, P293; Oka T, 2012, JPN J PSYCHOSOM MED, V52, P25; Oka T., 1994, JAPANESE J AUTOGENIC, V14, P1; Sakano Y., 1997, JAPANESE J AUTOGENIC, V16, P34; Schultz J. H., 1969, AUTOGENIC THERAPY; Schulz J. H., 1932, AUTOGENE TRAINING KO; Shigeno K., 2009, BIOMEDICAL RES, V30, P245; Subcommittee of International Headache Society, 2004, CEPHALALGIA S1, V24, P9; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Yamaguchi M, 2007, T JPN SOC MED BIOL E, V45, P161; Yamashiro I., 1991, JAPANESE J AUTOGENIC, V12, P25; Yokoyama K, 1990, Nihon Koshu Eisei Zasshi, V37, P913	72	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1090-0586	1573-3270		APPL PSYCHOPHYS BIOF	Appl. Psychophysiol. Biofeedback	DEC	2015	40	4					339	347		10.1007/s10484-015-9303-z		9	Psychology, Clinical	Psychology	CW7OD	WOS:000365187800009		
J	Maeda, S; Tanabe, H				Maeda, Sadahiro; Tanabe, Hiromasa			A characterization of the homogeneous ruled real hypersurface in a complex hyperbolic space in terms of the first curvature of some integral curves	ARCHIV DER MATHEMATIK			English	Article						Ruled real hypersurfaces; The homogeneous ruled real hyper-surface; Complex hyperbolic spaces; The first curvature of integral curves; Characteristic vector field; The vector U	FORMS	Due to the works of Berndt and others (J Reine Angew Math 395:132-141, 1989; Geom Dedicata 138:129-150, 2009; Trans Am Math Soc 359:3425-3438, 2007), we find that the class of all homogeneous real hypersurfaces M in has just one example which is minimal in this space. Furthermore, in this ambient space, a homogeneous real hypersurface M is minimal if and only if it is ruled. This fact implies that it is interesting to study this minimal homogeneous real hypersurface from the viewpoint of the geometry of ruled real hypersurfaces. It is known that the shape operator A of every ruled real hypersurface M is given by the characteristic field and the vector field U. The purpose of this paper is to characterize this minimal homogeneous real hypersurface in in the class of all ruled real hypersurfaces M by investigating the first curvature of all integral curves of the vector fields and U. Note that there exist minimal non-homogeneous ruled real hypersurfaces in (see Geom Dedicata 79:267-286, 1999; Hokkaido Math J 43:1-14, 2014).	[Maeda, Sadahiro] Saga Univ, Dept Math, Saga 8408502, Japan; [Tanabe, Hiromasa] Matsue Coll, Natl Inst Technol, Dept Sci, Matsue, Shimane 6908518, Japan	Maeda, S (reprint author), Saga Univ, Dept Math, 1 Honzyo, Saga 8408502, Japan.	smaeda@ms.saga-u.ac.jp; h-tanabe@matsue-ct.jp					Adachi T., 2014, HOKKAIDO MATH J, V43, P1; Adachi T., 1997, OSAKA J MATH, V21, P29; Maeda S, 2006, GEOMETRIAE DEDICATA, V123, P65, DOI 10.1007/s10711-006-9100-1; Berndt J, 2007, T AM MATH SOC, V359, P3425, DOI 10.1090/S0002-9947-07-04305-X; Berndt J, 2009, GEOMETRIAE DEDICATA, V138, P129, DOI 10.1007/s10711-008-9303-8; BERNDT J, 1989, J REINE ANGEW MATH, V395, P132; Maeda S, 2009, J MATH SOC JPN, V61, P315, DOI 10.2969/jmsj/06110315; Lohnherr M, 1999, GEOMETRIAE DEDICATA, V74, P267, DOI 10.1023/A:1005000122427; Niebergall R., 1998, REAL HYPERSURFACES C, P233	9	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0003-889X	1420-8938		ARCH MATH	Arch. Math.	DEC	2015	105	6					593	599		10.1007/s00013-015-0839-1		7	Mathematics	Mathematics	CW7IP	WOS:000365172100010		
J	Sohda, M; Misumi, Y; Oda, K				Sohda, Miwa; Misumi, Yoshio; Oda, Kimimitsu			TNF alpha triggers release of extracellular vesicles containing TNFR1 and TRADD, which can modulate TNF alpha responses of the parental cells	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						TNF alpha; TNFR1; TRADD; Extracellular vesicles	EXOSOME-LIKE VESICLES; NECROSIS-FACTOR RECEPTORS; TUMOR; ACTIVATION; GENERATION; SECRETION; CERAMIDE; PROTEIN; DEATH; BIG2	Tumor necrosis factor-alpha (TNF alpha)-induced reactions are effective to maintain homeostasis; however, excessive responses play progressive roles in the pathogenesis of various chronic inflammatory diseases. We demonstrate that TNF alpha triggered the release of its receptor TNFR1 as a content of extracellular vesicles (EVs) from the human bronchial epithelial cell, BEAS-2b. The TNFR1 cytoplasmic domain binding partner, TNFR-associated death domain (TRADD), was released by TNFa treatment along with TNFR1. TNF alpha-triggered release of EVs was decreased in the presence of amitriptyline, an inhibitor of acid sphingomyelinase (A-SMase), or of GW4869, an inhibitor of neutral sphingomyelinase (N-SMase), indicating that EVs containing TNFR1 and TRADD are released through A-SMase and N-SMase dependent manners. From sucrose density gradient analysis, each sphingomyelinase is involved in the generation of distinct populations of EVs. Inhibition of A-SMase or N-SMase resulted in significantly increased responses to TNFa in parental cells. Given that TRADD serves as a platform for the assembly of subsequent signaling molecules, the TNFa triggered release of TNFR1 and TRADD might be an effective strategy for down regulation of the TNFa responses of parental cells. (C) 2015 Elsevier Inc. All rights reserved.	[Sohda, Miwa; Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Biochem, Chuo Ku, Niigata 9518514, Japan; [Misumi, Yoshio] Fukuoka Univ, Sch Med, Dept Cell Biol, Jonan Ku, Fukuoka 8140180, Japan	Sohda, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Biochem, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	sohda@dent.niigata-u.ac.jp					TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Islam A, 2008, J BIOL CHEM, V283, P25364, DOI 10.1074/jbc.M804966200; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; PORTEU F, 1990, J EXP MED, V172, P599, DOI 10.1084/jem.172.2.599; Puimege L, 2014, CYTOKINE GROWTH F R, V25, P285, DOI 10.1016/j.cytogfr.2014.03.004; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.00167.x; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Bobrie A, 2012, J EXTRACELL VESICLES, V1, P18397, DOI DOI 10.3402/JEV.V1I0.18397; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475; Sonoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122212; Witwer K. W., 2013, J EXTRACELL VESICLES, V2, P20360, DOI DOI 10.3402/JEV.V2I0.20360; Yanez-Mo M., 2015, VESICLES, V14, P27066	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	DEC 1	2015	587						31	37		10.1016/j.abb.2015.10.009		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CW7BL	WOS:000365152800004		
J	Ishiwatari, S; Takahashi, M; Yasuda, C; Nakagawa, M; Saito, Y; Noguchi, N; Matsukuma, S				Ishiwatari, Shioji; Takahashi, Minako; Yasuda, Chie; Nakagawa, Maho; Saito, Yoshiro; Noguchi, Noriko; Matsukuma, Shoko			The protective role of DJ-1 in ultraviolet-induced damage of human skin: DJ-1 levels in the stratum corneum as an indicator of antioxidative defense	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						DJ-1; Stratum corneum; Tape stripping; Total antioxidant capacity	INTERLEUKIN-1 RECEPTOR ANTAGONIST; PARKINSONS-DISEASE; ATOPIC-DERMATITIS; ALPHA-SYNUCLEIN; OXIDIZED DJ-1; HORNY LAYER; IN-VIVO; PROTEIN; STRESS; ELEVATION	DJ-1 is a multifunctional protein associated with Parkinson's disease and plays a significant role in protecting nerve cells from oxidative stress. DJ-1 is expressed in the skin, although its function there is unknown. In this study, we investigated DJ-1 function in keratinocytes. DJ-1 was induced by H2O2 exposure and UV irradiation in keratinocytes. DJ-1 knockdown with small interfering RNA (siRNA) increased reactive oxygen species (ROS) and lactate dehydrogenase (LDH) release after UVB irradiation, suggesting that DJ-1 reduces ROS and might protect skin cells from UV damage in vitro. To investigate the in vivo role of DJ-1 in the skin, we determined DJ-1 levels in human stratum corneum samples obtained by the tape-stripping method. DJ-1 levels in the stratum corneum (scDJ-1) correlated with total antioxidant capacity. We also examined the effect of scDJ-1 on changes in skin after UVB irradiation. DJ-1 was elevated in SC from the upper arm 1 to 2 weeks after UVB irradiation. One day after UVB irradiation, L* (brightness) and a* (redness) values, indicators of skin color, were altered regardless of scDJ-1 expression. However, these values recovered more quickly in subjects with high scDJ-1 expression than in those with low scDJ-1 expression. These data suggest that DJ-1 in skin plays a significant role in protection against UV radiation and oxidative stress, and that DJ-1 levels in the SC might be an indicator of antioxidative defense against UV-induced damage.	[Ishiwatari, Shioji; Takahashi, Minako; Yasuda, Chie; Nakagawa, Maho; Matsukuma, Shoko] Fancl Res Inst, Totsuka Ku, Yokohama, Kanagawa 2440806, Japan; [Saito, Yoshiro; Noguchi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci Lab, Kyoto 6100394, Japan	Ishiwatari, S (reprint author), Fancl Res Inst, Totsuka Ku, Yokohama, Kanagawa 2440806, Japan.	shiishiwata@fancl.co.jp					Amarbayasgalan T, 2011, INT ARCH ALLERGY IMM, V157, P251; Amarbayasgalan T, 2012, INT ARCH ALLERGY IMM, V160, P63; Wulf HC, 2010, PHOTODERMATOL PHOTO, V26, P280, DOI 10.1111/j.1600-0781.2010.00544.x; Fan J, 2008, FEBS LETT, V582, P1151, DOI 10.1016/j.febslet.2008.03.003; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.imb.2005.12.030; Kikuchi K, 2008, BRIT J DERMATOL, V158, P969, DOI 10.1111/j.1365-2133.2008.08478.x; Saito Y, 2014, J NEUROPATH EXP NEUR, V73, P714, DOI 10.1097/NEN.0000000000000087; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Hellemans L, 2003, J INVEST DERMATOL, V120, P434, DOI 10.1046/j.1523-1747.2003.12056.x; Kikuchi K, 2003, DERMATOLOGY, V207, P269, DOI 10.1159/000073089; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Thiele JJ, 2001, CURR PROBL DERMATOL, V29, P26; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Hirao T, 1996, J INVEST DERMATOL, V106, P1102, DOI 10.1111/1523-1747.ep12340143; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Weber SU, 1999, J INVEST DERMATOL, V113, P1128, DOI 10.1046/j.1523-1747.1999.00789.x; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Clausen ML, 2013, BRIT J DERMATOL, V169, P587, DOI 10.1111/bjd.12419; El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014; Inoue Y, 2011, Br J Dermatol, V164, P560, DOI 10.1111/j.1365-2133.2010.10145.x; Damian DL, 1997, BRIT J DERMATOL, V136, P714; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Terui T, 1998, EXP DERMATOL, V7, P327, DOI 10.1111/j.1600-0625.1998.tb00332.x; Yamaguchi J, 2009, J DERMATOL SCI, V53, P48, DOI 10.1016/j.jdermsci.2008.08.011; Thiele JJ, 1998, J INVEST DERMATOL, V110, P756, DOI 10.1046/j.1523-1747.1998.00169.x; Morita E, 2010, ALLERGY, V65, P1166, DOI 10.1111/j.1398-9995.2010.02361.x; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Bonifati V, 2004, J MOL MED-JMM, V82, P163, DOI 10.1007/s00109-003-0512-1; Budden T, 2013, INT J MOL SCI, V14, P1132, DOI 10.3390/ijms14011132; Dornelles S, 2004, PHOTOCHEM PHOTOBIOL, V79, P540, DOI 10.1562/YG-03-08.1; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Pandel R, 2013, ISRN DERMATOL, V2013, P11; Poljsak B, 2012, DERMATOL RES PRACT, V2012, DOI DOI 10.1155/2012/135206; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	DEC	2015	307	10					925	935		10.1007/s00403-015-1605-8		11	Dermatology	Dermatology	CW7IV	WOS:000365172700009		
J	Hagino, T; Ochiai, S; Senga, S; Yamashita, T; Wako, M; Ando, T; Haro, H				Hagino, Tetsuo; Ochiai, Satoshi; Senga, Shinya; Yamashita, Takashi; Wako, Masanori; Ando, Takashi; Haro, Hirotaka			Meniscal tears associated with anterior cruciate ligament injury	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Meniscal tear; Anterior cruciate ligament (ACL); Meniscal repair	CARTILAGE INJURIES; RECONSTRUCTION; DELAY; TIME; KNEE; RISK	Purpose To investigate the frequency of meniscal tear and the location of tear associated with anterior cruciate ligament (ACL) injury. We studied 549 patients (552 knees) who were diagnosed with ACL injury by arthroscopy at our center between January 2006 and March 2014 (8 years and 3 months). The subjects comprised 289 males and 263 females ranging in age from 13 to 66 (mean 26.1) years. The cause of injury was sports-related in 89.1 %, and the mean interval from injury to initial arthroscopy was 23 months. The patients were divided into two groups: arthroscopy performed within 8 weeks after injury (acute group; 256 knees) and more than 8 weeks after injury (chronic group; 296 knees). Frequency of meniscal tear and location of tear were compared between two groups. The incidence of meniscal tear diagnosed by arthroscopic examination was 79.2 % (437 of 552 knees) in all subjects; 72.7 % (186 of 256 knees) in acute group and 84.8 % (251 of 296 knees) in chronic group, and was significantly higher in chronic group. Regarding the locations of meniscal tears, in acute group (186 knees), medial meniscal tear only was found in 20 knees (10.8 %), lateral meniscal tear only in 129 knees (69.4 %), and bilateral (including medial and lateral) meniscal tears in 37 knees (19.9 %). In chronic group (251 knees), medial meniscal tear only was found in 62 knees (24.7 %), lateral meniscal tear only in 85 knees (33.9 %), and bilateral meniscal tears in 104 knees (41.4 %). Lateral meniscal tear was commonly associated with acute ACL injury, while medial meniscal tear with chronic ACL injury. Bucket handle tear was observed in 25 knees (medial: 17 knees, lateral: 8 knees) in acute group, and 81 knees (medial: 69 knees, lateral: 12 knees) in chronic group, and was more common in the chronic group. The incidence of meniscal tear associated with ACL injury is higher in chronic cases; the number of medial meniscal tears is particularly high, many of which require meniscectomy. Early ACL reconstruction is recommended also for the prevention of secondary meniscal tear.	[Hagino, Tetsuo; Ochiai, Satoshi; Senga, Shinya; Yamashita, Takashi] Kofu Natl Hosp, Sports Med & Knee Ctr, Kofu, Yamanashi 4008533, Japan; [Wako, Masanori; Ando, Takashi; Haro, Hirotaka] Univ Yamanashi, Fac Med, Dept Orthopaed Surg, Kofu, Yamanashi, Japan	Hagino, T (reprint author), Kofu Natl Hosp, Sports Med & Knee Ctr, 11-35 Tenjin Cho, Kofu, Yamanashi 4008533, Japan.	tmhagino@amber.plala.or.jp					Anderson AF, 2015, AM J SPORT MED, V43, P275, DOI 10.1177/0363546514559912; SHOEMAKER SC, 1986, J BONE JOINT SURG AM, V68A, P71; Guenther ZD, 2014, CLIN ORTHOP RELAT R, V472, P990, DOI 10.1007/s11999-013-3369-9; Millett PJ, 2002, ARTHROSCOPY, V18, P955, DOI 10.1053/jars.2002.36114; Dumont GD, 2012, AM J SPORT MED, V40, P2128, DOI 10.1177/0363546512449994; Lawrence JTR, 2011, AM J SPORT MED, V39, P2582, DOI 10.1177/0363546511420818; COOPER DE, 1990, CLIN SPORT MED, V9, P589; Chhadia AM, 2011, AM J SPORT MED, V39, P1894, DOI 10.1177/0363546511410380; Noyes FR, 2012, ARTHROSCOPY, V28, P123, DOI 10.1016/j.arthro.2011.08.292; Bellabarba C, 1997, Am J Orthop (Belle Mead NJ), V26, P18; Ghodadra N, 2013, J KNEE SURG, V26, P185, DOI 10.1055/s-0032-1327450; Hagino Tetsuo, 2014, Eur J Orthop Surg Traumatol, V24, P99, DOI 10.1007/s00590-012-1138-1; Kilcoyne Kelly G, 2012, Orthopedics, V35, P208, DOI 10.3928/01477447-20120222-07; WARREN RF, 1983, CLIN ORTHOP RELAT R, P32	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	DEC	2015	135	12					1701	1706		10.1007/s00402-015-2309-4		6	Orthopedics; Surgery	Orthopedics; Surgery	CW5ZR	WOS:000365076500010		
J	Matsumoto, K; Mori, N; Ogawa, H; Akiyama, H				Matsumoto, Kazu; Mori, Nobuyuki; Ogawa, Hiroyasu; Akiyama, Haruhiko			Accuracy of a novel extramedullary femoral alignment guide system in primary total knee arthroplasty	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Total knee arthroplasty; Extramedullary guide; Femoral component; Coronal alignment; Sagittal alignment	COMPUTER-ASSISTED NAVIGATION; FOLLOW-UP; ROTATIONAL ALIGNMENT; TIBIAL ALIGNMENT; REPLACEMENT; INTRAMEDULLARY; AXIS; COMPONENT; METAANALYSIS; PROSTHESIS	Introduction We aimed to assess the accuracy of a new extramedullary guide system for achieving appropriate femoral component alignment in total knee arthroplasty (TKA) and to determine whether it differed between patients operated on by different surgeons. We performed 100 consecutive primary TKAs in 100 patients using a newly developed extramedullary guide, the "S guide"; 50 were performed by author KM at A Hospital, and 50 by author NM at B Hospital. All patients received the Vanguard RP mobile-bearing prosthesis (Biomet Japan, Tokyo, Japan). We assessed the coronal and sagittal alignment of the femoral component with the mechanical axis using plane radiographs. Data were analyzed statistically using Prism 5.0 software, and a p value of < 0.05 was regarded as indicating significance. The mean postoperative coronal alignment angle of the femoral component (alpha) was 0.1A degrees A A +/- A 1.4A degrees, with no significant differences between A Hospital and B Hospital (p = 0.67), and 98 % of patients had an alpha deviating by less than 3A degrees from the mechanical axis. The mean postoperative sagittal alignment angle of the femoral component (gamma) was 1.7A degrees A A +/- A 1.7A degrees, with no significant differences between the groups (p = 0.61), and 86 % of patients had a gamma deviating by less than 3A degrees from the mechanical axis. This study shows that the S-guide is reliable for use in TKA.	[Matsumoto, Kazu; Ogawa, Hiroyasu; Akiyama, Haruhiko] Gifu Univ, Grad Sch Med, Dept Orthoped Surg, Gifu 5011194, Japan; [Mori, Nobuyuki] Matsunami Gen Hosp, Dept Orthoped Surg, Gifu, Japan	Matsumoto, K (reprint author), Gifu Univ, Grad Sch Med, Dept Orthoped Surg, 1-1 Yanagido, Gifu 5011194, Japan.	mkazuu@gifu-u.ac.jp					Collier MB, 2007, J BONE JOINT SURG AM, V89A, P1306, DOI 10.2106/JBJS.F.00667; Jung WH, 2013, KNEE SURG SPORT TR A, V21, P629, DOI 10.1007/s00167-012-1994-6; Lustig S, 2012, INT ORTHOP, V36, P1835, DOI 10.1007/s00264-012-1580-z; Mason JB, 2007, J ARTHROPLASTY, V22, P1097, DOI 10.1016/j.arth.2007.08.001; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709; Dennis DA, 2011, CLIN ORTHOP RELAT R, V469, P10, DOI 10.1007/s11999-010-1485-3; Rodriguez JA, 2001, CLIN ORTHOP RELAT R, P10; [Anonymous], 1991, CLIN ORTHOPAEDICS; Thienpont E, 2014, BONE JOINT J, V96B, P1052, DOI 10.1302/0301-620X.96B8.33747; Krishnan SP, 2012, J BONE JOINT SURG BR, V94B, P1457, DOI 10.1302/0301-620X.94B11.29350; FAHMY NR, 1990, J BONE JOINT SURG AM, V72A, P19; Laskin RS, 2001, CLIN ORTHOP RELAT R, P95; Stulberg SD, 2002, J BONE JOINT SURG AM, V84A, P90; CATES HE, 1993, CLIN ORTHOP RELAT R, P32; Middleton FR, 2007, KNEE, V14, P204, DOI 10.1016/j.knee.2007.02.002; Dennis D A, 1993, J Arthroplasty, V8, P43, DOI 10.1016/S0883-5403(06)80106-3; Anderson KC, 2005, J ARTHROPLASTY, V20, P132, DOI 10.1016/j.arth.2005.05.009; Nam D, 2014, J ARTHROPLASTY, V29, P288, DOI 10.1016/j.arth.2013.06.006; Berend ME, 2004, CLIN ORTHOP RELAT R, P26, DOI 10.1097/01.blo.0000148578.22729.0e; Bardakos N, 2007, J ARTHROPLASTY, V22, P85, DOI 10.1016/j.arth.2007.04.018; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Engh G A, 1990, J Arthroplasty, V5, P1, DOI 10.1016/S0883-5403(06)80002-1; Gromov K, 2014, ACTA ORTHOP, V85, P480, DOI 10.3109/17453674.2014.940573; ISHII Y, 1995, CLIN ORTHOP RELAT R, P167; Jeon Suk Ha, 2012, Knee Surg Relat Res, V24, P99, DOI 10.5792/ksrr.2012.24.2.99; Kandel Leonid, 2006, J Knee Surg, V19, P256; Matsuda S, 1999, Am J Knee Surg, V12, P165; SCOTT WN, 1988, J BONE JOINT SURG AM, V70A, P1163; Volz R G, 1986, Orthop Rev, V15, P677; WHITESIDE LA, 1995, CLIN ORTHOP RELAT R, P168	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	DEC	2015	135	12					1743	1748		10.1007/s00402-015-2318-3		6	Orthopedics; Surgery	Orthopedics; Surgery	CW5ZR	WOS:000365076500015		
J	Avila-Tapies, R; Dominguez-Mujica, J				Avila-Tapies, Rosalia; Dominguez-Mujica, Josefina			Postcolonial migrations and diasporic linkages between Latin America and Japan and Spain	ASIAN AND PACIFIC MIGRATION JOURNAL			English	Article						migration linkages; preferential migration legislation; pendular mobility; Japan; Spain; Latin America	ETHNIC RETURN MIGRATION; FOREIGN-WORKERS; IMMIGRATION; POLICY	In the late 1980s, both Japan and Spain revised their legislation to confer preferential immigration rights to citizens from former colonies or their own diasporic descendants based on historical, cultural or ethnic belonging to the ancestral homeland. During the economic crisis, Spain, in 2008, and Japan, in 2009, reversed their policies through a government-sponsored voluntary return program for these preferred migrants. When the economy recovered, Japan in 2013 revisited its return migration program, resulting in pendular migrations driven by politics and macro-economic trends. This suggests that historical or cultural ties that favor the citizens of former colonies and diasporic communities have reinforced two-way transoceanic migratory processes, thereby contributing to strengthening old migration geographies.'	[Avila-Tapies, Rosalia] Doshisha Univ, Kyoto 6028580, Japan; [Dominguez-Mujica, Josefina] Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain	Avila-Tapies, R (reprint author), Doshisha Univ, Inst Study Humanities & Social Sci, Kamigyo Ku, Kyoto 6028580, Japan.	avila@ares.eonet.ne.jp					Alaez Corral B, 2005, HIST CONSTITUCIONAL, V6; Alvarez Rodriguez A, 2013, REV CIDOB AFERS INT; Diaz EM, 2012, CULT STUD, V26, P814, DOI 10.1080/09502386.2012.669774; Van Hear N, 2010, J ETHN MIGR STUD, V36, P1531, DOI 10.1080/1369183X.2010.489359; Tai E, 2009, ASIAN PAC MIGR J, V18, P315; Parsons CA, 2006, IMMIGRATION AND THE TRANSFORMATION OF EUROPE, P1, DOI 10.1017/CBO9780511493577.001; [Anonymous], 2005, EL MUNDO; Belot M, 2012, J POPUL ECON, V25, P1077, DOI 10.1007/s00148-011-0356-x; Skrentny JD, 2007, INT MIGR REV, V41, P793, DOI 10.1111/j.1747-7379.2007.00100.x; Ogawa N, 2011, ASIAN PAC MIGR J, V20, P133; King R, 2011, MOBILITIES-UK, V6, P451, DOI 10.1080/17450101.2011.603941; [Anonymous], 2001, PAIS; Calavita K, 1998, LAW SOC REV, V32, P529, DOI 10.2307/827756; Cook-Martin D, 2009, J ETHN MIGR STUD, V35, P151, DOI 10.1080/13691830802489309; Sole C, 2003, J ETHN MIGR STUD, V29, P121, DOI 10.1080/1369183032000076759; Castles S, 2010, J ETHN MIGR STUD, V36, P1565, DOI 10.1080/1369183X.2010.489381; Green P, 2010, ETHNOGRAPHY, V11, P515, DOI 10.1177/1466138110362007; Shipper AW, 2002, CRIT ASIAN STUD, V34, P41, DOI 10.1080/146727102760166590; Seol DH, 2009, ETHNICITIES, V9, P147, DOI 10.1177/1468796808099901; Arudou D, 2009, JAPAN TIMES; Avila Tapies R, 2006, BIBLIO 3W REV BIBLIO, V11; Bailey B, 1996, THESIS; Burgess C, 2012, ELECT J CONT JAPANES, V1; Cabinet Public Relations Office, 2013, NIKK TEIJ GAIK NI KA; Cairo Carou H, 2010, GEOPOLITICAS, V1, P41; Castles S, 1993, AGE MIGRATION INT PO; Centro de Investigaciones Sociologicas - Center of Sociological Researches (CIS), 2012, ACT HAC INM; Colectivo IOE, 2001, 4 M INT LOR EUR IMM; Cornelius Wayne, 1994, CONTROLLING IMMIGRAT; Council for the Promotion of Measures for Foreign Residents of Japanese Descent, 2010, BAS POL MEAS FOR RES; De Lucas J, 1998, REPENSANDO CIUDADANI, P9; Del Arenal Moyua C, 2011, POLITICA EXTERIOR ES; Dominguez-Mujica J, 2009, INMIGRACION INT MOTO, P173; Dominguez-Mujica J, 2014, INT MIGR, V52, P113, DOI 10.1111/imig.12023; Dowty A, 1989, CLOSED BORDERS CONT; Echeverri Buritica MM, 2014, PAPELES CEIC, V2014; Elosegui Itxaso M, 2008, REV CIDOB AFERS INT, V82/83, P117; Garcia Ballesteros A, 2014, SCRIPTA NOVA REV ELE, V16; Geddes A, 2003, POLITICS MIGRATION I; Gratius S, 2005, 49 REAL I ELC EST IN; Hein Patrick, 2012, ASIAN ETHNICITY, V13, P161; Hollifield J. E, 2014, CONTROLLING IMMIGRAT; Hollifield JF, 2011, HIGH SKILLED IMMIGRA, P50; Instituto Nacional de Estadistica - National Statistics Institute (INE), 2015, CONT MUN REG STAT; Ishii AA, 2007, TRANSCULTURAL JAPAN, P113; Ishikawa Y, 2011, BELGEO, V3, P129; Izquierdo Escribano A, 2002, ACT 3 C INM ESP RET, P232; Joppke Christian, 2005, SELECTING ORIGIN ETH; Kikumura-Yano A, 2002, ENCY JAPANESE DESCEN; Kondo Atsushi, 2002, ASIAN PAC MIGR J, V11, P415; Lane M, 2006, GLOBALIZAING MIGRATI, P131; Massey DS, 2004, INT MIGRATION PROSPE; Matsuyama LS, 2010, MAGUARE, V24, P157; McCabe K, 2009, MIGRATION INFORM SOU; Mendez E, 1979, CIERVO REV MENSUAL P, V339, P6; Ministry of Employment and Social Security, 2015, DAT RET VOL; Ministry of Health Labour and Welfare Japan (MHLW), 2015, RES SUPP PROGR THOS; Ministry of Justice Japan (MOJ), 2015, STAT SURV REG FOR; Ministry of Justice Japan (MOJ), 2015, STAT SURV LEG MIGR; Miyoshi H, 2003, GLOBAL JAPAN EXPERIE, P57; Observatorio de las Migraciones y de la Convivencia Intercultural, 2005, INF PROC NORM TRAB E; Osaki T, 2013, JAPAN TIMES; Pedone C, 2008, REMHU REV INTERDISCI, V16, P143; Penninx R, 2014, GLOB MIGRAT ISS, V4, P183, DOI 10.1007/978-3-319-08317-9_10; Roth Joshua Hotaka, 2002, BROKERED HOMELAND JA; Shin HJ, 2007, TRAJECTORIES NATION; Solanes Corella A, 2010, REV MINISTERIO TRABA, V90, P77; Sterett S, 2006, IMMIGRATION; Takenaka A, 2003, GLOBAL JAPAN EXPERIE, P222; Takeyuki Tsuda, 2003, STRANGERS ETHNIC HOM; Thranhardt D, 1999, J COMP POLICY ANAL R, V1, P203; Thranhardt D, 1995, MIGRATION EUROPEAN I; Tsuda T, 2009, DIASPORIC HOMECOMING; Waldrauch H., 2006, ACQUISITION LOSS NAT, V1, P121; Ward R, 2008, EXILE CULTURES MISPL, P99; Wetherall W, 2010, YOSHA RES; Yamanaka Keiko, 1996, DIASPORA, V5, P65, DOI 10.1353/dsp.1996.0002; YANEZ GALLARDO C, 1994, EMIGRACION ESPANOLA; Yepez del Castillo I, 2014, PAPELES CEIC, V2014	79	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0117-1968	2057-049X		ASIAN PAC MIGR J	Asian Pac. Migr. J.	DEC	2015	24	4					487	511		10.1177/0117196815610677		25	Demography	Demography	CW8LL	WOS:000365251000004		
J	Mori, K; Hailey, CJ; Krivonos, R; Hong, J; Ponti, G; Bauer, F; Perez, K; Nynka, M; Zhang, S; Tomsick, JA; Alexander, DM; Baganoff, FK; Barret, D; Barriere, N; Boggs, SE; Canipe, AM; Christensen, FE; Craig, WW; Forster, K; Giommi, P; Grefenstette, BW; Grindlay, JE; Harrison, FA; Hornstrup, A; Kitaguchi, T; Koglin, JE; Luu, V; Madsen, KK; Mao, PH; Miyasaka, H; Perri, M; Pivovaroff, MJ; Puccetti, S; Rana, V; Stern, D; Westergaard, NJ; Zhang, WW; Zoglauer, A				Mori, Kaya; Hailey, Charles J.; Krivonos, Roman; Hong, Jaesub; Ponti, Gabriele; Bauer, Franz; Perez, Kerstin; Nynka, Melania; Zhang, Shuo; Tomsick, John A.; Alexander, David M.; Baganoff, Frederick K.; Barret, Didier; Barriere, Nicolas; Boggs, Steven E.; Canipe, Alicia M.; Christensen, Finn E.; Craig, William W.; Forster, Karl; Giommi, Paolo; Grefenstette, Brian W.; Grindlay, Jonathan E.; Harrison, Fiona A.; Hornstrup, Allan; Kitaguchi, Takao; Koglin, Jason E.; Luu, Vy; Madsen, Kristen K.; Mao, Peter H.; Miyasaka, Hiromasa; Perri, Matteo; Pivovaroff, Michael J.; Puccetti, Simonetta; Rana, Vikram; Stern, Daniel; Westergaard, Niels J.; Zhang, William W.; Zoglauer, Andreas			NuSTAR HARD X-RAY SURVEY OF THE GALACTIC CENTER REGION. I. HARD X-RAY MORPHOLOGY AND SPECTROSCOPY OF THE DIFFUSE EMISSION	ASTROPHYSICAL JOURNAL			English	Article						Galaxy: center; radiation mechanisms: non-thermal; X-rays: general; X-rays: ISM	SGR-A-ASTERISK; PULSAR WIND NEBULAE; ENERGY GAMMA-RAYS; SUPERMASSIVE BLACK-HOLE; XMM-NEWTON OBSERVATIONS; KEV LINE EMISSION; SAGITTARIUS-A; MOLECULAR CLOUDS; SUPERNOVA-REMNANT; COSMIC-RAYS	We present the first sub-arcminute images of the Galactic Center above 10 keV, obtained with NuSTAR. NuSTAR resolves the hard X-ray source IGR J17456-2901 into non-thermal X-ray filaments, molecular clouds, point sources, and a previously unknown central component of hard X-ray emission (CHXE). NuSTAR detects four non-thermal X-ray filaments, extending the detection of their power-law spectra with Gamma similar to 1.3-2.3 up to similar to 50 keV. A morphological and spectral study of the filaments suggests that their origin may be heterogeneous, where previous studies suggested a common origin in young pulsar wind nebulae (PWNe). NuSTAR detects non-thermal X-ray continuum emission spatially correlated with the 6.4 keV Fe K alpha fluorescence line emission associated with two Sgr A molecular clouds: MC1 and the Bridge. Broadband X-ray spectral analysis with a Monte-Carlo based X-ray reflection model self-consistently determined their intrinsic column density (similar to 10(23) cm(-2)), primary X-ray spectra (power-laws with Gamma similar to 2) and set a lower limit of the X-ray luminosity of Sgr A* flare illuminating the Sgr A clouds to L-X >= 10(38) erg s(-1). Above similar to 20 keV, hard X-ray emission in the central 10 pc region around Sgr A* consists of the candidate PWN G359.95-0.04 and the CHXE, possibly resulting from an unresolved population of massive CVs with white dwarf masses M-WD similar to 0.9M(circle dot). Spectral energy distribution analysis suggests that G359.95-0.04 is likely the hard X-ray counterpart of the ultra-high gamma-ray source HESS J1745-290, strongly favoring a leptonic origin of the GC TeV emission.	[Mori, Kaya; Hailey, Charles J.; Perez, Kerstin; Nynka, Melania; Zhang, Shuo; Canipe, Alicia M.; Luu, Vy] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Krivonos, Roman; Tomsick, John A.; Barriere, Nicolas; Boggs, Steven E.; Craig, William W.; Zoglauer, Andreas] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Krivonos, Roman] Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; [Hong, Jaesub; Grindlay, Jonathan E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Ponti, Gabriele] Max Planck Inst Extraterr Phys, HEG, D-85748 Garching, Germany; [Bauer, Franz] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrofis, Santiago 22, Chile; [Bauer, Franz] Millennium Inst Astrophys, Santiago, Chile; [Bauer, Franz] Space Sci Inst, Boulder, CO 80301 USA; [Perez, Kerstin] Haverford Coll, Haverford, PA 19041 USA; [Alexander, David M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Baganoff, Frederick K.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Barret, Didier] Univ Toulouse, UPS OMP, IRAP, Toulouse, France; [Barret, Didier] CNRS, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France; [Christensen, Finn E.; Hornstrup, Allan; Westergaard, Niels J.] Tech Univ Denmark, DTU Space Natl Space Inst, DK-2800 Lyngby, Denmark; [Craig, William W.; Pivovaroff, Michael J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Forster, Karl; Grefenstette, Brian W.; Harrison, Fiona A.; Madsen, Kristen K.; Mao, Peter H.; Miyasaka, Hiromasa; Rana, Vikram] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Giommi, Paolo; Perri, Matteo; Puccetti, Simonetta] ASI Sci Data Ctr, I-00133 Rome, Italy; [Kitaguchi, Takao] Hiroshima Univ, Dept Phys Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Kitaguchi, Takao] Hiroshima Univ, Core Res Energet Universe, Higashihiroshima, Hiroshima 7398526, Japan; [Koglin, Jason E.] Kavli Inst Particle Astrophys & Cosmol, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Perri, Matteo; Puccetti, Simonetta] INAF Astronom Roma, I-00040 Monte Porzio Catone, Italy; [Stern, Daniel] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Zhang, William W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Mori, K (reprint author), Columbia Univ, Columbia Astrophys Lab, 538 W 120th St, New York, NY 10027 USA.	kaya@astro.columbia.edu		Puccetti, Simonetta/0000-0002-2734-7835	NASA [NNG08FD60C]; Russian Science Foundation [14-22-00271]; EU Marie Curie IntraEuropean fellowship [FP-PEOPLE-2012-IEF-331095]; Bundesministerium fur Wirtschaft und Technologie/DeutschesZentrum fur Luf-und R fahrt (BMWI/DLR) [FKZ 50 OR 1408]; Max Planck Society; CONICYT-Chile (Basal-CATA) [PFB-06/2007]; CONICYT-Chile (FONDECYT) [1141218]; CONICYT-Chile ("EMBIGGEN" Anillo) [ACT1101]; Ministry of Economy, Development, and Tourism's Millennium Science Initiative [IC120009]; NASA Headquarters under the NASA Earth and Space Science Fellowship Program-Grant [NNX13AM31]; French Space Agency (CNES)	This work was supported under NASA Contract No. NNG08FD60C, and made use of data from the NuSTAR mission, a project led by the California Institute of Technology, managed by the Jet Propulsion Laboratory, and funded by the National Aeronautics and Space Administration. We thank the NuSTAR Operations, Software and Calibration teams for support with the execution and analysis of these observations. This research has made use of the NuSTAR Data Analysis Software (NuSTARDAS) jointly developed by the ASI Science Data Center (ASDC, Italy) and the California Institute of Technology (USA). R. Krivonos acknowledges support from Russian Science Foundation through grant 14-22-00271. G. Ponti acknowledges support via an EU Marie Curie IntraEuropean fellowship under contract no. FP-PEOPLE-2012-IEF-331095, the Bundesministerium fur Wirtschaft und Technologie/DeutschesZentrum fur Luf-und R fahrt (BMWI/DLR, FKZ 50 OR 1408) and the Max Planck Society. F.E. Bauer acknowledges support from CONICYT-Chile (Basal-CATA PFB-06/2007, FONDECYT 1141218, "EMBIGGEN" Anillo ACT1101), and the Ministry of Economy, Development, and Tourism's Millennium Science Initiative through grant IC120009, awarded to The Millennium Institute of Astrophysics, MAS. S. Zhang is supported by NASA Headquarters under the NASA Earth and Space Science Fellowship Program-Grant "NNX13AM31." D. Barret acknowledges support from the French Space Agency (CNES). We thank Tahir Yaqoob for useful discussions on the MYTorus model.	Aharonian F, 2005, ASTRON ASTROPHYS, V432, pL25, DOI 10.1051/0004-6361:200500022; Aharonian F, 2004, ASTRON ASTROPHYS, V425, pL13, DOI 10.1051/0004-6361:200400055; Amo-Baladron MA, 2009, ASTROPHYS J, V694, P943, DOI 10.1088/0004-637X/694/2/943; Ballantyne DR, 2011, MON NOT R ASTRON SOC, V410, P1521, DOI 10.1111/j.1365-2966.2010.17533.x; Sunyaev R, 1998, MON NOT R ASTRON SOC, V297, P1279, DOI 10.1046/j.1365-8711.1998.01684.x; Heard V, 2013, MON NOT R ASTRON SOC, V428, P3462, DOI 10.1093/mnras/sts284; Perez K, 2015, NATURE, V520, P646, DOI 10.1038/nature14353; Murphy KD, 2009, MON NOT R ASTRON SOC, V397, P1549, DOI 10.1111/j.1365-2966.2009.15025.x; Wang QD, 2002, ASTROPHYS J, V581, P1148, DOI 10.1086/344401; Sakano M, 2004, MON NOT R ASTRON SOC, V350, P129, DOI 10.1111/j.1365-2966.2004.07571.x; Sakano M, 2003, MON NOT R ASTRON SOC, V340, P747, DOI 10.1046/j.1365-8711.2003.06299.x; Cramphorn CK, 2002, ASTRON ASTROPHYS, V389, P252, DOI 10.1051/0004-6361:20020521; Aharonian F, 2005, ASTROPHYS SPACE SCI, V300, P255, DOI 10.1007/s10509-005-1209-4; Quataert E, 2005, ASTROPHYS J, V635, pL45, DOI 10.1086/499126; Zhang L, 2008, ASTROPHYS J, V676, P1210, DOI 10.1086/527466; Koyama K, 1996, PUBL ASTRON SOC JPN, V48, P249; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Handa T, 2006, ASTROPHYS J, V636, P261, DOI 10.1086/497881; Murakami H, 2001, ASTROPHYS J, V558, P687, DOI 10.1086/322282; Nandra K, 2007, MON NOT R ASTRON SOC, V382, P194, DOI 10.1111/j.1365-2966.2007.12331.x; Wang QD, 2006, MON NOT R ASTRON SOC, V367, P937, DOI 10.1111/J.1365-2966.2006.09998.X; Muno MP, 2005, ASTROPHYS J, V622, pL113, DOI 10.1086/429721; Baganoff FK, 2001, NATURE, V413, P45, DOI 10.1038/35092510; Muno MP, 2008, ASTROPHYS J, V673, P251, DOI 10.1086/521641; Bykov AM, 2005, ASTROPHYS J, V624, pL41, DOI 10.1086/430499; Acero F, 2010, MON NOT R ASTRON SOC, V402, P1877, DOI 10.1111/j.1365-2966.2009.16014.x; Ponti G, 2010, ASTROPHYS J, V714, P732, DOI 10.1088/0004-637X/714/1/732; Aharonian F, 2009, ASTRON ASTROPHYS, V503, P817, DOI 10.1051/0004-6361/200811569; Yusef-Zadeh F, 2007, ASTROPHYS J, V656, P847, DOI 10.1086/510663; Jones PA, 2012, MON NOT R ASTRON SOC, V419, P2961, DOI 10.1111/j.1365-2966.2011.19941.x; KOYAMA K, 1989, NATURE, V339, P603, DOI 10.1038/339603a0; Freeman PE, 2001, PROC SPIE, V4477, P76, DOI 10.1117/12.447161; Tsuboi M, 1999, ASTROPHYS J SUPPL S, V120, P1, DOI 10.1086/313165; Reeves JN, 2000, MON NOT R ASTRON SOC, V316, P234, DOI 10.1046/j.1365-8711.2000.03510.x; Bykov AM, 2000, ASTROPHYS J, V538, P203, DOI 10.1086/309103; Muno MP, 2007, ASTROPHYS J, V656, pL69, DOI 10.1086/512236; Bamba A, 2010, ASTROPHYS J LETT, V719, pL116, DOI 10.1088/2041-8205/719/2/L116; Revnivtsev M, 2009, NATURE, V458, P1142, DOI 10.1038/nature07946; Lu FJ, 2003, ASTRON J, V126, P319, DOI 10.1086/375754; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Krivonos R, 2007, ASTRON ASTROPHYS, V463, P957, DOI 10.1051/0004-6361:20065626; Dogiel VA, 2009, PUBL ASTRON SOC JPN, V61, P1093; Ballantyne DR, 2007, ASTROPHYS J, V657, pL13, DOI 10.1086/513103; SUNYAEV RA, 1993, ASTROPHYS J, V407, P606, DOI 10.1086/172542; WORRALL DM, 1982, ASTROPHYS J, V255, P111, DOI 10.1086/159809; Kashyap VL, 2010, ASTROPHYS J, V719, P900, DOI 10.1088/0004-637X/719/1/900; Dogiel VA, 2009, PUBL ASTRON SOC JPN, V61, P1099; Tsuchiya K, 2004, ASTROPHYS J, V606, pL115, DOI 10.1086/421292; Ross RR, 2005, MON NOT R ASTRON SOC, V358, P211, DOI 10.1111/j.1365-2966.2005.08797.x; Revnivtsev M, 2006, ASTRON ASTROPHYS, V452, P169, DOI 10.1051/0004-6361:20054268; Weisskopf MC, 2007, ASTROPHYS J, V657, P1026, DOI 10.1086/510776; Reid MJ, 1999, ASTROPHYS J, V524, P816, DOI 10.1086/307855; Gabici S, 2009, MON NOT R ASTRON SOC, V396, P1629, DOI 10.1111/j.1365-2966.2009.14832.x; Wijnands R, 2006, ASTRON ASTROPHYS, V449, P1117, DOI 10.1051/0004-6361:20054129; YUSEFZADEH F, 1987, ASTROPHYS J, V322, P721, DOI 10.1086/165767; Lu FJ, 2008, ASTROPHYS J, V673, P915, DOI 10.1086/524369; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annuev.astro.42.053102.134031; Hinton JA, 2007, ASTROPHYS J, V657, P302, DOI 10.1086/510283; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Kusunose M, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/34; Dogiel V, 2009, PUBL ASTRON SOC JPN, V61, P901; Brightman M, 2011, MON NOT R ASTRON SOC, V413, P1206, DOI 10.1111/j.1365-2966.2011.18207.x; Yusef-Zadeh F, 2002, ASTROPHYS J, V570, P665, DOI 10.1086/340058; DAVIDSON JA, 1992, ASTROPHYS J, V387, P189, DOI 10.1086/171071; Albert J, 2006, ASTROPHYS J, V638, pL101, DOI 10.1086/501164; Gehrels N, 2004, ASTROPHYS J, V611, P1005, DOI 10.1086/422091; Wang QD, 2002, NATURE, V415, P148, DOI 10.1038/415148a; Tsuboi M, 2006, J PHYS CONF SER, V54, P16, DOI [10.1088/1742-6596/54/1/003, 10.1088/174-6596/54/1/003]; Johnson SP, 2009, MON NOT R ASTRON SOC, V399, P1429, DOI 10.1111/j.1365-2966.2009.15362.x; Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Yaqoob T, 2012, MON NOT R ASTRON SOC, V423, P3360, DOI 10.1111/j.1365-2966.2012.21129.x; Reid MJ, 2009, ASTROPHYS J, V705, P1548, DOI 10.1088/0004-637X/705/2/1548; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; Archer A, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/149; Arnaud KA, 1996, ASTR SOC P, V101, P17; Baganoff FK, 2003, ASTROPHYS J, V591, P891, DOI 10.1086/375145; Barriere NM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/123; Barriere NM, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/46; Belanger G, 2006, ASTROPHYS J, V636, P275, DOI 10.1086/497629; Bodaghee A, 2014, ASTROPHYS J, V791, DOI [10.1088/0004-637X/791/1/68, 10.1088/0004-637X/791/1]; BRANDUARDI G, 1976, MON NOT R ASTRON SOC, V175, pP47; Capelli R, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219544; Cembranos JAR, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/04/051; Chen W, 1997, ASTROPHYS J, V491, P312, DOI 10.1086/304921; Chernyakova M, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/60; Christopher MH, 2005, ASTROPHYS J, V622, P346, DOI 10.1086/427911; Clavel M, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321667; Degenaar N, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/155; Degenaar N, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219470; Dubus G, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0064-5; Etxaluze M, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321258; Ferriere K, 2009, ASTRON ASTROPHYS, V505, P1183, DOI 10.1051/0004-6361/200912617; Hailey C., 2015, APJ UNPUB; Harrison FA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/103; Hong J., 2015, APJ UNPUB; Inui T., 2009, PASJ, V61, P241; Kaspi VM, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/84; Koch EW, 2014, MON NOT R ASTRON SOC, V442, P372, DOI 10.1093/mnras/stu887; Koyama K., 2007, PASJ, V59, P245; Krivonos RA, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/107; Li ZY, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/154; Linden T, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/95; Lotti S., 2015, APJ UNPUB; Madsen KK, 2015, ASTROPHYS J SUPPL S, V220, DOI 10.1088/0067-0049/220/1/8; Maeda Y, 2002, ASTROPHYS J, V570, P671, DOI 10.1086/339773; MAGDZIARZ P, 1995, MON NOT R ASTRON SOC, V273, P837; Mori K, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L23; Muno MP, 2009, ASTROPHYS J SUPPL S, V181, P110, DOI 10.1088/0067-0049/181/1/110; Muno MP, 2004, ASTROPHYS J, V613, P326, DOI 10.1086/422865; Neilsen J, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/42; Neronov A., 2005, ARXIVASTROPH0506437; Nobukawa M, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L52; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; Nowak MA, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/95; Nynka M, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/119; Nynka M, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/2/L31; Odaka H, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/103; Park S, 2005, ASTROPHYS J, V631, P964, DOI 10.1086/432639; Ponti G., 2014, IAU S, V303, P333; Ponti G., 2013, ASTROPHYS SPACE SCI, V34, P331; REID MJ, 1993, ANNU REV ASTRON ASTR, V31, P345; Revnivtsev MG, 2004, ASTRON ASTROPHYS, V425, pL49, DOI 10.1051/0004-6361:200400064; Seifina E, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/99; Tatischeff V, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219016; Terrier R, 2010, ASTROPHYS J, V719, P143, DOI 10.1088/0004-637X/719/1/143; Wik DR, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/48; Yuasa T, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/129; Yusef-Zadeh F, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L11; Yusef-Zadeh F., 2002, Astrophysical Journal, Letters, V568, DOI 10.1086/340379; Yusef-Zadeh F, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/33; Zhang S, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/6; Zhang S., 2015, APJ IN PRESS	132	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2015	814	2							94	10.1088/0004-637X/814/2/94		24	Astronomy & Astrophysics	Astronomy & Astrophysics	CW9KJ	WOS:000365317300012		
J	Sasaki, K; Asano, K; Terasawa, T				Sasaki, Kento; Asano, Katsuaki; Terasawa, Toshio			TIME-DEPENDENT STOCHASTIC ACCELERATION MODEL FOR FERMI BUBBLES	ASTROPHYSICAL JOURNAL			English	Article						acceleration of particles; cosmic rays; Galaxy: center; gamma rays: ISM; radiation mechanisms: non-thermal	TURBULENT MAGNETIC-FIELD; REMNANT RX J1713.7-3946; COSMIC-RAY PROPAGATION; SGR A-ASTERISK; PARTICLE-ACCELERATION; MULTIWAVELENGTH EMISSION; RELATIVISTIC ELECTRONS; INTERSTELLAR-MEDIUM; SUPERNOVA-REMNANTS; MAGNETOHYDRODYNAMIC TURBULENCE	We study stochastic acceleration models for the Fermi bubbles. Turbulence is excited just behind the shock front via Kelvin-Helmholtz, Rayleigh-Taylor, or Richtmyer-Meshkov instabilities, and plasma particles are continuously accelerated by the interaction with the turbulence. The turbulence gradually decays as it goes away from the shock fronts. Adopting a phenomenological model for the stochastic acceleration, we explicitly solve the temporal evolution of the particle energy distribution in the turbulence. Our results show that the spatial distribution of high-energy particles is different from those for a steady solution. We also show that the contribution of electrons that escaped from the acceleration regions significantly softens the photon spectrum. The photon spectrum and surface brightness profile are reproduced by our models. If the escape efficiency is very high, the radio flux from the escaped low-energy electrons can be comparable to that of the WMAP haze. We also demonstrate hadronic models with the stochastic acceleration, but they are unlikely in the viewpoint of the energy budget.	[Sasaki, Kento; Asano, Katsuaki; Terasawa, Toshio] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan	Sasaki, K (reprint author), Univ Tokyo, Inst Cosm Ray Res, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778582, Japan.	kentos@icrr.u-tokyo.ac.jp; asanok@icrr.u-tokyo.ac.jp; terasawa@icrr.u-tokyo.ac.jp			MEXT of Japan [25400227]	We thank the anonymous referee for a careful review and valuable comments. We appreciate Y. Fujita and Y. Ohira for helpful discussion. This work is partially supported by the Grant-in-Aid for Scientific Research, No. 25400227 from the MEXT of Japan (KA).	Ackermann M, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.092004; Ackermann M, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/64; Ackermann M, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/3; O'Sullivan S, 2009, MON NOT R ASTRON SOC, V400, P248, DOI 10.1111/j.1365-2966.2009.15442.x; Inoue T, 2009, ASTROPHYS J, V695, P825, DOI 10.1088/0004-637X/695/2/825; Yang HYK, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/185; Fraternali F, 2015, MON NOT R ASTRON SOC, V447, pL70, DOI 10.1093/mnrasl/slu182; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Crocker RM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.101102; Mertsch P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.091101; Asano K, 2009, ASTROPHYS J, V705, P1714, DOI 10.1088/0004-637X/705/2/1714; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Zubovas K, 2012, MON NOT R ASTRON SOC, V424, P666, DOI 10.1111/j.1365-2966.2012.21250.x; Fan ZH, 2010, MON NOT R ASTRON SOC, V406, P1337, DOI 10.1111/j.1365-2966.2010.16767.x; Vladimirov AE, 2011, COMPUT PHYS COMMUN, V182, P1156, DOI 10.1016/j.cpc.2011.01.017; Cho JY, 2006, ASTROPHYS J, V638, P811, DOI 10.1086/498967; Liu SM, 2006, ASTROPHYS J, V647, P1099, DOI 10.1086/505171; Sharma M, 2014, MON NOT R ASTRON SOC, V441, P431, DOI 10.1093/mnras/stu497; Stawarz L, 2008, ASTROPHYS J, V681, P1725, DOI 10.1086/588813; Ohira Y, 2011, MON NOT R ASTRON SOC, V410, P1577, DOI 10.1111/j.1365-2966.2010.17539.x; Zubovas K, 2011, MON NOT R ASTRON SOC, V415, pL21, DOI 10.1111/j.1745-3933.2011.01070.x; Orlando E, 2013, MON NOT R ASTRON SOC, V436, P2127, DOI 10.1093/mnras/stt1718; Dobler G, 2008, ASTROPHYS J, V680, P1222, DOI 10.1086/587862; [Anonymous], 2001, PHYS REV E; Kakuwa J, 2015, MON NOT R ASTRON SOC, V449, P551, DOI 10.1093/mnras/stv281; Hardcastle MJ, 2009, MON NOT R ASTRON SOC, V393, P1041, DOI 10.1111/j.1365-2966.2008.14265.x; Melioli C, 2013, MON NOT R ASTRON SOC, V430, P3235, DOI 10.1093/mnras/stt126; Asano K, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/1/L18; Asano K, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/64; Asano K, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/115; Baumgartner V, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321261; Brandenburg A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.075001; Cheng KS, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/112; Cheng KS, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/2/135; Cheng KS, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/23; Cheng KS, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/1/L17; Crocker Roland M., 2015, Astrophysical Journal, V808, DOI 10.1088/0004-637X/808/2/107; Crocker RM, 2012, MON NOT R ASTRON SOC, V423, P3512, DOI 10.1111/j.1365-2966.2012.21149.x; Finkbeiner DP, 2004, ASTROPHYS J, V614, P186, DOI 10.1086/423482; Fujita Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/67; Fujita Y, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L20; Guo FL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/181; Kataoka J, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/57; Lacki BC, 2014, MON NOT R ASTRON SOC, V444, pL39, DOI 10.1093/mnrasl/slu107; Lynn JW, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/71; Mou GB, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/109; Mueller E., 1991, ASTRON ASTROPHYS, V251, P505; Murase K, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/164; Porter T. A., 2005, P 29 INT COSM RAY C, V4, P77; PTUSKIN VS, 1988, SOV ASTRON LETT+, V14, P255; Su M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/61; Tahara M, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/91; Yang CY, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/138; Yang RZ, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423562	54	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2015	814	2							93	10.1088/0004-637X/814/2/93		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CW9KJ	WOS:000365317300011		
J	Wang, ZX; Tanaka, YT; Wang, C; Kawabata, KS; Fukazawa, Y; Itoh, R; Tziamtzis, A				Wang, Zhongxiang; Tanaka, Yasuyuki T.; Wang, Chen; Kawabata, Koji S.; Fukazawa, Yasushi; Itoh, Ryosuke; Tziamtzis, Anestis			OPTICAL I-BAND LINEAR POLARIMETRY OF THE MAGNETAR 4U 0142+61 WITH SUBARU	ASTROPHYSICAL JOURNAL			English	Article						stars: neutron; polarization; pulsars: individual (4U 0142+61); X-rays: stars	X-RAY PULSARS; RADIO PULSARS; DEBRIS DISKS; VELA PULSAR; WHITE-DWARF; 1E 2259+586; POLARIZATION; EMISSION; TELESCOPE; REPEATER	Magnetars are known to have optical and/or infrared (IR) emission, but the origin of the emission is not well understood. In order to fully study their emission properties, we have carried out for the first time optical linear polarimetry of the magnetar 4U 0142+61, which has been determined from different observations to have a complicated broadband spectrum over optical and IR wavelengths. From our I-band imaging polarimetric observation, conducted with the 8.2-m Subaru telescope, we determine the degree of linear polarization to be P = 1.0 +/- 3.4%, or P <= 5.6% (90% confidence level). Considering models that were suggested for optical emission from magnetars, we discuss the implications of our result. The upper limit measurement indicates that, differing from radio pulsars, magnetars probably would not have strongly polarized optical emission if the emission arises from their magnetosphere as suggested.	[Wang, Zhongxiang; Tziamtzis, Anestis] Chinese Acad Sci, Shanghai Astron Observ, Shanghai 200030, Peoples R China; [Tanaka, Yasuyuki T.; Kawabata, Koji S.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Higashihiroshima, Hiroshima 7398526, Japan; [Wang, Chen] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Fukazawa, Yasushi; Itoh, Ryosuke] Hiroshima Univ, Dept Phys Sci, Higashihiroshima, Hiroshima 7398526, Japan	Wang, ZX (reprint author), Chinese Acad Sci, Shanghai Astron Observ, 80 Nandan Rd, Shanghai 200030, Peoples R China.				National Natural Science Foundation of China [11373055, 11273029]; Strategic Priority Research Program "The Emergence of Cosmological Structures" of Chinese Academy of Sciences [XDB09000000]	We thank the anonymous referee for helpful suggestions and Takashi Hattori for taking the data for us. This research was supported in part by the National Natural Science Foundation of China (11373055) and the Strategic Priority Research Program "The Emergence of Cosmological Structures" of the Chinese Academy of Sciences (Grant No. XDB09000000). C.W. acknowledeges the support from the National Natural Science Foundation of China (11273029).	CHENG FH, 1988, ASTROPHYS J, V328, P223, DOI 10.1086/166284; Han JL, 2009, ASTROPHYS J SUPPL S, V181, P557, DOI 10.1088/0067-0049/181/2/557; Wang ZX, 2006, NATURE, V440, P772, DOI 10.1038/nature04669; Durant M, 2006, ASTROPHYS J, V650, P1070, DOI 10.1086/506380; SCHMIDT GD, 1992, ASTRON J, V104, P1563, DOI 10.1086/116341; Makishima K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.171102; Tanaka YT, 2007, ASTROPHYS J, V665, pL55, DOI 10.1086/521025; Hurley K, 1999, NATURE, V397, P41, DOI 10.1038/16199; CHENG AF, 1979, ASTROPHYS J, V229, P348, DOI 10.1086/156959; Beloborodov AM, 2007, ASTROPHYS J, V657, P967, DOI 10.1086/508917; Moran P, 2013, MON NOT R ASTRON SOC, V433, P2564, DOI 10.1093/mnras/stt931; Hulleman F, 2000, NATURE, V408, P689; Rea N, 2010, SCIENCE, V330, P944, DOI 10.1126/science.1196088; Kern B, 2002, NATURE, V417, P527, DOI 10.1038/417527a; Durant M, 2006, ASTROPHYS J, V650, P1082, DOI 10.1086/507174; Lundqvist N, 2011, MON NOT R ASTRON SOC, V413, P611, DOI 10.1111/j.1365-2966.2010.18159.x; Kashikawa N, 2002, PUBL ASTRON SOC JPN, V54, P819; Kern B, 2003, ASTROPHYS J, V597, P1049, DOI 10.1086/378670; MORINI M, 1988, ASTROPHYS J, V333, P777, DOI 10.1086/166786; Wang C, 2010, MON NOT R ASTRON SOC, V403, P569, DOI 10.1111/j.1365-2966.2009.16074.x; Terasawa T, 2005, NATURE, V434, P1110, DOI 10.1038/nature03573; Slowikowska A, 2009, MON NOT R ASTRON SOC, V397, P103, DOI 10.1111/j.1365-2966.2009.14935.x; MIDDLEDITCH J, 1987, ASTROPHYS J, V315, P142, DOI 10.1086/165119; Mignani RP, 2007, ASTRON ASTROPHYS, V467, P1157, DOI 10.1051/0004-6361:20066026; Gould DM, 1998, MON NOT R ASTRON SOC, V301, P235, DOI 10.1046/j.1365-8711.1998.02018.x; Weltevrede P, 2008, MON NOT R ASTRON SOC, V391, P1210, DOI 10.1111/j.1365-2966.2008.13950.x; Hulleman F, 2004, ASTRON ASTROPHYS, V416, P1037, DOI 10.1051/0004-6361:20031756; Kawabata KS, 1999, PUBL ASTRON SOC PAC, V111, P898, DOI 10.1086/316387; Gonzalez ME, 2010, ASTROPHYS J, V716, P1345, DOI 10.1088/0004-637X/716/2/1345; Moran P, 2014, MON NOT R ASTRON SOC, V445, P835, DOI 10.1093/mnras/stu1791; Eichler D, 2002, ASTROPHYS J, V578, pL121, DOI 10.1086/344564; Garcia L, 2015, REV MEX ASTRON ASTR, V51, P3; Kaspi VM, 2007, ASTROPHYS SPACE SCI, V308, P1, DOI 10.1007/s10509-007-9309-y; Malheiro M, 2012, PUBL ASTRON SOC JPN, V64; Mereghetti S, 2013, BRAZ J PHYS, V43, P356, DOI 10.1007/s13538-013-0137-y; Mignani R. P., 2015, ASTRON ASTROPHYS, V583, P105; Olausen SA, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/6; PACZYNSKI B, 1990, ASTROPHYS J, V365, pL9, DOI 10.1086/185876; Rea N, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/27; Rueda JA, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L24; Tendulkar SP, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/32; Wagner SJ, 2000, ASTR SOC P, V202, P315; Wang ZX, 2014, PLANET SPACE SCI, V100, P19, DOI 10.1016/j.pss.2014.04.007; Wang ZX, 2012, PUBL ASTRON SOC JPN, V64; Wang Z., 2008, AIP C SER, V983, P274; Woods P. M., 2006, SOFT GAMMA REPEATERS, P547	46	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2015	814	2							89	10.1088/0004-637X/814/2/89		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CW9KJ	WOS:000365317300007		
J	Yan, L; Quimby, R; Ofek, E; Gal-Yam, A; Mazzali, P; Perley, D; Vreeswijk, PM; Leloudas, G; de Cia, A; Masci, F; Cenko, SB; Cao, Y; Kulkarni, SR; Nugent, PE; Rebbapragada, UD; Wozniak, PR; Yaron, O				Yan, Lin; Quimby, R.; Ofek, E.; Gal-Yam, A.; Mazzali, P.; Perley, D.; Vreeswijk, P. M.; Leloudas, G.; de Cia, A.; Masci, F.; Cenko, S. B.; Cao, Y.; Kulkarni, S. R.; Nugent, P. E.; Rebbapragada, Umaa D.; Wozniak, P. R.; Yaron, O.			DETECTION OF BROAD H alpha EMISSION LINES IN THE LATE-TIME SPECTRA OF A HYDROGEN-POOR SUPERLUMINOUS SUPERNOVA	ASTROPHYSICAL JOURNAL			English	Article						supernovae: general; supernovae: individual (iPTF13ehe, SN2007bi, PTF12dam)	PULSATIONAL PAIR-INSTABILITY; GAMMA-RAY BURSTS; LUMINOUS SUPERNOVAE; IC SUPERNOVAE; MAGNETIC-FIELDS; POPULATION III; LIGHT-CURVE; GALAXIES; STARS; EXPLOSIONS	iPTF13ehe is a hydrogen-poor superluminous supernova (SLSN) at z = 0.3434, with a slow-evolving light curve and spectral features similar to SN2007bi. It rises in 83-148 days to reach a peak bolometric luminosity of similar to 1.3 x 10(44) erg s(-1), then decays slowly at 0.015 mag day(-1). The measured ejecta velocity is similar to 13,000 km s(-1). The inferred explosion characteristics, such as the ejecta mass (70-220M(circle dot)), and the total radiative and kinetic energy (E-rad similar to 10(51) erg, E-kin similar to 2 x 10(53) erg), are typical of slow-evolving H-poor SLSN events. However, the late-time spectrum taken at +251 days (rest, post-peak) reveals a Balmer Ha emission feature with broad and narrow components, which has never been detected before among other H-poor SLSNe. The broad component has a velocity width of similar to 4500 km s(-1) and a similar to 300 km s(-1) blueward shift relative to the narrow component. We interpret this broad Ha emission with a luminosity of similar to 2 x 10(41) erg s(-1) as resulting from the interaction between the supernova ejecta and a discrete H-rich shell, located at a distance of similar to 4 x 1016 cm from the explosion site. This interaction causes the rest-frame r-band LC to brighten at late times. The fact that the late-time spectra are not completely absorbed by the shock-ionized H-shell implies that its Thomson scattering optical depth is likely. 1, thus setting upper limits on the shell mass <= 30M(circle dot). Of the existing models, a Pulsational Pair Instability supernova model can naturally explain the observed 30M(circle dot) H-shell, ejected from a progenitor star with an initial mass of (95-150) M-circle dot about 40 years ago. We estimate that at least similar to 15% of all SLSNe-I may have late-time Balmer emission lines.	[Yan, Lin; Masci, F.] CALTECH, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Quimby, R.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Quimby, R.] Univ Tokyo, UTIAS, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan; [Ofek, E.; Gal-Yam, A.; Vreeswijk, P. M.; Leloudas, G.; de Cia, A.; Yaron, O.] Weizmann Inst Sci, Fac Phys, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Mazzali, P.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Mazzali, P.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Perley, D.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Perley, D.; Leloudas, G.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; [Cenko, S. B.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Cenko, S. B.] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Cao, Y.; Kulkarni, S. R.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Nugent, P. E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Nugent, P. E.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Rebbapragada, Umaa D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Wozniak, P. R.] Los Alamos Natl Lab, Space & Remote Sensing, Los Alamos, NM 87545 USA	Yan, L (reprint author), CALTECH, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA.	lyan@ipac.caltech.edu			EU/FP7 via ERC [307260]; Quantum universe I-Core program, Israeli Committee for planning and budgeting; ISF; Minerva; Weizmann-UK "making connections" program; Kimmel award; ARCHES award; Danish National Research Foundation; Discovery Communications; National Science Foundation [AST-1005313]; US Department of Energy, Laboratory Directed Research and Development program; US Government; W. M. Keck Foundation	We thank the anonymous referee for the positive and constructive suggestions, which have helped to improve the paper. We benefited from discussions with Nick Scoville and Orly Gnat on collisional excitations in ISM. We thank Mansi Kasliwal, Thomas Prince, and Howard Bond for helping us obtain the P200 photometry at one epoch. Vicki Toy and John Capone from University of Maryland are acknowledged for taking the photometry observation using LMI on DCT. A.G.Y. is supported by EU/FP7 via ERC grant No. 307260, the Quantum universe I-Core program by the Israeli Committee for planning and budgeting and the ISF; by Minerva and ISF grants; by the Weizmann-UK "making connections" program; and by Kimmel and ARCHES awards. The Dark Cosmology Centre is funded by the Danish National Research Foundation. This paper made use of Lowell Observatory's Discovery Channel Telescope (DCT). Lowell operates the DCT in partnership with Boston University, Northern Arizona University, the University of Maryland, and the University of Toledo. Partial support of the DCT was provided by Discovery Communications. The Large Monolithic Imager (LMI) on DCT was built by Lowell Observatory using funds from the National Science Foundation (AST-1005313). LANL participation in iPTF is supported by the US Department of Energy as a part of the Laboratory Directed Research and Development program. A portion of this work was carried out at the Jet Propulsion Laboratory under a Research and Technology Development Grant, under contract with the National Aeronautics and Space Administration. US Government support is acknowledged. This research has made use of the NASA/IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. The authors wish to recognize and acknowledge the very significant cultural role and reverence that the summit of Mauna Kea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain.	Ade P. A. R., 2015, ARXIV150201589; Miller AA, 2009, ASTROPHYS J, V690, P1303, DOI 10.1088/0004-637X/690/2/1303; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Benetti S, 2014, MON NOT R ASTRON SOC, V441, P289, DOI 10.1093/mnras/stu538; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Smith N, 2007, ASTROPHYS J LETT, V671, pL17, DOI 10.1086/524681; Laher RR, 2014, PUBL ASTRON SOC PAC, V126, P674; Heger A, 2005, ASTROPHYS J, V626, P350, DOI 10.1086/429868; Mazzali PA, 2008, MON NOT R ASTRON SOC, V386, P1897, DOI 10.1111/j.1365-2966.2008.13199.x; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Faber SM, 2003, P SOC PHOTO-OPT INS, V4841, P1657, DOI 10.1117/12.460346; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; RAKAVY G, 1967, ASTROPHYS J, V148, P803, DOI 10.1086/149204; Drake AJ, 2009, ASTROPHYS J, V696, P870, DOI 10.1088/0004-637X/696/1/870; Mazzali PA, 2006, NATURE, V442, P1018, DOI 10.1038/nature05081; Cenko SB, 2006, PUBL ASTRON SOC PAC, V118, P1396, DOI 10.1086/508366; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Leloudas G, 2015, MON NOT R ASTRON SOC, V449, P917, DOI 10.1093/mnras/stv320; Davies B, 2009, ASTROPHYS J, V707, P844, DOI 10.1088/0004-637X/707/1/844; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334; Nicholl M, 2013, NATURE, V502, P346, DOI 10.1038/nature12569; Gezari S, 2009, ASTROPHYS J, V690, P1313, DOI 10.1088/0004-637X/690/2/1313; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Scannapieco E, 2005, ASTROPHYS J, V633, P1031, DOI 10.1086/444450; Mazzali PA, 2007, ASTROPHYS J, V670, P592, DOI 10.1086/521873; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; Moriya T, 2010, ASTROPHYS J LETT, V717, pL83, DOI 10.1088/2041-8205/717/2/L83; Kaiser N, 2002, P SOC PHOTO-OPT INS, V4836, P154, DOI 10.1117/12.457365; BOND JR, 1984, ASTROPHYS J, V280, P825, DOI 10.1086/162057; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395; Arnett D., 1996, SUPERNOVAE NUCLEOSYN, P421; ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Bersten MC, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/61; Bersten MC, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/31; Branch D., 2004, COSMIC EXPLOSIONS 3, P132, DOI 10.1017/CBO9780511536236.015; Chatzopoulos E, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/154; Chen T.-W., 2014, ARXIV14097728; Chevalier R. A., 2011, ASTROPHYS J LETT, V729, pLL6; CHEVALIER RA, 1980, ASTROPHYS J, V235, P186, DOI 10.1086/157623; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Gal-Yam A, 2012, SCIENCE, V337, P927, DOI 10.1126/science.1203601; Hogg D. W., 2002, ARXIVASTROPH0210394; Inserra C, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/128; Katz B., 2013, ARXIV13016766; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Lunnan R, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/138; Moriya TJ, 2014, ASTROPHYS J LETT, V790, DOI 10.1088/2041-8205/790/2/L16; Morlino G, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322006; Newman JA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/5; Nicholl M., 2015, ARXIV150501078; Ofek EO, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/154; Ofek EO, 2007, ASTROPHYS J, V659, pL13, DOI 10.1086/516749; Padmanabhan T, 2000, THEORETICAL ASTROPHY, V1, P622; Pastorello A, 2010, ASTROPHYS J LETT, V724, pL16, DOI 10.1088/2041-8205/724/1/L16; Rahmer G., 2008, P SPIE, V7014; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Sorokina E., 2015, ARXIV151000834; Waldman R, 2008, ASTROPHYS J, V685, P1103, DOI 10.1086/591267; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656; Yoon SC, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201117769; Young DR, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913004	66	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2015	814	2							108	10.1088/0004-637X/814/2/108		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CW9KJ	WOS:000365317300026		
J	Zhu, W; Gould, A; Beichman, C; Novati, SC; Carey, S; Gaudi, BS; Henderson, CB; Penny, M; Shvartzvald, Y; Yee, JC; Udalski, A; Poleski, R; Skowron, J; Kozlowski, S; Mroz, P; Pietrukowicz, P; Pietrzynski, G; Szymanski, MK; Soszynski, I; Ulaczyk, K; Wyrzykowski, L; Abe, F; Barry, RK; Bennett, DP; Bhattacharya, A; Bond, IA; Freeman, M; Fukui, A; Hirao, Y; Itow, Y; Koshimoto, N; Ling, H; Masuda, K; Matsubara, Y; Muraki, Y; Nagakane, M; Ohnishi, K; Saito, T; Sullivan, DJ; Sumi, T; Suzuki, D; Tristram, PJ; Rattenbury, N; Wakiyama, Y; Yonehara, A; Maoz, D; Kaspi, S; Friedmann, M				Zhu, Wei; Gould, Andrew; Beichman, Charles; Novati, Sebastiano Calchi; Carey, Sean; Gaudi, B. Scott; Henderson, Calen B.; Penny, Matthew; Shvartzvald, Yossi; Yee, Jennifer C.; Udalski, A.; Poleski, R.; Skowron, J.; Kozlowski, S.; Mroz, P.; Pietrukowicz, P.; Pietrzynski, G.; Szymanski, M. K.; Soszynski, I.; Ulaczyk, K.; Wyrzykowski, L.; Abe, F.; Barry, R. K.; Bennett, D. P.; Bhattacharya, A.; Bond, I. A.; Freeman, M.; Fukui, A.; Hirao, Y.; Itow, Y.; Koshimoto, N.; Ling, H.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Nagakane, M.; Ohnishi, K.; Saito, To.; Sullivan, D. J.; Sumi, T.; Suzuki, D.; Tristram, P. J.; Rattenbury, N.; Wakiyama, Y.; Yonehara, A.; Maoz, D.; Kaspi, S.; Friedmann, M.		OGLE Collaboration; MOA Collaboration; Wise Grp	PLANET SENSITIVITY FROM COMBINED GROUND- AND SPACE-BASED MICROLENSING OBSERVATIONS	ASTROPHYSICAL JOURNAL			English	Article						gravitational lensing: micro; planetary systems	PARALLAX SATELLITE MASS; SPITZER OBSERVATIONS; EXTRASOLAR PLANETS; MAGNIFICATION; COMPANIONS; STAR; LENS; SYSTEMS; EVENTS; FREQUENCY	To move one step forward toward a Galactic distribution of planets, we present the first planet sensitivity analysis for microlensing events with simultaneous observations from space and the ground. We present this analysis for two such events, OGLE-2014-BLG-0939 and OGLE-2014-BLG-0124, which both show substantial planet sensitivity even though neither of them reached high magnification. This suggests that an ensemble of low to moderate magnification events can also yield significant planet sensitivity, and therefore probability, for detecting planets. The implications of our results to the ongoing and future space-based microlensing experiments to measure the Galactic distribution of planets are discussed.	[Zhu, Wei; Gould, Andrew; Gaudi, B. Scott; Henderson, Calen B.; Penny, Matthew; Poleski, R.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Beichman, Charles; Novati, Sebastiano Calchi] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Novati, Sebastiano Calchi] Univ Salerno, Dipartimento Fis ER Caianiello, I-84084 Fisciano, SA, Italy; [Novati, Sebastiano Calchi] IIASS, I-84019 Vietri Sul Mare, SA, Italy; [Carey, Sean] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Henderson, Calen B.; Shvartzvald, Yossi] NASA Jet Prop Lab, Pasadena, CA 91109 USA; [Yee, Jennifer C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Udalski, A.; Poleski, R.; Skowron, J.; Kozlowski, S.; Mroz, P.; Pietrukowicz, P.; Pietrzynski, G.; Szymanski, M. K.; Soszynski, I.; Ulaczyk, K.; Wyrzykowski, L.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Abe, F.; Itow, Y.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Wakiyama, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Barry, R. K.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Bennett, D. P.; Bhattacharya, A.; Suzuki, D.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Bond, I. A.; Ling, H.] Massey Univ, North Shore Mail Ctr, Inst Informat & Math Sci, Auckland, New Zealand; [Freeman, M.; Rattenbury, N.] Univ Auckland, Dept Phys, Auckland 1, New Zealand; [Fukui, A.] Natl Astron Observ Japan, Okayama Astrophys Observ, Asakuchi, Okayama 7190232, Japan; [Hirao, Y.; Koshimoto, N.; Nagakane, M.; Sumi, T.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Ohnishi, K.] Nagano Natl Coll Technol, Nagano 3818550, Japan; [Saito, To.] Tokyo Metropolitan Coll Aeronaut, Tokyo 1168523, Japan; [Sullivan, D. J.] Victoria Univ, Sch Chem & Phys Sci, Wellington, New Zealand; [Tristram, P. J.] Mt John Univ Observ, Lake Tekapo 8770, New Zealand; [Yonehara, A.] Kyoto Sangyo Univ, Dept Phys, Fac Sci, Kyoto 6038555, Japan; [Maoz, D.; Kaspi, S.; Friedmann, M.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Zhu, W (reprint author), Ohio State Univ, Dept Astron, 140 W 18th Ave, Columbus, OH 43210 USA.	weizhu@astronomy.ohio-state.edu			JPL [1500811]; NASA through the Sagan Fellowship Program; NASA; National Science Centre, Poland [MAESTRO 2014/14/A/ST9/00121];  [JSPS23103002];  [JSPS24253004];  [JSPS26247023];  [JSPS25103508];  [23340064]	Work by W.Z. and A.G. was supported by JPL grant 1500811. Work by J.C.Y. and M.P. was performed under contract with the California Institute of Technology (Caltech)/Jet Propulsion Laboratory (JPL), funded by NASA through the Sagan Fellowship Program executed by the NASA Exoplanet Science Institute. Work by Y.S. is supported by an appointment to the NASA Postdoctoral Program at the Jet Propulsion Laboratory, administered by Oak Ridge Associated Universities through a contract with NASA. The OGLE project has received funding from the National Science Centre, Poland, grant MAESTRO 2014/14/A/ST9/00121 to AU. T.S. acknowledges the financial support from JSPS23103002, JSPS24253004, and JSPS26247023. The MOA project is supported by the grant JSPS25103508 and 23340064. This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA.	Yee JC, 2009, ASTROPHYS J, V703, P2082, DOI 10.1088/0004-637X/703/2/2082; Dong SB, 2006, ASTROPHYS J, V642, P842, DOI 10.1086/501224; Sako T, 2008, EXP ASTRON, V22, P51, DOI 10.1007/s10686-007-9082-5; Gould A, 2010, ASTROPHYS J, V720, P1073, DOI 10.1088/0004-637X/720/2/1073; Dong S, 2007, ASTROPHYS J, V664, P862, DOI 10.1086/518536; Griest K, 1998, ASTROPHYS J, V500, P37, DOI 10.1086/305729; Sumi T, 2010, ASTROPHYS J, V710, P1641, DOI 10.1088/0004-637X/710/2/1641; Ingrosso G, 2009, MON NOT R ASTRON SOC, V399, P219, DOI 10.1111/j.1365-2966.2009.15184.x; Gould A, 2009, ASTROPHYS J LETT, V698, pL147, DOI 10.1088/0004-637X/698/2/L147; Albrow MD, 2000, ASTROPHYS J, V535, P176, DOI 10.1086/308842; GOULD A, 1992, ASTROPHYS J, V396, P104, DOI 10.1086/171700; Gaudi BS, 2000, ASTROPHYS J, V528, P56, DOI 10.1086/308161; Yoo J, 2004, ASTROPHYS J, V603, P139, DOI 10.1086/381241; Rhie SH, 2000, ASTROPHYS J, V533, P378, DOI 10.1086/308634; MAO S, 1991, ASTROPHYS J, V374, pL37, DOI 10.1086/186066; Gould A, 1997, ASTROPHYS J, V477, P580, DOI 10.1086/303751; Smith MC, 2007, MON NOT R ASTRON SOC, V380, P805, DOI 10.1111/j.1365-2966.2007.12130.x; Pejcha O, 2009, ASTROPHYS J, V690, P1772, DOI 10.1088/0004-637X/690/2/1772; Gaudi BS, 2002, ASTROPHYS J, V566, P463, DOI 10.1086/337987; Shvartzvald Y, 2012, MON NOT R ASTRON SOC, V419, P3631, DOI 10.1111/j.1365-2966.2011.20014.x; Novati SC, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/20; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Clanton C, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/91; Dominik M, 1998, ASTRON ASTROPHYS, V333, pL79; Gaudi BS, 2012, ANNU REV ASTRON ASTR, V50, P411, DOI 10.1146/annurev-astro-081811-125518; Gould A, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L28; Gould A, 2008, ASTROPHYS J, V681, P1593, DOI 10.1086/588601; GOULD A, 1994, ASTROPHYS J, V421, pL75, DOI 10.1086/187191; GOULD A, 1992, ASTROPHYS J, V392, P442, DOI 10.1086/171443; Gould A, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/107; Henderson CB, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/52; Penny MT, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/142; REFSDAL S, 1966, MON NOT R ASTRON SOC, V134, P315; Udalski A, 2003, ACTA ASTRONOM, V53, P291; Udalski A, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/237; Yee JC, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/76; Yee JC, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/2/155; Zhu W., 2015, ARXIV151002097; Zhu W, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/73; Zhu W, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/1/8	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2015	814	2							129	10.1088/0004-637X/814/2/129		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CW9KJ	WOS:000365317300047		
J	Steffan, SA; Chikaraishi, Y; Horton, DR; Miliczky, E; Zalapa, JE; Jones, VP; Ohkouchi, N				Steffan, Shawn A.; Chikaraishi, Yoshito; Horton, David R.; Miliczky, Eugene; Zalapa, Juan E.; Jones, Vincent P.; Ohkouchi, Naohiko			Beneficial or not? Decoding carnivore roles in plant protection	BIOLOGICAL CONTROL			English	Article						N-15; Compound-specific; CSIA; Intraguild predation; Omnivore; Predator; Stable isotope fingerprinting; Trophic function	INTRAGUILD PREDATION; FOOD WEBS; LABORATORY EXPERIMENTS; ISOTOPIC ECOLOGY; STABLE-ISOTOPES; AMINO-ACIDS; ASSUMPTIONS; DIVERSITY; OMNIVORY; INSECTS	Carnivores indirectly protect plants by reducing herbivory. This important ecosystem service can be undermined, however, as carnivores feed upon fellow carnivores. Such intraguild predation is exceedingly common, yet measurement of the degree to which this occurs has remained elusive due to difficulties in measuring the trophic tendencies of free-roaming animals. Conventional molecular methods, such as bulk-isotopic analyses, do not produce reliably accurate trophic position estimates, and often the inaccuracy is substantial. With the advent of compound-specific isotopic analysis (CSIA), it is now possible to accurately quantify the lifetime trophic tendencies of wild carnivore populations. Unfortunately, CSIA is extraordinarily expensive and time-consuming, limiting the number of samples that can be analyzed. The need for high-quality trophic information has to be balanced with the inaccessibility of CSIA. Here, we propose coupling CSIA-derived trophic position estimates with conventional bulk-N-15 analysis, effectively calibrating site-specific bulk-N-15 data and thereby allowing for trophic position estimation using bulk data alone. We also create a framework that uses trophic position as a basis to characterize carnivores as beneficial for crop protection. Within an agricultural field, we demonstrated the utility of this new approach by measuring the trophic positions of six common arthropod species. We then compare these trophic position estimates to those deriving from conventional bulk-N-15 analysis. Our hybrid approach produced more accurate trophic position estimates than the stand-alone bulk-N-15 method. Ultimately, we were able to examine enough specimens to determine which carnivore populations were likely beneficial for plant protection, and which were not. Published by Elsevier Inc.	[Steffan, Shawn A.; Zalapa, Juan E.] USDA ARS, Madison, WI USA; [Steffan, Shawn A.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Chikaraishi, Yoshito; Ohkouchi, Naohiko] Japan Agcy Marine Earth Sci & Technol, Dept Biogeochem, Yokosuka, Kanagawa 2370061, Japan; [Horton, David R.; Miliczky, Eugene] USDA ARS, Yakima Agr Res Lab, Wapato, WA USA; [Jones, Vincent P.] Washington State Univ, Fruit Res & Extens Ctr, Dept Entomol, Wenatchee, WA USA	Steffan, SA (reprint author), Univ Wisconsin, Dept Entomol, 1630 Linden Dr, Madison, WI 53706 USA.	steffan@entomology.wisc.edu			USDA-ARS [3655-21220-001, 5352-22430-001]	This project was supported by USDA-ARS appropriated funds (3655-21220-001 and 5352-22430-001). Assistance with rearing and curating specimens was provided by M. Singleton, S. Horn, E. Wiesman, and C. Baker. Gratitude is extended to Drs. H. Gaines-Day, E. Chasen, and W. Snyder for helpful reviews of early manuscript drafts.	Gunduz EA, 2009, P R SOC B, V276, P987, DOI 10.1098/rspb.2008.1476; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; POLLARD SD, 1995, ANIM BEHAV, V49, P1443, DOI 10.1016/0003-3472(95)90065-9; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Straub CS, 2008, BIOL CONTROL, V45, P225, DOI 10.1016/j.biocontrol.2007.05.013; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.01; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Steffan SA, 2010, ECOLOGY, V91, P2242, DOI 10.1890/09-0787.1; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; LATTIN JD, 1989, ANNU REV ENTOMOL, V34, P383, DOI 10.1146/annurev.en.34.010189.002123; De la Barrera E, 2004, TRENDS PLANT SCI, V9, P65, DOI 10.1016/j.tplants.2003.12.003; Carvell G.E., 2015, R SOC OPEN SCI, V2, P1; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740; Chikaraishi Y., 2014, ECOL EVOL, P1; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Eubanks MD, 2003, ECOLOGY, V84, P2549, DOI 10.1890/02-0396; Foelix R. F., 2011, BIOL SPIDERS; Kinzig A.P., 2001, FUNCTIONAL CONSEQUEN; Leibold M. A., 2003, ECOLOGICAL NICHES LI; Mattila H.R., 2012, PLOS ONE, V7; McCutchan J., 2003, OIKOS, V2, P378; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Ogawa N.O., 2012, ECOL RES, V28, P697; Polls G., 1991, AM NAT, V138, P123; Price P.W., 2011, INSECT ECOLOGY BEHAV; Steffan SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076152; Vander Zanden M., 1997, CAN J FISH AQUAT SCI, V1158, P1142	40	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1049-9644	1090-2112		BIOL CONTROL	Biol. Control	DEC	2015	91						34	41		10.1016/j.biocontrol.2015.07.002		8	Biotechnology & Applied Microbiology; Entomology	Biotechnology & Applied Microbiology; Entomology	CW2EA	WOS:000364802700006		
J	Rim, H; Uefune, M; Ozawa, R; Takabayashi, J				Rim, Hojun; Uefune, Masayoshi; Ozawa, Rika; Takabayashi, Junji			Olfactory response of the omnivorous mirid bug Nesidiocoris tenuis to eggplants infested by prey: Specificity in prey developmental stages and prey species	BIOLOGICAL CONTROL			English	Article						Eggplant; Miridae; Noctuidae; Tetranychidae; Natural enemy; Prey choice	REUTER HEMIPTERA-MIRIDAE; PLANT VOLATILES; PREDATORY MITES; SPIDER-MITE; HOST; PARASITOIDS; INDUCTION; ECOLOGY; INSECT; DAMAGE	We studied olfactory responses of Nesidiocoris tenuis Reuter (Heteroptera: Miridae), an omnivorous mind bug, to volatiles from eggplants infested by different developmental stages of tobacco cutworms, Spodoptera litura Fabricius (Lepidoptera: Noctuidae) and of female two-spotted spider mites, Tetranychus urticae Koch (Acari: Tetranychidae). We first conducted predation experiments and found that N. tenuis preyed on first and second stadium larvae, but not on third and fourth stadium S. litura larvae. N. tenuis also preyed upon T. urticae females that had been reported to be less suitable prey species. When offered first stadium S. litura larvae and T. urticae females simultaneously, N. tenuis, preferred to prey upon S. litura larvae. We then tested the olfactory responses of N. tenuis to volatiles from eggplants using a Y-tube olfactometer. A significant preference for volatiles from uninfested eggplants over clean air was found. Volatiles of eggplants infested by either first, second or fourth stadium S. litura larvae were preferred over volatiles from uninfested eggplants. The olfactory preferences of N. tenuis to S. litura-infested eggplants were: eggplants infested by 10 first stadium larvae = eggplants infested by 10 second stadium larvae > eggplants infested by 1 fourth stadium larva. Volatiles from eggplants infested by 200 T. urticae females also attracted N. tennis, but the volatiles were not as attractive as those from eggplants infested by 10 first stadium larvae. Chemical analyses showed that volatiles from eggplants infested by different developmental stages of S. litura larvae had qualitative differences. First stadium larvae induced higher amounts of volatiles than second and fourth stadium larvae, despite the first stadium S. litura larvae doing the least damage. T. urticae female-induced volatiles were both qualitatively and quantitatively different from those induced by first stadium S. litura larvae. The specific olfactory responses of N. tenuis to different prey species/developmental stages were discussed in terms of prey availability and biological control. (C) 2015 Elsevier Inc. All rights reserved.	[Rim, Hojun; Ozawa, Rika; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Uefune, Masayoshi] Meijo Univ, Fac Agr, Dept Agrobiol Resources, Nagoya, Aichi 4688502, Japan	Takabayashi, J (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	justylor@gmail.com; muefune@meijo-u.ac.jp; junji@ecology.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (Mext); Mext scholarship	We thank two anonymous reviewers, Scott Groom and Indranil Mukherjee for their constructive comments. This study was supported in part by Grants for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (Mext) and by Mext scholarship for Research students.	Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Gohole LS, 2003, ENTOMOL EXP APPL, V107, P1, DOI 10.1046/j.1570-7458.2003.00030.x; Moayeri HRS, 2006, EXP APPL ACAROL, V40, P27, DOI 10.1007/s10493-006-9020-7; Sanchez JA, 2008, AGR FOREST ENTOMOL, V10, P75, DOI 10.1111/j.1461-9563.2007.00357.x; TAKABAYASHI J, 1992, ENTOMOL EXP APPL, V64, P187; Urbaneja A, 2009, J APPL ENTOMOL, V133, P292, DOI 10.1111/j.1439-0418.2008.01319.x; Urbaneja A, 2005, BIOCONTROL SCI TECHN, V15, P513, DOI 10.1080/09583150500088777; Itou M, 2013, ENTOMOL SCI, V16, P145, DOI 10.1111/j.1479-8298.2012.00552.x; Nakaishi K, 2011, JPN J APPL ENTOMOL Z, V55, P199, DOI 10.1303/jjaez.2011.199; Tatemoto S, 2008, J CHEM ECOL, V34, P605, DOI 10.1007/s10886-008-9469-4; Calvo J, 2009, BIOCONTROL, V54, P237, DOI 10.1007/s10526-008-9164-y; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; Gouinguene S, 2003, J CHEM ECOL, V29, P145, DOI 10.1023/A:1021984715420; Pierre PS, 2011, J CHEM ECOL, V37, P368, DOI 10.1007/s10886-011-9934-3; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Mochizuki M, 2007, ENTOMOL EXP APPL, V123, P57, DOI 10.1111/j.1570-7458.2007.00525.x; Castane C, 2011, BIOL CONTROL, V59, P22, DOI 10.1016/j.biocontrol.2011.03.007; Arno J, 2010, B ENTOMOL RES, V100, P105, DOI 10.1017/S0007485309006841; Cortesero AM, 1997, J CHEM ECOL, V23, P1589, DOI 10.1023/B:JOEC.0000006424.41365.0d; Uefune M, 2010, BIOL CONTROL, V54, P19, DOI 10.1016/j.biocontrol.2010.02.008; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Yoneya K, 2009, PHYSIOL ENTOMOL, V34, P379, DOI 10.1111/j.1365-3032.2009.00701.x; Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.1016/J.JSPS.2012.11.002; Karban R., 1997, INDUCED RESPONSES HE; Lins J.C.J., 2014, BIOCONTROL, P1; R Core Team, 2014, R LANG ENV STAT COMP; Reddy G.P., 2012, BIOCOMMUNICATION PLA, P281; Marcos Teresita F., 1992, Philippine Entomologist, V8, P1227; SAS Institute Inc, 2013, JMP VERS 11 2 1; Sokal R. R., 1995, BIOMETRY PRINCIPLES; Solsoloy A.D., 1994, Philippine Journal of Science, V123, P9; TAKABAYASHI J, 1995, J CHEM ECOL, V21, P273, DOI 10.1007/BF02036717; Takabayashi J., 2014, ELS; Torreno H.S., 1990, ENTOMOLOGY; Torreno Herminigildo S., 1994, Philippine Entomologist, V9, P426; Urbaneja A., 2003, IOBC WPRS B, V26, P159; Wei D., 1997, ACTA AGR U HENAN, V32, P55; Xue M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2201	41	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1049-9644	1090-2112		BIOL CONTROL	Biol. Control	DEC	2015	91						47	54		10.1016/j.biocontrol.2015.07.009		8	Biotechnology & Applied Microbiology; Entomology	Biotechnology & Applied Microbiology; Entomology	CW2EA	WOS:000364802700008		
J	Worel, N; Buser, A; Greinix, HT; Hagglund, H; Navarro, W; Pulsipher, MA; de Faveri, GN; Bengtsson, M; Billen, A; Espino, G; Fechter, M; Giudice, V; Holig, K; Kanamori, H; Kodera, Y; Leitner, G; Netelenbos, T; Niedervvieser, D; van Walraven, SM; Rocha, V; Torosian, T; Vergueiro, C; Weisdorf, D; Yabe, H; Halter, JP				Worel, Nina; Buser, Andreas; Greinix, Hildegard T.; Hagglund, Hans; Navarro, Willis; Pulsipher, Michael A.; de Faveri, Grazia Nicoloso; Bengtsson, Mats; Billen, Annelies; Espino, German; Fechter, Mirjam; Giudice, Valeria; Hoelig, Kristina; Kanamori, Heiwa; Kodera, Yoshihisa; Leitner, Gerda; Netelenbos, Tanja; Niedervvieser, Dietger; van Walraven, Suzanna M.; Rocha, Vanderson; Torosian, Tigran; Vergueiro, Carmen; Weisdorf, Daniel; Yabe, Hiromasa; Halter, Joerg P.			Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Related stem cell donor; Suitability criteria	COLONY-STIMULATING FACTOR; STEM-CELL TRANSPLANTATION; ACUTE MYOCARDIAL-INFARCTION; CREUTZFELDT-JAKOB-DISEASE; DRUG-INDUCED AGRANULOCYTOSIS; ACTIVE RHEUMATOID-ARTHRITIS; ISCHEMIC-HEART-DISEASE; G-CSF; BONE-MARROW; NONCARDIAC SURGERY	The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year continues to increase. Advances in HLA typing, better supportive care, and administration of reduced-intensity conditioning regimens allow treatment of older patients with older sibling donors. Pretransplant donor assessment and testing are very important processes affecting the quality and safety of donation. For unrelated HSC donors detailed recommendations for health assessment have been published, allowing donation only if they are unrestrictedly healthy. Eligibility criteria for related donors are less strict and vary significantly between centers. In situations where a family donor does not meet the suitability criteria for unrelated donors, involved physicians often struggle with the decision whether the matched relative is suitable for donation or not. On behalf of the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues, we intended to develop a consensus document with recommendations for donor workup and final clearance of family donors who would not be able to serve as unrelated donors because of their age or pre-existing diseases. This article covers different topics intending to support decision-making, with the goal of minimizing medical risk to the donor and protection of the recipient from transmissible diseases. (c) 2015 American Society for Blood and Marrow Transplantation.	[Worel, Nina; Leitner, Gerda] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, A-1090 Vienna, Austria; [Buser, Andreas] Swiss Red Cross, Ctr Blood Transfus, Basel, Switzerland; [Buser, Andreas; Halter, Joerg P.] Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; [Greinix, Hildegard T.] Med Univ Graz, Div Hematol, Graz, Austria; [Hagglund, Hans] Uppsala Univ, Dept Med Sci, Div Hematol, Uppsala, Sweden; [Navarro, Willis] Natl Marrow Donor Program, Minneapolis, MN USA; [Pulsipher, Michael A.] Univ Utah, Div Hematol & Hematol Malignancies, Huntsman Canc Inst, Primary Childrens Hosp, Salt Lake City, UT USA; [de Faveri, Grazia Nicoloso] Swiss Blood Stem Cell, Bern, Switzerland; [Bengtsson, Mats] Swedish Bone Marrow Donors, Tobias Registry, Uppsala, Sweden; [Bengtsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Billen, Annelies] UCL Canc Inst, London, England; [Espino, German] Univ Hosp Caja del Seguro Social, Hematol & Bone Marrow Transplantat Sect, Dept Internal Med, Panama City, Panama; [Fechter, Mirjam; van Walraven, Suzanna M.] Leiden Univ, Med Ctr, Europdonor Fdn Leiden, Leiden, Netherlands; [Giudice, Valeria] S Orsola Malpighi Univ Hosp, Dept Immunohematol & Transfus Med, Bologna, Italy; [Hoelig, Kristina] Tech Univ Dresden, Univ Hosp Carl Gustav Cams, Dept Internal Med 1, D-01062 Dresden, Germany; [Kanamori, Heiwa] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Asia Pacific Blood & Marrow Transplantat Grp, Sch Med, Nagakute, Aichi 48011, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Sch Med, Nagakute, Aichi 48011, Japan; [Netelenbos, Tanja] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [Niedervvieser, Dietger] Univ Hosp Leipzig, Dept Hematol, Leipzig, Germany; [van Walraven, Suzanna M.] World Marrow Donor Assoc, Eth Working Grp, Leiden, Netherlands; [van Walraven, Suzanna M.] Oxford Univ Hosp NHS Trust, British Bone Marrow Donor Registry, Oxford, England; [Rocha, Vanderson] NHS BT, Cord Blood Banks, Oxford, England; [Torosian, Tigran] Fdn DKMS Polska, Warsaw, Poland; [Vergueiro, Carmen] FCM Santa Casa de Selo Paulo, Disciplina Hematol & Oncol, Sao Paulo, Brazil; [Weisdorf, Daniel] Univ Minnesota, Bone Marrow Transplant Program, Minneapolis, MN 55455 USA; [Yabe, Hiromasa] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Tokyo 151, Japan	Worel, N (reprint author), Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	nina.worel@meduniwien.ac.at			Austrian Bone Marrow Donor Registry	Supported by the Austrian Bone Marrow Donor Registry, especially Gottfried Fischer, and the Swiss Blood Stem Cells, especially Ursula Python, in terms of organizing the workshop in Vienna.	Parkkali T, 1996, BONE MARROW TRANSPL, V17, P433; Shim W, 2011, CARDIOVASC RES, V89, P20, DOI 10.1093/cvr/cvq301; McSweeney PA, 2001, BLOOD, V97, P3390, DOI 10.1182/blood.V97.11.3390; Spitzer T, 1998, BONE MARROW TRANSPL, V21, P966, DOI 10.1038/sj.bmt.1701196; Nalesnik MA, 2011, AM J TRANSPLANT, V11, P1140, DOI 10.1111/j.1600-6143.2011.03565.x; Lysak D, 2011, J CLIN APHERESIS, V26, P9, DOI 10.1002/jca.20269; Sacchi N, 2008, BONE MARROW TRANSPL, V42, P9, DOI 10.1038/bmt.2008.76; Pulsipher MA, 2009, BLOOD, V113, P3604, DOI 10.1182/blood-2008-08-175323; Niederwieser D, 2003, BLOOD, V101, P1620, DOI 10.1182/blood-2002-05-1340; Tajiri J, 2005, THYROID, V15, P292, DOI 10.1089/thy.2005.15.292; Adler BK, 2001, BLOOD, V97, P3313, DOI 10.1182/blood.V97.10.3313; Moore J, 2001, BEST PRACT RES CL RH, V15, P711, DOI 10.1053/berh.2001.0189; Richa E, 2009, BIOL BLOOD MARROW TR, V15, P1394, DOI 10.1016/j.bbmt.2009.07.005; Niederwieser D, 2004, BONE MARROW TRANSPL, V34, P657, DOI 10.1038/sj.bmt.1704588; O'Donnell PV, 2010, BLOOD, V115, P5097, DOI 10.1182/blood-2010-01-262915; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Ince H, 2008, HEART, V94, P610, DOI 10.1136/hrt.2006.111385; Tulpule S, 2009, BONE MARROW TRANSPL, V44, P129, DOI 10.1038/bmt.2008.438; Burt RK, 2001, BONE MARROW TRANSPL, V28, P1, DOI 10.1038/sj.bmt.1703081; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Snowden JA, 1998, BRIT J HAEMATOL, V103, P601; Kodera Y, 2014, BONE MARROW TRANSPL, V49, P195, DOI 10.1038/bmt.2013.147; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Fan L, 2008, CARDIOVASC DRUG THER, V22, P45, DOI 10.1007/s10557-007-6072-9; Hoeks SE, 2009, AM J MED, V122, P559, DOI 10.1016/j.amjmed.2008.10.041; Armstrong RA, 2006, CLIN EXP OPTOM, V89, P3, DOI 10.1111/j.1444-0938.2006.00001.x; Funakoshi Y, 2010, BONE MARROW TRANSPL, V45, P1477, DOI 10.1038/bmt.2010.4; Lang CJG, 1998, J NEUROL SCI, V160, P128, DOI 10.1016/S0022-510X(98)00226-3; Snowden JA, 1998, BONE MARROW TRANSPL, V22, P1035, DOI 10.1038/sj.bmt.1701486; Al-Ali HK, 2011, BONE MARROW TRANSPL, V46, P1296, DOI 10.1038/bmt.2010.310; SMITH CIE, 1983, NEW ENGL J MED, V309, P1565, DOI 10.1056/NEJM198312223092508; Halter JP, 2013, BONE MARROW TRANSPL, V48, P220, DOI 10.1038/bmt.2012.119; Pilo F, 2013, BONE MARROW TRANSPL, V48, P36, DOI 10.1038/bmt.2012.112; Suzuya H, 2005, VOX SANG, V89, P229, DOI 10.1111/j.1423-0410.2005.00701.x; van Walraven SM, 2010, BONE MARROW TRANSPL, V45, P1269, DOI 10.1038/bmt.2009.354; Vial T, 1999, BIODRUGS, V11, P185, DOI 10.2165/00063030-199911030-00005; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Tsuchiyama J, 2000, ANN HEMATOL, V79, P269, DOI 10.1007/s002770050591; Tholpady A, 2013, TRANSFUSION, V53, P1146, DOI 10.1111/trf.12149; Confer DL, 2011, BONE MARROW TRANSPL, V46, P1409, DOI 10.1038/bmt.2010.323; Clare S, 2010, BONE MARROW TRANSPL, V45, P97, DOI 10.1038/bmt.2009.117; Tigue CC, 2007, BONE MARROW TRANSPL, V40, P185, DOI 10.1038/sj.bmt.1705722; Gratwohl A, 2013, CURR OPIN HEMATOL, V20, P485, DOI 10.1097/MOH.0b013e328364f573; Boyle AJ, 2006, INT J CARDIOL, V109, P21, DOI 10.1016/j.ijcard.2005.05.024; Halter J, 2009, HAEMATOL-HEMATOL J, V94, P94, DOI 10.3324/haematol.13668; De Hert S, 2011, EUR J ANAESTH, V28, P684, DOI 10.1097/EJA.0b013e3283499e3b; Wang YZ, 2005, INT J CARDIOL, V100, P477, DOI 10.1016/j.ijcard.2004.12.006; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261; GRAU JM, 1990, BONE MARROW TRANSPL, V5, P435; Tullo AB, 2006, CLIN EXP OPHTHALMOL, V34, P645, DOI 10.1111/j.1442-9071.2006.1308.x; Hill JM, 2005, J AM COLL CARDIOL, V46, P1643, DOI 10.1016/j.jacc.2005.01.067; Wiersum-Osselton JC, 2013, TRANSFUSION, V53, P96, DOI 10.1111/j.1537-2995.2012.03676.x; Sturfelt G, 1996, ANN RHEUM DIS, V55, P638, DOI 10.1136/ard.55.9.638; Dalal PG, 2014, PEDIATR ANESTH, V24, P359, DOI 10.1111/pan.12331; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Foundation for the Accreditation of Cellular Therapy and Joint Accreditation Committee-ISCT and EBMT, 2012, FACT JACIE INT STAND; Green M, 2015, TRANSPLANTATION, V99, P282, DOI 10.1097/TP.0000000000000584; Wei A, 2001, BLOOD, V97, P3998, DOI 10.1182/blood.V97.12.3998; Hough RE, 2005, BRIT J HAEMATOL, V128, P432, DOI 10.1111/j.1365-2141.2004.05298.x; Kristensen SD, 2014, EUR HEART J, V35, P2344, DOI 10.1093/eurheartj/ehu285; Lazarus John H, 2012, Eur Thyroid J, V1, P24, DOI 10.1159/000336102; Nasilowska-Adamska B, 2010, INT J HEMATOL, V92, P765, DOI 10.1007/s12185-010-0730-6; National Marrow Donor Program, 2009, NAT MARR DON PROGR S; Pasquini MC, 2013, CURRENT USE OUTCOME; Passweg JR, 2015, BONE MARROW TRANSPL, V50, P476, DOI 10.1038/bmt.2014.312; Rivero Fernandez M, 2007, GASTROENTEROL HEPATO, V30; Roth L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008538.pub2; Saklad M, 1941, ANESTHESIOLOGY, V2, P4; WMDA, 2014, WMDA DON MED SUIT RE; Noel L, 2010, TRANSPLANTATION, V90, P229, DOI 10.1097/TP.0b013e3181ec29f0	71	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	DEC	2015	21	12					2052	2060		10.1016/j.bbmt.2015.08.009		9	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CW4SF	WOS:000364981700004		
J	Ishida, H; Kato, M; Kudo, K; Taga, T; Tomizawa, D; Miyamura, T; Goto, H; Inagaki, J; Koh, K; Terui, K; Ogawa, A; Kawano, Y; Inoue, M; Sawada, A; Kato, K; Atsuta, Y; Yamashita, T; Adachi, S				Ishida, Hiroyuki; Kato, Motohiro; Kudo, Kazuko; Taga, Takashi; Tomizawa, Daisuke; Miyamura, Takako; Goto, Hiroaki; Inagaki, Jiro; Koh, Katsuyoshi; Terui, Kiminori; Ogawa, Atsushi; Kawano, Yoshifumi; Inoue, Masami; Sawada, Akihisa; Kato, Koji; Atsuta, Yoshiko; Yamashita, Takuya; Adachi, Souichi			Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Acute myeloid leukemia; Children; Hematopoietic stem cell transplantation; Busulfan; Total body irradiation	BONE-MARROW-TRANSPLANTATION; 1ST COMPLETE REMISSION; ACUTE MYELOBLASTIC-LEUKEMIA; PLUS CYCLOPHOSPHAMIDE; HEMATOLOGICAL MALIGNANCIES; REDUCED-INTENSITY; HOST-DISEASE; CHILDREN; AML; IMPACT	Pediatric patients with acute myeloid leukemia (AML) mainly receive myeloablative conditioning regimens based on busulfan (BU) or total body irradiation (TBI) before allogeneic hematopoietic cell transplantation (allo-HCT); however, the optimal conditioning regimen remains unclear. To identify which of these regimens is better for pediatric patients, we performed a retrospective analysis of nationwide registration data collected in Japan between 2006 and 2011 to assess the outcomes of patients receiving these regimens before a first allo-HCT. Myeloablative conditioning regimens based on i.v. BU (i.v. BU-MAC) (n = 69) or TBI (TBI-MAC) (n = 151) were compared in pediatric AML patients in first or second complete remission (CR1/CR2). The incidences of sinusoid obstruction syndrome, acute and chronic graft-versus-host disease, and early non-relapse mortality (NRM) before day 100 were similar for both conditioning groups; however, the incidence of bacterial infection during the acute period was higher in the TBI-MAC group (P =.008). Both groups showed a similar incidence of NRM, and there was no significant difference in the incidence of relapse between the groups. Univariate and multivariate analyses revealed no significant differences in the 2-year relapse-free survival rates for the i.v. BU-MAC and TBI-MAC groups in the CR1/CR2 setting (71% versus 67%, P =.36; hazard ratio,.73; 95% Cl,.43 to 1.24, respectively). TBI-MAC was no better than i.v. BU-MAC for pediatric AML patients in remission. Although this retrospective registry-based analysis has several limitations, i.v. BU-MAC warrants further evaluation in a prospective trial. (c) 2015 American Society for Blood and Marrow Transplantation.	[Ishida, Hiroyuki] Matsushita Mem Hosp, Dept Pediat & Blood & Marrow Transplantat, Moriguchi, Osaka 5708540, Japan; [Ishida, Hiroyuki] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 602, Japan; [Kato, Motohiro] Univ Tokyo, Dept Pediat & Cell Therapy & Transplantat Med, Tokyo, Japan; [Kudo, Kazuko] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi, Japan; [Taga, Takashi] Shiga Univ, Grad Sch Med, Dept Pediat, Otsu, Shiga, Japan; [Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan; [Miyamura, Takako] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Goto, Hiroaki] Kanagawa Childrens Med Ctr, Devis Hematooncol Regenerat Med, Yokohama, Kanagawa, Japan; [Inagaki, Jiro] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Terui, Kiminori] Hirosaki Univ, Dept Pediat, Grad Sch Med, Hirosaki, Aomori, Japan; [Ogawa, Atsushi] Niigata Canc Ctr Hosp, Dept Pediat, Niigata, Japan; [Kawano, Yoshifumi] Kagoshima Univ Med & Dent Hosp, Dept Pediat, Kagoshima, Japan; [Inoue, Masami; Sawada, Akihisa] Osaka Med Ctr, Dept Hematol Oncol, Osaka, Japan; [Inoue, Masami; Sawada, Akihisa] Res Inst Maternal & Child Hlth, Osaka, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol Oncol, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi 4648601, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Yamashita, Takuya] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo 104, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan	Ishida, H (reprint author), Matsushita Mem Hosp, Dept Pediat, 5-55 Sotojima Cho, Moriguchi, Osaka 5708540, Japan.	ishidah@koto.kpu-m.ac.jp			Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor, and Welfare [26300301-108]	Supported in part by a Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor, and Welfare (grant no. 26300301-108).	Socie G, 2001, BLOOD, V98, P3569, DOI 10.1182/blood.V98.13.3569; MICHEL G, 1994, J CLIN ONCOL, V12, P1217; Zwaan CM, 2003, BLOOD, V102, P2387, DOI 10.1182/blood-2002-12-3627; Matsuyama T, 1998, BONE MARROW TRANSPL, V22, P21, DOI 10.1038/sj.bmt.1701276; Gibson BES, 2005, LEUKEMIA, V19, P2130, DOI 10.1038/sj.leu.2403924; Ringden O, 1999, BLOOD, V93, P2196; Sisler IY, 2009, BIOL BLOOD MARROW TR, V15, P1620, DOI 10.1016/j.bbmt.2009.08.014; Michel G, 1997, J CLIN ONCOL, V15, P2238; Willard VW, 2014, J CLIN ONCOL, V32, P3982, DOI 10.1200/JCO.2014.56.2223; Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231; Kato M, 2013, BIOL BLOOD MARROW TR, V19, P1690, DOI 10.1016/j.bbmt.2013.09.012; Nagler A, 2013, J CLIN ONCOL, V31, P3549, DOI 10.1200/JCO.2013.48.8114; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Andersson BS, 2008, BIOL BLOOD MARROW TR, V14, P672, DOI 10.1016/j.bbmt.2008.03.009; Rubnitz JE, 2012, CANCER-AM CANCER SOC, V118, P6253, DOI 10.1002/cncr.27659; Ferry C, 2007, BONE MARROW TRANSPL, V40, P219, DOI 10.1038/sj.bmt.1705710; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kletzel M, 2006, BIOL BLOOD MARROW TR, V12, P472, DOI 10.1016/j.bbmt.2005.12.028; Majhail NS, 2012, BIOL BLOOD MARROW TR, V18, P861, DOI 10.1016/j.bbmt.2011.10.031; Litzow MR, 2002, BRIT J HAEMATOL, V119, P1115, DOI 10.1046/j.1365-2141.2002.03973.x; Bitan M, 2014, BLOOD, V123, P1615, DOI 10.1182/blood-2013-10-535716; von Neuhoff C, 2010, J CLIN ONCOL, V28, P2682, DOI 10.1200/JCO.2009.25.6321; Tsukimoto I, 2009, J CLIN ONCOL, V27, P4007, DOI 10.1200/JCO.2008.18.7948; Socie G, 2000, J CLIN ONCOL, V18, P348; Lange BJ, 2008, BLOOD, V111, P1044, DOI 10.1182/blood-2007-04-084293; Beier R, 2013, BONE MARROW TRANSPL, V48, P651, DOI 10.1038/bmt.2012.204; Creutzig U, 2006, J CLIN ONCOL, V24, P4499, DOI 10.1200/JCO.2006.06.5037; Lodewyck T, 2008, BLOOD REV, V22, P293, DOI 10.1016/j.blre.2008.03.008; Bredeson C, 2013, BLOOD, V122, P3871, DOI 10.1182/blood-2013-08-519009; Copelan EA, 2013, BLOOD, V122, P3863, DOI 10.1182/blood-2013-07-514448; de Berranger E, 2014, BONE MARROW TRANSPL, V49, P382, DOI 10.1038/bmt.2013.185; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Ishida H, 2015, PEDIATR BLOOD CANCER, V62, P883, DOI 10.1002/pbc.25389; Liu H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-15; Shi-Xia Xu, 2010, Leuk Lymphoma, V51, P50, DOI 10.3109/10428190903419130; Stern M, 2014, LEUKEMIA, V28, P2235, DOI 10.1038/leu.2014.145	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	DEC	2015	21	12					2141	2147		10.1016/j.bbmt.2015.08.011		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CW4SF	WOS:000364981700016		
J	Tanaka, M; Hashimoto, Y; Hasegawa, C				Tanaka, Makoto; Hashimoto, Yoshitaka; Hasegawa, Chihiro			An oral cathepsin K inhibitor ONO-5334 inhibits N-terminal and C-terminal collagen crosslinks in serum and urine at similar plasma concentrations in postmenopausal women	BONE			English	Article						Cathepsin K, ONO-5334; Pharmacokinetics; CTX; NTX; E-max model	BONE-MINERAL DENSITY; BIOCHEMICAL MARKERS; I COLLAGEN; SUBSITE SPECIFICITY; MATRIX DEGRADATION; RESORPTION MARKERS; TURNOVER; OSTEOPOROSIS; PHARMACOKINETICS; BALICATIB	Relationships between the plasma concentration of a cathepsin K inhibitor (ONO-5334) and inhibition of bone resorption markers N-telopeptide of type I collagen (NTX) and C-telopeptide of type I collagen (CTX) in serum and urinary NTX/creatinine and CTX/creatinine were examined in 10 postmenopausal women. The subjects received slow-release tablets of 100 mg ONO-5534 under fasted or fed conditions in a study with a crossover design. Inhibition of serum NTX and CTX levels and plasma concentrations of ONO-5334 were monitored at 0, 24, 48 and 168 h after dosing. Changes in urinary NTX/creatinine and CTX/creatinine levels in second morning urine were evaluated on 0, 1, 2 and 7 days after dosing. Data were analyzed using sigmoid maximal drug effect (E-max) models. The maximal inhibition, estimated E-max values, were -31.8% for serum NTX, -53.1% for serum CTX, -67.2% for urinary NTX/creatinine, and -95.2% for urinary CTX/creatinine. The estimated half maximal effective plasma concentrations (EC50) of ONO-5334 and confidence intervals were 1.79 (1.01 to 3.16) ng/mL for serum NTX, 2.07 (1.63 to 2.62) ng/mL for serum CTX, 1.85 (1.30 to 2.61) ng/mL for urinary NTX/creatinine, and 1.98 (0.94 to 3.76) ng/mL for urinary CTX/creatinine. EC50 values for the four crosslinks did not significantly differ, as indicated by the overlapping 95% confidence intervals. The highest signal-to-noise ratio was achieved with serum CTX, and was 2-fold higher than that on serum NTX. Inhibition for serum NTX and CTX, and urinary NTX/creatinine and CTX/creatinine by ONO-5334 were all correlated with correlation coefficients ranging from 0.55 to 0.80. In conclusion, data of ONO-5334 slow-releasing tablets in postmenopausal women were well fitted in E-max model. In all measured telopeptides, the maximal inhibition was obtained at urinary CTX/creatinine level, but serum CTX had the highest signal-to-noise ratio. Inhibition for all measured telopeptides by ONO-5334 were all correlated. The estimated half maximal effective plasma concentrations were not significantly different between all measured telopeptides. (C) 2015 Elsevier Inc. All rights reserved.	[Tanaka, Makoto] Ono Pharmaceut Co Ltd, Res Promot, Shimamoto, Osaka 6188585, Japan; [Hashimoto, Yoshitaka; Hasegawa, Chihiro] Ono Pharmaceut Co Ltd, Translat Med Ctr, Shimamoto, Osaka 6188585, Japan	Tanaka, M (reprint author), Ono Pharmaceut Co Ltd, Res Promot, 3-1-1 Sakurai, Shimamoto, Osaka 6188585, Japan.	mak.tanaka@ono.co.jp	TANAKA, MAKOTO/I-1679-2012				Alves MFM, 2003, BIOCHEM J, V373, P981, DOI 10.1042/BJ20030438; Anderson MS, 2014, J CLIN ENDOCR METAB, V99, P552, DOI 10.1210/jc.2013-1688; Yamashita DS, 2006, J MED CHEM, V49, P1597, DOI 10.1021/jm050915u; Desmarais S, 2008, MOL PHARMACOL, V73, P147, DOI 10.1124/mol.107.039511; TEZUKA K, 1994, J BIOL CHEM, V269, P1106; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Eastell R, 2011, J BONE MINER RES, V26, P1303, DOI 10.1002/jbmr.341; Engelke K, 2014, J BONE MINER RES, V29, P629, DOI 10.1002/jbmr.2080; Nishi Y, 1999, J BONE MINER RES, V14, P1902, DOI 10.1359/jbmr.1999.14.11.1902; Eastell R, 2000, J BONE MINER RES, V15, P594, DOI 10.1359/jbmr.2000.15.3.594; Henriksen DB, 2003, J BONE MINER RES, V18, P2180, DOI 10.1359/jbmr.2003.18.12.2180; Ochi Y, 2011, BONE, V49, P1351, DOI 10.1016/j.bone.2011.09.041; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Stroup GB, 2009, CALCIFIED TISSUE INT, V85, P344, DOI 10.1007/s00223-009-9279-x; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; Langdahl B, 2012, J BONE MINER RES, V27, P2251, DOI 10.1002/jbmr.1695; Falgueyret JP, 2005, J MED CHEM, V48, P7535, DOI 10.1021/jm0504961; Atley LM, 2000, BONE, V26, P241, DOI 10.1016/S8756-3282(99)00270-7; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Nagase S, 2012, BRIT J CLIN PHARMACO, V74, P959, DOI 10.1111/j.1365-2125.2012.04307.x; Clowes JA, 2005, J BONE MINER RES, V20, P1497, DOI 10.1359/JBMR.050524; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Peroni A, 2008, J AM ACAD DERMATOL, V59, P125, DOI 10.1016/j.jaad.2008.03.009; Adami S, 2006, J BONE MINER RES, V21, pS24; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025938x; Kumar S, 2007, BONE, V40, P122, DOI 10.1016/j.bone.2006.07.015; Wijkmans J, 2011, EXPERT OPIN THER PAT, V21, P1611, DOI 10.1517/13543776.2011.616283; Nagase S, 2012, J CLIN PHARMACOL, V52, P306, DOI 10.1177/0091270011399080; Aoshima H, 1998, BONE, V22, P73, DOI 10.1016/S8756-3282(97)00225-1; Jerome C, 2012, OSTEOPOROSIS INT, V23, P339, DOI 10.1007/s00198-011-1593-2; Tanaka M, 2014, J BONE MINER METAB, V32, P447, DOI 10.1007/s00774-013-0517-y; BLUMSOHN A, 1994, J CLIN ENDOCR METAB, V79, P730, DOI 10.1210/jc.79.3.730; Collins W. C.J., 2015, J BONE MINER RES  S1, V21, pS115; PECK WA, 1993, AM J MED, V94, P646; Eastell R, 2014, J BONE MINER RES, V29, P458, DOI 10.1002/jbmr.2047; Gabrielsson J., 2007, PHARMACOKINETIC PHAR; Hasegawa C, 2014, J CLIN PHARMACOL, V54, P23, DOI 10.1002/jcph.186; Nagase S, 2015, J BONE MINER METAB, V33, P93, DOI 10.1007/s00774-013-0558-2; Papanastasiou P, 2006, J BONE MINER RES, V21, pS59; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						178	185		10.1016/j.bone.2015.07.016		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800024		
J	Iwasaki, Y; Kazama, JJ; Yamato, H; Matsugaki, A; Nakano, T; Fukagawa, M				Iwasaki, Yoshiko; Kazama, Junichiro J.; Yamato, Hideyuki; Matsugaki, Aira; Nakano, Takayoshi; Fukagawa, Masafumi			Altered material properties are responsible for bone fragility in rats with chronic kidney injury	BONE			English	Article						Chronic kidney injury; Pentosidine; Biological apatite; Elastic bone mechanical property	COLLAGEN CROSS-LINKS; STAGE RENAL-DISEASE; HIP FRACTURE; RISK-FACTORS; BIOMECHANICAL PROPERTIES; SKELETAL RESISTANCE; PARATHYROID-HORMONE; MECHANICAL FUNCTION; CORTICAL BONE; HIGH-TURNOVER	Chronic kidney disease (CKD) is associated with an increased risk of fragility fractures, but the underlying pathophysiological mechanism remains obscure. We performed an in vivo experimental study to examine the roles of uremia and abnormal mineral/parathyroid metabolism in the development of bone metabolic abnormalities in uremic rats. Male Sprague-Dawley rats were divided into four groups, comprising sham operation (high turnover bone control = HTB-Cont), 5/6-nephrectomy (high turnover bone nephrectomized = HTB-Nx), thyroparathyroidectomy (low turnover bone control = LTB-Cont), and thyroparathyroidectomy plus 5/6 nephrectomy (low turnover bone nephrectomized = LTB-Nx), and maintained for 16 weeks. Uremia was successfully created in the LTB-Nx and HTB-Nx groups, while hyperparathyroidism was only found in the HTB-Nx group. Cancellous bone histomorphometry revealed significantly higher bone turnover in the HTB-Nx group than in the LTB-Nx group. Storage modulus at 1 Hz and tan delta in cortical bone of the femur, which represent the viscoelastic mechanical properties, were significantly lower in both Nx groups than in the Cont groups regardless of bone metabolism. Pentosidine-to-matrix ratio was increased and crystallinity was decreased in both Nx groups regardless of bone turnover. Mineral-to-matrix ratio was significantly decreased in the HTB-Nx group, but increased in the LTB-Nx group. Enzymatic collagen crosslinks were decreased in the HTB-Nx group. The degree of orientation of the c-axis in carbonated hydroxyapatite (biological apatite = BAp) crystallites was decreased in both Nx groups regardless of bone metabolism. Stepwise multivariate regression revealed that pentosodine-to-matrix ratio and BAp preferential c-axis orientation were significantly associated with storage modulus and tan delta. In conclusion, bone elastic mechanical properties deteriorated regardless of bone metabolism or bone mass in rats with chronic kidney injury. Various changes in bone mineral properties were associated with CKD, including abnormal parathyroid function, impaired bone turnover, and uremia associated with the accumulation of uremic toxins, were responsible for these changes. Pentosidine-to-matrix ratio and BAp orientation at position 5 were the two meaningful determinants of elastic bone mechanical strength, and both factors were associated with the severity of uremia, but not parathyroid function or bone metabolism. These two factors may account for the increased bone fragility among CKD patients. (C) 2015 Elsevier Inc. All rights reserved.	[Iwasaki, Yoshiko] Oita Univ Nursing & Hlth Sci, Dept Hlth Sci, Oita, Japan; [Kazama, Junichiro J.] Niigata Univ Med & Dent Hosp, Div Blood Purificat Therapy, Niigata, Japan; [Yamato, Hideyuki] Kureha Corp, Responsible Care Planning Div, Iwaki, Fukushima, Japan; [Matsugaki, Aira; Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Osaka, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol & Metab, Isehara, Kanagawa 25911, Japan	Kazama, JJ (reprint author), Niigata Univ Med & Dent Hosp, Div Blood Purificat Therapy, Niigata, Japan.				Japanese Society for the Promotion of Science [23591223, 123591215]; Kidney Foundation Japan [JKFB10-21]	We wish to thank Kiyoshi Miyashita for the technical advice on Raman spectroscopy. We also thank Mikio Sugano and Mieko Kuwahara for their technical assistance. This work was supported in part by a grant-in-aid from the Japanese Society for the Promotion of Science (no. 23591223 to YI and no. 123591215 to JJK) and from the Kidney Foundation Japan (no. JKFB10-21 to YI).	Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Kazama JJ, 2013, KIDNEY INT SUPPL, V3, P446, DOI 10.1038/kisup.2013.93; Garnero P, 2006, BONE, V38, P300, DOI 10.1016/j.bone.2005.09.014; Ensrud KE, 2007, ARCH INTERN MED, V167, P133, DOI 10.1001/archinte.167.2.133; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; DAVIS BL, 1966, ARCH ORAL BIOL, V11, P1241, DOI 10.1016/0003-9969(66)90017-3; Tanaka H, 2013, BONE, V56, P347, DOI 10.1016/j.bone.2013.07.002; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5; Iwasaki Y, 2013, BONE, V57, P477, DOI 10.1016/j.bone.2013.07.037; Ott SM, 2012, CURR OPIN NEPHROL HY, V21, P376, DOI 10.1097/MNH.0b013e32835421f6; Iwasaki-Ishizuka Y, 2005, NEPHROL DIAL TRANSPL, V20, P1904, DOI 10.1093/ndt/gfh876; Malluche HH, 2006, CLIN NEPHROL, V65, P235; Kazama JJ, 2011, THER APHER DIAL, V15, P23, DOI 10.1111/j.1744-9987.2011.00923.x; Iwasaki Y, 2011, BONE, V48, P1260, DOI 10.1016/j.bone.2011.03.672; Danese MD, 2006, AM J KIDNEY DIS, V47, P149, DOI 10.1053/j.ajkd.2005.09.024; Ascenzi MG, 2003, J STRUCT BIOL, V141, P22, DOI 10.1016/S1047-8477(02)00578-6; Wakasugi M, 2013, J BONE MINER METAB, V31, P315, DOI 10.1007/s00774-012-0411-z; Lin ZZ, 2014, BONE, V64, P235, DOI 10.1016/j.bone.2014.04.017; Malluche HH, 2012, J AM SOC NEPHROL, V23, P525, DOI 10.1681/ASN.2010121253; Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; Kazama JJ, 2015, J BONE MINER METAB, V33, P245, DOI 10.1007/s00774-014-0639-x; Maravic M, 2014, OSTEOPOROSIS INT, V25, P159, DOI 10.1007/s00198-013-2435-1; Mozar A, 2012, NEPHROL DIAL TRANSPL, V27, P2176, DOI 10.1093/ndt/gfr647; ASCENZI A, 1979, CALCIFIED TISSUE INT, V29, P101, DOI 10.1007/BF02408064; Zoehrer R, 2008, J CLIN ENDOCR METAB, V93, P3484, DOI 10.1210/jc.2008-0530; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Boskey AL, 2005, OSTEOPOROSIS INT, V16, P2031, DOI 10.1007/s00198-005-1992-3; Paschalis EP, 2003, J BONE MINER RES, V18, P1942, DOI 10.1359/jbmr.2003.18.11.1942; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Jadoul M, 2006, KIDNEY INT, V70, P1358, DOI 10.1038/sk.ki.5001754; Mitome J, 2011, CALCIFIED TISSUE INT, V88, P521, DOI 10.1007/s00223-011-9488-y; Nii-Kono T, 2007, KIDNEY INT, V71, P738, DOI 10.1038/sj.ki.5002097; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Lee JW, 2007, MATER TRANS, V48, P337, DOI 10.2320/matertrans.48.337; Bonefield W., 1977, NATURE, V270, P453; limori S, 2012, NEPHROL DIAL TRANSPL, V27, P345; Menard K.P., 2008, DYNAMIC MECH ANAL PR, P1; Miayata T., 1999, KIDNEY INT, V55, P389; NIH Consensus Development Panel on Osteoporosis Prevention, 2001, JAMA-J AM MED ASSOC, V285, P785; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Saito M, 2008, OSTEOPOROSIS INT, V19, P1343, DOI 10.1007/s00198-008-0585-3	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						247	254		10.1016/j.bone.2015.07.015		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800031		
J	Notomi, T; Kuno, M; Hiyama, A; Ezura, Y; Honma, M; Ishizuka, T; Ohura, K; Yawo, H; Noda, M				Notomi, Takuya; Kuno, Miyuki; Hiyama, Akiko; Ezura, Yoichi; Honma, Masashi; Ishizuka, Toru; Ohura, Kiyoshi; Yawo, Hiromu; Noda, Masaki			Membrane depolarization regulates intracellular RANKL transport in non-excitable osteoblasts	BONE			English	Article						PTH; VD3; Osteoclast; Voltage-gated Ca2+ channel; 1,25D(3)-MARRS receptor	CALCIUM-CHANNELS; RAT OSTEOBLASTS; CA2+ CHANNELS; OSTEOCLAST DIFFERENTIATION; PARATHYROID-HORMONE; EXPRESSION; CELLS; OSTEOPROTEGERIN; ACTIVATION; EXOCYTOSIS	Parathyroid hormone (PTH) and 1 alpha,25-dihydroxyvitamin D-3 (VD3) are important factors in Ca2+ homeostasis, and promote osteoclastogenesis by modulating receptor activator of nuclear factor kappa-B ligand (RANKL) mRNA expression. However, their contribution to RANKL. intracellular transport (RANKLiT), including the trigger for RANKL lysosomal vesicle (RANKL-lv) fusion to the cell membrane, is unclear. In neurons, depolarization of membrane potential increases the intracellular Ca2+ level ([Ca2+](i)) and promotes neurotransmitter release via fusion of the synaptic vesicles to the cell membrane. To determine whether membrane depolarization also regulates cellular processes such as RANKLiT in MC3T3-E1 osteoblasts (OBs), we generated a light-sensitive OB cell line and developed a system for altering their membrane potential via delivery of a blue light stimulus. In the membrane fraction of RANKL-overexpressing OBs, PTH and VD3 increased the membrane-bound RANKL (mbRANKL) level at 10 min after application without affecting the mRNA expression level, and depolarized the cell membrane while transiently increasing [Ca2+](i). In our novel OB line stably expressing the channelrhodopsin-wide receiver, blue light-induced depolarization increased the mbRANKL level, which was reversed by treatment of blockers for L-type voltage-gated Ca2+ channels and Ca2+ release from the endoplasmic reticulum. In co-cultures of osteoclast precursor-like RAW264.7 cells and light-sensitive OBs overexpressing RANKL, light stimulation induced an increase in tartrate-resistant acid phosphatase activity and promoted osteoclast differentiation. These results indicate that depolarization of the cell membrane is a trigger for RANKL-lv fusion to the membrane and that membrane potential contributes to the function of OBs. In addition, the non-genomic action of VD3-induced RANKL-1v fusion included the membrane-bound VD3 receptor (1,25D(3)-MARRS receptor). Elucidating the mechanism of RANKLiT regulation by PTH and VD3 will be useful for the development of drugs to prevent bone loss in osteoporosis and other bone diseases. (C) 2015 Elsevier Inc. All rights reserved.	[Notomi, Takuya; Hiyama, Akiko; Ohura, Kiyoshi] Osaka Dent Univ, Dept Pharmacol, Hirakata, Osaka 5731121, Japan; [Notomi, Takuya; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence, Program Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Notomi, Takuya; Kuno, Miyuki] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno, Osaka 5458585, Japan; [Honma, Masashi] Univ Tokyo, Tokyo Univ Hosp, Fac Med, Dept Pharm, Tokyo 1138655, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan	Notomi, T (reprint author), Osaka Dent Univ, Dept Pharmacol, 8-1 Kuzuhahanazono Cho, Hirakata, Osaka 5731121, Japan.	notomi@cc.osaka-dent.ac.jp; noda.mph@mri.tmd.ac.jp			Ministry of Education, Science and Culture of Japan [25670638, 26282182, 15K15558]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan [25670638] [26282182] [15K15558].	Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Suzuki T, 2013, BONE, V54, P172, DOI 10.1016/j.bone.2013.01.001; Nemere I, 2010, J BIOL CHEM, V285, P31859, DOI 10.1074/jbc.M110.116954; Veeraraghavan R, 2014, AM J PHYSIOL-HEART C, V306, pH619, DOI 10.1152/ajpheart.00760.2013; Matthews EA, 2007, EUR J NEUROSCI, V25, P3561, DOI 10.1111/j.1460-9568.2007.05605.x; Bergh JJ, 2006, AM J PHYSIOL-CELL PH, V290, pC822, DOI 10.1152/ajpcell.00403.2005; Pangalos M, 2011, J BIOENERG BIOMEMBR, V43, P311, DOI 10.1007/s10863-011-9354-7; Kariya Y, 2011, J BONE MINER RES, V26, P689, DOI 10.1002/jbmr.268; Gu Y, 1999, PFLUG ARCH EUR J PHY, V438, P553, DOI 10.1007/s004240051075; Chen JX, 2013, CELL SIGNAL, V25, P2362, DOI 10.1016/j.cellsig.2013.07.020; Sakai H, 2010, AM J PHYSIOL-CELL PH, V299, pC570, DOI 10.1152/ajpcell.00486.2009; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; EDELMAN A, 1986, AM J PHYSIOL, V251, pC483; Kariya Y, 2009, J BONE MINER RES, V24, P1741, DOI [10.1359/jbmr.090409, 10.1359/JBMR.090409]; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Li W, 1997, AM J PHYSIOL-ENDOC M, V273, pE599; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Atlas D, 2013, ANNU REV BIOCHEM, V82, P607, DOI 10.1146/annurev-biochem-080411-121438; CHESNOYMARCHAIS D, 1988, J PHYSIOL-LONDON, V398, P291; FRITSCH J, 1988, J BONE MINER RES, V3, P547; van Driel M, 2004, CURR PHARM DESIGN, V10, P2535; Notomi T, 2012, J BIOL CHEM, V287, P35057, DOI 10.1074/jbc.M111.328930; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Bhangu PS, 2001, BONE, V29, P16, DOI 10.1016/S8756-3282(01)00482-3; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Kraus RL, 1998, J BIOL CHEM, V273, P27205, DOI 10.1074/jbc.273.42.27205; Wen L, 2012, BIOCHEM BIOPH RES CO, V424, P439, DOI 10.1016/j.bbrc.2012.06.128; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim MH, 2013, J PHYSIOL-LONDON, V591, P3167, DOI 10.1113/jphysiol.2012.249482; Chen WK, 2010, J NEUROSCI, V30, P10360, DOI 10.1523/JNEUROSCI.1041-10.2010; Bootman MD, 2002, CURR BIOL, V12, P563; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Tringham E. W., 2007, J PHARMACOL EXP THER, V324, P806, DOI 10.1124/jpet.107.130641; Uchida Yushi, 2010, Bull Tokyo Dent Coll, V51, P221, DOI 10.2209/tdcpublication.51.221; Wysolmerski J., 2008, PRINC BONE BIOL, P555	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						306	314		10.1016/j.bone.2015.07.031		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800038		
J	Rahman, MM; Takeshita, S; Matsuoka, K; Kaneko, K; Naoe, Y; Sakaue-Sawano, A; Miyawaki, A; Ikeda, K				Rahman, M. Motiur; Takeshita, Sunao; Matsuoka, Kazuhiko; Kaneko, Keiko; Naoe, Yoshinori; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Ikeda, Kyoji			Proliferation-coupled osteoclast differentiation by RANKL: Cell density as a determinant of osteoclast formation	BONE			English	Article						Osteoclast; Differentiation; Cell cycle; DNA synthesis; Cell density	COLONY-STIMULATING FACTOR; IDENTIFICATION; DEMETHYLATION; MECHANISMS	Although it is widely recognized that the osteoclast differentiation induced by RANKL is linked to the anti-proliferative activity of the cytokine, we report here that RANKL in the presence of M-CSF actually stimulates DNA synthesis and cell proliferation during the early proliferative phase (0-48 h) of osteoclastogenesis ex vivo, while the same cytokine exerts an anti-proliferative activity in the latter half (48-96 h). A tracing of the individual cells using Fucci cell cycle indicators showed that waves of active DNA synthesis in the S phase during the period 0-48 h are followed by cell-cycle arrest and cell fusion after 48 h. Inhibition of DNA synthesis with hydroxyurea (HU) during the first half almost completely inhibited osteoclastogenesis; however, the same HU-treated cells, when re-plated at 48 h at increasing cell densities, exhibited restored osteoclast formation, suggesting that a sufficient number of cells, rather than prior DNA synthesis, is the most critical requirement for osteoclast formation. In addition, varying either the number of bone marrow macrophages at the start of osteoclastogenic cultures or pre-osteoclasts halfway through the process had a substantial impact on the number of osteoclasts that finally formed, as well as the timing of the peak of osteoclast formation. Thus, caution should be exerted in the performance of any manipulative procedure, whether pharmacological or genetic, that affects the cell number prior to cell fusion. Such procedures can have a profound effect on the number of osteoclasts that form, the final outcome of "differentiation", leading to misinterpretation of the results. (C) 2015 Elsevier Inc All rights reserved.	[Rahman, M. Motiur; Takeshita, Sunao; Matsuoka, Kazuhiko; Kaneko, Keiko; Naoe, Yoshinori; Ikeda, Kyoji] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Lab Cell Funct Dynam, BSI, Wako, Saitama, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] JST, ERATO, Life Funct & Dynam, Wako, Saitama, Japan	Ikeda, K (reprint author), Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan.	sunao@ncgg.go.jp; kikeda@ncgg.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22118007, 22118002]; Ministry of Health, Labor and Welfare of Japan [H26-17]	We thank Mie Suzuki for technical assistance and Makoto Nakanishi for valuable suggestions. This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (#22118007 to KI and #22118002 to AS-S) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a grant for Longevity Sciences from the Ministry of Health, Labor and Welfare of Japan (H26-17 to ST). Pacific Edit reviewed the manuscript before submission.	TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Sakaue-Sawano A, 2013, DEVELOPMENT, V140, P4624, DOI 10.1242/dev.099226; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Youn MY, 2010, GENES CELLS, V15, P1025, DOI 10.1111/j.1365-2443.2010.01441.x; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Miyamoto T, 2000, BLOOD, V96, P4335; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						392	399		10.1016/j.bone.2015.08.008		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800047		
J	Fujii, T; Ishikawa, M; Kubo, A; Tanaka, Y				Fujii, Toshiaki; Ishikawa, Mizuho; Kubo, Akiko; Tanaka, Yoshitaka			Effect of SI-591, a new class of cathepsin K inhibitor with peptidomimetic structure, on bone metabolism in vitro and in vivo	BONE			English	Article						Cathepsin K; Inhibitor; Osteoporosis; Bone resorption; Bone formation; Bone mineral density	LOW CALCIUM DIET; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; OVARIECTOMIZED RATS; BISPHOSPHONATES; TURNOVER; MICE; OSTEOPOROSIS; DEGRADATION	SI-591[N-[1-[[[(1S)-3-[[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]amino]-1-(1-methylethyl)-2,3-dioxopropyl]amino]carbonyl]cyclohexyl]-2-furancarboxamidel is an orally bioavailable compound that was synthesized as one of several unique peptidomimetic compounds without a basic group. This compound was found to have the ability to inhibit cathepsin K, a lysosomal cysteine protease. Cathepsin K is known to be expressed in osteoclasts and involved in bone loss processes. In this study, SI-591 was shown to inhibit the activity of various purified cathepsin molecules at nanomolar concentrations but had high selectivity for cathepsin K over other subtypes including B and L. SI-591 also decreased the level of CTX-I, a bone resorption marker, which was released from osteoclasts in vitro in a dose-dependent manner. The mobilization of calcium from the bones to the blood stream is known to increase in rats fed with a low calcium diet; SI-591 inhibited this increase in serum calcium level at an oral dose of 3 mg/kg. Furthermore, SI-591 significantly decreased the level of CTX-I and DPD, bone resorption markers, at oral doses of 10 mg/kg or less in ovariectomized rats, while it did not affect the level of BGP, a bone formation marker. In addition, SI-591 prevented bone mineral density loss in the lumber vertebrae and femurs in ovariectomized rats. These results suggest that SI-591 inhibits bone resorption without affecting osteoblast maturation. Therefore, SI-591, a novel cathepsin K inhibitor, could be a promising agent for the treatment of postmenopausal osteoporosis. (C) 2015 Central Research Laboratories, Seikagaku Corporation. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Fujii, Toshiaki; Ishikawa, Mizuho; Kubo, Akiko; Tanaka, Yoshitaka] SEIKAGAKU Corp, R&D Div, Cent Res Labs, Dept Pharmacol, Higashiyamato, Tokyo 2070021, Japan	Fujii, T (reprint author), SEIKAGAKU Corp, Res & Dev Div, Chiyoda Ku, Marunouchi Ctr Bldg 6-1, Tokyo 1000005, Japan.	toshiaki.fujii@seikagaku.co.jp					HASSAGER C, 1992, J BONE MINER RES, V7, P1307; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Gasser JA, 2008, J BONE MINER RES, V23, P544, DOI 10.1359/JBMR.071207; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; WOLINSKY I, 1974, COMP BIOCHEM PHYSIOL, V49, P183, DOI 10.1016/0300-9629(74)90554-4; Schilling AF, 2007, OSTEOPOROSIS INT, V18, P659, DOI 10.1007/s00198-006-0311-y; Desmarais S, 2008, MOL PHARMACOL, V73, P147, DOI 10.1124/mol.107.039511; Tada S, 2008, J BIOCHEM, V144, P499, DOI 10.1093/jb/mvn093; RISTELI J, 1993, CLIN CHEM, V39, P635; Kim MK, 2006, J PHARMACOL EXP THER, V318, P555, DOI 10.1124/jpet.106.102798; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; ORNOY A, 1974, CALC TISS RES, V15, P71, DOI 10.1007/BF02059044; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Whyte MP, 2009, J BONE MINER RES, V24, P1132, DOI [10.1359/jbmr.081253, 10.1359/JBMR.081253]; Sweet MG, 2009, AM FAM PHYSICIAN, V79, P193; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Falgueyret JP, 2005, J MED CHEM, V48, P7535, DOI 10.1021/jm0504961; Tamura Y, 2001, J BONE MINER RES, V16, P541, DOI 10.1359/jbmr.2001.16.3.541; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Mundy GR, 1999, CLIN CHEM, V45, P1347; Swaminathan R, 2001, CLIN CHIM ACTA, V313, P95, DOI 10.1016/S0009-8981(01)00656-8; Ito M, 1999, BONE, V25, P447, DOI 10.1016/S8756-3282(99)00197-0; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Bromme D, 1996, J BIOL CHEM, V271, P2126; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Cheng ZQ, 2009, J BONE MINER RES, V24, P209, DOI [10.1359/jbmr.81005, 10.1359/JBMR.81005]; Peroni A, 2008, J AM ACAD DERMATOL, V59, P125, DOI 10.1016/j.jaad.2008.03.009; Saag K, 2007, BONE, V40, P1238, DOI 10.1016/j.bone.2007.01.016; Bone HG, 2008, J CLIN ENDOCR METAB, V93, P2149, DOI 10.1210/jc.2007-2814; Adami S, 2006, J BONE MINER RES, V21, pS24; Kumar S, 2007, BONE, V40, P122, DOI 10.1016/j.bone.2006.07.015; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; MCDONALD JK, 1988, BIOCHEM BIOPH RES CO, V151, P827; Toral-Lopez J, 2011, J INVEST MED, V59, P277, DOI 10.231/JIM.0b013e318202a9db; BROMME D, 1987, BIOCHEM J, V245, P381; KIRSCHKE H, 1989, BIOCHEM J, V264, P467; Maclaughlin Eric J, 2006, Ther Clin Risk Manag, V2, P281, DOI 10.2147/tcrm.2006.2.3.281; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ranger T.M., 2012, J AM ACAD DERMATOL, V66, pe89; Suresh E, 2014, RHEUMATOLOGY, V53, P19, DOI 10.1093/rheumatology/ket236; Susa M., 2004, J TRANSL MED, V2, P6, DOI 10.1186/1479-5876-2-6; Thompson DD, 1995, BONE, V17, P125; Turner A. Simon, 2001, European Cells & Materials, V1, P66	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						427	434		10.1016/j.bone.2015.08.016		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800052		
J	Sakai, S; Takeda, S; Sugimoto, M; Shimizu, M; Shimonaka, Y; Yogo, K; Hashimoto, J; Bauss, F; Endo, K				Sakai, Sadaoki; Takeda, Satoshi; Sugimoto, Masanori; Shimizu, Masaru; Shimonaka, Yasushi; Yogo, Kenji; Hashimoto, Junko; Bauss, Frieder; Endo, Koichi			Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats	BONE			English	Article						Osteoporosis treatment; Combination therapy; Ibandronate; Eldecalcitol; Ovariectomized (OVX) rats	ACTIVE VITAMIN-D; POSTMENOPAUSAL OSTEOPOROSIS; BIOMECHANICAL PROPERTIES; INTRAVENOUS IBANDRONATE; TRABECULAR BONE; AGED RATS; IN-VITRO; D ANALOG; MASS; EFFICACY	Bisphosphonates are widely used in the treatment of osteoporosis and contribute to the reduction of bone fractures. Ibandronate (IBN) is a highly potent, nitrogen-containing bisphosphonate, which is administered orally or intravenously at extended dosing intervals. Vitamin D or active vitamin D-3 derivatives are also used in the treatment of osteoporosis, and are often used in combination with other drugs. In this study, we investigated the effect of treatment with the combination of once-monthly s.c. dosing of IBN plus once-daily oral eldecalcitol (ELD), an active vitamin D3 derivative, using aged ovariectomized (OVX) rats. Treatment was started the day after OVX, and analyses were performed 4, 8, and 12 weeks thereafter by determination of bone markers, bone mineral density, biomechanical properties, and histomorphometry. The combination treatment showed a synergistic effect in increasing both lumbar and femoral BMD, and resulted in a significant increase in bone ultimate load. The combination of IBN plus ELD acted synergistically to reduce bone resorption, whereas bone formation did not decrease any more than with monotherapy with either IBN or ELD. Bone formation independent of bone resorption (a process known as 'minimodeling') was not changed in vehicle treated OVX rats despite the increase in bone turnover. ELD upregulated minimodeling, which was however not diminished in the combination treatment. In conclusion, treatment with the combination of IBN plus ELD was beneficial in the treatment of osteoporosis in aged OVX rats. It exhibited a synergistic inhibitory effect on bone resorption and keeps bone formation at the level of sham controls. This uncoupling of bone resorption/bone formation was affected, to some extent, by minimodeling-based bone formation which is independent of bone resorption. This combination regimen which showed synergistic effect on BMD and bone ultimate load without inhibition of bone formation may be beneficial in long-term osteoporosis treatment to prevent bone fractures. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Sakai, Sadaoki; Takeda, Satoshi; Shimonaka, Yasushi; Yogo, Kenji; Endo, Koichi] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Prod Res Dept, Gotemba, Shizuoka 4128513, Japan; [Sugimoto, Masanori] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Res Headquarters, Pharmacol 3,Kita Ku, Saitama 3319530, Japan; [Shimizu, Masaru] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Discovery Pharmacol Dept, Gotemba, Shizuoka 4128513, Japan; [Hashimoto, Junko] Chugai Pharmaceut Co Ltd, Primary Lifecycle Management Dept, Chuo Ku, Tokyo 1038324, Japan; [Bauss, Frieder] Roche Innovat Ctr Penzberg, Roche Pharmaceut Res & Early Dev, Discovery Oncol, D-82377 Penzberg, Germany	Endo, K (reprint author), Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Prod Res Dept, 1-135 Komakado, Gotemba, Shizuoka 4128513, Japan.	sakaisdo@chugai-pharm.co.jp; takedasts@chugai-pharm.co.jp; m-sugimoto@so.taisho.co.jp; shimizumsr@chugai-pharm.co.jp; shimonakayss@chugai-pharm.co.jp; yogoknj@chugai-pharm.co.jp; hashimotojnk@chugai-pharm.co.jp; frieder.bauss@roche.com; endokui@chugai-pharm.co.jp					Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Vitte C, 1996, ENDOCRINOLOGY, V137, P2324, DOI 10.1210/en.137.6.2324; Cotte FE, 2010, OSTEOPOROSIS INT, V21, P145, DOI 10.1007/s00198-009-0930-1; Bauss F, 2002, J RHEUMATOL, V29, P990; de Freitas PHL, 2011, BONE, V49, P335, DOI 10.1016/j.bone.2011.05.022; Bauss F, 2002, J RHEUMATOL, V29, P2200; Kobayashi S, 2003, BONE, V32, P163, DOI 10.1016/S8756-3282(02)00947-X; Sakai S, 2009, J BONE MINER METAB, V27, P643, DOI 10.1007/s00774-009-0084-4; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Reginster JY, 2006, ANN RHEUM DIS, V65, P654, DOI 10.1136/ard.2005.044958; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; MUHLBAUER RC, 1991, J BONE MINER RES, V6, P1003; Eisman JA, 2008, J RHEUMATOL, V35, P488; Bauss F, 2007, BONE, V40, P265, DOI 10.1016/j.bone.2006.08.002; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; KATSUMATA T, 1995, J BONE MINER RES, V10, P921; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Sakai S, 2012, BONE, V50, P1054, DOI 10.1016/j.bone.2012.02.005; MOSEKILDE L, 1993, BONE, V14, P1, DOI 10.1016/8756-3282(93)90248-9; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Jee W. S. S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P232; Nakamura T, 2013, CALCIFIED TISSUE INT, V93, P137, DOI 10.1007/s00223-013-9734-6; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; PARFITT AM, 1987, J BONE MINER RES, V2, P595; VILLANUE.AR, 1974, STAIN TECHNOL, V49, P1	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						449	458		10.1016/j.bone.2015.08.004		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800055		
J	Saito, M; Kida, Y; Nishizawa, T; Arakawa, S; Okabe, H; Seki, A; Marumo, K				Saito, Mitsuru; Kida, Yoshikuni; Nishizawa, Tetsuro; Arakawa, Shotaro; Okabe, Hinako; Seki, Azusa; Marumo, Keishi			Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys	BONE			English	Article						Bazedoxifene; Collagen cross-links; Cancellous bone; OVX monkeys; Advanced glycation end products; Pentosidine	CANCELLOUS BONE; BIOMECHANICAL PROPERTIES; LYSYL OXIDASE; POSTMENOPAUSAL WOMEN; INDUCED-PENTOSIDINE; CORTICAL BONE; COLLAGEN; ESTROGEN; MICRODAMAGE; FRAGILITY	Bazedoxifene (BZA) is used for the treatment of post-menopausal osteoporosis. To elucidate changes in collagen, mineralization, and structural properties and their relationship to bone strength after treatment with BZA in ovariectomized (OVX) monkeys, the levels of collagen and enzymatic immature, mature, and non-enzymatic cross-links were simultaneously examined, as well as trabecular architecture and mineralization of vertebrae. Adult female cynomolgus monkeys were divided into 4 groups (n = 18 each) as follows: Sham group, OVX group, and OVX monkeys given either 0.2 or 0.5 mg/kg BZA for 18 months. Collagen concentration, enzymatic and non-enzymatic pentosidine cross-links, whole fluorescent advanced glycation end products (AGEs), trabecular architecture, mineralization, and cancellous bone strength of vertebrae were analyzed. The levels of enzymatic immature and mature cross-links, bone volume (BV/TV), and trabecular thickness (Tb.Th) in BZA-treated groups were significantly higher than those in the OVX control group. In contrast, the trabecular bone pattern factor (TBPf), the structure model index (SMI), the enzymatic cross-link ratio, and the levels of pentosidine and whole AGEs in BZA-treated groups were significantly lower than those in the OVX control group. Stepwise logistic regression analysis revealed that BV/TV, Tb.Th, TbPf, and pentosidine or whole AGEs independently affected ultimate load (model R-2 = 0.748, p < 0.001) and breaking energy (model R-2 = 0.702). Stiffness was affected by Tb.Th, enzymatic immature cross-link levels and their ratio (model R-2 = 0.400). Treatment with BZA prevented OVX-induced deterioration in the total levels of immature enzymatic cross-links and AGEs accumulation and structural properties such as BV/TV, Tb.Th, and TbPf, which contribute significantly to vertebral cancellous bone strength. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Saito, Mitsuru; Kida, Yoshikuni; Nishizawa, Tetsuro; Arakawa, Shotaro; Okabe, Hinako; Marumo, Keishi] Jikei Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1058461, Japan; [Seki, Azusa] HAMRI Co Ltd, Tsukuba Res Ctr, Ibaraki, Japan	Saito, M (reprint author), Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.				Pfizer Inc.; Eli Lilly; Chugai; Dai-ichi Sankyo; Asahikasei Pharma; Astellas Pharma; Taisho Toyama Pharma; Teijin Pharma; Ono Pharma	Mitsuru Saito received research grants and/or consulting or speaking fees from Pfizer Inc., Eli Lilly, Chugai, Dai-ichi Sankyo, Asahikasei Pharma, Astellas Pharma, Taisho Toyama Pharma, Teijin Pharma, and Ono Pharma. Yoshikuni Kida, Tetsuro Nishizawa, Shotaro Arakawa, Hinako Okabe, Azusa Seki, and Keishi Marumo declare that they have no conflict of interest.	Bruyere O, 2012, CALCIFIED TISSUE INT, V91, P244, DOI 10.1007/s00223-012-9629-y; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; Urbieta-Caceres VH, 2012, AM J PHYSIOL-ENDOC M, V302, pE979, DOI 10.1152/ajpendo.00411.2011; Garnero P, 2006, BONE, V38, P300, DOI 10.1016/j.bone.2005.09.014; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Gallant MA, 2014, BONE, V61, P191, DOI 10.1016/j.bone.2014.01.009; McCarthy AD, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-16; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Miller CP, 2001, J MED CHEM, V44, P1654, DOI 10.1021/jm010086m; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Saito M, 2010, BONE, V46, P1170, DOI 10.1016/j.bone.2009.12.008; Fox J, 2008, CALCIFIED TISSUE INT, V82, P212, DOI 10.1007/s00223-008-9108-7; Ural A, 2015, OSTEOPOROSIS INT, V26, P865, DOI 10.1007/s00198-014-2938-4; Khastgir G, 2001, OSTEOPOROSIS INT, V12, P465, DOI 10.1007/s001980170091; OZASA H, 1981, ENDOCRINOLOGY, V109, P618; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Chen JY, 2013, ARTERIOSCL THROM VAS, V33, P839, DOI 10.1161/ATVBAHA.112.300036; Ireland DC, 2002, J CELL BIOCHEM, V86, P251, DOI 10.1002/jcb.10228; Hemachandra LPMP, 2014, CANCER PREV RES, V7, P505, DOI 10.1158/1940-6207.CAPR-13-0296; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Robins SP, 2007, BIOCHEM SOC T, V35, P849, DOI 10.1042/BST0350849; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Allen MR, 2015, J BONE MINER RES, V30, P1441, DOI 10.1002/jbmr.2470; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; Burr DB, 2001, J BONE MINER RES, V16, P157, DOI 10.1359/jbmr.2001.16.1.157; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Komm BS, 2005, ENDOCRINOLOGY, V146, P3999, DOI 10.1210/en.2005-0030; SANADA H, 1978, BIOCHIM BIOPHYS ACTA, V541, P408, DOI 10.1016/0304-4165(78)90199-X; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Ellis AG, 2014, CURR MED RES OPIN, V30, P1617, DOI 10.1185/03007995.2014.908279; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Paschalis EP, 2003, J BONE MINER RES, V18, P955, DOI 10.1359/jbmr.2003.18.6.955; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; Komm Barry S, 2012, Ther Adv Musculoskelet Dis, V4, P21, DOI 10.1177/1759720X11422602; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Oxlund H., 1995, BONE S, V17, p365S; Saito M, 2011, OSTEOPOROSIS INT, V22, P2373, DOI 10.1007/s00198-010-1454-4; Saito M, 2006, OSTEOPOROSIS INT, V17, P986, DOI 10.1007/s00198-006-0087-0; Saito M, 2015, BONE, V73, P8, DOI 10.1016/j.bone.2014.11.025; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Saito M, 2008, OSTEOPOROSIS INT, V19, P1343, DOI 10.1007/s00198-008-0585-3; Saito M, 2006, CALCIFIED TISSUE INT, V79, P160, DOI 10.1007/s00223-006-0035-1; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Smith S. Y., 2014, J BONE MINER METAB, V32, P161; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62	49	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						573	580		10.1016/j.bone.2015.09.006		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800068		
J	Karasuyama, K; Yamamoto, T; Motomura, G; Sonoda, K; Kubo, Y; Iwamoto, Y				Karasuyama, Kazuyuld; Yamamoto, Takuaki; Motomura, Goro; Sonoda, Kazuhiko; Kubo, Yusuke; Iwamoto, Yukihide			The role of sclerotic changes in the starting mechanisms of collapse: A histomorphometric and FEM study on the femoral head of osteonecrosis	BONE			English	Article						Osteonecrosis of the femoral head; Collapse; Finite element analysis; Osteoclast	FINITE-ELEMENT-ANALYSIS; AVASCULAR NECROSIS; NONTRAUMATIC OSTEONECROSIS; PROXIMAL FEMUR; ALENDRONATE; BONE; HIP	Purpose: To assess the distributions of stress, strain, and fractured areas using a finite element model (FEM), and examine the osteoclastic activity histopathologically in osteonecrosis of the femoral head. Methods: Three femoral heads were obtained during hip arthroplasty for femoral head osteonecrosis. One sample with a normal area, two samples with a non-sclerotic boundary without collapse (Type 1), two samples with a non-collapsed sclerotic boundary (Type 2), and two samples with a collapsed sclerotic boundary (Type 3) were collected from each femoral head for the FEM and histopathological analyses. FEM was performed using CT data, and the distributions of von Mises equivalent stress, octahedral shear stress, octahedral shear strain, and simulated fractured area were evaluated. Furthermore, the osteoclast count at the boundary was compared for each type. Results: In normal and Type I samples, the distributions of von Mises equivalent stress, octahedral shear stress, octahedral shear strain, and the fractured area were equally concentrated along the whole analytical range; however, in the Type 2 and 3 samples, they were concentrated along the thickened bone trabeculae at the boundary, which corresponded to the fractured area. Histopathologically, a significantly increased osteoclast number was observed only at the collapsed sclerotic boundary. Conclusion: These results demonstrated that both shear stress and shear strain tend to be concentrated on thickened bone trabeculae at the boundary. Fracture analyses revealed that the boundary of sclerotic changes, which results from the repair process, may be the starting point of the fracture. Additionally, the osteoclastic activity increases after collapse. (C) 2015 Elsevier Inc. All rights reserved.	[Karasuyama, Kazuyuld; Yamamoto, Takuaki; Motomura, Goro; Sonoda, Kazuhiko; Kubo, Yusuke; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan	Yamamoto, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamataku@ortho.med.kyushu-u.ac.jp			Japan Agency for Medical Research and Development [H26-Itaku(Nan)-Ippan-031]; AMED; Japan Hip Joint Foundation; Japan Society for the Promotion of Science [15K10479]	This work was supported in part by a Research Grant for Intractable Diseases from the Japan Agency for Medical Research and Development (H26-Itaku(Nan)-Ippan-031), AMED, Japan Hip Joint Foundation, and a research grant from Japan Society for the Promotion of Science (15K10479).	BROWN TD, 1982, J BIOMECH, V15, P705, DOI 10.1016/0021-9290(82)90024-0; Nishii Takashi, 2006, Clin Orthop Relat Res, V443, P273, DOI 10.1097/01.blo.0000194078.32776.31; Agarwala S, 2005, RHEUMATOLOGY, V44, P352, DOI 10.1093/rheumatology/keh481; Bae JY, 2013, ANN BIOMED ENG, V41, P2528, DOI 10.1007/s10439-013-0851-1; Motomura G, 2011, J BONE JOINT SURG BR, V93B, P184, DOI [10.1302/0301-620X.93B225476, 10.1302/0301-620X.93B2.25476]; Lai KA, 2005, J BONE JOINT SURG AM, V87A, P2155, DOI 10.2106/JBJS.D.02959; KENZORA JE, 1985, ORTHOP CLIN N AM, V16, P681; Inoue K, 2014, J BONE MINER METAB, V32, P271, DOI 10.1007/s00774-013-0485-2; Chen CH, 2012, ARTHRITIS RHEUM-US, V64, P1572, DOI 10.1002/art.33498; BROWN TD, 1980, ACTA ORTHOP SCAND, V51, P429, DOI 10.3109/17453678008990819; Li WZ, 2009, J ORTHOP RES, V27, P694, DOI 10.1002/jor.20802; PATTERSON RJ, 1964, J BONE JOINT SURG AM, V46, P267; BROWN TD, 1983, J BIOMECH ENG-T ASME, V105, P171; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954; BULLOUGH PG, 1990, ANN RHEUM DIS, V49, P412, DOI 10.1136/ard.49.6.412; Yang JW, 2002, ARCH ORTHOP TRAUM SU, V122, P88, DOI 10.1007/s004020100324; Astrand J, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-19; Gardeniers J.W.M., 1993, ARCO NEWS LETT, V5, P79; Motomura G, 2014, NUCL MED COMMUN, V35, P1047, DOI 10.1097/MNM.0000000000000166; OHZONO K, 1992, CLIN ORTHOP RELAT R, P73; Serrano-Fochs S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120653; SUGIOKA Y, 1992, CLIN ORTHOP RELAT R, P111; Tai CL, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-262	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	DEC	2015	81						644	648		10.1016/j.bone.2015.09.009		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CX0FR	WOS:000365372800075		
J	Sugiura, N; Tang, DQ; Kurokochi, H; Saito, Y; Ide, Y				Sugiura, Nami; Tang, Dingqin; Kurokochi, Hiroyuki; Saito, Yoko; Ide, Yuji			Genetic structure of Quercus gilva Blume in Japan as revealed by chloroplast DNA sequences	BOTANY			English	Article						evergreen oak; shrine/temple forest; genetic structure; cpDNA sequence; human impact	LATE-QUATERNARY; DIVERSITY; POPULATIONS; PHYLOGEOGRAPHY; EVOLUTION; SOFTWARE; FAGACEAE; OAKS	Quercus gilva (Blume) is an evergreen oak species that is native to Japan, China, and Taiwan. Because of a long history of human impact, this species is threatened with extinction in several regions of Japan. The objective of this study was to identify the genetic structure of Q. gilva based on chloroplast DNA (cpDNA) sequencing analysis. We collected 123 samples from 25 populations in Japan, 8 samples from 1 population in China, and 46 samples from 5 populations in Taiwan. Approximately 1815 bp of cpDNA was sequenced for each of the 177 samples. Thirteen haplotypes were detected, with no cross-region distribution of haplotypes among the three geographically separated countries. There were large genetic differences among populations (G(ST) = 0.824, G'(ST) = 0.937). Six haplotypes (haplotypes 1, 2, 3, 4a, 4b, and 5) were detected in Japan; haplotype 4a was the most common, detected from 20 populations, and the other rare haplotypes, except for haplotype 4b, occurred at the edge of the species' distribution. In addition, four haplotypes (haplotypes 1, 2, 3, and 5) were quite different from the predominant haplotype (haplotype 4a), with more than four cpDNA mutations except for a mononucleotide repeat, suggesting that populations with these rare haplotypes should be conserved separately.	[Sugiura, Nami; Kurokochi, Hiroyuki; Saito, Yoko; Ide, Yuji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Tang, Dingqin] Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Linan 31300, Zhejiang, Peoples R China	Sugiura, N (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	nami@es.a.u-tokyo.ac.jp			JSPS KAKENHI [25450206]	We thank Dr. Shih-Wen Chung, Dr. Chien-Fan Chen, Dr. Chun-Chi Hung, and Dr. Wen-Liang Chiou of Taiwan Forestry Research Institute for their cooperation in sampling in Taiwan. We would also like to thank the following people and organizations for their support: Mitsukazu Mitsugi, the University of Tokyo Chiba Forest; Kasamoriji Temple; Hatoyama Town Hall; Dr. Toshio Katsuki, Tama Forest Sience Garden; Odawara High School; Kinomiya Shrine; Ito City Hall; Kamishiraiwa Omiya Shrine; Izu City Hall; Shuzenji Temple; University of Tokyo Arboricultural Research Institute; Nyakuichioji Shrine; Okabesengen Shrine; Fujieda City Hall; Aichi University; Okura Shrine; Shirashige Shrine; Okazaki City Hall; Dr. Ichiro Tamaki, the Academy of Forest Science and Culture; Mino City Hall; Jizoji Temple; Koubata Shrine; Hoteiyatsurugi Shrine; Takakura Shrine; Kokonoeitukushima Shrine; Koumyo Shrine; Shingu City Hall; Shingu City Library; Hokkaido University Wakayama Experimental Forest; Hiyoshi Shrine; Inabane-oji Shrine; Iwata Shrine; Yagami Shrine; Kamitonda Town Hall; Kashiharajingu Shrine; Yu Shrine; Man-yo-en Garden; Shinonome Shrine; Katsurakake Shrine; Shingu-kogo Shrine; Mine City Hall; Yamaguchi Prefecture; Usajingu Shrine; Usa City Hall; Miyazaki University Tano Forest Science Station; Kirishimamine Shrine; Takakura Shrine; Omura City Hall. This work was supported by grant No. 25450206 from JSPS KAKENHI.	PETIT RJ, 1993, THEOR APPL GENET, V87, P122, DOI 10.1007/BF00223755; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomaru N, 1997, HEREDITY, V78, P241; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Okaura T, 2007, GENES GENET SYST, V82, P465, DOI 10.1266/ggs.82.465; Kurokochi H, 2013, BOTANY, V91, P148, DOI 10.1139/cjb-2012-0159; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Takahashi T, 2005, J PLANT RES, V118, P83, DOI 10.1007/s10265-005-0198-2; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Fineschi S, 2000, MOL ECOL, V9, P1495, DOI 10.1046/j.1365-294x.2000.01029.x; Kurokochi Hiroyuki, 2014, Journal of Ecology and Environment, V37, P21, DOI 10.5141/ecoenv.2014.003; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Tate JA, 2003, SYST BOT, V28, P723; Fujii N, 2002, PLANT SYST EVOL, V232, P21, DOI 10.1007/s006060200024; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Iwasaki T, 2012, J PLANT RES, V125, P207, DOI 10.1007/s10265-011-0428-8; Okaura T, 2002, HEREDITY, V88, P322, DOI 10.1038/sj/hdy/6800048; Chiba Biodiversity Center, 2009, RED DAT BOOK CHIB PR, P165; Doyle J.J., 1990, FOCUS, V12, P13; Excoffier L., 2006, ARLEQUIN VERSION 3 1; Fujio S., 1993, JOMON YAYOI SEEN SUB; Hall T, 2004, BIOEDIT VERSION 7 0; Hashimoto D., 2006, KYUSHU J FOR RES, V59, P56; Ito S., 2007, VEG SCI, V24, P53; Kurata S., 1964, ILLUSTRATED IMPORTAN; Kurokochi H, 2015, BOTANY, V93, P133, DOI 10.1139/cjb-2014-0181; Maie K., 2013, INT J HUM CULT STUD, V23, P97; Mizunoe K., 2004, BURIED CULTURAL PROP, V11, P18; Momohara A, 1997, TECH B FAC HORT CHIN, V51, P127; Oba H., 1993, WILD FLOWERS JAPAN W; Okamoto M., 1979, B OSAKA MUS NAT HIST, V32, P31; Okayama Prefecture, 2009, RED DAT BOOK OK PREF; Prefecture Kagawa, 2004, RED DAT BOOK KAG PRE; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qi XS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-41; Suganuma T., 1974, FOR TECHNOL, V389, P6; Suzuki T., 1960, JPN SOC FOR ENV, V2, P1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taiwan Forestry Research Institute, 2012, AC FOR EXP TAIW, P74; Watanabe M., 1972, ANCIENT STUDY, V15, P266; Zhou Zhe-Kun, 1992, Acta Botanica Yunnanica, V14, P227	44	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1916-2790	1916-2804		BOTANY	Botany	DEC	2015	93	12					873	880		10.1139/cjb-2015-0025		8	Plant Sciences	Plant Sciences	CX0WX	WOS:000365419200006		
J	Matsuki, N; Inoue, M; Itoh, Y; Nagamoto, T; Hirakatal, A				Matsuki, Naoko; Inoue, Makoto; Itoh, Yuji; Nagamoto, Toshiyuki; Hirakatal, Akito			Changes in higher-order aberrations of intraocular lenses with intrascleral fixation	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							CILIARY SULCUS; ULTRASOUND BIOMICROSCOPY; CAPSULAR SUPPORT; REFRACTIVE ERROR; IMPLANTATION; DIAMETER; EYES; DECENTRATION; MANAGEMENT; SURGERY	Aim To determine the higher-order aberrations of intraocular lenses (IOLs) that are extended and fixed intrasclerally. Methods A computer-aided design system was used to calculate the length of an IOL when it was fixed to the sclera 2 mm posterior to the limbus in a Gullstrand eye model. An acrylic single-piece (SA60AT) or 2 three-piece IOLs (VA-60BBR; X-60) were fixed at lengths of 13, 14, 15 and 16 mm. A wavefront analyser was used to measure the higher-order aberrations within the central 3.0 and 5.2 mm optic diameters. Results The length of the IOL with the intrascleral fixation was calculated to be 13.9-14.9 mm in the eye model. The astigmatic aberration of the three-piece VA-60BBR and X-60 IOLs increased significantly with an extension of the IOLs within the central 5.2 mm (both p<0.001) but not that of the single-piece SA6OAT 10L. The coma aberration of the VA-60BBR IOL increased significantly within the central 5.2 mm with an increase in the extension (p=0.001) but not that of the SA6OAT and X-60 IOLs. The astigmatic and coma aberrations were significantly greater within the central 5.2 mm than within the central 3.0 mm for all IOLs (p<0.05). The cylindrical power increased from 0.034 D to 0.082 D with extensions from 13 to 16 mm. Conclusions When three-piece IOLs are extended widely for intrascleral fixation, the astigmatic and coma aberrations increase but the degree of change should not alter the postoperative vision appreciably.	[Matsuki, Naoko; Inoue, Makoto; Itoh, Yuji; Nagamoto, Toshiyuki; Hirakatal, Akito] Kyorin Univ, Kyorin Eye Ctr, Sch Med, Mitaka, Tokyo 1818611, Japan; [Nagamoto, Toshiyuki] Nagamoto Eye Clin, Tokyo, Japan	Inoue, M (reprint author), Kyorin Univ, Kyorin Eye Ctr, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	inoue@eye-center.org					Akimoto M, 2014, J CATARACT REFR SURG, V40, P179, DOI 10.1016/j.jcrs.2013.12.009; Agarwal A, 2008, J CATARACT REFR SURG, V34, P1433, DOI 10.1016/j.jcrs.2008.04.040; Ohta T, 2014, J CATARACT REFR SURG, V40, P2, DOI 10.1016/j.jcrs.2013.11.003; SMIDDY WE, 1995, J CATARACT REFR SURG, V21, P64; Kim KH, 2008, J CATARACT REFR SURG, V34, P632, DOI 10.1016/j.jcrs.2007.11.034; Hayashi K, 1999, OPHTHALMOLOGY, V106, P878, DOI 10.1016/S0161-6420(99)00504-7; FRIEDBERG MA, 1992, ARCH OPHTHALMOL-CHIC, V110, P413; Gabor SGB, 2007, J CATARACT REFR SURG, V33, P1851, DOI 10.1016/j.jcrs.2007.07.013; Scharioth GB, 2010, J CATARACT REFR SURG, V36, P254, DOI 10.1016/j.jcrs.2009.09.024; Hayashi K, 2005, J CATARACT REFR SURG, V31, P337, DOI 10.1016/j.jcrs.2004.06.042; Liu SW, 2013, EUR J OPHTHALMOL, V23, P732, DOI 10.5301/ejo.5000281; Savini G, 2014, J CATARACT REFR SURG, V40, P1473, DOI 10.1016/j.jcrs.2013.12.018; Por YM, 2005, SURV OPHTHALMOL, V50, P429, DOI 10.1016/j.survophthal.2005.06.010; Wagoner MD, 2003, OPHTHALMOLOGY, V110, P840, DOI 10.1016/S0161-6420(02)02000-6; Denoyer A, 2013, J CATARACT REFR SURG, V39, P1204, DOI 10.1016/j.jcrs.2013.02.052; CHANG S, 1995, AM J OPHTHALMOL, V119, P165; CHAN CK, 1992, OPHTHALMOLOGY, V99, P51; Oshika T, 2007, BRIT J OPHTHALMOL, V91, P185, DOI 10.1136/bjo.2006.099945; Petermeier K, 2012, J CATARACT REFR SURG, V38, P986, DOI 10.1016/j.jcrs.2011.12.027; Yamane S, 2014, OPHTHALMOLOGY, V121, P61, DOI 10.1016/j.ophtha.2013.08.043; Can I, 2010, J CATARACT REFR SURG, V36, P740, DOI 10.1016/j.jcrs.2009.11.013; Yokoyama S, 2011, J CATARACT REFR SURG, V37, P1251, DOI 10.1016/j.jcrs.2011.01.024; Gao J, 2013, J CATARACT REFR SURG, V39, P1011, DOI 10.1016/j.jcrs.2013.01.040; Totan Y, 2012, EYE, V26, P788, DOI 10.1038/eye.2012.19; Blum M, 1997, J CATARACT REFR SURG, V23, P91; Hannush S B, 2000, Curr Opin Ophthalmol, V11, P233, DOI 10.1097/00055735-200008000-00004	26	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	DEC	2015	99	12					1732	1738		10.1136/bjophthalmol-2015-307106		7	Ophthalmology	Ophthalmology	CW8YJ	WOS:000365285100028		
J	Ioku, N; Ishiwata, M				Ioku, Norisuke; Ishiwata, Michinori			On a variational problem associated with a Hardy type inequality involving a mean oscillation	CALCULUS OF VARIATIONS AND PARTIAL DIFFERENTIAL EQUATIONS			English	Article							LIEB-THIRRING INEQUALITIES; MAGNETIC DIRICHLET FORMS; SOBOLEV INEQUALITIES; SCHRODINGER-OPERATORS; DIRAC OPERATORS; NORMS; REARRANGEMENTS; POTENTIALS; SEMIGROUPS; EMBEDDINGS	We consider a minimizing problem associated with a critical Hardy type inequality involving a mean oscillation. We first introduce a dilation-invariant critical Hardy type inequality which contains a nonlocal term and then analyze the associated Euler-Lagrange equation with the aid of the scaling argument. We prove the nonexistence of minimizers for and the existence for p = 1.	[Ioku, Norisuke] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Ishiwata, Michinori] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan	Ioku, N (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan.	ioku@ehime-u.ac.jp					Adimurthi A., 2002, P AM MATH SOC, V130, P489; ALVINO A, 1989, NONLINEAR ANAL-THEOR, V13, P185, DOI 10.1016/0362-546X(89)90043-6; Laptev A, 2000, ACTA MATH-DJURSHOLM, V184, P87, DOI 10.1007/BF02392782; Bastero J, 2003, INDIANA U MATH J, V52, P1215, DOI 10.1512/iumj.2003.52.2364; Evans WD, 2005, MATH Z, V251, P267, DOI 10.1007/s00209-005-0798-5; KOLYADA VI, 1989, RUSS MATH SURV+, V44, P73, DOI 10.1070/RM1989v044n05ABEH002287; Laptev A, 1999, OPER THEOR, V108, P299; Bosi R, 2008, COMMUN PUR APPL ANAL, V7, P533; Ioku N, 2013, J FUNCT ANAL, V264, P2764, DOI 10.1016/j.jfa.2013.03.009; Hundertmark D, 2000, INVENT MATH, V140, P693, DOI 10.1007/s002220000077; Ishige K, 2012, J FUNCT ANAL, V262, P2695, DOI 10.1016/j.jfa.2011.12.024; DAVIES EB, 1991, J FUNCT ANAL, V102, P95, DOI 10.1016/0022-1236(91)90137-T; LIEB EH, 1976, REV MOD PHYS, V48, P553, DOI 10.1103/RevModPhys.48.553; Akutagawa K, 2013, CALC VAR PARTIAL DIF, V48, P67, DOI 10.1007/s00526-012-0542-z; MURATA M, 1986, DUKE MATH J, V53, P869, DOI 10.1215/S0012-7094-86-05347-0; Cianchi A, 2008, ANN I H POINCARE-AN, V25, P889, DOI 10.1016/j.anihpc.2007.05.003; Mastylo M, 2011, POTENTIAL ANAL, V35, P301, DOI 10.1007/s11118-010-9214-9; Balinsky A, 2004, J STAT PHYS, V116, P507, DOI 10.1023/B:JOSS.0000037228.35518.ca; Balinsky AA, 2003, MATH RES LETT, V10, P169; Cianchi A, 2009, INDIANA U MATH J, V58, P1051; Balinsky A, 2011, PUBL RES I MATH SCI, V47, P791, DOI 10.2977/PRIMS/51; Lundholm D, 2013, COMMUN MATH PHYS, V322, P883, DOI 10.1007/s00220-013-1748-4; Martin J, 2010, ADV MATH, V225, P121, DOI 10.1016/j.aim.2010.02.022; Milman M, 2004, COMMUN CONTEMP MATH, V6, P495, DOI 10.1142/S0219199704001380; Dolbeault J, 2004, J FUNCT ANAL, V216, P1, DOI 10.1016/j.jfa.2003.09.010; Martin J, 2007, J FUNCT ANAL, V252, P677, DOI 10.1016/j.jfa.2007.05.017; Bennett C., 1988, PURE APPL MATH; BENNETT C, 1981, ANN MATH, V113, P601, DOI 10.2307/2006999; Brezis H., 1997, REV MAT COMPLUT, V2, P443; Davies E.B., 1999, OPER THEORY ADV APPL, V110, P55; Detalla A., 2005, MATH J IBARAKI U, V37, P39; Detalla A., 2004, FAR E J MATH SCI, V14, P333; Dolbeault J, 2007, ANN SCI ECOLE NORM S, V40, P885, DOI 10.1016/j.ansens.2007.11.002; Frank RL, 2008, J AM MATH SOC, V21, P925; Frank RL, 2009, COMMUN MATH PHYS, V290, P789, DOI 10.1007/s00220-009-0759-7; HERBST IW, 1977, COMMUN MATH PHYS, V53, P285, DOI 10.1007/BF01609852; Ioku N, 2014, J FUNCT ANAL, V266, P2944, DOI 10.1016/j.jfa.2013.12.023; Ioku N, 2015, J MATH PURE APPL, V103, P900, DOI 10.1016/j.matpur.2014.09.006; KIRSCH W, 1988, ANN PHYS-NEW YORK, V183, P122, DOI 10.1016/0003-4916(88)90248-5; Kolyada V. I, 1989, MATH USSR SB, V136, P3, DOI 10.1070/SM1989v064n01ABEH003291; Laptev A, 2000, JOURNEES EQUATIONS D, VXX; LEDOUX M, 1988, CR ACAD SCI I-MATH, V306, P79; LIEB EH, 1988, COMMUN MATH PHYS, V118, P177, DOI 10.1007/BF01218577; Lieb E H, 2010, STABILITY MATTER QUA; Opic B., 1990, PITMAN RES NOTES MAT, V219; OTANI M, 1988, P JPN ACAD A-MATH, V64, P8; RAKOTOSON J. M., 1997, REV R ACAD CIENC EXA, V91, P17; Reed M., 1975, METHODS MODERN MATH, VII; TALENTI G., 1995, NONLINEAR ANAL FUNCT, V5, P177; Ul'janov P.L., 1968, MATH USSR IZV, V2, p[649, 601], DOI 10.1070/IM1968v002n03ABEH000650	50	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-2669	1432-0835		CALC VAR PARTIAL DIF	Calc. Var. Partial Differ. Equ.	DEC	2015	54	4					3949	3966		10.1007/s00526-015-0927-x		18	Mathematics, Applied; Mathematics	Mathematics	CX0UO	WOS:000365412700022		
J	Kawakami, Y				Kawakami, Yu			Function-theoretic Properties for the Gauss Maps of Various Classes of Surfaces	CANADIAN JOURNAL OF MATHEMATICS-JOURNAL CANADIEN DE MATHEMATIQUES			English	Article						Gauss map; minimal surface; constant mean curvature surface; front; ramification; omitted value; the Ahlfors island theorem; unicity theorem	MINIMAL-SURFACES; HYPERBOLIC 3-SPACE; FLAT FRONTS; SPACE; RAMIFICATION; CURVATURE; GEOMETRY; PROOF	We elucidate the geometric background of function-theoretic properties for the Gauss maps of several classes of immersed surfaces in three-dimensional space forms, for example, minimal surfaces in Euclidean three-space, improper affine spheres in the affine three-space, and constant mean curvature one surfaces and flat surfaces in hyperbolic three-space. To achieve this purpose, we prove an optimal curvature bound for a specified conformal metric on an open Riemann surface and give some applications. We also provide unicity theorems for the Gauss maps of these classes of surfaces.	[Kawakami, Yu] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Kawakami, Y (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	y-kwkami@se.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [24740044]	Partly supported by the Grant-in-Aid for Young Scientists (B) No. 24740044, Japan Society for the Promotion of Science.	Ahlfors L, 1935, ACTA MATH-DJURSHOLM, V65, P157, DOI 10.1007/BF02420945; Kawakami Y, 2013, MATH Z, V274, P1249, DOI 10.1007/s00209-012-1115-8; FUJIMOTO H, 1993, J MATH SOC JPN, V45, P481, DOI 10.2969/jmsj/04530481; Galvez JA, 2000, MATH ANN, V316, P419, DOI 10.1007/s002080050337; ESTUDILLO FJM, 1992, MATH PROC CAMBRIDGE, V111, P515, DOI 10.1017/S0305004100075587; Kokubu M, 2007, J MATH SOC JPN, V59, P265, DOI 10.2969/jmsj/1180135510; Kawakami Y, 2012, J MATH SOC JPN, V64, P799, DOI 10.2969/jmsj/06430799; XAVIER F, 1982, ANN MATH, V115, P667, DOI 10.2307/2007017; Kokubu M, 2003, OSAKA J MATH, V40, P697; Umehara M, 2011, B LOND MATH SOC, V43, P191, DOI 10.1112/blms/bdq094; OSSERMAN R, 1964, ANN MATH, V80, P340, DOI 10.2307/1970396; Kawakami Y, 2008, FORUM MATH, V20, P1055, DOI 10.1515/FORUM.2008.047; Kawakami Y, 2014, GEOMETRIAE DEDICATA, V171, P387, DOI 10.1007/s10711-013-9904-8; Kawakami Y, 2009, OSAKA J MATH, V46, P1059; Saji K, 2009, ANN MATH, V169, P491; Kokubu M, 2004, PAC J MATH, V216, P149; Kokubu M, 2005, PAC J MATH, V221, P303; FUJIMOTO H, 1992, J MATH SOC JPN, V44, P427, DOI 10.2969/jmsj/04430427; KLOTZ T, 1966, J ANAL MATH, V17, P209, DOI 10.1007/BF02788657; CHEN BY, 1987, J MATH PURE APPL, V66, P321; Kokubu M, 2009, J MATH SOC JPN, V61, P799, DOI 10.2969/jmsj/06130799; Martinez A, 2005, MATH Z, V249, P755, DOI 10.1007/s00209-004-0728-y; RU M, 1993, T AM MATH SOC, V339, P751, DOI 10.2307/2154296; Yu ZH, 1997, P AM MATH SOC, V125, P2997, DOI 10.1090/S0002-9939-97-03937-3; CHENG SY, 1976, ANN MATH, V104, P407, DOI 10.2307/1970963; UMEHARA M, 1993, ANN MATH, V137, P611, DOI 10.2307/2946533; CHERN S, 1960, AM J MATH, V82, P323, DOI 10.2307/2372738; FUJIMOTO H, 1988, J MATH SOC JPN, V40, P235; Umehara M, 2012, B LOND MATH SOC, V44, P617, DOI 10.1112/blms/bds017; Nakajo D, 2009, RESULTS MATH, V55, P139, DOI 10.1007/s00025-009-0399-4; Bergweiler W, 2000, CONFORM GEOM DYN, V4, P22, DOI 10.1090/S1088-4173-00-00057-6; BRYANT RL, 1987, ASTERISQUE, P321; Bryant R. L., 1987, ASTERISQUE, V154-155, P353; Calabi E., 1970, P S PURE APPL MATH, VXV, P223; Calabi E., 1958, MICH MATH J, V5, P105, DOI DOI 10.1307/MMJ/1028998055; Fujimoto H., 1993, ASPECTS MATH E, VE21; Imaizumi T., 2008, HOKKAIDO MATH J, V37, P561; Jorgens K., 1954, MATH ANN, V127, P130, DOI 10.1007/BF01361114; Kobayashi O., 1983, TOKYO J MATH, V6, P297; Kobayashi R., 2003, SUGAKU EXPOSITIONS, V16, P39; Lawson Jr H. B., 1980, MATH LECT SERIES, VI; Nevanlinna R., 1970, GRUNDLEHREN MATH WIS, V162; Nevanlinna R, 1927, ACTA MATH-DJURSHOLM, V48, P367, DOI 10.1007/BF02565342; Noguchi J., 1990, TRANSLATIONS MATH MO, V80; Noguchi J., 2014, GRUNDLEHREN MATH WIS, V350; OSSERMAN R., 1986, SURVEY MINIMAL SURFA; OSSERMAN R, 1959, COMMUN PUR APPL MATH, V12, P229, DOI 10.1002/cpa.3160120203; Ru M., 2001, NEVANLINNA THEORY IT; Sasaki S., 1973, KODAI MATH SEM REP, V25, P449, DOI 10.2996/kmj/1138846871; Umehara M., 1997, TSUKUBA J MATH, V21, P229; Umehara M., 2006, HOKKAIDO MATH J, V35, P13; Volkov Ju. A., 1971, MAT ZAMETKI, V10, P327	52	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-414X	1496-4279		CAN J MATH	Can. J. Math.-J. Can. Math.	DEC	2015	67	6					1411	1434		10.4153/CJM-2015-008-5		24	Mathematics	Mathematics	CW4SN	WOS:000364982500009		
J	Kuroishi, T				Kuroishi, Toshinobu			Regulation of immunological and inflammatory functions by biotin	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Review						biotin; biotin-dependent carboxylase; holocarboxylase synthetase; biotinidase; water-soluble vitamin	BLOOD MONONUCLEAR-CELLS; NF-KAPPA-B; MULTIPLE CARBOXYLASE DEFICIENCY; TRANSCRIPTION FACTORS SP1; FATTY-ACID COMPOSITION; HEAT-SHOCK PROTEINS; JURKAT CELLS; T-CELL; HOLOCARBOXYLASE SYNTHETASE; IMMUNE-RESPONSES	Biotin is a water-soluble B-complex vitamin and is well-known as a co-factor for 5 indispensable carboxylases. Holocarboxylase synthetase (HLCS) catalyzes the biotinylation of carboxylases and other proteins, whereas biotinidase catalyzes the release of biotin from biotinylated peptides. Previous studies have reported that nutritional biotin deficiency and genetic defects in either HLCS or biotinidase induces cutaneous inflammation and immunological disorders. Since biotin-dependent carboxylases involve various cellular metabolic pathways including gluconeogenesis, fatty acid synthesis, and the metabolism of branched-chain amino acids and odd-chain fatty acids, metabolic abnormalities may play important roles in immunological and inflammatory disorders caused by biotin deficiency. Transcriptional factors, including NF-kappa B and Sp1/3, are also affected by the status of biotin, indicating that biotin regulates immunological and inflammatory functions independently of biotin-dependent carboxylases. An in-vivo analysis with a murine model revealed the therapeutic effects of biotin supplementation on metal allergies. The novel roles of biotinylated proteins and their related enzymes have recently been reported. Non-carboxylase biotinylated proteins induce chemokine production. HLCS is a nuclear protein involved in epigenetic and chromatin regulation. In this review, comprehensive knowledge on the regulation of immunological and inflammatory functions by biotin and its potential as a therapeutic agent is discussed.	[Kuroishi, Toshinobu] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kuroishi, T (reprint author), Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	toshinobu.kuroishi.e1@tohoku.ac.jp			JSPS [25462913]	This work was supported by JSPS KAKENHI Grant No. 25462913.	Zempleni J, 2001, J NUTR, V131, P1479; Pindolia K, 2014, MOL GENET METAB, V112, P49, DOI 10.1016/j.ymgme.2014.02.008; Baumgartner ER, 1997, INT J VITAM NUTR RES, V67, P377; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Storm D, 1996, J IMMUNOL METHODS, V199, P87, DOI 10.1016/S0022-1759(96)00172-X; Tone M, 2002, J BIOL CHEM, V277, P8890, DOI 10.1074/jbc.M109889200; Wu Z, 2005, MOL CELL BIOL, V25, P9741, DOI 10.1128/MCB.25.22.9741-9752.2005; Manthey KC, 2002, J NUTR, V132, P887; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Kuroishi T, 2011, MOL GENET METAB, V104, P537, DOI 10.1016/j.ymgme.2011.08.030; Griffin JB, 2003, J NUTR, V133, P3409; Baez-Saldana A, 1998, AM J CLIN NUTR, V67, P431; MOCK DM, 1988, PEDIATR RES, V24, P396, DOI 10.1203/00006450-198809000-00023; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Kuroishi T, 2009, J NUTR, V139, P1031, DOI 10.3945/jn.108.097543; Baez-Saldana A, 2004, J NUTR, V134, P1970; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; van Eden W, 2012, CELL STRESS CHAPERON, V17, P281, DOI 10.1007/s12192-011-0311-5; Li Y, 2014, J NUTR BIOCHEM, V25, P475, DOI 10.1016/j.jnutbio.2013.12.008; Griffin JB, 2006, J NUTR BIOCHEM, V17, P272, DOI 10.1016/j.jnutbio.2005.05.005; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; De Maio A, 2013, SHOCK, V40, P239, DOI 10.1097/SHK.0b013e3182a185ab; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Mall GK, 2010, J NUTR, V140, P1086, DOI 10.3945/jn.110.121475; Yomogida K, 2012, CYTOKINE, V58, P431, DOI 10.1016/j.cyto.2012.02.007; Pindolia K, 2011, MOL GENET METAB, V102, P161, DOI 10.1016/j.ymgme.2010.10.005; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Liu DD, 2014, BIOCHEM J, V461, P477, DOI 10.1042/BJ20131208; Zempleni J, 2014, NUTR REV, V72, P369, DOI 10.1111/nure.12103; Stanley JS, 2002, J NUTR, V132, P1854; Ghosh S, 2012, J BIOL CHEM, V287, P32881, DOI 10.1074/jbc.M112.357889; Zempleni J, 1999, AM J PHYSIOL-CELL PH, V276, pC1079; Makino Y, 1999, J NUTR SCI VITAMINOL, V45, P347; Xue J, 2013, AM J PHYSIOL-CELL PH, V305, pC1240, DOI 10.1152/ajpcell.00279.2013; Wiedmann S, 2004, J NUTR BIOCHEM, V15, P433, DOI 10.1016/j.jnutbio.2004.02.005; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Kuroishi T, 2008, J LEUKOCYTE BIOL, V83, P912, DOI 10.1189/jlb.0607428; de la Vega-Monroy MLL, 2013, J NUTR BIOCHEM, V24, P169, DOI 10.1016/j.jnutbio.2012.03.020; Launay S, 1997, J BIOL CHEM, V272, P10746; FISCHER A, 1982, J CLIN IMMUNOL, V2, P35, DOI 10.1007/BF00915976; Tao YF, 2005, BIOCHEM BIOPH RES CO, V338, P700, DOI 10.1016/j.bbrc.2005.09.194; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Tone M, 2000, J IMMUNOL, V165, P286; Eng WK, 2013, BRIT J NUTR, V110, P321, DOI 10.1017/S0007114512005065; Mock DM, 2002, J NUTR BIOCHEM, V13, P462, DOI 10.1016/S0955-2863(02)00192-4; MOCK DM, 1991, SEMIN DERMATOL, V10, P296; RABIN BS, 1983, J NUTR, V113, P2316; Wiedmann S, 2003, J NUTR, V133, P716; MOCK DM, 1988, J NUTR, V118, P342; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; Calderone R.A., 2002, CANDIDA CANDIDASIS; Cowan M.J., 1979, LANCET, V314, P115, DOI [10.1016/S0140-6736(79)90002-3, DOI 10.1016/S0140-6736(79)90002-3]; Rodriguez-Melendez R, 2003, AM J PHYSIOL-CELL PH, V284, pC415, DOI 10.1152/ajpcell.00365.2002; Rodriguez-Melendez R, 2004, INT J VITAM NUTR RES, V74, P209, DOI 10.1024/0300-9831.74.3.209; Zempleni J, 2012, PRESENT KNOWLEDGE NU, V10, P359	63	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	DEC	2015	93	12					1091	1096		10.1139/cjpp-2014-0460		6	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CW6VR	WOS:000365137000009		
J	Kitaoka, K; Saito, K; Tokuuye, K				Kitaoka, Kumiko; Saito, Kazuhiro; Tokuuye, Koichi			Significance of CD4+T-cell count in the management of appendicitis in patients with HIV	CANADIAN JOURNAL OF SURGERY			English	Article								Identification of complicated appendicitis (CA) is critical to the management of appendicitis. However, previous studies have not investigated indicators of CA among patients with HIV or whether it is safe to use conservative treatment for appendicitis in these patients. Among 322 patients with appendicitis, we identified 14 who had HIV. Six of them were operated and 8 were treated with antibiotics; CA was diagnosed in 4. Patients with HIV and CA had a significantly lower CD4+ T-cell count than those with uncomplicated appendicitis. A white blood cell count lower than 7.4 x 10(9)/L was observed exclusively in patients with CA. No patient with HIV whose appendicitis was treated conservatively died or experienced a recurrence. We discuss our findings, which suggest the possibility of conservative treatment of appendicitis in patients with HIV and identification of CA by low CD4+ T-cell count.	[Kitaoka, Kumiko; Saito, Kazuhiro; Tokuuye, Koichi] Tokyo Med Univ, Dept Radiol, Tokyo 1608402, Japan	Kitaoka, K (reprint author), Tokyo Med Univ Hosp, Dept Radiol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	kumiko_kitaoka@yahoo.co.jp					Flum DR, 1997, J AM COLL SURGEONS, V184, P481; Bova R, 1998, AUST NZ J SURG, V68, P337, DOI 10.1111/j.1445-2197.1998.tb04767.x; Deeks SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3172; Giiti GC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-47; Kitaoka K, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-62	5	0	0	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	DEC	2015	58	6					429	430		10.1503/cjs.015714		2	Surgery	Surgery	CX1YP	WOS:000365492100003		
J	Kitabeppu, Y; Lakzian, S				Kitabeppu, Yu; Lakzian, Sajjad			Non-branching RCD(0, N) Geodesic Spaces with Small Linear Diameter Growth have Finitely Generated Fundamental Groups	CANADIAN MATHEMATICAL BULLETIN-BULLETIN CANADIEN DE MATHEMATIQUES			English	Article						Milnor conjecture; non negative Ricci curvature; curvature dimension condition; finitely generated; fundamental group; infinitesimally Hilbertian	NONNEGATIVE RICCI CURVATURE; METRIC-MEASURE-SPACES; COMPLETE MANIFOLDS; ALEXANDROV SPACES; GEOMETRY	In this paper, we generalize the finite generation result of Sormani to non-branching RCD (0, N) geodesic spaces (and in particular, Alexandroy spaces) with full support measures. This is a special case of the Minor's Conjecture for complete non-compact RCD (0, N) spaces. One of the key tools we use is the Abresch-Gromoll type excess estimates for non-smooth spaces obtained by Gigli-Mosconi.	[Kitabeppu, Yu] Kyoto Univ, Kyoto 6068501, Japan; [Lakzian, Sajjad] Univ Bonn, Hausdorff Inst Math, Bonn, Germany	Kitabeppu, Y (reprint author), Kyoto Univ, Kyoto 6068501, Japan.	y.kitabeppu@gmail.com; lakzians@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Hausdorff post-doctoral fellowship at the Hausdorff Institute for Mathematics, University of Bonn	Yu Kitabeppu is partly supported by the Grant-in-Aid for JSPS Fellows, The Ministry of Education, Culture, Sports, Science and Technology, Japan, and also partly supported by the grants of Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation during his stay in Bonn. Sajjad Lakzian is supported by the Hausdorff post-doctoral fellowship at the Hausdorff Institute for Mathematics, University of Bonn.	Abresch U., 1990, J AM MATH SOC, V3, P355, DOI 10.2307/1990957; ANDERSON MT, 1990, TOPOLOGY, V29, P41, DOI 10.1016/0040-9383(90)90024-E; Cheeger J, 1996, ANN MATH, V144, P189, DOI 10.2307/2118589; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P133, DOI 10.1007/s11511-006-0003-7; CHEEGER J, 1972, ANN MATH, V96, P413, DOI 10.2307/1970819; Cheeger J, 2000, J DIFFER GEOM, V54, P13; Sturm KT, 2006, ACTA MATH-DJURSHOLM, V196, P65, DOI 10.1007/s11511-006-0002-8; Wei GF, 2009, J DIFFER GEOM, V83, P377; Lott J, 2009, ANN MATH, V169, P903; Gigli N, 2014, DISCRETE CONT DYN-A, V34, P1481, DOI 10.3934/dcds.2014.34.1481; Perelman G, 1995, PROCEEDINGS OF THE INTERNATIONAL CONGRESS OF MATHEMATICIANS, VOLS 1 AND 2, P517; Liu G, 2013, INVENT MATH, V193, P367, DOI 10.1007/s00222-012-0428-x; Bacher K, 2010, J FUNCT ANAL, V259, P28, DOI 10.1016/j.jfa.2010.03.024; Kuwae K, 2001, MATH Z, V238, P269, DOI 10.1007/s002090100252; Sormani C, 2000, J DIFFER GEOM, V54, P547; Cheeger J, 1997, J DIFFER GEOM, V46, P406; Ambrosio L, 2014, DUKE MATH J, V163, P1405, DOI 10.1215/00127094-2681605; Burago D., 2001, GRADUATE STUDIES MAT, V33; Gigli N., ARXIV12056622; Gigli N., ARXIV13025555; LI P, 1986, ANN MATH, V124, P1, DOI 10.2307/1971385; Milnor John W., 1968, J DIFFER GEOM, V2, P1; Mitsuishi A, 2014, PAC J MATH, V270, P393, DOI 10.2140/pjm.2014.270.393; Petrunin A., 2011, MUNSTER J MATH, V4, P53; Rajala T., 2014, PARTIAL DIFFERENTIAL, V50, P831; Schoen R., 1982, ANN MATH STUD, V102, P209; Shatficar K., 2008, ADV MATH, V220, P791	27	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-4395	1496-4287		CAN MATH BULL	Can. Math. Bul.-Bul. Can. Math.	DEC	2015	58	4					787	798		10.4153/CMB-2015-052-4		12	Mathematics	Mathematics	CW6YH	WOS:000365143800010		
J	Fujiwara, Y; Nokihara, H; Yamada, Y; Yamamoto, N; Sunami, K; Utsumi, H; Asou, H; TakahashI, O; Ogasawara, K; Gueorguieva, I; Tamura, T				Fujiwara, Yutaka; Nokihara, Hiroshi; Yamada, Yasuhide; Yamamoto, Noboru; Sunami, Kuniko; Utsumi, Hirofumi; Asou, Hiroya; Takahash, Osamu, I; Ogasawara, Ken; Gueorguieva, Ivelina; Tamura, Tomohide			Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Galunisertib; LY2157299; Pharmacokinetics; Safety; TGF-beta	GROWTH-FACTOR-BETA; LY2157299 MONOHYDRATE; CANCER; INDUCTION	Inhibition of transforming growth factor-beta receptor I (TGF-beta RI)-mediated signaling pathways blocks tumor growth and metastases in nonclinical studies. Galunisertib (LY2157299), a small molecule inhibitor of TGF-beta RI serine/threonine kinase, had antitumor effects with acceptable safety/tolerability in a first-in-human dose (FHD) study conducted mainly in Caucasian patients with glioma. In this nonrandomized, open-label, dose-escalation study, we assessed safety/tolerability, pharmacokinetics (PK), and tumor response in Japanese patients. Patients with advanced and/or metastatic disease refractory were assigned sequentially to Cohort-1 (80 mg) or Cohort-2 (150 mg) of galunisertib, administered twice daily and treated using 2-week on, 2-week off treatment cycles. Dose escalation was guided by predefined PK criteria and dose-limiting toxicities (DLT). Safety assessments included treatment-emergent adverse events (TEAEs) and cardiac safety (ultrasound cardiography/Doppler imaging, electrocardiogram, chest computed tomography, and cardiotoxicity serum biomarkers). Twelve patients (Cohort-1, n = 3; Cohort-2, n = 9) were enrolled and the most common types of cancer were pancreatic (n = 5) and lung cancer (n = 3). Seven patients (Cohort-1, n = 2; Cohort-2, n = 5) experienced possibly galunisertib-related TEAEs. The most frequent related TEAEs were brain natriuretic peptide increased (n = 2), leukopenia (n = 2), and rash (n = 2). No cardiovascular toxicities or other DLTs were reported. PK profile of galunisertib was consistent with the FHD study. Maximum plasma concentration was reached within 2 h post-dose, and the mean elimination half-life was 9 h. Galunisertib had an acceptable tolerability and safety profile in Japanese patients with advanced cancers. NCT01722825.	[Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Sunami, Kuniko; Utsumi, Hirofumi; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo 1040045, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Oncol, Tokyo 1040045, Japan; [Asou, Hiroya; Takahash, Osamu, I] Eli Lilly Japan KK, Med Sci, Kobe, Hyogo, Japan; [Ogasawara, Ken] Eli Lilly Japan KK, Japan PK PD, Kobe, Hyogo, Japan; [Gueorguieva, Ivelina] Lilly Res Labs, Global PK PD, Windlesham, Surrey, England	Fujiwara, Y (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	yutakafu@ncc.go.jp			Eli Lilly and Company; Eli Lilly Japan K.K.	This study was sponsored by Eli Lilly and Company. Medical writing assistance was provided by Julie A. Ely, PhD, CMPP, and Serina Stretton, PhD, CMPP, of ProScribe-Envision Pharma Group, and was funded by Eli Lilly Japan K.K.	Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Pasche B, 2001, J CELL PHYSIOL, V186, P153, DOI 10.1002/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J; Rodon J, 2015, INVEST NEW DRUG, V33, P357, DOI 10.1007/s10637-014-0192-4; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Maier A, 2015, CELL ONCOL, V38, P131, DOI 10.1007/s13402-014-0210-8; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Gueorguieva I, 2014, BRIT J CLIN PHARMACO, V77, P796, DOI 10.1111/bcp.12256; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Dituri F, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0067109; Faivre SJ, 2014, J CLIN ONCOL S3, V32; Kovacs RJ, 2015, CARDIOVASC TOXICOL, V15, P309, DOI 10.1007/s12012-014-9297-4; Kozloff M, 2013, ASCO M, V31, P2563; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Rodon J, 2015, CLIN CANCER RES, V21, P553, DOI 10.1158/1078-0432.CCR-14-1380; Stauber AJ, 2014, J CLIN TOXICOL, DOI [10.4172/2161-0495.196, DOI 10.4172/2161-0495.196]; Suarez C, 2013, ASCO M, V31	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2015	76	6					1143	1152		10.1007/s00280-015-2895-4		10	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7ZJ	WOS:000365217800004		
J	Nakamichi, S; Nokihara, H; Yamamoto, N; Yamada, Y; Honda, K; Tamura, Y; Wakui, H; Sasaki, T; Yusa, W; Fujino, K; Tamura, T				Nakamichi, Shinji; Nokihara, Hiroshi; Yamamoto, Noboru; Yamada, Yasuhide; Honda, Kazunori; Tamura, Yosuke; Wakui, Hiroshi; Sasaki, Tatsuya; Yusa, Wataru; Fujino, Katsuki; Tamura, Tomohide			A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Lenvatinib; E7080; Phase 1; Angiogenesis; Japanese; Safety	THYROID-CANCER; E7080; ANGIOGENESIS; PLACEBO; TRIAL	This phase 1 study aimed to assess the tolerability, safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of lenvatinib capsules in Japanese patients with solid tumors when administered orally up to 24 mg on a once-daily (QD) continuous schedule. Patients were enrolled in one of the two sequential cohorts (20 or 24 mg) of lenvatinib on a 28-day cycle based on the conventional 3 + 3 dose escalation design. Adverse events (AEs) were graded using the Common Terminology Criteria for Adverse Events, version 4.0. Tolerability was judged based on dose-limiting toxicities (DLTs) during Cycle 1. The drug was defined as tolerable when the incidence of DLTs was less than 33 %. Nine patients received lenvatinib [20 mg (n = 3); 24 mg (n = 6)]. No DLTs were observed. The most common AEs were thrombocytopenia, blood thyroid stimulating hormone increased, and hypertension (89 %), followed by leukopenia, headache, and proteinuria (78 %). The area under the concentration-time curve and maximum observed concentration increased dose proportionally. The PK profiles were similar to those in non-Japanese phase 1 studies. One patient with leiomyosarcoma showed a partial response, and three patients have maintained stable disease for more than 6 months. The 24-mg QD continuous dose of lenvatinib was determined to be tolerable with encouraging anti-tumor activity in Japanese patients with solid tumors.	[Nakamichi, Shinji; Nokihara, Hiroshi; Yamamoto, Noboru; Honda, Kazunori; Tamura, Yosuke; Wakui, Hiroshi; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Dept Gastrointestinal Oncol, Tokyo, Japan; [Sasaki, Tatsuya; Yusa, Wataru] Eisai & Co Ltd, Clin Dev, Tokyo, Japan; [Fujino, Katsuki] Eisai & Co Ltd, Biostat, Tokyo, Japan	Tamura, T (reprint author), St Lukes Int Hosp, Chuo Ku, Akashi Cho 9-1, Tokyo 1048560, Japan.	tamuratomohide@gmail.com			Eisai Co., Ltd.	We thank all of the patients who participated in this study and their families, as well as all investigators, physicians, nurses, and clinical research coordinators who helped with this study; the Efficacy and Safety Evaluation Committee: Drs. Noriyuki Masuda (Kitasato University), Hiroshi Sakai (Saitama Cancer Center), and Masahiko Shibuya (Tokyo Metropolitan Komagome Hospital). We also thank Dr. Masahiro Fukuoka (Izumi Municipal hospital) for helpful suggestions as a medical advisor, Yuki Nishioka (Eisai Co., Ltd.) for PK/PD analysis, and Etsuko Ebisawa (Eisai Co., Ltd.) for medical writing. All authors retained full control over the manuscript content. This study was funded by Eisai Co., Ltd.	Boss DS, 2012, BRIT J CANCER, V106, P1598, DOI 10.1038/bjc.2012.154; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Shumaker R, 2014, INT J CLIN PHARM TH, V52, P284, DOI 10.5414/CP201937; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Penel N, 2013, CRIT REV ONCOL HEMAT, V88, P309, DOI 10.1016/j.critrevonc.2013.05.004; Yamada K, 2011, CLIN CANCER RES, V17, P2528, DOI 10.1158/1078-0432.CCR-10-2638; Cabanillas ME, 2015, CANCER-AM CANCER SOC, V121, P2749, DOI 10.1002/cncr.29395; Verheul HMW, 2004, J PATHOL, V202, P5, DOI 10.1002/path.1473; Matsui J, 2008, INT J CANCER, V122, P664, DOI 10.1002/ijc.23131; Havel L, 2014, ASCO M ABSTRACTS S, V32, P8043; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Molina AM, 2012, J CLIN ONCOL S, V30; Ronzoni M, 2010, ANN ONCOL, V21, P2382, DOI 10.1093/annonc/mdq261; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Tohyama O, 2014, J THYROID RES, V2014, DOI [DOI 10.1155/2014/638747, 10.1155/2014/638747]; Vergote I, 2013, J CLIN ONCOL S, V31; Yamamoto Yuji, 2014, Vasc Cell, V6, P18, DOI 10.1186/2045-824X-6-18	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2015	76	6					1153	1161		10.1007/s00280-015-2899-0		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7ZJ	WOS:000365217800005		
J	Kobayashi, S; Tomokuni, A; Gotoh, K; Takahashi, H; Akita, H; Marubashi, S; Yamada, T; Teshima, T; Nishiyama, K; Yano, M; Ohigashi, H; Ishikawa, O; Sakon, M				Kobayashi, Shogo; Tomokuni, Akira; Gotoh, Kunihito; Takahashi, Hidenori; Akita, Hirofumi; Marubashi, Shigeru; Yamada, Terumasa; Teshima, Teruki; Nishiyama, Kinji; Yano, Masahiko; Ohigashi, Hiroaki; Ishikawa, Osamu; Sakon, Masato			Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Biliary tract cancer; Chemoradiation; Neoadjuvant; Feasibility	PERIHILAR CHOLANGIOCARCINOMA; ADJUVANT GEMCITABINE; SURGICAL RESECTION; MAJOR HEPATECTOMY; PHASE-I; CHEMORADIATION; SURVIVAL; CHEMORESISTANCE; COMPLICATIONS; EMBOLIZATION	This study aimed to evaluate the safety of neoadjuvant gemcitabine combination radiation therapy in the treatment of biliary tract cancer and to investigate the pathological effects of chemoradiation therapy and its impact on survival. Chemoradiation therapy entailed three cycles of full dose of gemcitabine (1000 mg/m(2) at days 1, 8, and 15, every 4 weeks) with 50-60 Gy radiation (2 Gy/day) at the main tumor and the regional and para-aortic lymph nodes. The present study included 25 patients. All of the patients were pathologically diagnosed before treatment. The relative dose intensity of gemcitabine was 84 %. The average dose of radiation was 53.8 Gy. Sixty percent of the patients underwent pancreatoduodenectomy, and 32 % underwent hemi-hepatectomy due to bile duct cancer (n = 24) or gall bladder cancer (n = 1). During neoadjuvant therapy, 21 patients (84 %) suffered from adverse events. The common hematological adverse events were leukopenia (44 %) and thrombocytopenia (32 %). It was necessary to exchange the plastic biliary stent in 11 patients (44 %). An R0 resection was achieved in 96 % of the patients, with pathological lymph node metastasis noted in 16 %. Moderate or marked histological changes were noted in 32 % of the patients. The 3-year overall survival rate after the first treatment was 74.6 %, with a 3.2-year observation period. Neoadjuvant therapy was feasible and is expected to improve survival by controlling regional extension.	[Kobayashi, Shogo; Tomokuni, Akira; Gotoh, Kunihito; Takahashi, Hidenori; Akita, Hirofumi; Marubashi, Shigeru; Yamada, Terumasa; Yano, Masahiko; Ohigashi, Hiroaki; Ishikawa, Osamu; Sakon, Masato] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, Osaka, Osaka 5378511, Japan; [Teshima, Teruki; Nishiyama, Kinji] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg & Radiat Oncol, Osaka, Osaka 5378511, Japan	Kobayashi, S (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, Nakamichi 1-3-3, Osaka, Osaka 5378511, Japan.	s-kobayashi@umin.ac.jp			 [15K10202]	This study was funded by a Grant-in-Aid for Scientific Research (C, 15K10202).	Yamanaka K, 2014, INT J CLIN ONCOL, V19, P485, DOI 10.1007/s10147-013-0578-x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kobayashi S, 2011, J SURG ONCOL, V104, P499, DOI 10.1002/jso.21971; Kobayashi S, 2009, J SURG ONCOL, V100, P657, DOI 10.1002/jso.21409; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1016/0270-9139(95)90104-3; Glazer ES, 2012, J GASTROINTEST SURG, V16, P1666, DOI 10.1007/s11605-012-1935-1; Yamada D, 2013, EUR J CANCER, V49, P1725, DOI 10.1016/j.ejca.2012.12.002; Katayose Y, 2011, HEPATO-GASTROENTEROL, V58, P1866, DOI 10.5754/hge10106; Miyakawa S, 2009, J HEPATO-BILIARY-PAN, V16, P1, DOI 10.1007/s00534-008-0015-0; Murad SD, 2012, GASTROENTEROLOGY, V143, P88, DOI 10.1053/j.gastro.2012.04.008; Hasegawa S, 2007, WORLD J SURG, V31, P1256, DOI 10.1007/s00268-007-9001-y; Kobayashi S, 2010, J SURG ONCOL, V101, P376, DOI 10.1002/jso.21501; Aoba T, 2013, ANN SURG, V257, P718, DOI 10.1097/SLA.0b013e3182822277; Kobayashi S, 2011, J SURG ONCOL, V103, P223, DOI 10.1002/jso.21811; Ohigashi H, 2009, ANN SURG, V250, P88, DOI 10.1097/SLA.0b013e3181ad65cc; Nakashima S, 2015, CANCER SCI, V106, P584, DOI 10.1111/cas.12652; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; MAKUUCHI M, 1990, SURGERY, V107, P521; Takahashi H, 2013, ANN SURG, V258, P1040, DOI 10.1097/SLA.0b013e31829b3ce4; McMasters KM, 1997, AM J SURG, V174, P605, DOI 10.1016/S0002-9610(97)00203-1; Kobayashi S, 2011, J CANC THER, V2, P703; Kobayashi S, 2014, CANCER CHEMOTH PHARM, V74, P699, DOI 10.1007/s00280-014-2543-4; Nakashima S, 2014, J SURG ONCOL, V110, P1016, DOI 10.1002/jso.23767; Shimosato Y, 1971, JPN J CLIN ONCOL, V1, P19; Sobin LH, 2010, TNM CLASSIFICATION M	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2015	76	6					1191	1198		10.1007/s00280-015-2908-3		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7ZJ	WOS:000365217800009		
J	Hata, T; Honda, M; Kobayashi, M; Toyokawa, A; Tsuda, M; Tokunaga, Y; Takase, K; Miyake, M; Morita, S; Nagata, N; Sakamoto, J; Gosho, M; Mishima, H				Hata, Taishi; Honda, Michitaka; Kobayashi, Michiya; Toyokawa, Akihiro; Tsuda, Masahiro; Tokunaga, Yukihiko; Takase, Kozo; Miyake, Masakazu; Morita, Satoshi; Nagata, Naoki; Sakamoto, Junichi; Gosho, Masahiko; Mishima, Hideyuki			Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO)	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Colorectal cancer; Dexamethasone; Oxaliplatin; Venous pain	CAPECITABINE PLUS OXALIPLATIN; 1ST-LINE THERAPY; JAPANESE PATIENTS; XELOX; I/II	The aim of this phase II clinical trial was to evaluate the preventive effect of dexamethasone mixing injection for venous pain in patients with colorectal cancer during chemotherapy. Patients were randomized to receive a 2-h intravenous infusion of oxaliplatin 130 mg/m(2) on day 1 followed by capecitabine 1000 mg/m(2) (or S-1 40-60 mg/m(2)) twice daily on days 1 through 14 of every 3 weeks with or without dexamethasone 1.65 mg at the infusion on day 1. A total of 53 patients were enrolled. The analysis population consisted of 49 patients (arm A, with dexamethasone N = 24; arm B, without dexamethasone N = 25). The incidence of venous pain a parts per thousand yengrade 2 based on the CTCAE version 4.0 was 33.3 % in arm A and 56.0 % in arm B (relative risk 0.60; 95 % CI 0.31-1.16). The incidences based on the verbal rating scale for arms A and B were 50.0 and 64.0 %, respectively (relative risk 0.78; 95 % CI 0.48-1.28). The primary endpoint was not met in this preliminary study.	[Hata, Taishi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Honda, Michitaka] Japanese Fdn Canc Res, Dept Surg Gastroenterol, Inst Canc, Gastroenterol Ctr,Ariake Hosp,Koto Ku, Tokyo 1358550, Japan; [Kobayashi, Michiya] Kochi Med Sch, Dept Human Hlth & Med Sci, Kochi, Japan; [Toyokawa, Akihiro] Yodogawa Christians Hosp, Dept Surg, Osaka, Japan; [Tsuda, Masahiro] Hyogo Canc Ctr, Dept Gastroenterol Oncol, Kobe, Hyogo, Japan; [Tokunaga, Yukihiko] Japan Post Kyoto Teishin Hosp, Dept Surg, Kyoto, Japan; [Takase, Kozo] Hyogo Canc Ctr, Dept Surg, Kobe, Hyogo, Japan; [Miyake, Masakazu] Osaka Natl Hosp, Dept Surg, Osaka, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Nagata, Naoki] Kitakyushu Gen Hosp, Fukuoka, Japan; [Sakamoto, Junichi] Tokai Cent Hosp, Gifu, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Aichi, Japan; [Mishima, Hideyuki] Aichi Med Univ, Div Canc Ctr, Aichi, Japan	Honda, M (reprint author), Japanese Fdn Canc Res, Dept Surg Gastroenterol, Inst Canc, Gastroenterol Ctr,Ariake Hosp,Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	michitaka.honda@jfcr.or.jp			Epidemiological & Clinical Research Information Network (ECRIN)	The funding for this study was received from Epidemiological & Clinical Research Information Network (ECRIN).	Anami SMN, 2006, JPN J PHARM HLTH CAR, V32, P1105; ANDRE T, 2004, NEW ENGL J MED, V350, P2343, DOI DOI 10.1056/NEJM0A032709; Doi T, 2010, JPN J CLIN ONCOL, V40, P913, DOI 10.1093/jjco/hyq069; Cassidy J, 2011, BRIT J CANCER, V105, P58, DOI 10.1038/bjc.2011.201; Boku N, 2007, JPN J CLIN ONCOL, V37, P440, DOI 10.1093/jjco/hym069; Cassidy J, 2004, J CLIN ONCOL, V22, P2084, DOI 10.1200/JCO.2004.11.069; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Lara-Munoz C, 2004, ARCH MED RES, V35, P43, DOI 10.1016/j.arcmed.2003.07.007; Yamada Y, 2008, BRIT J CANCER, V98, P1034, DOI 10.1038/sj.bjc.6604271; Nagata K, 2012, SUPPORT CARE CANCER, V20, P951, DOI 10.1007/s00520-011-1166-0; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Raymond E, 1998, ANN ONCOL, V9, P1053, DOI 10.1023/A:1008213732429; ELFVING G, 1966, LANCET, V1, P953; Eric WBM, 1968, SURGERY, V63, P280; Matsuyama Kazuyo, 2011, Gan To Kagaku Ryoho, V38, P411; Yoshida Y., 2012, British Journal of Medicine and Medical Research, V2, P132	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2015	76	6					1209	1215		10.1007/s00280-015-2888-3		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7ZJ	WOS:000365217800011		
J	Kurihara, T; Kogo, M; Ishii, M; Shimada, K; Yoneyama, K; Kitamura, K; Shimizu, S; Yoshida, H; Kiuchi, Y				Kurihara, Tatsuya; Kogo, Mari; Ishii, Masakazu; Shimada, Ken; Yoneyama, Keiichiro; Kitamura, Katsuya; Shimizu, Shunichi; Yoshida, Hitoshi; Kiuchi, Yuji			Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Unresectable pancreatic cancer; Neutropenia; Gemcitabin; Prognosis	PHASE-III TRIAL; CELL LUNG-CANCER; PLUS GEMCITABINE; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; SURVIVAL; INDEX; EFFICACY; THERAPY; LINE	We conducted a retrospective cohort study to examine whether neutropenia could be an indicator of good prognosis in patients treated with gemcitabine (GEM) for unresectable pancreatic cancer. A total of 178 patients with unresectable pancreatic cancer, who were treated with first-line (n = 121) or second-line (n = 57) GEM, were included in our analyses. A Cox proportional hazard model was used to examine the effect of the grade of GEM-induced neutropenia on prognosis. Furthermore, the difference in survival time for each grade was assessed using a log-rank test. In the first-line population, the hazard ratios of patients with grade 2 or grade 3 neutropenia compared with the ratios of those without neutropenia (grade 0) were 0.43 (95% CI 0.27-0.70) and 0.37 (0.21-0.65), respectively (p < 0.05). The median survival time (MST) was 3.8 months for grade 0, 9.4 months for grade 2, and 10.1 for grade 3. Landmark analysis of the second-line population revealed a hazard ratio of 0.52 (0.30-0.82) for grade 1 and 0.49 for grade 2 (0.28-0.72) (p < 0.05). MST was 1.3 months for grade 0, 4.7 months for grade 1, and 4.6 months for grade 2. We found that neutropenia grade was an indicator of good prognosis in patients treated with first-line and second-line GEM for unresectable pancreatic cancer. A prospective study should be performed to examine whether dosage adjustment using neutropenia grade as an indicator would improve prognosis.	[Kurihara, Tatsuya; Ishii, Masakazu; Shimizu, Shunichi] Showa Univ, Sch Pharm, Dept Pharmacol Toxicol & Therapeut, Div Physiol & Pathol,Shinagawa Ku, Tokyo 1428555, Japan; [Kogo, Mari] Showa Univ, Sch Pharm, Dept Hosp Pharmaceut, Shinagawa Ku, Tokyo 1428555, Japan; [Shimada, Ken] Showa Univ, Koto Toyosu Hosp, Div Med Oncol, Dept Med,Koto Ku, Tokyo 1350061, Japan; [Yoneyama, Keiichiro] Showa Univ, Hlth Serv Ctr, Shinagawa Ku, Tokyo 1428555, Japan; [Kitamura, Katsuya; Yoshida, Hitoshi] Showa Univ, Sch Med, Div Gastroenterol, Dept Med,Shinagawa Ku, Tokyo 1428555, Japan; [Kiuchi, Yuji] Showa Univ, Ctr Pharmaceut Educ, Sch Pharmaceut Sci, Shinagawa Ku, Tokyo 1428555, Japan	Kurihara, T (reprint author), Showa Univ, Sch Pharm, Dept Pharmacol Toxicol & Therapeut, Div Physiol & Pathol,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	kurihara@pharm.showa-u.ac.jp					Rocconi RP, 2008, GYNECOL ONCOL, V108, P336, DOI 10.1016/j.ygyno.2007.10.012; Sunaga T, 2014, EUR J CANCER CARE, V23, P394, DOI 10.1111/ecc.12120; Shitara K, 2009, EUR J CANCER, V45, P1757, DOI 10.1016/j.ejca.2009.01.019; Yamanaka T, 2007, BRIT J CANCER, V97, P37, DOI 10.1038/sj.bjc.6603831; Bramhall SR, 2001, J CLIN ONCOL, V19, P3447; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Marechal R, 2007, ONCOLOGY-BASEL, V73, P41, DOI 10.1159/000120627; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; FREI E, 1980, AM J MED, V69, P585, DOI 10.1016/0002-9343(80)90472-6; Ahlgren JD, 1996, CANCER, V78, P654; Yoneyama K, 2012, HEPATO-GASTROENTEROL, V59, P894, DOI 10.5754/hge11567; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Reni M, 2005, LANCET ONCOL, V6, P369, DOI 10.1016/S1470-2045(05)70175-3; Pallis AG, 2008, LUNG CANCER, V62, P356, DOI 10.1016/j.lungcan.2008.03.030; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; DODWELL DJ, 1990, BRIT J CANCER, V61, P789, DOI 10.1038/bjc.1990.178; Gurney H, 2002, BRIT J CANCER, V86, P1297, DOI 10.1038/sj/bjc/6600139; Saarto T, 1997, BRIT J CANCER, V75, P301, DOI 10.1038/bjc.1997.49; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Newell D, 2002, BRIT J CANCER, V86, P1207, DOI 10.1038/sj/bjc/6600226; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Di Maio M, 2005, LANCET ONCOL, V6, P669, DOI 10.1016/S1470-2045(05)70255-2; Tanaka T, 2008, JPN J CLIN ONCOL, V38, P755, DOI 10.1093/jjco/hyn098; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Cameron DA, 2003, BRIT J CANCER, V89, P1837, DOI 10.1038/sj.bjc.6601366; Oettle H, 2005, ANN ONCOL, V16, P1639, DOI 10.1093/annonc/mdi309; Kurihara T, 2015, HEPATO-GASTROENTEROL, V62, P478, DOI 10.5754/hge141017; Sawaki A, 2008, J GASTROEN HEPATOL, V23, P1292, DOI 10.1111/j.1440-1746.2006.04734.x; Carus A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-189; Helmut S, 2003, INT J CANCER, V103, P335; Peter S, 2001, J CELL PHYSL, V189, P197; Ueno H, 2000, ONCOLOGY-BASEL, V59, P296, DOI 10.1159/000012186; Yamaguchi K, 2014, JPN J CLIN ONCOL, V44, P883, DOI 10.1093/jjco/hyu127	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2015	76	6					1217	1224		10.1007/s00280-015-2887-4		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7ZJ	WOS:000365217800012		
J	Daga, H; Takeda, K; Okada, H; Miyazaki, M; Ueda, S; Kaneda, H; Okamoto, I; Yoh, K; Goto, K; Konishi, K; Sarashina, A; Tanaka, T; Kaiser, R; Nakagawa, K				Daga, Haruko; Takeda, Koji; Okada, Hideaki; Miyazaki, Masaki; Ueda, Shinya; Kaneda, Hiroyasu; Okamoto, Isamu; Yoh, Kiyotaka; Goto, Koichi; Konishi, Koichi; Sarashina, Akiko; Tanaka, Tetsuya; Kaiser, Rolf; Nakagawa, Kazuhiko			Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Angiogenesis inhibitor; Clinical trial; Phase I; Nintedanib; Pemetrexed; Non-small cell lung cancer	TRIPLE ANGIOKINASE INHIBITOR; ADVANCED SOLID TUMORS; BIBF 1120; CONTROLLED-TRIAL; DOUBLE-BLIND; OPEN-LABEL; CARBOPLATIN; PACLITAXEL; GUIDELINES; EFFICACY	This open-label, phase I, dose-escalation part of a phase I/II study evaluated the safety, pharmacokinetics, and preliminary efficacy of nintedanib, a triple angiokinase inhibitor, combined with pemetrexed in Japanese patients with advanced non-small cell lung cancer (NSCLC) after first-line chemotherapy. A fixed dose of pemetrexed (500 mg/m(2) iv) was administered on Day 1 of each 21-day cycle followed by oral nintedanib twice daily (bid) on days 2-21, starting at 100 mg bid and escalating to 200 mg bid in 50-mg intervals, using a standard 3 + 3 design. After a parts per thousand yen4 cycles of combination therapy, patients could continue nintedanib monotherapy until disease progression or undue adverse events (AEs). Primary endpoints were maximum tolerated dose (MTD), defined as the highest dose at which the incidence of dose-limiting toxicities (DLTs) was < 33.3 % during the first treatment course, and AEs (CTCAE v3.0). DLTs were primarily defined as grade a parts per thousand yen3 non-hematologic or grade 4 hematologic AEs. Eighteen patients were included in the analysis. DLTs were experienced by 2/9 patients receiving 200 mg bid, 1/6 receiving 150 mg bid, and 0/3 receiving the lowest dose. The MTD of nintedanib plus pemetrexed was 200 mg bid. The most common drug-related AEs were elevated liver enzymes and gastrointestinal AEs. Two patients achieved partial response, and 10 had stable disease. Nintedanib plus pemetrexed had a manageable safety profile and showed promising signs of efficacy in previously treated Japanese patients with advanced NSCLC. As in Caucasian patients, the MTD of nintedanib was 200 mg bid. Clinical trial information NCT00979576.	[Daga, Haruko; Takeda, Koji; Okada, Hideaki] Osaka City Gen Hosp, Dept Med Oncol, Miyakojima Ku, Osaka 5340021, Japan; [Miyazaki, Masaki] Suita Municipal Hosp, Dept Internal Med, Suita, Osaka 5640082, Japan; [Ueda, Shinya] Kinki Univ, Fac Med, Nara Hosp, Nara 6300227, Japan; [Kaneda, Hiroyasu; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Osaka 5898511, Japan; [Okamoto, Isamu] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka 812, Japan; [Yoh, Kiyotaka; Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba 2778577, Japan; [Konishi, Koichi] Nippon Boehringer Ingelheim Co Ltd, Clin Trial Management Dept, Shinagawa Ku, Tokyo 1416017, Japan; [Sarashina, Akiko] Nippon Boehringer Ingelheim Co Ltd, Clin PK PD Dept, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Tanaka, Tetsuya] EPS Corp, Stat Anal Dept 1, Shinagawa Ku, Tokyo 1620814, Japan; [Kaiser, Rolf] Boehringer Ingelheim Pharma GmbH & Co KG, Clin Dev & Med Affairs, D-88397 Biberach An Der Riss, Germany	Daga, H (reprint author), Osaka City Gen Hosp, Dept Med Oncol, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	haruko-d@zeus.eonet.ne.jp			Boehringer Ingelheim	Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Aurora O'Brate of inVentiv Medical Communications during the preparation of this manuscript.	Ledermann JA, 2011, J CLIN ONCOL, V29, P3798, DOI 10.1200/JCO.2010.33.5208; Okamoto I, 2010, MOL CANCER THER, V9, P2825, DOI 10.1158/1535-7163.MCT-10-0379; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Stopfer P, 2011, XENOBIOTICA, V41, P297, DOI 10.3109/00498254.2010.545452; Reck M, 2011, ANN ONCOL, V22, P1374, DOI 10.1093/annonc/mdq618; Mross K, 2010, CLIN CANCER RES, V16, P311, DOI 10.1158/1078-0432.CCR-09-0694; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Makrilia N, 2009, EUR J INTERN MED, V20, P663, DOI 10.1016/j.ejim.2009.07.009; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Ellis PM, 2010, CLIN CANCER RES, V16, P2881, DOI 10.1158/1078-0432.CCR-09-2944; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Doebele RC, 2012, ANN ONCOL, V23, P2094, DOI 10.1093/annonc/mdr596; Eli Lilly and Company, 2013, AL PEM INJ PRESCR IN; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Hanna NH, 2013, J CLIN ONCOL, V31; Hilberg F, 2007, J THORAC ONCOL, V2, pS320; Kuribayashi K, 2014, J CANC BIOL RES, V2, P1026; National Cancer Institute, 2006, COMM TERM CRIT ADV E; National Comprehensive Cancer Network, 2015, NONSM CELL LUNG CANC; Qi WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055637; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	DEC	2015	76	6					1225	1233		10.1007/s00280-015-2896-3		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7ZJ	WOS:000365217800013		
J	Araki, H; Pang, XL; Komatsu, N; Soejima, M; Miyata, N; Takaki, M; Muta, S; Sasada, T; Noguchi, M; Koda, Y; Itoh, K; Kuhara, S; Tashiro, K				Araki, Hiromitsu; Pang, Xiaoliang; Komatsu, Nobukazu; Soejima, Mikiko; Miyata, Nawoe; Takaki, Mari; Muta, Shigeru; Sasada, Tetsuro; Noguchi, Masanori; Koda, Yoshiro; Itoh, Kyogo; Kuhara, Satoru; Tashiro, Kosuke			Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Haptoglobin; SNP; Biomarker; Peptide vaccine; Castration-resistant prostate cancer	PERIPHERAL-BLOOD; SERUM HAPTOGLOBIN; SUPPRESSOR-CELLS; IMMUNE-RESPONSE; MARKERS; ASSOCIATION; DISCOVERY; A-61C	Personalized peptide vaccination (PPV) is an attractive approach to cancer immunotherapy with strong immune-boosting effects conferring significant clinical benefit. However, as with most therapeutic agents, there is a difference in clinical efficacy among patients receiving PPV. Therefore, a useful biomarker is urgently needed for prognosticating clinical outcomes to preselect patients who would benefit the most from PPV. In this retrospective study, to detect a molecular prognosticator of clinical outcomes for PPV, we analyzed whole-genome gene expression profiles of peripheral blood mononuclear cells (PBMCs) in castration-resistant prostate cancer (CRPC) patients before administration of PPV. Cox regression analysis revealed that mRNA expression of myeloperoxidase, haptoglobin, and neutrophil elastase was significantly associated with overall survival (OS) among vaccinated CRPC patients (adjusted P < 0.01). By promoter sequence analysis of these three genes, we found that rs5472 of haptoglobin (HP), an acute-phase plasma glycoprotein, was strongly correlated to OS of vaccinated CRPC patients (P = 0.0047, hazard ratio 0.47; 95 % confidence interval 0.28-0.80). Furthermore, both HP mRNA expression in PBMCs and protein level in plasma of CRPC patients before administration of PPV exhibited rs5472 dependence (P < 0.001 for mRNA expression and P < 0.05 for protein level). Our findings suggest that rs5472 may play an important role in the immune response to PPV via regulation of HP. Thus, we concluded that rs5472 is a potential prognostic biomarker for PPV.	[Araki, Hiromitsu; Pang, Xiaoliang; Miyata, Nawoe; Takaki, Mari; Muta, Shigeru; Kuhara, Satoru; Tashiro, Kosuke] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Fukuoka 8128581, Japan; [Komatsu, Nobukazu; Sasada, Tetsuro] Kurume Univ, Dept Immunol & Immunotherapy, Sch Med, Kurume, Fukuoka 8300011, Japan; [Soejima, Mikiko; Koda, Yoshiro] Kurume Univ, Dept Forens Med & Human Genet, Sch Med, Kurume, Fukuoka 8300011, Japan; [Noguchi, Masanori] Kurume Univ, Div Clin Res, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; [Itoh, Kyogo] Kurume Univ, Canc Vaccine Ctr, Kurume, Fukuoka 830, Japan	Tashiro, K (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, 6-10-1 Hakozaki Higashi Ku, Fukuoka 8128581, Japan.	ktashiro@grt.kyushu-u.ac.jp			Taiho Pharmaceutical Co., Ltd.	Kyogo Itoh received research fund from Taiho Pharmaceutical Co., Ltd.	Harrop R, 2012, CANCER IMMUNOL IMMUN, V61, P2283, DOI 10.1007/s00262-012-1302-9; Komatsu N, 2012, CANCER-AM CANCER SOC, V118, P3208, DOI 10.1002/cncr.26636; Soejima M, 2014, CLIN CHIM ACTA, V433, P54, DOI 10.1016/j.cca.2014.02.029; LOUAGIE H, 1993, VACCINE, V11, P1188, DOI 10.1016/0264-410X(93)90041-U; Teye K, 2006, HUM BIOL, V78, P121, DOI 10.1353/hub.2006.0029; Pang X, 2013, BIOSCI BIOTECH BIOCH, V77, P766, DOI 10.1271/bbb.120893; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; Teye K, 2003, CLIN GENET, V64, P439, DOI 10.1034/j.1399-0004.2003.00149.x; Zhao CQ, 2007, NEOPLASIA, V9, P1, DOI 10.1593/neo.06619; Terasaki M, 2011, J CLIN ONCOL, V29, P337, DOI 10.1200/JCO.2010.29.7499; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; NEVO SS, 1968, AM J HUM GENET, V20, P461; Humphries JM, 2014, BBA-PROTEINS PROTEOM, V1844, P1051, DOI 10.1016/j.bbapap.2014.01.018; Noguchi M, 2013, CANCER IMMUNOL IMMUN, V62, P919, DOI 10.1007/s00262-012-1379-1; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Noguchi M, 2012, PROSTATE, V72, P834, DOI 10.1002/pros.21485; Yajima N, 2005, CLIN CANCER RES, V11, P5900, DOI 10.1158/1078-0432.CCR-05-0559; Elpek KG, 2014, CANCER IMMUNOL RES, V2, P655, DOI 10.1158/2326-6066.CIR-13-0209; Yamada A, 2013, CANCER SCI, V104, P15, DOI 10.1111/cas.12050; Araki H, 2012, FEBS OPEN BIO, V2, P76, DOI 10.1016/j.fob.2012.04.003; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Wobeto VPD, 2008, GENET MOL BIOL, V31, P602, DOI 10.1590/S1415-47572008000400002; Ang IL, 2006, J PROTEOME RES, V5, P2691, DOI 10.1021/pr060109r; Khaled YS, 2013, IMMUNOL CELL BIOL, V91, P493, DOI 10.1038/icb.2013.29; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bicho MC, 2013, ACUTE PHASE PROTEINS; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Cox SE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000362; GuhaThakurta D, 2013, EXPERT REV CLIN PHAR, V6, P387, DOI 10.1586/17512433.2013.811814; Savy M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011075; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Shimada E, 2006, JPN J TRANSFUS CELL, V52, P493; Ulivi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057401	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	DEC	2015	64	12					1565	1573		10.1007/s00262-015-1756-7		9	Oncology; Immunology	Oncology; Immunology	CW7KD	WOS:000365176600007		
J	Hasegawa, T; Yamakado, K; Takaki, H; Nakatsuka, A; Uraki, J; Yamanaka, T; Fujimori, M; Mizuno, S; Isaji, S; Sakuma, H				Hasegawa, Takaaki; Yamakado, Koichiro; Takaki, Haruyuki; Nakatsuka, Atsuhiro; Uraki, Junji; Yamanaka, Takashi; Fujimori, Masashi; Mizuno, Shugo; Isaji, Shuji; Sakuma, Hajime			Portal Venous Stent Placement for Malignant Portal Venous Stenosis or Occlusion: Who Benefits?	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Portal venous stent; Bile duct cancer; Pancreatic cancer; Palliative prognostic index	PALLIATIVE PROGNOSTIC INDEX; PANCREATIC-CANCER; VEIN STENOSIS; CT; CHOLANGIOCARCINOMA; CHEMOTHERAPY; OBSTRUCTION; SURVIVAL; IMPROVES; THERAPY	The purpose of this study was to evaluate the efficacy of portal venous (PV) stent placement and find groups who benefit from this procedure among patients with symptomatic PV hypertension caused by malignant tumors. From October 2001 to January 2013, 13 patients underwent PV stent placement because of PV stenosis or occlusion caused by bile duct cancer (n = 7), pancreatic cancer (n = 5), or nodal metastasis (n = 1). Technical success, changes in PV pressure gradient and palliative prognostic index (PPI) scores before and after stent placement, clinical outcomes, and complications were evaluated. Stent was successfully placed in all patients (100 %, 13/13), lowering the mean PV pressure gradient from 12.4 +/- A 4.5 mmHg (range 5-20 mmHg) to 0.5 +/- A 0.9 mmHg (range 0-3 mmHg, p < 0.000001). Symptoms were improved in all but one patient (92.3 %, 12/13). Although 10 patients (76.9 %, 10/13) with pre-stent placement PPI scores lower than 6 (mean 3.5 +/- A 1.7, range 0-5) were discharged from the hospital, the other 3 with the pre-stent placement PPI of 6 or more (mean 7.2 +/- A 1.6, range 6-9.5) died within 4 weeks (range 17-28 days) without discharge. The median survival time of discharged patients was 123 days, and it was 20 days in non-discharged patients (p = 0.0001). A major procedure-related complication of intraperitoneal hemorrhage occurred in one patient (7.7 %, 1/13). No significant factor was detected for the occurrence of complication. PV stent placement is a feasible, safe, and effective technique to relieve symptomatic PV hypertension caused by malignant tumors. The PPI score might be useful to stratify patients who benefit from this procedure.	[Hasegawa, Takaaki; Yamakado, Koichiro; Takaki, Haruyuki; Nakatsuka, Atsuhiro; Uraki, Junji; Yamanaka, Takashi; Fujimori, Masashi; Sakuma, Hajime] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan; [Mizuno, Shugo; Isaji, Shuji] Mie Univ, Sch Med, Dept Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie 5148507, Japan	Hasegawa, T (reprint author), Mie Univ, Sch Med, Dept Radiol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	hasegawat@clin.medic.mie-u.ac.jp					WITTE CL, 1985, ANN SURG, V202, P191, DOI 10.1097/00000658-198508000-00009; Ito K, 1997, RADIOGRAPHICS, V17, P897; Novellas S, 2009, CARDIOVASC INTER RAD, V32, P462, DOI 10.1007/s00270-008-9455-9; Zhou ZQ, 2014, ANZ J SURG, V84, P346, DOI 10.1111/ans.12046; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Nio Y, 2009, ANTICANCER RES, V29, P3329; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Glimelius B, 1996, ANN ONCOL, V7, P593; Tsuruga Y, 2013, WORLD J GASTROENTERO, V19, P2569, DOI 10.3748/wjg.v19.i16.2569; COHEN J, 1992, AM J MED, V92, P173, DOI 10.1016/0002-9343(92)90109-O; Maltoni M, 2012, ONCOLOGIST, V17, P446, DOI 10.1634/theoncologist.2011-0397; Denys A, 2004, EUR RADIOL, V14, P431, DOI 10.1007/s00330-003-2196-x; Rahma OE, 2013, ANN ONCOL, V24, P1972, DOI 10.1093/annonc/mdt166; Martin MDN, 2013, REV CLIN ESP, V213, P323, DOI 10.1016/j.rce.2013.04.007; Yamakado K, 2001, RADIOLOGY, V220, P150; Takaki H, 2009, HEPATO-GASTROENTEROL, V56, P407; Woodrum DA, 2009, J VASC INTERV RADIOL, V20, P593, DOI 10.1016/j.jvir.2009.02.010; Tsukamoto T, 2003, HEPATO-GASTROENTEROL, V50, P453; Sarin SK, 2002, SEMIN LIVER DIS, V22, P43, DOI 10.1055/s-2002-23206; Yamada Y, 2012, RADIOLOGY, V263, P419, DOI 10.1148/radiol.12111024; Ortner MEJ, 2003, GASTROENTEROLOGY, V125, P1355, DOI 10.1016/j.gastro.2003.07.015; Stone CA, 2008, J PAIN SYMPTOM MANAG, V35, P617, DOI 10.1016/j.jpainsymman.2007.07.006; Zoli M, 1996, HEPATOLOGY, V24, P1047; Fletcher JG, 2003, RADIOLOGY, V229, P81, DOI 10.1148/radiol.2291020582; Fernandez-Ruiz M, 2009, WORLD J GASTROENTERO, V15, P5279, DOI 10.3748/wjg.15.5279; El Amin H, 2010, Trop Gastroenterol, V31, P279; Macpherson A I, 1984, J R Coll Surg Edinb, V29, P4; Saad Wael E A, 2012, Semin Intervent Radiol, V29, P99, DOI 10.1055/s-0032-1312570; Sacks David, 2003, J Vasc Interv Radiol, V14, pS199	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	DEC	2015	38	6					1515	1522		10.1007/s00270-015-1123-2		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CW7ZW	WOS:000365219100015		
J	Inaba, Y; Yamaura, H; Sato, Y; Kato, M; Kawada, H; Murata, S; Hasegawa, T; Arai, Y				Inaba, Yoshitaka; Yamaura, Hidekazu; Sato, Yozo; Kato, Mina; Kawada, Hiroshi; Murata, Shinichi; Hasegawa, Takaaki; Arai, Yasuaki			Side-Hole Catheter Placement with Fixation and Embolization in Common Hepatic Artery for Hepatic Arterial Infusion Chemotherapy (Modified CHA-Coil Method) for Patients with Celiac Artery Stenosis or Occlusion	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Hepatic arterial infusion chemotherapy; Side-hole catheter; Catheter fixation; Common hepatic artery; Celiac artery	INTRAARTERIAL CHEMOTHERAPY; COLORECTAL-CANCER; LIVER METASTASES; 5-FLUOROURACIL; IMPLANTATION	We retrospectively assessed the feasibility of a side-hole catheter placement with fixation and embolization in the common hepatic artery (CHA) (modified CHA-coil method) for hepatic arterial infusion (HAI) chemotherapy. HAI catheter placement was attempted with modified CHA-coil method in five patients with unresectable hepatic malignancies between 2000 and 2013. The reason for using this method, the mode of catheter placement, and the duration of HAI were investigated. All patients had either occlusion or stenosis of the celiac artery (CA) or CHA, and, as a result, CHA blood flow had either reversed or decreased and hepatopetal GDA flow was observed. In three patients, the proper hepatic artery was extremely short. The side-hole catheter was inserted through the left subclavian artery and was placed from CA to the right gastroepiploic artery in an anterograde manner (n = 4) and from the superior mesenteric artery to the splenic artery in a retrograde manner through GDA (n = 1). The side hole of the catheter was positioned at the proximal portion of GDA. Using a separate catheter inserted from the right femoral artery, coils were placed around the indwelling catheter of CHA to embolize CHA and to fix the catheter. Coil mislocation was not observed, and catheter placement was successful in all patients. HAI chemotherapy was administered for a median of 136 days. The catheter displacement was not observed during HAI. The modified CHA-coil method can be used as a stable method for catheter placement when CHA is narrow or there is retrograde CHA blood flow.	[Inaba, Yoshitaka; Yamaura, Hidekazu; Sato, Yozo; Kato, Mina; Kawada, Hiroshi; Murata, Shinichi; Hasegawa, Takaaki] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Arai, Yasuaki] Natl Canc Ctr, Dept Diagnost Radiol, Tokyo 1040045, Japan	Inaba, Y (reprint author), Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	105824@aichi-cc.jp; h_yamau@aichi-cc.jp; ysato@aichi-cc.jp; minajima@aichi-cc.jp; h-kawada@aichi-cc.jp; smurata@aichi-cc.jp; t-hasegawa@aichi-cc.jp; arai-y3111@mvh.biglobe.ne.jp					Deschamps F, 2010, J VASC INTERV RADIOL, V21, P1681, DOI 10.1016/j.jvir.2010.08.003; Kemeny NE, 2006, J CLIN ONCOL, V24, P1395, DOI 10.1200/JCO.2005.03.8166; Nishiofuku H, 2010, CLIN COLORECTAL CANC, V9, P305, DOI 10.3816/CCC.2010.n.044; Irie T, 2001, J VASC INTERV RADIOL, V12, P1215, DOI 10.1016/S1051-0443(07)61682-0; Ueshima K, 2010, ONCOLOGY-BASEL, V78, P148, DOI 10.1159/000315244; Tanaka T, 2003, J VASC INTERV RADIOL, V14, P63, DOI 10.1097/01.RVI.0000052292.26939.59; Deschamps F, 2011, CARDIOVASC INTER RAD, V34, P973, DOI 10.1007/s00270-010-9996-6; Arai Yasuaki, 2007, Tech Vasc Interv Radiol, V10, P30, DOI 10.1053/j.tvir.2007.08.007; Inaba Y, 1992, Gan To Kagaku Ryoho, V19, P1564; Takeuchi Y, 1996, J JPN SOC ANGIOGRAPH, V11, P471	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	DEC	2015	38	6					1621	1626		10.1007/s00270-015-1089-0		6	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CW7ZW	WOS:000365219100028		
J	Kageyama, T; Isohisa, A; Mori, N; Suenaga, T				Kageyama, Takashi; Isohisa, Ai; Mori, Nobuyuki; Suenaga, Toshihiko			Contrast-enhanced magnetic resonance imaging in carbamazepine-induced aseptic meningitis	CEPHALALGIA			English	Editorial Material									[Kageyama, Takashi; Suenaga, Toshihiko] Tenri Hosp, Dept Neurol, Tenri, Nara 6328552, Japan; [Isohisa, Ai] Tenri Hosp, Gen Internal Med, Tenri, Nara 6328552, Japan; [Mori, Nobuyuki] Tenri Hosp, Radiol, Tenri, Nara 6328552, Japan	Kageyama, T (reprint author), Tenri Hosp, Dept Neurol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.	gohach65@yahoo.co.jp					KIOUMEHR F, 1995, J COMPUT ASSIST TOMO, V19, P713, DOI 10.1097/00004728-199509000-00005; HILTON E, 1989, J INFECT DIS, V159, P363	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	DEC	2015	35	14					1333	1333		10.1177/0333102415576722		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CW6UZ	WOS:000365135000012		
J	Hales, BJ; Hizawa, N; Jenmalm, M; Sverremark-Ekstrom, E; Wardlaw, AJ				Hales, B. J.; Hizawa, N.; Jenmalm, M.; Sverremark-Ekstroem, E.; Wardlaw, A. J.			Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy	CLINICAL AND EXPERIMENTAL ALLERGY			English	Review							COWS MILK ALLERGY; HYMENOPTERA VENOM IMMUNOTHERAPY; THYMIC STROMAL LYMPHOPOIETIN; EOSINOPHIL CATIONIC PROTEIN; INDUCED AIRWAY RESPONSES; DISPLAY POSITIVE SIGE; REGULATORY T-CELLS; EPITHELIAL-CELLS; SEVERE ASTHMA; HYPERSENSITIVITY REACTIONS	The pathogenesis of asthma continues to be a major topic of interest to our authors with reviews and original papers on the role of viruses, mechanisms of inflammation, biomarkers, and phenotypes of asthma being major topics. A number of papers described new treatments for asthma focusing on blocking the Th2 response reflecting the fact that two decades of work in this area is finally bearing fruit. The pathogenesis of chronic rhinosinusitis is a growing area of interest, but there has been less on the genetics of airways disease than in previous years possibly reflecting the degree of rigour (and therefore a smaller body of work), with which these sorts of studies are now being undertaken. There continues to be a wide range of papers dealing with mechanisms of allergic disease ranging from clinical-based studies to basic research and the use of in vivo animal models especially mice. As before, mechanisms and new approaches to immunotherapy are common themes. Several were published in the allergens section investigating modification of allergens to increase their effectiveness and reduce the risk of adverse events. Risk factors for allergic disease was a common theme in the epidemiology section and food allergy a common theme in clinical allergy with papers on the development of protocols to induce tolerance and attempts to find biomarkers to distinguish sensitization from allergic disease. This was another exciting year for the editors, and we hope the readers of the journal.	[Hales, B. J.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Hizawa, N.] Univ Tsukuba, Fac Med, Dept Pulm Med, Tsukuba, Ibaraki, Japan; [Jenmalm, M.] Linkoping Univ, Dept Clin & Expt Med, Unit Autoimmun & Immune Regulat, Div Clin Immunol, Linkoping, Sweden; [Sverremark-Ekstroem, E.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, MC, S-10691 Stockholm, Sweden; [Wardlaw, A. J.] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Wardlaw, A. J.] Leicester NHS Trust, Univ Hosp, Dept Med Res, Leicester, Leics, England	Wardlaw, AJ (reprint author), Glenfield Hosp, Inst Lung Hlth, Groby Rd, Leicester LE 9QP, Leics, England.	aw24@le.ac.uk			Leicester NIHR Respiratory Biomedical Research Unit	AJW is part funded by the Leicester NIHR Respiratory Biomedical Research Unit. The opinions expressed in this article are not necessarily those of the NIHR.	Abrahamsson TR, 2012, CLIN EXP ALLERGY, V129, P40; Agrawal R, 2014, CLIN EXP ALLERGY, V44, P1266, DOI 10.1111/cea.12390; Alkhouri H, 2012, CLIN EXP ALLERGY, V44, P381; Rueff F, 2014, CLIN EXP ALLERGY, V44, P736, DOI 10.1111/cea.12275; Pritchard DI, 2012, CLIN EXP ALLERGY, V42, P505, DOI 10.1111/j.1365-2222.2011.03911.x; Trzil JE, 2014, CLIN EXP ALLERGY, V44, P1546, DOI 10.1111/cea.12411; Amberbir A, 2014, CLIN EXP ALLERGY, V44, P563, DOI 10.1111/cea.12289; Bertelsen RJ, 2014, CLIN EXP ALLERGY, V44, P142, DOI 10.1111/cea.12231; Archila LD, 2014, CLIN EXP ALLERGY, V44, P986, DOI 10.1111/cea.12324; Yang W, 2014, CLIN EXP ALLERGY, V44, P79, DOI 10.1111/cea.12229; Vazquez-Ortiz M, 2014, CLIN EXP ALLERGY, V44, P1096, DOI 10.1111/cea.12364; Manthei DM, 2014, CLIN EXP ALLERGY, V44, P1484, DOI 10.1111/cea.12387; Shiraishi Y, 2014, CLIN EXP ALLERGY, V44, P1076, DOI 10.1111/cea.12280; Wickens K, 2013, CLIN EXP ALLERGY, V43, P1048, DOI 10.1111/cea.12154; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Gulen T, 2014, CLIN EXP ALLERGY, V44, P1179, DOI 10.1111/cea.12369; Parker LC, 2014, CLIN EXP ALLERGY, V44, P20, DOI 10.1111/cea.12182; van Hoffen E, 2014, CLIN EXP ALLERGY, V44, P1558, DOI 10.1111/cea.12319; Schwantes EA, 2014, CLIN EXP ALLERGY, V44, P813, DOI 10.1111/cea.12269; Kavanagh H, 2011, ALLERGY, V66, P523, DOI 10.1111/j.1398-9995.2010.02509.x; Fox AT, 2014, CLIN EXP ALLERGY, V44, P999, DOI 10.1111/cea.12325; Ahrens B, 2014, CLIN EXP ALLERGY, V44, P572, DOI 10.1111/cea.12284; Demehri S, 2014, CLIN EXP ALLERGY, V44, P851, DOI 10.1111/cea.12270; Leaker BR, 2014, CLIN EXP ALLERGY, V44, P1146, DOI 10.1111/cea.12370; Yao XJ, 2014, CLIN EXP ALLERGY, V44, P765, DOI 10.1111/cea.12298; Caillaud D, 2014, CLIN EXP ALLERGY, V44, P858, DOI 10.1111/cea.12310; Leysen J, 2014, CLIN EXP ALLERGY, V44, P458, DOI 10.1111/cea.12279; Song WJ, 2014, CLIN EXP ALLERGY, V44, P553, DOI 10.1111/cea.12239; Tosca MA, 2014, CLIN EXP ALLERGY, V44, P1094, DOI 10.1111/cea.12360; Aasbjerg K, 2014, CLIN EXP ALLERGY, V44, P417, DOI 10.1111/cea.12241; Dehlink E, 2009, CLIN EXP ALLERGY, V39, P246, DOI 10.1111/j.1365-2222.2008.03125.x; Tanabe T, 2014, CLIN EXP ALLERGY, V44, P540, DOI 10.1111/cea.12283; Gulen T, 2014, CLIN EXP ALLERGY, V44, P121, DOI 10.1111/cea.12225; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Lajoie S, 2014, CLIN EXP ALLERGY, V44, P976, DOI 10.1111/cea.12341; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Meulenbroek LAPM, 2014, CLIN EXP ALLERGY, V44, P529, DOI 10.1111/cea.12254; Scheerens H, 2014, CLIN EXP ALLERGY, V44, P38, DOI 10.1111/cea.12220; Abdelmotelb AM, 2014, CLIN EXP ALLERGY, V44, P822, DOI 10.1111/cea.12259; Waeckerle-Men Y, 2014, CLIN EXP ALLERGY, V44, P429, DOI 10.1111/cea.12245; Gueant JL, 2014, CLIN EXP ALLERGY, V44, P459, DOI 10.1111/cea.12278; Hui CCK, 2014, CLIN EXP ALLERGY, V44, P953, DOI 10.1111/cea.12330; Stoevesandt J, 2014, CLIN EXP ALLERGY, V44, P747, DOI 10.1111/cea.12276; Oreo KM, 2014, CLIN EXP ALLERGY, V44, P342, DOI 10.1111/cea.12223; MacGlashan D, 2014, CLIN EXP ALLERGY, V44, P713, DOI 10.1111/cea.12155; Westergaard CG, 2014, CLIN EXP ALLERGY, V44, P353, DOI 10.1111/cea.12243; Swerts S, 2014, CLIN EXP ALLERGY, V44, P307, DOI 10.1111/cea.12177; Zhang XY, 2014, CLIN EXP ALLERGY, V44, P1137, DOI 10.1111/cea.12345; Gaffin JM, 2014, CLIN EXP ALLERGY, V44, P681, DOI 10.1111/cea.12219; Morales E, 2012, CLIN EXP ALLERGY, V42, P918, DOI 10.1111/j.1365-2222.2012.03969.x; Epstein J, 2014, CLIN EXP ALLERGY, V44, P802, DOI 10.1111/cea.12316; Birmingham JM, 2014, CLIN EXP ALLERGY, V44, P1188, DOI 10.1111/cea.12365; Parsons KS, 2014, CLIN EXP ALLERGY, V44, P91, DOI 10.1111/cea.12218; Moingeon P, 2014, CLIN EXP ALLERGY, V44, P898, DOI 10.1111/cea.12343; Neighbour H, 2014, CLIN EXP ALLERGY, V44, P508, DOI 10.1111/cea.12244; Orivuori L, 2014, CLIN EXP ALLERGY, V44, P102, DOI 10.1111/cea.12199; Leysen J, 2014, CLIN EXP ALLERGY, V44, P1069, DOI 10.1111/cea.12344; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Gonzalez M, 2014, CLIN EXP ALLERGY, V44, P393, DOI 10.1111/cea.12215; Vazquez-Ortiz M, 2014, CLIN EXP ALLERGY, V44, P579, DOI 10.1111/cea.12273; Vazquez-Ortiz M, 2014, CLIN EXP ALLERGY, V44, P130, DOI 10.1111/cea.12233; Haahtela T, 2014, CLIN EXP ALLERGY, V44, P407, DOI 10.1111/cea.12240; Preece K, 2014, CLIN EXP ALLERGY, V44, P371, DOI 10.1111/cea.12258; Toyotome T, 2014, CLIN EXP ALLERGY, V44, P450, DOI 10.1111/cea.12260; Buslau A, 2014, CLIN EXP ALLERGY, V44, P1494, DOI 10.1111/cea.12427; Valent P, 2014, CLIN EXP ALLERGY, V44, P914, DOI 10.1111/cea.12318; Davies JM, 2014, CLIN EXP ALLERGY, V44, P790, DOI 10.1111/cea.12317; Mathias CB, 2014, CLIN EXP ALLERGY, V44, P589, DOI 10.1111/cea.12271; Trautmann A, 2014, CLIN EXP ALLERGY, V44, P1531, DOI 10.1111/cea.12437; Mackenzie KJ, 2014, CLIN EXP ALLERGY, V44, P9, DOI [10.1111/cea.12246, 10.1111/cea.12139]; Dua B, 2014, CLIN EXP ALLERGY, V44, P921, DOI 10.1111/cea.12297; Abrahamsson TR, 2014, CLIN EXP ALLERGY, V44, P842, DOI 10.1111/cea.12253; Curin M, 2014, CLIN EXP ALLERGY, V44, P882, DOI 10.1111/cea.12294; Bohle B, 2014, CLIN EXP ALLERGY, V44, P304, DOI 10.1111/cea.12263; Cianchetti S, 2014, CLIN EXP ALLERGY, V44, P673, DOI 10.1111/cea.12236; Elmose C, 2014, CLIN EXP ALLERGY, V44, P1525, DOI 10.1111/cea.12445; Dioszeghy V, 2014, CLIN EXP ALLERGY, V44, P867, DOI 10.1111/cea.12312; Gauvreau GM, 2014, CLIN EXP ALLERGY, V44, P29, DOI 10.1111/cea.12235; Sharpe R, 2014, CLIN EXP ALLERGY, V44, P631, DOI 10.1111/cea.12281; Vetander M, 2014, CLIN EXP ALLERGY, V44, P113, DOI 10.1111/cea.12203; Makela MJ, 2014, CLIN EXP ALLERGY, V44, P1420, DOI 10.1111/cea.12393; Shen C, 2014, CLIN EXP ALLERGY, V44, P831, DOI 10.1111/cea.12308; van Drongelen V, 2014, CLIN EXP ALLERGY, V44, P1515, DOI 10.1111/cea.12443; Hazebrouck S, 2014, CLIN EXP ALLERGY, V44, P602, DOI 10.1111/cea.12261; Mulder B, 2014, CLIN EXP ALLERGY, V44, P261, DOI 10.1111/cea.12227; Masthoff LJ, 2014, CLIN EXP ALLERGY, V44, P1539, DOI 10.1111/cea.12440; Hansel TT, 2013, LANCET, V381, P861, DOI 10.1016/S0140-6736(12)62202-8; Perkins JR, 2014, CLIN EXP ALLERGY, V44, P1461, DOI 10.1111/cea.12371; Obeng BB, 2014, CLIN EXP ALLERGY, V44, P965, DOI 10.1111/cea.12307; Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361; van der Vlugt LEPM, 2014, CLIN EXP ALLERGY, V44, P517, DOI 10.1111/cea.12238; Gunawardhana LP, 2014, CLIN EXP ALLERGY, V44, P47, DOI 10.1111/cea.12168; Nwaru BI, 2013, CLIN EXP ALLERGY, V43, P1263, DOI 10.1111/cea.12180; Negoro T, 2014, CLIN EXP ALLERGY, V44, P1154, DOI 10.1111/cea.12375; Rohde G, 2014, CLIN EXP ALLERGY, V44, P930, DOI 10.1111/cea.12313; Pavord ID, 2010, CLIN EXP ALLERGY, V40, P62, DOI 10.1111/j.1365-2222.2009.03410.x; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Diamant Z, 2014, CLIN EXP ALLERGY, V44, P1044, DOI 10.1111/cea.12357; Baba S, 2014, CLIN EXP ALLERGY, V44, P701, DOI 10.1111/cea.12287; Cao PP, 2014, CLIN EXP ALLERGY, V44, P690, DOI 10.1111/cea.12304; Luyt D, 2014, CLIN EXP ALLERGY, V44, P642, DOI 10.1111/cea.12302; Turner PJ, 2014, CLIN EXP ALLERGY, V44, P1458, DOI 10.1111/cea.12425; Strombeck A, 2014, CLIN EXP ALLERGY, V44, P940, DOI 10.1111/cea.12290; Costa J, 2014, CLIN EXP ALLERGY, V44, P319, DOI 10.1111/cea.12267; Darsow U, 2014, CLIN EXP ALLERGY, V44, P778, DOI 10.1111/cea.12303; Jarvinen KM, 2014, CLIN EXP ALLERGY, V44, P69, DOI 10.1111/cea.12228; Jiang H, 2012, ALLERGY, V67, P1078, DOI 10.1111/j.1398-9995.2012.02857.x; Slade CA, 2014, CLIN EXP ALLERGY, V44, P617, DOI 10.1111/cea.12295; Antico A, 2014, CLIN EXP ALLERGY, V44, P1314, DOI 10.1111/cea.12362; Arm JP, 2014, CLIN EXP ALLERGY, V44, P1371, DOI 10.1111/cea.12400; Berroa F, 2014, CLIN EXP ALLERGY, V44, P270, DOI 10.1111/cea.12237; Botturi K, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-25; Brandenberger C, 2014, CLIN EXP ALLERGY, V44, P1282, DOI 10.1111/cea.12388; Calderon MA, 2014, CLIN EXP ALLERGY, V44, P1228, DOI 10.1111/cea.12331; Cheng G, 2014, CLIN EXP ALLERGY, V44, P1274, DOI 10.1111/cea.12397; DunnGalvin A, 2011, CLIN EXP ALLERGY, V127, P633; Gonzalez-Quintela A, 2014, CLIN EXP ALLERGY, V44, P1061, DOI 10.1111/cea.12326; Gorissen DMW, 2014, CLIN EXP ALLERGY, V44, P1431, DOI 10.1111/cea.12413; Harb H, 2015, CLIN EXP ALLERGY, V135, P15; Jun YJ, 2014, CLIN EXP ALLERGY, V44, P197, DOI 10.1111/cea.12195; Jyonouchi S, 2014, CLIN EXP ALLERGY, V44, P58; Kupczyk M, 2014, CLIN EXP ALLERGY, V44, P212, DOI 10.1111/cea.12179; Kurukulaaratchy RJ, 2014, CLIN EXP ALLERGY, V44, P724; Levin M, 2014, CLIN EXP ALLERGY, V44, P288, DOI 10.1111/cea.12230; Levin M, 2014, CLIN EXP ALLERGY, V44, P1409, DOI 10.1111/cea.12423; Lin TY, 2014, CLIN EXP ALLERGY, V44, P1347, DOI 10.1111/cea.12421; Linhart B, 2014, CLIN EXP ALLERGY, V44, P278, DOI 10.1111/cea.12216; Manoharan A, 2014, CLIN EXP ALLERGY, V44, P1240, DOI 10.1111/cea.12352; Michaud B, 2014, CLIN EXP ALLERGY, V44, P222, DOI 10.1111/cea.12222; Minai-Fleminger Y, 2014, CLIN EXP ALLERGY, V44, P1335, DOI 10.1111/cea.12422; Morgan AR, 2014, CLIN EXP ALLERGY, V44, P1255, DOI 10.1111/cea.12394; Murdoch JR, 2014, CLIN EXP ALLERGY, V44, P1386, DOI 10.1111/cea.12395; Newson RB, 2014, CLIN EXP ALLERGY, V44, P250, DOI 10.1111/cea.12221; Okayama Y, 2014, CLIN EXP ALLERGY, V44, P238, DOI 10.1111/cea.12210; Pichler U, 2014, CLIN EXP ALLERGY, V44, P438; Pizzulli A, 2014, CLIN EXP ALLERGY, V44, P1246, DOI 10.1111/cea.12386; Randolph AG, 2014, CLIN EXP ALLERGY, V44, P231, DOI 10.1111/cea.12247; Royce SG, 2014, CLIN EXP ALLERGY, V44, P1399, DOI 10.1111/cea.12391; Shikhagaie MM, 2014, CLIN EXP ALLERGY, V44, P184, DOI 10.1111/cea.12176; Skaaby T, 2014, CLIN EXP ALLERGY, V44, P1361, DOI 10.1111/cea.12408; West CE, 2015, CLIN EXP ALLERGY, V45, P43; Yatagai Y, 2014, CLIN EXP ALLERGY, V44, P1327, DOI 10.1111/cea.12415; Ziyab AH, 2014, CLIN EXP ALLERGY, V44, P1170	144	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-7894	1365-2222		CLIN EXP ALLERGY	Clin. Exp. Allergy	DEC	2015	45	12					1723	1745		10.1111/cea.12663		23	Allergy; Immunology	Allergy; Immunology	CW9JN	WOS:000365315100003		
J	Tanimoto, H; Fukutomi, Y; Yasueda, H; Takeuchi, Y; Saito, A; Watai, K; Sekiya, K; Tsuburai, T; Asano, K; Taniguchi, M; Akiyama, K				Tanimoto, H.; Fukutomi, Y.; Yasueda, H.; Takeuchi, Y.; Saito, A.; Watai, K.; Sekiya, K.; Tsuburai, T.; Asano, K.; Taniguchi, M.; Akiyama, K.			Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients	CLINICAL AND EXPERIMENTAL ALLERGY			English	Article						allergen components; allergic bronchopulmonary aspergillosis; Aspergillus fumigatus; asthma; atopic dermatitis; component-resolved diagnostics; molecular-based allergy diagnostics; receiver operating characteristic analysis	EXACERBATED RESPIRATORY-DISEASE; SEVERE ASTHMA PHENOTYPES; LATENT CLASS ANALYSIS; PROSTAGLANDIN D-2; INDUCED SPUTUM; EOSINOPHILIC INFLAMMATION; INHALED CORTICOSTEROIDS; REFRACTORY ASTHMA; ASPIRIN CHALLENGE; CLUSTER-ANALYSIS	Background Distinguishing between patients with allergic bronchopulmonary aspergillosis (ABPA) and Aspergillus fumigatus (Af)-sensitized asthmatic patients without ABPA is sometimes difficult owing to the IgE-cross-reactivity between Af and other fungal allergens. Objective To establish the usefulness of molecular-based allergy diagnostics using allergen components from Af in distinguishing ABPA from Af-sensitized asthma without ABPA. Methods Sera from Japanese patients with ABPA (n = 53) and Af-sensitized asthma without ABPA (n = 253) were studied. The levels of IgE and IgG antibodies to allergen components from Af and IgE antibodies to different fugal allergen extracts were measured by ImmunoCAP. Comorbid atopic dermatitis (AD) was taken into consideration in the sensitization profile analysis. Results Patients with ABPA possessed significantly higher levels of IgE antibodies to Asp f 1, and Asp f 2 than asthmatic patients without ABPA. The areas under the receiver operating characteristic curves for the levels of IgE to Asp f 1 and Asp f 2 as diagnostic markers of ABPA were 0.75 and 0.78, respectively. The presence of IgE positivity to Asp f 1 and/or Asp f 2 resulted in increased sensitivity while losing little specificity. Comorbid AD was associated with higher levels of IgE to Asp f 6 (manganese superoxide dismutase from Af, a ubiquitous pan-allergen in fungi) and low but positive levels of IgE to other Af-components, which hampered the serological discrimination of ABPA. Conclusions and Clinical Relevance The levels of IgE to Asp f 1 and/or Asp f 2 can effectively differentiate ABPA from Af-sensitized asthma, suggesting that the amounts of IgE specific for these molecules are markers for genuine Af-sensitization in ABPA. However, comorbid AD must be taken into consideration in the interpretation of high IgE to Asp f 6. Establishing of IgE-sensitization profiles using panel of Af-allergen components provides valuable information for distinguishing genuine vs. cross-reactive sensitization in Af-sensitized patients.	[Tanimoto, H.; Fukutomi, Y.; Yasueda, H.; Saito, A.; Watai, K.; Sekiya, K.; Tsuburai, T.; Taniguchi, M.; Akiyama, K.] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa 2520392, Japan; [Takeuchi, Y.] Fujita Hlth Univ, Div Resp Med & Clin Allergy, Toyoake, Aichi, Japan; [Asano, K.] Tokai Univ, Sch Med, Div Pulm Med, Dept Med, Isehara, Kanagawa 25911, Japan	Fukutomi, Y (reprint author), Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	y-fukutomi@sagamihara-hosp.gr.jp			Environmental Restoration and Conservation Agency; Ministry of Health Labour and Welfare of Japan	This study was supported by a grant from the Environmental Restoration and Conservation Agency and the Health labour sciences research grant on allergic disease and immunology from the Ministry of Health Labour and Welfare of Japan.	Aggarwal S, 2010, CLIN EXP ALLERGY, V40, P85, DOI 10.1111/j.1365-2222.2009.03386.x; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; KUMLIN M, 1992, AM REV RESPIR DIS, V146, P96; LUNDGREN JD, 1985, ANN ALLERGY, V55, P5; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Vachier I, 2005, J ALLERGY CLIN IMMUN, V115, P55, DOI 10.1016/j.jaci.2004.09.038; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-0350C; Bolck A, 2004, POLIT ANAL, V12, P3, DOI 10.1093/pan/mph001; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI [10.1164/rccm.200711-1754OC, 10.1164/rccm.200711-17540C]; Sanak M, 2010, J CHROMATOGR B, V878, P1796, DOI 10.1016/j.jchromb.2010.05.012; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Higashi N, 2004, J ALLERGY CLIN IMMUN, V113, P277, DOI 10.1016/j.jaci.2003.10.068; Linzer DA, 2011, J STAT SOFTW, V42, P1; Higashi N, 2010, J ALLERGY CLIN IMMUN, V125, P1084, DOI 10.1016/j.jaci.2009.12.977; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Bochenek G, 2003, J ALLERGY CLIN IMMUN, V111, P743, DOI 10.1067/mai.2003.1387; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Maier NK, 2015, J IMMUNOL, V194, P2776, DOI 10.4049/jimmunol.1401611; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Sanak M, 2011, J ALLERGY CLIN IMMUN, V127, P1141, DOI 10.1016/j.jaci.2010.12.1108; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Gaber F, 2008, THORAX, V63, P1076, DOI 10.1136/thx.2008.101196; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Berry M, 2005, EUR RESPIR J, V25, P986, DOI 10.1183/09031936.05.00132404; Dente FL, 2010, ANN ALLERG ASTHMA IM, V104, P464, DOI 10.1016/j.anai.2010.04.003; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737; DWORSKI R, 1994, AM J RESP CRIT CARE, V149, P953; DAYTON CM, 1988, J AM STAT ASSOC, V83, P173, DOI 10.2307/2288938; Bochenek G, 2014, J ALLERGY CLIN IMMUN, V133, P98, DOI 10.1016/j.jaci.2013.07.004; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; Djukanovic R, 2002, EUR RESPIR J, V20, P1; Global Initiative for Asthma (GINA), 2014, GLOB STRAT ASTHM MAN; Mastalerz L, 2014, ALLERGY, V69, P1550, DOI 10.1111/all.12512; Micheletto C, 2006, Eur Ann Allergy Clin Immunol, V38, P20; Niankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111; Zhu X, 2005, BIOL PHARM BULL, V28, P1603	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-7894	1365-2222		CLIN EXP ALLERGY	Clin. Exp. Allergy	DEC	2015	45	12					1790	1800		10.1111/cea.12590		11	Allergy; Immunology	Allergy; Immunology	CW9JN	WOS:000365315100008		
J	Hisamatsu, T; Mabuchi, S; Sasano, T; Kuroda, H; Takahashi, R; Matsumoto, Y; Kawano, M; Kozasa, K; Takahashi, K; Sawada, K; Matsuo, K; Tamada, Y; Morii, E; Kitadai, Y; Kimura, T				Hisamatsu, Takeshi; Mabuchi, Seiji; Sasano, Tomoyuki; Kuroda, Hiromasa; Takahashi, Ryoko; Matsumoto, Yuri; Kawano, Mahiru; Kozasa, Katsumi; Takahashi, Kei; Sawada, Kenjiro; Matsuo, Koji; Tamada, Yutaka; Morii, Eiichi; Kitadai, Yasuhiko; Kimura, Tadashi			The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						VEGF-C; Lymphatic vascular endothelial progenitor cells; Lymphangiogenesis; Ovarian cancer	NODE METASTASIS; MAMMALIAN TARGET; PROGENITOR CELLS; POOR-PROGNOSIS; GASTRIC-CANCER; LUNG-CANCER; CARCINOMA; LYMPHANGIOGENESIS; PROGRESSION; INHIBITION	The aim of this study is to investigate the significance of lymphatic space invasion (LSI) and tumor VEGF-C expression in the lymphatic spread of ovarian cancer. By performing immunostaining using human ovarian cancer specimens, we first investigated the association between the extent of LSI and tumor VEGF-C expression, tumor lymphangiogenesis, or the lymphatic metastasis. Moreover, by performing in vitro and in vivo experiments, we elucidated the role of VEGF-C in tumor lymphangiogenesis and lymph node metastasis as well as its role as a therapeutic target in ovarian cancer. The presence of LSI was associated with lymph node metastasis in patients with ovarian cancer. VEGF-C overexpression was significantly associated with the increased LSI and LVD in ovarian cancer. VEGF-C stimulated the lymphangiogenesis in vitro, induced the new lymph vessel formation, and increased the lymph node metastasis in mice models of ovarian cancer. The attenuation of VEGF-C expression by the treatment with mTORC1 inhibitor significantly inhibited lymphangiogenesis, and decreased lymph node metastasis in mice models of ovarian cancer. The presence of LSI is an indicator of nodal metastasis and is associated with higher tumor VEGF-C expression and worse clinical outcome of ovarian cancer patients. VEGF-C plays a crucial role in tumor lymphangiogenesis and lymph node metastasis of ovarian cancer.	[Hisamatsu, Takeshi; Mabuchi, Seiji; Sasano, Tomoyuki; Kuroda, Hiromasa; Takahashi, Ryoko; Matsumoto, Yuri; Kawano, Mahiru; Kozasa, Katsumi; Takahashi, Kei; Sawada, Kenjiro; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Matsuo, Koji] Univ So Calif, Los Angeles Cty Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Los Angeles, CA 90031 USA; [Tamada, Yutaka] Kyosai Tachikawa Hosp, Dept Obstet & Gynecol, Tachikawa, Tokyo 1908531, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Kitadai, Yasuhiko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan	Mabuchi, S (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	smabumabu@hotmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [23592446]	We thank Mitsuyo Tone and Takako Sawamura for the immunohistochemical works. We also thank Ayako Okamura for her technical assistance and Yuko Morishita for her secretarial assistance. S. Mabuchi is supported in part by grant-in-aid for General Scientific Research, no. 23592446, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bauer SM, 2005, J VASC SURG, V41, P699, DOI 10.1016/j.jvs.2005.01.015; Tan YZ, 2014, J CELL MOL MED, V18, P422, DOI 10.1111/jcmm.12233; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Ueda M, 2005, CLIN CANCER RES, V11, P3225, DOI 10.1158/1078-0432.CCR-04-1148; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Patel V, 2011, CANCER RES, V71, P7103, DOI 10.1158/0008-5472.CAN-10-3192; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/JCI34739, 10.1172/jCI34739]; Gatta G, 1998, EUR J CANCER, V34, P2218, DOI 10.1016/S0959-8049(98)00326-8; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Li AJ, 2004, GYNECOL ONCOL, V92, P211, DOI 10.1016/j.ygyno.2003.09.002; Powless CA, 2011, GYNECOL ONCOL, V122, P536, DOI 10.1016/j.ygyno.2011.05.001; Hirashima K, 2010, ANN SURG ONCOL, V17, P2486, DOI 10.1245/s10434-010-1040-1; Kodama M, 2008, CLIN CANCER RES, V14, P7205, DOI 10.1158/1078-0432.CCR-08-0818; Yu GZ, 2009, CLIN CANCER RES, V15, P1821, DOI 10.1158/1078-0432.CCR-08-2138; Decio A, 2014, AM J PATHOL, V184, P1050, DOI 10.1016/j.ajpath.2013.12.030; Chan JK, 2007, OBSTET GYNECOL, V109, P12, DOI 10.1097/01.AOG.0000249610.95885.ef; Tamada Y, 2004, EUR J CANCER, V40, P158, DOI 10.1016/j.ejca.2003.08.008; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Mabuchi S, 2015, GYNECOL ONCOL, V137, P173, DOI 10.1016/j.ygyno.2015.02.003; Kim HS, 2008, ACTA OBSTET GYN SCAN, V87, P1136, DOI 10.1080/00016340802478158; Kobayashi S, 2007, CANCER SCI, V98, P726, DOI 10.1111/j.1349-7006.2007.00439.x; Koukourakis MI, 2005, J CLIN PATHOL, V58, P202, DOI 10.1136/jcp.2004.019174; Weber SK, 2012, INT J GYNECOL CANCER, V22, P1442, DOI 10.1097/IGC.0b013e318269139b; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Birner P, 2001, CLIN CANCER RES, V7, P93; Bogos K, 2009, CLIN CANCER RES, V15, P1741, DOI 10.1158/1078-0432.CCR-08-1372; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cheng DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055309; Matsuo K, 2012, CANCER MED-US, V1, P156, DOI 10.1002/cam4.31; Mikami M, 2014, J GYNECOL ONCOL, V25, P279, DOI 10.3802/jgo.2014.25.4.279; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI DOI 10.3322/CAAC.21166	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	DEC	2015	32	8					789	798		10.1007/s10585-015-9751-0		10	Oncology	Oncology	CW8EV	WOS:000365233200004		
J	Nojima, I; Koganemaru, S; Fukuyama, H; Mima, T				Nojima, Ippei; Koganemaru, Satoko; Fukuyama, Hidenao; Mima, Tatsuya			Static magnetic field can transiently alter the human intracortical inhibitory system	CLINICAL NEUROPHYSIOLOGY			English	Article						Static magnetic field; Magnetic resonance imaging; Transcranial magnetic stimulation; Short intracortical inhibition	HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; CORTICAL EXCITABILITY; ANTIEPILEPTIC DRUGS; AUDIOGENIC-SEIZURES; GH3 CELLS; FACILITATION; GABA; MECHANISMS; DEPRESSION	Objective: Although recent studies have shown the suppressive effects of static magnetic fields (SMFs) on the human primary motor cortex (M1) possibly due to the deformed neural membrane channels, the effect of the clinical MRI scanner bore has not been studied in the same way. Methods: We tested whether the MRI scanner itself and compact magnet can alter the M1 function using single-and paired-pulse transcranial magnetic stimulation (TMS). Results: We found the transient suppression of the corticospinal pathway in both interventions. In addition, the transient enhancement of the short-latency intracortical inhibition (SICI) was observed immediately after compact magnet stimulation. Conclusions: The present results suggest that not only the inhomogeneous SMFs induced by a compact magnet but also the homogeneous SMF produced by the MRI scanner bore itself can produce the transient cortical functional change. Significance: Static magnetic stimulation can modulate the intracortical inhibitory circuit of M1, which might be useful for clinical purposes. (C) 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Nojima, Ippei] Nagoya Univ, Grad Sch Med, Dept Phys Therapy, Nagoya, Aichi 4648601, Japan; [Koganemaru, Satoko; Fukuyama, Hidenao; Mima, Tatsuya] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan	Mima, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Brain Pathophysiol, Human Brain Res Ctr, Kyoto, Japan.	mima@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24300192, 25750203]	This study was partly supported by Grant-in-Aid for Scientific Research (B) 24300192 (to T.M.) and Grant-in Aid for Young Scientists (B) 25750203 (to I.N.) from the Japan Society for the Promotion of Science.	Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873; Atkinson IC, 2007, J MAGN RESON IMAGING, V26, P1222, DOI 10.1002/jmri.21150; Shirota Y, 2010, J NEUROPHYSIOL, V104, P1382, DOI 10.1152/jn.00164.2010; McLean MJ, 2008, EPILEPSY RES, V80, P119, DOI 10.1016/j.eplepsyres.2008.03.022; EDELMAN A, 1979, BIOCHEM BIOPH RES CO, V91, P118, DOI 10.1016/0006-291X(79)90591-6; Schlamann M, 2010, ACAD RADIOL, V17, P277, DOI 10.1016/j.acra.2009.10.004; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Rosen AD, 1996, BBA-BIOMEMBRANES, V1282, P149, DOI 10.1016/0005-2736(96)00053-3; Silbert BI, 2013, BRAIN STIMUL, V6, P817, DOI 10.1016/j.brs.2013.03.007; LEBIHAN D, 1986, RADIOLOGY, V161, P401; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817; Ortu E, 2008, J PHYSIOL-LONDON, V586, P5147, DOI 10.1113/jphysiol.2008.158956; Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008; Rossini D, 2010, NEUROPSYCHOBIOLOGY, V62, P91, DOI 10.1159/000315439; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Ikoma K, 1996, NEUROLOGY, V46, P1371; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Garibotto V, 2011, MOVEMENT DISORD, V26, P852, DOI 10.1002/mds.23553; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Coots A, 2004, J NEUROL SCI, V222, P55, DOI 10.1016/j.jns.2004.04.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501; Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; ROSEN AD, 1994, BBA-BIOMEMBRANES, V1193, P62, DOI 10.1016/0005-2736(94)90333-6; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; McLean MJ, 2003, EPILEPSY RES, V55, P105, DOI 10.1016/S0920-1211(03)00109-8; Koganemaru S, 2010, BRAIN, V133, P3373, DOI 10.1093/brain/awq193; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Di Lazzaro V, 2002, EXP BRAIN RES, V147, P108, DOI 10.1007/s00221-002-1223-5; Badawy RAB, 2012, FUNCT NEUROL, V27, P131; Ferreri F, 2006, ANN NEUROL, V60, P188, DOI 10.1002/ana.20906; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Buharin VE, 2014, J NEUROPHYSIOL, V111, P2656, DOI 10.1152/jn.00778.2013; Oliviero A, 2011, J PHYSIOL-LONDON, V589, P4949, DOI 10.1113/jphysiol.2011.211953; Eulenburg V, 2010, BRAIN RES REV, V63, P103, DOI 10.1016/j.brainresrev.2010.01.003; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainsrev.2004.03.003; de Vocht F, 2006, J MAGN RESON IMAGING, V23, P197, DOI 10.1002/jmri.20485; Kangarlu A, 1999, MAGN RESON IMAGING, V17, P1407, DOI 10.1016/S0730-725X(99)00086-7; Lam RW, 2008, CAN J PSYCHIAT, V53, P621; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Chen R, 1998, J NEUROPHYSIOL, V80, P2870; ROSEN AD, 1987, EXP NEUROL, V95, P679, DOI 10.1016/0014-4886(87)90308-6; Aldinucci C, 2003, BIOELECTROMAGNETICS, V24, P109, DOI 10.1002/bem.10071; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Boecker H, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0385-9; Hanajima R, 2002, J PHYSIOL-LONDON, V538, P253, DOI 10.1113/jphysiol.2001.013094; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443; Hanajima R, 2013, CLIN NEUROPHYSIOL, V124, pe41; Mian OS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078748; Rivadulla C, 2014, NEUROMODULATION, V17, P41; Rivadulla C, 2014, NEUROMODULATION, V17, P438, DOI 10.1111/ner.12125	58	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	DEC	2015	126	12					2314	2319		10.1016/j.clinph.2015.01.030		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CW9WW	WOS:000365349900013		
J	Takahashi, M; Kume, H; Koyama, K; Nakagawa, T; Fujimura, T; Morikawa, T; Fukayama, M; Homma, Y; Ohtomo, K; Momose, T				Takahashi, Miwako; Kume, Haruki; Koyama, Keitaro; Nakagawa, Tohru; Fujimura, Tetsuya; Morikawa, Teppei; Fukayama, Masashi; Homma, Yukio; Ohtomo, Kuni; Momose, Toshimitsu			Preoperative Evaluation of Renal Cell Carcinoma by Using F-18-FDG PET/CT	CLINICAL NUCLEAR MEDICINE			English	Article						F-18-FDG PET; CT; renal cell carcinoma; pathological nuclear grade	POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; GLUCOSE-TRANSPORTER-1 EXPRESSION; FUMARATE-HYDRATASE; CANCER; TUMORS; SUBTYPES; MASSES; CT; DIFFERENTIATION	Purpose This study aimed to characterize the FDG uptake of renal cell carcinoma (RCC) by the pathological subtype and nuclear grade. Patients and Methods We retrospectively identified patients who underwent F-18-FDG PET and subsequent partial or radical nephrectomy for renal tumors. The relationships of the SUV of renal tumor with subtypes, nuclear grade, and clinicopathological variables were investigated. Results Ninety-two tumors were analyzed, including 52 low-grade (G1 and G2) and 18 high-grade (G3 and G4) clear cell RCC; 7 chromophobe, 5 papillary, and 1 unclassified RCC; and 9 benign tumors (7 angiomyolipoma and 2 oncocytoma). The SUVs of high-grade clear cell RCC (mean SD, 6.8 +/- 5.1) and papillary RCC (6.6 +/- 3.7) were significantly higher than that of the controls (2.2 +/- 0.3). The SUV of high-grade clear cell RCC was higher than that of low-grade tumors (median, 4.0 vs. 2.2; P < 0.001). The optimal SUV cutoff value of 3.0 helped to differentiate high-grade from low-grade clear cell RCC, with 89% sensitivity and 87% specificity. On multiple regression analysis, a high grade was the most significant predictor of SUV for clear cell RCC. Conclusions FDG uptake higher than that observed in normal kidney tissues suggests a high-grade clear cell RCC or papillary RCC subtype. FDG-PET using SUV may have a role in prediction of pathological grade of renal tumor.	[Takahashi, Miwako; Koyama, Keitaro; Ohtomo, Kuni; Momose, Toshimitsu] Univ Tokyo, Dept Radiol, Div Nucl Med, Grad Sch Med, Tokyo 1138655, Japan; [Kume, Haruki; Nakagawa, Tohru; Fujimura, Tetsuya; Homma, Yukio] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo 1138655, Japan; [Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Grad Sch Med, Tokyo 1138655, Japan	Momose, T (reprint author), Univ Tokyo, Dept Radiol, Div Nucl Med, Bunkyo Ku, 3-1 Hongo 7 Chome, Tokyo 1138655, Japan.	tmomo-tky@umin.ac.jp					Kadota K, 2012, ANN SURG ONCOL, V19, P3598, DOI 10.1245/s10434-012-2414-3; Ozulker T, 2011, NUCL MED COMMUN, V32, P265, DOI 10.1097/MNM.0b013e3283442e3b; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Ferda J, 2013, ANTICANCER RES, V33, P2665; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Oyama N, 2014, CLIN NUCL MED, V39, pE208, DOI 10.1097/RLU.0000000000000287; Miyakita H, 2002, INT J UROL, V9, P15, DOI 10.1046/j.1442-2042.2002.00416.x; TORIZUKA T, 1995, J NUCL MED, V36, P1811; Kaschten B, 1998, J NUCL MED, V39, P778; Borgwardt L, 2005, J CLIN ONCOL, V23, P3030, DOI 10.1200/JCO.2005.02.074; Aide N, 2003, EUR J NUCL MED MOL I, V30, P1236, DOI 10.1007/s00259-003-1211-4; Rioux-Leclercq N, 2007, CANCER, V109, P868, DOI 10.1002/cncr.22463; Aparicio LMA, 2010, MOL MED REP, V3, P575, DOI 10.3892/mmr_00000300; Watanabe Y, 2013, INT J HEMATOL, V97, P43, DOI 10.1007/s12185-012-1225-4; Waldert M, 2008, BJU INT, V102, P1381, DOI 10.1111/j.1464-410X.2008.07999.x; Volpe A, 2010, WORLD J UROL, V28, P319, DOI 10.1007/s00345-010-0540-8; Lidgren A, 2008, BJU INT, V101, P480, DOI 10.1111/j.1464-410X.2007.07238.x; Nakhoda Z, 2013, HELL J NUCL MED, V16, P19, DOI 10.1967/s002449910067; Zokalj I, 2014, INT UROL NEPHROL, V46, P1089, DOI 10.1007/s11255-013-0631-8; Ho CL, 2012, CLIN NUCL MED, V37, P1075, DOI 10.1097/RLU.0b013e318266cde2; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Rakheja R, 2012, AM J ROENTGENOL, V198, P1409, DOI 10.2214/AJR.11.7560; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Heudel P, 2010, INT J CLIN ONCOL, V15, P588, DOI 10.1007/s10147-010-0120-3; Kumar R, 2005, MOL IMAGING BIOL, V7, P431, DOI 10.1007/s11307-005-0026-z; Gontero P, 2013, INT J UROL, V20, P356, DOI 10.1111/j.1442-2042.2012.03227.x; Ramdave S, 2001, J UROLOGY, V166, P825, DOI 10.1016/S0022-5347(05)65845-4; Suganuma N, 2007, BJU INT, V99, P1143, DOI 10.1111/j.1464-410X.2007.06765.x; Endo M, 2008, LUNG CANCER, V61, P350, DOI 10.1016/j.lungcan.2008.01.003; Rosales JC, 2010, J UROLOGY, V183, P1698, DOI 10.1016/j.juro.2010.01.024; Ficarra V, 2005, CANCER, V103, P68, DOI 10.1002/cncr.20749; Kim JK, 2002, AM J ROENTGENOL, V178; SHREVE P, 1995, J NUCL MED, V36, P1595; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Divgi CR, 2013, J CLIN ONCOL, V31, P187, DOI 10.1200/JCO.2011.41.2445; Kang DE, 2004, J UROLOGY, V171, P1806, DOI 10.1097/01.ju.0000120241.50061.e4; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Kubota K, 2014, ANN NUCL MED, V28, P1004, DOI 10.1007/s12149-014-0900-3	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	DEC	2015	40	12					936	940		10.1097/RLU.0000000000000875		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8DG	WOS:000365229000003		
J	Matsusaka, Y; Nakahara, T; Iwabuchi, Y; Kameyama, M; Murakami, K				Matsusaka, Yohji; Nakahara, Tadaki; Iwabuchi, Yu; Kameyama, Masashi; Murakami, Koji			Sternal Uptake of Tc-99m-MAA in Thoracic Outlet Syndrome	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						Tc-99m-MAA; sternum; thoracic outlet syndrome; SPECT; CT	VENA-CAVA OBSTRUCTION; HEPATIC LOCALIZATION; LIVER; MAA; VENOGRAPHY; VISUALIZATION; SCAN	Tc-99m-macroaggregated albumin (MAA) uptake in the vertebrae has been reported in central vein occlusion, although its sternal uptake is rarely seen. We present a case in which Tc-99m-MAA SPECT/CT showed spotty uptake in the sternum. Contrast-enhanced CT revealed marked narrowing of the left subclavian vein at the thoracic outlet with a developed collateral vein running, in the left anterior chest subcutaneous tissue, between the sternum and left axilla. In this case, IV injection of Tc-99m-MAA from the left forearm probably led to bone marrow uptake in the sternum due to retrograde venous flow through the collateral vein.	[Matsusaka, Yohji; Nakahara, Tadaki; Iwabuchi, Yu; Kameyama, Masashi; Murakami, Koji] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo 1608582, Japan	Nakahara, T (reprint author), Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	n-tadaki0909@poem.ocn.ne.jp					Schwartz M, 1996, J NUCL MED, V37, P1826; Esser JP, 2004, CLIN NUCL MED, V29, P793, DOI 10.1097/00003072-200412000-00004; Moralidis E, 2006, CLIN NUCL MED, V31, P598, DOI 10.1097/01.rlu.0000238190.83995.6f; BARTOLD K, 1986, CLIN NUCL MED, V11, P259, DOI 10.1097/00003072-198604000-00009; Yamada T, 1999, CLIN NUCL MED, V24, P533, DOI 10.1097/00003072-199907000-00019; VEA HW, 1985, CLIN NUCL MED, V10, P772, DOI 10.1097/00003072-198511000-00004; Meristoudis G, 2008, REV ESP MED NUCL, V27, P369; SUNEJA SK, 1989, J NUCL MED, V30, P113; KOLLA I, 1989, CLIN NUCL MED, V14, P433, DOI 10.1097/00003072-198906000-00008; First impressions, 1997, J NUCL MED, V38, p7A; Kume N, 1995, Ann Nucl Med, V9, P179; Moore R, 2015, VASC MED, V20, P182, DOI 10.1177/1358863X14568704	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	DEC	2015	40	12					971	972		10.1097/RLU.0000000000000979		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8DG	WOS:000365229000012		
J	Kruljac, I; Balenovic, A; Gacina, P; Imashuku, S; Vrkljan, M				Kruljac, Ivan; Balenovic, Antonija; Gacina, Petar; Imashuku, Shinsaku; Vrkljan, Milan			Complete Response of Adult-Onset CNS Langerhans Cell Histiocytosis Documented on F-18-FDG PET/CT	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						F-18-FDG PET; CT; Langerhans cell histiocytosis; chemotherapy; vinblastine; remission; response	TOMOGRAPHY; MANAGEMENT; THERAPY	We report a case of a 49-year-old woman with biopsy-proven multisystemic Langerhans cell histiocytosis (LCH) with hypothalamic involvement documented on F-18-FDG PET/CT. Chemotherapy with a combination of vinblastine, prednisolone, methotrexate, and 6-mercaptopurine was carried out. Two months later, a 90% reduction of the hypothalamic tumor mass was noted on magnetic resonance imaging, but with no signs of pathological F-18-FDG accumulation. The patient died 4 months later, and we found no signs of LCH on autopsy. Our case highlights the need for further studies regarding the role of F-18-FDG PET/CT in the assessment of treatment response in patients with LCH.	[Kruljac, Ivan; Vrkljan, Milan] Univ Zagreb, Univ Hosp Ctr Sestre Milosrdnice, Dept Endocrinol Diabet & Metab Dis Mladen Sekso, Sch Med, Zagreb 10000, Croatia; [Balenovic, Antonija] Medikol Clin, Dept Nucl Med, Zagreb, Croatia; [Gacina, Petar] Takasago Seibu Hosp, Div Pediat, Takasago, Hyogo, Japan; [Imashuku, Shinsaku] Univ Hosp Ctr Sestre Milosrdnice, Dept Hematol, Zagreb, Croatia	Kruljac, I (reprint author), Univ Zagreb, Univ Hosp Ctr Sestre Milosrdnice, Dept Endocrinol Diabet & Metab Dis Mladen Sekso, Sch Med, Vinogradska Cesta 29, Zagreb 10000, Croatia.	ivkruljac@gmail.com					Gadner H, 2013, BLOOD, V121, P5006, DOI 10.1182/blood-2012-09-455774; Janku F, 2010, J CLIN ONCOL, V28, pE633, DOI 10.1200/JCO.2010.29.9073; Arnaud L, 2009, ARTHRITIS RHEUM-US, V60, P3128, DOI 10.1002/art.24848; Broadbent V, 1998, HEMATOL ONCOL CLIN N, V12, P327, DOI 10.1016/S0889-8588(05)70513-X; Lee HJ, 2012, ANN NUCL MED, V26, P730, DOI 10.1007/s12149-012-0635-y; Imashuku S, 2011, INT J HEMATOL, V94, P556, DOI 10.1007/s12185-011-0955-z; Phillips M, 2009, PEDIATR BLOOD CANCER, V52, P97, DOI 10.1002/pbc.21782; Girschikofsky M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-72	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	DEC	2015	40	12					981	982		10.1097/RLU.0000000000000994		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CW8DG	WOS:000365229000017		
J	Kuroda, T; Tanabe, N; Wakamatsu, A; Takai, C; Sato, H; Nakatsue, T; Wada, Y; Nakano, M; Narita, I				Kuroda, Takeshi; Tanabe, Naohito; Wakamatsu, Ayako; Takai, Chinatsu; Sato, Hiroe; Nakatsue, Takeshi; Wada, Yoko; Nakano, Masaaki; Narita, Ichiei			High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus	CLINICAL RHEUMATOLOGY			English	Article						Magnetic resonance imaging; Osteonecrosis of the femoral head; Steroid; Systemic lupus erythematosus; Triglyceride	STEROID-INDUCED OSTEONECROSIS; AVASCULAR NECROSIS; DISEASE; JAPAN; MRI	The purpose of this study was to clarify the factors related to silent osteonecrosis of the femoral head (ONFH) in patients with systemic lupus erythematosus (SLE). Seventy-eight patients with SLE were selected on the basis of having been newly diagnosed and requiring high-dose prednisolone, including pulse therapy with methylprednisolone, as the initial treatment. All the patients initially underwent MRI at 3 months after the start of corticosteroid treatment to detect any early changes in the femoral head. These examinations were then performed again 3 months later. Laboratory parameters were evaluated at the start of steroid treatment and at 1 month thereafter. By 3 months after the start of corticosteroid treatment, silent ONFH was diagnosed by MRI in 21 patients (26.9 %), being bilateral in 11 patients and unilateral in 10. The occurrence of silent ONFH was not related to SLE disease activity index, serological activity, or renal function; it was also unrelated to body mass index (BMI), body surface area (BSA), and the initial dose of prednisolone per unit body weight. However, the total cholesterol level at 4 weeks after the start of steroid treatment tended to be higher in patients with silent ONFH. Patients with a higher triglyceride level showed a significantly higher frequency of silent ONFH both before (p = 0.002) and 4 weeks after (p = 0.036) steroid initiation. A high triglyceride level is an important risk factor for silent ONFH in patients with SLE, and large-scale epidemiologic surveys of such early events are needed in this patient population.	[Kuroda, Takeshi; Wakamatsu, Ayako; Takai, Chinatsu; Sato, Hiroe; Nakatsue, Takeshi; Wada, Yoko; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Chuo Ku, Niigata 9518510, Japan; [Tanabe, Naohito] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Higashi Ku, Niigata 9508680, Japan; [Nakano, Masaaki] Niigata Univ, Fac Med, Sch Hlth Sci, Dept Med Technol,Chuo Ku, Niigata 9518518, Japan	Kuroda, T (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kurodat@med.niigata-u.ac.jp; tanabena@gmail.com; a.sohma0@gmail.com; chinatsunachi.89@gmail.com; hiroe77212@hotmail.com; takeshinakatsue@gmail.com; yoko.wada@gmail.com; manakano@clg.niigata-u.ac.jp; naritai@med.niigata-u.ac.jp			Research Committee on Idiopathic Osteonecrosis of the Femoral Head of the Ministry of Health, Labour, and Welfare of Japan	This study was supported by a research grant from the Research Committee on Idiopathic Osteonecrosis of the Femoral Head of the Ministry of Health, Labour, and Welfare of Japan.	ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; Ichiseki T, 2004, J ORTHOP SCI, V9, P509, DOI 10.1007/s00776-004-0816-1; Takahashi S, 2012, J ORTHOP SCI, V17, P730, DOI 10.1007/s00776-012-0293-x; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; SELEZNICK MJ, 1991, J RHEUMATOL, V18, P1416; Du Bois D, 1916, ARCH INTERN MED, V17, P863; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459; Nishida K, 2008, CLIN ORTHOP RELAT R, V466, P1054, DOI 10.1007/s11999-008-0189-4; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Noda H, 2009, HYPERTENS RES, V32, P289, DOI 10.1038/hr.2009.14; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Calvo-Alen J, 2006, ANN RHEUM DIS, V65, P785, DOI 10.1136/ard.2005.040428; Sekiya F, 2010, RHEUMATOL INT, V30, P1587, DOI 10.1007/s00296-009-1194-y; Wang GJ, 2000, CLIN ORTHOP RELAT R, P295; KOO KH, 1995, J BONE JOINT SURG BR, V77B, P875; Nagasawa K, 2005, LUPUS, V14, P385, DOI 10.1191/0961203305lu2103oa; FESSLER BJ, 1995, RHEUM DIS CLIN N AM, V21, P81; LANDMANN J, 1987, J BONE JOINT SURG AM, V69A, P1226; Moskal J T, 1997, Am J Orthop (Belle Mead NJ), V26, P609; Oinuma K, 2000, J Orthop Sci, V5, P374, DOI 10.1007/s007760070046; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793	22	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	DEC	2015	34	12					2071	2077		10.1007/s10067-015-3075-y		7	Rheumatology	Rheumatology	CW7PF	WOS:000365190700010		
J	Tosaka-Ozuno, N; Akamatsu, H; Takahashi, H; Fujii, N; Yoshida, S				Tosaka-Ozuno, Nobuko; Akamatsu, Hokuto; Takahashi, Hiroshi; Fujii, Naoko; Yoshida, Shunji			Quantitative diagnosis of connective tissue disease-associated interstitial pneumonia using thoracic computed tomography images	CLINICAL RHEUMATOLOGY			English	Article						Computed tomography images; Connective tissue disease; Interstitial pneumonia; Quantitative analysis	LUNG-DISEASE; DERMATOMYOSITIS	Patients with polymyositis (PM) or dermatomyositis (DM) frequently show interstitial pneumonia (IP), which is sometimes rapidly progressive or resistant to treatment, thereby significantly affecting the prognosis. The diagnosis and response evaluation of IP are commonly performed qualitatively based on imaging findings, which may cause disagreement among rheumatologists in the evaluation of early lesions and atypical interstitial changes. To determine whether IP could be diagnosed in a quantitative manner during the early stage of PM/DM using a workstation that allows quantitative image processing. Thoracic computed tomography (CT) images of 20 PM/DM patients were reconstructed into a three-dimensional (3D) image using an image processing workstation. The CT values of the constituent voxels were arranged in a histogram of -1000 to +1000 Hounsfield units (HU). The most frequent lung field density was -900 to -801 HU, and relative size was as follows: IP (+) group 0.45 and IP (-) group 0.53. Between -1000 and -701 HU, relative size was not significantly different between the IP (+) group and IP (-) group. Between -700 and -1 HU, the relative size of the lung field was significantly larger in the IP (+) than in the IP (-) group, demonstrating its IP-diagnosing ability. Particularly, within the range from -700 to -301 HU, the macroscopically-assessed ground glass opacity was consistent with the CT value, which, in turn, was closely correlated with KL-6, the pre-existing marker for IP diagnosis. The results of this study may lead to the establishment of quantitative methods of evaluating IP and possible elucidation of the pathogenesis of IP.	[Tosaka-Ozuno, Nobuko; Yoshida, Shunji] Fujita Hlth Univ, Sch Med, Dept Internal Med, Sect Rheumatol & Infect Dis, Toyoake, Aichi 4701192, Japan; [Akamatsu, Hokuto] Fujita Hlth Univ, Sch Med, Dept Radiol, Toyoake, Aichi 4701192, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Div Med Stat, Toyoake, Aichi 4701192, Japan; [Fujii, Naoko] Fujita Hlth Univ, Banbuntane Hotokukai Hosp, Dept Radiol, Nagoya, Aichi 4548509, Japan	Tosaka-Ozuno, N (reprint author), Fujita Hlth Univ, Sch Med, Dept Internal Med, Sect Rheumatol & Infect Dis, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	n-tosaka@fujita-hu.ac.jp					Kameda H, 2005, J RHEUMATOL, V32, P1719; Kocheril SV, 2005, ARTHRIT RHEUM-ARTHR, V53, P549, DOI 10.1002/art.21322; Hasegawa M, 2009, THORAX, V64, P332, DOI 10.1136/thx.2008.103671; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Camiciottoli G, 2007, CHEST, V131, P672, DOI 10.1378/chest.06-1401; MILLAR AB, 1990, THORAX, V45, P602, DOI 10.1136/thx.45.8.602; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Christopher LS, 2011, JACC-CARDIOVASC IMAG, V4, P481; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Matthew JB, 2008, J AM COLL CARDIOL, V52, P1724	12	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	DEC	2015	34	12					2113	2118		10.1007/s10067-015-3103-y		6	Rheumatology	Rheumatology	CW7PF	WOS:000365190700016		
J	Bertsimas, D; Takeda, A				Bertsimas, Dimitris; Takeda, Akiko			Optimizing over coherent risk measures and non-convexities: a robust mixed integer optimization approach	COMPUTATIONAL OPTIMIZATION AND APPLICATIONS			English	Article						Coherent risk measure minimization; Robust optimization; Nonconvexity; Portfolio optimization; Binary classification	PERFORMANCE	Recently, coherent risk measure minimization was formulated as robust optimization and the correspondence between coherent risk measures and uncertainty sets of robust optimization was investigated. We study minimizing coherent risk measures under a norm equality constraint with the use of robust optimization formulation. Not only existing coherent risk measures but also a new coherent risk measure is investigated by setting a new uncertainty set. The norm equality constraint itself has a practical meaning or plays a role to prevent a meaningless solution, the zero vector, in the context of portfolio optimization or binary classification in machine learning, respectively. For such advantages, the convexity is sacrificed in the formulation. However, we show a condition for an input of our problem which guarantees that the nonconvex constraint is convexified without changing the optimality of the problem. If the input does not satisfy the condition, we propose to solve a mixed integer optimization problem by using the or -norm. The numerical experiments show that our approach has good performance for portfolio optimization and binary classification and also imply its flexibility of modelling that makes it possible to deal with various coherent risk measures.	[Bertsimas, Dimitris] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Takeda, Akiko] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo 1138656, Japan	Takeda, A (reprint author), Univ Tokyo, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	dbertsim@mit.edu; takeda@mist.i.u-tokyo.ac.jp					Rockafellar RT, 2002, J BANK FINANC, V26, P1443, DOI 10.1016/S0378-4266(02)00271-6; Artzner P, 1999, MATH FINANC, V9, P203, DOI 10.1111/1467-9965.00068; Brodie J, 2009, P NATL ACAD SCI USA, V106, P12267, DOI 10.1073/pnas.0904287106; Takeda A, 2013, NEURAL COMPUT, V25, P759, DOI 10.1162/NECO_a_00412; Xu H, 2009, IEEE DECIS CONTR P, P4655, DOI 10.1109/CDC.2009.5400598; Bertsimas D, 2009, OPER RES, V57, P1483, DOI 10.1287/opre.1080.0646; Stubbs RA, 2010, J PORTFOLIO MANAGE, V36, P48, DOI 10.3905/jpm.2010.36.4.048; Scholkopf B, 2000, NEURAL COMPUT, V12, P1207, DOI 10.1162/089976600300015565; DeMiguel V, 2009, MANAGE SCI, V55, P798, DOI 10.1287/mnsc.1080.0986; Natarajan K, 2009, OPER RES, V57, P1129, DOI 10.1287/opre.1080.0683; Takeda A, 2009, NEW GENERAT COMPUT, V27, P259, DOI 10.1007/s00354-008-0064-6; Bishop C.M., 2006, PATTERN RECOGNITION; Blake C.L., 1998, UCI REPOSITORY MACHI; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fischer T., 2001, WORKING PAPER; Gotoh Jun-ya, 2011, Computational Management Science, V8, DOI 10.1007/s10287-011-0130-2; Gotoh Jun-ya, 2014, Computational Management Science, V11, DOI 10.1007/s10287-013-0175-5; Perez-Cruz F., 2003, ADV LEARNING THEORY, P179; Rockafellar R, 2000, J RISK, V2, P21; Scholkopf B, 2002, LEARNING KERNELS; Ruszczynski A, 2006, MATH OPER RES, V31, P433, DOI 10.1287/moor.1050.0186; Takeda A., 2008, P 25 INT C MACH LEAR, P1056, DOI 10.1145/1390156.1390289	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0926-6003	1573-2894		COMPUT OPTIM APPL	Comput. Optim. Appl.	DEC	2015	62	3					613	639		10.1007/s10589-015-9755-3		27	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	CW9IA	WOS:000365311200002		
J	Stenger, B; Ukita, N; Sato, Y; Fua, P; Fleet, D				Stenger, Bjorn; Ukita, Norimichi; Sato, Yoichi; Fua, Pascal; Fleet, David			Special Section: Pose & Gesture	COMPUTER VISION AND IMAGE UNDERSTANDING			English	Editorial Material									[Stenger, Bjorn] Toshiba Res Europe, Cambridge, England; [Ukita, Norimichi] Nara Inst Sci & Technol, Nara 6300101, Japan; [Sato, Yoichi] Univ Tokyo, Tokyo 1138654, Japan; [Fua, Pascal] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Fleet, David] Univ Toronto, Toronto, ON M5S 1A1, Canada	Stenger, B (reprint author), Toshiba Res Europe, Cambridge, England.							0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1077-3142	1090-235X		COMPUT VIS IMAGE UND	Comput. Vis. Image Underst.	DEC	2015	141						94	94		10.1016/j.cviu.2015.10.011		1	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CW4SD	WOS:000364981500008		
J	Takao, S; Yamano, H; Sugihara, K; Kumagai, NH; Fujii, M; Yamanaka, Y				Takao, S.; Yamano, H.; Sugihara, K.; Kumagai, N. H.; Fujii, M.; Yamanaka, Y.			An improved estimation of the poleward expansion of coral habitats based on the inter-annual variation of sea surface temperatures	CORAL REEFS			English	Article						Poleward expansion; Coral reefs; Future projection; Global warming; Inter-annual variation; Sea surface temperature	SPECIES DISTRIBUTION MODELS; OCEAN ACIDIFICATION; CLIMATE-CHANGE; SCLERACTINIAN CORALS; LARVAL SETTLEMENT; JAPAN; REEFS; SCENARIOS; PATTERNS; REPRODUCTION	The poleward expansion of coral habitats has been observed along the Japanese coast since the 1930s. Previous modeling studies have projected a poleward expansion using decadal-mean sea surface temperatures (SSTs) in the coldest months. However, this poleward expansion could be affected by the inter-annual variation of SST in the coldest months, which has not been considered before. In this study, the simulated pattern of poleward expansion was compared between cases where coral mortality was considered based on the inter-annual variation of SST and the decadal-mean SST in the coldest months. Modeled monthly mean SSTs for historical and future global warming simulations from the most recent climate projection model (MIROC4h) were used. The poleward expansion of corals simulated by considering mortality based on the inter-annual variation of SST in the coldest months better reproduced the observed poleward expansion speed compared to the simulations without such a consideration. Our results show the importance of considering coral mortality based on the inter-annual variation of seawater temperature to produce a more realistic poleward expansion of coral habitats.	[Takao, S.; Fujii, M.; Yamanaka, Y.] Hokkaido Univ, Fac Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamano, H.; Sugihara, K.; Kumagai, N. H.] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan	Takao, S (reprint author), Hokkaido Univ, Fac Environm Earth Sci, Kita Ku, North 10 West 5, Sapporo, Hokkaido 0600810, Japan.	takao@ees.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)	This work was stimulated by a discussion with Akio Takenaka. We thank the World Climate Research Programme's Working Group on Coupled Modeling, which is responsible for the CMIP. Thanks are extended to the climate-modeling group for producing and making available the MIROC4h output. For the CMIP, the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provided coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. The monitoring of corals and SSTs was conducted by the "Monitoring Sites 1000'' program of Japanese Ministry of the Environment and the "Monitoring for Global Warming Effects on Marine Environment'' program of the Center for Global Environmental Research, National Institute for Environmental Studies. Additional SST data were provided by Keiichi Nomura and Tomoki Sunobe. We thank the editors and three anonymous reviewers for providing valuable comments that improved the manuscript significantly. This work was conducted under the framework of the "Precise Impact Assessments on Climate Change'' of the Program for Risk Information on Climate Change (SOUSEI Program) supported by the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT).	Yamano H, 2012, GEOLOGY, V40, P835, DOI 10.1130/G33293.1; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Muir PR, 2015, SCIENCE, V348, P1135, DOI 10.1126/science.1259911; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265; Jueterbock A, 2013, ECOL EVOL, V3, P1356, DOI 10.1002/ece3.541; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Sakamoto TT, 2012, J METEOROL SOC JPN, V90, P325, DOI 10.2151/jmsj.2012-301; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Nozawa Y, 2008, MAR BIOL, V155, P347, DOI 10.1007/s00227-008-1034-8; Ito M, 2014, PROG OCEANOGR, V121, P83, DOI 10.1016/j.pocean.2013.10.007; VERON JEN, 1992, CONT SHELF RES, V12, P835, DOI 10.1016/0278-4343(92)90047-N; Nojima S, 2008, NIPPON SUISAN GAKK, V74, P884, DOI 10.2331/suisan.74.884; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Hongo C, 2011, MAR GEOL, V279, P162, DOI 10.1016/j.margeo.2010.10.023; Yara Y, 2014, HYDROBIOLOGIA, V733, P19, DOI 10.1007/s10750-014-1838-0; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Takao S, 2015, ECOL EVOL, V5, P213, DOI 10.1002/ece3.1358; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Hoegh-Guldberg O, 2004, CORAL REEFS, V23, P444, DOI 10.1007/s00338-004-0401-2; HARRIOTT VJ, 1995, MAR FRESHWATER RES, V46, P457, DOI 10.1071/MF9950457; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Sugisaki Hiroya, 2010, P330; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI 10.1007/s10584-011-0148-z; Yara Y, 2012, BIOGEOSCIENCES, V9, P4955, DOI 10.5194/bg-9-4955-2012; Harii S, 2001, CORAL REEFS, V20, P19; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Ishii M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006831; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/nclimate1829, 10.1038/NCLIMATE1829]; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Japan Meteorological Agency, 2013, CLIM CHANG MON REP 2; Katoh O, 1994, J OCEANOGR, V50, P317, DOI 10.1007/BF02239520; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Mezaki T., 2007, KUROSHIO BIOSPHERE, V3, P33; Nomura K, 2009, J JPN CORAL REEF SOC, V11, P39; Pernetta JC, 1995, 33 IGBP; Stocker T.F., 2013, CONTRIBUTION WORKING; Sugihara K, 2015, ZOOXANTHELLATE SCLER; Sugihara K, 2009, J JPN CORAL REEF SOC, V11, P51, DOI DOI 10.3755/JCRS.11.51; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van Woesik R, 1995, CORAL COMMUNITIES HI; Yamano H, 2009, J JPN CORAL REEF SOC, V11, P71, DOI DOI 10.3755/JCRS.11.71; Yara Y, 2011, GALAXEA J CORAL REEF, V13, P11; Yara Y., 2009, J JAPANESE CORAL REE, V11, P131	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	DEC	2015	34	4					1125	1137		10.1007/s00338-015-1347-2		13	Marine & Freshwater Biology	Marine & Freshwater Biology	CW7KK	WOS:000365177300012		
J	Tanaka, K; Holcomb, M; Takahashi, A; Kurihara, H; Asami, R; Shinjo, R; Sowa, K; Rankenburg, K; Watanabe, T; McCulloch, M				Tanaka, Kentaro; Holcomb, Michael; Takahashi, Asami; Kurihara, Haruko; Asami, Ryuji; Shinjo, Ryuichi; Sowa, Kohki; Rankenburg, Kai; Watanabe, Tsuyoshi; McCulloch, Malcolm			Response of Acropora digitifera to ocean acidification: constraints from delta B-11, Sr, Mg, and Ba compositions of aragonitic skeletons cultured under variable seawater pH	CORAL REEFS			English	Article						Coral aragonite; Boron isotopes; Sr/Ca; Ocean acidification; Calcification	SEA-SURFACE TEMPERATURE; GREAT-BARRIER-REEF; CALCIUM-CARBONATE SATURATION; LIGHT-ENHANCED CALCIFICATION; CORAL STYLOPHORA-PISTILLATA; BORON ISOTOPIC COMPOSITIONS; SCLERACTINIAN CORALS; MARINE CARBONATES; UP-REGULATION; PHOTOSYNTHESIS	The response of Acropora digitifera to ocean acidification is determined using geochemical proxy measurements of the skeletal composition of A. digitifera cultured under a range of pH levels. We show that the chemical composition (delta B-11, Sr/Ca, Mg/Ca, and Ba/Ca) of the coral skeletons can provide quantitative constraints on the effects of seawater pH on the pH in the calcification fluid (pH(CF)) and the mechanisms controlling the incorporation of trace elements into coral aragonite. With the decline of seawater pH, the skeletal delta B-11 value decreased, while the Sr/Ca ratio showed an increasing trend. The relationship between Mg/Ca and Ba/Ca versus seawater pH was not significant. Inter-colony variation of delta B-11 was insignificant, although inter-colony variation was observed for Ba/Ca. The decreasing trend of pH(CF) calculated from delta B-11 was from similar to 8.5, 8.4, and 8.3 for seawater pH of similar to 8.1, 7.8, and 7.4, respectively. Model calculations based on Sr/Ca and pH(CF) suggest that upregulation of pH(CF) occurs via exchange of H+ with Ca2+ with kinetic effects (Rayleigh fractionation), reducing Sr/Ca relative to inorganic deposition of aragonite from seawater. We show that it is possible to constrain the overall carbonate chemistry of the calcifying fluid with estimates of the carbonate saturation of the calcifying fluid (Omega (CF)) being derived from skeletal Sr/Ca and pH(CF) (from delta B-11). These estimates suggest that the aragonite saturation state of the calcifying fluid Omega (CF) is elevated by a factor of 5-10 relative to ambient seawater under all treatment conditions.	[Tanaka, Kentaro; Sowa, Kohki; Watanabe, Tsuyoshi] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Tanaka, Kentaro; Holcomb, Michael; Sowa, Kohki; Rankenburg, Kai; McCulloch, Malcolm] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Holcomb, Michael; McCulloch, Malcolm] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, Crawley, WA 6009, Australia; [Takahashi, Asami] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Kurihara, Haruko] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan; [Asami, Ryuji; Shinjo, Ryuichi] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 9030213, Japan	Tanaka, K (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, N10 W8, Sapporo, Hokkaido 0600810, Japan.	kentaro.t1@gmail.com			ARC Laureate Fellowship; Super Science; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation [G2301]	We thank H. Osieriski for support of geochemical analyses. We also thank to J. Zinke, K. Shirai, M. Hori, and two anonymous reviewers for fruitful comments. We also thank International Research Hub Project for Climate Change, Coral Reef/Island Dynamics (the University of the Ryukyus), and Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (G2301), and the Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies. M. McCulloch and M. Holcomb were also supported by ARC Laureate Fellowship and Super Science funding, respectively.	Finch AA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033543; Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Beck JW, 1997, NATURE, V385, P705, DOI 10.1038/385705a0; Nagtegaal R, 2012, CHEM GEOL, V318, P6, DOI 10.1016/j.chemgeo.2012.05.006; Takahashi A, 2013, CORAL REEFS, V32, P305, DOI 10.1007/s00338-012-0979-8; DEVILLIERS S, 1994, GEOCHIM COSMOCHIM AC, V58, P197, DOI 10.1016/0016-7037(94)90457-X; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Shinjo R, 2013, MAR GEOL, V342, P58, DOI 10.1016/j.margeo.2013.06.002; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; Roche RC, 2011, CORAL REEFS, V30, P195, DOI 10.1007/s00338-010-0679-1; Cohen AL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001084; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Douville E, 2010, BIOGEOSCIENCES, V7, P2445, DOI 10.5194/bg-7-2445-2010; Finch AA, 2003, GEOCHIM COSMOCHIM AC, V67, P4519, DOI 10.1016/S0016-7037(03)00410-1; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284; Correge T, 2006, PALAEOGEOGR PALAEOCL, V232, P408, DOI 10.1016/j.palaeo.2005.10.014; Gattuso JP, 1999, AM ZOOL, V39, P160; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Allison N, 2011, GEOCHIM COSMOCHIM AC, V75, P6350, DOI 10.1016/j.gca.2011.08.012; Allison N, 2001, GEOCHIM COSMOCHIM AC, V65, P2669, DOI 10.1016/S0016-7037(01)00628-7; Grove CA, 2013, GEOCHEM GEOPHY GEOSY, V14, P1277, DOI 10.1002/ggge.20095; Klochko K, 2006, EARTH PLANET SC LETT, V248, P276, DOI 10.1016/j.epsl.2006.05.034; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Ries JB, 2010, CORAL REEFS, V29, P661, DOI 10.1007/s00338-010-0632-3; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; KINSMAN DJJ, 1969, GEOCHIM COSMOCHIM AC, V33, P1, DOI 10.1016/0016-7037(69)90089-1; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; Shirai K, 2008, GEOCHIM COSMOCHIM AC, V72, P5386, DOI 10.1016/j.gca.2008.07.026; Gladfelter EH, 2007, CORAL REEFS, V26, P883, DOI 10.1007/s00338-007-0278-y; Kuffner IB, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004128; Wei GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P2332, DOI 10.1016/j.gca.2009.02.009; Furla P, 2000, J EXP BIOL, V203, P3445; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Sinclair DJ, 2005, EARTH PLANET SC LETT, V237, P354, DOI 10.1016/j.epsl.2005.06.039; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Marshall JF, 2002, GEOCHIM COSMOCHIM AC, V66, P3263, DOI 10.1016/S0016-7037(02)00926-2; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; McCulloch MT, 1999, SCIENCE, V283, P202, DOI 10.1126/science.283.5399.202; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Reynaud S, 2007, GEOCHIM COSMOCHIM AC, V71, P354, DOI 10.1016/j.gca.2006.09.009; Elderfield H, 1996, EARTH PLANET SC LETT, V142, P409, DOI 10.1016/0012-821X(96)00105-7; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Reynaud S, 2004, MAR ECOL PROG SER, V279, P105, DOI 10.3354/meps279105; Gaetani GA, 2006, GEOCHIM COSMOCHIM AC, V70, P4617, DOI 10.1016/j.gca.2006.07.008; Wang BS, 2010, TALANTA, V82, P1378, DOI 10.1016/j.talanta.2010.07.010; Ishikawa T, 2011, J ANAL ATOM SPECTROM, V26, P359, DOI 10.1039/c0ja00060d; Fallon SJ, 1999, EARTH PLANET SC LETT, V172, P221, DOI 10.1016/S0012-821X(99)00200-9; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Honisch B, 2004, GEOCHIM COSMOCHIM AC, V68, P3675, DOI 10.1016/j.gca.2004.03.0026; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; SPIVACK AJ, 1986, ANAL CHEM, V58, P31, DOI 10.1021/ac00292a010; Atkinson M., 2005, J GEOPHYS RES-OCEANS, V110, DOI DOI 10.1029/2004JC002576; DeCarlo TM, 2015, GEOCHIM COSMOCHIM AC, V162, P151, DOI 10.1016/j.gca.2015.04.016; Holcomb M, 2014, SCI REP, V4, P4; Holcomb M, 2015, CHEM GEOL, V398, P11, DOI 10.1016/j.chemgeo.2015.01.019; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; McCulloch MT, 2014, RAPID COMMUN MASS SP, V28, P2704, DOI 10.1002/rcm.7065; Meibom A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021313; Trotter J., 2011, EARTH PLANET SC LETT, V303, P163, DOI DOI 10.1016/J.EPSL.2011.01.030; Venn A, 2011, PLOS ONE, V6; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	65	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	DEC	2015	34	4					1139	1149		10.1007/s00338-015-1319-6		11	Marine & Freshwater Biology	Marine & Freshwater Biology	CW7KK	WOS:000365177300013		
J	Ohki, S; Kowalski, RK; Kitanobo, S; Morita, M				Ohki, Shun; Kowalski, Radoslaw K.; Kitanobo, Seiya; Morita, Masaya			Changes in spawning time led to the speciation of the broadcast spawning corals Acropora digitifera and the cryptic species Acropora sp 1 with similar gamete recognition systems	CORAL REEFS			English	Article						Gamete recognition; Fertilization; Hybridization; Coral; Synchronous spawning; Reproductive isolation	MONTASTRAEA-ANNULARIS COMPLEX; REEF BUILDING CORALS; REPRODUCTIVE ISOLATION; FERTILIZATION SUCCESS; SPERM LIMITATION; SEA-URCHINS; HYBRIDIZATION; CRYOPRESERVATION; SCLERACTINIA; POPULATIONS	Multi-species spawning is reported in the coral genus Acropora, but hybridization in nature rarely occurs because of the incompatibility of gametes and the timing of spawning. However, the evolutionary relationships between gamete compatibility and spawning time are obscure. Investigations of gamete compatibility in sister species that spawn at different times may provide clues to answering this question. Acropora sp. 1 has been defined as a cryptic species of Acropora digitifera, and they are morphologically similar, but spawn in different months, suggesting that they are either a cryptic species or a different species. We examined the morphology and conducted crossing experiments using cryopreserved sperm. The morphologies (branch length, branch width, and outer diameter of axial corallites) of A. digitifera and Acropora sp. 1 differed significantly. A phylogenetic tree of partial Pax-C nuclear sequences from A. digitifera and Acropora sp. 1 shows that they are monophyletic and closely related genetically, based on F (ST) values and P-distance. These results imply that these two species originated recently from a common ancestor. In addition, cryopreserved sperm from both A. digitifera and Acropora sp. 1 showed bidirectional inter-crossing (cryopreserved sperm of A. digitifera and eggs of Acropora sp. 1 from Sesoko: 32.1 +/- A 6.7 %, control-conspecific cryopreserved sperm and eggs: 46.1 +/- A 10.6 %; cryopreserved sperm of Acropora sp. 1 and eggs of A. digitifera from Oku: 63.3 +/- A 16.6 %, control: 83.6 +/- A 6.0 %). The results suggest that the gametes of these two species are compatible and that the pre-zygotic isolation mechanism is relaxed because their gametes do not interact. Overall, these two species should be classified as distinct species, and changes in spawning time are related to speciation in a similar gamete recognition system.	[Ohki, Shun; Kitanobo, Seiya; Morita, Masaya] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa 9050227, Japan; [Kowalski, Radoslaw K.] Inst Anim Reprod & Food Res, Dept Gamete & Embryo Biol, Olsztyn, Poland; [Kitanobo, Seiya] Okinawa Inst Sci & Technol, Membrane Trafficking Unit, Onna, Okinawa 9040495, Japan	Morita, M (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, 3422 Sesoko, Motobu, Okinawa 9050227, Japan.	morita@lab.u-ryukyu.ac.jp			Okinawa Churashima Foundation [119]; Uruma Foundation [13-13]; Grant for Basic Science Research Projects from The Sumitomo Foundation [131244]	This study was partly supported by Okinawa Churashima Foundation (No. 119) to M.M., Uruma Foundation (Grant No. 13-13) to MM, and Grant for Basic Science Research Projects from The Sumitomo Foundation (Grant No. 131244) to M.M. We also appreciate to Prof. Andrew Baird of James Cook University to give us valuable comments to improve the paper.	Yund PO, 2000, TRENDS ECOL EVOL, V15, P10, DOI 10.1016/S0169-5347(99)01744-9; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Baird AH, 2010, PAC SCI, V64, P405, DOI 10.2984/64.3.405; Hatta M, 1999, MOL BIOL EVOL, V16, P1607; Marquez LM, 2002, P ROY SOC B-BIOL SCI, V269, P1289, DOI 10.1098/rspb.2002.2014; Wei NV, 2012, ZOOL STUD, V51, P85; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Geyer LB, 2005, EVOLUTION, V59, P97; HAYASHIBARA T, 1993, MAR ECOL PROG SER, V101, P253, DOI 10.3354/meps101253; Nakajima Y, 2012, MOL PHYLOGENET EVOL, V63, P527, DOI 10.1016/j.ympev.2012.01.006; Omori M, 2001, LIMNOL OCEANOGR, V46, P704; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Levitan DR, 2002, EVOLUTION, V56, P1599; Wilson JR, 2003, MAR ECOL PROG SER, V260, P115, DOI 10.3354/meps260115; WALLACE CC, 1994, ANNU REV ECOL SYST, V25, P237; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; Nozawa Y, 2012, BIOL BULL-US, V222, P192; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; Palumbi SR, 2012, EVOL ECOL, V26, P317, DOI 10.1007/s10682-011-9517-3; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Hagedorn M, 2006, CRYOBIOLOGY, V52, P33, DOI 10.1016/j.cryobiol.2005.09.008; Hayashibara T, 2002, CORAL REEFS, V21, P224; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Fukami H, 2003, MAR BIOL, V142, P679, DOI 10.1007/s00227-002-1001-8; Levitan DR, 2011, EVOLUTION, V65, P1254, DOI 10.1111/j.1558-5646.2011.01235.x; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Ohki S, 2014, CRYOBIOLOGY, V69, P134, DOI 10.1016/j.cryobiol.2014.06.005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Fogarty ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030486; Hagedorn M, 2014, ADV EXP MED BIOL, V753, P317, DOI 10.1007/978-1-4939-0820-2_13; Hagedorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033354; Hatta Masayuki, 2008, Galaxea - Tokyo, V10, P91; Isomura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056701; Wallace C. C., 1999, STAGHORN CORALS WORL	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	DEC	2015	34	4					1189	1198		10.1007/s00338-015-1337-4		10	Marine & Freshwater Biology	Marine & Freshwater Biology	CW7KK	WOS:000365177300018		
J	Nozawa, Y; Isomura, N; Fukami, H				Nozawa, Yoko; Isomura, Naoko; Fukami, Hironobu			Influence of sperm dilution and gamete contact time on the fertilization rate of scleractinian corals	CORAL REEFS			English	Article						Scleractinian coral; Acropora; Merulinidae; Sperm concentration; Contact time; Fertilization success	CNIDARIA ANTHOZOA SCLERACTINIA; BROADCAST-SPAWNING CORALS; TAXONOMIC CLASSIFICATION; ACROPORA-DIGITIFERA; REEF; SUCCESS; LIMITATION; FAMILIES; SPAWNERS; EGGS	This study presents new information on the influence of sperm dilution on the fertilization rates of eight broadcast-spawning scleractinian coral species [three Acropora species and five merulinid species (three genera)]. The presented information nearly doubled the existing information, now totaling 17 species comprising eight acroporid species and nine merulinid species. No obvious differences in the fertilization rates were observed at the family and genus levels; furthermore, the fertilization curve estimated uniquely for Favites pentagona exhibited a strong sigmoid shape, indicating the existence of species-specific variation. In addition, a general fertilization response against sperm dilution was observed for the first time in broadcast-spawning scleractinian corals. The fertilization rate peaked (> 75 %) at a sperm concentration of approximately 10(6) sperm mL(-1) (optimal concentration) and rapidly declined to < 50 % at a concentration of 10(4) sperm mL(-1). The influence of gamete contact time (10, 30, and 60 min) on fertilization rates was also examined in two Acropora and four merulinid species, at the optimal sperm concentration. No influence of gamete contact time on fertilization rates was observed in two of the examined species (Acropora papillare and Platygyra ryukyuensis), whereas reduced fertilization rates occurred mostly in the 10-min treatment for the other species. These results suggested that broadcast-spawning scleractinian corals can rapidly fertilize, indicating that these corals have a fair chance of achieving high fertilization success in the field under optimal conditions. The sperm concentration values (e.g., 10(4) sperm mL(-1), indicating < 50 % fertilization rates) may be useful in estimating the success of in situ fertilization of broadcast-spawning scleractinian corals, particularly in degraded, low-density populations where the degree of fertilization success is of management concern. Information on the fertilization ecology of scleractinian corals remains insufficient, and further study is necessary to understand fertilization dynamics in the field.	[Nozawa, Yoko] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Isomura, Naoko] Okinawa Natl Coll Technol, Dept Bioresources Engn, Nago City, Okinawa 9052192, Japan; [Fukami, Hironobu] Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan	Nozawa, Y (reprint author), Acad Sinica, Biodivers Res Ctr, 128 Acad Rd Sec 2, Taipei 115, Taiwan.	nozaway@gate.sinica.edu.tw			Biodiversity Research Center; Academia Sinica [23-2g]	The authors thank the staff of the Lyudao Marine Research Station for their support and, particularly, Adriana Santacruz-Castro, Che-Hung Lin, Chih-Hsien Liu, Gina Yang, and Huai-Shin Hsieh for their assistance in the field. Comments from three anonymous reviewers improved the original manuscript. This study was funded by an internal research grant from Biodiversity Research Center, Academia Sinica, and a thematic research grant from Academia Sinica (23-2g).	Yund PO, 2000, TRENDS ECOL EVOL, V15, P10, DOI 10.1016/S0169-5347(99)01744-9; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Miller K, 1997, BIOL BULL, V192, P98, DOI 10.2307/1542579; Okubo N, 2010, BIOL BULL-US, V218, P230; Huang DW, 2014, ZOOL J LINN SOC-LOND, V171, P277, DOI 10.1111/zoj.12140; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Iguchi A, 2009, ZYGOTE, V17, P225, DOI 10.1017/S096719940900519X; Omori M, 2001, LIMNOL OCEANOGR, V46, P704; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Nakamura R, 2011, MAR ECOL PROG SER, V436, P161, DOI 10.3354/meps09257; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Isomura N, 2013, MAR BIOL RES, V9, P181, DOI 10.1080/17451000.2012.707321; Coma R, 1997, J EXP MAR BIOL ECOL, V214, P107, DOI 10.1016/S0022-0981(97)00017-8; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Chui Apple Pui Yi, 2014, Journal of Marine Biology, P953587; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; Fogarty ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030486; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; R Core Team, 2014, R LANG ENV STAT COMP; Veron J, 2000, CORALS WORLD; Veron JEN, 1977, SCLERACTINIA E AUSTR; Wallace C. C., 1999, STAGHORN CORALS WORL	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	DEC	2015	34	4					1199	1206		10.1007/s00338-015-1338-3		8	Marine & Freshwater Biology	Marine & Freshwater Biology	CW7KK	WOS:000365177300019		
J	Tanaka, Y; Ogawa, H; Miyajima, T				Tanaka, Y.; Ogawa, H.; Miyajima, T.			Effects of nutrient enrichment on the release of dissolved organic carbon and nitrogen by the scleractinian coral Montipora digitata (vol 29, pg 675, 2010)	CORAL REEFS			English	Correction									[Tanaka, Y.; Ogawa, H.; Miyajima, T.] Univ Tokyo, Atmosphere & Ocean Res Inst, Marine Biogeochem Lab, Kashiwa, Chiba 2778564, Japan	Tanaka, Y (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Marine Biogeochem Lab, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778564, Japan.	ya-tanaka@aori.u-tokyo.ac.jp					Tanaka Y, 2010, CORAL REEFS, V29, P675, DOI 10.1007/s00338-010-0639-9	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0722-4028	1432-0975		CORAL REEFS	Coral Reefs	DEC	2015	34	4					1313	1313		10.1007/s00338-015-1356-1		1	Marine & Freshwater Biology	Marine & Freshwater Biology	CW7KK	WOS:000365177300032		
J	Shinoe, T; Goda, Y				Shinoe, Toru; Goda, Yukiko			Tuning synapses by proteolytic remodeling of the adhesive surface	CURRENT OPINION IN NEUROBIOLOGY			English	Article							LONG-TERM POTENTIATION; N-CADHERIN; MATRIX METALLOPROTEINASES; SYNAPTIC PLASTICITY; STRUCTURAL PLASTICITY; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSE; GABA(A) RECEPTORS; DENDRITIC SPINES; BETA-3 INTEGRINS	Cell adhesion molecules (CAMs) play a crucial role in organizing the synaptic interface and regulating synapse activity. In turn, CAMs can influence a variety of higher brain functions. In addition to their bona fide interacting partners on the apposed cell surface or the extracellular matrix (ECM) with which they form molecular bridges, synaptic CAMs bind to many other proteins with their intracellular and extracellular domains. The resulting multi-molecular complexes at the active zone and at the postsynaptic density (PSD) are thought to anchor components requisite for synaptic transmission. Recent studies demonstrating the proteolytic cleavage of synaptic CAMs underscore an exciting mechanism through which the synaptic microenvironment can be altered and thereby finely tune the efficacy of synaptic transmission.	[Shinoe, Toru; Goda, Yukiko] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Goda, Y (reprint author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	goda@brain.riken.jp			RIKEN Brain Science Institute; Japan Society for the Promotion of Science; JSPS from the Ministry of Education, Culture, Sports, Science and Technology of Japan [24700404, 26640022, 2604760, 15H04280]; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development	We thank Michael Colicos, Pete Chipman and Tom Chater for their helpful comments on the manuscript. Research in the authors' laboratory is supported by the RIKEN Brain Science Institute, Core-to-Core Program from the Japan Society for the Promotion of Science, JSPS Grants-in-Aid for Scientific Research (24700404, 26640022, 2604760, 15H04280) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development.	Saint-Michel E, 2009, BIOPHYS J, V97, P480, DOI 10.1016/j.bpj.2009.04.044; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Knapska E, 2013, J NEUROSCI, V33, P14591, DOI 10.1523/JNEUROSCI.5239-12.2013; McGeachie AB, 2012, EUR J NEUROSCI, V36, P2461, DOI 10.1111/j.1460-9568.2012.08163.x; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Pozo K, 2012, P NATL ACAD SCI USA, V109, P1323, DOI 10.1073/pnas.1113736109; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; McGeachie AB, 2011, NEUROSCI RES, V70, P24, DOI 10.1016/j.neures.2011.02.006; Ito-Ishida A, 2012, NEURON, V76, P549, DOI 10.1016/j.neuron.2012.07.027; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Franks KM, 2003, J NEUROSCI, V23, P3186; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Tu HJ, 2015, NEURON, V86, P1407, DOI 10.1016/j.neuron.2015.05.013; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Luthi A, 1997, J NEUROSCI, V17, P4688; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Benson DL, 1998, J NEUROSCI, V18, P6892; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Maro GS, 2015, NEURON, V86, P1420, DOI 10.1016/j.neuron.2015.05.015; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Benson DL, 2012, HIPPOCAMPUS, V22, P954, DOI 10.1002/hipo.20872; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Chen CC, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00028; Maartens Aidan P, 2015, Curr Top Dev Biol, V112, P233, DOI 10.1016/bs.ctdb.2014.11.020; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Vitureira N, 2012, NAT NEUROSCI, V15, P81, DOI 10.1038/nn.2995; Yam PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079679	66	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-4388	1873-6882		CURR OPIN NEUROBIOL	Curr. Opin. Neurobiol.	DEC	2015	35						148	155		10.1016/j.conb.2015.08.005		8	Neurosciences	Neurosciences & Neurology	CX0BO	WOS:000365362100022		
J	Hashimoto, H; Kitano, S; Yamagata, S; Maeshima, AM; Ueda, R; Ito, A; Tada, K; Fuji, S; Yamashita, T; Tomura, D; Nukaya, I; Mineno, J; Fukuda, T; Mori, S; Takaue, Y; Heike, Y				Hashimoto, Hisayoshi; Kitano, Shigehisa; Yamagata, Shizuka; Maeshima, Akiko Miyagi; Ueda, Ryosuke; Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Yamashita, Takuya; Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi; Fukuda, Takahiro; Mori, Shinichiro; Takaue, Yoichi; Heike, Yuji			Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation	CYTOTHERAPY			English	Article						haplo-identical hematopoietic stem cell transplantation; herpes simplex virus thymidine kinase suicide gene; T-cell function; T-cell repertoire; insertional oncogenesis	STEM-CELL TRANSPLANTATION; GRAFT-VERSUS-LEUKEMIA; T-CELLS; HEMATOLOGIC MALIGNANCIES; IMMUNE RECONSTITUTION; DNA-SYNTHESIS; HOST-DISEASE; HIGH-RISK; GANCICLOVIR; INFUSION	Background aims. Haplo-identical hematopoietic stem cell transplantation (HSCT) with add-back of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene (TK cells) is one of the most widely applied promising new gene therapy approaches. However, the immunological status of added-back TK cells after HSCT has yet to be well characterized. Methods. We investigated TK cells through the use of flow cytometry, T-cell receptor (TCR) V beta repertoire spectratyping and linear amplification-mediated polymerase chain reaction followed by insertion site analysis in a patient enrolled in our clinical trial. Results. A comparison of onset with remission of acute graft-versus-host disease confirmed that TK cells were predominantly eliminated and that proliferative CD8(+) non-TK cells were also depleted in response to ganciclovir administration. The TCR V beta-chain repertoire of both TK cells and non-TK cells markedly changed after administration of ganciclovir, and, whereas the TCR repertoire of non-TK cells returned to a normal spectratype long after transplantation, that of TK cells remained skewed. With the long-term prophylactic administration of acyclovir, TK cells oligoclonally expanded and the frequency of spliced variants of TK cells increased. Known cancer-associated genes were not evident near the oligoclonally expanded herpes simplex virus (HSV)-TK insertion sites. Conclusions. We demonstrate obvious differences in immunological status between TK cells and non-TK cells. In addition, we speculate that long-term prophylactic administration of acyclovir increases the risk of oligoclonal expansion of spliced forms of TK cells.	[Hashimoto, Hisayoshi; Ueda, Ryosuke] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 104, Japan; [Kitano, Shigehisa] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan; [Kitano, Shigehisa; Tada, Kohei] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Tokyo 104, Japan; [Yamagata, Shizuka; Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Yamashita, Takuya; Fukuda, Takahiro] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Maeshima, Akiko Miyagi] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Maeshima, Akiko Miyagi] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi] Takara Bio Inc, Ctr Cell & Gene Therapy, Tokyo, Japan; [Mori, Shinichiro] St Lukes Int Univ & Hosp, Dept Hematol & Oncol, Tokyo 1048560, Japan; [Takaue, Yoichi] St Lukes Int Univ & Hosp, Dept Res Planning & Management, Tokyo 1048560, Japan; [Heike, Yuji] St Lukes Int Univ & Hosp, Immunotherapy & Cell Therapy Serv, Tokyo 1048560, Japan; [Heike, Yuji] St Lukes Int Univ & Hosp, Lab Joint Res & Dev, Tokyo 1048560, Japan	Heike, Y (reprint author), St Lukes Int Univ & Hosp, Lab Joint Res & Dev, Immunotherapy & Cell Therapy Serv, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	heiyuji@luke.ac.jp			Japanese Ministry of Health, Labor and Welfare; National Cancer Research and Development Fund; JSPS	This work was supported by grants from the Japanese Ministry of Health, Labor and Welfare, the National Cancer Research and Development Fund and JSPS KAKENHI (Grants-in-Aid for Scientific Research). We would like to thank Dr Alexander M. Lesokhin of the Department of Medicine, Memorial Sloan-Kettering Cancer Center, for critically reviewing our manuscript. We are also grateful to our strategic partner and developer of TK, MolMed S.p.A., for all of their support, advice and technical information.	Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Ciceri F, 2007, BLOOD, V109, P4698, DOI 10.1182/blood-2006-05-023416; Garin MI, 2001, BLOOD, V97, P122, DOI 10.1182/blood.V97.1.122; STCLAIR MH, 1987, ANTIMICROB AGENTS CH, V31, P844; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Borchers S, 2011, HUM GENE THER, V22, P829, DOI 10.1089/hum.2010.162; MAVILIO F, 1994, BLOOD, V83, P1988; Chalmers D, 2001, MOL THER, V4, P146, DOI 10.1006/mthe.2001.0433; Claret EJ, 1997, J CLIN INVEST, V100, P855, DOI 10.1172/JCI119601; Ebeling SB, 2003, J VIROL METHODS, V109, P177, DOI 10.1016/S0166-0934(03)00069-7; Hashimoto H, 2015, INT J HEMATOL, V102, P101, DOI 10.1007/s12185-015-1801-5; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Ciceri F, 2005, CYTOTHERAPY, V7, P144, DOI 10.1080/14653240510018136; Tiberghien P, 2001, BLOOD, V97, P63, DOI 10.1182/blood.V97.1.63; Verfuerth S, 2000, BLOOD, V95, P3990; Traversari C, 2007, BLOOD, V109, P4708, DOI 10.1182/blood-2006-04-015230; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Cieri N, 2014, IMMUNOL REV, V257, P165, DOI 10.1111/imr.12130; Deschamps M, 2007, BLOOD, V110, P3842, DOI 10.1182/blood-2007-04-087346; Kanda Y, 2001, BONE MARROW TRANSPL, V28, P689, DOI 10.1038/sj.bmt.1703214; Kornblau SM, 2007, EXP HEMATOL, V35, P842, DOI 10.1016/j.exphem.2007.02.008; Battiwalla M, 2007, BIOL BLOOD MARROW TR, V13, P765, DOI 10.1016/j.bbmt.2007.03.009; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; Oliveira G, 2012, CURR OPIN HEMATOL, V19, P427, DOI 10.1097/MOH.0b013e32835822f5; Recchia A, 2006, P NATL ACAD SCI USA, V103, P1457, DOI 10.1073/pnas.0507496103; Marktel S, 2003, BLOOD, V101, P1290, DOI 10.1182/blood-2002-08-2351; Vago L, 2012, BLOOD, V120, P1820, DOI 10.1182/blood-2012-01-405670; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Cattoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015688; Ciceri F, 2014, J CLIN ONCOL S, V32, p5s; Lupo-Stanghellini MT, 2010, HUM GENE THER, V21, P241, DOI 10.1089/hum.2010.014; Mercier-Letondal P, 2008, HUM GENE THER, V19, P937, DOI 10.1089/hum.2007.156; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Weissinger EM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00076	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	DEC	2015	17	12					1820	1830		10.1016/j.jcyt.2015.08.005		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CW8JU	WOS:000365246500016		
J	Al Hajj, F; Dufrenot, G; Sugimoto, K; Wolf, R				Al Hajj, Fadia; Dufrenot, Gilles; Sugimoto, Kimiko; Wolf, Romain			Reactions to Shocks and Monetary Policy Regimes: Inflation Targeting Versus Flexible Currency Board in Sub-Saharan Africa	DEVELOPING ECONOMIES			English	Article						Inflation target; Currency board; African countries; E52; F41; Q33	UNITED-STATES; STICKY; RULES	The paper examines the monetary policy actions through which central banks in sub-Saharan Africa have tried to eliminate the negative impacts of the shocks facing their economies. We compare two different monetary policy regimes: a currency board regime (in the CFA zone) and an inflation targeting policy regime (Ghana and South Africa) when central banks respond to demand, supply, and fiscal shocks. We extend the usual forecasting and policy analysis system models to replicate the economic features of these economies during the period 2002-12 and to evaluate the impact of several policies in response to these shocks. We find that both policies are inappropriate in helping the economies escape from the effects of negative demand shocks, both are essential when negative shocks to primary balance occur, while inflation targeting dominates the currency board regime as a strategy to cope with positive shocks to inflation.	[Al Hajj, Fadia; Dufrenot, Gilles] Aix Marseille Univ, F-13290 Chateau Lafarge, France; [Al Hajj, Fadia; Dufrenot, Gilles] Aix Marseille Sch Econ, GREQAM, Chateau Lafarge, France; [Al Hajj, Fadia; Dufrenot, Gilles] Aix Marseille Sch Econ, CNRS, Chateau Lafarge, France; [Al Hajj, Fadia; Dufrenot, Gilles] Aix Marseille Sch Econ, EHESS, Chateau Lafarge, France; [Dufrenot, Gilles; Wolf, Romain] Banque France, Paris, France; [Dufrenot, Gilles] French Res Ctr Int Econ CEPII, Paris, France; [Sugimoto, Kimiko] Konan Univ, Nishinomiya, Hyogo, Japan	Dufrenot, G (reprint author), Aix Marseille Univ, Route Milles, F-13290 Chateau Lafarge, France.	gilles.dufrenot@univ-amu.fr					Adedeji Olumuyiwa S., 2007, 07232 IMF; Alpanda S, 2011, S AFR J ECON, V79, P50, DOI 10.1111/j.1813-6982.2011.01260.x; Andrle Michal, 2013, 1361 IMF; Roberts JM, 1997, J MONETARY ECON, V39, P173, DOI 10.1016/S0304-3932(97)00017-2; Abdih Y, 2010, APPL ECON, V42, P2009, DOI 10.1080/00036840701765411; Taylor JB, 2001, AM ECON REV, V91, P263, DOI 10.1257/aer.91.2.263; Lungu M, 2007, AFR DEV REV, V19, P432; Berg Andrew, 2006, 0680 IMF; Bernanke Ben S., 1995, J ECON PERSPECT, V9, P27; Bhattacharya Sudipto, 2011, SP202 FMG LOND SCH E; Burger P, 2012, S AFR J ECON, V80, P209, DOI 10.1111/j.1813-6982.2012.01321.x; Dagher Jihad, 2010, 10116 IMF; Dembo Toe Mathurin, 2010, DER1003 BANQ CENTR E; Douglas Laxton, 2009, 0965 IMF; Dufrenot Gilles J., 2005, 05164 IMF; Dufrenot G, 2011, J INT DEV, V23, P63, DOI 10.1002/jid.1631; Fielding David, 2012, EC CHANGE RESTRUCTUR, V45, P45; Gottschalk Jan, 2009, 09227 IMF; Harjes Thomas, 2008, 0848 IMF; Ilzetzki Ethan, 2011, COUNTRY CHRONOLOGIES; Klein Nir, 2012, 12177 IMF; Loyo Eduardo, 1999, TIGHT MONETARY PARAD; Mishra Prachi, 2012, 12143 IMF; Reinhart Carmen M., 2004, Q J ECON, VCXIX, P1; ROTEMBERG JJ, 1982, J POLIT ECON, V90, P1187, DOI 10.1086/261117; Roudet Stephane, 2007, 07194 IMF; TAYLOR JB, 1980, J POLIT ECON, V88, P1, DOI 10.1086/260845; TREHAN B, 1991, J MONEY CREDIT BANK, V23, P206, DOI 10.2307/1992777; Valdovinos Fernandez, 2011, 1159 IMF; Veyrune Romain, 2007, 0734 IMF; Victor Lledo, 2011, 11172 IMF	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	DEC	2015	53	4					237	271		10.1111/deve.12088		35	Economics; Planning & Development	Business & Economics; Public Administration	CW8UJ	WOS:000365274500001		
J	Albert, JR; Mori, S; Reyes, C; Tabuga, AD; Yamagata, T				Albert, Jose Ramon; Mori, Soya; Reyes, Celia; Tabuga, Aubrey D.; Yamagata, Tatsufumi			Income Disparity among Persons with Disabilities, Assessed by Education and Sex: Accentuated Gender Difference Found in Metro Manila, the Philippines	DEVELOPING ECONOMIES			English	Article						Disability; The Philippines; Asia; Rate of return on education; Gender; D31; I12; I20; I31; J16; J31; O53	LABOR-MARKETS; POVERTY; EARNINGS; RETURNS	How do persons with disabilities (PWDs) earn a living? This paper presents an investigation of the economic activities of PWDs in the Philippines, where, among developing countries, disability-related legislation is relatively progressive. In 2008, a field survey was conducted in cooperation with Disability People's Organizations using a tailor-made questionnaire in Metro Manila. The explanatory variables of income of PWDs were examined using Mincer regression. The conclusions are as follows. (1) There is remarkable income disparity among PWDs, differing with education and sex. (2) After controlling for PWDs' characteristics, it was found that female PWDs are likely to earn less than male PWDs. Such a significant income gap between men and women among PWDs is remarkable in the Philippines, where gender difference in income is generally small. This finding suggests that female PWDs are doubly disadvantaged in earning income.	[Albert, Jose Ramon; Reyes, Celia; Tabuga, Aubrey D.] Philippine Inst Dev Studies, Manila, Philippines; [Mori, Soya; Yamagata, Tatsufumi] JETRO, Inst Econ Dev, Chiba, Chiba, Japan	Yamagata, T (reprint author), Japan External Trade Org, Inst Econ Dev, Mihama Ku, 3-2-2 Wakaba, Chiba, Chiba 2618545, Japan.	tatsufumi_yamagata@ide.go.jp					Albert Jose Ramon, 2010, 259 IDE; Altman BM, 2006, RES SOC SCI DISABIL, V4, P1; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Yeo R, 2003, WORLD DEV, V31, P571, DOI 10.1016/S0305-750X(02)00218-8; Loeb M, 2008, DISABIL SOC, V23, P311, DOI 10.1080/09687590802038803; Card D., 1999, HDB LABOR EC A, V3A; Eide Arne H., 2011, LIVING CONDITIONS PE; Eide Arne H., 2011, DISABILITY POVERTY G; Eide Arne H., 2003, STF78A034512 SINTEF; Hausmann Ricardo, 2010, GLOBAL GENDER GAP RE; Illo Jeanne Frances, 1997, WOMEN PHILIPPINES; Lamichhane K, 2013, ECON EDUC REV, V37, P85, DOI 10.1016/j.econedurev.2013.08.007; Lanzona LA, 1998, J DEV ECON, V56, P27, DOI 10.1016/S0304-3878(98)00051-0; Maluccio John, 1998, 54 FCND INT FOOD POL; MINCER J, 1958, J POLIT ECON, V66, P281, DOI 10.1086/258055; National Statistics Office (NSO), 2004, 2000 CENS POP HOUS; Reyes Celia M., 2015, POVERTY REDUCTION DI; Schady NR, 2003, OXFORD B ECON STAT, V65, P171, DOI 10.1111/1468-0084.00042; United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), 2000, STUD WOM DEV, V3; Willis Robert J, 1986, HDB LABOR EC, V1; Yamagata Tatsufumi, 2015, POVERTY REDUCTION DI; Yamauchi F, 2013, ECON EDUC REV, V32, P196, DOI 10.1016/j.econedurev.2012.09.003; Yamauchi F, 2005, ECON DEV CULT CHANGE, V53, P959, DOI 10.1086/429151; Yap Josef, 2009, JOINT RES PROGRAM SE, V151	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	DEC	2015	53	4					289	302		10.1111/deve.12090		14	Economics; Planning & Development	Business & Economics; Public Administration	CW8UJ	WOS:000365274500003		
J	Tahara, F				Tahara, Fumiki			Local Societies and Rural Development: Self-organization and Participatory Development in Asia	DEVELOPING ECONOMIES			English	Book Review									[Tahara, Fumiki] Univ Tokyo, Tokyo, Japan	Tahara, F (reprint author), Univ Tokyo, Tokyo, Japan.						SHIGETOMI S, 2014, LOCAL SOC RURAL DEV	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	DEC	2015	53	4					305	308		10.1111/deve.12092		4	Economics; Planning & Development	Business & Economics; Public Administration	CW8UJ	WOS:000365274500005		
J	Yamada, T				Yamada, Takumi			Construction of lattices of solvable Lie groups from a viewpoint of matrices	DIFFERENTIAL GEOMETRY AND ITS APPLICATIONS			English	Article						Solvable Lie group; Lattice; Homogeneous space	KAHLER STRUCTURES; COMPACT SOLVMANIFOLDS	In this paper, we reconstruct lattices of famous solvable Lie groups from a viewpoint of matrices. As an application, we construct examples of solvable Lie groups which admit lattices. (C) 2015 Elsevier B.V. All rights reserved.	[Yamada, Takumi] Shimane Univ, Dept Math, Matsue, Shimane 6908504, Japan	Yamada, T (reprint author), Shimane Univ, Dept Math, Nishikawatsu Cho 1060, Matsue, Shimane 6908504, Japan.	t_yamada@riko.shimane-u.ac.jp					BENSON C, 1990, P AM MATH SOC, V108, P971, DOI 10.2307/2047955; Fernandez M, 1996, OSAKA J MATH, V33, P19; Sawai H, 2007, TOPOL APPL, V154, P3125, DOI 10.1016/j.topol.2007.08.006; NOMIZU K, 1954, ANN MATH, V59, P531, DOI 10.2307/1969716; Sawai H, 2012, OSAKA J MATH, V49, P1087; Auslander L., 1977, CBMS REGIONAL C SERI, V34; DEANDRES LC, 1989, GEOMETRIAE DEDICATA, V29, P227; Hasegawa K, 2005, J SYMPLECT GEOM, V3, P749; Nakamura I., 1975, J DIFFER GEOM, V10, P85; Sakane Y., 1976, OSAKA J MATH, V13, P187; Sawai H, 2005, TOPOL APPL, V149, P85, DOI 10.1016/j.topol.2004.09.002; Yamada T., 2002, TOKYO J MATH, V25, P261; Yamada T., 2005, TSUKUBA J MATH, V29, P79	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-2245	1872-6984		DIFFER GEOM APPL	Differ. Geom. Appl.	DEC	2015	43						45	55		10.1016/j.difgeo.2015.09.003		11	Mathematics, Applied; Mathematics	Mathematics	CX0FT	WOS:000365373000003		
J	Hosaka, T				Hosaka, Tetsuya			On equivariant homeomorphisms of boundaries of CAT(0) groups and Coxeter groups	DIFFERENTIAL GEOMETRY AND ITS APPLICATIONS			English	Article						CAT(0) space; CAT(0) group; Boundary; Geometric action; Equivariant homeomorphism; Coxeter group	ORBIT EQUIVALENCE RIGIDITY; NONPOSITIVE CURVATURE; IDEAL BOUNDARIES; GEODESIC SPACES; REFLECTIONS; MANIFOLD	In this paper, we investigate an equivariant homeomorphism of the boundaries partial derivative X and partial derivative Y of two proper CAT(0) spaces X and Y on which a CAT(0) group G acts geometrically. We provide a sufficient condition and an equivalent condition to obtain a G-equivariant homeomorphism of the boundaries partial derivative X and partial derivative Y as a continuous extension of the quasi-isometry phi : Gx(0) -> Gy(0) defined by phi(gx(0)) = gy(0) where x(0) is an element of X and y(0) is an element of Y. In this paper, we say that a CAT(0) group G is eguivariant (boundary) rigid, if G determines its ideal boundary by the equivariant homeomorphisms as above. As an application, we introduce some examples of (non-)equivariant rigid CAT(0) groups and we show that if Coxeter groups W-1 and W-2 are equivariant rigid as reflection groups, then so is W-1 * W-2. We also provide a conjecture on non-rigidity of boundaries of some CAT(0) groups. (C) 2015 Elsevier B.V. All rights reserved.	[Hosaka, Tetsuya] Shizuoka Univ, Dept Math, Suruga Ku, Shizuoka 4228529, Japan	Hosaka, T (reprint author), Shizuoka Univ, Dept Math, Suruga Ku, Shizuoka 4228529, Japan.	hosaka.tetsuya@shizuoka.ac.jp			JSPS KAKENHI [25800039]	This work was partly supported by JSPS KAKENHI Grant Number 25800039.	Alexandrov A. D., 1986, RUSS MATH SURV, V41, P1; Croke CB, 2002, GEOM FUNCT ANAL, V12, P479, DOI 10.1007/s00039-002-8255-7; Swenson EL, 1999, J DIFFER GEOM, V53, P327; Yamagata S, 2009, ADV STU P M, V55, P345; Croke CB, 2000, TOPOLOGY, V39, P549, DOI 10.1016/S0040-9383(99)00016-6; Hosaka T, 2003, P JPN ACAD A-MATH, V79, P33; Monod N, 2006, ANN MATH, V164, P825; Mihalik M, 2007, J GROUP THEORY, V10, P531, DOI 10.1515/JGT.2007.042; Papasoglu P, 2009, GEOM FUNCT ANAL, V19, P558, DOI 10.1007/s00039-009-0012-8; Hosaka T, 2012, ROCKY MT J MATH, V42, P1207, DOI 10.1216/RMJ-2012-42-4-1207; Dranishnikov AN, 2001, TOPOL APPL, V110, P29, DOI 10.1016/S0166-8641(99)00172-8; Hosaka T, 2004, HOUSTON J MATH, V30, P705; Caprace PE, 2010, GEOM FUNCT ANAL, V19, P1296, DOI 10.1007/s00039-009-0042-2; Caprace PE, 2011, GEOM FUNCT ANAL, V21, P851, DOI 10.1007/s00039-011-0126-7; Furman A, 2001, GEOM FUNCT ANAL, V11, P30, DOI 10.1007/PL00001671; Monod N, 2006, J AM MATH SOC, V19, P781, DOI 10.1090/S0894-0347-06-00525-X; Hruska GC, 2005, TOPOLOGY, V44, P441, DOI 10.1016/j.top.2004.10.001; [Anonymous], 2009, DISCRETE GROUPS GEOM; Hosaka T, 2002, TOPOL APPL, V122, P565, DOI 10.1016/S0166-8641(01)00196-1; Fischer H, 2003, TOPOLOGY, V42, P423, DOI 10.1016/S0040-9383(02)00014-9; Mihalik M, 1999, J LOND MATH SOC, V60, P757, DOI 10.1112/S0024610799008030; Mooney C, 2009, FUND MATH, V203, P97, DOI 10.4064/fm203-2-1; DAVIS MW, 1983, ANN MATH, V117, P293, DOI 10.2307/2007079; Bartels A, 2012, ANN MATH, V175, P631, DOI 10.4007/annals.2012.175.2.5; Hosaka T, 2006, TOPOL APPL, V153, P1860, DOI 10.1016/j.topol.2005.06.011; Wilson JM, 2005, J GROUP THEORY, V8, P229, DOI 10.1515/jgth.2005.8.2.229; Furman A, 1999, ANN MATH, V150, P1083, DOI 10.2307/121063; Geoghegan R, 2007, TOPOLOGY, V46, P129, DOI 10.1016/j.top.2006.12.002; Kida Y, 2010, ANN MATH, V171, P1851; Bestvina M, 1996, MICH MATH J, V43, P123; Bowers PL, 1996, GLASGOW MATH J, V38, P177; Dranishnikov AN, 1999, J PURE APPL ALGEBRA, V137, P139, DOI 10.1016/S0022-4049(97)00202-8; Hosaka T, 2012, MATH Z, V272, P1037, DOI 10.1007/s00209-011-0972-x; Bourbaki N., 1981, GROUPES ALGEBRES LIE; Bridson M. R., 1999, METRIC SPACES NONPOS; Brown K. S., 1980, BUILDINGS; Coornaert M., 1993, LECT NOTES MATH, V1539; Davis M. W., 2002, HDB GEOMETRIC TOPOLO, P373; Ghys E., 1990, PROGR MATH, V83; GROMOV M, 1991, LECT NOTES MATH, V1504, P39; Gromov M., 1993, LONDON MATH SOC LECT, V2, P1; Gromov M., 1987, MATH SCI RES I PUBL, V8, P75, DOI DOI 10.1007/978-1-4613-9586-7_3.MR919829; Hosaka T., 2011, TSUKUBA J MATH, V35, P153; Humphreys J.E., 1990, REFLECTION GROUPS CO; Mooney C., 2008, ALGEBR GEOM TOPOL, V8, P1667; Mostow G. D., 1968, PUBL MATH-PARIS, P53, DOI 10.1007/BF02684590; Mostow George D., 1973, ANN MATH STUDIES, V78; Moussong G., 1988, THESIS; Radcliffe D., 2001, THESIS	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-2245	1872-6984		DIFFER GEOM APPL	Differ. Geom. Appl.	DEC	2015	43						68	94		10.1016/j.difgeo.2015.09.004		27	Mathematics, Applied; Mathematics	Mathematics	CX0FT	WOS:000365373000006		
J	Yasumoto, M				Yasumoto, Masashi			Discrete maximal surfaces with singularities in Minkowski space	DIFFERENTIAL GEOMETRY AND ITS APPLICATIONS			English	Article						Discrete differential geometry; Maximal surface; Singularity		We describe discrete maximal surfaces with singularities in 3-dimensional Minkowski space and give a Weierstrass type representation for them. In the smooth case, maximal surfaces (spacelike surfaces with mean curvature identically 0) in Minkowski 3-space generally have certain singularities. We give a criterion that naturally describes the "singular set" for discrete maximal surfaces, including a classification of the various types of singularities that are possible in the discrete case. (C) 2015 Elsevier B.V. All rights reserved.	[Yasumoto, Masashi] Kobe Univ, Grad Sch Sci, Dept Math, Nada Ku, Kobe, Hyogo 6578501, Japan	Yasumoto, M (reprint author), Kobe Univ, Grad Sch Sci, Dept Math, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	myasu@math.kobe-u.ac.jp			JSPS/FWF bilateral joint project "Transformations and Singularities" between Austria and Japan;  [26-3154]	The author thanks Wayne Rossman, Udo Hertrich-Jeromin and Tim Hoffmann for helpful discussions, and he was partly supported by the Grant-in-Aid for JSPS Fellows Number 26-3154 and JSPS/FWF bilateral joint project "Transformations and Singularities" between Austria and Japan.	Bobenko AI, 1999, OXF LEC S MATH APPL, V16, P3; Pottmann H, 2010, ADV COMPUT MATH, V33, P45, DOI 10.1007/s10444-009-9119-6; Bobenko AI, 2010, MATH ANN, V348, P1, DOI 10.1007/s00208-009-0467-9; Bobenko AI, 2009, INT MATH RES NOTICES, P1976, DOI 10.1093/imrn/rnp008; Bobenko A. I., 1999, CRM P LECT NOTES, V255, P97; Bobenko A.I., 2008, GRADUATE STUDIES MAT, V98; Burstall F., 2014, RIMS KOKYUROKU, V1880, P133; Burstall F, 2015, GEOMETRIAE DEDICATA, V174, P1, DOI 10.1007/s10711-014-0001-4; Burstall F., ARXIV14061293; Hertrich-Jeromin U., 2003, LONDON MATH SOC LECT, V300; Hoffmann T., 2009, COE LECT NOTE; Kinoshita Y., 2010, OCAMI STUD, V3, P1; Kobayashi O., 1983, TOKYO J MATH, V6, P297; Bobenko A, 1996, J REINE ANGEW MATH, V475, P187; Umehara M., 2006, HOKKAIDO MATH J, V35, P13	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-2245	1872-6984		DIFFER GEOM APPL	Differ. Geom. Appl.	DEC	2015	43						130	154		10.1016/j.difgeo.2015.09.006		25	Mathematics, Applied; Mathematics	Mathematics	CX0FT	WOS:000365373000009		
J	Ohno, S; Sakai, T; Urakawa, H				Ohno, Shinji; Sakai, Takashi; Urakawa, Hajime			Biharmonic homogeneous hypersurfaces in compact symmetric spaces	DIFFERENTIAL GEOMETRY AND ITS APPLICATIONS			English	Article						Symmetric space; Symmetric triad; Hermann action; Harmonic map; Biharmonic map	CURVATURE VECTOR; HERMANN ACTIONS; SUBMANIFOLDS	In this paper, we study biharmonic hypersurfaces in Einstein manifolds. Then, we determine all the biharmonic hypersurfaces in irreducible symmetric spaces of compact type which are regular orbits of commutative Hermann actions of cohomogeneity one. (C) 2015 Elsevier B.V. All rights reserved.	[Ohno, Shinji; Sakai, Takashi] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan; [Urakawa, Hajime] Tohoku Univ, Inst Int Educ, Sendai, Miyagi 9808576, Japan	Sakai, T (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, Minami Osawa 1-1, Hachioji, Tokyo 1920397, Japan.	oono-shinji@ed.tmu.ac.jp; sakai-t@tmu.ac.jp; urakawa@math.is.tohoku.ac.jp			Japan Society for the Promotion of Science [26400073, 25400154]	The second author was supported by Grant-in-Aid for Scientific Research (C) No. 26400073, Japan Society for the Promotion of Science. The third author was supported by Grant-in-Aid for Scientific Research (C) No. 25400154, Japan Society for the Promotion of Science.	Loubeau E, 2007, T AM MATH SOC, V359, P5239, DOI 10.1090/S0002-9947-07-03934-7; HASANIS T, 1995, MATH NACHR, V172, P145, DOI 10.1002/mana.19951720112; Ikawa O, 2001, OSAKA J MATH, V38, P923; Ikawa O, 2011, J MATH SOC JPN, V63, P79, DOI 10.2969/jmsj/06310079; Nakauchi N, 2013, RESULTS MATH, V63, P467, DOI 10.1007/s00025-011-0209-7; Ou YL, 2012, MICH MATH J, V61, P531; Akutagawa K, 2013, GEOMETRIAE DEDICATA, V164, P351, DOI 10.1007/s10711-012-9778-1; Nakauchi N, 2011, ANN GLOB ANAL GEOM, V40, P125, DOI 10.1007/s10455-011-9249-1; Defever F, 1998, MATH NACHR, V196, P61; Sasahara T, 2005, PUBL MATH-DEBRECEN, V67, P285; Kollross A, 2002, T AM MATH SOC, V354, P571, DOI 10.1090/S0002-9947-01-02803-3; Ikawa O, 2009, J MATH SOC JPN, V61, P437, DOI 10.2969/jmsj/06120437; Nakauchi N, 2014, GEOMETRIAE DEDICATA, V169, P263, DOI 10.1007/s10711-013-9854-1; Caddeo R., 2001, CONT MATH, V288, P286; Chen B.Y., 1991, SOOCHOW J MATH, V17, P169; Eells J., 1983, CBMS REGIONAL C SERI, V50; GUOYING JIANG, 2009, NOTE MAT, V28, P209; Helgason S., 1978, DIFFERENTIAL GEOMETR; Ichiyama T., 2009, NOTE MATEMATICA, V28, P233; ICHIYAMA T., 2010, NOTE MAT, V30, P15; Ikawa O., 2012, P WORKSH DIFF GEOM S, P220; Ishihara S., 1975, HOKKAIDO MATH J, V4, P234; Kobayashi S., 1963, FDN DIFFERENTIAL GEO, VI; Koiso N., 2014, ARXIV14085494V1; MONTALDO S., 2006, REV UNION MAT ARGENT, V47, P1; Oniciuc C., 2002, AN STIINT U AL I CUZ, V48, P237; Ou Y. -L., ARXIV10061838V1	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-2245	1872-6984		DIFFER GEOM APPL	Differ. Geom. Appl.	DEC	2015	43						155	179		10.1016/j.difgeo.201.5.09.005		25	Mathematics, Applied; Mathematics	Mathematics	CX0FT	WOS:000365373000010		
J	Hagihara, A; Onozuka, D; Nagata, T; Abe, T; Hasegawa, M; Nabeshima, Y				Hagihara, Akihito; Onozuka, Daisuke; Nagata, Takashi; Abe, Takeru; Hasegawa, Manabu; Nabeshima, Yoshihiro			Ambulance Dispatches From Unaffected Areas After the Great East Japan Earthquake: Impact on Emergency Care in the Unaffected Areas	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						disaster planning; emergency medical services; epidemiological methods	HOSPITAL CARDIAC-ARREST; PREPAREDNESS	Objective Although dispatching ambulance crews from unaffected areas to a disaster zone is inevitable when a major disaster occurs, the effect on emergency care in the unaffected areas has not been studied. We evaluated whether dispatching ambulance crews from unaffected prefectures to those damaged by the Great East Japan Earthquake was associated with reduced resuscitation outcomes in out-of-hospital cardiac arrest (OHCA) cases in the unaffected areas. Methods We used the Box-Jenkins transfer function model to assess the relationship between ambulance crew dispatches and return of spontaneous circulation (ROSC) before hospital arrival or 1-month survival after the cardiac event. Results In a model whose output was the rate of ROSC before hospital arrival, dispatching 1000 ambulance crews was associated with a 0.474% decrease in the rate of ROSC after the dispatch in the prefectures (p=0.023). In a model whose output was the rate of 1-month survival, dispatching 1000 ambulance crews was associated with a 0.502% decrease in the rate of 1-month survival after the dispatch in the prefectures (p=0.011). Conclusions The dispatch of ambulances from unaffected prefectures to earthquake-stricken areas was associated with a subsequent decrease in the ROSC and 1-month survival rates in OHCA cases in the unaffected prefectures. (Disaster Med Public Health Preparedness. 2015;9:609-613)	[Hagihara, Akihito; Onozuka, Daisuke; Nabeshima, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Serv Management & Policy, Fukuoka 8128582, Japan; [Nagata, Takashi] Kyushu Univ, Dept Emergency, Fukuoka 8128582, Japan; [Nagata, Takashi] Kyushu Univ, Crit Care Ctr, Fukuoka 8128582, Japan; [Abe, Takeru] Yokohama City Univ, Med Ctr, Adv Crit Care & Emergency Ctr, Yokohama, Kanagawa, Japan; [Hasegawa, Manabu] Shimonoseki City Welf Dept, Yamaguchi, Japan	Hagihara, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Serv Management & Policy, Higashi Ku, Fukuoka 8128582, Japan.	hagihara@hsmp.med.kyushu-u.ac.jp	Onozuka, Daisuke/F-5067-2014	Onozuka, Daisuke/0000-0001-9596-9188	MEXT KAKENHI [24390130]	This work was supported by MEXT KAKENHI grant number 24390130. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kossobokov VG, 2013, NAT HAZARDS, V69, P1155, DOI 10.1007/s11069-012-0198-1; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; CHETWYND J, 1988, BRIT J ADDICT, V83, P409; Ishii M, 2013, DISASTER MED PUBLIC, V7, P507, DOI 10.1017/dmp.2013.97; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Savoia E, 2009, AM J PREV MED, V37, P150, DOI 10.1016/j.amepre.2009.03.023; CUMMINS RO, 1991, CIRCULATION, V84, P960; Emergency Disaster Countermeasures Headquarters, EM DIS COUNT HEADQ; Mc Gee M, 2000, INTRO TIME SERIES AN	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	DEC	2015	9	6					609	613		10.1017/dmp.2015.92		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CW9MP	WOS:000365323100004		
J	Ochi, S; Kato, S; Kobayashi, K; Kanatani, Y				Ochi, Sae; Kato, Shigeaki; Kobayashi, Kenichi; Kanatani, Yasuhiro			Disaster Vulnerability of Hospitals: A Nationwide Surveillance in Japan	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						disaster preparedness; hospital; nationwide surveillance; vulnerability analysis	EARTHQUAKE	Objective Hospital preparedness against disasters is key to achieving disaster mitigation for health. To gain a holistic view of hospitals in Japan, one of the most disaster-prone countries, a nationwide surveillance of hospital preparedness was conducted. Methods A cross-sectional, paper-based interview was conducted that targeted all of the 8701 registered hospitals in Japan. Preparedness was assessed with regard to local hazards, compliance to building code, and preparation of resources such as electricity, water, communication tools, and transportation tools. Results Answers were obtained from 6122 hospitals (response rate: 70.3%), among which 20.5% were public (national or city-run) hospitals and others were private. Eight percent were the hospitals assigned as disaster-base hospitals and the others were non-disaster-base hospitals. Overall compliance to building code, power generators, water tanks, emergency communication tools, and helicopter platforms was 90%, 84%, 95%, 43%, and 22%, respectively. Conclusion Major vulnerabilities in logistics in mega-cities and stockpiles required for chronic care emerged from the results of this nationwide surveillance of hospitals in Japan. To conduct further intensive surveillance to meet community health needs, appropriate sampling methods should be established on the basis of this preliminary study. Holistic vulnerability analysis of community hospitals will lead to more robust disaster mitigation at the local level. (Disaster Med Public Health Preparedness. 2015;9:614-618)	[Ochi, Sae; Kanatani, Yasuhiro] Natl Inst Publ Hlth, Dept Crisis Management, Saitama, Japan; [Ochi, Sae] Soma Cent Hosp, Dept Internal Med, Soma City, Fukushima 9760016, Japan; [Ochi, Sae] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London, England; [Kato, Shigeaki] Soma Cent Hosp, Dept Radiat Protect, Soma City, Fukushima 9760016, Japan; [Kobayashi, Kenichi] Natl Inst Publ Hlth, Dept Environm Hlth, Saitama, Japan	Ochi, S (reprint author), Soma Cent Hosp, Okinouchi 3-5-18, Soma City, Fukushima 9760016, Japan.	ochisae1024@gmail.com			Japan Ministry of Health, Labour, and Welfare	This research was funded by the Japan Ministry of Health, Labour, and Welfare.	[Anonymous], 2011, KAHOKU SHINPO; Schultz CH, 2003, NEW ENGL J MED, V348, P1349, DOI 10.1056/NEJMsa021807; Mulyasari F, 2013, INT J DISAST RISK SC, V4, P89, DOI 10.1007/s13753-013-0010-1; Redlener I, 2012, NEW ENGL J MED, V367, P2269, DOI 10.1056/NEJMp1213486; Ukai T, 1997, RENAL FAILURE, V19, P633; Barbera JA, 2009, DISASTER MED PUBLIC, V3, pS74, DOI 10.1097/DMP.0b013e31819f754c; Nagata Takashi, 2006, Prehosp Disaster Med, V21, P345; Roggen Inge, 2014, Prehosp Disaster Med, V29, P516, DOI 10.1017/S1049023X14000892; Tanaka H, 1998, J Emerg Med, V16, P439, DOI 10.1016/S0736-4679(98)00014-6; Wold Health Organization, 2015, HOSP SAF IND GUID EV	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	DEC	2015	9	6					614	618		10.1017/dmp.2015.101		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CW9MP	WOS:000365323100005		
J	Mulia, IE; Asano, T; Tkalich, P				Mulia, Iyan E.; Asano, Toshiyuki; Tkalich, Pavel			Retrieval of missing values in water temperature series using a data-driven model	EARTH SCIENCE INFORMATICS			English	Article						Water temperature; Artificial neural network; Genetic algorithm; Kohonen self-organizing map; Wavelet decomposition; Water quality	SELF-ORGANIZING MAP; NEURAL-NETWORK; TIME-SERIES; PREDICTION; PARAMETERS; SENSORS; ARIMA	A measurement buoy with attached sensors has been deployed at our study area to monitor hydrodynamics, water properties, and water quality conditions. High-resolution temporal data have been collected and streamed into an online system that is accessible in nearly real-time. However, in certain circumstances the sensors may fail to provide continuous and high quality data. This results in gaps or corrupted values. The aim of this study was to reconstruct the faulty values. This paper proposes a method based on a data-driven model, using an Artificial Neural Network combined with a Genetic Algorithm to generate a synthetic data series. The generated data can be used as a patch for the incomplete measured data. Additional improvements were achieved by removing seasonal patterns from the original time series using a wavelet decomposition prior to the data-driven model training process. Comparisons with a standard missing-data imputation method using the Kohonen self-organizing map were made to further asses the performance of the proposed data-driven model. The algorithm was applied to water temperature data, but the same approach is applicable to other parameters of interest.	[Mulia, Iyan E.; Asano, Toshiyuki] Kagoshima Univ, Dept Ocean & Civil Engn, Kagoshima 8900065, Japan; [Tkalich, Pavel] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore	Mulia, IE (reprint author), Kagoshima Univ, Dept Ocean & Civil Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	iyan.e.m@gmail.com; asano@oce.kagoshima-u.ac.jp; tmspt@nus.edu.sg			Public Utility Board of Singapore	The authors are grateful to the Public Utility Board of Singapore for sponsoring this work and to all Tropical Marine Science Institute (TMSI) colleagues for their valuable contributions to the success of this study. We would also like to thank the anonymous reviewers for their insightful comments and suggestions to improve the quality of the paper.	Aguilar-Martinez S, 2009, INT J OCEANOGR, DOI [10.1155/2009/167239, DOI 10.1155/2009/167239]; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Corani G, 2005, ECOL MODEL, V185, P513, DOI 10.1016/j.ecolmodel.2005.01.008; De Pascalis F, 2012, ESTUAR COAST SHELF S, V114, P118, DOI 10.1016/j.ecss.2011.12.002; Breaker LC, 2009, OCEAN MODEL, V27, P82, DOI 10.1016/j.ocemod.2008.12.001; Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037; Zhai L, 2011, J MARINE SYST, V88, P285, DOI 10.1016/j.jmarsys.2011.05.005; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Manov DV, 2004, J ATMOS OCEAN TECH, V21, P958, DOI 10.1175/1520-0426(2004)021<0958:MFRBOM>2.0.CO;2; Behera MR, 2013, MAR POLLUT BULL, V77, P380, DOI 10.1016/j.marpolbul.2013.09.043; Mulia IE, 2013, J HYDRO-ENVIRON RES, V7, P279, DOI 10.1016/j.jher.2013.04.003; Pairaud IL, 2011, J MARINE SYST, V88, P20, DOI 10.1016/j.jmarsys.2011.02.010; Mwale FD, 2012, PHYS CHEM EARTH, V50-52, P34, DOI 10.1016/j.pce.2012.09.006; Kohonen T, 1996, P IEEE, V84, P1358, DOI 10.1109/5.537105; Babovic V, 2005, J MARINE SYST, V53, P1, DOI 10.1016/j.jmarsys.2004.05.028; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431; Lamrini B, 2011, NEURAL COMPUT APPL, V20, P575, DOI 10.1007/s00521-011-0526-5; Bixler GD, 2012, PHILOS T R SOC A, V370, P2381, DOI 10.1098/rsta.2011.0502; Gazzaz NM, 2012, MAR POLLUT BULL, V64, P2409, DOI 10.1016/j.marpolbul.2012.08.005; Hatzikos E, 2009, EXPERT SYST APPL, V36, P6773, DOI 10.1016/j.eswa.2008.08.051; Adeloye AJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010690; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Elshorbagy W, 2013, MAR POLLUT BULL, V73, P170, DOI 10.1016/j.marpolbul.2013.05.025; Delauney L, 2010, OCEAN SCI, V6, P503, DOI 10.5194/os-6-503-2010; May R, 2011, ARTIFICIAL NEURAL NETWORKS - METHODOLOGICAL ADVANCES AND BIOMEDICAL APPLICATIONS, P19; Singh KP, 2009, ECOL MODEL, V220, P888, DOI 10.1016/j.ecolmodel.2009.01.004; MALLAT SG, 1989, T AM MATH SOC, V315, P69, DOI 10.2307/2001373; Wei SK, 2012, HYDROL PROCESS, V26, P281, DOI 10.1002/hyp.8227; Chen H, 2010, 20 INT OFFSH POL ENG; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Haykin S., 2009, NEURAL NETWORKS LEAR; Lavenberg K, 1944, Q APPL MATH, V2, P164; Mulia IE, 2013, P JSCE, V4, P70; Nelson M, 1999, J FORECASTING, V18, P359, DOI 10.1002/(SICI)1099-131X(199909)18:5<359::AID-FOR746>3.0.CO;2-P; Pang WC, 2003, SINGAPORE MARITIME P, P151; Patil K, 2013, INT J OCEANOGR, DOI [10.1155/2013/302479, DOI 10.1155/2013/302479]; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sundarambal P., 2008, MARINE POLLUTION B, V56, P1586	38	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1865-0473	1865-0481		EARTH SCI INFORM	Earth Sci. Inform.	DEC	2015	8	4					787	798		10.1007/s12145-015-0210-x		12	Computer Science, Interdisciplinary Applications; Geosciences, Multidisciplinary	Computer Science; Geology	CW8RM	WOS:000365266900006		
J	Nagai, H; Fuchiwaki, Y				Nagai, Hidenori; Fuchiwaki, Yusuke			Portable Microfluidic System for Rapid Genetic Testing	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						polymerase chain reaction (PCR); genetic testing; point of care testing (POCT); microfluidics	POLYMERASE-CHAIN-REACTION; FLOW; PCR; AMPLIFICATION; CHIP; MUTATIONS; DNA	Polymerase chain reaction (PCR) is a key technology of genetic testing, but the long thermal cycling time has been a problem in achieving rapid diagnosis of pathogenic organisms and cancer. We describe a simple, portable, and rapid genetic testing system based on ultrafast segment flow and fluorescent detection. In particular, we improved the flow-through PCR to accelerate the thermal cycling time and simplify the operation for practical use. The PCR solution was injected in a small volume of about several microliters by an air syringe, and flowed as segment flow. The segment of PCR solution was moved in a serpentine microchannel on a microfluidic device over two temperature zones for denaturation and annealing/extension reactions. The base plate formed upon the serpentine microchannel pattern was made of cyclo-olefin polymer (COP) and covered with a thin transparent film. Furthermore, a specialized portable system was developed for the microfluidic device of a segment-flow PCR. Heater units, a syringe pump, a fluorescence detector, and PC were integrated in a suitcase for portable use. Using this portable system, a microorganism modeling anthrax and a point mutation of FGFR3 gene were successfully detected within 6.5 min. (C) 2015 Wiley Periodicals, Inc.	[Nagai, Hidenori; Fuchiwaki, Yusuke] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan	Nagai, H (reprint author), Natl Inst Adv Ind Sci & Technol, Tokyo, Japan.						Fuchiwaki Y, 2011, ANAL SCI, V27, P225, DOI 10.2116/analsci.27.225; WITTWER CT, 1989, NUCLEIC ACIDS RES, V17, P4353, DOI 10.1093/nar/17.11.4353; Wheeler EK, 2011, ANALYST, V136, P3707, DOI 10.1039/c1an15365j; Yamanaka K, 2011, ANALYST, V136, P2064, DOI 10.1039/c1an15066a; Schneegass I, 2001, LAB CHIP, V1, P42, DOI 10.1039/b103846j; King C, 2007, MICROFLUID NANOFLUID, V3, P463, DOI 10.1007/s10404-006-0139-y; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Miyake M, 2007, BIOCHEM BIOPH RES CO, V362, P865, DOI 10.1016/j.bbrc.2007.08.092; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P349; Nagai H, 2001, BIOSENS BIOELECTRON, V16, P1015, DOI 10.1016/S0956-5663(01)00248-2; Hashimoto M, 2006, BIOSENS BIOELECTRON, V21, P1915, DOI 10.1016/j.bios.2006.01.014; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Fuchiwaki Y, 2011, BIOSENS BIOELECTRON, V27, P88, DOI 10.1016/j.bios.2011.06.022	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					1	6		10.1002/ecj.11753		6	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500001		
J	Morioka, K; Asano, D				Morioka, Kazuyuki; Asano, David			A Method of Constructing Phase Spreading Sequences for CPM-CDMA Systems	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						continuous phase modulation; continuous phase frequency shift keying; minimum shift keying; Gaussian minimum shift keying; code division multiple access; phase spreading sequence	MULTIPLE-ACCESS COMMUNICATIONS; PERFORMANCE; DESIGN	In this paper, a construction method for phase spreading sequences that is suitable for CPM-CDMA systems is proposed. Using these sequences, the performance of asynchronous CPM-CDMA systems with traditional BPSK/OQPSK-CDMA systems and the trade-off between the spreading factor and modulation parameters are considered. Numerical results show that the optimal modulation index for CPFSK-CDMA systems is h=0.5 and the performance is better for lower values of BbTc in GMSK-CDMA systems. Also, we found that the user capacities of MSK-CDMA systems are 2.3 times larger than those of BPSK/OQPSK-CDMA systems. (C) 2015 Wiley Periodicals, Inc.	[Morioka, Kazuyuki] Shinshu Univ, Grad Sch Engn, Nagano, Japan; [Asano, David] Shinshu Univ, Dept Comp Sci & Engn, Nagano, Japan	Morioka, K (reprint author), Shinshu Univ, Grad Sch Engn, Nagano, Japan.						Andrews K, 2002, INTERPLANETARY NETWO, V151, P1; Cheng S, 2009, IEEE T WIREL COMMUN, V8, P1792, DOI 10.1109/TWC.2009.071311; LOK TM, 1994, IEEE J SEL AREA COMM, V12, P716, DOI 10.1109/49.286678; Hsu RT, 1998, IEEE T COMMUN, V46, P533, DOI 10.1109/26.664309; LANE WD, 1990, IEEE J SEL AREA COMM, V8, P728, DOI 10.1109/49.56380; LEHNERT JS, 1992, IEEE T COMMUN, V40, P1119, DOI 10.1109/26.142802; Landolsi MA, 1999, IEEE T COMMUN, V47, P1737, DOI 10.1109/26.803509; GARBER FD, 1981, IEEE T COMMUN, V29, P305, DOI 10.1109/TCOM.1981.1094989; AULIN T, 1982, IEEE T COMMUN, V30, P1199, DOI 10.1109/TCOM.1982.1095574; Asano DK, 1998, P 1998 IEEE 5 INT S, V1, P9; Hsu F. T., 1994, IEEE Transactions on Communications, V42, DOI 10.1109/TCOMM.1994.583414; Lampe LHJ, 2003, ICC 03 11 15 MAY, V5, P3282, DOI 10.1109/ICC.2003.1204051; Morioka K, 2011, P IEICE GEN C; Svensson A, 1985, P C INF SCI SYST CIS, P526; Xiong F, 2000, DIGITAL MODULATION T; Yang F, 1999, GLOB TEL C 1999 GL B, V1, P914	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					7	16		10.1002/ecj.11755		10	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500002		
J	Matsuo, K; Aoki, Y				Matsuo, Kiyoshi; Aoki, Yoshimitsu			Depth Interpolation Using Tangent Planes on Superpixels of a Color Image	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						depth image interpolation; image segmentation; superpixel		This paper describes a method for accurately interpolating a low-resolution depth image using a high-resolution color image. In our method, first, tangent planes on each superpixel are estimated from sparse depth information and dense color information. Then, the neighboring superpixels that have smooth-connectable tangent planes are connected, and image segmentation to smooth surfaces is achieved. Finally, the low-resolution depth image is interpolated by using this smooth surface segmentation. In experiments with images from the Middlebury stereo data sets, our method interpolates each image at a high rate, and achieves the lowest error when compared to existing techniques. (C) 2015Wiley Periodicals, Inc.	[Matsuo, Kiyoshi] Keio Univ, Grad Sch Sci & Technol, Tokyo 108, Japan; [Aoki, Yoshimitsu] Keio Univ, Dept Elect, Grad Sch Sci & Technol, Tokyo 108, Japan	Matsuo, K (reprint author), Keio Univ, Grad Sch Sci & Technol, Tokyo 108, Japan.						Anderson D, 2005, INT C SENS TECHN, P2; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Levoy M, 2000, COMP GRAPH, P131; Garcia F, 2010, IEEE IMAGE PROC, P2805, DOI 10.1109/ICIP.2010.5651112; Hinterstoisser S, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P858, DOI 10.1109/ICCV.2011.6126326; Park J, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P1623; Bok Y, 2011, INT J COMPUT VISION, V94, P36, DOI 10.1007/s11263-010-0397-8; Jung JI, 2012, IEEE T CONSUM ELECTR, V58, P1399; Date, 2012, P VIS ENG WORKSH 201; Diebel J., 2006, NIPS, V18, P291; Kim YM, 2009, 2009 IEEE 12 INT C C, P1542, DOI 10.1109/ICCVW.2009.5457430; Kneip L, 2009, IEEE INT C ROB AUT, P1447; Kopf J., 2007, ACM T GRAPHIC, V26, P2, DOI DOI 10.1145/1276377.1276379; Levinshtein A, 2009, IEEE T PATTERN ANAL, V31, P2290, DOI 10.1109/TPAMI.2009.96; Nguyen H., 2012, INT J ANTENN PROPAG, V2012, P1; Rusu R.B., 2011, 2011 IEEE INT C ROB, P1; Scharstein D., 2007, IEEE C COMP VIS PATT, P1; Yang Q., 2007, IEEE C COMP VIS PATT, P1	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					17	29		10.1002/ecj.11756		13	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500003		
J	Kawashima, K; Mineta, T; Makino, E; Kawashima, T; Shibata, T				Kawashima, Kenta; Mineta, Takashi; Makino, Eiji; Kawashima, Takahiro; Shibata, Takayuki			Self-Align Fabrication of Narrow-Gapped Dual AFM Tip Using Si Trench Refilling with SOG and Magnetostrictive Film Stacked Dual Cantilever Formation	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						narrow-gapped; dual AFM tip; trench refilling with SOG; dual AFM cantilever; magnetostrictive film		This paper reports on a novel self-align fabrication process of narrow-gapped dual AFM (atomic force microscope) tip. The dual AFM tip was fabricated on (100) orientated Si substrate by using narrow trench etching, trench refilling with SOG (spin-on-glass), CMP (chemical-mechanical polishing), and Si crystalline anisotropic etching. Through the process, a sharp dual AFM tip with a gap of 500nm, which was defined only by the etched trench width, was successfully fabricated. Although another fabrication process using an acrylic-nitrile-styrene-epoxy resin refilling was also attempted, a dual tip was not obtained due to the poor adhesion of the resin in the silicon etching process. In addition, a dual AFM cantilever (magnetostrictive film/Si 2.0m) was formed by MEMS fabrication. The fabricated FePd 0.4m/Si 2.0m and Ni 1.3m/Si 2.0m cantilever were individually deflected to 1.4m at 300 Gauss and 0.4m at 240 Gauss due to effects of magnetic flux and negative magnetostriction, respectively. (C) 2015 Wiley Periodicals, Inc.	[Kawashima, Kenta] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan; [Mineta, Takashi] Yamagata Univ, Grad Sch Sci & Engn, Dept Mech Syst Engn, Yamagata 990, Japan; [Makino, Eiji] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori, Japan; [Kawashima, Takahiro; Shibata, Takayuki] Toyohashi Univ Technol, Toyohashi, Aichi, Japan	Kawashima, K (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan.				JKA First Research Subsidy;  [A-21246019];  [B-23360108]	This investigation was supported in part by Grants-in Aid for Scientific Research (A-21246019, B-23360108) and by a JKA First Research Subsidy. The silica sol for CMP was provided by Nitta Haas Inc., and Elionix Inc. provided assistance in electron beam lithography. The authors express their gratitude to all concerned.	Morita S, 2009, J MICRO-NANOLITH MEM, V8, DOI 10.1117/1.3142970; Furuya Y, 1998, MATER T JIM, V39, P1248; Chen PH, 2004, MICROELECTRON J, V35, P985, DOI 10.1016/j.mejo.2004.06.021; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; MARCUS RB, 1990, APPL PHYS LETT, V56, P236, DOI 10.1063/1.102841; Okazaki T, 2007, MATER TRANS, V48, P117, DOI 10.2320/matertrans.48.117; Kanezawa M, 2007, TRANSDUCERS '07 & Eurosensors XXI. 2007 14th International Conference on Solid-State Sensors, Actuators and Microsystems, DOI 10.1109/SENSOR.2007.4300232; Kawashima K, 2012, JSME ANN M; Kawashima K, 2012, IEEJ 29 SENS S SENS, P584; Kawashima K, 2012, 23 JSME C FRONT BIOE, P101; Mineta T, 2012, 38 INT C MICR; Morita Y, 2004, PACRIM CMP 2004, P53; Takahashi T, 2010, IEEJ T SENSORS MICRO, V130, P421; Umino A, 2009, JSME ANN M, V8, P238; Yamasaki T, 2007, T J SOC MECH ENG A, V73, P120	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					30	36		10.1002/ecj.11760		7	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500004		
J	Ohmura, M; Tanaka, T				Ohmura, Michiroh; Tanaka, Takeshi			Circuit Design Education by Introducing Circuit Diagram-Based CPU Design	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						circuit design education; CPU; programmable logic device		There are many subjects that relate to electrical and electronics circuits. Practical education for those subjects usually introduce hardware description languages such as VHDL and Verilog HDL, but it is not easy to understand the relation to basic logic circuits drawn as circuit diagrams. In this paper, we introduce practical education in which basic digital circuits are drawn, simulated, and executed on an experiment board with a programmable logic device, and then newly designed 2-bit CPUs which use those basic digital circuits are drawn, simulated, and executed on the experiment board. Students can learn basic digital circuits themselves, and their operations which relate to each other in the newly designed 2-bit CPU. The effectiveness of the newly introduced practical education is confirmed by tests and a questionnaire survey. (C) 2015 Wiley Periodicals, Inc.	[Ohmura, Michiroh; Tanaka, Takeshi] Hiroshima Inst Technol, Hiroshima, Japan	Ohmura, M (reprint author), Hiroshima Inst Technol, Hiroshima, Japan.						Amano H, 2013, DIGITAL CIRCUITS EVE, P1; [Anonymous], SYLL FAC COMP INF SC; [Anonymous], 2008, 1121 IEEJ INV COMM E, P1; [Anonymous], SYLL FAC COMP SCI SY; Ohmura M, 2011, IEEJ T FM, V131, P931; Shimura M., 2006, CURRENT STATUS RES M, P1; Sueyoshi T, 2001, IEICE T, VJ84-D-I, P917; Suzuki G., 2004, INTRO SYSTEM LSI DES, P1	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					46	54		10.1002/ecj.11764		9	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500006		
J	Takeuchi, N				Takeuchi, Nozomi			Comparison of One- and Zero-Dimensional Reaction Models of Liquid-Phase Radicals for Plasma Generated on Gas-Liquid Interface	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						plasma on gas-liquid interface; simulation of chemical reactions; mass transfer; radical	ELECTRICAL-DISCHARGE; HYDROXYL RADICALS; CORONA DISCHARGE; AQUEOUS-SOLUTION; MECHANISM	One- and zero-dimensional (0D) numerical models of plasma generated over a solution were established. Gas- and liquid-phase reactions and mass transfer through a gas-liquid interface for OH radical, hydrogen peroxide, and HO2 radical were considered, and the decomposition of acetic acid in water was evaluated. In a 1D model with a small diffusion coefficient (10(-9) m(2)/s) in liquid phase, the diffusion rate was the rate-limiting factor of the decomposition of acetic acid. With such a small diffusion coefficient, the concentrations of OH radical and acetic acid in the 0D model showed large differences from those in the 1D model. When the time scale of diffusion in the liquid phase was shorter than that of the decomposition reaction between OH radical and acetic acid, reasonable results were obtained in the 0D model. (C) 2015 Wiley Periodicals, Inc.	[Takeuchi, Nozomi] Tokyo Inst Technol, Tokyo, Japan	Takeuchi, N (reprint author), Tokyo Inst Technol, Tokyo, Japan.				JSPS [B-25790071]	This study was assisted by a JSPS Grant-in-Aid for Young Scientists (B-25790071).	Bruggeman P, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/4/045025; JOSHI AA, 1995, J HAZARD MATER, V41, P3, DOI 10.1016/0304-3894(94)00099-3; Tochikubo F, 2004, JPN J APPL PHYS 1, V43, P315, DOI 10.1143/JJAP.43.315; Matsui Y, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034015; Sahni M, 2006, IND ENG CHEM RES, V45, P5819, DOI 10.1021/ie0601504; Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001; PEYROUS R, 1989, J PHYS D APPL PHYS, V22, P1658, DOI 10.1088/0022-3727/22/11/015; Hieda J, 2008, J VAC SCI TECHNOL A, V26, P854, DOI 10.1116/1.2919139; Shimizu T, 2011, J PHOTOPOLYM SCI TEC, V24, P421, DOI 10.2494/photopolymer.24.421; Leitner NKV, 1996, J PHOTOCH PHOTOBIO A, V99, P137; Takeuchi N, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/1/015006; [Anonymous], 2011, HDB CHEM ENG; Daito S, 2000, JPN J APPL PHYS 1, V39, P4914, DOI 10.1143/JJAP.39.4914; Chirokov A., 2003, THESIS; Cussler EL, 2009, DIFFUSION MASS TRANS, P117; Cussler EL, 2009, DIFFUSION MASS TRANS, P237; Hashimoto K., 1993, CHEM REACTION ENG; Ishii Y, 2012, IEEJ T FM, V132, P428; PANDIS SN, 1989, J GEOPHYS RES-ATMOS, V94, P1105, DOI 10.1029/JD094iD01p01105; Yasuoka K., 2009, IEEJ T FM, V129, P15; Yasuoka K., 2009, INT J PLASMA ENV SCI, V3, P22	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					55	62		10.1002/ecj.11765		8	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500007		
J	Kamimura, K; Hayashi, H; Hatauchi, T				Kamimura, Kohei; Hayashi, Hitoshi; Hatauchi, Takaaki			Determination of Adjacent Nodes for Power-Efficient Wireless Sensor Networks	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						sensor network; mesh network; determination of adjacent nodes; low power consumption; reliability		This paper proposes a method for determination of adjacent nodes to facilitate the formation of power-efficient wireless sensor networks that are robust to channel variations caused by movement in the surrounding communication environment. Whereas conventional methods determine adjacent nodes in wireless sensor networks using one ID packet, our proposed method uses several ID packets that are collected in link investigation cycles. This method improves the battery life of the overall network system and thereby facilitates highly-reliable communication networks. (C) 2015 Wiley Periodicals, Inc.	[Kamimura, Kohei; Hayashi, Hitoshi] Sophia Univ, Tokyo, Japan; [Hatauchi, Takaaki] Fuji Elect Co Ltd, Tokyo, Japan	Kamimura, K (reprint author), Sophia Univ, Tokyo, Japan.						Analog Devices, 2011, ADF7023 J HIGH PERF, V9; [Anonymous], 2012, SIG U BUS AIR MESH C; Kominami D, 2009, 2009 6TH INTERNATIONAL SYMPOSIUM ON WIRELESS COMMUNICATION SYSTEMS (ISWCS 2009), P141, DOI 10.1109/ISWCS.2009.5285327; [Anonymous], 2006, WIRELESS MAC PHYS SP; [Anonymous], 2011, OP SIM SPEC VER 10; Buettner X, 2006, P 4 INT C EMB NETW S, P307; Fujiwara J, 2011, Patent No. [2011-61678, 201161678]; Hatauti T, 2008, IEEJ T ELECT INF SYS, V128, P1761, DOI 10.1541/ieejeiss.128.1761; Kagami O, 2010, NTT TECHNICAL REV, V8, P1; Maeki A, 2006, IEICE T COM B, VE89-B, P3438; Nishiyama H, 2006, MITSUBISHI ELECT TEC, V80, P552; Onodera K, 2007, Patent No. [2007, 181042, 2007181042]; Polastre J, 2006, P INT C EMB NETW SEN, P95; Rajendran V, 2003, P 1 INT C EMB NETW S, P181, DOI DOI 10.1145/958491.958513; Riverbed Technology Inc., 2013, OPNET MOD WIR MOD; Saito H, 2005, IEICE T B, VJ88-B, P2128; Shimizu T, 2013, IEICE TECH REP, V112, P275; Tobe Y., 2007, IEICE T B, VJ90-B, P711; van Hoesel LFW, 2004, INSS 04, P205	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					63	71		10.1002/ecj.11766		9	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500008		
J	Shiomitsu, E; Sakoda, T				Shiomitsu, Eiichi; Sakoda, Tatsuya			Characteristics of an Underwater Plasma Source with a Porous Glass Membrane	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						underwater plasma; OH radical; gas-liquid interface; advanced oxidation processes		The advanced oxidation process (AOP) with hydroxyl radicals (OH) is considered to be useful for water purification through oxidation; therefore, we proposed an underwater plasma source with a porous glass membrane which performed the functions of bubble supply and the formation of microdischarges. We observed bubble formation and light emission from discharges on the surface of the membrane using a high-speed camera and a spectroscope, respectively. In addition, the dependence of gas pressure on the generation of OH radical and the decomposition of recalcitrant organic matter were examined. The obtained results showed that AOP may be more effective when the operating gas pressure is set higher than a pressure which could form bubbles. (C) 2015Wiley Periodicals, Inc.	[Shiomitsu, Eiichi; Sakoda, Tatsuya] Miyazaki Univ, Miyazaki, Japan	Shiomitsu, E (reprint author), Miyazaki Univ, Miyazaki, Japan.						Sakoda T, 2008, JPN J APPL PHYS, V47, P8030, DOI 10.1143/JJAP.47.8030; Fukawa F, 2012, T IEEJ A, V132, P667; Ihara S, 2012, T IEEJ A, V132, P656; Kanazawa S, 2010, IESJ J, V34, P14; Kawano S, 2011, IESJ J, V31, P143; Kukizaki M, 2006, 51 MIYAZ PREF IND TE, P20; Michii T, 2011, T IEEJ A, V131, P853; Nakamuro K., 1994, ACTUAL USE OZONE ENV, P79; Saito T, 2012, T IEEJ A, V132, P656; Sakoda T, 2009, J PLASMA FUSION RES, V8, P623; Shibahara D, 2010, IEJ, V34, P2; Somiya I., 2004, OZONE HDB JAPAN OZON, P10; Sone Toshifumi, 2007, Transactions of the Institute of Electrical Engineers of Japan, Part A, V127, DOI 10.1541/ieejfms.127.574; Takahashi K, 2011, J IEEJ, V131, P76	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2015	98	12					72	79		10.1002/ecj.11772		8	Engineering, Electrical & Electronic	Engineering	CW9LZ	WOS:000365321500009		
J	Barrs, K				Barrs, Keith			Errors in the use of English in the Japanese linguistic landscape	ENGLISH TODAY			English	Article									[Barrs, Keith] Hiroshima Shudo Univ, English Language & Literature Dept, Hiroshima, Japan; [Barrs, Keith] Univ Leicester, Sch Educ, Leicester LE1 7RH, Leics, England	Barrs, K (reprint author), Hiroshima Shudo Univ, English Language & Literature Dept, Hiroshima, Japan.	keithbarrs@hotmail.com					Preston DR, 2004, J SOCIOLING, V8, P359, DOI 10.1111/j.1467-9841.2004.00265.x; Barrs K, 2011, ENGL TODAY, V27, P15, DOI 10.1017/S0266078411000320; Daulton F. E., 2008, JAPANS BUILT IN LEXI; Dougill John, 2008, ENGL TODAY, V24, P18; Hyde B, 2002, ENGL TODAY, V18, P3; Irwin M, 2011, STUD LANG C, V125, P1; Kay G., 1995, WORLD ENGLISH, V14, P67, DOI 10.1111/j.1467-971X.1995.tb00340.x; Seargeant P, 2009, CRIT LANG LIT STUD, P1; Stanlaw J, 2004, JAPANESE ENGLISH LAN; Thompson I., 2001, LEARNER ENGLISH TEAC, P296, DOI 10.1017/CBO9780511667121	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-0784	1474-0567		ENGL TODAY	Engl. Today	DEC	2015	31	4					30	33		10.1017/S026607841500036X		4	Linguistics; Language & Linguistics	Linguistics	CW7FU	WOS:000365164200006		
J	Park, H; Satoh, H; Miki, A; Urushihara, H; Sawada, Y				Park, Hyerim; Satoh, Hiroki; Miki, Akiko; Urushihara, Hisashi; Sawada, Yasufumi			Medications associated with falls in older people: systematic review of publications from a recent 5-year period	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY			English	Review						Accidental falls; Pharmaceutical preparations; Aged; Systematic review	NURSING-HOME RESIDENTS; RISK-FACTORS; ELDERLY-PATIENTS; PSYCHOTROPIC-DRUGS; ADVERSE OUTCOMES; COMMUNITY; POLYPHARMACY; ADULTS; METAANALYSIS; CARE	Falls are an important public health problem in older people. Medication use is considered a risk factor for falls. This study systematically reviewed recent studies to determine the medications that might be associated with the risk of falling in older people. We conducted a systematic review of prospective and retrospective studies identified through the MEDLINE and CINAHL databases that quantitatively assessed the contribution of medications to falls risk in participants a parts per thousand yen60 years old published in English between May 2008 and April 2013. The search identified 1,895 articles; 36 articles met the inclusion criteria. Of the 19 studies that investigated the effect of polypharmacy on the risk of falling, six studies reported that the risk of falling increased with polypharmacy. Data on the use of antihypertensive medications including calcium channel blockers, beta-blockers, and angiotensin system blocking medications were collected in 14 studies, with mixed results. Twenty-nine studies reported an association between the risk of falls and psychotropic medications including sedatives and hypnotics, antidepressants, and benzodiazepines. The use of sedatives and hypnotics and antidepressants including tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin norepinephrine reuptake inhibitors appears to be related with an increased risk of falls. It is not clear if the use of antihypertensive medications is associated with the risk of falls in older people.	[Park, Hyerim; Satoh, Hiroki; Miki, Akiko; Sawada, Yasufumi] Univ Tokyo, Grad Sch Pharmaceut Sci, Endowed Lab Drug Lifetime Management, Bunkyo Ku, Tokyo 1130033, Japan; [Urushihara, Hisashi] Keio Univ, Div Drug Dev & Regulatory Sci, Fac Pharm, Minato Ku, Tokyo 1058512, Japan	Sawada, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Endowed Lab Drug Lifetime Management, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sawada@mol.f.u-tokyo.ac.jp			Eli Lilly Japan; Eisai Co., Ltd.	HU is a paid consultant of Eli Lilly Japan and Eisai Co., Ltd. The other authors declare that they have no conflict of interest.	Gurwitz JH, 2004, ARCH INTERN MED, V164, P1957, DOI 10.1001/archinte.164.18.1957; Neumann L, 2013, J NUTR HEALTH AGING, V17, P264, DOI 10.1007/s12603-012-0390-8; Deandrea S, 2013, ARCH GERONTOL GERIAT, V56, P407, DOI 10.1016/j.archger.2012.12.006; Iinattiniemi S, 2009, SCAND J PRIM HEALTH, V27, P25, DOI 10.1080/02813430802588683; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Lee JSW, 2008, AGING CLIN EXP RES, V20, P447; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Ackroyd-Stolarz Stacy, 2009, Can J Hosp Pharm, V62, P276; van Strien AM, 2013, MATURITAS, V74, P357, DOI 10.1016/j.maturitas.2013.01.004; Rhalimi M, 2009, DRUG AGING, V26, P847, DOI 10.2165/11317610-000000000-00000; Chang CM, 2011, INT J GERIATR PSYCH, V26, P602, DOI 10.1002/gps.2569; Darowski A, 2009, DRUG AGING, V26, P381, DOI 10.2165/00002512-200926050-00002; Wilson NM, 2011, J AM GERIATR SOC, V59, P875, DOI 10.1111/j.1532-5415.2011.03386.x; Agashivala N, 2009, DRUG AGING, V26, P853, DOI 10.2165/11316800-000000000-00000; Yamashita T, 2011, J AGING HEALTH, V23, P682, DOI 10.1177/0898264310390941; Wong AKW, 2013, J AM GERIATR SOC, V61, P776, DOI 10.1111/jgs.12205; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Gribbin J, 2010, AGE AGEING, V39, P592, DOI 10.1093/ageing/afq092; Masud T, 2001, AGE AGEING, V30, P3; Gribbin J, 2011, DRUG AGING, V28, P895, DOI 10.2165/11592860-000000000-00000; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Pellfolk T, 2009, INT PSYCHOGERIATR, V21, P187, DOI 10.1017/S1041610208007837; Kojima T, 2012, GERIATR GERONTOL INT, V12, P425, DOI 10.1111/j.1447-0594.2011.00783.x; Lackner TE, 2008, J AM GERIATR SOC, V56, P862, DOI 10.1111/j.1532-5415.2008.01680.x; Tomaschitz A, 2010, CLIN CHIM ACTA, V411, P1354, DOI 10.1016/j.cca.2010.05.037; Wilson IB, 2007, J GEN INTERN MED, V22, P6, DOI 10.1007/s11606-006-0093-0; Anstey KJ, 2008, J GERONTOL B-PSYCHOL, V63, pP249; Linjakumpu T, 2002, J CLIN EPIDEMIOL, V55, P809, DOI 10.1016/S0895-4356(02)00411-0; Shin KR, 2009, INT NURS REV, V56, P387, DOI 10.1111/j.1466-7657.2009.00723.x; Hohl CM, 2001, ANN EMERG MED, V38, P666, DOI 10.1067/mem.2001.119456; Moden B, 2010, J EPIDEMIOL COMMUN H, V64, P440, DOI 10.1136/jech.2009.098947; Roig M, 2011, RESP MED, V105, P461, DOI 10.1016/j.rmed.2010.08.015; Nanda S, 2011, J GERONTOL NURS, V37, P22, DOI 10.3928/00989134-20100730-01; Masud T, 2013, AGE AGEING, V42, P121, DOI 10.1093/ageing/afs118; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Salazar JA, 2007, EXPERT OPIN DRUG SAF, V6, P695, DOI 10.1517/14740338.6.6.695; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Whitney J, 2012, ARCH GERONTOL GERIAT, V55, P690, DOI 10.1016/j.archger.2012.05.010; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30; Yu PL, 2009, BIOMED ENVIRON SCI, V22, P179, DOI 10.1016/S0895-3988(09)60043-X; SRA JS, 1994, AM J CARDIOL, V73, P33, DOI 10.1016/0002-9149(94)90723-4; Sylliaas H, 2012, AGING CLIN EXP RES, V24, P251; Mamun K, 2009, GERIATR GERONTOL INT, V9, P276, DOI 10.1111/j.1447-0594.2009.00533.x; Ferrer A, 2012, ARCH GERONTOL GERIAT, V54, P352, DOI 10.1016/j.archger.2011.06.004; Beer C, 2011, BRIT J CLIN PHARMACO, V71, P592, DOI 10.1111/j.1365-2125.2010.03875.x; Azidah AK, 2012, CURR GERONTOL GERIAT, V2012, DOI DOI 10.1155/2012/539073; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Boutin T, 2012, J AM MED DIR ASSOC, V13, p[187, e15]; Coupland C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4551; Damian J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-6; Federal Interagency Forum on Aging-Related Statistics, 2012, OLD AM 2012 KEY IND; GIBSON MJ, 1987, DAN MED BULL, V34, P1; Lin P, 2003, CAN ALZHEIMER DIS RE, P10; Spoelstra Sandra L, 2013, Oncol Nurs Forum, V40, pE69, DOI 10.1188/13.ONF.E69-E78; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; von Heideken WP, 2009, ARCH GERONTOL GERIAT, V49, P390; World Health Organization, 2007, WHO GLOB REP FALLP	60	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0031-6970	1432-1041		EUR J CLIN PHARMACOL	Eur. J. Clin. Pharmacol.	DEC	2015	71	12					1429	1440		10.1007/s00228-015-1955-3		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CW7LG	WOS:000365179600002		
J	Kagami, T; Sugimoto, M; Ichikawa, H; Sahara, S; Uotani, T; Yamade, M; Hamaya, Y; Iwaizumi, M; Osawa, S; Sugimoto, K; Miyajima, H; Furuta, T				Kagami, Takuma; Sugimoto, Mitsushige; Ichikawa, Hitomi; Sahara, Shu; Uotani, Takahiro; Yamade, Mihoko; Hamaya, Yasushi; Iwaizumi, Moriya; Osawa, Satoshi; Sugimoto, Ken; Miyajima, Hiroaki; Furuta, Takahisa			One-day front-loading with four doses of rabeprazole followed by a standard twice-daily regimen provides sufficient acid inhibition in extensive metabolizers of CYP2C19	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						Proton pump inhibitor; Rabeprazole; CYP2C19; Intragastric pH	HELICOBACTER-PYLORI INFECTION; S-MEPHENYTOIN 4'-HYDROXYLATION; PROTON PUMP INHIBITOR; GASTROESOPHAGEAL-REFLUX DISEASE; TRIPLE THERAPY; GENOTYPIC DIFFERENCES; INTRAGASTRIC PH; DUAL THERAPY; CURE RATES; CYTOCHROME-P450 2C19	Four times daily dosing (qid) with a proton pump inhibitor can cause rapid increase in intragastric pH. We investigated the efficacy of the front-loading with rabeprazole 10 mg qid on a subsequent regimen with rabeprazole 10 mg twice daily (bid) for 7 days in extensive metabolizers (EMs) of CYP2C19. Five EMs received three different 1-week regimens in a crossover manner as follows: (1) rabeprazole 10 mg bid for 7 days; (2) a front-loading regimen of rabeprazole (rabeprazole 10 mg qid on day 0 and bid on days 1 to 7); and (3) rabeprazole 10 mg qid for 7 days. Five intermediate metabolizers (IMs) and four poor metabolizers (PMs) received rabeprazole 10 mg bid regimen only. Twenty-four-hour intragastric pH-monitorings were performed on days 1, 4, and 7. Area under the intragastric pH-time curves (AUCs) from days 1 to 7 was calculated using 24-h median intragastric pHs on days 1, 4, and 7. Twenty-four-hour intragastric pHs in the front-loading group on days 1, 4, and 7 were 5.1, 4.9, and 5.1, respectively. The median AUC with front-loading in EMs (34.4, pH center dot day) was significantly higher than that in EMs with rabeprazole 10 mg bid (30.74, p = 0.043). No statistically significant differences in median AUCs were noted among front-loading in EMs, rabeprazole 10 mg qid in EMs (37.2), rabeprazole 10 mg bid in IMs (37.3), and PMs (39.4). The one-day front-loading regimen of rabeprazole 10 mg qid provided sufficient acid inhibition for 7 days, even in CYP2C19 EMs.	[Kagami, Takuma; Sugimoto, Mitsushige; Ichikawa, Hitomi; Sahara, Shu; Uotani, Takahiro; Yamade, Mihoko; Hamaya, Yasushi; Sugimoto, Ken; Miyajima, Hiroaki] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Iwaizumi, Moriya] Hamamatsu Univ Sch Med, Dept Clin Oncol, Hamamatsu, Shizuoka 4313192, Japan; [Osawa, Satoshi] Hamamatsu Univ Sch Med, Dept Endoscop & Photodynam Med, Hamamatsu, Shizuoka 4313192, Japan; [Furuta, Takahisa] Hamamatsu Univ Sch Med, Clin Res Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Furuta, T (reprint author), Hamamatsu Univ Sch Med, Clin Res Ctr, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	furuta@hama-med.ac.jp			Takeda Pharmaceutical Co., Ltd.; AstraZeneca KK; Eisai Co., Ltd.; Daiichi-Sankyo Co. Ltd.	The First Department of Medicine and the Center for Clinical Research at Hamamatsu University School of Medicine have received grants from Takeda Pharmaceutical Co., Ltd., AstraZeneca KK, Eisai Co., Ltd., and Daiichi-Sankyo Co. Ltd. The authors have no other conflicts of interest that are directly relevant to the content of this article.	WALSH JH, 1995, NEW ENGL J MED, V333, P984; Ramsjo M, 2010, EUR J CLIN PHARMACOL, V66, P871, DOI 10.1007/s00228-010-0835-0; Sugimoto K, 2008, BRIT J CLIN PHARMACO, V65, P437, DOI 10.1111/j.1365-2125.2007.03057.x; Zvyaga T, 2012, DRUG METAB DISPOS, V40, P1698, DOI 10.1124/dmd.112.045575; Furuta T, 2001, CLIN PHARMACOL THER, V69, P158, DOI 10.1067/mcp.2001.113959; Furuta T, 2005, CLIN GASTROENTEROL H, V3, P564, DOI 10.1053/S1542-3565(04)00779-7; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; HUNT RH, 1993, AM J GASTROENTEROL, V88, P481; Furuta T, 2003, HEPATO-GASTROENTEROL, V50, P2274; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Miehlke S, 2003, HELICOBACTER, V8, P310, DOI 10.1046/j.1523-5378.2003.00158.x; HEIFETS LB, 1992, AM REV RESPIR DIS, V145, P856; Furuta T, 1999, CLIN PHARMACOL THER, V65, P552, DOI 10.1016/S0009-9236(99)70075-5; SOHN DR, 1992, J PHARMACOL EXP THER, V262, P1195; Suzuki S, 2012, SENSORS-BASEL, V12, P16614, DOI 10.3390/s121216614; Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27; Pearce RE, 1996, J PHARMACOL EXP THER, V277, P805; Horai Y, 2001, ALIMENT PHARM THERAP, V15, P793, DOI 10.1046/j.1365-2036.2001.00980.x; Sugimoto M, 2014, EUR J CLIN PHARMACOL, V70, P1073, DOI 10.1007/s00228-014-1713-y; Shirai N, 2001, ALIMENT PHARM THER, V15, P1929, DOI 10.1046/j.1365-2036.2001.01108.x; Sohn DR, 1997, CLIN PHARMACOL THER, V61, P574, DOI 10.1016/S0009-9236(97)90137-5; Furuta T, 2007, CLIN PHARMACOL THER, V81, P521, DOI 10.1038/sj.clpt.6100043; GRAYSON ML, 1989, EUR J CLIN MICROBIOL, V8, P888, DOI 10.1007/BF01963775; Sahara S, 2015, DIGESTION, V91, P277, DOI 10.1159/000381419; Sugimoto M, 2004, CLIN PHARMACOL THER, V76, P290, DOI 10.1016/j.clpt.2004.06.008; Scott D, 1998, GUT, V43, pS56; Kurzawski M, 2006, EUR J CLIN PHARMACOL, V62, P877, DOI 10.1007/s00228-006-0183-2; Sugimoto M, 2005, CLIN PHARMACOL THER, V77, P302, DOI 10.1016/j.clpt.2004.10.010; CHIBA K, 1993, J PHARMACOL EXP THER, V266, P52; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Furuta T, 2002, CLIN PHARMACOL THER, V72, P453, DOI 10.1067/mcp.2002.127637; Fock KM, 2005, WORLD J GASTROENTERO, V11, P3091; YASUDA S, 1995, CLIN PHARMACOL THER, V58, P143, DOI 10.1016/0009-9236(95)90192-2; Sugimoto M, 2007, HELICOBACTER, V12, P317, DOI 10.1111/j.1523-5378.2007.00508.x; Saitoh T, 2002, ALIMENT PHARM THERAP, V16, P1811, DOI 10.1046/j.0269-2813.2002.01348.x; Sugimoto M, 2012, ALIMENT PHARM THER, V36, P627, DOI 10.1111/apt.12014; Furuta T, 2001, PHARMACOGENETICS, V11, P341, DOI 10.1097/00008571-200106000-00009; Shirai N, 2007, EUR J CLIN PHARMACOL, V63, P743, DOI 10.1007/s00228-007-0302-8; Malfertheiner P, 1997, GUT, V41, P8; Satoh K, 2002, J GASTROENTEROL, V37, P34, DOI 10.1007/BF02990097; Marcus EA, 2012, ALIMENT PHARM THER, V36, P972, DOI 10.1111/apt.12059; CHANG M, 1995, BRIT J CLIN PHARMACO, V39, P511	42	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0031-6970	1432-1041		EUR J CLIN PHARMACOL	Eur. J. Clin. Pharmacol.	DEC	2015	71	12					1467	1475		10.1007/s00228-015-1941-9		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CW7LG	WOS:000365179600006		
J	Yamamoto, Y; Takahashi, Y; Imai, K; Mishima, N; Kagawa, Y; Inoue, Y				Yamamoto, Yoshiaki; Takahashi, Yukitoshi; Imai, Katsumi; Mishima, Nobuyuki; Kagawa, Yoshiyuki; Inoue, Yushi			Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						Hyperammonemia; Valproic acid; Pharmacoepidemiology; Drug utilization; Pharmacovigilance	VALPROIC ACID THERAPY; NATIONWIDE POPULATION; CARNITINE DEFICIENCY; ADULT EPILEPSY; CHILDREN; TRENDS; PATTERNS	The purpose of the present study was to examine the relationship between the incidence of hyperammonemia and changes in the prescribing of concomitant antiepileptic drugs (AEDs) in patients receiving valproic acid. We evaluated 40,363 plasma samples from 6009 epilepsy patients obtained from 2006 to 2013. Hyperammonemia was defined as a plasma ammonia level exceeding 100 mu g/dL. In 2006, 32.6 % of the plasma samples were from patients with concomitant use of phenytoin but this decreased to 16.0 % in 2013. Lamotrigine and levetiracetam were approved in 2008 and 2010, respectively, and were prescribed for patients who provided 27.8 and 14.9 % of the plasma samples in 2013. The incidence rate of hyperammonemia (per 100 person years) decreased markedly from 40.8 (95 % confidence interval (CI), 37.7-43.9) in 2006 to 14.2 (95 % CI, 12.5-15.9) in 2013. In any year reviewed, concomitant use of phenytoin, phenobarbital, carbamazepine, or carbonic anhydrase inhibitors was a risk factor for hyperammonemia. Among enzyme-inducing AEDs, concomitant use of phenytoin was associated with the highest risk of hyperammonemia. Drug interactions caused by enzyme-inducing AEDs, especially phenytoin, are closely related to the development of hyperammonemia. This study demonstrated that introduction of new AEDs changed the co-prescribing pattern in patients receiving valproic acid, resulting in a marked decrease of hyperammonemia. Although their higher cost may be problematic, new AEDs are beneficial for reducing the risk of drug interactions.	[Yamamoto, Yoshiaki; Takahashi, Yukitoshi; Imai, Katsumi; Mishima, Nobuyuki; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Dept Clin Res, Natl Epilepsy Ctr, Shizuoka 4208688, Japan; [Yamamoto, Yoshiaki; Takahashi, Yukitoshi; Kagawa, Yoshiyuki] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut, Shizuoka 4228526, Japan; [Kagawa, Yoshiyuki] Shizuoka Prefectural Gen Hosp, Lab Clin Pharmacokinet & Drug Safety, Shizuoka 4208527, Japan	Yamamoto, Y (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Dept Clin Res, Natl Epilepsy Ctr, 886 Urushiyama, Shizuoka 4208688, Japan.	yamamoty-3@hosp.go.jp			Japanese Ministry of Education, Science, Sports and Culture (MEXT) [26860123]	This study was partly funded by a grant-in-aid for Young Scientists (Kakenhi No. 26860123) from the Japanese Ministry of Education, Science, Sports and Culture (MEXT).	Hsieh LP, 2011, EPILEPSY RES, V96, P81, DOI 10.1016/j.eplepsyres.2011.05.003; Nicholas JM, 2012, SEIZURE-EUR J EPILEP, V21, P466, DOI 10.1016/j.seizure.2012.04.014; KONDO T, 1992, EPILEPSIA, V33, P550, DOI 10.1111/j.1528-1157.1992.tb01708.x; Hung TY, 2011, EPILEPSIA, V52, P2043, DOI 10.1111/j.1528-1167.2011.03279.x; De Vivo DC, 1998, EPILEPSIA, V39, P1216; Oun A, 2006, EUR J NEUROL, V13, P465, DOI 10.1111/j.1468-1331.2006.01268.x; Aires CCP, 2011, J HEPATOL, V55, P426, DOI 10.1016/j.jhep.2010.11.031; COULTER DL, 1991, J CHILD NEUROL, V6, P7, DOI 10.1177/088307389100600102; Brodie MJ, 1997, EPILEPSY RES, V26, P423, DOI 10.1016/S0920-1211(96)01007-8; Yamamoto Y, 2013, EPILEPSIA, V54, P983, DOI 10.1111/epi.12125; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; VERBIEST HBC, 1992, ACTA NEUROL SCAND, V86, P275; Chicharro AV, 2007, EPILEPSY BEHAV, V11, P361, DOI 10.1016/j.yebeh.2007.06.015; Verrotti A, 1999, INT J CLIN LAB RES, V29, P36, DOI 10.1007/s005990050060; Brodie MJ, 2013, EPILEPSIA, V54, P11, DOI 10.1111/j.1528-1167.2012.03671.x; Patsalos PN, 2013, CLIN PHARMACOKINET, V52, P927, DOI 10.1007/s40262-013-0087-0; de Groot MCH, 2014, EPILEPSIA, V55, P666, DOI 10.1111/epi.12557; Yamamoto Y, 2012, EPILEPSY RES, V101, P202, DOI 10.1016/j.eplepsyres.2012.04.001; Nakajima Y, 2011, BRAIN DEV-JPN, V33, P816, DOI 10.1016/j.braindev.2010.12.003; Hollingworth SA, 2010, PHARMACOEPIDEM DR S, V19, P82, DOI 10.1002/pds.1871; Savica R, 2007, EUR J NEUROL, V14, P1317, DOI 10.1111/j.1468-1331.2007.01970.x; Fukuda M, 2015, BRAIN DEV-JPN, V37, P790, DOI 10.1016/j.braindev.2014.12.004; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Italiano D, 2015, BRIT J CLIN PHARMACO, V79, P1010, DOI 10.1111/bcp.12577; Landmark CJ, 2011, EPILEPSY RES, V95, P51, DOI 10.1016/j.eplepsyres.2011.02.012; Coulter D L, 1995, J Child Neurol, V10 Suppl 2, pS32; COULTER DL, 1981, J PEDIATR-US, V99, P317, DOI 10.1016/S0022-3476(81)80489-1; Pickrell WO, 2014, SEIZURE-EUR J EPILEP, V23, P77, DOI 10.1016/j.seizure.2013.09.007; Tseng YL, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000066; Tsiropoulos I, 2006, ACTA NEUROL SCAND, V113, P405, DOI 10.1111/j.0404.2006.00639.x; van de Vrie-Hoekstra NW, 2008, EUR J CLIN PHARMACOL, V64, P1013, DOI 10.1007/s00228-008-0480-z	31	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0031-6970	1432-1041		EUR J CLIN PHARMACOL	Eur. J. Clin. Pharmacol.	DEC	2015	71	12					1517	1524		10.1007/s00228-015-1939-3		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CW7LG	WOS:000365179600012		
J	Bosch, DGM; Boonstra, FN; Kinoshita, T; Jhangiani, S; de Ligt, J; Cremers, FPM; Lupski, JR; Murakami, Y; de Vries, BBA				Bosch, Danille G. M.; Boonstra, F. Nienke; Kinoshita, Taroh; Jhangiani, Shalini; de Ligt, Joep; Cremers, Frans P. M.; Lupski, James R.; Murakami, Yoshiko; de Vries, Bert B. A.			Cerebral visual impairment and intellectual disability caused by PGAP1 variants	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION SYNDROME; HYPOTONIA-SEIZURES SYNDROME; ANCHOR-SYNTHESIS PATHWAY; FACTOR-XII GENE; CAUSE HYPERPHOSPHATASIA; LOW-VISION; MUTATIONS; DEFICIENCY; BIOSYNTHESIS; PROTEINS	Homozygous variants in PGAP1 (post-GPI attachment to proteins 1) have recently been identified in two families with developmental delay, seizures and/or spasticity. PGAP1 is a member of the glycosylphosphatidylinositol anchor biosynthesis and remodeling pathway and defects in this pathway are a subclass of congenital disorders of glycosylation. Here we performed whole-exome sequencing in an individual with cerebral visual impairment (CVI), intellectual disability (ID), and factor XII deficiency and revealed compound heterozygous variants in PGAP1, c.274_276del (p.(Pro92del)) and c.921_925del (p.(Lys308Asnfs(star)25)). Subsequently, PGAP1-deficient Chinese hamster ovary (CHO)-cell lines were transfected with either mutant or wild-type constructs and their sensitivity to phosphatidylinositol-specific phospholipase C (PI-PLC) treatment was measured. The mutant constructs could not rescue the PGAP1-deficient CHO cell lines resistance to PI-PLC treatment. In addition, lymphoblastoid cell lines (LCLs) of the affected individual showed no sensitivity to PI-PLC treatment, whereas the LCLs of the heterozygous carrier parents were partially resistant. In conclusion, we report novel PGAP1 variants in a boy with CVI and ID and a proven functional loss of PGAP1 and show, to our knowledge, for the first time this genetic association with CVI.	[Bosch, Danille G. M.; de Ligt, Joep; Cremers, Frans P. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Bosch, Danille G. M.; Boonstra, F. Nienke] Inst Visually Impaired, Bartimeus, Zeist, Netherlands; [Bosch, Danille G. M.; de Ligt, Joep; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Bosch, Danille G. M.; Boonstra, F. Nienke; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Kinoshita, Taroh; Murakami, Yoshiko] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Jhangiani, Shalini; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	de Vries, BBA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Internal Postal Code 836,POB 9101, NL-6500 HB Nijmegen, Netherlands.	Bert.deVries@radboudumc.nl			Stichting ODAS; Vereniging Bartimeus-Sonneheerdt [5781251]; Dutch Organization for Health Research and Development [917-86-319, 912-12-109]; National Institutes of Health; National Human Genome Research Institute [U54HG006542]	We are grateful to the individual involved and his family for their support and cooperation. We thank the technical ophthalmological assistant P. Rison for his assistance during the ophthalmological examination. This work has been supported by grants from Stichting ODAS (to FNB and FPMC), Vereniging Bartimeus-Sonneheerdt (5781251 to FNB and FPMC), and the Dutch Organization for Health Research and Development (917-86-319 and 912-12-109 to BBAdV). In addition, this study was accomplished in part through the Center for Mendelian Genomics research effort funded by the National Institutes of Health and supported by the National Human Genome Research Institute grant U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics.	de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Boonstra N, 2012, ACTA OPHTHALMOL, V90, P277, DOI 10.1111/j.1755-3768.2011.02205.x; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; Bosch DGM, 2014, AM J HUM GENET, V94, P303, DOI 10.1016/j.ajhg.2014.01.002; Ueda Y, 2007, J BIOL CHEM, V282, P30373, DOI 10.1074/jbc.M705601200; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; SCHLOESSER M, 1995, HUM MOL GENET, V4, P1235, DOI 10.1093/hmg/4.7.1235; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; McConville MJ, 2000, MOL MEMBR BIOL, V17, P1; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Nakashima M, 2014, NEUROGENETICS, V15, P193, DOI 10.1007/s10048-014-0408-y; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Zoltewicz JS, 1999, DEVELOPMENT, V126, P5085; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; Bosch DGM, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-59; Bosch DGM, 2014, EUR J PAEDIATR NEURO, V18, P677, DOI 10.1016/j.ejpn.2014.05.002; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22; Jensen Hanne, 2003, Ophthalmic Genet, V24, P81, DOI 10.1076/opge.24.2.81.13994; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; McKean DM, 2012, BIOL OPEN, V1, P874, DOI 10.1242/bio.20121982; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Schloesser M, 1997, BLOOD, V90, P3967; Sparks SE, 1993, GENEREVIEWS; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1018-4813	1476-5438		EUR J HUM GENET	Eur. J. Hum. Genet.	DEC	2015	23	12					1689	1693		10.1038/ejhg.2015.42		5	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CW6TC	WOS:000365129700017		
J	Ozawa, H; Kumazaki, M; Ueki, S; Morita, M; Usuku, S				Ozawa, Hiroki; Kumazaki, Makoto; Ueki, Satoshi; Morita, Masahiro; Usuku, Shuzo			Detection and Genetic Analysis of Noroviruses and Sapoviruses in Sea Snail	FOOD AND ENVIRONMENTAL VIROLOGY			English	Article						Norovirus; Sapovirus; Sea snail; Phylogenetic analysis	REVERSE TRANSCRIPTION-PCR; NORWALK-LIKE VIRUSES; HEPATITIS-A VIRUS; GASTROENTERITIS OUTBREAK; SHELLFISH SAMPLES; GENOGROUP-I; ASSAY; CALICIVIRUSES; CONTAMINATION; EPIDEMIOLOGY	An outbreak of acute gastroenteritis occurred at a restaurant in Yokohama in December 2011. Because many of the customers had consumed raw sea snail, sea snail was suspected to be the source of this outbreak. To determine whether sea snail contains Norovirus (NoV) or Sapovirus (SaV), we analyzed 27 sea snail samples collected over 5 months (May, June, August, October, and December 2012) and 59.3 % were positive for NoV and/or SaV. The levels of NoV ranged from 1.5 x 10(3) to 1.5 x 10(5) copies/g tissue, and those of SaV from 1.5 x 10(2) to 1.3 x 10(3) copies/g tissue. The highest levels were observed in sea snails collected in December. A phylogenetic analysis of the NoVs showed that the viral strains were NoV genotypes GI.4, GI.6, GII.4, GII.12, GII.13, and GII.14, and the SaV strains were genotypes GI.2 and GI.3. The NoV GII.4 Sydney 2012 variants were only detected in December. This variant was a major source of gastroenteritis in Japan in the winter of 2012/2013. In contrast, the NoV GII.4 strains detected in May and June 2012 were not the Sydney 2012 variant. This study demonstrates that sea snail contains multiple genogroups and genotypes of NoV and SaV strains. We conclude that the sea snail presents a risk of gastroenteritis when consumed raw.	[Ozawa, Hiroki; Kumazaki, Makoto; Ueki, Satoshi; Morita, Masahiro; Usuku, Shuzo] Yokohama City Inst Hlth, Dept Testing & Res, Kanazawa Ku, Yokohama, Kanagawa 2360051, Japan	Ozawa, H (reprint author), Yokohama City Inst Hlth, Dept Testing & Res, Kanazawa Ku, Tomiokahigashi 2-7-1, Yokohama, Kanagawa 2360051, Japan.	hi07-ozawa@city.yokohama.jp					Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Prato R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-37; Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x; Wang J, 2012, MAR ENVIRON RES, V80, P62, DOI 10.1016/j.marenvres.2012.06.011; Schaeffer J, 2013, INT J FOOD MICROBIOL, V166, P244, DOI 10.1016/j.ijfoodmicro.2013.07.022; Hymas W, 2007, J VIROL METHODS, V142, P10, DOI 10.1016/j.jviromet.2006.12.009; Le Guyader FS, 2010, J CLIN MICROBIOL, V48, P915, DOI 10.1128/JCM.01664-09; Iizuka S, 2010, J MED VIROL, V82, P1247, DOI 10.1002/jmv.21791; Sugieda M, 1996, EPIDEMIOL INFECT, V116, P339; Wang QH, 2007, VACCINE, V25, P5453, DOI 10.1016/j.vaccine.2006.12.032; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Prato R, 2013, INT J FOOD MICROBIOL, V162, P125, DOI 10.1016/j.ijfoodmicro.2012.12.025; Gallimore CI, 2005, INT J FOOD MICROBIOL, V103, P323, DOI 10.1016/j.ijfoodmicro.2005.02.003; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Miura T, 2013, APPL ENVIRON MICROB, V79, P6585, DOI 10.1128/AEM.02112-13; Okada M, 2006, ARCH VIROL, V151, P2503, DOI 10.1007/s00705-006-0820-1; Le Guyader FS, 2008, J CLIN MICROBIOL, V46, P4011, DOI 10.1128/JCM.01044-08; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Manso CF, 2013, FOOD ENVIRON VIROL, V5, P110, DOI 10.1007/s12560-013-9108-2; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Berke T, 1997, J MED VIROL, V52, P419, DOI 10.1002/(SICI)1096-9071(199708)52:4<419::AID-JMV13>3.0.CO;2-B; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Hoehne M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-69; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Baker K, 2010, J PUBLIC HLTH, V33, P205; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Morillo Simone Guadagnucci, 2011, Rev Assoc Med Bras, V57, P453; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Ming HX, 2013, J FOOD SAFETY, V33, P209, DOI 10.1111/jfs.12041	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-0334	1867-0342		FOOD ENVIRON VIROL	Food Environ. Virol.	DEC	2015	7	4					325	332		10.1007/s12560-015-9205-5		8	Environmental Sciences; Microbiology; Virology	Environmental Sciences & Ecology; Microbiology; Virology	CW5JG	WOS:000365031000003		
J	Caipo, M; Cahill, S; Kenny, M; Wachsmuth, K; Toyofuku, H; Hielm, S; Carolissen, V; Bruno, A; Mulholland, C; Kojima, M; Esteban, E				Caipo, M.; Cahill, S.; Kenny, M.; Wachsmuth, K.; Toyofuku, H.; Hielm, S.; Carolissen, V.; Bruno, A.; Mulholland, C.; Kojima, M.; Esteban, E.			The development of illustrative examples for the establishment and application of microbiological criteria for foods and their role in international standard development	FOOD CONTROL			English	Editorial Material									[Caipo, M.] Reg Off Latin Amer & Caribbean, Food & Agr Org United Nat, Santiago, Chile; [Cahill, S.; Kenny, M.] Food & Agr Org United Nat, Milan, Italy; [Toyofuku, H.] Yamaguchi Univ, Joint Fac Vet Med, Yamaguchi, Japan; [Hielm, S.; Carolissen, V.; Bruno, A.] Food & Agr Org United Nat, Joint FAO WHO Food Stand Programme, Milan, Italy; [Mulholland, C.] WHO, Geneva, Switzerland; [Kojima, M.] Minist Hlth, Dept Food Safety, Labour & Welf, Tokyo, Japan; [Esteban, E.] USDA, FSIS OPHS, New York, NY USA	Caipo, M (reprint author), Reg Off Latin Amer & Caribbean, Food & Agr Org United Nat, Santiago, Chile.	Marisa.Caipo@fao.org					van Schothorst M, 2009, FOOD CONTROL, V20, P967, DOI 10.1016/j.foodcont.2008.11.005; Andersen JK, 2011, FOOD CONTROL, V22, P1495, DOI 10.1016/j.foodcont.2010.07.018; Mead G, 2010, J FOOD PROTECT, V73, P1566; Wallace CA, 2014, FOOD CONTROL, V35, P233, DOI 10.1016/j.foodcont.2013.07.012; CAC, 2007, ANN 2 CAC GL 63 2007; CAC (Codex Alimentarius Commission), 2013, 211997 CACGL; Manfreda G., 2014, INT J FOOD MICROBIOL; Valero A., 2014, INT J FOOD MICROBIOL	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-7135	1873-7129		FOOD CONTROL	Food Control	DEC	2015	58				SI		1	6		10.1016/j.foodcont.2015.06.043		6	Food Science & Technology	Food Science & Technology	CW5TI	WOS:000365059100001		
J	Indorato, F; Akashi, YJ; Rossitto, C; Raffino, C; Bartoloni, G				Indorato, Francesca; Akashi, Yoshihiro J.; Rossitto, Carlo; Raffino, Cataldo; Bartoloni, Giovanni			Takotsubo cardiomyopathy associated with rupture of the left ventricular apex: assessment of histopathological features of a fatal case and literature review	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article						Takotsubo cardiomyopathy; Ventricular rupture; Stress cardiomyopathy; Emotional stress	APICAL BALLOONING SYNDROME; TAKO-TSUBO CARDIOMYOPATHY; CLINICAL CHARACTERISTICS; AMPULLA CARDIOMYOPATHY; STRESS CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; EMOTIONAL-STRESS; EPIDEMIOLOGY; ESTROGEN	Takotsubo cardiomyopathy, also known as "broken heart syndrome," is a cardiac entity characterized by transient left ventricular dysfunction without obstructive atherosclerotic coronary artery disease. An episode of emotional stress is believed to act as a trigger in the development of this syndrome, which typically occurs in female patients. We report a fatal case of a previously healthy 70-year-old woman who suffered an out-of-hospital cardiac arrest and cardiac rupture during emotional distress, due to Takotsubo cardiomyopathy. Ventricular rupture with Takotsubo cardiomyopathy is rare, but our case emphasizes the importance of dealing with this serious and potentially life-threatening disease. Takotsubo cardiomyopathy should be considered as a differential diagnosis in cases of early-developing heart failure, and clinicians should subsequently use adequate diagnostic and therapeutic options.	[Indorato, Francesca; Bartoloni, Giovanni] Univ Catania, Sect Legal Med, Dept GF Ingrassia, I-95123 Catania, Italy; [Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol, Kawasaki, Kanagawa, Japan; [Rossitto, Carlo; Raffino, Cataldo] Garibaldi Nesima Hosp, Diagnost Pathol, Catania, Italy	Indorato, F (reprint author), Univ Catania, Sect Legal Med, Dept GF Ingrassia, Via S Sofia,87 Edificio C, I-95123 Catania, Italy.	fra.indorato@gmail.com					Akashi Y J, 2002, Heart, V87, pE1, DOI 10.1136/heart.87.2.e1; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Eshtehardi P, 2009, INT J CARDIOL, V135, P370, DOI 10.1016/j.ijcard.2008.03.088; REICH P, 1985, ANNU REV MED, V36, P397; Akashi YJ, 2015, NAT REV CARDIOL, V12, P387, DOI 10.1038/nrcardio.2015.39; Akashi YJ, 2003, QJM-INT J MED, V96, P563, DOI 10.1093/qjmed/hcg096; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Akashi YJ, 2002, J ELECTROCARDIOL, V35, P351, DOI 10.1054/jelc.2002.36277; Kawai S, 2007, CIRC J, V71, P990, DOI 10.1253/circj.71.990; Morel O, 2009, J CARD FAIL, V15, P206, DOI 10.1016/j.cardfail.2008.10.031; Syed FF, 2011, EUROPACE, V13, P780, DOI 10.1093/europace/euq435; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Abe Y, 2003, J AM COLL CARDIOL, V41, P737, DOI 10.1016/S0735-1097(02)02925-X; Kumar S, 2011, CLIN CARDIOL, V34, P672, DOI 10.1002/clc.20957; Sharkey SW, 2011, J AM COLL CARDIOL, V57, P1496, DOI 10.1016/j.jacc.2010.11.029; Elsokkari I, 2013, INT J CARDIOL, V167, pE46, DOI 10.1016/j.ijcard.2013.03.090; Akashi YJ, 2003, CAN J CARDIOL, V19, P449; Liang JJ, 2013, HEART LUNG, V42, P270, DOI 10.1016/j.hrtlng.2013.04.003; Kuo BT, 2010, GENDER MED, V7, P71, DOI 10.1016/j.genm.2010.01.006; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Wedekind H, 2006, HERZ, V31, P339, DOI 10.1007/s00059-006-2822-x; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Eitel I, 2010, EUR RADIOL, V20, P422, DOI 10.1007/s00330-009-1549-5; Bybee KA, 2004, ANN INTERN MED, V141, P858; Khullar M, 1989, Indian Heart J, V41, P307; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	31	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	DEC	2015	11	4					577	583		10.1007/s12024-015-9711-7		7	Medicine, Legal; Pathology	Legal Medicine; Pathology	CW7GZ	WOS:000365167500015		
J	Uchida, K; Unuma, K; Uemura, K				Uchida, Kyoko; Unuma, Kana; Uemura, Koichi			A fatality in a child with severe fatty liver due to n-butane and isopentane poisoning resulting from long-term inhalation of an antiperspirant aerosol	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Letter							SUDDEN-DEATH		[Uchida, Kyoko; Unuma, Kana; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Bunkyo Ku, Tokyo 1138519, Japan; [Unuma, Kana; Uemura, Koichi] Osaka Prefectural Med Examiners Off, Osaka 5400007, Japan	Unuma, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	unumlegm@tmd.ac.jp					Ago Mihoko, 2002, Leg Med (Tokyo), V4, P113, DOI 10.1016/S1344-6223(01)00063-3; Sugie H, 2004, FORENSIC SCI INT, V143, P211, DOI 10.1016/j.forsciint.2004.02.038; Girard F, 2008, ANN FR ANESTH, V27, P83, DOI 10.1016/j.annfar.2007.10.036; Niitsu H, 2009, RES PRACT FORENS MED, V52, P47; Rohrig TP, 1997, AM J FOREN MED PATH, V18, P299, DOI 10.1097/00000433-199709000-00015	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	DEC	2015	11	4					631	632		10.1007/s12024-015-9712-6		2	Medicine, Legal; Pathology	Legal Medicine; Pathology	CW7GZ	WOS:000365167500028		
J	Nagoshi, H; Taki, T; Chinen, Y; Tatekawa, S; Tsukamoto, T; Maegawa, S; Yamamoto-Sugitani, M; Tsutsumi, Y; Kobayashi, T; Matsumoto, Y; Horiike, S; Okuno, Y; Fujiwara, S; Hata, H; Kuroda, J; Taniwaki, M				Nagoshi, Hisao; Taki, Tomohiko; Chinen, Yoshiaki; Tatekawa, Shotaro; Tsukamoto, Taku; Maegawa, Saori; Yamamoto-Sugitani, Mio; Tsutsumi, Yasuhiko; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Okuno, Yutaka; Fujiwara, Shiho; Hata, Hiroyuki; Kuroda, Junya; Taniwaki, Masafumi			Transcriptional Dysregulation of the Deleted in Colorectal Carcinoma Gene in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance	GENES CHROMOSOMES & CANCER			English	Article							DCC GENE; HEMATOLOGICAL MALIGNANCIES; DECREASED EXPRESSION; CANCER; RECEPTOR; IDENTIFICATION; PATHOGENESIS; LEUKEMIA	The deleted in colorectal carcinoma (DCC) gene at 18q21 encodes a netrin-1 receptor, a tumor suppressor that prevents cell growth. While allele loss or decreased expression of DCC has been associated with the progression of solid tumors and hematologic malignancies, including leukemias and malignant lymphomas, its involvement has not been evaluated in multiple myeloma (MM), a plasma cell malignancy characterized by complex and heterogenous molecular abnormalities. We here show that 10 of 11 human myeloma-derived cell lines (HMCLs) expressed non-translated aberrant DCC transcriptional variants, in which exon 2 fuses with intron 1 instead of exon 1 (mt.DCC). Among them, two co-expressed wild type transcripts (wt.DCC), while eight co-expressed the splicing variant (sv.DCC) lacking exon 1. The remaining HMCL expressed only sv.DCC. In addition, analyses revealed that there were two types of mt.DCC that differed in their fusion of intron 1 with exon 2. In patient-derived samples from 30 MM and 8 monoclonal gammopathy of undetermined significance (MGUS) patients, wt.DCC was expressed in 53% of MM, but not in MGUS, while 23% of MM and 75% of MGUS expressed only sv.DCC. Considering that 25% of MGUS, 57% of MM, and 91% HMCLs expressed mt. DCC, our results suggest that the acquisition of mt.DCC might be a secondary genetic change in plasma cell dyscrasia. (C) 2015 Wiley Periodicals, Inc.	[Nagoshi, Hisao; Chinen, Yoshiaki; Tatekawa, Shotaro; Tsukamoto, Taku; Maegawa, Saori; Yamamoto-Sugitani, Mio; Tsutsumi, Yasuhiko; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Kuroda, Junya; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kyoto 6028566, Japan; [Taki, Tomohiko; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Mol Diagnost & Therapeut, Kyoto 6028566, Japan; [Tsutsumi, Yasuhiko] Japanese Red Cross, Kyoto Daini Hosp, Dept Hematol, Kyoto, Japan; [Okuno, Yutaka; Fujiwara, Shiho] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 860, Japan; [Hata, Hiroyuki] Kumamoto Univ, Div Informat Clin Sci, Kumamoto 860, Japan	Nagoshi, H (reprint author), Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	hnagoshi@koto.kpu-m.ac.jp			National Cancer Center Research and Development Fund of Japan [23-A-17]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Supported by: National Cancer Center Research and Development Fund of Japan; Grant number: 23-A-17; Grant-in-Aid of Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nagoshi H, 2012, CANCER RES, V72, P4954, DOI 10.1158/0008-5472.CAN-12-0213; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; YOUNES A, 1995, BLOOD, V85, P2813; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; Shimura Y, 2012, MOL CANCER THER, V11, P2600, DOI 10.1158/1535-7163.MCT-12-0605; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; ITOH F, 1993, INT J CANCER, V53, P260, DOI 10.1002/ijc.2910530215; Kobayashi S, 2011, GENE CHROMOSOME CANC, V50, P207, DOI 10.1002/gcc.20845; Mehlen P, 1998, NATURE, V395, P801; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Rashid NU, 2014, BLOOD, V124, P3110, DOI 10.1182/blood-2014-04-569327; Ho KYK, 1999, HISTOPATHOLOGY, V35, P249; Kobayashi S, 2014, INT J ONCOL, V44, P1193, DOI 10.3892/ijo.2014.2291; Chinen Y, 2008, ONCOGENE, V27, P2249, DOI 10.1038/sj.onc.1210857; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; MIYAKE K, 1994, LEUKEMIA LYMPHOMA, V16, P13, DOI 10.3109/10428199409114135; MIYAKE K, 1993, BLOOD, V82, P927; Castets M, 2011, NATURE, V482, P534; PORFIRI E, 1995, LEUKEMIA LYMPHOMA, V18, P69, DOI 10.3109/10428199509064924	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-2257	1098-2264		GENE CHROMOSOME CANC	Gene Chromosomes Cancer	DEC	2015	54	12					788	795		10.1002/gcc.22290		8	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CX0RZ	WOS:000365405700008		
J	Braulke, F; Muller-Thomas, C; Gotze, K; Platzbecker, U; Germing, U; Hofmann, WK; Giagounidis, AAN; Lubbert, M; Greenberg, PL; Bennett, JM; Sole, F; Slovak, ML; Ohyashiki, K; Le Beau, MM; Tuchler, H; Pfeilstocker, M; Hildebrandt, B; Aul, C; Stauder, R; Valent, P; Fonatsch, C; Bacher, U; Trumper, L; Haase, D; Schanz, J				Braulke, Friederike; Mueller-Thomas, Catharina; Goetze, Katharina; Platzbecker, Uwe; Germing, Ulrich; Hofmann, Wolf-Karsten; Giagounidis, Aristoteles A. N.; Luebbert, Michael; Greenberg, Peter L.; Bennett, John M.; Sole, Francesc; Slovak, Marilyn L.; Ohyashiki, Kazuma; Le Beau, Michelle M.; Tuechler, Heinz; Pfeilstoecker, Michael; Hildebrandt, Barbara; Aul, Carlo; Stauder, Reinhard; Valent, Peter; Fonatsch, Christa; Bacher, Ulrike; Truemper, Lorenz; Haase, Detlef; Schanz, Julie			Frequency of del(12p) is Commonly Underestimated in Myelodysplastic Syndromes: Results from a German Diagnostic Study in Comparison with an International Control Group	GENES CHROMOSOMES & CANCER			English	Article							PROGNOSTIC SCORING SYSTEM; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL-ABNORMALITIES; CYTOGENETIC ABNORMALITIES; SHORT ARM; LENALIDOMIDE; DELETION; IMPACT; MDS; MALIGNANCIES	In myelodysplastic syndromes (MDS), deletion of the short arm of chromosome 12 (del(12p)) is usually a small abnormality, rarely detected as a single aberration by chromosome banding analysis (CBA) of bone marrow metaphases. Del(12p) has been described in 0.6 to 5% of MDS patients at initial diagnosis and is associated with a good to intermediate prognosis as a sole anomaly according to current scoring systems. Here, we present the results of a systematic del(12p) testing in a German prospective diagnostic study (clinicaltrials.gov: NCT01355913) on 367 MDS patients in whom CD34+ peripheral blood cells were analysed for the presence of del(12p) by sequential fluorescence in situ hybridization (FISH) analyses. A cohort of 2,902 previously published MDS patients diagnosed by CBA served as control. We demonstrate that, using a sensitive FISH technique, 12p deletion occurs significantly more frequently in MDS than previously described (7.6% by CD34+ PB-FISH vs. 1.6% by CBA, P < 0.001) and is often associated with other aberrations (93% by CD34+ PB-FISH vs. 60% by CBA). Additionally, the detection rate can be increased by repeated analyses in a patient over time which is important for the patients prognosis to distinguish a sole anomaly from double or complex aberrations. To our knowledge, this is the first study to screen for 12p deletions with a suitable probe for ETV6/TEL in 12p13. Our data suggest that the supplement of a probe for the detection of a 12p deletion to common FISH probe panels helps to avoid missing a del(12p), especially as part of more complex aberrations. (C) 2015 Wiley Periodicals, Inc.	[Braulke, Friederike; Bacher, Ulrike; Truemper, Lorenz; Haase, Detlef; Schanz, Julie] Univ Med Goettingen, Dept Hematol & Oncol, Gottingen, Germany; [Mueller-Thomas, Catharina; Goetze, Katharina] Tech Univ Munich, Dept Hematol & Oncol, D-80290 Munich, Germany; [Platzbecker, Uwe] Univ Dresden, Dept Hematol & Oncol, Dresden, Germany; [Germing, Ulrich] Univ Dusseldorf, Dept Hematol & Oncol, Dusseldorf, Germany; [Hofmann, Wolf-Karsten] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Giagounidis, Aristoteles A. N.] Marien Hosp, Dept Hematol & Oncol, Dusseldorf, Germany; [Luebbert, Michael] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany; [Greenberg, Peter L.] Stanford Univ, Ctr Canc, Dept Hematol, Stanford, CA 94305 USA; [Bennett, John M.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Sole, Francesc] Inst Recerca Leukemia Josep Carreras, Badalona, Spain; [Slovak, Marilyn L.] Sonora Quest Labs, Phoenix, AZ USA; [Ohyashiki, Kazuma] Tokyo Med Univ, Tokyo 1608402, Japan; [Le Beau, Michelle M.] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA; [Tuechler, Heinz] Hanusch Hosp, Boltzmann Inst Leukemia Res, Vienna, Austria; [Pfeilstoecker, Michael] Hanusch Hosp, Med Dept Hematol & Oncol 3, Vienna, Austria; [Pfeilstoecker, Michael] Hanusch Hosp, L Boltzmann Cluster Oncol, Vienna, Austria; [Hildebrandt, Barbara] Univ Dusseldorf, Dept Human Genet, Dusseldorf, Germany; [Aul, Carlo] St Johannes Hosp, Dept Hematol Oncol & Clin Immunol, Duisburg, Germany; [Stauder, Reinhard] Med Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Fonatsch, Christa] Med Univ Vienna, Dept Med Genet, Vienna, Austria	Braulke, F (reprint author), Univ Gottingen, Univ Med, Dept Hematol & Oncol, Robert Koch Str 40, D-37075 Gottingen, Germany.	friederike.braulke@med.uni-goettingen.de			Celgene(R) Germany; Instituto de Salud Carlos III, Ministerio de Economia y Competividad, Spain [PI 11/02010, PI/14/00013]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC, FEDER) [RD12/0036/0044]; Sociedad Espanola Hematologia y Hemoterapia; (GRE) Generalitat de Catalunya [2014 SGR225]; Jose Carreras Leukamie-Stiftung [AR 14/34]; Fundacio Internacional Josep Carreras; Celgene Spain; "la Caixa" Foundation	Supported by: Celgene (R) Germany; Instituto de Salud Carlos III, Ministerio de Economia y Competividad, Spain, Grant numbers: PI 11/02010 and PI/14/00013; Red Tematica de Investigacion Cooperativa en Cancer (RTICC, FEDER), Grant number: RD12/0036/0044; Sociedad Espanola Hematologia y Hemoterapia; 2014 SGR225 (GRE) Generalitat de Catalunya, Jose Carreras Leukamie-Stiftung, Grant number: Ref. AR 14/34; Fundacio Internacional Josep Carreras; and Celgene Spain; "la Caixa" Foundation.	Sanchez-Garcia J, 2014, BRIT J HAEMATOL, V166, P189, DOI 10.1111/bjh.12876; Platzbecker U, 2013, LEUKEMIA, V27, P1403, DOI 10.1038/leu.2013.26; Schanz J, 2011, J CLIN ONCOL, V29, P1963, DOI 10.1200/JCO.2010.28.3978; Sole F, 2005, HAEMATOL-HEMATOL J, V90, P1168; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; Sole F, 2000, BRIT J HAEMATOL, V108, P346; KOBAYASHI H, 1994, BLOOD, V84, P3473; Hoglund M, 1996, BLOOD, V87, P324; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Jabbour E, 2013, AM J HEMATOL, V88, P831, DOI 10.1002/ajh.23513; Saumell S, 2012, BRIT J HAEMATOL, V159, P311, DOI 10.1111/bjh.12035; Streubel B, 1998, BRIT J HAEMATOL, V100, P521, DOI 10.1046/j.1365-2141.1998.00591.x; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Braulke F, 2013, LEUKEMIA RES, V37, P900, DOI 10.1016/j.leukres.2013.03.019; Braulke F, 2010, LEUKEMIA RES, V34, P1296, DOI 10.1016/j.leukres.2010.01.010; Cherry AM, 2012, LEUKEMIA RES, V36, P832, DOI 10.1016/j.leukres.2012.03.013; SATO Y, 1995, BLOOD, V86, P1525; Fenaux P, 2004, SEMIN HEMATOL, V41, P6, DOI 10.1053/j.seminhematol.2004.02.002; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Huang WT, 2009, LEUKEMIA RES, V33, P847, DOI 10.1016/j.leukres.2008.10.008; Greenberg P, 1997, BLOOD, V89, P2079; Pinheiro RF, 2009, BRAZ J MED BIOL RES, V42, P1110, DOI 10.1590/S0100-879X2009001100018; Schanz J, 2012, J CLIN ONCOL, V30, P820, DOI 10.1200/JCO.2011.35.6394; Mallo M, 2011, LEUKEMIA, V25, P110, DOI 10.1038/leu.2010.231; Makishima H, 2010, LEUKEMIA RES, V34, P447, DOI 10.1016/j.leukres.2009.08.023; Braulke F, 2015, HAEMATOLOGICA, V100, P205, DOI 10.3324/haematol.2014.110452; Costa D, 2010, LEUKEMIA RES, V34, P1437, DOI 10.1016/j.leukres.2010.02.019; Schanz J, 2014, BLOOD, V124, P4656; Shaffer LG, 2013, RECOMMENDATIONS INT; Silverman LR, 2000, CANC MED, P1931	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-2257	1098-2264		GENE CHROMOSOME CANC	Gene Chromosomes Cancer	DEC	2015	54	12					809	817		10.1002/gcc.22292		9	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CX0RZ	WOS:000365405700010		
J	Lee, JM; Boyle, EA; Gamo, T; Obata, H; Norisuye, K; Echegoyen, Y				Lee, Jong-Mi; Boyle, Edward A.; Gamo, Toshitaka; Obata, Hajime; Norisuye, Kazuhiro; Echegoyen, Yolanda			Impact of anthropogenic Pb and ocean circulation on the recent distribution of Pb isotopes in the Indian Ocean	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							WESTERN NORTH-ATLANTIC; ATMOSPHERIC TRACE-METALS; PERSIAN-GULF WATER; ARABIAN SEA; SURFACE WATERS; LEAD ISOTOPES; CONCENTRATION PROFILES; SUSPENDED PARTICLES; PARTICULATE MATTER; SOURCE SIGNATURES	Pb and Pb isotope ratios in the modern ocean have been altered significantly by anthropogenic Pb inputs over the past century. Most studies of anthropogenic Pb in the ocean have focused on the North Atlantic and North Pacific Oceans, and the impact of anthropogenic Pb inputs to the Indian Ocean and processes controlling the distribution of Pb in the Indian Ocean are poorly known. This study presents the Pb and Pb isotopic composition (Pb-206/Pb-207, Pb-208/Pb-207) of 11 deep stations from the Indian Ocean Japanese GEOTRACES cruise (KH-09-5), from the Bay of Bengal and Arabian Sea to the Southern Ocean (62 degrees S). The Pb isotope ratios of the Indian Ocean range 1.140-1.190 for Pb-206/Pb-207 and 2.417-2.468 for Pb-208/Pb-207, with lower ratios appearing in the shallow waters of the northern Indian Ocean and higher ratios appearing in the deep layers of the Southern Ocean. This result agrees with a previous study on Pb concentrations (Echegoyen et al., 2014) showing that the Indian Ocean, particularly its northern part, is largely perturbed by anthropogenic Pb inputs. Pb-206/Pb-207 and Pb-208/Pb-207 of the Indian sector Southern Ocean are still lower than natural Pb, showing this region was also affected by anthropogenic Pb. Anomalously low or high Pb-206/Pb-207 and Pb-208/Pb-207 were observed in the thermocline and shallow waters of the southern Indian Ocean and the Arabian Sea, which are ascribed to water mass distribution (e.g., Subantarctic Mode Water) and evolving Pb isotope ratios of this region as dominant anthropogenic Pb sources change. Pb-206/Pb-207 and Pb-208/Pb-207 in the Bay of Bengal are higher than those in the Arabian Sea, which might be the result of the anthropogenic Pb inputs from different provenance or seawater exchanging Pb isotopes with natural particles derived from rivers and/or sediments at the basin boundaries. (C) 2015 Elsevier Ltd. All rights reserved.	[Lee, Jong-Mi; Boyle, Edward A.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Gamo, Toshitaka; Obata, Hajime] Univ Tokyo, Atmosphere & Ocean Res Inst, Dept Chem Oceanog, Kashiwa, Chiba, Japan; [Norisuye, Kazuhiro] Niigata Univ, Dept Environm Sci, Niigata, Japan; [Echegoyen, Yolanda] Univ Zaragoza, Dept Analyt Chem, Zaragoza 50018, Spain	Lee, JM (reprint author), Univ Calif Santa Cruz, Earth & Marine Sci Bldg Rm A415,1156 High St, Santa Cruz, CA 95064 USA.	jm_lee@ucsc.edu			Singapore National Research Foundation; Spanish Ministry of Science and Innovation; Steel Foundation for Environmental Protection Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan [19253006, 23253001]	We would like to thank the crew, officers, and onboard scientists of R/V Hakuho Maru during the KH-09-5 cruise for their help with sampling and routine analysis. MIT laboratory expenses were supported by a grant from the Singapore National Research Foundation to the Singapore Massachusetts Institute of Technology Alliance for Research and Technology - Center for Environmental Sensing and Modeling project. Y.E. thanks the Spanish Ministry of Science and Innovation for a postdoctoral MICINN-Fulbright grant. Sample collection was supported by grants from the Steel Foundation for Environmental Protection Technology and from Grant-in-Aid of Scientific Research (Nos. 19253006 and 23253001) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	COOPER JA, 1969, EARTH PLANET SC LETT, V6, P467, DOI 10.1016/0012-821X(69)90118-6; Oelkers EH, 2012, CR GEOSCI, V344, P646, DOI 10.1016/j.crte.2012.08.005; Witt MLI, 2010, MAR CHEM, V121, P2, DOI 10.1016/j.marchem.2010.02.005; CHUNG Y, 1987, EARTH PLANET SC LETT, V85, P28, DOI 10.1016/0012-821X(87)90018-5; Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139; Monna F, 2006, ATMOS ENVIRON, V40, P6554, DOI 10.1016/j.atmosenv.2006.05.064; Noble AE, 2015, DEEP-SEA RES PT II, V116, P208, DOI 10.1016/j.dsr2.2014.11.011; Grasse P, 2012, EARTH PLANET SC LETT, V353, P198, DOI 10.1016/j.epsl.2012.07.044; Farmer JG, 1999, ENVIRON GEOCHEM HLTH, V21, P257, DOI 10.1023/A:1006688515919; Povinec PP, 2011, EARTH PLANET SC LETT, V302, P14, DOI 10.1016/j.epsl.2010.11.026; Nriagu JO, 1996, SCI TOTAL ENVIRON, V181, P93, DOI 10.1016/0048-9697(95)04954-1; Bollhofer A, 2006, SCI TOTAL ENVIRON, V366, P579, DOI 10.1016/j.scitotenv.2005.11.016; Kumar SP, 1999, J GEOPHYS RES-OCEANS, V104, P1455, DOI 10.1029/1998JC900022; Witt M, 2006, ATMOS ENVIRON, V40, P5435, DOI 10.1016/j.atmosenv.2006.04.041; Diaz-Somoano M, 2009, ENVIRON SCI TECHNOL, V43, P1078, DOI 10.1021/es801818r; Singh SP, 2012, GEOCHIM COSMOCHIM AC, V94, P38, DOI 10.1016/j.gca.2012.07.017; Kelly AE, 2009, EARTH PLANET SC LETT, V283, P93, DOI 10.1016/j.epsl.2009.03.045; Gallon C, 2011, ENVIRON SCI TECHNOL, V45, P9874, DOI 10.1021/es2020428; Bollhofer A, 2001, GEOCHIM COSMOCHIM AC, V65, P1727, DOI 10.1016/S0016-7037(00)00630-X; Banse K, 2009, GEOPHYS MONOGR SER, V185, P87, DOI 10.1029/2008GM000704; Alleman LY, 2001, DEEP-SEA RES PT II, V48, P2811, DOI 10.1016/S0967-0645(01)00019-4; PREMCHAND K, 1982, INDIAN J MAR SCI, V11, P321; ROSMAN KJR, 1994, GEOPHYS RES LETT, V21, P2669, DOI 10.1029/94GL02603; Lee JM, 2014, EARTH PLANET SC LETT, V398, P37, DOI 10.1016/j.epsl.2014.04.030; MORLEY NH, 1993, DEEP-SEA RES PT I, V40, P1043, DOI 10.1016/0967-0637(93)90089-L; Hamelin B, 1997, GEOCHIM COSMOCHIM AC, V61, P4423, DOI 10.1016/S0016-7037(97)00242-1; MANTYLA AW, 1995, J GEOPHYS RES-OCEANS, V100, P2417, DOI 10.1029/94JC02564; DANIELSSON LG, 1980, MAR CHEM, V8, P199, DOI 10.1016/0304-4203(80)90010-9; BENNINGER LK, 1978, GEOCHIM COSMOCHIM AC, V42, P1165, DOI 10.1016/0016-7037(78)90111-4; Frank M, 1998, EARTH PLANET SC LETT, V158, P121, DOI 10.1016/S0012-821X(98)00055-7; Diaz-Somoano M, 2007, INT J COAL GEOL, V71, P28, DOI 10.1016/j.coal.2006.05.006; Barbante C, 1998, ANN GLACIOL, V27, P674; SHEN GT, 1988, J GEOPHYS RES-OCEANS, V93, P15715, DOI 10.1029/JC093iC12p15715; TOOLE JM, 1993, DEEP-SEA RES PT I, V40, P1973, DOI 10.1016/0967-0637(93)90042-2; CUMMING GL, 1975, EARTH PLANET SC LETT, V28, P155, DOI 10.1016/0012-821X(75)90223-X; Amakawa H, 2000, GEOCHIM COSMOCHIM AC, V64, P1715, DOI 10.1016/S0016-7037(00)00333-1; Nriagu J, 1996, SCI TOTAL ENVIRON, V191, P69, DOI 10.1016/0048-9697(96)05249-7; Sallee JB, 2006, OCEAN DYNAM, V56, P525, DOI 10.1007/s10236-005-0054-x; Wang W, 2006, SCI TOTAL ENVIRON, V364, P175, DOI 10.1016/j.scitotenv.2005.07.002; Li F, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009190; VERON AJ, 1993, J GEOPHYS RES-OCEANS, V98, P18269, DOI 10.1029/93JC01639; Singh SK, 2002, EARTH PLANET SC LETT, V202, P645, DOI 10.1016/S0012-821X(02)00822-1; Bollhofer A, 2000, GEOCHIM COSMOCHIM AC, V64, P3251, DOI 10.1016/S0016-7037(00)00436-1; WESTERLUND S, 1991, GEOCHIM COSMOCHIM AC, V55, P2127, DOI 10.1016/0016-7037(91)90092-J; VERON AJ, 1994, GEOCHIM COSMOCHIM AC, V58, P3199, DOI 10.1016/0016-7037(94)90047-7; Jeandel C, 1998, GEOCHIM COSMOCHIM AC, V62, P2597, DOI 10.1016/S0016-7037(98)00169-0; NOZAKI Y, 1976, EARTH PLANET SC LETT, V32, P304, DOI 10.1016/0012-821X(76)90070-4; SHETYE SR, 1994, P INDIAN AS-EARTH, V103, P107; TUREKIAN KK, 1977, GEOCHIM COSMOCHIM AC, V41, P1139, DOI 10.1016/0016-7037(77)90109-0; SHERRELL RM, 1992, EARTH PLANET SC LETT, V111, P155, DOI 10.1016/0012-821X(92)90176-V; GARIEPY C, 1985, EARTH PLANET SC LETT, V74, P220, DOI 10.1016/0012-821X(85)90023-8; Echegoyen Y, 2014, P NATL ACAD SCI USA, V111, P15328, DOI 10.1073/pnas.1417370111; Wu JF, 2010, GEOCHIM COSMOCHIM AC, V74, P4629, DOI 10.1016/j.gca.2010.05.017; YOU Y, 1993, DEEP-SEA RES PT I, V40, P13, DOI 10.1016/0967-0637(93)90052-5; McCartney MS, 1982, J MAR RES, V40, P427; SCHAULE BK, 1981, EARTH PLANET SC LETT, V54, P97, DOI 10.1016/0012-821X(81)90072-8; FLEGAL AR, 1983, EARTH PLANET SC LETT, V64, P19, DOI 10.1016/0012-821X(83)90049-3; Wu JF, 1997, GEOCHIM COSMOCHIM AC, V61, P3279, DOI 10.1016/S0016-7037(97)89711-6; FLEGAL AR, 1993, NATURE, V365, P242, DOI 10.1038/365242a0; ELBAZPOULICHET F, 1984, NATURE, V308, P409, DOI 10.1038/308409a0; COCHRAN JK, 1983, EARTH PLANET SC LETT, V65, P433, DOI 10.1016/0012-821X(83)90180-2; Veron AJ, 1998, ENVIRON RES, V78, P104, DOI 10.1006/enrs.1998.3856; Clift PD, 2002, EARTH PLANET SC LETT, V200, P91, DOI 10.1016/S0012-821X(02)00620-9; SCHARER U, 1986, EARTH PLANET SC LETT, V77, P35, DOI 10.1016/0012-821X(86)90130-5; SHERRELL RM, 1992, J GEOPHYS RES-OCEANS, V97, P11257, DOI 10.1029/92JC00759; BACON MP, 1976, EARTH PLANET SC LETT, V32, P277, DOI 10.1016/0012-821X(76)90068-6; BOYLE EA, 1986, J GEOPHYS RES-OCEANS, V91, P8573, DOI 10.1029/JC091iC07p08573; Senior K, 2006, FRONT ECOL ENVIRON, V4, P7; Rajeev K, 2000, J GEOPHYS RES-ATMOS, V105, P2029, DOI 10.1029/1999JD900414; Karstensen J, 1997, GEOPHYS RES LETT, V24, P2777, DOI 10.1029/97GL02708; Fine RA, 2008, DEEP-SEA RES PT I, V55, P20, DOI 10.1016/j.dsr.2007.10.002; Chen JM, 2005, ATMOS ENVIRON, V39, P1245, DOI 10.1016/j.atmosenv.2004.10.041; Reuer MK, 2003, CHEM GEOL, V200, P137, DOI 10.1016/S0009-2541(03)00186-4; SARIN MM, 1994, P INDIAN AS-EARTH, V103, P211; Prasad TG, 2001, J GEOPHYS RES-OCEANS, V106, P17059, DOI 10.1029/2000JC000480; Boyle EA, 2012, LIMNOL OCEANOGR-METH, V10, P653, DOI 10.4319/lom.2012.10.653; Clift PD, 2001, GEOL SOC AM BULL, V113, P1039, DOI 10.1130/0016-7606(2001)113<1039:DOTIFA>2.0.CO;2; Wu JF, 1997, ANAL CHEM, V69, P2464, DOI 10.1021/ac961204u; Brown J. S., 1962, ECON GEOL, V57, P673, DOI 10.2113/gsecongeo.57.5.673; Cheng H., 2010, ENVIRON POLLUT, V157, P1134; Doe B.R., 1970, LEAD ISOTOPES; FINE RA, 1993, DEEP-SEA RES PT I, V40, P2021, DOI 10.1016/0967-0637(93)90043-3; France-Lanord C., 1990, CHEM GEOL, V84, P368, DOI DOI 10.1016/0009-2541(90)90269-D; Gordon A. L., 1972, ANTARCTIC OCEANOLOGY, P59; Goswami V, 2014, GEOCHIM COSMOCHIM AC, V145, P30, DOI 10.1016/j.gca.2014.09.006; Hanawa K., 2001, OCEAN CIRCULATION CL; Johnes M. T., 2012, GEOCHIM COSMOCHIM AC, V77, P108; Lacan F., 2005, GEOPHYS RES LETT, V31; McCartney M. S., 1977, DEEP SEA RES S, V24, P103; MILLIMAN JD, 1983, J GEOL, V91, P1; Paul M, 2015, ANAL CHIM ACTA, V863, P59, DOI 10.1016/j.aca.2014.12.012; Sangster DF, 2000, ENVIRON REV, V8, P115; Schaule B. K., 1983, Trace Metals in Sea Water. Proceedings of the NATO Advanced Research Institute; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; SCOR Working Group, 2007, CHEM ERDE-GEOCHEM, V67, P87; Tomczak M., 2003, REGIONAL OCEANOGRAPH; UNEP, 2007, GLOB CAMP EL LEAD GA; Vlastelic I, 2001, GEOCHIM COSMOCHIM AC, V65, P4303, DOI 10.1016/S0016-7037(01)00713-X; Vu HTD, 2013, NATURE SCI, V3, P1; Wyrtki K., 1973, BIOL INDIAN OCEAN, P18, DOI DOI 10.1007/978-3-642-65468-8_3; Zubrick C. M., 2012, LIMNOL OCEANOGR-METH, V10, P270	101	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	DEC 1	2015	170						126	144		10.1016/j.gca.2015.08.013		19	Geochemistry & Geophysics	Geochemistry & Geophysics	CW2KP	WOS:000364821400008		
J	Takayanagi, H; Asami, R; Otake, T; Abe, O; Miyajima, T; Kitagawa, H; Iryu, Y				Takayanagi, Hideko; Asami, Ryuji; Otake, Tsuguo; Abe, Osamu; Miyajima, Toshihiro; Kitagawa, Hiroyuki; Iryu, Yasufumi			Quantitative analysis of intraspecific variations in the carbon and oxygen isotope compositions of the modern cool-temperate brachiopod Terebratulina crossei	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							BIOLOGICAL CARBONATES; TEREBRATALIA-TRANSVERSA; PHANEROZOIC SEAWATER; SOUTHWESTERN JAPAN; STABLE-ISOTOPES; DELTA-O-18; CALCITE; CORALS; SHELLS; SEA	This study unravels intraspecific variations in the carbon isotope (delta C-13) and oxygen isotope (delta O-18) compositions of shells of the modern cool-temperate brachiopod Terebratulina crossei collected at a water depth of 70 m in Otsuchi Bay, northeastern Honshu, Japan. Brachiopod shells have been used as proxies of the delta C-13 values of dissolved inorganic carbon (DIC) (delta C-13(DIC)) and seawater temperature/delta O-18 (delta O-18(SW)) values to reconstruct the evolution of Phanerozoic oceans. To identify more reliable shell portions as the proxies, we conducted a rigorous time-series comparison of delta C-13 and delta O-18 values between the brachiopod shells and calcite precipitated in isotopic equilibrium with ambient seawater (equilibrium calcite) (delta C-13(EC) and delta O-18(EC) values, respectively). Samples were collected from the outer and inner surfaces of the secondary shell layer along the maximum growth axis (ontogenetic-series and inner-series samples, respectively). The ontogenetic-series delta C-13 values, which showed regular annual and irregular non-annual cycles, partly fell in but were mostly less than the range of the delta C-13(EC) values. The delta C-13 cycles were often associated with one or two minor negative peaks. The peaks were likely resulted from an increased incorporation of respiration-derived C-12 due to elevated metabolic activity during spawning. The ontogenetic-series delta O-18 values showed distinct seasonal variations and were mostly within the range of delta O-18(EC) values. The amplitude of the delta O-18 profiles was relatively large during the younger fast-growth stage, and decreased during the senescent slow-growth stage. The inner-series delta C-13 and delta O-18 values of individual shells varied within narrow ranges. The inner-series delta C-13 values were close to the minimum delta C-13(EC) values. The inner-series delta O-18 values were in the upper range of the delta O-18(EC) values. Kinetic isotope fractionation effects were evident, but its degree varied among different shells. We identified the shell portions reliably recording past ocean environments. The best estimates of annual average delta C-13(DIC) values were obtained from ontogenetic-series delta C-13 values near the anterior shell edge and from inner-series delta C-13 values; those of the annual average seawater temperature were obtained from ontogenetic-series delta O-18 values from the entire transect and from the fast-growth stage. (C) 2015 Elsevier Ltd. All rights reserved.	[Takayanagi, Hideko; Iryu, Yasufumi] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Planetary Sci, Nagoya, Aichi 4648601, Japan; [Takayanagi, Hideko; Iryu, Yasufumi] Tohoku Univ, Grad Sch Sci, Inst Geol & Paleontol, Sendai, Miyagi 9808578, Japan; [Asami, Ryuji] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 9030213, Japan; [Otake, Tsuguo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 1138657, Japan; [Abe, Osamu; Kitagawa, Hiroyuki] Nagoya Univ, Grad Sch Environm Studies, Hydrospher Atmospher Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Miyajima, Toshihiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Dept Chem Oceanog, Kashiwa, Chiba 2778564, Japan	Takayanagi, H (reprint author), Tohoku Univ, Grad Sch Sci, Inst Geol & Paleontol, Sendai, Miyagi 9808578, Japan.	hidekot@m.tohoku.ac.jp			Japan Society for the Promotion of Science [21340152, 26302008]	We are most grateful to K. Yamamoto for providing samples of T. crossei and seawater from Otsuchi Bay, and for his continuous encouragement. We gratefully acknowledge M. Kurosawa, K. Morita, and M. Hirano for their assistance with field works, and M. Takagi and Y. Yokosawa for providing oceanographic records for Otsuchi Bay. We also thank K. Endo and M. Saito for their useful information on the modern brachiopods from Otsuchi Bay. Deep appreciation is expressed to Y. Tsuji and E. Shimbo for their assistance with the stable isotope measurements. We also thank J. Nemoto for taking photographs. This research was financially supported, in part, by a research fellowship from the Japan Society for the Promotion of Science (to H.T.) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21340152 and 26302008 to Y. I.). We would like to express our condolences to the people of Otsuchi, who suffered from the catastrophic effects of the earthquake and its associated tsunami on 11 March 2011. The manuscript was significantly improved by the comments and suggestions of Y. Rosenthal and two anonymous reviewers.	LOWENSTAM HA, 1961, J GEOL, V69, P241; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; Takayanagi H, 2013, GEOCHIM COSMOCHIM AC, V115, P115, DOI 10.1016/j.gca.2013.03.026; GROSSMAN EL, 1991, GEOL SOC AM BULL, V103, P953, DOI 10.1130/0016-7606(1991)103<0953:SISOBF>2.3.CO;2; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; Asami R, 2004, PALAEOGEOGR PALAEOCL, V212, P1, DOI 10.1016/j.palaeo.2004.05.014; Williams A, 1996, PHILOS T R SOC B, V351, P1171, DOI 10.1098/rstb.1996.0101; Takayanagi H, 2012, GEOCHEM J, V46, P77; POPP BN, 1986, GEOL SOC AM BULL, V97, P1262, DOI 10.1130/0016-7606(1986)97<1262:BAIOOI>2.0.CO;2; Abe O, 2009, ISOT ENVIRON HEALT S, V45, P247, DOI 10.1080/10256010903083847; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Cusack M, 2012, CHEM GEOL, V334, P139, DOI 10.1016/j.chemgeo.2012.10.021; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; Yamamoto K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047134; Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/s0016-7037(00)01203-6; Rollion-Bard C, 2003, EARTH PLANET SC LETT, V215, P275, DOI 10.1016/S0012-821X(03)00391-1; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Jimenez-Lopez C, 2004, GEOCHIM COSMOCHIM AC, V68, P3367, DOI 10.1016/j.gca.2003.11.033; Wenzel B, 2000, GEOCHIM COSMOCHIM AC, V64, P1859, DOI 10.1016/S0016-7037(00)00337-9; Zezina ON, 2010, PALEONTOL J+, V44, P1176, DOI 10.1134/S0031030110090030; Yamamoto K, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003190; QING HR, 1994, GEOCHIM COSMOCHIM AC, V58, P4429, DOI 10.1016/0016-7037(94)90345-X; CARPENTER SJ, 1995, GEOCHIM COSMOCHIM AC, V59, P3749, DOI 10.1016/0016-7037(95)00291-7; Gillikin DP, 2006, ORG GEOCHEM, V37, P1371, DOI 10.1016/j.orggeochem.2006.03.008; JAMES MA, 1992, ADV MAR BIOL, V28, P175, DOI 10.1016/S0065-2881(08)60040-1; Oguma S, 2002, J OCEANOGR, V58, P825, DOI 10.1023/A:1022823213855; HUGHES WW, 1988, MAR BIOL, V98, P511, DOI 10.1007/BF00391542; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; Yamamoto K, 2010, PALAEOGEOGR PALAEOCL, V291, P348, DOI 10.1016/j.palaeo.2010.03.006; VEIZER J, 1986, GEOCHIM COSMOCHIM AC, V50, P1679, DOI 10.1016/0016-7037(86)90130-4; WADLEIGH MA, 1992, GEOCHIM COSMOCHIM AC, V56, P431, DOI 10.1016/0016-7037(92)90143-7; Brand U, 2013, CHEM GEOL, V359, P23, DOI 10.1016/j.chemgeo.2013.09.014; Parkinson D, 2005, CHEM GEOL, V219, P193, DOI 10.1016/j.chemgeo.2005.02.002; Auclair AC, 2003, CHEM GEOL, V202, P59, DOI 10.1016/S0009-2541(03)00233-X; Veizer J, 1997, PALAEOGEOGR PALAEOCL, V132, P159, DOI 10.1016/S0031-0182(97)00052-7; TARUTANI T, 1969, GEOCHIM COSMOCHIM AC, V33, P987, DOI 10.1016/0016-7037(69)90108-2; Zeebe RE, 1999, GEOCHIM COSMOCHIM AC, V63, P2001, DOI 10.1016/S0016-7037(99)00091-5; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Asami R, 2009, EARTH PLANET SC LETT, V288, P96, DOI 10.1016/j.epsl.2009.09.011; BRAND U, 1989, BIOGEOCHEMISTRY, V7, P159, DOI 10.1007/BF00004216; Bitner M.A., 2006, MEMOIRES MUSEUM NATL, V24, P15; Brand U., 1989, PALAEOGEOGR PALAEOCL, V75, P311, DOI 10.1016/0031-0182(89)90192-2; Broecker Wallace S., 1992, Global Biogeochemical Cycles, V6, P315, DOI 10.1029/92GB01672; Chuang S. H, 1990, REPROD BIOL INVERT B, VIV, P212; Cooper G. A, 1973, SCI REP TOHOKU U, V6, P371; Cooper G. A, 1978, SMITHSONIAN CONTRIBU, V38, P1; Cooper G. A, 1988, SMITHSONIAN CONTRIBU, V64, P1; Craig R. S., 2001, Records of the Western Australian Museum, V20, P199; Curry G. B., 1984, FOSSILS CLIMATE, P75; Emig C. C., 1997, TREATISE INVERTEBR H, V1, P473; Friedman I., 1977, 440 US GEOL SURV, V440, pKK1; Hanawa K., 1987, J OCEANOGR SOC JAPAN, V42, P435; Hatai K. M., 1940, Science Reports of the Tohoku University Ser 2 Geol, V20, P1; Korte C, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002160; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P163, DOI 10.1016/0016-7037(89)90283-4; Okazaki M., 1994, B COASTAL OCEANOGR, V32, P15; Otobe H., 2009, COAST MAR SCI, V33, P1; Rohlf F.J., 1994, BIOMETRY PRINCIPLES; Williams A., 2002, TREATISE INVERTEBR H, V4, P921; Yamamoto K., 2013, PALEONTOL RES, V16, P12	60	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	DEC 1	2015	170						301	320		10.1016/j.gca.2015.08.006		20	Geochemistry & Geophysics	Geochemistry & Geophysics	CW2KP	WOS:000364821400018		
J	Kato, N				Kato, Naoki			Lie foliations transversely modeled on nilpotent Lie algebras	GEOMETRIAE DEDICATA			English	Article						Lie foliations; Foliations; Nilpotent Lie algebras; Nilpotent Lie groups	FLOWS	In this paper, we study on the following two problems of realization for Lie foliations. (1) Which pair of Lie algebras can be realized as a Lie -foliation in a closed manifold with the structure Lie algebra ? (2) Which pair can be realized as a Lie -flow in a closed manifold with the structure Lie algebra ? We give a complete answer to (1) in the case where is a nilpotent Lie algebra and give a complete answer to (2) in the case where is a nilpotent Lie algebra which has a rational structure.	[Kato, Naoki] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1539814, Japan	Kato, N (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1539814, Japan.	knaoki@ms.u-tokyo.ac.jp					GALLEGO E, 1991, T AM MATH SOC, V326, P529, DOI 10.2307/2001772; Herrera B, 1996, J MATH SOC JPN, V48, P769, DOI 10.2969/jmsj/04840769; MOLINO P, 1985, MANUSCRIPTA MATH, V51, P145, DOI 10.1007/BF01168350; Caron P., 1980, CR HEBD ACAD SCI, V280, P477; Chao C.Y., 1962, P AM MATH SOC, V13, P903, DOI 10.2307/2034084; Corwin L., 1990, REPRESENTATIONS NILP; FEDIDA E, 1971, CR ACAD SCI A MATH, V272, P999; Haefliger A., 1984, RES NOTES MATH, V131; Llabres M., 1988, ANN FS U TOULOUSE, V95, P243; Llabres M., 1988, THESIS; Mal'cev A.I., 1962, T AM MATH SOC, V9, P276; Meigniez G., 1995, ANN FAC SCI TOULOUSE, V4, P801; MOLINO P, 1982, P K NED AKAD A MATH, V85, P45; MOLINO P, 1979, CR ACAD SCI A MATH, V289, P421; Molino P., 1988, PROGR MATH, V73; Raghunathan M.S., 1988, ERGEB MATH GRENZGEB, V68	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	DEC	2015	179	1					21	37		10.1007/s10711-015-0065-9		17	Mathematics	Mathematics	CW7JP	WOS:000365175100002		
J	Miyazaki, K; Koike, Y; Kunishima, S; Ishii, R; Danbara, M; Horie, R; Yatomi, Y; Higashihara, M				Miyazaki, Koji; Koike, Yukako; Kunishima, Shinji; Ishii, Ryuji; Danbara, Mikio; Horie, Ryouichi; Yatomi, Yutaka; Higashihara, Masaaki			Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia	HEMATOLOGY			English	Article						Giant platelet syndrome with thrombocytopenia; Immune thrombocytopenia; Immature platelet fraction	RETICULATED PLATELETS; DISORDERS; THROMBOCYTOPENIA; IDENTIFICATION; MUTATIONS; BLOOD	Background: Reticulated platelets (RPs) as measured using flow cytometry are useful parameters of thrombopoiesis; however, difficulties remain with standardization between laboratories. On the other hand, immature platelet fraction (IPF) measurement, as determined using an automated hematology analyzer, is simple, reproducible, and displays a good correlation with RP, although specific factors may affect its value. We previously noticed that a small proportion of patients exhibit extremely high IPF values that do not correlate with flow cytometrically measured RP. Objectives: We investigated the mechanism of the aberrant increase in IPF values of different types of macrothrombocytopenia. Patients/methods: IPF, RP, and other platelet indexes were analyzed using samples from 15 congenital macrothrombocytopenic patients from 12 families, 150 immune thrombocytopenic patients, and 27 normal individuals. We further monitored the change in IPF values and morphology during platelet agglutination. Results: IPF values were about five times higher in MYH9 disorders (IPF 48.6 +/- 1.9%) and about twice as high in other macrothrombocytopenias (IPF 18.4 +/- 2.1%) than in immune thrombocytopenic patients with similar platelet counts (IPF 9.2 +/- 0.3%). We then examined changes in IPF values during ethylenediaminetetraacetic acid-and macroglobulinemia-induced platelet agglutination. The IPF value significantly increased in a timedependent manner along with the formation of platelet clumps and was strongly influenced by a few tiny platelet aggregates. Conclusions: These results suggested that IPF values are influenced by platelet size. Furthermore, IPF could be a useful and convenient parameter for screening of macrothrombocytopenia, which presents with a disproportionately high IPF value.	[Miyazaki, Koji; Ishii, Ryuji; Danbara, Mikio; Horie, Ryouichi; Higashihara, Masaaki] Kitasato Univ, Sch Med, Dept Hematol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Koike, Yukako] Toranomon Gen Hosp, Dept Clin Lab, Minato Ku, Tokyo 1058470, Japan; [Kunishima, Shinji] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag,Naka Ku, Nagoya, Aichi 4600001, Japan; [Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Bunkyo Ku, Tokyo 1138655, Japan	Miyazaki, K (reprint author), Kitasato Univ, Sch Med, Dept Hematol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	miyazakk@med.kitasato-u.ac.jp			Ministry of Education, Science, and Culture of Japan	This work was supported by a Grant-in-aid for Scientific Research to KM from the Ministry of Education, Science, and Culture of Japan.	Albanyan A, 2008, J Thromb Haemost, V6, P2213, DOI 10.1111/j.1538-7836.2008.03163.x; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; SHREINER DP, 1973, BLOOD, V42, P541; Noris P, 2009, J THROMB HAEMOST, V7, P2131, DOI 10.1111/j.1538-7836.2009.03614.x; Meintker L, 2013, CLIN CHEM LAB MED, V51, P2125, DOI 10.1515/cclm-2013-0252; Koike Y, 1998, THROMB HAEMOSTASIS, V79, P1106; Koike Y, 2010, EUR J HAEMATOL, V84, P183, DOI 10.1111/j.1600-0609.2009.01364.x; Lippi G, 2012, CLIN LAB, V58, P801, DOI 10.7754/Clin.Lab.2011.111001; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Osei-Bimpong A, 2009, HEMATOLOGY, V14, P118, DOI 10.1179/102453309X385098; Miyazaki K, 2009, EUR J HAEMATOL, V83, P230, DOI 10.1111/j.1600-0609.2009.01274.x; Noris P, 2014, BLOOD, V124, pE4, DOI 10.1182/blood-2014-03-564328	12	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1024-5332	1607-8454		HEMATOLOGY	Hematology	DEC	2015	20	10					587	592		10.1179/1607845415Y.0000000021		6	Hematology	Hematology	CX0SL	WOS:000365406900006		
J	Takami, N				Takami, Norikazu			The Baffling New Inflation: How Cost-Push Inflation Theories Influenced Policy Debate in the Late-1950s United States	HISTORY OF POLITICAL ECONOMY			English	Article							PRICE LEVELS; EMPLOYMENT; GROWTH; UNEMPLOYMENT; ARTICLE; ECONOMY		[Takami, Norikazu] Hitotsubashi Univ, Inst Econ Res, Tokyo, Japan	Takami, N (reprint author), Hitotsubashi Univ, Inst Econ Res, Tokyo, Japan.	takami.jp@gmail.com			Suntory Foundation; Waseda University [2013A-806, 2013C-025]	This research was supported by Suntory Foundation Research Grants for Young Scholars and Waseda University Grants for Special Research Projects (project numbers 2013A-806 and 2013C-025). I wish to thank Roger E. Backhouse, James Forder, Craufurd D. Goodwin, Tiago Mata, Masazumi Wakatabe, and colleagues to whom I presented an earlier draft of this paper for feedback at a session at the 2014 meeting of the History of Economics Society and a 2014 lunch seminar at the Center for the History of Political Economy at Duke University. The minutes of the Federal Open Market Committee, mentioned early in the article, are available online at http://www.federalreserve.gov/monetarypolicy/fomc_historical.htm.	BRONFENBRENNER M, 1963, AM ECON REV, V53, P593; [Anonymous], 1958, REV EC STAT, V40, P309; Leeson R, 1997, HIST POLIT ECON, V29, P445; Jacobs M, 1997, J AM HIST, V84, P910, DOI 10.2307/2953088; Brazelton WR, 1997, J ECON PERSPECT, V11, P189; Burke D. W., COMMUNICATION; Chandler L. V., 1960, AM ECON REV, V50, P212; Council of Economic Advisers, 1957, EC REP PRES; CULBERTSON JM, 1960, J POLIT ECON, V68, P617, DOI 10.1086/258396; Dubofsky M., 2004, LAB AM HIST; Dunlop J. T., 1961, POTENTIALS AM EC SEL; Eckstein O., 1959, STUDY PAPERS, V2 and 3; Forder J., 2010, DISCUSSION PAPER SER, V516; Friedman M, 1951, IMPACT UNION, P204; Galbraith J. K., 1957, ATLANTIC MONTHLY, P37; Goodwin C. D., 1975, EXHORTATION CONTROLS; HARRISON WB, 1981, AM J ECON SOCIOL, V40, P317, DOI 10.1111/j.1536-7150.1981.tb01644.x; HOOVER CB, 1960, Q J ECON, V74, P374, DOI 10.2307/1883056; Hoover K., 1988, NEW CLASSICAL MACROE; Jacobs M., 2003, DEMOCRATIC EXPT NEW, P250; Joint Economic Committee, 1958, REL PRIC EC STAB GRO; Joint Economic Committee, 1958, EC POL QUEST; Joint Economic Committee, 1960, STAFF REP EMPL GROWT; Joint Economic Committee, 1959, EMPL GROWTH PRIC LEV; Kareken J., 1963, STABILIZATION POLICI, P14; Laidler D., 2000, 20002 U W ONT DEP EC; Leeson R, 1997, HIST POLIT ECON, V29, P117; Meltzer A., 2009, HIST FEDERAL RESERVE, V2; Minsky H., 1960, REV ECON STAT, V43, P1; Parker R., 2005, JK GALBRAITH HIS LIF; Reynolds L. G., 1960, AM EC ASS PAPERS P, V50, P195; Robbins L., 1958, LLOYDS BANK REV, V48, P1; ROBINSON R, 1960, AM ECON REV, V50, P996; Samuelson P. A., 1960, AM ECON REV, V50, P177; Samuelson R., 2008, GREAT INFLATION ITS; Schultze C., 1959, RECENT INFLATION US; Slichter S., 1956, NY TIMES MAGAZINE; Slichter SH, 1954, AM ECON REV, V44, P322; Slichter S., 1957, NATIONS BUS, P94; Slichter S., 1957, NATIONS BUS, P29; Slichter S., 1958, NEW REPUBLIC, P8; Slichter S., 1956, NY TIMES MAGAZINE; Slichter S., 1956, NY TIMES MAGAZINE; Snowdon B., 2005, MODERN MACROECONOMIC; Stein H., 1984, PRESIDENTIAL EC MAKI; Thorp W., 1959, THE NEW INFLATION; TOBIN J, 1972, AM ECON REV, V62, P1; Weintraub E. R., 2014, SIDNEY WEINTRAUB AM; WONNACOTT P, 1960, POLIT SCI QUART, V75, P560, DOI 10.2307/2145803; Young N. B., 2000, WRIGHT PATMAN POPULI	50	0	0	DUKE UNIV PRESS	DURHAM	905 W MAIN ST, STE 18-B, DURHAM, NC 27701 USA	0018-2702	1527-1919		HIST POLIT ECON	Hist. Polit. Econ.	DEC	2015	47	4					605	629		10.1215/00182702-3321336		25	Economics; History Of Social Sciences	Business & Economics; Social Sciences - Other Topics	CW5WP	WOS:000365067600003		
J	Yamamoto, K; Tsutsui, S; Yamamoto, Y				Yamamoto, Kota; Tsutsui, Seijiro; Yamamoto, Yuji			Constrained paths based on the Farey sequence in learning to juggle	HUMAN MOVEMENT SCIENCE			English	Article						Learning dynamics; Coordination pattern; Frequency locking; Task performance	PHASE-TRANSITIONS; CASCADE; TASK; ORGANIZATION; EXPERTISE; GAZE	In this article we report the results of a study conducted to investigate the learning dynamics of three-ball juggling from the perspective of frequency locking. Based on the Farey sequence, we predicted that four stable coordination patterns, corresponding to dwell ratios of 0.83, 0.75, 0.67, and 0.50, would appear in the learning process. We examined the learning process in terms of task performance, taking into account individual differences in the amount of learning. We observed that the participants acquired individual-specific coordination patterns in a relatively early stage of learning, and that those coordination patterns were preserved in subsequent learning, even though performance in terms of number of successful consecutive throws increased substantially. This increase appeared to be related to a reduction in spatial variability of the juggling movements. Finally, the observed coordination patterns were in agreement with the predicted patterns, with the proviso that the pattern corresponding to a dwell ratio of 0.50 was not realized and only a hint of evidence was found for the dwell ratio of 0.67. This implies that the dwell ratios of 0.83 and 0.75 in particular exhibited a stable coordination structure due to strong frequency locking between the temporal variables of juggling. (C) 2015 Elsevier B.V. All rights reserved.	[Yamamoto, Kota; Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4640814, Japan; [Tsutsui, Seijiro] Aichi Univ Educ, Dept Hlth Sci & Phys Educ, Kariya, Aichi 4488542, Japan	Yamamoto, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	ykota13@gmail.com			MEXT, Japan [24240085]	We thank two anonymous reviewers and the editor for suggestions that improve the manuscript. This work was partially supported by Grants-in-Aid for Scientific Research (A) 24240085 from MEXT, Japan.	Huys R, 2004, HUM MOVEMENT SCI, V23, P315, DOI 10.1016/j.humov.2004.08.009; Huys R, 2003, BIOL CYBERN, V88, P302, DOI 10.1007/s00422-002-0379-1; Dessing JC, 2012, EXP BRAIN RES, V216, P635, DOI 10.1007/s00221-011-2967-6; BEEK PJ, 1992, J EXP PSYCHOL HUMAN, V18, P934, DOI 10.1037/0096-1523.18.4.934; BEEK PJ, 1992, J MOTOR BEHAV, V24, P85; Huys R, 2002, J SPORT SCI, V20, P171, DOI 10.1080/026404102317284745; Bebko JM, 2003, J MOTOR BEHAV, V35, P109; Hashizume K, 2004, HUM MOVEMENT SCI, V23, P207, DOI 10.1016/j.humov.2004.08.003; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Leroy D, 2008, GAIT POSTURE, V28, P265, DOI 10.1016/j.gaitpost.2007.12.071; King AC, 2012, NEUROSCI LETT, V529, P144, DOI 10.1016/j.neulet.2012.08.014; BEEK P J, 1989, Ecological Psychology, V1, P55, DOI 10.1207/s15326969eco0101_4; BEEK PJ, 1995, SCI AM, V273, P92; Beek P. J., 1988, COGNITION ACTION SKI, P257; Huys R., 2004, MOTOR CONTROL, V7, P188; Park S. W., 2013, FRONTIERS COMPUTATIO, V7, P1; PEPER CE, 1995, BIOL CYBERN, V73, P301, DOI 10.1007/BF00199466; Winter D.A., 2005, BIOMECHANICS MOTOR C; Zelic G., 2012, PLOS ONE, V7, P1	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	DEC	2015	44						102	110		10.1016/j.humov.2015.08.008		9	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CX0BK	WOS:000365361700010		
J	Jacobs, KJP; Stevens, BJ; Wada, O; Mukai, T; Ohnishi, D; Hogg, RA				Jacobs, K. J. P.; Stevens, B. J.; Wada, O.; Mukai, T.; Ohnishi, D.; Hogg, R. A.			A Dual-Pass High Current Density Resonant Tunneling Diode for Terahertz Wave Applications	IEEE ELECTRON DEVICE LETTERS			English	Article						Resonant tunnelling diode; terahertz; manufacturability	DEVICES; FUTURE	We report on a dual-pass high current density resonant tunneling diode (RTD) for terahertz wave applications. This technique reduces the overall fabrication complexity and improves the reproducibility for creating low resistance ohmic contacts. With our dual-pass technique, we demonstrate accurate control over the final device area by measuring the RTD current-voltage characteristic during the fabrication process and guiding the emitter current through the full RTD structure with a second contact electrode on the collector side. We go on to show how we may extract important information about the RTD performance using this method.	[Jacobs, K. J. P.; Stevens, B. J.; Wada, O.; Hogg, R. A.] Univ Sheffield, Dept Elect & Elect Engn, Sheffield S3 7HQ, S Yorkshire, England; [Mukai, T.; Ohnishi, D.] Rohm Co Ltd, Sensor Business Strategy, Opt Device Res & Dev Div, Ukyo Ku, Tokyo 6158585, Japan	Jacobs, KJP (reprint author), Univ Sheffield, Dept Elect & Elect Engn, Sheffield S3 7HQ, S Yorkshire, England.	elp11kjj@gmail.com			EPSRC	The authors wish to gratefully acknowledge D. T. D. Childs and K. Kennedy for helpful discussions. K. J. P. Jacobs gratefully acknowledges EPSRC for a studentship, and O. Wada gratefully acknowledges The Leverhulme Trust for a Visiting Professorship.	Maekawa T, 2014, ELECTRON LETT, V50, P1214, DOI 10.1049/el.2014.2362; Asada M, 2011, IEICE ELECTRON EXPR, V8, P1110, DOI 10.1587/elex.8.1110; Sugiyama H, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.05120; Song HJ, 2011, IEEE T THZ SCI TECHN, V1, P256, DOI 10.1109/TTHZ.2011.2159552; Romanczyk B, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4808362; Kleine-Ostmann T, 2011, J INFRARED MILLIM TE, V32, P143, DOI 10.1007/s10762-010-9758-1; WADA O, 1976, P IEEE, V64, P566, DOI 10.1109/PROC.1976.10168; BROEKAERT TPE, 1990, J APPL PHYS, V68, P4310, DOI 10.1063/1.346226; Jin N, 2005, IEEE T ELECTRON DEV, V52, P2129, DOI 10.1109/TED.2005.856183; Wells J, 2009, IEEE MICROW MAG, V10, P104, DOI 10.1109/MMM.2009.932081; Wilkinson CDW, 2002, JPN J APPL PHYS 1, V41, P4261, DOI 10.1143/JJAP.41.4261; Baraskar A., 2010, J VAC SCI TECHNOL B, V28, pC517; Jacobs KJP, 2015, J CRYST GROWTH, V418, P102, DOI 10.1016/j.jcrysgro.2015.02.017; Jacobs K. J. P., 2015, P 40 INT C INFR MILL, P1; Kajiyama K., 1973, APPL PHYS LETT, V23; Mukai T., 2011, OPT TER SCI TECHN M; Wei W., 2012, J SEMICOND, V33	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2015	36	12					1295	1298		10.1109/LED.2015.2491339		4	Engineering, Electrical & Electronic	Engineering	CW9CF	WOS:000365295300012		
J	Ke, JJ; Namura, K; Retamal, JRD; Ho, CH; Minamitake, H; Wei, TC; Tsai, DS; Lin, CH; Suzuki, M; He, JH				Ke, Jr-Jian; Namura, Kyoko; Retamal, Jose R. D.; Ho, Chih-Hsiang; Minamitake, Haruhiko; Wei, Tzu-Chiao; Tsai, Dung-Sheng; Lin, Chun-Ho; Suzuki, Motofumi; He, Jr-Hau			Surface-Controlled Metal Oxide Resistive Memory	IEEE ELECTRON DEVICE LETTERS			English	Article						ZnO; oxygen chemisorption; surface roughness; resistive random-access memory		To explore the surface effect on resistive random-access memory (ReRAM), the impact of surface roughness on the characteristics of ZnO ReRAM was studied. The thickness-independent resistance and the higher switching probability of ZnO ReRAM with rough surfaces indicate the importance of surface oxygen chemisorption on the switching process. Furthermore, the improvements in switching probability, switching voltage, and resistance distribution observed for ReRAM with rough surfaces can be attributed to the stable oxygen adatoms under various ambience conditions. The findings validate the surface-controlled stability and the uniformity of ReRAM and can serve as the guideline for developing practical device applications.	[Ke, Jr-Jian; Retamal, Jose R. D.; Wei, Tzu-Chiao; Lin, Chun-Ho; He, Jr-Hau] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Ke, Jr-Jian; Tsai, Dung-Sheng] Natl Taiwan Univ, Dept Elect Engn, Grad Inst Photon & Optoelect, Taipei 10617, Taiwan; [Namura, Kyoko; Minamitake, Haruhiko; Suzuki, Motofumi] Kyoto Univ, Dept Micro Engn, Kyoto 6068501, Japan; [Ho, Chih-Hsiang] Purdue Univ, Dept Elect & Comp Engn, W Lafayette, IN 47907 USA	He, JH (reprint author), King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal 239556900, Saudi Arabia.	jrhau.he@kaust.edu.sa			Chung-Hua Institution for Economic Research	This work was supported by the Chung-Hua Institution for Economic Research. The review of this letter was arranged by Editor C. V. Mouli. (Corresponding author: Jr-Hau He.)	Inoue IH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035105; Kang D, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2723543; Huang TH, 2013, J MATER CHEM C, V1, P7593, DOI 10.1039/c3tc31542h; Yang PK, 2013, P IEEE, V101, P1732, DOI 10.1109/JPROC.2013.2260112; Ke JJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3659296; Chen CY, 2010, PURE APPL CHEM, V82, P2055, DOI 10.1351/PAC-CON-09-12-05; Dolatshahi-Pirouz A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115427; Huang TH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04402; Waser R., 2009, ADV MATER, V21, P2632, DOI DOI 10.1002/ADMA.200900375	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2015	36	12					1307	1309		10.1109/LED.2015.2493343		3	Engineering, Electrical & Electronic	Engineering	CW9CF	WOS:000365295300015		
J	Seo, MW; Kawahito, S; Kagawa, K; Yasutomi, K				Seo, Min-Woong; Kawahito, Shoji; Kagawa, Keiichiro; Yasutomi, Keita			A 0.27e(rms)(-) Read Noise 220-mu V/e(-) Conversion Gain Reset-Gate-Less CMOS Image Sensor With 0.11-mu m CIS Process	IEEE ELECTRON DEVICE LETTERS			English	Article						CMOS image sensors (CISs); low read noise; high conversion gain; photon counting; photoelectron counting histogram (PCH)		A low temporal read noise and high conversion gain reset-gate-less CMOS image sensor (CIS) has been developed and demonstrated for the first time at photoelectron-counting-level imaging. To achieve a high pixel conversion gain without fine or special processes, the proposed pixel has two unique structures: 1) coupling capacitance between the transfer gate and floating diffusion (FD) and 2) coupling capacitance between the reset gate and FD, for removing parasitic capacitances around the FD node. As a result, a CIS with the proposed pixels is able to achieve a high pixel conversion gain of 220 mu V/e(-) and a low read noise of 0.27e(rms)(-) using correlated multiple-sampling-based readout circuitry.	[Seo, Min-Woong; Kawahito, Shoji; Kagawa, Keiichiro; Yasutomi, Keita] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan	Kawahito, S (reprint author), Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan.	kawahito@idl.rie.shizuoka.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25220905]; MEXT/JST COI-STREAM Program; Cooperative Research Project Programs through the Research Institute of Electrical Communication, Tohoku University; Research Institute of Electronics, Shizuoka University	This work was supported in part by a Grant-in-Aid for Scientific Research through the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under Grant 25220905, in part by the MEXT/JST COI-STREAM Program, and in part by the Cooperative Research Project Programs through the Research Institute of Electrical Communication, Tohoku University and the Research Institute of Electronics, Shizuoka University. The review of this letter was arranged by Editor J.-M. Liu. (Corresponding author: Shoji Kawahito).	Seo MW, 2013, IEEE SENS J, V13, P2922, DOI 10.1109/JSEN.2013.2264483; Kawai N, 2005, IEICE ELECTRON EXPR, V2, P379, DOI 10.1587/elex.2.379; Seo MW, 2012, IEEE J SOLID-ST CIRC, V47, P272, DOI 10.1109/JSSC.2011.2164298; Seo MW, 2012, IEEE T ELECTRON DEV, V59, P3396, DOI 10.1109/TED.2012.2215871; Seitz P, 2011, SPRINGER SER OPT SCI, V160, P1, DOI 10.1007/978-3-642-18443-7_1; Ma JJ, 2015, IEEE ELECTR DEVICE L, V36, P926, DOI 10.1109/LED.2015.2456067; Dutton N. A. W., 2014, S VLSI CIRC, P1, DOI DOI 10.1109/VLSIC.2014.6858428; Fossum Eric R., 2013, IEEE Journal of the Electron Devices Society, V1, DOI 10.1109/JEDS.2013.2284054; Ma J., 2015, IEEE J ELECT DEVICES, V3, P73; Wakashima S., 2015, S VLSI CIRC, pC88, DOI [10.1109/VLSIC.2015.7231334, DOI 10.1109/VLSIC.2015.7231334]; Yeh S.-F., 2015, S VLSI CIRC, pC84, DOI [10.1109/VLSIC.2015.7231332, DOI 10.1109/VLSIC.2015.7231332]	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2015	36	12					1344	1347		10.1109/LED.2015.2496359		4	Engineering, Electrical & Electronic	Engineering	CW9CF	WOS:000365295300025		
J	Bin Liaqat, H; Xia, F; Ma, JH; Yang, LT; Ahmed, AM; Asabere, NY				Bin Liaqat, Hannan; Xia, Feng; Ma, Jianhua; Yang, Laurence Tianruo; Ahmed, Ahmedin Mohammed; Asabere, Nana Yaw			Social-Similarity-Aware TCP With Collision Avoidance in Ad Hoc Social Networks	IEEE SYSTEMS JOURNAL			English	Article						Ad hoc social networks (ASNETs); congestion avoidance; resource efficiency; similarity; Transport Control Protocol (TCP)	MULTIHOP WIRELESS NETWORKS; SATELLITE IP NETWORKS; ENHANCEMENT; TRANSPORT; DESIGN; PEACH; VENO	An ad hoc social network (ASNET), which explores social connectivity between users of mobile devices, is becoming one of the most important forms of today's Internet. In this context, maximum bandwidth utilization of intermediate nodes in resource scarce environments is one of the challenging tasks. The traditional Transport Control Protocol (TCP) uses the round-trip time mechanism for sharing bandwidth resources between users. However, it does not explore socially aware properties between nodes and cannot differentiate effectively between various types of packet losses in wireless networks. In this paper, a socially aware congestion avoidance protocol, namely, TIBIAS, which takes advantage of similarity-matching social properties among intermediate nodes, is proposed to improve the resource efficiency of ASNETs. TIBIAS performs efficient data transfer over TCP. During the course of bandwidth resource allocation, it gives high priority for maximally matched interest similarity between different TCP connections on ASNET links. TIBIAS does not require any modification at lower layers or on receiver nodes. Experimental results show that TIBIAS performs better as compared with existing protocols, in terms of link utilization, unnecessary reduction of the congestion window, throughput, and retransmission ratio.	[Bin Liaqat, Hannan; Xia, Feng; Ahmed, Ahmedin Mohammed; Asabere, Nana Yaw] Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China; [Ma, Jianhua] Hosei Univ, Fac Comp & Informat Sci, Koganei, Tokyo 1848584, Japan; [Yang, Laurence Tianruo] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Peoples R China; [Yang, Laurence Tianruo] St Francis Xavier Univ, Dept Comp Sci, Antigonish, NS B2G 2W5, Canada	Bin Liaqat, H (reprint author), Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China.	ltyang@stfx.ca			Natural Science Foundation of China [60903153]; Liaoning Provincial Natural Science Foundation of China [201202032]; Fundamental Research Funds for Central Universities	This work was supported in part by the Natural Science Foundation of China under Grant 60903153, by Liaoning Provincial Natural Science Foundation of China under Grant 201202032, and by the Fundamental Research Funds for the Central Universities.	Al-Jubari Ammar Mohammed, 2011, EURASIP J WIREL COMM, V2011, P1; Allman M., 2009, TCP CONGESTION CONTR; Ratnasamy S, 2001, ACM SIGCOMM COMP COM, V31, P161, DOI 10.1145/964723.383072; Buscarino A, 2012, IEEE SYST J, V6, P531, DOI 10.1109/JSYST.2012.2192054; Fu CP, 2003, IEEE J SEL AREA COMM, V21, P216, DOI 10.1109/JSAC.2002.807336; Xu K, 2004, IEEE J SEL AREA COMM, V22, P747, DOI 10.1109/JSAC.2004.825989; Balakrishnan H, 1997, IEEE ACM T NETWORK, V5, P756, DOI 10.1109/90.650137; Amadeo M, 2013, COMPUT COMMUN, V36, P792, DOI 10.1016/j.comcom.2013.01.006; Akyildiz IF, 2001, IEEE ACM T NETWORK, V9, P307, DOI 10.1109/90.929853; El-Ocla H, 2010, WIREL NETW, V16, P183, DOI 10.1007/s11276-008-0123-4; Akyildiz IF, 2002, IEEE COMMUN LETT, V6, P303, DOI 10.1109/LCOMM.2002.801317; Zhou B, 2006, IEEE COMMUN LETT, V10, P441, DOI [10.1109/LCOMM.2006.1638609, 10.1109/LCOMM.2006.06007]; de Oliveira R, 2007, IEEE T MOBILE COMPUT, V6, P192, DOI 10.1109/TMC.2007.19; Krishnan R, 2004, COMPUT NETW, V46, P343, DOI 10.1016/j.comnet.2004.06.012; Hui P, 2008, MOBIHOC'08: PROCEEDINGS OF THE NINTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P241, DOI 10.1145/1374618.1374652; Floyd S, 1993, IEEE ACM T NETWORK, V1, P397, DOI 10.1109/90.251892; El Khayat I, 2010, WIREL NETW, V16, P273, DOI 10.1007/s11276-008-0129-y; Nishiyama H, 2010, IEEE WIREL COMMUN, V17, P7, DOI 10.1109/MWC.2010.5450655; Pietilainen AK, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P49; Li J, 2012, MOBILE NETW APPL, V17, P192, DOI 10.1007/s11036-011-0330-6; Liu L, 2008, J SUPERCOMPUT, V44, P217, DOI 10.1007/s11227-007-0156-y; Rahnama H, 2011, IEEE SYST J, V5, P80, DOI 10.1109/JSYST.2010.2065093; Liu L, 2009, PEER PEER NETW APPL, V2, P98, DOI 10.1007/s12083-008-0023-5; Katsaros D, 2010, IEEE NETWORK, V24, P23, DOI 10.1109/MNET.2010.5634439; Mei A, 2012, IEEE T DEPEND SECURE, V9, P569, DOI 10.1109/TDSC.2012.37; Daly E, 2007, MOBIHOC'07: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P32; Carofiglio G., 2012, P IEEE INFOCOM NOMEN, P304; Gao D., 2008, P IEEE GLOBECOM, P1; Jacobson V., 1992, TCP EXTENSIONS HIGH; Jahanbakhsh K., 2010, P 2 INT WORKSH MOB O, P159, DOI DOI 10.1145/1755743.1755773; Kulkarni P., 2009, IEEE WIR COMM NETW C, P1; [李倩倩 Li Qianqian], 2010, [高分子通报, Polymer Bulletin], P1; Li X., 2007, INT J PARALLEL EMERG, V22, P15, DOI 10.1080/17445760601029412; Mascolo S., 2001, P 7 ANN INT C MOB CO, P287, DOI 10.1145/381677.381704; Mtibaa A., 2010, P IEEE INFOCOM, P1, DOI DOI 10.1109/INFCOM.2010.5462261; Ramakrishnan K., 1999, PROPOSAL ADD EXPLICI; Rozhnova N., 2012, P IEEE C COMP COMM I, P322; Stevens W., 2001, TCP SLOW START CONGE; Terry M., 2002, P HUM FACT COMP SYST, P816; Yang ZQ, 2010, PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND INDUSTRIAL ENGINEERING, VOLS I AND II, P468	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-8184	1937-9234		IEEE SYST J	IEEE Syst. J.	DEC	2015	9	4					1273	1284		10.1109/JSYST.2014.2305191		12	Computer Science, Information Systems; Engineering, Electrical & Electronic; Operations Research & Management Science; Telecommunications	Computer Science; Engineering; Operations Research & Management Science; Telecommunications	CX0SE	WOS:000365406200017		
J	Huang, HW; Guo, S; Li, P; Ye, BL; Stojmenovic, I				Huang, Huawei; Guo, Song; Li, Peng; Ye, Baoliu; Stojmenovic, Ivan			Joint Optimization of Rule Placement and Traffic Engineering for QoS Provisioning in Software Defined Network	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Software-defined network; ternary content addressable memory; rule placement; multipath routing	CONGESTION CONTROL	Software-Defined Network (SDN) is a promising network paradigm that separates the control plane and data plane in the network. It has shown great advantages in simplifying network management such that new functions can be easily supported without physical access to the network switches. However, Ternary Content Addressable Memory (TCAM), as a critical hardware storing rules for high-speed packet processing in SDN-enabled devices, can be supplied to each device with very limited quantity because it is expensive and energy-consuming. To efficiently use TCAM resources, we propose a rule multiplexing scheme, in which the same set of rules deployed on each node apply to the whole flow of a session going through but towards different paths. Based on this scheme, we study the rule placement problem with the objective of minimizing rule space occupation for multiple unicast sessions under QoS constraints. We formulate the optimization problem jointly considering routing engineering and rule placement under both existing and our rule multiplexing schemes. Via an extensive review of the state-of-the-art work, to the best of our knowledge, we are the first to study the non-routing-rule placement problem. Finally, extensive simulations are conducted to show that our proposals significantly outperform existing solutions.	[Huang, Huawei; Guo, Song; Li, Peng] Univ Aizu, Sch Comp Sci & Engn, Performance Evaluat Lab, Fukushima 9658580, Japan; [Ye, Baoliu] Nanjing Univ, Natl Key Lab Novel Software Technol, Nanjing 210046, Jiangsu, Peoples R China; [Stojmenovic, Ivan] Univ Ottawa, Sch Informat Technol & Engn, Ottawa, ON, Canada	Huang, HW (reprint author), Univ Aizu, Sch Comp Sci & Engn, Performance Evaluat Lab, Fukushima 9658580, Japan.	davyhwang.cug@gmail.com; sguo@u-aizu.ac.jp; pengli@u-aizu.ac.jp; yebl@nju.edu.cn			NSFC [61170069, 61373014, 61321491]	This work was partially supported by NSFC Grants (No. 61170069, 61373014 and 61321491). S. Guo is the corresponding author.	[Anonymous], 2013, OP SPEC; Han HZ, 2006, IEEE ACM T NETWORK, V14, P1260, DOI 10.1109/TNET.2006.886738; Kanizo Y, 2013, IEEE INFOCOM SER, P545; Zhang C, 2005, IEEE INFOCOM SER, P607; Wang H, 2005, IEEE IC COMP COM NET, P187; Agarwal S, 2013, IEEE INFOCOM SER, P2211; Key P, 2007, IEEE INFOCOM SER, P143, DOI 10.1109/INFCOM.2007.25; McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; Nakibly G, 2015, IEEE ACM T NETWORK, V23, P138, DOI 10.1109/TNET.2013.2292895; Yu ML, 2010, ACM SIGCOMM COMP COM, V40, P351, DOI 10.1145/1851275.1851224; Casado M, 2009, IEEE ACM T NETWORK, V17, P1270, DOI 10.1109/TNET.2009.2026415; Pagiamtzis K, 2006, IEEE J SOLID-ST CIRC, V41, P712, DOI 10.1109/JSSC.2005.864128; Gude N, 2008, ACM SIGCOMM COMP COM, V38, P105, DOI 10.1145/1384609.1384625; Wang WH, 2003, PERFORM EVALUATION, V52, P119, DOI 10.1016/S0166-5316(02)00176-1; Benson T., 2011, CONEXT 11, P1; Bosshart P., 2013, P ACM SIGCOMM 2013 C, P99; Cai Z., 2010, TR1008 RIC U; Durr F., 2012, 201204 U STUTTG I PA; Huang D. Y., 2013, P 2 ACM SIGCOMM WORK, P43, DOI DOI 10.1145/2491185.2491188; Huang H., 2014, P IEEE INT C COMM SY, P1; Jin X., 2014, P ACM C SIGCOMM, P539; Kang N., 2013, P 9 CONEXT, P13, DOI 10.1145/2535372.2535373; Katta N., 2013, TR96613 PRINC U DEP; Khalili R, 2013, IEEE ACM T NETWORK, V21, P1651, DOI 10.1109/TNET.2013.2274462; Mendonca M., 2013, IEEE COMMUN SURV TUT, V16, P1617; Moshref M., 2012, P 4 USENIX C HOT TOP, P23; Optimization G., 2013, GUR OPT REF MAN; Sherwood R., 2010, OSDI10, P1; Spitznagel E., 2003, Proceedings. 11th IEEE International Conference on Network Protocols; Stephens B., 2012, P 8 INT C EM NETW EX, P49; Sun G., 2012, P IEEE INT C GLOB CO, P2517; Sun Y., 2010, P INT C POW SYST TEC, P1	32	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	DEC	2015	64	12					3488	3499		10.1109/TC.2015.2401031		12	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CW3BP	WOS:000364867200013		
J	Yao, H; Zeng, D; Huang, HW; Guo, S; Barnawi, A; Stojmenovic, I				Yao, Hong; Zeng, Deze; Huang, Huawei; Guo, Song; Barnawi, Ahmed; Stojmenovic, Ivan			Opportunistic Offloading of Deadline-Constrained Bulk Cellular Traffic in Vehicular DTNs	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Cellular traffic offloading; opportunistic networks; minimum offloading problem; delay tolerant networks	NETWORKS	The ever-growing cellular traffic demand has laid a heavy burden on cellular networks. The recent rapid development in vehicle-to-vehicle communication techniques makes vehicular delay-tolerant network (VDTN) an attractive candidate for traffic offloading from cellular networks. In this paper, we study a bulk traffic offloading problem with the goal of minimizing the cellular communication cost under the constraint that all the subscribers receive their desired whole content before it expires. It needs to determine the initial offloading points and the dissemination scheme for offloaded traffic in a VDTN. By novelly describing the content delivery process via a contact-based flow model, we formulate the problem in a linear programming (LP) form, based on which an online offloading scheme is proposed to deal with the network dynamics (e. g., vehicle arrival/departure). Furthermore, an offline LP-based analysis is derived to obtain the optimal solution. The high efficiency of our online algorithm is extensively validated by simulation results.	[Yao, Hong; Zeng, Deze] China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China; [Huang, Huawei; Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Japan; [Barnawi, Ahmed] King Abdulaziz Univ, Fac Comp & IT, Jeddah 21413, Saudi Arabia; [Stojmenovic, Ivan] Deakin Univ, Sch Informat Technol, Melbourne, Australia; [Stojmenovic, Ivan] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Stojmenovic, Ivan] Univ Ottawa, Sch Elect Engn & Comp Sci, Ottawa, ON K1N 6N5, Canada	Yao, H (reprint author), China Univ Geosci, Sch Comp Sci, Wuhan 430074, Peoples R China.	yaohong@cug.edu.cn; dazzae@gmail.com; d8152101@u-aizu.ac.jp; sguo@u-aizu.ac.jp; ambarnawi@kau.edu.sa			NSF of China [61272470, 61402425]; Fundamental Research Funds for National University, China University of Geosciences, Wuhan [CUG14065, CUGL150830]	This work was supported in part by the NSF of China (Grant No. 61272470, 61402425) and the Fundamental Research Funds for National University, China University of Geosciences, Wuhan (Grant No. CUG14065, CUGL150830). S. Guo is the corresponding author.	Jiang D, 2008, IEEE VTS VEH TECHNOL, P2036; Hui P, 2011, IEEE T MOBILE COMPUT, V10, P1576, DOI 10.1109/TMC.2010.246; Sardari M, 2009, IEEE INFOCOM 2009 - IEEE CONFERENCE ON COMPUTER COMMUNICATIONS WORKSHOPS, P182; BAUM LE, 1965, ANN MATH STAT, V36, P1835, DOI 10.1214/aoms/1177699813; Park JS, 2006, IEEE WIREL COMMUN, V13, P76, DOI 10.1109/WC-M.2006.250362; Han B, 2012, IEEE T MOBILE COMPUT, V11, P821, DOI 10.1109/TMC.2011.101; Lu XF, 2013, CHINA COMMUN, V10, P35, DOI 10.1109/CC.2013.6549257; Zhang XL, 2007, MOBICOM'07: PROCEEDINGS OF THE THIRTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P195; Whitbeck J, 2012, PERVASIVE MOB COMPUT, V8, P682, DOI 10.1016/j.pmcj.2012.02.001; Li M, 2011, IEEE J SEL AREA COMM, V29, P223, DOI 10.1109/JSAC.2011.110121; Zhang D, 2013, IEEE T PARALL DISTR, V24, P479, DOI 10.1109/TPDS.2012.142; Fragouli C, 2008, IEEE ACM T NETWORK, V16, P450, DOI 10.1109/TNET.2007.901080; Chuang YJ, 2012, IEEE WCNC, P3188; Barbera M., 2011, P INT C DCOSS, P1; Burgess J., 2006, INFOCOM, V6, P1; Chen B.B., 2009, P IEEE INFOCOM 09 AP, P1404, DOI 10.1109/INFCOM2009.5062056; Deb S, 2006, IEEE T INFORM THEORY, V52, P2486, DOI 10.1109/TIT.2006.874532; Dimatteo S., 2011, P IEEE MASS, P192; Doering M., 2010, P 5 ACM WORKSH CHALL, P71, DOI 10.1145/1859934.1859950; Fragouli C., 2006, P IEEE INFOCOM, P1, DOI DOI 10.1109/INFOCOM.2006.45; Go Y., 2012, P ACM INT WORKSH MOB, P61; Gurobi Optimization, 2013, GUR OPT REF MAN; Han B., 2010, P 5 ACM WORKSH CHALL, P31, DOI 10.1145/1859934.1859943; Kashihara S., 2012, P IEEE INT C MOB COM, P142; Li Y., 2011, P 6 ACM WORKSH CHALL, P43; Lu R., 2010, P IEEE INFOCOM, P1; Luo J., 2010, P IEEE ICC, P1; Mishra A. R., 2004, FUNDAMENTALS CELLULA; Soares V., 2009, P NEXT GEN INT NETW, P1; Whitbeck J., 2011, P IEEE INT S WORLD W, P1; Xu Q., 2004, P 1 ACM INT WORKSH V, P19, DOI DOI 10.1145/1023875.1023879; Yan T., 2012, P IEEE SECON, P272, DOI DOI 10.1109/SEC0N.2012.6275787	32	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	DEC	2015	64	12					3515	3527		10.1109/TC.2015.2401012		13	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CW3BP	WOS:000364867200015		
J	Zaitsu, K; Tatsumura, K; Matsumoto, M; Oda, M; Yasuda, S				Zaitsu, Koichiro; Tatsumura, Kosuke; Matsumoto, Mari; Oda, Masato; Yasuda, Shinichi			Nonvolatile Programmable Switch With Adjacently Integrated Flash Memory and CMOS Logic for Low-Power and High-Speed FPGA	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Embedded flash memory; field-programmable gate array (FPGA); metal-oxide-nitride-oxide-semiconductor (MONOS); nonvolatile programmable logic device	GATE ARRAY; EMBEDDED FLASH; TECHNOLOGY	Novel nonvolatile programmable switch for low-power and high-speed field-programmable gate array (FPGA) where flash memory is adjacently integrated to CMOS logic is demonstrated. The flash memory and the high-speed switching transistor (SwTr) are fabricated close to each other without deteriorating their respective performance. Furthermore, programming schemes to write and erase the flash memory are optimized so that the memory is successfully programmed without any damage to the SwTrs. Flash-based configuration memory in the nonvolatile programmable switch has only half the area of the conventional static random-access memory-based one, and it can be placed in each block in FPGA, enabling efficient power gating that offers low-power FPGA operation.	[Zaitsu, Koichiro; Tatsumura, Kosuke; Matsumoto, Mari; Oda, Masato; Yasuda, Shinichi] Toshiba Co Ltd, Corp Res & Dev Ctr, Adv LSI Technol Lab, Kawasaki, Kanagawa 2128582, Japan	Zaitsu, K (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Adv LSI Technol Lab, Kawasaki, Kanagawa 2128582, Japan.	koichiro.zaitsu@toshiba.co.jp; kosuke.tatsumura@toshiba.co.jp; mari.matsumoto@toshiba.co.jp; masato2.oda@toshiba.co.jp; shinichi3.yasuda@toshiba.co.jp					Han KJ, 2007, IEEE CUST INTEGR CIR, P89; Greene J, 2011, FPGA 11: PROCEEDINGS OF THE 2011 ACM/SIGDA INTERNATIONAL SYMPOSIUM ON FIELD PROGRAMMABLE GATE ARRAYS, P87; Yaegashi T, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P190; Tanachutiwat S, 2011, IEEE T VLSI SYST, V19, P2023, DOI 10.1109/TVLSI.2010.2063444; MINAMI S, 1993, IEEE T ELECTRON DEV, V40, P2011, DOI 10.1109/16.239742; [Anonymous], 2008, 2008 S VLSI; Wang JJ, 2004, IEEE T NUCL SCI, V51, P3759, DOI 10.1109/TNS.2004.839255; Kojima H, 2007, INT EL DEVICES MEET, P677, DOI 10.1109/IEDM.2007.4419036; Fong S, 2012, IEEE ELECTR DEVICE L, V33, P1261, DOI 10.1109/LED.2012.2204950; Masui S, 2003, IEEE J SOLID-ST CIRC, V38, P715, DOI 10.1109/JSSC.2003.810034; Eitan B, 2000, IEEE ELECTR DEVICE L, V21, P543, DOI 10.1109/55.877205; Huang KJ, 2014, IEEE T CIRCUITS-I, V61, P2605, DOI 10.1109/TCSI.2014.2312499; Banno N, 2014, IEEE T ELECTRON DEV, V61, P3827, DOI 10.1109/TED.2014.2355830; Cong H.-I. L., 1999, U. S. Patent, Patent No. [6 002 610, 6002610]; Gaillardon Pierre-Emmanuel, 2010, Proceedings of the 2010 17th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2010), DOI 10.1109/ICECS.2010.5724454; Guillemenet Y., 2008, P INT C FPL, P421; Han K. J., 2007, P 22 IEEE NONV SEM M, P32; Jia J. Y., 2012, P ISWPC JUL, P1; Liauw Y. Y., 2012, P INT SOL STAT CIRC, P406; Ogura T., 2010, U. S. Patent, Patent No. [7 742 336, 7742336]; Rezzak N., 2014, P IEEE RAD EFF DAT W, P1; Yang S., 1991, LOGIC SYNTHESIS OPTI; Yeh C. C., 2002, P IEEE INT EL DEV M, P931; Zhao W., 2009, ACM T EMBED COMPUT S, V9, P2	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	DEC	2015	62	12					4009	4014		10.1109/TED.2015.2486802		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CW8CB	WOS:000365225700013		
J	Sugaya, I; Okada, M; Mitsuishi, H; Maeda, H; Shimoda, T; Izumi, S; Nakahira, H; Okamoto, K				Sugaya, Isao; Okada, Masashi; Mitsuishi, Hajime; Maeda, Hidehiro; Shimoda, Toshimasa; Izumi, Shigeto; Nakahira, Hosei; Okamoto, Kazuya			High-Precision Wafer-Level Cu-Cu Bonding for 3-DICs	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						3-D IC (3-DIC); thermocompression bonding; wafer-to-wafer (W2W)		A high-precision Cu-Cu bonding system for 3-D ICs (3-DICs) fabrication adopting a new precision alignment methodology is proposed. A new pressure profile control system is applied in the thermocompression bonding process. Experimental results show that the alignment capability is 250 nm or better, with similar overlay accuracy (|average|+3s) for permanent bonding. These developments are expected to contribute to the fabrication of future 3-DICs.	[Sugaya, Isao; Okada, Masashi; Maeda, Hidehiro; Shimoda, Toshimasa] Nikon Inc, Res Lab, Yokohama, Kanagawa 2448533, Japan; [Mitsuishi, Hajime] Nikon Inc, Core Technol Ctr, Yokohama, Kanagawa 2448533, Japan; [Izumi, Shigeto; Okamoto, Kazuya] Nikon Inc, Yokohama, Kanagawa 2448533, Japan; [Nakahira, Hosei] Nikon Inc, Precis Equipment Co, Yokohama, Kanagawa 2448533, Japan; [Okamoto, Kazuya] Osaka Univ, Osaka 5650871, Japan	Sugaya, I (reprint author), Nikon Inc, Res Lab, Yokohama, Kanagawa 2448533, Japan.	isao.sugaya@nikon.com; masashi.okada1@nikon.com; hajime.mitsuishi@nikon.com; hidehiro.maeda@nikon.com; toshimasa.shimoda@nikon.com; shigeto.izumi@nikon.com; hosei.nakahira@nikon.com; kazuya.okamoto@nikon.com					[Anonymous], 2013, INT TECHNOLOGY ROADM; Koyanagi M., 1998, IEEE Micro, V18, DOI 10.1109/40.710867; Okada M., 2014, P IEEE IEDM; Okamoto K., 2008, ECS T, V16, P15, DOI 10.1149/1.2982850; Sugaya I., 2014, P IEEE S3S OCT, P1; Sugaya I., 2015, P 26 ANN SEMI ADV SE, P429; Teh W. H., 2010, P IEEE IITC BURL CA, P1; Xie Y., 2006, J EMERG TECHNOL COMP, V2, P65, DOI DOI 10.1145/1148015.1148016	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	DEC	2015	62	12					4148	4154		10.1109/TED.2015.2493238		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CW8CB	WOS:000365225700033		
J	Hosotani, F; Inuzuka, Y; Hasegawa, M; Hirobayashi, S; Misawa, T				Hosotani, Fumitaka; Inuzuka, Yuya; Hasegawa, Masaya; Hirobayashi, Shigeki; Misawa, Tadanobu			Image Denoising With Edge-Preserving and Segmentation Based on Mask NHA	IEEE TRANSACTIONS ON IMAGE PROCESSING			English	Article						Image denoising; image segmentation; image representation; edge detection; non-harmonic analysis (NHA)	LEARNED DICTIONARIES; SPARSE; REPRESENTATIONS; RESTORATION; ALGORITHMS; GRADIENT; NOISE	In this paper, we propose a zero-mean white Gaussian noise removal method using a high-resolution frequency analysis. It is difficult to separate an original image component from a noise component when using discrete Fourier transform or discrete cosine transform for analysis because sidelobes occur in the results. The 2D non-harmonic analysis (2D NHA) is a high-resolution frequency analysis technique that improves noise removal accuracy because of its sidelobe reduction feature. However, spectra generated by NHA are distorted, because of which the signal of the image is non-stationary. In this paper, we analyze each region with a homogeneous texture in the noisy image. Non-uniform regions that occur due to segmentation are analyzed by an extended 2D NHA method called Mask NHA. We conducted an experiment using a simulation image, and found that Mask NHA denoising attains a higher peak signal-to-noise ratio (PSNR) value than the state-of-the-art methods if a suitable segmentation result can be obtained from the input image, even though parameter optimization was incomplete. This experimental result exhibits the upper limit on the value of PSNR in our Mask NHA denoising method. The performance of Mask NHA denoising is expected to approach the limit of PSNR by improving the segmentation method.	[Hosotani, Fumitaka; Inuzuka, Yuya; Hasegawa, Masaya] Toyama Univ, Grad Sch Sci & Engn Educ, Dept Intellectual Informat Engn, Toyama 9308555, Japan; [Hirobayashi, Shigeki; Misawa, Tadanobu] Toyama Univ, Dept Sci & Engn, Toyama 9308555, Japan	Hosotani, F (reprint author), Toyama Univ, Grad Sch Sci & Engn Educ, Dept Intellectual Informat Engn, Toyama 9308555, Japan.	fum0622@gmail.com; m1471104@ems.u-toyama.ac.jp; d1471002@ems.u-toyama.ac.jp; hirobays@eng.u-toyama.ac.jp; misawa@eng.u-toyama.ac.jp					Foi A, 2007, IEEE T IMAGE PROCESS, V16, P1395, DOI 10.1109/TIP.2007.891788; Cao X, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.022503; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Hasegawa M, 2013, IEEE T IMAGE PROCESS, V22, P3008, DOI 10.1109/TIP.2013.2253475; Ueda T, 2013, IEEE T IMAGE PROCESS, V22, P2946, DOI 10.1109/TIP.2012.2228490; Hirakawa K, 2006, IEEE T IMAGE PROCESS, V15, P2730, DOI 10.1109/TIP.2006.877352; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Guleryuz OG, 2007, IEEE T IMAGE PROCESS, V16, P3020, DOI 10.1109/TIP.2007.908078; Zhang L, 2010, PATTERN RECOGN, V43, P1531, DOI 10.1016/j.patcog.2009.09.023; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Christoudias CM, 2002, INT C PATT RECOG, P150; Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Liu HT, 2010, IEEE T IMAGE PROCESS, V19, P1414, DOI 10.1109/TIP.2010.2041406; Tian H, 2001, IEEE J SOLID-ST CIRC, V36, P92, DOI 10.1109/4.896233; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Dosselmann R, 2011, SIGNAL IMAGE VIDEO P, V5, P81, DOI 10.1007/s11760-009-0144-1; Chatterjee P, 2009, IEEE T IMAGE PROCESS, V18, P1438, DOI 10.1109/TIP.2009.2018575; Mairal J, 2008, MULTISCALE MODEL SIM, V7, P214, DOI 10.1137/070697653; Yang SY, 2013, J VIS COMMUN IMAGE R, V24, P181, DOI 10.1016/j.jvcir.2012.07.011; Xiao Y, 2011, PATTERN RECOGN, V44, P1708, DOI 10.1016/j.patcog.2011.02.002; Katkovnik V, 2010, INT J COMPUT VISION, V86, P1, DOI 10.1007/s11263-009-0272-7; Mairal J, 2008, IEEE T IMAGE PROCESS, V17, P53, DOI 10.1109/TIP.2007.911828; Canny J, 1986, MACH INTELL, V8, P679, DOI DOI 10.1109/TPAMI.1986.4767851; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Ichinose T., 2012, APPL FINANCIAL EC, V22, P197; Li H.-Q., 2008, COMPUT ENG DESIGN, V9, P046; Loader C, 1999, LOCAL REGRESSION LIK, V47; Tomasi C, 1998, P 6 INT C COMP VIS I, P839; Yoshizawa T., 2011, EURASIP J AUDIO SPEE, V5, P1	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7149	1941-0042		IEEE T IMAGE PROCESS	IEEE Trans. Image Process.	DEC	2015	24	12					6025	6033		10.1109/TIP.2015.2494461		9	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CW4US	WOS:000364992700003		
J	Miura, K; Matsui, A; Katsura, S				Miura, Kazumasa; Matsui, Ayaka; Katsura, Seiichiro			High-Stiff Motion Reproduction Using Position-Based Motion-Copying System With Acceleration-Based Bilateral Control	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Acceleration control; bilateral control; haptics; motion control; motion database; motion-copying system	DISTURBANCE-OBSERVER; MANIPULATOR; FEEDBACK	This paper presents the advantages of a highstiff motion-reproduction system based on a motion-copying system using acceleration-based bilateral control and analyzes its performance. A motion-copying system has been proposed for saving and reproducing human motions. In previous studies on motion-copying systems, stored motion data could not be reproduced under the condition that a difference existed in the disturbance between the motion-saving phase and the motion-reproducing phase. To overcome these drawbacks, a high-stiff motion-reproduction system that is robust against such differences has been proposed. In this study, comparative analyses of motion-reproduction systems are conducted by deriving the transfer functions of the motion-reproducing phase, and the superiority of the proposedmethod to other motion-reproduction systems (conventional motion-copying and position control systems) is shown. Finally, the validity and performance of the proposed method are verified through the experimental results. The proposed method should contribute to the advancement of motion-copying systems toward industrial applications.	[Miura, Kazumasa; Matsui, Ayaka; Katsura, Seiichiro] Keio Univ, Dept Syst Design Engn, Katsura Lab, Yokohama, Kanagawa 2238522, Japan	Miura, K (reprint author), Keio Univ, Dept Syst Design Engn, Katsura Lab, Yokohama, Kanagawa 2238522, Japan.	miura@katsura.sd.keio.ac.jp; matsui@katsura.sd.keio.ac.jp; katsura@sd.keio.ac.jp			Japan Society for the Promotion of Science KAKENHI	This work was supported by the Japan Society for the Promotion of Science KAKENHI.	Yokokura Y, 2008, AMC '08: 10TH INTERNATIONAL WORKSHOP ON ADVANCED MOTION CONTROL, VOLS 1 AND 2, PROCEEDINGS, P613; Yajima S, 2014, IEEE T IND ELECTRON, V61, P3765, DOI 10.1109/TIE.2013.2286086; KOMADA S, 1990, IEEE T IND ELECTRON, V37, P6, DOI 10.1109/41.45837; Tsunashima N, 2012, IEEE T IND ELECTRON, V59, P1074, DOI 10.1109/TIE.2011.2161247; Choi HT, 2000, J DYN SYST-T ASME, V122, P535, DOI 10.1115/1.1286520; Mita T, 1998, IEEE T IND ELECTRON, V45, P488, DOI 10.1109/41.679007; Mitsantisuk C, 2012, IEEE T IND ELECTRON, V59, P4383, DOI 10.1109/TIE.2011.2173092; Shang WW, 2014, IEEE T CONTR SYST T, V22, P314, DOI 10.1109/TCST.2013.2243149; Jinzenji A, 2001, IEEE T MAGN, V37, P888, DOI 10.1109/20.917637; Motoi N, 2014, IEEE T IND ELECTRON, V61, P1009, DOI 10.1109/TIE.2013.2251738; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Yokokura Y, 2014, IEEE T IND ELECTRON, V61, P6213, DOI 10.1109/TIE.2014.2308142; Katsura S, 2008, IEEE T IND ELECTRON, V55, P1699, DOI 10.1109/TIE.2007.907664; Yokokura Y, 2009, IEEE T IND ELECTRON, V56, P3906, DOI 10.1109/TIE.2009.2027927; Bucher R., 2008, RTAI LAB TUTORIAL SC; Fitzgerald C., 2013, P IEEE INT C TECHN P, P1; FUJIMOTO Y, 1995, IEEE T IND ELECTRON, V42, P272, DOI 10.1109/41.382138; Iida W., 2004, P 8 IEEE INT WORKSH, P217; Kaneko K., 1991, P INT C IND EL CONTR, V1, P849; Kazerooni H., 1989, IEEE Control Systems Magazine, V9, DOI 10.1109/37.16768; Matsui A., 2013, P 18 MICR C MOC, P1; Matsumoto Y, 2003, P IEEE INT C IND TEC, V2, P802; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Nozaki T., 2014, IEEJ J IND APPL, V3, P1; Ohishi K., 1983, P IEEJ INT POW EL C, P1209; Shimono T., 2006, P IEEE IECON NOV, P5252; Studenny J., 1984, Proceedings of the 23rd IEEE Conference on Decision and Control (Cat. No. 84CH2093-3); White M. T., 1996, P IFAC 13 TRIENN WOR, P489	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	DEC	2015	62	12					7631	7642		10.1109/TIE.2015.2458957		12	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CW5EZ	WOS:000365019500032		
J	Bechet, F; Ogawa, K; Sariyildiz, E; Ohnishi, K				Bechet, Francis; Ogawa, Kenji; Sariyildiz, Emre; Ohnishi, Kouhei			Electrohydraulic Transmission System for Minimally Invasive Robotics	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Electrohydraulic transmission system (EHTS); flexible actuator; minimally invasive surgery (MIS); natural orifice transluminal telesurgery (NOTES); organ palpation; telesurgery	BILATERAL TELEOPERATION; DISTURBANCE-OBSERVER; HAPTIC FEEDBACK; MOTION CONTROL; FORCE; SURGERY; DESIGN; COMPENSATION; MANIPULATOR; ELONGATION	It is a well-known fact that minimally invasive surgery (MIS) has many benefits, e.g., unnecessary trauma and blood loss can be minimized by opening tiny surgery scars, recovery process of patients can be lessened, and the possibilities of complications can be decreased. Although robots are widely used in MIS due to their fundamental superiorities such as high precision, current surgery robots mainly suffer from absence/limitation of haptic feedback during operation. This paper proposes a novel electrohydraulic haptic transmission system to improve the haptic feedback of a surgery robot. This new device replaces the highly nonlinear mechanical friction of thrust wire by viscous friction and avoids the backlash due to the incompressibility of fluid. Moreover, since the fluid is constantly occupying the entire volume of the hydraulic tube, the system behavior during bending of the tube can be modeled much easier than the thrust wire, for which position, shape, and bending angles of the inner wire inside the outer tube are hardly predictable. The validity of the proposal and its superiorities over conventional transmission mechanisms, such as thrust wire, are experimentally verified.	[Bechet, Francis; Ogawa, Kenji; Sariyildiz, Emre; Ohnishi, Kouhei] Keio Univ, Dept Syst Design Engn, Ohnishi Lab, Yokohama, Kanagawa 2238522, Japan	Bechet, F (reprint author), Denso Corp, Basis Elect R&D Div, Kariya, Aichi 4488661, Japan.	francis_bechet@denso.co.jp; kenji@sum.sd.keio.ac.jp; bieemre@nus.edu.sg; ohnishi@sd.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25220903]	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant-in-Aid for Scientific Research (S), 25220903, 2013.	Chan LP, 2014, IEEE T HUM-MACH SYST, V44, P337, DOI 10.1109/THMS.2014.2303983; Bolopion A, 2013, IEEE T AUTOM SCI ENG, V10, P496, DOI 10.1109/TASE.2013.2245122; Sun ZL, 2014, IEEE-ASME T MECH, V19, P1243, DOI 10.1109/TMECH.2013.2278613; Beccani M, 2014, IEEE T BIO-MED ENG, V61, P353, DOI 10.1109/TBME.2013.2279337; Beelen MJ, 2013, CONTROL ENG PRACT, V21, P1694, DOI 10.1016/j.conengprac.2013.08.002; Phee SJ, 2010, P I MECH ENG C-J MEC, V224, P1495, DOI 10.1243/09544062JMES1880; Puangmali P, 2012, IEEE-ASME T MECH, V17, P646, DOI 10.1109/TMECH.2011.2116033; Nisky I, 2013, IEEE T HUM-MACH SYST, V43, P570, DOI 10.1109/TSMC.2013.2284487; Ishii C, 2010, IEEE-ASME T MECH, V15, P671, DOI 10.1109/TMECH.2009.2031641; Bechet F, 2014, PROC IEEE INT SYMP, P1174, DOI 10.1109/ISIE.2014.6864780; Sariyildiz E, 2015, IEEE T IND ELECTRON, V62, P1581, DOI 10.1109/TIE.2014.2361611; Ogawa K, 2014, PROC IEEE INT SYMP, P1250, DOI 10.1109/ISIE.2014.6864793; Hyodo S, 2009, IEEE T IND ELECTRON, V56, P36, DOI 10.1109/TIE.2008.2006231; Wanninayake IB, 2013, IEEE T BIO-MED ENG, V60, P2735, DOI 10.1109/TBME.2013.2264287; Chen L, 2014, IEEE T IND ELECTRON, V61, P1424, DOI 10.1109/TIE.2013.2258300; Sariyildiz E, 2015, IEEE-ASME T MECH, V20, P750, DOI 10.1109/TMECH.2014.2321014; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Baki P, 2012, P IEEE RAS-EMBS INT, P805, DOI 10.1109/BioRob.2012.6290770; Taniguchi K, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P601, DOI 10.1109/ROBIO.2007.4522230; Tortora G, 2014, IEEE-ASME T MECH, V19, P1821, DOI 10.1109/TMECH.2013.2296531; Talasaz A, 2013, IEEE T HAPTICS, V6, P217, DOI [10.1109/TOH.2012.64, 10.1109/ToH.2012.64]; Chiang LS, 2009, IEEE ASME INT C ADV, P332, DOI 10.1109/AIM.2009.5229991; Sariyildiz E, 2015, IEEE T IND ELECTRON, V62, P414, DOI 10.1109/TIE.2014.2327009; Mizoguchi T, 2014, IEEE T IND ELECTRON, V61, P1033, DOI 10.1109/TIE.2013.2264787; Nakajima Y, 2014, IEEE T IND ELECTRON, V61, P3753, DOI 10.1109/TIE.2013.2287258; Bechet F., 2014, P IEEE AMC MAR, P260; Buerger S. P., 2010, ADV HAPTICS; Dachs G., 2006, P 28 IEEE EMBS ANN I, P1505; Iida W., 2004, P 8 IEEE INT WORKSH, P217; Liu W. S., 2012, P IEEE CICC SEP, P1; Matsuo M., 2013, P 17 INT C TRANSDUCE, P1440; Mitsantisuk C., 2011, Proceedings of the 2011 1st International Symposium on Access Spaces (ISAS), DOI 10.1109/ISAS.2011.5960921; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Prasanga D. K., 2013, P IEEE ISIE MAY, P1; Stedman T. L., 2012, STEDMANS MED DICT HL; Tsuji K., 2006, P 9 IEEE INT WORKSH, P329; Wagner C. R., 2002, P 10 S HAPT INT VIRT, P68, DOI 10.1109/HAPTIC.2002.998943; Weichao Sun, 2013, IEEE Transactions on Industrial Electronics, V60, DOI 10.1109/TIE.2012.2206340; Yakoubi R., 2012, ROBOTIC SYSTEMS APPL	39	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	DEC	2015	62	12					7643	7654		10.1109/TIE.2015.2453930		12	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CW5EZ	WOS:000365019500033		
J	Chen, SF; Amagai, Y; Maruyama, M; Kaneko, N				Chen, Shih-Fang; Amagai, Yasutaka; Maruyama, Michitaka; Kaneko, Nobu-hisa			Uncertainty Evaluation of a 10 V RMS Sampling Measurement System Using the AC Programmable Josephson Voltage Standard	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Digital-to-analog conversion; electrical variable measurement; Josephson arrays; Josephson effect; quantization; signal synthesis; standards; uncertainty	WAVE; CONVERTER; ERROR	We have evaluated the uncertainty in the differential sampling measurement of the rms amplitude of 10 V waveform synthesis based on an ac programmable Josephson voltage standard system with a compact cooler and a modified digital voltmeter (DVM). The error due to a sampling DVM timer is much reduced with an external 20-MHz frequency reference for the sampling DVM. The thermal electromotive force voltage of our reverse-polarity relay switch is sufficiently small and stable for the application of a differential sampling system. We have also performed a variety of measurements to evaluate this differential sampling technique. The evaluation results show that the overall expanded uncertainty is 1.3 parts in 10(6) (k = 2) for the frequency of 62.5 Hz at an rms amplitude of 10 V.	[Chen, Shih-Fang] Ctr Measurement Stand, Ind Technol Res Inst, Hsinchu 30011, Taiwan; [Amagai, Yasutaka; Maruyama, Michitaka; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Chen, SF (reprint author), Ctr Measurement Stand, Ind Technol Res Inst, Hsinchu 30011, Taiwan.	csf0317@itri.org.tw			Center for Measurement Standards/Industrial Technology Research Institute; National Metrology Institute of Japan/Advanced Industrial Science and Technology	Manuscript received March 9, 2015; revised April 23, 2015; accepted June 10, 2015. Date of publication July 22, 2015; date of current version November 6, 2015. This work was supported in part by the Center for Measurement Standards/Industrial Technology Research Institute and in part by the National Metrology Institute of Japan/Advanced Industrial Science and Technology in order to advance precision measurements of DC and AC Voltage with quantum-based programmable Josephson voltage standard systems. The Associate Editor coordinating the review process was Dr. Regis Landim.	Amagai Y., 2012, CPEM C JUL, P674; Amagai Y., 2014, CPEM C AUG, P264; Burroughs CJ, 2008, IEEE T INSTRUM MEAS, V57, P1322, DOI 10.1109/TIM.2008.917260; Burroughs CJ, 2009, IEEE T INSTRUM MEAS, V58, P761, DOI 10.1109/TIM.2008.2007041; Maruyama M, 2010, 2010 CONFERENCE ON PRECISION ELECTROMAGNETIC MEASUREMENTS CPEM, P8, DOI 10.1109/CPEM.2010.5544216; Williams JM, 2011, IET SCI MEAS TECHNOL, V5, P163, DOI 10.1049/iet-smt.2010.0168; GOEKE WC, 1989, HEWLETT-PACKARD J, V40, P8; Yamada T, 2010, IEEE T APPL SUPERCON, V20, P21, DOI 10.1109/TASC.2009.2033939; Eklund G, 2011, IEEE T INSTRUM MEAS, V60, P2399, DOI 10.1109/TIM.2010.2101190; Rufenacht A, 2013, IEEE T INSTRUM MEAS, V62, P1587, DOI 10.1109/TIM.2013.2237993; Amagai Y, 2013, IEEE T INSTRUM MEAS, V62, P1621, DOI 10.1109/TIM.2013.2245182; HAMILTON CA, 1995, IEEE T INSTRUM MEAS, V44, P223, DOI 10.1109/19.377816; van den Brom HE, 2007, MEAS SCI TECHNOL, V18, P3316, DOI 10.1088/0957-0233/18/11/008; Chen S.-F., 2014, CPEM C AUG, P258; Kim M.-S., 2010, MEAS SCI TECHNOL, V21; Lee J, 2013, METROLOGIA, V50, P612, DOI 10.1088/0026-1394/50/6/612; Maruyama M., 2014, CPEM C AUG, P416; Rufenacht Alain, 2009, IEEE Transactions on Instrumentation and Measurement, V58, DOI 10.1109/TIM.2008.2008087; Yamamori H, 2012, IEICE T ELECTRON, VE95C, P329, DOI [10.1587/transele.E95.C329, 10.1587/transele.E95.C.329]; Yamamori H., 2006, APPL PHYS LETT, V88	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	DEC	2015	64	12					3308	3314		10.1109/TIM.2015.2450355		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CW3CR	WOS:000364870100015		
J	Nishitani, Y; Kaneko, Y; Ueda, M				Nishitani, Yu; Kaneko, Yukihiro; Ueda, Michihito			Supervised Learning Using Spike-Timing-Dependent Plasticity of Memristive Synapses	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Memristor; spike-timing-dependent plasticity (STDP); spiking neural network (SNN) hardware; supervised learning	MFS FETS; NETWORKS; CIRCUITS; NEURONS; SYSTEMS	We propose a supervised learning model that enables error backpropagation for spiking neural network hardware. The method is modeled by modifying an existing model to suit the hardware implementation. An example of a network circuit for the model is also presented. In this circuit, a three-terminal ferroelectric memristor (3T-FeMEM), which is a field-effect transistor with a gate insulator composed of ferroelectric materials, is used as an electric synapse device to store the analog synaptic weight. Our model can be implemented by reflecting the network error to the write voltage of the 3T-FeMEMs and introducing a spike-timing-dependent learning function to the device. An XOR problem was successfully demonstrated as a benchmark learning by numerical simulations using the circuit properties to estimate the learning performance. In principle, the learning time per step of this supervised learning model and the circuit is independent of the number of neurons in each layer, promising a high-speed and low-power calculation in large-scale neural networks.	[Nishitani, Yu; Kaneko, Yukihiro; Ueda, Michihito] Panasonic Corp, Adv Res Div, Kyoto 6190237, Japan	Nishitani, Y (reprint author), Panasonic Corp, Adv Res Div, Kyoto 6190237, Japan.	nishitani.yu@jp.panasonic.com; kaneko.yukihiro001@jp.panasonic.com; ueda.michihito@jp.panasonic.com					Nishiyama M, 2000, NATURE, V408, P584; Yoon SM, 1999, IEEE ELECTR DEVICE L, V20, P229; SCHUETZE SM, 1983, TRENDS NEUROSCI, V6, P164, DOI 10.1016/0166-2236(83)90078-4; Ghosh-Dastidar S, 2007, INTEGR COMPUT-AID E, V14, P187; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; McKennoch S, 2006, IEEE IJCNN, P3970; Kato Y, 2008, JPN J APPL PHYS, V47, P2719, DOI 10.1143/JJAP.47.2719; Chanthbouala A, 2012, NAT MATER, V11, P860, DOI [10.1038/nmat3415, 10.1038/NMAT3415]; Sharad M, 2012, IEEE T NANOTECHNOL, V11, P843, DOI 10.1109/TNANO.2012.2202125; Yoon SM, 1999, IEEE ELECTR DEVICE L, V20, P526, DOI 10.1109/55.791931; Kaneko Y, 2014, IEEE T ELECTRON DEV, V61, P2827, DOI 10.1109/TED.2014.2331707; Snider GS, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURES, P85, DOI 10.1109/NANOARCH.2008.4585796; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; Bichler O, 2012, IEEE T ELECTRON DEV, V59, P2206, DOI 10.1109/TED.2012.2197951; ISHIWARA H, 1993, JPN J APPL PHYS 1, V32, P442, DOI 10.1143/JJAP.32.442; Bi GQ, 1998, J NEUROSCI, V18, P10464; Ghosh-Dastidar S, 2009, NEURAL NETWORKS, V22, P1419, DOI 10.1016/j.neunet.2009.04.003; Kuzum D, 2012, IEEE T ELECTRON DEV, V59, P3489, DOI 10.1109/TED.2012.2217146; Ramakrishnan S, 2011, IEEE T BIOMED CIRC S, V5, P244, DOI 10.1109/TBCAS.2011.2109000; Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Rajendran B, 2013, IEEE T ELECTRON DEV, V60, P246, DOI 10.1109/TED.2012.2227969; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Gerstner W., 2002, SPIKING NEURON MODEL; Kandel E. R., 1991, PRINCIPLES NEURAL SC; Kaneko Y., 2011, APPL PHYS LETT, V99; Mead C., 1989, ANALOG VLSI NEURAL S; Nishitani Y., 2012, J APPL PHYS, V111; Nishitani Y., 2013, JPN J APPL PHYS, V52; Rumelhart D., 1986, NATURE, V536, P323, DOI DOI 10.1038/323533A0; Shi J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3676; Tanaka H, 2009, IEICE T FUND ELECTR, VE92A, P1690, DOI 10.1587/transfun.E92.A.1690; Ueda M., 2011, J APPL PHYS, V110; Zhu LQ, 2014, NAT COMMUN, V5, P3158	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	DEC	2015	26	12					2999	3008		10.1109/TNNLS.2015.2399491		10	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CW9IQ	WOS:000365312800003		
J	Hayashi, H; Shibanoki, T; Shima, K; Kurita, Y; Tsuji, T				Hayashi, Hideaki; Shibanoki, Taro; Shima, Keisuke; Kurita, Yuichi; Tsuji, Toshio			A Recurrent Probabilistic Neural Network with Dimensionality Reduction Based on Time-series Discriminant Component Analysis	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Dimensionality reduction; Gaussian mixture model (GMM); hidden Markov model (HMM); neural network (NN); pattern classification	CLASSIFICATION; RECOGNITION; PCA	This paper proposes a probabilistic neural network (NN) developed on the basis of time-series discriminant component analysis (TSDCA) that can be used to classify high-dimensional time-series patterns. TSDCA involves the compression of high-dimensional time series into a lower dimensional space using a set of orthogonal transformations and the calculation of posterior probabilities based on a continuous-density hidden Markov model with a Gaussian mixture model expressed in the reduced-dimensional space. The analysis can be incorporated into an NN, which is named a time-series discriminant component network (TSDCN), so that parameters of dimensionality reduction and classification can be obtained simultaneously as network coefficients according to a backpropagation through time-based learning algorithm with the Lagrange multiplier method. The TSDCN is considered to enable high-accuracy classification of high-dimensional time-series patterns and to reduce the computation time taken for network training. The validity of the TSDCN is demonstrated for high-dimensional artificial data and electroencephalogram signals in the experiments conducted during the study.	[Hayashi, Hideaki] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398521, Japan; [Shibanoki, Taro] Ibaraki Univ, Coll Engn, Hitachi, Ibaraki 3168511, Japan; [Shima, Keisuke] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan; [Kurita, Yuichi; Tsuji, Toshio] Hiroshima Univ, Inst Engn, Higashihiroshima 7398521, Japan	Hayashi, H (reprint author), Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398521, Japan.	hayashi@bsys.hiroshima-u.ac.jp; sibanoki@mx.ibaraki.ac.jp; shima@ynu.ac.jp; kurita@bsys.hiroshima-u.ac.jp; tsuji@bsys.hiroshima-u.ac.jp	Tsuji, Toshio/D-6210-2011	Tsuji, Toshio/0000-0002-7689-3963			STREIT RL, 1994, IEEE T NEURAL NETWOR, V5, P764, DOI 10.1109/72.317728; Xiang SM, 2008, PATTERN RECOGN, V41, P3600, DOI 10.1016/j.patcog.2008.05.018; Lotlikar R, 2000, IEEE T NEURAL NETWOR, V11, P452, DOI 10.1109/72.839014; CAELLI TM, 1993, NEURAL NETWORKS, V6, P613, DOI 10.1016/S0893-6080(05)80106-6; Caelli T, 1999, P IEEE, V87, P1497, DOI 10.1109/5.784227; Prekopcsak Z, 2012, ADV DATA ANAL CLASSI, V6, P185, DOI 10.1007/s11634-012-0110-6; Güler Nihal Fatma, 2005, J Med Syst, V29, P241, DOI 10.1007/s10916-005-5184-7; Zhou TY, 2013, IEEE T IMAGE PROCESS, V22, P244, DOI 10.1109/TIP.2012.2202678; Subasi A, 2010, EXPERT SYST APPL, V37, P8659, DOI 10.1016/j.eswa.2010.06.065; Nie FP, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P993; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Jeong YS, 2011, PATTERN RECOGN, V44, P2231, DOI 10.1016/j.patcog.2010.09.022; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Tao DC, 2007, IEEE DATA MINING, P302, DOI 10.1109/ICDM.2007.105; Nie FP, 2010, IEEE T IMAGE PROCESS, V19, P1921, DOI 10.1109/TIP.2010.2044958; Nie FP, 2009, PATTERN RECOGN, V42, P105, DOI 10.1016/j.patcog.2008.03.012; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Agarwal M, 2010, 2010 INTERNATIONAL CONFERENCE ON SIGNAL ACQUISITION AND PROCESSING: ICSAP 2010, PROCEEDINGS, P310, DOI 10.1109/ICSAP.2010.51; Tao DC, 2009, IEEE T PATTERN ANAL, V31, P260, DOI 10.1109/TPAMI.2008.70; Huang Y, 2012, IEEE T NEUR NET LEAR, V23, P519, DOI 10.1109/TNNLS.2011.2178037; PERLOVSKY LI, 1991, NEURAL NETWORKS, V4, P89, DOI 10.1016/0893-6080(91)90035-4; Xu D, 2008, IEEE T PATTERN ANAL, V30, P1985, DOI 10.1109/TPAMI.2008.129; Tsuji T, 2003, IEEE T NEURAL NETWOR, V14, P304, DOI 10.1109/TNN.2003.809403; WERBOS PJ, 1990, P IEEE, V78, P1550, DOI 10.1109/5.58337; Fontaine JL, 2001, COMPUT CHEM ENG, V25, P1045, DOI 10.1016/S0098-1354(01)00679-2; Hayashi H, 2013, IEEE ENG MED BIO, P5394, DOI 10.1109/EMBC.2013.6610768; Bache K., 2013, UCI MACHINE LEARNING; Bellman R., 1961, ADAPTIVE CONTROL PRO, V4; Bu N., 2010, P 10 IEEE INT C INF, P1, DOI 10.1109/ITAB.2010.5687668; Buza K, 2011, PAKDD 11, P149; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; HOLM S, 1979, SCAND J STAT, V6, P65; Hoya T., 2003, P ICA2003, P197; Jordan M. I., 1997, ADV PSYCHOL, V121, P471; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Lines J., 2012, P 18 ACM SIGKDD INT, P289; Mahajan K., 2011, IJEAT, V1, P80; Midhat A., 2008, PROJECT BCI EEG MOTO; Radovanovic M., 2010, P 10 SIAM INT C DAT, P677; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Spiegel S., 2011, P 5 INT WORKSH KNOWL, P34; WAIBEL A, 1989, IEEE T ACOUST SPEECH, V37, P328, DOI 10.1109/29.21701; Xing E., 2002, ADV NEURAL INFORM PR, V15, P505; Xing Z., 2010, ACM SIGKDD EXPLOR NE, V12, P40, DOI DOI 10.1145/1882471.1882478; Zak M., 1989, PHYS LETT, V2, P259, DOI DOI 10.1016/0893-6080(89)90036-1	45	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	DEC	2015	26	12					3021	3033		10.1109/TNNLS.2015.2400448		13	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CW9IQ	WOS:000365312800005		
J	Xia, YL; Jahanchahi, C; Nitta, T; Mandic, DP				Xia, Yili; Jahanchahi, Cyrus; Nitta, Tohru; Mandic, Danilo P.			Performance Bounds of Quaternion Estimators	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Augmented quaternion statistics; mean square error (MSE); quaternion widely linear (WL) model; semi-WL (SWL) model	RANDOM VECTORS; COMPLEX; FILTER; SIGNAL	The quaternion widely linear (WL) estimator has been recently introduced for optimal second-order modeling of the generality of quaternion data, both second-order circular (proper) and second-order noncircular (improper). Experimental evidence exists of its performance advantage over the conventional strictly linear (SL) as well as the semi-WL (SWL) estimators for improper data. However, rigorous theoretical and practical performance bounds are still missing in the literature, yet this is crucial for the development of quaternion valued learning systems for 3-D and 4-D data. To this end, based on the orthogonality principle, we introduce a rigorous closed-form solution to quantify the degree of performance benefits, in terms of the mean square error, obtained when using the WL models. The cases when the optimal WL estimation can simplify into the SWL or the SL estimation are also discussed.	[Xia, Yili] Southeast Univ, Sch Informat Sci & Engn, Nanjing 210018, Jiangsu, Peoples R China; [Xia, Yili; Jahanchahi, Cyrus; Mandic, Danilo P.] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London SW7 2AZ, England; [Nitta, Tohru] Natl Inst Adv Ind Sci & Technol, Math Neuroinformat Grp, Tsukuba, Ibaraki 3058568, Japan	Xia, YL (reprint author), Southeast Univ, Sch Informat Sci & Engn, Nanjing 210018, Jiangsu, Peoples R China.	yili.xia06@gmail.com; cyrus.jahanchahi05@imperial.ac.uk; tohru-nitta@aist.go.jp; d.mandic@imperial.ac.uk			Engineering and Physical Sciences Research Council [EP/H026266/1]; Natural Science Foundation of Jiangsu Province [BK20140645]; National Natural Science Foundation of China [61401094]	This work was supported in part by the Engineering and Physical Sciences Research Council under Grant EP/H026266/1, in part by the Natural Science Foundation of Jiangsu Province under Grant BK20140645, and in part by the National Natural Science Foundation of China under Grant 61401094.	Amblard P. O., 2004, P IMA C MATH SIGN PR, P23; Took CC, 2011, SIGNAL PROCESS, V91, P214, DOI 10.1016/j.sigpro.2010.06.024; Ell TA, 2007, COMPUT MATH APPL, V53, P137, DOI 10.1016/j.camwa.2006.10.029; PICINBONO B, 1995, IEEE T SIGNAL PROCES, V43, P2030, DOI 10.1109/78.403373; Jahanchahi C, 2014, INT CONF DIGIT SIG, P254, DOI 10.1109/ICDSP.2014.6900839; Miron S, 2006, IEEE T SIGNAL PROCES, V54, P1218, DOI 10.1109/TSP.2006.870630; Picinbono B, 1996, IEEE T SIGNAL PROCES, V44, P2637, DOI 10.1109/78.539051; Took CC, 2010, IEEE T SIGNAL PROCES, V58, P4427, DOI 10.1109/TSP.2010.2048323; Javidi S, 2011, IEEE T NEURAL NETWOR, V22, P1967, DOI 10.1109/TNN.2011.2171362; Buchholz S, 2008, INT J NEURAL SYST, V18, P75, DOI 10.1142/S0129065708001403; Said S, 2008, IEEE T SIGNAL PROCES, V56, P1522, DOI 10.1109/TSP.2007.910477; Jahanchahi C, 2014, IEEE T NEUR NET LEAR, V25, P533, DOI 10.1109/TNNLS.2013.2277540; Via J, 2011, IEEE T SIGNAL PROCES, V59, P1586, DOI 10.1109/TSP.2010.2101065; Sloin A, 2014, IEEE T SIGNAL PROCES, V62, P5487, DOI 10.1109/TSP.2014.2349874; Navarro-Moreno J, 2012, IEEE SIGNAL PROC LET, V19, P868, DOI 10.1109/LSP.2012.2221700; Ujang BC, 2011, IEEE T NEURAL NETWOR, V22, P1193, DOI 10.1109/TNN.2011.2157358; Sabatini AM, 2006, IEEE T BIO-MED ENG, V53, P1346, DOI [10.1109/TBME.2006.875664, 10.1109/TMBE.2006.875664]; NEESER FD, 1993, IEEE T INFORM THEORY, V39, P1293, DOI 10.1109/18.243446; Via J, 2010, IEEE T INFORM THEORY, V56, P3502, DOI 10.1109/TIT.2010.2048440; Took CC, 2009, IEEE T SIGNAL PROCES, V57, P1316, DOI 10.1109/TSP.2008.2010600; Vakhania NN, 1999, THEOR PROBAB APPL+, V43, P99, DOI 10.1137/S0040585X97976696; Arena P., 1998, NEURAL NETWORKS MULT; Mandic D. P., 2009, COMPLEX VALUED NONLI; Nitta T., 2013, APPL MATH, V4, P1616; Olhede SC, 2014, IEEE T INFORM THEORY, V60, P6491, DOI 10.1109/TIT.2014.2342734; PICINBONO B, 1994, IEEE T SIGNAL PROCES, V42, P3473, DOI 10.1109/78.340781; Schreier P J, 2010, STAT SIGNAL PROCESSI; Took C. C., 2010, RENEW ENERG, V36, P1754; Xia YL, 2015, IEEE T NEUR NET LEAR, V26, P663, DOI 10.1109/TNNLS.2014.2320715	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	DEC	2015	26	12					3287	3292		10.1109/TNNLS.2015.2388782		6	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CW9IQ	WOS:000365312800026		
J	Zhou, JJ; Zhou, DJ; Zhu, JY; Goto, S				Zhou, Jinjia; Zhou, Dajiang; Zhu, Jiayi; Goto, Satoshi			A Frame-Parallel 2 Gpixel/s Video Decoder Chip for UHDTV and 3-DTV/FTV Applications	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						3-D TV; application-specified integrated circuit (ASIC); H.264/Advanced Video Coding; Super High Version; ultrahigh definition television (UHDTV); video decoder; VLSI	H.264/AVC; ARCHITECTURE; COMPRESSION	The first single-chip design that supports real-time H.264/Advanced Video Coding decoding of 8k (7680 x 4320) 60 frames/s is realized. It also supports multiview decoding for up to 32 720p views or 16 1080p views. To significantly improve the throughput and reduce the memory bandwidth requirement, frame-level parallelism is exploited for the proposed design. First, a frame dependency protection scheme enables frame-parallel decoding, by reusing multiple replicas of an existing design. This results in a system throughput of 2 Gpixels/s, at least 3.75 times better than previous chips. Moreover, a reference window synchronization scheme and a 2-level hybrid caching structure are proposed to achieve 44% memory bandwidth reduction of motion compensation, by utilizing frame-level data reuse. The bandwidth reduction results in 22% Dynamic Random-Access Memory power saving of the whole decoder.	[Zhou, Jinjia; Zhou, Dajiang; Zhu, Jiayi; Goto, Satoshi] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan	Zhou, JJ (reprint author), Waseda Univ, Kitakyushu, Fukuoka 8080135, Japan.	zhou@ruri.waseda.jp; zhou@fuji.waseda.jp; jzhu@aoni.waseda.jp; goto@waseda.jp					Tsai CH, 2013, IEEE ASIAN SOLID STA, P305; Cheng CC, 2009, IEEE T CIRC SYST VID, V19, P141, DOI 10.1109/TCSVT.2008.2009250; [Anonymous], 2010, P IEEE S VLSI JUN; Lin PC, 2009, ISCAS: 2009 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-5, P365; Zhou DJ, 2009, 2009 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P262; [Anonymous], 2005, H264 ITUT; Ku CW, 2006, IEEE T CIRC SYST VID, V16, P917, DOI 10.1109/TCSVT.2006.879992; Zhou DJ, 2011, IEEE J SOLID-ST CIRC, V46, P777, DOI 10.1109/JSSC.2011.2109550; Sze V, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P773, DOI 10.1109/ICIP.2009.5414245; Kim J, 2010, IEEE T CIRC SYST VID, V20, P848, DOI 10.1109/TCSVT.2010.2045923; Zhu JY, 2008, IEEE INT SYMP CIRC S, P3518; Lin YC, 2009, IEEE T VLSI SYST, V17, P838, DOI 10.1109/TVLSI.2008.2008456; [Anonymous], 2013, H265 ITUT; Tanimoto M, 2006, SIGNAL PROCESS-IMAGE, V21, P454, DOI 10.1016/j.image.2006.03.009; Sze V, 2009, IEEE J SOLID-ST CIRC, V44, P2943, DOI 10.1109/JSSC.2009.2028933; [Anonymous], 2012, BT2020 ITUR; Chen X., 2009, P 2 INT WORKSH COMP, P362; Chi C. C., 2010, P INT C SUP, P105, DOI 10.1145/1810085.1810102; Chien C.-D., 2007, ISSCC FEB, P282; Chuang T.-D., 2010, IEEE INT SOL STAT CI, P330; Lin C. C., 2006, IEEE INT SOL STAT CI, P1596; Lin CC, 2007, IEEE J SOLID-ST CIRC, V42, P170, DOI 10.1109/JSSC.2006.886537; Sullivan GJ, 2005, P IEEE, V93, P18, DOI 10.1109/JPROC.2004.839617; Tikekar M., 2014, IEEE J SOLID-ST CIRC, V9, P61; Zhou D., 2012, ISSCC, P224; Zhou DJ, 2009, IEICE T FUND ELECTR, VE92A, P3203, DOI 10.1587/transfun.E92.A.3203; Zhou JJ, 2010, IEICE T FUND ELECTR, VE93A, P1425, DOI 10.1587/transfun.E93.A.1425	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	DEC	2015	23	12					2768	2781		10.1109/TVLSI.2014.2385780		14	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CW7VA	WOS:000365206300002		
J	He, G; Zhou, DJ; Li, YS; Chen, ZX; Zhang, TR; Goto, S				He, Gang; Zhou, Dajiang; Li, Yunsong; Chen, Zhixiang; Zhang, Tianruo; Goto, Satoshi			High-Throughput Power-Efficient VLSI Architecture of Fractional Motion Estimation for Ultra-HD HEVC Video Encoding	IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS			English	Article						Chip implementation; fractional motion estimation (FME); High Efficiency Video Coding (HEVC); ultra high definition (ultra-HD); VLSI architecture	ESTIMATION DESIGN; H.264/AVC; ALGORITHM; INTERPOLATION; PREDICTION	Fractional motion estimation (FME) significantly enhances video compression efficiency, but its high computational complexity also limits the real-time processing capability. In this brief, we present a VLSI implementation of FME design in High Efficiency Video Coding for ultrahigh definition video applications. We first propose a bilinear quarter pixel approximation, together with a search pattern based on it to reduce the complexity of interpolation and fractional search process. Furthermore, a data reuse strategy is exploited to reduce the hardware cost of transform. In addition, using the considered pixel parallelism and dedicated access pattern for memory, we fully pipeline the computation and achieve high hardware utilization. This design has been implemented as a 65-nm CMOS chip and verified. The measured throughput reaches 995 Mpixels/s for 7680 x 4320 30 frames/s at 188 MHz, at least 4.7 times faster than prior arts. The corresponding power dissipation is 198.6 mW, with a power efficiency of 0.2 nJ/pixel. Due to the optimization, our work achieves more than 52% improvement on power efficiency, relative to previous works in H.264.	[He, Gang; Li, Yunsong] Xidian Univ, Sch Telecommun Engn, Xian 710071, Peoples R China; [Zhou, Dajiang; Chen, Zhixiang; Zhang, Tianruo; Goto, Satoshi] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan	He, G (reprint author), Xidian Univ, Sch Telecommun Engn, Xian 710071, Peoples R China.	ghe@xidian.edu.cn; zhou@fuji.waseda.jp; ysli@mail.xidian.edu.cn; zhixiang.chen1985@gmail.com; skyives@126.com; goto@waseda.jp			Semiconductor Technology Academic Research Center (STARC) Program, Japan; National Natural Science Foundation of China [61222101]; Fundamental Research Funds for the Central Universities (Xidian University), China	This work was supported in part by the Semiconductor Technology Academic Research Center (STARC) Program, Japan, in part by National Natural Science Foundation of China Under Grant 61222101, and in part by Fundamental Research Funds for the Central Universities (Xidian University), China. The fabrication chip was provided by the VLSI Design and Education Center, the University of Tokyo in collaboration with STARC, e-shuttle and Fujitsu.	Chen YH, 2009, IEEE T CIRC SYST VID, V19, P1118, DOI 10.1109/TCSVT.2009.2020323; Guo ZY, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P1117; Wang YJ, 2007, IEEE T CIRC SYST VID, V17, P578, DOI 10.1109/TCSVT.2007.894050; [Anonymous], 2013, JVTG050 JOINT COLL T; Chen TC, 2006, IEEE INT SYMP CIRC S, P5331; Li H, 2013, INT CONF ACOUST SPEE, P1399; Jou SY, 2013, IEEE WORKSHOP SIG, P247; Kao CY, 2010, IEEE T VLSI SYST, V18, P662, DOI 10.1109/TVLSI.2009.2013629; Tsung PK, 2009, IEEE INT CON MULTI, P9; Ugur K, 2013, IEEE J-STSP, V7, P946, DOI 10.1109/JSTSP.2013.2272771; He G, 2013, IEEE ASIAN SOLID STA, P301; Zhou DJ, 2007, IEEE INT SYMP CIRC S, P2910, DOI 10.1109/ISCAS.2007.377858; Ding L. F., 2009, IEEE ISSCC, P154; Kim G., 2011, P IEEE ICME JUL, P661; Lin YK, 2008, IEEE T CIRCUITS-I, V55, P1526, DOI 10.1109/TCSI.2008.916681; Sotetsumoto T., 2013, PROC IEEE INT CONF O, P1; Tsai S.-F., 2013, P S VLSI CIRC VLSIC, pC188	17	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-8210	1557-9999		IEEE T VLSI SYST	IEEE Trans. Very Large Scale Integr. (VLSI) Syst.	DEC	2015	23	12					3138	3142		10.1109/TVLSI.2014.2386897		5	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CW7VA	WOS:000365206300039		
J	Sun, Y; Quan, CQ; Kang, X; Zhang, ZP; Ren, FJ				Sun, Yan; Quan, Changqin; Kang, Xin; Zhang, Zuopeng; Ren, Fuji			Customer emotion detection by emotion expression analysis on adverbs	INFORMATION TECHNOLOGY & MANAGEMENT			English	Article						Affective computing; E-business; Customer emotions; Adverb analysis	INFORMATION-SYSTEMS; SERVICE WORKFLOW; ENVIRONMENT; MODELS	The growing interests of affective computing (AC) and its implementation in e-business demand researchers to explore the applications of AC techniques in detecting customer emotions. Recent studies have shown that language is powerful in conveying emotions, and a good understanding of major language features bears great implications for customer relationship management. However, the effect of adverbs in text emotion prediction has only been briefly mentioned in a few related works, but never thoroughly studied. This paper addresses the gap by investigating how to detect customer emotions through analyzing the adverbs in emotion expressions. In particular, we develop a Japanese adverb emotion corpus, analyze emotion usage of adverbs, and further derive an adverb-emotion lexicon and its rule base. Utilizing these resources, we design and perform experiments to classify emotions in sentences so as to evaluate the effectiveness of different adverb features including adverbs, adverb emotions, and adverb emotion rules. Our experiments and analysis show the great impact of adverbs on emotion expressions, which can be applied to assist e-businesses in improving customer related processes.	[Sun, Yan; Kang, Xin; Ren, Fuji] Univ Tokushima, Fac Engn, Tokushima 7708506, Japan; [Quan, Changqin] Hefei Univ Technol, Sch Comp & Informat, AnHui Prov Key Lab Affect Comp & Adv Intelligent, Hefei 230009, Peoples R China; [Zhang, Zuopeng] SUNY Coll Plattsburgh, Sch Business & Econ, Plattsburgh, NY 12901 USA	Quan, CQ (reprint author), Hefei Univ Technol, Sch Comp & Informat, AnHui Prov Key Lab Affect Comp & Adv Intelligent, Hefei 230009, Peoples R China.	sssyyy917@hotmail.com; quanchqin@gmail.com; kangxin4@hotmail.com; zzhan001@plattsburgh.edu; ren@is.tokushima-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [22240021]; National High-Tech Research & Development Program of China 863 Program [2012AA011103]; National Natural Science Foundation of China [61203312]	This research has been partially supported by the Ministry of Education, Science, Sports and Culture of Japan under Grant-in-Aid for Scientific Research (A) No. 22240021, and the National High-Tech Research & Development Program of China 863 Program under Grant No. 2012AA011103, and National Natural Science Foundation of China under Grant No. 61203312.	Qian YF, 2011, INFORM TECHNOL MANAG, V12, P55, DOI 10.1007/s10799-011-0095-4; Li L, 2012, IEEE T INF TECHNOL B, V16, P515, DOI 10.1109/TITB.2012.2198317; Ren FJ, 2012, INFORM TECHNOL MANAG, V13, P321, DOI 10.1007/s10799-012-0138-5; [Anonymous], 2007, P 8 ACM C EL COMM EC, DOI 10.1145/1250910.1250938; Zhou ZD, 2012, IEEE T IND INFORM, V8, P630, DOI 10.1109/TII.2012.2197004; Calvo RA, 2010, IEEE T AFFECT COMPUT, V1, P18, DOI 10.1109/T-AFFC.2010.1; Li L, 2011, INFORM TECHNOL MANAG, V12, P49, DOI 10.1007/s10799-011-0100-y; Viriyasitavat W, 2012, IEEE T IND INFORM, V8, P631, DOI 10.1109/TII.2011.2182519; Guo JZ, 2011, INFORM TECHNOL MANAG, V12, P121, DOI 10.1007/s10799-011-0082-9; Smith AK, 2002, J ACAD MARKET SCI, V30, P5, DOI 10.1177/03079450094298; Flaxer D, 2007, ENTERP INFORM SYST, V1, P177, DOI 10.1080/17517570701254965; Liang LH, 2008, ENTERP INFORM SYST, V2, P1, DOI 10.1080/17517570701846539; Xu LD, 2012, IEEE T IND INFORM, V8, P639, DOI 10.1109/TII.2012.2187908; Groth M, 2009, ACAD MANAGE J, V52, P958, DOI 10.5465/AMJ.2009.44634116; Xu LD, 2012, IEEE T IND INFORM, V8, P669, DOI 10.1109/TII.2012.2188901; Wang P, 2011, INFORM TECHNOL MANAG, V12, P161, DOI 10.1007/s10799-011-0098-1; [Anonymous], 2009, P 15 ACM SIGKDD INT, DOI 10.1145/1557019.1557148; Liu B, 2011, INFORM TECHNOL MANAG, V12, P67, DOI 10.1007/s10799-011-0091-8; Puccinelli NM, 2009, J RETAILING, V85, P15, DOI 10.1016/j.jretai.2008.11.003; Guo JZ, 2012, IEEE T SYST MAN CY A, V42, P316, DOI 10.1109/TSMCA.2011.2162946; Quan CQ, 2010, COMPUT SPEECH LANG, V24, P726, DOI 10.1016/j.csl.2010.02.002; Beheshti HM, 2010, ENTERP INF SYST-UK, V4, P445, DOI 10.1080/17517575.2010.511276; Gray P, 2000, IEE P-VIS IMAGE SIGN, V147, P493, DOI 10.1049/ip-vis:20000539; Fischer S, 2004, LECT NOTES COMPUT SC, V3068, P309; Asada H, 1994, DICT CONT ADVERB USA; Asada H, 2002, DICT CONT USAGE ONOM; ChaSen, JAP MORPH AN SYST; Christopher W, 2011, INFORM TECHNOL MANAG, V12, P387; Consoli D, 2009, P CHALL CONT KNOWL B, P996; Galitsky B, 2004, P 17 INT FLOR ART IN; Grandey A. A., 2004, J ORGAN BEHAV, V25, P1, DOI DOI 10.1002/JOB.252; Hatzivassiloglou V, 2000, P 18 C COMP LING ASS, V1, P299, DOI DOI 10.3115/990820.990864; Hu M., 2004, P 10 ACM SIGKDD INT, P168, DOI DOI 10.1145/1014052.1014073; Khan I, 2012, INT J ADV RES TECHNO, V1, P106; Mahmoud N, 2008, FRONTIERS ENTERPRISE; Matsumoto K, 2005, DEV EMOTION CORPUS C, P91; Matsumoto K, 2007, J NATURAL LANGUAGE P, V14, P239; Mika S, 2005, P 11 ANN C ANN ASS N, P33; Mika S, 2003, FORUM INFORM TECHNOL, P117; Miyajima T, 1982, ILLUSTRAT JAPANESE F; Morita Y, 1985, ANAL RES MISUSAGE JA; Morrison D, 2007, SPEECH COMMUN, V49, P98, DOI 10.1016/j.specom.2006.11.004; Mu R, 2009, P EL INF SYST C EL I; Onishi M, 1943, DISCUSSION LANGUAGE; Pang B., 2002, P ACL 02 C EMP METH, V10, P79, DOI DOI 10.3115/1118693.1118704; Popescu A, 2005, P C HUM LANG TECHN E, P339; Ren E, 2010, INT J ADV INTELLIGEN, V2, P107; Shimamoto K, 1989, DICT LEARNERS JAPANE; Sun Y, 2009, P IEEE NLP KE 09; Tanaka T, 2004, P 10 ANN C ANN ASS N, P345; Turney P. D., 2002, P 40 ANN M ASS COMP, P417, DOI DOI 10.3115/1073083.1073153; Hachani S, 2013, ENTERP INF SYST-UK, V7, P79, DOI 10.1080/17517575.2012.688221; Wiebe J, 2005, LANG RESOUR EVAL, V39, P164; Xu S, 2011, INF TECHNOL MANAG, V13, P201; Yamamoto M, 2007, EMOTION CLASSIFICATI, P31	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1385-951X	1573-7667		INFORM TECHNOL MANAG	Inf. Technol. Manag.	DEC	2015	16	4					303	311		10.1007/s10799-014-0204-2		9	Information Science & Library Science; Management	Information Science & Library Science; Business & Economics	CW8OW	WOS:000365260000003		
J	Wang, ZZ; Guo, J				Wang, Zhenzhong; Guo, Jiang			Research on an optimized machining method for parallel grinding of f-theta optics (vol 80, pg 1411, 2015)	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Correction									[Wang, Zhenzhong; Guo, Jiang] Xiamen Univ, Dept Mech & Elect Engn, Xiamen 361005, Peoples R China	Guo, J (reprint author), RIKEN, Ctr Adv Photon RAP, Ultrahigh Precis Opt Technol Team, Wako, Saitama 3510198, Japan.	guojiang3302@163.com					Wang ZZ, 2015, INT J ADV MANUF TECH, V80, P1411, DOI 10.1007/s00170-015-7042-1	1	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	DEC	2015	81	9-12					2197	2197		10.1007/s00170-015-8004-3		1	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	CW8BR	WOS:000365224400060		
J	Matsushita, K; Minamishima, T; Goda, A; Ishiguro, H; Kosho, H; Sakata, K; Satoh, T; Yoshino, H				Matsushita, Kenichi; Minamishima, Toshinori; Goda, Ayumi; Ishiguro, Haruhisa; Kosho, Hideyasu; Sakata, Konomi; Satoh, Toru; Yoshino, Hideaki			Comparison of the reliability of E/E' to estimate pulmonary capillary wedge pressure in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Doppler; E/E'; Pulmonary capillary wedge pressure; Heart failure with preserved ejection fraction	VENTRICULAR FILLING PRESSURES; DIASTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; RECOMMENDATIONS; ASSOCIATION; GUIDELINES	Accurate assessment of pulmonary capillary wedge pressure (PCWP) is essential for physicians to effectively manage patients with acute decompensated heart failure. The ratio of early transmittal velocity to tissue Doppler mitral annular early diastolic velocity (E/E') is used to estimate PCWP noninvasively in a wide range of cardiac patients. However, it remains contentious as to whether mitral E/E' is a reliable predictor of PCWP. In the present study, acute heart failure patients were divided into two groups on the basis of left ventricular (LV) systolic function: those with preserved ejection fraction (HFpEF) and those with reduced ejection fraction (HFrEF). The usefulness of mitral E/E' in estimating PCWP was compared between the two groups. Fifty consecutive patients who were admitted with acute decompensated heart failure and underwent both right-sided cardiac catheterization and transthoracic echocardiography during hospitalization were analyzed retrospectively. Pearson's correlation was used to evaluate associations between Doppler parameters and PCWP. E/E' was positively correlated with PCWP (r = 0.56, P = 0.01) in the heart failure with preserved ejection fraction group. However, no significant relationship was observed between PCWP and mitral E/E' (P = 0.85) in the heart failure with reduced ejection fraction group. There were no significant correlations between any of the conventional parameters considered (LVEF, left atrial dimension, E/A, IVRT, and DT) with PCWP in either group. In conclusion, mitral E/E' is useful for estimating PCWP in patients with acute heart failure with preserved ejection fraction but may not in those with reduced ejection fraction.	[Matsushita, Kenichi; Minamishima, Toshinori; Goda, Ayumi; Ishiguro, Haruhisa; Kosho, Hideyasu; Sakata, Konomi; Satoh, Toru; Yoshino, Hideaki] Kyorin Univ, Div Cardiol, Dept Internal Med 2, Sch Med, Mitaka, Tokyo 1818611, Japan	Matsushita, K (reprint author), Kyorin Univ, Div Cardiol, Dept Internal Med 2, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	kenichi-matsushita@umin.ac.jp; yoshino@ks.kyorin-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [26461086]	The authors thank Ms. Keiko Nishizawa for data collection. This work was supported, in part, by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (KAKENHI 26461086; to K. Matsushita).	Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Ommen SR, 2000, CIRCULATION, V102, P1788; NAGUEH SF, 1995, AM J CARDIOL, V75, P1256, DOI 10.1016/S0002-9149(99)80773-5; Weintraub NL, 2010, CIRCULATION, V122, P1975, DOI 10.1161/CIR.0b013e3181f9a223; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Nieminen MS, 2005, EUR HEART J, V26, P384; Bruch C, 2005, AM J CARDIOL, V95, P892, DOI 10.1016/j.amjcard.2004.12.017; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Nagueh SF, 1998, CIRCULATION, V98, P1644; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Sohn DW, 1999, J AM SOC ECHOCARDIOG, V12, P927, DOI 10.1016/S0894-7317(99)70145-8; Mullens W, 2009, CIRCULATION, V119, P62, DOI 10.1161/CIRCULATIONAHA.108.779223; Firstenberg MS, 2000, J AM COLL CARDIOL, V36, P1664, DOI 10.1016/S0735-1097(00)00909-8; Dokainish H, 2004, CIRCULATION, V109, P2432, DOI 10.1161/01.CIR.0000127882.58426.7A	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2015	31	8					1497	1502		10.1007/s10554-015-0718-7		6	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CW9BS	WOS:000365293900003		
J	Amanuma, M; Kondo, T; Sano, T; Sekine, T; Takayanagi, T; Matsutani, H; Arai, T; Morita, H; Ishizaka, K; Arakita, K; Iwasa, A; Takase, S				Amanuma, Makoto; Kondo, Takeshi; Sano, Tomonari; Sekine, Takako; Takayanagi, Tomoya; Matsutani, Hideyuki; Arai, Takehiro; Morita, Hitomi; Ishizaka, Kazumasa; Arakita, Kazumasa; Iwasa, Akiko; Takase, Shinichi			Subtraction coronary computed tomography in patients with severe calcification	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Coronary artery; Coronary CT angiography; Calcification; Subtraction	CT ANGIOGRAPHY; CALCIUM SCORE; HEART-RATE; DISEASE; LESIONS	To investigate the clinical usefulness of subtraction coronary computed tomographic angiography (CCTA) in patients with severe calcification. A 320-row area detector CT system was used in this study. The subjects were 78 patients (47 men and 31 women, 739 years of age) with an Agatston score of > 300 who were able to undergo prospective one-beat scanning during a single breath-hold. The CCTA findings were compared against invasive coronary angiography. The diagnostic capabilities of CCTA for the severely calcified segments with and without the additional information provided by subtraction CCTA were compared. Severe calcification was observed in 174 (31.9 %) of the 546 segments, and non-assessable regions were observed in 74 (13.6 %) of the segments. The addition of subtraction CCTA information improved the diagnostic accuracy for segments with severe calcification from 67.8 to 82.8 % on a per-segment basis and from 70.1 to 82.1 % on a per-patient basis, with non-assessable segments considered to be stenotic. When non-assessable segments were considered to be an incorrect diagnosis, the diagnostic accuracy was improved from 48.3 to 75.9 % on a per-segment basis and from 43.3 to 79.1 % on a per-patient basis. In addition, when evaluation was limited to non-assessable segments, subtraction CCTA provided a diagnostic accuracy of 81.1 % when non-assessable segments were considered to be stenotic or 66.2 % when non-assessable segments were considered to be an incorrect diagnosis. Subtraction CCTA improves the diagnostic capabilities of CCTA in patients with severe calcification.	[Amanuma, Makoto; Sano, Tomonari; Sekine, Takako; Takayanagi, Tomoya; Matsutani, Hideyuki; Arai, Takehiro; Morita, Hitomi; Ishizaka, Kazumasa; Takase, Shinichi] Takase Clin, Takasaki, Gumma, Japan; [Kondo, Takeshi] Jukokai Cent Hosp, Miyoshi, Aichi, Japan; [Arakita, Kazumasa; Iwasa, Akiko] Toshiba Med Syst Corp, Otawara, Tochigi, Japan	Amanuma, M (reprint author), Takase Clin, Takasaki, Gumma, Japan.	ten@gunma-u.ac.jp					AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827; Amanuma M, 2015, JPN J RADIOL, V33, P122, DOI 10.1007/s11604-015-0389-2; Yoshioka K, 2012, CARDIOL CLIN, V30, P93, DOI 10.1016/j.ccl.2011.10.004; Yoshioka K, 2015, INT J CARDIOVAS IMAG, V31, P51, DOI 10.1007/s10554-015-0630-1; Tanaka R, 2013, INT J CARDIOVAS IMAG, V29, P75, DOI 10.1007/s10554-013-0316-5; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Ahn SJ, 2013, J COMPUT ASSIST TOMO, V37, P387, DOI 10.1097/RCT.0b013e318282d61c; Machida H, 2015, RADIOGRAPHICS, V35, P991, DOI 10.1148/rg.2015140181; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Funama Y, 2014, PHYS MEDICA, V30, P385, DOI 10.1016/j.ejmp.2013.10.003; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; Palumbo AA, 2009, EUR RADIOL, V19, P2127, DOI 10.1007/s00330-009-1398-2; Mahabadi AA, 2010, RADIOLOGY, V257, P614, DOI 10.1148/radiol.10100140; Bastarrika G, 2009, RADIOLOGY, V253, P317, DOI 10.1148/radiol.2532081738; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Dewey M, 2011, RADIOLOGY, V258, P329, DOI 10.1148/radiol.10100161; Chen MY, 2013, INT J CARDIOVAS IMAG, V29, P1167, DOI 10.1007/s10554-013-0190-1; Austen W G, 1975, Circulation, V51, P5; Razeto M, P SPIE, V8768; Sano T, 2013, JPN J RAD TECHNOL, V69, P244; Schuetz GM, 2012, BMJ-BRIT MED J, V24, pe6717; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2015	31	8					1635	1642		10.1007/s10554-015-0746-3		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CW9BS	WOS:000365293900020		
J	Yoneda, K; Kubota, Y				Yoneda, Kozo; Kubota, Yasuo			Lupus pernio-like skin metastasis of adenocarcinoma	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter									[Yoneda, Kozo; Kubota, Yasuo] Kagawa Univ, Dept Dermatol, Fac Med, Takamatsu, Kagawa 760, Japan	Yoneda, K (reprint author), Kagawa Univ, Dept Dermatol, Fac Med, Takamatsu, Kagawa 760, Japan.	kyoneda@med.kagawa-u.ac.jp					Besnier E, 1889, ANN DERMATOL SYPHIL, V10, P333; MacKee PH, 2005, PATHOLOGY SKIN CLIN, P1497; Tenneson M, 1892, B SOC FR DERMATOL SY, V3, P417; Weedon D, 2002, PATHOLOGY SKIN, P1045	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	DEC	2015	54	12					E543	E545		10.1111/ijd.12934		3	Dermatology	Dermatology	CW6SW	WOS:000365129100008		
J	Iida, M; Iiba, M; Kusunoki, K; Miyamoto, Y; Isoda, H				Iida, Masahiro; Iiba, Masanori; Kusunoki, Koichi; Miyamoto, Yuji; Isoda, Hiroshi			Seismic Responses of Two RC Buildings and One Wood Building Based on an Input Wave Field	INTERNATIONAL JOURNAL OF GEOMECHANICS			English	Article						Structural dynamics; Three-dimensional analysis; Concrete structures; Wood structures; Soft soils; Soil-structure interactions; Surface waves; Underground structures	SOIL	A recently proposed three-dimensional (3D) linear method for examining soil-building interactions based on an input seismic wave field is, after some improvements, applied to estimate seismic building responses in the reclaimed zone of Tokyo Bay, where ground motions include a considerable amount of surface waves, thus reconfirming the effects of the method in a different situation. A seismic wave field involves seismic waves propagating in a 3D medium. The proposed method was developed with the goal of adequately treating seismic surface waves trapped by a (several-kilometers) deep underground structure in a soil-building interaction system. Two simulations were carried out. The first simulation successfully reproduced surface, downhole, and building accelerograms that were recorded at one borehole station during two medium-sized earthquakes. In the second simulation, seismic responses of a midrise RC model building and a wood model building were favorably calculated at the other borehole station for the 1923 Kanto earthquake. The building responses also were compared with those calculated by two standard response analyses, demonstrating the superiority of the proposed method. (C) 2014 American Society of Civil Engineers.	[Iida, Masahiro; Kusunoki, Koichi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Iiba, Masanori] Bldg Res Inst, Tsukuba, Ibaraki 3050802, Japan; [Miyamoto, Yuji] Osaka Univ, Dept Architecture, Suita, Osaka 5650871, Japan; [Isoda, Hiroshi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan	Iida, M (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	iida@eri.u-tokyo.ac.jp; iiba-m@kenken.go.jp; kusunoki@eri.u-tokyo.ac.jp; miyamoto@arch.eng.osaka-u.ac.jp; hisoda@rish.kyoto-u.ac.jp					Abe Y., 1984, P 8 WORLD C EARTHQ E, VIII, P585; TOKI K, 1987, EARTHQUAKE ENG STRUC, V15, P945, DOI 10.1002/eqe.4290150803; Iida M, 2005, B SEISMOL SOC AM, V95, P1101, DOI 10.1785/0120040010; Iida M, 2013, INT J GEOMECH, V13, P430, DOI 10.1061/(ASCE)GM.1943-5622.0000232; Iida M, 2004, B SEISMOL SOC AM, V94, P598, DOI 10.1785/0120030059; Maheshwari BK, 2011, INT J GEOMECH, V11, P335, DOI 10.1061/(ASCE)GM.1943-5622.0000087; Ashour M, 2003, J GEOTECH GEOENVIRON, V129, P404, DOI 10.1061/(ASCE)1090-0241(2003)129:6(404); Architectural Institute of Japan, 1985, P 1 SOIL BUILD DYN I, P77; Building Center of Japan, 2013, BUILD STAND LAW JAP; Iida M., 2006, International Journal of Geomechanics, V6, P342, DOI 10.1061/(ASCE)1532-3641(2006)6:5(342); Ishihara T., 1994, THESIS; Ishihara T., 1993, P JAPAN SOC ENG, V465, P145; Kim YongSeok, 2004, International Journal of Geomechanics, V4, P104, DOI 10.1061/(ASCE)1532-3641(2004)4:2(104); Kobayashi K., 1989, P 2 SOIL BUILD INT S, P25; Ohta T., 1978, P 5 JAP EARTHQ ENG S, P561; Tabatabaiefar SHR, 2013, INT J GEOMECH, V13, P409, DOI 10.1061/(ASCE)GM.1943-5622.0000231	16	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1532-3641	1943-5622		INT J GEOMECH	Int. J. Geomech.	DEC	2015	15	6							04014093	10.1061/(ASCE)GM.1943-5622.0000444		10	Engineering, Geological	Engineering	CW6PQ	WOS:000365120100009		
J	Watanabe, K; Hirano, T; Katsumi, K; Ohashi, M; Ishikawa, A; Koike, R; Endo, N; Nishizawa, M; Shimohata, T				Watanabe, Kei; Hirano, Toru; Katsumi, Keiichi; Ohashi, Masayuki; Ishikawa, Atsushi; Koike, Ryoko; Endo, Naoto; Nishizawa, Masatoyo; Shimohata, Takayoshi			Characteristics and exacerbating factors of chronic low back pain in Parkinson's disease	INTERNATIONAL ORTHOPAEDICS			English	Article						Parkinson's disease; Low back pain; Exacerbation factors; Spinal alignment; Quality of life	VITAMIN-D; SYMPTOMS	Background The aim of this study was to determine the exacerbating factors of chronic low back pain (LBP) and strategic points against LBP in patients with Parkinson's disease (PD). Methods Forty-four consecutive PD patients complaining of LBP were included. Clinical characteristics of PD and LBP, spinal musculoskeletal condition, and clinical health status were evaluated. Results Patient age at PD and LBP onset was contiguous, and LBP time period was mainly described as constant or upon waking up. Exacerbating factors of LBP included modified Hoehn and Yahr stage and motor complications of PD, such as the wearing-off phenomenon and dyskinesia. Bone quality demonstrated osteopenia due to elevated bone resorption, with vitamins K and D insufficiencies. Spinal alignment demonstrated an increased sagittal vertical axis (120.2 +/- 65.4 mm) with decreased lumbar lordosis (-24.0 +/- 20.6 degrees) and lumbar range of motion (28.7 +/- 10.2 degrees), which were significantly related to severity of LBP and quality of life assessments. Conclusions This study demonstrated that exacerbating factors of LBP include stage of motor function, motor complications of PD and stooped posture with decreased lumbar lordosis and range of lumbar movement. Therefore, control of PD, including motor complications, active treatment for osteoporosis and therapeutic exercise, are important for treating chronic LBP in patients with PD.	[Watanabe, Kei; Hirano, Toru; Katsumi, Keiichi; Ohashi, Masayuki; Endo, Naoto] Niigata Univ, Med & Dent Gen Hosp, Dept Orthoped Surg, Chuo Ku, Niigata, Niigata 9518510, Japan; [Nishizawa, Masatoyo; Shimohata, Takayoshi] Niigata Univ, Dept Neurol, Brain Res Inst, Niigata, Niigata 9518510, Japan; [Ishikawa, Atsushi] Brain Dis Ctr Agano Hosp, Dept Neurol, Agano City, Niigata, Japan; [Koike, Ryoko] Nishi Niigata Chuo Natl Hosp, Dept Neurol, Niigata, Niigata, Japan	Watanabe, K (reprint author), Niigata Univ, Med & Dent Gen Hosp, Dept Orthoped Surg, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan.	Keiwatanabe_39jp@live.jp					Wang LY, 2015, MOVEMENT DISORD, V30, P560, DOI 10.1002/mds.26117; Kim YE, 2013, PARKINSONISM RELAT D, V19, P666, DOI 10.1016/j.parkreldis.2013.03.002; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Etchepare F, 2006, JOINT BONE SPINE, V73, P298, DOI 10.1016/j.jbspin.2005.05.006; Beiske AG, 2009, PAIN, V141, P173, DOI 10.1016/j.pain.2008.12.004; Negre-Pages L, 2008, MOVEMENT DISORD, V23, P1361, DOI 10.1002/mds.22142; Oh JK, 2014, SPINE, V39, pE833, DOI 10.1097/BRS.0000000000000366; Ames CP, 2012, J NEUROSURG-SPINE, V16, P547, DOI 10.3171/2012.2.SPINE11320; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Fukui M, 2007, J ORTHOP SCI, V12, P443, DOI 10.1007/s00776-007-1162-x; KOLLER WC, 1984, NEUROLOGY, V34, P957; Yoshida G, 2014, SPINE, V39, P1121, DOI 10.1097/BRS.0000000000000360; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Broetz D, 2007, MOVEMENT DISORD, V22, P853, DOI 10.1002/mds.21439; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Jenkinson C, 2012, PARKINSONS DIS QUEST, P18; Li CL, 2015, NEUROL SCI, V36, P247, DOI 10.1007/s10072-014-1928-9; OBrien MF, 2005, RADIOGRAPHIC MEASURE; Shiraki M, 2007, JPN J MED PHARM SCI, V57, P537	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	DEC	2015	39	12					2433	2438		10.1007/s00264-015-3011-4		6	Orthopedics	Orthopedics	CW7ME	WOS:000365182500016		
J	Narazaki, S; Furumatsu, T; Tanaka, T; Fujii, M; Miyazawa, S; Inoue, H; Shimamura, Y; Saiga, K; Ozaki, T				Narazaki, Shinji; Furumatsu, Takayuki; Tanaka, Takaaki; Fujii, Masataka; Miyazawa, Shinichi; Inoue, Hiroto; Shimamura, Yasunori; Saiga, Kenta; Ozaki, Toshifumi			Postoperative change in the length and extrusion of the medial meniscus after anterior cruciate ligament reconstruction	INTERNATIONAL ORTHOPAEDICS			English	Article						Anterior cruciate ligament reconstruction; Medial meniscus; Meniscal length; Meniscal extrusion	DEFICIENT KNEE; IN-VITRO; OSTEOARTHRITIS; MENISCECTOMY; INJURY; TEAR; REPLACEMENT; REPAIR; RISK	Purpose The medial meniscus is a secondary stabilizer of anterior tibial translation in anterior cruciate ligament (ACL)-deficient knees. ACL reconstruction effectively restores an increased anterior tibial translation in the ACL-deficient knee. However, knee osteoarthritis sometimes develops in ACL-reconstructed patients during a long-term follow-up period. We hypothesized that the medial meniscal position would be different between the ACL-deficient and reconstructed knees. The aim of this study was to investigate pre-operative and postoperative location of the medial meniscus in patients who underwent ACL reconstruction. Methods ACL-reconstructed knees (28 knees) and normal knees (27 knees) were investigated. Medial tibial plateau length (MTPL) and medial tibial plateau width (MTPW) were determined using radiographic images. Magnetic resonance imaging (MRI)-based medial meniscal length (MML), medial meniscal width (MMW), and medial meniscal extrusion (MME) were measured. Postoperative change in the MML, MMW, and MME were evaluated and compared with those in normal knees. Results No significant differences between the ACL-deficient (pre-operative) and normal groups were noted. The ACL-reconstructed (postoperative) group showed an increase in the MML, in the percentage of the MML (%MML = 100 MML/MTPL), and in the MME. Significant differences between postoperative and normal groups were observed in the MML, %MML, and MME. MMW and MMW percentage (100 MMW/MTPW) were similar in all groups. Conclusions The anteroposterior length and radial extrusion of the medial meniscus increased after ACL reconstruction. Transposition of the medial meniscus may be a possible cause of developing further degenerative knee joint disorders after ACL reconstruction.	[Narazaki, Shinji; Furumatsu, Takayuki; Tanaka, Takaaki; Fujii, Masataka; Miyazawa, Shinichi; Inoue, Hiroto; Shimamura, Yasunori; Saiga, Kenta; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Kita Ku, Okayama 7008558, Japan	Furumatsu, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	matino@md.okayama-u.ac.jp	FURUMATSU, Takayuki/B-2233-2011		Japan Society for the Promotion of Science [24791546]	We are grateful to Prof. Nobuhiro Abe (Kawasaki Medical School, Okayama, Japan) for his support. This work was supported by Grants from the Japan Society for the Promotion of Science (No. 24791546).	Mills PM, 2008, OSTEOARTHR CARTILAGE, V16, P1526, DOI 10.1016/j.joca.2008.04.014; Seon JK, 2009, ARTHROSCOPY, V25, P123, DOI 10.1016/j.arthro.2008.09.020; LEVY IM, 1982, J BONE JOINT SURG AM, V64, P883; Wenger A, 2012, EUR RADIOL, V22, P211, DOI 10.1007/s00330-011-2234-z; Papageorgiou CD, 2001, AM J SPORT MED, V29, P226; Petersen W, 2014, ARCH ORTHOP TRAUM SU, V134, P237, DOI 10.1007/s00402-013-1873-8; Bloecker K, 2013, OSTEOARTHR CARTILAGE, V21, P419, DOI 10.1016/j.joca.2012.11.015; BYLSKIAUSTROW DI, 1994, J BIOMECH, V27, P421, DOI 10.1016/0021-9290(94)90018-3; Kluczynski MA, 2013, AM J SPORT MED, V41, P2759, DOI 10.1177/0363546513503448; Leroux T, 2014, J BONE JOINT SURG AM, V96A, P2, DOI 10.2106/JBJS.M.00393; Berthiaume MJ, 2005, ANN RHEUM DIS, V64, P556, DOI 10.1136/ard.2004.023796; Stone KR, 2007, ARTHROSCOPY, V23, P503, DOI 10.1016/j.arthro.2006.12.025; INOUE M, 1987, AM J SPORT MED, V15, P15, DOI 10.1177/036354658701500103; Dunn WR, 2004, AM J SPORT MED, V32, P1906, DOI 10.1177/0363546504265006; McDermott ID, 2004, KNEE SURG SPORT TR A, V12, P130, DOI 10.1007/s00167-003-0366-7; Lebel B, 2008, AM J SPORT MED, V36, P1275, DOI 10.1177/0363546508314721; Furumatsu T, 2014, INT ORTHOP, V38, P1393, DOI 10.1007/s00264-013-2238-1; Haut TL, 2000, J ORTHOPAED RES, V18, P228, DOI 10.1002/jor.1100180210; Richmond JC, 2011, ARTHROSCOPY, V27, P149, DOI 10.1016/j.arthro.2010.11.060; Pujol N, 2009, KNEE SURG SPORT TR A, V17, P396, DOI 10.1007/s00167-008-0711-y; Sakata K, 2013, ACTA MED OKAYAMA, V67, P65; Vrancken ACT, 2013, INT ORTHOP, V37, P291, DOI 10.1007/s00264-012-1682-7; Delince P, 2012, KNEE SURG SPORT TR A, V20, P48, DOI 10.1007/s00167-011-1614-x; Matsuo T, 2014, KNEE SURG SPORT TR A, V22, P2128, DOI 10.1007/s00167-013-2646-1; Musahl V, 2010, AM J SPORT MED, V38, P1591, DOI 10.1177/0363546510364402; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P222, DOI 10.1007/s00167-010-1274-2; Shaffer B, 2000, AM J SPORT MED, V28, P524; Allen CR, 2000, J ORTHOPAED RES, V18, P109, DOI 10.1002/jor.1100180116; Ikuma H, 2008, ACTA MED OKAYAMA, V62, P185; Vedi V, 1999, J BONE JOINT SURG BR, V81B, P37, DOI 10.1302/0301-620X.81B1.8928; Fujii M, 2014, KNEE SURG SPORTS TRA; Furumatsu T, ORTHOP TRAU IN PRESS; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; Magnussen Robert A, 2009, J Knee Surg, V22, P347; Matsumoto H, 2001, J Orthop Sci, V6, P28, DOI 10.1007/s007760170021; Sakata K, 2013, INT ORTHOP, V37, P159, DOI 10.1007/s00264-012-1728-x	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	DEC	2015	39	12					2481	2487		10.1007/s00264-015-2704-z		7	Orthopedics	Orthopedics	CW7ME	WOS:000365182500022		
J	Kan, H; Arai, Y; Nakagawa, S; Inoue, H; Hara, K; Minami, G; Inoue, A; Kanamura, H; Ikoma, K; Fujiwara, H; Kubo, T				Kan, Hiroyuki; Arai, Yuji; Nakagawa, Shuji; Inoue, Hiroaki; Hara, Kunio; Minami, Ginjiro; Inoue, Atsuo; Kanamura, Hitoshi; Ikoma, Kazuya; Fujiwara, Hiroyoshi; Kubo, Toshikazu			Characteristics of medial plica syndrome complicated with cartilage damage	INTERNATIONAL ORTHOPAEDICS			English	Article						Medial plica syndrome; Medial femoral condyle; Impingement; Cartilage damage	SYNOVIAL PLICA; SHELF SYNDROME; KNEE; DIAGNOSIS; PAIN	Purpose This study was designed to evaluate the characteristics of patients with medial plica syndrome and associated cartilage damage. Methods The study subjects included 44 patients with 57 knees arthroscopically diagnosed with medial plica syndrome. Subjects were divided into those with severe cartilage damage, defined as International Cartilage Research Society (ICRS) stage 2 or higher, and those with mild cartilage damage, defined as ICRS stage 1 or lower. Local findings, period from onset to surgery, arthroscopic findings, and postoperative results were compared in the two groups. Results The shapes of the medial synovial plica were types C and D of the Sakakibara classification in the severe group, and types A, B, and C in the mild group. Patellar ballottement tended to be more common in the severe than in the mild group (P = 0.059). The duration from onset to surgery was significantly longer in the severe than in the mild group (29.0 vs. 11.6 months, P = 0.043). Postoperative results were significantly better in the mild than in the severe group (P = 0.0017). Conclusions The shape of the medial synovial plica and the duration between symptom onset and surgery were associated with cartilage damage. Surgical treatment should be considered when the medial synovial plica covers part of the anterior aspect of the medial femoral condyle or ruptures, or when pain persists over a long period, thus reducing the potential for cartilage damage.	[Kan, Hiroyuki; Arai, Yuji; Nakagawa, Shuji; Inoue, Hiroaki; Hara, Kunio; Minami, Ginjiro; Inoue, Atsuo; Kanamura, Hitoshi; Ikoma, Kazuya; Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan	Arai, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, 465 Kawaramachi Hirokoji, Kyoto 6028566, Japan.	kan180@jt6.so-net.ne.jp; yarai89046@nike.eonet.ne.jp					Guney A, 2010, KNEE SURG SPORT TR A, V18, P1526, DOI 10.1007/s00167-010-1125-1; VAUGHANLANE T, 1982, J BONE JOINT SURG BR, V64, P475; Yilmaz C, 2005, INT ORTHOP, V29, P291, DOI 10.1007/s00264-005-0676-0; Lyu SR, 2010, KNEE SURG SPORT TR A, V18, P769, DOI 10.1007/s00167-009-0946-2; Kim SJ, 2007, ARTHROSCOPY, V23, P1303, DOI 10.1016/j.arthro.2007.06016; Uysal M, 2008, INT ORTHOP, V32, P799, DOI 10.1007/s00264-007-0438-2; Fulkerson JP, 2002, AM J SPORT MED, V30, P447; Paczesny L, 2009, RADIOLOGY, V251, P439, DOI 10.1148/radiol.2512081652; Irha E, 2003, J PEDIATR ORTHOP B, V12, P44, DOI 10.1097/01.bpb.0000043562.17315.f8; KLEIN W, 1983, ARCH ORTHOP TRAUM SU, V102, P67, DOI 10.1007/BF02498717; Christoforakis JJ, 2006, KNEE SURG SPORT TR A, V14, P1292, DOI 10.1007/s00167-006-0085-y; Schindler OS, 2014, KNEE SURG SPORT TR A, V22, P247, DOI 10.1007/s00167-013-2368-4; Weckstrom M, 2010, KNEE, V17, P103, DOI 10.1016/j.knee.2009.07.010; MITAL MA, 1979, ORTHOP CLIN N AM, V10, P713; Bellary SS, 2012, CLIN ANAT, V25, P423, DOI 10.1002/ca.21278; HARDAKER WT, 1980, J BONE JOINT SURG AM, V62, P221; HARREWYN JM, 1982, REV RHUM, V49, P3; AMATUZZI MM, 1990, AM J SPORT MED, V18, P466, DOI 10.1177/036354659001800503; JACKSON RW, 1982, ORTHOP CLIN N AM, V13, P307; NOTTAGE WM, 1983, AM J SPORT MED, V11, P211, DOI 10.1177/036354658301100405; Nakanishi K, 1996, ACTA RADIOL, V37, P567; Stubbings N, 2014, KNEE, V21, P486, DOI 10.1016/j.knee.2013.11.001; DANDY D J, 1990, Arthroscopy, V6, P79, DOI 10.1016/0749-8063(90)90002-U; Jawish R, 2015, INT ORTHOP; MATSUSUE Y, 1994, ARTHROSCOPY, V10, P281, DOI 10.1016/S0749-8063(05)80112-4; Muse G L, 1985, Arthroscopy, V1, P63, DOI 10.1016/S0749-8063(85)80081-5; Nakayama A, 2011, ARTHROSCOPY, V11, P1523; Sakakibara J, 1976, J JPN ORTHOP ASSOC, V17, P279	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	DEC	2015	39	12					2489	2494		10.1007/s00264-015-2782-y		6	Orthopedics	Orthopedics	CW7ME	WOS:000365182500023		
J	Ogasawara, S; Chiba, T; Ooka, Y; Suzuki, E; Kanogawa, N; Saito, T; Motoyama, T; Tawada, A; Kanai, F; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Suzuki, Eiichiro; Kanogawa, Naoya; Saito, Tomoko; Motoyama, Tenyu; Tawada, Akinobu; Kanai, Fumihiko; Yokosuka, Osamu			Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma	INVESTIGATIONAL NEW DRUGS			English	Article						Hepatocellular carcinoma; Sorafenib; The Albumin-Bilirubin grade; Child-Pugh B; Liver function	CHILD-PUGH CLASS; PHASE-III TRIAL	Background: The Albumin-Bilirubin (ALBI) grade has been proposed as a new, simple, and objective method of assessing liver function. However, there is lack of data in sorafenib-treated patients with advanced hepatocellular carcinoma (HCC). Methods: We evaluated the correlations between the ALBI grade and Child-Pugh score, adverse events, and survival in 89 patients with advanced HCC who were prospectively treated with sorafenib. Results: Majority of patients with ALBI grade 1 (14/15 patients, 93 %) had a Child-Pugh score of 5. Patients with ALBI grade 2 had a wide range of liver function according to the Child-Pugh scores, with scores of 5, 6, 7, and a parts per thousand yen8. We divided ALBI grade 2 patients into ALBI grade 2A and 2B groups according to the median ALBI score among patients with ALBI grade 2. Although no significant difference was observed, the incidence of liver dysfunction in sorafenib-treated patients with ALBI grades 1, 2A, and 2B was 7 %, 19 %, and 35 %, respectively. Overall survival in the ALBI grade 2B group was significantly shorter than that in the ALBI grade 1 and 2A groups. Thus, ALBI grade 2B was an independent predictor of poor prognosis in addition to elevated serum aspartate aminotransferase levels, increased serum alpha-fetoprotein level, and macrovascular invasion. Conclusion: Sorafenib may be indicated for all patients with advanced HCC and ALBI grade 1 and for some with ALBI grade 2. The subdivision of patients with ALBI grade 2 increases the utility of ALBI in identifying patients indicated for sorafenib therapy.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Suzuki, Eiichiro; Kanogawa, Naoya; Saito, Tomoko; Motoyama, Tenyu; Tawada, Akinobu; Kanai, Fumihiko; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608670, Japan	Chiba, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	techiba@faculty.chiba-u.jp			Bayer Yakuhin Co., Ltd.	This study was supported by a grant from Bayer Yakuhin Co., Ltd.	Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Ogasawara S, 2015, INVEST NEW DRUG, V33, P729, DOI 10.1007/s10637-015-0237-3; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Pressiani T, 2013, ANN ONCOL, V24, P406, DOI 10.1093/annonc/mds343; Kim JE, 2011, CANCER CHEMOTH PHARM, V68, P1285, DOI 10.1007/s00280-011-1616-x; Furuse J, 2008, CANCER SCI, V99, P159, DOI 10.1111/j.1349-7006.2007.00648.x; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Child C G, 1964, Major Probl Clin Surg, V1, P1; Llovet JM, 2012, J HEPATOL, V56, P908; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kudo M, 2010, DIG DIS, V29, P339	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	DEC	2015	33	6					1257	1262		10.1007/s10637-015-0292-9		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CW7PR	WOS:000365192100012		
J	Salkovskis, PM; Kobori, O				Salkovskis, Paul M.; Kobori, Osamu			Reassuringly calm? Self-reported patterns of responses to reassurance seeking in obsessive compulsive disorder	JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY			English	Article						Obsessive-compulsive disorder; Cognitive theory of OCD; Reassurance seeking; Excessive reassurance seeking; Reassurance seeking questionnaire (ReSQ)	SPONTANEOUS DECAY; ANXIETY; EXTINCTION; INVENTORY; URGES	Background and objectives: The perception of threat and associated feelings of anxiety typically prompt people to seek safety; reassurance seeking is an interpersonal strategy almost universally used to reduce the immediate perception of risk. Excessive Reassurance Seeking (ERS) is considered to be particularly prominent and unequivocally counter-productive in people suffering from anxiety disorders in general and OCD in particular, producing short term relief but a longer term return and worsening of the original anxiety. We evaluated the extent and specificity of the effects of ERS in OCD and mechanisms involved in both anxiety relief and the hypothesized later return of anxiety. Method: Self rated effects of reassurance seeking were investigated in 153 individuals with OCD, 50 with panic disorder, and 52 healthy controls, evaluating reactions to the provision and non-provision of reassurance. Results: Reassurance is associated with short term relief then longer term return of both discomfort and the urge to seek further reassurance in both anxious groups; healthy controls do not experience significant resurgence. Greater return of anxiety and urge to seek more reassurance were associated with higher levels of overall reassurance seeking. Limitations: The findings were based on retrospective self-report of naturally occurring episodes of ERS; prospective studies and induced behaviours are now needed. Conclusions: Not only is reassurance a quick fix for people experiencing OCD, but in the absence of treatment the only fix! The findings explain why reassurance seeking continues despite advice that it will worsen anxiety problems. Such advice is potentially harmful to patients and their loved ones.. (C) 2015 Elsevier Ltd. All rights reserved.	[Salkovskis, Paul M.] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Kobori, Osamu] Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan	Salkovskis, PM (reprint author), Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England.						de Silva P, 2003, BEHAV RES THER, V41, P129, DOI 10.1016/S0005-7967(01)00132-2; RACHMAN S, 1976, BEHAV RES THER, V14, P445, DOI 10.1016/0005-7967(76)90091-7; Kobori O, 2012, J OBSESS-COMPULS REL, V1, P25, DOI 10.1016/j.jocrd.2011.09.001; SALKOVSKIS PM, 1986, BEHAV RES THER, V24, P597, DOI 10.1016/0005-7967(86)90041-0; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; SEGAL DL, 1994, COMPR PSYCHIAT, V35, P316, DOI 10.1016/0010-440X(94)90025-6; Kobori O, 2013, BEHAV COGN PSYCHOTH, V41, P1, DOI 10.1017/S1352465812000665; Beck A. T., 1987, MANUAL BECK DEPRESSI; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; First M. B., 1996, STRUCTURED CLIN INTE; HALLAM RS, 1974, BEHAV THER, V5, P565, DOI 10.1016/S0005-7894(74)80048-1; Parrish C. L, 2009, J ANXIETY DIORD, V24, P211; Salkovskis PM, 2000, BEHAV RES THER, V38, P347, DOI 10.1016/S0005-7967(99)00071-6; SALKOVSKIS PM, 1989, BEHAV RES THER, V27, P677, DOI 10.1016/0005-7967(89)90152-6; Tolin DF, 2001, J AM ACAD CHILD PSY, V40, P1111, DOI 10.1097/00004583-200109000-00021	15	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7916	1873-7943		J BEHAV THER EXP PSY	J. Behav. Ther. Exp. Psychiatry	DEC	2015	49		B		SI		203	208		10.1016/j.jbtep.2015.09.002		6	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CX1MU	WOS:000365461100011		
J	Hamaguchi, Y; Tahara, Y; Hitosugi, M; Shibata, S				Hamaguchi, Yutaro; Tahara, Yu; Hitosugi, Masashi; Shibata, Shigenobu			Impairment of Circadian Rhythms in Peripheral Clocks by Constant Light Is Partially Reversed by Scheduled Feeding or Exercise	JOURNAL OF BIOLOGICAL RHYTHMS			English	Article						biological rhythm; abnormal lighting; scheduled feeding; scheduled exercise; clock gene	SUPRACHIASMATIC NUCLEUS CONTROLS; GENE-EXPRESSION; BEHAVIORAL ACTIVITY; LOCOMOTOR-ACTIVITY; OSCILLATORS; MAMMALS; LIVER; PHASE; RATS; MICE	In mammals, circadian rhythms in peripheral organs are impaired when animals are maintained in abnormal environmental light-dark cycles such as constant light (LL). This conclusion is based on averaged data from groups of experimental animals sacrificed at each time point. To investigate the effect of LL housing on the peripheral clocks of individual mice, an in vivo imaging system was used to observe the circadian bioluminescence rhythm in peripheral tissues of the liver, kidney, and submandibular salivary gland in PER2::LUCIFERASE knock-in mice. Using this technique, we demonstrated that the majority of individual peripheral tissues still had rhythmic oscillations of their circadian clocks in LL conditions. However, LL housing caused decreased amplitudes and a broad distribution of peak phases in PER2::LUCIFERASE oscillations irrespective of the state of the animals' behavioral rhythmicity. Because both scheduled feeding and scheduled exercise are effective recovery stimuli for circadian clock deficits, we examined whether scheduled feeding or scheduled exercise could reverse this impairment. The results showed that scheduled feeding or exercise could not restore the amplitude of peripheral clocks in LL. On the other hand, the LL-induced broad phase distribution was reversed, and peak phases were entrained to a specific time point by scheduled feeding but only slightly by scheduled exercise. The present results demonstrate that LL housing impairs peripheral circadian clock oscillations by altering both amplitude and phase in individual mice. The broad distribution of clock phases was clearly reversed by scheduled feeding, suggesting the importance of scheduled feeding as an entraining stimulus for impaired peripheral clocks.	[Hamaguchi, Yutaro; Tahara, Yu; Hitosugi, Masashi; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan	Shibata, S (reprint author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan.	shibatas@waseda.jp			Council for Science, Technology and Innovation, SIP, "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); Ministry of Education, Culture, Sports, Science and Technology of Japan [26220201]	This work was partially supported by the Council for Science, Technology and Innovation, SIP, "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) (S.S.), and by a Grant-in-Aid for Scientific Research (S) (26220201) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.S.).	Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Caldelas I, 2005, EUR J NEUROSCI, V22, P921, DOI 10.1111/j.1460-9568.2005.04284.x; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; GALLARA RV, 1995, ARCH ORAL BIOL, V40, P73, DOI 10.1016/0003-9969(94)00137-Z; Mahoney MM, 2010, INT J ENDOCRINOL, DOI 10.1155/2010/813764; Malloy JN, 2012, AM J PHYSIOL-GASTR L, V303, pG461, DOI 10.1152/ajpgi.00369.2011; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Novakova M, 2011, NEUROSCIENCE, V197, P65, DOI 10.1016/j.neuroscience.2011.09.028; WARREN WS, 1994, PHYSIOL BEHAV, V55, P1091, DOI 10.1016/0031-9384(94)90392-1; Polidarova L, 2011, CHRONOBIOL INT, V28, P204, DOI 10.3109/07420528.2010.548615; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Wideman CH, 2009, NUTR NEUROSCI, V12, P233, DOI 10.1179/147683009X423436; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P37, DOI 10.1177/0748730409352843; Tahara Y, 2010, J BIOL RHYTHM, V25, P9, DOI 10.1177/0748730409352782; Schaap J, 2001, EUR J NEUROSCI, V13, P1955, DOI 10.1046/j.0953-816x.2001.01561.x; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Tahara Y, 2013, NEUROSCIENCE, V253, P78, DOI 10.1016/j.neuroscience.2013.08.049; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Menaker M, 2013, CURR OPIN NEUROBIOL, V23, P741, DOI 10.1016/j.conb.2013.03.003; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Schroeder AM, 2012, J PHYSIOL-LONDON, V590, P6213, DOI 10.1113/jphysiol.2012.233676; Kobayashi H, 2004, GENES CELLS, V9, P857, DOI 10.1111/j.1365-2443.2004.00769.x; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Moriya T, 2000, J NEUROSCI RES, V60, P212, DOI 10.1002/(SICI)1097-4547(20000415)60:2<212::AID-JNR10>3.0.CO;2-P; Dellavia S, 2000, ACTA ODONTOL LATINOA, V13, P3; Kuroda H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00711	45	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0748-7304	1552-4531		J BIOL RHYTHM	J. Biol. Rhythms	DEC	2015	30	6					533	542		10.1177/0748730415609727		10	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CW5JZ	WOS:000365033000007		
J	Berg, P; Roloff, C; Beuing, O; Voss, S; Sugiyama, SI; Aristokleous, N; Anayiotos, AS; Ashton, N; Revell, A; Bressloff, NW; Brown, AG; Chung, BJ; Cebral, JR; Copelli, G; Fu, WY; Qiao, AK; Geers, AJ; Hodis, S; Dragomir-Daescu, D; Nordahl, E; Suzen, YB; Khan, MO; Valen-Sendstad, K; Kono, K; Menon, PG; Albal, PG; Mierka, O; Munster, R; Morales, HG; Bonnefous, O; Osman, J; Goubergrits, L; Pallares, J; Cito, S; Passalacqua, A; Piskin, S; Pekkan, K; Ramalho, S; Marques, N; Sanchi, S; Schumacher, KR; Sturgeon, J; Svihlova, H; Hron, J; Usera, G; Mendina, M; Xiang, JP; Meng, H; Steinman, DA; Janiga, G				Berg, Philipp; Roloff, Christoph; Beuing, Oliver; Voss, Samuel; Sugiyama, Shin-Ichiro; Aristokleous, Nicolas; Anayiotos, Andreas S.; Ashton, Neil; Revell, Alistair; Bressloff, Neil W.; Brown, Alistair G.; Chung, Bong Jae; Cebral, Juan R.; Copelli, Gabriele; Fu, Wenyu; Qiao, Aike; Geers, Arjan J.; Hodis, Simona; Dragomir-Daescu, Dan; Nordahl, Emily; Suzen, Yildirim Bora; Khan, Muhammad Owais; Valen-Sendstad, Kristian; Kono, Kenichi; Menon, Prahlad G.; Albal, Priti G.; Mierka, Otto; Muenster, Raphael; Morales, Hernan G.; Bonnefous, Odile; Osman, Jan; Goubergrits, Leonid; Pallares, Jordi; Cito, Salvatore; Passalacqua, Alberto; Piskin, Senol; Pekkan, Kerem; Ramalho, Susana; Marques, Nelson; Sanchi, Stephane; Schumacher, Kristopher R.; Sturgeon, Jess; Svihlova, Helena; Hron, Jaroslav; Usera, Gabriel; Mendina, Mariana; Xiang, Jianping; Meng, Hui; Steinman, David A.; Janiga, Gabor			The Computational Fluid Dynamics Rupture Challenge 2013-Phase II: Variability of Hemodynamic Simulations in Two Intracranial Aneurysms	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						computational fluid dynamics; challenge; intracranial aneurysm; variability	CONFOUNDING FACTOR DISSEMINATION; UNRUPTURED CEREBRAL ANEURYSMS; BOUNDARY-CONDITIONS; MODELS; FLOW; REPRODUCIBILITY; PREDICTION; AORTA; WALL; GAP	With the increased availability of computational resources, the past decade has seen a rise in the use of computational fluid dynamics (CFD) for medical applications. There has been an increase in the application of CFD to attempt to predict the rupture of intracranial aneurysms, however, while many hemodynamic parameters can be obtained from these computations, to date, no consistent methodology for the prediction of the rupture has been identified. One particular challenge to CFD is that many factors contribute to its accuracy; the mesh resolution and spatial/temporal discretization can alone contribute to a variation in accuracy. This failure to identify the importance of these factors and identify a methodology for the prediction of ruptures has limited the acceptance of CFD among physicians for rupture prediction. The International CFD Rupture Challenge 2013 seeks to comment on the sensitivity of these various CFD assumptions to predict the rupture by undertaking a comparison of the rupture and blood-flow predictions from a wide range of independent participants utilizing a range of CFD approaches. Twenty-six groups from 15 countries took part in the challenge. Participants were provided with surface models of two intracranial aneurysms and asked to carry out the corresponding hemodynamics simulations, free to choose their own mesh, solver, and temporal discretization. They were requested to submit velocity and pressure predictions along the center-line and on specified planes. The first phase of the challenge, described in a separate paper, was aimed at predicting which of the two aneurysms had previously ruptured and where the rupture site was located. The second phase, described in this paper, aims to assess the variability of the solutions and the sensitivity to the modeling assumptions. Participants were free to choose boundary conditions in the first phase, whereas they were prescribed in the second phase but all other CFD modeling parameters were not prescribed. In order to compare the computational results of one representative group with experimental results, steady-flow measurements using particle image velocimetry (PIV) were carried out in a silicone model of one of the provided aneurysms. Approximately 80% of the participating groups generated similar results. Both velocity and pressure computations were in good agreement with each other for cycle-averaged and peak-systolic predictions. Most apparent "outliers" (results that stand out of the collective) were observed to have underestimated velocity levels compared to the majority of solutions, but nevertheless identified comparable flow structures. In only two cases, the results deviate by over 35% from the mean solution of all the participants. Results of steady CFD simulations of the representative group and PIV experiments were in good agreement. The study demonstrated that while a range of numerical schemes, mesh resolution, and solvers was used, similar flow predictions were observed in the majority of cases. To further validate the computational results, it is suggested that time-dependent measurements should be conducted in the future. However, it is recognized that this study does not include the biological aspects of the aneurysm, which needs to be considered to be able to more precisely identify the specific rupture risk of an intracranial aneurysm.	[Berg, Philipp; Roloff, Christoph; Voss, Samuel; Janiga, Gabor] Univ Magdeburg, D-39106 Magdeburg, Germany; [Beuing, Oliver] Univ Hosp Magdeburg, D-39120 Magdeburg, Germany; [Sugiyama, Shin-Ichiro] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808574, Japan; [Aristokleous, Nicolas; Anayiotos, Andreas S.] Cyprus Univ Technol, CY-3036 Lemesos, Cyprus; [Ashton, Neil; Revell, Alistair] Univ Manchester, Manchester M60 1QD, Lancs, England; [Bressloff, Neil W.] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Brown, Alistair G.] CD Adapco, London W6 7NL, England; [Chung, Bong Jae; Cebral, Juan R.] George Mason Univ, Fairfax, VA 22030 USA; [Copelli, Gabriele] Univ Parma, I-43125 Parma, Italy; [Fu, Wenyu; Qiao, Aike] Beijing Univ Technol, Beijing 100124, Peoples R China; [Geers, Arjan J.] Univ Pompeu Fabra, Barcelona 08002, Spain; [Hodis, Simona; Dragomir-Daescu, Dan] Texas A&M Univ, Kingsville, TX 78363 USA; [Hodis, Simona; Dragomir-Daescu, Dan] Mayo Clin, Rochester, MN 55905 USA; [Nordahl, Emily; Suzen, Yildirim Bora] N Dakota State Univ, Fargo, ND 58102 USA; [Khan, Muhammad Owais; Valen-Sendstad, Kristian; Steinman, David A.] Univ Toronto, Toronto, ON M5S 3G8, Canada; [Kono, Kenichi] Wakayama Rosai Hosp, Wakayama 6408505, Japan; [Menon, Prahlad G.; Albal, Priti G.] Sun Yat Sen Univ Carnegie Mellon Univ Joint Inst, Pittsburgh, PA 15219 USA; [Mierka, Otto; Muenster, Raphael] Univ Dortmund, D-44227 Dortmund, Germany; [Morales, Hernan G.; Bonnefous, Odile] Medisys Philips Res, F-92156 Paris, France; [Osman, Jan; Goubergrits, Leonid] Charite, D-13353 Berlin, Germany; [Pallares, Jordi; Cito, Salvatore] Univ Rovira & Virgili, E-43007 Tarragona, Spain; [Passalacqua, Alberto] Iowa State Univ, Ames, IA 50011 USA; [Piskin, Senol; Pekkan, Kerem] Koc Univ, TR-34450 Istanbul, Turkey; [Ramalho, Susana; Marques, Nelson] BlueCAPE Lda CAE Solut, P-2665305 Milharado, Portugal; [Schumacher, Kristopher R.; Sturgeon, Jess] MRIGlobal, Kansas City, MO 64110 USA; [Svihlova, Helena; Hron, Jaroslav] Charles Univ Prague, Prague 18675, Czech Republic; [Usera, Gabriel; Mendina, Mariana] Gabriel Usera, Montevideo 11300, Uruguay; [Xiang, Jianping; Meng, Hui] SUNY Buffalo, Buffalo, NY 14203 USA	Berg, P (reprint author), Univ Magdeburg, D-39106 Magdeburg, Germany.		Meng, Hui/F-7929-2010; Hron, Jaroslav/C-5915-2011; Aristokleous, Nicolas/F-6610-2015	Hron, Jaroslav/0000-0001-5862-2353; Aristokleous, Nicolas/0000-0002-0206-7773	Federal Ministry of Education and Research in Germany within Research Campus STIMULATE [03FO16102A]; International Max Planck Research School for Analysis, Design, and Optimization in Chemical and Biomedical Process Engineering Magdeburg	We would like to acknowledge Pedro Lylyk (University of Buenos Aires, Argentina) for providing the opportunity to present the results in a plenary session at the ICS 2013 in Buenos Aires. The work is partly funded by the Federal Ministry of Education and Research in Germany within the Research Campus STIMULATE under Grant No. 03FO16102A. Furthermore, the authors warmly acknowledge the fruitful discussions with Daniel Rufenacht (Swiss Neuro Institute SNI Hirslanden Clinic, Zurich). Special thanks are addressed to Mathias Neugebauer (Department of Simulation and Graphics, University Magdeburg, Germany) as well as Abouelmagd H. A. Abdelsamie (Department of Fluid Dynamics and Technical Flows, University of Magdeburg, Germany), who carried out the 3D reconstruction of the patient-specific aneurysms and supported the postprocessing, respectively. Finally, the first author acknowledges the International Max Planck Research School for Analysis, Design, and Optimization in Chemical and Biomedical Process Engineering Magdeburg for financial support.	Cebral JR, 2012, AM J NEURORADIOL, V33, P396, DOI 10.3174/ajnr.A2994; Moyle KR, 2006, J BIOMECH ENG-T ASME, V128, P371, DOI 10.1115/1.2187035; Humphrey JD, 2012, J BIOMECH, V45, P805, DOI 10.1016/j.jbiomech.2011.11.021; Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Cavazzuti M, 2010, J BIOMECH, V43, P2645, DOI 10.1016/j.jbiomech.2010.04.042; Zhang Y, 2011, EUR NEUROL, V66, P359, DOI 10.1159/000332814; Liou TM, 1997, EXP FLUIDS, V23, P317, DOI 10.1007/s003480050116; Marzo A, 2011, ANN BIOMED ENG, V39, P884, DOI 10.1007/s10439-010-0187-z; Valen-Sendstad K, 2014, AM J NEURORADIOL, V35, P536, DOI 10.3174/ajnr.A3793; Hoi Y, 2006, J BIOMECH ENG-T ASME, V128, P844, DOI 10.1115/1.2354209; Liou TM, 2004, EXP MECH, V44, P253, DOI 10.1177/0014485104039770; Prasad AK, 2000, EXP FLUIDS, V29, P103, DOI 10.1007/s003480000143; Roloff C, 2013, INT J HEAT FLUID FL, V43, P212, DOI 10.1016/j.ijheatfluidflow.2013.06.006; Hariharan P, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003440; Marzo A, 2009, COMPUT METHOD BIOMEC, V12, P431, DOI 10.1080/10255840802654335; Sadasivan C, 2013, ANN BIOMED ENG, V41, P1347, DOI 10.1007/s10439-013-0800-z; Robertson AM, 2015, ANN BIOMED ENG, V43, P1502, DOI 10.1007/s10439-015-1252-4; Jansen IGH, 2014, AM J NEURORADIOL, V35, P1543, DOI 10.3174/ajnr.A3901; Goubergrits L, 2012, J R SOC INTERFACE, V9, P677, DOI 10.1098/rsif.2011.0490; Janiga G, 2015, AM J NEURORADIOL, V36, P530, DOI 10.3174/ajnr.A4157; Boutsianis E, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3002886; Nixon AM, 2010, J NEUROSURG, V112, P1240, DOI 10.3171/2009.10.JNS09759; Yagi T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1031; Curtis SL, 2012, AM J NEURORADIOL, V33, P1182, DOI 10.3174/ajnr.A2915; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; Cebral JR, 2011, AM J NEURORADIOL, V32, P27, DOI 10.3174/ajnr.A2398; Bonneville F, 2006, NEUROIMAG CLIN N AM, V16, P371, DOI 10.1016/j.nic.2006.05.001; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Stamatopoulos C, 2011, EXP FLUIDS, V50, P1695, DOI 10.1007/s00348-010-1034-6; Tateshima S, 2007, AM J NEURORADIOL, V28, P622; Teunissen LL, 1996, STROKE, V27, P544; Neugebauer M, 2013, INT J COMPUT ASS RAD, V8, P279, DOI 10.1007/s11548-012-0779-1; Geers AJ, 2014, J BIOMECH, V47, P178, DOI 10.1016/j.jbiomech.2013.09.033; Janiga G, 2013, J BIOMECH, V46, P7, DOI 10.1016/j.jbiomech.2012.08.047; Qian Y, 2011, AM J NEURORADIOL, V32, P1948, DOI 10.3174/ajnr.A2655; Kallmes DF, 2012, AM J NEURORADIOL, V33, P395, DOI 10.3174/ajnr.A2993; Steinman DA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023382; Wong GKC, 2011, J CLIN NEUROSCI, V18, P1285, DOI 10.1016/j.jocn.2011.02.014; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; Berg P., 2012, 15 C MOD FLUID FLOW, P128; Bordás Róbert, 2012, Interv Med Appl Sci, V4, P193, DOI 10.1556/IMAS.4.2012.4.4; Cito S, 2015, ANN BIOMED ENG, V43, P154, DOI 10.1007/s10439-014-1082-9; Fiorella D, 2011, AJNR Am J Neuroradiol, V32, pE95, DOI 10.3174/ajnr.A2534; Ford MD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2900724; Monch T., 2011, COMPUT GRAPHICS, V35, P755; Morita A, 2012, NEW ENGL J MED, V366, P2474; Okada Koichiro, 2011, Journal of Biorheology, V25, DOI 10.1007/s12573-011-0035-2; Radaellia AG, 2008, J BIOMECH, V41, P2069, DOI 10.1016/j.jbiomech.2008.04.035; Turjman AS, 2014, CIRCULATION, V129, P373, DOI 10.1161/CIRCULATIONAHA.113.001444; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710	50	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2015	137	12							121008	10.1115/1.4031794		13	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CW8SR	WOS:000365270000008		
J	Terry-Lorenzo, RT; Masuda, K; Sugao, K; Fang, QK; Orsini, MA; Sacchi, S; Pollegioni, L				Terry-Lorenzo, Ryan T.; Masuda, Keiki; Sugao, Kohtaroh; Fang, Q. Kevin; Orsini, Michael A.; Sacchi, Silvia; Pollegioni, Loredano			High-Throughput Screening Strategy Identifies Allosteric, Covalent Human D-Amino Acid Oxidase Inhibitor	JOURNAL OF BIOMOLECULAR SCREENING			English	Article						covalent inhibitors; D-serine; schizophrenia; neuropathic pain	PHOSPHOMANNOSE ISOMERASE INHIBITORS; D-SERINE CATABOLISM; D-ASPARTATE OXIDASE; ESCHERICHIA-COLI; NMDA RECEPTORS; GENE G72; SCHIZOPHRENIA; EXPRESSION; DISORDER; PLG72	Genome-wide association studies have linked polymorphisms in the gene G72 to schizophrenia risk in several human populations. Although controversial, biochemical experiments have suggested that the mechanistic link of G72 to schizophrenia is due to the G72 protein product, pLG72, exerting a regulatory effect on human D-amino acid oxidase (hDAAO) activity. In an effort to identify hDAAO inhibitors of novel mechanism of action, we designed a pLG72-directed hDAAO activity assay suitable for high-throughput screening (HTS). During assay development, we confirmed that pLG72 was an inhibitor of hDAAO. Thus, our assay employed an IC20 pLG72 concentration that was high enough to allow dynamic pLG72-hDAAO complexes to form but with sufficient remaining hDAAO activity to measure during an HTS. After conducting an approximately 150,000-compound HTS, we further characterized a class of compound hits that were less potent hDAAO inhibitors when pLG72 was present. Focusing primarily on compound 2 [2-(2,5-dimethylphenyl)-6-fluorobenzo[d]isothiazol-3(2H)-on], we demonstrated that these compounds inhibited hDAAO via an allosteric, covalent mechanism. Although there is significant interest in the therapeutic potential of compound 2 and its analogues, their sensitivity to reducing agents and their capacity to bind cysteines covalently would need to be addressed during therapeutic drug development.	[Terry-Lorenzo, Ryan T.; Fang, Q. Kevin; Orsini, Michael A.] Sunov Pharmaceut, Discovery & Preclin Res Dept, Marlborough, MA 01752 USA; [Masuda, Keiki; Sugao, Kohtaroh] Sumitomo Dainippon Pharma DSP, Genom Sci Labs, Osaka, Japan; [Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Varese, Italy; [Sacchi, Silvia; Pollegioni, Loredano] Politecn Milan, Prot Factory, I-20133 Milan, Italy; [Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Milan, Italy	Terry-Lorenzo, RT (reprint author), Sunov Pharmaceut, 84 Waterford Dr, Marlborough, MA 01752 USA.	Ryan.Terry-Lorenzo@sunovion.com					Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Bhakuni BS, 2012, TETRAHEDRON LETT, V53, P1354, DOI 10.1016/j.tetlet.2012.01.003; Caldinelli L, 2009, PROTEIN SCI, V18, P801, DOI 10.1002/pro.86; Sacchi S, 2008, J BIOL CHEM, V283, P22244, DOI 10.1074/jbc.M709153200; Lu J, 2013, J BIOL CHEM, V288, P27456, DOI 10.1074/jbc.M113.495101; Sacchi S, 2012, AMINO ACIDS, V43, P1833, DOI 10.1007/s00726-012-1345-4; Baell JB, 2013, AUST J CHEM, V66, P1483, DOI 10.1071/CH13551; Zhou Q, 2013, NEUROPHARMACOLOGY, V74, P69, DOI 10.1016/j.neuropharm.2013.03.030; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Molla G, 2006, FEBS LETT, V580, P2358, DOI 10.1016/j.febslet.2006.03.045; Cappelletti P, 2014, FEBS J, V281, P708, DOI 10.1111/febs.12616; Frattini LF, 2011, FEBS J, V278, P4362, DOI 10.1111/j.1742-4658.2011.08354.x; Ferraris D, 2008, J MED CHEM, V51, P3357, DOI 10.1021/jm800200u; Caldinelli L, 2010, PROTEIN SCI, V19, P1500, DOI 10.1002/pro.429; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Sparey T, 2008, BIOORG MED CHEM LETT, V18, P3386, DOI 10.1016/j.bmcl.2008.04.020; Molla G, 2006, PROTEIN EXPRES PURIF, V46, P150, DOI 10.1016/j.pep.2005.08.003; Otte DM, 2011, NEUROPSYCHOPHARMACOL, V36, P2233, DOI 10.1038/npp.2011.109; Sacchi S, 2011, MOL CELL NEUROSCI, V48, P20, DOI 10.1016/j.mcn.2011.06.001; Negri A, 1999, BBA-PROTEIN STRUCT M, V1431, P212, DOI 10.1016/S0167-4838(99)00027-8; Chang SLY, 2014, INT J MOL SCI, V15, P29, DOI 10.3390/ijms15010029; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; COLLIER PJ, 1990, J APPL BACTERIOL, V69, P578, DOI 10.1111/j.1365-2672.1990.tb01551.x; Simonic T, 1997, BIOCHEM J, V322, P729; Shi GQ, 2000, TETRAHEDRON LETT, V41, P2295, DOI 10.1016/S0040-4039(00)00164-7; Drews E, 2013, NEUROSCI BIOBEHAV R, V37, P2410, DOI 10.1016/j.neubiorev.2012.10.009; Trevillyan JM, 1999, ARCH BIOCHEM BIOPHYS, V364, P19, DOI 10.1006/abbi.1999.1099; Kvajo M, 2008, MOL PSYCHIATR, V13, P685, DOI 10.1038/sj.mp.4002052; Benzel I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-94; Fang K. Q., 2005, Patent, Patent No. [WO2005066143A2, 2005066143]; Hopkins S. C., 2013, PHARM RES PER, V1, P1; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Terry-Lorenzo RT, 2014, BIOSCIENCE REP, V34, P487, DOI 10.1042/BSR20140071	35	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0571	1552-454X		J BIOMOL SCREEN	J. Biomol. Screen	DEC	2015	20	10					1218	1231		10.1177/1087057115600413		14	Biochemical Research Methods; Biotechnology & Applied Microbiology; Chemistry, Analytical	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry	CX1BF	WOS:000365430500003		
J	Takeuchi, S; Nagatani, K; Otani, N; Wada, K; Mori, K				Takeuchi, Satoru; Nagatani, Kimihiro; Otani, Naoki; Wada, Kojiro; Mori, Kentaro			Electrocardiograph abnormalities in intracerebral hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Electrocardiography; Insular cortex; Intracerebral hemorrhage; Stroke	SUBARACHNOID HEMORRHAGE; ECG ABNORMALITIES; ACUTE STROKE; INSULAR INVOLVEMENT; CARDIAC-ARRHYTHMIAS; LESIONS	This study investigated the prevalence and type of electrocardiography (ECG) abnormalities, and their possible association with the clinical/radiological findings in 118 consecutive patients with non-traumatic, non-neoplastic intracerebral hemorrhage (ICH). ECG frequently demonstrates abnormalities in patients with ischemic stroke and subarachnoid hemorrhage, but little is known of ECG changes in ICH patients. Clinical and radiological information was retrospectively reviewed. ECG recordings that were obtained within 24 hours of the initial hemorrhage were analyzed. Sixty-six patients (56%) had one or more ECG abnormalities. The most frequent was ST depression (24%), followed by left ventricular hypertrophy (20%), corrected QT interval (QTc) prolongation (19%), and T wave inversion (19%). The logistic regression analysis demonstrated the following: insular involvement was an independent predictive factor of ST depression (p < 0.001; odds ratio OR 10.18; 95% confidence interval [CI] 2.84-36.57); insular involvement (p < 0.001; OR 23.98; 95% Cl 4.91-117.11) and presence of intraventricular hemorrhage (p < 0.001; OR 8.72; 95% CI 2.69-28.29) were independent predictive factors of QTc prolongation; deep hematoma location (p < 0.001; OR 19.12; 95% CI 3.82-95.81) and hematoma volume >30 ml (p = 0.001; OR 6.58; 95% CI 2.11-20.46) were independent predictive factors of T wave inversion. We demonstrate associations between ECG abnormalities and detailed characteristics of ICH. (C) 2015 Elsevier Ltd. All rights reserved.	[Takeuchi, Satoru; Nagatani, Kimihiro; Otani, Naoki; Wada, Kojiro; Mori, Kentaro] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan	Takeuchi, S (reprint author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s.takeuchi@room.ocn.ne.jp					ANDREOLI A, 1987, STROKE, V18, P558; Afsar N, 2003, ARCH NEUROL-CHICAGO, V60, P346, DOI 10.1001/archneur.60.3.346; OPPENHEIMER SM, 1994, CURR OPIN NEUROL, V7, P20, DOI 10.1097/00019052-199402000-00005; Machado C, 1997, J ELECTROCARDIOL, V30, P31, DOI 10.1016/S0022-0736(97)80032-5; van Bree MDR, 2010, NEUROCRIT CARE, V12, P50, DOI 10.1007/s12028-009-9283-z; Tatschl C, 2006, CEREBROVASC DIS, V21, P47, DOI 10.1159/000089594; Christensen H, 2005, J NEUROL SCI, V234, P99, DOI 10.1016/j.jns.2005.03.039; Junttila E, 2013, ANESTH ANALG, V116, P190, DOI 10.1213/ANE.0b013e318270034a; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Christensen H, 2005, J NEUROL NEUROSUR PS, V76, P269, DOI 10.1136/jnnp.2004.037531; Mandrioli J, 2004, J NEUROL NEUROSUR PS, V75, P1788, DOI 10.1136/jnnp.2003.035295; LEPESCHKIN E, 1952, CIRCULATION, V6, P378; HACHINSKI VC, 1992, ARCH NEUROL-CHICAGO, V49, P697; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Arruda W O, 1992, Arq Neuropsiquiatr, V50, P269; CECHETTO DF, 1993, STROKE, V24, pI6; Cechetto DF, 1993, STROKE, V24, P110; Kothari Rashmi U., 1996, Stroke, V27, P1304; LANZINO G, 1994, J NEUROSURG ANESTH, V6, P156; OPPENHEIMER SM, 1991, BRAIN RES, V550, P115, DOI 10.1016/0006-8993(91)90412-O; Popescu Dan, 2012, Maedica (Buchar), V7, P290	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2015	22	12					1959	1962		10.1016/j.jocn.2015.04.028		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CX0EV	WOS:000365370600021		
J	Zheng, H; Kanie, S				Zheng, Hao; Kanie, Shunji			Combined Thermal-Hydraulic-Mechanical Frost Heave Model Based on Takashi's Equation	JOURNAL OF COLD REGIONS ENGINEERING			English	Article						Thermal-hydraulic-mechanical; Frost heave; Finite-element method (FEM); Takashi's equation	COUPLED HEAT; MOISTURE TRANSPORT; SOILS; PREDICTION	The purpose of this study is to establish a numerical simulation model that addresses the combined thermal-hydraulic-mechanical process of frost heave. Of the several practical frost heave estimation theories, the authors adopt Takashi's equation, which has been successfully applied to one-dimensional frost heave estimation. In this paper, Takashi's equation is used to assess the frost heave ratio during freezing. Takashi's equation is expanded for a two-dimensional evaluation by introducing an anisotropic parameter to distribute the frost heave ratio in different directions. This model couples Fourier's law for heat transfer and Darcy's law for unfrozen water flow. Latent heat is seriously evaluated by equivalent heat capacity method. For the thermal and hydraulic processes, this model considers temperature-and pressure-dependent hydraulic conductivity by an empirical equation. Both saturated and unsaturated conditions are addressed in this model. A finite-element method is adopted, and the time domain solution employed is the widely accepted Crank-Nicolson method. Specifically, it is assumed that the pore water pressure head and water content at freezing are zero. In this situation, it is not necessary to consider the hydraulic condition during the freezing process because it is accepted that Takashi's equation can deal with the hydraulic process of freezing. Future complex and detailed models will require a more complete understanding and formulation of the processes in freezing zone; however, this is outside the scope of this paper. Finally, in order to demonstrate the applicability of this model, simple examples and simulations are provided. (C) 2014 American Society of Civil Engineers.	[Zheng, Hao] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Kanie, Shunji] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan	Zheng, H (reprint author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan.	zhenghao@ec.hokudai.ac.jp					DOMENICO PA, 1973, GEOL SOC AM BULL, V84, P3803, DOI 10.1130/0016-7606(1973)84<3803:TAOFCH>2.0.CO;2; Liu Z, 2011, ACTA GEOTECH, V6, P51, DOI 10.1007/s11440-011-0135-6; Konrad JM, 1996, COLD REG SCI TECHNOL, V24, P263, DOI 10.1016/0165-232X(95)00028-A; Miyata Y, 1998, JSME INT J B-FLUID T, V41, P590; Taber S, 1930, J GEOL, V38, P303; GUYMON GL, 1974, WATER RESOUR RES, V10, P995, DOI 10.1029/WR010i005p00995; KONRAD JM, 1984, CAN GEOTECH J, V21, P100; HARLAN RL, 1973, WATER RESOUR RES, V9, P1314, DOI 10.1029/WR009i005p01314; Konrad JM, 2002, CAN GEOTECH J, V39, P1231, DOI 10.1139/T02-077; Berg R. L., 1980, 8010 CRREL; Beskow G., 1935, SWEDISH GEOLOGICAL S, P41; Edlefsen N. E., 1943, HILGARDIA, V15, P31; GUYMON GL, 1984, J ENERG RESOUR-ASME, V106, P336; Guymon G. L., 1993, 932 CRREL; Japanese Geotechnical Society, 2003, 01712003 JGS; Kanie S., 2012, 15 INT C COLD REG EN, P19; Kanie S., 2006, CURRENT PRACTICES CO; Takashi T., 1978, P 3 INT C PERM, V1, P736; Williams P. J., 1964, GEOTECHNIQUE, V14, P231	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0887-381X	1943-5495		J COLD REG ENG	J. Cold Reg. Eng.	DEC	2015	29	4							UNSP 04014019	10.1061/(ASCE)CR.1943-5495.0000089		19	Engineering, Environmental; Engineering, Civil; Geosciences, Multidisciplinary	Engineering; Geology	CW6QZ	WOS:000365123800004		
J	Colliaux, D; Yger, P; Kaneko, K				Colliaux, David; Yger, Pierre; Kaneko, Kunihiko			Impact of sub and supra-threshold adaptation currents in networks of spiking neurons	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Adaptation; Neuronal dynamics	PRIMARY VISUAL-CORTEX; CORTICAL PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; IN-VIVO; FREQUENCY ADAPTATION; FIRE NEURONS; DYNAMICS; MODEL; PLASTICITY; CONDUCTANCES	Neuronal adaptation is the intrinsic capacity of the brain to change, by various mechanisms, its dynamical responses as a function of the context. Such a phenomena, widely observed in vivo and in vitro, is known to be crucial in homeostatic regulation of the activity and gain control. The effects of adaptation have already been studied at the single-cell level, resulting from either voltage or calcium gated channels both activated by the spiking activity and modulating the dynamical responses of the neurons. In this study, by disentangling those effects into a linear (sub-threshold) and a non-linear (supra-threshold) part, we focus on the the functional role of those two distinct components of adaptation onto the neuronal activity at various scales, starting from single-cell responses up to recurrent networks dynamics, and under stationary or non-stationary stimulations. The effects of slow currents on collective dynamics, like modulation of population oscillation and reliability of spike patterns, is quantified for various types of adaptation in sparse recurrent networks.	[Colliaux, David] UPMC Univ Paris, CNRS UMR 7222, Inst Syst Intelligents & Robot, F-75005 Paris, France; [Yger, Pierre] ENS, Inst Etud Cognit, F-75230 Paris 05, France; [Yger, Pierre] Univ Paris 06, Univ Paris 04, Inst Vis, UMRS968, Paris, France; [Yger, Pierre] INSERM, U968, Paris, France; [Yger, Pierre] CNRS, UMR7210, Paris, France; [Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Colliaux, D (reprint author), UPMC Univ Paris, CNRS UMR 7222, Inst Syst Intelligents & Robot, 4 Pl Jussieu, F-75005 Paris, France.	colliaux@isir.upmc.fr			Japan Society for the Promotion of Science; Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Fondation pour la Recherche Medicale (FRM)	This work is supported by the Japan Society for the Promotion of Science. This work is also supported in part by the Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. P.Y was supported by the Fondation pour la Recherche Medicale (FRM).	Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Lu Y, 2004, J COMP NEUROL, V470, P93, DOI 10.1002/cne.11037; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; RICCIARDI LM, 1979, BIOL CYBERN, V35, P1, DOI 10.1007/BF01845839; Tabak J, 2000, J NEUROSCI, V20, P3041; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Tsodyks M, 2000, J NEUROSCI, V20; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Andrade R, 2011, NEUROPHARMACOLOGY, V61, P382, DOI 10.1016/j.neuropharm.2011.01.015; Prescott SA, 2008, J NEUROSCI, V28, P13649, DOI 10.1523/JNEUROSCI.1792-08.2008; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Richardson MJE, 2005, NEURAL COMPUT, V17, P923, DOI 10.1162/0899766053429444; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549; Nataraj K, 2010, NEURON, V68, P750, DOI 10.1016/j.neuron.2010.09.033; Grillner S, 1997, SCIENCE, V278, P1087, DOI 10.1126/science.278.5340.1087; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Ermentrout B, 1998, NEURAL COMPUT, V10, P1721, DOI 10.1162/089976698300017106; Gigante G, 2007, MATH BIOSCI, V207, P336, DOI 10.1016/j.mbs.2006.11.010; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Horton JC, 2005, PHILOS T ROY SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; Benda J, 2010, J NEUROPHYSIOL, V104, P2806, DOI 10.1152/jn.00240.2010; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Touboul J, 2008, BIOL CYBERN, V99, P319, DOI 10.1007/s00422-008-0267-4; LANSKY P, 1987, BIOL CYBERN, V56, P19, DOI 10.1007/BF00333064; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Pospischil M, 2011, BIOL CYBERN, V105, P167, DOI 10.1007/s00422-011-0458-2; Binzegger T, 2007, J NEUROSCI, V27, P12242, DOI 10.1523/JNEUROSCI.3753-07.2007; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; van Vreeswijk C, 2001, NEURAL COMPUT, V13, P959; Cortes JM, 2013, P NATL ACAD SCI USA, V110, P16610, DOI 10.1073/pnas.1316071110; Benucci A, 2013, NAT NEUROSCI, V16, P724, DOI 10.1038/nn.3382; Pozzorini C, 2013, NAT NEUROSCI, V16, P942, DOI 10.1038/nn.3431; Mattia M, 2012, COGN NEURODYNAMICS, V6, P239, DOI 10.1007/s11571-011-9179-4; La Camera G, 2004, NEURAL COMPUT, V16, P2101, DOI 10.1162/0899766041732468; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Deemyad T, 2012, J PHYSIOL-LONDON, V590, P4839, DOI 10.1113/jphysiol.2012.234401; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Giugliano M, 2004, J NEUROPHYSIOL, V92, P977, DOI 10.1152/jn.00067.2004; Stimberg M, 2009, CEREB CORTEX, V19, P2166, DOI 10.1093/cercor/bhn240; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Boerlin M., 2013, PLOS COMPUTATIONAL B, V9; Buzsaki G., 2010, NEURON, V4, P362; Clewley R., 2012, PLOS COMPUTATIONAL B, V8; Davison Andrew P, 2008, Front Neuroinform, V2, P11, DOI 10.3389/neuro.11.011.2008; Ermentrout GB, 2010, MATH FDN NEUROSCIENC; Farkhooi F., 2011, PHYS REV E, V83; Gewaltig M.-O., 2007, NEST NEURAL SIMULATI; Gigante G., 2007, PHYS REV LETT, P98; Hertag L, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00116; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Kuznetsov Y.A, 1998, ELEMENTS APPL BIFURC, P591; Ladenbauer J, 2014, J NEUROPHYSIOL, V111, P939, DOI 10.1152/jn.00586.2013; Ostojic S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001056; Ostojic S, 2014, NATURE NEUROSCIENCE; Papoulis A., 1965, PROBABILITY RANDOM V; Rossant C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00009; Sacerdote L, 2013, LECT NOTES MATH, V2058, P99, DOI 10.1007/978-3-642-32157-3_5; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; Vreeswijk CV, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	65	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	DEC	2015	39	3					255	270		10.1007/s10827-015-0575-3		16	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	CW7LB	WOS:000365179100002		
J	Futagi, D; Kitano, K				Futagi, Daiki; Kitano, Katsunori			Ryanodine-receptor-driven intracellular calcium dynamics underlying spatial association of synaptic plasticity	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Calcium signaling; Intracellular; Ryanodine receptor; Simulation	HIPPOCAMPAL PYRAMIDAL NEURONS; ACTION-POTENTIAL BACKPROPAGATION; LONG-TERM POTENTIATION; CA2+ RELEASE CHANNELS; PROTEIN-KINASE-II; DENDRITIC SPINES; INOSITOL 1,4,5-TRISPHOSPHATE; RAT HIPPOCAMPUS; STORES; DEPRESSION	Synaptic modifications induced at one synapse are accompanied by hetero-synaptic changes at neighboring sites. In addition, it is suggested that the mechanism of spatial association of synaptic plasticity is based on intracellular calcium signaling that is mainly regulated by two types of receptors of endoplasmic reticulum calcium store: the ryanodine receptor (RyR) and the inositol triphosphate receptor (IP3R). However, it is not clear how these types of receptors regulate intracellular calcium flux and contribute to the outcome of calcium-dependent synaptic change. To understand the relation between the synaptic association and store-regulated calcium dynamics, we focused on the function of RyR calcium regulation and simulated its behavior by using a computational neuron model. As a result, we observed that RyR-regulated calcium release depended on spike timings of pre- and postsynaptic neurons. From the induction site of calcium release, the chain activation of RyRs occurred, and spike-like calcium increase propagated along the dendrite. For calcium signaling, the propagated calcium increase did not tend to attenuate; these characteristics came from an all-or-none behavior of RyR-sensitive calcium store. Considering the role of calcium dependent synaptic plasticity, the results suggest that RyR-regulated calcium propagation induces a similar change at the synapses. However, according to the dependence of RyR calcium regulation on the model parameters, whether the chain activation of RyRs occurred, sensitively depended on spatial expression of RyR and nominal fluctuation of calcium flux. Therefore, calcium regulation of RyR helps initiate rather than relay calcium propagation.	[Futagi, Daiki] Ritsumeikan Univ, Grad Sch Informat Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Kitano, Katsunori] Ritsumeikan Univ, Dept Human & Comp Intelligence, Kusatsu, Shiga 5258577, Japan	Futagi, D (reprint author), Ritsumeikan Univ, Grad Sch Informat Sci & Engn, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	futagi@cns.ci.ritsumei.ac.jp			JSPS [15H05877]	This work was supported by JSPS KAKENHI Grant Number 15H05877 (KK).	Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151; Nishiyama M, 2000, NATURE, V408, P584; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; FURUICHI T, 1994, J NEUROSCI, V14, P4794; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28; HIRSCH JC, 1992, SYNAPSE, V12, P82, DOI 10.1002/syn.890120110; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Jung HY, 1997, J NEUROSCI, V17, P6639; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Futatsugi A, 1999, NEURON, V24, P701, DOI 10.1016/S0896-6273(00)81123-X; Golding NL, 2001, J NEUROPHYSIOL, V86, P2998; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/physiol.2002.020362; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Khodakhah K, 1997, BIOPHYS J, V73, P3349; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718; SEYMOURLAURENT KJ, 1995, J NEUROSCI, V15, P2592; Stuart G, 1998, J NEUROSCI, V18, P3501; BRADLER JE, 1989, SYNAPSE, V4, P132, DOI 10.1002/syn.890040207; Keizer J, 1996, BIOPHYS J, V71, P3477; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Gasparini S, 2007, J PHYSIOL-LONDON, V580, P787, DOI 10.1113/jphysiol.2006.121343; Usachev YM, 1997, J NEUROSCI, V17, P7404; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; SHARP AH, 1993, J NEUROSCI, V13, P3051; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Bi GQ, 1998, J NEUROSCI, V18, P10464; Bi GQ, 2002, BIOL CYBERN, V87, P319, DOI 10.1007/s00422-002-0349-7; Reyes M, 1996, J NEUROSCI, V16, P5951; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.00043.2002; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; HARRIS KM, 1989, J NEUROSCI, V9, P2982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; Fitzpatrick JS, 2009, J PHYSIOL-LONDON, V587, P1439, DOI 10.1113/jphysiol.2009.168930; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Watanabe S, 2006, J PHYSIOL-LONDON, V575, P455, DOI 10.1113/jphysiol.2006.114231; Hulme SR, 2012, J NEUROSCI, V32, P6785, DOI 10.1523/JNEUROSCI.0634-12.2012; BEZPROZVANNY I, 1991, NATURE, V351, P751; Bliss T. V., 1993, NATURE, V6407, P31	56	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	DEC	2015	39	3					329	347		10.1007/s10827-015-0579-z		19	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	CW7LB	WOS:000365179100006		
J	Teramura, M; Wynn, S; Reshalaitihan, M; Kyuno, W; Sato, T; Ohtani, M; Kawashima, C; Hanada, M				Teramura, M.; Wynn, S.; Reshalaitihan, M.; Kyuno, W.; Sato, T.; Ohtani, M.; Kawashima, C.; Hanada, M.			Supplementation with difructose anhydride III promotes passive calcium absorption in the small intestine immediately after calving in dairy cows	JOURNAL OF DAIRY SCIENCE			English	Article						hypocalcemia; calcium; difructose anhydride (DFA) III; paracellular pathway; dairy cow	CATION-ANION DIFFERENCE; TIGHT JUNCTION PERMEABILITY; PREVENTING MILK FEVER; PARTURIENT HYPOCALCEMIA; HOLSTEIN COWS; CACO-2 CELLS; SUBCLINICAL HYPOCALCEMIA; MOLECULAR PHYSIOLOGY; BONE METABOLISM; CATTLE	The incidence of hypocalcemia increases in high-parity dairy cows because resorption of bone Ca is delayed in these animals, and they appear to have a reduced ability to absorb Ca from the intestine during the early postpartum period. Difructose anhydride (DFA) III has been shown to promote the absorption of intestinal Ca via a paracellular pathway. However, past studies have not reported this effect in peripartum dairy cows. Therefore, we investigated the effect of DFA III supplementation on Ca metabolism during the peripartum period to determine whether DFA III promotes intestinal Ca absorption via this route. Seventy-four multiparous Holstein cows were separated into DFA and control groups based on their parity and body weight. The feed of the DFA group was supplemented with 40 g/d of DFA III from -14 to 6 d relative to calving. The control group did not receive DFA III. At calving (0 h relative to calving), serum Ca declined below 9 mg/dL in both groups. However, serum Ca concentrations were greater in the DFA group than in the control group at 6, 12, 24, and 48 h relative to calving, and the time required for serum Ca to recover to 9 mg/dL during the postpartum period was shorter in the high-parity cows in the DFA group than in those in the control group. Parathyroid hormone concentrations increased immediately after calving in both groups and were greater in the control group than in the DFA group at 12 and 24 h relative to calving. Serum 1,25-dihydroxyvitamin D concentrations increased at 0 and 12 h relative to calving in both groups and were higher in the control group than in the DFA group at 72 h relative to calving. Serum concentrations of the bone-resorption marker cross-linked N-telopeptide of type I collagen (NTX) were not different between the groups during peripartum period, and serum NTX in all cows was lower at 0, 6, 12, 24, 48, and 72 h relative to calving than at -21, 4, and 5 d relative to calving. Thus, DFA treatment induced faster recovery of serum Ca, although bone resorption was restrained. In conclusion, DFA III promotes intestinal passive Ca absorption via the paracellular pathway during the early postpartum period; this absorption is unaffected by aging.	[Teramura, M.; Wynn, S.] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Teramura, M.; Kyuno, W.; Sato, T.; Ohtani, M.] Nippon Beet Sugar Mfg Co Ltd, Obihiro, Hokkaido 0800831, Japan; [Reshalaitihan, M.; Kawashima, C.; Hanada, M.] Obihiro Univ Agr & Vet Med, Obihiro, Hokkaido 0808555, Japan	Teramura, M (reprint author), Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan.	teramu@nitten.co.jp					BLOCK E, 1984, J DAIRY SCI, V67, P2939; Tang VW, 2003, BIOPHYS J, V84, P1660; HORST RL, 1978, AM J PHYSIOL, V235, pE634; Coblentz WK, 2010, J DAIRY SCI, V93, P1148, DOI 10.3168/jds.2009-2701; Sakurai H, 1997, BIOSCI BIOTECH BIOCH, V61, P989; [Anonymous], 2009, J ANIM SCI; GOFF JP, 1993, J DAIRY SCI, V76, P101, DOI 10.3168/jds.S0022-0302(93)77328-2; Goff JP, 2006, ANIM FEED SCI TECH, V126, P237, DOI 10.1016/j.anifeedsci.2005.08.005; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053; OETZEL GR, 1991, J DAIRY SCI, V74, P3900; Karczewski J, 2000, AM J PHYSIOL-GASTR L, V279, pG660; Mineo H, 2002, J NUTR, V132, P3394; Sato T, 2012, J DAIRY SCI, V95, P5336, DOI 10.3168/jds.2011-4989; Horst RL, 1997, J DAIRY SCI, V80, P1269; DeGaris PJ, 2008, VET J, V176, P58, DOI 10.1016/j.tvjl.2007.12.029; Penner GB, 2008, J DAIRY SCI, V91, P1959, DOI 10.3168/jds.2007-0882; Liesegang A, 2000, J DAIRY SCI, V83, P1773; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Charbonneau E, 2006, J DAIRY SCI, V89, P537; VANDEBRAAK AE, 1987, RES VET SCI, V42, P101; Suzuki T, 2004, J NUTR, V134, P1935; GOFF JP, 1990, J DAIRY SCI, V73, P406; Saitou M, 2000, MOL BIOL CELL, V11, P4131; Kurosaki N, 2007, J VET MED SCI, V69, P185, DOI 10.1292/jvms.69.185; PHILLIPPO M, 1994, RES VET SCI, V56, P303, DOI 10.1016/0034-5288(94)90146-5; Bronner F, 1998, J NUTR, V128, P917; Teramura M, 2015, J DAIRY SCI, V98, P2533, DOI 10.3168/jds.2014-9004; Suzuki T, 2006, LIFE SCI, V79, P401, DOI 10.1016/j.lfs.2006.01.044; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851; GOINGS RL, 1974, J DAIRY SCI, V57, P1184; Taylor MS, 2009, J DAIRY SCI, V92, P223, DOI 10.3168/jds.2008-1345; Reinhardt TA, 2011, VET J, V188, P122, DOI 10.1016/j.tvjl.2010.03.025; Suzuki T, 1998, BIOSCI BIOTECH BIOCH, V62, P837, DOI 10.1271/bbb.62.837; CURTIS CR, 1983, J AM VET MED ASSOC, V183, P559; Lindmark T, 1998, J PHARMACOL EXP THER, V284, P362; Goff JP, 2008, VET J, V176, P50, DOI [10.1016/j.tvjl.2007.12.020, 10.1016/j.tvj1.2007.12.020]; Liesegang A, 2007, J ANIM PHYSIOL AN N, V91, P120, DOI 10.1111/j.1439-0396.2006.00651.x; HIBBS JW, 1955, J DAIRY SCI, V38, P65; CONSTABLE PD, 1991, J AM VET MED ASSOC, V199, P892; Goff JP, 1997, J DAIRY SCI, V80, P176; Bushinsky DA, 1996, AM J PHYSIOL-RENAL, V271, pF216; Goff JP, 2014, J DAIRY SCI, V97, P1520, DOI 10.3168/jds.2013-7467; Takagi M, 2011, ANIM NUTR FEED TECHN, V11, P147; Moreira VR, 2009, J DAIRY SCI, V92, P5189, DOI 10.3168/jds.2009-2289; AOAC, 2003, OFFICIAL METHODS ANA; Bronner F, 1987, PHYSL GASTROINTESTIN, P1419; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68; ENDER F, 1971, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V28, P233; GOFF JP, 1991, J DAIRY SCI, V74, P3863; GOFF JP, 1989, ENDOCRINOLOGY, V125, P49; Kikuchi H, 2004, J APPL GLYCOSCI, V51, P291; Nakai T., 2007, NIHON CHIKUSAN GAKKA, V78, P57, DOI 10.2508/chikusan.78.57; NRC. National Research Council, 2001, NUTR REQ DAIR CATTL; RAMBERG CF, 1984, AM J PHYSIOL, V246, pR698; Sato T., 2007, ANIM SCI J, V78, P37; Sato T., 2006, NIHON CHIKUSAN GAKKA, V77, P395, DOI 10.2508/chikusan.77.395; Schonewille T. J, 1999, J DAIRY SCI, V82, P1317; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583	59	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	DEC	2015	98	12					8688	8697		10.3168/jds.2015-9576		10	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CW4SE	WOS:000364981600043		
J	Kayano, M; Kida, K				Kayano, M.; Kida, K.			Identifying alterations in metabolic profiles of dairy cows over the past two decades in Japan using principal component analysis	JOURNAL OF DAIRY SCIENCE			English	Article						blood enzyme; blood metabolite; energy balance; liver dysfunction	NUTRITIONAL-STATUS; MILK-PRODUCTION; ENERGY-BALANCE; HERDS	The aim of this study was to identify the metabolic changes that have occurred in Holstein-Friesian cows in Japan over the past 2 decades, based on long-term metabolic profiles. From 1987 to 2004, metabolic profile tests were conducted in 1,700 dairy herds containing 50,000 cows. The cows were divided into 5 lactation stage groups: early (calving to 49 d in milk, DIM), peak (50-109 DIM), mid (110-209 DIM), and late (210 to dry-off) lactation and the dry period. Principal component analysis was applied to the metabolic profiles at each lactation stage separately to investigate changes in metabolic profiles across the multiyear periods 1987-1992, 1993-1998, and 1999-2004. We determined that cows have probably experienced increasing negative energy balance, energy deficiency, and liver dysfunction during the past 2 decades in Japan.	[Kayano, M.] Obihiro Univ Agr & Vet Med, Global Agromed Res Ctr, Obihiro, Hokkaido 0808555, Japan; [Kayano, M.; Kida, K.] Obihiro Univ Agr & Vet Med, Field Ctr Anim Sci & Agr, Obihiro, Hokkaido 0808555, Japan	Kida, K (reprint author), Obihiro Univ Agr & Vet Med, Field Ctr Anim Sci & Agr, Inada Cho, Obihiro, Hokkaido 0808555, Japan.	kidak@obihiro.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [24700290]	The metabolic profile tests were conducted at the Agricultural Mutual Aid Association (NOSAI; Hokkaido, Japan). The authors especially thank the animal doctors at NOSAI and farmers in Hokkaido for their help in this study. This study was supported, in part, by Grant-in-Aid for Young Scientists 24700290 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan.	Andrews A. H., 2000, HLTH DAIRY CATTLE; Macrae AI, 2006, VET REC, V159, P655; Gonzalez FD, 2011, J VET SCI, V12, P251, DOI 10.4142/jvs.2011.12.3.251; ADAMS RS, 1978, J DAIRY SCI, V61, P1671; Butler WR, 2005, ADV DAIRY TECHNOL, V17, P35; Cavestany D, 2005, J VET MED A, V52, P1, DOI 10.1111/j.1439-0442.2004.00679.x; PAYNE JM, 1970, VET REC, V87, P150; Kida K, 2002, J VET MED SCI, V64, P1003, DOI 10.1292/jvms.64.1003; BUTLER WR, 1989, J DAIRY SCI, V72, P767; Mudron P, 1999, J VET MED A, V46, P219, DOI 10.1046/j.1439-0442.1999.00206.x; Holtenius K, 2004, VET J, V168, P65, DOI 10.1016/j.tvjl.2003.09.015; LEE AJ, 1978, J DAIRY SCI, V61, P1652; Kida K, 2003, J VET MED SCI, V65, P671, DOI 10.1292/jvms.65.671; Kida K, 2002, J VET MED SCI, V64, P557, DOI 10.1292/jvms.64.557; Eicher R., 2003, ACTA VET SCAND S98, V44, P203; Kaneko J. J., 1989, CLIN BIOCH DOMESTIC; KUDLAC E, 1995, VET MED-CZECH, V40, P201; NRC. National Research Council, 2001, NUTR REQ DAIR CATTL; PAYNE JM, 1972, P ROY SOC MED, V65, P181; Payne J. M., 1987, METABOLIC PROFILE TE; ROWLANDS GJ, 1984, BRIT VET J, V140, P550; Stengarde L, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-31	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	DEC	2015	98	12					8764	8774		10.3168/jds.2015-9791		11	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CW4SE	WOS:000364981600050		
J	Takahashi, N				Takahashi, N.			Oral Microbiome Metabolism: From "Who Are They?" to "What Are They Doing?"	JOURNAL OF DENTAL RESEARCH			English	Review						amino acid; carbohydrate; dental caries; oral biofilm; oral malodor; periodontal diseases	ACID-NEUTRALIZING ACTIVITY; PYRUVATE FORMATE-LYASE; PORPHYROMONAS-GINGIVALIS; PREVOTELLA-INTERMEDIA; STREPTOCOCCUS-MUTANS; DENTAL-CARIES; FUSOBACTERIUM-NUCLEATUM; HYDROGEN-SULFIDE; METHYL MERCAPTAN; LACTATE METABOLISM	Recent advances in molecular biology have facilitated analyses of the oral microbiome ("Who are they?"); however, its functions (e.g., metabolic activities) are poorly understood ("What are they doing?"). This review aims to summarize our current understanding of the metabolism of the oral microbiome. Saccharolytic bacteria-including Streptococcus, Actinomyces, and Lactobacillus species-degrade carbohydrates into organic acids via the Embden-Meyerhof-Parnas pathway and several of its branch pathways, resulting in dental caries, while alkalization and acid neutralization via the arginine deiminase system, urease, and so on, counteract acidification. Proteolytic/amino acid-degrading bacteria, including Prevotella and Porphyromonas species, break down proteins and peptides into amino acids and degrade them further via specific pathways to produce short-chain fatty acids, ammonia, sulfur compounds, and indole/skatole, which act as virulent and modifying factors in periodontitis and oral malodor. Furthermore, it is suggested that ethanol-derived acetaldehyde can cause oral cancer, while nitrate-derived nitrite can aid caries prevention and systemic health. Microbial metabolic activity is influenced by the oral environment; however, it can also modify the oral environment, enhance the pathogenicity of bacteria, and induce microbial selection to create more pathogenic microbiome. Taking a metabolomic approach to analyzing the oral microbiome is crucial to improving our understanding of the functions of the oral microbiome.	[Takahashi, N.] Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 9808575, Japan	Takahashi, N (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	nobu-t@dent.tohoku.ac.jp			KAKENHI from the Japan Society for the Promotion of Science, Japan [60183852]	This study was partly supported by KAKENHI (no. 60183852) from the Japan Society for the Promotion of Science, Japan. The author declares no potential conflicts of interest with respect to the authorship and/or publication of this article.	ABBE K, 1991, Proceedings of the Finnish Dental Society, V87, P477; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; CROW VL, 1983, J BACTERIOL, V153, P76; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; HAUSMAN SZ, 1984, J BACTERIOL, V160, P211; PIANOTTI R, 1986, J DENT RES, V65, P913, DOI 10.1177/00220345860650061101; Takahashi N, 2010, J DENT RES, V89, P1383, DOI 10.1177/0022034510377792; HAMID MA, 1994, ARCH ORAL BIOL, V39, P967, DOI 10.1016/0003-9969(94)90080-9; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; Kurita-Ochiai T, 2008, J DENT RES, V87, P51; Ratcliff PA, 1999, J PERIODONTOL, V70, P485, DOI 10.1902/jop.1999.70.5.485; Fukamachi H, 2005, BIOCHEM BIOPH RES CO, V331, P127, DOI 10.1016/j.bbrc.2005.03.139; Washio J, 2005, J MED MICROBIOL, V54, P889, DOI 10.1099/jmm.0.46118-0; TRAHAN L, 1991, ORAL MICROBIOL IMMUN, V6, P41, DOI 10.1111/j.1399-302X.1991.tb00450.x; ABBE K, 1982, J BACTERIOL, V152, P175; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108; CURTIS MA, 1983, INFECT IMMUN, V42, P431; Saito K, 2001, J PERIODONTAL RES, V36, P355, DOI 10.1034/j.1600-0765.2001.360602.x; Washio J, 2014, APPL ENVIRON MICROB, V80, P4184, DOI 10.1128/AEM.00606-14; ABBE K, 1983, INFECT IMMUN, V39, P1007; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takahashi N, 2003, ORAL MICROBIOL IMMUN, V18, P109, DOI 10.1034/j.1399-302X.2003.00054.x; HAYES ML, 1974, ARCH ORAL BIOL, V19, P361, DOI 10.1016/0003-9969(74)90177-0; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI 10.1038/nrd2466; Codipilly D, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/1/017017; Takahashi N, 1999, CRIT REV ORAL BIOL M, V10, P487; Sheng JY, 2010, CAN J MICROBIOL, V56, P539, DOI [10.1139/w10-039, 10.1139/W10-039]; Doel JJ, 2004, EUR J ORAL SCI, V112, P424, DOI 10.1111/j.1600-0722.2004.00153.x; NG SKC, 1971, J BACTERIOL, V105, P999; Takahashi N, 1997, ORAL MICROBIOL IMMUN, V12, P323, DOI 10.1111/j.1399-302X.1997.tb00733.x; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; CARLSSON J, 1983, INFECT IMMUN, V40, P70; Yoshida Y, 2009, MICROBIOL-SGM, V155, P968, DOI 10.1099/mic.0.024174-0; Uematsu H, 2003, ARCH ORAL BIOL, V48, P423, DOI 10.1016/S0003-9969(03)00031-1; GHARBIA SE, 1991, J GEN MICROBIOL, V137, P1201; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269; Uematsu H, 2007, ORAL MICROBIOL IMMUN, V22, P381, DOI 10.1111/j.1399-302X.2007.00374.x; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000; Takahashi N, 2011, J DENT RES, V90, P1463, DOI 10.1177/0022034511423395; Takahashi N, 2000, ORAL MICROBIOL IMMUN, V15, P96, DOI 10.1034/j.1399-302x.2000.150205.x; TAKAHASHI N, 1987, INFECT IMMUN, V55, P652; Homann N, 2001, ORAL ONCOL, V37, P153, DOI 10.1016/S1368-8375(00)00076-2; OHTA H, 1991, ORAL MICROBIOL IMMUN, V6, P76, DOI 10.1111/j.1399-302X.1991.tb00455.x; Takahashi N, 2001, J DENT RES, V80, P1425; Doel JJ, 2005, EUR J ORAL SCI, V113, P14, DOI 10.1111/j.1600-0722.2004.00184.x; Curtis MA, 2011, INFECT IMMUN, V79, P1187, DOI 10.1128/IAI.00900-10; PERSSON S, 1990, ORAL MICROBIOL IMMUN, V5, P195, DOI 10.1111/j.1399-302X.1990.tb00645.x; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Sterer N, 2006, J DENT RES, V85, P910; Liu YL, 2012, INT J ORAL SCI, V4, P135, DOI 10.1038/ijos.2012.54; Sterer N, 2002, J DENT RES, V81, P182; Smalley JW, 2000, CURR MICROBIOL, V41, P328, DOI 10.1007/s002840010144; Carlsson J., 1986, TXB CARIOLOGY, P74; De Boever Erika H., 1994, Journal of Clinical Dentistry, V4, P114; Gottschalk G., 1985, BACTERIAL METABOLISM; Hendrickson EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-185; Marsh P D, 1994, Adv Dent Res, V8, P263; Takahashi N, 2005, INT C SER, V1284, P103, DOI 10.1016/j.ics.2005.06.071	63	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2015	94	12					1628	1637		10.1177/0022034515606045		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW9QX	WOS:000365334400002		
J	Kantaputra, PN; Kaewgahya, M; Hatsadaloi, A; Vogel, P; Kawasaki, K; Ohazama, A; Cairns, JRK				Kantaputra, P. N.; Kaewgahya, M.; Hatsadaloi, A.; Vogel, P.; Kawasaki, K.; Ohazama, A.; Cairns, J. R. Ketudat			GREMLIN 2 Mutations and Dental Anomalies	JOURNAL OF DENTAL RESEARCH			English	Article						hypodontia; microdontia; missing teeth; short tooth roots; taurodontism; tooth agenesis	TOOTH MORPHOGENESIS; WNT10A MUTATIONS; EXPRESSION; BMP4; MSX1; DAN; CERBERUS; AGENESIS; ANTAGONISTS; ACTIVATION	Isolated or nonsyndromic tooth agenesis or hypodontia is the most common human malformation. It has been associated with mutations in MSX1, PAX9, EDA, AXIN2, EDAR, EDARADD, and WNT10A. GREMLIN 2 (GREM2) is a strong bone morphogenetic protein (BMP) antagonist that is known to regulate BMPs in embryogenesis and tissue development. Bmp4 has been shown to have a role in tooth development. Grem2(-/-) mice have small, malformed maxillary and mandibular incisors, indicating that Grem2 has important roles in normal tooth development. Here, we demonstrate for the first time that GREM2 mutations are associated with human malformations, which include isolated tooth agenesis, microdontia, short tooth roots, taurodontism, sparse and slow-growing hair, and dry and itchy skin. We sequenced WNT10A, WNT10B, MSX1, EDA, EDAR, EDARADD, AXIN2, and PAX9 in all 7 patients to rule out the effects of other ectodermal dysplasias and other tooth-related genes and did not find mutations in any of them. GREM2 mutations exhibit variable expressivity even within the same families. The inheritance is autosomal dominant with incomplete penetrance. The expression of Grem2 during the early development of mouse teeth and hair follicles and the evaluation of the likely effects of the mutations on the protein structure substantiate these new findings.	[Kantaputra, P. N.; Kaewgahya, M.] Chiang Mai Univ, Ctr Excellence Med Genet Res, Chiang Mai 50200, Thailand; [Kantaputra, P. N.; Kaewgahya, M.] Chiang Mai Univ, Fac Dent, Dept Orthodont & Pediat Dent, Div Pediat Dent, Chiang Mai 50200, Thailand; [Kantaputra, P. N.] Dentaland Clin, Chiang Mai, Thailand; [Hatsadaloi, A.] Dent Home Clin, Khon Kaen, Thailand; [Vogel, P.] St Jude Childrens Res Hosp, Dept Vet Pathol, Memphis, TN 38105 USA; [Kawasaki, K.; Ohazama, A.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Oral Anat, Niigata, Japan; [Cairns, J. R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima, Thailand; [Cairns, J. R. Ketudat] Suranaree Univ Technol, Ctr Biomol Struct Funct & Applicat, Nakhon Ratchasima, Thailand; [Cairns, J. R. Ketudat] Chulabhorn Res Inst, Biochem Lab, Bangkok, Thailand	Kantaputra, PN (reprint author), Chiang Mai Univ, Ctr Excellence Med Genet Res, Chiang Mai 50200, Thailand.	dentaland17@gmail.com			Center of Excellence in Medical Genetics Research (Chiang Mai University); Thailand Research Fund	The authors are grateful to the patients and their families for their kind cooperation and allowing them to use their medical and dental information for publication. This research was supported by the Center of Excellence in Medical Genetics Research (Chiang Mai University) and The Thailand Research Fund. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; Zhao X, 2000, MECH DEVELOP, V99, P29, DOI 10.1016/S0925-4773(00)00467-6; Minabe-Saegusa C, 1998, DEV GROWTH DIFFER, V40, P343; Tucker AS, 1999, J DENT RES, V78, P826; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Vogel P, 2015, VET PATHOL, V52, P224, DOI 10.1177/0300985814528218; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Cheung CL, 2013, J CLIN ENDOCR METAB, V98, pE1557, DOI 10.1210/jc.2013-1983; Im J, 2007, BIOCHEM BIOPH RES CO, V354, P296, DOI 10.1016/j.bbrc.2006.12.205; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Kantaputra P, 2014, AM J MED GENET A, V164, P1041, DOI 10.1002/ajmg.a.36388; Kantaputra P, 2014, AM J MED GENET A, V164, P360, DOI 10.1002/ajmg.a.36280; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Kantaputra P, 2011, AM J MED GENET A, V155A, P1119, DOI 10.1002/ajmg.a.33840; Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1067/mod.2000.103257; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Hinck AP, 2012, FEBS LETT, V586, P1860, DOI 10.1016/j.febslet.2012.05.028; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Yin W, 2015, J DENT RES, V94, P878, DOI 10.1177/0022034515583999; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Sun JP, 2006, J BIOL CHEM, V281, P29349, DOI 10.1074/jbc.M603833200; Zuniga E, 2011, DEVELOPMENT, V138, P5147, DOI 10.1242/dev.067785; Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705	27	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2015	94	12					1646	1652		10.1177/0022034515608168		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW9QX	WOS:000365334400004		
J	Ganeko, K; Masaki, C; Shibata, Y; Mukaibo, T; Kondo, Y; Nakamoto, T; Miyazaki, T; Hosokawa, R				Ganeko, K.; Masaki, C.; Shibata, Y.; Mukaibo, T.; Kondo, Y.; Nakamoto, T.; Miyazaki, T.; Hosokawa, R.			Bone Aging by Advanced Glycation End Products: A Multiscale Mechanical Analysis	JOURNAL OF DENTAL RESEARCH			English	Article						methionine; collagen; elasticity; biomechanical phenomena; hardness tests; Raman spectroscopy	CORTICAL BONE; INSTRUMENTED INDENTATION; PERIODONTAL-LIGAMENT; BIOLOGICAL-MATERIALS; ELASTIC-MODULUS; NANOINDENTATION; FRACTURE; HARDNESS; TISSUES; MODELS	The quality and quantity of mandibular bone are essential prerequisites for osseointegrated implants. Only the Hounsfield unit on preoperative computed tomography is currently used as a clinical index. Nevertheless, a considerable mismatch occurs between bone quality and the Hounsfield unit. Loss of bone toughness during aging has been accepted based on empirical evidence, but this concept is unlikely evidence based at the level of mechanical properties. Nonenzymatic bone matrix cross-links associated with advanced glycation end products predominate as a consequence of aging. Thus, loss of tissue integrity could diminish the bone toughening mechanism. Here, we demonstrate an impaired bone toughening mechanism caused by mimicking aging in rabbits on a methionine-rich diet, which enabled an enhanced nonenzymatically cross-linked bone matrix. A 3-point bending test revealed a greater reduction in femoral fracture resistance in rabbits on a methionine-rich diet, despite higher maximum and normalized breaking forces (287.3 N and 88.1%, respectively), than in rabbits on a normal diet (262.2 N and 79.7%, respectively). In situ nanoindentation on mandibular cortical bone obtained from rabbits on a methionine-rich diet did not enable strain rate-dependent stiffening and consequent large-dimensional recovery during rapid loading following constant displacement after a rapid-load indentation test as compared with those in rabbits on a normal diet. Such nanoscale structure-function relationships dictate resistance to cracking propagation at the material level and allow for the overall bone toughening mechanism to operate under large external stressors. The strain-dependent stiffening was likely associated with strain-energy transfer to the superior cross-linked bone matrix network of the normal diet, while the reduction in the enzymatically cross-linked matrix in bone samples from rabbits on a methionine-rich diet likely diminished the intrinsic bone toughening mechanism. The present study also provides a precise protocol for evaluating bone mechanical properties at the material level based on observations from a series of nanoindentation experiments.	[Ganeko, K.; Masaki, C.; Mukaibo, T.; Kondo, Y.; Nakamoto, T.; Hosokawa, R.] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka 8038580, Japan; [Shibata, Y.; Miyazaki, T.] Showa Univ, Sch Dent, Dept Conservat Dent, Div Biomat & Engn, Tokyo 142, Japan	Hosokawa, R (reprint author), Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	hosokawa@kyu-dent.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [25253103]	This study was supported by Grant-in-Aid for Scientific Research (A), no. 25253103, from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. The authors are grateful to Dr. Azusa Seki for helping with specimen preparation and testing. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Bar-On B, 2013, J STRUCT BIOL, V183, P149, DOI 10.1016/j.jsb.2013.05.012; Taylor D, 2007, J MATER SCI, V42, P8911, DOI 10.1007/s10853-007-1698-3; TURNER CH, 1992, J ORTHOPAED RES, V10, P581, DOI 10.1002/jor.1100100413; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; FIELD JS, 1995, J MATER RES, V10, P101, DOI 10.1557/JMR.1995.0101; Bjarnason NH, 2000, CLIN ENDOCRINOL, V52, P225, DOI 10.1046/j.1365-2265.2000.00919.x; Lettry S, 2003, BONE, V32, P35, DOI 10.1016/S8756-3282(02)00921-3; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Manabe T, 2007, BONE, V40, P1475, DOI 10.1016/j.bone.2007.01.015; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Sanctuary CS, 2005, J APPL PHYSIOL, V99, P2369, DOI 10.1152/japplphysiol.00486.2005; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; Xu CQ, 2009, J RAMAN SPECTROSC, V40, P1780, DOI 10.1002/jrs.2320; Maruyama N, 2014, NANOSCALE, V6, P14863, DOI 10.1039/c4nr03180f; Chai J, 2012, INT J ORAL MAX IMPL, V27, P888; Jang IK, 2014, NANOMED-NANOTECHNOL, V10, P629, DOI 10.1016/j.nano.2013.09.007; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Morris MD, 2004, SPECTROSC-INT J, V18, P155; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Oyen ML, 2008, J MATER RES, V23, P1307, DOI 10.1557/JMR.2008.0156; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.0002; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Cheng YT, 2005, J MATER RES, V20, P3061, DOI 10.1557/JMR.2005.0389; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; Barthelat F, 2012, MATER RES SOC S P, V1420, P61; Hosokawa R, 2014, J PROSTHODONT RES, V57, P1; Kaku M, 2014, J PROSTHODONT RES, V58, P193, DOI 10.1016/j.jpor.2014.08.003; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Ural A, 2014, OSTEOPOROSIS INT, V26, P865; Wenchang T, 2003, INT J NONLIN MECH, V38, P645, DOI DOI 10.1016/S0020-7462(01)00121-4	34	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2015	94	12					1684	1690		10.1177/0022034515602214		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW9QX	WOS:000365334400009		
J	Yamaba, S; Yamada, S; Kajikawa, T; Awata, T; Sakashita, H; Tsushima, K; Fujihara, C; Yanagita, M; Murakami, S				Yamaba, S.; Yamada, S.; Kajikawa, T.; Awata, T.; Sakashita, H.; Tsushima, K.; Fujihara, C.; Yanagita, M.; Murakami, S.			PLAP-1/Asporin Regulates TLR2-and TLR4-induced Inflammatory Responses	JOURNAL OF DENTAL RESEARCH			English	Article						periodontal ligament (PDL); extracellular matrix (ECM); periodontitis; LPS; ECM protein; inflammatory cytokines	PERIODONTAL-LIGAMENT CELLS; TOLL-LIKE RECEPTOR-2; GROWTH-FACTOR-BETA; PROTEOGLYCAN DECORIN; NEGATIVE REGULATION; GINGIVAL TISSUE; EXPRESSION; BIGLYCAN; SUSCEPTIBILITY; MACROPHAGES	Periodontal ligament-associated protein 1 (PLAP-1)/asporin is an extracellular matrix protein preferentially expressed in periodontal ligaments. PLAP-1/asporin inhibits the cytodifferentiation and mineralization of periodontal ligament cells and has important roles in the maintenance of periodontal tissue homeostasis. However, the involvement of PLAP-1/asporin in inflammatory responses during periodontitis is poorly understood. This study hypothesized that PLAP-1/asporin might affect the pathogenesis of periodontitis by regulating periodontopathic bacteria-induced inflammatory responses. Proinflammatory cytokine expression induced by Toll-like receptor 2 (TLR2) and TLR4 was significantly downregulated when PLAP-1/asporin was overexpressed in periodontal ligament cells. Similarly, recombinant PLAP-1/asporin inhibited TLR2-and TLR4-induced proinflammatory cytokine expression in macrophages. We also confirmed that NF-kappa B activity induced by TLR2 and TLR4 signaling was suppressed by the addition of recombinant PLAP-1/asporin. Furthermore, I.B kinase a degradation induced by TLR4 was reduced by PLAP-1/asporin. Immunoprecipitation assays demonstrated the binding abilities of PLAP-1/asporin to both TLR2 and TLR4. Taken together, PLAP-1/asporin negatively regulates TLR2-and TLR4induced inflammatory responses through direct molecular interactions. These findings indicate that PLAP-1/asporin has a defensive role in periodontitis lesions by suppressing pathophysiologic TLR signaling and that the modulating effects of PLAP-1/asporin might be useful for periodontal treatments.	[Yamaba, S.; Yamada, S.; Kajikawa, T.; Awata, T.; Sakashita, H.; Tsushima, K.; Fujihara, C.; Yanagita, M.; Murakami, S.] Osaka Univ, Grad Sch, Dept Periodontol, Suita, Osaka 5650871, Japan	Yamada, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	satoru@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [26293437, 15H02579]	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (26293437, 15H02579). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Fatemi K, 2013, AUST DENT J, V58, P315, DOI 10.1111/adj.12089; Tomoeda M, 2008, BIOCHEM BIOPH RES CO, V371, P191, DOI 10.1016/j.bbrc.2008.03.158; Kawai T, 2001, J IMMUNOL, V167, P5887; HILDEBRAND A, 1994, BIOCHEM J, V302, P527; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Meng HX, 2007, PERIODONTOL 2000, V43, P133, DOI 10.1111/j.1600-0757.2006.00204.x; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JC123755; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Mori Y, 2003, ORAL MICROBIOL IMMUN, V18, P54, DOI 10.1034/j.1399-302X.2003.180109.x; Awata T, 2015, J DENT RES, V94, P1417, DOI 10.1177/0022034515598507; JOHNSON DA, 1976, J PERIODONTAL RES, V11, P349, DOI 10.1111/j.1600-0765.1976.tb00089.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Inubushi T, 2012, J BIOL CHEM, V287, P23527, DOI 10.1074/jbc.M111.324673; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Beklen A, 2009, ORAL MICROBIOL IMMUN, V24, P38, DOI 10.1111/j.1399-302X.2008.00473.x; Kornman KS, 1997, PERIODONTOL 2000, V14, P33, DOI 10.1111/j.1600-0757.1997.tb00191.x; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lee EH, 2011, J CELL PHYSIOL, V226, P1676, DOI 10.1002/jcp.22498; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; LeBouder E, 2003, J IMMUNOL, V171, P6680; Terashima Y, 2008, J CELL PHYSIOL, V216, P640, DOI 10.1002/jcp.21443; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamada S, 2001, GENE, V275, P279, DOI 10.1016/S0378-1119(01)00683-7; Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Hourai S, 2014, J BONE MINER RES, V29, P1446; Kajikawa T, 2014, J DENT RES, V93, P400, DOI 10.1177/0022034513520549; Mariotti A, 1999, Ann Periodontol, V4, P7, DOI 10.1902/annals.1999.4.1.7; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868	37	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2015	94	12					1706	1714		10.1177/0022034515606859		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW9QX	WOS:000365334400012		
J	Albogha, MH				Albogha, M. H.			Letter to the Editor, "Multiscale Analyses of the Bone-implant Interface"	JOURNAL OF DENTAL RESEARCH			English	Letter									[Albogha, M. H.] Damascus Univ, Fac Dent Sci, Dept Orthodont, Damascus, Syria; [Albogha, M. H.] Kyushu Univ, Sect Orthodont & Dentofacial Orthoped, Grad Sch Dent Sci, Fukuoka 8128582, Japan	Albogha, MH (reprint author), Kyushu Univ, 3-1-1 Higashi Ku, Fukuoka 8128582, Japan.	hassanbuga@hotmail.com	Albogha, Mhd Hassan/B-1840-2015	Albogha, Mhd Hassan/0000-0001-9063-520X			Tabassum A, 2014, CLIN ORAL IMPLAN RES, V25, P487, DOI 10.1111/clr.12180; Cha JY, 2015, J DENT RES, V94, P482, DOI 10.1177/0022034514566029; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089343	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2015	94	12					1782	1782		10.1177/0022034515590378		1	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CW9QX	WOS:000365334400021		
J	Soga, Y; Takahara, M; Iida, O; Suzuki, K; Hirano, K; Kawasaki, D; Shintani, Y; Yamaoka, T; Ando, K				Soga, Yoshimitsu; Takahara, Mitsuyoshi; Iida, Osamu; Suzuki, Kenji; Hirano, Keisuke; Kawasaki, Daizo; Shintani, Yoshiaki; Yamaoka, Terutoshi; Ando, Kenji			Relationship Between Primary Patency and Lesion Length Following Bare Nitinol Stent Placement for Femoropopliteal Disease	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						endovascular therapy; femoropopliteal disease; lesion length; occlusion; patency; popliteal artery; stenosis; stent; superficial femoral artery	SUPERFICIAL FEMORAL-ARTERY; ENDOVASCULAR BRACHYTHERAPY; ANGIOPLASTY; RESTENOSIS; TRIAL; SAFETY	Purpose: To evaluate the relationship between 1-year primary patency and lesion length in patients with femoropopliteal disease treated with bare nitinol stents. Methods: The study was a retrospective analysis of a prospectively maintained multicenter database. Between January 2004 and December 2011, 1047 consecutive patients (mean age 72 years; 765 men) underwent femoropopliteal stenting with nitinol stents in 1373 limbs. The mean vessel diameter was 5.3 +/- 0.7 mm and the mean lesion length was 142 +/- 75 mm. One-year follow-up data were collected and analyzed to ascertain which lesion length would be expected to demonstrate a 1-year primary patency above the established 66% objective performance goal (OPG). Results: The lower limit of the 95% confidence interval (CI) for the unadjusted 1-year primary patency was >66% when the lesion length was <= 243 mm. After adjustment of the covariates to match those of the OPG-derived population, the 1-year primary patency decreased linearly with longer lesion length. The 1-year primary patency was 83.2% (95% CI 79.8% to 86.1%) for a 100-mm lesion length, 76.4% (95% CI 71.7% to 80.5%) for a 200-mm lesion length, and 70.7% (95% CI 62.4% to 77.7%) for a 300-mm lesion length. The maximum lesion length providing a 1-year primary patency significantly greater than 66% was calculated to be 263 mm. Conclusion: The 1-year primary patency of femoropopliteal lesions treated with bare nitinol stents decreased linearly with longer lesion length. The maximum lesion length providing a higher patency rate than the OPG of 66% was similar to 25 cm.	[Soga, Yoshimitsu; Ando, Kenji] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka 8020001, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Grad Sch Med, Dept Diabet Care Med, Suita, Osaka, Japan; [Iida, Osamu] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan; [Suzuki, Kenji] Tokyo Saiseikai Cent Hosp, Dept Cardiol, Tokyo, Japan; [Hirano, Keisuke] Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawasaki, Daizo] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan; [Shintani, Yoshiaki] Shin Koga Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Yamaoka, Terutoshi] Matsuyama Red Cross Hosp, Dept Vasc Surg, Matsuyama, Ehime, Japan	Soga, Y (reprint author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8020001, Japan.	sogacchy@yahoo.co.jp					Zeller T, 2014, J ENDOVASC THER, V21, P765, DOI 10.1583/14-4790R.1; Pokrajac B, 2005, RADIOTHER ONCOL, V74, P3, DOI 10.1016/j.radonc.2004.08.015; Mewissen MW, 2009, J ENDOVASC THER, V16, P63; Rocha-Singh KJ, 2007, CATHETER CARDIO INTE, V69, P910, DOI 10.1002/ccd.21104; Vardi M, 2014, CATHETER CARDIO INTE, V83, P975, DOI 10.1002/ccd.25179; Miki K, 2013, CIRC J, V77, P1543, DOI 10.1253/circj.CJ-12-1182; Minar E, 2000, CIRCULATION, V102, P2694; Liistro F, 2013, JACC-CARDIOVASC INTE, V6, P1295, DOI 10.1016/j.jcin.2013.07.010; Zdanowski Z, 1999, INT ANGIOL, V18, P251; Iida O, 2011, CATHETER CARDIO INTE, V78, P611, DOI 10.1002/ccd.23064; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; van der Zaag ES, 2004, EUR J VASC ENDOVASC, V28, P132, DOI 10.1016/j.ejvs.2004.04.003; Bosiers M, 2011, J VASC SURG, V54, P1042, DOI 10.1016/j.jvs.2011.03.272; Dake MD, 2013, J AM COLL CARDIOL, V61, P2417, DOI 10.1016/j.jacc.2013.03.034; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Werner M, 2014, EUROINTERVENTION, V10, P861, DOI 10.4244/EIJV10I7A147	16	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	DEC	2015	22	6					862	867		10.1177/1526602815610118		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CW9JP	WOS:000365315300005		
J	Sekhar, BS; Muthukumar, P				Sekhar, B. Satya; Muthukumar, P.			Development of Double-Stage Metal Hydride-Based Hydrogen Compressor for Heat Transformer Application	JOURNAL OF ENERGY ENGINEERING			English	Article						Metal hydride; Hydrogen compressor; Double-stage; Performance test	SYSTEM; TESTS	For the development of a double-stage metal hydride-based heat transformer (DS-MHHT), three metal hydrides, namely, A, B, and C, with different thermo-physical properties are required. Hydrides A and B together act as a hydrogen compressor, and hydride C upgrades the heat input quality. In the present paper, the performance tests of a double-stage metal hydride-based hydrogen compressor (DS-MHHC) employed in the development of metal hydride-based heat transformer are presented. The metal hydrides chosen for the present study are LaNi5 and La0.35Ce0.45Ca0.2Ni4.95Al0.05. The effects of supply pressure and heat source (desorption) temperature on the delivery pressure, amount of hydrogen compressed, and isentropic efficiency of the hydrogen compressor were investigated. It is observed that an increase in supply pressure up to 10 bar significantly increases the delivery pressure, which reduces the compressor efficiency significantly. A maximum compression ratio of 22 was obtained when the DS-MHHC operated at 2 bar supply pressure and 140 degrees C heat source temperature. At supply conditions of 10 bar supply pressure and 140 degrees C heat source temperature, the maximum delivery pressure achieved was 74 bar. (C) 2014 American Society of Civil Engineers.	[Sekhar, B. Satya] Natl Inst Adv Sci & Technol AIST, Energy Technol Res Inst, Tsukuba, Ibaraki, Japan; [Sekhar, B. Satya; Muthukumar, P.] IIT Guwahati, Dept Mech Engn, Gauhati 781039, India	Sekhar, BS (reprint author), Natl Inst Adv Sci & Technol AIST, Energy Technol Res Inst, Tsukuba, Ibaraki, Japan.	bhogilla@iitgernet.in					Willers E, 1999, INT J HYDROGEN ENERG, V24, P269, DOI 10.1016/S0360-3199(98)00058-5; Muthukumar P, 2005, INT J HYDROGEN ENERG, V30, P879, DOI 10.1016/j.ijhydene.2004.09.003; Sekhar BS, 2013, INT J HYDROGEN ENERG, V38, P15428, DOI 10.1016/j.ijhydene.2013.09.103; Vanhanen JP, 1999, INT J HYDROGEN ENERG, V24, P441, DOI 10.1016/S0360-3199(98)00095-0; Sekhar BS, 2012, INT J HYDROGEN ENERG, V37, P3818, DOI 10.1016/j.ijhydene.2011.05.114; Sekhar BS, 2013, INT J HYDROGEN ENERG, V38, P7178, DOI 10.1016/j.ijhydene.2013.03.135; SUDA S, 1991, J LESS-COMMON MET, V172, P1092, DOI 10.1016/S0022-5088(06)80017-2; Luo G, 2010, INT J HYDROGEN ENERG, V35, P8262, DOI 10.1016/j.ijhydene.2009.12.020; Wang XH, 2007, INT J HYDROGEN ENERG, V32, P4011, DOI 10.1016/j.ijhydene.2007.03.002; Hopkins RR, 2010, INT J HYDROGEN ENERG, V35, P5693, DOI 10.1016/j.ijhydene.2010.03.065; Isselhorst A, 1995, J ALLOY COMPD, V231, P888, DOI 10.1016/0925-8388(95)01777-1; Muthukumar P, 2012, INT J HYDROGEN ENERG, V37, P3797, DOI 10.1016/j.ijhydene.2011.05.104; Kim JK, 2008, INT J HYDROGEN ENERG, V33, P870, DOI 10.1016/j.ijhydene.2007.10.027; Laurencelle P., 2009, J ALLOY COMPD, V475, P810; Tusher E., 1984, INT J HYDROGEN ENERG, V9, P783; Werner R., 1991, J LESS-COMMON MET, V174, P1122	16	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9402	1943-7897		J ENERG ENG	J. Energy Eng.-ASCE	DEC	2015	141	4							UNSP 04014049	10.1061/(ASCE)EY.1943-7897.0000246		6	Energy & Fuels; Engineering, Civil	Energy & Fuels; Engineering	CW6PT	WOS:000365120400023		
J	Waseda, T; Kinoshita, T; Cavaleri, L; Toffoli, A				Waseda, Takuji; Kinoshita, T.; Cavaleri, L.; Toffoli, A.			Third-order resonant wave interactions under the influence of background current fields	JOURNAL OF FLUID MECHANICS			English	Article						surface gravity waves; waves/free-surface flows	ENERGY-TRANSFER; GRAVITY-WAVES; PROGRESSIVE WAVES; EQUILIBRIUM RANGE; DIRECTIONAL WAVE; SURFACE-WAVES; FREAK WAVES; WATER-WAVES; DEEP-WATER; GENERATION	A series of experiments were conducted in a wave basin (50 in long, 10 in wide and 5 in deep) generating two waves propagating at an angle by a directional wavemaker. When the two waves were selected from a resonant triplet, an initially non-existing wave grew as the waves propagated down the tank. The linear growth rate of the resonating wave agreed well with third order resonance theory based on Zakharov's reduced gravity equation. Additional experiments with opposing and coflowing mean current with large temporal and spatial variations were conducted. As the flow rate increased, the linear growth was suppressed. As reproduced numerically with Zakharov's equation, the resonant interaction saturated at time scales inversely proportional to the magnitude of the forced random resonance detuning It is conjectured that the resonance is detuned by the variation and not by the mean of the current field due to wavelength-dependent Doppler shift and to the refraction of Wave rays. Further analysis of the spectral evolution revealed that while discrete peaks appear at high frequencies as a result of dynamical cascading, a continuously saturated spectrum develops in the background as the current speed increases. Additional experiments were conducted studying the evolution of the random directional wave on a dynamical time scale under the influence of current. Due to random resonance detuning by the current, the spectral tail tended to be suppressed.	[Waseda, Takuji] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan; [Kinoshita, T.] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Cavaleri, L.] Inst Marine Sci, I-30122 Venice, Italy; [Toffoli, A.] Swinburne Univ Technol, Ctr Ocean Engn Sci & Technol, Hawthorn, Vic 3122, Australia	Waseda, T (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan.	waseda@k.u-tokyo.ac.jp		Toffoli, Alessandro/0000-0003-3112-6856	Japan Society for Promoting Science; EU [SPA.2011.5-03]	The first author thanks T. Hirobe, H. Tomita, W. Choi, V. Shrira and E. Kartashova for the discussion over the years it took to complete this paper. The work was supported partially by Grants-in-Aid for Scientific Research (KAKEN), Japan Society for Promoting Science. L.C. was supported by the EU-funded project MyWave, Theme (SPA.2011.5-03). A.T. also acknowledges the International Science Linkages (ISL) Program of the Australian Academy of Science. The numerical solution of Zakharov's equation is based on a code developed in cooperation with O. Oshri when the first author was at the University of California, Santa Barbara.	MILES JW, 1957, J FLUID MECH, V3, P185, DOI 10.1017/S0022112057000567; JONES AF, 1984, J FLUID MECH, V138, P53, DOI 10.1017/S0022112084000033; Trulsen K, 1999, PHYS FLUIDS, V11, P235, DOI 10.1063/1.869915; HASSELMANN S, 1985, J PHYS OCEANOGR, V15, P1369, DOI 10.1175/1520-0485(1985)015<1369:CAPOTN>2.0.CO;2; Hjelmervik KB, 2009, J FLUID MECH, V637, P267, DOI 10.1017/S0022112009990607; Onorato M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.184502; Fuhrman DR, 2006, J FLUID MECH, V563, P415, DOI 10.1017/S0022112006001236; Liu Z, 2015, J FLUID MECH, V763, P1, DOI 10.1017/jfm.2014.658; Janssen PAEM, 2003, J PHYS OCEANOGR, V33, P863, DOI 10.1175/1520-0485(2003)33<863:NFIAFW>2.0.CO;2; PHILLIPS OM, 1958, J FLUID MECH, V4, P426, DOI 10.1017/S0022112058000550; KRASITSKII VP, 1994, J FLUID MECH, V272, P1, DOI 10.1017/S0022112094004350; Annenkov SY, 2006, J FLUID MECH, V561, P181, DOI 10.1017/S0022112006000632; Toffoli A, 2015, J FLUID MECH, V769, P277, DOI 10.1017/jfm.2015.132; Waseda T, 2009, J PHYS OCEANOGR, V39, P621, DOI 10.1175/2008JPO4031.1; STEWART RH, 1974, DEEP-SEA RES, V21, P1039, DOI 10.1016/0011-7471(74)90066-7; YAO YT, 1994, J FLUID MECH, V276, P211, DOI 10.1017/S0022112094002533; Liu Z, 2014, J FLUID MECH, V742, P664, DOI 10.1017/jfm.2014.2; Liao SJ, 2011, COMMUN NONLINEAR SCI, V16, P1274, DOI 10.1016/j.cnsns.2010.06.026; Madsen PA, 2006, J FLUID MECH, V557, P369, DOI 10.1017/S0022112006009815; Hammack JL, 2005, J FLUID MECH, V532, P1, DOI 10.1017/S0022112005003733; PHILLIPS OM, 1985, J FLUID MECH, V156, P505, DOI 10.1017/S0022112085002221; Badulin SI, 2005, NONLINEAR PROC GEOPH, V12, P891; Tanaka M, 2001, J FLUID MECH, V444, P199; Cavaleri L, 2007, PROG OCEANOGR, V75, P603, DOI 10.1016/j.pocean.2007.05.005; Pushkarev A, 2003, PHYSICA D, V184, P29, DOI 10.1016/S0167-2789(03)00212-4; HASSELMANN K, 1962, J FLUID MECH, V12, P481, DOI 10.1017/S0022112062000373; KIT E, 1987, J FLUID MECH, V181, P265, DOI 10.1017/S0022112087002088; Tulin MP, 1999, J FLUID MECH, V378, P197, DOI 10.1017/S0022112098003255; Toffoli A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.051201; Xu DL, 2012, J FLUID MECH, V710, P379, DOI 10.1017/jfm.2012.370; Stiassnie M, 2005, WAVE MOTION, V41, P307, DOI 10.1016/j.wavemoti.2004.07.002; PHILLIPS OM, 1960, J FLUID MECH, V9, P1, DOI 10.1017/S0022112060000888; LONGUETHIGGINS MS, 1962, J FLUID MECH, V12, P321, DOI 10.1017/S0022112062000233; White BS, 1998, J FLUID MECH, V355, P113, DOI 10.1017/S0022112097007751; BENNEY DJ, 1962, J FLUID MECH, V14, P577, DOI 10.1017/S0022112062001469; DALRYMPLE RA, 1989, J HYDRAUL RES, V27, P23; Hirobe T, 2013, THESIS; Janssen P.A.E.M., 2004, INTERACTION OCEAN WA; Kartashova E, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/30003; Kartashova E, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/44001; LONGUETH.MS, 1966, J FLUID MECH, V25, P417, DOI 10.1017/S0022112066000168; MCGOLDRI.LF, 1966, J FLUID MECH, V25, P437, DOI 10.1017/S002211206600017X; Mei C. C., 2005, THEORY APPL OCEAN SU, V23; Qingpu Z, 1996, ACTA MECH SINICA, V12, P24, DOI 10.1007/BF02486759; Takezawa S., 1988, J SOC NAV ARCHIT JPN, V163, P222; Tamura H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006014; Tomita H., 1989, THESIS; Wu CH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002612; Zakharov V.E., 1968, J APPL MECH TECH PHY, V9, P190, DOI DOI 10.1007/BF00913182	49	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	DEC	2015	784						51	73		10.1017/jfm.2015.578		23	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CW7KO	WOS:000365177700010		
J	Takei, Y; Katz, RF				Takei, Yasuko; Katz, Richard F.			Consequences of viscous anisotropy in a deforming, two-phase aggregate. Why is porosity-band angle lowered by viscous anisotropy?	JOURNAL OF FLUID MECHANICS			English	Article						magma and lava flow; non-Newtonian flows; rheology	DRIVEN MELT SEGREGATION; PARTIALLY MOLTEN ROCKS; SHEAR; STRESS; MANTLE; DEFORMATION; EQUATIONS; CREEP; FLOW	In laboratory experiments that impose shear deformation on partially molten aggregates of initially uniform porosity, melt segregates into high-porosity sheets (bands in cross-section). The bands emerge at 15 degrees-20 degrees to the shear plane. A model of viscous anisotropy can explain these low angles whereas previous simpler models have failed to do so. The anisotropic model is complex, however, and the reason that it produces low-angle bands has not been understood. Here we show that there are two mechanisms: (i) suppression of the well-known tensile instability, and (ii) creation of a new shear-driven instability. We elucidate these mechanisms using linearised stability analysis in a coordinate system that is aligned with the perturbations. We consider the general case of anisotropy that varies dynamically with deviatoric stress, but approach it by first considering uniform anisotropy that is imposed a priori and showing the difference between static and dynamic cases. We extend the model of viscous anisotropy to include a strengthening in the direction of maximum compressive stress. Our results support the hypothesis that viscous anisotropy is the cause of low band angles in experiments.	[Takei, Yasuko] Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan; [Katz, Richard F.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	Takei, Y (reprint author), Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan.	ytakei@eri.u-tokyo.ac.jp			European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC [279925]; International Research Promotion Office; Leverhulme Trust	The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 279925. R.F.K. visited the Earthquake Research Institute of the University of Tokyo with support from the International Research Promotion Office; he is grateful for support by the Leverhulme Trust. Numerical simulations were performed at the Advanced Research Computing facility of the University of Oxford. The authors are grateful for stimulating discussions with M. Spiegelman, D. L. Kohlstedt and C. Qi, and for helpful and encouraging reviews by S. Butler and two anonymous referees.	Takei Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005852; Qi C, 2015, P NATL ACAD SCI USA, V112, P12616, DOI 10.1073/pnas.1513790112; Daines MJ, 1997, J GEOPHYS RES-SOL EA, V102, P10257, DOI 10.1029/97JB00393; COOPER RF, 1989, ACTA METALL MATER, V37, P1759, DOI 10.1016/0001-6160(89)90061-8; Rudge JF, 2011, GEOPHYS J INT, V184, P699, DOI 10.1111/j.1365-246X.2010.04870.x; STEVENSON DJ, 1989, GEOPHYS RES LETT, V16, P1067, DOI 10.1029/GL016i009p01067; Mei S, 2002, EARTH PLANET SC LETT, V201, P491, DOI 10.1016/S0012-821X(02)00745-8; Holtzman BK, 2007, J PETROL, V48, P2379, DOI 10.1093/petrology/egm065; King DSH, 2010, J PETROL, V51, P21, DOI 10.1093/petrology/egp062; Allwright J, 2014, GEOPHYS J INT, V199, P1608, DOI 10.1093/gji/ggu345; Katz RF, 2013, J FLUID MECH, V734, P456, DOI 10.1017/jfm.2013.483; Takei Y, 2013, J FLUID MECH, V734, P424, DOI 10.1017/jfm.2013.482; Takei Y, 1998, J GEOPHYS RES-SOL EA, V103, P18183, DOI 10.1029/98JB01489; Katz RF, 2007, PHYS EARTH PLANET IN, V163, P52, DOI 10.1016/j.pepi.2007.04.016; Katz RF, 2006, NATURE, V442, P676, DOI 10.1038/nature05039; [Anonymous], 2003, GEOCHEM GEOPHY GEOSY, DOI [10.1029/2001GC000258, DOI 10.1029/2001GC000258]; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Rudge JF, 2015, GEOPHYS J INT, V201, P640, DOI 10.1093/gji/ggv040; Butler SL, 2012, PHYS EARTH PLANET IN, V200, P28, DOI 10.1016/j.pepi.2012.03.011; Zimmerman ME, 1999, GEOPHYS RES LETT, V26, P1505, DOI 10.1029/1999GL900259; Balay S., 2004, PETSC USERS MANUAL; DREW DA, 1983, ANNU REV FLUID MECH, V15, P261, DOI 10.1146/annurev.fl.15.010183.001401; King D. S. H., 2011, GEOCHEM GEOPHY GEOSY, V12, P12019; MCKENZIE D, 1984, J PETROL, V25, P713; Simpson G, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006376; Simpson G, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006375; Spiegelman M, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000499; Takei Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005850; Takei Y, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006568	29	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	DEC	2015	784						199	224		10.1017/jfm.2015.592		26	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CW7KO	WOS:000365177700015		
J	Arima, K; Okabe, H; Hashimoto, D; Chikamoto, A; Kuroki, H; Taki, K; Kaida, T; Higashi, T; Nitta, H; Komohara, Y; Beppu, T; Takeya, M; Baba, H				Arima, Kota; Okabe, Hirohisa; Hashimoto, Daisuke; Chikamoto, Akira; Kuroki, Hideyuki; Taki, Katsunobu; Kaida, Takayoshi; Higashi, Takaaki; Nitta, Hidetoshi; Komohara, Yoshihiro; Beppu, Toru; Takeya, Motohiro; Baba, Hideo			The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Intraductal papillary mucinous neoplasm; Malignant potential; Neutrophil-to-lymphocyte ratio	INTERNATIONAL CONSENSUS GUIDELINES; SINGLE-INSTITUTION EXPERIENCE; INCIDENTAL PANCREATIC CYSTS; HEPATOCELLULAR-CARCINOMA; CLINICOPATHOLOGICAL CHARACTERISTICS; 1423 PANCREATICODUODENECTOMIES; SYMPTOMATIC PATIENTS; UPDATED EXPERIENCE; PROGNOSTIC SCORE; CANCER	Accurately identifying malignant components in patients with pancreatic intraductal papillary mucinous neoplasms (IPMN) remains challenging. Preoperative neutrophil-to-lymphocyte ratio (NLR) is a marker of poor prognosis in patients with several types of malignancy. This study assessed whether NLR was predictive of intraductal papillary mucinous carcinoma (IPMC) in patients with IPMN. This study retrospectively assessed 76 patients who underwent curative resection for IPMN from 1995 to 2015. The correlation between the presence of malignant components and preoperative NLR was analyzed. Preoperative NLR in IPMC was significantly higher in patients with in IPMC (2.51 +/- 0.84) than in patients with intraductal papillary mucinous adenoma (2.01 +/- 0.71, P = 0.0079) and healthy volunteers (1.37 +/- 0.33, P < 0.0001). NLR was significantly reduced after curative tumor resection. The main duct type (P = 0.0231) and NLR > 2.074 (P = 0.0329) were independent predictors of IPMC in all patients. Combined criteria including international consensus guidelines, CA19-9 > 37 IU/ml, and NLR > 2.074 shows a high positive predictive value of 78 % and high specificity of 96 %. Preoperative NLR is a useful supportive marker to predict IPMC in patients with IPMN.	[Arima, Kota; Okabe, Hirohisa; Hashimoto, Daisuke; Chikamoto, Akira; Kuroki, Hideyuki; Taki, Katsunobu; Kaida, Takayoshi; Higashi, Takaaki; Nitta, Hidetoshi; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Fac Life Sci,Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan	Arima, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; KAWATA A, 1992, JPN J CLIN ONCOL, V22, P256; YAMASHITA J, 1995, J LEUKOCYTE BIOL, V57, P375; Braga M, 2011, ANN SURG, V254, P702, DOI 10.1097/SLA.0b013e31823598fb; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Zhang XM, 2002, RADIOLOGY, V223, P547, DOI 10.1148/radiol.2232010815; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Jablonska E, 2005, CYTOKINE, V30, P93, DOI 10.1016/j.cyto.2004.12.004; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Wang WL, 2015, BIOMED REP, V3, P43, DOI 10.3892/br.2014.376; Sugiura T, 2013, ANN SURG ONCOL, V20, P4330, DOI 10.1245/s10434-013-3227-8; Bottger TC, 1999, WORLD J SURG, V23, P164; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Gomez D, 2008, J SURG ONCOL, V97, P513, DOI 10.1002/jso.21001; Raimondo M, 2002, AM J GASTROENTEROL, V97, P2553; Sohn TA, 2001, ANN SURG, V234, P313, DOI 10.1097/00000658-200109000-00005; Yamao K, 2000, HEPATO-GASTROENTEROL, V47, P1129; Izawa T, 2001, CANCER, V92, P1807, DOI 10.1002/1097-0142(20011001)92:7<1807::AID-CNCR1697>3.0.CO;2-0; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Kimura W, 1995, INT J PANCREATOL, V18, P197; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Tanaka M, 2004, PANCREAS, V28, P282, DOI 10.1097/00006676-200404000-00013; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Sohn TA, 2004, ANN SURG, V239, P788, DOI 10.1097/01.sla.0000128306.90650.aa; Maker AV, 2015, J AM COLL SURGEONS, V220, P243, DOI 10.1016/j.jamcollsurg.2014.11.001; Bottger TC, 1999, WORLD J SURG, V23, P171; Braga M, 2011, ANN SURG, V254, P707; Fernandez-del Castillo C, 2003, ARCH SURG-CHICAGO, V138, P427; Fritz S, 2014, ANN SURG, V260, P848, DOI 10.1097/SLA.0000000000000980; Fu SJ, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0011-7; Paramanathan A, 2014, SURG ONCOL, V23, P31, DOI 10.1016/j.suronc.2013.12.001; Warshaw AL, 2001, ANN SURG, V234, P321; Warshaw AL, 2004, ANN SURG, V239, P797; Szkandera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078225; Tanaka M, 2014, DIGESTION, V90, P265, DOI 10.1159/000370111; Callery M, 2003, ARCH SURG-CHICAGO, V138, P433; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111906	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	DEC	2015	19	12					2171	2177		10.1007/s11605-015-2973-2		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CW4AB	WOS:000364932400011		
J	Kaneko, M; Ohashi, H; Takamura, T; Kawame, H				Kaneko, Mikiko; Ohashi, Hirofumi; Takamura, Tomoko; Kawame, Hiroshi			Psychosocial Responses to being Identified as a Balanced Chromosomal Translocation Carrier: a Qualitative Investigation of Parents in Japan	JOURNAL OF GENETIC COUNSELING			English	Article						Balanced chromosomal translocation; Carrier testing; Psychosocial responses; Genetic counseling; Japan	CYSTIC-FIBROSIS; ADULT CARRIERS; FOLLOW-UP; FAMILIES; IMPACT; EXPERIENCES	Undergoing chromosome analysis and receiving the results may have various psychosocial effects. To identify the impact on balanced translocation carriers identified through affected offspring, we conducted semi-structured interviews with eleven parents at Saitama Children's Medical Center. The results of the interviews were analyzed qualitatively by the KJ (Kawakita Jiro) method. Categories and subcategories of the various thoughts, emotions and responses experienced by balanced chromosomal translocation carriers were extracted. Participants' reactions were mixed, and appeared to be interrelated in some cases. Parents' reactions were sometimes ambivalent with regard to effects on reproductive issues and disclosure of test results. We recommend genetic counseling before and after carrier testing to help parents cope with the mixed and complex thoughts and feelings that arise upon being identified as a carrier.	[Kaneko, Mikiko; Kawame, Hiroshi] Ochanomizu Univ, Dept Genet Counseling, Bunkyo Ku, Tokyo 1128610, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; [Takamura, Tomoko] Ochanomizu Univ, Dept Dev & Clin Psychol, Tokyo 1128610, Japan; [Kawame, Hiroshi] Tohoku Univ, Div Genom Med Support & Genet Counseling, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan	Kaneko, M (reprint author), Ochanomizu Univ, Dept Genet Counseling, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan.	mikiki515@gmail.com					Anido Aimee, 2005, J Genet Couns, V14, P295, DOI 10.1007/s10508-005-0001-4; Anido Aimee, 2007, J Genet Couns, V16, P97, DOI 10.1007/s10897-006-9049-0; SUSLAK L, 1985, AM J MED GENET, V20, P227, DOI 10.1002/ajmg.1320200204; McConkieRosell A, 1997, AM J MED GENET, V68, P62, DOI 10.1002/(SICI)1096-8628(19970110)68:1<62::AID-AJMG12>3.0.CO;2-M; WOLFF G, 1989, CLIN GENET, V35, P404; Bache I, 2007, GENET MED, V9, P185, DOI 10.1097/GIM.0b013e3180314671; Axworthy D, 1996, LANCET, V347, P1443; Marteau TM, 1997, HEALTH PSYCHOL, V16, P51; Williams JK, 1997, WESTERN J NURS RES, V19, P71, DOI 10.1177/019394599701900105; Henneman L, 2002, GENET TEST, V6, P195, DOI 10.1089/109065702761403351; Dunn NF, 2008, HAEMOPHILIA, V14, P584, DOI 10.1111/j.1365-2516.2007.01649.x; James CA, 2006, GENET MED, V8, P234, DOI 10.1097/01.gim.0000215177.28010.6e; Bakker H., 1994, J MED GENET, V31, P364; Fisher N. L., 1996, CULTURAL ETHNIC DIVE; Kaneko M., 2013, J PEDIAT SOC, V117, P1781; Kawakita J., 1986, KJ METHOD; Kawame Hiroshi, 2005, Nihon Rinsho, V63 Suppl 12, P99; Lakeman P, 2008, GENET MED, V10, P320, DOI 10.1097/GIM.0b013e318188d04c; Skirton Heather, 2004, Paediatr Nurs, V16, P18; Skirton H, 1995, Prof Nurse, V10, P496; Sutherland G. R., 2004, CHROMOSOME ABNORMALI, P3	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-7700	1573-3599		J GENET COUNS	J. Genet. Couns.	DEC	2015	24	6					922	930		10.1007/s10897-015-9828-6		9	Genetics & Heredity	Genetics & Heredity	CW7NL	WOS:000365185800006		
J	Ueno, M; Hayami, S; Shigekawa, Y; Kawai, M; Hirono, S; Okadal, K; Tamai, H; Shingaki, N; Mori, Y; Ichinose, M; Yamaue, H				Ueno, Masaki; Hayami, Shinya; Shigekawa, Yoshinobu; Kawai, Manabu; Hirono, Seiko; Okadal, Ken-ichi; Tamai, Hideyuki; Shingaki, Naoki; Mori, Yoshiyuki; Ichinose, Masao; Yamaue, Hiroki			Prognostic impact of surgery and radiofrequency ablation on single nodular HCC <= 5 cm: Cohort study based on serum HCC markers	JOURNAL OF HEPATOLOGY			English	Article						Hepatocellular carcinoma; Tumor marker; Surgery; Radiofrequency ablation	GAMMA-CARBOXY PROTHROMBIN; SMALL HEPATOCELLULAR-CARCINOMA; REACTIVE ALPHA-FETOPROTEIN; RANDOMIZED CONTROLLED-TRIAL; JAPANESE NATIONWIDE SURVEY; ENDOTHELIAL GROWTH-FACTOR; SURGICAL RESECTION; POOR-PROGNOSIS; NONSURGICAL TREATMENT; CIRRHOTIC-PATIENTS	Background & Aims: Serological markers of hepatocellular carcinoma (HCC) indicate its invasiveness. We aimed to investigate whether the prognostic impact of surgical resection (SR) and radiofrequency thermal ablation (RFA) on patients with single nodular HCC <= 5 cm were different regarding positive conditions of the following three HCC markers: alpha-fetoprotein (AFP); lens culinaris agglutinin-reactive fraction of AFP; and des-gamma-carboxy prothrombin. Methods: This study reviewed 296 patients with single nodular HCC <= 5 cm with Child-Pugh grade A between 2001 and 2011 (SR, n = 136; RFA, n = 160). Based on positive conditions of previous HCC markers (defined as non-positive, single-positive, double-positive, and triple-positive), overall survival (OS) and prognostic factors were analyzed. Results: Five-year OS rates of SR and RFA among all patients were 70.1% and 69.8%, respectively (p = 0.14). However, when stratified by the positive conditions of three HCC markers, their rates of non-, single-, double-, and triple-positive patients were 60.6%, 78.2%, 54.2%, and 75.9% in the SR group, whereas rates were 83.3%, 75.7%, 62.2%, and 47.6% in the RFA group (p values between SR and RFA of each tumor marker condition were 0.45, 0.10, 0.77, and <0.01, respectively). Multivariate analyses showed that RFA itself became an independent prognostic factor in the triple-positive group, with an odds ratio of 1.78 (95% confidence interval, 1.16-2.72). Conclusions: Positive conditions of three HCC markers differently influenced survival rates of those who underwent SR and RFA when treating single nodular HCC <= 5 cm. RFA itself became an independent prognostic risk when all three HCC markers were positive. Preoperative evaluation of multiple HCC markers might become an index for selecting treatment modalities. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Ueno, Masaki; Hayami, Shinya; Shigekawa, Yoshinobu; Kawai, Manabu; Hirono, Seiko; Okadal, Ken-ichi; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama 6418510, Japan; [Tamai, Hideyuki; Shingaki, Naoki; Mori, Yoshiyuki; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama 6418510, Japan	Yamaue, H (reprint author), Wakayama Med Univ, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yamaue-h@wakayama-med.ac.jp					Ueno M, 2009, DIGEST SURG, V26, P392, DOI 10.1159/000229973; Shirai K, 2011, HEPATOL RES, V41, P738, DOI 10.1111/j.1872-034X.2011.00841.x; Kudo M, 2004, J GASTROENTEROL, V39, P205, DOI 10.1007/s00535-003-1280-y; Fox R, 2014, BRIT J CANCER, V110, P2090, DOI 10.1038/bjc.2014.130; Ni JY, 2013, J CANCER RES CLIN, V139, P2021, DOI 10.1007/s00432-013-1530-1; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Cho YK, 2011, J GASTROEN HEPATOL, V26, P1354, DOI 10.1111/j.1440-1746.2011.06812.x; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Abu-Hilal M, 2008, J GASTROINTEST SURG, V12, P1521, DOI 10.1007/s11605-008-0553-4; Feng K, 2012, J HEPATOL, V57, P794, DOI [10.1016/j.jhep.2012.05.007, 10.1016/j.jhep.2012.07.022]; Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Poon RTP, 2007, ANN SURG ONCOL, V14, P1835, DOI 10.1245/s10434-007-9366-z; Agrawal S, 2011, ANN SURG, V253, P656, DOI 10.1097/SLA.0b013e3181fc08ca; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Miyaaki H, 2007, J GASTROENTEROL, V42, P962, DOI 10.1007/s00535-007-2117-x; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Kiriyama S, 2011, ANN SURG, V254, P984, DOI 10.1097/SLA.0b013e3182215016; Tranchart H, 2012, WORLD J SURG, V36, P2684, DOI 10.1007/s00268-012-1723-9; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Cheng BQ, 2008, JAMA-J AM MED ASSOC, V299, P1669, DOI 10.1001/jama.299.14.1669; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Shimauchi Y, 2000, ONCOL REP, V7, P249; Kobayashi M, 2009, CANCER, V115, P571, DOI 10.1002/cncr.24031; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Ng KK, 2008, J GASTROINTEST SURG, V12, P183, DOI 10.1007/s11605-007-0276-y; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Uchiyama K, 2008, J HEPATO-BILIARY-PAN, V15, P596, DOI 10.1007/s00534-007-1326-2; Kumada T, 2014, J GASTROENTEROL, V49, P555, DOI 10.1007/s00535-013-0883-1; Saito S, 2005, HEPATOLOGY, V41, P1297, DOI 10.1002/hep.20684; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Nomura F, 1999, AM J GASTROENTEROL, V94, P650, DOI 10.1111/j.1572-0241.1999.00930.x; Ahn KS, 2013, ANN SURG, V258, P1014, DOI 10.1097/SLA.0b013e318281eda3; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Shiina S, 2002, ONCOLOGY-BASEL, V62, P64, DOI 10.1159/000048278; Mita Y, 1998, CANCER, V82, P1643, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B; Mori Y, 2009, HEPATOL INT, V3, P509, DOI 10.1007/s12072-009-9131-4; Diaz-Sanchez A, 2013, SCAND J GASTROENTERO, V48, P334, DOI 10.3109/00365521.2012.746391; Manghisi G, 1998, HEPATOLOGY, V28, P751; Kono M, 2014, DIGEST DIS, V32, P670, DOI 10.1159/000367999; Mori Y, 2015, HEPATOL RES, V45, P75, DOI 10.1111/hepr.12311; Rossi S, 1996, AM J ROENTGENOL, V167, P759	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	DEC	2015	63	6					1352	1359				8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX0DE	WOS:000365366300010		
J	Koda, M; Tokunaga, S; Okamoto, T; Hodozuka, M; Miyoshi, K; Kishina, M; Fujise, Y; Kato, J; Matono, T; Sugihara, T; Oyama, K; Hosho, K; Okano, J; Murawaki, Y; Kakite, S; Yamashita, E				Koda, Masahiko; Tokunaga, Shiho; Okamoto, Toshiaki; Hodozuka, Masanori; Miyoshi, Kennichi; Kishina, Manabu; Fujise, Yuki; Kato, Jun; Matono, Tomomitsu; Sugihara, Takaaki; Oyama, Kenji; Hosho, Keiko; Okano, Jun-ichi; Murawaki, Yoshikazu; Kakite, Suguru; Yamashita, Eijiro			Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma	JOURNAL OF HEPATOLOGY			English	Article						Ablative margin; Hepatocellular carcinoma; Radiofrequency ablation; Prognosis; Local tumor progression; Gd-EOB-DTPA; Gadoxetic acid	LOCAL TUMOR PROGRESSION; RISK-FACTORS; CT; SURVIVAL; THERAPY; FERUCARBOTRAN; FEASIBILITY; RECURRENCE; OUTCOMES; NODULES	Background & Aims: The aim of this study was to investigate the feasibility of ablative margin (AM) grading by magnetic resonance imaging (MRI) with Gd-EOB-DTPA administered prior to radiofrequency ablation (RFA), and to identify factors for achieving a sufficient AM and predictors for local tumor progression. Methods: A total of 124 hepatocellular carcinomas (HCCs) were treated by RFA after Gd-EOB-DTPA administration. MRI and enhanced CT were performed within seven hours and one month after RFA. The AM assessment was categorized using three grades: AM (+), low-intensity area with continuous high-intensity rim; AM zero, low-intensity area with discontinuous high-intensity rim; and AM (-), low-intensity area extends beyond the high-intensity rim. Patients were followed and local tumor progression was observed. Results: AM (+), AM zero, AM (-), and indeterminate were found in 34, 33, 26, and 31 nodules, respectively. The overall agreement rate between MRI and enhanced CT for the diagnosis of AM was 56.8%. The kappa coefficient was 0.326 (p <0.001), indicating moderate agreement. Multivariate logistic regression analysis showed that a significant factor for the achievement of AM (+) on MRI was no contiguous vessels. The cumulative local tumor progression rates (0% at 1, 2, and 3 years) in 33 AM (+) nodules were significantly lower than those (3.6%, 11.5%, and 18.3% at 1, 2, and 3 years respectively) in 32 AM zero nodules. A multivariate Cox proportional hazards model identified tumor size as an independent predictor for local tumor progression. Conclusion: Gd-EOB-DTPA-MRI enabled an early assessment of RFA effectiveness in the majority of HCC nodules. Local tumor progression was not detected in AM (+) nodules during the follow-up. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Koda, Masahiko; Tokunaga, Shiho; Okamoto, Toshiaki; Hodozuka, Masanori; Miyoshi, Kennichi; Kishina, Manabu; Fujise, Yuki; Kato, Jun; Matono, Tomomitsu; Murawaki, Yoshikazu] Tottori Univ, Dept Internal Med 2, Yonago, Tottori 6838504, Japan; [Sugihara, Takaaki; Oyama, Kenji; Hosho, Keiko; Okano, Jun-ichi; Kakite, Suguru; Yamashita, Eijiro] Tottori Univ, Sch Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 6838504, Japan	Koda, M (reprint author), Tottori Univ, Dept Internal Med 2, Yonago, Tottori 6838504, Japan.	masakoda@grape.med.tottori-u.ac.jp					Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Lu TL, 2012, EUR J RADIOL, V81, pE944, DOI 10.1016/j.ejrad.2012.06.011; Park MH, 2008, RADIOGRAPHICS, V28, P379, DOI 10.1148/rg.282075038; Imai Y, 2000, HEPATOLOGY, V32, P205, DOI 10.1053/jhep.2000.9113; Koda M, 2012, EUR J RADIOL, V81, P1400, DOI 10.1016/j.ejrad.2011.03.004; Okusaka T, 2002, CANCER, V95, P1931, DOI 10.1002/cncr.10892; Makino Y, 2013, HEPATOL RES, V43, P950, DOI 10.1111/hepr.12049; Zytoon AA, 2007, JPN J CLIN ONCOL, V37, P658, DOI 10.1093/jjco/hym086; Kakite S, 2011, EUR J RADIOL, V78, P282, DOI 10.1016/j.ejrad.2011.01.048; Tokunaga S, 2012, BRIT J RADIOL, V85, P745, DOI 10.1259/bjr/64518148; Nishikawa H, 2013, J GASTROENTEROL, V48, P951, DOI 10.1007/s00535-012-0690-0; Koda M, 2013, J GASTROENTEROL, V48, P1283, DOI 10.1007/s00535-012-0747-0; Mori K, 2009, RADIOLOGY, V251, P557, DOI 10.1148/radiol.2512081161; Schwarz RE, 2008, AM J SURG, V195, P829, DOI 10.1016/j.amjsurg.2007.10.010; Nishikawa H, 2011, J GASTROENTEROL, V46, P1418, DOI 10.1007/s00535-011-0452-4; Park Y, 2010, EUR J RADIOL, V75, P391, DOI 10.1016/j.ejrad.2009.04.054; Mulier S, 2005, ANN SURG, V242, P158, DOI 10.1097/01.sla.0000171032.99149.fe; Sasaki A, 2005, CANCER, V103, P299, DOI 10.1002/cncr.20797; Nakazawa T, 2007, AM J ROENTGENOL, V188, P480, DOI 10.2214/AJR.05.2079; Kikuchi L, 2014, WORLD J GASTROENTERO, V20, P1585, DOI 10.3748/wjg.v20.i6.1585; Okubo H, 2010, HEPATOL RES, V40, P1034, DOI 10.1111/j.1872-034X.2010.00709.x; Koda M, 2012, HEPATOL RES, V42, P1058, DOI 10.1111/j.1872-034X.2012.01025.x; Kim YS, 2010, AM J ROENTGENOL, V195, P758, DOI 10.2214/AJR.09.2954; Peng ZW, 2008, SURG ONCOL, V17, P23, DOI 10.1016/j.suronc.2007.08.002; Liu CH, 2010, EUR RADIOL, V20, P877, DOI 10.1007/s00330-009-1610-4; Koda M, 2012, EUR J RADIOL, V81, P2730, DOI 10.1016/j.ejrad.2011.11.013; Ikeda K, 2007, INT J ONCOL, V31, P485; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST, P17; Mori Y, 2015, HEPATOL RES, V45, P75, DOI 10.1111/hepr.12311; Motoyama T, 2014, ABDOM IMAGING, V39, P262, DOI 10.1007/s00261-013-0054-0; Saito Kazuhiro, 2005, Magn Reson Med Sci, V4, P1, DOI 10.2463/mrms.4.1; The Japan Society of Hepatology, 2013, CLIN PRACT GUID HEP; Vossen Josephina A, 2006, Tech Vasc Interv Radiol, V9, P125, DOI 10.1053/j.tvir.2007.02.004	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	DEC	2015	63	6					1360	1367				8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CX0DE	WOS:000365366300011		
J	Koga, D; Kusumi, S; Bochimoto, H; Watanabe, T; Ushiki, T				Koga, Daisuke; Kusumi, Satoshi; Bochimoto, Hiroki; Watanabe, Tsuyoshi; Ushiki, Tatsuo			Correlative Light and Scanning Electron Microscopy for Observing the Three-Dimensional Ultrastructure of Membranous Cell Organelles in Relation to Their Molecular Components	JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY			English	Article						correlative light and electron microscopy; gonadotrope; immunofluorescence microscopy; osmium maceration method; pituitary gland; scanning electron microscopy; Tokuyasu method	RAT ADRENAL-CORTEX; INTRACELLULAR STRUCTURES; ULTRATHIN CRYOSECTIONS; MITOCHONDRIAL CRISTAE; GOLGI-APPARATUS; RESOLUTION; CRYOULTRAMICROTOMY; TOMOGRAPHY; CASTRATION; HYPOPHYSIS	Although the osmium maceration method has been used to observe three-dimensional (3D) structures of membranous cell organelles with scanning electron microscopy (SEM), the use of osmium tetroxide for membrane fixation and the removal of cytosolic soluble proteins largely impairs the antigenicity of molecules in the specimens. In the present study, we developed a novel method to combine cryosectioning with the maceration method for correlative immunocytochemical analysis. We first immunocytochemically stained a semi-thin cryosection cut from a pituitary tissue block with a cryo-ultramicrotome, according to the Tokuyasu method, before preparing an osmium-macerated specimen from the remaining tissue block. Correlative microscopy was performed by observing the same area between the immunostained section and the adjacent face of the tissue block. Using this correlative method, we could accurately identify the gonadotropes of pituitary glands in various experimental conditions with SEM. At 4 weeks after castration, dilated cisternae of rough endoplasmic reticulum (RER) were distributed throughout the cytoplasm. On the other hand, an extremely dilated cisterna of the RER occupied the large region of the cytoplasm at 12 weeks after castration. This novel method has the potential to analyze the relationship between the distribution of functional molecules and the 3D ultrastructure in different composite tissues.	[Koga, Daisuke; Ushiki, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Div Microscop Anat & Bioimaging, Niigata, Japan; [Bochimoto, Hiroki; Watanabe, Tsuyoshi] Asahikawa Med Univ, Dept Microscop Anat & Cell Biol, Asahikawa, Hokkaido 0788510, Japan; [Kusumi, Satoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Div Morphol Sci, Kagoshima 890, Japan	Koga, D (reprint author), Asahikawa Med Univ, Dept Microscop Anat & Cell Biol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	daisukek@asahikawa-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [26860128]; Tsukada Grant for Niigata University Medical Research	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (#26860128) and Tsukada Grant for Niigata University Medical Research.	Addison WHF, 1917, J COMP NEUROL, V28, P441, DOI 10.1002/cne.900280207; Koga D, 2006, ARCH HISTOL CYTOL, V69, P357, DOI 10.1679/aohc.69.357; FARQUHAR MG, 1954, ENDOCRINOLOGY, V54, P516; Koga D, 2012, J ELECTRON MICROSC, V61, P105, DOI 10.1093/jmicro/dfr098; Ellison ET, 1934, ENDOCRINOLOGY, V18, P555; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P707; GEUZE HJ, 1981, J CELL BIOL, V89, P653, DOI 10.1083/jcb.89.3.653; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; TANAKA K, 1984, J MICROSC-OXFORD, V133, P213; TANAKA K, 1991, J ELECTRON MICR TECH, V17, P15, DOI 10.1002/jemt.1060170104; HANAKI M, 1985, J ELECTRON MICROSC, V34, P373; Watanabe T, 2012, J HISTOCHEM CYTOCHEM, V60, P588, DOI 10.1369/0022155412448791; HAINFELD JF, 1987, SCIENCE, V236, P450, DOI 10.1126/science.3563522; van Donselaar E, 2007, TRAFFIC, V8, P471, DOI 10.1111/j.1600-0854.2007.00552.x; LEA PJ, 1989, AM J ANAT, V184, P245, DOI 10.1002/aja.1001840308; Isola R, 2010, MITOCHONDRION, V10, P472, DOI 10.1016/j.mito.2010.05.007; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Koike M, 2013, EUR J NEUROSCI, V37, P816, DOI 10.1111/ejn.12096; Smith C, 2012, NATURE, V492, P293, DOI 10.1038/492293a; TANAKA K, 1986, J SUBMICR CYTOL PATH, V18, P1; TANAKA K, 1981, BIOMED RES-TOKYO, V2, P63; Takizawa T, 2000, J HISTOCHEM CYTOCHEM, V48, P481; Zhang PJ, 2013, CURR OPIN STRUC BIOL, V23, P763, DOI 10.1016/j.sbi.2013.07.017; Benedetti L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07033; Bos E, 2014, J STRUCT BIOL, V186, P273, DOI 10.1016/j.jsb.2014.03.021; Costoff A, 1973, ULTRASTRUCTURE RAT A, P26; Shu X, 2011, PLOS BIOL, V4; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0022-1554	1551-5044		J HISTOCHEM CYTOCHEM	J. Histochem. Cytochem.	DEC	2015	63	12					968	979		10.1369/0022155415609099		12	Cell Biology	Cell Biology	CX2VA	WOS:000365553700007		
J	Yorozuya, A; Ettema, R				Yorozuya, Atsuhiro; Ettema, Robert			Three Abutment Scour Conditions at Bridge Waterways	JOURNAL OF HYDRAULIC ENGINEERING			English	Article						Bridges; Abutments; Scour; Hydraulic structures; Sediment transport; Foundations	FLOW	This paper presents findings from an extensive, laboratory-based study of scour at bridge abutments located in compound channels. The study considered aspects of abutment construction, including abutment and floodplain erodibility, and examined how these aspects influence scour development. Its findings show that three basic scour conditions can develop at abutments in compound channels: scour of the main-channel bed, when the floodplain is far less erodible than the bed of the main channel (Scour Condition A); scour of the floodplain around an abutment, for abutments set back on a floodplain (Scour Condition B); and scour at an abutment column exposed once an abutment is breached (Scour Condition C). These conditions may combine, depending on abutment location and site circumstances. The authors present laboratory observations and data associated with Scour Conditions A and B. The data are analyzed in terms of a formulation concept that treats Scour Conditions A and B as essentially scour at a short contraction (the bridge opening), for which flow nonuniformity and turbulence amplify scour depth associated with a long contraction. The amplification is greatest for small contractions and diminishes for larger contractions that force greater magnitude and uniformity of flow velocity through a bridge opening. (C) 2015 American Society of Civil Engineers.	[Yorozuya, Atsuhiro] Publ Works Res Inst, Int Ctr Water Hazard & Risk Management, Ibaraki 3058516, Japan; [Ettema, Robert] Univ Wyoming, Coll Engn & Appl Sci, Dept Civil & Architectural Engn, Laramie, WY 82071 USA	Ettema, R (reprint author), Univ Wyoming, Coll Engn & Appl Sci, Dept Civil & Architectural Engn, Laramie, WY 82071 USA.	yorozuya@pwri.go.jp; rettema@uwyo.edu			U.S. Transportation Research Board's National Cooperative Highway Research Program [NCHRP 24-20]	The study presented here was conducted as part of Project NCHRP 24-20 of the U.S. Transportation Research Board's National Cooperative Highway Research Program. The authors thank members of the project's advisory panel and NCHRP's David Reynaud for guidance in conducting the project.	Morales R, 2013, J HYDRAUL ENG, V139, P470, DOI 10.1061/(ASCE)HY.1943-7900.0000693; Fujita I, 1998, J HYDRAUL RES, V36, P397; Morales R, 2008, J HYDRAUL ENG-ASCE, V134, P800, DOI 10.1061/(ASCE)0733-9429(2008)134:6(800); Melville B, 2006, J HYDRAUL ENG-ASCE, V132, P235, DOI 10.1061/(ASCE)0733-9429(2006)132:3(235); Oben-Nyarko K, 2011, J HYDRAUL ENG-ASCE, V137, P1598, DOI 10.1061/(ASCE)HY.1943-7900.0000446; Arneson L. A., 2012, FHWAHIF12003 US DEP; ASCE, 1975, MAN ENG PRACT 54; Chang F, 1999, STREAM STABILITY SCO, P401; Chang F., 1998, P WAT RES ENG 98, P169; Ettema R., 2010, 2420 NCHRP TRANSP RE; FHWA (Federal Highway Administration), 2009, HEC23 FHWA US DOT; Idil P., 2004, THESIS; Iowa DOT, 2000, BRIDG DES MAN; Lagasse P. F., 2001, 01003 FHWA NHI; Laursen E. M., 1963, J HYDRAUL DIV AM SOC, V89, P93; Laursen E. M., 1960, J HYDR DIV ASCE, V86, P39; Melville BW, 2000, BRIDGE SCOUR; MSHA (Maryland State Highway Administration), 2010, MAN HYDR HYDR DES; Sturm T. W., 2011, 242702 NCHRP TRANSP; Yorozuya A., 2005, THESIS	20	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9429	1943-7900		J HYDRAUL ENG	J. Hydraul. Eng.-ASCE	DEC	2015	141	12							04015028	10.1061/(ASCE)HY.1943-7900.0001053		12	Engineering, Civil; Engineering, Mechanical; Water Resources	Engineering; Water Resources	CW6SY	WOS:000365129300005		
J	Berki, DM; Liu, L; Choon, SE; Burden, AD; Griffiths, CEM; Navarini, AA; Tan, ES; Irvine, AD; Ranki, A; Ogo, T; Petrof, G; Mahil, SK; Duckworth, M; Allen, MH; Vito, P; Trembath, RC; McGrath, J; Smith, CH; Capon, F; Barker, JN				Berki, Dorottya M.; Liu, Lu; Choon, Siew-Eng; Burden, A. David; Griffiths, Christopher E. M.; Navarini, Alexander A.; Tan, Eugene S.; Irvine, Alan D.; Ranki, Annamari; Ogo, Takeshi; Petrof, Gabriela; Mahil, Satveer K.; Duckworth, Michael; Allen, Michael H.; Vito, Pasquale; Trembath, Richard C.; McGrath, John; Smith, Catherine H.; Capon, Francesca; Barker, Jonathan N.			Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							PITYRIASIS-RUBRA-PILARIS; SUSCEPTIBILITY LOCI; SPLICING SIGNALS; VARIANTS	Caspase recruitment family member 14 (CARD14, also known as CARMA2), is a scaffold protein that mediates NF-kappa B signal transduction in skin keratinocytes. Gain-of-function CARD14 mutations have been documented in familial forms of psoriasis vulgaris (PV) and pityriasis rubra pilaris (PRP). More recent investigations have also implicated CARD14 in the pathogenesis of pustular psoriasis. Follow-up studies, however, have been limited, so that it is not clear to what extent CARD14 alleles account for the above conditions. Here, we sought to address this question by carrying out a systematic CARD14 analysis in an extended patient cohort (n = 416). We observed no disease alleles in subjects with familial PV (n= 159), erythrodermic psoriasis (n = 23), acral pustular psoriasis (n = 100), or sporadic PRP (n = 29). Conversely, our analysis of 105 individuals with generalized pustular psoriasis (GPP) identified a low-frequency variant (p.Asp176His) that causes constitutive CARD14 oligomerization and shows a significant association with GPP in Asian populations (P = 8.4 x 10(-5); odds ratio = 6.4). These data indicate that the analysis of CARD14 mutations could help stratify pustular psoriasis cohorts but would be mostly uninformative in the context of psoriasis and sporadic PRP.	[Berki, Dorottya M.; Mahil, Satveer K.; Capon, Francesca] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Liu, Lu; Petrof, Gabriela; Duckworth, Michael; Allen, Michael H.; McGrath, John; Smith, Catherine H.; Barker, Jonathan N.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Choon, Siew-Eng] Hosp Sultanah Aminah, Dept Dermatol, Johor Baharu, Malaysia; [Burden, A. David] Univ Glasgow, Dept Dermatol, Glasgow G12 8QQ, Lanark, Scotland; [Griffiths, Christopher E. M.] Univ Manchester, Dept Dermatol, Manchester, Lancs, England; [Navarini, Alexander A.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Tan, Eugene S.] Natl Skin Ctr, Singapore, Singapore; [Irvine, Alan D.] Our Ladys Childrens Hosp, Paediat Dermatol, Dublin, Ireland; [Irvine, Alan D.] Univ Dublin Trinity Coll, Med Clin, Dublin 2, Ireland; [Ranki, Annamari] Univ Helsinki, Dept Dermatol Venereol & Allerg Dis, Helsinki, Finland; [Ranki, Annamari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Ogo, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiol, Osaka, Japan; [Vito, Pasquale] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy; [Trembath, Richard C.] Univ London, Barts & London Sch Med & Dent, London, England	Capon, F (reprint author), Guys Hosp, Div Genet, 9th Floor Tower Wing, London SE1 9RT, England.	francesca.capon@kcl.ac.uk; jonathan.barker@kcl.ac.uk	McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	Department of Health via the NIHR comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; NIHR, through the Dermatology Clinical Research Network; Medical Research Council [MR/L011808/1, MR/L001543/1]; Psoriasis Association	We thank Liisa Vakeva, Hazel H Oon, WS Chong, and Colin T Theng for their contribution to patient ascertainment. We acknowledge support from the Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We also acknowledge the support of the NIHR, through the Dermatology Clinical Research Network, with case ascertainment. This work was supported by a Medical Research Council Stratified Medicine award (grant MR/L011808/1). DMB's PhD studentship is funded by the Psoriasis Association. SKM is supported by a Medical Research Council Clinical Training Fellowship (MR/L001543/1).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Adzhubei I, 2013, CURR PROTOC HUM GENE, V7, P20, DOI DOI 10.1002/0471142905.HG0720S76; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz S, 2009, NUCLEIC ACIDS RES, V37, pW189, DOI 10.1093/nar/gkp320; Ammar M, 2013, BRIT J DERMATOL, V168, P583, DOI 10.1111/bjd.12050; Eytan O, 2014, BRIT J DERMATOL, V170, P1196, DOI 10.1111/bjd.12799; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Qin PP, 2014, J INVEST DERMATOL, V134, P2994, DOI 10.1038/jid.2014.269; Setta-Kaffetzi N, 2013, J INVEST DERMATOL, V133, P1366, DOI 10.1038/jid.2012.490; Hussain S, 2015, J ALLERGY CLIN IMMUN, V135, P1067, DOI 10.1016/j.jaci.2014.09.043; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Berki DM, 2014, J INVEST DERMATOL, V134, P271, DOI 10.1038/jid.2013.285; Sugiura K, 2014, J INVEST DERMATOL, V134, P1755, DOI 10.1038/jid.2014.46; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Fuchs-Telem D, 2012, AM J HUM GENET, V91, P163, DOI 10.1016/j.ajhg.2012.05.010; Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cochrane Collaboration, 2012, REV MAN REVMAN; Harden JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111255; Judge MR, 2004, ROOKS TXB DERMATOLOG, V2; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mossner R, 2015, J INVEST DERMATOL	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	DEC	2015	135	12					2964	2970		10.1038/jid.2015.288		7	Dermatology	Dermatology	CW7LT	WOS:000365181100014		
J	Ando, N; Nakamura, Y; Aoki, R; Ishimaru, K; Ogawa, H; Okumura, K; Shibata, S; Shimada, S; Nakao, A				Ando, Noriko; Nakamura, Yuki; Aoki, Rui; Ishimaru, Kayoko; Ogawa, Hideoki; Okumura, Ko; Shibata, Shigenobu; Shimada, Shinji; Nakao, Atsuhito			Circadian Gene Clock Regulates Psoriasis-Like Skin Inflammation in Mice	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							DELTA T-CELLS; INNATE LYMPHOID-CELLS; LANGERHANS CELLS; PLAQUE-FORMATION; IL-23; PATHOGENESIS; BIOLOGY; LIGAND	There are several reports suggesting that the pathophysiology of psoriasis may be associated with aberrant circadian rhythms. However, the mechanistic link between psoriasis and the circadian time-keeping system, "the circadian clock," remains unclear. This study determined whether the core circadian gene, Clock, had a regulatory role in the development of psoriasis. For this purpose, we compared the development of psoriasis-like skin inflammation induced by the Toll-like receptor 7 ligand imiquimod (IMQ) between wild-type mice and mice with a loss-of-function mutation of Clock. We also compared the development of IMQ-induced dermatitis between wild-type mice and mice with a loss-of-function mutation of Period2 (Per2), another key circadian gene that inhibits CLOCK activity. We found that Clock mutation ameliorated IMQ-induced dermatitis, whereas the Per2 mutation exaggerated IMQ-induced dermatitis, when compared with wild-type mice associated with decreased or increased IL-23 receptor (IL-23R) expression in gamma/delta(+) T cells, respectively. In addition, CLOCK directly bound to the promoter of IL-23R in gamma/delta(+) T cells, and IL-23R expression in the mouse skin was under circadian control. These findings suggest that Clock is a novel regulator of psoriasis-like skin inflammation in mice via direct modulation of IL-23R expression in gamma/delta(+) T cells, establishing a mechanistic link between psoriasis and the circadian clock.	[Ando, Noriko; Aoki, Rui; Shimada, Shinji] Univ Yamanashi, Dept Dermatol, Fac Med, Yamanashi, Chuo 4093898, Japan; [Nakamura, Yuki; Ishimaru, Kayoko; Nakao, Atsuhito] Univ Yamanashi, Dept Immunol, Fac Med, Yamanashi, Chuo 4093898, Japan; [Ogawa, Hideoki; Okumura, Ko; Nakao, Atsuhito] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo, Japan	Nakao, A (reprint author), Univ Yamanashi, Dept Immunol, Fac Med, 1110 Shimokato, Yamanashi, Chuo 4093898, Japan.	anakao@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	We thank Tomoko Tohno and Mutsuko Hara for general assistance. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Bacaksiz A, 2012, WIEN KLIN WOCHENSCHR, V124, P822, DOI 10.1007/s00508-012-0294-y; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Zheng BH, 1999, NATURE, V400, P169; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Li WQ, 2013, J INVEST DERMATOL, V133, P565, DOI 10.1038/jid.2012.285; Nakamura Y, 2014, J ALLERGY CLIN IMMUN, V133, P568, DOI 10.1016/j.jaci.2013.07.040; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Zeeuwen PLJM, 2013, CURR OPIN ALLERGY CL, V13, P514, DOI 10.1097/ACI.0b013e328364ebeb; Chiricozzi A, 2014, EXPERT OPIN THER TAR, V18, P513, DOI 10.1517/14728222.2014.889686; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Heib V, 2007, BLOOD, V110, P946, DOI 10.1182/blood-2006-07-036889; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Tanioka M, 2009, J INVEST DERMATOL, V129, P1225, DOI 10.1038/jid.2008.345; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; GELFANT S, 1982, J INVEST DERMATOL, V78, P58, DOI 10.1111/1523-1747.ep12497933; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Ward NL, 2014, J INVEST DERMATOL, V134, P2305, DOI 10.1038/jid.2014.216; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; MOZZANICA N, 1988, ACTA DERM-VENEREOL, V68, P312	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	DEC	2015	135	12					3001	3008		10.1038/jid.2015.316		8	Dermatology	Dermatology	CW7LT	WOS:000365181100018		
J	Tatsuno, K; Fujiyama, T; Yamaguchi, H; Waki, M; Tokura, Y				Tatsuno, Kazuki; Fujiyama, Toshiharu; Yamaguchi, Hayato; Waki, Michihiko; Tokura, Yoshiki			TSLP Directly Interacts with Skin-Homing Th2 Cells Highly Expressing its Receptor to Enhance IL-4 Production in Atopic Dermatitis	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CD4(+) T-CELLS; CUTTING EDGE; INFLAMMATION; MECHANISMS; RESPONSES; DISEASE	Thymic stromal lymphopoietin (TSLP) is overtly expressed on skin lesions of atopic dermatitis (AD), and the initiative role of TSLP-activated DCs in AD has gained much attention in the past few years, while its actions on other immune cells such as T cells have been given less notice. We aimed to clarify whether TSLP receptor (TSLPR) is expressed on certain populations of T cells and whether TSLP possesses the capability to directly interact with T cells from AD patients. Peripheral lymphocytes from 51 AD patients are analyzed by flow cytometry, and ex vivo experiments using peripheral blood and lesional skin-derived T cells were conducted. TSLPR expression was defined to CD4(+) T cells, and CD4(+)CCR4(+)CXCR3(-)CCR7(-)CCR10(+)CLA(+)T cells in AD patients exhibited enhanced TSLPR expression. The frequency of TSLPR(+)CD4(+)T cells correlated with disease activity. CD4(+)T cells from AD patients directly interacted with TSLP to produce a higher amount of IL-4 than those from normal subjects, and this action was attenuated with anti-TSLPR antibody. The importance of IL-4 in the induction of TSLPR expression was found in AD T cells. Our findings indicate that T cells from AD patients possess strong potential to directly interact with TSLP to promote Th2 response.	[Tatsuno, Kazuki; Fujiyama, Toshiharu; Yamaguchi, Hayato; Waki, Michihiko; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Tatsuno, K (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ktat@hama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan; Ministry of Health, Labour and Welfare in Japan; Janssen Pharmaceutical Companies of Johnson Johnson	We thank Ms. Manami Iwasaki for her excellent technical support in sample preparations. This work was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan, the Ministry of Health, Labour and Welfare in Japan, and Janssen Pharmaceutical Companies of Johnson & Johnson.	Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Hashizume H, 2010, ACTA DERM-VENEREOL, V90, P468, DOI 10.2340/00015555-0927; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rochman I, 2007, J IMMUNOL, V178, P6720; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Yamaguchi H, 2013, J DERMATOL SCI, V72, P240, DOI 10.1016/j.jdermsci.2013.07.009; Larson RP, 2013, J IMMUNOL, V190, P4474, DOI 10.4049/jimmunol.1201677; Corrigan CJ, 2009, ALLERGY, V64, P1014, DOI 10.1111/j.1398-9995.2009.01947.x; Omori M, 2007, J IMMUNOL, V178, P1396; Akamatsu T, 2008, CLIN EXP IMMUNOL, V154, P98, DOI 10.1111/j.1365-2249.2008.03731.x; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Shimada Y, 2004, J DERMATOL SCI, V34, P201, DOI 10.1016/j.jdermsci.2004.01.001; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	DEC	2015	135	12					3017	3024		10.1038/jid.2015.318		8	Dermatology	Dermatology	CW7LT	WOS:000365181100020		
J	Guillermain, E; Aikawa, K; Kuhnhenn, J; Ricci, D; Weinand, U				Guillermain, Elisa; Aikawa, Kazuhiko; Kuhnhenn, Jochen; Ricci, Daniel; Weinand, Udo			Large-Scale Procurement of Radiation Resistant Single-Mode Optical Fibers for CERN	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						Optical fibre; procurement process; quality assurance; quality control; radiation effects; radiation induced attenuation (RIA)	WAVE-GUIDES; ABSORPTION; FLUORINE; DEFECTS; SILICA	2400 km of special radiation resistant optical fibres were procured by CERN (European Organization for Nuclear Research), for the installation of more than 55 km of optical fibre cables in the accelerator complex underground during the Long Shutdown 1 (LS1). In the frame of this large-scale industrial production, a thorough quality assurance plan (QAP) was put in place and followed at each step of the process. In-depth qualification of optical fibres preceded the 17-month procurement process. All supplied batches were tested for their resistance to radiation, leading to more than 65 quality control irradiation tests. During the cable assembly process and the installations works, a full traceability down to the optical fibre level was ensured. The actions put in place in the frame of the QAP led to successful installation works and to full respect of the LS1 planning.	[Guillermain, Elisa; Ricci, Daniel] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Aikawa, Kazuhiko] Fujikura Ltd, Sakura 2858550, Japan; [Kuhnhenn, Jochen; Weinand, Udo] Fraunhofer Inst Nat Wissensch Tech Trendanalysen, D-53879 Euskirchen, Germany	Guillermain, E (reprint author), CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland.	elisa.guillermain@cern.ch; kazuhiko.aikawa@jp.fujikura.com; jochen.kuhnhenn@int.fraunhofer.de; daniel.ricci@cern.ch; udo.weinand@int.fraunhofer.de					Aikawa K., 2008, U.S. Patent, Patent No. [7 440 673 B2, 7440673]; Aikawa K., 2008, FUJIKURA TECH REV, V37, P9; Guillermain E, 2014, IEEE T NUCL SCI, V61, P1834, DOI 10.1109/TNS.2014.2306992; Wijnands T, 2008, IEEE T NUCL SCI, V55, P2216, DOI 10.1109/TNS.2008.2001859; Kuhnhenn J, 2009, IEEE T NUCL SCI, V56, P2160, DOI 10.1109/TNS.2009.2019605; GRIFFIOEN W, 1989, J LIGHTWAVE TECHNOL, V7, P297, DOI 10.1109/50.17770; Youngman RE, 2004, J NON-CRYST SOLIDS, V349, P10, DOI 10.1016/j.jnoncrysol.2004.08.255; MATTERN PL, 1975, IEEE T NUCL SCI, V22, P2468, DOI 10.1109/TNS.1975.4328152; FRIEBELE EJ, 1981, APPL OPTICS, V20, P3448, DOI 10.1364/AO.20.003448; Wijnands T, 2011, J LIGHTWAVE TECHNOL, V29, P3393, DOI 10.1109/JLT.2011.2168512; Friebele E. J., 1985, P SOC PHOTO-OPT INS, V541, P319; FRIEBELE EJ, 1984, NUCL INSTRUM METH B, V1, P355, DOI 10.1016/0168-583X(84)90092-2; Griscom D. L., 1991, J CERAM SOC JPN, V89, P899; GRISCOM DL, 1985, P SOC PHOTO-OPT INST, V541, P38; Henschel H., 2002, T NUCL SCI, V49, P179; International Electrotechnical Commission, 2008, 60793250 IEC; Lamont M., 2005, ESTIMATES ANN PROTON; Origho G, 2008, NUCL INSTRUM METH B, V266, P2918, DOI 10.1016/j.nimb.2008.03.181; Risch B.G., 2012, P 61 INT WIR CABL S, V61, P543; Schonbacher H., 1979, 7904 CERN	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8724	1558-2213		J LIGHTWAVE TECHNOL	J. Lightwave Technol.	DEC 1	2015	33	23					4878	4884		10.1109/JLT.2015.2449263		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CW8CS	WOS:000365227600001		
